PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Stanton, BZ; Hodges, C; Calarco, JP; Braun, SMG; Ku, WL; Kadoch, C; Zhao, K; Crabtree, GR				Stanton, Benjamin Z.; Hodges, Courtney; Calarco, Joseph P.; Braun, Simon M. G.; Ku, Wai Lim; Kadoch, Cigall; Zhao, Keji; Crabtree, Gerald R.			Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; REMODELING COMPLEXES; NEURAL DEVELOPMENT; CANCER GENOME; BAF COMPLEXES; POLYCOMB; FAMILY; GENE; DNA; TRANSFORMATION	Trithorax-group proteins and their mammalian homologs, including those in BAF (mSWI/SNF) complexes, are known to oppose the activity of Polycomb repressive complexes (PRCs)(1-5). This opposition underlies the tumor-suppressive role of BAF subunits(3,5-7) and is expected to contribute to neurodevelopmental disorders(8,9). However, the mechanisms underlying opposition to Polycomb silencing are poorly understood. Here we report that recurrent disease-associated mutations in BAF subunits induce genome-wide increases in PRC deposition and activity. We show that point mutations in SMARCA4 (also known as BRG1) mapping to the ATPase domain cause loss of direct binding between BAF and PRC1 that occurs independently of chromatin. Release of this direct interaction is ATP dependent, consistent with a transient eviction mechanism. Using a new chemical-induced proximity assay, we find that BAF directly evicts Polycomb factors within minutes of its occupancy, thereby establishing a new mechanism for the widespread BAF-PRC opposition underlying development and disease.	[Stanton, Benjamin Z.; Hodges, Courtney; Calarco, Joseph P.; Braun, Simon M. G.; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Stanton, Benjamin Z.; Hodges, Courtney; Calarco, Joseph P.; Braun, Simon M. G.; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Stanton, Benjamin Z.; Ku, Wai Lim; Zhao, Keji] NHLBI, Syst Biol Ctr, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA; [Kadoch, Cigall] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kadoch, Cigall] Harvard Med Sch, Boston, MA USA; [Kadoch, Cigall] Broad Inst MIT & Harvard, Cambridge, MA USA; [Crabtree, Gerald R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute	Crabtree, GR (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Crabtree, GR (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.; Zhao, K (corresponding author), NHLBI, Syst Biol Ctr, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA.; Crabtree, GR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	zhaok@hlbi.nih.gov; crabtree@stanford.edu		Hodges, H. Courtney/0000-0003-4441-497X; Crabtree, Robert/0000-0002-6639-8707; Braun, Simon/0000-0003-2622-9914; Stanton, Benjamin/0000-0002-2613-2955	NIH S10 Shared Instrumentation Grant [1S10RR02664701]; SFARI Foundation; NIH grants [R37NS046789, R01CA163915]; Division of Intramural Research, NHLBI/NIH; Swiss National Science Foundation (SNSF) postdoctoral fellowship; NCI career transition award [K99CA187565]; NATIONAL CANCER INSTITUTE [R01CA163915, K99CA187565, T32CA009302, DP2CA195762] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS046789] Funding Source: NIH RePORTER	NIH S10 Shared Instrumentation Grant; SFARI Foundation; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swiss National Science Foundation (SNSF) postdoctoral fellowship; NCI career transition award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This paper is dedicated to the memory of Joseph P. Calarco, a great friend and passionate scientist. We apologize to our colleagues whose work we could not cite owing to space constraints. We thank G. Hu, W Jin, E. Chory, J. Bradner, and D. Hargreaves for helpful discussions and E. Miller for sharing curated GEO data sets. Aridla conditional deletion cells were a gift from D. Hargreaves (Salk Institute). All libraries were sequenced by the DNA Sequencing and Genomics Core facility of NHLBI. Analysis was performed using the Stanford BioX3 cluster, supported by NIH S10 Shared Instrumentation Grant 1S10RR02664701. This work was also supported by the SFARI Foundation (G.R.C.), NIH grants R37NS046789 (G.R.C.) and R01CA163915 (G.R.C.), and the Division of Intramural Research, NHLBI/NIH (K.Z.). G.R.C. is an HHMI Investigator. S.M.G.B. is supported by a Swiss National Science Foundation (SNSF) postdoctoral fellowship. C.H. is supported by NCI career transition award K99CA187565.	AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Deciphering Developmental Disorders Study, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Hu DQ, 2013, NAT STRUCT MOL BIOL, V20, P1093, DOI 10.1038/nsmb.2653; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kadoch C., 2016, NAT GENET; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; McKenna ES, 2008, MOL CELL BIOL, V28, P6223, DOI 10.1128/MCB.00658-08; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Rodriguez-Nieto S, 2011, HUM MUTAT, V32, pE1999, DOI 10.1002/humu.21415; Santen GWE, 2013, HUM MUTAT, V34, P1519, DOI 10.1002/humu.22394; Schoenfelder S, 2015, NAT GENET, V47, P1179, DOI 10.1038/ng.3393; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Smith CL, 2005, MOL CELL BIOL, V25, P5880, DOI 10.1128/MCB.25.14.5880-5892.2005; Son EY, 2014, AM J MED GENET C, V166, P333, DOI 10.1002/ajmg.c.31416; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Taylor MD, 2000, AM J HUM GENET, V66, P1403, DOI 10.1086/302833; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wollmann P, 2011, NATURE, V475, P403, DOI 10.1038/nature10215; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021	50	119	120	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					282	288		10.1038/ng.3735	http://dx.doi.org/10.1038/ng.3735			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27941795	Green Accepted			2022-12-25	WOS:000393148600018
J	Han, MKL; de Rooij, J				Han, Mitchell K. L.; de Rooij, Johan			Resolving the cadherin-F-actin connection	NATURE CELL BIOLOGY			English	Editorial Material							VINCULIN PHOSPHORYLATION; ADHERENS JUNCTIONS; ALPHA-CATENIN; MECHANOTRANSDUCTION; ADHESIONS; VASP; CELL	Cadherin adhesion complexes have recently emerged as sensors of tissue tension that regulate key developmental processes. Super-resolution microscopy experiments now unravel the spatial organization of the interface between cadherins and the actin cytoskeleton and reveal how vinculin, a central component in cadherin mechanotransduction, is regulated by mechanical and biochemical signals.	[Han, Mitchell K. L.; de Rooij, Johan] Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	de Rooij, J (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, NL-3584 CG Utrecht, Netherlands.	j.derooij-4@umcutrecht.nl	de rooij, johan/C-1325-2019	Han, Mitchell/0000-0002-9243-1136				Atherton P, 2016, EXP CELL RES, V343, P21, DOI 10.1016/j.yexcr.2015.11.017; Auernheimer V, 2015, J CELL SCI, V128, P3435, DOI 10.1242/jcs.172031; Bays JL, 2014, J CELL BIOL, V205, P251, DOI 10.1083/jcb.201309092; Bertocchi C, 2017, NAT CELL BIOL, V19, P28, DOI 10.1038/ncb3456; Han MKL, 2016, TRENDS CELL BIOL, V26, P612, DOI 10.1016/j.tcb.2016.03.005; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kris AS, 2008, BIOCHEM BIOPH RES CO, V375, P134, DOI 10.1016/j.bbrc.2008.07.132; Ladoux B, 2015, INTEGR BIOL-UK, V7, P1109, DOI 10.1039/c5ib00070j; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Leerberg J. M., 2014, CURR BIOL, V24, P1689; Munjal A, 2014, DEVELOPMENT, V141, P1789, DOI 10.1242/dev.091645; Oldenburg J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17225; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Twiss F, 2013, CELL MOL LIFE SCI, V70, P4101, DOI 10.1007/s00018-013-1329-x; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	16	10	10	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2017	19	1					14	16		10.1038/ncb3457	http://dx.doi.org/10.1038/ncb3457			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EG9AI	28008179				2022-12-25	WOS:000391349000004
J	Guryanova, OA; Shank, K; Spitzer, B; Luciani, L; Koche, RP; Garrett-Bakelman, FE; Ganzel, C; Durham, BH; Mohanty, A; Hoermann, G; Rivera, SA; Chramiec, AG; Pronier, E; Bastian, L; Keller, MD; Tovbin, D; Loizou, E; Weinstein, AR; Gonzalez, AR; Lieu, YK; Rowe, JM; Pastore, F; McKenney, AS; Krivtsov, AV; Sperr, WR; Cross, JR; Mason, CE; Tallman, MS; Arcila, ME; Abdel-Wahab, O; Armstrong, SA; Kubicek, S; Staber, PB; Gonen, M; Paietta, EM; Melnick, AM; Nimer, SD; Mukherjee, S; Levine, RL				Guryanova, Olga A.; Shank, Kaitlyn; Spitzer, Barbara; Luciani, Luisa; Koche, Richard P.; Garrett-Bakelman, Francine E.; Ganzel, Chezi; Durham, Benjamin H.; Mohanty, Abhinita; Hoermann, Gregor; Rivera, Sharon A.; Chramiec, Alan G.; Pronier, Elodie; Bastian, Lennart; Keller, Matthew D.; Tovbin, Daniel; Loizou, Evangelia; Weinstein, Abby R.; Gonzalez, Adriana Rodriguez; Lieu, Yen K.; Rowe, Jacob M.; Pastore, Friederike; McKenney, Anna Sophia; Krivtsov, Andrei V.; Sperr, Wolfgang R.; Cross, Justin R.; Mason, Christopher E.; Tallman, Martin S.; Arcila, Maria E.; Abdel-Wahab, Omar; Armstrong, Scott A.; Kubicek, Stefan; Staber, Philipp B.; Goenen, Mithat; Paietta, Elisabeth M.; Melnick, Ari M.; Nimer, Stephen D.; Mukherjee, Siddhartha; Levine, Ross L.			DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling	NATURE MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; DNA METHYLTRANSFERASE DNMT3A; HEMATOPOIETIC STEM-CELLS; CLONAL HEMATOPOIESIS; SOMATIC MUTATIONS; TET2; IMPACT; LEADS; IDENTIFICATION; INACTIVATION	Although the majority of patients with acute myeloid leukemia (AML) initially respond to chemotherapy, many of them subsequently relapse, and the mechanistic basis for AML persistence following chemotherapy has not been determined. Recurrent somatic mutations in DNA methyltransferase 3A (DNMT3A), most frequently at arginine 882 (DNMT3A(R882)), have been observed in AML(1-3) and in individuals with clonal hematopoiesis in the absence of leukemic transformation(4,5). Patients with DNMT3A(R882) AML have an inferior outcome when treated with standard-dose daunorubicin-based induction chemotherapy(6,7), suggesting that DNMT3A(R882) cells persist and drive relapse(8). We found that Dnmt3a mutations induced hematopoietic stem cell expansion, cooperated with mutations in the FMS-like tyrosine kinase 3 gene (Flt3(ITD)) and the nucleophosmin gene (Npm1(c)) to induce AML in vivo, and promoted resistance to anthracycline chemotherapy. In patients with AML, the presence of DNMT3A(R882) mutations predicts minimal residual disease, underscoring their role in AML chemoresistance. DNMT3A(R882) cells showed impaired nucleosome eviction and chromatin remodeling in response to anthracycline treatment, which resulted from attenuated recruitment of histone chaperone SPT-16 following anthracycline exposure. This defect led to an inability to sense and repair DNA torsional stress, which resulted in increased mutagenesis. Our findings identify a crucial role for DNMT3A(R882) mutations in driving AML chemoresistance and highlight the importance of chromatin remodeling in response to cytotoxic chemotherapy.	[Guryanova, Olga A.; Shank, Kaitlyn; Durham, Benjamin H.; Pronier, Elodie; Bastian, Lennart; Keller, Matthew D.; Tovbin, Daniel; Weinstein, Abby R.; Gonzalez, Adriana Rodriguez; Pastore, Friederike; McKenney, Anna Sophia; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Spitzer, Barbara; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Luciani, Luisa; Nimer, Stephen D.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Koche, Richard P.; Chramiec, Alan G.; Krivtsov, Andrei V.; Armstrong, Scott A.; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA; [Koche, Richard P.; Loizou, Evangelia; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Garrett-Bakelman, Francine E.; Melnick, Ari M.] Weill Cornell Med, Dept Med, Div Hematol & Oncol, New York, NY USA; [Ganzel, Chezi; Rowe, Jacob M.] Shaare Zedek Med Ctr, Dept Hematol, Jerusalem, Israel; [Mohanty, Abhinita; Arcila, Maria E.] Mem Sloan Kettering Canc Ctr, Diagnost Mol Pathol Lab, 1275 York Ave, New York, NY 10021 USA; [Hoermann, Gregor] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Rivera, Sharon A.; Lieu, Yen K.; Mukherjee, Siddhartha] Columbia Univ, Irving Canc Res Ctr, New York, NY 10027 USA; [Sperr, Wolfgang R.; Staber, Philipp B.] Med Univ Vienna, Comprehens Canc Ctr Vienna, Div Hematol & Hemostaseol, Vienna, Austria; [Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, 1275 York Ave, New York, NY 10021 USA; [Mason, Christopher E.] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Mason, Christopher E.] Cornell Univ, Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Tallman, Martin S.; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA; [Kubicek, Stefan] Austrian Acad Sci, CeMM Res Ctr Mol Med, Christian Doppler Lab Chem Genet & Antiinfect, Vienna, Austria; [Goenen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Paietta, Elisabeth M.] Montefiore Med Ctr, Dept Oncol, 111 E 210Th St, Bronx, NY 10467 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Miami; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Memorial Sloan Kettering Cancer Center; Medical University of Vienna; Columbia University; Medical University of Vienna; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Memorial Sloan Kettering Cancer Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA.; Mukherjee, S (corresponding author), Columbia Univ, Irving Canc Res Ctr, New York, NY 10027 USA.; Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA.; Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA.	sm3252@columbia.edu; leviner@mskcc.org	levine, ross/AAE-7658-2019; Gonen, Mithat/E-4826-2012; Sperr, Mast/V-4767-2019; Kubicek, Stefan/C-2089-2017; Staber, Philipp Bernhard/ADK-1536-2022; Melnick, Ari/AAA-5763-2020; Mason, Christopher/HCH-3977-2022; Arcila, Maria/ABE-2235-2021; Mohanty, Abhinita S/AAM-7687-2020; Krivtsov, Andrei/AAJ-9966-2021; Hoermann, Gregor/B-8832-2016	Gonen, Mithat/0000-0001-8683-8477; Sperr, Mast/0000-0002-7778-5219; Kubicek, Stefan/0000-0003-0855-8343; Staber, Philipp Bernhard/0000-0001-6729-7708; Sperr, Wolfgang/0000-0003-3288-8027; Krivtsov, Andrei/0000-0002-5511-1686; Hoermann, Gregor/0000-0002-7374-4380; Spitzer, Barbara/0000-0003-1603-1381; Koche, Richard/0000-0002-6820-5083; Mohanty, Abhinita/0000-0002-6876-0482; Durham, Benjamin/0000-0001-8090-5448; McKenney, Anna Sophia/0000-0003-4464-6869; Guryanova, Olga/0000-0002-6514-8466	Austrian Science Fund FWF [P 27132] Funding Source: Medline; NCI NIH HHS [U10 CA180791, U10 CA180827, K08 CA169055, UG1 CA189859, R00 CA178191, P30 CA008748, R01 CA169784, U10 CA180820, F30 CA183497, U10 CA180794, K99 CA178191, U24 CA196172, K12 CA184746] Funding Source: Medline; NIGMS NIH HHS [T32 GM007739] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA180791, P30CA008748, UG1CA189859, K08CA169055, F30CA183497, R00CA178191, K99CA178191, U10CA180827, U24CA196172, U10CA180794, U10CA180820, R01CA169784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1545896] Funding Source: National Science Foundation	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Chen XY, 2015, J CLIN ONCOL, V33, P1258, DOI 10.1200/JCO.2014.58.3518; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Dinant C, 2013, MOL CELL, V51, P469, DOI 10.1016/j.molcel.2013.08.007; Gaidzik VI, 2013, BLOOD, V121, P4769, DOI 10.1182/blood-2012-10-461624; GANZEL C, 2014, BLOOD, V124, P1016, DOI DOI 10.1182/BLOOD.V124.21.1016.1016; Garrett-Bakelman FE, 2015, JOVE-J VIS EXP, DOI 10.3791/52246; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; HAVRE PA, 1995, CANCER RES, V55, P4420; Holz-Schietinger C, 2012, J BIOL CHEM, V287, P30941, DOI 10.1074/jbc.M112.366625; Ivey A, 2016, NEW ENGL J MED, V374, P422, DOI [10.1056/NEJMoa1507471, 10.1056/NEJMc1603847]; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Ostronoff F, 2013, LEUKEMIA, V27, P238, DOI 10.1038/leu.2012.168; Othus M, 2016, LEUKEMIA, V30, P2080, DOI 10.1038/leu.2016.120; Paietta E, 2015, BEST PRACT RES CL HA, V28, P98, DOI 10.1016/j.beha.2015.10.006; Paietta E, 2012, HEMATOL-AM SOC HEMAT, P35, DOI 10.1182/asheducation-2012.1.35; Pang BX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2921; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Sehgal AR, 2015, CLIN CANCER RES, V21, P1614, DOI 10.1158/1078-0432.CCR-14-0327; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Tie RX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093353; Walter RB, 2015, LEUKEMIA, V29, P137, DOI 10.1038/leu.2014.173; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; WESTFALL PH, 1989, J AM STAT ASSOC, V84, P780, DOI 10.2307/2289666; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yang F, 2014, BBA-REV CANCER, V1845, P84, DOI 10.1016/j.bbcan.2013.12.002; Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895	52	154	156	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1488	+		10.1038/nm.4210	http://dx.doi.org/10.1038/nm.4210			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27841873	Green Accepted			2022-12-25	WOS:000389549000028
J	Lieberman, TD; Wilson, D; Misra, R; Xiong, LL; Moodley, P; Cohen, T; Kishony, R				Lieberman, Tami D.; Wilson, Douglas; Misra, Reshma; Xiong, Lealia L.; Moodley, Prashini; Cohen, Ted; Kishony, Roy			Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis	NATURE MEDICINE			English	Article							DRUG-RESISTANT TUBERCULOSIS; TRANSMISSION; MICROEVOLUTION; HETEROGENEITY; EVOLUTION; PATHOGEN; STRAINS; PATIENT; SPUTUM; CULTIVATION	Mycobacterium tuberculosis remains a leading cause of death worldwide, especially among individuals infected with HIV1. Whereas phylogenetic analysis has revealed M. tuberculosis spread throughout history(2-5) and in local outbreaks(6-8), much less is understood about its dissemination within the body. Here we report genomic analysis of 2,693 samples collected post mortem from lung and extrapulmonary biopsies of 44 subjects in KwaZulu-Natal, South Africa, who received minimal antitubercular treatment and most of whom were HIV seropositive. We found that purifying selection occurred within individual patients, without the need for patient-to-patient transmission. Despite negative selection, mycobacteria diversified within individuals to form sublineages that co-existed for years. These sublineages, as well as distinct strains from mixed infections, were differentially distributed throughout the lung, suggesting temporary barriers to pathogen migration. As a consequence, samples taken from the upper airway often captured only a fraction of the population diversity, challenging current methods of outbreak tracing and resistance diagnostics. Phylogenetic analysis indicated that dissemination from the lungs to extrapulmonary sites was as frequent as between lung sites, supporting the idea of similar migration routes within and between organs, at least in subjects with HIV. Genomic diversity therefore provides a record of pathogen diversification and repeated dissemination across the body.	[Lieberman, Tami D.; Xiong, Lealia L.; Kishony, Roy] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Lieberman, Tami D.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wilson, Douglas] Univ KwaZulu Natal, Edendale Hosp, Dept Internal Med, Pietermaritzburg, South Africa; [Misra, Reshma; Moodley, Prashini] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Infect Prevent & Control, Durban, South Africa; [Cohen, Ted] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Cohen, Ted] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Cohen, Ted] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kishony, Roy] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Kishony, Roy] Technion Israel Inst Technol, Fac Comp Sci, Haifa, Israel	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); University of Kwazulu Natal; University of Kwazulu Natal; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Kishony, R (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Cohen, T (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Cohen, T (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Cohen, T (corresponding author), Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Kishony, R (corresponding author), Technion Israel Inst Technol, Fac Biol, Haifa, Israel.; Kishony, R (corresponding author), Technion Israel Inst Technol, Fac Comp Sci, Haifa, Israel.	theodore.cohen@yale.edu; rkishony@technion.ac.il		/0000-0001-5430-3937; Cohen, Ted/0000-0002-8091-7198; Xiong, Lealia/0000-0001-7636-5936	NIGMS NIH HHS [R01 GM081617, U54 GM088558] Funding Source: Medline; NIH HHS [DP2 OD006663] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617, U54GM088558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006663] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036; Black PA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2067-2; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Cleary B, 2015, NAT BIOTECHNOL, V33, P1053, DOI 10.1038/nbt.3329; Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; COHN ML, 1968, AM REV RESPIR DIS, V98, P295; Colijn C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018327; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Didelot X, 2014, MOL BIOL EVOL, V31, P1869, DOI 10.1093/molbev/msu121; Eldholm V, 2016, ELIFE, V5, DOI 10.7554/eLife.16644; Eldholm V, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0490-3; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Garcia de Viedma D, 2003, J INFECT DIS, V187, P695, DOI 10.1086/368368; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Hatherell HA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0566-x; Jiao W, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-35; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Kay GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7717; Krishnan N, 2010, TUBERCULOSIS, V90, P361, DOI 10.1016/j.tube.2010.08.005; Lee RS, 2015, P NATL ACAD SCI USA, V112, P13609, DOI 10.1073/pnas.1507071112; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Liu QY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17507; MANKIEWICZ E, 1975, AM REV RESPIR DIS, V111, P307; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; MIDDLEBROOK G, 1947, J EXP MED, V86, P175, DOI 10.1084/jem.86.2.175; Paterson GK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7560; Pepperell CS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003543; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Prideaux B, 2015, NAT MED, V21, P1223, DOI 10.1038/nm.3937; Somerville W, 2005, J CLIN MICROBIOL, V43, P2996, DOI 10.1128/JCM.43.6.2996-2997.2005; Ssengooba W, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1737-2; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Turajlic S, 2016, SCIENCE, V352, P169, DOI 10.1126/science.aaf2784; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Worby CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003549; World Health Organization, 2015, 20151204 WHO; Zetola NM, 2014, J INFECT DIS, V209, P1754, DOI 10.1093/infdis/jiu040	51	77	77	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1470	+		10.1038/nm.4205	http://dx.doi.org/10.1038/nm.4205			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27798613	Green Accepted			2022-12-25	WOS:000389549000025
J	Lilla, EA; Yokoyama, K				Lilla, Edward A.; Yokoyama, Kenichi			Carbon extension in peptidylnucleoside biosynthesis by radical SAM enzymes	NATURE CHEMICAL BIOLOGY			English	Article							NIKKOMYCIN BIOSYNTHESIS; FUNCTIONAL-CHARACTERIZATION; NUCLEOSIDE ANTIBIOTICS; DISCOVERY; PROTEINS; ACIDS; IRON	Nikkomycins and polyoxins are antifungal peptidylnucleoside antibiotics active against human and plant pathogens. Here we report that during peptidylnucleoside biosynthesis in Streptomyces cacaoi and S. tendae, the C5' extension of the nucleoside essential for downstream structural diversification is catalyzed by a conserved radical S-adenosyl-L-methionine (SAM) enzyme, PolH or NikJ. This is distinct from the nucleophilic mechanism reported for antibacterial nucleosides and represents a new mechanism of nucleoside natural product biosynthesis.	[Lilla, Edward A.; Yokoyama, Kenichi] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Yokoyama, Kenichi] Duke Univ, Dept Chem, Durham, NC 27706 USA	Duke University; Duke University	Yokoyama, K (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.; Yokoyama, K (corresponding author), Duke Univ, Dept Chem, Durham, NC 27706 USA.	ken.yoko@duke.edu		Yokoyama, Kenichi/0000-0001-5625-469X	Duke University Medical Center; National Institute of General Medical Sciences [R01 GM115729]; North Carolina Biotechnology Center [2014-IDG-1017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115729] Funding Source: NIH RePORTER	Duke University Medical Center; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); North Carolina Biotechnology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G.R. Dubay for assistance with the MS measurements. We thank A.A. Ribeiro at the Duke NMR center for the assistance in collecting NMR data. This work was supported by the Duke University Medical Center and National Institute of General Medical Sciences R01 GM115729 (to K.Y.). EPR spectrometer was supported by an Institutional Development Grant (ID 2014-IDG-1017) from the North Carolina Biotechnology Center.	Barnard-Britson S, 2012, J AM CHEM SOC, V134, P18514, DOI 10.1021/ja308185q; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Chen WQ, 2016, J IND MICROBIOL BIOT, V43, P401, DOI 10.1007/s10295-015-1636-3; Chen WQ, 2009, J BIOL CHEM, V284, P10627, DOI 10.1074/jbc.M807534200; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Frey PA, 2014, ACCOUNTS CHEM RES, V47, P540, DOI 10.1021/ar400194k; Ginj C, 2005, CHEMBIOCHEM, V6, P1974, DOI 10.1002/cbic.200500208; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hover BM, 2013, J AM CHEM SOC, V135, P7019, DOI 10.1021/ja401781t; ISONO K, 1978, J AM CHEM SOC, V100, P3937, DOI 10.1021/ja00480a052; ISONO K, 1975, J AM CHEM SOC, V97, P943, DOI 10.1021/ja00837a070; ISONO K, 1988, J ANTIBIOT, V41, P1711, DOI 10.7164/antibiotics.41.1711; Kudo F, 2014, J AM CHEM SOC, V136, P13909, DOI 10.1021/ja507759f; Mahanta N, 2013, J AM CHEM SOC, V135, P15318, DOI 10.1021/ja408594p; Munro CA, 2013, ADV APPL MICROBIOL, V83, P145, DOI 10.1016/B978-0-12-407678-5.00004-0; Oberdorfer G, 2012, J BIOL CHEM, V287, P31427, DOI 10.1074/jbc.M112.352096; Palmer G., 1967, METHOD ENZYMOL, V10, P594; Reuveni M, 2000, CROP PROT, V19, P393, DOI 10.1016/S0261-2194(00)00030-2; SCHUZ TC, 1992, J ANTIBIOT, V45, P199, DOI 10.7164/antibiotics.45.199; Shubitz LF, 2014, J INFECT DIS, V209, P1949, DOI 10.1093/infdis/jiu029; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Wyszynski FJ, 2012, NAT CHEM, V4, P539, DOI [10.1038/NCHEM.1351, 10.1038/nchem.1351]; Yang ZY, 2011, J BIOL CHEM, V286, P7885, DOI 10.1074/jbc.M110.203562; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138	27	34	34	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					905	+		10.1038/NCHEMBIO.2187	http://dx.doi.org/10.1038/NCHEMBIO.2187			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27642865	Green Accepted			2022-12-25	WOS:000386798800009
J	Stanzione, M; Baumann, M; Papanikos, F; Dereli, I; Lange, J; Ramlal, A; Trankner, D; Shibuya, H; de Massy, B; Watanabe, Y; Jasin, M; Keeney, S; Toth, A				Stanzione, Marcello; Baumann, Marek; Papanikos, Frantzeskos; Dereli, Ihsan; Lange, Julian; Ramlal, Angelique; Traenkner, Daniel; Shibuya, Hiroki; de Massy, Bernard; Watanabe, Yoshinori; Jasin, Maria; Keeney, Scott; Toth, Attila			Meiotic DNA break formation requires the unsynapsed chromosome axis-binding protein IHO1 (CCDC36) in mice	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; MAMMALIAN MEIOSIS; PROPHASE ARREST; MOUSE HORMAD1; RECOMBINATION; SPO11; SYNAPSIS; INACTIVATION	DNA double-strand breaks (DSBs) are induced by SPO11 during meiosis to initiate recombination-mediated pairing and synapsis of homologous chromosomes. Germline genome integrity requires spatiotemporal control of DSB formation, which involves the proteinaceous chromosome axis along the core of each meiotic chromosome. In particular, a component of unsynapsed axes, HORMAD1, promotes DSB formation in unsynapsed regions where DSB formation must occur to ensure completion of synapsis. Despite its importance, the underlying mechanism has remained elusive. We identify CCDC36 as a direct interactor of HORMAD1 (IHO1) that is essential for DSB formation. Underpinning this function, IHO1 and conserved SPO11-auxiliary proteins MEI4 and REC114 assemble chromatin-bound recombinosomes that are predicted activators of DSB formation. HORMAD1 is needed for robust recruitment of IHO1 to unsynapsed axes and efficient formation and/or stabilization of these recombinosomes. Thus, we propose that HORMAD1-IHO1 interaction provides a mechanism for the selective promotion of DSB formation along unsynapsed chromosome axes.	[Stanzione, Marcello; Baumann, Marek; Papanikos, Frantzeskos; Dereli, Ihsan; Ramlal, Angelique; Traenkner, Daniel; Toth, Attila] Tech Univ Dresden, Fac Med, Inst Physiol Chem, Fetscherstr 74, D-01307 Dresden, Germany; [Lange, Julian; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Shibuya, Hiroki; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Yayoi 1-1-1, Tokyo 1130032, Japan; [de Massy, Bernard] Univ Montpellier, CNRS, UPR 1142, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier, France; [Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Baumann, Marek] GlaxoSmithKline Biol NL SmithKline Beecham Pharma, Zirkusstr 40, D-01069 Dresden, Germany; [Ramlal, Angelique] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands; [Shibuya, Hiroki] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden	Technische Universitat Dresden; Memorial Sloan Kettering Cancer Center; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; GlaxoSmithKline; Radboud University Nijmegen; University of Gothenburg	Toth, A (corresponding author), Tech Univ Dresden, Fac Med, Inst Physiol Chem, Fetscherstr 74, D-01307 Dresden, Germany.	attila.toth@mailbox.tu-dresden.de	Keeney, Scott/GVR-8515-2022; Toth, Attila/C-9624-2013	Toth, Attila/0000-0001-5744-3847; Stanzione, Marcello/0000-0001-5842-8649; Watanabe, Yoshinori/0000-0002-5488-4812; Shibuya, Hiroki/0000-0002-3400-0741	DIGS-BB programme; Deutsche Forschungsgemeinschaft (DFG) [TO421/3-2, SPP1384: TO421/4-2, TO421/51, TO421/6-1, TO421/8-1, TO421/8-2]; JSPS; European Research Council Executive Agency under the European Community's Seventh Framework Programme (FP7) [322788]; NIH [R01 GM105421]; American Cancer Society [PF-12-157-01-DMC]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118175, R35GM118092, R01GM105421] Funding Source: NIH RePORTER	DIGS-BB programme; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Research Council Executive Agency under the European Community's Seventh Framework Programme (FP7); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Jessberger (Institute of Physiological Chemistry, Faculty of Medicine at the TU Dresden, Germany) for sharing ideas, antibodies (anti-SYCP3 and anti-STAG3) and departmental support; M. Stevense for discussion, and revising and proofreading the manuscript; G. Vader (Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany) for sharing budding yeast protocols, E. Marcon (Donnelly Centre, University of Toronto, Canada) for the anti-RPA antibody; F. Schwarz (Genomics and Proteomics Core Facilities, German Cancer Research Center-DKFZ, Germany) and the protein interaction unit of Genomics and Proteomics Core Facility at the German Cancer Research Center-DKFZ for yeast two-hybrid vectors and for performing yeast two-hybrid screens; M. P. Thelen (Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, USA) for the anti-SPO11 antibody, M. A. Handel (The Jackson Laboratory, USA) for histone H1T antibody; D. Drechsel (Max Planck Institute of Molecular Cell Biology and Genetics, Germany) and the EMBL protein expression and purification facility for protein expression vectors; K. Daniel (Biotechnology Center TU Dresden-BIOTEC, Germany) for testis and somatic tissue cDNAs. We thank the DIGS-BB programme for supporting M.S. The Deutsche Forschungsgemeinschaft (DFG; grants: TO421/3-2, SPP1384: TO421/4-2, TO421/51, TO421/6-1, TO421/8-1 and 8-2) supported M.S., M.B., F.P., I.D., A.R., D.T. and A.T.; The JSPS Research Fellowship supported H.S., Y.W.; B.d.M. was funded by grants from the Centre National pour la Recherche Scientifique (CNRS) and the European Research Council Executive Agency under the European Community's Seventh Framework Programme (FP7/2007-2013 Grant Agreement no. [322788]); the NIH (R01 GM105421) supported J.L., M.J. and S.K.; J.L. was supported in part by American Cancer Society fellowship PF-12-157-01-DMC. S.K. is an Investigator of the Howard Hughes Medical Institute.	Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Bellani MA, 2005, J CELL SCI, V118, P3233, DOI 10.1242/jcs.02466; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Cloutier JM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005462; Daniel K, 2011, NAT CELL BIOL, V13, P599, DOI 10.1038/ncb2213; Fukuda T, 2010, EXP CELL RES, V316, P158, DOI 10.1016/j.yexcr.2009.08.007; Gietz RD, 1997, MOL CELL BIOCHEM, V172, P67, DOI 10.1023/A:1006859319926; Halow E., 1999, USING ANTIBODIES LAB; HUNTER N, 2007, MEIOTIC RECOMBINATIO; Inselman A, 2003, CYTOGENET GENOME RES, V103, P277, DOI 10.1159/000076813; Kaiser C., 1994, METHODS YEAST GENETI; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Keeney S, 2014, ANNU REV GENET, V48, P187, DOI 10.1146/annurev-genet-120213-092304; Koegl Manfred, 2007, Briefings in Functional Genomics & Proteomics, V6, P302, DOI 10.1093/bfgp/elm035; Kogo H, 2012, GENES CELLS, V17, P897, DOI 10.1111/gtc.12005; Kogo H, 2012, GENES CELLS, V17, P439, DOI 10.1111/j.1365-2443.2012.01600.x; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Kumar R, 2015, J CELL SCI, V128, P1800, DOI 10.1242/jcs.165464; Kumar R, 2010, GENE DEV, V24, P1266, DOI 10.1101/gad.571710; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lam I, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016634; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Latypov V, 2010, MOL CELL BIOL, V30, P1570, DOI 10.1128/MCB.00919-09; Li J, 2006, GENETICS, V173, P1969, DOI 10.1534/genetics.106.058768; Libby BJ, 2003, P NATL ACAD SCI USA, V100, P15706, DOI 10.1073/pnas.2432067100; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Lorenz A, 2006, CHROMOSOMA, V115, P330, DOI 10.1007/s00412-006-0053-9; Mahadevaiah SK, 2008, J CELL BIOL, V182, P263, DOI 10.1083/jcb.200710195; Maleki S, 2007, CHROMOSOMA, V116, P471, DOI 10.1007/s00412-007-0111-y; Miyoshi T, 2012, MOL CELL, V47, P722, DOI 10.1016/j.molcel.2012.06.023; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Pacheco S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005017; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; Rosenberg SC, 2015, J CELL BIOL, V211, P745, DOI 10.1083/jcb.201509076; Royo H, 2013, GENE DEV, V27, P1484, DOI 10.1101/gad.219477.113; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Sasanuma H, 2007, NUCLEIC ACIDS RES, V35, P1119, DOI 10.1093/nar/gkl1162; Shibuya H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004821; Shin YH, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106773; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; Shoji M, 2005, DEV BIOL, V282, P524, DOI 10.1016/j.ydbio.2005.03.030; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Wojtasz L, 2012, GENE DEV, V26, P958, DOI 10.1101/gad.187559.112; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Wojtasz L, 2009, CYTOM PART A, V75A, P547, DOI 10.1002/cyto.a.20729; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	64	84	88	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1208	+		10.1038/ncb3417	http://dx.doi.org/10.1038/ncb3417			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27723721	Green Accepted			2022-12-25	WOS:000387165600014
J	Holbrook-Smith, D; Toh, S; Tsuchiya, Y; McCourt, P				Holbrook-Smith, Duncan; Toh, Shigeo; Tsuchiya, Yuichiro; McCourt, Peter			Small-molecule antagonists of germination of the parasitic plant Striga hermonthica	NATURE CHEMICAL BIOLOGY			English	Article							STRIGOLACTONE RECEPTORS; ARABIDOPSIS-THALIANA; INHIBITION; GIBBERELLIN; STIMULANTS; OROBANCHE; RESPONSES; HORMONES; DWARF14	Striga spp. (witchweed) is an obligate parasitic plant that attaches to host roots to deplete them of nutrients. In Sub-Saharan Africa, the most destructive Striga species, Striga hermonthica, parasitizes major food crops affecting two-thirds of the arable land and over 100 million people. One potential weakness in the Striga infection process is the way it senses the presence of a host crop. Striga only germinates in the presence of the plant hormone strigolactone, which exudes from a host root. Hence small molecules that perturb strigolactone signaling may be useful tools for disrupting the Striga lifecycle. Here we developed a chemical screen to suppress strigolactone signaling in the model plant Arabidopsis. One compound, soporidine, specifically inhibited a S. hermonthica strigolactone receptor and inhibited the parasite's germination. This indicates that strigolactone-based screens using Arabidopsis are useful in identifying lead compounds to combat Striga infestations.	[Holbrook-Smith, Duncan; Toh, Shigeo; McCourt, Peter] Univ Toronto, Cell & Syst Biol, Toronto, ON, Canada; [Holbrook-Smith, Duncan; Toh, Shigeo; McCourt, Peter] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada; [Tsuchiya, Yuichiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi, Japan	University of Toronto; University of Toronto; Nagoya University	McCourt, P (corresponding author), Univ Toronto, Cell & Syst Biol, Toronto, ON, Canada.; McCourt, P (corresponding author), Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada.	peter.mccourt@utoronto.ca	Toh, Shigeo/E-4438-2014; Tsuchiya, Yuichiro/D-9777-2015; Toh, Shigeo/ABB-9441-2021	Toh, Shigeo/0000-0002-6077-4556; Tsuchiya, Yuichiro/0000-0002-4599-1069; Holbrook-Smith, Duncan/0000-0003-0787-3165	National Science & Engineering Research Council of Canada (NSERC) [300001]; NSERC	National Science & Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors wish to acknowledge support from National Science & Engineering Research Council of Canada (NSERC 300001) to P.M. D.H.-S. was partially supported on an NSERC Postgraduate Scholarship-Doctoral (PGS D).	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Berner DK, 1997, WEED TECHNOL, V11, P704, DOI 10.1017/S0890037X00043293; Conn CE, 2015, SCIENCE, V349, P540, DOI 10.1126/science.aab1140; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Huang K, 2012, HEREDITY, V108, P96, DOI 10.1038/hdy.2011.52; JOHNSON AW, 1976, WEED RES, V16, P223, DOI 10.1111/j.1365-3180.1976.tb00406.x; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Lomenick Brett, 2011, Curr Protoc Chem Biol, V3, P163; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Samejima H., 2016, PEST MANAG SCI; Scaffidi A, 2014, PLANT PHYSIOL, V165, P1221, DOI 10.1104/pp.114.240036; Teka H. B., 2014, African Journal of Plant Science, V8, P492; Toh S, 2015, SCIENCE, V350, P203, DOI 10.1126/science.aac9476; Toh S, 2014, CHEM BIOL, V21, P988, DOI 10.1016/j.chembiol.2014.07.005; Toh S, 2012, PLANT CELL PHYSIOL, V53, P107, DOI 10.1093/pcp/pcr176; Tsuchiya Y, 2015, SCIENCE, V349, P864, DOI 10.1126/science.aab3831; Tsuchiya Y, 2010, NAT CHEM BIOL, V6, P741, DOI [10.1038/NCHEMBIO.435, 10.1038/nchembio.435]; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Umehara M, 2015, PLANT CELL PHYSIOL, V56, P1059, DOI 10.1093/pcp/pcv028; Wallace IM, 2011, CHEM BIOL, V18, P1273, DOI 10.1016/j.chembiol.2011.07.018; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Zhao LH, 2015, CELL RES, V25, P1219, DOI 10.1038/cr.2015.122; Zwanenburg B., 2016, PEST MANAG SCI; Zwanenburg B, 2013, BIOORG MED CHEM LETT, V23, P5182, DOI 10.1016/j.bmcl.2013.07.004	27	41	41	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					724	+		10.1038/nchembio.2129	http://dx.doi.org/10.1038/nchembio.2129			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27428512				2022-12-25	WOS:000382255100014
J	Nolan, E; Vaillant, F; Branstetter, D; Pal, B; Giner, G; Whitehead, L; Lok, SW; Mann, GB; Rohrbach, K; Huang, LY; Soriano, R; Smyth, GK; Dougall, WC; Visvader, JE; Lindeman, GJ				Nolan, Emma; Vaillant, Francois; Branstetter, Daniel; Pal, Bhupinder; Giner, Goeknur; Whitehead, Lachlan; Lok, Sheau W.; Mann, Gregory B.; Rohrbach, Kathy; Huang, Li-Ya; Soriano, Rosalia; Smyth, Gordon K.; Dougall, William C.; Visvader, Jane E.; Lindeman, Geoffrey J.		Kathleen Cuningham Fdn Consortium	RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers	NATURE MEDICINE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MAMMARY EPITHELIAL-CELLS; BRCA2 MUTATION CARRIERS; RISK-REDUCING SURGERY; STEM-CELL; TUMOR-DEVELOPMENT; OVARIAN-CANCER; GLAND; MICE; PROLIFERATION	Individuals who have mutations in the breast-cancer-susceptibility gene BRCA1 (hereafter referred to as BRCA1-mutation carriers) frequently undergo prophylactic mastectomy to minimize their risk of breast cancer. The identification of an effective prevention therapy therefore remains a 'holy grail' for the field. Precancerous BRCA1(mut/+) tissue harbors an aberrant population of luminal progenitor cells1, and deregulated progesterone signaling has been implicated in BRCA1-associated oncogenesis(2-5). Coupled with the findings that tumor necrosis factor superfamily member 11 (TNFSF11; also known as RANKL) is a key paracrine effector of progesterone signaling(6-10) and that RANKL and its receptor TNFRSF11A (also known as RANK) contribute to mammary tumorigenesis(11-13), we investigated a role for this pathway in the pre-neoplastic phase of BRCA1-mutation carriers. We identified two subsets of luminal progenitors (RANK(+) and RANK-) in histologically normal tissue of BRCA1-mutation carriers and showed that RANK+ cells are highly proliferative, have grossly aberrant DNA repair and bear a molecular signature similar to that of basal-like breast cancer. These data suggest that RANK+ and not RANK-progenitors are a key target population in these women. Inhibition of RANKL signaling by treatment with denosumab in three-dimensional breast organoids derived from pre-neoplastic BRCA1mut/+ tissue attenuated progesterone-induced proliferation. Notably, proliferation was markedly reduced in breast biopsies from BRCA1-mutation carriers who were treated with denosumab. Furthermore, inhibition of RANKL in a Brca1-deficient mouse model substantially curtailed mammary tumorigenesis. Taken together, these findings identify a targetable pathway in a putative cell-of-origin population in BRCA1-mutation carriers and implicate RANKL blockade as a promising strategy in the prevention of breast cancer.	[Nolan, Emma; Vaillant, Francois; Pal, Bhupinder; Lok, Sheau W.; Visvader, Jane E.; Lindeman, Geoffrey J.] Walter & Eliza Hall Inst Med Res WEHI, ACRF Stem Cells & Canc Div, Parkville, Vic, Australia; [Nolan, Emma; Vaillant, Francois; Pal, Bhupinder; Giner, Goeknur; Visvader, Jane E.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Branstetter, Daniel; Rohrbach, Kathy; Huang, Li-Ya; Soriano, Rosalia] Amgen Inc, Dept Pathol, Seattle, WA USA; [Giner, Goeknur; Smyth, Gordon K.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic, Australia; [Whitehead, Lachlan] Walter & Eliza Hall Inst Med Res, Syst Biol & Personalized Med Div, Imaging Lab, Parkville, Vic, Australia; [Lok, Sheau W.; Lindeman, Geoffrey J.] Royal Melbourne Hosp, Familial Canc Ctr, Parkville, Vic, Australia; [Lok, Sheau W.; Lindeman, Geoffrey J.] Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic, Australia; [Mann, Gregory B.] Royal Melbourne Hosp, Breast Serv, Parkville, Vic, Australia; [Mann, Gregory B.] Royal Womens Hosp, Parkville, Vic, Australia; [Mann, Gregory B.] Univ Melbourne, Dept Surg, Parkville, Vic, Australia; [Kathleen Cuningham Fdn Consortium] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic, Australia; [Dougall, William C.] Amgen Inc, Therapeut Innovat Unit, Seattle, WA USA; [Lindeman, Geoffrey J.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Lindeman, Geoffrey J.] Victorian Comprehens Canc Ctr, Familial Canc Ctr, Parkville, Vic, Australia; [Branstetter, Daniel] Cynosure Clin Res LLC, North Bend, WA USA; [Dougall, William C.] Queensland Inst Med Res, Berghofer Med Res Inst, Herston, Qld, Australia	University of Melbourne; Amgen; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Royal Melbourne Hospital; Royal Melbourne Hospital; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Amgen; University of Melbourne; QIMR Berghofer Medical Research Institute	Visvader, JE; Lindeman, GJ (corresponding author), Walter & Eliza Hall Inst Med Res WEHI, ACRF Stem Cells & Canc Div, Parkville, Vic, Australia.; Visvader, JE (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.; Lindeman, GJ (corresponding author), Royal Melbourne Hosp, Familial Canc Ctr, Parkville, Vic, Australia.; Lindeman, GJ (corresponding author), Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic, Australia.; Lindeman, GJ (corresponding author), Univ Melbourne, Dept Med, Parkville, Vic, Australia.; Lindeman, GJ (corresponding author), Victorian Comprehens Canc Ctr, Familial Canc Ctr, Parkville, Vic, Australia.	visvader@wehi.edu.au; lindeman@wehi.edu.au	Smyth, Gordon/B-5276-2008; Pal, Bhupinder/AAF-4011-2020	Smyth, Gordon/0000-0001-9221-2892; Nolan, Emma/0000-0001-8093-8733; Pal, Bhupinder/0000-0002-3684-4331; Thorne, Heather/0000-0003-3610-2511; Dougall, William/0000-0001-9487-251X; Lindeman, Geoffrey/0000-0001-9386-2416	Victorian Government; Australian National Health and Medical Research Council (NHMRC) [1016701, 1040978, 1054618]; NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS); Victorian State Government through the Victorian Cancer Agency; Victorian State Government through Operational Infrastructure Support; National Breast Cancer Foundation (Australia) [NC-13-32, PS-15-042]; Amgen Inc.; Qualtrough Cancer Research Fund; Joan Marshall Breast Cancer Research Fund; Australian Cancer Research Foundation; Cancer Council Victoria Scholarship; Cancer Therapeutics CRC Top-Up Scholarship; VCA Early Career Seed Grant [13035]; NHMRC Fellowships [1058892, 637307, 1078730]; NHMRC Australia Fellowship [1037230]; National Breast Cancer Foundation [IF-12-06, NC-13-32, PS-15-042, In-15-071] Funding Source: researchfish	Victorian Government; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government through the Victorian Cancer Agency; Victorian State Government through Operational Infrastructure Support; National Breast Cancer Foundation (Australia); Amgen Inc.(Amgen); Qualtrough Cancer Research Fund; Joan Marshall Breast Cancer Research Fund; Australian Cancer Research Foundation; Cancer Council Victoria Scholarship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Therapeutics CRC Top-Up Scholarship(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); VCA Early Career Seed Grant; NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	We are grateful to the women who generously donated breast tissue for our studies and to the surgical, pathology and tissue bank colleagues for their substantial assistance and support. We thank L. Taylor, K. Shackleton, S. Nightingale and H. Liu for expert assistance; the Animal, FACS, Imaging and Histology facilities at WEHI; C. Perou and K. Hoadley for kind provision of the PAM50 subtypes; and A. Y. Rhee (Amgen Inc.) for assistance with the manuscript submission. We are grateful to H. Thorne and all kConFab staff, members and families for their contributions to this resource and to the Victorian Cancer Biobank (supported by the Victorian Government), which also provided coded breast tissue and data. We thank H. Yasuda for advice on the antibody to mouse RANKL and K. U. Wagner (Eppley Institute, Nebraska) for MMTV-Cre A mice. This work was supported by the Australian National Health and Medical Research Council (NHMRC) (grant numbers 1016701 (J.E.V. and G.J.L.), 1040978 (G.B.M., J.E.V. and G.J.L.) and 1054618 (G.K.S.)), NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS) (to WEHI; E.N., F.V., B.P., G.G., L.W., S.W.L., G.K.S., J.E.V. and G.J.L.), the Victorian State Government through the Victorian Cancer Agency and Operational Infrastructure Support, the National Breast Cancer Foundation (Australia) (grant numbers NC-13-32 and PS-15-042; to J.E.V. and G.J.L.); Amgen Inc. (J.E.V. and G.J.L.), the Qualtrough Cancer Research Fund (J.E.V. and G.J.L.), the Joan Marshall Breast Cancer Research Fund (J.E.V. and G.J.L.) and the Australian Cancer Research Foundation (to WEHI; E.N., F.V., B.P., G.G., L.W., S.W.L., G.K.S., J.E.V. and G.J.L.). E.N. is supported by a Cancer Council Victoria Scholarship and a Cancer Therapeutics CRC Top-Up Scholarship; B.P. is supported by a VCA Early Career Seed Grant 13035; G.K.S. and G.J.L. are supported by NHMRC Fellowships 1058892 (G.K.S.), 637307 (G.J.L.) and 1078730 (G.J.L.); and J.E.V. is supported by NHMRC Australia Fellowship 1037230.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Branstetter DG, 2012, CLIN CANCER RES, V18, P4415, DOI 10.1158/1078-0432.CCR-12-0578; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Eirew P, 2012, STEM CELLS, V30, P344, DOI 10.1002/stem.1001; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Fernandez-Valdivia R, 2012, MOL CELL ENDOCRINOL, V357, P91, DOI 10.1016/j.mce.2011.09.030; Fu NY, 2015, NAT CELL BIOL, V17, P365, DOI 10.1038/ncb3117; Gnant M, 2015, LANCET, V386, P433, DOI 10.1016/S0140-6736(15)60995-3; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Hartmann LC, 2016, NEW ENGL J MED, V374, P454, DOI 10.1056/NEJMra1503523; Heemskerk-Gerritsen BA, 2015, JNCI-J NATL CANCER I, V107, P107; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Joshi PA, 2015, STEM CELL REP, V5, P31, DOI 10.1016/j.stemcr.2015.05.012; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; King TA, 2004, CANCER RES, V64, P5051, DOI 10.1158/0008-5472.CAN-04-1283; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Ma YX, 2006, MOL ENDOCRINOL, V20, P14, DOI 10.1210/me.2004-0488; Mann GJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1377; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Pal B, 2013, CELL REP, V3, P411, DOI 10.1016/j.celrep.2012.12.020; Pasquale P, 2013, STEM CELLS, V31, P1954, DOI 10.1002/stem.1454; Pathania S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6496; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phillips KA, 2014, FUTURE ONCOL, V10, P499, DOI 10.2217/fon.13.278; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Sedic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8505; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tanos T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005654; To C, 2014, CANCER PREV RES, V7, P698, DOI 10.1158/1940-6207.CAPR-14-0047; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Venkitaraman AR, 2014, SCIENCE, V343, P1470, DOI 10.1126/science.1252230; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Widschwendter M, 2013, LANCET ONCOL, V14, P1226, DOI 10.1016/S1470-2045(13)70448-0; Wood CE, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3456; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	54	167	170	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					933	+		10.1038/nm.4118	http://dx.doi.org/10.1038/nm.4118			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27322743				2022-12-25	WOS:000381000200019
J	Zhang, XY; Khan, S; Jiang, H; Antonyak, MA; Chen, X; Spiegelman, NA; Shrimp, JH; Cerione, RA; Lin, HN				Zhang, Xiaoyu; Khan, Saba; Jiang, Hong; Antonyak, Marc A.; Chen, Xiao; Spiegelman, Nicole A.; Shrimp, Jonathan H.; Cerione, Richard A.; Lin, Hening			Identifying the functional contribution of the defatty-acylase activity of SIRT6	Nature Chemical Biology			English	Article							HISTONE DEACETYLASE SIRT6; TUMOR-SUPPRESSOR; NAD ANALOGS; LIFE-SPAN; LYSINE; PROGRESSION; SECRETION; LONGEVITY; CHROMATIN; SIRTUINS	Mammalian sirtuin 6 (SIRT6) exhibits many pivotal functions and multiple enzymatic activities, but the contribution of each activity to the various functions is unclear. We identified a SIRT6 mutant (G60A) that possesses efficient defatty-acylase activity but has substantially decreased deacetylase activity in vitro and no detectable deacetylase activity in cells. The G60A mutant has a decreased ability to bind NAD(+), but the presence of fatty-acyl lysine peptides restores NAD+ binding, explaining the retention of the defatty-acylase activity. Using this mutant, we found that the defatty-acylase activity of SIRT6 regulates the secretion of numerous proteins. Notably, many ribosomal proteins were secreted via exosomes from Sirt6 knockout mouse embryonic fibroblasts, and these exosomes increased NIH 3T3 cell proliferation compared with control exosomes. Our data indicate that distinct activities of SIRT6 regulate different pathways and that the G60A mutant is a useful tool to study the contribution of defatty-acylase activity to SIRT6's various functions.	[Zhang, Xiaoyu; Khan, Saba; Jiang, Hong; Chen, Xiao; Spiegelman, Nicole A.; Shrimp, Jonathan H.; Cerione, Richard A.; Lin, Hening] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Antonyak, Marc A.; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Lin, Hening] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute	Lin, HN (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.; Lin, HN (corresponding author), Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA.	hl379@cornell.edu		Zhang, Xiaoyu/0000-0002-0951-9664; Lin, Hening/0000-0002-0255-2701; Spiegelman, Nicole/0000-0001-8981-8375; Shrimp, Jonathan/0000-0001-9872-942X	US National Institutes of Health (NIH) SIG grant [1S10 OD017992-01]; NYSTEM [CO29155]; NIH [S10OD018516]; NIH NIGMS [R01 GM098596]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, R01GM098596] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017992, S10OD018516] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) SIG grant; NYSTEM; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Mostoslavsky (Massachusetts General Hospital) for providing the Sirt6 WT and KO MEFs, P. Chen (Cornell University) for the use of the fluorescence spectrophotometer and S. Zhang (proteomic and MS facility of Cornell University) for help with the SILAC experiments. SILAC experiments performed on a mass spectrometer were supported by a US National Institutes of Health (NIH) SIG grant 1S10 OD017992-01. Imaging data were acquired in the Cornell BRC imaging facility using a Zeiss LSM880 confocal/multiphoton microscope funded by NYSTEM (CO29155) and NIH (S10OD018516). This work is supported by a grant from the NIH NIGMS (R01 GM098596 to H.L.).	Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Ewald CY, 2015, NATURE, V519, P97, DOI 10.1038/nature14021; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; Huang Z, 2012, ONCOGENE, V31, P3709, DOI 10.1038/onc.2011.529; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jedrusik-Bode M, 2013, J CELL SCI, V126, P5166, DOI 10.1242/jcs.130708; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Jiang H, 2010, J AM CHEM SOC, V132, P9363, DOI 10.1021/ja101588r; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Schwer B., P NATL ACAD SCI US, V107, P21790; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Soo CY, 2012, IMMUNOLOGY, V136, P192, DOI 10.1111/j.1365-2567.2012.03569.x; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhu AY, 2012, ACS CHEM BIOL, V7, P155, DOI 10.1021/cb200230x	30	63	63	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2016	12	8					614	+		10.1038/NCHEMBIO.2106	http://dx.doi.org/10.1038/NCHEMBIO.2106			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2UW	27322069	Green Accepted			2022-12-25	WOS:000380640100008
J	Resnik-Docampo, M; Koehler, CL; Clark, RI; Schinaman, JM; Sauer, V; Wong, DM; Lewis, S; D'Alterio, C; Walker, DW; Jones, DL				Resnik-Docampo, Martin; Koehler, Christopher L.; Clark, Rebecca I.; Schinaman, Joseph M.; Sauer, Vivien; Wong, Daniel M.; Lewis, Sophia; D'Alterio, Cecilia; Walker, David W.; Jones, D. Leanne			Tricellular junctions regulate intestinal stem cell behaviour to maintain homeostasis	NATURE CELL BIOLOGY			English	Article							DROSOPHILA-MELANOGASTER; TISSUE HOMEOSTASIS; EPITHELIAL BARRIER; POSTERIOR MIDGUT; DISCS LARGE; LIFE-SPAN; AGE; GLIOTACTIN; PROTEIN; GUT	Ageing results in loss of tissue homeostasis across taxa(1). In the intestine of Drosophila melanogaster, ageing is correlated with an increase in intestinal stem cell (ISC) proliferation, a block in terminal differentiation of progenitor cells, activation of inflammatory pathways, and increased intestinal permeability(2). However, causal relationships between these phenotypes remain unclear. Here, we demonstrate that ageing results in altered localization and expression of septate junction proteins in the posterior midgut, which is quite pronounced in differentiated enterocytes (ECs) at tricellular junctions (TCJs). Acute loss of the TCJ protein Gliotactin (Gli) in ECs results in increased ISC proliferation and a block in differentiation in intestines from young flies, demonstrating that compromised TCJ function is sufficient to alter ISC behaviour in a non -autonomous manner. Blocking the Jun N-terminal kinase signalling pathway is sufficient to suppress changes in ISC behaviour, but has no effect on loss of intestinal barrier function, as a consequence of Gli depletion. Our work demonstrates a pivotal link between TCJs, stem cell behaviour, and intestinal homeostasis and provides insights into causes of age-onset and gastrointestinal diseases.	[Resnik-Docampo, Martin; Koehler, Christopher L.; Sauer, Vivien; Wong, Daniel M.; Lewis, Sophia; D'Alterio, Cecilia; Jones, D. Leanne] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Clark, Rebecca I.; Schinaman, Joseph M.; Walker, David W.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Walker, David W.; Jones, D. Leanne] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Jones, D. Leanne] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Clark, Rebecca I.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Durham University	Jones, DL (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.; Jones, DL (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.; Jones, DL (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.	leannejones@ucla.edu	resnik-docampo, martin/B-7671-2019; Clark, Rebecca/J-9135-2015	resnik-docampo, martin/0000-0001-7016-9061; Clark, Rebecca/0000-0002-1194-5048	Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California, Los Angeles; Rose Hills Foundation; NIH [AG028092, AG040288, AG049157]; UCLA-Caltech Medical Scientist Training Program [GM08042]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028092, R01AG040288, R01AG049157] Funding Source: NIH RePORTER	Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California, Los Angeles; Rose Hills Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA-Caltech Medical Scientist Training Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank H. Jasper (The Buck Institute for Research on Aging, USA), V. Auld (University of British Columbia, Canada), J. F. de Celis (CBMSO, Spain), M. Furuse (Kobe University, Japan), the Vienna Drosophila RNAi Center (VDRC), and Bloomington Stock Center for reagents, M. Cilluffo from the Brain Research 12. Institute at UCLA EM core facility, and the Jones and Walker laboratories for comments on the manuscript. In addition, we would like to thank Y. Wu and E. Stefani for their sharing their time, expertise, and STED technology. This work was supported by the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California, Los Angeles and the Rose Hills Foundation (D.L.J.), and the NIH: AG028092 (D.L.J.), AG040288 (D.L.J. and D.W.W.), AG049157 (D.W.W.), and a training grant that supports the UCLA-Caltech Medical Scientist Training Program, GM08042 (S.L.).	AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, EXP GERONTOL, V46, P349, DOI 10.1016/j.exger.2010.11.003; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Byri S, 2015, DEV CELL, V33, P535, DOI 10.1016/j.devcel.2015.03.023; Choi YJ, 2008, BBA-GEN SUBJECTS, V1780, P1093, DOI 10.1016/j.bbagen.2008.06.008; Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; FRISTROM DK, 1982, J CELL BIOL, V94, P77, DOI 10.1083/jcb.94.1.77; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Hildebrandt A, 2015, DEV BIOL, V400, P237, DOI 10.1016/j.ydbio.2015.02.008; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106; Li HJ, 2016, DIS MODEL MECH, V9, P487, DOI 10.1242/dmm.024232; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Meier J, 2009, DIGEST DIS, V27, P240, DOI 10.1159/000228556; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Padash-Barmchi M, 2013, J CELL SCI, V126, P1134, DOI 10.1242/jcs.113803; Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054; Ren WY, 2014, AGING CLIN EXP RES, V26, P183, DOI 10.1007/s40520-013-0148-0; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Schulte J, 2003, J CELL BIOL, V161, P991, DOI 10.1083/jcb.200303192; Schulte J, 2006, J CELL SCI, V119, P4391, DOI 10.1242/jcs.03208; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054	31	54	54	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2017	19	1					52	59		10.1038/ncb3454	http://dx.doi.org/10.1038/ncb3454			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EG9AI	27992405	Green Accepted			2022-12-25	WOS:000391349000008
J	Rezaeian, AH; Li, CF; Wu, CY; Zhang, X; Delacerda, J; You, MJ; Han, F; Cai, Z; Jeong', YS; Jin, G; Phan, L; Chou, PC; Lee, MH; Hung, MC; Sarbassov, D; Lin, HK				Rezaeian, Abdol-Hossein; Li, Chien-Feng; Wu, Ching-Yuan; Zhang, Xian; Delacerda, Jorge; You, M. James; Han, Fei; Cai, Zhen; Jeong, Yun Seong; Jin, Guoxiang; Phan, Liem; Chou, Ping-Chieh; Lee, Mong-Hong; Hung, Mien-Chie; Sarbassov, Dos; Lin, Hui-Kuan			A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1 alpha activation, tumorigenesis and metastasis	NATURE CELL BIOLOGY			English	Article							HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE RESPONSE; GENOMIC INSTABILITY; ATM ACTIVATION; PROTEIN; TUMOR; UBIQUITIN; CANCER; MONOUBIQUITINATION; UBIQUITYLATION	The understanding of how hypoxia stabilizes and activates HIF1 alpha in the nucleus with related oncogenic signals could revolutionize targeted therapy for cancers. Here, we find that histone H2AX displays oncogenic activity by serving as a crucial regulator of HIF1 alpha signalling. H2AX interacts with HIF1 alpha to prevent its degradation and nuclear export in order to allow successful VHL-independent HIF1 alpha transcriptional activation. We show that mono-ubiquitylation and phosphorylation of H2AX, which are strictly mediated by hypoxia-induced E3 ligase activity of TRAF6 and ATM, critically regulate HIF1 alpha-driven tumorigenesis. Importantly, TRAF6 and gamma H2AX are overexpressed in human breast cancer, correlate with activation of HIF1 alpha signalling, and predict metastatic outcome. Thus, TRAF6 and H2AX overexpression and gamma H2AX-mediated HIF1 alpha enrichment in the nucleus of cancer cells lead to overactivation of HIF1 alpha-driven tumorigenesis, glycolysis and metastasis. Our findings suggest that TRAF6-mediated mono-ubiquitylation and subsequent phosphorylation of H2AX may serve as potential means for cancer diagnosis and therapy.	[Rezaeian, Abdol-Hossein; Wu, Ching-Yuan; Zhang, Xian; Han, Fei; Cai, Zhen; Jeong, Yun Seong; Jin, Guoxiang; Phan, Liem; Chou, Ping-Chieh; Lee, Mong-Hong; Hung, Mien-Chie; Sarbassov, Dos; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Rezaeian, Abdol-Hossein] Inst Pasteur, Dept Mol Med, Tehran 13169, Iran; [Li, Chien-Feng] Chi Mei Fdn Med Ctr, Dept Pathol, Tainan 710, Taiwan; [Li, Chien-Feng] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 704, Taiwan; [Zhang, Xian; Han, Fei; Cai, Zhen; Jin, Guoxiang; Chou, Ping-Chieh; Lin, Hui-Kuan] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Delacerda, Jorge] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [You, M. James; Jeong, Yun Seong; Lee, Mong-Hong; Hung, Mien-Chie; Sarbassov, Dos] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [You, M. James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Lin, Hui-Kuan] China Med Univ, Grad Inst Basic Med Sci, Taichung 404, Taiwan; [Lin, Hui-Kuan] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan	University of Texas System; UTMD Anderson Cancer Center; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Chi Mei Hospital; National Health Research Institutes - Taiwan; Wake Forest University; Wake Forest Baptist Medical Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Rezaeian, AH; Lin, HK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Rezaeian, AH (corresponding author), Inst Pasteur, Dept Mol Med, Tehran 13169, Iran.; Lin, HK (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA.; Lin, HK (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung 404, Taiwan.; Lin, HK (corresponding author), Asia Univ, Dept Biotechnol, Taichung 413, Taiwan.	ahrezaeian@mdanderson.org; hulin@wakehealth.edu	Hung, Mien-Chie/ABD-5911-2021; Sarbassov, Dos/AAS-4950-2020; Rezaeian, Abdol-Hossein/AAV-6900-2021	Hung, Mien-Chie/0000-0003-4317-4740; Sarbassov, Dos/0000-0002-6848-1133; Zhang, Xian/0000-0001-9674-7886; Phan, Liem/0000-0003-1194-216X; Li, Chien-Feng/0000-0002-9527-7576; Lee, Mong-Hong/0000-0001-8675-8215	NIH R01 grants [R01CA182424-01A1, R01CA193813-01]; MD Anderson Cancer Center SPORE development grant; R. Clark Fellowship award; MD Anderson Cancer Center Prostate Moonshot Program funds; Wake Forest University School of Medicine;  [MOST104-2314-B-384-009-MY3];  [MOHW104-TDU-M-212-133004]; NATIONAL CANCER INSTITUTE [R01CA193813, R01CA136787, P30CA016672, R01CA149321, R01CA182424] Funding Source: NIH RePORTER	NIH R01 grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center SPORE development grant; R. Clark Fellowship award; MD Anderson Cancer Center Prostate Moonshot Program funds; Wake Forest University School of Medicine; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank F. Alt (Harvard University, USA) for providing H2AX null mice. We also thank S. Piccolo (University of Podova, Italy), X. Lin (The University of Texas MD Anderson Cancer Center, USA), J. Chen (The University of Texas MD Anderson Cancer Center, USA), M. D. Bohmann (University of Rochester, USA), M. Eilers (University of Wurzburg, Germany), J. L. Wrana (Mount Sinai Hospital, Canada), X. Yang (University of Pennsylvania, USA), J. Cheng (Shanghai Jiao Tong University, China), E. Yeh (University of Missouri, USA), Z. Lou (Mayo Clinic, USA) and B. Gan (The University of Texas MD Anderson Cancer Center, USA) for reagents and equipment. This work was supported by NIH R01 grants (R01CA182424-01A1, R01CA193813-01), the MD Anderson Cancer Center SPORE development grant, the R. Clark Fellowship award, MD Anderson Cancer Center Prostate Moonshot Program funds, and Start-up funds from Wake Forest University School of Medicine to H.-K.L. and MOST104-2314-B-384-009-MY3 and MOHW104-TDU-M-212-133004 grants from Taiwan to C.-F.L.	Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; HU GF, 1994, P NATL ACAD SCI USA, V91, P12096, DOI 10.1073/pnas.91.25.12096; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; LaGory EL, 2016, NAT CELL BIOL, V18, P356, DOI 10.1038/ncb3330; LEVINGER L, 1982, CELL, V28, P375, DOI 10.1016/0092-8674(82)90355-5; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Monteiro ANA, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e51; Monteiro FL, 2014, ONCOTARGET, V5, P3428, DOI 10.18632/oncotarget.2007; Mujcic H, 2014, CURR MOL MED, V14, P565, DOI 10.2174/1566524014666140603115831; Nakazawa MS, 2016, NAT REV CANCER, V16, P663, DOI 10.1038/nrc.2016.84; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rezaeian Abdol Hossein, 2013, Methods Mol Biol, V936, P157; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Walsh SH, 2005, LEUKEMIA, V19, P464, DOI 10.1038/sj.leu.2403651; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wu CY, 2011, J BIOL CHEM, V286, P30806, DOI 10.1074/jbc.M111.257469; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yang WL, 2010, ONCOGENE, V29, P4493, DOI 10.1038/onc.2010.190; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991	43	63	68	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2017	19	1					38	51		10.1038/ncb3445	http://dx.doi.org/10.1038/ncb3445			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EG9AI	27918549	Green Accepted			2022-12-25	WOS:000391349000007
J	Shingu, T; Ho, AL; Yuan, L; Zhou, X; Dai, CX; Zheng, SY; Wang, QH; Zhong, Y; Chang, Q; Horner, JW; Liebelt, BD; Yao, Y; Hu, BL; Chen, YW; Fuller, GN; Verhaak, RGW; Heimberger, AB; Hu, J				Shingu, Takashi; Ho, Allen L.; Yuan, Liang; Zhou, Xin; Dai, Congxin; Zheng, Siyuan; Wang, Qianghu; Zhong, Yi; Chang, Qing; Horner, James W.; Liebelt, Brandon D.; Yao, Yu; Hu, Baoli; Chen, Yiwen; Fuller, Gregory N.; Verhaak, Roeland G. W.; Heimberger, Amy B.; Hu, Jian			Qki deficiency maintains sternness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation	NATURE GENETICS			English	Article							RNA-BINDING PROTEIN; CANCER; QUAKING; NICHE; GROWTH; DIFFERENTIATION; TUMORIGENICITY; NEUROGENESIS; SUPPRESSOR; EXPRESSION	Stem cells, including cancer stem cells (CSCs), require niches to maintain sternness, yet it is unclear how CSCs maintain sternness in the suboptimal environment outside their niches during invasion. Postnatal co-deletion of Pten and Trp53 in mouse neural stem cells (NSCs) leads to the expansion of these cells in their subventricular zone (SVZ) niches but fails to maintain sternness outside the SVZ. We discovered that Qki is a major regulator of NSC sternness. Qk deletion on a Pten(-/-); Trp53(-/-) background helps NSCs maintain their sternness outside the SVZ in Nes-CreER(T2); QkL/L; ptenuL; Trp53(L/L) mice, which develop glioblastoma with a penetrance of 92% and a median survival time of 105 d. Mechanistically, Qk deletion decreases endolysosome-mediated degradation and enriches receptors essential for maintaining self-renewal on the cytoplasmic membrane to cope with low ligand levels outside niches. Thus, downregulation of endolysosome levels by Qki loss helps glioma stem cells (GSCs) maintain their sternness in suboptimal environments outside their niches.	[Shingu, Takashi; Yuan, Liang; Zhou, Xin; Dai, Congxin; Hu, Baoli; Hu, Jian] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Ho, Allen L.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Zheng, Siyuan; Wang, Qianghu; Verhaak, Roeland G. W.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Zheng, Siyuan; Wang, Qianghu; Chen, Yiwen; Verhaak, Roeland G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Zhong, Yi] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Chang, Qing; Horner, James W.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Liebelt, Brandon D.; Heimberger, Amy B.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Liebelt, Brandon D.] Houston Methodist Neurol Inst, Dept Neurosurg, Houston, TX USA; [Yao, Yu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Fuller, Gregory N.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Stanford University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Hu, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	jhu3@mdanderson.org	Verhaak, Roel/ABE-7058-2020; Zheng, sy/GRS-3136-2022; Shingu, Takashi/AAS-4820-2021; Zhou, Xin/AAD-6937-2019	Zheng, Siyuan/0000-0002-1031-9424; Fuller, Gregory/0000-0001-9447-2647	NIH [K99/R00, R00 CA172700, R01 CA120813]; University of Texas Rising STARs award; NCI Brain Cancer SPORE Career Development Award [2P50CA127001]; Sidney Kimmel Scholar Award; HHMI Medical Research Fellows Program; NCI [R00CA175290]; Texas CPRIT [RR140071]; NATIONAL CANCER INSTITUTE [R00CA175290, R00CA172700, P30CA016672, R01CA120813, P50CA127001] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Rising STARs award; NCI Brain Cancer SPORE Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Scholar Award; HHMI Medical Research Fellows Program; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Texas CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Jiang, Z. Fang, and K. Zhao for mouse husbandry and care, and all members of the Hu laboratory for helpful discussions. We thank Y. Qi for performing alternative splicing analyses. We thank K. Ryszard Gabrusiewicz for helping us analyze the glioblastoma TMA. We thank K. Dunner for electron microscopy studies. We also thank D.M. Wildrick for editorial assistance. J.H. is supported by an NIH K99/R00 Pathway to Independence Award (R00 CA172700), a University of Texas Rising STARs award, an NCI Brain Cancer SPORE Career Development Award (2P50CA127001), and a Sidney Kimmel Scholar Award. A.L.H. was supported by the HHMI Medical Research Fellows Program. A.B.H. is supported by NIH R01 CA120813. Y.C. is supported by NCI R00CA175290 and Texas CPRIT grant RR140071.	Bandopadhayay P, 2016, NAT GENET, V48, P273, DOI 10.1038/ng.3500; Bian YQ, 2012, BIOCHEM BIOPH RES CO, V422, P187, DOI 10.1016/j.bbrc.2012.04.138; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chen AJ, 2012, GENE DEV, V26, P1459, DOI 10.1101/gad.189001.112; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chen YT, 2007, J BIOL CHEM, V282, P23553, DOI 10.1074/jbc.M702045200; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Darbelli L, 2016, WIRES RNA, V7, P399, DOI 10.1002/wrna.1344; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hu J, 2013, P NATL ACAD SCI USA, V110, P14520, DOI 10.1073/pnas.1308610110; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lu W, 2014, CANCER BIOL THER, V15, P1174, DOI 10.4161/cbt.29502; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Qaddoumi I, 2016, ACTA NEUROPATHOL, V131, P833, DOI 10.1007/s00401-016-1539-z; Rich JN, 2008, COLD SH Q B, V73, P411, DOI 10.1101/sqb.2008.73.060; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Scherer H., 1938, AM J CANC, V34, P333, DOI [DOI 10.1158/AJC.1938.333, 10.1158/ajc.1938.333]; Scherer HJ, 1940, BRAIN, V63, P1, DOI 10.1093/brain/63.1.1; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang YL, 2013, MOL CELL BIOL, V33, P1233, DOI 10.1128/MCB.01604-12; Yang GD, 2010, GASTROENTEROLOGY, V138, P231, DOI 10.1053/j.gastro.2009.08.001; Ying HQ, 2010, P NATL ACAD SCI USA, V107, P6912, DOI 10.1073/pnas.0914930107; Yu F, 2014, ONCOL REP, V31, P1459, DOI 10.3892/or.2013.2957; Zhao Y, 2014, CANCER BIOL THER, V15, P108, DOI 10.4161/cbt.26722; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	47	52	56	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					75	86		10.1038/ng.3711	http://dx.doi.org/10.1038/ng.3711			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27841882	Green Accepted			2022-12-25	WOS:000390976600013
J	Soyk, S; Muller, NA; Park, SJ; Schmalenbach, I; Jiang, K; Hayama, R; Zhang, L; Van Eck, J; Jimenez-Gomez, JM; Lippman, ZB				Soyk, Sebastian; Mueller, Niels A.; Park, Soon Ju; Schmalenbach, Inga; Jiang, Ke; Hayama, Ryosuke; Zhang, Lei; Van Eck, Joyce; Jimenez-Gomez, Jose M.; Lippman, Zachary B.			Variation in the flowering gene SELF PRUNING 5G promotes day-neutrality and early yield in tomato	NATURE GENETICS			English	Article							NATURAL VARIATION; CULTIVATED TOMATO; CIRCADIAN CLOCK; GROWTH; FT; REGULATOR; PHOTOPERIOD; PROTEINS; CONSTANS; FLORIGEN	Plants evolved so that their flowering is triggered by seasonal changes in day lengths. However, day-length sensitivity in crops limits their geographical range of cultivation, and thus modification of the photoperiod response was critical for their domestication(2-11). Here we show that loss of day-length-sensitive flowering in tomato was driven by the florigen paralog and flowering repressor SELF-PRUNING 5G (SP5G). SP5G expression is induced to high levels during long days in wild species, but not in cultivated tomato because of cis-regulatory variation. CRISPR/Cas9-engineered mutations in SP5G cause rapid flowering and enhance the compact determinate growth habit of field tomatoes, resulting in a quick burst of flower production that translates to an early yield. Our findings suggest that pre-existing variation in SP5G facilitated the expansion of cultivated tomato beyond its origin near the equator in South America, and they provide a compelling demonstration of the power of gene editing to rapidly improve yield traits in crop breeding.	[Soyk, Sebastian; Jiang, Ke; Lippman, Zachary B.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Mueller, Niels A.; Schmalenbach, Inga; Zhang, Lei; Jimenez-Gomez, Jose M.] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Park, Soon Ju] Wonkwang Univ, Div Biol Sci, Iksan, South Korea; [Hayama, Ryosuke] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Van Eck, Joyce] Boyce Thompson Inst Plant Res, Ithaca, NY USA; [Jimenez-Gomez, Jose M.] Univ Paris Saclay, CNRS, Inst Jean Pierre Bourgin, INRA,AgroParisTech, Versailles, France; [Mueller, Niels A.] Univ Copenhagen, Copenhagen Plant Sci Ctr, Frederiksberg, Denmark; [Jiang, Ke] Dow AgroSci, Indianapolis, IN USA; [Hayama, Ryosuke] Int Christian Univ, Dept Nat Sci, Tokyo, Japan	Cold Spring Harbor Laboratory; Max Planck Society; Wonkwang University; Max Planck Society; Cornell University; Boyce Thompson Institute for Plant Research; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; Dow Chemical Company; International Christian University	Lippman, ZB (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.; Jimenez-Gomez, JM (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany.; Jimenez-Gomez, JM (corresponding author), Univ Paris Saclay, CNRS, Inst Jean Pierre Bourgin, INRA,AgroParisTech, Versailles, France.	jose.jimenez-gomez@versailles.inra.fr; lippman@cshl.edu		Muller, Niels A./0000-0001-5213-042X; Van Eck, Joyce/0000-0002-8005-365X; Soyk, Sebastian/0000-0003-0325-4404; Jimenez-Gomez, Jose M/0000-0002-5033-7192	EMBO Long-Term Fellowship [ALTF 1589-2014]; Next-Generation BioGreen 21 Program (PMBC) [PJ011912012016]; German Research Foundation (DFG) [SCHM2793/1-1]; Max Planck Society; German Research Foundation under the German-Israeli Project Cooperation program (DFG DIP project) [FE552/12-1]; National Science Foundation Plant Genome Research Program [IOS-1237880]; BARD [IS-4818-15]; US-Israel Binational Agricultural Research AMP; Development fund; Agriculture and Food Research Initiative competitive grant from the USDA National Institute of Food and Agriculture [2016-67013-24452]	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Next-Generation BioGreen 21 Program (PMBC); German Research Foundation (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); German Research Foundation under the German-Israeli Project Cooperation program (DFG DIP project)(German Research Foundation (DFG)); National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); BARD; US-Israel Binational Agricultural Research AMP; Development fund; Agriculture and Food Research Initiative competitive grant from the USDA National Institute of Food and Agriculture	We thank all members of the Lippman lab and Y. Eshed for valuable discussions. We also thank M. Koornneef for his constant support and useful discussions. We thank C. Brooks, A. KraMer and J. Dalrymple for technical support; T. Mulligan; S. Vermylen; A. Krainer from CSHL; K. Dunn and M. Treat from Robert Treat Farm in Milford, Connecticut; and staff from Cornell University's Long Island Horticultural Research and Extension Center in Riverhead, New York, for assistance with plant care. We thank U. Tartler and A. Lautscham for their help at the Max Planck Institute for Plant Breeding Research. This research was supported by an EMBO Long-Term Fellowship (ALTF 1589-2014 to S.S.), the Next-Generation BioGreen 21 Program (PMBC, PJ011912012016 to S.J.P.), the German Research Foundation (DFG project number SCHM2793/1-1 to LS.), the Max Planck Society (IS.), the German Research Foundation under the German-Israeli Project Cooperation program (DFG DIP project number FE552/12-1 to J.M.J.-G.), the National Science Foundation Plant Genome Research Program (IOS-1237880 to J.V.E. and Z.B.L.), BARD (IS-4818-15 to Z.B.L.), the US-Israel Binational Agricultural Research & Development fund (Z.B.L.), and an Agriculture and Food Research Initiative competitive grant from the USDA National Institute of Food and Agriculture (2016-67013-24452 to Z.B.L.).	Abelenda JA, 2016, CURR BIOL, V26, P872, DOI 10.1016/j.cub.2016.01.066; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; BINCHY A, 1970, IRISH J AGR RES, V9, P261; Birchler JA, 2010, NEW PHYTOL, V186, P54, DOI 10.1111/j.1469-8137.2009.03087.x; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Bolger A, 2014, NAT GENET, V46, P1034, DOI 10.1038/ng.3046; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Cao K, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01213; Chitwood DH, 2013, PLANT CELL, V25, P2465, DOI 10.1105/tpc.113.112391; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; DEVICENTE MC, 1993, GENETICS, V134, P585; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; ESHED Y, 1995, GENETICS, V141, P1147; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hecht V, 2011, PLANT CELL, V23, P147, DOI 10.1105/tpc.110.081042; Ho WWH, 2014, PLANT CELL, V26, P552, DOI 10.1105/tpc.113.115220; HURD RG, 1973, ANN APPL BIOL, V73, P221, DOI 10.1111/j.1744-7348.1973.tb01328.x; Ishikawa R, 2011, MOL GENET GENOMICS, V285, P461, DOI 10.1007/s00438-011-0621-4; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Jaeger KE, 2013, PLANT CELL, V25, P820, DOI 10.1105/tpc.113.109355; Jiang K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004043; Jones CM, 2007, AM J BOT, V94, P935, DOI 10.3732/ajb.94.6.935; Kloosterman B, 2013, NATURE, V495, P246, DOI 10.1038/nature11912; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lifschitz E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00465; Liu LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5558; MacArthur JW, 1932, J HERED, V23, P395, DOI 10.1093/oxfordjournals.jhered.a103514; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Muller NA, 2016, NAT GENET, V48, P89, DOI 10.1038/ng.3447; Ogiso-Tanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075959; Park SJ, 2014, NAT GENET, V46, P1337, DOI 10.1038/ng.3131; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Pease JB, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002379; Peralta IE., 2005, MONOGR SYST BOT MO B, V104, P227; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Pnueli L, 2001, PLANT CELL, V13, P2687, DOI 10.1105/tpc.13.12.2687; Ranc N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-130; RICK CM, 1978, SCI AM, V239, P77; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Strickler SR, 2015, PEERJ, V3, DOI 10.7717/peerj.793; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Thouet J, 2008, PLANT PHYSIOL, V148, P61, DOI 10.1104/pp.108.124164; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang Y, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0653-9; WITTWER S. H., 1963, PROC AMER SOC HORT SCI, V83, P688; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yeager AF, 1927, J HERED, V18, P263, DOI 10.1093/oxfordjournals.jhered.a102869	60	209	236	18	292	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					162	168		10.1038/ng.3733	http://dx.doi.org/10.1038/ng.3733			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27918538				2022-12-25	WOS:000390976600024
J	Barban, N; Jansen, R; de Vlaming, R; Vaez, A; Mandemakers, JJ; Tropf, FC; Shen, X; Wilson, JF; Chasman, DI; Nolte, IM; Tragante, V; van der Laan, SW; Perry, JRB; Kong, A; Ahluwalia, TS; Albrecht, E; Yerges-Armstrong, L; Atzmon, G; Auro, K; Ayers, K; Bakshi, A; Ben-Avraham, D; Berger, K; Bergman, A; Bertram, L; Bielak, LF; Bjornsdottir, G; Bonder, MJ; Broer, L; Bui, M; Barbieri, C; Cavadino, A; Chavarro, JE; Turman, C; Concas, MP; Cordell, HJ; Davies, G; Eibich, P; Eriksson, N; Esko, T; Eriksson, J; Falahi, F; Felix, JF; Fontana, MA; Franke, L; Gandin, I; Gaskins, AJ; Gieger, C; Gunderson, EP; Guo, XQ; Hayward, C; He, CY; Hofer, E; Huang, HY; Joshi, PK; Kanoni, S; Karlsson, R; Kiechl, S; Kifley, A; Kluttig, A; Kraft, P; Lagou, V; Lecoeur, C; Lahti, J; Li-Gao, RF; Lind, PA; Liu, T; Makalic, E; Mamasoula, C; Matteson, L; Mbarek, H; McArdle, PF; McMahon, G; Meddens, SFW; Mihailov, E; Miller, M; Missmer, SA; Monnereau, C; van der Most, PJ; Myhre, R; Nalls, MA; Nutile, T; Kalafati, IP; Porcu, E; Prokopenko, I; Rajan, KB; Rich-Edwards, J; Rietveld, CA; Robino, A; Rose, LM; Rueedi, R; Ryan, KA; Saba, Y; Schmidt, D; Smith, JA; Stolk, L; Streeten, E; Tonjes, A; Thorleifsson, G; Ulivi, S; Wedenoja, J; Wellmann, J; Willeit, P; Yao, J; Yengo, L; Zhao, JH; Zhao, W; Zhernakova, DV; Amin, N; Andrews, H; Balkau, B; Barzilai, N; Bergmann, S; Biino, G; Bisgaard, H; Bonnelykke, K; Boomsma, DI; Buring, JE; Campbell, H; Cappellani, S; Ciullo, M; Cox, SR; Cucca, F; Toniolo, D; Davey-Smith, G; Deary, IJ; Dedoussis, G; Deloukas, P; van Duijn, CM; de Geus, EJC; Eriksson, JG; Evans, DA; Faul, JD; Sala, CF; Froguel, P; Gasparini, P; Girotto, G; Grabe, HJ; Greiser, KH; Groenen, PJF; de Haan, HG; Haerting, J; Harris, TB; Heath, AC; Heikkila, K; Hofman, A; Homuth, G; Holliday, EG; Hopper, J; Hypponen, E; Jacobsson, B; Jaddoe', VWV; Johannesson, M; Kahonen, M; Kajantie, E; Kardia, SLR; Keavney, B; Kolcic, I; Koponen, P; Kovacs, P; Kronenberg, F; Kutalik, Z; La Bianca, M; Lachance, G; Iacono, WG; Lai, S; Lehtimaki, T; Liewald, DC; Lindgren, CM; Liu, YM; Luben, R; Lucht, M; Luoto, R; Magnus, P; Magnusson, PKE; Martin, NG; McGue, M; McQuillan, R; Medland, SE; Meisinger, C; Mellstrom, D; Metspalu, A; Traglia, M; Milani, L; Mitchell, P; Montgomery, GW; Mook-Kanamori, D; de Mutsert, R; Nohr, EA; Ohlsson, C; Olsen, P; Ong, KK; Paternoster, L; Pattie, A; Penninx, BWJH; Perola, M; Peyser, PA; Pirastu, M; Polasek, O; Power, C; Kaprio, J; Raffel, LJ; Raikkonen, K; Raitakari, O; Ridker, PM; Ring, SM; Roll, K; Rudan, I; Ruggiero, D; Rujescu, D; Salomaa, V; Schlessinger, D; Schmidt, H; Schmidt, R; Schupf, N; Smit, J; Sorice, R; Spector, TD; Starr, JM; Stockl, D; Strauch, K; Stumvoll, M; Swertz, MA; Thorsteinsdottir, U; Thurik, AR; Timpson, NJ; Tung, JY; Uitterlinden, AG; Vaccargiu, S; Viikari, J; Vitart, V; Volzke, H; Vollenweider, P; Vuckovic, D; Waage, J; Wagner, GG; Wang, JJ; Wareham, NJ; Weir, DR; Willemsen, G; Willeit, J; Wright, AF; Zondervan, KT; Stefansson, K; Krueger, RF; Lee, JJ; Benjamin, DJ; Cesarini, D; Koellinger, PD; den Hoed, M; Snieder, H; Mills, MC				Barban, Nicola; Jansen, Rick; de Vlaming, Ronald; Vaez, Ahmad; Mandemakers, Jornt J.; Tropf, Felix C.; Shen, Xia; Wilson, James F.; Chasman, Daniel I.; Nolte, Illa M.; Tragante, Vinicius; van der Laan, Sander W.; Perry, John R. B.; Kong, Augustine; Ahluwalia, Tarunveer S.; Albrecht, Eva; Yerges-Armstrong, Laura; Atzmon, Gil; Auro, Kirsi; Ayers, Kristin; Bakshi, Andrew; Ben-Avraham, Danny; Berger, Klaus; Bergman, Aviv; Bertram, Lars; Bielak, Lawrence F.; Bjornsdottir, Gyda; Bonder, Marc Jan; Broer, Linda; Bui, Minh; Barbieri, Caterina; Cavadino, Alana; Chavarro, Jorge E.; Turman, Constance; Concas, Maria Pina; Cordell, Heather J.; Davies, Gail; Eibich, Peter; Eriksson, Nicholas; Esko, Tonu; Eriksson, Joel; Falahi, Fahimeh; Felix, Janine F.; Fontana, Mark Alan; Franke, Lude; Gandin, Ilaria; Gaskins, Audrey J.; Gieger, Christian; Gunderson, Erica P.; Guo, Xiuqing; Hayward, Caroline; He, Chunyan; Hofer, Edith; Huang, Hongyan; Joshi, Peter K.; Kanoni, Stavroula; Karlsson, Robert; Kiechl, Stefan; Kifley, Annette; Kluttig, Alexander; Kraft, Peter; Lagou, Vasiliki; Lecoeur, Cecile; Lahti, Jari; Li-Gao, Ruifang; Lind, Penelope A.; Liu, Tian; Makalic, Enes; Mamasoula, Crysovalanto; Matteson, Lindsay; Mbarek, Hamdi; McArdle, Patrick F.; McMahon, George; Meddens, S. Fleur W.; Mihailov, Evelin; Miller, Mike; Missmer, Stacey A.; Monnereau, Claire; van der Most, Peter J.; Myhre, Ronny; Nalls, Mike A.; Nutile, Teresa; Kalafati, Ioanna Panagiota; Porcu, Eleonora; Prokopenko, Inga; Rajan, Kumar B.; Rich-Edwards, Janet; Rietveld, Cornelius A.; Robino, Antonietta; Rose, Lynda M.; Rueedi, Rico; Ryan, Kathleen-A; Saba, Yasaman; Schmidt, Daniel; Smith, Jennifer A.; Stolk, Lisette; Streeten, Elizabeth; Toenjes, Anke; Thorleifsson, Gudmar; Ulivi, Sheila; Wedenoja, Juho; Wellmann, Juergen; Willeit, Peter; Yao, Jie; Yengo, Loic; Zhao, Jing Hua; Zhao, Wei; Zhernakova, Dania V.; Amin, Najaf; Andrews, Howard; Balkau, Beverley; Barzilai, Nir; Bergmann, Sven; Biino, Ginevra; Bisgaard, Hans; Bonnelykke, Klaus; Boomsma, Dorret I.; Buring, Julie E.; Campbell, Harry; Cappellani, Stefania; Ciullo, Marina; Cox, Simon R.; Cucca, Francesco; Toniolo, Daniela; Davey-Smith, George; Deary, Ian J.; Dedoussis, George; Deloukas, Panos; van Duijn, Cornelia M.; de Geus, Eco J. C.; Eriksson, Johan G.; Evans, Denis A.; Faul, Jessica D.; Sala, Cinzia Felicita; Froguel, Philippe; Gasparini, Paolo; Girotto, Giorgia; Grabe, Hans-Joergen; Greiser, Karin Halina; Groenen, Patrick J. F.; de Haan, Hugoline G.; Haerting, Johannes; Harris, Tamara B.; Heath, Andrew C.; Heikkila, Kauko; Hofman, Albert; Homuth, Georg; Holliday, Elizabeth G.; Hopper, John; Hypponen, Elina; Jacobsson, Bo; Jaddoe', Vincent W. V.; Johannesson, Magnus; Kahonen, Mika; Kajantie, Eero; Kardia, Sharon L. R.; Keavney, Bernard; Kolcic, Ivana; Koponen, Paivikki; Kovacs, Peter; Kronenberg, Florian; Kutalik, Zoltan; La Bianca, Martina; Lachance, Genevieve; Iacono, William G.; Lai, Sandra; Lehtimaki, Terho; Liewald, David C.; Lindgren, Cecilia M.; Liu, Yongmei; Luben, Robert; Lucht, Michael; Luoto, Riitta; Magnus, Per; Magnusson, Patrik K. E.; Martin, Nicholas G.; McGue, Matt; McQuillan, Ruth; Medland, Sarah E.; Meisinger, Christa; Mellstrom, Dan; Metspalu, Andres; Traglia, Michela; Milani, Lili; Mitchell, Paul; Montgomery, Grant W.; Mook-Kanamori, Dennis; de Mutsert, Renee; Nohr, Ellen A.; Ohlsson, Claes; Olsen, Porn; Ong, Ken K.; Paternoster, Lavinia; Pattie, Alison; Penninx, Brenda W. J. H.; Perola, Markus; Peyser, Patricia A.; Pirastu, Mario; Polasek, Ozren; Power, Chris; Kaprio, Jaakko; Raffel, Leslie J.; Raikkonen, Katri; Raitakari, Olli; Ridker, Paul M.; Ring, Susan M.; Roll, Kathryn; Rudan, Igor; Ruggiero, Daniela; Rujescu, Dan; Salomaa, Veikko; Schlessinger, David; Schmidt, Helena; Schmidt, Reinhold; Schupf, Nicole; Smit, Johannes; Sorice, Rossella; Spector, Tim D.; Starr, John M.; Stockl, Doris; Strauch, Konstantin; Stumvoll, Michael; Swertz, Morris A.; Thorsteinsdottir, Unnur; Thurik, A. Roy; Timpson, Nicholas J.; Tung, Joyce Y.; Uitterlinden, Andre G.; Vaccargiu, Simona; Viikari, Jorma; Vitart, Veronique; Voelzke, Henry; Vollenweider, Peter; Vuckovic, Dragana; Waage, Johannes; Wagner, Gert G.; Wang, Jie Jin; Wareham, Nicholas J.; Weir, David R.; Willemsen, Gonneke; Willeit, Johann; Wright, Alan F.; Zondervan, Krina T.; Stefansson, Kari; Krueger, Robert F.; Lee, James J.; Benjamin, Daniel J.; Cesarini, David; Koellinger, Philipp D.; den Hoed, Marcel; Snieder, Harold; Mills, Melinda C.		Bios Consortium; LifeLines Cohort Study	Genome-wide analysis identifies 12 loci influencing human reproductive behavior	NATURE GENETICS			English	Article							POLYCYSTIC-OVARY-SYNDROME; GENE POLYMORPHISMS; QUALITY-CONTROL; HUMAN-DISEASES; ASSOCIATION; FERTILITY; INSIGHTS; PROTEIN; MOUSE; TRANSLOCATION	The genetic architecture of human reproductive behavior age at first birth (AFB) and number of children ever born (NEB) has a strong relationship with fitness, human development, infertility and risk of neuropsychiatric disorders. However, very few genetic loci have been identified, and the underlying mechanisms of AFB and NEB are poorly understood. We report a large genome-wide association study of both sexes including 251,151 individuals for AFB and 343,072 individuals for NEB. We identified 12 independent loci that are significantly associated with AFB and/or NEB in a SNP-based genome-wide association study and 4 additional loci associated in a gene-based effort. These loci harbor genes that are likely to have a role, either directly or by affecting non-local gene expression, in human reproduction and infertility, thereby increasing understanding of these complex traits.	[Barban, Nicola; Tropf, Felix C.; Mills, Melinda C.] Univ Oxford, Dept Sociol, Oxford, England; [Barban, Nicola; Tropf, Felix C.; Mills, Melinda C.] Univ Oxford, Nuffield Coll, Oxford, England; [Jansen, Rick; Penninx, Brenda W. J. H.; Smit, Johannes] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [de Vlaming, Ronald; Rietveld, Cornelius A.; Thurik, A. Roy; Uitterlinden, Andre G.; Koellinger, Philipp D.] Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands; [de Vlaming, Ronald; Felix, Janine F.; Monnereau, Claire; Rietveld, Cornelius A.; Amin, Najaf; van Duijn, Cornelia M.; Hofman, Albert; Jaddoe', Vincent W. V.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [de Vlaming, Ronald; Meddens, S. Fleur W.; Rietveld, Cornelius A.; Groenen, Patrick J. F.; Hofman, Albert; Thurik, A. Roy; Uitterlinden, Andre G.; Koellinger, Philipp D.] Erasmus Univ, Inst Behav & Biol, Rotterdam, Netherlands; [Vaez, Ahmad; Nolte, Illa M.; Falahi, Fahimeh; van der Most, Peter J.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Vaez, Ahmad] Isfahan Univ Med Sci, Res Inst Primordial Prevent Noncommunicable Dis, Esfahan, Iran; [Mandemakers, Jornt J.] Wageningen Univ Res, Sociol Consumpt & Households, Wageningen, Netherlands; [Shen, Xia; Karlsson, Robert; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Shen, Xia; Wilson, James F.; Hayward, Caroline; Vitart, Veronique; Wright, Alan F.] Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Shen, Xia; Wilson, James F.; Joshi, Peter K.; Campbell, Harry; McQuillan, Ruth; Rudan, Igor] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland; [Chasman, Daniel I.; Rose, Lynda M.; Buring, Julie E.; Ridker, Paul M.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel I.; Rose, Lynda M.; Buring, Julie E.; Ridker, Paul M.] Harvard Med Sch, Boston, MA USA; [Tragante, Vinicius] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [van der Laan, Sander W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Lab Expt Cardiol, Utrecht, Netherlands; [Perry, John R. B.; Zhao, Jing Hua; Ong, Ken K.; Wareham, Nicholas J.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Kong, Augustine] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Kong, Augustine; Bjornsdottir, Gyda; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Ahluwalia, Tarunveer S.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Ahluwalia, Tarunveer S.] Steno Diabet Ctr, Gentofte, Denmark; [Ahluwalia, Tarunveer S.; Bisgaard, Hans; Bonnelykke, Klaus; Waage, Johannes] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, COPSAC, Copenhagen, Denmark; [Albrecht, Eva; Strauch, Konstantin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Yerges-Armstrong, Laura; McArdle, Patrick F.; Ryan, Kathleen-A; Streeten, Elizabeth] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Atzmon, Gil; Barzilai, Nir] Albert Einstein Coll Med, Dept Med, Inst Aging Res, Bronx, NY 10467 USA; [Atzmon, Gil; Barzilai, Nir] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10467 USA; [Atzmon, Gil; Ben-Avraham, Danny] Albert Einstein Coll Med, Inst Aging Res, Dept Genet, Bronx, NY 10467 USA; [Atzmon, Gil] Univ Haifa, Dept Nat Sci, Haifa, Israel; [Auro, Kirsi; Perola, Markus; Kaprio, Jaakko; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland; [Auro, Kirsi; Heikkila, Kauko; Perola, Markus; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Ayers, Kristin; Cordell, Heather J.; Mamasoula, Crysovalanto; Keavney, Bernard] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England; [Bakshi, Andrew] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Berger, Klaus; Wellmann, Juergen] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; [Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Bertram, Lars] Univ Lubeck, Lubeck Interdisciplinary Platform Genome Analyt, Inst Neurogenet, Lubeck, Germany; [Bertram, Lars] Univ Lubeck, Inst Integrat & Expt Genom, Lubeck, Germany; [Bertram, Lars] Imperial Coll, Fac Med, Sch Publ Hlth, London, England; [Bielak, Lawrence F.; Smith, Jennifer A.; Zhao, Wei; Kardia, Sharon L. R.; Peyser, Patricia A.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Bonder, Marc Jan; Franke, Lude; Zhernakova, Dania V.; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Genom Coordinat Ctr, Groningen, Netherlands; [Broer, Linda; Stolk, Lisette; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Bui, Minh; Makalic, Enes; Schmidt, Daniel; Hopper, John] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Barbieri, Caterina; Toniolo, Daniela; Sala, Cinzia Felicita; Traglia, Michela] San Raffaele Res Inst, Div Genet & Cell Biol, Milan, Italy; [Cavadino, Alana; Hypponen, Elina; Power, Chris] UCL Inst Child Hlth, Populat Policy & Practice, London, England; [Cavadino, Alana] Queen Mary Univ London, Wolfson Inst Preventat Med, Ctr Environm & Prevent Med, London, England; [Chavarro, Jorge E.; Gaskins, Audrey J.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Chavarro, Jorge E.; Rich-Edwards, Janet] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Chavarro, Jorge E.; Rich-Edwards, Janet] Harvard Med Sch, Boston, MA USA; [Chavarro, Jorge E.; Turman, Constance; Huang, Hongyan; Kraft, Peter; Missmer, Stacey A.; Rich-Edwards, Janet; Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Concas, Maria Pina; Pirastu, Mario; Vaccargiu, Simona] CNR, UOS Sassari, Inst Genet & Biomed Res, Sassari, Italy; [Davies, Gail; Cox, Simon R.; Deary, Ian J.; Liewald, David C.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Davies, Gail; Cox, Simon R.; Deary, Ian J.; Pattie, Alison] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Eibich, Peter] Univ Oxford, Hlth Econ Res Ctr, Oxford, England; [Eriksson, Nicholas; Tung, Joyce Y.] 23andMe Inc, Mountain View, CA USA; [Mihailov, Evelin; Metspalu, Andres; Milani, Lili; Perola, Markus] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Esko, Tonu] Broad Inst MIT & Harvard, Cambridge, MA USA; [Eriksson, Joel; Mellstrom, Dan; Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Felix, Janine F.; Monnereau, Claire; Jaddoe', Vincent W. V.] Univ Med Ctr Rotterdam, Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Felix, Janine F.; Monnereau, Claire; Jaddoe', Vincent W. V.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Fontana, Mark Alan; Benjamin, Daniel J.] Univ Southern Calif, Ctr Econ & Social Res, Los Angeles, CA USA; [Gandin, Ilaria; Gasparini, Paolo; Girotto, Giorgia; Vuckovic, Dragana] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Gieger, Christian; Meisinger, Christa] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Gunderson, Erica P.] Kaiser Permanente Northern Calif, Div Res, Cardiovasc & Metab Condit Sect, Oakland, CA USA; [Guo, Xiuqing; Yao, Jie; Roll, Kathryn] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [He, Chunyan] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA; [Hofer, Edith; Schmidt, Reinhold] Med Univ Graz, Clin Div Neurogeriatr, Dept Neurol, Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Kanoni, Stavroula; Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Kiechl, Stefan; Willeit, Peter; Willeit, Johann] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Kifley, Annette; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Westmead, NSW, Australia; [Kifley, Annette; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Inst Med Res, Westmead, NSW, Australia; [Kluttig, Alexander; Haerting, Johannes] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Saale, Germany; [Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Lagou, Vasiliki] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium; [Lagou, Vasiliki] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Lagou, Vasiliki] VIB, Translat Immunol Lab, Leuven, Belgium; [Lecoeur, Cecile; Yengo, Loic; Balkau, Beverley; Froguel, Philippe] Univ Lille, CNRS, Inst Pasteur Lille, Lille, France; [Lahti, Jari; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Lahti, Jari] Univ Helsinki, Helsinki Coll Adv Studies, Helsinki, Finland; [Lahti, Jari; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Li-Gao, Ruifang; de Haan, Hugoline G.; Mook-Kanamori, Dennis; de Mutsert, Renee] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Lind, Penelope A.; Martin, Nicholas G.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Psychiat Genet, Herston Brisbane, Qld, Australia; [Liu, Tian] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Liu, Tian] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Berlin, Germany; [Matteson, Lindsay] Univ Minnesota, Dept Psychol, Minnesota Ctr Twin & Family Res, Minneapolis, MN USA; [Mbarek, Hamdi; Boomsma, Dorret I.; de Geus, Eco J. C.; Willemsen, Gonneke] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Mbarek, Hamdi; Boomsma, Dorret I.; de Geus, Eco J. C.; Penninx, Brenda W. J. H.; Smit, Johannes; Willemsen, Gonneke] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [McMahon, George] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Meddens, S. Fleur W.; Koellinger, Philipp D.] Vrije Univ Amsterdam, Complex Trait Genet, Amsterdam, Netherlands; [Miller, Mike; Iacono, William G.; McGue, Matt; Krueger, Robert F.; Lee, James J.] Univ Minnesota, Dept Psychol, Minneapolis, MN USA; [Missmer, Stacey A.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA USA; [Missmer, Stacey A.] Harvard Med Sch, Boston, MA USA; [Myhre, Ronny; Jacobsson, Bo; Magnus, Per] Inst Publ Hlth, Area Hlth Data & Digitalizat, Dept Genet & Bioinformat, Oslo, Norway; [Nalls, Mike A.] NIA, Lab Neurogenet, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Nutile, Teresa; Ciullo, Marina; Ruggiero, Daniela; Sorice, Rossella] CNR, Inst Genet & Biophys A Buzzati Traverso, Naples, Italy; [Kalafati, Ioanna Panagiota; Dedoussis, George] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens, Greece; [Porcu, Eleonora; Cucca, Francesco; Lai, Sandra] Cittadella Univ Monserrato, Ist Ric Genet & Biomed, CMR, Cagliari, Italy; [Porcu, Eleonora; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy; [Prokopenko, Inga] Imperial Coll London, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Prokopenko, Inga; Lindgren, Cecilia M.] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Prokopenko, Inga; Lindgren, Cecilia M.] Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Rajan, Kumar B.; Evans, Denis A.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Rich-Edwards, Janet] Brigham & Womens Hosp, Connors Ctr Womens Hlth & Gender Biol, 75 Francis St, Boston, MA 02115 USA; [Rich-Edwards, Janet] Harvard Med Sch, Boston, MA USA; [Robino, Antonietta; Ulivi, Sheila; Cappellani, Stefania; La Bianca, Martina] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Rueedi, Rico; Bergmann, Sven] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland; [Rueedi, Rico; Bergmann, Sven; Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Saba, Yasaman; Schmidt, Helena] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria; [Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Wedenoja, Juho; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Willeit, Peter] Kings British Heart Fdn Ctr, Kings Coll London, London, England; [Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Yengo, Loic] Univ Queensland, Ctr Neurogenet & Stat Genom, Brisbane, Qld, Australia; [Andrews, Howard] New York State Psychiat Inst & Hosp, Data Coordinating Ctr, New York, NY 10032 USA; [Biino, Ginevra] Natl Res Council Italy, Inst Mol Genet, Pavia, Italy; [Ciullo, Marina; Sorice, Rossella] IRCCS Neuromed, Pozzilli, Isernia, Italy; [Davey-Smith, George; Paternoster, Lavinia; Ring, Susan M.; Timpson, Nicholas J.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Eriksson, Johan G.; Lucht, Michael] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Faul, Jessica D.; Weir, David R.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA; [Gasparini, Paolo; Girotto, Giorgia; Vuckovic, Dragana] Sidra, Div Expt Genet, Doha, Qatar; [Grabe, Hans-Joergen] Univ Med Greifswald, Dept Psychiat, Greifswald, Germany; [Greiser, Karin Halina] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Groenen, Patrick J. F.] Erasmus Univ, Erasmus Sch Econ, Econometric Inst, Rotterdam, Netherlands; [Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Heath, Andrew C.; Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Genet Epidemiol, Brisbane, Qld, Australia; [Homuth, Georg] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Holliday, Elizabeth G.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Holliday, Elizabeth G.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Hypponen, Elina] Univ South Australia, Sansom Inst Hlth Res, Ctr Populat Hlth Res, Adelaide, SA, Australia; [Hypponen, Elina] Univ South Australia, Sch Hlth Sci, Adelaide, SA, Australia; [Hypponen, Elina] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Jacobsson, Bo] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, Stockholm, Sweden; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, Tampere, Finland; [Kahonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Kahonen, Mika] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Kajantie, Eero] Helsinki Univ Cent Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, MRC Oulu, Dept Obstet & Gynecol, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Keavney, Bernard] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England; [Kolcic, Ivana; Polasek, Ozren] Univ Split, Fac Med, Dept Publ Hlth, Split, Croatia; [Koponen, Paivikki] Natl Inst Hlth & Welf, Hlth Monitoring Unit, Helsinki, Finland; [Kovacs, Peter; Stumvoll, Michael] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany; [Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol, Innsbruck, Austria; [Kutalik, Zoltan] Lausanne Univ Hosp CHUV, Inst Social & Prevent Med, Lausanne, Switzerland; [Lachance, Genevieve; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Lehtimaki, Terho] Univ Tampere, Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, Tampere, Finland; [Lindgren, Cecilia M.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Lindgren, Cecilia M.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Liu, Yongmei] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Luben, Robert] Univ Cambridge, Strangeways Res Lab, Cambridge, England; [Luoto, Riitta] UKK Inst Hlth Promot, Tampere, Finland; [McGue, Matt] Univ Southern Denmark, Inst Publ Hlth, Danish Aging Res Ctr, Odense, Denmark; [McGue, Matt] Univ Southern Denmark, Inst Publ Hlth, Danish Twin Registry, Odense, Denmark; [Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Montgomery, Grant W.] Univ Queensland, Mol Biosci, Brisbane, Qld, Australia; [Mook-Kanamori, Dennis] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Mook-Kanamori, Dennis] King Faisal Specialist Hosp & Res Ctr, Epidemiol Sect, Dept BESC, Riyadh, Saudi Arabia; [Nohr, Ellen A.] Univ Southern Denmark, Dept Clin Res, Res Unit Gynecol & Obstet, Odense, Denmark; [Olsen, Porn] Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark; [Raffel, Leslie J.] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA 90048 USA; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Rujescu, Dan] Martin Luther Univ Halle Wittenberg, Dept Psychiat, Halle, Saale, Germany; [Schlessinger, David] NIA, Lab Genet, Baltimore, MD 21224 USA; [Schupf, Nicole; Stockl, Doris] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY USA; [Schupf, Nicole; Stockl, Doris] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Thurik, A. Roy] Montpellier Business Sch, Montpellier, France; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Viikari, Jorma] Turku Univ Hosp, Div Med, Turku, Finland; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Vollenweider, Peter] Lausanne Univ Hosp CHUV, Dept Internal Med, Lausanne, Switzerland; [Wagner, Gert G.] Max Planck Inst Human Dev, German Socioecon Panel Study SOEP, Berlin, Germany; [Wagner, Gert G.] Berlin Univ Technol TUB, Berlin, Germany; [Zondervan, Krina T.] Univ Oxford, Wellcome Trust Ctr Human Genet, Genet & Genom Epidemiol Unit, Oxford, England; [Zondervan, Krina T.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Endometriosis CaRe Ctr, Oxford, England; [Benjamin, Daniel J.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Cesarini, David] NYU, Dept Econ, New York, NY 10003 USA; [Cesarini, David] Res Inst Ind Econ, Stockholm, Sweden; [den Hoed, Marcel] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden	University of Oxford; University of Oxford; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; University of Groningen; Isfahan University Medical Science; Wageningen University & Research; Karolinska Institutet; University of Edinburgh; University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Cambridge; University of Iceland; Novo Nordisk Foundation; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University System of Maryland; University of Maryland Baltimore; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Haifa; Finland National Institute for Health & Welfare; University of Helsinki; Newcastle University - UK; University of Queensland; University of Munster; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Lubeck; University of Lubeck; Imperial College London; University of Michigan System; University of Michigan; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Melbourne; University of London; University College London; University of London; Queen Mary University London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Edinburgh; University of Edinburgh; University of Oxford; University of Tartu; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Gothenburg; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Southern California; University of Trieste; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Medical University of Graz; Medical University of Graz; University of London; Queen Mary University London; Medical University of Innsbruck; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Martin Luther University Halle Wittenberg; Harvard University; Harvard T.H. Chan School of Public Health; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Helsinki; University of Helsinki; Folkhalsan Research Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; QIMR Berghofer Medical Research Institute; Max Planck Society; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Bristol; Vrije Universiteit Amsterdam; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Harokopio University Athens; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Cagliari; University of Sassari; Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Rush University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; IRCCS Burlo Garofolo; University of Lausanne; Swiss Institute of Bioinformatics; Medical University of Graz; Leipzig University; University of Helsinki; University of London; King's College London; University of Cambridge; University of Queensland; New York State Psychiatry Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Neuromed; University of Bristol; King Abdulaziz University; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; University of Michigan System; University of Michigan; Sidra Medical & Research Center; Greifswald Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Erasmus University Rotterdam; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); QIMR Berghofer Medical Research Institute; Greifswald Medical School; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of South Australia; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Gothenburg; Stockholm School of Economics; Tampere University; Tampere University; Tampere University Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; University of Manchester; University of Split; Finland National Institute for Health & Welfare; Leipzig University; Medical University of Innsbruck; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of London; King's College London; Tampere University; Tampere University; University of Oxford; University of Oxford; Wake Forest University; University of Cambridge; UKK Institute; University of Southern Denmark; University of Southern Denmark; University of Tartu; University of Queensland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; King Faisal Specialist Hospital & Research Center; University of Southern Denmark; Aarhus University; Cedars Sinai Medical Center; University of Turku; University of Turku; Martin Luther University Halle Wittenberg; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Columbia University; Columbia University; University of Edinburgh; University of Munich; University of Iceland; Montpellier Business School; University of Turku; University of Turku; Greifswald Medical School; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Max Planck Society; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; National Bureau of Economic Research; New York University; Research Institute of Industrial Economics (IFN); Uppsala University	Barban, N; Mills, MC (corresponding author), Univ Oxford, Dept Sociol, Oxford, England.; Snieder, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.; den Hoed, M (corresponding author), Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden.	nicola.barban@sociology.ox.ac.uk; marcel.den_hoed@medsci.uu.se; h.snieder@umcg.nl; melinda.mills@nuffield.ox.ac.uk	Stumvoll, Michael/ABE-1121-2021; Medland, Sarah E/C-7630-2013; Ciullo, Marina/AAE-3041-2020; Johannesson, Magnus/E-9680-2011; Medland, Sarah/AAT-7595-2020; Traglia, Michela/AAX-5816-2020; Kraft, Peter/GQH-8448-2022; Bertram, Lars/K-3889-2015; Penninx, Brenda WJH/S-7627-2017; Chavarro, Jorge E/AAE-5665-2021; Gaskins, Audrey/K-6246-2019; Li-Gao, Ruifang/B-7172-2018; Kaprio, Jaakko/A-1820-2008; Kolcic, Ivana/E-2713-2017; Prokopenko, Inga/H-3241-2014; Gasparini, Paolo/B-6173-2014; Hypponen, Elina/B-2596-2014; FROGUEL, Philippe/O-6799-2017; Lahti, Jari/P-7987-2018; Biino, Ginevra/B-5334-2013; Willeit, Peter/HCI-7091-2022; Schmidt, Reinhold/E-1137-2014; Heikkilä, Kauko/E-5578-2019; Ahluwalia, Tarunveer Singh/C-5549-2009; Deary, Ian J/C-6297-2009; Lehtimäki, Terho/AAD-1094-2022; Bisgaard, Hans/N-4761-2016; Raitakari, Olli/AAQ-7389-2021; Meisinger, Christine/B-5358-2014; Wagner, Gert G./AIC-8679-2022; de Geus, Eco J.C./M-9318-2015; Wedenoja, Juho/AAX-7008-2020; Concas, Maria Pina/K-2266-2018; Toniolo, Daniela/AAE-2969-2019; Dedoussis, George/AAN-7252-2021; Boomsma, Dorret I/AAX-4470-2020; Luben, Robert N/H-5519-2015; den Hoed, Marcel/I-7138-2017; ruggiero, daniela/K-5638-2016; Milani, Lili/N-1097-2019; Vaez, Ahmad/B-4336-2018; Campbell, Harry/E-2959-2010; Fox, Laura J/C-6249-2016; wang, jie/GRS-0942-2022; Cavadino, Alana/CAG-8915-2022; Wang, Jie Jin/P-1499-2014; Cox, Simon R./HDN-8568-2022; Lai, Sandra/AAY-4176-2020; Gandin, Ilaria/B-2634-2017; Davey Smith, George/A-7407-2013; Timpson, Nicholas John/O-7548-2015; Rujescu, Dan/GRS-3875-2022; Prokopenko, Inga/AAU-9895-2020; Yengo, Loic/D-2692-2017; Colaus, PsyColaus/K-6607-2013; Lahti, Jari/P-2283-2019; Lind, Penelope A/ABC-5341-2021; Mitchell, Paul/P-1498-2014; Kronenberg, Florian/B-1736-2008; Kalafati, Ioanna-Panagiota/AAJ-2287-2020; Lind, Penelope A/B-2553-2009; Sala, Cinzia Felicita/AAN-1900-2020; Kutalik, Zoltan/HHZ-5697-2022; Polasek, Ozren/B-6002-2011; Jacobsson, Bo/O-8007-2014; Thurik, Roy/A-9386-2012; Stefansson, Kari/AAE-7187-2019; Attrill, Lauren/V-1688-2018; Kanoni, Stavroula/AAN-7161-2021; Magnusson, Patrik KE/C-4458-2017; Wilson, James F/A-5704-2009; Ohlsson, Claes/AGP-3544-2022; Shen, Xia/AAO-4233-2020; Rudan, Igor/I-1467-2012; van der Laan, Sander W./N-1330-2019; Montgomery, Grant W/B-7148-2008; Franke, Lude/P-7036-2016; Girotto, Giorgia/I-9452-2018; Robino, Antonietta/K-9398-2016; Zondervan, Krina/M-1143-2013	Stumvoll, Michael/0000-0001-6225-8240; Medland, Sarah E/0000-0003-1382-380X; Ciullo, Marina/0000-0002-9621-9984; Johannesson, Magnus/0000-0001-8759-6393; Medland, Sarah/0000-0003-1382-380X; Bertram, Lars/0000-0002-0108-124X; Penninx, Brenda WJH/0000-0001-7779-9672; Chavarro, Jorge E/0000-0002-4436-9630; Li-Gao, Ruifang/0000-0003-0650-1351; Kaprio, Jaakko/0000-0002-3716-2455; Kolcic, Ivana/0000-0001-7918-6052; Prokopenko, Inga/0000-0003-1624-7457; Hypponen, Elina/0000-0003-3670-9399; FROGUEL, Philippe/0000-0003-2972-0784; Lahti, Jari/0000-0002-4310-5297; Biino, Ginevra/0000-0002-9936-946X; Willeit, Peter/0000-0002-1866-7159; Heikkilä, Kauko/0000-0002-9256-8028; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Deary, Ian J/0000-0002-1733-263X; Lehtimäki, Terho/0000-0002-2555-4427; Bisgaard, Hans/0000-0003-4131-7592; de Geus, Eco J.C./0000-0001-6022-2666; Wedenoja, Juho/0000-0002-6155-0378; Concas, Maria Pina/0000-0003-3598-2537; Toniolo, Daniela/0000-0001-9545-6032; Dedoussis, George/0000-0002-7798-6221; Luben, Robert N/0000-0002-5088-6343; den Hoed, Marcel/0000-0001-8081-428X; ruggiero, daniela/0000-0003-3898-7827; Milani, Lili/0000-0002-5323-3102; Vaez, Ahmad/0000-0001-9048-3795; Campbell, Harry/0000-0002-6169-6262; Cavadino, Alana/0000-0002-5709-367X; Wang, Jie Jin/0000-0001-9491-4898; Cox, Simon R./0000-0003-4036-3642; Gandin, Ilaria/0000-0003-3196-2491; Davey Smith, George/0000-0002-1407-8314; Timpson, Nicholas John/0000-0002-7141-9189; Yengo, Loic/0000-0002-4272-9305; Lahti, Jari/0000-0002-4310-5297; Lind, Penelope A/0000-0002-3887-2598; Kronenberg, Florian/0000-0003-2229-1120; Lind, Penelope A/0000-0002-3887-2598; Kutalik, Zoltan/0000-0001-8285-7523; Polasek, Ozren/0000-0002-5765-1862; Jacobsson, Bo/0000-0001-5079-2374; Thurik, Roy/0000-0002-0242-6908; Kanoni, Stavroula/0000-0002-1691-9615; Magnusson, Patrik KE/0000-0002-7315-7899; Wilson, James F/0000-0001-5751-9178; Ohlsson, Claes/0000-0002-9633-2805; Shen, Xia/0000-0003-4390-1979; Rudan, Igor/0000-0001-6993-6884; van der Laan, Sander W./0000-0001-6888-1404; Montgomery, Grant W/0000-0002-4140-8139; Franke, Lude/0000-0002-5159-8802; Kovacs, Peter/0000-0002-0290-5423; Broer, Linda/0000-0003-0011-123X; de Vlaming, Ronald/0000-0001-6416-6067; Kraft, Peter/0000-0002-4472-8103; Girotto, Giorgia/0000-0003-4507-6589; Kong, Augustine/0000-0001-8193-5438; s, hema/0000-0002-3440-9475; Makalic, Enes/0000-0003-3017-0871; Keavney, Bernard/0000-0001-9573-0812; Lagou, Vasiliki/0000-0003-3165-8940; cappellani, stefania/0000-0002-1126-5202; Bonder, Marc Jan/0000-0002-8431-3180; Smith, Jennifer Ann/0000-0002-3575-5468; Lindgren, Cecilia/0000-0002-4903-9374; Willemsen, Gonneke/0000-0003-3755-0236; Cordell, Heather/0000-0002-1879-5572; Jansen, Rick/0000-0002-3333-6737; Bjornsdottir, Gyda/0000-0002-8100-0306; de Haan, Hugoline/0000-0003-1126-4776; Joshi, Peter/0000-0002-6361-5059; Bui, Minh/0000-0002-9099-6870; Mbarek, Hamdi/0000-0002-1108-0371; Saba, Yasaman/0000-0002-3549-2493; Vuckovic, Dragana/0000-0001-9343-6142; Bakshi, Andrew/0000-0001-5650-7036; Ayers, Kristin/0000-0002-4984-5229; Robino, Antonietta/0000-0003-2152-2353; Gasparini, Paolo/0000-0002-0859-0856; NUTILE, TERESA/0000-0001-7062-8352; Groenen, Patrick/0000-0001-6683-8971; Kahonen, Mika/0000-0002-4510-7341; Koellinger, Philipp/0000-0001-7413-0412; Bergmann, Sven/0000-0002-6785-9034; Bonnelykke, Klaus/0000-0003-2003-1018; Van Duijn, Cornelia/0000-0002-2374-9204; Barban, Nicola/0000-0002-4362-4652; Amin, Najaf/0000-0002-8944-1771; Raikkonen, Katri/0000-0003-3124-3470; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Faul, Jessica/0000-0002-6969-6478; CUCCA, Francesco/0000-0002-7414-1995; Zondervan, Krina/0000-0002-0275-9905	ERC Consolidator Grant SOCIOGENOME [615603]; Dutch Science Foundation (NWO) grant (VIDI grant) [452-10-012]; UK ESRC/NCRM SOCGEN grant [ES/N011856/1]; European Union [320116]; Wellcome Trust ISSF; John Fell Fund; Swedish Research Council [2015-03657, 421-2013-1061, 537-2014-371]; Swedish Heart-Lung Foundation [20140543]; US National Science Foundation (EAGER: 'Workshop for the Formation of a Social Science Genetic Association Consortium'); National Institutes of Health Office of Behavioral and Social Science Research; Ragnar Soderberg Foundation [E9/11]; Jan Wallander and Tom Hedelius Foundation; ERC [647648 EdGe]; Pershing Square Fund of the Foundations of Human Behavior; NIA/NIH [P01-AG005842, P01-AG005842-20S2, P30-AG012810, T32-AG000186-23, R01-AG042568-02]; British Heart Foundation [RG/15/12/31616] Funding Source: researchfish; Economic and Social Research Council [ES/N011856/1] Funding Source: researchfish; Lundbeck Foundation [R163-2013-16235] Funding Source: researchfish; Medical Research Council [G1001799, MC_UU_12015/2, MC_UU_12013/1, MC_PC_13048, MC_UU_12015/1, G9815508, MR/K026992/1, 1201677, MR/N01104X/1, MR/J012165/1, MC_UU_12013/3, MC_PC_U127561128, MC_U106179471, MC_U106179472] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10027, NF-SI-0507-10228] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005785, NNF12OC1016374, NNF14OC0010513, NNF15OC0016362] Funding Source: researchfish; ESRC [ES/N011856/1] Funding Source: UKRI; MRC [MC_UU_12015/1, G1001799, MR/N01104X/1, MC_PC_U127561128, MC_UU_12013/1, MC_U106179472, MC_UU_12015/2, MC_UU_12013/3, MR/J012165/1] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR001881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042568, U01AG016976, ZIAAG006000, P01AG005842, T32AG000186, P30AG038072, P30AG012810, ZIAAG000647, ZIAAG000675, R01AG051635] Funding Source: NIH RePORTER	ERC Consolidator Grant SOCIOGENOME; Dutch Science Foundation (NWO) grant (VIDI grant); UK ESRC/NCRM SOCGEN grant(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Union(European Commission); Wellcome Trust ISSF(Wellcome Trust); John Fell Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); US National Science Foundation (EAGER: 'Workshop for the Formation of a Social Science Genetic Association Consortium')(National Science Foundation (NSF)); National Institutes of Health Office of Behavioral and Social Science Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragnar Soderberg Foundation; Jan Wallander and Tom Hedelius Foundation; ERC(European Research Council (ERC)European Commission); Pershing Square Fund of the Foundations of Human Behavior(Pershing Square Foundation); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	For full acknowledgments, see the Supplementary Note. Funding to lead this consortium was provided by grants awarded to M.C.M.: ERC Consolidator Grant SOCIOGENOME (615603), a Dutch Science Foundation (NWO) grant (VIDI grant 452-10-012), a UK ESRC/NCRM SOCGEN grant (ES/N011856/1), the European Union's FP7 Families And Societies project (320116), and the Wellcome Trust ISSF and John Fell Fund. M.d.H. was supported by grants from the Swedish Research Council (2015-03657) and the Swedish Heart-Lung Foundation (20140543). Research was carried out in collaboration with the Social Science Genetic Association Consortium (SSGAC), with funding from the US National Science Foundation (EAGER: 'Workshop for the Formation of a Social Science Genetic Association Consortium'), a Supplementary grant from the National Institutes of Health Office of Behavioral and Social Science Research, the Ragnar Soderberg Foundation (E9/11), the Swedish Research Council (421-2013-1061), the Jan Wallander and Tom Hedelius Foundation, an ERC Consolidator Grant (647648 EdGe), the Pershing Square Fund of the Foundations of Human Behavior and the NIA/NIH through grants P01-AG005842, P01-AG005842-20S2, P30-AG012810 and T32-AG000186-23 to NBER and R01-AG042568-02 to the University of Southern California. X.S. was supported by a grant from the Swedish Research Council (537-2014-371). We thank X. Ding for research assistance, N. Pirastu, K. Coward and L. Layman for valuable comments, and the University of Oxford Advanced Research Computing (ARC) facility (http://dx.doi.org/10.5281/zenodo.22558). This research has been conducted using the UK Biobank Resource.	Adham IM, 2005, MOL CELL BIOL, V25, P7657, DOI 10.1128/MCB.25.17.7657-7664.2005; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Alves MG, 2015, CELL TISSUE RES, V362, P431, DOI 10.1007/s00441-015-2217-5; Bagley DC, 2012, J BIOL CHEM, V287, P25577, DOI 10.1074/jbc.M112.354043; Balbo N, 2013, EUR J POPUL, V29, P1, DOI 10.1007/s10680-012-9277-y; Bao S, 2016, J CLIN RES PEDIATR E, V8, P135, DOI 10.4274/jcrpe.2259; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Bonder M.J., 2015, DIS VARIANTS ALTER T; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buensuceso AV, 2016, ENDOCRINOLOGY, V157, P942, DOI 10.1210/en.2015-1216; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cao GT, 2002, J HUM GENET, V47, P373, DOI 10.1007/s100380200053; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chiu YC, 2014, DEV NEUROBIOL, V74, P723, DOI 10.1002/dneu.22166; Day FR, 2016, NAT GENET, V48, P617, DOI 10.1038/ng.3551; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; Day FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9464; de Mattos CS, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0114-2; El-Alfy M, 2006, J ANDROL, V27, P686, DOI 10.2164/jandrol.106.000596; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Fang WL, 2012, J CELL PHYSIOL, V227, P2430, DOI 10.1002/jcp.22978; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fisher R.A., 1930, GENETICAL THEORY NAT; Franklin RB, 2003, J INORG BIOCHEM, V96, P435, DOI 10.1016/S0162-0134(03)00249-6; Heath E, 2010, CHROMOSOME RES, V18, P851, DOI 10.1007/s10577-010-9170-7; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Impera L, 2008, ONCOGENE, V27, P6187, DOI 10.1038/onc.2008.214; Jisa E, 2003, J STEROID BIOCHEM, V84, P141, DOI 10.1016/S0960-0760(03)00023-2; Joshi NR, 2015, HUM REPROD, V30, P2881, DOI 10.1093/humrep/dev229; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lamp M, 2011, GYNECOL ENDOCRINOL, V27, P425, DOI 10.3109/09513590.2010.495434; Lisle RS, 2013, REPRODUCTION, V145, P381, DOI 10.1530/REP-12-0338; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Ly-Huynh JD, 2011, BIOL REPROD, V85, P1191, DOI 10.1095/biolreprod.111.091686; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; McAllister JM, 2014, P NATL ACAD SCI USA, V111, pE1519, DOI 10.1073/pnas.1400574111; Mehta D, 2016, JAMA PSYCHIAT, V73, P497, DOI 10.1001/jamapsychiatry.2016.0129; MENKEN J, 1985, DEMOGRAPHY, V22, P469, DOI 10.2307/2061583; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Mills MC, 2015, KOLNER Z SOZIOL SOZ, V67, P397, DOI 10.1007/s11577-015-0319-4; Mishra A, 2015, TWIN RES HUM GENET, V18, P86, DOI 10.1017/thg.2014.79; Mojiminiyi OA, 2010, SCAND J CLIN LAB INV, V70, P554, DOI 10.3109/00365513.2010.526242; O'Bryan MK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003628; O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Okkelman IA, 2014, CELL TISSUE RES, V358, P481, DOI 10.1007/s00441-014-1972-z; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Perry JRB, 2013, HUM MOL GENET, V22, P1465, DOI 10.1093/hmg/dds551; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pers TH, 2013, NUCLEIC ACIDS RES, V41, pW104, DOI 10.1093/nar/gkt387; PONGLIKITMONGKOL M, 1988, EMBO J, V7, P3385, DOI 10.1002/j.1460-2075.1988.tb03211.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rahmioglu N, 2014, HUM REPROD UPDATE, V20, P702, DOI 10.1093/humupd/dmu015; Reese KL, 2010, MOL REPROD DEV, V77, P759, DOI 10.1002/mrd.21217; Rietveld CA, 2014, P NATL ACAD SCI USA, V111, P13790, DOI 10.1073/pnas.1404623111; Ruan YB, 2011, J BIOL CHEM, V286, P29417, DOI 10.1074/jbc.M111.274647; Sakamoto O, 1997, J CLIN INVEST, V99, P701, DOI 10.1172/JCI119214; Szucs M, 2015, ANDROLOGIA, V47, P519, DOI 10.1111/and.12296; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Tropf FC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126821; Tsukamoto S, 2013, J REPROD DEVELOP, V59, P33; Urano A, 2005, MOL CELL BIOL, V25, P6834, DOI 10.1128/MCB.25.15.6834-6845.2005; Vaez A, 2015, CIRC-CARDIOVASC GENE, V8, P487, DOI 10.1161/CIRCGENETICS.114.000714; van der Most PJ, 2014, BIOINFORMATICS, V30, P1185, DOI 10.1093/bioinformatics/btt745; Van Maldergem L, 2006, J MED GENET, V43, P148, DOI 10.1136/jmg.2005.031781; Varshney GK, 2016, NUCLEIC ACIDS RES, V44, pD822, DOI 10.1093/nar/gkv998; Venkatesh T, 2014, APPL CLIN GENET, V7, P235, DOI 10.2147/TACG.S40809; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zhang CG, 2013, AM J PHYSIOL-ENDOC M, V305, pE1384, DOI 10.1152/ajpendo.00406.2013; Zhernakova D., 2015, HYPOTHESIS FREE IDEN	79	146	147	1	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1462	1472		10.1038/ng.3698	http://dx.doi.org/10.1038/ng.3698			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27798627	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000389011100006
J	Chu, J; Vila-Farres, X; Inoyama, D; Ternei, M; Cohen, LJ; Gordon, EA; Reddy, BVB; Charlop-Powers, Z; Zebroski, HA; Gallardo-Macias, R; Jaskowski, M; Satish, S; Park, S; Perlin, DS; Freundlich, JS; Brady, SF				Chu, John; Vila-Farres, Xavier; Inoyama, Daigo; Ternei, Melinda; Cohen, Louis J.; Gordon, Emma A.; Reddy, Boojala Vijay B.; Charlop-Powers, Zachary; Zebroski, Henry A.; Gallardo-Macias, Ricardo; Jaskowski, Mark; Satish, Shruthi; Park, Steven; Perlin, David S.; Freundlich, Joel S.; Brady, Sean F.			Discovery of MRSA active antibiotics using primary sequence from the human microbiome	NATURE CHEMICAL BIOLOGY			English	Article							NATURAL-PRODUCTS; GUT MICROBIOME; PEPTIDE; DOMAINS	Here we present a natural product discovery approach, whereby structures are bioinformatically predicted from primary sequence and produced by chemical synthesis (synthetic-bioinformatic natural products, syn-BNPs), circumventing the need for bacterial culture and gene expression. When we applied the approach to nonribosomal peptide synthetase gene clusters from human-associated bacteria, we identified the humimycins. These antibiotics inhibit lipid II flippase and potentiate beta-lactam activity against methicillin-resistant Staphylococcus aureus in mice, potentially providing a new treatment regimen.	[Chu, John; Vila-Farres, Xavier; Ternei, Melinda; Cohen, Louis J.; Gordon, Emma A.; Reddy, Boojala Vijay B.; Charlop-Powers, Zachary; Brady, Sean F.] Rockefeller Univ, Lab Genet Encoded Small Mol, 1230 York Ave, New York, NY 10021 USA; [Inoyama, Daigo; Gallardo-Macias, Ricardo; Jaskowski, Mark; Satish, Shruthi; Freundlich, Joel S.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Zebroski, Henry A.] Rockefeller Univ, Prote Resource Ctr, 1230 York Ave, New York, NY 10021 USA; [Park, Steven; Perlin, David S.] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ USA	Rockefeller University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rockefeller University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Brady, SF (corresponding author), Rockefeller Univ, Lab Genet Encoded Small Mol, 1230 York Ave, New York, NY 10021 USA.	sbrady@rockefeller.edu		Chu, John/0000-0002-7033-7229; Charlop-Powers, Zachary/0000-0001-8816-4680	Rainin Foundation; US National Institutes of Health [U19AI109713, F32 29 AI110029]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI110029, U19AI109713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007792] Funding Source: NIH RePORTER	Rainin Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Fischetti (MRSA), Tomasz (MRSA) and Marraffini (S. aureus, S. delphini, S. intermedius, and S. pseudo-intermedius) laboratories at the Rockefeller University for providing strains. This work was supported by the Rainin Foundation, US National Institutes of Health grants U19AI109713 (D.S.P.) and F32 29 AI110029 (Z.C.-P.).	Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Charlop-Powers Z, 2015, ELIFE, V4, DOI 10.7554/eLife.05048; Charlop-Powers Z, 2014, CURR OPIN MICROBIOL, V19, P70, DOI 10.1016/j.mib.2014.05.021; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cockerill FR, 2012, METHODS DILUTION ANT; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; D'Argenio V, 2015, CLIN CHIM ACTA, V451, P97, DOI 10.1016/j.cca.2015.01.003; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/NCHEMBIO.1659, 10.1038/nchembio.1659]; Garrison E, 2012, GENOMICS, V1207, P3907, DOI DOI 10.48550/ARXIV.1207.3907; Graham Joanna E, 2007, Invest Ophthalmol Vis Sci, V48, P5616; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kitagawa W, 2008, MICROBES ENVIRON, V23, P167, DOI 10.1264/jsme2.23.167; Kohli RM, 2002, NATURE, V418, P658, DOI 10.1038/nature00907; Kraal L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097279; Lee SH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7364; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Minowa Y, 2007, J MOL BIOL, V368, P1500, DOI 10.1016/j.jmb.2007.02.099; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Piel J, 2011, ANNU REV MICROBIOL, V65, P431, DOI 10.1146/annurev-micro-090110-102805; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rasmussen TT, 2000, APMIS, V108, P663, DOI 10.1034/j.1600-0463.2000.d01-13.x; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; Sewell EWC, 2014, J ANTIBIOT, V67, P43, DOI 10.1038/ja.2013.100; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; WANG SS, 1973, J AM CHEM SOC, V95, P1328, DOI 10.1021/ja00785a602; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437	33	90	98	9	63	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1004	+		10.1038/nchembio.2207	http://dx.doi.org/10.1038/nchembio.2207			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27748750	Green Accepted			2022-12-25	WOS:000388582900007
J	Waring, MJ; Chen, HW; Rabow, AA; Walker, G; Bobby, R; Boiko, S; Bradbury, RH; Callis, R; Clark, E; Dale, I; Daniels, DL; Dulak, A; Flavell, L; Holdgate, G; Jowitt, TA; Kikhney, A; McAlister, M; Mendez, J; Ogg, D; Patel, J; Petteruti, P; Robb, GR; Robers, MB; Saif, S; Stratton, N; Svergun, DI; Wang, WX; Whittaker, D; Wilson, DM; Yao, Y				Waring, Michael J.; Chen, Huawei; Rabow, Alfred A.; Walker, Graeme; Bobby, Romel; Boiko, Scott; Bradbury, Rob H.; Callis, Rowena; Clark, Edwin; Dale, Ian; Daniels, Danette L.; Dulak, Austin; Flavell, Liz; Holdgate, Geoff; Jowitt, Thomas A.; Kikhney, Alexey; McAlister, Mark; Mendez, Jacqui; Ogg, Derek; Patel, Joe; Petteruti, Philip; Robb, Graeme R.; Robers, Matthew B.; Saif, Sakina; Stratton, Natalie; Svergun, Dmitri I.; Wang, Wenxian; Whittaker, David; Wilson, David M.; Yao, Yi			Potent and selective bivalent inhibitors of BET bromodomains	NATURE CHEMICAL BIOLOGY			English	Article							INVESTIGATIONAL ONCOLOGY AGENTS; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; SUPER-ENHANCERS; SMALL-MOLECULE; CELL IDENTITY; DISCOVERY; CHROMATIN; PROTEINS; BINDING	Proteins of the bromodomain and extraterminal (BET) family, in particular bromodomain-containing protein 4 (BRD4), are of great interest as biological targets. BET proteins contain two separate bromodomains, and existing inhibitors bind to them monovalently. Here we describe the discovery and characterization of probe compound biBET, capable of engaging both bromodomains simultaneously in a bivalent, in cis binding mode. The evidence provided here was obtained in a variety of biophysical and cellular experiments. The bivalent binding results in very high cellular potency for BRD4 binding and pharmacological responses such as disruption of BRD4-mediator complex subunit 1 foci with an EC50 of 100 pM. These compounds will be of considerable utility as BET/BRD4 chemical probes. This work illustrates a novel concept in ligand design-simultaneous targeting of two separate domains with a drug-like small molecule-providing precedent for a potentially more effective paradigm for developing ligands for other multi-domain proteins.	[Waring, Michael J.; Rabow, Alfred A.; Walker, Graeme; Bobby, Romel; Bradbury, Rob H.; Callis, Rowena; Dale, Ian; Flavell, Liz; Holdgate, Geoff; McAlister, Mark; Ogg, Derek; Robb, Graeme R.; Stratton, Natalie; Whittaker, David; Wilson, David M.] AstraZeneca, Alderley Pk, England; [Waring, Michael J.] Newcastle Univ, Sch Chem, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England; [Chen, Huawei; Boiko, Scott; Clark, Edwin; Dulak, Austin; Patel, Joe; Petteruti, Philip; Saif, Sakina; Wang, Wenxian; Yao, Yi] AstraZeneca, Waltham, MA USA; [Daniels, Danette L.; Mendez, Jacqui; Robers, Matthew B.] Promega Corp, Madison, WI USA; [Jowitt, Thomas A.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Kikhney, Alexey; Svergun, Dmitri I.] European Mol Biol Lab, Hamburg, Germany	Newcastle University - UK; AstraZeneca; Promega Corporation; University of Manchester; European Molecular Biology Laboratory (EMBL)	Waring, MJ (corresponding author), AstraZeneca, Alderley Pk, England.; Waring, MJ (corresponding author), Newcastle Univ, Sch Chem, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England.	mike.waring@newcastle.ac.uk; edwin.clark@astrazeneca.com		Jowitt, Thomas/0000-0002-4045-0933; Svergun, Dmitri/0000-0003-0830-5696; mcalister, mark/0000-0003-3986-1767; Waring, Michael/0000-0002-9110-8783				Arnold D.L., 2015, International patent application, Patent No. [WO 2015081284, 2015081284]; Arnold L. D., 2013, Patent No. [WO 2013/033268 A2, 2013033268, WO2013033268A2]; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Baud MGJ, 2014, SCIENCE, V346, P638, DOI 10.1126/science.1249830; Blanc E., 2011, BUSTER VERSION 2 11; Bradbury RH, 2016, J MED CHEM, V59, P7801, DOI 10.1021/acs.jmedchem.6b00070; Bradbury RH, 2013, BIOORG MED CHEM LETT, V23, P1945, DOI 10.1016/j.bmcl.2013.02.056; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Buttar D, 2010, BIOORGAN MED CHEM, V18, P7486, DOI 10.1016/j.bmc.2010.08.052; Callis R, 2015, J BIOMOL SCREEN, V20, P748, DOI 10.1177/1087057115580298; Camenisch G, 1998, EUR J PHARM SCI, V6, P313, DOI 10.1016/S0928-0987(97)10019-7; Chen H., 2016, MOL CANC THER; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Helmus JJ, 2013, J BIOMOL NMR, V55, P355, DOI 10.1007/s10858-013-9718-x; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Krishnamurthy V.M., 2006, FRAGMENT BASED APPRO; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Loddick SA, 2013, MOL CANCER THER, V12, P1715, DOI 10.1158/1535-7163.MCT-12-1174; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Machleidt T, 2015, ACS CHEM BIOL, V10, P1797, DOI 10.1021/acschembio.5b00143; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Mirguet O, 2013, J MED CHEM, V56, P7501, DOI 10.1021/jm401088k; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Morris J, 2013, MOL CANCER THER, V12, DOI 10.1158/1535-7163.TARG-13-A102; Morris J, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-5475; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Philpott M, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-14; Prinjha RK, 2012, TRENDS PHARMACOL SCI, V33, P146, DOI 10.1016/j.tips.2011.12.002; Quinn E., 2013, CANCER RES, V73, P4238; Robers MB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10091; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Smart O. S., 2011, GRADE VERSION 1 2 9; Stathis A, 2014, EUR J CANCER, V50, P196, DOI 10.1016/S0959-8049(14)70726-9; Sun HY, 2007, J AM CHEM SOC, V129, P15279, DOI 10.1021/ja074725f; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Vidler LR, 2012, J MED CHEM, V55, P7346, DOI 10.1021/jm300346w; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Williams FP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154607; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; ZAVA DT, 1979, ENDOCRINOLOGY, V104, P1008, DOI 10.1210/endo-104-4-1007; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	62	79	79	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1097	+		10.1038/NCHEMBIO.2210	http://dx.doi.org/10.1038/NCHEMBIO.2210			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27775716	Green Submitted, Bronze			2022-12-25	WOS:000388582900020
J	Wilfert, AB; Chao, KR; Kaushal, M; Jain, S; Zollner, S; Adams, DR; Conrad, DF				Wilfert, Amy B.; Chao, Katherine R.; Kaushal, Madhurima; Jain, Sanjay; Zollner, Sebastian; Adams, David R.; Conrad, Donald F.			Genome-wide significance testing of variation from single case exomes	NATURE GENETICS			English	Article							SEQUENCE VARIANTS; GENETIC-VARIATION; HUMAN-DISEASE; MUTATION; ASSOCIATION; GUIDELINES; FRAMEWORK	Standard techniques from genetic epidemiology are ill-suited to formally assess the significance of variants identified from a single case. We developed a statistical inference framework for identifying unusual functional variation from a single exome or genome, what we refer to as the 'n-of-one' problem. Using this approach we assessed our ability to identify the causal genotypes in over 5 million simulated cases of Mendelian disease, identifying 39% of disease genotypes as the most damaging unit in a typical exome background. We applied our approach to 129 n-of-one families from the Undiagnosed Diseases Program, nominating 60% of 30 disease genes determined to be diagnostic by a standard clinical workup. Our method can currently produce well-calibrated P values when applied to single genomes, can facilitate integration of multiple data types for n-of-one analyses, and, with further work, could become a widely used epidemiological method like linkage analysis or genome-wide association analysis.	[Wilfert, Amy B.; Conrad, Donald F.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Chao, Katherine R.; Adams, David R.] NIH, Undiagnosed Dis Program, Bldg 10, Bethesda, MD 20892 USA; [Kaushal, Madhurima; Jain, Sanjay] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Jain, Sanjay; Conrad, Donald F.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA; [Zollner, Sebastian] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan	Conrad, DF (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.; Conrad, DF (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA.	dconrad@genetics.wustl.edu		Adams, David/0000-0002-6660-1242; jain, sanjay/0000-0003-2804-127X; Wilfert, Amy/0000-0001-8590-222X; Conrad, Donald/0000-0003-3828-8970	US National Institutes of Health [R01MH101810]; March of Dimes Foundation [6-FY14-430]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087011, R01HD078641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007178, T32HG000045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101810] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Wilson and M. Stephens for helpful comments, N. Huang for useful discussions and for providing updated versions of some annotations used in this work, K. Vigh-Conrad for assistance in preparing the figures, D. MacArthur, M. Lek and the members of the ExAC Consortium for generous prepublication sharing of their data, and M. Hoffmann and WU Kidney Translational Research Core (KTRC) for patient enrolment and Genome Technology Access Center (GTAC) for exome sequencing of CAKUT patients. Our work was supported by US National Institutes of Health grant R01MH101810 (to D.F.C.), March of Dimes Foundation grant #6-FY14-430 (to S.J.).	Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Kantarci S, 2008, AM J MED GENET A, V146A, P1842, DOI 10.1002/ajmg.a.32381; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lohmueller KE, 2014, CURR OPIN GENET DEV, V29, P139, DOI 10.1016/j.gde.2014.09.005; Lopes AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003349; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Mitchell AA, 2005, GENOME RES, V15, P960, DOI 10.1101/gr.3761405; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rey RA, 2013, ANDROLOGY-US, V1, P3, DOI 10.1111/j.2047-2927.2012.00008.x; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Stenson Peter D, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s39; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111	21	23	23	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1455	1461		10.1038/ng.3697	http://dx.doi.org/10.1038/ng.3697			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27776118	Green Accepted			2022-12-25	WOS:000389011100005
J	Hanse, RJ; Pritchard, CC; Shendure, J; Salipante, SJ				Hanse, Ronald J.; Pritchard, Colin C.; Shendure, Jay; Salipante, Stephen J.			Classification and characterization of microsatellite instability across 18 cancer types	NATURE MEDICINE			English	Article							DNA MISMATCH REPAIR; COLORECTAL-CANCER; GASTRIC CANCERS; HUMAN GENOME; MSI-H; MUTATIONS; CARCINOMA; EXPRESSION; TUMORS; GENES	Microsatellite instability (MSI), the spontaneous loss or gain of nucleotides from repetitive DNA tracts, is a diagnostic phenotype for gastrointestinal, endometrial, and colorectal tumors, yet the landscape of instability events across a wider variety of cancer types remains poorly understood. To explore MSI across malignancies, we examined 5,930 cancer exomes from 18 cancer types at more than 200,000 microsatellite loci and constructed a genomic classifier for MSI. We identified MSI-positive tumors in 14 of the 18 cancer types. We also identified loci that were more likely to be unstable in particular cancer types, resulting in specific instability signatures that involved cancer-associated genes, suggesting that instability patterns reflect selective pressures and can potentially identify novel cancer drivers. We also observed a correlation between survival outcomes and the overall burden of unstable microsatellites, suggesting that MSI may be a continuous, rather than discrete, phenotype that is informative across cancer types. These analyses offer insight into conserved and cancer-specific properties of MSI and reveal opportunities for improved methods of clinical MSI diagnosis and cancer gene discovery.	[Hanse, Ronald J.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Pritchard, Colin C.; Salipante, Stephen J.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Salipante, SJ (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.; Shendure, J (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.	shendure@uw.edu; stevesal@uw.edu	Shendure, Jay/AAU-3684-2021	Hause, Ronald/0000-0002-5229-7366	Damon Runyon Cancer Research Foundation [DRG-2224-15]; Congressionally Directed Medical Research Program [PC131820]; Young Investigator Award from the Prostate Cancer Foundation	Damon Runyon Cancer Research Foundation; Congressionally Directed Medical Research Program(United States Department of Defense); Young Investigator Award from the Prostate Cancer Foundation	We thank A. McKenna and other members of S.J.S. and J.S.'s laboratories for helpful advice and assistance. This work was supported in part by the Damon Runyon Cancer Research Foundation (DRG-2224-15 to R.J.H.), a Congressionally Directed Medical Research Program (PC131820 to C.C.P.), and a Young Investigator Award from the Prostate Cancer Foundation (to C.C.P.).	Altavilla G, 2010, ONCOL REP, V24, P927, DOI 10.3892/or_00000938; Amira N, 2003, J UROLOGY, V170, P1151, DOI 10.1097/01.ju.0000086551.22844.cd; Bacher JW, 2004, DIS MARKERS, V20, P237, DOI 10.1155/2004/136734; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; Dacic S, 2007, AM J CLIN PATHOL, V127, P282, DOI 10.1309/CRCU356U7146YC31; de la Chapelle A, 2010, J CLIN ONCOL, V28, P3380, DOI 10.1200/JCO.2009.27.0652; Dorard C, 2011, NAT MED, V17, P1283, DOI 10.1038/nm.2457; Duval A, 2002, CANCER RES, V62, P1609; Duval A, 2001, HUM MOL GENET, V10, P513, DOI 10.1093/hmg/10.5.513; Eckert A, 2007, BRAIN PATHOL, V17, P146, DOI 10.1111/j.1750-3639.2007.00049.x; Eckert KA, 2009, MOL CARCINOGEN, V48, P379, DOI 10.1002/mc.20499; FIELD JK, 1995, BRIT J CANCER, V71, P1065, DOI 10.1038/bjc.1995.205; Forgacs E, 2001, ONCOGENE, V20, P1005, DOI 10.1038/sj.onc.1204211; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Goel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009393; Hampel H, 2006, CANCER RES, V66, P7810, DOI 10.1158/0008-5472.CAN-06-1114; Huang MN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13321; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Jensen KC, 2008, AM J SURG PATHOL, V32, P1029, DOI 10.1097/PAS.0b013e31816380c4; Jung B, 2004, GASTROENTEROLOGY, V126, P654, DOI 10.1053/j.gastro.2004.01.008; Kazachkov Y, 1998, LIVER, V18, P156; Kim MS, 2013, DIGEST DIS SCI, V58, P3376, DOI 10.1007/s10620-013-2808-5; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Laiho P, 2002, CANCER RES, V62, P1166; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063056; Martinez R, 2005, J CANCER RES CLIN, V131, P87, DOI 10.1007/s00432-004-0592-5; McIver LJ, 2014, BREAST CANCER RES TR, V145, P791, DOI 10.1007/s10549-014-2908-8; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Mori Y, 2002, CANCER RES, V62, P3641; Murphy KM, 2006, J MOL DIAGN, V8, P305, DOI 10.2353/jmoldx.2006.050092; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; Oki E, 1999, ONCOGENE, V18, P2143, DOI 10.1038/sj.onc.1202583; Onda M, 2001, CLIN CANCER RES, V7, P3444; Pawlik TM, 2004, DIS MARKERS, V20, P199, DOI 10.1155/2004/368680; Pritchard CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5988; Salipante SJ, 2014, CLIN CHEM, V60, P1192, DOI 10.1373/clinchem.2014.223677; Samowitz WS, 2001, CANCER EPIDEM BIOMAR, V10, P917; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shin N, 2011, INT J CANCER, V128, P2872, DOI 10.1002/ijc.25641; Sonay TB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1902-9; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; Yoon K, 2013, GENOME RES, V23, P1109, DOI 10.1101/gr.145706.112	50	458	484	5	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1342	1350		10.1038/nm.4191	http://dx.doi.org/10.1038/nm.4191			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27694933				2022-12-25	WOS:000387302300028
J	Exell, JC; Thompson, MJ; Finger, LD; Shaw, SJ; Debreczeni, J; Ward, TA; McWhirter, C; Sioberg, CLB; Molina, DM; Abbott, WM; Jones, CD; Nissink, JWM; Durant, ST; Grasby, JA				Exell, Jack C.; Thompson, Mark J.; Finger, L. David; Shaw, Steven J.; Debreczeni, Judit; Ward, Thomas A.; McWhirter, Claire; Sioberg, Catrine L. B.; Molina, Daniel Martinez; Abbott, W. Mark; Jones, Clifford D.; Nissink, J. Willem M.; Durant, Stephen T.; Grasby, Jane A.			Cellularly active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN FLAP ENDONUCLEASE-1; STRAND BREAK REPAIR; DNA END RESECTION; EXONUCLEASE 1; REPLICATION; IDENTIFICATION; COMPLEXES; MECHANISM; CANCER; EXO1	The structure-specific nuclease human flap endonuclease-1 (hFEN1) plays a key role in DNA replication and repair and may be of interest as an oncology target. We present the crystal structure of inhibitor-bound hFEN1, which shows a cyclic N-hydroxyurea bound in the active site coordinated to two magnesium ions. Three such compounds had similar IC50 values but differed subtly in mode of action. One had comparable affinity for protein and protein-substrate complex and prevented reaction by binding to active site catalytic metal ions, blocking the necessary unpairing of substrate DNA. Other compounds were more competitive with substrate. Cellular thermal shift data showed that both inhibitor types engaged with hFEN1 in cells, and activation of the DNA damage response was evident upon treatment with inhibitors. However, cellular EC50 values were significantly higher than in vitro inhibition constants, and the implications of this for exploitation of hFEN1 as a drug target are discussed.	[Exell, Jack C.; Thompson, Mark J.; Finger, L. David; Shaw, Steven J.; Grasby, Jane A.] Univ Sheffield, Krebs Inst, Dept Chem, Ctr Chem Biol, Sheffield, S Yorkshire, England; [Debreczeni, Judit; McWhirter, Claire; Abbott, W. Mark] AstraZeneca, Innovat Med & Early Dev Biotech Unit, Discovery Sci, Cambridge, England; [Ward, Thomas A.] AstraZeneca, Biosci, Oncol Innovat Med & Early Dev Biotech Unit, Alderley Pk, Cheshire, England; [Sioberg, Catrine L. B.; Molina, Daniel Martinez] Pelago Biosci AB, Solna, Sweden; [Jones, Clifford D.] AstraZeneca, Oncol Innovat Med & Early Dev Biotech Unit, Chem, Alderley Pk, England; [Nissink, J. Willem M.] AstraZeneca, Oncol Innovat Med & Early Dev Biotech Unit, Chem, Cambridge, England; [Durant, Stephen T.; Grasby, Jane A.] Oncol Innovat Med & Early Dev Biotech Unit, Biosci, Cambridge, England; [Exell, Jack C.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA	University of Sheffield; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; University of California System; University of California Davis	Grasby, JA (corresponding author), Univ Sheffield, Krebs Inst, Dept Chem, Ctr Chem Biol, Sheffield, S Yorkshire, England.; Nissink, JWM (corresponding author), AstraZeneca, Oncol Innovat Med & Early Dev Biotech Unit, Chem, Cambridge, England.; Durant, ST; Grasby, JA (corresponding author), Oncol Innovat Med & Early Dev Biotech Unit, Biosci, Cambridge, England.	willem.nissink@astrazeneca.com; stephen.durant@astrazeneca.com; j.a.grasby@sheffield.ac.uk	Nissink, J. Willem M./C-1507-2010; Ward, Thomas/O-8002-2019	Nissink, J. Willem M./0000-0003-2572-9140; Ward, Thomas/0000-0003-0937-4554; McWhirter, Claire/0000-0003-3316-205X; Shaw, Steven/0000-0002-1236-1810	U.K. Biotechnology and Biological Sciences Research Council [BB/K009079/1, BB/M00404X/1]; AstraZeneca; U.K. Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/M00404X/1, BB/K009079/1, BB/L013851/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1623361] Funding Source: researchfish; BBSRC [BB/L013851/1, BB/K009079/1, BB/M00404X/1] Funding Source: UKRI	U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); U.K. Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by U.K. Biotechnology and Biological Sciences Research Council grants BB/K009079/1 and BB/M00404X/1 (both to J.A.G.) and AstraZeneca. J.C.E. thanks the U.K. Engineering and Physical Sciences Research Council and AstraZeneca for a studentship. The authors thank C. Phillips for assistance with submissions of the crystallographic data and T. McGuire for synthetic support.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Chang JH, 2011, NAT STRUCT MOL BIOL, V18, P270, DOI 10.1038/nsmb.1984; CLEGG RM, 1992, BIOCHEMISTRY-US, V31, P4846, DOI 10.1021/bi00135a016; Craggs TD, 2014, NUCLEIC ACIDS RES, V42, P1857, DOI 10.1093/nar/gkt1116; Dahl G, 2013, DRUG DISCOV TODAY, V18, P697, DOI 10.1016/j.drudis.2013.02.010; Desai A, 2014, STEM CELLS, V32, P582, DOI 10.1002/stem.1596; Di Santo R, 2014, J MED CHEM, V57, P539, DOI 10.1021/jm400674a; Dorjsuren D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1082; Durant ST, 2012, J CANCER, V3, P67, DOI 10.7150/jca.3965; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschenfeldt William H., 2010, Journal of Structural and Functional Genomics, V11, P31, DOI 10.1007/s10969-010-9082-y; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Finger LD, 2013, NUCLEIC ACIDS RES, V41, P9839, DOI 10.1093/nar/gkt737; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; Grasby JA, 2012, TRENDS BIOCHEM SCI, V37, P74, DOI 10.1016/j.tibs.2011.10.003; Guo ZG, 2012, MOL CELL, V47, P444, DOI 10.1016/j.molcel.2012.05.042; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Hwang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139435; Illuzzi JL, 2012, CURR MED CHEM, V19, P3922; Izumi T, 1998, CARCINOGENESIS, V19, P525, DOI 10.1093/carcin/19.3.525; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kim CY, 1999, J BIOL CHEM, V274, P1233, DOI 10.1074/jbc.274.3.1233; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Lam JS, 2006, BJU INT, V98, P445, DOI 10.1111/j.1464-410X.2006.06224.x; McManus KJ, 2009, P NATL ACAD SCI USA, V106, P3276, DOI 10.1073/pnas.0813414106; McWhirter C, 2013, J BIOMOL SCREEN, V18, P567, DOI 10.1177/1087057113476551; Mohan V., 2013, NEW RES DIRECTIONS D; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nikolova T, 2009, ANTICANCER RES, V29, P2453; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Panda H., BIOCHEMISTRY, V48, P9952; Parikh Sudip S., 1999, Current Opinion in Structural Biology, V9, P37, DOI 10.1016/S0959-440X(99)80006-2; Patel N, 2013, J BIOL CHEM, V288, P34239, DOI 10.1074/jbc.M113.509489; Patel N, 2012, NUCLEIC ACIDS RES, V40, P4507, DOI 10.1093/nar/gks051; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Shibata Y, 2002, J BIOL CHEM, V277, P746, DOI 10.1074/jbc.M109461200; Singh P, 2008, MOL CANCER RES, V6, P1710, DOI 10.1158/1541-7786.MCR-08-0269; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tomlinson CG, 2011, J BIOL CHEM, V286, P30878, DOI 10.1074/jbc.M111.230391; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Tumey LN, 2005, BIOORG MED CHEM LETT, V15, P277, DOI 10.1016/j.bmcl.2004.10.086; van Pel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003254; WAGA S, 1994, J BIOL CHEM, V269, P10923; Yeo JE, 2014, HUM MOL GENET, V23, P3695, DOI 10.1093/hmg/ddu078; Yoshimoto K, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00186; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884	57	40	41	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					815	+		10.1038/NCHEMBIO.2148	http://dx.doi.org/10.1038/NCHEMBIO.2148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27526030	Green Accepted			2022-12-25	WOS:000384248600013
J	Svensson, RU; Parker, SJ; Eichner, LJ; Kolar, MJ; Wallace, M; Brun, SN; Lombardo, PS; Van Nostrand, JL; Hutchins, A; Vera, L; Gerken, L; Greenwood, J; Bhat, S; Harriman, G; Westlin, WF; Harwood, HJ; Saghatelian, A; Kapeller, R; Metallo, CM; Shaw, RJ				Svensson, Robert U.; Parker, Seth J.; Eichner, Lillian J.; Kolar, Matthew J.; Wallace, Martina; Brun, Sonja N.; Lombardo, Portia S.; Van Nostrand, Jeanine L.; Hutchins, Amanda; Vera, Lilliana; Gerken, Laurie; Greenwood, Jeremy; Bhat, Sathesh; Harriman, Geraldine; Westlin, William F.; Harwood, H. James, Jr.; Saghatelian, Alan; Kapeller, Rosana; Metallo, Christian M.; Shaw, Reuben J.			Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models	NATURE MEDICINE			English	Article							PHOSPHORYLATION SITES; HEPATIC STEATOSIS; AMPK; PROSTATE; SURVIVAL; SYNTHASE; ALPHA; HOMEOSTASIS; LIPOGENESIS; METABOLISM	Continuous de novo fatty acid synthesis is a common feature of cancer that is required to meet the biosynthetic demands of a growing tumor. This process is controlled by the rate-limiting enzyme acetyl-CoA carboxylase (ACC), an attractive but traditionally intractable drug target. Here we provide genetic and pharmacological evidence that in preclinical models ACC is required to maintain the de novo fatty acid synthesis needed for growth and viability of non-small-cell lung cancer (NSCLC) cells. We describe the ability of ND-646-an allosteric inhibitor of the ACC enzymes ACC1 and ACC2 that prevents ACC subunit dimerization to suppress fatty acid synthesis in vitro and in vivo. Chronic ND-646 treatment of xenograft and genetically engineered mouse models of NSCLC inhibited tumor growth. When administered as a single agent or in combination with the standard-of-care drug carboplatin, ND-646 markedly suppressed lung tumor growth in the Kras;Trp53(-/-) (also known as KRAS p53) and Kras;Stk11(-/-) (also known as KRAS Lkb1) mouse models of NSCLC. These findings demonstrate that ACC mediates a metabolic liability of NSCLC and that ACC inhibition by ND-646 is detrimental to NSCLC growth, supporting further examination of the use of ACC inhibitors in oncology.	[Svensson, Robert U.; Eichner, Lillian J.; Brun, Sonja N.; Lombardo, Portia S.; Van Nostrand, Jeanine L.; Hutchins, Amanda; Vera, Lilliana; Gerken, Laurie; Shaw, Reuben J.] Salk Inst Biol Studies, Dept Mol & Cell Biol, San Diego, CA 92138 USA; [Parker, Seth J.; Wallace, Martina; Metallo, Christian M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kolar, Matthew J.; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA USA; [Greenwood, Jeremy; Bhat, Sathesh] Schrodinger, New York, NY USA; [Harriman, Geraldine; Westlin, William F.; Harwood, H. James, Jr.; Kapeller, Rosana] Nimbus Therapeut, Cambridge, MA 02141 USA; [Metallo, Christian M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Dept Mol & Cell Biol, San Diego, CA 92138 USA.; Kapeller, R (corresponding author), Nimbus Therapeut, Cambridge, MA 02141 USA.	rosana.kapeller@nimbustx.com; shaw@salk.edu	Metallo, Christian/HCH-3476-2022	Metallo, Christian/0000-0003-2404-3040; Van Nostrand, Jeanine/0000-0003-1363-9527; Parker, Seth/0000-0001-7971-8848; Kolar, Matthew/0000-0001-8054-9121; Wallace, Martina/0000-0001-8272-5678	US National Institutes of Health (NIH) [R01CA172229, P01CA120964, R01CA188652]; Samuel Waxman Cancer Research Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG- MED002]; US Department of Defense [W81-XWH-13-1-01-5]; American Cancer Society (ACS) [124183-PF-13-023-01-CSM]; T32 postdoctoral training grant [5 T32 CA009370, T32: 5T32CA009370-33]; American Cancer Society [PF-15-037-01-DMC]; F31 NIH predoctoral training fellowship [F31CA196066-01]; UCSD Medical Scientist Training Program fellowship [2 T32 GM007198]; T32 predoctoral training grant [T32 GM 007240]; Damon Runyon Cancer Research Foundation fellowship [DRG-2219-15]; Salk [CCSG P30 CA014195]; next-generation sequencing (NGS) core facility at the Salk Institute - NIH-NCI [CCSG P30 014195]; Chapman Foundation; Glenn Foundation; Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE [T32CA009370, F31CA196066, P01CA120964, R01CA172229, R01CA188652, P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240, T32GM007198] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; Leona M. and Harry B. Helmsley Charitable Trust; US Department of Defense(United States Department of Defense); American Cancer Society (ACS)(American Cancer Society); T32 postdoctoral training grant; American Cancer Society(American Cancer Society); F31 NIH predoctoral training fellowship; UCSD Medical Scientist Training Program fellowship; T32 predoctoral training grant; Damon Runyon Cancer Research Foundation fellowship; Salk; next-generation sequencing (NGS) core facility at the Salk Institute - NIH-NCI; Chapman Foundation; Glenn Foundation; Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the US National Institutes of Health (NIH) (grant no. R01CA172229 (R.J.S.), P01CA120964 (R.J.S.) and R01CA188652 (C.M.M.)), the Samuel Waxman Cancer Research Foundation (R.J.S.), The Leona M. and Harry B. Helmsley Charitable Trust (grant no. 2012-PG- MED002; R.J.S.) and the US Department of Defense (grant no. W81-XWH-13-1-01-5; C.M.M. and R.J.S.). R.U.S. was supported by a postdoctoral fellowship from the American Cancer Society (ACS#124183-PF-13-023-01-CSM). L.J.E. was supported by a T32 postdoctoral training grant to the Salk Institute Cancer Center (5 T32 CA009370) and a postdoctoral fellowship from the American Cancer Society (PF-15-037-01-DMC). S.J.P. was supported by an F31 NIH predoctoral training fellowship (F31CA196066-01). M.J.K. is supported by a UCSD Medical Scientist Training Program fellowship (2 T32 GM007198). P.S.L. was supported by a T32 predoctoral training grant (T32 GM 007240). S.N.B. is supported by a T32 postdoctoral training grant to the Salk Institute Cancer Center (T32: 5T32CA009370-33), J.L.V.N. is supported by a Damon Runyon Cancer Research Foundation fellowship (DRG-2219-15). We thank K. McIntyre and the histology core at the Salk Institute, which is also supported in part through the Salk CCSG P30 CA014195 grant, as well as the next-generation sequencing (NGS) core facility at the Salk Institute, which is supported with funding from the NIH-NCI CCSG P30 014195 grant, the Chapman Foundation, the Glenn Foundation and the Helmsley Charitable Trust. We also thank R. Farid for Figure 2b, E. Smith for Figure 2j, G. Wahl for the p53-specific antibody used in the IHC experiments and P. Hollstein for technical assistance.	Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Camarda R, 2016, NAT MED, V22, P427, DOI 10.1038/nm.4055; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Cho YS, 2010, BIOCHEM BIOPH RES CO, V391, P187, DOI 10.1016/j.bbrc.2009.11.029; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gandhi L, 2009, CANCER PREV RES, V2, P330, DOI 10.1158/1940-6207.CAPR-08-0213; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Harriman G, 2016, P NATL ACAD SCI USA, V113, pE1796, DOI 10.1073/pnas.1520686113; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Lee WNP, 2000, AM J PHYSIOL-ENDOC M, V279, pE425, DOI 10.1152/ajpendo.2000.279.2.E425; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; O'Brien AJ, 2015, BIOCHEM J, V469, P177, DOI 10.1042/BJ20150122; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Swinnen JV, 2005, CANCER RES, V65, P2441, DOI 10.1158/0008-5472.CAN-04-3025; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang C, 2009, BIOCHEM BIOPH RES CO, V385, P302, DOI 10.1016/j.bbrc.2009.05.045; Wei J, 2015, NATURE, V526, P723, DOI 10.1038/nature15375; Zadra G, 2014, EMBO MOL MED, V6, P519, DOI 10.1002/emmm.201302734; Zhang Feng, 2012, World J Biol Chem, V3, P167, DOI 10.4331/wjbc.v3.i8.167; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	33	266	277	0	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1108	1119		10.1038/nm.4181	http://dx.doi.org/10.1038/nm.4181			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27643638	Green Accepted, Green Submitted			2022-12-25	WOS:000384872500014
J	Belyy, V; Schlager, MA; Foster, H; Reimer, AE; Carter, AP; Yildiz, A				Belyy, Vladislav; Schlager, Max A.; Foster, Helen; Reimer, Armando E.; Carter, Andrew P.; Yildiz, Ahmet			The mammalian dynein-dynactin complex is a strong opponent to kinesin in a tug-of-war competition	NATURE CELL BIOLOGY			English	Article							CYTOPLASMIC DYNEIN; AXONAL-TRANSPORT; CARGO TRANSPORT; MOTOR; FORCE; MICROTUBULES; PROCESSIVITY; MECHANISM; AUTOINHIBITION; RECRUITMENT	Kinesin and dynein motors transport intracellular cargos bidirectionally by pulling them in opposite directions along microtubules, through a process frequently described as a 'tug of war'(1). While kinesin produces 6 pN of force, mammalian dynein was found to be a surprisingly weak motor (0.5-1.5 pN) in vitro, suggesting that many dyneins are required to counteract the pull of a single kinesin(2). Mammalian dynein's association with dynactin and Bicaudal-D2 (BICD2) activates its processive motility(3-6), but it was unknown how this affects dynein's force output. Here, we show that formation of the dynein-dynactin-BICD2 (DDB) complex increases human dynein's force production to 4.3 pN. An in vitro tug-of-war assay revealed that a single DDB successfully resists a single kinesin. Contrary to previous reports, the clustering of many dyneins is not required to win the tug of war. Our work reveals the key role of dynactin and a cargo adaptor protein in shifting the balance of forces between dynein and kinesin motors during intracellular transport.	[Belyy, Vladislav; Reimer, Armando E.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Schlager, Max A.; Foster, Helen; Carter, Andrew P.] MRC, Mol Biol Lab, Div Struct Studies, Francis Crick Ave, Cambridge CB2 0QH, England; [Yildiz, Ahmet] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Yildiz, Ahmet] Univ Calif Berkeley, Dept Cellular & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; MRC Laboratory Molecular Biology; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Yildiz, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.; Yildiz, A (corresponding author), Univ Calif Berkeley, Dept Cellular & Mol Biol, Berkeley, CA 94720 USA.	yildiz@berkeley.edu	; Yildiz, Ahmet/E-6167-2015	Carter, Andrew/0000-0001-7292-5430; Yildiz, Ahmet/0000-0003-4792-174X; Belyy, Vladislav/0000-0003-2813-8215; Foster, Helen/0000-0002-4691-5746	NIH [GM094522]; NSF CAREER Award [MCB-1055017]; Medical Research Council, UK [MC_UP_A025_1011]; Wellcome Trust New Investigator Award [WT100387]; EMBO Young Investigator Award; Marie Curie Intra European Fellowship; NSF Graduate Research Fellowship [DGE 1106400]; MRC [MC_UP_A025_1011] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1011] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094522] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust New Investigator Award(Wellcome Trust); EMBO Young Investigator Award(European Molecular Biology Organization (EMBO)); Marie Curie Intra European Fellowship(European Commission); NSF Graduate Research Fellowship(National Science Foundation (NSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Can, L. S. Ferro, A. Chien and J. Bandana for helpful discussions. This work was supported by the NIH (GM094522 (A.Y.)), an NSF CAREER Award (MCB-1055017 (A.Y.)), the Medical Research Council, UK (MC_UP_A025_1011 (A.P.C.)), a Wellcome Trust New Investigator Award (WT100387) and an EMBO Young Investigator Award (both to A.P.C.), a Marie Curie Intra European Fellowship (M.A.S.), and an NSF Graduate Research Fellowship (DGE 1106400 (V.B.)).	Ayloo S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5807; Belyy V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6544; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Chowdhury S, 2015, NAT STRUCT MOL BIOL, V22, P345, DOI 10.1038/nsmb.2996; Cleary FB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5587; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Diehl MR, 2006, SCIENCE, V311, P1468, DOI 10.1126/science.1122125; Fu MM, 2014, TRENDS CELL BIOL, V24, P564, DOI 10.1016/j.tcb.2014.05.002; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Hancock WO, 2014, NAT REV MOL CELL BIO, V15, P615, DOI 10.1038/nrm3853; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Kaan HYK, 2011, SCIENCE, V333, P883, DOI 10.1126/science.1204824; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Leidel C, 2012, BIOPHYS J, V103, P492, DOI 10.1016/j.bpj.2012.06.038; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Moughamian AJ, 2013, J NEUROSCI, V33, P13190, DOI 10.1523/JNEUROSCI.0935-13.2013; Nicholas MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7206; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Rai A, 2016, CELL, V164, P722, DOI 10.1016/j.cell.2015.12.054; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Tripathy SK, 2014, NAT CELL BIOL, V16, P1192, DOI 10.1038/ncb3063; Urnavicius L, 2015, SCIENCE, V347, P1441, DOI 10.1126/science.aaa4080; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373	38	97	98	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2016	18	9					1018	1024		10.1038/ncb3393	http://dx.doi.org/10.1038/ncb3393			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DU7TF	27454819	Green Accepted			2022-12-25	WOS:000382416800011
J	Chen, BE; Zheng, BH; DeRan, M; Jarugumilli, GK; Fu, JJ; Brooks, YS; Wu, X				Chen, Baoen; Zheng, Baohui; DeRan, Michael; Jarugumilli, Gopala K.; Fu, Jianjun; Brooks, Yang S.; Wu, Xu			ZDHHC7-mediated S-palmitoylation of Scribble regulates cell polarity	NATURE CHEMICAL BIOLOGY			English	Article							PROMOTES MAMMARY TUMORIGENESIS; PROTEIN PALMITOYLATION; BREAST-CANCER; HIPPO PATHWAY; LOCALIZATION; RAS; DEREGULATION; EXPRESSION; STABILITY; ACYLATION	Scribble (SCRIB) is a tumor-suppressor protein, playing critical roles in establishing and maintaining epithelial cell polarity. SCRIB is frequently amplified in human cancers but does not localize properly to cell-cell junctions, suggesting that mislocalization of SCRIB disrupts its tumor-suppressive activities. Using chemical reporters, here we showed that SCRIB localization was regulated by S-palmitoylation at conserved cysteine residues. Palmitoylation-deficient mutants of SCRIB were mislocalized, leading to disruption of cell polarity and loss of their tumor-suppressive activities to oncogenic YAP, MAPK and PI3K/AKT pathways. We further found that ZDHHC7 was the major palmitoyl acyltransferase regulating SCRIB. Knockout of ZDHHC7 led to SCRIB mislocalization and YAP activation, and disruption of SCRIB's suppressive activities in HRas(V12)-induced cell invasion. In summary, we demonstrated that ZDHHC7-mediated SCRIB palmitoylation is critical for SCRIB membrane targeting, cell polarity and tumor suppression, providing new mechanistic insights of how dynamic protein palmitoylation regulates cell polarity and tumorigenesis.	[Chen, Baoen; Zheng, Baohui; DeRan, Michael; Jarugumilli, Gopala K.; Fu, Jianjun; Brooks, Yang S.; Wu, Xu] Harvard Med Sch, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Wu, X (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	xwu@cbrc2.mgh.harvard.edu			Stewart Rahr-MRA (Melanoma Research Alliance) Young Investigator Award; American Cancer Society [124929-RSG-13-291-01-TBE]; National Institutes of Health [R01CA181537, R01DK107651-01];  [1S10RR027673-01]; NATIONAL CANCER INSTITUTE [R01CA181537] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107651] Funding Source: NIH RePORTER	Stewart Rahr-MRA (Melanoma Research Alliance) Young Investigator Award; American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Stewart Rahr-MRA (Melanoma Research Alliance) Young Investigator Award, Research Scholar Award from American Cancer Society (124929-RSG-13-291-01-TBE), and grants from National Institutes of Health (R01CA181537 and R01DK107651-01) to X.W. We appreciate W.-L. Yan for his generous philanthropic donation to Massachusetts General Hospital to support Y.S.B.'s training and research. We thank M. Fukata (National Institute for Physiological Sciences, Japan) for the expression vectors of DHHC proteins, the Confocal Imaging Core at Cutaneous Biology Research Center of Massachusetts General Hospital, and the Shared Instrumentation Grant that covered the purchase of the microscope (1S10RR027673-01), and the Taplin Mass Spec Core at Harvard Medical School for proteomic studies.	Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Chan P, 2016, NAT CHEM BIOL, V12, P282, DOI [10.1038/nchembio.2036, 10.1038/NCHEMBIO.2036]; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Elsum IA, 2013, J CELL SCI, V126, P3990, DOI 10.1242/jcs.129387; Elsum IA, 2013, CELLS TISSUES ORGANS, V198, P1, DOI 10.1159/000348423; Feigin ME, 2014, CANCER RES, V74, P3180, DOI 10.1158/0008-5472.CAN-13-3415; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Godde NJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004323; Hang HC, 2011, CHEM REV, V111, P6341, DOI 10.1021/cr2001977; Hannoush AN, 2010, NAT CHEM BIOL, V6, P498, DOI [10.1038/NCHEMBIO.388, 10.1038/nchembio.388]; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hungermann D, 2011, J PATHOL, V224, P517, DOI 10.1002/path.2938; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Legouis R, 2003, EMBO REP, V4, P1096, DOI 10.1038/sj.embor.7400006; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Li Y, 2012, J BIOL CHEM, V287, P523, DOI 10.1074/jbc.M111.306183; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Pearson HB, 2011, J CLIN INVEST, V121, P4257, DOI 10.1172/JCI58509; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rossin A, 2015, CELL DEATH DIFFER, V22, P643, DOI 10.1038/cdd.2014.153; Santoni MJ, 2002, TRENDS GENET, V18, P494, DOI 10.1016/S0168-9525(02)02738-5; Vaira V, 2011, AM J PATHOL, V178, P2478, DOI 10.1016/j.ajpath.2011.02.028; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wei XC, 2014, ARTERIOSCL THROM VAS, V34, P346, DOI 10.1161/ATVBAHA.113.302848; Yang CC, 2015, P NATL ACAD SCI USA, V112, P1785, DOI 10.1073/pnas.1420850112; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang MM, 2010, P NATL ACAD SCI USA, V107, P8627, DOI 10.1073/pnas.0912306107; Zheng BH, 2013, J AM CHEM SOC, V135, P7082, DOI 10.1021/ja311416v	46	58	58	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					686	+		10.1038/nchembio.2119	http://dx.doi.org/10.1038/nchembio.2119			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27380321	Green Submitted, Green Accepted			2022-12-25	WOS:000382255100009
J	Lee, J; Liu, JL; Feng, XD; Hernandez, MAS; Mucka, P; Ibi, D; Choi, JW; Ozcan, U				Lee, Jaemin; Liu, Junli; Feng, Xudong; Hernandez, Mario Andres Salazar; Mucka, Patrick; Ibi, Dorina; Choi, Jae Won; Ozcan, Umut			Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice	NATURE MEDICINE			English	Article							CONNECTS ER STRESS; ENERGY-BALANCE; WITHANIA-SOMNIFERA; BODY-WEIGHT; MOUSE MODEL; OBESE GENE; RESISTANCE; NEURONS; PROTEIN; IDENTIFICATION	The increasing global prevalence of obesity and its associated disorders points to an urgent need for the development of novel and effective therapeutic strategies that induce healthy weight loss. Obesity is characterized by hyperleptinemia and central leptin resistance. In an attempt to identify compounds that could reverse leptin resistance and thus promote weight loss, we analyzed a library of small molecules that have mRNA expression profiles similar to that of celastrol, a naturally occurring compound that we previously identified as a leptin sensitizer. Through this process, we identified another naturally occurring compound, withaferin A, that also acts as a leptin sensitizer. We found that withaferin-A treatment of mice with diet-induced obesity (DIO) resulted in a 20-25% reduction of body weight, while also decreasing obesity-associated abnormalities, including hepatic steatosis. Withaferin-A treatment marginally affected the body weight of ob/ob and db/db mice, both of which are deficient in leptin signaling. In addition, withaferin A, unlike celastrol, has beneficial effects on glucose metabolism that occur independently of its leptin-sensitizing effect. Our results show that the metabolic abnormalities of DIO can be mitigated by sensitizing animals to endogenous leptin, and they indicate that withaferin A is a potential leptin sensitizer with additional antidiabetic actions.	[Lee, Jaemin; Liu, Junli; Feng, Xudong; Hernandez, Mario Andres Salazar; Mucka, Patrick; Ibi, Dorina; Choi, Jae Won; Ozcan, Umut] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Ozcan, U (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.	umut.ozcan@childrens.harvard.edu	Salazar, Mario/GSN-2646-2022; Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141	Department of Medicine, Boston Children's Hospital; US National Institutes of Health [R01DK098496]; American Diabetes Association Career Development grant [7-09-CD-10]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098496] Funding Source: NIH RePORTER	Department of Medicine, Boston Children's Hospital; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Career Development grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We greatly appreciate M. White for his time spent on critical reading of our manuscript and for his contributions and suggestions. We thank S. Cabi and I. Cakir for their initial experimental contributions to this work. We also thank S. Mert and B. Akosman for their help on some of the experiments, and S. Huang and M. Mulcahey-Maynard for measurement of serum T3 levels. TSC<SUP>+/+</SUP> and TSC<SUP>-/-</SUP> MEFs were kindly provided by D. Kwiatkowski (Dana-Farber Cancer Institute). This work was mainly supported by funds provided to U.O. from the Department of Medicine, Boston Children's Hospital, and also by grant R01DK098496 (U.O.) from the US National Institutes of Health and American Diabetes Association Career Development grant #7-09-CD-10 (U.O.).	Arch JRS, 1998, INT J OBESITY, V22, P1159, DOI 10.1038/sj/ijo/0800779; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dalamaga M, 2013, CELL METAB, V18, P29, DOI 10.1016/j.cmet.2013.05.010; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Dietrich MO, 2013, TRENDS NEUROSCI, V36, P65, DOI 10.1016/j.tins.2012.12.005; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Hakansson ML, 1998, J NEUROSCI, V18, P559; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Harris RBS, 2006, ENDOCRINOLOGY, V147, P1365, DOI 10.1210/en.2005-1156; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; KAPLAN MM, 1979, ENDOCRINOLOGY, V104, P58, DOI 10.1210/endo-104-1-58; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Long LH, 2014, J CLIN INVEST, V124, P4017, DOI 10.1172/JCI76220; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Myers MG, 2012, CELL METAB, V15, P150, DOI 10.1016/j.cmet.2012.01.002; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park SW, 2013, SEMIN IMMUNOPATHOL, V35, P351, DOI 10.1007/s00281-013-0370-z; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Ramirez S, 2015, FEBS LETT, V589, P1678, DOI 10.1016/j.febslet.2015.04.025; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Williams KW, 2014, CELL METAB, V20, P471, DOI 10.1016/j.cmet.2014.06.002; Winters M, 2006, ALTERN MED REV, V11, P269; Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	57	150	155	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1023	+		10.1038/nm.4145	http://dx.doi.org/10.1038/nm.4145			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27479085	Green Submitted, Green Accepted			2022-12-25	WOS:000382542800013
J	Ben-Shaanan, TL; Azulay-Debby, H; Dubovik, T; Starosvetsky, E; Korin, B; Schiller, M; Green, NL; Admon, Y; Hakim, F; Shen-Orr, SS; Rolls, A				Ben-Shaanan, Tamar L.; Azulay-Debby, Hilla; Dubovik, Tania; Starosvetsky, Elina; Korin, Ben; Schiller, Maya; Green, Nathaniel L.; Admon, Yasmin; Hakim, Fahed; Shen-Orr, Shai S.; Rolls, Asya			Activation of the reward system boosts innate and adaptive immunity	NATURE MEDICINE			English	Article							DOPAMINE; PLACEBO; BRAIN; STIMULATION; RESPONSES; ACCUMBENS; BEHAVIOR; RELEASE; NEURONS; DISEASE	Positive expectations contribute to the clinical benefits of the placebo effect(1,2). Such positive expectations are mediated by the brain's reward system(3,4); however, it remains unknown whether and how reward system activation affects the body's physiology and, specifically, immunity. Here we show that activation of the ventral tegmental area (VTA), a key component of the reward system, strengthens immunological host defense. We used 'designer receptors exclusively activated by designer drugs' (DREADDs) to directly activate dopaminergic neurons in the mouse VTA and characterized the subsequent immune response after exposure to bacteria (Escherichia coli), using time-of-flight mass cytometry (CyTOF) and functional assays. We found an increase in innate and adaptive immune responses that were manifested by enhanced antibacterial activity of monocytes and macrophages, reduced in vivo bacterial load and a heightened T cell response in the mouse model of delayed-type hypersensitivity. By chemically ablating the sympathetic nervous system (SNS), we showed that the reward system's effects on immunity are, at least partly, mediated by the SNS. Thus, our findings establish a causal relationship between the activity of the VTA and the immune response to bacterial infection.	[Ben-Shaanan, Tamar L.; Azulay-Debby, Hilla; Dubovik, Tania; Starosvetsky, Elina; Korin, Ben; Schiller, Maya; Green, Nathaniel L.; Admon, Yasmin; Hakim, Fahed; Shen-Orr, Shai S.; Rolls, Asya] Technion Israel Inst Technol, Rappaport Fac Med, Dept Immunol, Haifa, Israel; [Ben-Shaanan, Tamar L.; Azulay-Debby, Hilla; Korin, Ben; Schiller, Maya; Green, Nathaniel L.; Rolls, Asya] Technion Israel Inst Technol, Rappaport Fac Med, Ctr Sci & Engn Neuronal Syst, Haifa, Israel; [Hakim, Fahed] Rambam Hlth Care Campus, Pediat Pulm Unit, Haifa, Israel; [Shen-Orr, Shai S.] Technion Israel Inst Technol, Fac Biol, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology	Shen-Orr, SS; Rolls, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Immunol, Haifa, Israel.; Rolls, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Ctr Sci & Engn Neuronal Syst, Haifa, Israel.; Shen-Orr, SS (corresponding author), Technion Israel Inst Technol, Fac Biol, Haifa, Israel.	shenorr@technion.ac.il; rolls@technion.ac.il		Rolls, Asya/0000-0001-5862-4287; Shen-Orr, Shai/0000-0002-6991-7736; Ben-Shaanan, Tamar L./0000-0001-6519-1715	FP-7-CIG grant [618654]; Israel Science Foundation (ISF) grants [1862/15, 1365/12]; Technion V.P.R. Fund-Malat Family; Adelis Foundation; Rappaport Institute of Biomedical Research	FP-7-CIG grant; Israel Science Foundation (ISF) grants; Technion V.P.R. Fund-Malat Family; Adelis Foundation; Rappaport Institute of Biomedical Research	We would like to thank A. Ziv-Kenet for his help with CyTOF data analysis, A. D. Eban-Rothchild, C. Tourino, D. Melamed, N. Karin, G. Wildbaum, R. Hershberg and M. Rahat for helpful discussions, A. Mor, F. Zaknoon, J. Jammal, S. Yaron and S. Katz for their help with bacterial experiments, Y. Posen, G. Ginzburg and E. Reisin-Tzur for editing the paper, H. Amitay for her help with the behavioral analysis, and O. Goldberger and the Biomedical core facility at the Technion Faculty of Medicine for technical support. This research was supported by the FP-7-CIG grant 618654 (A.R.), the Israel Science Foundation (ISF) grants 1862/15 (A.R.) and 1365/12 (S.S.S.-O.), the Technion V.P.R. Fund-Malat Family (A.R.), the Adelis Foundation (A.R.) and the Rappaport Institute of Biomedical Research (S.S.S.-O.).	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Balfour ME, 2004, NEUROPSYCHOPHARMACOL, V29, P718, DOI 10.1038/sj.npp.1300350; Barak Y, 2006, AUTOIMMUN REV, V5, P523, DOI 10.1016/j.autrev.2006.02.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; D'Acquisto F, 2014, BIOCHEM PHARMACOL, V91, P287, DOI 10.1016/j.bcp.2014.07.016; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Eisenberger NI, 2012, NAT NEUROSCI, V15, P669, DOI 10.1038/nn.3086; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Fredrickson BL, 2013, P NATL ACAD SCI USA, V110, P13684, DOI 10.1073/pnas.1305419110; GRATTON A, 1988, BRAIN RES BULL, V21, P319, DOI 10.1016/0361-9230(88)90247-X; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; HELLER ED, 1990, AVIAN PATHOL, V19, P345, DOI 10.1080/03079459008418685; Howick J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058247; Huston JP, 2013, TRENDS PHARMACOL SCI, V34, P162, DOI 10.1016/j.tips.2013.01.004; Koopman FA, 2011, MOL MED, V17, P937, DOI 10.2119/molmed.2011.00065; KOSTRZEWA RM, 1974, PHARMACOL REV, V26, P199; LACOSTA S, 1994, BRAIN RES, V664, P225, DOI 10.1016/0006-8993(94)91976-3; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; MITTWOCHJAFFE T, 1995, NEUROREPORT, V6, P789, DOI 10.1097/00001756-199503270-00021; Nakamoto T, 2011, J APPL PHYSIOL, V110, P1342, DOI 10.1152/japplphysiol.01233.2010; National Research Council, 2011, GUIDE CARE USE LAB A; Nieh EH, 2013, BRAIN RES, V1511, P73, DOI 10.1016/j.brainres.2012.11.001; Parmigiani G, 2002, J ROY STAT SOC B, V64, P717, DOI 10.1111/1467-9868.00358; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Saurer TB, 2009, J PHARMACOL EXP THER, V329, P1040, DOI 10.1124/jpet.108.148627; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Segerstrom SC, 1998, J PERS SOC PSYCHOL, V74, P1646, DOI 10.1037/0022-3514.74.6.1646; Segerstrom SC, 2010, PSYCHOL SCI, V21, P448, DOI 10.1177/0956797610362061; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Walach H, 2011, PHILOS T R SOC B, V366, P1870, DOI 10.1098/rstb.2010.0401	38	104	107	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					940	+		10.1038/nm.4133	http://dx.doi.org/10.1038/nm.4133			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376577				2022-12-25	WOS:000381000200020
J	Parker, CC; Gopalakrishnan, S; Carbonetto, P; Gonzales, NM; Leung, E; Park, YJ; Aryee, E; Davis, J; Blizard, DA; Ackert-Bicknell, CL; Lionikas, A; Pritchard, JK; Palmer, AA				Parker, Clarissa C.; Gopalakrishnan, Shyam; Carbonetto, Peter; Gonzales, Natalia M.; Leung, Emily; Park, Yeonhee J.; Aryee, Emmanuel; Davis, Joe; Blizard, David A.; Ackert-Bicknell, Cheryl L.; Lionikas, Arimantas; Pritchard, Jonathan K.; Palmer, Abraham A.			Genome-wide association study of behavioral, physiological and gene expression traits in outbred CFW mice	NATURE GENETICS			English	Article							ADVANCED INTERCROSS LINES; HETEROGENEOUS STOCK MICE; RNA-SEQ; COMPLEX TRAITS; METHAMPHETAMINE SENSITIVITY; OSTEOGENESIS IMPERFECTA; LINKAGE DISEQUILIBRIUM; PREPULSE INHIBITION; CANDIDATE GENES; MOUSE TESTIS	Although mice are the most widely used mammalian model organism, genetic studies have suffered from limited mapping resolution due to extensive linkage disequilibrium ( LD) that is characteristic of crosses among inbred strains. Carworth Farms White ( CFW) mice are a commercially available outbred mouse population that exhibit rapid LD decay in comparison to other available mouse populations. We performed a genome-wide association study ( GWAS) of behavioral, physiological and gene expression phenotypes using 1,200 male CFW mice. We used genotyping by sequencing ( GBS) to obtain genotypes at 92,734 SNPs. We also measured gene expression using RNA sequencing in three brain regions. Our study identified numerous behavioral, physiological and expression quantitative trait loci ( QTLs). We integrated the behavioral QTL and eQTL results to implicate specific genes, including Azi2 in sensitivity to methamphetamine and Zmynd11 in anxiety-like behavior. The combination of CFW mice, GBS and RNA sequencing constitutes a powerful approach to GWAS in mice.	[Parker, Clarissa C.; Gopalakrishnan, Shyam; Carbonetto, Peter; Gonzales, Natalia M.; Leung, Emily; Park, Yeonhee J.; Aryee, Emmanuel; Davis, Joe; Palmer, Abraham A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Parker, Clarissa C.] Middlebury Coll, Dept Psychol, Middlebury, VT 05753 USA; [Parker, Clarissa C.] Middlebury Coll, Program Neurosci, Middlebury, VT 05753 USA; [Gopalakrishnan, Shyam] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Carbonetto, Peter] AncestryDNA, San Francisco, CA USA; [Blizard, David A.] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Ackert-Bicknell, Cheryl L.] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY USA; [Ackert-Bicknell, Cheryl L.] Univ Rochester, Dept Orthoped & Rehabil, Rochester, NY USA; [Lionikas, Arimantas] Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen, Scotland; [Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Palo Alto, CA 94304 USA; [Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA; [Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Palmer, Abraham A.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Palmer, Abraham A.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of Chicago; University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Rochester; University of Rochester; University of Aberdeen; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Chicago; University of California System; University of California San Diego; University of California System; University of California San Diego	Palmer, AA (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.; Palmer, AA (corresponding author), Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA.; Palmer, AA (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.; Palmer, AA (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.	aapalmer@ucsd.edu	Gopalakrishnan, Shyam/J-1546-2019; Ackert-Bicknell, Cheryl/AAC-6833-2019	Gopalakrishnan, Shyam/0000-0002-2004-6810; Ackert-Bicknell, Cheryl/0000-0003-4253-4775	NIH [R01GM097737, P50DA037844, T32DA07255, T32GM07197, R01AR056280, R01AR060234]; Human Frontiers Science Program; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060234, R01AR056280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197, R01GM097737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007255, P50DA037844] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors wish to acknowledge technical assistance from: D. Godfrey, S. Lionikaite, V. Lionikaite, A. S. Lionikiene and J. Zekos as well as technical and intellectual input from M. Abney, J. Borevitz, K. Broman, N. Cai, R. Cheng, N. Cox, R. Davies, J. Flint, L. Goodstadt, P. Grabowski, B. Harr, E. Leffler, R. Mott, J. Nicod, J. Novembre, A. Price, M. Stephens, D. Weeks and X. Zhou. This project was funded by NIH R01GM097737 and P50DA037844 (A. A. P.), NIH T32DA07255 (C.C.P.), NIH T32GM07197 (N.M.G.), NIH R01AR056280 (D. A. B.), NIH R01AR060234 (C.L.A.-B.), the Fellowship from the Human Frontiers Science Program (P.C.) and the Howard Hughes Medical Institute (J.K.P.).	Abney M, 2015, GENET EPIDEMIOL, V39, P249, DOI 10.1002/gepi.21893; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; [Anonymous], 2013, AM J HUM GENET, V93, P1151, DOI 10.1016/j.ajhg.2013.10.015; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Calabrese G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003150; Cheng RY, 2013, GENETICS, V193, P1015, DOI 10.1534/genetics.112.146332; Cheng RY, 2010, GENETICS, V185, P1033, DOI 10.1534/genetics.110.116863; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Chesler EJ, 2014, MAMM GENOME, V25, P3, DOI 10.1007/s00335-013-9492-9; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; CHURCHILL GA, 1994, GENETICS, V138, P963; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Coury F, 2013, P NATL ACAD SCI USA, V110, P2163, DOI 10.1073/pnas.1206392110; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Demarest K, 2001, BEHAV GENET, V31, P79, DOI 10.1023/A:1010261909853; Eberle MA, 2006, PLOS GENET, V2, P1319, DOI 10.1371/journal.pgen.0020142; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Farber CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002038; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Gatti DM, 2014, G3-GENES GENOM GENET, V4, P1623, DOI 10.1534/g3.114.013748; Ghazalpour A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000149; Grabowski PP, 2014, MOL ECOL, V23, P4059, DOI 10.1111/mec.12845; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Le SQ, 2011, GENOME RES, V21, P952, DOI 10.1101/gr.113084.110; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lionikas A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-592; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Long JR, 2004, EUR J HUM GENET, V12, P383, DOI 10.1038/sj.ejhg.5201152; LYNCH CJ, 1969, LAB ANIM CARE, V19, P214; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mendis SHS, 2011, BIOL REPROD, V84, P379, DOI 10.1095/biolreprod.110.086231; Meyers SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-337; Mithraprabhu S, 2010, BIOL REPROD, V82, P980, DOI 10.1095/biolreprod.109.079855; Morgan AP, 2016, G3-GENES GENOM GENET, V6, P263, DOI 10.1534/g3.115.022087; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mott R, 2013, ANNU REV GENOM HUM G, V14, P421, DOI 10.1146/annurev-genom-091212-153419; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Palmer AA, 2005, MAMM GENOME, V16, P291, DOI 10.1007/s00335-004-2451-8; Parker CC, 2012, GENES BRAIN BEHAV, V11, P52, DOI 10.1111/j.1601-183X.2011.00747.x; Parker CC, 2014, GENETICS, V198, P103, DOI 10.1534/genetics.114.167056; Parker CC, 2012, BEHAV GENET, V42, P437, DOI 10.1007/s10519-011-9524-8; Parker Clarissa C., 2011, Frontiers in Genetics, V2, P32, DOI 10.3389/fgene.2011.00032; Parker CC, 2011, MAMM GENOME, V22, P563, DOI 10.1007/s00335-011-9349-z; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; RICE MC, 1980, NATURE, V283, P157, DOI 10.1038/283157a0; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sala D, 2014, J CLIN INVEST, V124, P1914, DOI 10.1172/JCI72327; Samocha KE, 2010, GENES BRAIN BEHAV, V9, P759, DOI 10.1111/j.1601-183X.2010.00613.x; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Sittig LJ, 2016, GENES BRAIN BEHAV, V15, P260, DOI 10.1111/gbb.12262; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; SYKES B, 1986, LANCET, V2, P69; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tomaszewski J, 2007, P NATL ACAD SCI USA, V104, P11322, DOI 10.1073/pnas.0703445104; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Walter NAR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-379; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	99	64	65	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					919	+		10.1038/ng.3609	http://dx.doi.org/10.1038/ng.3609			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27376237	Green Submitted, Green Accepted			2022-12-25	WOS:000380755100016
J	Liu, TW; Myschyshyn, M; Sinclair, DA; Cecioni, S; Beja, K; Honda, BM; Morin, RD; Vocadlo, DJ				Liu, Ta-Wei; Myschyshyn, Mike; Sinclair, Donald A.; Cecioni, Samy; Beja, Kevin; Honda, Barry M.; Morin, Ryan D.; Vocadlo, David J.			Genome-wide chemical mapping of O-GlcNAcylated proteins in Drosophila melanogaster	NATURE CHEMICAL BIOLOGY			English	Article							BETA-N-ACETYLGLUCOSAMINE; POLYCOMB; TRANSFERASE; GENE; ROLES; SITES	N-Acetylglucosamine beta-O-linked to nucleocytoplasmic proteins (O-GlcNAc) is implicated in the regulation of gene expression in organisms, from humans to Drosophila melanogaster. Within Drosophila, O-GlcNAc transferase (OGT) is one of the Polycomb group proteins (PcGs) that act through Polycomb group response elements (PREs) to silence homeotic (HOX) and other PcG target genes. Using Drosophila, we identify new O-GlcNAcylated PcG proteins and develop an antibody-free metabolic feeding approach to chemoselectively map genomic loci enriched in O-GlcNAc using next-generation sequencing. We find that O-GlcNAc is distributed to specific genomic loci both in cells and in vivo. Many of these loci overlap with PREs, but O-GlcNAc is also present at other loci lacking PREs. Loss of OGT leads to altered gene expression not only at loci containing PREs but also at loci lacking PREs, including several heterochromatic genes. These data suggest that O-GlcNAc acts through multiple mechanisms to regulate gene expression in Drosophila.	[Liu, Ta-Wei; Cecioni, Samy; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC, Canada; [Liu, Ta-Wei; Myschyshyn, Mike; Sinclair, Donald A.; Beja, Kevin; Honda, Barry M.; Morin, Ryan D.; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada; [Cecioni, Samy; Vocadlo, David J.] Univ Alberta, Gunning Lemieux Chem Ctr, Canadian Glyc Network, Edmonton, AB T6G 2M7, Canada	Simon Fraser University; Simon Fraser University; University of Alberta	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC, Canada.; Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada.; Vocadlo, DJ (corresponding author), Univ Alberta, Gunning Lemieux Chem Ctr, Canadian Glyc Network, Edmonton, AB T6G 2M7, Canada.	dvocadlo@sfu.ca	Morin, Ryan/AAE-7824-2019; Vocadlo, David J/E-5508-2014; Liu, Ta-Wei/GPX-8295-2022	Morin, Ryan/0000-0003-2932-7800; Vocadlo, David J/0000-0001-6897-5558; Myschyshyn, Mike/0000-0002-2310-000X	Discovery Grant the Natural Sciences and Engineering Research (NSERC) [RGPIN/-2015-05426]; Canadian Institutes of Health Research (CIHR) [MOP-102756]; Genome Canada/Genome British Columbia [173CIC]; CIHR; Canada Research Chairs program; NSERC	Discovery Grant the Natural Sciences and Engineering Research (NSERC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada/Genome British Columbia(Genome Canada); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support through a Discovery Grant the Natural Sciences and Engineering Research (D.J.V., NSERC, RGPIN/-2015-05426) and the Canadian Institutes of Health Research (D.J.V., as., B.M.H., CIHR, MOP-102756) is gratefully acknowledged. This project was also supported in part by a contract from Genome Canada/Genome British Columbia (173CIC). R.D.M. thanks the CIHR for a new investigator award. D.J.V. acknowledges the kind support of the Canada Research Chairs program for a Tier I Canada Research Chair in Chemical Glycobiology and NSERC for support as an E.W.R. Steacie Memorial Fellow. S.C. thanks the CIHR for a postdoctoral fellowships. M.M. thanks NSERC for a CGS-M graduate fellowship. The authors thank J. Kassis (National Institutes of Health, Bethesda, Maryland, USA), J. Muller (Max Planck Institute of Biochemistry, Frankfurt, Germany, H. Brock (University of British Columbia, Canada), D. Arndt-Jovin (Max Planck Institute for Biophysical Chemistry, Gottingen, Germany) and W Herr (University of Lausanne, Lausanne, Switzerland) for generously providing antibodies, A. Wilson for his assistance in ChIP data analysis, D. Fornika for assistance with performing ChIP sequencing, and T. Cruz-Sanchez, G. Cavalli, and Y. Zhu for early support of this work.	Akan I, 2016, J BIOL CHEM, V291, P9906, DOI 10.1074/jbc.M115.704783; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chuh KN, 2014, J AM CHEM SOC, V136, P12283, DOI 10.1021/ja504063c; Cummings R.D., 2009, ANTIBODIES LECTINS G; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Eissenberg JC, 2014, TRENDS GENET, V30, P103, DOI 10.1016/j.tig.2014.01.002; Gambetta MC, 2015, CHROMOSOMA, V124, P429, DOI 10.1007/s00412-015-0513-1; Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hedou J, 2009, PROTEOMICS, V9, P2139, DOI 10.1002/pmic.200800617; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; KASSIS JA, 1994, GENETICS, V136, P1025; Kassis JA, 2013, ADV GENET, V81, P83, DOI 10.1016/B978-0-12-407677-8.00003-8; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lin W, 2015, CHEMBIOCHEM, V16, P2571, DOI 10.1002/cbic.201500544; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mariappa D, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150234; McKay CS, 2014, CHEM BIOL, V21, P1075, DOI 10.1016/j.chembiol.2014.09.002; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Niessen HEC, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-10; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Peach SE, 2012, MOL CELL PROTEOMICS, V11, P128, DOI 10.1074/mcp.M111.015941; Pindyurin AV, 2016, NUCLEIC ACIDS RES, V44, P5646, DOI 10.1093/nar/gkw176; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Sprung R, 2005, J PROTEOME RES, V4, P950, DOI 10.1021/pr050033j; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Verdoes M, 2008, CHEMBIOCHEM, V9, P1735, DOI 10.1002/cbic.200800231; Verhelst SHL, 2007, ANGEW CHEM INT EDIT, V46, P1284, DOI 10.1002/anie.200603811; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wang R, 2013, J AM CHEM SOC, V135, P1048, DOI 10.1021/ja309412s; Zaro Balyn W, 2013, Methods Mol Biol, V951, P57, DOI 10.1007/978-1-62703-146-2_5; Zeng J, 2012, NUCLEIC ACIDS RES, V40, P5848, DOI 10.1093/nar/gks209; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]	45	28	28	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					161	167		10.1038/NCHEMBIO.2247	http://dx.doi.org/10.1038/NCHEMBIO.2247			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27918560				2022-12-25	WOS:000393533000010
J	Shao, CW; Bao, BL; Xie, ZY; Chen, XY; Li, B; Jia, XD; Yao, QL; Orti, G; Li, WH; Li, XH; Hamre, K; Xu, J; Wang, L; Chen, FY; Tian, YS; Schreiber, AM; Wang, N; Wei, F; Zhang, JL; Dong, ZD; Gao, L; Gai, JW; Sakamoto, T; Mo, SD; Chen, WJ; Shi, Q; Li, H; Xiu, YJ; Li, YZ; Xu, WT; Shi, ZY; Zhang, GJ; Power, DM; Wang, QY; Schartl, M; Chen, SL				Shao, Changwei; Bao, Baolong; Xie, Zhiyuan; Chen, Xinye; Li, Bo; Jia, Xiaodong; Yao, Qiulin; Orti, Guillermo; Li, Wenhui; Li, Xihong; Hamre, Kristin; Xu, Juan; Wang, Lei; Chen, Fangyuan; Tian, Yongsheng; Schreiber, Alex M.; Wang, Na; Wei, Fen; Zhang, Jilin; Dong, Zhongdian; Gao, Lei; Gai, Junwei; Sakamoto, Takashi; Mo, Sudong; Chen, Wenjun; Shi, Qiong; Li, Hui; Xiu, Yunji; Li, Yangzhen; Xu, Wenteng; Shi, Zhiyi; Zhang, Guojie; Power, Deborah M.; Wang, Qingyin; Schartl, Manfred; Chen, Songlin			The genome and transcriptome of Japanese flounder provide insights into flatfish asymmetry	NATURE GENETICS			English	Article							HIPPOGLOSSUS L. LARVAE; THYROID-HORMONE; RETINOIC ACID; METAMORPHOSIS; PIGMENTATION; RECEPTOR; EVOLUTION; PRODUCT; GENES	Flatfish have the most extreme asymmetric body morphology of vertebrates. During metamorphosis, one eye migrates to the contralateral side of the skull, and this migration is accompanied by extensive craniofacial transformations and simultaneous development of lopsided body pigmentation(1-5). The evolution of this developmental and physiological innovation remains enigmatic. Comparative genomics of two flatfish and transcriptomic analyses during metamorphosis point to a role for thyroid hormone and retinoic acid signaling, as well as phototransduction pathways. We demonstrate that retinoic acid is critical in establishing asymmetric pigmentation and, via cross-talk with thyroid hormones, in modulating eye migration. The unexpected expression of the visual opsins from the phototransduction pathway in the skin translates illumination differences and generates retinoic acid gradients that underlie the generation of asymmetry. Identifying the genetic underpinning of this unique developmental process answers long-standing questions about the evolutionary origin of asymmetry, but it also provides insight into the mechanisms that control body shape in vertebrates.	[Shao, Changwei; Jia, Xiaodong; Li, Xihong; Wang, Lei; Tian, Yongsheng; Wang, Na; Dong, Zhongdian; Mo, Sudong; Xiu, Yunji; Li, Yangzhen; Xu, Wenteng; Wang, Qingyin; Chen, Songlin] Yellow Sea Fisheries Res Inst, CAFS, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China; [Shao, Changwei; Jia, Xiaodong; Li, Xihong; Wang, Lei; Tian, Yongsheng; Wang, Na; Dong, Zhongdian; Mo, Sudong; Xiu, Yunji; Li, Yangzhen; Xu, Wenteng; Wang, Qingyin; Chen, Songlin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Bao, Baolong; Chen, Xinye; Xu, Juan; Wei, Fen; Gao, Lei; Gai, Junwei; Chen, Wenjun; Li, Hui; Shi, Zhiyi] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Xie, Zhiyuan; Li, Bo; Yao, Qiulin; Li, Wenhui; Chen, Fangyuan; Zhang, Jilin; Shi, Qiong; Zhang, Guojie] BGI Shenzhen, Shenzhen, Peoples R China; [Orti, Guillermo] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Hamre, Kristin] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Hamre, Kristin] Univ Bergen, Dept Biol, Bergen, Norway; [Schreiber, Alex M.] St Lawrence Univ, Dept Biol, Canton, NY 13617 USA; [Sakamoto, Takashi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo, Japan; [Power, Deborah M.] Univ Algarve, Ctr Ciencias Mar CCMAR, Comparat Endocrinol & Integrat Biol, Faro, Portugal; [Power, Deborah M.] Shanghai Ocean Univ, Minist Educ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Schartl, Manfred] Univ Wurzburg, Physiol Chem, Biozentrum, Wurzburg, Germany; [Schartl, Manfred] Univ Clin Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Schartl, Manfred] Texas A&M Univ, Inst Adv Studies, College Stn, TX USA	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Beijing Genomics Institute (BGI); George Washington University; University of Bergen; Saint Lawrence University; Tokyo University of Marine Science & Technology; Universidade do Algarve; Shanghai Ocean University; University of Wurzburg; University of Wurzburg; Texas A&M University System; Texas A&M University College Station		dpower@ualg.pt; qywang@public.qd.sd.cn; phch1@biozentrum.uni-wuerzburg.de; chensl@ysfri.ac.cn	Shao, Changwei/I-2054-2016; Hamre, Kristin/D-3477-2012; Power, Deborah M/D-3333-2011; Zhang, Guojie/J-7273-2019; Xu, Wenteng/Q-1552-2018; SAKAMOTO, Takashi/O-1949-2014	Shao, Changwei/0000-0002-6953-2203; Hamre, Kristin/0000-0002-8302-3827; Power, Deborah M/0000-0003-1366-0246; Zhang, Guojie/0000-0001-6860-1521; SAKAMOTO, Takashi/0000-0002-8399-851X; Zhang, Jilin/0000-0002-9976-1605; Orti, Guillermo/0000-0002-6886-2323; Xiu, Yunji/0000-0002-3134-1874	National Natural Science Foundation of China [31130057, 31461163005, 31530078, 31472269, 31472262, 31472273]; State 863 High Technology R&D Project of China [2012AA092203, 2012AA10A408, 2012AA10A403-2]; Education and Research of Guangdong Province [2013B090800017]; Taishan Scholar Climb Project Fund of Shandong of China; Taishan Scholar Project Fund of Shandong of China for Young Scientists; Shanghai Universities First-class Disciplines Project of Fisheries; Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institutions of Higher Learning; Shanghai Municipal Science, Special Project on the Integration of Industry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State 863 High Technology R&D Project of China(National High Technology Research and Development Program of China); Education and Research of Guangdong Province; Taishan Scholar Climb Project Fund of Shandong of China; Taishan Scholar Project Fund of Shandong of China for Young Scientists; Shanghai Universities First-class Disciplines Project of Fisheries; Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institutions of Higher Learning; Shanghai Municipal Science, Special Project on the Integration of Industry	We sincerely thank Q.S. Tang, F.Z. Zhao, H.R. Lin and J.F. Gui for their support and help with the Japanese flounder genome project. We also thank A.V.M. Canon, J. Rotllant, Y.S. Fu, and J.A. Graves for constructive discussion. We acknowledge financial support from the National Natural Science Foundation of China (grants 31130057, 31461163005, and 31530078 to S.C.; grant 31472269 to C.S.; grant 31472262 to B.B.; and grant 31472273 to NM), the State 863 High Technology R&D Project of China (grants 2012AA092203 and 2012AA10A408 to S.C.; grant 2012AA10A403-2 to C.S.), and the Education and Research of Guangdong Province (grant 2013B090800017 to Q.S.). This research also received funding from the Taishan Scholar Climb Project Fund of Shandong of China (S.C.), the Taishan Scholar Project Fund of Shandong of China for Young Scientists (C.S.), the Shanghai Universities First-class Disciplines Project of Fisheries (B.B.), the Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institutions of Higher Learning (B.B.), and the Shanghai Municipal Science, Special Project on the Integration of Industry (B.B.).	Bao BL, 2011, DEV BIOL, V351, P200, DOI 10.1016/j.ydbio.2010.12.032; Blomhoff R., 1994, Vitamin A in health and disease., P1; Bolker JA, 2000, J FISH BIOL, V56, P1029, DOI 10.1111/j.1095-8649.2000.tb02121.x; Campinho MA, 2015, MOL CELL ENDOCRINOL, V404, P16, DOI 10.1016/j.mce.2014.12.025; Castillo AI, 2004, MOL CELL BIOL, V24, P502, DOI 10.1128/MCB.24.2.502-513.2004; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Davis PJ, 2016, NAT REV ENDOCRINOL, V12, P111, DOI 10.1038/nrendo.2015.205; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Friedman M, 2008, NATURE, V454, P209, DOI 10.1038/nature07108; Hamre K, 2007, AQUACULT NUTR, V13, P65, DOI 10.1111/j.1365-2095.2007.00467.x; Hamre K, 2008, AQUACULTURE, V277, P101, DOI 10.1016/j.aquaculture.2008.02.020; Heimeier RA, 2010, GEN COMP ENDOCR, V168, P181, DOI 10.1016/j.ygcen.2010.02.016; Inoue T, 2010, FEBS LETT, V584, P3233, DOI 10.1016/j.febslet.2010.06.020; INUI Y, 1985, GEN COMP ENDOCR, V60, P450, DOI 10.1016/0016-6480(85)90080-2; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Li LK, 2013, ICHTHYOL RES, V60, P178, DOI 10.1007/s10228-012-0332-9; McCaffery P, 1996, P NATL ACAD SCI USA, V93, P12570, DOI 10.1073/pnas.93.22.12570; McMenamin SK, 2014, SCIENCE, V345, P1358, DOI 10.1126/science.1256251; Nakamura A, 2007, ACTA TROP, V103, P222, DOI 10.1016/j.actatropica.2007.06.009; ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0; Power DM, 2008, REV FISH SCI, V16, P95, DOI 10.1080/10641260802325377; Ramirez MD, 2015, J EXP BIOL, V218, P1513, DOI 10.1242/jeb.110908; Schreiber AM, 2013, CURR TOP DEV BIOL, V103, P167, DOI 10.1016/B978-0-12-385979-2.00006-X; Schreiber AM, 2006, J EXP BIOL, V209, P610, DOI 10.1242/jeb.02056; Shao CW, 2015, DNA RES, V22, P161, DOI 10.1093/dnares/dsv001; Silver DL, 2006, ADV EXP MED BIOL, V589, P155; Song WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031929; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0	30	137	171	8	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					119	124		10.1038/ng.3732	http://dx.doi.org/10.1038/ng.3732			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27918537	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000390976600017
J	Srinivasan, S; Nwachukwu, JC; Bruno, NE; Dharmarajan, V; Goswami, D; Kastrati, I; Novick, S; Nowak, J; Cavett, V; Zhou, HB; Boonmuen, N; Zhao, YC; Min, J; Frasor, J; Katzenellenbogen, BS; Griffin, PR; Katzenellenbogen, JA; Nettles, KW				Srinivasan, Sathish; Nwachukwu, Jerome C.; Bruno, Nelson E.; Dharmarajan, Venkatasubramanian; Goswami, Devrishi; Kastrati, Irida; Novick, Scott; Nowak, Jason; Cavett, Valerie; Zhou, Hai-Bing; Boonmuen, Nittaya; Zhao, Yuechao; Min, Jian; Frasor, Jonna; Katzenellenbogen, Benita S.; Griffin, Patrick R.; Katzenellenbogen, John A.; Nettles, Kendall W.			Full antagonism of the estrogen receptor without a prototypical ligand side chain	NATURE CHEMICAL BIOLOGY			English	Article							POSITIVE BREAST-CANCER; ENDOCRINE-THERAPY; ACTIVATION FUNCTION; STRUCTURAL BASIS; BINDING DOMAIN; DEGRADER SERD; ALPHA; TAMOXIFEN; RESISTANCE; MUTATIONS	Resistance to endocrine therapies remains a major clinical problem for the treatment of estrogen receptor-alpha (ER alpha)-positive breast cancer. On-target side effects limit therapeutic compliance and use for chemoprevention, highlighting an unmet need for new therapies. Here we present a full-antagonist ligand series lacking the prototypical ligand side chain that has been universally used to engender antagonism of ER alpha through poorly understood structural mechanisms. A series of crystal structures and phenotypic assays reveal a structure-based design strategy with separate design elements for antagonism and degradation of the receptor, and access to a structurally distinct space for further improvements in ligand design. Understanding structural rules that guide ligands to produce diverse ER alpha-mediated phenotypes has broad implications for the treatment of breast cancer and other estrogen-sensitive aspects of human health including bone homeostasis, energy metabolism, and autoimmunity.	[Srinivasan, Sathish; Nwachukwu, Jerome C.; Bruno, Nelson E.; Nowak, Jason; Cavett, Valerie; Nettles, Kendall W.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Dharmarajan, Venkatasubramanian; Goswami, Devrishi; Novick, Scott; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Kastrati, Irida; Frasor, Jonna] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Zhou, Hai-Bing] Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, State Key Lab Virol,Sch Pharmaceut Sci, Wuhan, Peoples R China; [Boonmuen, Nittaya; Zhao, Yuechao; Katzenellenbogen, Benita S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Min, Jian; Katzenellenbogen, John A.] Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA	Scripps Research Institute; Scripps Research Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Wuhan University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nettles, KW (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	knettles@scripps.edu	Kastrati, Irida/L-4641-2019; Zhou, Haibing/B-2915-2017	Kastrati, Irida/0000-0002-8086-1411; Zhou, Haibing/0000-0001-8498-063X; Nwachukwu, Jerome/0000-0003-4313-9187	National Institutes of Health [PHS 5R37DK015556, 5R33CA132022, 5R0IDK077085, 1U01GM102148, 5R01CA130932]; Breast Cancer Research Foundation; BallenIsles Men's Golf Association; Frenchman's Creek Women for Cancer Research; Susan G. Komen for the Cure [PDF12229484]; National Natural Science Foundation of China [81172935, 81373255, 81573279]; Hubei Province's Outstanding Medical Academic Leader Program; US Department of Energy Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences (NIGMS) [P41GM103393]; NATIONAL CANCER INSTITUTE [R33CA132022, R01CA130932, R01CA200669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077085, R37DK015556, R01DK015556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, U01GM102148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; BallenIsles Men's Golf Association; Frenchman's Creek Women for Cancer Research; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province's Outstanding Medical Academic Leader Program; US Department of Energy Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research support from the National Institutes of Health (PHS 5R37DK015556 to J.A.K.; 5R33CA132022, 5R0IDK077085 to K.W.N.; 1U01GM102148 to K.W.N and P.R.G., and 5R01CA130932 to J.F), The Breast Cancer Research Foundation (to B.S.K.), BallenIsles Men's Golf Association (to J.C.N.), Frenchman's Creek Women for Cancer Research (to S.S.), Susan G. Komen for the Cure (PDF12229484 to IK), and the National Natural Science Foundation of China (81172935, 81373255, 81573279), Hubei Province's Outstanding Medical Academic Leader Program (to H.-B.Z.). Use of the Stanford Synchrotron Radiation Lightsource (SSRL), SLAG National Accelerator Laboratory is supported by the US Department of Energy Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (NIGMS) (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or the NIH.	Abot A, 2013, ENDOCRINOLOGY, V154, P2222, DOI 10.1210/en.2012-2059; Andruska ND, 2015, P NATL ACAD SCI USA, V112, P4737, DOI 10.1073/pnas.1403685112; Bhatt S, 2012, MOL CELL BIOL, V32, P1928, DOI 10.1128/MCB.06561-11; Billon-Gales A, 2009, P NATL ACAD SCI USA, V106, P2053, DOI 10.1073/pnas.0808742106; Bruning JB, 2010, NAT CHEM BIOL, V6, P837, DOI 10.1038/NCHEMBIO.451; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Carlson KE, 1997, BIOCHEMISTRY-US, V36, P14897, DOI 10.1021/bi971746l; Chinenov Y, 2013, MOL CELL ENDOCRINOL, V380, P55, DOI 10.1016/j.mce.2013.04.006; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Connor CE, 2001, CANCER RES, V61, P2917; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Fan MY, 2003, MOL ENDOCRINOL, V17, P356, DOI 10.1210/me.2002-0323; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Kastrati I, 2015, ONCOGENE, V34, P2309, DOI 10.1038/onc.2014.180; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kuske B, 2006, ENDOCR-RELAT CANCER, V13, P1121, DOI 10.1677/erc.1.01257; Lai A, 2015, J MED CHEM, V58, P4888, DOI 10.1021/acs.jmedchem.5b00054; Laxmi YRS, 2010, INT J CANCER, V127, P1718, DOI 10.1002/ijc.25167; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Lupien M, 2007, MOL ENDOCRINOL, V21, P797, DOI 10.1210/me.2006-0074; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Nettles KW, 2008, MOL ENDOCRINOL, V22, P263, DOI 10.1210/me.2007-0324; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; Nwachukwu JC, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156701; Nwachukwu JC, 2014, ELIFE, V3, DOI 10.7554/eLife.02057; Patani N, 2014, MOL CELL ENDOCRINOL, V382, P683, DOI 10.1016/j.mce.2013.09.038; Pike ACW, 2001, STRUCTURE, V9, P145, DOI 10.1016/S0969-2126(01)00568-8; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Srinivasan S, 2013, NAT CHEM BIOL, V9, P326, DOI [10.1038/NCHEMBIO.1214, 10.1038/nchembio.1214]; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Wardell SE, 2015, ENDOCR-RELAT CANCER, V22, P713, DOI 10.1530/ERC-15-0287; Wardell SE, 2013, CLIN CANCER RES, V19, P2420, DOI 10.1158/1078-0432.CCR-12-3771; Wardell SE, 2011, BIOCHEM PHARMACOL, V82, P122, DOI 10.1016/j.bcp.2011.03.031; Willson TM, 1997, ENDOCRINOLOGY, V138, P3901, DOI 10.1210/en.138.9.3901; Wittmann BM, 2007, CANCER RES, V67, P9549, DOI 10.1158/0008-5472.CAN-07-1590; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Yu KD, 2012, J CLIN ENDOCR METAB, V97, pE2201, DOI 10.1210/jc.2012-2423; Zheng YF, 2012, CHEMMEDCHEM, V7, P1094, DOI 10.1002/cmdc.201200048; Zhu MH, 2012, ORG BIOMOL CHEM, V10, P8692, DOI 10.1039/c2ob26531a	45	37	38	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					111	118		10.1038/nchembio.2236	http://dx.doi.org/10.1038/nchembio.2236			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27870835	Green Accepted			2022-12-25	WOS:000393267200021
J	Abdu, Y; Maniscalco, C; Heddleston, JM; Chew, TL; Nance, J				Abdu, Yusuff; Maniscalco, Chelsea; Heddleston, John M.; Chew, Teng-Leong; Nance, Jeremy			Developmentally programmed germ cell remodelling by endodermal cell cannibalism	NATURE CELL BIOLOGY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; INTEGRATIVE GENOMICS VIEWER; CAENORHABDITIS-ELEGANS; C.-ELEGANS; APOPTOTIC CELLS; SORTING NEXIN-9; PHAGOCYTOSIS; CLEARANCE; MIGRATION; MEMBRANE	Primordial germ cells (PGCs) in many species associate intimately with endodermal cells, but the significance of such interactions is largely unexplored. Here, we show that Caenorhabditis elegans PGCs form lobes that are removed and digested by endodermal cells, dramatically altering PGC size and mitochondrial content. We demonstrate that endodermal cells do not scavenge lobes PGCs shed, but rather, actively remove lobes from the cell body. CED-10 (Rac)-induced actin, DYN-1 (dynamin) and LST-4 (SNX9) transiently surround lobe necks and are required within endodermal cells for lobe scission, suggesting that scission occurs through a mechanism resembling vesicle endocytosis. These findings reveal an unexpected role for endoderm in altering the contents of embryonic PGCs, and define a form of developmentally programmed cell remodelling involving intercellular cannibalism. Active roles for engulfing cells have been proposed in several neuronal remodelling events, suggesting that intercellular cannibalism may be a more widespread method used to shape cells than previously thought.	[Abdu, Yusuff; Maniscalco, Chelsea; Nance, Jeremy] NYU Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Heddleston, John M.; Chew, Teng-Leong] Howard Hughes Med Inst, Adv Imaging Ctr, Janelia Res Campus, Ashburn, VA 20147 USA; [Nance, Jeremy] NYU Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute; New York University	Nance, J (corresponding author), NYU Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA.; Nance, J (corresponding author), NYU Sch Med, Dept Cell Biol, New York, NY 10016 USA.	Jeremy.Nance@med.nyu.edu		Nance, Jeremy/0000-0003-4212-7731; Abdu, Yusuff/0000-0002-4574-4455	Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; NIH [R35GM118081, R21HD084809]; NYSTEM [C029561]; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD084809] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118081] Funding Source: NIH RePORTER	Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center (CGC), National Bioresource Project (NBRP), and Z. Zhou (Baylor College of Medicine, USA) for providing worm strains. Caged rhodamine dextran was a gift from K. Oegema (University of California, San Diego). We thank T. Hurd (NYU School of Medicine, USA) for sharing TMRE dye and mitochondrial discussion; J. H. Choi (NYU School of Medicine, USA) for assistance in developing the technique for cell culture experiments; D. McIntyre (NYU School of Medicine, USA) for designing a nitrogen gas immobilization chamber for embryos; and L. Christiaen (New York University, USA), N. Ringstad (NYU School of Medicine, USA), T. Hurd (NYU School of Medicine, USA) and members of the Nance laboratory for comments on the manuscript. Library preparation and sequencing of genomic DNA samples was performed at the NYULMC Genome Technology Center, which is partially supported by a Cancer Center Support Grant (P30CA016087) at the Laura and Isaac Perlmutter Cancer Center. Funding was provided by the NIH (R35GM118081, R21HD084809 to J.N.), NYSTEM (C029561 to J.N.) and HHMI (J.M.H., T.-L.C). Y.A. is an HHMI International Student Research fellow.	Almendinger J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018325; Armenti ST, 2014, DEV BIOL, V394, P110, DOI 10.1016/j.ydbio.2014.07.019; Badour K, 2007, P NATL ACAD SCI USA, V104, P1593, DOI 10.1073/pnas.0610543104; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; BRENNER S, 1974, GENETICS, V77, P71; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Cheng SY, 2015, J CELL BIOL, V210, P485, DOI 10.1083/jcb.201501038; Chihara D, 2012, DEVELOPMENT, V139, P2547, DOI 10.1242/dev.079863; Chu DS, 2013, ADV EXP MED BIOL, V757, P171, DOI 10.1007/978-1-4614-4015-4_7; Cinalli RM, 2008, CELL, V132, P559, DOI 10.1016/j.cell.2008.02.003; Corty Megan M, 2013, J Cell Biol, V203, P395, DOI 10.1083/jcb.201306099; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; DeGennaro M, 2011, DEV CELL, V20, P233, DOI 10.1016/j.devcel.2010.12.007; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukushige T, 2005, DEV BIOL, V279, P446, DOI 10.1016/j.ydbio.2004.12.012; Fukuyama M, 2012, BIOL OPEN, V1, P929, DOI 10.1242/bio.2012836; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Green RA, 2013, J CELL BIOL, V203, P505, DOI 10.1083/jcb.201306036; Han C, 2014, NEURON, V81, P544, DOI 10.1016/j.neuron.2013.11.021; Head BP, 2011, MOL BIOL CELL, V22, P831, DOI 10.1091/mbc.E10-07-0600; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Lei L, 2016, SCIENCE, V352, P95, DOI 10.1126/science.aad2156; Lu N, 2011, MOL BIOL CELL, V22, P354, DOI 10.1091/mbc.E10-09-0756; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Lynch AM, 2012, CURR BIOL, V22, P1891, DOI 10.1016/j.cub.2012.08.024; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Minevich G, 2012, GENETICS, V192, P1249, DOI 10.1534/genetics.112.144204; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Owraghi M, 2010, DEV BIOL, V340, P209, DOI 10.1016/j.ydbio.2009.09.042; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rohrschneider MR, 2013, DEV BIOL, V379, P139, DOI 10.1016/j.ydbio.2013.03.019; Rolland SG, 2009, J CELL BIOL, V186, P525, DOI 10.1083/jcb.200905070; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; STROME S, 1982, P NATL ACAD SCI-BIOL, V79, P1558, DOI 10.1073/pnas.79.5.1558; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Takamura K, 2002, DEV GENES EVOL, V212, P11, DOI 10.1007/s00427-001-0204-1; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Wang XC, 2016, CELL MOL LIFE SCI, V73, P2221, DOI 10.1007/s00018-016-2196-z; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Wolf T, 2014, EXP GERONTOL, V56, P114, DOI 10.1016/j.exger.2014.04.002; Wolke U, 2007, DEVELOPMENT, V134, P2227, DOI 10.1242/dev.004952; Xaver M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004067; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007	60	36	37	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2016	18	12					1302	+		10.1038/ncb3439	http://dx.doi.org/10.1038/ncb3439			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	ED8PY	27842058	Green Accepted			2022-12-25	WOS:000389134600008
J	Gresl, T; Storz, U; Sandercock, C				Gresl, Theresa; Storz, Ulrich; Sandercock, Colin			An update on obtaining and enforcing therapeutic antibody patent claims	NATURE BIOTECHNOLOGY			English	Editorial Material									[Gresl, Theresa] Int Maize & Wheat Improvement Ctr CIMMYT, El Batan, Texcoco, Mexico; [Storz, Ulrich] Michalski Huttermann & Partner Dusseldorf, Dusseldorf, Germany; [Sandercock, Colin] Perkins Coie LLP, Washington, DC USA	CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Storz, U (corresponding author), Michalski Huttermann & Partner Dusseldorf, Dusseldorf, Germany.	storz@mhpatent.de						Sandercock CG, 2012, NAT BIOTECHNOL, V30, P615, DOI 10.1038/nbt.2291	1	3	5	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1242	1245		10.1038/nbt.3735	http://dx.doi.org/10.1038/nbt.3735			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27926725				2022-12-25	WOS:000390185300011
J	Lin, ZW; Dong, M; Zhang, YG; Lee, EA; Lin, HN				Lin, Zhewang; Dong, Min; Zhang, Yugang; Lee, Eunyoung Alisa; Lin, Hening			Cbr1 is a Dph3 reductase required for the tRNA wobble uridine modification	NATURE CHEMICAL BIOLOGY			English	Article							DIPHTHAMIDE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; ELONGATOR; TOXIN; STEP; IDENTIFICATION; TRANSLATION; CATALYZES; VERSATILE; MODULES	Diphthamide and the tRNA wobble uridine modifications both require diphthamide biosynthesis 3 (Dph3) protein as an electron donor for the iron-sulfur clusters in their biosynthetic enzymes. Here, using a proteomic approach, we identified Saccharomyces cerevisiae cytochrome b(5) reductase (Cbr1) as a NADH-dependent reductase for Dph3. The NADH-and Cbr1-dependent reduction of Dph3 may provide a regulatory linkage between cellular metabolic state and protein translation.	[Lin, Zhewang; Dong, Min; Zhang, Yugang; Lee, Eunyoung Alisa; Lin, Hening] Cornell Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Ithaca, NY 14850 USA	Cornell University; Howard Hughes Medical Institute	Lin, HN (corresponding author), Cornell Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Ithaca, NY 14850 USA.	hl379@cornell.edu	Dong, Min/D-5367-2016	Dong, Min/0000-0001-6655-2818; Lin, Zhewang/0000-0003-1301-6661; Zhang, Yugang/0000-0002-1141-5821; Lin, Hening/0000-0002-0255-2701	US National Institutes of Health (NIH) [R01GM088276]; Singapore Agency for Science, Technology and Research (A<SUP>star</SUP>STAR) scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088276] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Agency for Science, Technology and Research (A<SUP>star</SUP>STAR) scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Zhang for the help with the mass spectrometry experiment. We are grateful to S. Shuman (Memorial Sloan Kettering Cancer Center) for providing us with the plasmid pLF16. pFA6a-NATMX6 was a gift from S. Emr (Cornell University). pFA6a-6xGLY-3xFLAG-HIS3MX6 was a gift from M. Hochstrasser (Yale University). pFA6a-His3MX6 was a gift from J. Pringle (University of North Carolina at Chapel Hill). This work is supported by US National Institutes of Health (NIH; R01GM088276). Z.L. is supported by a Singapore Agency for Science, Technology and Research (A<SUP>star</SUP>STAR) scholarship.	Bar C, 2008, MOL MICROBIOL, V69, P1221, DOI 10.1111/j.1365-2958.2008.06350.x; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; BIANCHI V, 1993, BIOCHEM BIOPH RES CO, V197, P792, DOI 10.1006/bbrc.1993.2548; CHEN JYC, 1985, MOL CELL BIOL, V5, P3357, DOI 10.1128/MCB.5.12.3357; de Crecy-Lagard V, 2010, MOL BIOL EVOL, V27, P2062, DOI 10.1093/molbev/msq096; Dong M, 2014, J AM CHEM SOC, V136, P1754, DOI 10.1021/ja4118957; Du MJ, 1997, BIOCHEM BIOPH RES CO, V235, P779, DOI 10.1006/bbrc.1997.6873; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; Glatt S, 2015, STRUCTURE, V23, P149, DOI 10.1016/j.str.2014.11.008; HONJO T, 1968, J BIOL CHEM, V243, P3553; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Jablonowski D, 2001, GENETICS, V159, P1479; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Karlsborn T, 2014, RNA BIOL, V11, P1519, DOI 10.4161/15476286.2014.992276; Keppetipola N, 2009, RNA, V15, P1036, DOI 10.1261/rna.1637809; Kolaj-Robin O, 2015, FEBS J, V282, P819, DOI 10.1111/febs.13199; Lamb DC, 1999, FEBS LETT, V462, P283, DOI 10.1016/S0014-5793(99)01548-3; Lin ZW, 2014, J AM CHEM SOC, V136, P6179, DOI 10.1021/ja5009272; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2012, P NATL ACAD SCI USA, V109, P13817, DOI 10.1073/pnas.1206933109; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mann M, 2014, METHODS MOL BIOL, V1188, P1, DOI 10.1007/978-1-4939-1142-4_1; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; Selvadurai K, 2014, NAT CHEM BIOL, V10, P810, DOI [10.1038/nchembio.1610, 10.1038/NCHEMBIO.1610]; Su XY, 2012, P NATL ACAD SCI USA, V109, P19983, DOI 10.1073/pnas.1214346109; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138	27	9	9	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					995	+		10.1038/nchembio.2190	http://dx.doi.org/10.1038/nchembio.2190			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27694803	Green Accepted			2022-12-25	WOS:000388582900004
J	Abi-Dargham, A; Horga, G				Abi-Dargham, Anissa; Horga, Guillermo			The search for imaging biomarkers in psychiatric disorders	NATURE MEDICINE			English	Article							VOXEL-BASED MORPHOMETRY; COCAINE DEPENDENCE; SCHIZOPHRENIA; PSYCHOSIS; DOPAMINE; DEPRESSION; PATTERN; NEUROINFLAMMATION; CLASSIFICATION; METAANALYSIS	The field of medicine is moving toward the use of biomarkers for the optimization of individualized care. This is a particular challenge for the field of psychiatry, in which diagnosis is based on a descriptive collection of behaviors without the availability of any objective test to stratify patients. Neuroimaging techniques such as molecular imaging with positron-emission tomography (PET) or structural and functional magnetic resonance imaging (MRI) provide an opportunity to bring psychiatry from an era of subjective descriptive classification into objective and tangible brain-based measures. Here we provide steps toward the development of robust, reliable and valid biomarkers. The success of such development is crucial because it will enable the field of psychiatry to move forward into the era of modern medicine.	[Abi-Dargham, Anissa; Horga, Guillermo] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Abi-Dargham, Anissa; Horga, Guillermo] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Abi-Dargham, Anissa] Columbia Univ, Dept Radiol, New York, NY 10027 USA	Columbia University; New York State Psychiatry Institute; Columbia University	Abi-Dargham, A (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.; Abi-Dargham, A (corresponding author), New York State Psychiat Inst & Hosp, New York, NY 10032 USA.; Abi-Dargham, A (corresponding author), Columbia Univ, Dept Radiol, New York, NY 10027 USA.	aa324@cumc.columbia.edu	Horga, Guillermo/M-8036-2016	Horga, Guillermo/0000-0002-9049-9786	US National Institutes of Health [K23MH101637]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH101637] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	G.H. is funded by the US National Institutes of Health (grant K23MH101637).	Addington J, 2015, J NERV MENT DIS, V203, P328, DOI 10.1097/NMD.0000000000000290; Bansal R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050698; Brown MRG, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00069; Cannon TD, 2008, ARCH GEN PSYCHIAT, V65, P28, DOI 10.1001/archgenpsychiatry.2007.3; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Demjaha A, 2012, AM J PSYCHIAT, V169, P1203, DOI 10.1176/appi.ajp.2012.12010144; Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647; El Achkar CM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0559-8; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fritz HC, 2014, NEUROPSYCHOPHARMACOL, V39, P2594, DOI 10.1038/npp.2014.112; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Horga G, 2014, J CHILD PSYCHOL PSYC, V55, P659, DOI 10.1111/jcpp.12185; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Huys QJM, 2016, NAT NEUROSCI, V19, P404, DOI 10.1038/nn.4238; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027; Kenk M, 2015, SCHIZOPHRENIA BULL, V41, P85, DOI 10.1093/schbul/sbu157; Kessler RC, 2008, AM J PSYCHIAT, V165, P703, DOI 10.1176/appi.ajp.2008.08010126; Konova AB, 2012, EUR J NEUROSCI, V36, P2979, DOI 10.1111/j.1460-9568.2012.08211.x; Koutsouleris N, 2009, ARCH GEN PSYCHIAT, V66, P700, DOI 10.1001/archgenpsychiatry.2009.62; Laughren TP, 2010, J CLIN PSYCHIAT, V71, P1196, DOI 10.4088/JCP.10m06262gry; Marquand AF, 2012, NEUROIMAGE, V60, P1015, DOI 10.1016/j.neuroimage.2012.01.058; Martinez D, 2004, NEUROPSYCHOPHARMACOL, V29, P1190, DOI 10.1038/sj.npp.1300420; Martinez D, 2012, BIOL PSYCHIAT, V71, P192, DOI 10.1016/j.biopsych.2011.08.024; Martinez D, 2011, AM J PSYCHIAT, V168, P634, DOI 10.1176/appi.ajp.2010.10050748; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Normanno N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1147-7; Perlis RH, 2011, MOL PSYCHIATR, V16, P1076, DOI 10.1038/mp.2011.63; Plichta MM, 2012, NEUROIMAGE, V60, P1746, DOI 10.1016/j.neuroimage.2012.01.129; Radua J, 2015, JAMA PSYCHIAT, V72, P1243, DOI 10.1001/jamapsychiatry.2015.2196; Radua J, 2010, ARCH GEN PSYCHIAT, V67, P701, DOI 10.1001/archgenpsychiatry.2010.70; Schmaal L., 2016, MOL PSYCHIAT; Schnack HG, 2014, NEUROIMAGE, V84, P299, DOI 10.1016/j.neuroimage.2013.08.053; Schobel SA, 2013, NEURON, V78, P81, DOI 10.1016/j.neuron.2013.02.011; Schobel SA, 2009, ARCH GEN PSYCHIAT, V66, P938, DOI 10.1001/archgenpsychiatry.2009.115; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Slifstein M, 2015, JAMA PSYCHIAT, V72, P316, DOI 10.1001/jamapsychiatry.2014.2414; Soni A., 2009, 5 MOST COSTLY CONDIT, P1; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; Van Snellenberg JX, 2016, BIOL PSYCHIAT, V80, P617, DOI 10.1016/j.biopsych.2016.02.017	42	105	105	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1248	1255		10.1038/nm.4190	http://dx.doi.org/10.1038/nm.4190			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27783066				2022-12-25	WOS:000387302300016
J	Schmitt, AM; Garcia, JT; Hung, T; Flynn, RA; Shen, Y; Qu, K; Payumo, AY; Peres-da-Silva, A; Broz, DK; Baum, R; Guo, SL; Chen, JK; Attardi, LD; Chang, HY				Schmitt, Adam M.; Garcia, Julia T.; Hung, Tiffany; Flynn, Ryan A.; Shen, Ying; Qu, Kun; Payumo, Alexander Y.; Peres-da-Silva, Ashwin; Broz, Daniela Kenzelmann; Baum, Rachel; Guo, Shuling; Chen, James K.; Attardi, Laura D.; Chang, Howard Y.			An inducible long noncoding RNA amplifies DNA damage signaling	NATURE GENETICS			English	Article							GASTROINTESTINAL-SYNDROME; CELL-TYPES; IN-VIVO; P53; MICE; APOPTOSIS; LNCRNA; EXPRESSION; ENHANCERS; CHROMATIN	Long noncoding RNAs (IncRNAs) are prevalent genes with frequently precise regulation but mostly unknown functions. Here we demonstrate that IncRNAs guide the organismal DNA damage response. DNA damage activated transcription of the DINO (Damage Induced Noncoding) IncRNA via p53. DINO was required for p53-dependent gene expression, cell cycle arrest and apoptosis in response to DNA damage, and DINO expression was sufficient to activate damage signaling and cell cycle arrest in the absence of DNA damage. DINO bound to p53 protein and promoted its stabilization, mediating a p53 auto-amplification loop. Dino knockout or promoter inactivation in mice dampened p53 signaling and ameliorated acute radiation syndrome in vivo. Thus, inducible IncRNA can create a feedback loop with its cognate transcription factor to amplify cellular signaling networks.	[Schmitt, Adam M.; Garcia, Julia T.; Hung, Tiffany; Flynn, Ryan A.; Shen, Ying; Qu, Kun; Peres-da-Silva, Ashwin; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Schmitt, Adam M.; Attardi, Laura D.] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Payumo, Alexander Y.; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Payumo, Alexander Y.; Chen, James K.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Broz, Daniela Kenzelmann; Attardi, Laura D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Schmitt, Adam M.; Baum, Rachel] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Guo, Shuling] Ionis Pharmaceut, Dept Antisense Drug Discovery, Carlsbad, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Memorial Sloan Kettering Cancer Center; Ionis Pharmaceuticals, Inc.	Chang, HY (corresponding author), Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.	howchang@stanford.edu	Chen, James/G-9972-2011; Qu, Kun/G-3359-2012	Chen, James/0000-0002-9220-8436; Flynn, Ryan/0000-0001-5013-0442; Schmitt, Adam/0000-0002-7723-0651; Baum, Rachel/0000-0002-6419-5279	NIH [R01-ES023168, R01-CA118750, R01-HG004361, P50-HG007735, DP1-HD075622]; ASCO Conquer Cancer Foundation/Susan G. Komen Young Investigator Award; Stanford Radiation Oncology Kaplan Funds; NIH/NCI Cancer Center Support Grant [P30 CA008748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075622] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009302, P30CA008748, R01CA118750, P30CA124435] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, K12GM081266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASCO Conquer Cancer Foundation/Susan G. Komen Young Investigator Award; Stanford Radiation Oncology Kaplan Funds; NIH/NCI Cancer Center Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Nabel for able assistance. This study was supported by NIH R01-ES023168, R01-CA118750, R01-HG004361, P50-HG007735 to H.Y.C., NIH DP1-HD075622 to J.K.C., and ASCO Conquer Cancer Foundation/Susan G. Komen Young Investigator Award and Stanford Radiation Oncology Kaplan Funds to A.M.S. This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002918; Leibowitz BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4494; Leveille N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7520; Li MM, 2015, CELL STEM CELL, V16, P669, DOI 10.1016/j.stem.2015.04.002; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Quinn JJ, 2016, GENE DEV, V30, P191, DOI 10.1101/gad.272187.115; Riley KJL, 2007, RNA, V13, P1825, DOI 10.1261/rna.673407; Sanchez Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6812; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Westphal CH, 1998, CANCER RES, V58, P5637; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	31	143	155	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1370	1376		10.1038/ng.3673	http://dx.doi.org/10.1038/ng.3673			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27668660	Green Accepted			2022-12-25	WOS:000386543400013
J	Strikoudis, A; Lazaris, C; Trimarchi, T; Neto, ALG; Yang, Y; Ntziachristos, P; Rothbart, S; Buckley, S; Dolgalev, I; Stadtfeld, M; Strahl, BD; Dynlacht, BD; Tsirigos, A; Aifantis, I				Strikoudis, Alexandros; Lazaris, Charalampos; Trimarchi, Thomas; Galvao Neto, Antonio L.; Yang, Yan; Ntziachristos, Panagiotis; Rothbart, Scott; Buckley, Shannon; Dolgalev, Igor; Stadtfeld, Matthias; Strahl, Brian D.; Dynlacht, Brian D.; Tsirigos, Aristotelis; Aifantis, Iannis			Regulation of transcriptional elongation in pluripotency and cell differentiation by the PHD-finger protein Phf5a	NATURE CELL BIOLOGY			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; PAF1 COMPLEX; HISTONE MODIFICATIONS; PAUSE RELEASE; MOUSE EMBRYOS; SELF-RENEWAL; EXPRESSION; GENOME	Pluripotent embryonic stem cells (ESCs) self-renew or differentiate into all tissues of the developing embryo and cell-specification factors are necessary to balance gene expression. Here we delineate the function of the PHD-finger protein 5a (Phf5a) in ESC self-renewal and ascribe its role in regulating pluripotency, cellular reprogramming and myoblast specification. We demonstrate that Phf5a is essential for maintaining pluripotency, since depleted ESCs exhibit hallmarks of differentiation. Mechanistically, we attribute Phf5a function to the stabilization of the Paf1 transcriptional complex and control of RNA polymerase II elongation on pluripotency loci. Apart from an ESC-specific factor, we demonstrate that Phf5a controls differentiation of adult myoblasts. Our findings suggest a potent mode of regulation by Phf5a in stem cells, which directs their transcriptional programme, ultimately regulating maintenance of pluripotency and cellular reprogramming.	[Strikoudis, Alexandros; Lazaris, Charalampos; Trimarchi, Thomas; Galvao Neto, Antonio L.; Yang, Yan; Ntziachristos, Panagiotis; Buckley, Shannon; Dolgalev, Igor; Dynlacht, Brian D.; Tsirigos, Aristotelis; Aifantis, Iannis] NYU, Dept Pathol, Sch Med, New York, NY 10016 USA; [Strikoudis, Alexandros; Lazaris, Charalampos; Trimarchi, Thomas; Yang, Yan; Ntziachristos, Panagiotis; Buckley, Shannon; Dolgalev, Igor; Dynlacht, Brian D.; Tsirigos, Aristotelis; Aifantis, Iannis] NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Strikoudis, Alexandros; Lazaris, Charalampos; Trimarchi, Thomas; Ntziachristos, Panagiotis; Buckley, Shannon; Dolgalev, Igor; Stadtfeld, Matthias; Aifantis, Iannis] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA; [Lazaris, Charalampos; Dolgalev, Igor; Tsirigos, Aristotelis] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Galvao Neto, Antonio L.] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA; [Rothbart, Scott; Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Rothbart, Scott; Strahl, Brian D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Dolgalev, Igor] NYU, Sch Med, Genome Technol Ctr, Off Collaborat Sci, New York, NY 10016 USA; [Stadtfeld, Matthias] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Ntziachristos, Panagiotis] Northwestern Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA; [Buckley, Shannon] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	New York University; New York University; New York University; New York University; New York University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; New York University; New York University; University of Nebraska System; University of Nebraska Medical Center	Tsirigos, A; Aifantis, I (corresponding author), NYU, Dept Pathol, Sch Med, New York, NY 10016 USA.; Tsirigos, A; Aifantis, I (corresponding author), NYU, Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.; Aifantis, I (corresponding author), NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA.; Tsirigos, A (corresponding author), NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA.	aristotelis.tsirigos@nyumc.org; iannis.aifantis@nyumc.org	Ntziachristos, Panagiotis/CAG-2071-2022; Lazaris, Charalampos/J-9230-2015; Dolgalev, Igor/AAY-6406-2020; Strahl, Brian D/C-7601-2012	Lazaris, Charalampos/0000-0002-7345-8288; Dolgalev, Igor/0000-0003-4451-126X; Strahl, Brian D/0000-0002-4947-6259; Stadtfeld, Matthias/0000-0002-5852-9906; Tsirigos, Aristotelis/0000-0002-7512-8477; Galvao Neto, Manoel/0000-0003-4549-3606	National Institutes of Health (NIH)/National Cancer Institute (NCI) [P30CA016087-30]; NYSTEM institutional NYU Stem Cell Training Grant [C026880]; NIH [RO1CA133379, RO1CA105129, RO1CA149655, 5RO1CA173636, 1RO1CA194923]; NYSTEM programme of the New York State Health Department [NYSTEM-N11G-255]; NATIONAL CANCER INSTITUTE [R00CA188293, R01CA194923, R01CA149655, R01CA173636, R01CA133379, R00CA181343, P30CA016086, P30CA016087, R01CA105129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067132, R01GM111852] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYSTEM institutional NYU Stem Cell Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM programme of the New York State Health Department; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Aifantis laboratory for useful comments and discussions throughout the duration of this project; Z. Gao and P. Voigt for experimental help with glycerol gradients and helpful discussions; K. J. Armache and P. De Ioannes Fernandez for help with protein purification, helpful discussions and manuscript preparation; H.-J. Fehling for the Dppa4-RFP/Brachyury-GFP reporter ESC line; A. Heguy and the NYU Genome Technology Center (supported in part by National Institutes of Health (NIH)/National Cancer Institute (NCI) grant P30CA016087-30) for expertize with sequencing experiments; the NYU Histology Core (5P30CA16087-31) for assistance; C. Loomis and L. Chiriboga for immunohistochemistry experiments; and H. Li and T. Liu at the Center for Advanced Proteomics Research, New Jersey School of Medicine for mass spectrometry. This work has used computing resources at the High Performance Computing Facility of the Center of Health Informatics and Bioinformatics at the NYU Medical Center. A.S. is supported by the NYSTEM institutional NYU Stem Cell Training Grant (C026880). I.A. is supported by the NIH (RO1CA133379, RO1CA105129, RO1CA149655, 5RO1CA173636, 1RO1CA194923) and the NYSTEM programme of the New York State Health Department (NYSTEM-N11G-255).	Akanuma T, 2007, EMBO REP, V8, P858, DOI 10.1038/sj.embor.7401045; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Chen FX, 2015, CELL, V162, P1003, DOI 10.1016/j.cell.2015.07.042; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Falck E, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-43; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gloeckner Christian Johannes, 2009, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1920s57; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hubert CG, 2013, GENE DEV, V27, P1032, DOI 10.1101/gad.212548.112; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Langenbacher AD, 2011, DEV BIOL, V353, P19, DOI 10.1016/j.ydbio.2011.02.011; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Liu LQ, 2014, CELL STEM CELL, V15, P574, DOI 10.1016/j.stem.2014.09.018; Madan B, 2009, MOL CELL BIOL, V29, P3186, DOI 10.1128/MCB.01970-08; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Nguyen CT, 2010, DEV BIOL, V341, P167, DOI 10.1016/j.ydbio.2010.02.020; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Ponnusamy MP, 2009, STEM CELLS, V27, P3001, DOI 10.1002/stem.237; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rzymski T, 2008, CYTOGENET GENOME RES, V121, P232, DOI 10.1159/000138890; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Shelton M, 2014, STEM CELL REP, V3, P516, DOI 10.1016/j.stemcr.2014.07.001; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Smith E, 2013, GENE DEV, V27, P1079, DOI 10.1101/gad.215137.113; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Springer ML, 2002, CURR PROTOC HUM GENE; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Trappe R, 2002, BIOCHEM BIOPH RES CO, V297, P1049, DOI 10.1016/S0006-291X(02)02276-3; Trappe R, 2002, BIOCHEM BIOPH RES CO, V293, P816, DOI 10.1016/S0006-291X(02)00277-2; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Yu M, 2015, SCIENCE, V350, P1383, DOI 10.1126/science.aad2338; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	62	35	41	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1127	+		10.1038/ncb3424	http://dx.doi.org/10.1038/ncb3424			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27749823	Green Accepted, Green Submitted			2022-12-25	WOS:000387165600007
J	Ruderfer, DM; Hamamsy, T; Lek, M; Karczewski, KJ; Kavanagh, D; Samocha, KE; Daly, MJ; MacArthur, DG; Fromer, M; Purcell, SM				Ruderfer, Douglas M.; Hamamsy, Tymor; Lek, Monkol; Karczewski, Konrad J.; Kavanagh, David; Samocha, Kaitlin E.; Daly, Mark J.; MacArthur, Daniel G.; Fromer, Menachem; Purcell, Shaun M.		Exome Aggregation Consortium	Patterns of genic intolerance of rare copy number variation in 59,898 human exomes	NATURE GENETICS			English	Article							STRUCTURAL VARIATION; GENOME; IDENTIFICATION; MAP	Copy number variation (CNV) affecting protein-coding genes contributes substantially to human diversity and disease. Here we characterized the rates and properties of rare genic CNVs (<0.5% frequency) in exome sequencing data from nearly 60,000 individuals in the Exome Aggregation Consortium (ExAC) database. On average, individuals possessed 0.81 deleted and 1.75 duplicated genes, and most (70%) carried at least one rare genic CNV. For every gene, we empirically estimated an index of relative intolerance to CNVs that demonstrated moderate correlation with measures of genic constraint based on single-nucleotide variation (SNV) and was independently correlated with measures of evolutionary conservation. For individuals with schizophrenia, genes affected by CNVs were more intolerant than in controls. The ExAC CNV data constitute a critical component of an integrated database spanning the spectrum of human genetic variation, aiding in the interpretation of personal genomes as well as population-based disease studies. These data are freely available for download and visualization online.	[Ruderfer, Douglas M.; Hamamsy, Tymor; Kavanagh, David; Fromer, Menachem; Purcell, Shaun M.] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA; [Ruderfer, Douglas M.; Kavanagh, David; Fromer, Menachem; Purcell, Shaun M.] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Ruderfer, Douglas M.; Lek, Monkol; Karczewski, Konrad J.; Samocha, Kaitlin E.; Daly, Mark J.; MacArthur, Daniel G.; Fromer, Menachem; Purcell, Shaun M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lek, Monkol; Karczewski, Konrad J.; Samocha, Kaitlin E.; Daly, Mark J.; MacArthur, Daniel G.; Fromer, Menachem; Purcell, Shaun M.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Purcell, Shaun M.] Brigham & Womens Hosp, Harvard Med Sch, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ruderfer, DM; Purcell, SM (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA.; Ruderfer, DM; Purcell, SM (corresponding author), Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Ruderfer, DM; Purcell, SM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Purcell, SM (corresponding author), Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; Purcell, SM (corresponding author), Brigham & Womens Hosp, Harvard Med Sch, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA.	douglas.ruderfer@mssm.edu; shaun.purcell@mssm.edu	Ware, James S/G-5139-2012; Ruderfer, Douglas M/M-5795-2016; Daly, Mark J/B-2453-2017	Ware, James S/0000-0002-6110-5880; Ruderfer, Douglas M/0000-0002-2365-386X; Daly, Mark J/0000-0002-0949-8752; Samocha, Kaitlin/0000-0002-1704-3352; MacArthur, Daniel/0000-0002-5771-2290	Institute for Genomics and Multiscale Biology; NIH [R01-HG005827, R01-MH099126]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, U54DK105566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099126] Funding Source: NIH RePORTER	Institute for Genomics and Multiscale Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to acknowledge E. Ruder and K. Shakir for their help in running XHMM at the large scale required for over 60,000 samples. Work at the Icahn School of Medicine at Mount Sinai was supported by the Institute for Genomics and Multiscale Biology (including computational resources and staff expertise provided by the Department of Scientific Computing) and NIH grants R01-HG005827 and R01-MH099126 (to S.M.P.).	Buchanan JA, 2008, GENET MED, V10, P639, DOI [10.1097/GIM.0b013e318183f848, 10.1097GIM.0b013e318183f848]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Desachy G, 2015, MOL PSYCHIATR, V20, P170, DOI 10.1038/mp.2014.179; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Fu WQ, 2013, ANNU REV GENOM HUM G, V14, P467, DOI 10.1146/annurev-genom-091212-153509; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; JACOBS PA, 1959, LANCET, V1, P710; JACOBS PA, 1978, CLIN GENET, V13, P37; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; LEJEUNE J., 1959, ARCH FRANC PEDIATRIE, V16, P962; LEK M, 2016, NATURE; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Poultney CS, 2013, AM J HUM GENET, V93, P607, DOI 10.1016/j.ajhg.2013.09.001; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Szatkiewicz JP, 2014, MOL PSYCHIATR, V19, P762, DOI 10.1038/mp.2014.40; Ye YN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-769; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871	35	116	119	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1107	1111		10.1038/ng.3638	http://dx.doi.org/10.1038/ng.3638			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27533299	Green Accepted, Green Submitted			2022-12-25	WOS:000384391600005
J	Minster, RL; Hawley, NL; Su, CT; Sun, G; Kershaw, EE; Cheng, H; Buhule, OD; Lin, J; Reupena, MS; Viali, S; Tuitele, J; Naseri, T; Urban, Z; Deka, R; Weeks, DE; McGarvey, ST				Minster, Ryan L.; Hawley, Nicola L.; Su, Chi -Ting; Sun, Guangyun; Kershaw, Erin E.; Cheng, Hong; Buhule, Olive D.; Lin, Jerome; Reupena, Muagututia Sefuiva; Viali, Satupditea; Tuitele, John; Naseri, Take; Urban, Zsolt; Deka, Ranjan; Weeks, Daniel E.; McGarvey, Stephen T.			A thrifty variant in CREBRF strongly influences body mass index in Samoans	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SAMPLE-SIZE REQUIREMENTS; INSULIN-RESISTANCE; AMERICAN-SAMOA; OBESITY; ADIPOSITY; GENE; ADIPOGENESIS; IMPUTATION; SELECTION	Samoans are a unique founder population with a high prevalence of obesity(1-3), making them well suited for identifying new genetic contributors to obesity(4). We conducted a genome-wide association study (GWAS) in 3,072 Samoans, discovered a variant, rs12513649, strongly associated with body mass index (BMI) (P = 5.3 x 10(-14)), and replicated the association in 2,102 additional Samoans (P = 1.2 x 10(-9)). Targeted sequencing identified a strongly associated missense variant, rs373863828 (p.Arg457Gln), in CREBRF (meta P = 1.4 x 10(-20)). Although this variant is extremely rare in other populations, it is common in Samoans (frequency of 0.259), with an effect size much larger than that of any other known common BMI risk variant (1.36-1.45 kg/m(2) per copy of the risk-associated allele). In comparison to wild-type CREBRF, the Arg457Gln variant when overexpressed selectively decreased energy use and increased fat storage in an adipocyte cell model. These data, in combination with evidence of positive selection of the allele encoding p.Arg457Gln, support a 'thrifty' variant hypothesis as a factor in human obesity.	[Minster, Ryan L.; Su, Chi -Ting; Lin, Jerome; Urban, Zsolt; Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Hawley, Nicola L.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Chron Disease, New Haven, CT USA; [Sun, Guangyun; Cheng, Hong; Deka, Ranjan] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Kershaw, Erin E.] Univ Pittsburgh, Dept Med, Div Endocrinol, Pittsburgh, PA USA; [Buhule, Olive D.; Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Reupena, Muagututia Sefuiva] Govt Samoa, Bur Stat, Apia, Samoa, New Zealand; [Viali, Satupditea] Samoa Natl Hlth Serv, Apia, Samoa, New Zealand; [Tuitele, John] Amer Samoa Govt, Dept Hlth, Pago Pago, AS USA; [Naseri, Take] Govt Samoa, Minist Hlth, Apia, Samoa, New Zealand; [McGarvey, Stephen T.] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Int Hlth Inst, Providence, RI 02912 USA; [McGarvey, Stephen T.] Brown Univ, Dept Anthropol, Providence, RI 02912 USA; [Su, Chi -Ting] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Buhule, Olive D.] Eunice Kennedy Shrivel Natl Inst Child Hlth & Hum, Biostat & Bioinformat Branch, Div Intramural Populat Hlth Res, US NIH, Bethesda, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; University System of Ohio; University of Cincinnati; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; Brown University; National Taiwan University; National Taiwan University Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	McGarvey, ST (corresponding author), Brown Univ, Sch Publ Hlth, Dept Epidemiol, Int Hlth Inst, Providence, RI 02912 USA.; McGarvey, ST (corresponding author), Brown Univ, Dept Anthropol, Providence, RI 02912 USA.	stephen_mcgarvey@brown.edu	Weeks, Daniel E/B-2995-2012; Kershaw, Erin E/G-9587-2013; Urban, Zsolt/A-2018-2013	Weeks, Daniel E/0000-0001-9410-7228; Kershaw, Erin E/0000-0002-3887-4868; Su, Chi-Ting/0000-0002-2926-3950; Urban, Zsolt/0000-0003-3890-1843; Minster, Ryan/0000-0001-7382-6717; Hawley, Nicola/0000-0002-2601-3454	NIH [R01-HL093093, R01-AG09375, R01-HL52611, R01-DK59642, P30 ES006096, R01-DK55406, R01-HL090648, R01-DK090166]; Brown University student research funds; American Samoan Department of Health; Samoan Ministry of Health; Samoan Bureau of Statistics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052611, R01HL090648, R01HL093093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090166, R01DK059642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown University student research funds; American Samoan Department of Health; Samoan Ministry of Health; Samoan Bureau of Statistics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank the Samoan participants of the study, and local village authorities and the many Samoan and other field workers over the years. We acknowledge the Samoan Ministry of Health and the Samoan Bureau of Statistics, and the American Samoan Department of Health for their support of this research. We also acknowledge S.S. Shiva and C.G. Corey at the University of Pittsburgh Center for Metabolism and Mitochondrial Biology for assistance with cellular bioenergetic profiling. This work was funded by NIH grants R01-HL093093 (S.T.M.), R01-AG09375 (S.T.M.), R01-HL52611 (I. Kamboh), R01-DK59642 (S.T.M.), P30 ES006096 (S.M.Ho), R01-DK55406. (R.D.), R01-HL090648 (Z.U.), and R01-DK090166 (E.E.K.) and by Brown University student research funds. Genotyping was performed in the Core Genotyping Laboratory at the University of Cincinnati, funded by NIH grant P30 ES006096 (S.M. Ho). Illumina sequencing was conducted at the Genetic Resources Core Facility, Johns Hopkins Institute of Genetic Medicine (Baltimore).	Aberg K, 2009, OBESITY, V17, P518, DOI 10.1038/oby.2008.558; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cadzow M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00293; Chen R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-548; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Eicher JD, 2015, NUCLEIC ACIDS RES, V43, pD799, DOI 10.1093/nar/gku1202; Exome Aggregation Consortium, 2016, AN PROT COD GEN VAR; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Green R. C., 2007, GROWTH COLLAPSE PACI, P203; Hawley NL, 2014, AM J HUM BIOL, V26, P491, DOI 10.1002/ajhb.22553; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Keighley ED, 2006, AM J HUM BIOL, V18, P112, DOI 10.1002/ajhb.20469; Keuper M, 2014, FASEB J, V28, P761, DOI 10.1096/fj.13-238725; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kim TH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.490; Kirch P., 2007, GROWTH COLLAPSE PACI, P1; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Leslie R, 2014, BIOINFORMATICS, V30, P185, DOI 10.1093/bioinformatics/btu273; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Ma X, 2011, BIOCHEM J, V439, P27, DOI 10.1042/BJ20101475; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Martyn AC, 2012, MOL CELL BIOL, V32, P5140, DOI 10.1128/MCB.01142-12; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGarvey S. T., 1989, HUMAN POPULATION BIO, P263; MCGARVEY ST, 1994, J POLYNESIAN SOC, V103, P29; MCGARVEY ST, 1993, AM J HUM BIOL, V5, P17, DOI 10.1002/ajhb.1310050106; MCGARVEY ST, 1991, AM J CLIN NUTR, V53, pS1586, DOI 10.1093/ajcn/53.6.1586S; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Staples J, 2014, AM J HUM GENET, V95, P553, DOI 10.1016/j.ajhg.2014.10.005; Staples J, 2013, GENET EPIDEMIOL, V37, P136, DOI 10.1002/gepi.21684; Stocker H, 2015, DEV CELL, V33, P245, DOI 10.1016/j.devcel.2015.04.013; Swinburn BA, 1999, INT J OBESITY, V23, P1178, DOI 10.1038/sj.ijo.0801053; Szpiech ZA, 2014, MOL BIOL EVOL, V31, P2824, DOI 10.1093/molbev/msu211; Tiebe M, 2015, DEV CELL, V33, P272, DOI 10.1016/j.devcel.2015.03.013; Tishkoff S, 2015, SCIENCE, V349, P1282, DOI 10.1126/science.aad0584; Tsai Hui-ju, 2004, Human Genomics, V1, P327; Vankoningsloo S, 2006, J CELL SCI, V119, P1266, DOI 10.1242/jcs.02848; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang X, 2016, EUR J HUM GENET, V24, P592, DOI 10.1038/ejhg.2015.150; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; ZIMMET P, 1990, DIABETES METAB REV, V6, P91, DOI 10.1002/dmr.5610060203	68	137	139	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1049	+		10.1038/ng.3620	http://dx.doi.org/10.1038/ng.3620			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27455349	Green Accepted			2022-12-25	WOS:000382398800016
J	Wang, YM; Zhao, Z; Rege, SV; Wang, M; Si, G; Zhou, Y; Wang, S; Griffin, JH; Goldman, SA; Zlokovic, BV				Wang, Yaoming; Zhao, Zhen; Rege, Sanket V.; Wang, Min; Si, Gabriel; Zhou, Yi; Wang, Su; Griffin, John H.; Goldman, Steven A.; Zlokovic, Berislav V.			3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice	NATURE MEDICINE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ISCHEMIC-STROKE; THERAPEUTIC WINDOW; NEUROGENESIS; ANALOG; BRAIN; MOUSE; APOPTOSIS; 3K3A-APC; DEFICITS	Activated protein C (APC) is a blood protease with anticoagulant activity and cell-signaling activities mediated by the activation of protease-activated receptor 1 (F2R, also known as PAR1) and F2RL1 (also known as PAR3) via noncanonical cleavage(1). Recombinant variants of APC, such as the 3K3A-APC (Lys191-193Ala) mutant in which three Lys residues (KKK191-193) were replaced with alanine, and/or its other mutants with reduced (> 90%) anticoagulant activity, engineered to reduce APC-associated bleeding risk while retaining normal cell-signaling activity, have shown benefits in preclinical models of ischemic stroke(2-6), brain trauma(7), multiple sclerosis(8), amyotrophic lateral sclerosis(9), sepsis(10,11), ischemic and reperfusion injury of heart(12), kidney and liver(13), pulmonary, kidney and gastrointestinal inflammation(1,11), diabetes(14) and lethal body radiation(15). On the basis of proof-of-concept studies and an excellent safety profile in humans, 3K3A-APC has advanced to clinical trials as a neuroprotectant in ischemic stroke(16,17). Recently, 3K3A-APC has been shown to stimulate neuronal production by human neural stem and progenitor cells (NSCs) in vitro18 via a PAR1-PAR3-sphingosine-1-phosphate-receptor 1-Akt pathway(19), which suggests the potential for APC-based treatment as a strategy for structural repair in the human central nervous (CNS) system. Here we report that late postischemic treatment of mice with 3K3A-APC stimulates neuronal production by transplanted human NSCs, promotes circuit restoration and improves functional recovery. Thus, 3K3A-APC-potentiated neuronal recruitment from engrafted NSCs might offer a new approach to the treatment of stroke and related neurological disorders.	[Wang, Yaoming; Zhao, Zhen; Rege, Sanket V.; Wang, Min; Si, Gabriel; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Wang, Yaoming; Zhao, Zhen; Rege, Sanket V.; Wang, Min; Si, Gabriel; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Zhou, Yi] Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Neurobiol, Chongqing, Peoples R China; [Wang, Su; Goldman, Steven A.] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Wang, Su; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Wang, Su; Goldman, Steven A.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic & Translat Neurosci, Copenhagen, Denmark; [Griffin, John H.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Griffin, John H.] Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA	University of Southern California; University of Southern California; Army Medical University; University of Rochester; University of Rochester; University of Copenhagen; Scripps Research Institute; University of California System; University of California San Diego	Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.; Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	zlokovic@usc.edu	Zlokovic, Berislav/ABE-7362-2020; zhao, zhen/A-2080-2012	Zlokovic, Berislav/0000-0002-6802-8232; zhao, zhen/0000-0001-8967-5570; Griffin, John/0000-0002-4302-2547; Goldman, Steven/0000-0002-5498-4303	NIH [9R01NS090904-16, RO1HL052246, PO1 HL031950, R01NS75345]; National Natural Science Foundation of China [31371116]; Adelson Medical Research Foundation; New York State Stem Cell Research Board (NYSTEM); Novo Nordisk Foundation; Lundbeck Foundation; National Multiple Sclerosis Society; ALS Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052246, P01HL031950, R01HL021544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099578, R01MH104701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075345, R01NS090904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF13OC0004260] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Adelson Medical Research Foundation; New York State Stem Cell Research Board (NYSTEM); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); National Multiple Sclerosis Society(National Multiple Sclerosis Society); ALS Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors want to acknowledge the NIH grants 9R01NS090904-16 (B.V.Z.), RO1HL052246 and PO1 HL031950 (J.H.G.), R01NS75345 (S.A.G.); National Natural Science Foundation of China grant 31371116 (Y.Z.); and grants from the Adelson Medical Research Foundation, New York State Stem Cell Research Board (NYSTEM), Novo Nordisk Foundation, Lundbeck Foundation, National Multiple Sclerosis Society and ALS Association (S.A.G.).	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Albers GW, 2011, STROKE, V42, P2645, DOI 10.1161/STROKEAHA.111.618850; [Anonymous], 2014, SAFETY EVALUATION 3K; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; Esmon CT, 2012, SEMIN IMMUNOPATHOL, V34, P127, DOI 10.1007/s00281-011-0284-6; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; Fuchs EJ, 2014, IMMUNOL REV, V258, P64, DOI 10.1111/imr.12154; Furukawa N, 2006, J BIOCHEM, V140, P831, DOI 10.1093/jb/mvj216; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; Goldman SA, 2016, CELL STEM CELL, V18, P174, DOI 10.1016/j.stem.2016.01.012; Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974; Guo H, 2013, J NEUROSCI, V33, P6181, DOI 10.1523/JNEUROSCI.4491-12.2013; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; Li DD, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00193; Loubele STBG, 2009, ARTERIOSCL THROM VAS, V29, P1087, DOI 10.1161/ATVBAHA.109.188656; Lyden P, 2013, CURR PHARM DESIGN, V19, P7479; MARKGRAF CG, 1994, STROKE, V25, P153, DOI 10.1161/01.STR.25.1.153; Park SW, 2009, KIDNEY INT, V76, P739, DOI 10.1038/ki.2009.255; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Savitz SI, 2013, STROKE, V44, pS107, DOI 10.1161/STROKEAHA.112.679605; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vanni MP, 2014, J NEUROSCI, V34, P15931, DOI 10.1523/JNEUROSCI.1818-14.2014; Walker CT, 2010, BRAIN RES, V1347, P125, DOI 10.1016/j.brainres.2010.05.075; Wang S, 2010, J NEUROSCI, V30, P14635, DOI 10.1523/JNEUROSCI.1729-10.2010; Wang YM, 2013, STROKE, V44, P3529, DOI 10.1161/STROKEAHA.113.003350; Wang YM, 2013, BRAIN RES, V1507, P97, DOI 10.1016/j.brainres.2013.02.023; Wang YM, 2012, STROKE, V43, P2444, DOI 10.1161/STROKEAHA.112.658997; Wen ZM, 2012, NEURAL REGEN RES, V7, P578, DOI 10.3969/j.issn.1673-5374.2012.08.003; Williams PD, 2012, CURR PHARM DESIGN, V18, P4215; Winkler EA, 2014, P NATL ACAD SCI USA, V111, pE1035, DOI 10.1073/pnas.1401595111; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	43	58	58	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1050	+		10.1038/nm.4154	http://dx.doi.org/10.1038/nm.4154			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27548576	Green Accepted			2022-12-25	WOS:000382542800016
J	Pearson, RD; Amato, R; Auburn, S; Miotto, O; Almagro-Garcia, J; Amaratunga, C; Suon, S; Mao, S; Noviyanti, R; Trimarsanto, H; Marfurt, J; Anstey, NM; William, T; Boni, MF; Dolecek, C; Tran, HT; White, NJ; Michon, P; Siba, P; Tavul, L; Harrison, G; Barry, A; Mueller, I; Ferreira, MU; Karunaweera, N; Randrianarivelojosia, M; Gao, Q; Hubbart, C; Hart, L; Jeffery, B; Drury, E; Mead, D; Kekre, M; Campino, S; Manske, M; Cornelius, VJ; MacInnis, B; Rockett, KA; Miles, A; Rayner, JC; Fairhurst, RM; Nosten, F; Price, RN; Kwiatkowski, DP				Pearson, Richard D.; Amato, Roberto; Auburn, Sarah; Miotto, Olivo; Almagro-Garcia, Jacob; Amaratunga, Chanaki; Suon, Seila; Mao, Sivanna; Noviyanti, Rintis; Trimarsanto, Hidayat; Marfurt, Jutta; Anstey, Nicholas M.; William, Timothy; Boni, Maciej F.; Dolecek, Christiane; Hien Tinh Tran; White, Nicholas J.; Michon, Pascal; Siba, Peter; Tavul, Livingstone; Harrison, Gabrielle; Barry, Alyssa; Mueller, Ivo; Ferreira, Marcelo U.; Karunaweera, Nadira; Randrianarivelojosia, Milijaona; Gao, Qi; Hubbart, Christina; Hart, Lee; Jeffery, Ben; Drury, Eleanor; Mead, Daniel; Kekre, Mihir; Campino, Susana; Manske, Magnus; Cornelius, Victoria J.; MacInnis, Bronwyn; Rockett, Kirk A.; Miles, Alistair; Rayner, Julian C.; Fairhurst, Rick M.; Nosten, Francois; Price, Ric N.; Kwiatkowski, Dominic P.			Genomic analysis of local variation and recent evolution in Plasmodium vivax	NATURE GENETICS			English	Article							DRUG-RESISTANCE GENES; DNA-SEQUENCING DATA; DUFFY-BLOOD-GROUP; MALARIA; FALCIPARUM; DIVERSITY; CHLOROQUINE; INFECTIONS; REVEALS; POLYMORPHISMS	The widespread distribution and relapsing nature of Plasmodium vivax infection present major challenges for the elimination of malaria. To characterize the genetic diversity of this parasite in individual infections and across the population, we performed deep genome sequencing of > 200 clinical samples collected across the Asia-Pacific region and analyzed data on > 300,000 SNPs and nine regions of the genome with large copy number variations. Individual infections showed complex patterns of genetic structure, with variation not only in the number of dominant clones but also in their level of relatedness and inbreeding. At the population level, we observed strong signals of recent evolutionary selection both in known drug resistance genes and at new loci, and these varied markedly between geographical locations. These findings demonstrate a dynamic landscape of local evolutionary adaptation in the parasite population and provide a foundation for genomic surveillance to guide effective strategies for control and elimination of P. vivax.	[Pearson, Richard D.; Amato, Roberto; Miotto, Olivo; Drury, Eleanor; Mead, Daniel; Kekre, Mihir; Campino, Susana; Manske, Magnus; Cornelius, Victoria J.; MacInnis, Bronwyn; Rockett, Kirk A.; Miles, Alistair; Rayner, Julian C.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England; [Pearson, Richard D.; Amato, Roberto; Miotto, Olivo; Almagro-Garcia, Jacob; Hubbart, Christina; Hart, Lee; Jeffery, Ben; Cornelius, Victoria J.; Rockett, Kirk A.; Miles, Alistair; Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, MRC Ctr Genom & Global Hlth, Oxford, England; [Auburn, Sarah; Marfurt, Jutta; Anstey, Nicholas M.; Price, Ric N.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Auburn, Sarah; Marfurt, Jutta; Price, Ric N.] Charles Darwin Univ, Darwin, NT, Australia; [Miotto, Olivo; White, Nicholas J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Amaratunga, Chanaki] NIAID, NIH, Rockville, MD USA; [Suon, Seila] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Mao, Sivanna] Sampov Meas Referral Hosp, Pursat, Cambodia; [Noviyanti, Rintis; Trimarsanto, Hidayat] Eijkman Inst Mol Biol, Jakarta, Indonesia; [William, Timothy] Sabah Menzies Sch Hlth Res, Clin Res Unit, Infect Dis Soc, Kota Kinabalu, Sabah, Malaysia; [William, Timothy] Queen Elizabeth Hosp, Clin Res Ctr, Kota Kinabalu, Sabah, Malaysia; [Boni, Maciej F.; Dolecek, Christiane; Hien Tinh Tran] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Michon, Pascal; Siba, Peter; Tavul, Livingstone] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Michon, Pascal] Divine Word Univ, Fac Med & Hlth Sci, Madang, Papua N Guinea; [Harrison, Gabrielle; Barry, Alyssa; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Div Populat Hlth & Immun, Parkville, Vic, Australia; [Harrison, Gabrielle; Barry, Alyssa; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Ferreira, Marcelo U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil; [Karunaweera, Nadira] Univ Colombo, Fac Med, Dept Parasitol, Colombo, Sri Lanka; [Randrianarivelojosia, Milijaona] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Gao, Qi] Minist Hlth, Jiangsu Inst Parasit Dis, Key Lab Parasit Dis Control & Prevent, Prov Key Lab Parasite Mol Biol, Wuxi, Jiangsu, Peoples R China; [Nosten, Francois] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Fac Trop Med, Mae Sot, Thailand; [Nosten, Francois; Price, Ric N.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England	Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; Charles Darwin University; Menzies School of Health Research; Charles Darwin University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Center Parasitology, Entomology & Malaria Control; Eijkman Institute; University of Oxford; PNG Institute Of Medical Research; Walter & Eliza Hall Institute; University of Melbourne; Universidade de Sao Paulo; University of Colombo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Kwiatkowski, DP (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.; Kwiatkowski, DP (corresponding author), Wellcome Trust Ctr Human Genet, MRC Ctr Genom & Global Hlth, Oxford, England.	dominic@sanger.ac.uk	Campino, Susana/AAM-2577-2020; White, Nick/AAC-6527-2019; Mead, Daniel/AAE-6629-2019; Miotto, Olivo/AAE-7124-2019; Nosten, Francois/AAC-5509-2019; Ferreira, Marcelo U/G-8289-2011; Auburn, Sarah/N-2266-2013	Campino, Susana/0000-0003-1403-6138; White, Nick/0000-0002-1897-1978; Mead, Daniel/0000-0001-7717-4330; Miotto, Olivo/0000-0001-8060-6771; Nosten, Francois/0000-0002-7951-0745; Ferreira, Marcelo U/0000-0002-5293-9090; Price, Richard/0000-0003-2000-2874; Karunaweera, Nadira/0000-0003-3985-1817; Kwiatkowski, Dominic/0000-0002-5023-0176; Amato, Roberto/0000-0001-8633-9221; Trimarsanto, Hidayat/0000-0003-2436-8283; Miles, Alistair/0000-0001-9018-4680; Randrianarivelojosia, Milijaona/0000-0003-2767-0349; Hart, Lee/0000-0002-6473-0964; Barry, Alyssa/0000-0002-1189-2310; Noviyanti, Rintis/0000-0003-1383-3274; Auburn, Sarah/0000-0002-4638-536X; Rayner, Julian/0000-0002-9835-1014; Manske, Magnus/0000-0001-5916-0947	Wellcome Trust [098051, 090770/Z/09/Z, 091625]; Medical Research Council [G0600718]; UK Department for International Development [M006212]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001066, ZIAAI001000] Funding Source: NIH RePORTER; Medical Research Council [MR/M006212/1] Funding Source: researchfish; MRC [G0600718, MR/M006212/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients and communities that provided samples for this study, and our many colleagues who supported this work in the field. Sequencing, data analysis and project coordination were funded by the Wellcome Trust (098051, 090770/Z/09/Z), the Medical Research Council (G0600718) and the UK Department for International Development (M006212). A.B. and I.M. acknowledge the Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Medical Research Institutes Infrastructure Support Scheme (NHMRC IRIISS). S.A. and R.N.P. are funded by the Wellcome Trust (Senior Fellowship in Clinical Science awarded to R.N.P., 091625). This study was supported in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Alam MT, 2011, ANTIMICROB AGENTS CH, V55, P155, DOI 10.1128/AAC.00691-10; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Auburn S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053160; Auburn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032891; Barry AE, 2015, PATHOG GLOB HEALTH, V109, P142, DOI 10.1179/2047773215Y.0000000012; Battle KE, 2012, ADV PARASIT, V80, P1, DOI 10.1016/B978-0-12-397900-1.00001-3; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Bright AT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002882; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chan ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001811; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dharia NV, 2010, P NATL ACAD SCI USA, V107, P20045, DOI 10.1073/pnas.1003776107; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flannery EL, 2015, ACS INFECT DIS, V1, P367, DOI 10.1021/acsinfecdis.5b00049; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Hester J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002569; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Imwong M, 2003, ANTIMICROB AGENTS CH, V47, P1514, DOI 10.1128/AAC.47.5.1514-1521.2003; Imwong M, 2012, J INFECT DIS, V205, P680, DOI 10.1093/infdis/jir806; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Korsinczky M, 2004, ANTIMICROB AGENTS CH, V48, P2214, DOI 10.1128/AAC.48.6.2214-2222.2004; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin JT, 2015, J INFECT DIS, V212, P999, DOI 10.1093/infdis/jiv142; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menard D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002489; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Miles A., 2015, 024182 BIORXIV; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Nair S, 2014, GENOME RES, V24, P1028, DOI 10.1101/gr.168286.113; Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Pava Z, 2016, ANTIMICROB AGENTS CH, V60, P361, DOI 10.1128/AAC.02207-15; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Suwanarusk R, 2008, J INFECT DIS, V198, P1558, DOI 10.1086/592451; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; Tachibana SI, 2012, NAT GENET, V44, P1051, DOI 10.1038/ng.2375; Tao ZY, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-251; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Westenberger SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000653; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; Winter DJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004252	53	112	115	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					959	964		10.1038/ng.3599	http://dx.doi.org/10.1038/ng.3599			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27348299	Green Accepted, Green Submitted			2022-12-25	WOS:000380755100022
J	Li, PL; Kaiser, P; Lampiris, HW; Kim, P; Yukl, SA; Havlir, DV; Greene, WC; Wong, JK				Li, Peilin; Kaiser, Philipp; Lampiris, Harry W.; Kim, Peggy; Yukl, Steven A.; Havlir, Diane V.; Greene, Warner C.; Wong, Joseph K.			Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation	NATURE MEDICINE			English	Article							SIGNAL-ACTIVATION; RETINOIC ACID; T-CELL; RNA; REPLICATION; RECOGNITION; ACITRETIN	The persistence of latent HIV proviruses in long-lived CD4(+) T cells despite antiretroviral therapy (ART)(1-3) is a major obstacle to viral eradication(4-6). Because current candidate latency reversing agents (LRAs) induce HIV transcription, but fail to clear these cellular reservoirs(7,8), new approaches for killing these reactivated latent HIV reservoir cells are urgently needed. HIV latency depends upon the transcriptional quiescence of the integrated provirus and the circumvention of immune defense mechanisms(4-6,9). These defenses include cell-intrinsic innate responses that use pattern-recognition receptors (PRRs) to detect viral pathogens, and that subsequently induce apoptosis of the infected cell(10). Retinoic acid (RA)-inducible gene I (RIG-I, encoded by DDX58) forms one class of PRRs that mediates apoptosis and the elimination of infected cells after recognition of viral RNA(11-14). Here we show that acitretin, an RA derivative approved by the US Food and Drug Administration (FDA), enhances RIG-I signaling ex vivo, increases HIV transcription, and induces preferential apoptosis of HIV-infected cells. These effects are abrogated by DDX58 knockdown. Acitretin also decreases proviral DNA levels in CD4(+) T cells from HIV-positive subjects on suppressive ART, an effect that is amplified when combined with suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor. Pharmacological enhancement of an innate cellular-defense network could provide a means by which to eliminate reactivated cells in the latent HIV reservoir.	[Li, Peilin; Kaiser, Philipp; Lampiris, Harry W.; Kim, Peggy; Yukl, Steven A.; Wong, Joseph K.] San Francisco VA Med Ctr, Med Serv, Infect Dis Sect, San Francisco, CA 94121 USA; [Li, Peilin; Lampiris, Harry W.; Yukl, Steven A.; Havlir, Diane V.; Greene, Warner C.; Wong, Joseph K.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Havlir, Diane V.] San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94110 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Biol, San Francisco, CA 94143 USA; [Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Li, PL (corresponding author), San Francisco VA Med Ctr, Med Serv, Infect Dis Sect, San Francisco, CA 94121 USA.; Li, PL (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	peilin.li@ucsf.edu	Li, Peilin/CAG-5411-2022		NIH [1R21AI104445-01A1, R56 AI116342, R21 AI116218]; Department of Veterans Affairs Merit Review Award [5101 BX001048]; UCSF-Gladstone Center for AIDS Research Virology Core [P30AI027763, U19 AI096113]; amfAR Institute for HIV Cure Research [109301]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI116218, R21AI104445, P30AI027763, U19AI096113, R33AI116218, R56AI116342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108349] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000520, I01BX001048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); UCSF-Gladstone Center for AIDS Research Virology Core; amfAR Institute for HIV Cure Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank the study participants, without whom this research could not have been performed. We thank S. Deeks, H. Gunthard, C. Lopez, and H. Hatano for their helpful comments and support, and M. Vu for assistance with participant recruitment. We thank J.C.W. Carroll for graphics arts, S. Ordway for editorial assistance, and S. Wilcox for administrative assistance. We thank the US National Institutes of Health (NIH) AIDS Reagent Program, Division of AIDS, NIAID, NIH for cell lines, plasmid, and reagents. This work was supported by the NIH (grants 1R21AI104445-01A1 (P.L.), R56 AI116342 and R21 AI116218 (J.K.W.)), the Department of Veterans Affairs Merit Review Award 5101 BX001048 (J.K.W.), the UCSF-Gladstone Center for AIDS Research Virology Core P30AI027763 (W.C.G. and J.K.W.), U19 AI096113 (W.C.G.) and research supported as part of the amfAR Institute for HIV Cure Research with grant number 109301(W.G., J.K.W., and P.L.).	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Badley AD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.248; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Britto AMA, 2013, AIDS, V27, P1879, DOI 10.1097/QAD.0b013e328361cfbf; Broz P, 2013, NAT REV IMMUNOL, V13, P551, DOI 10.1038/nri3479; Buccheri L, 1997, ARCH DERMATOL, V133, P711, DOI 10.1001/archderm.133.6.711; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Dietze EC, 2003, BIOCHEM BIOPH RES CO, V302, P841, DOI 10.1016/S0006-291X(03)00266-3; Doehle BP, 2009, J VIROL, V83, P10395, DOI 10.1128/JVI.00849-09; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Huang SL, 2000, MOL CELL ENDOCRINOL, V159, P15, DOI 10.1016/S0303-7207(99)00207-5; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017; Lassen KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030176; Marcu MG, 2006, MED CHEM, V2, P169, DOI 10.2174/157340606776056133; Ortiz NEG, 2013, DERMATOL THER, V26, P390, DOI 10.1111/dth.12086; Pace MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002818; Passaes CP, 2014, VIROLOGY, V454, P340, DOI 10.1016/j.virol.2014.02.021; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Raverdeau M, 2014, J IMMUNOL, V192, P2953, DOI 10.4049/jimmunol.1303245; Rehwinkel J, 2010, J CLIN IMMUNOL, V30, P491, DOI 10.1007/s10875-010-9384-7; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Schlee M, 2013, IMMUNOBIOLOGY, V218, P1322, DOI 10.1016/j.imbio.2013.06.007; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Wang YZ, 2013, J LEUKOCYTE BIOL, V94, P337, DOI 10.1189/jlb.0313158; Wiegand UW, 1998, J AM ACAD DERMATOL, V39, pS25, DOI 10.1016/S0190-9622(98)70441-4; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida T, 2004, BIOCHEM BIOPH RES CO, V321, P961, DOI 10.1016/j.bbrc.2004.07.054	39	64	66	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					807	811		10.1038/nm.4124	http://dx.doi.org/10.1038/nm.4124			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27294875	Green Accepted			2022-12-25	WOS:000379366900020
J	Workman, MJ; Mahe, MM; Trisno, S; Poling, HM; Watson, CL; Sundaram, N; Chang, CF; Schiesser, J; Aubert, P; Stanley, EG; Elefanty, AG; Miyaoka, Y; Mandegar, MA; Conklin, BR; Neunlist, M; Brugmann, SA; Helmrath, MA; Wells, JM				Workman, Michael J.; Mahe, Maxime M.; Trisno, Stephen; Poling, Holly M.; Watson, Carey L.; Sundaram, Nambirajan; Chang, Ching-Fang; Schiesser, Jacqueline; Aubert, Philippe; Stanley, Edouard G.; Elefanty, Andrew G.; Miyaoka, Yuichiro; Mandegar, Mohammad A.; Conklin, Bruce R.; Neunlist, Michel; Brugmann, Samantha A.; Helmrath, Michael A.; Wells, James M.			Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system	NATURE MEDICINE			English	Article							HIRSCHSPRUNG DISEASE; NEURONS; MOUSE; GUT; COLON; EXPRESSION; LINEAGES; MOTILITY; THERAPY; PHOX2B	The enteric nervous system (ENS) of the gastrointestinal tract controls many diverse functions, including motility and epithelial permeability. Perturbations in ENS development or function are common, yet there is no human model for studying ENS-intestinal biology and disease. We used a tissue-engineering approach with embryonic and induced pluripotent stem cells (PSCs) to generate human intestinal tissue containing a functional ENS. We recapitulated normal intestinal ENS development by combining human-PSC-derived neural crest cells (NCCs) and developing human intestinal organoids (HIOs). NCCs recombined with HIOs in vitro migrated into the mesenchyme, differentiated into neurons and glial cells and showed neuronal activity, as measured by rhythmic waves of calcium transients. ENS-containing HIOs grown in vivo formed neuroglial structures similar to a myenteric and submucosal plexus, had functional interstitial cells of Cajal and had an electromechanical coupling that regulated waves of propagating contraction. Finally, we used this system to investigate the cellular and molecular basis for Hirschsprung's disease caused by a mutation in the gene PHOX2B. This is, to the best of our knowledge, the first demonstration of human-PSC-derived intestinal tissue with a functional ENS and how this system can be used to study motility disorders of the human gastrointestinal tract.	[Workman, Michael J.; Trisno, Stephen; Chang, Ching-Fang; Schiesser, Jacqueline; Brugmann, Samantha A.; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Mahe, Maxime M.; Poling, Holly M.; Watson, Carey L.; Sundaram, Nambirajan; Helmrath, Michael A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gen & Thorac Surg, Cincinnati, OH 45229 USA; [Chang, Ching-Fang; Brugmann, Samantha A.] Cincinnati Childrens Hosp Med Ctr, Div Plast Surg, Cincinnati, OH 45229 USA; [Aubert, Philippe; Neunlist, Michel] Univ Nantes, INSERM, CHU Nantes Inst Malad Appareil Digestif, UMR 913, Nantes, France; [Stanley, Edouard G.; Elefanty, Andrew G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Stanley, Edouard G.; Elefanty, Andrew G.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Pediat, Parkville, Vic 3052, Australia; [Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Miyaoka, Yuichiro; Mandegar, Mohammad A.; Conklin, Bruce R.] Gladstone Inst, San Francisco, CA USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Mol Med, San Francisco, CA 94143 USA; [Conklin, Bruce R.; Wells, James M.] Univ Calif San Francisco, Dept Cellular Pharmacol, San Francisco, CA 94143 USA; [Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Dev Endocrinol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cincinnati Children's Hospital Medical Center	Wells, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.; Helmrath, MA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Gen & Thorac Surg, Cincinnati, OH 45229 USA.; Wells, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dev Endocrinol, Cincinnati, OH 45229 USA.	michael.helmrath@cchmc.org; james.wells@cchmc.org	Neunlist, Michel/K-2388-2015; Conklin, Bruce/E-4738-2019; Mahe, Maxime M/G-5552-2017; Stanley, Ed G/A-2985-2013	Mahe, Maxime M/0000-0003-2560-193X; Stanley, Ed G/0000-0002-6389-3665; Miyaoka, Yuichiro/0000-0002-8874-4738; Workman, Michael/0000-0003-2113-5580; Trisno, Stephen/0000-0003-0937-4474; Chang, Ching-Fang/0000-0001-6754-2769; Conklin, Bruce/0000-0003-1463-6061; Aubert, Philippe/0000-0002-3126-6202; Mandegar, Mohammad Ali/0000-0002-5323-7891; Schiesser, Jacqueline/0000-0002-5655-4382; poling, holly/0000-0002-3595-1944; Elefanty, Andrew/0000-0001-6448-8314	US National Institutes of Health [U18TR000546, U18EB021780, U01DK103117, R0IDK098350, R01DK092456]; Athena Blackburn Research Scholar Award in Neuroenteric Diseases; Cincinnati Digestive Disease Center Award [P30 DK0789392]; Clinical Translational Science Award [U54 RR025216]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U18TR000546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U18EB021780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092456, U01DK103117, K99DK110414, R01DK098350, P30DK078392] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Athena Blackburn Research Scholar Award in Neuroenteric Diseases; Cincinnati Digestive Disease Center Award; Clinical Translational Science Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Zorn, N. Shroyer and members of the Wells and Zorn laboratories for reagents and feedback. We thank M. Kofron for assistance with confocal imaging. We thank S. Danzer, R. Pun, J. Piero, M. Marotta and M. Oria for help with the equipment for the electrical field stimulation experiments. We thank K. Campbell and J. Kuerbitz for providing antibodies for the neurochemical analysis. This work was supported by US National Institutes of Health grants U18TR000546 (J.M.W.), U18EB021780 (J.M.W. and M.A.H.), U01DK103117 (J.M.W. and M.A.H.), R0IDK098350 (J.M.W.) and R01DK092456 (J.M.W.), and an Athena Blackburn Research Scholar Award in Neuroenteric Diseases (M.M.M.). We also acknowledge core support from the Cincinnati Digestive Disease Center Award (P30 DK0789392; Pilot and Feasibility Award), Clinical Translational Science Award (U54 RR025216) and technical support from Cincinnati Children's Hospital Medical Center (CCHMC) Confocal Imaging Core and the CCHMC human Pluripotent Stem Cell Facility.	Anderson G, 2007, EXP NEUROL, V207, P4, DOI 10.1016/j.expneurol.2007.05.010; Anlauf M, 2003, J COMP NEUROL, V459, P90, DOI 10.1002/cne.10599; BAETGE G, 1989, DEV BIOL, V132, P189, DOI 10.1016/0012-1606(89)90217-0; Bajaj R, 2005, PEDIATRICS, V115, pE737, DOI 10.1542/peds.2004-1910; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bergner AJ, 2014, J COMP NEUROL, V522, P514, DOI 10.1002/cne.23423; Blaugrund E, 1996, DEVELOPMENT, V122, P309; Bohorquez DV, 2015, J CLIN INVEST, V125, P782, DOI 10.1172/JCI78361; Burns AJ, 2016, DEV BIOL, V417, P229, DOI 10.1016/j.ydbio.2016.04.001; Burns AJ, 2014, NAT REV GASTRO HEPAT, V11, P317, DOI 10.1038/nrgastro.2013.226; Burns AJ, 2009, SEMIN PEDIATR SURG, V18, P196, DOI 10.1053/j.sempedsurg.2009.07.001; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Denham M, 2015, STEM CELLS, V33, P1759, DOI 10.1002/stem.1991; Erickson CS, 2014, NEUROGASTROENT MOTIL, V26, P874, DOI 10.1111/nmo.12343; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Fu M, 2004, ANAT EMBRYOL, V208, P33, DOI 10.1007/s00429-003-0371-0; Fu M, 2003, DEV DYNAM, V228, P1, DOI 10.1002/dvdy.10350; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Hao MM, 2016, DEV BIOL, V417, P168, DOI 10.1016/j.ydbio.2016.05.030; Hao MM, 2009, J CELL MOL MED, V13, P1193, DOI 10.1111/j.1582-4934.2009.00813.x; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Huebsch N, 2015, TISSUE ENG PART C-ME, V21, P467, DOI [10.1089/ten.tec.2014.0283, 10.1089/ten.TEC.2014.0283]; Kabouridis PS, 2015, NEURON, V85, P289, DOI 10.1016/j.neuron.2014.12.037; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Lui VCH, 2008, GASTROENTEROLOGY, V134, P1104, DOI 10.1053/j.gastro.2008.01.028; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; McKeown SJ, 2013, WIRES DEV BIOL, V2, P113, DOI 10.1002/wdev.57; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Obermayr F, 2013, NAT REV GASTRO HEPAT, V10, P43, DOI 10.1038/nrgastro.2012.234; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Saffrey MJ, 2013, DEV BIOL, V382, P344, DOI 10.1016/j.ydbio.2013.03.015; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Wallace AS, 2005, CELL TISSUE RES, V319, P367, DOI 10.1007/s00441-004-1023-2; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Young HM, 1999, DEV DYNAM, V216, P137, DOI 10.1002/(SICI)1097-0177(199910)216:2<137::AID-DVDY5>3.0.CO;2-6; Young HM, 2001, DEV BIOL, V229, P503, DOI 10.1006/dbio.2000.0100	39	312	325	3	155	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					49	59		10.1038/nm.4233	http://dx.doi.org/10.1038/nm.4233			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27869805	Green Accepted			2022-12-25	WOS:000391646800013
J	Brown, CT; Olm, MR; Thomas, BC; Banfield, JF				Brown, Christopher T.; Olm, Matthew R.; Thomas, Brian C.; Banfield, Jillian F.			Measurement of bacterial replication rates in microbial communities	NATURE BIOTECHNOLOGY			English	Article							GENOME SEQUENCES; REVEALS; METABOLISM; RECONSTRUCTION; IDENTIFICATION; CHROMOSOMES; ORGANISMS; COVERAGE; PHYLUM; RARE	Culture-independent microbiome studies have increased our understanding of the complexity and metabolic potential of microbial communities. However, to understand the contribution of individual microbiome members to community functions, it is important to determine which bacteria are actively replicating. We developed an algorithm, iRep, that uses draft-quality genome sequences and single time-point metagenome sequencing to infer microbial population replication rates. The algorithm calculates an index of replication (iRep) based on the sequencing coverage trend that results from bi-directional genome replication from a single origin of replication. We apply this method to show that microbial replication rates increase after antibiotic administration in human infants. We also show that uncultivated, groundwater-associated, Candidate Phyla Radiation bacteria only rarely replicate quickly in subsurface communities undergoing substantial changes in geochemistry. Our method can be applied to any genome-resolved microbiome study to track organism responses to varying conditions, identify actively growing populations and measure replication rates for use in modeling studies.	[Brown, Christopher T.; Olm, Matthew R.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Thomas, Brian C.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.; Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.; Banfield, JF (corresponding author), Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu	Olm, Matthew/S-5974-2019	Olm, Matthew/0000-0001-5540-350X; Banfield, Jill/0000-0001-8203-8771; Brown, Chris/0000-0002-7758-6447	NIH [R01A1092531]; Sloan Foundation grant [APSF-2012-10-05]; US Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231, DE-SC0004918]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092531] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation grant; US Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH grant R01A1092531 Sloan Foundation grant APSF-2012-10-05, and by the US Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research under award number DE-AC02-05CH11231 (Sustainable Systems Scientific Focus Area and DOE-JGI) and award number DE-SC0004918 (Systems Biology Knowledge Base Focus Area). We thank T. Raveh-Sadka, B. Brooks, and D. Burstein for helpful discussions, and M. Albertsen for comments regarding GC sequencing bias.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/nmeth.3103, 10.1038/NMETH.3103]; Anantharaman K, 2016, PEERJ, V4, DOI 10.7717/peerj.1607; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; BREMER H, 1977, J THEOR BIOL, V69, P645, DOI 10.1016/0022-5193(77)90373-3; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Carini P., 2016, RELIC DNA IS ABUNDAN; Castelle CJ, 2015, CURR BIOL, V25, P690, DOI 10.1016/j.cub.2015.01.014; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Eloe-Fadrosh EA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10476; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; Gong J, 2014, SYST APPL MICROBIOL, V37, P35, DOI 10.1016/j.syapm.2013.08.007; He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.48, 10.1038/NMICROBIOL.2016.48]; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Kopf SH, 2016, P NATL ACAD SCI USA, V113, pE110, DOI 10.1073/pnas.1512057112; Korem T, 2015, SCIENCE, V349, P1101, DOI 10.1126/science.aac4812; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Luef B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7372; Luo F, 2016, ENVIRON MICROBIOL, V18, P2923, DOI 10.1111/1462-2920.13121; Nelson WC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00713; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Paczia N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-122; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; PRESCOTT DM, 1972, P NATL ACAD SCI USA, V69, P2842, DOI 10.1073/pnas.69.10.2842; Raveh-Sadka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05477; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Seitz KW, 2016, ISME J, V10, P1696, DOI 10.1038/ismej.2015.233; Sernova NV, 2008, BRIEF BIOINFORM, V9, P376, DOI 10.1093/bib/bbn031; Sharon I, 2015, GENOME RES, V25, P534, DOI 10.1101/gr.183012.114; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Skovgaard O, 2011, GENOME RES, V21, P1388, DOI 10.1101/gr.117416.110; Soro V, 2014, APPL ENVIRON MICROB, V80, P6480, DOI 10.1128/AEM.01827-14; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808; WAKE RG, 1972, J MOL BIOL, V68, P501, DOI 10.1016/0022-2836(72)90102-7; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Wu YW, 2016, BIOINFORMATICS, V32, P605, DOI 10.1093/bioinformatics/btv638	45	186	188	3	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1256	1263		10.1038/nbt.3704	http://dx.doi.org/10.1038/nbt.3704			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27819664	Green Accepted, Green Submitted			2022-12-25	WOS:000390185300016
J	Choi, S; Hedman, AC; Sayedyahossein, S; Thapa, N; Sacks, DB; Anderson, RA				Choi, Suyong; Hedman, Andrew C.; Sayedyahossein, Samar; Thapa, Narendra; Sacks, David B.; Anderson, Richard A.			Agonist-stimulated phosphatidylinositol-3,4,5-trisphosphate generation by scaffolded phosphoinositide kinases	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESION KINASE; PHOSPHATE KINASE; EXOCYST COMPLEX; BREAST-CANCER; LEADING-EDGE; CELL-LINE; IQGAP1; MEMBRANE; ACTIVATION; 3-KINASE	Generation of the lipid messenger phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P-3) is crucial for development, cell growth and survival, and motility, and it becomes dysfunctional in many diseases including cancers. Here we reveal a mechanism for PtdIns(3,4,5)P-3 generation by scaffolded phosphoinositide kinases. In this pathway, class I phosphatidylinositol-3-OH kinase (PI(3)K) is assembled by IQGAP1 with PI(4)KIII alpha and PIPKI alpha, which sequentially generate PtdIns(3,4,5) P3 from phosphatidylinositol. By scaffolding these kinases into functional proximity, the PtdIns(4,5)P-2 generated is selectively used by PI(3)K for PtdIns(3,4,5)P-3 generation, which then signals to PDK1 and Akt that are also in the complex. Moreover, multiple receptor types stimulate the assembly of this IQGAP1-PI(3) K signalling complex. Blockade of IQGAP1 interaction with PIPKI alpha or PI(3)K inhibited PtdIns(3,4,5)P-3 generation and signalling, and selectively diminished cancer cell survival, revealing a target for cancer chemotherapy.	[Choi, Suyong; Thapa, Narendra; Anderson, Richard A.] Univ Wisconsin, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA; [Hedman, Andrew C.; Sayedyahossein, Samar; Sacks, David B.] NIH, Dept Lab Med, 10 Ctr Dr, Bethesda, MD 20892 USA	University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA	Anderson, RA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	raanders@wisc.edu		Sacks, David/0000-0003-3100-0735; Sayedyahossein, Samar/0000-0003-1773-4740; Anderson, Richard/0000-0001-6265-8359	National Institutes of Health (NIH); Intramural Research Program of the NIH; American Heart Association fellowships; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA104708] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057549, R01GM051968] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association fellowships(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CLINICAL CENTER	We would like to thank T. Balla for the PH domain constructs, and all members of the R.A.A. and D.B.S. laboratories, A. Rapreager, P. Lambert, M. Sussman and R. Kimple (University of Wisconsin-Madison) for helpful discussions. This work was supported by National Institutes of Health (NIH) grants to R.A.A., the Intramural Research Program of the NIH to D.B.S. and American Heart Association fellowships to S.C.	Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla A., MOL BIOL CELL, V19; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BAZENET CE, 1992, METHOD ENZYMOL, V209, P189; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Burke JE, 2015, TRENDS BIOCHEM SCI, V40, P88, DOI 10.1016/j.tibs.2014.12.003; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Choi SY, 2015, BBA-MOL CELL BIOL L, V1851, P711, DOI 10.1016/j.bbalip.2015.01.009; Choi S, 2013, EMBO J, V32, P2617, DOI 10.1038/emboj.2013.191; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doughman RL, 2003, J BIOL CHEM, V278, P23036, DOI 10.1074/jbc.M211397200; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feigin ME, 2014, P NATL ACAD SCI USA, V111, P4191, DOI 10.1073/pnas.1320239111; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Huang YE, 2003, MOL BIOL CELL, V14, P1913, DOI 10.1091/mbc.E02-10-0703; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Li Z, 2013, REGEN MED, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0056412; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Matsunaga H, 2014, BIOCHEM BIOPH RES CO, V444, P360, DOI 10.1016/j.bbrc.2014.01.041; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; Monteleon CL, 2015, J INVEST DERMATOL, V135, P2258, DOI 10.1038/jid.2015.140; Pei Y., 2011, CANCER CELL, V21, P155; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Sbroggio M, 2011, J CELL SCI, V124, P3515, DOI 10.1242/jcs.091140; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Semenas J, 2014, P NATL ACAD SCI USA, V111, pE3689, DOI 10.1073/pnas.1405801111; Sharma VP, 2008, J LEUKOCYTE BIOL, V84, P440, DOI 10.1189/jlb.0907636; Shimaya A, 2004, J BIOL CHEM, V279, P55277, DOI 10.1074/jbc.M411540200; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; SOULE HD, 1990, CANCER RES, V50, P6075; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Sun Y, 2013, BIOESSAYS, V35, P513, DOI 10.1002/bies.201200171; Sun Y, 2013, DEV CELL, V25, P144, DOI 10.1016/j.devcel.2013.03.010; Tan J, 2013, CANCER DISCOV, V3, P1156, DOI 10.1158/2159-8290.CD-12-0595; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Yao H, 2014, AM J CARDIOVASC DRUG, V14, P433, DOI 10.1007/s40256-014-0089-9	78	64	65	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2016	18	12					1324	+		10.1038/ncb3441	http://dx.doi.org/10.1038/ncb3441			59	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	ED8PY	27870828	Green Accepted			2022-12-25	WOS:000389134600010
J	Gopalan, P; Hao, W; Blei, DM; Storey, JD				Gopalan, Prem; Hao, Wei; Blei, David M.; Storey, John D.			Scaling probabilistic models of genetic variation to millions of humans	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; INFERENCE; ANCESTRY	A major goal of population genetics is to quantitatively understand variation of genetic polymorphisms among individuals. The aggregated number of genotyped humans is currently on the order of millions of individuals, and existing methods do not scale to data of this size. To solve this problem, we developed TeraStructure, an algorithm to fit Bayesian models of genetic variation in structured human populations on tera-sample-sized data sets (10(12) observed genotypes; for example, 1 million individuals at 1 million SNPs). TeraStructure is a scalable approach to Bayesian inference in which subsamples of markers are used to update an estimate of the latent population structure among individuals. We demonstrate that TeraStructure performs as well as existing methods on current globally sampled data, and we show using simulations that TeraStructure continues to be accurate and is the only method that can scale to tera-sample sizes.	[Gopalan, Prem] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Hao, Wei; Storey, John D.] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA; [Blei, David M.] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Blei, David M.] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA	Princeton University; Princeton University; Columbia University; Columbia University	Storey, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA.; Blei, DM (corresponding author), Columbia Univ, Dept Stat, New York, NY 10027 USA.; Blei, DM (corresponding author), Columbia Univ, Dept Comp Sci, New York, NY 10027 USA.	david.blei@columbia.edu; istorey@princeton.edu		Storey, John/0000-0001-5992-402X	US NIH [R01 HG006448]; ONR [N00014-12-1-0764, N00014-11-1-0651]; DARPA [FA8750-14-2-0009, N66001-15-C-4032]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006448] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [1502780] Funding Source: National Science Foundation	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR(Office of Naval Research); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	W.H. and J.D.S. were supported in part by US NIH grant R01 HG006448 and ONR grant N00014-12-1-0764. D.M.B. is supported in part by ONR N00014-11-1-0651, DARPA FA8750-14-2-0009 and DARPA N66001-15-C-4032. We thank A. Ochoa for suggesting the design of the scenario B simulation.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Duchi J, 2011, J MACH LEARN RES, V12, P2121; GEISSER S, 1979, J AM STAT ASSOC, V74, P153, DOI 10.2307/2286745; Hoffman MD, 2013, J MACH LEARN RES, V14, P1303; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Pritchard JK, 2000, GENETICS, V155, P945; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Ranganath R., 2013, P 30 INT C MACH LEAR, V28, P298; Wainwright MJ, 2008, FOUND TRENDS MACH LE, V1, P1, DOI 10.1561/2200000001	17	21	22	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1587	1590		10.1038/ng.3710	http://dx.doi.org/10.1038/ng.3710			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27819665	Green Accepted, Green Submitted			2022-12-25	WOS:000389011100022
J	Das, R; Strowig, T; Verma, R; Koduru, S; Hafemann, A; Hopf, S; Kocoglu, MH; Borsotti, C; Zhang, L; Branagan, A; Eynon, E; Manz, MG; Flavell, RA; Dhodapkar, MV				Das, Rituparna; Strowig, Till; Verma, Rakesh; Koduru, Srinivas; Hafemann, Anja; Hopf, Stephanie; Kocoglu, Mehmet H.; Borsotti, Chiara; Zhang, Lin; Branagan, Andrew; Eynon, Elizabeth; Manz, Markus G.; Flavell, Richard A.; Dhodapkar, Madhav V.			Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice	NATURE MEDICINE			English	Article							MULTIPLE-MYELOMA CELLS; MONOCLONAL GAMMOPATHY; DISEASE PROGRESSION; MODEL; INTERLEUKIN-6; HETEROGENEITY; MEDICINE; FREQUENT; IMMUNITY	Most human cancers, including myeloma, are preceded by a precursor state. There is an unmet need for in vivo models to study the interaction of human preneoplastic cells in the bone marrow microenvironment with non-malignant cells. Here, we genetically humanized mice to permit the growth of primary human preneoplastic and malignant plasma cells together with non-malignant cells in vivo. Growth was largely restricted to the bone marrow, mirroring the pattern in patients with myeloma. Xenografts captured the genomic complexity of parental tumors and revealed additional somatic changes. Moreover, xenografts from patients with preneoplastic gammopathy showed progressive growth, suggesting that the clinical stability of these lesions may in part be due to growth controls extrinsic to tumor cells. These data demonstrate a new approach to investigate the entire spectrum of human plasma cell neoplasia and illustrate the utility of humanized models for understanding the functional diversity of human tumors.	[Das, Rituparna; Verma, Rakesh; Koduru, Srinivas; Kocoglu, Mehmet H.; Zhang, Lin; Branagan, Andrew; Dhodapkar, Madhav V.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Strowig, Till; Hafemann, Anja; Hopf, Stephanie; Branagan, Andrew; Eynon, Elizabeth; Flavell, Richard A.; Dhodapkar, Madhav V.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Borsotti, Chiara; Manz, Markus G.] Univ Zurich Hosp, Div Hematol, Zurich, Switzerland; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Dhodapkar, Madhav V.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA; [Strowig, Till] Helmholtz Ctr Infect Res, Braunschweig, Germany	Yale University; Yale University; University of Zurich; University Zurich Hospital; Howard Hughes Medical Institute; Yale University; Yale University; Helmholtz Association; Helmholtz-Center for Infection Research	Dhodapkar, MV (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.; Flavell, RA; Dhodapkar, MV (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.; Flavell, RA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.; Dhodapkar, MV (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA.	richard.flavell@yale.edu; madhav.dhodapkar@yale.edu	Koduru, Srinivas V/L-3637-2019; Borsotti, Chiara/ABF-8176-2020	Koduru, Srinivas V/0000-0001-6827-2908; Borsotti, Chiara/0000-0001-9704-0647; Strowig, Till/0000-0003-0185-1459; Branagan, Andrew/0000-0002-3868-9267; Manz, Markus/0000-0002-4676-7931; Das, Rituparna/0000-0002-6497-5240	US National Institutes of Health [CA156689, CA106802, CA197603]; clinical research priority program of the University of Zurich; NATIONAL CANCER INSTITUTE [R35CA197603, P30CA016359, R01CA156689, R01CA106802] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); clinical research priority program of the University of Zurich; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by funds from the US National Institutes of Health (CA156689, CA106802, CA197603) and the clinical research priority program of the University of Zurich. The authors thank F. Giraldez-Lopez, I. Tikhonova, S. Mane and M. Youngblood for assistance with sequencing analyses and C. Weibel, J. Alderman and C. Foster (all at Yale School of Medicine) for assistance with mouse colonies.	Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Dhodapkar MV, 2015, BLOOD, V126, P2475, DOI 10.1182/blood-2015-03-632919; Dhodapkar MV, 2015, SEMIN ONCOL, V42, P617, DOI 10.1053/j.seminoncol.2015.05.009; Dhodapkar MV, 2014, BLOOD, V123, P78, DOI 10.1182/blood-2013-07-515239; Dhodapkar MV, 2003, J EXP MED, V198, P1753, DOI 10.1084/jem.20031030; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Ghobrial IM, 2012, BLOOD, V120, P20, DOI 10.1182/blood-2012-01-379024; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; Hanamura I, 2006, BLOOD, V108, P1724, DOI 10.1182/blood-2006-03-009910; Hosen N, 2012, LEUKEMIA, V26, P2135, DOI 10.1038/leu.2012.80; Kim D, 2012, LEUKEMIA, V26, P2530, DOI 10.1038/leu.2012.140; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Koduru S, 2012, BLOOD, V119, P2302, DOI 10.1182/blood-2011-08-376236; Kukreja A, 2006, J EXP MED, V203, P1859, DOI 10.1084/jem.20052136; Lawson MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9983; Lopez-Corral L, 2011, CLIN CANCER RES, V17, P1692, DOI 10.1158/1078-0432.CCR-10-1066; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Melchor L, 2014, LEUKEMIA, V28, P1705, DOI 10.1038/leu.2014.13; Nair S, 2016, NEW ENGL J MED, V374, P555, DOI 10.1056/NEJMoa1508808; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Schuler J, 2013, EXPERT OPIN BIOL TH, V13, pS111, DOI 10.1517/14712598.2013.799131; Spisek R, 2007, J EXP MED, V204, P831, DOI 10.1084/jem.20062387; Tassone P, 2005, BLOOD, V106, P713, DOI 10.1182/blood-2005-01-0373; Walker BA, 2014, LEUKEMIA, V28, P384, DOI 10.1038/leu.2013.199; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913; Zhao S, 2014, LEUKEMIA, V28, P1548, DOI 10.1038/leu.2014.59	31	83	89	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1351	1357		10.1038/nm.4202	http://dx.doi.org/10.1038/nm.4202			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27723723	Green Accepted			2022-12-25	WOS:000387302300029
J	Feasey, NA; Hadfield, J; Keddy, KH; Dallman, TJ; Jacobs, J; Deng, X; Wigley, P; Barquist, LB; Langridge, GC; Feltwell, T; Harris, SR; Mather, AE; Fookes, M; Aslett, M; Msefula, C; Kariuki, S; Maclennan, CA; Onsare, RS; Weill, FX; Le Hello, S; Smith, AM; McClelland, M; Desai, P; Parry, CM; Cheesbrough, J; French, N; Campos, J; Chabalgoity, JA; Betancor, L; Hopkins, KL; Nair, S; Humphrey, TJ; Lunguya, O; Cogan, TA; Tapia, MD; Sow, SO; Tennant, SM; Bornstein, K; Levine, MM; Lacharme-Lora, L; Everett, DB; Kingsley, RA; Parkhill, J; Heyderman, RS; Dougan, G; Gordon, MA; Thomson, NR				Feasey, Nicholas A.; Hadfield, James; Keddy, Karen H.; Dallman, Timothy J.; Jacobs, Jan; Deng, Xiangyu; Wigley, Paul; Barquist, Lars Barquist; Langridge, Gemma C.; Feltwell, Theresa; Harris, Simon R.; Mather, Alison E.; Fookes, Maria; Aslett, Martin; Msefula, Chisomo; Kariuki, Samuel; Maclennan, Calman A.; Onsare, Robert S.; Weill, Francois-Xavier; Le Hello, Simon; Smith, Anthony M.; McClelland, Michael; Desai, Prerak; Parry, Christopher M.; Cheesbrough, John; French, Neil; Campos, Josefina; Chabalgoity, Jose A.; Betancor, Laura; Hopkins, Katie L.; Nair, Satheesh; Humphrey, Tom J.; Lunguya, Octavie; Cogan, Tristan A.; Tapia, Milagritos D.; Sow, Samba O.; Tennant, Sharon M.; Bornstein, Kristin; Levine, Myron M.; Lacharme-Lora, Lizeth; Everett, Dean B.; Kingsley, Robert A.; Parkhill, Julian; Heyderman, Robert S.; Dougan, Gordon; Gordon, Melita A.; Thomson, Nicholas R.			Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings	NATURE GENETICS			English	Article							ENTERICA SEROVAR ENTERITIDIS; NONTYPHOIDAL SALMONELLA; SEROTYPE ENTERITIDIS; TYPHIMURIUM ST313; HOST ADAPTATION; UNITED-KINGDOM; EVOLUTION; EPIDEMIC; AFRICA; SURVEILLANCE	An epidemiological paradox surrounds Salmonella enterica serovar Enteritidis. In high-income settings, it has been responsible for an epidemic of poultry-associated, self-limiting enterocolitis, whereas in sub-Saharan Africa it is a major cause of invasive nontyphoidal Salmonella disease, associated with high case fatality. By whole-genome sequence analysis of 675 isolates of S. Enteritidis from 45 countries, we show the existence of a global epidemic clade and two new clades of S. Enteritidis that are geographically restricted to distinct regions of Africa. The African isolates display genomic degradation, a novel prophage repertoire, and an expanded multidrug resistance plasmid. S. Enteritidis is a further example of a Salmonella serotype that displays niche plasticity, with distinct clades that enable it to become a prominent cause of gastroenteritis in association with the industrial production of eggs and of multidrug-resistant, bloodstream-invasive infection in Africa.	[Feasey, Nicholas A.; Parry, Christopher M.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Feasey, Nicholas A.; Hadfield, James; Langridge, Gemma C.; Feltwell, Theresa; Harris, Simon R.; Mather, Alison E.; Fookes, Maria; Aslett, Martin; Maclennan, Calman A.; Parkhill, Julian; Dougan, Gordon; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Cambridge, England; [Feasey, Nicholas A.; Heyderman, Robert S.; Gordon, Melita A.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Feasey, Nicholas A.; Wigley, Paul; French, Neil; Lacharme-Lora, Lizeth; Everett, Dean B.; Gordon, Melita A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Keddy, Karen H.; Smith, Anthony M.] Natl Inst Communicable Dis, Ctr Enter Dis, Johannesburg, South Africa; [Keddy, Karen H.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Dallman, Timothy J.; Nair, Satheesh] Publ Hlth England, Gastrointestinal Bacteria Reference Unit, Colindale, England; [Jacobs, Jan] Inst Trop Med, Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Deng, Xiangyu] Univ Georgia, Dept Food Sci & Technol, Ctr Food Safety, Athens, GA 30602 USA; [Deng, Xiangyu] Ctr Dis Control & Prevent, Atlanta, GA USA; [Barquist, Lars Barquist] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Msefula, Chisomo] Univ Malawi, Coll Med, Blantyre, Malawi; [Kariuki, Samuel; Onsare, Robert S.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Maclennan, Calman A.] Univ Oxford, Nuffield Dept Med, Jenner Inst, Oxford, England; [Weill, Francois-Xavier; Le Hello, Simon] Inst Pasteur, Paris, France; [McClelland, Michael; Desai, Prerak] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA USA; [Parry, Christopher M.; Thomson, Nicholas R.] London Sch Hyg & Trop Med, London, England; [Parry, Christopher M.] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Cheesbrough, John] Univ Liverpool, Dept Epidemiol & Populat Hlth, Liverpool, Merseyside, England; [Campos, Josefina] Carlos G Malbran Inst, ANLIS, Enteropathogen Div, Buenos Aires, DF, Argentina; [Chabalgoity, Jose A.; Betancor, Laura] Univ Republica, Fac Med, Inst Higiene, Montevideo, Uruguay; [Hopkins, Katie L.] Publ Hlth England, Antimicrobial Resistance & Healthcare Associated, Colindale, England; [Humphrey, Tom J.] Swansea Univ, Swansea Med Sch, Swansea, W Glam, Wales; [Lunguya, Octavie] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO; [Lunguya, Octavie] Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO; [Cogan, Tristan A.] Univ Bristol, Sch Vet Sci, Bristol, Avon, England; [Tapia, Milagritos D.; Tennant, Sharon M.; Bornstein, Kristin; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Sow, Samba O.] Ctr Dev Vaccins, Bamako, Mali; [Kingsley, Robert A.] Inst Food Res, Norwich, Norfolk, England; [Heyderman, Robert S.] UCL, Div Infect & Immun, London, England; [Mather, Alison E.] Univ Cambridge, Dept Vet Med, Cambridge, England	Liverpool School of Tropical Medicine; Wellcome Trust Sanger Institute; University of Malawi; University of Liverpool; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Public Health England; Institute of Tropical Medicine (ITM); KU Leuven; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; University of Wurzburg; University of Malawi; Kenya Medical Research Institute; University of Oxford; Jenner Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California Irvine; University of London; London School of Hygiene & Tropical Medicine; Nagasaki University; University of Liverpool; Universidad de la Republica, Uruguay; Public Health England; Swansea University; Institute Nacional de Recherche Biomedical; University of Bristol; University System of Maryland; University of Maryland Baltimore; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of London; University College London; University of Cambridge	Thomson, NR (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.; Thomson, NR (corresponding author), London Sch Hyg & Trop Med, London, England.	nicholas.feasey@Istmed.ac.uk	Barquist, Lars/H-6529-2019; Thomson, Nicholas R/P-5988-2014; Parkhill, Julian/G-4703-2011; Dallman, Timothy J/ABD-6662-2021; Msefula, Chisomo/AAY-9107-2020; Le Hello, Simon/K-6584-2018; Le Hello, Simon/GWM-8436-2022; Desai, Prerak/ABF-8529-2020; Jacobs, Jan/GRX-7316-2022; Keddy, Karen Helena/AAZ-2189-2020; Gordon, Melita/F-5563-2012	Barquist, Lars/0000-0003-4732-2667; Thomson, Nicholas R/0000-0002-4432-8505; Parkhill, Julian/0000-0002-7069-5958; Le Hello, Simon/0000-0001-7993-4305; Keddy, Karen Helena/0000-0001-8640-2235; Nair, Satheesh/0000-0002-7297-1485; Wigley, Paul/0000-0001-6563-0773; McClelland, Michael/0000-0003-1788-9347; Gordon, Melita/0000-0002-0629-0884; Weill, Francois-Xavier/0000-0001-9941-5799; Kingsley, Robert/0000-0002-0194-6485; Langridge, Gemma/0000-0001-8037-2741; French, Neil/0000-0003-4814-8293; Campos, Josefina/0000-0003-1409-0441; Everett, Dean/0000-0002-8458-6779; Deng, Xiangyu/0000-0002-7251-2529; Hopkins, Katie/0000-0001-7279-5322; Feasey, Nicholas/0000-0003-4041-1405; Heyderman, Robert/0000-0003-4573-449X	Wellcome Trust [098051, WT092152MA, 101113/Z/13/Z]; Institut Pasteur; Institut de Veille Sanitaire; French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence) [ANR-10-LABX-62-IBEID]; NIH [R01 AI099525-02]; Biotechnology and Biological Sciences Research Council at the University of Cambridge [BB/M014088/1]; antibiotic resistance surveillance project in the Democratic Republic of the Congo - Belgian Directorate General of Development Cooperation (Antwerp, Belgium); antibiotic resistance surveillance project in the Democratic Republic of the Congo - Institute of Tropical Medicine (Antwerp, Belgium); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099525] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/M014088/1] Funding Source: researchfish; BBSRC [BB/M014088/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Institut Pasteur(European Commission); Institut de Veille Sanitaire; French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence)(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council at the University of Cambridge(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); antibiotic resistance surveillance project in the Democratic Republic of the Congo - Belgian Directorate General of Development Cooperation (Antwerp, Belgium); antibiotic resistance surveillance project in the Democratic Republic of the Congo - Institute of Tropical Medicine (Antwerp, Belgium); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust. We would like to thank the members of the Pathogen Informatics Team and the core sequencing teams at the Wellcome Trust Sanger Institute (Cambridge, UK). We are grateful to D. Harris for work in managing the sequence data.; This work was supported by a number of organizations. The authors from the Wellcome Trust Sanger Institute were funded by Wellcome Trust award 098051. N.A.F. was supported by Wellcome Trust research fellowship WT092152MA. N.A.F., R.S.H., and this work were supported by a strategic award from the Wellcome Trust for the MLW Clinical Research Programme (101113/Z/13/Z). The authors from the Institut Pasteur were funded by the Institut Pasteur, by the Institut de Veille Sanitaire, and by the French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence, grant ANR-10-LABX-62-IBEID). J.J. was supported by the antibiotic resistance surveillance project in the Democratic Republic of the Congo, funded by Project 2.01 of the Third Framework Agreement between the Belgian Directorate General of Development Cooperation and the Institute of Tropical Medicine (Antwerp, Belgium). S.K. was supported by NIH grant R01 AI099525-02. A.E.M. was supported by Wellcome Trust grant 098051 while at the Wellcome Trust Sanger Institute and by Biotechnology and Biological Sciences Research Council grant BB/M014088/1 at the University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055254; Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; Betancor L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-237; Braden CR, 2006, CLIN INFECT DIS, V43, P512, DOI 10.1086/505973; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Cooke FJ, 2007, J CLIN MICROBIOL, V45, P2590, DOI 10.1128/JCM.00729-07; den Bakker HC, 2014, EMERG INFECT DIS, V20, P1306, DOI 10.3201/eid2008.131399; Deng XY, 2014, EMERG INFECT DIS, V20, P1481, DOI 10.3201/eid2009.131095; Dhawi AA, 2011, VET MICROBIOL, V153, P198, DOI 10.1016/j.vetmic.2011.07.013; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Feasey NA, 2015, CLIN INFECT DIS, V61, pS363, DOI 10.1093/cid/civ691; Feasey NA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003979; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Friedman CR, 1996, LANCET, V347, P1705, DOI 10.1016/S0140-6736(96)91542-1; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Herrero-Fresno A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084566; Inns T, 2015, EUROSURVEILLANCE, V20, P15, DOI 10.2807/1560-7917.ES2015.20.16.21098; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Kariuki S, 2015, CLIN INFECT DIS, V61, pS317, DOI 10.1093/cid/civ711; Kingsley RA, 2013, MBIO, V4, DOI 10.1128/mBio.00565-13; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Langridge GC, 2015, P NATL ACAD SCI USA, V112, P863, DOI 10.1073/pnas.1416707112; Magnet S, 1999, J BACTERIOL, V181, P6650, DOI 10.1128/JB.181.21.6650-6655.1999; Nuccio SP, 2015, P NATL ACAD SCI USA, V112, P647, DOI 10.1073/pnas.1423499112; Nuccio SP, 2014, MBIO, V5, DOI 10.1128/mBio.00929-14; O'Brien SJ, 2013, CLIN INFECT DIS, V56, P705, DOI 10.1093/cid/cis967; Okoro CK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003611; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parsons BN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002487; Ramachandran G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003394; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; RODRIGUE DC, 1990, EPIDEMIOL INFECT, V105, P21, DOI 10.1017/S0950268800047609; Rodriguez I, 2011, J ANTIMICROB CHEMOTH, V66, P218, DOI 10.1093/jac/dkq386; Rodriguez I, 2012, EMERG INFECT DIS, V18, P1173, DOI 10.3201/eid1807.120063; Rotger R, 1999, Int Microbiol, V2, P177; Shah DH, 2012, INFECT IMMUN, V80, P4203, DOI 10.1128/IAI.00790-12; Taylor AJ, 2015, J CLIN MICROBIOL, V53, P3334, DOI 10.1128/JCM.01280-15; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Ward LR, 2000, SCIENCE, V287, P1753, DOI 10.1126/science.287.5459.1753c; Zheng J, 2014, J CLIN MICROBIOL, V52, P1490, DOI 10.1128/JCM.00051-14	44	107	108	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1211	1217		10.1038/ng.3644	http://dx.doi.org/10.1038/ng.3644			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27548315	Green Submitted, Green Accepted, Bronze, Green Published			2022-12-25	WOS:000384391600016
J	Li, ZR; Li, J; Gu, JP; Lai, JYH; Duggan, BM; Zhang, WP; Li, ZL; Li, YX; Tong, RB; Xu, Y; Lin, DH; Moore, BS; Qian, PY				Li, Zhong-Rui; Li, Jie; Gu, Jin-Ping; Lai, Jennifer Y. H.; Duggan, Brendan M.; Zhang, Wei-Peng; Li, Zhi-Long; Li, Yong-Xin; Tong, Rong-Biao; Xu, Ying; Lin, Dong-Hai; Moore, Bradley S.; Qian, Pei-Yuan			Divergent biosynthesis yields a cytotoxic aminomalonate-containing precolibactin	NATURE CHEMICAL BIOLOGY			English	Article							COLIBACTIN BIOSYNTHESIS; ESCHERICHIA-COLI; CELLS; DNA; MECHANISM; GENOTOXIN; PATHWAY; CLONING	Colibactin is an as-yet-uncharacterized genotoxic secondary metabolite produced by human gut bacteria. Here we report the biosynthetic discovery of two new precolibactin molecules from Escherichia coli, including precolibactin-886, which uniquely incorporates the highly sought genotoxicity-associated aminomalonate building block into its unprecedented macrocyclic structure. This work provides new insights into the biosynthetic logic and mode of action of this colorectal-cancer-linked microbial chemical.	[Li, Zhong-Rui; Lai, Jennifer Y. H.; Zhang, Wei-Peng; Li, Yong-Xin; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Li, Zhong-Rui; Lai, Jennifer Y. H.; Zhang, Wei-Peng; Li, Yong-Xin; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Environm Sci Programs, Kowloon, Hong Kong, Peoples R China; [Li, Jie; Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Gu, Jin-Ping; Lin, Dong-Hai] Xiamen Univ, Coll Chem & Chem Engn, High Field NMR Res Ctr, Xiamen, Peoples R China; [Duggan, Brendan M.; Moore, Bradley S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Li, Zhi-Long; Tong, Rong-Biao] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Xu, Ying] Shenzhen Univ, Coll Life Sci & Oceanog, Shenzhen Key Lab Marine Bioresource & Ecoenvironm, Shenzhen Engn Lab Marine Algal Biotechnol, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of California System; University of California San Diego; Scripps Institution of Oceanography; Xiamen University; University of California System; University of California San Diego; Hong Kong University of Science & Technology; Shenzhen University	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.; Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Environm Sci Programs, Kowloon, Hong Kong, Peoples R China.; Moore, BS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.; Moore, BS (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	bsmoore@ucsd.edu; boqianpy@ust.hk	LI, JIE/G-5775-2017; Duggan, Brendan M./I-9258-2019; Xu, Ying/E-2072-2018; Tong, Rongbiao/AAN-4053-2020	LI, JIE/0000-0003-1786-0245; Duggan, Brendan M./0000-0002-7034-8374; Xu, Ying/0000-0003-4658-3283; Tong, Rongbiao/0000-0002-2740-5222; Qian, Pei-Yuan/0000-0003-4074-9078; Moore, Bradley/0000-0002-4652-1253; Li, Yong-xin/0000-0003-4422-2302; Li, Zhilong/0000-0002-0219-2072	China Ocean Mineral Resources Research and Development Association [13.5]; NIH [R01-GM85770]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085770] Funding Source: NIH RePORTER	China Ocean Mineral Resources Research and Development Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously supported by grants from the China Ocean Mineral Resources Research and Development Association (13.5 program to P.-Y.Q.) and the NIH (R01-GM85770 to B.S.M.). We thank P.R. Jensen, J. Busch, C.B. Naman, and Y.K. Tam for technical advice and access to equipment.	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Aslan K, 2008, ANAL CHEM, V80, P4125, DOI 10.1021/ac800519r; Balskus EP, 2015, NAT PROD REP, V32, P1534, DOI 10.1039/c5np00091b; Bian XY, 2015, CHEM SCI, V6, P3154, DOI 10.1039/c5sc00101c; Bian XY, 2013, CHEMBIOCHEM, V14, P1194, DOI 10.1002/cbic.201300208; Bode HB, 2015, ANGEW CHEM INT EDIT, V54, P10408, DOI 10.1002/anie.201505341; Brachmann AO, 2015, CHEM COMMUN, V51, P13138, DOI 10.1039/c5cc02718g; Brotherton CA, 2015, ORG LETT, V17, P1545, DOI 10.1021/acs.orglett.5b00432; Brotherton CA, 2013, J AM CHEM SOC, V135, P3359, DOI 10.1021/ja312154m; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Engel P, 2015, APPL ENVIRON MICROB, V81, P1502, DOI 10.1128/AEM.03283-14; Fujii K, 1997, ANAL CHEM, V69, P5146, DOI 10.1021/ac970289b; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Healy AR, 2016, J AM CHEM SOC, V138, P5426, DOI 10.1021/jacs.6b02276; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li YX, 2015, SCI REP-UK, V5, DOI 10.1038/srep09383; Li ZR, 2015, CHEMBIOCHEM, V16, P1715, DOI 10.1002/cbic.201500239; Liu TG, 2006, CHEM BIOL, V13, P945, DOI 10.1016/j.chembiol.2006.07.006; Lock RB, 1996, CANCER RES, V56, P4006; Melo TMVDPE, 2002, J ORG CHEM, V67, P66, DOI 10.1021/jo010504v; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Olier M, 2012, GUT MICROBES, V3, P501, DOI 10.4161/gmic.21737; PATONAY T, 1995, J ORG CHEM, V60, P2368, DOI 10.1021/jo00113a015; Rohm B, 2010, ORG BIOMOL CHEM, V8, P1520, DOI 10.1039/b925483h; Ross AC, 2013, J AM CHEM SOC, V135, P1155, DOI 10.1021/ja3119674; Vizcaino MI, 2015, NAT CHEM, V7, P411, DOI [10.1038/NCHEM.2221, 10.1038/nchem.2221]; Vizcaino MI, 2014, J AM CHEM SOC, V136, P9244, DOI 10.1021/ja503450q; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Yamanaka K, 2014, P NATL ACAD SCI USA, V111, P1957, DOI 10.1073/pnas.1319584111; Zha L, 2016, ACS CHEM BIOL, V11, P1287, DOI 10.1021/acschembio.6b00014	33	54	57	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					773	775		10.1038/nchembio.2157	http://dx.doi.org/10.1038/nchembio.2157			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27547923	Green Accepted			2022-12-25	WOS:000384248600006
J	Morita, S; Noguchi, H; Horii, T; Nakabayashi, K; Kimura, M; Okamura, K; Sakai, A; Nakashitna, H; Hata, K; Nakashima, K; Hatada, I				Morita, Sumiyo; Noguchi, Hirofumi; Horii, Takuro; Nakabayashi, Kazuhiko; Kimura, Mika; Okamura, Kohji; Sakai, Atsuhiko; Nakashitna, Hideyuki; Hata, Kenichiro; Nakashima, Kinichi; Hatada, Izuho			Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions	NATURE BIOTECHNOLOGY			English	Article							METHYLATION; GENE; 5-METHYLCYTOSINE; DIFFERENTIATION; ACTIVATION; EXPRESSION	Despite the importance of DNA methylation in health and disease, technologies to readily manipulate methylation of specific sequences for functional analysis and therapeutic purposes are lacking. Here we adapt the previously described dCas9-SunTag for efficient, targeted demethylation of specific DNA loci. The original SunTag consists of ten copies of the GCN4 peptide separated by 5-amino-acid linkers. To achieve efficient recruitment of an anti-GCN4 scFv fused to the ten eleven (TET) 1 hydroxylase, which induces demethylation, we changed the linker length to 22 amino acids. The system attains demethylation efficiencies >50% in seven out of nine loci tested. Four of these seven loci showed demethylation of >90%. We demonstrate targeted demethylation of CpGs in regulatory regions and demethylation-dependent 1.7- to 50-fold upregulation of associated genes both in cell culture (embryonic stem cells, cancer cell lines, primary neural precursor cells) and in vivo in mouse fetuses.	[Morita, Sumiyo; Horii, Takuro; Kimura, Mika; Hatada, Izuho] Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma, Japan; [Noguchi, Hirofumi; Sakai, Atsuhiko; Nakashitna, Hideyuki; Nakashima, Kinichi] Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Fukuoka, Japan; [Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Okamura, Kohji] Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Tokyo, Japan	Gunma University; Kyushu University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Hatada, I (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma, Japan.	hatada@gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Agency for Medical Research and Development (AMED); AMED-CREST; AMED;  [15K14452]	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED-CREST; AMED; 	This work was supported by the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); The Japan Agency for Medical Research and Development (AMED) to I.H. and AMED-CREST and AMED to K.N.; and a Grant-in-Aid for Challenging Exploratory Research (grant number 15K14452) to K.N. The authors plan to make the reagents widely available to the academic community through Addgene (http://www.addgene.org/?gclid=CKvf88_a2ccCFQNwvAodSbUGiQ). We appreciate the technical assistance provided by The Research Support Center, Research Center for Human Disease Modeling, Kyushu University Graduate School of Medical Sciences.	Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Carey N, 2011, DRUG DISCOV TODAY, V16, P683, DOI 10.1016/j.drudis.2011.05.004; Chen H, 2014, NUCLEIC ACIDS RES, V42, P1563, DOI 10.1093/nar/gkt1019; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Heller EA, 2014, NAT NEUROSCI, V17, P1720, DOI 10.1038/nn.3871; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Li K, 2015, ONCOTARGET, V6, P10030, DOI 10.18632/oncotarget.3192; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Oki Y, 2006, REV RECENT CLIN TRIA, V1, P169, DOI 10.2174/157488706776876490; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; Reik W, 2001, ELECTROPHORESIS, V22, P2838, DOI 10.1002/1522-2683(200108)22:14&lt;2838::AID-ELPS2838&gt;3.0.CO;2-M; Stolzenburg S, 2015, ONCOGENE, V34, P5427, DOI 10.1038/onc.2014.470; Tabata H, 2002, J NEUROSCI RES, V69, P723, DOI 10.1002/jnr.10345; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9	29	260	272	4	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2016	34	10					1060	1065		10.1038/nbt.3658	http://dx.doi.org/10.1038/nbt.3658			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EA0ZG	27571369				2022-12-25	WOS:000386317500021
J	Ulz, P; Thallinger, GG; Auer, M; Graf, R; Kashofer, K; Jahn, SW; Abete, L; Pristauz, G; Petru, E; Geigl, JB; Heitzer, E; Speicher, MR				Ulz, Peter; Thallinger, Gerhard G.; Auer, Martina; Graf, Ricarda; Kashofer, Karl; Jahn, Stephan W.; Abete, Luca; Pristauz, Ganda; Petru, Edgar; Geigl, Jochen B.; Heitzer, Ellen; Speicher, Michael R.			Inferring expressed genes by whole-genome sequencing of plasma DNA	NATURE GENETICS			English	Article							CELL-FREE DNA; CIRCULATING TUMOR DNA; LIQUID BIOPSIES; PROSTATE-CANCER; BREAST-CANCER; TRANSPLANTATION; QUANTIFICATION; MUTATIONS; THERAPY; ORIGIN	The analysis of cell-free DNA (cfDNA) in plasma represents a rapidly advancing field in medicine. cfDNA consists predominantly of nucleosome-protected DNA shed into the bloodstream by cells undergoing apoptosis. We performed whole-genome sequencing of plasma DNA and identified two discrete regions at transcription start sites (TSSs) where nucleosome occupancy results in different read depth coverage patterns for expressed and silent genes. By employing machine learning for gene classification, we found that the plasma DNA read depth patterns from healthy donors reflected the expression signature of hematopoietic cells. In patients with cancer having metastatic disease, we were able to classify expressed cancer driver genes in regions with somatic copy number gains with high accuracy. We were able to determine the expressed isoform of genes with several TSSs, as confirmed by RNA-seq analysis of the matching primary tumor. Our analyses provide functional information about cells releasing their DNA into the circulation.	[Ulz, Peter; Auer, Martina; Graf, Ricarda; Geigl, Jochen B.; Heitzer, Ellen; Speicher, Michael R.] Med Univ Graz, Inst Human Genet, Graz, Austria; [Thallinger, Gerhard G.] Graz Univ Technol, Inst Mol Biotechnol, Graz, Austria; [Thallinger, Gerhard G.] BioTechMed OMICS Ctr Graz, Graz, Austria; [Kashofer, Karl; Jahn, Stephan W.; Abete, Luca] Med Univ Graz, Inst Pathol, Graz, Austria; [Pristauz, Ganda; Petru, Edgar] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria	Medical University of Graz; Graz University of Technology; Medical University of Graz; Medical University of Graz	Speicher, MR (corresponding author), Med Univ Graz, Inst Human Genet, Graz, Austria.	michael.speicher@medunigraz.at	Speicher, Michael R/B-5362-2013; Ulz, Peter/B-7528-2014	Speicher, Michael R/0000-0003-0105-955X; Ulz, Peter/0000-0001-5941-1160; Geigl, Jochen/0000-0001-9160-0682	CANCER-ID - Innovative Medicines Joint Undertaking (IMI JU)	CANCER-ID - Innovative Medicines Joint Undertaking (IMI JU)	We are grateful to S. Perakis for critical reading and editing of this manuscript. This work was supported by CANCER-ID, a project funded by the Innovative Medicines Joint Undertaking (IMI JU).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chandrananda D, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0107-z; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Giordano SH, 2014, J CLIN ONCOL, V32, P2078, DOI 10.1200/JCO.2013.54.0948; Heidary M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0421-y; Heitzer E, 2016, MOL ONCOL, V10, P494, DOI 10.1016/j.molonc.2015.12.004; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm477; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Helsten T, 2016, CLIN CANCER RES, V22, P259, DOI 10.1158/1078-0432.CCR-14-3212; Ivanov M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S13-S1; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lui YNYN, 2002, CLIN CHEM, V48, P421; Mohan S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004271; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Ramachandran S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500587; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Sun K, 2015, P NATL ACAD SCI USA, V112, pE5503, DOI 10.1073/pnas.1508736112; Ulz P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12008; Ulz P, 2016, NAT GENET, V48, P104, DOI 10.1038/ng.3468; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	34	182	186	5	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1273	1278		10.1038/ng.3648	http://dx.doi.org/10.1038/ng.3648			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27571261	Green Submitted			2022-12-25	WOS:000384391600024
J	Chen, Y; Yang, F; Zubovic, L; Pavelitz, T; Yang, W; Godin, K; Walker, M; Zheng, SX; Macchi, P; Varani, G				Chen, Yu; Yang, Fan; Zubovic, Lorena; Pavelitz, Tom; Yang, Wen; Godin, Katherine; Walker, Matthew; Zheng, Suxin; Macchi, Paolo; Varani, Gabriele			Targeted inhibition of oncogenic miR-21 maturation with designed RNA-binding proteins	NATURE CHEMICAL BIOLOGY			English	Article							SEQUENCE-SPECIFIC BINDING; SINGLE-STRANDED RNA; MICRORNA BIOGENESIS; MOLECULAR-BASIS; APICAL-LOOP; RECOGNITION; SPECIFICITY; PRECURSORS; EXPRESSION; CLEAVAGE	The RNA recognition motif (RRM) is the largest family of eukaryotic RNA-binding proteins. Engineered RRMs with well-defined specificity would provide valuable tools and an exacting test of the current understanding of specificity. We have redesigned the specificity of an RRM using rational methods and demonstrated retargeting of its activity in cells. We engineered the conserved RRM of human Rbfox proteins to specifically bind to the terminal loop of a microRNA precursor (pre-miR-21) with high affinity and inhibit its processing by Drosha and Dicer. We further engineered Giardia Dicer by replacing its PAZ domain with the designed RRM. The reprogrammed enzyme degrades pre-miR-21 specifically in vitro and suppresses mature miR-21 levels in cells, which results in increased expression of the tumor suppressor PDCD4 and significantly decreased viability for cancer cells. The results demonstrate the feasibility of rationally engineering the sequence-specificity of RRMs and of using this ubiquitous platform for diverse biological applications.	[Chen, Yu; Yang, Fan; Pavelitz, Tom; Yang, Wen; Godin, Katherine; Walker, Matthew; Zheng, Suxin; Varani, Gabriele] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Zubovic, Lorena; Macchi, Paolo] Univ Trento, Ctr Integrat Biol CIBIO, Trento, Italy; [Chen, Yu] Seattle Childrens Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Trento; Seattle Children's Hospital	Chen, Y; Varani, G (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.; Chen, Y (corresponding author), Seattle Childrens Res Inst, Seattle, WA USA.	yu.chen@seattlechildrens.org; varani@chem.washington.edu	YANG, WEN/A-1993-2014	Yang, Fan/0000-0002-0841-8933	US National Institutes of Health [1R01 GM103834]; University of Trento; Autonomous Province of Trento (Madelena Project); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103834] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Trento; Autonomous Province of Trento (Madelena Project); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to J. Mandic and other members of G.V.'s laboratory for technical assistance. We thank the Analytical Biopharmacy Core for access to ITC in the School of Pharmacy at the University of Washington. This work was supported by US National Institutes of Health Grant 1R01 GM103834 to G.V., the University of Trento (Progetto Biotecnologie, P.M.) and the Autonomous Province of Trento (Madelena Project, P.M.).	Agrawal AA, 2014, P NATL ACAD SCI USA, V111, P17420, DOI 10.1073/pnas.1412743111; Allers J, 2001, J MOL BIOL, V311, P75, DOI 10.1006/jmbi.2001.4857; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Blakeley BD, 2014, ACS CHEM BIOL, V9, P1320, DOI 10.1021/cb500138h; Castilla-Liorente V, 2013, BIOCHEM SOC T, V41, P861, DOI 10.1042/BST20130058; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P5147, DOI 10.1093/nar/gkh785; Chen Y, 2016, NUCLEIC ACIDS RES, V44, P4381, DOI 10.1093/nar/gkw177; Chen Y, 2013, FEBS J, V280, P3734, DOI 10.1111/febs.12375; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Choudhury NR, 2012, BIOCHEM SOC T, V40, P789, DOI 10.1042/BST20120053; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Diaz JP, 2014, RNA, V20, P528, DOI 10.1261/rna.042911.113; Filipovska A, 2011, NAT CHEM BIOL, V7, P425, DOI [10.1038/NCHEMBIO.577, 10.1038/nchembio.577]; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Lunse CE, 2010, ANGEW CHEM INT EDIT, V49, P4674, DOI 10.1002/anie.200906919; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mackay JP, 2011, NAT STRUCT MOL BIOL, V18, P256, DOI 10.1038/nsmb.2005; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Minuchehr Z, 2005, PROTEIN PEPTIDE LETT, V12, P379, DOI 10.2174/0929866053765617; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Peroutka RJ, 2008, PROTEIN SCI, V17, P1586, DOI 10.1110/ps.035576.108; Price Sr, 1998, PRACT APPROACH SER, V192, P37; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Tenzer S, 2013, J PROTEOME RES, V12, P2869, DOI 10.1021/pr400193j; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Nguyen TA, 2015, CELL, V161, P1374, DOI 10.1016/j.cell.2015.05.010; Wang Y, 2013, FEBS J, V280, P3755, DOI 10.1111/febs.12367; Weeks KM, 2011, ACCOUNTS CHEM RES, V44, P1280, DOI 10.1021/ar200051h; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645; Zheng S, 2007, FEBS J, V274, P6378, DOI 10.1111/j.1742-4658.2007.06155.x	47	31	31	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					717	+		10.1038/nchembio.2128	http://dx.doi.org/10.1038/nchembio.2128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27428511	Green Submitted, Green Accepted			2022-12-25	WOS:000382255100013
J	Frank, JA; Yushchenko, DA; Hodson, DJ; Lipstein, N; Nagpal, J; Rutter, GA; Rhee, JS; Gottschalk, A; Brose, N; Schultz, C; Trauner, D				Frank, James Allen; Yushchenko, Dmytro A.; Hodson, David J.; Lipstein, Noa; Nagpal, Jatin; Rutter, Guy A.; Rhee, Jeong-Seop; Gottschalk, Alexander; Brose, Nils; Schultz, Carsten; Trauner, Dirk			Photoswitchable diacylglycerols enable optical control of protein kinase C	NATURE CHEMICAL BIOLOGY			English	Article							BETA-CELL; LEVAMISOLE RESISTANCE; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; INSULIN-SECRETION; PANCREATIC-ISLETS; GLUCOSE; ACTIVATION; RECEPTOR; DOMAINS	Increased levels of the second messenger lipid diacylglycerol (DAG) induce downstream signaling events including the translocation of C1-domain-containing proteins toward the plasma membrane. Here, we introduce three light-sensitive DAGs, termed PhoDAGs, which feature a photoswitchable acyl chain. The PhoDAGs are inactive in the dark and promote the translocation of proteins that feature C1 domains toward the plasma membrane upon a flash of UV-A light. This effect is quickly reversed after the termination of photostimulation or by irradiation with blue light, permitting the generation of oscillation patterns. Both protein kinase C and Munc13 can thus be put under optical control. PhoDAGs control vesicle release in excitable cells, such as mouse pancreatic islets and hippocampal neurons, and modulate synaptic transmission in Caenorhabditis elegans. As such, the PhoDAGs afford an unprecedented degree of spatiotemporal control and are broadly applicable tools to study DAG signaling.	[Frank, James Allen; Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Frank, James Allen; Trauner, Dirk] Univ Munich, Ctr Integrated Prot Sci, Munich, Germany; [Yushchenko, Dmytro A.; Schultz, Carsten] EMBL, Cell Biol & Biophys Unit, Heidelberg, Germany; [Yushchenko, Dmytro A.] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Hodson, David J.; Rutter, Guy A.] Imperial Coll London, Hammersmith Hosp, Sect Cell Biol & Funct Genom, Dept Med,ICTEM, London, England; [Hodson, David J.] Univ Birmingham, IMSR, Birmingham, W Midlands, England; [Hodson, David J.] Univ Birmingham, Ctr Membrane Proteins & Receptors COMPARE, Birmingham, W Midlands, England; [Hodson, David J.; Brose, Nils] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab CEDAM, Birmingham, W Midlands, England; [Lipstein, Noa; Rhee, Jeong-Seop; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, Gottingen, Germany; [Nagpal, Jatin; Gottschalk, Alexander] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Nagpal, Jatin; Gottschalk, Alexander] Goethe Univ Frankfurt, Inst Biochem, Dept Biochem Chem & Pharm, Frankfurt, Germany	University of Munich; University of Munich; European Molecular Biology Laboratory (EMBL); Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Imperial College London; University of Birmingham; University of Birmingham; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt	Trauner, D (corresponding author), Univ Munich, Dept Chem, Munich, Germany.; Trauner, D (corresponding author), Univ Munich, Ctr Integrated Prot Sci, Munich, Germany.; Schultz, C (corresponding author), EMBL, Cell Biol & Biophys Unit, Heidelberg, Germany.	schultz@embl.de; dirk.trauner@lmu.de	Gottschalk, Alexander/D-3155-2011; Yushchenko, Dmytro/J-1020-2017	Gottschalk, Alexander/0000-0002-1197-6119; Yushchenko, Dmytro/0000-0003-0355-6197; Hodson, David/0000-0002-8641-8568; Rutter, Guy/0000-0001-6360-0343; Lipstein, Noa/0000-0002-0755-5899; Schultz, Carsten/0000-0002-5824-2171; Nagpal, Jatin/0000-0002-9204-6182	Deutsche Forschungsgemeinschaft (DFG) [SFB 1032, TRR 152]; European Research Council (ERC) [268795]; DFG [TRR 83, TRR 186, FOR1279 GO1011/4-1, GO1011/4-2]; EIPOD Programme at EMBL; EU [229597]; IOCB installation grant; Diabetes UK RD Lawrence [12/0004431]; EFSD/Novo Nordisk Rising Star and Birmingham fellowships; MRC [MR/N00275X/1]; Imperial Confidence in Concept (ICiC) grants; Wellcome Trust [WT098424AIA]; Royal Society Wolfson Research Merit awards; UK Medical Research Council [MR/J0003042/1, MR/L020149/1, MR/L02036X/1]; Biological and Biotechnology Research Council [BB/J015873/1]; Diabetes UK [11/0004210, 15/0005275]; Cluster of Excellence Frankfurt [EXC115]; Biotechnology and Biological Sciences Research Council [BB/J015873/1] Funding Source: researchfish; Medical Research Council [MR/N00275X/1, MC_PC_14100, MR/L020149/1] Funding Source: researchfish; BBSRC [BB/J015873/1] Funding Source: UKRI; MRC [MC_PC_14100, MR/L020149/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); EIPOD Programme at EMBL; EU(European Commission); IOCB installation grant; Diabetes UK RD Lawrence(Diabetes UK); EFSD/Novo Nordisk Rising Star and Birmingham fellowships; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial Confidence in Concept (ICiC) grants; Wellcome Trust(Wellcome Trust); Royal Society Wolfson Research Merit awards(Royal Society of London); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biological and Biotechnology Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); Cluster of Excellence Frankfurt; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Sumser, J. Broichhagen and T. Fehrentz for insightful discussions leading to the preparation of the manuscript, and M. Duca, S. Wouters, R. Mitchell and N. Johnston for experimental assistance. We thank F. Stein for providing macros for image analysis. We are grateful for the technical support of EMBL's Advanced Light Microscopy Facility. D.T. and J.A.F. are supported by the Deutsche Forschungsgemeinschaft (DFG) (SFB 1032 project B09, TRR 152) and the European Research Council (ERC Advanced Grant 268795 to D.T.). C.S. is supported by the DFG (TRR 83 and TRR 186). D.A.Y. was funded by the EIPOD Programme at EMBL, EU grant 229597 and an IOCB installation grant. D.J.H. was supported by Diabetes UK RD Lawrence (12/0004431), EFSD/Novo Nordisk Rising Star and Birmingham fellowships. D.J.H. and G.A.R. were supported by MRC project (MR/N00275X/1) and Imperial Confidence in Concept (ICiC) grants. G.A.R. was supported by Wellcome Trust Senior Investigator (WT098424AIA) and Royal Society Wolfson Research Merit awards and grants from the UK Medical Research Council (MR/J0003042/1, MR/L020149/1 and MR/L02036X/1), the Biological and Biotechnology Research Council (BB/J015873/1) and Diabetes UK (11/0004210; 15/0005275). J.N. was supported by DFG grants FOR1279 GO1011/4-1 and GO1011/4-2 and Cluster of Excellence Frankfurt (EXC115) (all grants to A.G.).	Almena M, 2011, TRENDS BIOCHEM SCI, V36, P593, DOI 10.1016/j.tibs.2011.06.005; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; Basu J, 2007, J NEUROSCI, V27, P1200, DOI 10.1523/JNEUROSCI.4908-06.2007; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BRENNER S, 1974, GENETICS, V77, P71; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Burgalossi A, 2012, NAT PROTOC, V7, P1351, DOI 10.1038/nprot.2012.074; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Dadi PK, 2014, J BIOL CHEM, V289, P12435, DOI 10.1074/jbc.M114.562587; Das J, 2014, CHEM REV, V114, P12108, DOI 10.1021/cr300481j; DAVIS RJ, 1985, J BIOL CHEM, V260, P1562; Feng SH, 2014, ANGEW CHEM INT EDIT, V53, P6720, DOI 10.1002/anie.201402294; Fleming JT, 1997, J NEUROSCI, V17, P5843; Fliegl H, 2003, J AM CHEM SOC, V125, P9821, DOI 10.1021/ja034433o; Frank JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8118; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jacobson DA, 2007, J BIOL CHEM, V282, P7442, DOI 10.1074/jbc.M607858200; Kaneko YK, 2013, ENDOCRINOLOGY, V154, P4089, DOI 10.1210/en.2013-1356; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Konrad DB, 2016, CHEM-EUR J, V22, P4364, DOI 10.1002/chem.201505061; LEWIS JA, 1980, GENETICS, V95, P905; Lou XL, 2008, J NEUROSCI, V28, P8257, DOI 10.1523/JNEUROSCI.0550-08.2008; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Marignani PA, 1996, BIOCHEM BIOPH RES CO, V225, P469, DOI 10.1006/bbrc.1996.1196; Nadler A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10056; Nadler A, 2013, ANGEW CHEM INT EDIT, V52, P6330, DOI 10.1002/anie.201301716; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; PESSIN MS, 1989, J BIOL CHEM, V264, P8729; PlengeTellechea F, 1997, J BIOL CHEM, V272, P2794, DOI 10.1074/jbc.272.5.2794; Putyrski M, 2012, FEBS LETT, V586, P2097, DOI 10.1016/j.febslet.2012.04.061; Rand J.B., 2007, WORMBOOK; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Reither G, 2006, J CELL BIOL, V174, P521, DOI 10.1083/jcb.200604033; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rutter GA, 2015, CELL MOL LIFE SCI, V72, P453, DOI 10.1007/s00018-014-1755-4; Toettcher JE, 2011, NAT METHODS, V8, P35, DOI [10.1038/nmeth.f.326, 10.1038/NMETH.F.326]; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Violin JD, 2003, IUBMB LIFE, V55, P653, DOI 10.1080/152165401310001642216; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; WENDER PA, 1988, P NATL ACAD SCI USA, V85, P7197, DOI 10.1073/pnas.85.19.7197; Wierda KDB, 2007, NEURON, V54, P275, DOI 10.1016/j.neuron.2007.04.001; Wuttke A, 2013, FASEB J, V27, P1610, DOI 10.1096/fj.12-221499; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	56	90	90	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					755	+		10.1038/nchembio.2141	http://dx.doi.org/10.1038/nchembio.2141			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27454932	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000382255100019
J	Moon, JS; Nakahira, K; Chung, KP; DeNicola, GM; Koo, MJ; Pabon, MA; Rooney, KT; Yoon, JH; Ryter, SW; Stout-Delgado, H; Choi, AMK				Moon, Jong-Seok; Nakahira, Kiichi; Chung, Kuei-Pin; DeNicola, Gina M.; Koo, Michael Jakun; Pabon, Maria A.; Rooney, Kristen T.; Yoon, Joo-Heon; Ryter, Stefan W.; Stout-Delgado, Heather; Choi, Augustine M. K.			NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages	NATURE MEDICINE			English	Article							INSULIN-RESISTANCE; BETA-CELL; PALMITOYLTRANSFERASE-I; DIABETES-MELLITUS; NAD(P)H OXIDASE; NOX4; CARNITINE; DISEASE; STRESS; METABOLISM	Altered metabolism has been implicated in the pathogenesis of inflammatory diseases. NADPH oxidase 4 (NOX4), a source of cellular superoxide anions, has multiple biological functions that may be of importance in inflammation and in the pathogenesis of human metabolic diseases, including diabetes. However, the mechanisms by which NOX4-dependent metabolic regulation affect the innate immune response remain unclear. Here we show that deficiency of NOX4 resulted in reduced expression of carnitine palmitoyltransferase 1A (CPT1A), which is a key mitochondrial enzyme in the fatty acid oxidation (FAO) pathway. The reduced FAO resulted in less activation of the nucleotide-binding domain, leucine-rich-repeat-containing receptor (NLR), pyrin-domain-containing 3 (NLRP3) inflammasome in human and mouse macrophages. In contrast, NOX4 deficiency did not inhibit the activation of the NLR family, CARD-domain-containing 4 (NLRC4), the NLRP1 or the absent in melanoma 2 (AIM2) inflammasomes. We also found that inhibition of FAO by etomoxir treatment suppressed NLRP3 inflammasome activation. Furthermore, Nox4-deficient mice showed substantial reduction in caspase-1 activation and in interleukin (IL)-1b and IL-18 production, and there was improved survival in a mouse model of NLRP3-mediated Streptococcus pneumoniae infection. The pharmacologic inhibition of NOX4 by either GKT137831, which is currently in phase 2 clinical trials, or VAS-2870 attenuated NLRP3 inflammasome activation. Our results suggest that NOX4-mediated FAO promotes NLRP3 inflammasome activation.	[Moon, Jong-Seok; Nakahira, Kiichi; Chung, Kuei-Pin; DeNicola, Gina M.; Koo, Michael Jakun; Pabon, Maria A.; Rooney, Kristen T.; Ryter, Stefan W.; Stout-Delgado, Heather; Choi, Augustine M. K.] Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY USA; [Moon, Jong-Seok; Nakahira, Kiichi; Chung, Kuei-Pin; DeNicola, Gina M.; Koo, Michael Jakun; Pabon, Maria A.; Rooney, Kristen T.; Ryter, Stefan W.; Stout-Delgado, Heather; Choi, Augustine M. K.] New York Presbyterian Hosp, New York, NY USA; [Moon, Jong-Seok; Nakahira, Kiichi; Chung, Kuei-Pin; Koo, Michael Jakun; Rooney, Kristen T.; Ryter, Stefan W.; Stout-Delgado, Heather; Choi, Augustine M. K.] Weill Cornell Med Coll, Div Pulm & Crit Care Med, New York, NY USA; [Chung, Kuei-Pin] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Chung, Kuei-Pin] Natl Taiwan Univ, Ctr Canc, Taipei, Taiwan; [Yoon, Joo-Heon] Yonsei Univ, Coll Med, Res Ctr Nat Human Def Syst, Seoul, South Korea; [Yoon, Joo-Heon] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Yoon, Joo-Heon] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul, South Korea	Cornell University; NewYork-Presbyterian Hospital; Cornell University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, AMK (corresponding author), Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY USA.; Choi, AMK (corresponding author), New York Presbyterian Hosp, New York, NY USA.; Choi, AMK (corresponding author), Weill Cornell Med Coll, Div Pulm & Crit Care Med, New York, NY USA.	amc2056@med.cornell.edu	Pabon Porras, Maria/CAG-5118-2022; Stout-Delgado, Heather/ABB-5628-2020; Moon, James C/F-1031-2014	Moon, James C/0000-0001-8071-1491; CHUNG, KUEI-PIN/0000-0003-1916-8068; Stout-Delgado, Heather/0000-0002-2387-6924; DeNicola, Gina/0000-0001-6611-6696; Rooney, Kristen T/0000-0002-7495-1437	US National Institutes of Health [P01 HL108801, R01 HL079904, R01 HL055330]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132198, R01HL079904, R01HL055330, P01HL108801, P01HL114501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044755, K01AG034999] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health (grant no. P01 HL108801, R01 HL079904, R01 HL055330; all to A.M.K.C.). We thank E. Finkelsztein for technical assistance.	Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Choi AMK, 2011, NAT IMMUNOL, V12, P379, DOI 10.1038/ni.2028; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Goettsch C, 2013, J CLIN INVEST, V123, P4731, DOI 10.1172/JCI67603; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Mensink RP, 2005, LIPIDS, V40, P1201, DOI 10.1007/s11745-005-1486-x; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moon JS, 2015, CELL REP, V12, P102, DOI 10.1016/j.celrep.2015.05.046; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Rasmussen BB, 2002, J CLIN INVEST, V110, P1687, DOI 10.1172/JCI200215715; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Susztak K, 2005, PLOS MED, V2, P152, DOI 10.1371/journal.pmed.0020045; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; TUTWILER GF, 1985, P SOC EXP BIOL MED, V178, P288; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; VARANASI U, 1994, P NATL ACAD SCI USA, V91, P3107, DOI 10.1073/pnas.91.8.3107; Wanders RJA, 2010, J INHERIT METAB DIS, V33, P479, DOI 10.1007/s10545-010-9104-8; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	53	198	207	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1002	+		10.1038/nm.4153	http://dx.doi.org/10.1038/nm.4153			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27455510	Green Accepted			2022-12-25	WOS:000382542800011
J	Ogura, Y; Parsons, WH; Kamat, SS; Cravatt, BF				Ogura, Yuji; Parsons, William H.; Kamat, Siddhesh S.; Cravatt, Benjamin F.			A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines	NATURE CHEMICAL BIOLOGY			English	Article							ENDOGENOUS CANNABINOID PRECURSOR; ISCHEMIC RAT-BRAIN; ETHANOLAMINE PHOSPHOLIPIDS; BIOSYNTHESIS; ANANDAMIDE; METABOLISM; DISCOVERY; CONGENERS; ACYLATION; NEURONS	More than 30 years ago, a calcium-dependent enzyme activity was described that generates N-acyl phosphatidylethanolamines (NAPEs), which are precursors for N-acyl ethanolamine (NAE) lipid transmitters, including the endocannabinoid anandamide. The identity of this calcium-dependent N-acyltransferase (CaNAT) has remained mysterious. Here, we use activity-based protein profiling to identify the poorly characterized serine hydrolase PLA2G4E as a mouse brain Ca-NAT and show that this enzyme generates NAPEs and NAEs in mammalian cells.	[Ogura, Yuji; Parsons, William H.; Kamat, Siddhesh S.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA; [Ogura, Yuji; Parsons, William H.; Kamat, Siddhesh S.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Cravatt, BF (corresponding author), Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA.; Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu		Parsons, William/0000-0001-6065-2340; Kamat, Siddhesh/0000-0001-6132-7574	US National Institutes of Health [DA033760]; Hewitt Foundation; American Chemical Society; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033760] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hewitt Foundation; American Chemical Society(American Chemical Society); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to H.Y. Lee for assistance with enzyme assays and G. Simon for numerous helpful discussions and critical reading of the manuscript. This work was supported by the US National Institutes of Health (DA033760), a Hewitt Foundation for Medical Research Fellowship (to W.H.P.) and the ninth Irving S. Sigal Postdoctoral Fellowship from the American Chemical Society (to S.S.K.).	Blankman JL, 2013, PHARMACOL REV, V65, P849, DOI 10.1124/pr.112.006387; Cadas H, 1996, J NEUROSCI, V16, P3934; Cadas H, 1997, J NEUROSCI, V17, P1226; Ghomashchi F, 2010, J BIOL CHEM, V285, P36100, DOI 10.1074/jbc.M110.165647; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Moesgaard B, 2000, J LIPID RES, V41, P985; NATARAJAN V, 1986, BIOCHIM BIOPHYS ACTA, V878, P32, DOI 10.1016/0005-2760(86)90341-3; NATARAJAN V, 1983, J NEUROCHEM, V41, P1303, DOI 10.1111/j.1471-4159.1983.tb00825.x; Niphakis MJ, 2014, ANNU REV BIOCHEM, V83, P341, DOI 10.1146/annurev-biochem-060713-035708; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Petrosino S, 2009, CURR OPIN CHEM BIOL, V13, P309, DOI 10.1016/j.cbpa.2009.04.616; Piper DE, 2015, J LIPID RES, V56, P1711, DOI 10.1194/jlr.M059873; Rahman IAS, 2014, PHARMACOL RES, V86, P1, DOI 10.1016/j.phrs.2014.04.001; REDDY PV, 1983, BIOCHIM BIOPHYS ACTA, V750, P472, DOI 10.1016/0005-2760(83)90187-X; Shinohara N, 2011, J LIPID RES, V52, P1927, DOI 10.1194/jlr.M015081; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Sun YX, 2004, BIOCHEM J, V380, P749, DOI 10.1042/BJ20040031; Uyama T, 2012, J BIOL CHEM, V287, P31905, DOI 10.1074/jbc.M112.368712; Viader A, 2016, ELIFE, V5, DOI 10.7554/eLife.12345; Wellner N, 2013, BBA-MOL CELL BIOL L, V1831, P652, DOI 10.1016/j.bbalip.2012.08.019; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	24	69	72	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					669	+		10.1038/nchembio.2127	http://dx.doi.org/10.1038/nchembio.2127			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27399000	Green Accepted			2022-12-25	WOS:000382255100006
J	Li, Y; Oosting, M; Deelen, P; Ricano-Ponce, I; Smeekens, S; Jaeger, M; Matzaraki, V; Swertz, MA; Xavier, RJ; Franke, L; Wijmenga, C; Joosten, LAB; Kumar, V; Netea, MG				Li, Yang; Oosting, Marije; Deelen, Patrick; Ricano-Ponce, Isis; Smeekens, Sanne; Jaeger, Martin; Matzaraki, Vasiliki; Swertz, Morris A.; Xavier, Ramnik J.; Franke, Lude; Wijmenga, Cisca; Joosten, Leo A. B.; Kumar, Vinod; Netea, Mihai G.			Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi	NATURE MEDICINE			English	Article							HUMAN IMMUNE-SYSTEM; INFECTIOUS-DISEASE; PROTEIN ABUNDANCE; STAT1 MUTATIONS; LOW-FREQUENCY; WHOLE-BLOOD; VARIANTS; GENOME; RNA; ARCHITECTURE	Little is known about the inter-individual variation of cytokine responses to different pathogens in healthy individuals. To systematically describe cytokine responses elicited by distinct pathogens and to determine the effect of genetic variation on cytokine production, we profiled cytokines produced by peripheral blood mononuclear cells from 197 individuals of European origin from the 200 Functional Genomics (200FG) cohort in the Human Functional Genomics Project (http://www.humanfunctionalgenomics.org), obtained over three different years. We compared bacteria- and fungi-induced cytokine profiles and found that most cytokine responses were organized around a physiological response to specific pathogens, rather than around a particular immune pathway or cytokine. We then correlated genome-wide single-nucleotide polymorphism (SNP) genotypes with cytokine abundance and identified six cytokine quantitative trait loci (QTLs). Among them, a cytokine QTL at the NAA35-GOLM1 locus markedly modulated interleukin (IL)-6 production in response to multiple pathogens and was associated with susceptibility to candidemia. Furthermore, the cytokine QTLs that we identified were enriched among SNPs previously associated with infectious diseases and heart diseases. These data reveal and begin to explain the variability in cytokine production by human immune cells in response to pathogens.	[Li, Yang; Deelen, Patrick; Ricano-Ponce, Isis; Matzaraki, Vasiliki; Swertz, Morris A.; Franke, Lude; Wijmenga, Cisca; Kumar, Vinod] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Oosting, Marije; Smeekens, Sanne; Jaeger, Martin; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Oosting, Marije; Smeekens, Sanne; Jaeger, Martin; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Deelen, Patrick; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Xavier, Ramnik J.] Harvard Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA USA; [Xavier, Ramnik J.] Harvard Med Sch, Boston, MA USA; [Xavier, Ramnik J.] Broad Inst MIT & Harvard Univ, Cambridge, MA USA	University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kumar, V (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands.	v.kumar@umcg.nl; mihai.netea@radboudumc.nl	Joosten, Leo AB/H-3138-2015; Li, Yang/HGT-8446-2022; Wijmenga, Cisca/D-2173-2009; Kumar, Vinod/ABC-4866-2020; Smeekens, Sanne/AAZ-2061-2021; Jaeger, Martin/H-3359-2015; Matzaraki, Vasiliki/V-7081-2018; Wijmenga, Cisca/AAE-7719-2019; Ricaño-Ponce, Isis/ABC-5454-2020; Oosting, Marije/H-7437-2015; Deelen, Patrick/B-3566-2013; Franke, Lude/P-7036-2016; Matzaraki, Vasiliki/GZB-0509-2022; Smeekens, Sanne/G-8307-2011; Netea, Mihai/N-5155-2014; Matzaraki, Vasiliki/AAK-7880-2020	Joosten, Leo AB/0000-0001-6166-9830; Li, Yang/0000-0003-4022-7341; Kumar, Vinod/0000-0002-2775-6049; Smeekens, Sanne/0000-0002-7835-914X; Jaeger, Martin/0000-0001-6994-493X; Matzaraki, Vasiliki/0000-0002-5852-6801; Wijmenga, Cisca/0000-0002-5635-1614; Ricaño-Ponce, Isis/0000-0002-7530-9526; Deelen, Patrick/0000-0002-5654-3966; Franke, Lude/0000-0002-5159-8802; Matzaraki, Vasiliki/0000-0002-5852-6801; Smeekens, Sanne/0000-0002-7835-914X; Matzaraki, Vasiliki/0000-0002-5852-6801	ERC Consolidator Grant [3310372]; ERC Advanced Grant (FP)/ERC [2012-322698]; Dutch Digestive Diseases Foundation [MLDS WO11-30]; European Union's Seventh Framework Programme (EU FP7) TANDEM project [HEALTH-F3-2012-305279]; Netherlands Organization for Scientific Research (NWO) VENI grant [863.13.011]; Netherlands Organization for Scientific Research [184021007]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	ERC Consolidator Grant(Estonian Research Council); ERC Advanced Grant (FP)/ERC; Dutch Digestive Diseases Foundation; European Union's Seventh Framework Programme (EU FP7) TANDEM project; Netherlands Organization for Scientific Research (NWO) VENI grant(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank all volunteers from the 200 Functional Genomics cohort of the Human Functional Genomics Project for participation in the study. The authors would like to thank K. McIntyre for editing the final text. This study was partially supported by a ERC Consolidator Grant (3310372) to M.G.N. and by the ERC Advanced Grant (FP/2007-2013/ERC grant 2012-322698 to C.W.), the Dutch Digestive Diseases Foundation (MLDS WO11-30 to C.W. and V.K.), the European Union's Seventh Framework Programme (EU FP7) TANDEM project (HEALTH-F3-2012-305279 to C.W. and V.K.), and a Netherlands Organization for Scientific Research (NWO) VENI grant (863.13.011 to Y.L.). This study made use of data generated by the 'Genome of the Netherlands' project, which is funded by the Netherlands Organization for Scientific Research (grant no. 184021007). The data were made available as a Rainbow Project of BBMRI-NL.	Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Deelen Patrick, 2014, BMC Res Notes, V7, P901, DOI 10.1186/1756-0500-7-901; Deelen P, 2014, EUR J HUM GENET, V22, P1321, DOI 10.1038/ejhg.2014.19; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; ENDRES S, 1988, CLIN IMMUNOL IMMUNOP, V49, P424, DOI 10.1016/0090-1229(88)90130-4; ENDRES S, 1989, EUR J IMMUNOL, V19, P2327, DOI 10.1002/eji.1830191222; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Zambrano-Zaragoza JF, 2014, INT J INFLAMM, V2014, DOI 10.1155/2014/651503; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Hill AVS, 2012, PHILOS T R SOC B, V367, P840, DOI 10.1098/rstb.2011.0275; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Juschke C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r133; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Kayama Hisako, 2013, Immune Netw, V13, P227, DOI 10.4110/in.2013.13.6.227; Kladney RD, 2002, HEPATOLOGY, V35, P1431, DOI 10.1053/jhep.2002.32525; Kladney RD, 2000, GENE, V249, P53, DOI 10.1016/S0378-1119(00)00136-0; Kumar V, 2014, CURR OPIN IMMUNOL, V31, P51, DOI 10.1016/j.coi.2014.09.007; Kumar V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5675; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Liang HY, 2012, CANCER BIOMARK, V11, P161, DOI 10.3233/CBM-2012-00276; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Liu XY, 2011, CLIN CHEM LAB MED, V49, P1311, DOI 10.1515/CCLM.2011.640; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Netea MG, 1996, CYTOKINE, V8, P739, DOI 10.1006/cyto.1996.0098; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Rubicz R, 2015, EUR J HUM GENET, V23, P1544, DOI 10.1038/ejhg.2015.24; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Smeekens SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2343; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; van Crevel R, 1999, J IMMUNOL METHODS, V222, P145, DOI 10.1016/S0022-1759(98)00192-6; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004	54	107	110	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					952	+		10.1038/nm.4139	http://dx.doi.org/10.1038/nm.4139			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376574	Green Accepted			2022-12-25	WOS:000381000200022
J	Lee, JG; Takahama, S; Zhang, GF; Tomarev, SI; Ye, YH				Lee, Jin-Gu; Takahama, Shokichi; Zhang, Guofeng; Tomarev, Stanislav I.; Ye, Yihong			Unconventional secretion of misfolded proteins promotes adaptation to proteasome dysfunction in mammalian cells	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; QUALITY CONTROL; NEURODEGENERATIVE DISEASES; UBIQUITIN LIGASE; ALPHA-SYNUCLEIN; USP19; DEGRADATION; TRANSMISSION; MECHANISMS; EXOSOMES	To safeguard proteomic integrity, cells rely on the proteasome to degrade aberrant polypeptides, but it is unclear how cells remove defective proteins that have escaped degradation owing to proteasome insufficiency or dysfunction. Here we report a pathway termed misfolding-associated protein secretion, which uses the endoplasmic reticulum (ER)-associated deubiquitylase USP19 to preferentially export aberrant cytosolic proteins. Intriguingly, the catalytic domain of USP19 possesses an unprecedented chaperone activity, allowing recruitment of misfolded proteins to the ER surface for deubiquitylation. Deubiquitylated cargos are encapsulated into ER-associated late endosomes and secreted to the cell exterior. USP19-deficient cells cannot efficiently secrete unwanted proteins, and grow more slowly than wild-type cells following exposure to a proteasome inhibitor. Together, our findings delineate a protein quality control (PQC) pathway that, unlike degradation-based PQC mechanisms, promotes protein homeostasis by exporting misfolded proteins through an unconventional protein secretion process.	[Lee, Jin-Gu; Ye, Yihong] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Takahama, Shokichi; Tomarev, Stanislav I.] NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Zhang, Guofeng] NIBIB, Biomed Engn & Phys Sci Shared Resource, NIH, Bethesda, MD 20892 USA; [Takahama, Shokichi] Kumamoto Univ, Matsushita Project Lab, Ctr AIDS Res, Kumamoto 8600811, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Kumamoto University	Ye, YH (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov		Lee, Jin-Gu/0000-0001-9477-6990	NATIONAL EYE INSTITUTE [ZIAEY000311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075142, ZIADK075044] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersson V, 2013, AGING-US, V5, P802, DOI 10.18632/aging.100613; Baixauli F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00403; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Combaret L, 2005, AM J PHYSIOL-ENDOC M, V288, pE693, DOI 10.1152/ajpendo.00281.2004; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hasegawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029460; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Lee JG, 2014, J BIOL CHEM, V289, P3510, DOI 10.1074/jbc.M113.538934; Lee JG, 2013, BIOESSAYS, V35, P377, DOI 10.1002/bies.201200159; Lee JG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2532; Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Malhotra V, 2013, EMBO J, V32, P1660, DOI 10.1038/emboj.2013.104; Mei YD, 2011, J BIOL CHEM, V286, P35380, DOI 10.1074/jbc.M111.282020; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Mohamed NV, 2013, EUR J NEUROSCI, V37, P1939, DOI 10.1111/ejn.12229; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Oh SH, 2016, CELL REP, V14, P835, DOI 10.1016/j.celrep.2015.12.075; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ryno LM, 2013, CURR OPIN CHEM BIOL, V17, P346, DOI 10.1016/j.cbpa.2013.04.009; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Steringer JP, 2015, J MOL BIOL, V427, P1202, DOI 10.1016/j.jmb.2014.07.012; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsunemi T, 2014, J NEUROSCI, V34, P15281, DOI 10.1523/JNEUROSCI.1629-14.2014; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wiles B, 2015, MOL BIOL CELL, V26, P913, DOI 10.1091/mbc.E14-06-1129; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Zhang M, 2015, ELIFE, V4, DOI 10.7554/eLife.11205; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	47	125	127	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2016	18	7					765	+		10.1038/ncb3372	http://dx.doi.org/10.1038/ncb3372			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DP9TS	27295555				2022-12-25	WOS:000378840900009
J	Liu, SL; Sheng, R; Jung, JH; Wang, L; Stec, E; O'Connor, MJ; Song, S; Bikkavilli, RK; Winn, RA; Lee, D; Baek, K; Ueda, K; Levitan, I; Kim, KP; Cho, W				Liu, Shu-Lin; Sheng, Ren; Jung, Jae Hun; Wang, Li; Stec, Ewa; O'Connor, Matthew J.; Song, Seohyoen; Bikkavilli, Rama Kamesh; Winn, Robert A.; Lee, Daesung; Baek, Kwanghee; Ueda, Kazumitsu; Levitan, Irena; Kim, Kwang-Pyo; Cho, Wonhwa			Orthogonal lipid sensors identify transbilayer asymmetry of plasma membrane cholesterol	NATURE CHEMICAL BIOLOGY			English	Article							DEPENDENT CYTOLYSIN; PROTEIN; TRAFFICKING; TRANSPORT; DOMAIN; ORGANIZATION; SPHINGOMYELIN; ACTIVATION; MECHANISM; CANCER	Controlled distribution of lipids across various cell membranes is crucial for cell homeostasis and regulation. We developed an imaging method that allows simultaneous in situ quantification of cholesterol in two leaflets of the plasma membrane (PM) using tunable orthogonal cholesterol sensors. Our imaging revealed marked transbilayer asymmetry of PM cholesterol (TAPMC) in various mammalian cells, with the concentration in the inner leaflet (IPM) being -12-fold lower than that in the outer leaflet (OPM). The asymmetry was maintained by active transport of cholesterol from IPM to OPM and its chemical retention at OPM. Furthermore, the increase in the IPM cholesterol level was triggered in a stimulus-specific manner, allowing cholesterol to serve as a signaling lipid. We found excellent correlation between the IPM cholesterol level and cellular Wnt signaling activity, suggesting that TAPMC and stimulus-induced PM cholesterol redistribution are crucial for tight regulation of cellular processes under physiological conditions.	[Liu, Shu-Lin; Sheng, Ren; Wang, Li; Stec, Ewa; O'Connor, Matthew J.; Song, Seohyoen; Lee, Daesung; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Jung, Jae Hun; Kim, Kwang-Pyo] Kyung Hee Univ, Dept Appl Chem, Yongin, South Korea; [Bikkavilli, Rama Kamesh; Winn, Robert A.; Levitan, Irena] Univ Illinois, Dept Med, Chicago, IL USA; [Baek, Kwanghee; Cho, Wonhwa] Kyung Hee Univ, Dept Genet Engn, Yongin, South Korea; [Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan; [Ueda, Kazumitsu] Kyoto Univ, Div Appl Life Sci, Kyoto, Japan	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Kyung Hee University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Kyung Hee University; Kyoto University; Kyoto University	Cho, W (corresponding author), Univ Illinois, Dept Chem, Chicago, IL 60607 USA.; Cho, W (corresponding author), Kyung Hee Univ, Dept Genet Engn, Yongin, South Korea.	wcho@uic.edu	Kim, Kwang Pyo/AAG-1815-2020; Baek, Kwanghee/N-2760-2018	Baek, Kwanghee/0000-0002-1364-1355; Ueda, Kazumitsu/0000-0003-2980-6078; Kim, Kwang Pyo/0000-0003-0095-3787	US National Institutes of Health [GM68849, GM110128, HL-073965, HL-083298]; Japan Society for the Promotion of Science [25221203]; NATIONAL CANCER INSTITUTE [U54CA202995, U54CA203000, U54CA202997] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073965, R01HL083298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849, R35GM122530, R01GM110128] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Heuck (University of Massachusetts) for a kind gift of the D4 domain construct and P. Subbaiah, T. Steck and Y. Lange for helpful discussion. This work was supported by the grants from the US National Institutes of Health (GM68849 and GM110128 to W.C. and HL-073965 and HL-083298 to I.L.) and from the Japan Society for the Promotion of Science (25221203 to K.U.).	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Brachet A, 2015, J CELL BIOL, V208, P791, DOI 10.1083/jcb.201407122; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; Das A, 2013, P NATL ACAD SCI USA, V110, P10580, DOI 10.1073/pnas.1309273110; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Frechin M, 2015, NATURE, V523, P88, DOI 10.1038/nature14429; Gimpl G, 2010, SUBCELL BIOCHEM, V51, P1, DOI 10.1007/978-90-481-8622-8_1; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Hamilton JA, 2003, CURR OPIN LIPIDOL, V14, P263, DOI 10.1097/00041433-200306000-00006; Heuck AP, 2010, SUBCELL BIOCHEM, V51, P551, DOI 10.1007/978-90-481-8622-8_20; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Irvine R, 2004, CURR BIOL, V14, pR308, DOI 10.1016/j.cub.2004.03.051; Kobayashi A, 2006, J LIPID RES, V47, P1791, DOI 10.1194/jlr.M500546-JLR200; LANGE Y, 1989, J BIOL CHEM, V264, P3786; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu SL, 2014, ANGEW CHEM INT EDIT, V53, P14387, DOI 10.1002/anie.201408153; Luu W, 2013, IUBMB LIFE, V65, P675, DOI 10.1002/iub.1182; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mondal M, 2009, MOL BIOL CELL, V20, P581, DOI 10.1091/mbc.E08-07-0785; Murate M, 2016, CHEM PHYS LIPIDS, V194, P58, DOI 10.1016/j.chemphyslip.2015.08.009; Nagao K, 2011, FEBS J, V278, P3190, DOI 10.1111/j.1742-4658.2011.08170.x; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Pagler TA, 2011, CIRC RES, V108, P194, DOI 10.1161/CIRCRESAHA.110.228619; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Raiborg C, 2015, EMBO J, V34, P1848, DOI 10.15252/embj.201591481; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; RAY TK, 1969, J BIOL CHEM, V244, P5528; Sheng R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5393; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Silvente-Poirot S, 2012, CURR OPIN PHARMACOL, V12, P673, DOI 10.1016/j.coph.2012.10.004; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Sumandea M, 1999, BIOCHEMISTRY-US, V38, P16290, DOI 10.1021/bi9921384; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; van Meer G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004671; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Yoon Y, 2011, NAT CHEM, V3, P868, DOI [10.1038/NCHEM.1163, 10.1038/nchem.1163]; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	53	119	120	0	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2017	13	3					268	+		10.1038/NCHEMBIO.2268	http://dx.doi.org/10.1038/NCHEMBIO.2268			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL2DY	28024150	Green Accepted			2022-12-25	WOS:000394431500008
J	Ghosh, A; Smith, M; James, SE; Davila, ML; Velardi, E; Argyropoulos, KV; Gunset, G; Perna, F; Kreines, FM; Levy, ER; Lieberman, S; Jay, HV; Tuckett, AZ; Zakrzewski, JL; Tan, L; Young, LF; Takvorian, K; Dudakov, JA; Jenq, RR; Hanash, AM; Motta, ACF; Murphy, GF; Liu, C; Schietinger, A; Sadelain, M; van den Brink, MRM				Ghosh, Arnab; Smith, Melody; James, Scott E.; Davila, Marco L.; Velardi, Enrico; Argyropoulos, Kimon V.; Gunset, Gertrude; Perna, Fabiana; Kreines, Fabiana M.; Levy, Emily R.; Lieberman, Sophie; Jay, Hillary V.; Tuckett, Andrea Z.; Zakrzewski, Johannes L.; Tan, Lisa; Young, Lauren F.; Takvorian, Kate; Dudakov, Jarrod A.; Jenq, Robert R.; Hanash, Alan M.; Motta, Ana Carolina F.; Murphy, George F.; Liu, Chen; Schietinger, Andrea; Sadelain, Michel; van den Brink, Marcel R. M.			Donor CD19 CART cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity	NATURE MEDICINE			English	Article							CHIMERIC ANTIGEN RECEPTOR; CD19-TARGETED T-CELLS; MALIGNANCIES; TRANSPLANTATION; PERSISTENCE; REMISSIONS; INFUSION; THERAPY; TUMORS; GVHD	Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for hematological malignancies. However, graft-versus-host disease (GVHD) and relapse after allo-HSCT remain major impediments to the success of allo-HSCT. Chimeric antigen receptors (CARs) direct tumor cell recognition of-adoptively transferred T cells(1-5). CD19 is an attractive CAR target, which is expressed in most B cell malignancies, as well as in healthy B cells(6,7). Clinical trials using autologous CD19-targeted T cells have shown remarkable promise in various B cell malignancies(8-15). However, the use of allogeneic CAR T cells poses a concern in that it may increase risk of the occurrence of GVHD, although this has not been reported in selected patients infused with donor-derived CD19 CAR T cells after allo-HSCT16,17. To understand the mechanism whereby allogeneic CD19 CAR T cells may mediate anti-lymphoma activity without causing a significant increase in the incidence of GVHD, we studied donor-derived CD19 CAR T cells in allo-HSCT and lyMphoma models in mice. We demonstrate that alloreactive. I cells expressing CD28-costimulated CD19 CARs experience enhanced stimulation, resulting in the progressive loss of both their effector function and proliferative potential, clonal deletion, and significantly decreased occurrence of GVHD. Concurrently, the other CAR T cells that were present in bulk donor T cell populations retained their anti-lymphoma activity in accordance with the requirement that both the T cell receptor (TCR) and CAR be engaged to accelerate T cell exhaustion. In contrast, first-generation and 4-1BB-costimulated CAR T cells increased the occurrence of GVHD. These findings could explain the reduced risk of GVHD occurring with cumulative TCR and CAR signaling.	[Ghosh, Arnab; Smith, Melody; James, Scott E.; Velardi, Enrico; Argyropoulos, Kimon V.; Kreines, Fabiana M.; Levy, Emily R.; Lieberman, Sophie; Jay, Hillary V.; Tuckett, Andrea Z.; Tan, Lisa; Young, Lauren F.; Takvorian, Kate; Dudakov, Jarrod A.; Jenq, Robert R.; Hanash, Alan M.; Schietinger, Andrea; Sadelain, Michel; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Ghosh, Arnab; Smith, Melody; James, Scott E.; Velardi, Enrico; Argyropoulos, Kimon V.; Kreines, Fabiana M.; Levy, Emily R.; Lieberman, Sophie; Jay, Hillary V.; Tuckett, Andrea Z.; Tan, Lisa; Young, Lauren F.; Takvorian, Kate; Dudakov, Jarrod A.; Jenq, Robert R.; Hanash, Alan M.; Schietinger, Andrea; Sadelain, Michel; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA; [James, Scott E.; Davila, Marco L.; Gunset, Gertrude; Perna, Fabiana; Sadelain, Michel; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA; [Zakrzewski, Johannes L.] Mem Sloan Kettering Canc Ctr, Pediat, 1275 York Ave, New York, NY 10021 USA; [Motta, Ana Carolina F.; Murphy, George F.] Brigham & Womens Hosp, Dept Pathol, Program Dermatopathol, 75 Francis St, Boston, MA 02115 USA; [Motta, Ana Carolina F.; Murphy, George F.] Harvard Med Sch, Boston, MA USA; [Liu, Chen] Rutgers Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Newark, NJ USA; [Davila, Marco L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, Tampa, FL USA; [Dudakov, Jarrod A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA; [Motta, Ana Carolina F.] Univ Sao Paulo, Sao Paulo, Brazil	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; H Lee Moffitt Cancer Center & Research Institute; Fred Hutchinson Cancer Center; Universidade de Sao Paulo	Sadelain, M; van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Sadelain, M; van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.; Sadelain, M; van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA.	sadelaim@mskcc.org; vandenbm@mskcc.org	Velardi, Enrico/AAB-7443-2019; velardi, Enrico/AAC-5440-2022; Kreines, Fabiana/AAV-8837-2020; van den Brink, Marcel R. M./HGB-9434-2022; Motta, Ana Carolina F/J-2683-2012; Davila, Marco/P-7912-2014	Velardi, Enrico/0000-0001-8383-0453; Motta, Ana Carolina F/0000-0002-3887-9239; Davila, Marco/0000-0002-6270-3065; Ghosh, Arnab/0000-0003-3355-5427; Smith, Melody/0000-0002-2702-0381	National Institutes of Health [R01-HL069929, R01-A1101406, P01-CA023766, R01-AI100288]; LLS; Lymphoma Foundation; Susan and Peter Solomon Divisional Genomics Program; MSKCC Cycle for Survival; MSK Cancer Center Support Grant/Core Grant [P30-CA008748]; NIH [PA-16-288, R01-AI100288-08S1]; M.J. Lacher Research Fellowship (The Lymphoma Foundation); American Society for Blood and Marrow Transplantation New Investigator Award; NIH T32 grant [T32-CA009207]; ASH-AMFDP career development award; Damon Runyon Fund [K08-CA148821]; LLS TRP grant [6465-15, K08-CA160659]; Imaging and Radiation Sciences (IMRAS) Program of MSKCC; NATIONAL CANCER INSTITUTE [K08CA160659, K08CA148821, P01CA023766, P30CA008748, T32CA009207, R00CA176376] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL115355, R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101406, R01AI100288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LLS; Lymphoma Foundation; Susan and Peter Solomon Divisional Genomics Program; MSKCC Cycle for Survival; MSK Cancer Center Support Grant/Core Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.J. Lacher Research Fellowship (The Lymphoma Foundation); American Society for Blood and Marrow Transplantation New Investigator Award; NIH T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASH-AMFDP career development award; Damon Runyon Fund; LLS TRP grant; Imaging and Radiation Sciences (IMRAS) Program of MSKCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are thankful to M. Sayegh (Brigham and Women's Hospital and Children's Hospital Boston) for ABM mice, R. Negrin (Stanford University) for the A20-TGL cell line, E. Campeau (University of Massachusetts) for pENTR1A, D. Vignali (University of Pittsburgh Medical Center) for mouse TCR OTI-2A.pMIG II, and P. Khavari (Stanford University) for LZRS-Rfa plasmid. We appreciate the help of J. White, LCP, RARC, the flow cytometry core facility, the integrative genomics core, and the computational biology core at MSKCC. We also appreciate the help of H. Poeck in critical reading of the manuscript. This research was supported by National Institutes of Health award numbers R01-HL069929 (M.R.M.v.d.B.), R01-A1101406 (M.R.M.v.d.B.), P01-CA023766 (M.R.M.v.d.B.), and R01-AI100288 (M.R.M.v.d.B.), LLS (M. Sadelain), the Lymphoma Foundation, the Susan and Peter Solomon Divisional Genomics Program, MSKCC Cycle for Survival, and P30-CA008748 MSK Cancer Center Support Grant/Core Grant. A.G. is a fellow of the Lymphoma Research Foundation. M. Smith received funding from an NIH Diversity Supplement (PA-16-288) under R01-AI100288-08S1, the M.J. Lacher Research Fellowship (The Lymphoma Foundation), and the American Society for Blood and Marrow Transplantation New Investigator Award. M. Smith and S.J. are supported under an NIH T32 grant (T32-CA009207). S.J. is also a Young Investigator Awardee from the Conquer Cancer Foundation of ASCO. M.L.D. is supported by an ASH-AMFDP career development award, the Damon Runyon Fund, and K08-CA148821 (NCI). J.L.Z. is supported by LLS TRP grant 6465-15 and K08-CA160659 (NCI). A.Z.T. is supported by a grant from the Imaging and Radiation Sciences (IMRAS) Program of MSKCC. The content is solely the responsibility of the authors and does not represent the official views of the National Cancer Institute or the National Institutes of Health.	Bar M, 2013, BIOL BLOOD MARROW TR, V19, P949, DOI 10.1016/j.bbmt.2013.03.001; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Brudno JN, 2016, J CLIN ONCOL, V34, P1112, DOI 10.1200/JCO.2015.64.5929; Cruz CRY, 2013, BLOOD, V122, P2965, DOI 10.1182/blood-2013-06-506741; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Davila ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061338; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Ghosh A, 2013, CANCER RES, V73, P4687, DOI 10.1158/0008-5472.CAN-12-4699; Ghosh A, 2013, J CLIN INVEST, V123, P2654, DOI 10.1172/JCI66301; Gill S, 2015, IMMUNOL REV, V263, P68, DOI 10.1111/imr.12243; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hasan M, 2002, EUR J IMMUNOL, V32, P3463, DOI 10.1002/1521-4141(200212)32:12<3463::AID-IMMU3463>3.0.CO;2-B; Ho WY, 2003, CANCER CELL, V3, P431, DOI 10.1016/S1535-6108(03)00113-2; Jacoby E, 2016, BLOOD, V127, P1361, DOI 10.1182/blood-2015-08-664250; James SE, 2009, BLOOD, V114, P5454, DOI 10.1182/blood-2009-08-232967; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2013, BLOOD, V122, P4129, DOI 10.1182/blood-2013-08-519413; Kochenderfer JN, 2010, BLOOD, V116, P3875, DOI 10.1182/blood-2010-01-265041; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sadelain M, 2015, J CLIN INVEST, V125, P3392, DOI 10.1172/JCI80010; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Small TN, 2009, BIOL BLOOD MARROW TR, V15, P104, DOI 10.1016/j.bbmt.2008.10.016; Srinivasan M, 2012, BLOOD, V119, P1570, DOI 10.1182/blood-2011-07-364414; Teague RM, 2008, IMMUNITY, V28, P662, DOI 10.1016/j.immuni.2008.03.012; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	36	136	148	1	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					242	249		10.1038/nm.4258	http://dx.doi.org/10.1038/nm.4258			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28067900	Green Accepted			2022-12-25	WOS:000393729000016
J	Luo, Y; de Lange, KM; Jostins, L; Moutsianas, L; Randall, J; Kennedy, NA; Lamb, CA; McCarthy, S; Ahmad, T; Edwards, C; Serra, EG; Hart, A; Hawkey, C; Mansfield, JC; Mowat, C; Newman, WG; Nichols, S; Pollard, M; Satsangi, J; Simmons, A; Tremelling, M; Uhlig, H; Wilson, DC; Lee, JC; Prescott, NJ; Lees, CW; Mathew, CG; Parkes, M; Barrett, JC; Anderson, CA				Luo, Yang; de lange, Katrina M.; Jostins, Luke; Moutsianas, Loukas; Randall, Joshua; Kennedy, Nicholas A.; Lamb, Christopher A.; McCarthy, Shane; Ahmad, Tariq; Edwards, Cathryn; Serra, Eva Goncalves; Hart, Ailsa; Hawkey, Chris; Mansfield, John C.; Mowat, Craig; Newman, William G.; Nichols, Sam; Pollard, Martin; Satsangi, Jack; Simmons, Alison; Tremelling, Mark; Uhlig, Holm; Wilson, David C.; Lee, James C.; Prescott, Natalie J.; Lees, Charlie W.; Mathew, Christopher G.; Parkes, Miles; Barrett, Jeffrey C.; Anderson, Carl A.			Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7	NATURE GENETICS			English	Article							ADENYLYL-CYCLASE VII; WIDE ASSOCIATION; MISSING HERITABILITY; SUSCEPTIBILITY LOCI; CROHNS-DISEASE; ULCERATIVE-COLITIS; IMMUNE-RESPONSES; VARIANTS; SCHIZOPHRENIA; RISK	To further resolve the genetic architecture of the inflammatory bowel diseases ulcerative colitis and Crohn's disease, we sequenced the whole genomes of 4,280 patients at low coverage and compared them to 3,652 previously sequenced population controls across 73.5 million variants. We then imputed from these sequences into new and existing genome-wide association study cohorts and tested for association at similar to 12 million variants in a total of 16,432 cases and 18,843 controls. We discovered a 0.6% frequency missense variant in ADCY7 that doubles the risk of ulcerative colitis. Despite good statistical power, we did not identify any other new low-frequency risk variants and found that such variants explained little heritability. We detected a burden of very rare, damaging missense variants in known Crohn's disease risk genes, suggesting that more comprehensive sequencing studies will continue to improve understanding of the biology of complex diseases.	[Luo, Yang; de lange, Katrina M.; Moutsianas, Loukas; Randall, Joshua; McCarthy, Shane; Serra, Eva Goncalves; Nichols, Sam; Pollard, Martin; Barrett, Jeffrey C.; Anderson, Carl A.] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Hinxton, England; [Luo, Yang] Harvard Med Sch, Brigham & Womens Hosp, Div Genet & Rheumatol, Boston, MA 02115 USA; [Luo, Yang] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Jostins, Luke] Univ Oxford, Wellcome Trust Ctr Human Genet, Headington, England; [Jostins, Luke] Univ Oxford, Christ Church, St Aldates, England; [Kennedy, Nicholas A.; Ahmad, Tariq] Univ Exeter, Precis Med Exeter, Exeter, Devon, England; [Kennedy, Nicholas A.; Ahmad, Tariq] Royal Devon & Exeter Fdn Trust, IBD Pharmacogenet, Exeter, Devon, England; [Lamb, Christopher A.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Edwards, Cathryn] Torbay Hosp, Dept Gastroenterol, Torquay, England; [Hart, Ailsa] St Marks Hosp, Dept Med, Harrow, Middx, England; [Hawkey, Chris] Queens Med Ctr, Nottingham Digest Dis Ctr, Nottingham, England; [Mansfield, John C.] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Mowat, Craig] Ninewells Hosp, Dept Med, Dundee, Scotland; [Mowat, Craig] Sch Med, Dundee, Scotland; [Newman, William G.] Manchester Acad Hlth Sci Ctr, Genet Med, Manchester, Lancs, England; [Newman, William G.] Univ Manchester, Manchester Ctr Genom Med, Manchester, Lancs, England; [Satsangi, Jack; Lees, Charlie W.] Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Simmons, Alison; Uhlig, Holm] Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford, England; [Simmons, Alison] Univ Oxford, Weatherall Inst Mol Med, Human Immunol Unit, Oxford, England; [Tremelling, Mark] Norfolk & Norwich Univ Hosp, Gastroenterol & Gen Med, Norwich, Norfolk, England; [Uhlig, Holm] Univ Oxford, Dept Pediat, Oxford, England; [Wilson, David C.] Royal Hosp Sick Children, Paediatr Gastroenterol & Nutr, Edinburgh, Midlothian, Scotland; [Wilson, David C.] Univ Edinburgh, Child Life & Hlth, Edinburgh, Midlothian, Scotland; [Lee, James C.; Parkes, Miles] Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge, England; [Prescott, Natalie J.; Mathew, Christopher G.] Guys Hosp, Kings Coll London, Fac Life Sci & Med, Dept Med & Mol Genet, London, England; [Mathew, Christopher G.] Univ Witwatersrand, Fac Hlth Sci, Sydney Brenner Inst Mol Biosci, Johannesburg, South Africa	Wellcome Trust Sanger Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Exeter; Newcastle University - UK; Imperial College London; University of Nottingham; Newcastle University - UK; University of Dundee; University of Dundee; University of Manchester; University of Manchester; University of Edinburgh; University of Oxford; University of Oxford; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of Oxford; University of Edinburgh; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Witwatersrand	Barrett, JC; Anderson, CA (corresponding author), Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Hinxton, England.	jb26@sanger.ac.uk; ca3@sanger.ac.uk	Pollard, Martin O./G-7205-2012; Mowat, Craig/AAD-1851-2019; Prescott, Natalie/AHE-5121-2022; Prescott, Natalie J/F-6490-2011; Kennedy, Nicholas Alexander/AET-5648-2022; Lamb, Christopher/GPS-9148-2022; Lee, James/ABD-5920-2020; hart, ailsa/AFO-1919-2022; Mathew, Christopher George/G-3434-2015	Pollard, Martin O./0000-0001-8738-0920; Mowat, Craig/0000-0002-5021-415X; Prescott, Natalie/0000-0002-5901-7371; Prescott, Natalie J/0000-0002-5901-7371; Kennedy, Nicholas Alexander/0000-0003-4368-1961; Lamb, Christopher/0000-0002-7271-4956; Lee, James/0000-0001-5711-9385; Edwards, Cathryn/0000-0002-5550-9184; Moutsianas, Loukas/0000-0001-5453-345X; McCarthy, Shane/0000-0002-2715-4187; Barrett, Jeffrey/0000-0002-1152-370X; Anderson, Carl/0000-0003-1719-7009; Simmons, Alison/0000-0003-3454-0710; Luo, Yang/0000-0001-7385-6166; Mathew, Christopher George/0000-0003-4178-1838; Hawkey, Chris/0000-0002-6031-1017; Lees, Charlie/0000-0002-0732-8215; Parkes, Miles/0000-0002-6467-0631; Newman, William/0000-0002-6382-4678; Uhlig, Holm/0000-0002-6111-7355	Wellcome Trust [098051, 093885/Z/10/Z]; Medical Research Council, UK [MR/J00314X/1]; Crohn's and Colitis UK; Woolf Fisher Trust scholarship; NIHR; Crohn's and Colitis Foundation of America (CCFA); Leona M. and Harry B. Helmsley Charitable Trust; UK Department of Health via NIHR comprehensive Biomedical Research Centre awards; BRC; NIHR Newcastle Biomedical Research Centre; Economic and Social Research Council; ESRC [ES/H029745/1] Funding Source: UKRI; MRC [G0800759, MC_UU_12010/7, MR/J00314X/1, MC_UU_00008/7, G0800675, MR/M00533X/1] Funding Source: UKRI; Economic and Social Research Council [ES/H029745/1] Funding Source: researchfish; Medical Research Council [MC_UU_12010/7, MR/M00533X/1, MR/J00314X/1, 1202121, G0800759, G0800675, G0600329, MC_UU_00008/7] Funding Source: researchfish; Medical Research Foundation [C0482] Funding Source: researchfish; National Institute for Health Research [CL-2014-01-005, NIHR-RP-R3-12-026] Funding Source: researchfish; Wellcome Trust [102974/Z/13/Z] Funding Source: researchfish; Chief Scientist Office [ETM/75, ETM/137, CZB/4/540] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M10-2, M14-5, M11-1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Crohn's and Colitis UK; Woolf Fisher Trust scholarship; NIHR(National Institute for Health Research (NIHR)); Crohn's and Colitis Foundation of America (CCFA); Leona M. and Harry B. Helmsley Charitable Trust; UK Department of Health via NIHR comprehensive Biomedical Research Centre awards; BRC; NIHR Newcastle Biomedical Research Centre; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Chief Scientist Office; Crohn&quot;s and Colitis UK	We thank all individuals who contributed samples to the study. This work was co-funded by the Wellcome Trust (098051) and the Medical Research Council, UK (MR/J00314X/1). Case collections were supported by Crohn's and Colitis UK. K.M.d.L., L.M., Y.L., C.A.L., C.A.A. and J.C.B. are supported by the Wellcome Trust (098051; 093885/Z/10/Z). K.M.d.L. is supported by a Woolf Fisher Trust scholarship. C.A.L. is a clinical lecturer funded by the NIHR. H.U. is supported by the Crohn's and Colitis Foundation of America (CCFA) and the Leona M. and Harry B. Helmsley Charitable Trust. We acknowledge support from the UK Department of Health via NIHR comprehensive Biomedical Research Centre awards to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and to Addenbrooke's Hospital, Cambridge, in partnership with the University of Cambridge, and the BRC to the Oxford IBD cohort study, University of Oxford. This research was also supported by the NIHR Newcastle Biomedical Research Centre. The UK Household Longitudinal Study is led by the Institute for Social and Economic Research at the University of Essex and funded by the Economic and Social Research Council. The survey was conducted by NatCen, and the genome-wide scan data were analyzed and deposited by the Wellcome Trust Sanger Institute. Information on how to access the data can be found on the Understanding Society website. We are grateful for genotyping data from the British Society for Surgery of the Hand Genetics of Dupuytren's Disease consortium and L. Southam for assistance with genotype intensities. This research has been conducted using the UK Biobank Resource.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Bhatia G., 2016, SUBTLE STRATIFICATIO; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Chen GB, 2014, HUM MOL GENET, V23, P4710, DOI 10.1093/hmg/ddu174; Dahle MK, 2005, INFECT IMMUN, V73, P7290, DOI 10.1128/IAI.73.11.7290-7296.2005; Danjou F, 2015, NAT GENET, V47, P1264, DOI 10.1038/ng.3307; de Lange K. M., 2017, NAT GENET; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Derkach A, 2014, BIOINFORMATICS, V30, P2179, DOI 10.1093/bioinformatics/btu196; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Duan BY, 2010, J IMMUNOL, V185, P335, DOI 10.4049/jimmunol.0903474; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Genovese G, 2016, NAT NEUROSCI, V19, P1433, DOI 10.1038/nn.4402; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Huang H., 2015, ASS MAPPING INFLAMMA; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Jiang LI, 2013, MOL IMMUNOL, V54, P14, DOI 10.1016/j.molimm.2012.10.027; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Julia A, 2014, HUM MOL GENET, V23, P6927, DOI 10.1093/hmg/ddu398; Kenny EE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002559; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Li YR, 2015, NAT MED, V21, P1018, DOI 10.1038/nm.3933; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Prescott NJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004955; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Risoe PK, 2015, HUM IMMUNOL, V76, P427, DOI 10.1016/j.humimm.2015.03.018; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Singh T, 2016, NAT NEUROSCI, V19, P571, DOI 10.1038/nn.4267; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang SK, 2014, GUT, V63, P80, DOI 10.1136/gutjnl-2013-305193; Zimmerman NP, 2012, INFLAMM BOWEL DIS, V18, P1081, DOI 10.1002/ibd.21898; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	48	98	99	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					186	192		10.1038/ng.3761	http://dx.doi.org/10.1038/ng.3761			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	28067910	Green Submitted, Green Accepted			2022-12-25	WOS:000393148600007
J	Maillo, C; Martin, J; Sebastian, D; Hernandez-Alvarez, M; Garcia-Rocha, M; Reina, O; Zorzano, A; Fernandez, M; Mendez, R				Maillo, Carlos; Martin, Judit; Sebastian, David; Hernandez-Alvarez, Maribel; Garcia-Rocha, Mar; Reina, Oscar; Zorzano, Antonio; Fernandez, Mercedes; Mendez, Raul			Circadian- and UPR-dependent control of CPEB4 mediates a translational response to counteract hepatic steatosis under ER stress	NATURE CELL BIOLOGY			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA TRANSLATION; CELL DIFFERENTIATION; RHYTHMIC ACTIVATION; LIPID-METABOLISM; KNOCKOUT MICE; LIVER-DISEASE; MOUSE-LIVER; CLOCK	The cytoplasmic polyadenylation element-binding (CPEB) proteins regulate pre-mRNA processing and translation of CPE-containing mRNAs in early embryonic development and synaptic activity. However, specific functions in adult organisms are poorly understood. Here we show that CPEB4 is required for adaptation to high-fat-diet- and ageing-induced endoplasmic reticulum (ER) stress, and subsequent hepatosteatosis. Stress-activated liver CPEB4 expression is dual-mode regulated. First, Cpeb4 mRNA transcription is controlled by the circadian clock, and then its translation is regulated by the unfolded protein response (UPR) through upstream open reading frames within the 5'UTR. Thus, the CPEB4 protein is synthesized only following ER stress but the induction amplitude is circadian. In turn, CPEB4 activates a second wave of UPR translation required to maintain ER and mitochondria! homeostasis. Our results suggest that combined transcriptional and translational Cpeb4 regulation generates a 'circadian mediator', which coordinates hepatic UPR activity with periods of high ER-protein-folding demand. Accordingly, CPEB4 deficiency results in non-alcoholic fatty liver disease.	[Maillo, Carlos; Martin, Judit; Sebastian, David; Hernandez-Alvarez, Maribel; Garcia-Rocha, Mar; Reina, Oscar; Zorzano, Antonio; Mendez, Raul] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Sebastian, David; Hernandez-Alvarez, Maribel; Zorzano, Antonio] Fac Biol, Dept Bioquim & Biol Mol, Barcelona 08028, Spain; [Sebastian, David; Hernandez-Alvarez, Maribel; Zorzano, Antonio] Inst Salud Carlos III, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid 28029, Spain; [Fernandez, Mercedes] Univ Barcelona, IDIBAPS Biomed Res Inst, E-08036 Barcelona, Spain; [Fernandez, Mercedes] Inst Salud Carlos III, CIBER Hepat & Digest Dis CIBEREHD, Madrid 28029, Spain; [Mendez, Raul] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; ICREA	Mendez, R (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.; Fernandez, M (corresponding author), Univ Barcelona, IDIBAPS Biomed Res Inst, E-08036 Barcelona, Spain.; Fernandez, M (corresponding author), Inst Salud Carlos III, CIBER Hepat & Digest Dis CIBEREHD, Madrid 28029, Spain.; Mendez, R (corresponding author), Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain.	mercefernandez@ub.edu; raul.mendez@irbbarcelona.org	Sebastián, David/ABH-1574-2020; Zorzano, Antonio/R-5479-2018; Hernández-Alvarez, María Isabel/Z-4830-2019	Garcia-Rocha, Mar/0000-0003-2467-2090; Hernandez-Alvarez, Maria Isabel/0000-0003-2483-7000; Reina Garcia, Oscar/0000-0002-1031-2732; Mendez, Raul/0000-0002-1952-6905; Sebastian, David/0000-0002-7260-3869	Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2011-30121, BIO2012-31043, BFU2014-54122-P, CSD2009-00080, SAF2014-55473-R]; European Union FEDER funds; Fundacion Botin by the Banco Santander through its Santander Universities Global Division; Scientific Foundation of the Spanish Association Against Cancer (AECC); Worldwide Cancer Research Foundation; 'la Caixa' predoctoral fellowship; Severo Ochoa Award of Excellence from MINECO (Government of Spain); ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness (MINECO); European Union FEDER funds(European Commission); Fundacion Botin by the Banco Santander through its Santander Universities Global Division; Scientific Foundation of the Spanish Association Against Cancer (AECC); Worldwide Cancer Research Foundation; 'la Caixa' predoctoral fellowship(La Caixa Foundation); Severo Ochoa Award of Excellence from MINECO (Government of Spain); ICREA(ICREA)	We thank the Advance Digital Microscopy, Biostatistics/Bioinformatics, Histopathology, Mouse Mutant, and Functional Genomics facilities at IRB Barcelona. We also thank S. Aznar-Benitah, J. Guinovart and members of R.M.'s laboratory for useful discussion and T. Yates for correcting the manuscript. This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (MINECO, BFU2011-30121, BIO2012-31043, BFU2014-54122-P, Consolider RNAREG CSD2009-00080, SAF2014-55473-R), the European Union FEDER funds, the Fundacion Botin by the Banco Santander through its Santander Universities Global Division, the Scientific Foundation of the Spanish Association Against Cancer (AECC), and the Worldwide Cancer Research Foundation. C.M. held a 'la Caixa' predoctoral fellowship. IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). GIBER is an initiative from the Instituto de Salud Carlos III.	Afroz T, 2014, GENE DEV, V28, P1498, DOI 10.1101/gad.241133.114; Alexandrov IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002457; Bava FA, 2013, NATURE, V495, P121, DOI 10.1038/nature11901; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Calderone V, 2016, GASTROENTEROLOGY, V150, P982, DOI 10.1053/j.gastro.2015.11.038; Cretenet G, 2010, CELL METAB, V11, P47, DOI 10.1016/j.cmet.2009.11.002; Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115; Drisaldi B, 2015, CELL REP, V11, P1694, DOI 10.1016/j.celrep.2015.04.061; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; Garcia-Pras E., 2016, GUT; Giangarra V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138794; Guillen-Boixet J, 2016, ELIFE, V5, DOI 10.7554/eLife.19298; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hu WQ, 2014, DEV CELL, V30, P660, DOI 10.1016/j.devcel.2014.07.008; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Ivshina M, 2014, ANNU REV CELL DEV BI, V30, P393, DOI 10.1146/annurev-cellbio-101011-155831; Jouffe C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24631; Kan MC, 2010, MOL CELL BIOL, V30, P5658, DOI 10.1128/MCB.00716-10; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kojima S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17059; Kojima S, 2012, GENE DEV, V26, P2724, DOI 10.1101/gad.208306.112; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Mauvoisin D, 2014, P NATL ACAD SCI USA, V111, P167, DOI 10.1073/pnas.1314066111; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Rao MS, 2001, SEMIN LIVER DIS, V21, P43, DOI 10.1055/s-2001-12928; Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang LW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004021; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang SY, 2014, CURR OPIN LIPIDOL, V25, P125, DOI 10.1097/MOL.0000000000000056; Wang XP, 2010, BIOINFORM BIOL INSIG, V4, P61, DOI 10.4137/BBI.S5087; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wethmar K, 2016, ONCOGENE, V35, P1736, DOI 10.1038/onc.2015.233; Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021	60	44	47	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2017	19	2					94	105		10.1038/ncb3461	http://dx.doi.org/10.1038/ncb3461			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EJ8BL	28092655				2022-12-25	WOS:000393447200005
J	Mathur, R; Alver, BH; San Roman, AK; Wilson, BG; Wang, XF; Agoston, AT; Park, PJ; Shivdasani, RA; Roberts, CWM				Mathur, Radhika; Alver, Burak H.; San Roman, Adrianna K.; Wilson, Boris G.; Wang, Xiaofeng; Agoston, Agoston T.; Park, Peter J.; Shivdasani, Ramesh A.; Roberts, Charles W. M.			ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice	NATURE GENETICS			English	Article							GASTRIC-CANCER; SWI/SNF COMPLEXES; SUPPRESSOR; EXPRESSION; GASDERMIN; TARGET	Genes encoding subunits of SWI/SNF (BAF) chromatin remodeling complexes are collectively mutated in similar to 20% of all human cancers(1,2). Although ARID1A is the most frequent target of mutations, the mechanism by which its inactivation promotes tumorigenesis is unclear. Here we demonstrate that Arid1a functions as a tumor suppressor in the mouse colon, but not the small intestine, and that invasive ARID1A-deficient adenocarcinomas resemble human colorectal cancer (CRC). These tumors lack deregulation of APC/beta-catenin signaling components, which are crucial gatekeepers in common forms of intestinal cancer. We find that ARID1A normally targets SWI/SNF complexes to enhancers, where they function in coordination with transcription factors to facilitate gene activation. ARID1B preserves SWI/SNF function in ARID1A-deficient cells, but defects in SWI/SNF targeting and control of enhancer activity cause extensive dysregulation of gene expression. These findings represent an advance in colon cancer modeling and implicate enhancer-mediated gene regulation as a principal tumor-suppressor function of ARID1A.	[Mathur, Radhika; San Roman, Adrianna K.] Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Mathur, Radhika; Wilson, Boris G.; Wang, Xiaofeng; Roberts, Charles W. M.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Alver, Burak H.; Park, Peter J.] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA; [San Roman, Adrianna K.; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [San Roman, Adrianna K.; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Agoston, Agoston T.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; [Park, Peter J.; Shivdasani, Ramesh A.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Park, Peter J.; Shivdasani, Ramesh A.] Harvard Med Sch, Boston, MA USA; [Roberts, Charles W. M.] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; St Jude Children's Research Hospital	Roberts, CWM (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Roberts, CWM (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles_roberts@dfci.harvard.edu	Roberts, Charles/N-2541-2018	Roberts, Charles/0000-0003-1135-1896; Park, Peter/0000-0001-9378-960X; Alver, Burak/0000-0002-5019-7652	US National Institutes of Health [R01CA172152, R01DK081113]; Claudia Adams Barr grant; Innovation Award from Alex's Lemonade Stand; US National Institutes of Health predoctoral fellowships [1F31CA199994, 1F31CA180784]; Pathway to Independence Award from the US National Institutes of Health [K99CA197640]; Cure AT/RT Now foundation; Avalanna Fund; Garrett B. Smith Foundation; Miles for Mary; ALSAC/St. Jude; Lind Family; NCI Cancer Center Support Grant [P30CA06516]; NATIONAL CANCER INSTITUTE [P50CA127003, F31CA180784, R01CA172152, P30CA006516, K99CA197640, F31CA199994, R01CA113794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081113] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Adams Barr grant; Innovation Award from Alex's Lemonade Stand; US National Institutes of Health predoctoral fellowships; Pathway to Independence Award from the US National Institutes of Health; Cure AT/RT Now foundation; Avalanna Fund; Garrett B. Smith Foundation; Miles for Mary; ALSAC/St. Jude(American Lebanese Syrian Associated Charities (ALSAC)); Lind Family; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Robine (Institut Curie) for providing Vil1-CreER<SUP>T2</SUP>transgenic mice, S.H. Orkin for guidance, and members of the Roberts and Orkin laboratories for discussion. This work was supported by US National Institutes of Health grants R01CA172152 (C.W.M.R.) and R01DK081113 (R.A.S.), by a Claudia Adams Barr grant (C.W.M.R.), and by an Innovation Award from Alex's Lemonade Stand (C.W.M.R.). R.M. and A.K.S.R. were supported by US National Institutes of Health predoctoral fellowships (1F31CA199994 and 1F31CA180784). X.W. was supported by the Pathway to Independence Award from the US National Institutes of Health (K99CA197640). The Cure AT/RT Now foundation, the Avalanna Fund, the Garrett B. Smith Foundation, Miles for Mary, ALSAC/St. Jude (C.W.M.R.), and the Lind Family (R.A.S.) provided additional support. We also thank the Dana-Farber/Harvard Cancer Center Rodent Histopathology Core and Specialized Histopathology Core, which are supported in part by NCI Cancer Center Support Grant P30CA06516.	Alexander JM, 2015, DEVELOPMENT, V142, P1418, DOI 10.1242/dev.109496; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cajuso T, 2014, INT J CANCER, V135, P611, DOI 10.1002/ijc.28705; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Greenson JK, 2009, AM J SURG PATHOL, V33, P126, DOI 10.1097/PAS.0b013e31817ec2b1; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hamilton SR, 2010, WHO CLASSIFICATION T, P134; He F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0164-3; Helming KC, 2014, CANCER CELL, V26, P309, DOI 10.1016/j.ccr.2014.07.018; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Jass JR, 1999, J CLIN PATHOL, V52, P455, DOI 10.1136/jcp.52.6.455; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Masliah-Planchon J, 2015, ANNU REV PATHOL-MECH, V10, P145, DOI 10.1146/annurev-pathol-012414-040445; McCart AE, 2008, PATHOL RES PRACT, V204, P479, DOI 10.1016/j.prp.2008.03.004; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saeki N, 2000, MAMM GENOME, V11, P718, DOI 10.1007/s003350010138; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Yan HB, 2014, CARCINOGENESIS, V35, P867, DOI 10.1093/carcin/bgt398	32	186	189	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					296	302		10.1038/ng.3744	http://dx.doi.org/10.1038/ng.3744			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27941798	Green Accepted, Green Submitted			2022-12-25	WOS:000393148600020
J	Rebelein, JG; Stiebritz, MT; Lee, CC; Hu, YL				Rebelein, Johannes G.; Stiebritz, Martin T.; Lee, Chi Chung; Hu, Yilin			Activation and reduction of carbon dioxide by nitrogenase iron proteins	NATURE CHEMICAL BIOLOGY			English	Article							VINELANDII FE PROTEIN; FERROUS REDOX STATE; MONOXIDE DEHYDROGENASE; CLOSTRIDIUM-THERMOACETICUM; DISULFIDE; CATALYSIS; FIXATION; CO	The iron (Fe) proteins of molybdenum (Mo) and vanadium (V) nitrogenases mimic carbon monoxide (CO) dehydrogenase in catalyzing the interconversion between CO2 and CO under ambient conditions. Catalytic reduction of CO2 to CO is achieved in vitro and in vivo upon redox changes of the Fe-protein associated [Fe4S4] clusters. These observations establish the Fe protein as a model for investigation of CO2 activation while suggesting its biotechnological adaptability for recycling the greenhouse gas into useful products.	[Rebelein, Johannes G.; Stiebritz, Martin T.; Lee, Chi Chung; Hu, Yilin] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of California System; University of California Irvine	Hu, YL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	yilinh@uci.edu	Stiebritz, Martin/AAU-8443-2021; Rebelein, Johannes G/AAH-8009-2021	Stiebritz, Martin/0000-0001-8024-4352; Rebelein, Johannes G/0000-0003-2560-716X	UCI startup funds; Hellman Fellowship	UCI startup funds; Hellman Fellowship	This work is supported by UCI startup funds and a Hellman Fellowship (to Y.H.).	Angove HC, 1998, J BIOL CHEM, V273, P26330, DOI 10.1074/jbc.273.41.26330; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; ENSIGN SA, 1995, BIOCHEMISTRY-US, V34, P5372, DOI 10.1021/bi00016a008; Erickson JA, 1999, BIOCHEMISTRY-US, V38, P14279, DOI 10.1021/bi991389+; Hoffman BM, 2014, CHEM REV, V114, P4041, DOI 10.1021/cr400641x; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; Hu YL, 2015, J BIOL INORG CHEM, V20, P435, DOI 10.1007/s00775-014-1225-3; Hu YL, 2011, SCIENCE, V333, P753, DOI 10.1126/science.1206883; Jacobs D, 2013, BIOCHEMISTRY-US, V52, P4791, DOI 10.1021/bi301547b; Jeoung JH, 2007, SCIENCE, V318, P1461, DOI 10.1126/science.1148481; Jeoung JH, 2014, METAL IONS LIFE SCI, V14, P37, DOI 10.1007/978-94-017-9269-1_3; KUMAR M, 1994, BIOCHEMISTRY-US, V33, P9769, DOI 10.1021/bi00198a048; Kung Y, 2011, CURR OPIN CHEM BIOL, V15, P276, DOI 10.1016/j.cbpa.2010.11.005; Lee CC, 2010, SCIENCE, V329, P642, DOI 10.1126/science.1191455; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; Lowery TJ, 2006, P NATL ACAD SCI USA, V103, P17131, DOI 10.1073/pnas.0603223103; Orme-Johnson W. H, 1973, IRON SULFUR PROTEINS, P195; Rebelein JG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13641; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Vincent KA, 2003, CHEM COMMUN, P2590, DOI 10.1039/b308188e	21	34	34	9	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					147	149		10.1038/NCHEMBIO.2245	http://dx.doi.org/10.1038/NCHEMBIO.2245			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27893704				2022-12-25	WOS:000393533000007
J	Wang, XF; Lee, RS; Alver, BH; Haswel, JR; Wang, S; Mieczkowski, J; Drier, Y; Gillespie, SM; Archer, TC; Wu, JN; Tzvetkov, EP; Troisi, EC; Pomeroy, SL; Biegel, JA; Tolstorukov, MY; Bernstein, BE; Park, PJ; Roberts, CWM				Wang, Xiaofeng; Lee, Ryan S.; Alver, Burak H.; Haswel, Jeffrey R.; Wang, Su; Mieczkowski, Jakub; Drier, Yotam; Gillespie, Shawn M.; Archer, Tenley C.; Wu, Jennifer N.; Tzvetkov, Evgeni P.; Troisi, Emma C.; Pomeroy, Scott L.; Biegel, Jaclyn A.; Tolstorukov, Michael Y.; Bernstein, Bradley E.; Park, Peter J.; Roberts, Charles W. M.			SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation	NATURE GENETICS			English	Article							ATYPICAL TERATOID/RHABDOID TUMORS; SUPER-ENHANCERS; RHABDOID TUMORS; CELL IDENTITY; TRANSCRIPTION FACTORS; CANCER; GENES; SUPPRESSOR; MUTATIONS; TRANSFORMATION	SMARCB1 (also known as SNF5, INI1, and BAF47), a core subunit of the SWI/SNF (BAF) chromatin-remodeling complex(1,2), is inactivated in nearly all pediatric rhabdoid tumors(3-5). These aggressive cancers are among the most genomically stable(6-8), suggesting an epigenetic mechanism by which SMARCB1 loss drives transformation. Here we show that, despite having indistinguishable mutational landscapes, human rhabdoid tumors exhibit distinct enhancer H3K27ac signatures, which identify remnants of differentiation programs. We show that SMARCB1 is required for the integrity of SWI/SNF complexes and that its loss alters enhancer targeting-markedly impairing SWI/SNF binding to typical enhancers, particularly those required for differentiation, while maintaining SWI/SNF binding at super-enhancers. We show that these retained super-enhancers are essential for rhabdoid tumor survival, including some that are shared by all subtypes, such as SPRY1, and other lineage-specific super-enhancers, such as SOX2 in brain-derived rhabdoid tumors. Taken together, our findings identify a new chromatin based epigenetic mechanism underlying the tumor-suppressive activity of SMARCB1.	[Wang, Xiaofeng; Lee, Ryan S.; Haswel, Jeffrey R.; Wu, Jennifer N.; Tzvetkov, Evgeni P.; Troisi, Emma C.; Roberts, Charles W. M.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Wang, Xiaofeng; Lee, Ryan S.; Haswel, Jeffrey R.; Wu, Jennifer N.; Tzvetkov, Evgeni P.; Troisi, Emma C.; Roberts, Charles W. M.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Wang, Xiaofeng; Lee, Ryan S.; Haswel, Jeffrey R.; Wu, Jennifer N.; Tzvetkov, Evgeni P.; Troisi, Emma C.; Roberts, Charles W. M.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Alver, Burak H.; Wang, Su; Park, Peter J.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02215 USA; [Mieczkowski, Jakub; Tolstorukov, Michael Y.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Drier, Yotam; Gillespie, Shawn M.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Drier, Yotam; Gillespie, Shawn M.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Drier, Yotam; Gillespie, Shawn M.; Bernstein, Bradley E.] Harvard Med Sch, Boston, MA 02115 USA; [Drier, Yotam; Gillespie, Shawn M.; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Archer, Tenley C.; Pomeroy, Scott L.] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Biegel, Jaclyn A.] Univ Southern Calif, Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Biegel, Jaclyn A.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Park, Peter J.] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Roberts, Charles W. M.] St Jude Childrens Res Hosp, Ctr Comprehens Canc, 332 N Lauderdale St, Memphis, TN 38105 USA; [Roberts, Charles W. M.] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Children's Hospital Los Angeles; University of Southern California; University of Southern California; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Roberts, CWM (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Roberts, CWM (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.; Roberts, CWM (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Park, PJ (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02215 USA.; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Bernstein, BE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Bernstein, BE (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Park, PJ (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Roberts, CWM (corresponding author), St Jude Childrens Res Hosp, Ctr Comprehens Canc, 332 N Lauderdale St, Memphis, TN 38105 USA.; Roberts, CWM (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	bernstein.bradley@mgh.harvard.edu; peter_park@hms.harvard.edu; charles.roberts@stjude.org	Drier, Yotam/K-5208-2012; Roberts, Charles/N-2541-2018; Mieczkowski, Jakub/G-7251-2019; Lee, Ryan/AAE-4319-2019	Drier, Yotam/0000-0003-1725-2995; Roberts, Charles/0000-0003-1135-1896; Mieczkowski, Jakub/0000-0002-2091-012X; Alver, Burak/0000-0002-5019-7652; Archer, Tenley/0000-0003-2723-4192; Gillespie, Shawn/0000-0003-1913-0860; Wang, Su/0000-0002-9463-6530	Pathway to Independence Award from the US National Institutes of Health [K99CA197640]; Rally Foundation for Childhood Cancer Research; Truth 365; St. Baldrick's Foundation; NSF Graduate Research Fellowship; US National Institutes of Health grants [R01CA172152, R0ICA113794, U54HG006991]; Avalanna Fund; Cure AT/RT Now Foundation; Garrett B. Smith Foundation; Miles for Mary; ALSAC/St. Jude; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA172152, R01CA113794, K99CA197640, R01CA109467] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991] Funding Source: NIH RePORTER	Pathway to Independence Award from the US National Institutes of Health; Rally Foundation for Childhood Cancer Research; Truth 365; St. Baldrick's Foundation; NSF Graduate Research Fellowship(National Science Foundation (NSF)); US National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avalanna Fund; Cure AT/RT Now Foundation; Garrett B. Smith Foundation; Miles for Mary; ALSAC/St. Jude(American Lebanese Syrian Associated Charities (ALSAC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Roberts and Park laboratories for assistance and discussion. We thank J. Francois (Boston Children's Hospital), J. Roth (Children's Hospital of Philadelphia), M. Lear (St. Jude Children's Research Hospital), and J. Silterra (Broad Institute) for their help in acquiring and performing preliminary clinical analysis of primary tumor samples; R. Rubio (Dana-Farber Cancer Institute) and M. Uziel (Broad Institute) for their assistance in sequencing samples; N. Shoresh (Broad Institute) for assistance in accessing Roadmap Epigenomics data; and R. Tomaino (Harvard Medical School) for assistance in proteomic analysis. X.W. was supported by the Pathway to Independence Award from the US National Institutes of Health (K99CA197640), a postdoctoral fellowship from the Rally Foundation for Childhood Cancer Research and The Truth 365, and a research grant from St. Baldrick's Foundation. R.S.L. was partially supported by an NSF Graduate Research Fellowship. This work was supported by US National Institutes of Health grants R01CA172152 (C.W.M.R.), R0ICA113794 (C.W.M.R.), and U54HG006991 (B.E.B.). The Avalanna Fund, the Cure AT/RT Now Foundation, the Garrett B. Smith Foundation, Miles for Mary, and ALSAC/St. Jude (C.W.M.R.) provided additional support.	Abrahams A, 2010, IUBMB LIFE, V62, P92, DOI 10.1002/iub.275; Alexander JM, 2015, DEVELOPMENT, V142, P1418, DOI 10.1242/dev.109496; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Biegel JA, 1999, CANCER RES, V59, P74; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Chun HJE, 2016, CANCER CELL, V29, P394, DOI 10.1016/j.ccell.2016.02.009; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; Eaton KW, 2011, PEDIATR BLOOD CANCER, V56, P7, DOI 10.1002/pbc.22831; Hasselblatt M, 2013, GENE CHROMOSOME CANC, V52, P185, DOI 10.1002/gcc.22018; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Kaur H, 2015, J NEUROPATH EXP NEUR, V74, P177, DOI 10.1097/NEN.0000000000000161; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Wang X, 2011, J CLIN INVEST, V121, P3834, DOI 10.1172/JCI37210; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001; Yu Y, 2013, CELL, V152, P248, DOI 10.1016/j.cell.2012.12.006; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	30	144	147	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					289	295		10.1038/ng.3746	http://dx.doi.org/10.1038/ng.3746			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27941797	Green Submitted, Green Accepted			2022-12-25	WOS:000393148600019
J	Granata, A; Serrano, F; Bernard, WG; McNamara, M; Low, L; Sastry, P; Sinha, S				Granata, Alessandra; Serrano, Felipe; Bernard, William George; McNamara, Madeline; Low, Lucinda; Sastry, Priya; Sinha, Sanjay			An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death	NATURE GENETICS			English	Article							AORTIC-ANEURYSM PROGRESSION; PLURIPOTENT STEM-CELLS; TGF-BETA ACTIVATION; ANGIOTENSIN-II; SIGNALING PATHWAYS; FBN1 MUTATIONS; MOUSE MODEL; DISEASE; MICE; INDUCTION	Marfan syndrome (MFS) is a heritable connective tissue disorder caused by mutations in FBN1, which encodes the extracellular matrix protein fibrillin-1. To investigate the pathogenesis of aortic aneurysms in MFS, we generated a vascular model derived from human induced pluripotent stem cells (MFS-hiPSCs). Our MFS-hiPSC-derived smooth muscle cells (SMCs) recapitulated the pathology seen in Marfan aortas, including defects in fibrillin-1 accumulation, extracellular matrix degradation, transforming growth factor-beta (TGF-beta) signaling, contraction and apoptosis; abnormalities were corrected by CRISPR-based editing of the FBN1 mutation. TGF-beta inhibition rescued abnormalities in fibrillin-1 accumulation and matrix metalloproteinase expression. However, only the noncanonical p38 pathway regulated SMC apoptosis, a pathological mechanism also governed by Krilppel-like factor 4 (KLF4). This model has enabled us to dissect the molecular mechanisms of MFS, identify novel targets for treatment (such as p38 and KLF4) and provided an innovative human platform for the testing of new drugs.	[Granata, Alessandra] Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge Biomed Campus, Cambridge, England; [Serrano, Felipe; Bernard, William George; McNamara, Madeline; Sastry, Priya; Sinha, Sanjay] Univ Cambridge, Wellcome Trust MRC Cambridge Stem Cell Inst, Anne McLaren Lab, Cambridge, England; [Serrano, Felipe; Bernard, William George; McNamara, Madeline; Low, Lucinda; Sastry, Priya; Sinha, Sanjay] Univ Cambridge, Div Cardiovasc Med, Cambridge, England; [McNamara, Madeline; Sinha, Sanjay] Univ Cambridge, British Heart Fdn Oxbridge Ctr Regenerat Med, Cambridge, England; [Sastry, Priya] Papworth Hosp NHS Fdn Trust, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Papworth Hospital		ss661@cam.ac.uk	Sinha, Sanjay/AAF-1692-2021	Sinha, Sanjay/0000-0001-5900-1209; Granata, Alessandra/0000-0001-5051-8201; Bernard, William/0000-0002-2622-5115	Evelyn Trust; NIHR Cambridge Biomedical Research Centre; British Heart Foundation [FS/13/29/30024, RM/13/3/30159, FS/11/77/29327]; British Heart Foundation [RG/17/5/32936] Funding Source: researchfish; Medical Research Council [MC_PC_12009] Funding Source: researchfish; Stroke Association [TSA2016/02] Funding Source: researchfish	Evelyn Trust; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Stroke Association	The authors thank L. Vallier, the hiPSC core facility at the Anne McLaren Laboratory and I. Geti for help in generating the MFS hiPSC lines. We thank N. Figg for sectioning and staining of the teratomas, J. Sterling for help with skin biopsies, J. Skepper at the Cambridge Advance Imaging Centre at the University of Cambridge for the transmission electron microscopy images and C. Verstreken at the Cambridge Stem Cell Institute for providing the static stretching membranes. We also thank Z. Mallat for useful comments on the manuscript. This work was supported by Evelyn Trust, the NIHR Cambridge Biomedical Research Centre and the British Heart Foundation (FS/13/29/30024 (S.S.), RM/13/3/30159 (S.S. and M.M.) and FS/11/77/29327 (W.B.)).	Attanasio M, 2008, CLIN GENET, V74, P39, DOI 10.1111/j.1399-0004.2008.01007.x; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Carta L, 2009, J BIOL CHEM, V284, P5630, DOI 10.1074/jbc.M806962200; Cheung C, 2014, NAT PROTOC, V9, P929, DOI 10.1038/nprot.2014.059; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; Clark PR, 2011, MICROCIRCULATION, V18, P102, DOI 10.1111/j.1549-8719.2010.00071.x; Cook JR, 2015, ARTERIOSCL THROM VAS, V35, P911, DOI 10.1161/ATVBAHA.114.305150; Cook JR, 2014, J CLIN INVEST, V124, P1329, DOI 10.1172/JCI71059; Crosas-Molist E, 2015, ARTERIOSCL THROM VAS, V35, P960, DOI 10.1161/ATVBAHA.114.304412; Dietz HC, 2005, AM J MED GENET C, V139C, P4, DOI 10.1002/ajmg.c.30068; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; Doyle JJ, 2012, FEBS LETT, V586, P2003, DOI 10.1016/j.febslet.2012.05.027; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Hsieh JK, 2000, ARTERIOSCL THROM VAS, V20, P973, DOI 10.1161/01.ATV.20.4.973; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Humphrey JD, 2014, SCIENCE, V344, P476, DOI 10.1126/science.1253026; Jones JA, 2009, J VASC RES, V46, P119, DOI 10.1159/000151766; Jovanovic J, 2008, BIOCHEM SOC T, V36, P257, DOI 10.1042/BST0360257; Kaartinen V, 2003, NAT GENET, V33, P331, DOI 10.1038/ng0303-331; Keane MG, 2008, CIRCULATION, V117, P2802, DOI 10.1161/CIRCULATIONAHA.107.693523; Lacro RV, 2014, NEW ENGL J MED, V371, P2061, DOI 10.1056/NEJMoa1404731; LAIHO M, 1987, J BIOL CHEM, V262, P17467; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; MCKUSICK VA, 1955, CIRCULATION, V11, P321, DOI 10.1161/01.CIR.11.3.321; Meilhac O, 2003, FASEB J, V17, P1301, DOI 10.1096/fj.02-0687fje; Milewicz DM, 2005, CIRCULATION, V111, pE150, DOI 10.1161/01.CIR.0000155243.70456.F4; Milleron O, 2015, EUR HEART J, V36, P2160, DOI 10.1093/eurheartj/ehv151; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; Quarto N, 2012, P NATL ACAD SCI USA, V109, P215, DOI 10.1073/pnas.1113442109; Ramirez F, 2007, CURR OPIN GENET DEV, V17, P252, DOI 10.1016/j.gde.2007.04.006; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Schrijver I, 1999, AM J HUM GENET, V65, P1007, DOI 10.1086/302582; Sinha S, 2014, CELL MOL LIFE SCI, V71, P2271, DOI 10.1007/s00018-013-1554-3; Syyong HT, 2011, J VASC RES, V48, P150, DOI 10.1159/000318804; Syyong HT, 2009, BRIT J PHARMACOL, V158, P1597, DOI 10.1111/j.1476-5381.2009.00439.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Touyz RM, 2000, PHARMACOL REV, V52, P639; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Wassmann S, 2007, J MOL CELL CARDIOL, V43, P301, DOI 10.1016/j.yjmcc.2007.06.001; Wernig F, 2003, HYPERTENSION, V41, P903, DOI 10.1161/01.HYP.0000062882.42265.88; Yu Q, 2000, GENE DEV, V14, P163; Zhou Y, 2006, BIOCHEM BIOPH RES CO, V339, P633, DOI 10.1016/j.bbrc.2005.11.060	58	100	101	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					97	109		10.1038/ng.3723	http://dx.doi.org/10.1038/ng.3723			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27893734	Green Accepted			2022-12-25	WOS:000390976600015
J	Henninger, J; Santoso, B; Hans, S; Durand, E; Moore, J; Mosimann, C; Brand, M; Traver, D; Zon, L				Henninger, Jonathan; Santoso, Buyung; Hans, Stefan; Durand, Ellen; Moore, Jessica; Mosimann, Christian; Brand, Michael; Traver, David; Zon, Leonard			Clonal fate mapping quantifies the number of haematopoietic stem cells that arise during development	NATURE CELL BIOLOGY			English	Article							AORTIC ENDOTHELIUM; IN-VIVO; ZEBRAFISH; IDENTIFICATION; TRACKING; MOUSE; COLONIZATION; TRANSITION; EXPRESSION; DYNAMICS	Haematopoietic stem cells (HSCs) arise in the developing aorta during embryogenesis. The number of HSC clones born has been estimated through transplantation, but experimental approaches to assess the absolute number of forming HSCs in a native setting have remained challenging. Here, we applied single-cell and clonal analysis of HSCs in zebrafish to quantify developing HSCs. Targeting creER(T2) in developing cd41:eGFP(+) HSCs enabled long-term assessment of their blood contribution. We also applied the Brainbow-based multicolour Zebrabow system with drhcreER(T2) that is active in early haematopoiesis to induce heritable colour barcoding unique to each HSC and its progeny. Our findings reveal that approximately 21 HSC clones exist prior to HSC emergence and 30 clones are present during peak production from aortic endothelium. Our methods further reveal that stress haematopoiesis, including sublethal irradiation and transplantation, reduces clonal diversity. Our findings provide quantitative insights into the early clonal events that regulate haematopoietic development.	[Henninger, Jonathan; Durand, Ellen; Moore, Jessica; Zon, Leonard] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Henninger, Jonathan; Durand, Ellen; Moore, Jessica; Zon, Leonard] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Henninger, Jonathan; Durand, Ellen; Moore, Jessica; Zon, Leonard] Harvard Med Sch, Harvard Stem Cell Inst, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; [Henninger, Jonathan; Durand, Ellen; Zon, Leonard] Harvard Univ, Biol & Biomed Sci, Cambridge, MA 02138 USA; [Santoso, Buyung; Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Hans, Stefan; Brand, Michael] Tech Univ Dresden, Biotechnol Ctr, Tatzberg 47-49, D-01307 Dresden, Germany; [Hans, Stefan; Brand, Michael] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Tatzberg 47-49, D-01307 Dresden, Germany; [Mosimann, Christian] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; University of California System; University of California San Diego; Technische Universitat Dresden; Technische Universitat Dresden; University of Zurich; University of California System; University of California San Diego	Zon, L (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.; Zon, L (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.; Zon, L (corresponding author), Harvard Med Sch, Harvard Stem Cell Inst, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA.; Zon, L (corresponding author), Harvard Univ, Biol & Biomed Sci, Cambridge, MA 02138 USA.; Traver, D (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.; Traver, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	dtraver@ucsd.edu; zon@enders.tch.harvard.edu	Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512; Henninger, Jonathan/0000-0002-9604-2007; Mosimann, Christian/0000-0002-0749-2576	HHMI; NIH [F31HL126338, R01-DK074482, F32DK752433, R01-HL04880, P01-HL032262, 5P30-DK49216, 5R01-DK53298, 5U01-HL10001, R24-DK09276]; Deutsche Forschungsgemeinschaft [SFB655]; TU Dresden; European Union (Zf Health); MPN Research Foundation Grant; EMBO long-term fellowship; HSFP long-term fellowship; SNF advanced fellowship; SNF professorship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL126338, U01HL100001, P01HL032262, U01HL134812, R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK110805, P30DK049216, R24DK092760, R01DK074482, R01DK053298] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TU Dresden(European Commission); European Union (Zf Health)(European Commission); MPN Research Foundation Grant; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); HSFP long-term fellowship; SNF advanced fellowship; SNF professorship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the following for their support and contributions: M. Distel, E. Butko, J. Bertrand and D. Stachura for critical reading of the manuscript; K. Richter for laboratory management; J. Abkowitz for comments and suggestions; A. Schier and A. Pan for the Zebrabow-M line and guidance; L. Ding and D. Tom at the HMS Enhanced Neuroimaging Core for help with confocal microscopy. This work was supported by HHMI and NIH F31HL126338 (J.H.), NIH R01-DK074482 (D.T.), NIH F32DK752433 (B.S.), the Deutsche Forschungsgemeinschaft (SFB655), the TU Dresden and the European Union (Zf Health), NIH R01-HL04880, NIH P01-HL032262, NIH 5P30-DK49216, NIH 5R01-DK53298, NIH 5U01-HL10001, NIH R24-DK09276 and an MPN Research Foundation Grant. C.M. received funding from an EMBO long-term fellowship, an HSFP long-term fellowship, an SNF advanced fellowship and an SNF professorship.	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Arora N, 2014, DEV CELL, V29, P621, DOI 10.1016/j.devcel.2014.04.013; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Dixon G., 2012, ISRN HEMATOL, V2012, P1; Gupta V, 2012, NATURE, V484, P479, DOI 10.1038/nature11045; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; Hess I, 2013, P NATL ACAD SCI USA, V110, P4327, DOI 10.1073/pnas.1219847110; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kim S, 2014, CELL STEM CELL, V14, P473, DOI 10.1016/j.stem.2013.12.012; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Loulier K, 2014, NEURON, V81, P505, DOI 10.1016/j.neuron.2013.12.016; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Ma DD, 2011, BLOOD, V118, P289, DOI 10.1182/blood-2010-12-327403; Martinez RJ, 2015, J IMMUNOL METHODS, V424, P28, DOI 10.1016/j.jim.2015.04.018; Mosimann C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9146; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; Weissman TA, 2015, GENETICS, V199, P293, DOI 10.1534/genetics.114.172510; Xu J, 2015, DEV CELL, V34, P632, DOI 10.1016/j.devcel.2015.08.018; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	33	66	67	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2017	19	1					17	27		10.1038/ncb3444	http://dx.doi.org/10.1038/ncb3444			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EG9AI	27870830	Green Accepted			2022-12-25	WOS:000391349000005
J	Kumar, P; Kaushik, A; Lloyd, EP; Li, SG; Mattoo, R; Ammerman, NC; Bell, DT; Perryman, AL; Zandi, TA; Ekins, S; Ginell, SL; Townsend, CA; Freundlich, JS; Lamichhane, G				Kumar, Pankaj; Kaushik, Amit; Lloyd, Evan P.; Li, Shao-Gang; Mattoo, Rohini; Ammerman, Nicole C.; Bell, Drew T.; Perryman, Alexander L.; Zandi, Trevor A.; Ekins, Sean; Ginell, Stephan L.; Townsend, Craig A.; Freundlich, Joel S.; Lamichhane, Gyanu			Non-classical transpeptidases yield insight into new antibacterials	NATURE CHEMICAL BIOLOGY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MEROPENEM-CLAVULANATE; L,D-TRANSPEPTIDASE 2; BETA-LACTAMASE; CROSS-LINKING; CELL-WALL; CARBAPENEMS; PEPTIDOGLYCAN; INACTIVATION; RESISTANCE	Bacterial survival requires an intact peptidoglycan layer, a three-dimensional exoskeleton that encapsulates the cytoplasmic membrane. Historically, the final steps of peptidoglycan synthesis are known to be carried out by D,D-transpeptidases, enzymes that are inhibited by the beta-lactams, which constitute >50% of all antibacterials in clinical use. Here, we show that the carbapenem subclass of beta-lactams are distinctly effective not only because they inhibit D,D-transpeptidases and are poor substrates for beta-lactamases, but primarily because they also inhibit non-classical transpeptidases, namely the L,D-transpeptidases, which generate the majority of linkages in the peptidoglycan of mycobacteria. We have characterized the molecular mechanisms responsible for inhibition of L,D-transpeptidases of Mycobacterium tuberculosis and a range of bacteria including ESKAPE pathogens, and used this information to design, synthesize and test simplified carbapenems with potent antibacterial activity.	[Kumar, Pankaj; Kaushik, Amit; Mattoo, Rohini; Ammerman, Nicole C.; Bell, Drew T.; Lamichhane, Gyanu] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA; [Lloyd, Evan P.; Townsend, Craig A.] Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA; [Li, Shao-Gang; Perryman, Alexander L.; Freundlich, Joel S.] Rutgers State Univ, Sch Med, Dept Physiol & Pharmacol, New Brunswick, NJ USA; [Li, Shao-Gang; Perryman, Alexander L.; Freundlich, Joel S.] Rutgers State Univ, Sch Med, Dept Med, New Brunswick, NJ USA; [Zandi, Trevor A.] Johns Hopkins Univ, Dept Biophys, Baltimore, MD USA; [Ekins, Sean] Collaborat Chem, Fuquay Varina, NC USA; [Ginell, Stephan L.] Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA	Johns Hopkins University; Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Johns Hopkins University; United States Department of Energy (DOE); Argonne National Laboratory	Lamichhane, G (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA.	lamichhane@jhu.edu	Li, Shao-Gang/O-4223-2019; Kumar, Pankaj/AAV-1848-2020; Kaushik, Amit/J-8836-2019	Kumar, Pankaj/0000-0001-9163-3273; Kaushik, Amit/0000-0002-5622-1721; Lloyd, Evan/0000-0001-6984-7400; Ammerman, Nicole C./0000-0001-9359-9144; Lamichhane, Gyanu/0000-0002-2214-0114; Mattoo, Rohini/0000-0003-2185-0031; Kumar, Pankaj/0000-0001-8650-5250	NIH [R21AI111739, DP2OD008459]; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI111739, R21AI111739] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008459] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Assistance of V. Chauhan for protein expression is appreciated. We thank L. Basta for critical discussions. R aeruginosa PA14 was a kind gift from S. Lory, Harvard University. Discovery Studio was kindly provided to S.E. and J.S.F. by Biovia. This study was supported by NIH awards R21AI111739 and DP2OD008459 to G.L. Structural results shown in this report are derived in part from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Abe T., 1996, Japan patent, Patent No. [JPH0812676, 0812676]; Chambers HF, 2005, ANTIMICROB AGENTS CH, V49, P2816, DOI 10.1128/AAC.49.7.2816-2821.2005; CHARNAS RL, 1978, BIOCHEMISTRY-US, V17, P2185, DOI 10.1021/bi00604a025; Cordillot M, 2013, ANTIMICROB AGENTS CH, V57, P5940, DOI 10.1128/AAC.01663-13; Correale S, 2013, ACTA CRYSTALLOGR D, V69, P1697, DOI 10.1107/S0907444913013085; De Lorenzo S, 2013, EUR RESPIR J, V41, P1386, DOI 10.1183/09031936.00124312; Dhar N, 2015, ANTIMICROB AGENTS CH, V59, P1308, DOI 10.1128/AAC.03461-14; Diacon AH, 2016, NEW ENGL J MED, V375, P393, DOI 10.1056/NEJMc1513236; Drawz SM, 2010, BIOCHEMISTRY-US, V49, P329, DOI 10.1021/bi9015988; Ekins S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063240; England K, 2012, ANTIMICROB AGENTS CH, V56, P3384, DOI 10.1128/AAC.05690-11; Erdemli SB, 2012, STRUCTURE, V20, P2103, DOI 10.1016/j.str.2012.09.016; FUNGTOMC JC, 1995, ANTIMICROB AGENTS CH, V39, P394, DOI 10.1128/AAC.39.2.394; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; HIKIDA M, 1992, J ANTIMICROB CHEMOTH, V30, P129, DOI 10.1093/jac/30.2.129; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Kaushik A, 2015, ANTIMICROB AGENTS CH, V59, P6561, DOI 10.1128/AAC.01158-15; Kim HS, 2013, ACTA CRYSTALLOGR D, V69, P420, DOI 10.1107/S0907444912048998; Kumar P, 2012, MOL MICROBIOL, V86, P367, DOI 10.1111/j.1365-2958.2012.08199.x; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Li WJ, 2013, CELL RES, V23, P728, DOI 10.1038/cr.2013.53; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Meroueh SO, 2003, J AM CHEM SOC, V125, P9612, DOI 10.1021/ja034861u; Natsugari H., 1983, Japan patent, Patent No. [WO1983000867, 1983000867]; Palmero Domingo, 2015, Arch Bronconeumol, V51, pe49, DOI 10.1016/j.arbres.2015.03.012; Payen MC, 2012, INT J TUBERC LUNG D, V16, P558, DOI 10.5588/ijtld.11.0414; Rullas J, 2015, ANTIMICROB AGENTS CH, V59, P4997, DOI 10.1128/AAC.01063-15; Schoonmaker MK, 2014, J BACTERIOL, V196, P1394, DOI 10.1128/JB.01396-13; Seki M., 1996, J CHEM SOC P1, V23, P2851; Silva JRA, 2016, J BIOMOL STRUCT DYN, V34, P304, DOI 10.1080/07391102.2015.1029000; Veziris N, 2011, ANTIMICROB AGENTS CH, V55, P2597, DOI 10.1128/AAC.01824-10; Walsh C., 2003, ANTIBIOTICS ACTIONS; Wivagg CN, 2014, J ANTIBIOT, V67, P645, DOI 10.1038/ja.2014.94; World Health Organization, 2020, GLOBAL TUBERCULOSIS	34	85	90	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					54	61		10.1038/NCHEMBIO.2237	http://dx.doi.org/10.1038/NCHEMBIO.2237			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27820797	Green Accepted			2022-12-25	WOS:000393267200013
J	Lo, MT; Hinds, DA; Tung, JY; Franz, C; Fan, CC; Wang, YP; Smeland, OB; Schork, A; Holland, D; Kauppi, K; Sanyal, N; Escott-Price, V; Smith, DJ; O'Donovan, M; Stefansson, H; Bjornsdottir, G; Thorgeirsson, TE; Stefansson, K; McEvoy, LK; Dale, AM; Andreassen, OA; Chen, CH				Lo, Min-Tzu; Hinds, David A.; Tung, Joyce Y.; Franz, Carol; Fan, Chun-Chieh; Wang, Yunpeng; Smeland, Olav B.; Schork, Andrew; Holland, Dominic; Kauppi, Karolina; Sanyal, Nilotpal; Escott-Price, Valentina; Smith, Daniel J.; O'Donovan, Michael; Stefansson, Hreinn; Bjornsdottir, Gyda; Thorgeirsson, Thorgeir E.; Stefansson, Kari; McEvoy, Linda K.; Dale, Anders M.; Andreassen, Ole A.; Chen, Chi-Hua			Genome-wide analyses for personality traits identify six genomic loci and show correlations with psychiatric disorders	NATURE GENETICS			English	Article							BIPOLAR DISORDER; 5-FACTOR MODEL; NEUROTICISM; ASSOCIATION; SCHIZOPHRENIA; METAANALYSIS; HERITABILITY; TEMPERAMENT; PERFORMANCE	Personality is influenced by genetic and environmental factors(1) and associated with mental health. However, the underlying genetic determinants are largely unknown. We identified six genetic loci, including five novel loci(2,3), significantly associated with personality traits in a meta-analysis of genome-wide association studies (N = 123,132-260,861). Of these genome-wide significant loci, extraversion was associated with variants in WSCD2 and near PCDH15, and neuroticism with variants on chromosome 8p23.1 and in L3MBTL2. We performed a principal component analysis to extract major dimensions underlying genetic variations among five personality traits and six psychiatric disorders (N = 5,422-18,759). The first genetic dimension separated personality traits and psychiatric disorders, except that neuroticism and openness to experience were clustered with the disorders. High genetic correlations were found between extraversion and attention-deficit- hyperactivity disorder (ADHD) and between openness and schizophrenia and bipolar disorder. The second genetic dimension was closely aligned with extraversion-introversion and grouped neuroticism with internalizing psychopathology (e.g., depression or anxiety).	[Lo, Min-Tzu; Fan, Chun-Chieh; Schork, Andrew; Kauppi, Karolina; Sanyal, Nilotpal; McEvoy, Linda K.; Dale, Anders M.; Chen, Chi-Hua] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Hinds, David A.; Tung, Joyce Y.] 23andMe Inc, Mountain View, CA USA; [Franz, Carol; Dale, Anders M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Fan, Chun-Chieh; Schork, Andrew] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Wang, Yunpeng; Holland, Dominic; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Wang, Yunpeng; Smeland, Olav B.; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway; [Wang, Yunpeng; Smeland, Olav B.; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Kauppi, Karolina] Umea Univ, Dept Radiat Sci, S-90187 Umea, Sweden; [Escott-Price, Valentina; O'Donovan, Michael] Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales; [Smith, Daniel J.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Stefansson, Hreinn; Bjornsdottir, Gyda; Thorgeirsson, Thorgeir E.; Stefansson, Kari] deCODE Genet Amgen, Reykjavik, Iceland	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oslo; University of Oslo; Umea University; Cardiff University; University of Glasgow	Chen, CH (corresponding author), Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA.	chc101@ucsd.edu	Stefansson, Kari/AAE-7187-2019; Smeland, Olav Bjerkehagen/AAM-5284-2020; O'Donovan, Michael C/P-7005-2018; Andreassen, Ole A./AAY-7531-2020; Wang, Yunpeng/W-8871-2018	Smeland, Olav Bjerkehagen/0000-0002-3761-5215; O'Donovan, Michael C/0000-0001-7073-2379; Wang, Yunpeng/0000-0001-9831-1090; Sanyal, Nilotpal/0000-0003-4814-7602; Kauppi, Karolina/0000-0003-4908-341X; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Bjornsdottir, Gyda/0000-0002-8100-0306; Smith, Daniel/0000-0002-2267-1951; Franz, Carol/0000-0002-8987-1755; Hinds, David/0000-0002-4911-803X	National Institute of Mental Health [R01MH100351]; NARSAD Young Investigator award; South-East Norway Regional Health Authority [2016-064]; Research Council of Norway through a FRIPRO Mobility Grant [251134]; European Union's Seventh Framework Programme for research, technological development and demonstration under Marie Curie grant [608695]; Lister Institute Prize fellowship; US National Institutes of Health NIDA [R01-DA017932, R01-DA034076]; Innovative Medicines Initiative Joint Undertaking [115008]; European Union's Seventh Framework Programme (FP7); EU [GA 28613]; National Institute of Mental Health [R01MH100351]; NARSAD Young Investigator award; South-East Norway Regional Health Authority [2016-064]; Research Council of Norway through a FRIPRO Mobility Grant [251134]; European Union's Seventh Framework Programme for research, technological development and demonstration under Marie Curie grant [608695]; Lister Institute Prize fellowship; US National Institutes of Health NIDA [R01-DA017932, R01-DA034076]; Innovative Medicines Initiative Joint Undertaking [115008]; European Union's Seventh Framework Programme (FP7); EU [GA 28613]; MRC [MR/P005748/1, UKDRI-3003, MR/L023784/2] Funding Source: UKRI; Medical Research Council [MR/L023784/2, MR/L010305/1, MR/P005748/1, UKDRI-3003] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022381, R01AG050595, R01AG018386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017932, R01DA034076] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD Young Investigator award(NARSAD); South-East Norway Regional Health Authority; Research Council of Norway through a FRIPRO Mobility Grant(Research Council of Norway); European Union's Seventh Framework Programme for research, technological development and demonstration under Marie Curie grant; Lister Institute Prize fellowship; US National Institutes of Health NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7); EU(European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD Young Investigator award(NARSAD); South-East Norway Regional Health Authority; Research Council of Norway through a FRIPRO Mobility Grant(Research Council of Norway); European Union's Seventh Framework Programme for research, technological development and demonstration under Marie Curie grant; Lister Institute Prize fellowship; US National Institutes of Health NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7); EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the customers, research participants and employees of 23andMe for making this work possible. This project was funded by National Institute of Mental Health R01MH100351 (M.-TL., N.S. and C.-H.C.), NARSAD Young Investigator award (C.-H.C.), South-East Norway Regional Health Authority (2016-064) (O.B.S.), and Research Council of Norway through a FRIPRO Mobility Grant, contract no. 251134 (Y.W.). The FRIPRO Mobility grant scheme (FRICON) is cofunded by the European Union's Seventh Framework Programme for research, technological development and demonstration under Marie Curie grant agreement no. 608695. D.J.S. is supported by a Lister Institute Prize fellowship. The research leading to deCODE results was supported in part by the US National Institutes of Health NIDA (R01-DA017932 and R01-DA034076) and the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115008, of which resources are composed of a European Federation of Pharmaceutical Industries and Associations (EFPIA) in-kind contribution and financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EU-funded FP7-People-2011-IAPP grant PsychDPC (GA 28613) (H.S., G.B., T.E.T. and KS.).	Aberg K, 2010, BIOL PSYCHIAT, V67, P279, DOI 10.1016/j.biopsych.2009.08.036; Barnett JH, 2011, PSYCHOL MED, V41, P1593, DOI 10.1017/S0033291710002333; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; de Moor MHM, 2015, JAMA PSYCHIAT, V72, P642, DOI 10.1001/jamapsychiatry.2015.0554; DeYoung CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00762; Franke B, 2016, NAT NEUROSCI, V19, P420, DOI 10.1038/nn.4228; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; GRAY JA, 1970, BEHAV RES THER, V8, P249, DOI 10.1016/0005-7967(70)90069-0; Green E, 2005, AM J PSYCHIAT, V162, P35, DOI 10.1176/appi.ajp.162.1.35; Greenwood TA, 2012, BIOL PSYCHIAT, V72, P303, DOI 10.1016/j.biopsych.2012.01.018; Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jakobwitz S, 2006, PERS INDIV DIFFER, V40, P331, DOI 10.1016/j.paid.2005.07.006; Karalunas SL, 2014, JAMA PSYCHIAT, V71, P1015, DOI 10.1001/jamapsychiatry.2014.763; Kendler KS, 2010, PSYCHOL MED, V40, P801, DOI 10.1017/S0033291709991140; Kim HN, 2013, J HUM GENET, V58, P667, DOI 10.1038/jhg.2013.75; Mezquita L, 2015, PERS INDIV DIFFER, V79, P98, DOI 10.1016/j.paid.2015.02.002; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Poropat AE, 2014, BRIT J EDUC PSYCHOL, V84, P239, DOI 10.1111/bjep.12019; Power RA, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.96; Power RA, 2015, NAT NEUROSCI, V18, P953, DOI 10.1038/nn.4040; Rietveld CA, 2014, P NATL ACAD SCI USA, V111, P13790, DOI 10.1073/pnas.1404623111; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith DJ, 2016, MOL PSYCHIATR, V21, P749, DOI 10.1038/mp.2016.49; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Trull Timothy J, 2013, Dialogues Clin Neurosci, V15, P135; Van Os J, 2001, PSYCHOL MED, V31, P1129, DOI 10.1017/S0033291701004044; Vukasovic T, 2015, PSYCHOL BULL, V141, P769, DOI 10.1037/bul0000017	32	195	201	2	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					152	156		10.1038/ng.3736	http://dx.doi.org/10.1038/ng.3736			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27918536	Green Accepted, Green Published			2022-12-25	WOS:000390976600022
J	Sheridan, C				Sheridan, Cormac			CRISPR therapeutics push into human testing	NATURE BIOTECHNOLOGY			English	News Item																		ENGL N, 2014, J MED, V370, P901; 2014, NAT BIOTECHNOL, V33, P247; 2015, NAT MED, V21, P914; 2016, NATURE, V539, P479; NAT BIOTECHNOL, V34, P796	5	12	13	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					3	5		10.1038/nbt0117-3	http://dx.doi.org/10.1038/nbt0117-3			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	28072788				2022-12-25	WOS:000392460800003
J	Spencer-Smith, R; Koide, A; Zhou, Y; Eguchi, RR; She, F; Gajwani, P; Santana, D; Gupta, A; Jacobs, M; Herrero-Garcia, E; Cobbert, J; Lavoie, H; Smith, M; Rajakulendran, T; Dowdell, E; Okur, MN; Dementieva, I; Sicheri, F; Therrien, M; Hancock, JF; Ikura, M; Koide, S; O'Bryan, JP				Spencer-Smith, Russell; Koide, Akiko; Zhou, Yong; Eguchi, Raphael R.; She, Fern; Gajwani, Priyanka; Santana, Dianicha; Gupta, Ankit; Jacobs, Miranda; Herrero-Garcia, Erika; Cobbert, Jacqueline; Lavoie, Hugo; Smith, Matthew; Rajakulendran, Thanashan; Dowdell, Evan; Okur, Mustafa Nazir; Dementieva, Irina; Sicheri, Frank; Therrien, Marc; Hancock, John F.; Ikura, Mitsuhiko; Koide, Shohei; O'Bryan, John P.			Inhibition of RAS function through targeting an allosteric regulatory site	NATURE CHEMICAL BIOLOGY			English	Article							K-RAS; EFFECTOR INTERACTIONS; BINDING-PROTEINS; STRUCTURAL BASIS; III DOMAIN; H-RAS; ACTIVATION; DIMERIZATION; GTP; SOS	RAS GTPases are important mediators of oncogenesis in humans. However, pharmacological inhibition of RAS has proved challenging. Here we describe a functionally critical region, located outside the effector lobe of RAS, that can be targeted for inhibition. We developed NS1, a synthetic binding protein (monobody) that bound with high affinity to both GTP- and GDP-bound states of H-RAS and K-RAS but not N-RAS. NS1 potently inhibited growth factor signaling and oncogenic H-RAS- and K-RAS-mediated signaling and transformation but did not block oncogenic N-RAS, BRAF or MEK1. NS1 bound the alpha 4-beta 6-alpha 5 region of RAS, which disrupted RAS dimerization and nanoclustering and led to blocking of CRAF-BRAF heterodimerization and activation. These results establish the importance of the alpha 4-beta 6-alpha 5 interface in RAS-mediated signaling and define a previously unrecognized site in RAS for inhibiting RAS function.	[Spencer-Smith, Russell; Gajwani, Priyanka; Santana, Dianicha; Jacobs, Miranda; Herrero-Garcia, Erika; Cobbert, Jacqueline; Okur, Mustafa Nazir; O'Bryan, John P.] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA; [Spencer-Smith, Russell; Gajwani, Priyanka; Santana, Dianicha; Jacobs, Miranda; Herrero-Garcia, Erika; Cobbert, Jacqueline; Okur, Mustafa Nazir; O'Bryan, John P.] Univ Illinois, Ctr Canc, Chicago, IL 60607 USA; [Spencer-Smith, Russell; Herrero-Garcia, Erika; O'Bryan, John P.] Jesse Brown VA Med Ctr, Chicago, IL USA; [Koide, Akiko; Eguchi, Raphael R.; She, Fern; Gupta, Ankit; Dowdell, Evan; Dementieva, Irina; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Koide, Akiko; Gupta, Ankit; Koide, Shohei] NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA; [Koide, Akiko] NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Zhou, Yong; Hancock, John F.] Univ Texas Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA; [Lavoie, Hugo; Therrien, Marc] Univ Montreal, Dept Pathol & Cell Biol, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Smith, Matthew; Ikura, Mitsuhiko] Univ Toronto, Princess Margaret Canc Ctr, Campbell Family Canc Res Inst, Dept Med Biophys, Toronto, ON, Canada; [Rajakulendran, Thanashan; Sicheri, Frank] Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol, Toronto, ON, Canada; [Rajakulendran, Thanashan; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Rajakulendran, Thanashan; Sicheri, Frank] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Koide, Shohei] NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Chicago; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Texas System; University of Texas Health Science Center Houston; Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; New York University; NYU Langone Medical Center	O'Bryan, JP (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA.; O'Bryan, JP (corresponding author), Univ Illinois, Ctr Canc, Chicago, IL 60607 USA.; O'Bryan, JP (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL USA.; Koide, S (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; Koide, S (corresponding author), NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA.; Koide, S (corresponding author), NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	shohei.koide@nyumc.org; obryanj@uic.edu	Smith, Matthew J/AAI-8060-2020; Sicheri, Frank/F-8856-2013	Smith, Matthew J/0000-0003-2896-9350; Zhou, Yong/0000-0002-0214-8151; O'Bryan, John/0000-0001-5386-1080; Eguchi, Raphael/0000-0002-2704-8464; Ikura, Mitsuhiko/0000-0002-9524-1303; Lavoie, Hugo/0000-0003-0560-2409; Sha, Fern/0000-0002-7110-2544; Hancock, John/0000-0003-0542-4710; Koide, Shohei/0000-0001-5473-4358; Smith, Matthew/0000-0002-9436-2592; Spencer-Smith, Russell/0000-0002-8865-0520	DOE Office of Science [DE-AC02-06CH11357]; US National Institutes of Health (NIH) F31 Predoctoral Award [CA192822]; CIHR award [FDN 143277]; Merit Review Award from the US Department of Veterans Affairs Biomedical Laboratory Research and Development Service [1I01BX002095]; NIH [CA116708, CA201717, GM090324]; Catalyst award from the Chicago Biomedical Consortium; Searles Funds at the Chicago Community Trust; NATIONAL CANCER INSTITUTE [R01CA116708, F31CA192822, R21CA201717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090324] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002095] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); US National Institutes of Health (NIH) F31 Predoctoral Award; CIHR award(Canadian Institutes of Health Research (CIHR)); Merit Review Award from the US Department of Veterans Affairs Biomedical Laboratory Research and Development Service; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Catalyst award from the Chicago Biomedical Consortium; Searles Funds at the Chicago Community Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract number DE-AC02-06CH11357. The contents do not represent the views of the US Department of Veterans Affairs or the United States Government. We thank J. Kuriyan and Y. Kondo (University of California, Berkeley (UC Berkeley)) for the purified Sos protein; S. Campbell (University of North Carolina at Chapel Hill (UNC)) for the K-RAS expression construct; A. Cox (UNC) for the N-RAS(G12D) construct; W Hahn (Dana-Farber Cancer Institute) for the pBabe-Puro-MEK-DD (Addgene plasmid 15268); G. Clark (University of Louisville) for pCGN-RAF; B. Kreutz (University of Illinois at Chicago) for assistance with the fluorescent nucleotide exchange assays; D. Morrison (National Cancer Institute, NIH) for purified MEK(K97R); A. Aplin (Thomas Jefferson University) for A375 human melanoma cells; and C.-D. Hu (Purdue University) for expression constructs consisting of the Flag-tagged N terminus or HA-tagged C terminus of Venus. R.S.-S. is supported by a US National Institutes of Health (NIH) F31 Predoctoral Award (CA192822). This work was supported in part by a CIHR award to F. Sicheri (FDN 143277), a Merit Review Award (1I01BX002095) from the US Department of Veterans Affairs Biomedical Laboratory Research and Development Service to J.P.O., NIH awards to J.P.O. (CA116708 and CA201717) and S.K. (GM090324) and a Catalyst award from the Chicago Biomedical Consortium with support from the Searles Funds at the Chicago Community Trust to S.K. and J.P.O.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Burns MC, 2014, P NATL ACAD SCI USA, V111, P3401, DOI 10.1073/pnas.1315798111; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox Adrienne D, 2010, Small GTPases, V1, P2; FERAMISCO JR, 1985, NATURE, V314, P639, DOI 10.1038/314639a0; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Herrero A, 2015, CANCER CELL, V28, P170, DOI 10.1016/j.ccell.2015.07.001; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Koide S, 2012, METHOD ENZYMOL, V503, P135, DOI 10.1016/B978-0-12-396962-0.00006-9; Kovrigina EA, 2015, BIOPHYS J, V109, P1000, DOI 10.1016/j.bpj.2015.07.020; Leshchiner ES, 2015, P NATL ACAD SCI USA, V112, P1761, DOI 10.1073/pnas.1413185112; Lim SM, 2014, ANGEW CHEM INT EDIT, V53, P199, DOI 10.1002/anie.201307387; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Patgiri A, 2011, NAT CHEM BIOL, V7, P585, DOI [10.1038/NCHEMBIO.612, 10.1038/nchembio.612]; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; SANTOS E, 1988, J BIOL CHEM, V263, P9853; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Sha F, 2013, P NATL ACAD SCI USA, V110, P14924, DOI 10.1073/pnas.1303640110; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Tan J., 1998, J BIOL CHEM, V273, P24052; Wong KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045360; Wu XH, 2013, MEDCHEMCOMM, V4, P378, DOI 10.1039/c2md20329d; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619; Zhou Y, 2014, MOL CELL BIOL, V34, P862, DOI 10.1128/MCB.01227-13	41	167	175	6	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					62	68		10.1038/NCHEMBIO.2231	http://dx.doi.org/10.1038/NCHEMBIO.2231			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27820802	Green Accepted			2022-12-25	WOS:000393267200014
J	Takemoto, K; Iwanari, H; Tada, H; Suyama, K; Sano, A; Nagai, T; Hamakubo, T; Takahashi, T				Takemoto, Kiwamu; Iwanari, Hiroko; Tada, Hirobumi; Suyama, Kumiko; Sano, Akane; Nagai, Takeharu; Hamakubo, Takao; Takahashi, Takuya			Optical inactivation of synaptic AMPA receptors erases fear memory	NATURE BIOTECHNOLOGY			English	Article							LONG-TERM POTENTIATION; ASSISTED LIGHT INACTIVATION; IN-VIVO; GLUTAMATE RECEPTORS; LASER INACTIVATION; EXCITATORY SYNAPSES; COCAINE EXPOSURE; PROTEIN FUNCTION; TRAFFICKING; PLASTICITY	The synaptic delivery of neurotransmitter receptors, such as GluA1 AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors, mediates important processes in cognitive function, including memory acquisition and retention. Understanding the roles of these receptors has been hampered by the lack of a method to inactivate them in vivo with high spatiotemporal precision. We developed a technique to inactivate synaptic GIuA1 AMPA receptors in vivo using chromophore-assisted light inactivation (CALI). We raised a monoclonal antibody specific for the extracellular domain of GluA1 that induced effective CALI when conjugated with a photosensitizer (eosin). Mice that had been injected in the CA1 hippocampal region with the antibody conjugate underwent a fear memory task. Exposing the hippocampus to green light using an implanted cannula erased acquired fear memory in the animals by inactivation of synaptic GluA1. Our optical technique for inactivating synaptic proteins will enable elucidation of their physiological roles in cognition.	[Takemoto, Kiwamu; Tada, Hirobumi; Suyama, Kumiko; Sano, Akane; Takahashi, Takuya] Yokohama City Univ, Dept Physiol, Grad Sch Med, Yokohama, Kanagawa, Japan; [Takemoto, Kiwamu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama, Japan; [Iwanari, Hiroko; Hamakubo, Takao] Univ Tokyo, Dept Quantitat Biol & Med, Res Ctr Adv Sci & Technol RCAST, Meguro Ku, Tokyo, Japan; [Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan	Yokohama City University; Japan Science & Technology Agency (JST); University of Tokyo; Osaka University	Takemoto, K; Takahashi, T (corresponding author), Yokohama City Univ, Dept Physiol, Grad Sch Med, Yokohama, Kanagawa, Japan.; Takemoto, K (corresponding author), Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama, Japan.	takemotk@yokohama-cu.ac.jp; takahast@yokohama-cu.ac.jp	Takemoto, Kiwamu/AAE-9926-2019; Tada, Hirobumi/ABB-7665-2020; Takemoto, Kiwamu/HGD-3429-2022	Takemoto, Kiwamu/0000-0002-3301-3268; Nagai, Takeharu/0000-0003-2650-9895	Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency; Japan Science and Technology Agency [21700412]; NEDO; Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and Development, AMED; Grants-in-Aid for Scientific Research [15K15041] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NEDO(New Energy and Industrial Technology Development Organization (NEDO)); Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project was supported by Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency (K.T.), JSPS Grant-in-Aid for Young Scientists (B) 21700412 (K.T.), Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (T.T.), NEDO (H.I. and T.H.) and partially supported by the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and Development, AMED (T.T.), Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development, AMED (T.T.). We thank Y. Hayashi for critical reading of this manuscript, K. Takamiya for providing the GluAl-deficient mice, and K. Sakimura for providing the expression vectors for mouse GluAl (GluA1/pBOS), GluA2 (GluA2/pBOS), and GluA3 (GluA3/pBOS). We also thank M. Kawato and T. Bando for valuable advice and helpful discussion.	Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Coombs ID, 2009, NEUROSCIENCE, V162, P656, DOI 10.1016/j.neuroscience.2009.01.004; Coombs ID, 2012, J NEUROSCI, V32, P9796, DOI 10.1523/JNEUROSCI.0345-12.2012; Dingledine R, 1999, PHARMACOL REV, V51, P7; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; Hanley JG, 2014, SEMIN CELL DEV BIOL, V27, P14, DOI 10.1016/j.semcdb.2013.12.002; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jacobson K, 2008, TRENDS CELL BIOL, V18, P443, DOI 10.1016/j.tcb.2008.07.001; JAY DG, 1988, P NATL ACAD SCI USA, V85, P5454, DOI 10.1073/pnas.85.15.5454; Jitsuki S, 2011, NEURON, V69, P780, DOI 10.1016/j.neuron.2011.01.016; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Kleindienst T, 2011, NEURON, V72, P1012, DOI 10.1016/j.neuron.2011.10.015; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lin JY, 2013, NEURON, V79, P241, DOI 10.1016/j.neuron.2013.05.022; LINDEN KG, 1992, BIOPHYS J, V61, P956, DOI 10.1016/S0006-3495(92)81902-1; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mitsushima D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3760; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sakurai T, 2002, P NATL ACAD SCI USA, V99, P10795, DOI 10.1073/pnas.162161499; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Takemoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02629; Takemoto K, 2011, ACS CHEM BIOL, V6, P401, DOI 10.1021/cb100431e; Tour O, 2003, NAT BIOTECHNOL, V21, P1505, DOI 10.1038/nbt914; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wolf ME, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00072; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	54	54	54	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					38	47		10.1038/nbt.3710	http://dx.doi.org/10.1038/nbt.3710			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	27918547				2022-12-25	WOS:000392460800021
J	Dolgin, E				Dolgin, Elie			New anti-IL-23 drugs raise hopes for psoriasis plaque clearance	NATURE BIOTECHNOLOGY			English	News Item																		2015, NAT BIOTECHNOL, V33, P3; 2015, NAT BIOTECHNOL, V33, P894	2	5	5	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1218	1219		10.1038/nbt1216-1218	http://dx.doi.org/10.1038/nbt1216-1218			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27926724				2022-12-25	WOS:000390185300005
J	Eisenberg, T; Abdellatif, M; Schroeder, S; Primessnig, U; Stekovic, S; Pendl, T; Harger, A; Schipke, J; Zimmermann, A; Schmidt, A; Tong, MM; Ruckenstuhl, C; Dammbrueck, C; Gross, AS; Herbst, V; Magnes, C; Trausinger, G; Narath, S; Meinitzer, A; Hu, ZH; Kirsch, A; Eller, K; Carmona-Gutierrez, D; Buttner, S; Pietrocola, F; Knittelfelder, O; Schrepfer, E; Rockenfeller, P; Simonini, C; Rahn, A; Horsch, M; Moreth, K; Beckers, J; Fuchs, H; Gailus-Durner, V; Neff, F; Janik, D; Rathkolb, B; Rozman, J; de Angelis, MH; Moustafa, T; Haemmerle, G; Mayr, M; Willeit, P; von Frieling-Salewsky, M; Pieske, B; Scorrano, L; Pieber, T; Pechlaner, R; Willeit, J; Sigrist, SJ; Linke, WA; Muhlfeld, C; Sadoshima, J; Dengjel, J; Kiechl, S; Kroemer, G; Sedej, S; Madeo, F				Eisenberg, Tobias; Abdellatif, Mahmoud; Schroeder, Sabrina; Primessnig, Uwe; Stekovic, Slaven; Pendl, Tobias; Harger, Alexandra; Schipke, Julia; Zimmermann, Andreas; Schmidt, Albrecht; Tong, Mingming; Ruckenstuhl, Christoph; Dammbrueck, Christopher; Gross, Angelina S.; Herbst, Viktoria; Magnes, Christoph; Trausinger, Gert; Narath, Sophie; Meinitzer, Andreas; Hu, Zehan; Kirsch, Alexander; Eller, Kathrin; Carmona-Gutierrez, Didac; Buettner, Sabrina; Pietrocola, Federico; Knittelfelder, Oskar; Schrepfer, Emilie; Rockenfeller, Patrick; Simonini, Corinna; Rahn, Alexandros; Horsch, Marion; Moreth, Kristin; Beckers, Johannes; Fuchs, Helmut; Gailus-Durner, Valerie; Neff, Frauke; Janik, Dirk; Rathkolb, Birgit; Rozman, Jan; de Angelis, Martin Hrabe; Moustafa, Tarek; Haemmerle, Guenter; Mayr, Manuel; Willeit, Peter; von Frieling-Salewsky, Marion; Pieske, Burkert; Scorrano, Luca; Pieber, Thomas; Pechlaner, Raimund; Willeit, Johann; Sigrist, Stephan J.; Linke, Wolfgang A.; Muehlfeld, Christian; Sadoshima, Junichi; Dengjel, Joern; Kiechl, Stefan; Kroemer, Guido; Sedej, Simon; Madeo, Frank			Cardioprotection and lifespan extension by the natural polyamine spermidine	NATURE MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; EJECTION FRACTION; ARGININE BIOAVAILABILITY; MITOCHONDRIAL AUTOPHAGY; MYOCARDIAL HYPERTROPHY; ROBUST QUANTIFICATION; AMINO-ACIDS; MICE; MASS; DYSFUNCTION	Aging is associated with an increased risk of cardiovascular disease and death. Here we show that oral supplementation of the natural polyamine spermidine extends the lifespan of mice and exerts cardioprotective effects, reducing cardiac hypertrophy and preserving diastolic function in old mice. Spermidine feeding enhanced cardiac autophagy, mitophagy and mitochondrial respiration, and it also improved the mechano-elastical properties of cardiomyocytes in vivo, coinciding with increased titin phosphorylation and suppressed subclinical inflammation. Spermidine feeding failed to provide cardioprotection in mice that lack the autophagy-related protein Atg5 in cardiomyocytes. In Dahl salt-sensitive rats that were fed a high-salt diet, a model for hypertension-induced congestive heart failure, spermidine feeding reduced systemic blood pressure, increased titin phosphorylation and prevented cardiac hypertrophy and a decline in diastolic function, thus delaying the progression to heart failure. In humans, high levels of dietary spermidine, as assessed from food questionnaires, correlated with reduced blood pressure and a lower incidence of cardiovascular disease. Our results suggest a new and feasible strategy for protection against cardiovascular disease.	[Eisenberg, Tobias; Schroeder, Sabrina; Stekovic, Slaven; Pendl, Tobias; Harger, Alexandra; Zimmermann, Andreas; Ruckenstuhl, Christoph; Dammbrueck, Christopher; Gross, Angelina S.; Carmona-Gutierrez, Didac; Buettner, Sabrina; Knittelfelder, Oskar; Rockenfeller, Patrick; Moustafa, Tarek; Haemmerle, Guenter; Madeo, Frank] Graz Univ, Inst Mol Biosci, NAWI Graz, Graz, Austria; [Eisenberg, Tobias; Sedej, Simon; Madeo, Frank] BioTechMed Graz, Graz, Austria; [Abdellatif, Mahmoud; Primessnig, Uwe; Schmidt, Albrecht; Herbst, Viktoria; Simonini, Corinna; Pieske, Burkert; Sedej, Simon] Med Univ Graz, Dept Cardiol, Graz, Austria; [Primessnig, Uwe; Pieske, Burkert] Charite, Dept Internal Med & Cardiol, Campus Virchow Klinikum, Berlin, Germany; [Harger, Alexandra; Moustafa, Tarek; Pieber, Thomas] Med Univ Graz, Dept Internal Med, Graz, Austria; [Schipke, Julia; Rahn, Alexandros; Muehlfeld, Christian] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Schipke, Julia; Muehlfeld, Christian] Cluster Excellence REBIRTH Regenerat Biol Reconst, Hannover, Germany; [Tong, Mingming; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ USA; [Magnes, Christoph; Trausinger, Gert; Narath, Sophie; Pieber, Thomas] Joanneum Res Forsch Gesell mbH, HLTH, Inst Biomed & Hlth Sci, Graz, Austria; [Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Hu, Zehan; Dengjel, Joern] Univ Freiburg, FRIAS Freiburg Inst Adv Studies, ZBSA Ctr Biol Syst Anal, Dept Dermatol,Med Ctr,BIOSS Ctr Biol Signalling S, Freiburg, Germany; [Hu, Zehan; Dengjel, Joern] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Kirsch, Alexander; Eller, Kathrin] Med Univ Graz, Clin Div Nephrol, Graz, Austria; [Buettner, Sabrina] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Pietrocola, Federico; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Gustave Roussy Comprehens Canc Ctr, Cell Biol & Metabol Platforms, Villejuif, France; [Kroemer, Guido] INSERM, U1138, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Univ Paris 06, Paris, France; [Schrepfer, Emilie; Scorrano, Luca] Univ Padua, Dept Biol, Padua, Italy; [Schrepfer, Emilie; Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Rockenfeller, Patrick] Univ Kent, Sch Biosci, Kent Fungal Grp, Canterbury, Kent, England; [Horsch, Marion; Moreth, Kristin; Beckers, Johannes; Fuchs, Helmut; Gailus-Durner, Valerie; Neff, Frauke; Janik, Dirk; Rathkolb, Birgit; Rozman, Jan; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, German Mouse Clin, Inst Expt Genet, Neuherberg, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] Tech Univ Munich, Chair Expt Genet, Sch Life Sci Weihenstephan, Freising Weihenstephan, Germany; [Beckers, Johannes; Rathkolb, Birgit; Rozman, Jan; de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany; [Neff, Frauke; Janik, Dirk] Helmholtz Zentrum Munchen, Inst Pathol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Rathkolb, Birgit] Ludwig Maximilians Univ Munchen, Inst Mol Anim Breeding & Biotechnol, Gene Ctr, Munich, Germany; [Mayr, Manuel] Kings Coll London, Kings British Heart Fdn Ctr, London, England; [Willeit, Peter; Pechlaner, Raimund; Willeit, Johann; Kiechl, Stefan] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [von Frieling-Salewsky, Marion; Linke, Wolfgang A.] Ruhr Univ Bochum, Dept Cardiovasc Physiol, Bochum, Germany; [Pieske, Burkert] German Heart Ctr Berlin, Dept Internal Med & Cardiol, Berlin, Germany; [Sigrist, Stephan J.] Free Univ Berlin, Inst Biol, Berlin, Germany; [Sigrist, Stephan J.] Charite, NeuroCure, Berlin, Germany; [Kroemer, Guido] Hop Europeen Georges Pompidou, Pole Biol, Paris, France; [Kroemer, Guido] Karolinska Inst, Dept Womens & Childrens Hlth, Karolinska Univ Hosp, Stockholm, Sweden	University of Graz; Medical University of Graz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Graz; Hannover Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Medical University of Graz; University of Freiburg; University of Fribourg; Medical University of Graz; Stockholm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Padua; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Kent; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of London; King's College London; Medical University of Innsbruck; University of Cambridge; Ruhr University Bochum; German Heart Center Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Madeo, F (corresponding author), Graz Univ, Inst Mol Biosci, NAWI Graz, Graz, Austria.; Sedej, S; Madeo, F (corresponding author), BioTechMed Graz, Graz, Austria.; Sedej, S (corresponding author), Med Univ Graz, Dept Cardiol, Graz, Austria.; Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, Paris, France.; Kroemer, G (corresponding author), Gustave Roussy Comprehens Canc Ctr, Cell Biol & Metabol Platforms, Villejuif, France.; Kroemer, G (corresponding author), INSERM, U1138, Paris, France.; Kroemer, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Kroemer, G (corresponding author), Univ Paris 06, Paris, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, Pole Biol, Paris, France.; Kroemer, G (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Karolinska Univ Hosp, Stockholm, Sweden.	kroemer@orange.fr; simon.sedej@medunigraz.at; frank.madeo@uni-graz.at	Gailus-Durner, Valerie/M-7337-2014; Rozman, Jan/A-2540-2010; Scorrano, Luca/K-3967-2019; Pietrocola, Federico/AAW-9621-2020; Sedej, Simon/L-3066-2015; Schipke, Julia/AAU-6891-2021; Kroemer, Guido/AAY-9859-2020; Dengjel, Joern/AAI-3682-2020; Willeit, Peter/HCI-7091-2022; Hu, Zehan/AAZ-8321-2021; Abdellatif, Mahmoud/AAD-5810-2019; de Angelis, Martin Hrabe/F-5531-2012; Beckers, Johannes/K-7237-2012; KROEMER, Guido/B-4263-2013; Eisenberg, Tobias/AAV-7806-2021; Moustafa, Tarek/P-9509-2016; Pieske, Burkert/M-8089-2016	Rozman, Jan/0000-0002-8035-8904; Scorrano, Luca/0000-0002-8515-8928; Pietrocola, Federico/0000-0002-2930-234X; Sedej, Simon/0000-0002-4419-6821; Willeit, Peter/0000-0002-1866-7159; Abdellatif, Mahmoud/0000-0002-5042-9054; de Angelis, Martin Hrabe/0000-0002-7898-2353; Beckers, Johannes/0000-0001-7874-3822; KROEMER, Guido/0000-0002-9334-4405; Pieber, Thomas/0000-0003-3554-0405; Zimmermann, Andreas/0000-0003-2249-944X; Eller, Kathrin/0000-0002-6214-5008; Ruckenstuhl, Christoph/0000-0002-4338-4679; Moustafa, Tarek/0000-0002-6755-4687; Mayr, Manuel/0000-0002-0597-829X; Kirsch, Alexander/0000-0001-6711-7834; Pieske, Burkert/0000-0002-6466-5306; Hu, Zehan/0000-0001-6182-4781; Pechlaner, Raimund/0000-0001-9006-5606; Gross, Angelina Sarah/0000-0002-8096-0831; Eisenberg, Tobias/0000-0003-3559-1130; Schmidt, Albrecht/0000-0003-4783-4603; Knittelfelder, Oskar/0000-0002-1565-7238; Buttner, Sabrina/0000-0002-2786-8542; Rockenfeller, Patrick/0000-0002-1643-3885; Dengjel, Joern/0000-0002-9453-4614; Magnes, Christoph/0000-0002-5153-7444; Linke, Wolfgang/0000-0003-0801-3773; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Sadoshima, Junichi/0000-0003-3724-4132; Haemmerle, Guenter/0000-0001-9900-5896; Madeo, Frank/0000-0002-5070-1329	Austrian Science Fund FWF (Austria) [P23490-B12, P24381, P 27893, I1000]; BMWFW; Karl-Franzens University; Austrian Science Fund FWF [P27637-B28, P27183-B24]; Austrian Heart Foundation (Osterreichischer Herzfonds); Austrian Academy of Sciences; FWF [P27637-B28]; Swedish Research Council [2015-05468]; DFG [CRC1140]; Swiss National Science Foundation [31003A-166482/1]; Austrian Science Fund (FWF) [J3742-B28]; NAWI Graz; EU (FP7) program MEDIA; German Research Foundation [SFB1002, TPA8]; LeDucq Foundation; Canceropole Ile-de-France; Institut National du Cancer (INCa); European Research Council (ERC); LabEx Immuno-Oncology; Paris Alliance of Cancer Research Institutes (PACRI); Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease (ICEMED)'; Helmholtz Alliance ('Imaging and Curing Environmental Metabolic Diseases (ICEMED)'); German Federal Ministry of Education and Research [01KX1012]; Bundesministerium fur Bildung und Forschung [01GQ1420A]; Forschungszentrum fur neurodegenerative Erkrankungen; Deutsche Forschungsgemeinschaft [Exc 257]; Austrian Research Promotion Agency FFG: ' Research Center of Excellence in Vascular Ageing-Tyrol, VASCage' - BMVIT [843536]; Wirtschaftsagentur Wien; Standortagentur Tirol; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas's NHS Foundation Trust; King's College London; King's College Hospital; British Heart Foundation [FS/13/2/29892, FS/11/29/28759] Funding Source: researchfish	Austrian Science Fund FWF (Austria)(Austrian Science Fund (FWF)); BMWFW; Karl-Franzens University; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Heart Foundation (Osterreichischer Herzfonds); Austrian Academy of Sciences; FWF(Austrian Science Fund (FWF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); DFG(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NAWI Graz; EU (FP7) program MEDIA; German Research Foundation(German Research Foundation (DFG)); LeDucq Foundation(Leducq Foundation); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); European Research Council (ERC)(European Research Council (ERC)European Commission); LabEx Immuno-Oncology; Paris Alliance of Cancer Research Institutes (PACRI); Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease (ICEMED)'; Helmholtz Alliance ('Imaging and Curing Environmental Metabolic Diseases (ICEMED)'); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Forschungszentrum fur neurodegenerative Erkrankungen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Research Promotion Agency FFG: ' Research Center of Excellence in Vascular Ageing-Tyrol, VASCage' - BMVIT; Wirtschaftsagentur Wien; Standortagentur Tirol; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas's NHS Foundation Trust; King's College London(General Electric); King's College Hospital; British Heart Foundation(British Heart Foundation)	We thank N. Mizushima (University of Tokyo) for providing Atg5<SUP>fl/fl</SUP> mice and K. Chien (Harvard University) for providing MLC2a-Cre mice. We are grateful to R. Schreiber for assistance with high-resolution respirometry. F.M. is grateful to the Austrian Science Fund FWF (Austria) for grants P23490-B12, P24381, P 27893, I1000 and 'SFB Lipotox', as well as to BMWFW and the Karl-Franzens University for grant 'Unkonventionelle Forschung'. S. Sedej is supported by the Austrian Science Fund FWF through grant P27637-B28 and by a grant from the Austrian Heart Foundation (Osterreichischer Herzfonds). T.E. is recipient of an APART fellowship from the Austrian Academy of Sciences. M.A. received funding from the FWF (grant P27637-B28) and was trained within the frame of the Ph. D Program Molecular Medicine of the Medical University of Graz. S.B. is supported by the Austrian Science Fund FWF (grant P27183-B24) and the Swedish Research Council (grant 2015-05468). J.D. is supported by the DFG via grant CRC1140 and by the Swiss National Science Foundation, grant 31003A-166482/1. P. R. is supported by the Austrian Science Fund (FWF) project J3742-B28 and NAWI Graz. W.A.L. is supported by EU (FP7) program MEDIA and the German Research Foundation grant SFB1002, TPA8. G.K. is supported by the LeDucq Foundation, the Canceropole Ile-de-France, the Institut National du Cancer (INCa), the European Research Council (ERC), LabEx Immuno-Oncology and the Paris Alliance of Cancer Research Institutes (PACRI). The project was supported by grants from the Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease' (J.B.), the Helmholtz Alliance ('Imaging and Curing Environmental Metabolic Diseases (ICEMED)'; J.B.) and the German Federal Ministry of Education and Research (Infrafrontier grant 01KX1012) (M.H.d.A.). S. J. S. was supported by grants from the Bundesministerium fur Bildung und Forschung (Smartage, 01GQ1420A), the Forschungszentrum fur neurodegenerative Erkrankungen and the Deutsche Forschungsgemeinschaft (Exc 257). S. K., J.W., R. P., P.W. and M.M. are supported by an excellence initiative (Competence Centers for Excellent Technologies; COMET) of the Austrian Research Promotion Agency FFG: ' Research Center of Excellence in Vascular Ageing-Tyrol, VASCage' (K-Project Nr. 843536) funded by the BMVIT, BMWFW, the Wirtschaftsagentur Wien and the Standortagentur Tirol. This work was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas's NHS Foundation Trust and King's College London in partnership with King's College Hospital. M. M. is a Senior Research fellow of the British Heart Foundation. The authors are grateful for the support by staff members of the animal facilities of the Institutes of Biomedical Research (IBF, Medical University of Graz) and Molecular Biosciences (IMB, University of Graz) and acknowledge the Center for Medical Research (ZMF) of the Medical University of Graz for assistance.	Abdellatif M, 2016, AM J PHYSIOL-HEART C, V310, pH4, DOI 10.1152/ajpheart.00399.2015; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503; Borbely A, 2005, CIRCULATION, V111, P774, DOI 10.1161/01.CIR.0000155257.33485.6D; Braun RJ, 2015, CELL REP, V10, P1557, DOI 10.1016/j.celrep.2015.02.009; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Buttner S, 2014, CELL CYCLE, V13, P3903, DOI 10.4161/15384101.2014.973309; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; CHEN PY, 1991, J CLIN INVEST, V88, P1559, DOI 10.1172/JCI115467; Chiao YA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025148; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Doi R, 2000, J HYPERTENS, V18, P111, DOI 10.1097/00004872-200018010-00016; Duicu OM, 2013, CAN J PHYSIOL PHARM, V91, P593, DOI 10.1139/cjpp-2012-0422; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Gori M, 2014, EUR HEART J, V35, P3442, DOI 10.1093/eurheartj/ehu254; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Hamdani N, 2013, CIRC RES, V112, P664, DOI 10.1161/CIRCRESAHA.111.300105; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Heinzel FR, 2015, J APPL PHYSIOL, V119, P1233, DOI 10.1152/japplphysiol.00374.2015; Kastenmayer RJ, 2006, J AM ASSOC LAB ANIM, V45, P8; KELLY RP, 1992, CIRCULATION, V86, P513, DOI 10.1161/01.CIR.86.2.513; Klotz S, 2006, HYPERTENSION, V47, P901, DOI 10.1161/01.HYP.0000215579.81408.8e; Ky B, 2013, J AM COLL CARDIOL, V62, P1165, DOI 10.1016/j.jacc.2013.03.085; LaRocca TJ, 2013, MECH AGEING DEV, V134, P314, DOI 10.1016/j.mad.2013.04.004; Leoncini G, 2009, J HYPERTENS, V27, P1064, DOI 10.1097/HJH.0b013e3283281213; Linke WA, 2014, CIRC RES, V114, P1052, DOI 10.1161/CIRCRESAHA.114.301286; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946; Magnes C, 2014, J CHROMATOGR A, V1331, P44, DOI 10.1016/j.chroma.2013.12.061; Mayhew TM, 2008, PLACENTA, V29, P1, DOI 10.1016/j.placenta.2007.05.010; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; MENDEZ J, 1960, METABOLISM, V9, P184; Miller RA, 2007, AGING CELL, V6, P565, DOI 10.1111/j.1474-9726.2007.00311.x; Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Muehlfeld C, 2010, CARDIOVASC PATHOL, V19, P65, DOI 10.1016/j.carpath.2008.10.015; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Neagoe C, 2002, CIRCULATION, V106, P1333, DOI 10.1161/01.CIR.0000029803.93022.93; Ommen SR, 2000, CIRCULATION, V102, P1788; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Qu P, 2000, HYPERTENS RES, V23, P613, DOI 10.1291/hypres.23.613; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020; Rozman Jan, 2015, Curr Protoc Mouse Biol, V5, P65, DOI 10.1002/9780470942390.mo140111; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salvioli S, 2006, CURR PHARM DESIGN, V12, P3161, DOI 10.2174/138161206777947470; Schindler CE, 2014, AM J PHYSIOL-REG I, V307, pR434, DOI 10.1152/ajpregu.00123.2014; Schwarz EL, 2005, CLIN CHIM ACTA, V354, P83, DOI 10.1016/j.cccn.2004.11.016; Sedej S, 2014, J AM COLL CARDIOL, V63, P1569, DOI 10.1016/j.jacc.2013.11.010; Sedej S, 2010, CARDIOVASC RES, V87, P50, DOI 10.1093/cvr/cvq007; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502; Shirakabe A, 2016, J MOL CELL CARDIOL, V92, P134, DOI 10.1016/j.yjmcc.2016.02.007; Soda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064357; Sourij H, 2011, ATHEROSCLEROSIS, V218, P220, DOI 10.1016/j.atherosclerosis.2011.04.041; Sprenger Adrian, 2013, Methods Mol Biol, V961, P179, DOI 10.1007/978-1-62703-227-8_10; Stegemann C, 2014, CIRCULATION, V129, P1821, DOI 10.1161/CIRCULATIONAHA.113.002500; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Tournoux F, 2011, J AM SOC ECHOCARDIOG, V24, P465, DOI 10.1016/j.echo.2010.12.019; Treuting PM, 2008, J GERONTOL A-BIOL, V63, P813, DOI 10.1093/gerona/63.8.813; TROY BL, 1972, CIRCULATION, V45, P602, DOI 10.1161/01.CIR.45.3.602; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wei JW, 2012, AMINO ACIDS, V42, P2031, DOI 10.1007/s00726-011-0924-0; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Willeit P, 2014, J AM COLL CARDIOL, V64, P851, DOI 10.1016/j.jacc.2014.03.061; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wolf D, 2005, J AM SOC NEPHROL, V16, P1360, DOI 10.1681/ASN.2004100837; Yeganeh B, 2014, PHARMACOL THERAPEUT, V143, P87, DOI 10.1016/j.pharmthera.2014.02.007; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	88	567	585	10	197	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1428	+		10.1038/nm.4222	http://dx.doi.org/10.1038/nm.4222			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27841876	Green Accepted, Green Submitted			2022-12-25	WOS:000389549000020
J	Huggett, B				Huggett, Brady			America's drug problem	NATURE BIOTECHNOLOGY			English	Article									[Huggett, Brady] Nat Biotechnol, New York, NY 10004 USA		Huggett, B (corresponding author), Nat Biotechnol, New York, NY 10004 USA.							[Anonymous], 2016, RESTAURANTS VOTED MO; [Anonymous], 2016, CMS PROPOSES TEST B; [Anonymous], 2016, MED USE SPENDING US; Claxton G., 2015, EMPLOYER HLTH BENEFI; Claxton G, 2016, PAYMENTS COST SHARIN; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; IMS Health, 2016, IMS HLTH STUDY US DR; Kapczynski A, 2016, HEALTH AFFAIR, V35, P791, DOI 10.1377/hlthaff.2015.1120; Karlin-Smith S, 2016, POLITICO; Kirzinger A, 2016, KAISER HLTH TRACKING; Parker-Hope T., 2016, NY TIMES; Sullivan T., 2016, VERMONT 1 STATE PASS; Tefferi A, 2015, MAYO CLIN PROC, V90, P996, DOI 10.1016/j.mayocp.2015.06.001; Truven Health Analytics, 2013, TRUVEN HLTH ANALYTIC	14	4	5	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1231	1241		10.1038/nbt.3734	http://dx.doi.org/10.1038/nbt.3734			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27842061				2022-12-25	WOS:000390185300010
J	Lopez-Sambrooks, C; Shrimal, S; Khodier, C; Flaherty, DP; Rinis, N; Charest, JC; Gao, NG; Zhao, P; Wells, L; Lewis, TA; Lehrman, MA; Gilmore, R; Golden, JE; Contessa, JN				Lopez-Sambrooks, Cecilia; Shrimal, Shiteshu; Khodier, Carol; Flaherty, Daniel P.; Rinis, Natalie; Charest, Jonathan C.; Gao, Ningguo; Zhao, Peng; Wells, Lance; Lewis, Timothy A.; Lehrman, Mark A.; Gilmore, Reid; Golden, Jennifer E.; Contessa, Joseph N.			Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells	NATURE CHEMICAL BIOLOGY			English	Article							ASSISTED CARBOHYDRATE ELECTROPHORESIS; DOLICHOL-LINKED OLIGOSACCHARIDES; N-GLYCOSYLATION; LUNG-CANCER; PROTEIN GLYCOSYLATION; MOLECULAR-BASIS; EGFR MUTATIONS; ACCEPTOR SITES; IN-VIVO; TRANSFERASE	Asparagine (N)-linked glycosylation is a protein modification critical for glycoprotein folding, stability, and cellular localization. To identify small molecules that inhibit new targets in this biosynthetic pathway, we initiated a cell-based high-throughput screen and lead-compound-optimization campaign that delivered a cell-permeable inhibitor, NGI-1. NGI-1 targets oligosaccharyltransferase (OST), a hetero-oligomeric enzyme that exists in multiple isoforms and transfers oligosaccharides to recipient proteins. In non-small-cell lung cancer cells, NGI-1 blocks cell-surface localization and signaling of the epidermal growth factor receptor (EGFR) glycoprotein, but selectively arrests proliferation in only those cell lines that are dependent on EGFR (or fibroblast growth factor, FGFR) for survival. In these cell lines, OST inhibition causes cell-cycle arrest accompanied by induction of p21, autofluorescence, and cell morphology changes, all hallmarks of senescence. These results identify OST inhibition as a potential therapeutic approach for treating receptor-tyrosine-kinase-dependent tumors and provides a chemical probe for reversibly regulating N-linked glycosylation in mammalian cells.	[Lopez-Sambrooks, Cecilia; Rinis, Natalie; Charest, Jonathan C.; Contessa, Joseph N.] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Shrimal, Shiteshu; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Khodier, Carol; Lewis, Timothy A.] Broad Inst MIT & Harvard, Ctr Sci Therapeut, Cambridge, MA USA; [Flaherty, Daniel P.; Golden, Jennifer E.] Univ Kansas, Specialized Chem Ctr, Lawrence, KS 66045 USA; [Gao, Ningguo; Lehrman, Mark A.] UT Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX USA; [Zhao, Peng; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Contessa, Joseph N.] Yale Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Golden, Jennifer E.] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA	Yale University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Kansas; University System of Georgia; University of Georgia; Yale University; University of Wisconsin System; University of Wisconsin Madison	Contessa, JN (corresponding author), Yale Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.; Contessa, JN (corresponding author), Yale Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	joseph.contessa@yale.edu		Flaherty, Daniel/0000-0002-8305-0606; Zhao, Peng/0000-0002-9296-5293; Wells, Lance/0000-0003-4956-5363; Lewis, Timothy/0000-0001-9748-9575; Golden, Jennifer/0000-0002-6813-3710	US National Institutes of Health (NIH) [R03DA033178, R01CA172391]; American Cancer Society; NIH [RO1GM43768, RO1GM038545, P41GM103490]; NIH-MLPCN program [U54HG005031, U54HG005032]; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA172391] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001862] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005032, U54HG005031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490, R01GM038545, R01GM043768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033178] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-MLPCN program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by US National Institutes of Health (NIH) R03DA033178 and R01CA172391, and in part by a Research Scholar Grant from the American Cancer Society (J.N.C.) and by NIH RO1GM43768 (R.G.) and RO1GM038545 (M.A.L.). Additional funding was provided by the NIH-MLPCN program U54HG005031 (Kansas University) and U54HG005032 (Broad Institute). The mass spectrometry work was supported by NIH grant P41GM103490.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bennett DC, 2013, TRANSL ONCOL, V6, P382, DOI 10.1593/tlo.13232; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Contessa JN, 2010, CLIN CANCER RES, V16, P3205, DOI 10.1158/1078-0432.CCR-09-3331; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Frank CG, 2008, NATURE, V454, pE3, DOI 10.1038/nature07165; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; Gao NG, 2002, GLYCOBIOLOGY, V12, P353, DOI 10.1093/glycob/12.5.353; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Jelk J, 2013, J BIOL CHEM, V288, P20616, DOI 10.1074/jbc.M113.479642; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2001, GLYCOBIOLOGY, V11, P321, DOI 10.1093/glycob/11.4.321; Kellenberger C, 1997, BIOCHEMISTRY-US, V36, P12554, DOI 10.1021/bi971465d; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; Lehrman MA, 2007, GLYCOBIOLOGY, V17, p75R, DOI 10.1093/glycob/cwm029; Leung ELH, 2009, MOL CANCER RES, V7, P923, DOI 10.1158/1541-7786.MCR-09-0003; Maeda Y, 1998, EMBO J, V17, P4920, DOI 10.1093/emboj/17.17.4920; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Reiss G, 1997, EMBO J, V16, P1164, DOI 10.1093/emboj/16.6.1164; Roboti P, 2012, J CELL SCI, V125, P3474, DOI 10.1242/jcs.103952; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schneider A, 2012, NAT MED, V18, P71, DOI 10.1038/nm.2548; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Shrimal S, 2013, J CELL SCI, V126, P5513, DOI 10.1242/jcs.139584; Shrimal S, 2013, J CELL BIOL, V201, P81, DOI 10.1083/jcb.201301031; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; TAKATSUKI A, 1971, J ANTIBIOT, V24, P215, DOI 10.7164/antibiotics.24.215; Weerapana E, 2003, ORG BIOMOL CHEM, V1, P93, DOI 10.1039/b209342a; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	45	63	66	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1023	+		10.1038/nchembio.2194	http://dx.doi.org/10.1038/nchembio.2194			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27694802	Green Submitted, Green Accepted			2022-12-25	WOS:000388582900010
J	Wicks, P; Heywood, J				Wicks, Paul; Heywood, Jamie			Getting stem cell patients 'on the grid'	NATURE BIOTECHNOLOGY			English	Letter							ALS; TRANSPLANTATION		[Wicks, Paul; Heywood, Jamie] PatientsLikeMe, Cambridge, MA 02142 USA		Wicks, P (corresponding author), PatientsLikeMe, Cambridge, MA 02142 USA.	pwicks@patientslikeme.com	Wicks, Paul/C-6128-2011	Wicks, Paul/0000-0002-2293-9284				ALSUntangled Group, 2015, AMYOTROPH LATERAL SC, V16, P142; [Anonymous], 2016, NAT BIOTECHNOL, V34, P891; Bedlack RS, 2016, NEUROLOGY, V86, P808, DOI 10.1212/WNL.0000000000002251; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chew S, 2007, AMYOTROPH LATERAL SC, V8, P314, DOI 10.1080/17482960701419315; Dobkin BH, 2006, NEUROREHAB NEURAL RE, V20, P5, DOI 10.1177/1545968305284675; Glass JD, 2016, NEUROLOGY, V87, P392, DOI 10.1212/WNL.0000000000002889; Janson CG, 2001, J HEMATOTH STEM CELL, V10, P913, DOI 10.1089/152581601317211015; Judson H.F, 2005, TECHNOL REV; Levine T.D, 2016, AMYOTROPH LATERAL SC; loannidis J.P.A., 2014, BMJ-BRIT MED J, V349, pg7089; Mcelroy D., 2004, TELEGRAPH; Piepers S, 2010, AMYOTROPH LATERAL SC, V11, P328, DOI 10.3109/17482961003663555; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; US Department of Justice, 2014, BROWNSV DOCT SENT ST; Weiner J., 2004, HIS BROTHERS KEEPER; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837	17	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1228	1230		10.1038/nbt.3740	http://dx.doi.org/10.1038/nbt.3740			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27926718	Bronze			2022-12-25	WOS:000390185300009
J	Fumagalli, F; Noack, J; Bergmann, TJ; Presmanes, EC; Pisoni, GB; Fasana, E; Fregno, I; Galli, C; Loi, M; Solda, T; D'Antuono, R; Raimondi, A; Jung, M; Melnyk, A; Schorr, S; Schreiber, A; Simonelli, L; Varani, L; Wilson-Zbinden, C; Zerbe, O; Hofmann, K; Peter, M; Quadroni, M; Zimmermann, R; Molinari, M				Fumagalli, Fiorenza; Noack, Julia; Bergmann, Timothy J.; Presmanes, Eduardo Cebollero; Pisoni, Giorgia Brambilla; Fasana, Elisa; Fregno, Ilaria; Galli, Carmela; Loi, Marisa; Solda, Tatiana; D'Antuono, Rocco; Raimondi, Andrea; Jung, Martin; Melnyk, Armin; Schorr, Stefan; Schreiber, Anne; Simonelli, Luca; Varani, Luca; Wilson-Zbinden, Caroline; Zerbe, Oliver; Hofmann, Kay; Peter, Matthias; Quadroni, Manfredo; Zimmermann, Richard; Molinari, Maurizio			Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery	NATURE CELL BIOLOGY			English	Article							SELECTIVE AUTOPHAGY; MAMMALIAN-CELLS; QUALITY-CONTROL; ER; DEGRADATION; PROTEINS; CANCER; AMPLIFICATION; MECHANISMS; REGULATORS	The endoplasmic reticulum (ER) is a site of protein biogenesis in eukaryotic cells. Perturbing ER homeostasis activates stress programs collectively called the unfolded protein response (UPR). The UPR enhances production of ER-resident chaperones and enzymes to reduce the burden of misfolded proteins. On resolution of ER stress, ill-defined, selective autophagic programs remove excess ER components. Here we identify Sec62, a constituent of the translocon complex regulating protein import in the mammalian ER, as an ER-resident autophagy receptor. Sec62 intervenes during recovery from ER stress to selectively deliver ER components to the autolysosomal system for clearance in a series of events that we name recovER-phagy. Sec62 contains a conserved LC3-interacting region in the C-terminal cytosolic domain that is required for its function in recovER-phagy, but is dispensable for its function in the protein translocation machinery. Our results identify Sec62 as a critical molecular component in maintenance and recovery of ER homeostasis.	[Fumagalli, Fiorenza; Noack, Julia; Bergmann, Timothy J.; Presmanes, Eduardo Cebollero; Pisoni, Giorgia Brambilla; Fasana, Elisa; Fregno, Ilaria; Galli, Carmela; Loi, Marisa; Solda, Tatiana; D'Antuono, Rocco; Simonelli, Luca; Varani, Luca; Molinari, Maurizio] Univ Svizzera Italiana, CH-6900 Lugano, Switzerland; [Fumagalli, Fiorenza; Noack, Julia; Bergmann, Timothy J.; Presmanes, Eduardo Cebollero; Pisoni, Giorgia Brambilla; Fasana, Elisa; Fregno, Ilaria; Galli, Carmela; Loi, Marisa; Solda, Tatiana; D'Antuono, Rocco; Simonelli, Luca; Varani, Luca; Molinari, Maurizio] Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Fumagalli, Fiorenza] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3000 Bern, Switzerland; [Bergmann, Timothy J.; Pisoni, Giorgia Brambilla; Fregno, Ilaria] Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland; [Raimondi, Andrea] Ist Sci San Raffaele, Expt Imaging Ctr, I-20132 Milan, Italy; [Jung, Martin; Melnyk, Armin; Schorr, Stefan; Zimmermann, Richard] Univ Saarland, Med Biochem & Mol Biol, D-66421 Homburg, Germany; [Schreiber, Anne; Wilson-Zbinden, Caroline; Peter, Matthias] Swiss Fed Inst Technol, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland; [Zerbe, Oliver] Univ Zurich, Dept Chem, CH-8057 Zurich, Switzerland; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Quadroni, Manfredo] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Molinari, Maurizio] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland	Universita della Svizzera Italiana; Universita della Svizzera Italiana; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Saarland University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Cologne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Molinari, M (corresponding author), Univ Svizzera Italiana, CH-6900 Lugano, Switzerland.; Molinari, M (corresponding author), Inst Res Biomed, CH-6500 Bellinzona, Switzerland.; Molinari, M (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	maurizio.molinari@irb.usi.ch	Molinari, Maurizio/N-2587-2019; Jung, Martin/D-2207-2012; D'Antuono, Rocco/HDM-4063-2022; Jung, Martin/AAM-4547-2021; Raimondi, Andrea/AAN-2475-2020	Molinari, Maurizio/0000-0002-7636-5829; Jung, Martin/0000-0002-1482-7020; D'Antuono, Rocco/0000-0003-0180-6500; Jung, Martin/0000-0002-1482-7020; Loi, Marisa/0000-0002-9186-8379; Raimondi, Andrea/0000-0002-4563-386X; Quadroni, Manfredo/0000-0002-2720-4084; Schreiber, Anne/0000-0001-6766-2808; Fregno, Ilaria/0000-0003-0546-8764; Simonelli, Luca/0000-0001-6331-7716; Varani, Luca/0000-0002-0963-0987; Peter, Matthias/0000-0002-2160-6824	Signora Alessandra; Foundation for Research on Neurodegenerative Diseases; Swiss National Science Foundation (SNF); Comel Foundation; Gelu Foundation; ETH; ERC; SNF; Oncosuisse; German Research Foundation (DFG)	Signora Alessandra; Foundation for Research on Neurodegenerative Diseases; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Comel Foundation; Gelu Foundation; ETH(ETH Zurich); ERC(European Research Council (ERC)European Commission); SNF; Oncosuisse; German Research Foundation (DFG)(German Research Foundation (DFG))	We are indebted to D. Ron for having suggested the use of CPA. We thank A. Helenius (Institute of Biochemistry, ETH Zurich, Zurich, Switzerland), A. Smith, M. Komatsu (Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan), T. Johansen (Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo, Norway), N. Mizushima (Department of Bioregulation and Metabolism, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan), P. Paganetti, F. Reggiori, C. Tacchetti and C. Guerra for gifts of reagents, discussions and critical reading of the manuscript. We are grateful to the ALEMBIC facility at San Raffaele Scientific Institute, Milan, Italy for help with electron microscopy analysis and to E. Neuhaus and T. Mohlmann at Technical University, Kaiserslautern, Germany for giving us access to their Biacore system. M.M. is supported by Signora Alessandra, the Foundation for Research on Neurodegenerative Diseases, the Swiss National Science Foundation (SNF) and the Comel and Gelu Foundations. M.M. and M.P. are recipients of a Sinergia grant of the SNF, and M.P. is supported by the ETH and an ERC advanced fellowship. L.V. is supported by SNF and Oncosuisse. R.Z. and K.H. are supported by the German Research Foundation (DFG).	Ampofo E, 2013, BBA-GEN SUBJECTS, V1830, P2938, DOI 10.1016/j.bbagen.2012.12.020; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; BOLENDER RP, 1973, J CELL BIOL, V56, P746, DOI 10.1083/jcb.56.3.746; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Conti BJ, 2015, MOL CELL, V58, P269, DOI 10.1016/j.molcel.2015.02.018; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; FELDMAN D, 1980, J HISTOCHEM CYTOCHEM, V28, P997, DOI 10.1177/28.9.7410819; Greiner M, 2011, INT J CANCER, V128, P2284, DOI 10.1002/ijc.25580; Greiner M, 2011, PROSTATE, V71, P1074, DOI 10.1002/pros.21324; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hagerstrand D, 2013, CANCER DISCOV, V3, P1044, DOI 10.1158/2159-8290.CD-12-0592; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Jadhav B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10133; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Johnson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075394; Jung V, 2006, MOL CANCER RES, V4, P169, DOI 10.1158/1541-7786.MCR-05-0165; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koenig PA, 2014, J BIOL CHEM, V289, P34490, DOI 10.1074/jbc.M114.604132; Ktistakis NT, 2016, TRENDS CELL BIOL, V26, P624, DOI 10.1016/j.tcb.2016.03.006; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Linxweiler M, 2012, AM J PATHOL, V180, P473, DOI 10.1016/j.ajpath.2011.10.039; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Okamoto K, 2014, J CELL BIOL, V205, P435, DOI 10.1083/jcb.201402054; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Pirot P, 2007, DIABETOLOGIA, V50, P1006, DOI 10.1007/s00125-007-0609-0; Pisoni GB, 2016, TRAFFIC, V17, P341, DOI 10.1111/tra.12373; Pisoni GB, 2015, MOL BIOL CELL, V26, P3390, DOI 10.1091/mbc.E15-05-0321; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rubinsztein DC, 2015, NATURE, V522, P291, DOI 10.1038/nature14532; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Vittal V, 2015, J BIOL CHEM, V290, P21244, DOI 10.1074/jbc.R115.675165; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang X, 2005, J CELL SCI, V118, P723, DOI 10.1242/jcs.01671; Wemmert S, 2016, ONCOL LETT, V11, P1661, DOI 10.3892/ol.2016.4135; Weng L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-39; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yan L, 2014, J CELL SCI, V127, P1417, DOI 10.1242/jcs.135293; Zimmermann R, 2006, TRENDS MOL MED, V12, P567, DOI 10.1016/j.molmed.2006.10.004	55	229	236	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1173	+		10.1038/ncb3423	http://dx.doi.org/10.1038/ncb3423			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27749824	Green Accepted			2022-12-25	WOS:000387165600011
J	Stanley, D; Mason, LJ; Mackin, KE; Srilchanta, YN; Lyras, D; Prakash, MD; Nurgali, K; Venegas, A; Hill, MD; Moore, RJ; Wong, CHY				Stanley, Dragana; Mason, Linda J.; Mackin, Kate E.; Srilchanta, Yogitha N.; Lyras, Dena; Prakash, Monica D.; Nurgali, Kulmira; Venegas, Andres; Hill, Michael D.; Moore, Robert J.; Wong, Connie H. Y.			Translocation and dissemination of commensal bacteria in post-stroke infection	NATURE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; VENTILATOR-ASSOCIATED PNEUMONIA; CENTRAL-NERVOUS-SYSTEM; STAPHYLOCOCCUS-AUREUS; ASPIRATION PNEUMONIA; STROKE; COMPLICATIONS; DYSFUNCTION; RESISTANCE; MICROBIOTA	Bacterial infection is highly prevalent in patients who have had a stroke. Despite the potential contribution of micro-aspiration in post-stroke pneumonia, we found that the majority of the microorganisms detected in the patients who developed infections after having a stroke were common commensal bacteria that normally reside in the intestinal tracts. In a mouse model of ischemic stroke, post-stroke infection was only observed in mice that were born and raised in specific-pathogen-free facilities; this was not seen in mice that were born and raised in germ-free facilities. Using high-throughput 16S rRNA gene amplicon sequencing and bioinformatics analyses, we provide evidence demonstrating that the source of the bacteria forming the microbial community in the lungs of post-stroke mice was indeed the host small intestine. Additionally, stroke-induced gut barrier permeability and dysfunction preceded the dissemination of orally inoculated bacteria to peripheral tissues. This study identifies a novel pathway in which stroke promotes the translocation and dissemination of selective strains of bacteria that originated from the host gut microbiota.	[Stanley, Dragana] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld, Australia; [Mason, Linda J.] Monash Univ, Dept Biochem, Clayton, Vic, Australia; [Mackin, Kate E.; Srilchanta, Yogitha N.; Lyras, Dena; Moore, Robert J.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Mackin, Kate E.; Srilchanta, Yogitha N.; Lyras, Dena; Moore, Robert J.] Monash Univ, Dept Microbiol, Clayton, Vic, Australia; [Prakash, Monica D.; Nurgali, Kulmira] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis, St Albans, Vic, Australia; [Venegas, Andres; Hill, Michael D.] Univ Calgary, Dept Clin Neurosci, Stroke Unit, Calgary, AB, Canada; [Venegas, Andres; Hill, Michael D.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Moore, Robert J.] RMIT Univ, Sch Sci, Bundoora, Vic, Australia; [Wong, Connie H. Y.] Monash Univ, Sch Clin Sci, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia	Central Queensland University; Monash University; Monash University; Monash University; Victoria University; University of Calgary; University of Calgary; Royal Melbourne Institute of Technology (RMIT); Monash University	Wong, CHY (corresponding author), Monash Univ, Sch Clin Sci, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia.	connie.wong@monash.edu	Stanley, Dragana/AAC-2596-2020; Prakash, Monica/AAK-1548-2021; Hill, Michael D/C-9073-2012; Moore, Robert J/D-8352-2011	Stanley, Dragana/0000-0001-7019-4726; Hill, Michael D/0000-0002-6269-1543; Moore, Robert J/0000-0002-0776-5861; Wong, Connie/0000-0002-9020-1847; Prakash, Monica/0000-0002-2814-7560; Lyras, Dena/0000-0003-2345-9271; Srikhanta, Yogitha/0000-0002-7513-9969; Nurgali, Kulmira/0000-0002-2597-6929	Australia Research Council (ARC); Australian National Heart Foundation (NHF); Australian National Health and Medical Research Council (NHMRC); Alberta Innovates [201300690] Funding Source: researchfish	Australia Research Council (ARC)(Australian Research Council); Australian National Heart Foundation (NHF)(National Heart Foundation of Australia); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Alberta Innovates	We thank the staff at Monash Animal Research Facilities, Monash Micromon, Monash Micro Imaging and Monash Histology Platform, which are managed by Monash University The bioinformatics data was analyzed using the Isaac Newton high-performance computing system at Central Queensland University We wish to acknowledge the help from J. Bell that was provided for all aspects of the high-performance computing. We thank E.A. Palombo (Swinburne University of Technology) for providing a streptomycin-resistant derivative of the E. coli strain ATCC700927 (EDL933), designated DLL206. The work was supported by the Australia Research Council (ARC) (D.S. and C.H.Y.W.), the Australian National Heart Foundation (NHF) (C.H.Y.W.) and the Australian National Health and Medical Research Council (NHMRC) (C.H.Y.W.).	Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gauguet S, 2015, INFECT IMMUN, V83, P4003, DOI 10.1128/IAI.00037-15; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hannawi Y, 2013, CEREBROVASC DIS, V35, P430, DOI 10.1159/000350199; Hill LT, 2013, NUTRITION, V29, P948, DOI 10.1016/j.nut.2012.12.023; Ho PL, 2009, CHEST, V136, P1119, DOI 10.1378/chest.09-0285; Kalra L, 2015, LANCET, V386, P1835, DOI 10.1016/S0140-6736(15)00126-9; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Marik PE, 1999, CHEST, V115, P178, DOI 10.1378/chest.115.1.178; Martinez RM, 2014, J CLIN MICROBIOL, V52, P30, DOI 10.1128/JCM.02072-13; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Menuet Magalie, 2008, J Med Case Rep, V2, P373, DOI 10.1186/1752-1947-2-373; Messika J, 2012, INTENS CARE MED, V38, P2007, DOI 10.1007/s00134-012-2699-5; Miller RF, 2005, INT J STD AIDS, V16, P763, DOI 10.1258/095646205774763243; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sheth K, 2001, Curr Opin Crit Care, V7, P99, DOI 10.1097/00075198-200104000-00008; Stechmiller J K, 1997, Am J Crit Care, V6, P204; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Umar Shahid, 2010, Curr Gastroenterol Rep, V12, P340, DOI 10.1007/s11894-010-0130-3; Valentine S., 2013, EXAMINATION BEHAV BA; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Winek K, 2016, STROKE, V47, P1354, DOI 10.1161/STROKEAHA.115.011800; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	35	201	215	7	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1277	1284		10.1038/nm.4194	http://dx.doi.org/10.1038/nm.4194			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27694934				2022-12-25	WOS:000387302300020
J	Yu, VY; Chang, MCY				Yu, Vivian Y.; Chang, Michelle C. Y.			High-yield chemical synthesis by reprogramming central metabolism	NATURE BIOTECHNOLOGY			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; CONSERVATION	Altering the hardwired stoichiometry of central metabolism in yeast enables efficient synthesis of the isoprenoid beta-farnesene.	[Yu, Vivian Y.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Yu, Vivian Y.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chang, Michelle C. Y.] Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Chang, MCY (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Chang, MCY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	mcchang@berkeley.edu						BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Bogorad IW, 2013, NATURE, V502, P693, DOI 10.1038/nature12575; Kozak BU, 2014, METAB ENG, V21, P46, DOI 10.1016/j.ymben.2013.11.005; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/NCHEMBIO.970, 10.1038/nchembio.970]; Meadows AL, 2016, NATURE, V537, P694, DOI 10.1038/nature19769; Nielsen J, 2016, CELL, V164, P1185, DOI 10.1016/j.cell.2016.02.004; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; SONNLEITNER B, 1986, BIOTECHNOL BIOENG, V28, P927, DOI 10.1002/bit.260280620; Stephanopoulos G., 1998, J METABOLIC ENG PRIN; van Rossum HM, 2016, METAB ENG, V36, P99, DOI 10.1016/j.ymben.2016.03.006	10	2	2	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1128	1129		10.1038/nbt.3723	http://dx.doi.org/10.1038/nbt.3723			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27824836	Bronze			2022-12-25	WOS:000387506500024
J	Cuculis, L; Abil, Z; Zhao, HM; Schroeder, CM				Cuculis, Luke; Abil, Zhanar; Zhao, Huimin; Schroeder, Charles M.			TALE proteins search DNA using a rotationally decoupled mechanism	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; TARGET LOCATION; IONIC-STRENGTH; III EFFECTORS; DIFFUSION; REVEALS; LOCALIZATION; SPECIFICITY; RECOGNITION; DOMAINS	Transcription activator-like effector (TALE) proteins are a class of programmable DNA-binding proteins used extensively for gene editing. Despite recent progress, however, little is known about their sequence search mechanism. Here, we use single-molecule experiments to study TALE search along DNA. Our results show that TALEs utilize a rotationally decoupled mechanism for nonspecific search, despite remaining associated with DNA templates during the search process. Our results suggest that the protein helical structure enables TALEs to adopt a loosely wrapped conformation around DNA templates during nonspecific search, facilitating rapid one-dimensional (1D) diffusion under a range of solution conditions. Furthermore, this model is consistent with a previously reported two-state mechanism for TALE search that allows these proteins to overcome the search speed-stability paradox. Taken together, our results suggest that TALE search is unique among the broad class of sequence-specific DNA-binding proteins and supports efficient 1D search along DNA.	[Cuculis, Luke; Zhao, Huimin; Schroeder, Charles M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Abil, Zhanar; Zhao, Huimin] Univ Illinois, Dept Biochem, Urbana, IL USA; [Schroeder, Charles M.] Univ Illinois, Dept Biomol & Chem Engn, Urbana, IL 61801 USA; [Schroeder, Charles M.] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Schroeder, Charles M.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Schroeder, CM (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.; Schroeder, CM (corresponding author), Univ Illinois, Dept Biomol & Chem Engn, Urbana, IL 61801 USA.; Schroeder, CM (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.; Schroeder, CM (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	cms@illinois.edu		Schroeder, Charles/0000-0001-6023-2274	David and Lucile Packard Foundation; Institute for Genomic Biology at the University of Illinois at Urbana-Champaign; FMC Corporation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Institute for Genomic Biology at the University of Illinois at Urbana-Champaign; FMC Corporation	We thank T. Ha (University of Illinois Urbana-Champaign) for providing the plasmid for the aldehyde labeling scheme and S. Li for assistance in acquiring transmission electron microscope images of quantum dots. C.M.S. is funded by the David and Lucile Packard Foundation. H.Z. and L.C. are funded by the Institute for Genomic Biology at the University of Illinois at Urbana-Champaign. L.C. is funded by the FMC Corporation.	Bagchi B, 2008, J PHYS CHEM B, V112, P6282, DOI 10.1021/jp077568f; Barbi M, 2013, ADV PROTEIN CHEM STR, V92, P253, DOI 10.1016/B978-0-12-411636-8.00007-9; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Berdien B, 2014, GENE THER, V21, P539, DOI 10.1038/gt.2014.26; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2013, J BIOL CHEM, V288, P2092, DOI 10.1074/jbc.M112.407460; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Carrico IS, 2007, NAT CHEM BIOL, V3, P321, DOI 10.1038/nchembio878; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cho WK, 2012, STRUCTURE, V20, P1264, DOI 10.1016/j.str.2012.04.017; Cravens SL, 2014, BIOCHEMISTRY-US, V53, P7680, DOI 10.1021/bi501011m; Cuculis L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8277; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Desruisseaux C, 2001, MACROMOLECULES, V34, P44, DOI 10.1021/ma0002702; Dikic J, 2012, NUCLEIC ACIDS RES, V40, P4064, DOI 10.1093/nar/gkr1309; Dunn AR, 2011, NUCLEIC ACIDS RES, V39, P7487, DOI 10.1093/nar/gkr459; Esadze A, 2014, NUCLEIC ACIDS RES, V42, P7039, DOI 10.1093/nar/gku418; Etson CM, 2010, P NATL ACAD SCI USA, V107, P1900, DOI 10.1073/pnas.0912664107; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Kampmann M, 2004, J BIOL CHEM, V279, P38715, DOI 10.1074/jbc.M404504200; Kochaniak AB, 2009, J BIOL CHEM, V284, P17700, DOI 10.1074/jbc.M109.008706; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; Lei HX, 2014, ADV PROTEIN CHEM STR, V94, P347, DOI 10.1016/B978-0-12-800168-4.00009-3; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Richter A, 2016, METHODS MOL BIOL, V1338, P9, DOI 10.1007/978-1-4939-2932-0_2; Schreiber T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120214; Schroeder C. M., 2008, SINGLE MOL TECHNIQUE, P461; SCHURR JM, 1979, BIOPHYS CHEM, V9, P413, DOI 10.1016/0301-4622(75)80057-3; Schwarz FW, 2013, SCIENCE, V340, P353, DOI 10.1126/science.1231122; Shi XH, 2012, NAT METHODS, V9, P499, DOI [10.1038/NMETH.1954, 10.1038/nmeth.1954]; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Terakawa T, 2012, J AM CHEM SOC, V134, P14555, DOI 10.1021/ja305369u; Vestergaard CL, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022726; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; Xiong K, 2016, NUCLEIC ACIDS RES, V44, P2266, DOI 10.1093/nar/gkw035; Yardimci H, 2012, METHODS, V57, P179, DOI 10.1016/j.ymeth.2012.03.033; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	52	37	38	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					831	+		10.1038/NCHEMBIO.2152	http://dx.doi.org/10.1038/NCHEMBIO.2152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27526029				2022-12-25	WOS:000384248600015
J	Esmail, H; Lai, RP; Lesosky, M; Wilkinson, KA; Graham, CM; Coussens, AK; Oni, T; Warwick, JM; Said-Hartley, Q; Koegelenberg, CF; Walzl, G; Flynn, JL; Young, DB; Barry, CE; O'Garra, A; Wilkinson, RJ				Esmail, Hanif; Lai, Rachel P.; Lesosky, Maia; Wilkinson, Katalin A.; Graham, Christine M.; Coussens, Anna K.; Oni, Tolu; Warwick, James M.; Said-Hartley, Qonita; Koegelenberg, Coenraad F.; Walzl, Gerhard; Flynn, JoAnne L.; Young, Douglas B.; Barry, Clifton E., III; O'Garra, Anne; Wilkinson, Robert J.			Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[F-18] fluoro-D-glucose positron emission and computed tomography	NATURE MEDICINE			English	Article							PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; FUTURE-PROSPECTS; INFECTION; PREVALENCE; STRATEGIES; DISEASE; ADULTS; LUNG	Tuberculosis is classically divided into states of latent infection and active disease. Using combined positron emission and computed tomography in 35 asymptomatic, antiretroviral-therapy-naive, HIV-1-infected adults with latent tuberculosis, we identified ten individuals with pulmonary abnormalities suggestive of subclinical, active disease who were substantially more likely to progress to clinical disease. Our findings challenge the conventional two-state paradigm and may aid future identification of biomarkers that are predictive of progression.	[Esmail, Hanif; Young, Douglas B.; Wilkinson, Robert J.] Imperial Coll London, Dept Med, London, England; [Esmail, Hanif; Lesosky, Maia; Wilkinson, Katalin A.; Coussens, Anna K.; Oni, Tolu; Barry, Clifton E., III; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, Cape Town, South Africa; [Esmail, Hanif] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Lai, Rachel P.; Wilkinson, Katalin A.; Graham, Christine M.; Young, Douglas B.; O'Garra, Anne; Wilkinson, Robert J.] Francis Crick Inst Mill Hill Lab, London, England; [Lesosky, Maia] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Warwick, James M.] Univ Stellenbosch, Dept Med Imaging & Clin Oncol, Cape Town, South Africa; [Said-Hartley, Qonita] Groote Schuur Hosp, Dept Radiol, Cape Town, South Africa; [Koegelenberg, Coenraad F.; Walzl, Gerhard] Univ Stellenbosch, Dept Med, Cape Town, South Africa; [Walzl, Gerhard; Barry, Clifton E., III] Univ Stellenbosch, Dept Biomed Sci, Fac Med & Hlth Sci, Cape Town, South Africa; [Flynn, JoAnne L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Barry, Clifton E., III] NIAID, TB Res Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Barry, Clifton E., III] Univ Cape Town, Dept Pathol, Cape Town, South Africa; [O'Garra, Anne] Imperial Coll London, Natl Heart & Lung Inst, London, England	Imperial College London; University of Cape Town; University of Oxford; Francis Crick Institute; University of Cape Town; Stellenbosch University; University of Cape Town; Stellenbosch University; Stellenbosch University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cape Town; Imperial College London	Esmail, H; Wilkinson, RJ (corresponding author), Imperial Coll London, Dept Med, London, England.; Esmail, H; Wilkinson, RJ (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, Cape Town, South Africa.; Esmail, H (corresponding author), Univ Oxford, Radcliffe Dept Med, Oxford, England.; Wilkinson, RJ (corresponding author), Francis Crick Inst Mill Hill Lab, London, England.	hanif.esmail@ndcls.ox.ac.uk; r.j.wilkinson@imperial.ac.uk	Wilkinson, Katalin/AAQ-7713-2021; Barry, Clifton E/ABE-7992-2020; Coussens, Anna Kathleen/AAN-2949-2021; Barry, III, Clifton/H-3839-2012; Lesosky, Maia/AAM-4174-2020; Wilkinson, Katalin/AAF-6805-2020; Flynn, JoAnne/ABC-7371-2020; Walzl, Gerhard/N-6371-2016	Wilkinson, Katalin/0000-0002-9796-2040; Barry, Clifton E/0000-0002-2927-270X; Coussens, Anna Kathleen/0000-0002-7086-2621; Barry, III, Clifton/0000-0002-2927-270X; Lesosky, Maia/0000-0002-2026-958X; Graham, Christine/0000-0001-9329-6231; Wilkinson, Robert/0000-0002-2753-1800; O'Garra, Anne/0000-0001-9845-6134; Walzl, Gerhard/0000-0003-2487-125X; Warwick, James/0000-0002-2810-0543; Esmail, Hanif/0000-0002-4278-9316; Lai, Rachel/0000-0003-3418-850X; Oni, Tolu/0000-0003-4499-1910	Wellcome Trust [090170, 104803]; Bill and Melinda Gates Foundation-Wellcome Trust Grand challenges in Global Health [37822]; US National Institutes of Health (NIH) [R01 HL106804]; intramural research program of the NIH-NIAID; European Union [FP& HEALTH F3-2012-305578]; National Research Foundation of South Africa [96841]; Research Councils of the UK via the Francis Crick Institute [10218, U117565642]; Medical Research Council of South Africa (Strategic Health Innovations partnership); Medical Research Council [MC_U117565642, 1365570, 1105853, MC_U117588499] Funding Source: researchfish; Wellcome Trust [104803/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10126, 10222, 10218] Funding Source: researchfish; MRC [MC_U117565642, MC_U117588499] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106804] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation-Wellcome Trust Grand challenges in Global Health; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); intramural research program of the NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union(European Commission); National Research Foundation of South Africa(National Research Foundation - South Africa); Research Councils of the UK via the Francis Crick Institute; Medical Research Council of South Africa (Strategic Health Innovations partnership)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Wellcome Trust (grant no. 090170 (H.E.) and 104803 (R.J.W.)), the Bill and Melinda Gates Foundation-Wellcome Trust Grand challenges in Global Health (grant no. 37822; D.B.Y.), the US National Institutes of Health (NIH) (grant no. R01 HL106804; J.L.F.) and the intramural research program of the NIH-NIAID (C.E.B.). R.J.W. also received support from the European Union (grant no. FP& HEALTH F3-2012-305578), the National Research Foundation of South Africa (grant no. 96841), the Research Councils of the UK via the Francis Crick Institute (grant no. 10218 and U117565642) and the Medical Research Council of South Africa (Strategic Health Innovations partnership).	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Coleman MT, 2014, INFECT IMMUN, V82, P2400, DOI 10.1128/IAI.01599-13; Corbett EL, 2013, INT J TUBERC LUNG D, V17, P1125, DOI 10.5588/ijtld.13.0117; CRAVEN SA, 1979, S AFR MED J, V55, P89; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Ghesani N, 2014, AM J RESP CRIT CARE, V189, P748, DOI 10.1164/rccm.201311-1976LE; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hunter RL, 2011, TUBERCULOSIS, V91, P497, DOI 10.1016/j.tube.2011.03.007; Koppaka R, 2004, TOMANS TUBERCULOSIS, P51; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Mamede M, 2005, NEOPLASIA, V7, P369, DOI 10.1593/neo.04577; Oni T, 2011, THORAX, V66, P669, DOI 10.1136/thx.2011.160168; Opie EL, 1917, J EXP MED, V25, P855, DOI 10.1084/jem.25.6.855; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Rybicki BA, 2007, SEMIN RESP CRIT CARE, V28, P22, DOI 10.1055/s-2007-970331; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; STEAD WW, 1967, NEW ENGL J MED, V277, P1008, DOI 10.1056/NEJM196711092771906; STEINBRUECK P, 1972, Bulletin of the International Union Against Tuberculosis, V47, P135; TRAMONTANA JM, 1995, MOL MED, V1, P384, DOI 10.1007/BF03401576; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1	20	108	113	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1090	1093		10.1038/nm.4161	http://dx.doi.org/10.1038/nm.4161			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27595321	Green Submitted, Green Accepted			2022-12-25	WOS:000384872500011
J	Shekhar-Guturja, T; Gunaherath, GMKB; Wijeratne, EMK; Lambert, JP; Averette, AF; Lee, SC; Kim, T; Bahn, YS; Tripodi, F; Ammar, R; Dohl, K; Niewola-Staszkowska, K; Schmitt, L; Loewith, RJ; Roth, FP; Sanglard, D; Andes, D; Nislow, C; Coccetti, P; Gingras, AC; Heitman, J; Gunatilaka, AAL; Cowen, LE				Shekhar-Guturja, Tanvi; Gunaherath, G. M. Kamal B.; Wijeratne, E. M. Kithsiri; Lambert, Jean-Philippe; Averette, Anna F.; Lee, Soo Chan; Kim, Taeyup; Bahn, Yong-Sun; Tripodi, Farida; Ammar, Ron; Doehl, Katja; Niewola-Staszkowska, Karolina; Schmitt, Lutz; Loewith, Robbie J.; Roth, Frederick P.; Sanglard, Dominique; Andes, David; Nislow, Corey; Coccetti, Paola; Gingras, Anne-Claude; Heitman, Joseph; Gunatilaka, A. A. Leslie; Cowen, Leah E.			Dual action antifungal small molecule modulates multidrug efflux and TOR signaling	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE CK2; ABC TRANSPORTER PDR5; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; FUNGAL-INFECTIONS; DRUG-RESISTANCE; GENE-EXPRESSION; CYCLOSPORINE-A; CELL-GROWTH; YEAST	There is an urgent need for new strategies to treat invasive fungal infections, which are a leading cause of human mortality. Here, we establish two activities of the natural product beauvericin, which potentiates the activity of the most widely deployed class of antifungal against the leading human fungal pathogens, blocks the emergence of drug resistance, and renders antifungal-resistant pathogens responsive to treatment in mammalian infection models. Harnessing genome sequencing of beauvericin-resistant mutants, affinity purification of a biotinylated beauvericin analog, and biochemical and genetic assays reveals that beauvericin blocks multidrug efflux and inhibits the global regulator TORC1 kinase, thereby activating the protein kinase CK2 and inhibiting the molecular chaperone Hsp90. Substitutions in the multidrug transporter Pdr5 that enable beauvericin efflux impair antifungal efflux, thereby impeding resistance to the drug combination. Thus, dual targeting of multidrug efflux and TOR signaling provides a powerful, broadly effective therapeutic strategy for treating fungal infectious disease that evades resistance.	[Shekhar-Guturja, Tanvi; Roth, Frederick P.; Gingras, Anne-Claude; Cowen, Leah E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Gunaherath, G. M. Kamal B.; Wijeratne, E. M. Kithsiri; Gunatilaka, A. A. Leslie] Univ Arizona, Sch Nat Resources & Environm, Coll Agr & Life Sci, Nat Prod Ctr, Tucson, AZ USA; [Lambert, Jean-Philippe; Roth, Frederick P.; Gingras, Anne-Claude] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Averette, Anna F.; Lee, Soo Chan; Kim, Taeyup; Heitman, Joseph] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC USA; [Bahn, Yong-Sun] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea; [Tripodi, Farida] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Tripodi, Farida] SYSBIO, Ctr Syst Biol, Milan, Italy; [Ammar, Ron] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Doehl, Katja; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany; [Niewola-Staszkowska, Karolina; Loewith, Robbie J.] Univ Geneva, Dept Mol Biol, Geneva, Switzerland; [Sanglard, Dominique] Univ Lausanne Hosp, Inst Microbiol, Lausanne, Switzerland; [Sanglard, Dominique] Univ Hosp Ctr, Lausanne, Switzerland; [Andes, David] Univ Wisconsin, Dept Med, Madison, WI USA; [Andes, David] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI USA; [Nislow, Corey] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	University of Toronto; University of Arizona; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Duke University; Yonsei University; University of Milano-Bicocca; University of Toronto; Heinrich Heine University Dusseldorf; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of British Columbia	Cowen, LE (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	leah.cowen@utoronto.ca	Andes, David/ABE-8033-2020; Gingras, Anne-Claude/E-9982-2010; Coccetti, Paola/Y-2365-2019; Loewith, Robbie J/S-6289-2016; Sanglard, Dominique/K-6032-2017; Tripodi, Farida/I-3759-2019; Roth, Frederick P/H-6308-2011; Heitman, Joseph/ABC-6006-2021; Gingras, Anne-Claude/ABA-8341-2020; Bahn, Yong-Sun/C-1211-2012	Gingras, Anne-Claude/0000-0002-6090-4437; Coccetti, Paola/0000-0001-5898-5883; Loewith, Robbie J/0000-0002-2482-603X; Sanglard, Dominique/0000-0002-5244-4178; Gingras, Anne-Claude/0000-0002-6090-4437; Tripodi, Farida/0000-0003-1246-979X; Ammar, Ron/0000-0002-6006-7392; Andes, David/0000-0002-7927-9950; Cowen, Leah/0000-0001-5797-0110; Bahn, Yong-Sun/0000-0001-9573-5752; Lambert, Jean-Philippe/0000-0002-0833-1221	Ontario Graduate Scholarship; University of Toronto Open Fellowship; Canadian Institutes of Health Research (CIHR) Operating Grants [MOP-86452, MOP-119520]; Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grants [06261, 462167]; NSERC E.W.R. Steacie Memorial Fellowship [477598]; Canada Research Chair in Microbial Genomics and Infectious Disease; DUKE PO1 [AI104533-01]; RO1 [AI112595-02]; General International Collaborative R&D program - Ministry of Trade, Industry and Energy (MOTIE) in Republic of Korea [N0001720]; US Institutes of Health Grants [R01 CA090265, P41 GM094060]; CIHR Foundation Grant; Genome Canada Genomics Innovation Network (GIN) Node and Technical Development Grants; Canada Research Chair in Functional Proteomics; CIHR; TD Bank Health Research Fellowship at the Lunenfeld-Tanenbaum Research Institute; Italian Government; MIUR; NATIONAL CANCER INSTITUTE [R01CA090265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI104533, R01AI112595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM094060] Funding Source: NIH RePORTER	Ontario Graduate Scholarship(Ontario Graduate Scholarship); University of Toronto Open Fellowship(University of Toronto); Canadian Institutes of Health Research (CIHR) Operating Grants(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC E.W.R. Steacie Memorial Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Microbial Genomics and Infectious Disease(Canada Research Chairs); DUKE PO1; RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General International Collaborative R&D program - Ministry of Trade, Industry and Energy (MOTIE) in Republic of Korea; US Institutes of Health Grants; CIHR Foundation Grant(Canadian Institutes of Health Research (CIHR)); Genome Canada Genomics Innovation Network (GIN) Node and Technical Development Grants; Canada Research Chair in Functional Proteomics; CIHR(Canadian Institutes of Health Research (CIHR)); TD Bank Health Research Fellowship at the Lunenfeld-Tanenbaum Research Institute; Italian Government; MIUR(Ministry of Education, Universities and Research (MIUR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Donnelly Sequencing Centre for whole genome sequencing; the 2013 MGY360H1 class for performing and analyzing whole-genome sequencing data for a subset of the resistant mutants in the ABC16 background; D. Kim for assistance with genome sequencing analysis of the resistant mutants in the yor1 Delta background; and all members of the Cowen lab for discussions. T.S.-G. is supported by the Ontario Graduate Scholarship and University of Toronto Open Fellowship. L.E.C. is supported by the Canadian Institutes of Health Research (CIHR) Operating Grants (MOP-86452 and MOP-119520), the Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grants (06261 and 462167), an NSERC E.W.R. Steacie Memorial Fellowship (477598), and a Canada Research Chair in Microbial Genomics and Infectious Disease. J.H. is supported by the DUKE PO1 (AI104533-01) and RO1 (AI112595-02) for antifungal drug discovery. Y.-S.B is supported by the General International Collaborative R&D program funded by Ministry of Trade, Industry and Energy (MOTIE) in Republic of Korea (N0001720). A.A.L.G. is supported by US Institutes of Health Grants (R01 CA090265 and P41 GM094060). A.-C.G. is supported by a CIHR Foundation Grant, Genome Canada Genomics Innovation Network (GIN) Node and Technical Development Grants, and a Canada Research Chair in Functional Proteomics. J.-P.L was supported by a postdoctoral fellowship from the CIHR and by a TD Bank Health Research Fellowship at the Lunenfeld-Tanenbaum Research Institute. P.C. is supported by the Italian Government (FA). F.T. is supported by a postdoctoral fellowship from MIUR.	Anderson TM, 2014, NAT CHEM BIOL, V10, P400, DOI 10.1038/nchembio.1496; Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Bruno VM, 2005, MOL MICROBIOL, V56, P559, DOI 10.1111/j.1365-2958.2005.04562.x; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Choi Hyungwon, 2012, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0815s39; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Coccetti P, 2004, MOL MICROBIOL, V51, P447, DOI 10.1046/j.1365-2958.2003.03836.x; Coccetti P, 2006, BIOCHEM BIOPH RES CO, V346, P786, DOI 10.1016/j.bbrc.2006.05.171; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2013, CURR OPIN MICROBIOL, V16, P377, DOI 10.1016/j.mib.2013.03.005; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; Cruz MC, 2001, ANTIMICROB AGENTS CH, V45, P3162, DOI 10.1128/AAC.45.11.3162-3170.2001; Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Egner R, 1998, MOL BIOL CELL, V9, P523, DOI 10.1091/mbc.9.2.523; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Fukuda T, 2004, J ANTIBIOT, V57, P117, DOI 10.7164/antibiotics.57.117; GOFFEAU A, 1988, METHOD ENZYMOL, V157, P528; Gupta RP, 2014, J BIOL CHEM, V289, P15272, DOI 10.1074/jbc.M114.553065; Hawle P, 2007, EUKARYOT CELL, V6, P521, DOI 10.1128/EC.00343-06; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003390; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Kubinski K, 2007, MOL CELL BIOCHEM, V295, P229, DOI 10.1007/s11010-006-9292-6; Kumar R, 2005, MOL BIOCHEM PARASIT, V141, P29, DOI 10.1016/j.molbiopara.2005.01.012; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Leach MD, 2012, NAT REV MICROBIOL, V10, P693, DOI 10.1038/nrmicro2875; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma JF, 1997, MOL PHARMACOL, V51, P922, DOI 10.1124/mol.51.6.922; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; Mollapour M, 2011, MOL CELL, V41, P672, DOI 10.1016/j.molcel.2011.02.011; Piper PW, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120138; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Roemer T, 2011, CHEM BIOL, V18, P148, DOI 10.1016/j.chembiol.2011.01.009; Sanchez-Casalongue ME, 2015, J BIOL CHEM, V290, P7221, DOI 10.1074/jbc.M114.626523; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Suzuki Y, 2011, NAT METHODS, V8, P159, DOI 10.1038/NMETH.1550; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Tripodi F, 2010, BIOCHEM BIOPH RES CO, V398, P44, DOI 10.1016/j.bbrc.2010.06.028; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wang QG, 2012, MOLECULES, V17, P2367, DOI 10.3390/molecules17032367; Xu YQ, 2008, CHEM BIOL, V15, P898, DOI 10.1016/j.chembiol.2008.07.011; Zhang LX, 2007, P NATL ACAD SCI USA, V104, P4606, DOI 10.1073/pnas.0609370104	57	54	57	2	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					867	+		10.1038/NCHEMBIO.2165	http://dx.doi.org/10.1038/NCHEMBIO.2165			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27571477	Green Accepted			2022-12-25	WOS:000384248600020
J	Frede, J; Greulich, P; Nagy, T; Simons, BD; Jones, PH				Frede, Julia; Greulich, Philip; Nagy, Tibor; Simons, Benjamin D.; Jones, Philip H.			A single dividing cell population with imbalanced fate drives oesophageal tumour growth	NATURE CELL BIOLOGY			English	Article							HISTONE MESSENGER-RNA; PROGENITOR CELLS; CANCER; STEM; EXPRESSION; SKIN; DIFFERENTIATION; SORAFENIB; ORIGIN; INFLAMMATION	Understanding the cellular mechanisms of tumour growth is key for designing rational anticancer treatment. Here we used genetic lineage tracing to quantify cell behaviour during neoplastic transformation in a model of oesophageal carcinogenesis. We found that cell behaviour was convergent across premalignant tumours, which contained a single proliferating cell population. The rate of cell division was not significantly different in the lesions and the surrounding epithelium. However, dividing tumour cells had a uniform, small bias in cell fate so that, on average, slightly more dividing than non-dividing daughter cells were generated at each round of cell division. In invasive cancers induced by Krasm expression, dividing cell fate became more strongly biased towards producing dividing over non-dividing cells in a subset of clones. These observations argue that agents that restore the balance of cell fate may prove effective in checking tumour growth, whereas those targeting cycling cells may show little selectivity.	[Frede, Julia; Nagy, Tibor; Jones, Philip H.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Greulich, Philip; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England; [Greulich, Philip; Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England; [Jones, Philip H.] Univ Cambridge, MRC Canc Unit, Hutchison MRC Res Ctr, Box 197,Cambridge Biomed Campus, Cambridge CB2 0XZ, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Jones, PH (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.; Jones, PH (corresponding author), Univ Cambridge, MRC Canc Unit, Hutchison MRC Res Ctr, Box 197,Cambridge Biomed Campus, Cambridge CB2 0XZ, England.	pj3@sanger.ac.uk	Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Jones, Philip H/0000-0002-5904-795X; Nagy, Tibor/0000-0002-4451-0796; Frede, Julia/0000-0002-4380-9673; Greulich, Philip/0000-0001-5247-6738	Cancer Research UK Programme Grant [C609/A17257]; DFG Research Fellowship; EPSRC Critical Mass Grant; Wellcome Trust [098357/Z/12/Z]; Cancer Research UK; Medical Research Council; Cancer Research UK [17257] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish; Medical Research Council [MC_PC_12009, MC_UU_12022/3] Funding Source: researchfish; EPSRC [EP/F032773/1] Funding Source: UKRI; MRC [MC_UU_12022/3] Funding Source: UKRI	Cancer Research UK Programme Grant(Cancer Research UK); DFG Research Fellowship(German Research Foundation (DFG)); EPSRC Critical Mass Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Malhotra, Consultant Upper GI Pathologist at Addenbrookes Hospital Cambridge for assistance with histopathology. This work was funded by a Cancer Research UK Programme Grant (C609/A17257) to P.H.J., a Medical Research Council Grant-in-Aid and core support at the Wellcome Trust Sanger Institute. P.G. was funded by a DFG Research Fellowship and an EPSRC Critical Mass Grant. B.D.S. acknowledges the support of the Wellcome Trust (grant number 098357/Z/12/Z) and the core funding to the Gurdon Institute by the Wellcome Trust and Cancer Research UK.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Alcolea MP, 2015, CELL CYCLE, V14, P9, DOI 10.4161/15384101.2014.988027; Alcolea MP, 2014, NAT CELL BIOL, V16, P612, DOI 10.1038/ncb2963; Alcolea MP, 2013, NAT REV CANCER, V13, P161, DOI 10.1038/nrc3460; Arnault JP, 2012, CLIN CANCER RES, V18, P263, DOI 10.1158/1078-0432.CCR-11-1344; Arnault JP, 2009, J CLIN ONCOL, V27, pE59, DOI 10.1200/JCO.2009.23.4823; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HARRIS ME, 1991, MOL CELL BIOL, V11, P2416, DOI 10.1128/MCB.11.5.2416; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hobbs RP, 2015, NAT GENET, V47, P933, DOI 10.1038/ng.3355; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jensen MA, 2014, NAT STRUCT MOL BIOL, V21, P189, DOI 10.1038/nsmb.2756; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Kitadai Y, 2001, INT J CANCER, V93, P662, DOI 10.1002/ijc.1379; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kubota Y, 2009, FRONT BIOSCI-LANDMRK, V14, P3872, DOI [10.2735/3495, 10.2741/3495]; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Liu KC, 2013, CELL STEM CELL, V12, P304, DOI 10.1016/j.stem.2013.01.007; Maddipati R, 2015, CANCER DISCOV, V5, P1086, DOI 10.1158/2159-8290.CD-15-0120; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ohkoshi A, 2013, CANCER PREV RES, V6, P149, DOI 10.1158/1940-6207.CAPR-12-0401-T; Opitz OG, 2002, J CLIN INVEST, V110, P761, DOI 10.1172/JCI200215324; Parsons BL, 2008, MUTAT RES-REV MUTAT, V659, P232, DOI 10.1016/j.mrrev.2008.05.004; PIERCE GB, 1971, CANCER RES, V31, P127; REUBER MD, 1977, J NATL CANCER I, V58, P313, DOI 10.1093/jnci/58.2.313; Roshan A, 2016, NAT CELL BIOL, V18, P145, DOI 10.1038/ncb3282; Ross-Innes CS, 2015, NAT GENET, V47, P1038, DOI 10.1038/ng.3357; Rubio C A, 1987, In Vivo, V1, P35; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schneider TC, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2060-4; Schoppmann SF, 2013, SURGERY, V153, P526, DOI 10.1016/j.surg.2012.10.007; Shapiro J, 2015, LANCET ONCOL, V16, P1090, DOI 10.1016/S1470-2045(15)00040-6; Shin K, 2014, NAT CELL BIOL, V16, P469, DOI 10.1038/ncb2956; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Takahashi K, 1997, J BIOL CHEM, V272, P11979, DOI 10.1074/jbc.272.18.11979; Taylor PR, 2013, CANCER EPIDEM BIOMAR, V22, P540, DOI 10.1158/1055-9965.EPI-12-1347; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Wang GQ, 2005, GUT, V54, P187, DOI 10.1136/gut.2004.046631; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; WILSON JB, 1990, CELL, V61, P1315, DOI 10.1016/0092-8674(90)90695-B; WINTON DJ, 1989, BRIT J CANCER, V60, P59, DOI 10.1038/bjc.1989.220; Zheng W, 2014, J CLIN INVEST, V124, P878, DOI 10.1172/JCI71603	56	34	34	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2016	18	9					967	978		10.1038/ncb3400	http://dx.doi.org/10.1038/ncb3400			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DU7TF	27548914	Green Accepted			2022-12-25	WOS:000382416800007
J	Gohl, DM; Vangay, P; Garbe, J; MacLean, A; Hauge, A; Becker, A; Gould, TJ; Clayton, JB; Johnson, TJ; Hunter, R; Knights, D; Beckman, KB				Gohl, Daryl M.; Vangay, Pajau; Garbe, John; MacLean, Allison; Hauge, Adam; Becker, Aaron; Gould, Trevor J.; Clayton, Jonathan B.; Johnson, Timothy J.; Hunter, Ryan; Knights, Dan; Beckman, Kenneth B.			Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies	NATURE BIOTECHNOLOGY			English	Article							RIBOSOMAL-RNA GENE; SEQUENCING PLATFORMS; PCR COAMPLIFICATION; CHIMERIC MOLECULES; STORAGE-CONDITIONS; DNA-POLYMERASE; CYCLE NUMBER; ILLUMINA; BIAS; GENERATION	Amplicon-based marker gene surveys form the basis of most microbiome and other microbial community studies. Such PCR-based methods have multiple steps, each of which is susceptible to error and bias. Variance in results has also arisen through the use of multiple methods of next-generation sequencing (NGS) amplicon library preparation. Here we formally characterized errors and biases by comparing different methods of amplicon-based NGS library preparation. Using mock community standards, we analyzed the amplification process to reveal insights into sources of experimental error and bias in amplicon-based microbial community and microbiome experiments. We present a method that improves on the current best practices and enables the detection of taxonomic groups that often go undetected with existing methods.	[Gohl, Daryl M.; MacLean, Allison; Hauge, Adam; Becker, Aaron; Beckman, Kenneth B.] Univ Minnesota, Genom Ctr, Minneapolis, MN 55455 USA; [Vangay, Pajau] Univ Minnesota, Biomed Informat & Computat Biol, Minneapolis, MN USA; [Garbe, John] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN USA; [Gould, Trevor J.] Univ Minnesota, Inst Informat, Minneapolis, MN USA; [Clayton, Jonathan B.; Johnson, Timothy J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Hunter, Ryan] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN USA; [Knights, Dan] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Knights, Dan] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Hauge, Adam] Illumina, San Diego, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Illumina	Gohl, DM (corresponding author), Univ Minnesota, Genom Ctr, Minneapolis, MN 55455 USA.	dmgohl@umn.edu	Clayton, Jonathan Brent/I-1176-2019	Clayton, Jonathan Brent/0000-0003-3709-3362; Hunter, Ryan/0000-0003-3841-1676; Vangay, Pajau/0000-0002-9231-0692; Gohl, Daryl/0000-0002-4434-2788; Johnson, Timothy/0000-0001-7556-9347	Minnesota Partnership for Biotechnology and Medical Genomics (grant MNP IF) [14.09]; Margot Marsh Biodiversity Foundation; US National Institutes of Health (PharmacoNeuroImmunology Fellowship NIH/NIDA) [T32 DA007097-32]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007097] Funding Source: NIH RePORTER	Minnesota Partnership for Biotechnology and Medical Genomics (grant MNP IF); Margot Marsh Biodiversity Foundation; US National Institutes of Health (PharmacoNeuroImmunology Fellowship NIH/NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the staff of the University of Minnesota Genomics Center for helpful discussions and technical support. This work was supported by the Minnesota Partnership for Biotechnology and Medical Genomics (grant MNP IF #14.09). This work was carried out in part using computing resources at the University of Minnesota Supercomputing Institute. This work was also supported by the Margot Marsh Biodiversity Foundation and the US National Institutes of Health (PharmacoNeuroImmunology Fellowship NIH/NIDA T32 DA007097-32 to J.B.C.).	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; [Anonymous], 2012, PLOS ONE, V7; Ayyadevara S, 2000, ANAL BIOCHEM, V284, P11, DOI 10.1006/abio.2000.4635; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Amore R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2194-9; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Eloe-Fadrosh EA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.32, 10.1038/nmicrobiol.2015.32]; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hansen MC, 1998, FEMS MICROBIOL ECOL, V26, P141, DOI 10.1016/S0168-6496(98)00031-2; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Illumina, 2013, 15044223 ILL; Ishii K, 2001, APPL ENVIRON MICROB, V67, P3753, DOI 10.1128/AEM.67.8.3753-3755.2001; Jones MB, 2015, P NATL ACAD SCI USA, V112, P14024, DOI 10.1073/pnas.1519288112; Kennedy K, 2014, APPL ENVIRON MICROB, V80, P5717, DOI 10.1128/AEM.01451-14; Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nelson MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094249; Patin NV, 2013, MICROB ECOL, V65, P709, DOI 10.1007/s00248-012-0145-4; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Quail MA, 2012, NAT METHODS, V9, P10, DOI 10.1038/nmeth.1814; REYSENBACH AL, 1992, APPL ENVIRON MICROB, V58, P3417, DOI 10.1128/AEM.58.10.3417-3418.1992; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sinha R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0841-8; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; WAGNER A, 1994, SYST BIOL, V43, P250, DOI 10.2307/2413465; Wang GCY, 1996, MICROBIOL-SGM, V142, P1107, DOI 10.1099/13500872-142-5-1107; Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhao JC, 2011, J CLIN MICROBIOL, V49, P3717, DOI 10.1128/JCM.01189-11; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160; Zhou JZ, 2013, MBIO, V4, DOI 10.1128/mBio.00324-13	66	367	374	9	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2016	34	9					942	+		10.1038/nbt.3601	http://dx.doi.org/10.1038/nbt.3601			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DW0RE	27454739				2022-12-25	WOS:000383348500019
J	Sharon, E; Sibener, LV; Battle, A; Fraser, HB; Garcia, KC; Pritchard, JK				Sharon, Eilon; Sibener, Leah V.; Battle, Alexis; Fraser, Hunter B.; Garcia, K. Christopher; Pritchard, Jonathan K.			Genetic variation in MHC proteins is associated with T cell receptor expression biases	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; AMINO-ACIDS; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; THYMIC SELECTION; GERMLINE BIAS; IMMUNE-SYSTEM; CLASS-I; RECOGNITION; REPERTOIRE	In each individual, a highly diverse T cell receptor (TCR) repertoire interacts with peptides presented by major histocompatibility complex (MHC) molecules. Despite extensive research, it remains controversial whether germline-encoded TCR-MHC contacts promote TCR-MHC specificity and, if so, whether differences exist in TCR V gene compatibilities with different MHC alleles. We applied expression quantitative trait locus (eQTL) mapping to test for associations between genetic variation and TCR V gene usage in a large human cohort. We report strong trans associations between variation in the MHC locus and TCR V gene usage. Fine-mapping of the association signals identifies specific amino acids from MHC genes that bias V gene usage, many of which contact or are spatially proximal to the TCR or peptide in the TCR-peptide-MHC complex. Hence, these MHC variants, several of which are linked to autoimmune diseases, can directly affect TCR-MHC interaction. These results provide the first examples of trans-QTL effects mediated by protein-protein interactions and are consistent with intrinsic TCR-MHC specificity.	[Sharon, Eilon; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Sharon, Eilon; Fraser, Hunter B.; Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Sibener, Leah V.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol Physiol, Stanford, CA 94305 USA; [Sibener, Leah V.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Sibener, Leah V.] Stanford Univ, Program Immunol, Stanford, CA 94305 USA; [Battle, Alexis] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Garcia, K. Christopher; Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Johns Hopkins University; Howard Hughes Medical Institute; Stanford University	Pritchard, JK (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Pritchard, JK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol Physiol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.; Garcia, KC; Pritchard, JK (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kcgarcia@stanford.edu; pritch@stanford.edu		Sharon, Eilon/0000-0002-1262-350X	NIH [HG0070736, 1R01GM097171-01A1, RO1AI03867, U19AI057229]; Howard Hughes Medical Institute; EMBO Long-Term Fellowship; National Science Foundation Graduate Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103867, U19AI057229, R01AI048540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Golan, D. Knowles, A. Fu, M. Birnbaum, M. Gee, J. Mendoza, A. Bhaskar and T. Raj for helpful discussions and the anonymous referees for valuable comments. This work was supported by NIH grants HG0070736, 1R01GM097171-01A1, RO1AI03867 and U19AI057229, the Howard Hughes Medical Institute, the EMBO Long-Term Fellowship and a National Science Foundation Graduate Research Fellowship.	Adams JJ, 2016, NAT IMMUNOL, V17, P87, DOI 10.1038/ni.3310; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blevins SJ, 2016, P NATL ACAD SCI USA, V113, pE1276, DOI 10.1073/pnas.1522069113; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Castro CD, 2015, IMMUNOL REV, V267, P30, DOI 10.1111/imr.12327; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Garcia KC, 2012, TRENDS IMMUNOL, V33, P429, DOI 10.1016/j.it.2012.05.005; Garcia KC, 2012, IMMUNITY, V36, P887, DOI 10.1016/j.immuni.2012.05.018; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; GULWANIAKOLKAR B, 1995, J IMMUNOL, V154, P3843; Gutierrez-Arcelus M, 2016, NAT REV GENET, V17, P160, DOI 10.1038/nrg.2015.33; Holland SJ, 2012, P NATL ACAD SCI USA, V109, pE3111, DOI 10.1073/pnas.1210882109; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu XL, 2015, NAT GENET, V47, P898, DOI 10.1038/ng.3353; Ishwaran H, 2005, J AM STAT ASSOC, V100, P764, DOI 10.1198/016214505000000051; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Klarenbeek PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140815; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; MCDEVITT HO, 1974, LANCET, V1, P1269; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; MITCHELL TJ, 1988, J AM STAT ASSOC, V83, P1023, DOI 10.2307/2290129; Miyadera H, 2015, J HUM GENET, V60, P697, DOI 10.1038/jhg.2015.100; Murray JS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00268; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Parrish HL, 2016, P NATL ACAD SCI USA, V113, P3000, DOI 10.1073/pnas.1518499113; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Roudier J, 2000, ARTHRITIS RES, V2, P217, DOI 10.1186/ar91; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Sinclair C, 2013, P NATL ACAD SCI USA, V110, pE2905, DOI 10.1073/pnas.1304859110; SOTTINI A, 1991, EUR J IMMUNOL, V21, P2455, DOI 10.1002/eji.1830211023; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Wallace C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005272; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zvyagin IV, 2014, P NATL ACAD SCI USA, V111, P5980, DOI 10.1073/pnas.1319389111	68	82	84	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					995	+		10.1038/ng.3625	http://dx.doi.org/10.1038/ng.3625			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27479906	Green Accepted			2022-12-25	WOS:000382398800009
J	Alexandrov, V; Brunner, D; Menalled, LB; Kudwa, A; Watson-Johnson, J; Mazzella, M; Russell, I; Ruiz, MC; Torello, J; Sabath, E; Sanchez, A; Gomez, M; Filipov, I; Cox, K; Kwan, M; Ghavami, A; Ramboz, S; Lager, B; Wheeler, VC; Aaronson, J; Rosinski, J; Gusella, JF; MacDonald, ME; Howland, D; Kwak, S				Alexandrov, Vadim; Brunner, Dani; Menalled, Liliana B.; Kudwa, Andrea; Watson-Johnson, Judy; Mazzella, Matthew; Russell, Ian; Ruiz, Melinda C.; Torello, Justin; Sabath, Emily; Sanchez, Ana; Gomez, Miguel; Filipov, Igor; Cox, Kimberly; Kwan, Mei; Ghavami, Afshin; Ramboz, Sylvie; Lager, Brenda; Wheeler, Vanessa C.; Aaronson, Jeff; Rosinski, Jim; Gusella, James F.; MacDonald, Marcy E.; Howland, David; Kwak, Seung			Large-scale phenome analysis defines a behavioral signature for Huntington's disease genotype in mice	NATURE BIOTECHNOLOGY			English	Article							IN MOUSE MODEL; CAG-REPEAT LENGTH; DRUG DISCOVERY; TIME-COURSE; DEFICITS; ONSET; MOTOR; AGE; TARGETS; TASK	Rapid technological advances for the frequent monitoring of health parameters have raised the intriguing possibility that an individual's genotype could be predicted from phenotypic data alone. Here we used a machine learning approach to analyze the phenotypic effects of polymorphic mutations in a mouse model of Huntington's disease that determine disease presentation and age of onset. The resulting model correlated variation across 3,086 behavioral traits with seven different CAG-repeat lengths in the huntingtin gene (Htt). We selected behavioral signatures for age and CAG-repeat length that most robustly distinguished between mouse lines and validated the model by correctly predicting the repeat length of a blinded mouse line. Sufficient discriminatory power to accurately predict genotype required combined analysis of >200 phenotypic features. Our results suggest that autosomal dominant disease-causing mutations could be predicted through the use of subtle behavioral signatures that emerge in large-scale, combinatorial analyses. Our work provides an open data platform that we now share with the research community to aid efforts focused on understanding the pathways that link behavioral consequences to genetic variation in Huntington's disease.	[Alexandrov, Vadim; Brunner, Dani; Menalled, Liliana B.; Kudwa, Andrea; Watson-Johnson, Judy; Mazzella, Matthew; Russell, Ian; Ruiz, Melinda C.; Torello, Justin; Sabath, Emily; Sanchez, Ana; Gomez, Miguel; Filipov, Igor; Cox, Kimberly; Kwan, Mei; Ghavami, Afshin; Ramboz, Sylvie] PsychoGenics Inc, Tarrytown, NY USA; [Lager, Brenda; Aaronson, Jeff; Rosinski, Jim; Howland, David; Kwak, Seung] CHDI Management CHDI Fdn, Princeton, NJ USA; [Wheeler, Vanessa C.; Gusella, James F.; MacDonald, Marcy E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Alexandrov, V (corresponding author), PsychoGenics Inc, Tarrytown, NY USA.	vadim.alexandrov@psychogenics.com	Gomez, Miguel I./AAD-3707-2019; Beukeboom, L.W./D-1808-2012; Pen, Ido/F-2478-2010; Feldmeyer, Barbara/E-5067-2015; Feldmeyer, Barbara/F-9652-2013	Feldmeyer, Barbara/0000-0002-0413-7245; Mazzella, Matthew/0000-0003-3584-1670	CHDI Foundation, Inc.	CHDI Foundation, Inc.	We are grateful to E. Leahy, V. Rivera, J. Rivera, K. Cheng, D. Lignore and L. Homa for their assistance. We thank S. Noble, D. Baker and J.-M. Lee for their thoughtful comments. This work was supported by CHDI Foundation, Inc., a nonprofit biomedical research organization exclusively dedicated to developing therapeutics that slow the progression of Huntington's disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, all research was conceptualized, planned and directed by all authors listed and conducted under a fee-for-service agreement at the contract research organization PsychoGenics, Inc.	Alexandrov V, 2015, EUR J PHARMACOL, V750, P82, DOI 10.1016/j.ejphar.2014.11.047; Balci F., 2013, PLOS CURR; Bezprozvanny I, 2010, DRUG NEWS PERSPECT, V23, P518, DOI 10.1358/dnp.2010.23.8.1500435; Brooks S., 2010, BRAIN RES B, V88, P148; Bruining H, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-11; Brunner D, 2012, BEHAV PROCESS, V89, P187, DOI 10.1016/j.beproc.2011.10.011; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cichocki A., 2006, ADAPTIVE BLIND SIGNA; CRAUFURD D, 1993, J MED GENET, V30, P1008, DOI 10.1136/jmg.30.12.1008; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Dorsey ER, 2008, ARCH NEUROL-CHICAGO, V65, P1582, DOI 10.1001/archneur.65.12.1582; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; Farrar AM, 2014, J HUNTINGTONS DIS, V3, P145, DOI 10.3233/JHD-130061; Geisser S., 2017, PREDICTIVE INFERENCE; GEYER MA, 1986, PHARMACOL BIOCHEM BE, V25, P277, DOI 10.1016/0091-3057(86)90266-2; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; HARPER P. S., 1996, HUNTINGTONS DIS; Houghten RA, 2008, J COMB CHEM, V10, P3, DOI 10.1021/cc7001205; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Jacobsen JC, 2011, HUM MOL GENET, V20, P2846, DOI 10.1093/hmg/ddr195; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; KANAZAWA I, 1985, J NEUROL SCI, V70, P151, DOI 10.1016/0022-510X(85)90084-X; Keene CD, 2009, ACTA NEUROPATHOL, V117, P329, DOI 10.1007/s00401-008-0465-0; Kieburtz K, 2001, NEUROLOGY, V57, P397; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Meghanathan N., 2013, ADV COMPUTING INFORM, V177; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Menalled LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009793; Oakeshott S., 2012, PLOS CURR, V4; Oakeshott Stephen, 2011, PLoS Curr, V3, pRRN1225, DOI 10.1371/currents.RRN1225; Raymond LA, 2011, NEUROSCIENCE, V198, P252, DOI 10.1016/j.neuroscience.2011.08.052; Roberds SL, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00103; STEEL R. G. D., 1960, Principles and procedures of statistics.; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Subramaniam S, 2011, NEUROPHARMACOLOGY, V60, P1187, DOI 10.1016/j.neuropharm.2010.10.025; Suzuki K, 2012, NEUROBIOL DIS, V46, P336, DOI 10.1016/j.nbd.2012.01.014; Trueman RC, 2012, BRAIN RES BULL, V88, P156, DOI 10.1016/j.brainresbull.2011.03.012; Trueman RC, 2009, BEHAV BRAIN RES, V203, P215, DOI 10.1016/j.bbr.2009.05.006; Trueman RC, 2008, BEHAV BRAIN RES, V189, P317, DOI 10.1016/j.bbr.2008.01.020; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wojaczynska-Stanek K, 2006, J CHILD NEUROL, V21, P1068, DOI 10.1177/7010.2006.00244; Wood NI, 2007, NEUROBIOL DIS, V25, P342, DOI 10.1016/j.nbd.2006.09.015	47	27	28	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2016	34	8					838	+		10.1038/nbt.3587	http://dx.doi.org/10.1038/nbt.3587			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2VJ	27376585				2022-12-25	WOS:000381339600020
J	Cox, AG; Hwang, KL; Brown, KK; Evason, KJ; Beltz, S; Tsomides, A; O'Connor, K; Galli, GG; Yimlamai, D; Chhangawala, S; Yuan, M; Lien, EC; Wucherpfennig, J; Nissim, S; Minami, A; Cohen, DE; Camargo, FD; Asara, JM; Houvras, Y; Stainier, DYR; Goessling, W				Cox, Andrew G.; Hwang, Katie L.; Brown, Kristin K.; Evason, Kimberley J.; Beltz, Sebastian; Tsomides, Allison; O'Connor, Keelin; Galli, Giorgio G.; Yimlamai, Dean; Chhangawala, Sagar; Yuan, Min; Lien, Evan C.; Wucherpfennig, Julia; Nissim, Sahar; Minami, Akihiro; Cohen, David E.; Camargo, Fernando D.; Asara, John M.; Houvras, Yariv; Stainier, Didier Y. R.; Goessling, Wolfram			Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth	NATURE CELL BIOLOGY			English	Article							AMPK-MEDIATED REGULATION; HIPPO PATHWAY ACTIVITY; L-FABP GENE; BETA-CATENIN; CELL-GROWTH; RAT-LIVER; PROTEIN; EXPRESSION; SYNTHETASE; TUMORS	The Hippo pathway is an important regulator of organ size and tumorigenesis. It is unclear, however, how Hippo signalling provides the cellular building blocks required for rapid growth. Here, we demonstrate that transgenic zebrafish expressing an activated form of the Hippo pathway effector Yap1 (also known as YAP) develop enlarged livers and are prone to liver tumour formation. Transcriptomic and metabolomic profiling identify that Yap1 reprograms glutamine metabolism. Yap1 directly enhances glutamine synthetase (glul) expression and activity, elevating steady-state levels of glutamine and enhancing the relative isotopic enrichment of nitrogen during de novo purine and pyrimidine biosynthesis. Genetic or pharmacological inhibition of GLUL diminishes the isotopic enrichment of nitrogen into nucleotides, suppressing hepatomegaly and the growth of liver cancer cells. Consequently, Yap-driven liver growth is susceptible to nucleotide inhibition. Together, our findings demonstrate that Yap1 integrates the anabolic demands of tissue growth during development and tumorigenesis by reprogramming nitrogen metabolism to stimulate nucleotide biosynthesis.	[Cox, Andrew G.; Hwang, Katie L.; Beltz, Sebastian; Tsomides, Allison; O'Connor, Keelin; Wucherpfennig, Julia; Nissim, Sahar; Minami, Akihiro; Cohen, David E.; Goessling, Wolfram] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Hwang, Katie L.] Harvard Med Sch, Harvard MIT MD PhD Program, Boston, MA 02115 USA; [Brown, Kristin K.; Yuan, Min; Lien, Evan C.; Asara, John M.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Evason, Kimberley J.] Univ Utah, Salt Lake City, UT 84112 USA; [Galli, Giorgio G.; Yimlamai, Dean; Camargo, Fernando D.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA; [Chhangawala, Sagar; Houvras, Yariv] Weill Cornell Med Coll, New York, NY 10065 USA; [Camargo, Fernando D.; Goessling, Wolfram] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Stainier, Didier Y. R.] Max Planck Inst, D-61231 Bad Nauheim, Germany; [Goessling, Wolfram] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA; [Goessling, Wolfram] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Galli, Giorgio G.] Novartis Inst BioMed Res, Dis Area Oncol, CH-4056 Basel, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; Harvard Medical School; Cornell University; Harvard University; Max Planck Society; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Novartis	Goessling, W (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.; Goessling, W (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Goessling, W (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA.; Goessling, W (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	wgoessling@partners.org	Evason, Kimberley/AAC-2506-2020; Yimlamai, Dean/AAA-6607-2020	Yimlamai, Dean/0000-0002-7936-7168; camargo, fernando/0000-0002-5630-5909; Wucherpfennig, Julia/0000-0003-3471-6624; Galli, Giorgio/0000-0002-9401-060X; Chhangawala, Sagar/0000-0001-9626-1034; Nissim, Sahar/0000-0002-2303-6415; Lien, Evan/0000-0001-7866-4761; Houvras, Yariv/0000-0003-0751-3215; BROWN, KRISTIN/0000-0002-4991-8870; Stainier, Didier/0000-0002-0382-0026; Cox, Andrew/0000-0003-4189-9422	Irwin Arias Postdoctoral Fellowship American Liver Foundation; Liver Scholar Award from the American Liver Foundation; HDDC Pilot Feasibility Grant from the Harvard Digestive Disease Center [P30 DK034854]; NIH NIGMS [T32GM007753]; NIH NCI [5K08CA172288, 5P01CA120964, 5P30CA006516]; NIH NIDDK [RO1DK60322, RO1DK090311]; NIH [K08DK105351, R01AR064036, R01DK099559]; Packard Foundation; American-Italian Cancer Foundation; Damon Runyon Cancer Research Foundation [DRG-10910]; Claudia Adams Barr Program for Innovative Cancer Research; Pew Scholar in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [P30CA006516, P01CA120964, K08CA172288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099559, K08DK105351, K08DK105326, R01DK105198, R37DK048873, R01DK090311, P30DK034854, R01DK060322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Irwin Arias Postdoctoral Fellowship American Liver Foundation; Liver Scholar Award from the American Liver Foundation; HDDC Pilot Feasibility Grant from the Harvard Digestive Disease Center; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); American-Italian Cancer Foundation; Damon Runyon Cancer Research Foundation; Claudia Adams Barr Program for Innovative Cancer Research; Pew Scholar in the Biomedical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an Irwin Arias Postdoctoral Fellowship (A.G.C.) and Liver Scholar Award (A.G.C.) from the American Liver Foundation, an HDDC Pilot Feasibility Grant from the Harvard Digestive Disease Center, P30 DK034854 (A.G.C., D.Y), NIH NIGMS T32GM007753 (K.L.H.), NIH NCI 5K08CA172288 (K.J.E.), NIH NIDDK RO1DK60322 (D.YR.S.), NIH NIDDK RO1DK090311 (W.G.), NIH K08DK105351 (D.Y.), R01AR064036 (F.D.C.) and R01DK099559 (F.D.C.), and the Packard Foundation (D.Y.R.S.). J.M.A. is partially supported by NIH NCI 5P01CA120964 and 5P30CA006516. G.G.G. is supported by an American-Italian Cancer Foundation postdoctoral research fellowship. K.J.E. was a Robert Black Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-10910). D.Y. is a Gilead Sciences Scholar in Liver Disease. W.G. is supported by the Claudia Adams Barr Program for Innovative Cancer Research, and is a Pew Scholar in the Biomedical Sciences.	Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Adler JJ, 2013, J BIOL CHEM, V288, P15181, DOI 10.1074/jbc.M112.446534; Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bioulac-Sage P, 2007, HEPATOLOGY, V46, P740, DOI 10.1002/hep.21743; Bott AJ, 2015, CELL METAB, V22, P1068, DOI 10.1016/j.cmet.2015.09.025; Bucking C, 2013, J EXP ZOOL PART A, V319, P391, DOI 10.1002/jez.1802; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Cunningham JT, 2014, CELL, V157, P1088, DOI 10.1016/j.cell.2014.03.052; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; DEUEL TF, 1978, J BIOL CHEM, V253, P6111; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; Galli GG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002711; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen CG, 2015, CELL RES, V25, P1299, DOI 10.1038/cr.2015.140; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Her GM, 2003, DEV DYNAM, V227, P347, DOI 10.1002/dvdy.10324; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Li H, 2012, LIVER INT, V32, P38, DOI 10.1111/j.1478-3231.2011.02646.x; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Morin N, 2010, J MICROBIOL METH, V80, P148, DOI 10.1016/j.mimet.2009.11.012; Nault JC, 2014, HEPATOLOGY, V60, P1983, DOI 10.1002/hep.27372; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park YY, 2016, HEPATOLOGY, V63, P159, DOI 10.1002/hep.28223; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt A, 2011, TOXICOLOGY, V281, P7, DOI 10.1016/j.tox.2011.01.006; SKAPER SD, 1978, BIOCHEM J, V172, P457, DOI 10.1042/bj1720457; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Spitsbergen JM, 2000, TOXICOL PATHOL, V28, P705, DOI 10.1177/019262330002800511; SUDOL M, 1994, ONCOGENE, V9, P2145; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Tardito S, 2015, NAT CELL BIOL, V17, P1556, DOI 10.1038/ncb3272; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	70	114	122	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2016	18	8					886	+		10.1038/ncb3389	http://dx.doi.org/10.1038/ncb3389			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DS5NO	27428308	Green Submitted, Green Accepted			2022-12-25	WOS:000380829200009
J	Deeks, SG; Lewin, SR; Ross, AL; Ananworanich, J; Benkirane, M; Cannon, P; Chomont, N; Douek, D; Lifson, JD; Lo, YR; Kuritzkes, D; Margolis, D; Mellors, J; Persaud, D; Tucker, JD; Barre-Sinoussi, F; Alter, G; Auerbach, J; Autran, B; Barouch, DH; Behrens, G; Cavazzana, M; Chen, ZW; Cohen, EA; Corbelli, GM; Eholie, S; Eyal, N; Fidler, S; Garcia, L; Grossman, C; Henderson, G; Henrich, TJ; Jefferys, R; Kiem, HP; McCune, J; Moodley, K; Newman, PA; Nijhuis, M; Nsubuga, MS; Ott, M; Palmer, S; Richman, D; Saez-Cirion, A; Sharp, M; Siliciano, J; Silvestri, G; Singh, J; Spire, B; Taylor, J; Tolstrup, M; Valente, S; van Lunzen, J; Walensky, R; Wilson, I; Zack, J				Deeks, Steven G.; Lewin, Sharon R.; Ross, Anna Laura; Ananworanich, Jintanat; Benkirane, Monsef; Cannon, Paula; Chomont, Nicolas; Douek, Daniel; Lifson, Jeffrey D.; Lo, Ying-Ru; Kuritzkes, Daniel; Margolis, David; Mellors, John; Persaud, Deborah; Tucker, Joseph D.; Barre-Sinoussi, Francoise; Alter, Galit; Auerbach, Judith; Autran, Brigitte; Barouch, Dan H.; Behrens, Georg; Cavazzana, Marina; Chen, Zhiwei; Cohen, Eric A.; Corbelli, Giulio Maria; Eholie, Serge; Eyal, Nir; Fidler, Sarah; Garcia, Laurindo; Grossman, Cynthia; Henderson, Gail; Henrich, Timothy J.; Jefferys, Richard; Kiem, Hans-Peter; McCune, Joseph; Moodley, Keymanthri; Newman, Peter A.; Nijhuis, Monique; Nsubuga, Moses Supercharger; Ott, Melanie; Palmer, Sarah; Richman, Douglas; Saez-Cirion, Asier; Sharp, Matthew; Siliciano, Janet; Silvestri, Guido; Singh, Jerome; Spire, Bruno; Taylor, Jeffrey; Tolstrup, Martin; Valente, Susana; van Lunzen, Jan; Walensky, Rochelle; Wilson, Ira; Zack, Jerome		Int AIDS Soc Cure Working Grp	International AIDS Society global scientific strategy: towards an HIV cure 2016	NATURE MEDICINE			English	Article							CD4(+) T-CELLS; SUPPRESSIVE ANTIRETROVIRAL THERAPY; BROADLY NEUTRALIZING ANTIBODIES; HISTONE DEACETYLASE INHIBITOR; HIGHLY PATHOGENIC SIV; LATENT HIV-1; VIRAL RESERVOIR; IN-VIVO; RALTEGRAVIR INTENSIFICATION; STAKEHOLDER ENGAGEMENT	Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a global population of more than 35 million people living with HIV, there is intense interest in developing a cure for HIV infection. The International AIDS Society convened a group of international experts to develop a scientific strategy for research towards an HIV cure. This Perspective summarizes the group's strategy.	[Deeks, Steven G.; Auerbach, Judith; Henrich, Timothy J.; McCune, Joseph] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Lewin, Sharon R.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Lewin, Sharon R.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic, Australia; [Ross, Anna Laura] ANRS, Int & Sci Relat Off, Paris, France; [Ananworanich, Jintanat] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Ananworanich, Jintanat] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Benkirane, Monsef] Univ Montpellier, CNRS UPR 1142, Inst Human Genet, Mol Virol Lab, Montpellier, France; [Cannon, Paula] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Chomont, Nicolas] Univ Montreal, Fac Med, CRCHUM, Montreal, PQ, Canada; [Chomont, Nicolas] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Douek, Daniel] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD 21702 USA; [Lo, Ying-Ru] World Hlth Org Reg Off Western Pacific, Manila, Philippines; [Kuritzkes, Daniel; Henrich, Timothy J.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Margolis, David; Henderson, Gail] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Mellors, John] Univ Pittsburgh, Dept Med, Div Infect Dis, 930 Scaife Hall, Pittsburgh, PA 15260 USA; [Persaud, Deborah] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Persaud, Deborah] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Tucker, Joseph D.] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China; [Barre-Sinoussi, Francoise] Inst Pasteur, Paris, France; [Alter, Galit; Barouch, Dan H.] MIT & Harvard, Ragon Inst MGH, Boston, MA USA; [Autran, Brigitte] Univ Paris 06, Sorbonne Univ, CIMI, Paris, France; [Autran, Brigitte] CIMI Paris, INSERM, U1135, Paris, France; [Autran, Brigitte] Hop La Pitie Salpetriere, AP HP, Dept Immunol, Paris, France; [Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Behrens, Georg] Hannover Med Sch, Clin Immunol & Rhematol, Hannover, Germany; [Cavazzana, Marina] Hop Necker Enfants Malad, Ctr Invest Clin Biotherapie, Paris, France; [Chen, Zhiwei] Univ Hong Kong, AIDS Inst, Pok Fu Lam, Hong Kong, Peoples R China; [Cohen, Eric A.] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ, Canada; [Corbelli, Giulio Maria] European AIDS Treatment Grp, Rome, Italy; [Eholie, Serge] Ctr Hosp Univ Treichville, Programme PAC CI, Abidjan, Cote Ivoire; [Eyal, Nir] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Fidler, Sarah] Imperial Coll London, Dept Med, London, England; [Garcia, Laurindo] B Change Grp, Manila, Philippines; [Grossman, Cynthia] NIMH, NIH, Bethesda, MD 20892 USA; [Jefferys, Richard] Treatment Act Grp, New York, NY 10016 USA; [Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Moodley, Keymanthri] Univ Stellenbosch, Dept Med, Ctr Med Eth & Law, Western Cape, South Africa; [Newman, Peter A.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Nijhuis, Monique] Univ Med Ctr Utrecht, Dept Med Microbiol, Virol, Utrecht, Netherlands; [Nsubuga, Moses Supercharger] Joint Clin Res Ctr, Kampala, Uganda; [Ott, Melanie] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Palmer, Sarah] Univ Sydney, Westmead Millennium Inst Med Res, Sydney, NSW, Australia; [Richman, Douglas] Virginia San Diego Healthcare Syst, San Diego, CA 92161 USA; [Richman, Douglas] Univ Calif San Diego, San Diego, CA 92103 USA; [Saez-Cirion, Asier] Inst Pasteur, Paris, France; [Sharp, Matthew] Independent HIV Educ & Advocacy Consultant, San Francisco, CA USA; [Siliciano, Janet] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Silvestri, Guido] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Singh, Jerome] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; [Spire, Bruno] INSERM, UMR S912, Marseille, France; [Taylor, Jeffrey] CARE Collaboratory Community Advisory Board, Palm Springs, CA USA; [Tolstrup, Martin] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Valente, Susana] Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL 33458 USA; [van Lunzen, Jan] ViiV Healthcare, London, England; [Walensky, Rochelle] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Wilson, Ira] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Zack, Jerome] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of Melbourne; Royal Melbourne Hospital; Florey Institute of Neuroscience & Mental Health; Monash University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Southern California; Universite de Montreal; Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hannover Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Hong Kong; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Fred Hutchinson Cancer Center; Stellenbosch University; University of Toronto; Utrecht University; Utrecht University Medical Center; Joint Clinic Research Center - United Arab Emirates; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Sydney; University of California System; University of California San Diego; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Johns Hopkins University; Emory University; University of Kwazulu Natal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Aarhus University; Scripps Research Institute; GlaxoSmithKline; Harvard University; Harvard Medical School; Massachusetts General Hospital; Brown University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Deeks, SG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	steven.deeks@ucsf.edu	Barouch, Dan/Y-3918-2019; Behrens, Georg MN/Q-4486-2016; Lewin, Sharon/Z-3297-2019; Saez-Cirion, Asier/A-8640-2008; Singh, Jerome Amir/ABG-1573-2021; Chomont, Nicolas/ABG-2545-2020; Chen, Zhiwei/B-7793-2019; Ananworanich, Jintanat/AAC-6348-2021; Spire, Bruno/F-5546-2013; Eholie, Serge/T-6008-2019; Newman, Peter A/P-7056-2019	Saez-Cirion, Asier/0000-0003-2406-7536; Chomont, Nicolas/0000-0001-9747-5018; Chen, Zhiwei/0000-0002-4511-2888; Ananworanich, Jintanat/0000-0003-1369-3224; Spire, Bruno/0000-0002-3546-8020; Newman, Peter A/0000-0003-0444-5915; Lewin, Sharon Ruth/0000-0002-0330-8241; Fidler, Sarah/0000-0003-1676-7583; Walensky, Rochelle P./0000-0002-8795-379X; Cavazzana, Marina/0000-0002-0264-0891; Tolstrup, Martin/0000-0001-7020-5173; Deeks, Steven/0000-0001-6371-747X; Tucker, Joseph/0000-0003-2804-1181	federal funds from the NCI/NIH [HHSN261200800001E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113, R01AI108366, P30AI050410, P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; Medical Research Council [MR/L00528X/1] Funding Source: researchfish; MRC [MR/L00528X/1] Funding Source: UKRI	federal funds from the NCI/NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	J.L. is supported in part by federal funds from the NCI/NIH under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the DHHS, nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. government. The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army, the Department of Defense or the US National Institutes of Health. Y.-R.L. is a World Health Organization (WHO) staff member. The opinions herein are those of the authors and should not be construed as official or representing the views of the WHO. The authors acknowledge T. Rasmussen, T. Mota and M. Crane for assistance with preparation of figures.	Amon JJ, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-5; Ananworanich J, 2014, AIDS, V28, P1015, DOI 10.1097/QAD.0000000000000178; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Assoumou L, 2015, AIDS, V29, P2003, DOI 10.1097/QAD.0000000000000734; Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Barouch DH, 2014, SCIENCE, V345, P169, DOI 10.1126/science.1255512; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132; Beard BC, 2010, J CLIN INVEST, V120, P2345, DOI 10.1172/JCI40767; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Bui JK, 2016, J VIROL, V90, P1673, DOI 10.1128/JVI.02520-15; Burbelo PD, 2014, J INFECT DIS, V209, P1613, DOI 10.1093/infdis/jit667; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Calantone N, 2014, IMMUNITY, V41, P493, DOI 10.1016/j.immuni.2014.08.014; Cannon P, 2011, CURR OPIN HIV AIDS, V6, P74, DOI 10.1097/COH.0b013e32834122d7; Casazza JP, 2013, J INFECT DIS, V207, P1829, DOI 10.1093/infdis/jit098; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Cheret A, 2015, J ANTIMICROB CHEMOTH, V70, P2108, DOI 10.1093/jac/dkv084; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chu CE, 2015, AIDS RES HUM RETROV, V31, P78, DOI [10.1089/aid.2014.0200, 10.1089/AID.2014.0200]; Chun TW, 2014, P NATL ACAD SCI USA, V111, P13151, DOI 10.1073/pnas.1414148111; Churchill MJ, 2015, J NEUROVIROL, V21, P290, DOI 10.1007/s13365-014-0271-5; Cillo AR, 2014, P NATL ACAD SCI USA, V111, P7078, DOI 10.1073/pnas.1402873111; Connick E, 2007, J IMMUNOL, V178, P6975, DOI 10.4049/jimmunol.178.11.6975; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; De Maria A, 2014, NEW ENGL J MED, V370, P678, DOI 10.1056/NEJMc1315498; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Del Prete GQ, 2016, ANTIMICROB AGENTS CH, V60, P1560, DOI 10.1128/AAC.02625-15; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Denton PW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003872; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Elliott JH, 2015, LANCET HIV, V2, pE520, DOI 10.1016/S2352-3018(15)00226-X; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Euler Z, 2015, AIDS RES HUM RETROV, V31, P13, DOI [10.1089/aid.2014.0235, 10.1089/AID.2014.0235]; Evans VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003799; Fauci AS, 2014, JAMA-J AM MED ASSOC, V312, P335, DOI 10.1001/jama.2014.4754; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Frange P, 2016, LANCET HIV, V3, pE49, DOI 10.1016/S2352-3018(15)00232-5; Freedberg KA, 2015, J VIRUS ERAD, V1, P245; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hatano H, 2013, J INFECT DIS, V208, P1436, DOI 10.1093/infdis/jit453; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Henderson GE, 2015, AIDS RES HUM RETROV, V31, P56, DOI [10.1089/aid.2014.0219, 10.1089/AID.2014.0219]; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Honeycutt JB, 2016, J CLIN INVEST, V126, P1353, DOI 10.1172/JCI84456; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hurst J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9495; Imamichi H, 2014, AIDS, V28, P1091, DOI 10.1097/QAD.0000000000000223; Jiang GC, 2014, AIDS, V28, P1555, DOI 10.1097/QAD.0000000000000289; Jones RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004287; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Katlama C, 2016, AIDS, V30, P221, DOI 10.1097/QAD.0000000000000894; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Khoury G., AIDS IN PRESS; Kitchen SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002649; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Li JZ, 2016, AIDS, V30, P343, DOI 10.1097/QAD.0000000000000953; Lo YR, 2015, AIDS PATIENT CARE ST, V29, P389, DOI 10.1089/apc.2014.0348; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Lorenzo-Redondol R., NATURE IN PRESS; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Micci L, 2015, J CLIN INVEST, V125, P4497, DOI 10.1172/JCI81400; Moodley K, 2016, AIDS CARE, V28, P524, DOI 10.1080/09540121.2015.1112351; Mousseau G, 2015, MBIO, V6, DOI 10.1128/mBio.00465-15; Mousseau G, 2015, CURR TOP MICROBIOL, V389, P121, DOI 10.1007/82_2015_435; Muenchhoff M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00391; Murray JM, 2014, J VIROL, V88, P3516, DOI 10.1128/JVI.03331-13; Newman PA, 2014, EXPERT REV VACCINES, V13, P1553, DOI 10.1586/14760584.2014.953484; Pate KAM, 2015, J INFECT DIS, V212, P1387, DOI 10.1093/infdis/jiv230; Peay HL, 2015, J VIRUS ERAD, V1, P51; Pegu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9447; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Persaud D, 2014, JAMA PEDIATR, V168, P1138, DOI 10.1001/jamapediatrics.2014.1560; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Procopio FA, 2015, EBIOMEDICINE, V2, P874, DOI 10.1016/j.ebiom.2015.06.019; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Santangelo PJ, 2015, NAT METHODS, V12, P427, DOI [10.1038/NMETH.3320, 10.1038/nmeth.3320]; Sax PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113031; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Smith DJ, 2015, P NATL ACAD SCI USA, V112, P1523, DOI 10.1073/pnas.1424877112; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Stock PG, 2014, AM J TRANSPLANT, V14, P1136, DOI 10.1111/ajt.12699; Sung JAM, 2015, J CLIN INVEST, V125, P4077, DOI 10.1172/JCI82314; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tucker JD, 2014, JAIDS-J ACQ IMM DEF, V67, pE110, DOI 10.1097/QAI.0000000000000305; Tucker JD, 2014, AIDS, V28, P1247, DOI 10.1097/QAD.0000000000000210; Tyagi M, 2010, J VIROL, V84, P6425, DOI 10.1128/JVI.01519-09; UNAIDS, 2014, THE GAP REP; Uprety P, 2015, CLIN INFECT DIS, V61, P1862, DOI 10.1093/cid/civ688; van der Sluis RM, 2015, AIDS, V29, P1003, DOI 10.1097/QAD.0000000000000637; Van Praag RME, 2001, J CLIN IMMUNOL, V21, P218, DOI 10.1023/A:1011091300321; Vandergeeten C, 2013, BLOOD, V121, P4321, DOI 10.1182/blood-2012-11-465625; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Wightman F, 2015, AIDS, V29, P504, DOI 10.1097/QAD.0000000000000562; Wightman F, 2013, AIDS, V27, P2853, DOI 10.1097/QAD.0000000000000067; Williams JP, 2014, ELIFE, V3, DOI 10.7554/eLife.03821; Younan PM, 2013, BLOOD, V122, P179, DOI 10.1182/blood-2013-01-482224; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347	125	324	330	4	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					839	850		10.1038/nm.4108	http://dx.doi.org/10.1038/nm.4108			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27400264	Green Published, Green Accepted			2022-12-25	WOS:000381000200009
J	Krishnamoorthy, L; Cotruvo, JA; Chan, J; Kaluarachchi, H; Muchenditsi, A; Pendyala, VS; Jia, S; Aron, AT; Ackerman, CM; Vander Wal, MN; Guan, T; Smaga, LP; Farhi, SL; New, EJ; Lutsenko, S; Chang, CJ				Krishnamoorthy, Lakshmi; Cotruvo, Joseph A., Jr.; Chan, Jefferson; Kaluarachchi, Harini; Muchenditsi, Abigael; Pendyala, Venkata S.; Jia, Shang; Aron, Allegra T.; Ackerman, Cheri M.; Vander Wal, Mark N.; Guan, Timothy; Smaga, Lukas P.; Farhi, Samouil L.; New, Elizabeth J.; Lutsenko, Svetlana; Chang, Christopher J.			Copper regulates cyclic-AMP-dependent lipolysis	Nature Chemical Biology			English	Article							CGMP-INHIBITED PHOSPHODIESTERASE; MECHANISMS LINKING OBESITY; HORMONE-SENSITIVE LIPASE; WILSON-DISEASE; LIPID-METABOLISM; PROTEIN-KINASE; NUCLEOTIDE PHOSPHODIESTERASES; INSULIN-RESISTANCE; FLUORESCENT-PROBES; ADIPOCYTES	Cell signaling relies extensively on dynamic pools of redox-inactive metal ions such as sodium, potassium, calcium and zinc, but their redox-active transition metal counterparts such as copper and iron have been studied primarily as static enzyme cofactors. Here we report that copper is an endogenous regulator of lipolysis, the breakdown of fat, which is an essential process in maintaining body weight and energy stores. Using a mouse model of genetic copper misregulation, in combination with pharmacological alterations in copper status and imaging studies in a 3T3-L1 white adipocyte model, we found that copper regulates lipolysis at the level of the second messenger, cyclic AMP (cAMP), by altering the activity of the cAMP-degrading phosphodiesterase PDE3B. Biochemical studies of the copper-PDE3B interaction establish copper-dependent inhibition of enzyme activity and identify a key conserved cysteine residue in a PDE3-specific loop that is essential for the observed copper-dependent lipolytic phenotype.	[Krishnamoorthy, Lakshmi; Cotruvo, Joseph A., Jr.; Chan, Jefferson; Kaluarachchi, Harini; Jia, Shang; Aron, Allegra T.; Ackerman, Cheri M.; Vander Wal, Mark N.; Guan, Timothy; Smaga, Lukas P.; Farhi, Samouil L.; New, Elizabeth J.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Krishnamoorthy, Lakshmi; Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Muchenditsi, Abigael; Pendyala, Venkata S.; Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Chang, Christopher J.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Chan, Jefferson] Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA; [New, Elizabeth J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Johns Hopkins University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Illinois System; University of Illinois Urbana-Champaign; University of Sydney	Chang, CJ (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Chang, CJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Chang, CJ (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Chang, CJ (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	chrischang@berkeley.edu	New, Elizabeth/G-6104-2014; Cotruvo, Joseph/N-5127-2019; 贾, 上/P-7344-2019; Cotruvo, Joseph A/C-5700-2019	New, Elizabeth/0000-0002-2310-254X; 贾, 上/0000-0001-6285-8959; Cotruvo, Joseph A/0000-0003-4243-8257; Krishnamoorthy, Lakshmi/0000-0002-4083-526X; Krishnamoorthy, Lakshmi/0000-0002-3469-8166; Farhi, Samouil/0000-0003-1359-4568	US National Institutes of Health (NIH) [GM 79465, GM067166, GM101502]; Howard Hughes Medical Institute; Jane Coffin Childs Memorial Fund for Medical Research; Human Frontiers Science Program; National Science Foundation Graduate Research Fellowship; Hertz Foundation Graduate Fellowship; Chemical Biology Training Grant from the NIH [T32 GM066698]; German National Academic Foundation with an international scholarship; Amgen; Royal Commission for the Exhibition of 1851; University of California Berkeley; Merage Foundation for the American Dream Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166, R01GM101502, T32GM066698, R01GM079465] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Jane Coffin Childs Memorial Fund for Medical Research; Human Frontiers Science Program(Human Frontier Science Program); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Hertz Foundation Graduate Fellowship; Chemical Biology Training Grant from the NIH; German National Academic Foundation with an international scholarship; Amgen(Amgen); Royal Commission for the Exhibition of 1851; University of California Berkeley(University of California System); Merage Foundation for the American Dream Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the US National Institutes of Health (NIH) (GM 79465 to C.J.C., GM067166 and GM101502 to S.L.) for providing funding for this work. C.J.C. and L.K. are supported by the Howard Hughes Medical Institute. J.A.C. is supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research. J.C. was supported by a postdoctoral fellowship from the Human Frontiers Science Program. A.T.A. was supported by a National Science Foundation Graduate Research Fellowship. C.M.A. was supported by a Hertz Foundation Graduate Fellowship. A.T.A. and C.M.A. were partially supported by Chemical Biology Training Grant T32 GM066698 from the NIH. L.P.S. was supported by the German National Academic Foundation with an international scholarship. S.L.F. was supported by scholarships from Amgen and Merage Foundation for the American Dream Scholarship. E.J.N. was supported by a fellowship from the Royal Commission for the Exhibition of 1851. We thank members of the UCB Cell Culture Facility (A. Fischer, X. Zhang, A. Killilea, C. Tosta), which is funded by the University of California Berkeley, for 3T3-L1 cultures; J. Larsen and C. Mangels for expert technical assistance; V. Manganiello (Laboratory of Biochemical Physiology, NIH) for mPDE3B plasmids; and M. Uhm for advice regarding PDE3B overexpression.	Ahmad F, 2007, BIOCHEM J, V404, P257, DOI 10.1042/BJ20060960; Aigner E, 2010, AM J GASTROENTEROL, V105, P1978, DOI 10.1038/ajg.2010.170; ALOTHMAN AA, 1992, J NUTR, V122, P1199, DOI 10.1093/jn/122.6.1199; Angeletti B, 2005, J BIOL CHEM, V280, P17930, DOI 10.1074/jbc.M412034200; Aron AT, 2015, ACCOUNTS CHEM RES, V48, P2434, DOI 10.1021/acs.accounts.5b00221; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; Burkhead J. L., 2013, LIPID METABOLISM; CARR TP, 1990, METABOLISM, V39, P518, DOI 10.1016/0026-0495(90)90011-Z; Chang CJ, 2015, NAT CHEM BIOL, V11, P744, DOI 10.1038/nchembio.1913; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Chung YW, 2015, P NATL ACAD SCI USA, V112, pE2253, DOI 10.1073/pnas.1416230112; Cobine PA, 2000, BIOCHEMISTRY-US, V39, P6857, DOI 10.1021/bi000015+; Cotruvo JA, 2008, P NATL ACAD SCI USA, V105, P14383, DOI 10.1073/pnas.0807348105; Cotruvo JA, 2015, CHEM SOC REV, V44, P4400, DOI 10.1039/c4cs00346b; Degerman E, 1997, J BIOL CHEM, V272, P6823, DOI 10.1074/jbc.272.11.6823; Dodani SC, 2014, P NATL ACAD SCI USA, V111, P16280, DOI 10.1073/pnas.1409796111; Dodani SC, 2011, P NATL ACAD SCI USA, V108, P5980, DOI 10.1073/pnas.1009932108; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; DWORKIN M, 1977, J BIOL CHEM, V252, P864; Engle TE, 2011, J ANIM SCI, V89, P591, DOI 10.2527/jas.2010-3395; Gerbasi V, 2003, NEUROCHEM RES, V28, P867, DOI 10.1023/A:1023219308890; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gray NE, 2012, J BIOL CHEM, V287, P8444, DOI 10.1074/jbc.M111.294124; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Hong-Hermesdorf A, 2014, NAT CHEM BIOL, V10, P1034, DOI 10.1038/nchembio.1662; Hung SH, 2006, J BIOL CHEM, V281, P29236, DOI 10.1074/jbc.M606558200; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2007, MOL BIOSYST, V3, P816, DOI 10.1039/b711118p; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; KAWAMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P732, DOI 10.1073/pnas.78.2.732; Kenan Y, 2000, J BIOL CHEM, V275, P12331, DOI 10.1074/jbc.275.16.12331; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; LEONARD WR, 1991, J ORG CHEM, V56, P1961, DOI 10.1021/jo00005a059; Lippard S. J., 1994, PRINCIPLES BIOINORGA; Lutsenko S, 2008, BIOCHEM SOC T, V36, P1233, DOI 10.1042/BST0361233; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; MCMILLIN DR, 1978, BIOINORG CHEM, V8, P179, DOI 10.1016/S0006-3061(00)80243-4; OMBURO GA, 1995, ARCH BIOCHEM BIOPHYS, V323, P1, DOI 10.1006/abbi.1995.0001; Ovadia H, 2011, J BIOL CHEM, V286, P30433, DOI 10.1074/jbc.M111.235945; POUNTNEY DL, 1994, BIOCHEMISTRY-US, V33, P9699, DOI 10.1021/bi00198a040; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Scapin G, 2004, BIOCHEMISTRY-US, V43, P6091, DOI 10.1021/bi049868i; Seessle J, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-83; Snyder PB, 2005, J LIPID RES, V46, P494, DOI 10.1194/jlr.M400362-JLR200; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Tang KM, 1997, BIOCHEM J, V323, P217; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Varnerin JP, 2004, PROTEIN EXPRES PURIF, V35, P225, DOI 10.1016/j.pep.2004.01.009; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Xue BZ, 2001, FASEB J, V15, P2527, DOI 10.1096/fj.01-0278fje; Zhou DQ, 2012, FASEB J, V26, P4733, DOI 10.1096/fj.12-206862; Zhou LB, 2011, BBA-MOL BASIS DIS, V1812, P527, DOI 10.1016/j.bbadis.2010.10.001	60	97	98	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2016	12	8					586	+		10.1038/NCHEMBIO.2098	http://dx.doi.org/10.1038/NCHEMBIO.2098			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2UW	27272565	Green Accepted, Green Submitted			2022-12-25	WOS:000380640100004
J	Mooijman, D; Dey, SS; Boisset, JC; Crosetto, N; van Oudenaarden, A				Mooijman, Dylan; Dey, Siddharth S.; Boisset, Jean-Charles; Crosetto, Nicola; van Oudenaarden, Alexander			Single-cell 5hmC sequencing reveals chromosome-wide cell-to-cell variability and enables lineage reconstruction	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; RNA-SEQ; BASE-RESOLUTION; ES CELLS; DNA; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; DYNAMICS; GENOME; DIFFERENTIATION	The epigenetic DNA modification 5-hydroxymethylcytosine (5hmC) has crucial roles in development and gene regulation(1-7). Quantifying the abundance of this epigenetic mark at the single-cell level could enable us to understand its roles. We present a single-cell, genome-wide and strand-specific 5hmC sequencing technology, based on 5hmC glucosylation and glucosylation-dependent digestion of DNA, that reveals pronounced cell-to-cell variability in the abundance of 5hmC on the two DNA strands of a given chromosome. We develop a mathematical model that reproduces the strand bias and use this model to make two predictions. First, the variation in strand bias should decrease when 5hmC turnover increases. Second, the strand bias of two sister cells should be strongly anti-correlated. We validate these predictions experimentally, and use our model to reconstruct lineages of two-and four-cell mouse embryos, showing that single-cell 5hmC sequencing can be used as a lineage reconstruction tool.	[Mooijman, Dylan; Dey, Siddharth S.; Boisset, Jean-Charles; Crosetto, Nicola; van Oudenaarden, Alexander] KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Mooijman, Dylan; Dey, Siddharth S.; Boisset, Jean-Charles; Crosetto, Nicola; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, Canc Genom Netherlands, Utrecht, Netherlands; [Crosetto, Nicola] Karolinska Inst, Sci Life Lab, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Stockholm, Sweden	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Karolinska Institutet	van Oudenaarden, A (corresponding author), KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.; van Oudenaarden, A (corresponding author), Univ Med Ctr Utrecht, Canc Genom Netherlands, Utrecht, Netherlands.	a.vanoudenaarden@hubrecht.eu	van Oudenaarden, Alexander/AAA-1705-2019	Dey, Siddharth S./0000-0002-1161-1654	NWO (VICI award); ERC grants [ERC-AdG 294325-GeneNoiseControl]	NWO (VICI award)(Netherlands Organization for Scientific Research (NWO)); ERC grants	We thank L. Kaaij, M. Bienko, M. Staps, M. Welling, W. Reik and members of the van Oudenaarden laboratory for constructive feedback. We would also like to thank S. van der Elst and R. van der Linden for their assistance with flow sorting and M. Verheul and E. de Bruijn at the Utrecht DNA Sequencing Facility for assistance with Illumina sequencing. This work was supported by NWO (VICI award) and ERC (ERC-AdG 294325-GeneNoiseControl) grants.	Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Falconer E, 2012, NAT METHODS, V9, P1107, DOI [10.1038/NMETH.2206, 10.1038/nmeth.2206]; Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Horton JR, 2014, NUCLEIC ACIDS RES, V42, P7947, DOI 10.1093/nar/gku497; Huh YH, 2013, P NATL ACAD SCI USA, V110, P16862, DOI 10.1073/pnas.1310323110; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shukla A, 2015, GENE, V564, P109, DOI 10.1016/j.gene.2015.03.075; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/NMETH.3035, 10.1038/nmeth.3035]; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Sun ZY, 2013, CELL REP, V3, P567, DOI 10.1016/j.celrep.2013.01.001; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhao L, 2014, GENOME RES, V24, P1296, DOI 10.1101/gr.163147.113	29	83	86	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2016	34	8					852	+		10.1038/nbt.3598	http://dx.doi.org/10.1038/nbt.3598			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2VJ	27347753				2022-12-25	WOS:000381339600022
J	Niu, BF; Scott, AD; Sengupta, S; Bailey, MH; Batra, P; Ning, J; Wyczalkowski, MA; Liang, WW; Zhang, QY; McLellan, MD; Sun, SQ; Tripathi, P; Lou, C; Ye, K; Mashl, RJ; Wallis, J; Wendl, MC; Chen, F; Ding, L				Niu, Beifang; Scott, Adam D.; Sengupta, Sohini; Bailey, Matthew H.; Batra, Prag; Ning, Jie; Wyczalkowski, Matthew A.; Liang, Wen-Wei; Zhang, Qunyuan; McLellan, Michael D.; Sun, Sam Q.; Tripathi, Piyush; Lou, Carolyn; Ye, Kai; Mashl, R. Jay; Wallis, John; Wendl, Michael C.; Chen, Feng; Ding, Li			Protein-structure-guided discovery of functional mutations across 19 cancer types	NATURE GENETICS			English	Article							SOMATIC MUTATIONS; DATA-BANK; IMPACT; NETWORKS; THERAPY; DRIVERS; GENOMES; GENES	Local concentrations of mutations are well known in human cancers. However, their three-dimensional spatial relationships in the encoded protein have yet to be systematically explored. We developed a computational tool, HotSpot3D, to identify such spatial hotspots ( clusters) and to interpret the potential function of variants within them. We applied HotSpot3D to >4,400 TCGA tumors across 19 cancer types, discovering >6,000 intra-and intermolecular clusters, some of which showed tumor and/or tissue specificity. In addition, we identified 369 rare mutations in genes including TP53, PTEN, VHL, EGFR, and FBXW7 and 99 medium-recurrence mutations in genes such as RUNX1, MTOR, CA3, PI3, and PTPN11, all mapping within clusters having potential functional implications. As a proof of concept, we validated our predictions in EGFR using high-throughput phosphorylation data and cell-line-based experimental evaluation. Finally, mutation-drug cluster and network analysis predicted over 800 promising candidates for druggable mutations, raising new possibilities for designing personalized treatments for patients carrying specific mutations.	[Niu, Beifang; Scott, Adam D.; Sengupta, Sohini; Bailey, Matthew H.; Batra, Prag; Ning, Jie; Wyczalkowski, Matthew A.; Liang, Wen-Wei; Zhang, Qunyuan; McLellan, Michael D.; Sun, Sam Q.; Lou, Carolyn; Ye, Kai; Mashl, R. Jay; Wallis, John; Wendl, Michael C.; Ding, Li] Washington Univ, McDonnell Genome Inst, St Louis, MO 63130 USA; [Scott, Adam D.; Sengupta, Sohini; Bailey, Matthew H.; Wyczalkowski, Matthew A.; Liang, Wen-Wei; Sun, Sam Q.; Lou, Carolyn; Mashl, R. Jay; Wendl, Michael C.; Ding, Li] Washington Univ, Dept Med, Div Oncol, St Louis, MO 63130 USA; [Ning, Jie; Tripathi, Piyush; Chen, Feng; Ding, Li] Washington Univ, Div Nephrol, Dept Med, St Louis, MO 63130 USA; [Zhang, Qunyuan; Ye, Kai; Wendl, Michael C.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Wendl, Michael C.] Washington Univ, Dept Math, St Louis, MO 63130 USA; [Chen, Feng; Ding, Li] Washington Univ, Siteman Canc Ctr, St Louis, MO 63130 USA; [Chen, Feng] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63130 USA; [Niu, Beifang] Chinese Acad Sci, Dept High Performance Comp Technol & Applicat Dev, Comp Network Informat Ctr, Beijing, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Chinese Academy of Sciences; Computer Network Information Center, CAS	Ding, L (corresponding author), Washington Univ, McDonnell Genome Inst, St Louis, MO 63130 USA.; Ding, L (corresponding author), Washington Univ, Dept Med, Div Oncol, St Louis, MO 63130 USA.; Chen, F; Ding, L (corresponding author), Washington Univ, Div Nephrol, Dept Med, St Louis, MO 63130 USA.; Chen, F; Ding, L (corresponding author), Washington Univ, Siteman Canc Ctr, St Louis, MO 63130 USA.; Chen, F (corresponding author), Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63130 USA.	fchen@wustl.edu; lding@genome.wustl.edu	Ye, Kai/GSD-9856-2022; Ye, Kai/B-3640-2012	Ye, Kai/0000-0002-2851-6741; MCLELLAN, MICHAEL/0000-0002-2703-8784; Scott, Adam/0000-0003-4066-6053; Bailey, Matthew H./0000-0003-4526-9727; Wyczalkowski, Matthew/0000-0003-4197-551X	National Cancer Institute [R01CA180006, R01CA178383]; National Human Genome Research Institute [U01HG006517]; US Department of Defense [PC130118 (W81XWH-14-1-0458)]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK087960]; Precision Medicine Pathway at the Washington University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA178383, R01CA180006] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087960] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US Department of Defense(United States Department of Defense); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Precision Medicine Pathway at the Washington University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Friesel (Maine Medical Center Research Institute) for NIH3T3 clone 2.2 cells. We thank K. Johnson, C. Kandoth, M. Bharadwaj, and K. Huang for suggestions on data analysis. We also thank M. Xie, R. Jayasinghe, and H. Greulich for suggestions on experiments. This work was supported by National Cancer Institute grants R01CA180006 and R01CA178383 and National Human Genome Research Institute grant U01HG006517 to L.D.F.C. is supported in part by US Department of Defense grant PC130118 (W81XWH-14-1-0458) and National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK087960. M.H.B. is in part supported by the Precision Medicine Pathway at the Washington University School of Medicine.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betts MJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1094; Carter H, 2010, CANCER BIOL THER, V10, P582, DOI 10.4161/cbt.10.6.12537; Choi YL, 2012, CARCINOGENESIS, V33, P956, DOI 10.1093/carcin/bgs099; Cohen M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000470; Dangalchev C, 2006, PHYSICA A, V365, P556, DOI 10.1016/j.physa.2005.12.020; de Biase D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083607; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; FRIESEL R, 1989, MOL CELL BIOL, V9, P1857, DOI 10.1128/MCB.9.5.1857; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Hardman WE, 2004, J NUTR, V134, p3427S, DOI 10.1093/jn/134.12.3427S; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kancha RK, 2009, CLIN CANCER RES, V15, P460, DOI 10.1158/1078-0432.CCR-08-1757; Kerner GSMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070346; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Niknafs N, 2013, HUM GENET, V132, P1235, DOI 10.1007/s00439-013-1325-0; Ohanian M, 2012, EXPERT OPIN PHARMACO, V13, P927, DOI 10.1517/14656566.2012.672974; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ryan M, 2009, BIOINFORMATICS, V25, P1431, DOI 10.1093/bioinformatics/btp242; Ryslik GA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-231; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Singh A, 2008, NUCLEIC ACIDS RES, V36, pD815, DOI 10.1093/nar/gkm659; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; Teyra J, 2013, NAT METHODS, V10, P43, DOI 10.1038/nmeth.2300; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	37	92	92	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					827	+		10.1038/ng.3586	http://dx.doi.org/10.1038/ng.3586			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27294619	Green Accepted			2022-12-25	WOS:000380755100005
J	Schulze, A; Beliu, G; Helmerich, DA; Schubert, J; Pearl, LH; Prodromou, C; Neuweiler, H				Schulze, Andrea; Beliu, Gerti; Helmerich, Dominic A.; Schubert, Jonathan; Pearl, Laurence H.; Prodromou, Chrisostomos; Neuweiler, Hannes			Cooperation of local motions in the Hsp90 molecular chaperone ATPase mechanism	Nature Chemical Biology			English	Article							ESCHERICHIA-COLI HSP90; SHOCK-PROTEIN 90; CONFORMATIONAL DYNAMICS; COCHAPERONE AHA1; STRUCTURAL BASIS; IN-VIVO; HYDROLYSIS; CYCLE; CANCER; COMPLEX	The Hsp90 chaperone is a central node of protein homeostasis, activating many diverse client proteins. Hsp90 functions as a molecular clamp that closes and opens in response to the binding and hydrolysis of ATP. Crystallographic studies have defined distinct conformational states of the mechanistic core, implying structural changes that have not yet been observed in solution. Here we engineered one-nanometer fluorescence probes based on photoinduced electron transfer into the yeast Hsp90 to observe these motions. We found that the ATPase activity of the chaperone was reflected in the kinetics of specific structural rearrangements at remote positions that acted cooperatively. Nanosecond single-molecule fluorescence fluctuation analysis uncovered that critical structural elements that undergo rearrangement were mobile on a sub-millisecond time scale. We identified a two-step mechanism for lid closure over the nucleotide-binding pocket. The activating co-chaperone Aha1 mobilized the lid of apo Hsp90, suggesting an early role in the catalytic cycle.	[Schulze, Andrea; Beliu, Gerti; Helmerich, Dominic A.; Schubert, Jonathan; Neuweiler, Hannes] Univ Wurzburg, Dept Biotechnol & Biophys, Wurzburg, Germany; [Pearl, Laurence H.; Prodromou, Chrisostomos] Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton, E Sussex, England	University of Wurzburg; University of Sussex	Neuweiler, H (corresponding author), Univ Wurzburg, Dept Biotechnol & Biophys, Wurzburg, Germany.	hannes.neuweiler@uni-wuerzburg.de	Neuweiler, Hannes/W-7917-2019; Prodromou, Chrisostomos/ABA-9133-2021	Prodromou, Chrisostomos/0000-0003-4320-1147; Beliu, Gerti/0000-0003-1862-7912; Pearl, Laurence/0000-0002-6910-1809	Deutsche Forschungsgemeinschaft [NE 1201/3-1]; Wellcome Trust [095605/Z11/Z]; German Excellence Initiative	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); German Excellence Initiative	We thank the Deutsche Forschungsgemeinschaft (grant NE 1201/3-1 to H.N.) and the Wellcome Trust (Senior Investigator Award 095605/Z11/Z to L.H.P.). A.S. was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences (University of Wurzburg).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; Cullman SB, 2006, SEMIN ONCOL, V33, P457, DOI 10.1053/j.seminoncol.2006.04.001; Cunningham CN, 2012, PROTEIN SCI, V21, P1162, DOI 10.1002/pro.2103; Daidone I, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000645; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; Gianni S, 2007, BIOPHYS CHEM, V128, P105, DOI 10.1016/j.bpc.2007.04.008; Graf C, 2009, EMBO J, V28, P602, DOI 10.1038/emboj.2008.306; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Jhaveri K, 2014, EXPERT OPIN INV DRUG, V23, P611, DOI 10.1517/13543784.2014.902442; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lavery LA, 2014, MOL CELL, V53, P330, DOI 10.1016/j.molcel.2013.12.023; Li J, 2013, NAT STRUCT MOL BIOL, V20, P326, DOI 10.1038/nsmb.2502; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Mishra P, 2014, MOL CELL, V53, P344, DOI 10.1016/j.molcel.2013.12.024; Nagy PD, 2011, VIROLOGY, V411, P374, DOI 10.1016/j.virol.2010.12.061; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Neuweiler H, 2004, CURR PHARM BIOTECHNO, V5, P285, DOI 10.2174/1389201043376896; Neuweiler H, 2010, P NATL ACAD SCI USA, V107, P22106, DOI 10.1073/pnas.1011666107; Neuweiler H, 2009, P NATL ACAD SCI USA, V106, P18569, DOI 10.1073/pnas.0910860106; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Ries J, 2014, J AM CHEM SOC, V136, P17136, DOI 10.1021/ja508760a; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Roughley SD, 2011, J MED CHEM, V54, P3989, DOI 10.1021/jm200350g; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Santiveri CM, 2010, BIOPOLYMERS, V94, P779, DOI 10.1002/bip.21436; Sauer M, 2014, METHODS MOL BIOL, V1076, P597, DOI 10.1007/978-1-62703-649-8_27; Schuler B, 2013, CURR OPIN STRUC BIOL, V23, P36, DOI 10.1016/j.sbi.2012.10.008; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vaiana AC, 2003, J AM CHEM SOC, V125, P14564, DOI 10.1021/ja036082j; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	54	42	42	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2016	12	8					628	+		10.1038/NCHEMBIO.2111	http://dx.doi.org/10.1038/NCHEMBIO.2111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2UW	27322067	Green Accepted			2022-12-25	WOS:000380640100010
J	Papillon-Cavanagh, S; Lu, C; Gayden, T; Mikael, LG; Bechet, D; Karamboulas, C; Ailles, L; Karamchandani, J; Marchione, DM; Garcia, BA; Weinreb, I; Goldstein, D; Lewis, PW; Dancu, OM; Dhaliwal, S; Stecho, W; Howlett, CJ; Mymryk, JS; Barrett, JW; Nichols, AC; Allis, CD; Majewski, J; Jabado, N				Papillon-Cavanagh, Simon; Lu, Chao; Gayden, Tenzin; Mikael, Leonie G.; Bechet, Denise; Karamboulas, Christina; Ailles, Laurie; Karamchandani, Jason; Marchione, Dylan M.; Garcia, Benjamin A.; Weinreb, Ilan; Goldstein, David; Lewis, Peter W.; Dancu, Octavia Maria; Dhaliwal, Sandeep; Stecho, William; Howlett, Christopher J.; Mymryk, Joe S.; Barrett, John W.; Nichols, Anthony C.; Allis, C. David; Majewski, Jacek; Jabado, Nada			Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas	NATURE GENETICS			English	Article							HUMAN-PAPILLOMAVIRUS; DRIVER MUTATIONS; NSD1 MUTATIONS; REVEALS; CANCER; LANDSCAPE; ACTIVATION; GENES	Human papillomavirus (HPV)-negative head and neck squamous cell carcinomas (HNSCCs) are deadly and common cancers. Recent genomic studies implicate multiple genetic pathways, including cell signaling, cell cycle and immune evasion, in their development. Here we analyze public data sets and uncover a previously unappreciated role of epigenome deregulation in the genesis of 13% of HPV-negative HNSCCs. Specifically, we identify novel recurrent mutations encoding p.Lys36Met (K36M) alterations in multiple H3 histone genes. histones. We further validate the presence of these alterations in multiple independent HNSCC data sets and show that, along with previously described NSD1 mutations, they correspond to a specific DNA methylation cluster. The K36M substitution and NSD1 defects converge on altering methylation of histone H3 at K36 (H3K36), subsequently blocking cellular differentiation and promoting oncogenesis. Our data further indicate limited redundancy for NSD family members in HPV-negative HNSCCs and suggest a potential role for impaired H3K36 methylation in their development. Further investigation of drugs targeting chromatin regulators is warranted in HPV-negative HNSCCs driven by aberrant H3K36 methylation.	[Papillon-Cavanagh, Simon; Gayden, Tenzin; Bechet, Denise; Dancu, Octavia Maria; Majewski, Jacek; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Lu, Chao; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10021 USA; [Mikael, Leonie G.; Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Mikael, Leonie G.; Jabado, Nada] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Karamboulas, Christina; Ailles, Laurie] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Karamchandani, Jason] McGill Univ, Montreal Neurol Hosp, Dept Pathol, Montreal, PQ, Canada; [Marchione, Dylan M.; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Epigenet Program, Philadelphia, PA 19104 USA; [Marchione, Dylan M.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Weinreb, Ilan] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Goldstein, David] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Otolaryngol, Toronto, ON, Canada; [Goldstein, David] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, Toronto, ON, Canada; [Lewis, Peter W.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53706 USA; [Lewis, Peter W.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Dhaliwal, Sandeep] Univ Western Ontario, Dept Otolaryngol Head & Neck Surg, London, ON, Canada; [Dhaliwal, Sandeep; Barrett, John W.; Nichols, Anthony C.] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Stecho, William; Howlett, Christopher J.] Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada; [Mymryk, Joe S.] Univ Western Ontario, Dept Microbiol & Immunol, Oncol & Otolaryngol Head & Neck Surg, London, ON, Canada; [Mymryk, Joe S.; Barrett, John W.; Nichols, Anthony C.] London Reg Canc Program, London, ON, Canada; [Mymryk, Joe S.; Barrett, John W.; Nichols, Anthony C.] Lawson Hlth Res Inst, London, ON, Canada	McGill University; Rockefeller University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; McGill University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Majewski, J; Jabado, N (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Jabado, N (corresponding author), McGill Univ, Dept Pediat, Montreal, PQ, Canada.; Jabado, N (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	jacek.majewski@mcgill.ca; nada.jabado@mcgill.ca	Stecho, William/E-1656-2013; Papillon-Cavanagh, Simon/AAS-8749-2020; barrett, john/ABD-8414-2020; Jabado, Nada/AAN-4026-2020; Nichols, Anthony Charles/H-9595-2019; goldstein, David/AAT-6302-2020	Stecho, William/0000-0002-2891-9348; Papillon-Cavanagh, Simon/0000-0002-0372-2266; Nichols, Anthony Charles/0000-0002-0760-980X; Marchione, Dylan/0000-0001-6941-0604; Lewis, Peter/0000-0002-9816-7823; Lu, Chao/0000-0003-0982-8122	US National Institutes of Health (NIH) [P01CA196539, K99CA212257, T32GM008275]; Rockefeller University; Wisconsin Institute for Discovery; Greater Milwaukee Foundation; Sidney Kimmel Foundation (Kimmel Scholar Award); Canadian Institutes for Health Research (CIHR) [MOP 142491, MOP 340674]; Cedars Cancer Foundation; Leukemia and Lymphoma Society Dr. Robert Arceci Scholar Award; Genome Canada; Genome Quebec; Institute for Cancer Research of the CIHR; McGill University; Damon Runyon Cancer Research Foundation [DRG-2195-14]; Fond de la Recherche du Quebec en Sante; Canada Research Chair (tier 2); TD Trust/Montreal Children's Hospital Foundation; CIHR; Montreal Children's Hospital Foundation; NATIONAL CANCER INSTITUTE [P01CA196539, K99CA212257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; Wisconsin Institute for Discovery; Greater Milwaukee Foundation; Sidney Kimmel Foundation (Kimmel Scholar Award); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cedars Cancer Foundation; Leukemia and Lymphoma Society Dr. Robert Arceci Scholar Award(Leukemia and Lymphoma Society); Genome Canada(Genome Canada); Genome Quebec; Institute for Cancer Research of the CIHR; McGill University; Damon Runyon Cancer Research Foundation; Fond de la Recherche du Quebec en Sante; Canada Research Chair (tier 2)(Canada Research Chairs); TD Trust/Montreal Children's Hospital Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); Montreal Children's Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank EMD Millipore for its role in H3.3K36M antibody generation, A. Ponce de Leon for help with figure formatting, and the TCGA group for the wealth of data available and for their rapid and helpful answers to other enquiries we had on this data set. This research was supported by US National Institutes of Health (NIH) grants (P01CA196539 to N.J., J.M., P.W.L., B.A.G. and C.D.A.; K99CA212257 to CL.; T32GM008275 to D.M.M.), the Rockefeller University (to C.D.A.), startup funding provided by the Wisconsin Institute for Discovery (to P.W.L.), the Greater Milwaukee Foundation (to P.W.L.), the Sidney Kimmel Foundation (Kimmel Scholar Award to P.W.L.), Canadian Institutes for Health Research (CIHR) grants (MOP 142491 to J.S.M. and A.C.N.; MOP 340674 to A.C.N.) and the Cedars Cancer Foundation (N.J.). B.A.G. is funded by a Leukemia and Lymphoma Society Dr. Robert Arceci Scholar Award. This work was performed within the context of the I-CHANGE consortium and supported by funding from Genome Canada, Genome Quebec, the Institute for Cancer Research of the CIHR, McGill University and the Montreal Children's Hospital Foundation. C.L. is a Kandarian Family Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2195-14). N.J. is a member of the Penny Cole Laboratory and the recipient of a Chercheur Boursier, Chaire de Recherche Award from the Fond de la Recherche du Quebec en Sante. J.M. holds a Canada Research Chair (tier 2). S.P.-C. is supported by a studentship from the Fond de la Recherche du Quebec en Sante. D.B. and T.G. are supported by a fellowship from the TD Trust/Montreal Children's Hospital Foundation and CIHR, respectively.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Baxi S, 2012, J NATL COMPR CANC NE, V10, P806, DOI 10.6004/jnccn.2012.0084; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Choufani S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10207; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; De Cecco L, 2015, ONCOTARGET, V6, P9627, DOI 10.18632/oncotarget.3301; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Douglas J, 2003, AM J HUM GENET, V72, P132, DOI 10.1086/345647; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Gaykalova DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093102; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hammerman PS, 2015, CANCER DISCOV, V5, P239, DOI 10.1158/2159-8290.CD-14-1205; Hayes DN, 2015, J CLIN ONCOL, V33, P3227, DOI 10.1200/JCO.2015.62.1086; Hedberg ML, 2016, J CLIN INVEST, V126, P1606, DOI 10.1172/JCI86862; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Nikbakht H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11185; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Saloura V, 2015, MOL CANCER RES, V13, P293, DOI 10.1158/1541-7786.MCR-14-0292-T; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun WY, 2014, ANN NY ACAD SCI, V1333, P33, DOI 10.1111/nyas.12599; Sun WY, 2014, CANCER RES, V74, P1091, DOI 10.1158/0008-5472.CAN-13-1259; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Vokes EE, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv344; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	40	143	146	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					180	185		10.1038/ng.3757	http://dx.doi.org/10.1038/ng.3757			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	28067913	Green Accepted			2022-12-25	WOS:000393148600006
J	Babon, JAB; DeNicola, ME; Blodgett, DM; Crevecoeur, I; Buttrick, TS; Maehr, R; Bottino, R; Naji, A; Kaddis, J; Elyaman, W; James, EA; Haliyur, R; Brissova, M; Overbergh, L; Mathieu, C; Delong, T; Haskins, K; Pugliese, A; Campbell-Thompson, M; Mathews, C; Atkinson, MA; Powers, AC; Harlan, DM; Kent, SC				Babon, Jenny Aurielle B.; DeNicola, Megan E.; Blodgett, David M.; Crevecoeur, Inne; Buttrick, Thomas S.; Maehr, Rene; Bottino, Rita; Naji, Ali; Kaddis, John; Elyaman, Wassim; James, Eddie A.; Haliyur, Rachana; Brissova, Marcela; Overbergh, Lut; Mathieu, Chantal; Delong, Thomas; Haskins, Kathryn; Pugliese, Alberto; Campbell-Thompson, Martha; Mathews, Clayton; Atkinson, Mark A.; Powers, Alvin C.; Harlan, David M.; Kent, Sally C.			Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes	NATURE MEDICINE			English	Article							POSTTRANSLATIONAL MODIFICATION; RECENT-ONSET; PANCREAS; INSULIN; MELLITUS; EPITOPES; PATHOGENESIS; PEPTIDE; IMMUNOSUPPRESSION; AUTOANTIGENS	A major therapeutic goal for type 1 diabetes (T1D) is to induce autoantigen-specific tolerance of T cells. This could suppress autoimmunity in those at risk for the development of T1D, as well as in those with established disease who receive islet replacement or regeneration therapy. Because functional studies of human autoreactive T cell responses have been limited largely to peripheral blood-derived T cells(1-3), it is unclear how representative the peripheral T cell repertoire is of T cells infiltrating the islets. Our knowledge of the insulitic T cell repertoire is derived from histological and immunohistochemical analyses of insulitis(4-8), the identification of autoreactive CD8(+) T cells in situ, in islets of human leukocyte antigen (HLA)-A2(+) donors(9) and isolation and identification of DQ8 and DQ2-DQ8 heterodimer-restricted, proinsulin-reactive CD4(+) T cells grown from islets of a single donor with T1D(10). Here we present an analysis of 50 of a total of 236 CD4(+) and CD8(+) T cell lines grown from individual handpicked islets or clones directly sorted from handpicked, dispersed islets from nine donors with T1D. Seventeen of these T cell lines and clones reacted to a broad range of studied native islet antigens and to post-translationally modified peptides. These studies demonstrate the existence of a variety of islet-infiltrating, islet-autoantigen reactive T cells in individuals with T1D, and these data have implications for the design of successful immunotherapies.	[Babon, Jenny Aurielle B.; DeNicola, Megan E.; Blodgett, David M.; Harlan, David M.; Kent, Sally C.] Univ Massachusetts, Sch Med, Dept Med, Div Diabet,Diabet Ctr Excellence, Worcester, MA 01655 USA; [Crevecoeur, Inne; Overbergh, Lut; Mathieu, Chantal] Katholieke Univ Leuven, Dept Clin & Expt Med, Lab Clin & Expt Endocrinol, Leuven, Belgium; [Buttrick, Thomas S.; Elyaman, Wassim] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA; [Buttrick, Thomas S.; Elyaman, Wassim] Harvard Med Sch, Boston, MA USA; [Maehr, Rene] Univ Massachusetts, Sch Med, Program Mol Med, Diabet Ctr Excellence, Worcester, MA USA; [Bottino, Rita] Allegheny Singer Res Inst, Inst Cellular Therapeut, 320 E N Ave, Pittsburgh, PA 15212 USA; [Bottino, Rita] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Naji, Ali] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Kaddis, John] City Hope Natl Med Ctr, Beckman Res Inst, Dept Informat Sci, Duarte, CA USA; [James, Eddie A.] Virginia Mason, Benaroya Res Inst, Seattle, WA USA; [Haliyur, Rachana; Brissova, Marcela; Powers, Alvin C.] Vanderbilt Univ, Med Ctr, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN USA; [Delong, Thomas; Haskins, Kathryn] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO USA; [Pugliese, Alberto] Univ Miami, Diabet Res Inst, Miami, FL USA; [Campbell-Thompson, Martha; Mathews, Clayton; Atkinson, Mark A.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Campbell-Thompson, Martha; Mathews, Clayton; Atkinson, Mark A.] Univ Florida, Dept Immunol, Gainesville, FL USA; [Campbell-Thompson, Martha; Mathews, Clayton; Atkinson, Mark A.] Univ Florida, Dept Lab Med, Gainesville, FL USA; [Powers, Alvin C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Powers, Alvin C.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	University of Massachusetts System; University of Massachusetts Worcester; KU Leuven; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Carnegie Mellon University; University of Pennsylvania; City of Hope; Beckman Research Institute of City of Hope; Benaroya Research Institute; Virginia Mason Medical Center; Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Miami; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Kent, SC (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Diabet,Diabet Ctr Excellence, Worcester, MA 01655 USA.	Sally.Kent@umassmed.edu	Elyaman, Wassim/AAJ-1562-2021; mathieu, chantal/ABD-5505-2021; Overbergh, Lut/AAC-3515-2020; James, Eddie/V-4929-2019; Campbell-Thompson, Martha/A-7584-2010	mathieu, chantal/0000-0002-4055-5233; James, Eddie/0000-0002-7217-5729; Campbell-Thompson, Martha/0000-0001-6878-1235; Elyaman, Wassim/0000-0001-7238-374X; Kaddis, John/0000-0002-6752-7670; Haliyur, Rachana/0000-0002-3916-4286	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI126189, P01AI042288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, R24DK106755, U01DK089572, UC4DK104155, P30DK020593, UC4DK104194, R01DK074656, R01DK081166, UC4DK104211, UC4DK108120, U01DK072473, U01DK104162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI126189, P01 AI042288] Funding Source: Medline; NIDDK NIH HHS [P30 DK020593, P60 DK020593, R01 DK074656, U01 DK104162, UC4 DK104155, R24 DK106755, UC4 DK104194, UC4 DK104211, U01 DK089572, R01 DK081166, UC4 DK108120, U01 DK072473] Funding Source: Medline; NIGMS NIH HHS [T32 GM007347] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arif S, 2014, DIABETES, V63, P3835, DOI 10.2337/db14-0365; Atkinson MA, 2015, DIABETES CARE, V38, P979, DOI 10.2337/dc15-0144; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Bottino R., 2012, J TRANSPLANT, V2012; Campbell-Thompson ML, 2013, DIABETOLOGIA, V56, P2541, DOI 10.1007/s00125-013-3043-5; Campbell-Thompson M, 2016, DIABETES, V65, P719, DOI 10.2337/db15-0779; Codina-Busqueta E, 2011, J IMMUNOL, V186, P3787, DOI 10.4049/jimmunol.1002423; CONRAD B, 1994, NATURE, V371, P351, DOI 10.1038/371351a0; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Dai C, 2012, DIABETOLOGIA, V55, P707, DOI 10.1007/s00125-011-2369-0; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Delong T, 2012, DIABETES, V61, P3239, DOI 10.2337/db12-0112; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gudmann NS, 2015, AUTOIMMUNITY, V48, P73, DOI 10.3109/08916934.2014.962024; ITOH N, 1993, J CLIN INVEST, V92, P2313, DOI 10.1172/JCI116835; Joffe M, 2012, INT IMMUNOL, V24, P447, DOI 10.1093/intimm/dxs042; Krogvold L, 2016, DIABETOLOGIA, V59, P492, DOI 10.1007/s00125-015-3820-4; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; Liu EH, 2009, DIABETOLOGIA, V52, P1369, DOI 10.1007/s00125-009-1342-7; Mannering SI, 2005, J EXP MED, V202, P1191, DOI 10.1084/jem.20051251; McGinty JW, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0657-7; McGinty JW, 2014, DIABETES, V63, P3033, DOI 10.2337/db13-1952; McLaughlin RJ, 2016, CLIN EXP IMMUNOL, V185, P133, DOI 10.1111/cei.12775; Nepom GT, 2005, ADV IMMUNOL, V88, P51, DOI 10.1016/S0065-2776(05)88002-2; Pathiraja V, 2015, DIABETES, V64, P172, DOI 10.2337/db14-0858; Rodriguez-Calvo T, 2014, DIABETES, V63, P3880, DOI 10.2337/db14-0549; Rondas Dieter, 2015, Diabetes, V64, P573, DOI 10.2337/db14-0621; Rowe PA, 2011, SEMIN IMMUNOPATHOL, V33, P29, DOI 10.1007/s00281-010-0208-x; SIBLEY RK, 1985, LAB INVEST, V53, P132; Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006; Staeva TP, 2013, DIABETES, V62, P9, DOI 10.2337/db12-0562; Strollo R, 2015, DIABETOLOGIA, V58, P2851, DOI 10.1007/s00125-015-3746-x; van Lummel M, 2016, DIABETES, V65, P732, DOI 10.2337/db15-1031; van Lummel M, 2014, DIABETES, V63, P237, DOI 10.2337/db12-1214; VELD PI, 2010, DIABETES, V59, P1702, DOI DOI 10.2337/DB09-1698; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Yin L, 2013, PROTEIN CELL, V4, P8, DOI 10.1007/s13238-012-2077-7	40	189	191	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1482	+		10.1038/nm.4203	http://dx.doi.org/10.1038/nm.4203			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27798614	Green Accepted			2022-12-25	WOS:000389549000027
J	Kawano, F; Okazaki, R; Yazawa, M; Sato, M				Kawano, Fuun; Okazaki, Risako; Yazawa, Masayuki; Sato, Moritoshi			A photoactivatable Cre-loxP recombination system for optogenetic genome engineering	NATURE CHEMICAL BIOLOGY			English	Article							SITE-SPECIFIC RECOMBINATION; GENE-EXPRESSION; FLUORESCENT PROTEINS; DNA RECOMBINATION; TEMPORAL CONTROL; MAMMALIAN-CELLS; LIGHT; ACTIVATION; MICE; COMPLEMENTATION	Genome engineering techniques represented by the Cre-loxP recombination system have been used extensively for biomedical research. However, powerful and useful techniques for genome engineering that have high spatiotemporal precision remain elusive. Here we develop a highly efficient photoactivatable Cre recombinase (PA-Cre) to optogenetically control genome engineering in vivo. PA-Cre is based on the reassembly of split Cre fragments by light-inducible dimerization of the Magnet system. PA-Cre enables sharp induction (up to 320-fold) of DNA recombination and is efficiently activated even by low-intensity illumination (similar to 0.04 W m(-2)) or short periods of pulsed illumination (similar to 30 s). We demonstrate that PA-Cre allows for efficient DNA recombination in an internal organ of living mice through noninvasive external illumination using a LED light source. The present PA-Cre provides a powerful tool to greatly facilitate optogenetic genome engineering in vivo.	[Kawano, Fuun; Okazaki, Risako; Sato, Moritoshi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Kawano, Fuun; Yazawa, Masayuki] Columbia Univ, Dept Rehabil & Regenerat Med, New York, NY USA; [Yazawa, Masayuki] Columbia Univ, Dept Pharmacol, New York, NY USA	University of Tokyo; Columbia University; Columbia University	Sato, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	cmsato@mail.ecc.u-tokyo.ac.jp	Kawano, Fuun/U-5777-2019; Sato, Moritoshi/O-2735-2018	Sato, Moritoshi/0000-0002-3095-5831	Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Agency for Medical Research and Development (AMED); Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS); JSPS	Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Y. Nihongaki for his technical assistance in experiments with mice. We also thank S.E. Park, J.R. Quejada and S. Su for proofreading the manuscript. This work was supported by Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) and Japan Agency for Medical Research and Development (AMED). This work was also supported by a grant from the Takeda Science Foundation to M.S. This work was also supported by grants from Japan Society for the Promotion of Science (JSPS) to M.S. and JSPS Postdoctoral Fellowships for Research Abroad to F.K.	Akoplan A, 2005, ADV GENET, V55, P1, DOI 10.1016/S0065-2660(05)55001-6; Araki K, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-29; Boulina M, 2013, DEVELOPMENT, V140, P1605, DOI 10.1242/dev.088930; Brown KA, 2015, CHEM COMMUN, V51, P5702, DOI 10.1039/c4cc09442e; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Casanova E, 2003, GENESIS, V37, P25, DOI 10.1002/gene.10227; Casanova E, 2002, GENESIS, V34, P208, DOI 10.1002/gene.10153; Duo C, 2002, PHARMACOL BIOCHEM BE, V71, P269, DOI 10.1016/S0091-3057(01)00656-6; Edwards WF, 2009, ACS CHEM BIOL, V4, P441, DOI 10.1021/cb900041s; Faal T, 2015, MOL BIOSYST, V11, P783, DOI 10.1039/c4mb00581c; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/nmeth.2996, 10.1038/NMETH.2996]; Gaj T, 2014, BIOTECHNOL BIOENG, V111, P1, DOI 10.1002/bit.25096; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; Gautier A, 2014, NAT CHEM BIOL, V10, P533, DOI [10.1038/nchembio.1534, 10.1038/NCHEMBIO.1534]; Gierut Jessica J, 2014, Cold Spring Harb Protoc, V2014, P339, DOI 10.1101/pdb.top069807; Gorka AP, 2014, J AM CHEM SOC, V136, P14153, DOI 10.1021/ja5065203; Guo F, 1999, P NATL ACAD SCI USA, V96, P7143, DOI 10.1073/pnas.96.13.7143; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Guo ZM, 2005, ACTA BIOCH BIOPH SIN, V37, P133, DOI 10.1111/j.1745-7270.2005.00011.x; Inlay MA, 2013, CHEM COMMUN, V49, P4971, DOI 10.1039/c3cc42179a; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Jung-Hwan Kim, 2011, International Journal of Service Science, Management, Engineering, and Technology, V2, P1, DOI 10.4018/jssmet.2011070101; Kawano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7256; Kellendonk C, 1996, NUCLEIC ACIDS RES, V24, P1404, DOI 10.1093/nar/24.8.1404; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Langer SJ, 2002, NUCLEIC ACIDS RES, V30, P3067, DOI 10.1093/nar/gkf421; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Link KH, 2005, J AM CHEM SOC, V127, P13088, DOI 10.1021/ja0531226; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lu X, 2012, BIOCONJUGATE CHEM, V23, P1945, DOI 10.1021/bc300319c; Luo J, 2016, CHEM COMMUN, V52, P8529, DOI 10.1039/c6cc03934k; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Meinke G, 2016, CHEM REV, V116, P12785, DOI 10.1021/acs.chemrev.6b00077; Muller K, 2015, BIOL CHEM, V396, P145, DOI 10.1515/hsz-2014-0199; Oberdoerffer P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng140; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Roshangar L, 2010, J OBSTET GYNAECOL RE, V36, P224, DOI 10.1111/j.1447-0756.2009.01129.x; Sando R, 2013, NAT METHODS, V10, P1085, DOI [10.1038/NMETH.2640, 10.1038/nmeth.2640]; Schindler SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13627; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; STERNBERG N, 1981, J MOL BIOL, V150, P603, DOI 10.1016/0022-2836(81)90384-3; Tang JCY, 2015, NAT NEUROSCI, V18, P1334, DOI 10.1038/nn.4081; Taslimi A, 2016, NAT CHEM BIOL, V12, P425, DOI [10.1038/nchembio.2063, 10.1038/NCHEMBIO.2063]; Thomson JG, 2003, GENESIS, V36, P162, DOI 10.1002/gene.10211; Vaidya AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001945; van Duyne GD, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0014-2014; Zhang ZW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf089; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	53	101	108	5	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1059	+		10.1038/NCHEMBIO.2205	http://dx.doi.org/10.1038/NCHEMBIO.2205			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27723747				2022-12-25	WOS:000388582900015
J	Levy, G; Habib, N; Guzzardi, MA; Kitsberg, D; Bomze, D; Ezra, E; Uygun, BE; Uygun, K; Trippler, M; Schlaak, JF; Shibolet, O; Sklan, EH; Cohen, M; Timm, J; Friedman, N; Nahmias, Y				Levy, Gahl; Habib, Naomi; Guzzardi, Maria Angela; Kitsberg, Daniel; Bomze, David; Ezra, Elishai; Uygun, Basak E.; Uygun, Korkut; Trippler, Martin; Schlaak, Joerg F.; Shibolet, Oren; Sklan, Ella H.; Cohen, Merav; Timm, Joerg; Friedman, Nir; Nahmias, Yaakov			Nuclear receptors control pro-viral and antiviral metabolic responses to hepatitis C virus infection	NATURE CHEMICAL BIOLOGY			English	Article							GENE-EXPRESSION; FLUX ANALYSIS; RNA REPLICATION; TARGET; ALPHA; LIVER; ACID; HEPATOCYTES; ACTIVATION; MICROARRAY	Viruses lack the basic machinery needed to replicate and therefore must hijack the host's metabolism to propagate. Virus-induced metabolic changes have yet to be systematically studied in the context of host transcriptional regulation, and such studies shoul offer insight into host-pathogen metabolic interplay. In this work we identified hepatitis C virus (HCV)-responsive regulators by coupling system-wide metabolic-flux analysis with targeted perturbation of nuclear receptors in primary human hepatocytes. We found HCV-induced upregulation of glycolysis, ketogenesis and drug metabolism, with glycolysis controlled by activation of HNF4 alpha, ketogenesis by PPAR alpha and FXR, and drug metabolism by PXR. Pharmaceutical inhibition of HNF4 alpha reversed HCV-induced glycolysis, blocking viral replication while increasing apoptosis in infected cells showing virus-induced dependence on glycolysis. In contrast, pharmaceutical inhibition of PPAR alpha or FXR reversed HCV-induced ketogenesis but increased viral replication, demonstrating a novel host antiviral response. Our results show that virus-induced changes to a host's metabolism can be detrimental to its life cycle, thus revealing a biologically complex relationship between virus and host.	[Levy, Gahl; Habib, Naomi; Guzzardi, Maria Angela; Kitsberg, Daniel; Bomze, David; Ezra, Elishai; Cohen, Merav; Friedman, Nir; Nahmias, Yaakov] Hebrew Univ Jerusalem, Benin Sch Comp Sci & Engn, Grass Ctr Bioengn, Jerusalem, Israel; [Levy, Gahl; Habib, Naomi; Kitsberg, Daniel; Bomze, David; Cohen, Merav; Friedman, Nir; Nahmias, Yaakov] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Jerusalem, Israel; [Habib, Naomi] Broad Inst Harvard & MIT, Klarman Cell Observ, Cambridge, MA USA; [Guzzardi, Maria Angela] Natl Res Council CNR, Inst Clin Physiol, Pisa, Italy; [Ezra, Elishai] Jerusalem Coll Technol, Fac Engn, Jerusalem, Israel; [Uygun, Basak E.; Uygun, Korkut] Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA; [Trippler, Martin; Schlaak, Joerg F.] Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Shibolet, Oren] Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol, Liver Unit, Tel Aviv, Israel; [Shibolet, Oren] Sackler Fac Med, Tel Aviv, Israel; [Sklan, Ella H.] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Timm, Joerg] Univ Dusseldorf, Fac Med, Inst Virol, Dusseldorf, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Harvard University; Massachusetts General Hospital; University of Duisburg Essen; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Heinrich Heine University Dusseldorf	Nahmias, Y (corresponding author), Hebrew Univ Jerusalem, Benin Sch Comp Sci & Engn, Grass Ctr Bioengn, Jerusalem, Israel.; Nahmias, Y (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Jerusalem, Israel.	ynahmias@cs.huji.ac.il	Nahmias, Yaakov/AAM-3872-2020; Friedman, Nir/H-9692-2012; Habib, Naomi/AAA-8937-2020; Timm, Jörg/P-7652-2019; Uygun, Basak/I-1792-2012; Guzzardi, Maria-Angela/K-1389-2016; Nahmias, Yaakov/H-4725-2013; Uygun, Korkut/AAH-3950-2020; Ezra, Elishai/G-4459-2016	Nahmias, Yaakov/0000-0002-6051-616X; Friedman, Nir/0000-0002-9678-3550; Timm, Jörg/0000-0001-7799-3045; Uygun, Basak/0000-0002-2600-7900; Guzzardi, Maria-Angela/0000-0001-9574-5088; Nahmias, Yaakov/0000-0002-6051-616X; Uygun, Korkut/0000-0003-2088-7860; Ezra, Elishai/0000-0003-1304-8022; Bomze, David/0000-0003-2958-7055; Cohen, Merav/0000-0001-7802-0499	European Research Council [242699, 681870]; British Council BIRAX Regenerative Medicine award [06BX14SFYN]	European Research Council(European Research Council (ERC)European Commission); British Council BIRAX Regenerative Medicine award	The authors thank M.-L. Izamis and M. Zimerman for technical support, K.J. Archer for providing GSE14323 phenotypic data, A. Regev for important insight, and the Rina and Samuel M. Frankel Family Foundation for its generous gift to the Nahmias lab. Some primary human hepatocytes were kindly provided by S.C. Strom (University of Pittsburgh, Pittsburg, Pennsylvania, USA). The Huh7.5.1 human hepatoma cell line was provided by F. Chisari (Scripps Research Institute, La Jolla, California, USA). Plasmids containing the JFH-1 full-length genome were kindly provided by T. Wakita (National Institute of Infectious Diseases, Tokyo, Japan); plasmids containing the JC1-RFP full-length genome were kindly provided by R. Bartenschlager (University of Heidelberg, Heidelberg, Germany). The PXR reporter construct was a kind gift from C. Liddle (University of Sydney, Australia). This work was funded by European Research Council Starting Grant TMIHCV (project 242699), European Research Council Consolidator Grant OCLD (project 681870) and the British Council BIRAX Regenerative Medicine award (project 06BX14SFYN).	Arrese M, 2010, ANN HEPATOL, V9, pS112, DOI 10.1016/S1665-2681(19)31735-1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avior Y, 2015, HEPATOLOGY, V62, P265, DOI 10.1002/hep.27803; Avior Y, 2013, FOOD FUNCT, V4, P831, DOI 10.1039/c3fo60063g; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Chan C, 2003, BIOTECHNOL BIOENG, V81, P33, DOI 10.1002/bit.10453; Chan C, 2003, METAB ENG, V5, P1, DOI 10.1016/S1096-7176(02)00011-3; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Clarke B, 1996, J MOL CELL CARDIOL, V28, P341, DOI 10.1006/jmcc.1996.0032; Corey KE, 2009, HEPATOLOGY, V50, P1030, DOI 10.1002/hep.23219; Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Fu D, 2013, P NATL ACAD SCI USA, V110, P7288, DOI 10.1073/pnas.1304285110; Gardner JP, 2003, P NATL ACAD SCI USA, V100, P4498, DOI 10.1073/pnas.0831128100; Goldwasser J, 2011, J HEPATOL, V55, P963, DOI 10.1016/j.jhep.2011.02.011; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hertz R, 2001, BIOCHEM PHARMACOL, V61, P1057, DOI 10.1016/S0006-2952(01)00578-0; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikeda M, 2007, ADV DRUG DELIVER REV, V59, P1277, DOI 10.1016/j.addr.2007.03.021; Izamis ML, 2011, BIOTECHNOL BIOENG, V108, P839, DOI 10.1002/bit.22998; Kandathil AJ, 2013, GASTROENTEROLOGY, V145, P1404, DOI 10.1053/j.gastro.2013.08.034; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Kiselyuk A, 2012, CHEM BIOL, V19, P806, DOI 10.1016/j.chembiol.2012.05.014; Lee K, 2000, METAB ENG, V2, P312, DOI 10.1006/mben.2000.0160; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Matsui C, 2012, J VIROL, V86, P12903, DOI 10.1128/JVI.01418-12; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Mihm S, 2010, DIGEST DIS, V28, P280, DOI 10.1159/000282103; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Moxley JF, 2009, P NATL ACAD SCI USA, V106, P6477, DOI 10.1073/pnas.0811091106; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Nahmias Y, 2006, FASEB J, V20, P2531, DOI 10.1096/fj.06-6192fje; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Qadri I, 2006, MOL PHARMACOL, V70, P627, DOI 10.1124/mol.106.023499; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Teng MW, 2012, CELL, V151, P1569, DOI 10.1016/j.cell.2012.11.051; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Vacca M, 2013, MOL CELL ENDOCRINOL, V368, P108, DOI 10.1016/j.mce.2012.06.025; Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Wieland S, 2014, HEPATOLOGY, V59, P2121, DOI 10.1002/hep.26770; Woodhouse SD, 2010, HEPATOLOGY, V52, P443, DOI 10.1002/hep.23733; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030621, 10.1371/journal.pone.0039076]	60	33	36	1	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1037	+		10.1038/NCHEMBIO.2193	http://dx.doi.org/10.1038/NCHEMBIO.2193			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27723751	Green Accepted			2022-12-25	WOS:000388582900012
J	Benson, AK				Benson, Andrew K.			The gut microbiome-an emerging complex trait	NATURE GENETICS			English	Editorial Material							GENETICS; SHAPE	As the first series of genetic analyses of gut microbiome composition in humans is now emerging, the results should be met with enthusiasm, but also with caution. Findings from the initial offerings demonstrate how population-scale approaches can provide deeper insights into host microbiome interactions while at the same time illustrating that our understanding of the architecture of highly complex microbiome 'traits' is still rudimentary.	[Benson, Andrew K.] Univ Nebraska, Dept Food Sci & Technol, Nebraska Food Hlth Ctr, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Benson, AK (corresponding author), Univ Nebraska, Dept Food Sci & Technol, Nebraska Food Hlth Ctr, Lincoln, NE 68583 USA.	abenson1@unl.edu		Benson, Andrew/0000-0001-6330-0252				Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Leamy LJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0552-6; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Org E, 2015, GENOME RES, V25, P1558, DOI 10.1101/gr.194118.115; Srinivas G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3462; Turpin W, 2016, NAT GENET, V48, P1413, DOI 10.1038/ng.3693; Visscher PM, 2016, NAT GENET, V48, P707, DOI 10.1038/ng.3604; Visscher PM, 2016, GENETICS, V202, P377, DOI 10.1534/genetics.115.180513; Wang J, 2016, NAT GENET, V48, P1396, DOI 10.1038/ng.3695	15	28	29	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1301	1302		10.1038/ng.3707	http://dx.doi.org/10.1038/ng.3707			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27787511				2022-12-25	WOS:000386543400004
J	Muffat, J; Yuan, BB; Mitalipoya, M; Omer, A; Corcoran, S; Bakiasi, G; Tsai, LH; Aubourg, P; Ransohoff, RM; Jaenisch, R				Muffat, Julien; Yuan, Bingbing; Mitalipoya, Maisam; Omer, Attya; Corcoran, Sean; Bakiasi, Grisilda; Tsai, Li-Huei; Aubourg, Patrick; Ransohoff, Richard M.; Jaenisch, Rudolf			Efficient derivation of microglia-like cells from human pluripotent stem cells	NATURE MEDICINE			English	Article							TISSUE-RESIDENT MACROPHAGES; RETT-SYNDROME; MYELOID CELLS; BRAIN; NEURONS; MOUSE; PU.1; DIFFERENTIATION; PRECURSORS; ONTOGENY	Microglia, the only lifelong resident immune cells of the central nervous system (CNS), are highly specialized macrophages that have been recognized to have a crucial role in neurodegenerative diseases such as Alzheimer's, Parkinson's and adrenoleukodystrophy (ALD). However, in contrast to other cell types of the human CNS, bona fide microglia have not yet been derived from cultured human pluripotent stem cells. Here we establish a robust and efficient protocol for the rapid production of microglia-like cells from human (h) embryonic stem (ES) and induced pluripotent stem (iPS) cells that uses defined serum free culture conditions. These in vitro pluripotent stem cell-derived microglia-like cells (termed pMGLs) faithfully recapitulate the expected ontogeny and characteristics of their in vivo counterparts, and they resemble primary fetal human and mouse microglia. We generated these cells from multiple disease-specific cell lines and find that pMGLs derived from an hES model of Rett syndrome are smaller than their isogenic controls. We further describe a platform to study the integration and live behavior of pMGLs in organotypic 3D cultures. This modular differentiation system allows for the study of microglia in highly defined conditions as they mature in response to developmentally relevant cues, and it provides a framework in which to study the long-term interactions of microglia residing in a tissue-like environment.	[Muffat, Julien; Yuan, Bingbing; Mitalipoya, Maisam; Omer, Attya; Corcoran, Sean; Bakiasi, Grisilda; Tsai, Li-Huei; Jaenisch, Rudolf] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Omer, Attya] Univ Paris 11, INSERM, U1169, Orsay, France; [Corcoran, Sean; Jaenisch, Rudolf] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bakiasi, Grisilda] Bryn Mawr Coll, Bryn Mawr, PA 19010 USA; [Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA; [Aubourg, Patrick] GTDesign, Le Kremlin Bicetre, France; [Ransohoff, Richard M.] Biogen, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Massachusetts Institute of Technology (MIT); Bryn Mawr College; Massachusetts Institute of Technology (MIT); Northwell Health; Biogen	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Jaenisch, R (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jaenisch@wi.mit.edu	Li, Yun/C-3367-2011	Li, Yun/0000-0002-5849-5910; OMER JAVED, Attya/0000-0001-8889-5686; Muffat, Julien/0000-0003-1889-7023	European Leukodystrophy Association; Brain & Behavior Research Foundation; Simons postdoctoral fellowship; International Rett Syndrome Foundation (IRSF) postdoctoral fellowship; Simons undergraduate scholarship; Amgen Scholarship; H.H.M.I.; Simons Foundation [SFARI 204106]; NIH [HD 045022, R37-CA084198, NS088538, IRF1 AG042978]; ELA foundation; Emerald foundation and Biogen; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG042978, RF1AG048029] Funding Source: NIH RePORTER	European Leukodystrophy Association; Brain & Behavior Research Foundation(NARSAD); Simons postdoctoral fellowship; International Rett Syndrome Foundation (IRSF) postdoctoral fellowship; Simons undergraduate scholarship; Amgen Scholarship; H.H.M.I.(Howard Hughes Medical Institute); Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ELA foundation; Emerald foundation and Biogen; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank L. Freland-Gobaille, D. Fu, R. Alagappan, T. Lungjangwa and S. Elmsaouri for technical support, and all members of the Jaenisch lab for helpful discussions. We thank P. Thiru and G. Bell at WIBR's Bioinformatics and Research Computing group for help and advice with sequencing-data analysis. Confocal microscopy and wound assays were performed at the Keck Facility, with the precious help of W Salmon. We thank P. Wisniewski and C. Zollo for help with cell sorting. We thank T. Volkert, J. Love and S. Gupta at the WIGTC for help with library preparation and sequencing. J.M. received funding from the European Leukodystrophy Association and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation. Y.L. received funding from a Simons postdoctoral fellowship, an International Rett Syndrome Foundation (IRSF) postdoctoral fellowship and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation. S.C. was the recipient of a Simons undergraduate scholarship and an Amgen Scholarship. G.B. was supported by H.H.M.I. Work for this project was supported by a grant from the Simons Foundation (SFARI 204106 R.J.), NIH grants HD 045022, R37-CA084198 and NS088538, the ELA foundation, the Emerald foundation and Biogen (to R.J.) and NIH IRF1 AG042978 to L.-H.T.	Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Aubourg P, 2015, BRAIN, V138, DOI 10.1093/brain/awv271; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Beutner C, 2010, NAT PROTOC, V5, P1481, DOI 10.1038/nprot.2010.90; Butovsky O, 2007, MOL CELL NEUROSCI, V35, P490, DOI 10.1016/j.mcn.2007.04.009; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Derecki NC, 2013, TRENDS IMMUNOL, V34, P144, DOI 10.1016/j.it.2012.10.002; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; PALIS J, 1995, BLOOD, V86, P156, DOI 10.1182/blood.V86.1.156.bloodjournal861156; Ransohoff RM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020560; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Smith Amy M, 2013, Methods Mol Biol, V1041, P41, DOI 10.1007/978-1-62703-520-0_6; Smith AM, 2013, GLIA, V61, P929, DOI 10.1002/glia.22486; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI 10.1038/nbt.2915; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Vitner EB, 2015, BIOL CHEM, V396, P659, DOI 10.1515/hsz-2014-0301; Vitry S, 2003, J NEUROSCI, V23, P10724; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008; Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	43	351	359	7	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1358	1367		10.1038/nm.4189	http://dx.doi.org/10.1038/nm.4189			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27668937	Green Published, Green Accepted			2022-12-25	WOS:000387302300030
J	Quadrato, G; Brown, J; Arlotta, P				Quadrato, Giorgia; Brown, Juliana; Arlotta, Paola			The promises and challenges of human brain organoids as models of neuropsychiatric disease	NATURE MEDICINE			English	Article							PLURIPOTENT STEM-CELLS; IPSC-DERIVED NEURONS; PSYCHIATRIC-DISORDERS; HUMAN ES; CEREBRAL ORGANOIDS; SELF-ORGANIZATION; GENETIC RISK; SCHIZOPHRENIA; DIFFERENTIATION; DYSREGULATION	Neuropsychiatric disorders such as autism spectrum disorder (ASD), schizophrenia (SCZ) and bipolar disorder (BPD) are of great societal and medical importance, but the complexity of these diseases and the challenges of modeling the development and function of the human brain have made these disorders difficult to study experimentally. The recent development of 3D brain organoids derived from human pluripotent stem cells offers a promising approach for investigating the phenotypic underpinnings of these highly polygenic disorders and for understanding the contribution of individual risk variants and complex genetic background to human pathology. Here we discuss the advantages, limitations and future applications of human brain organoids as in vitro models of neuropsychiatric disease.	[Quadrato, Giorgia; Brown, Juliana; Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Arlotta, P (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	paola_arlotta@harvard.edu	Quadrato, Giorgia/G-7808-2018	Quadrato, Giorgia/0000-0003-0717-4874; Brown, Juliana/0000-0002-0412-8197	US National Institutes of Health [NS078164, MH101268]; Stanley Center for Psychiatric Disease of the Broad Institute of MIT and Harvard; Harvard Brain Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078164] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Center for Psychiatric Disease of the Broad Institute of MIT and Harvard; Harvard Brain Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Hyman, L. Rubin, E. Robinson and K. Lilliehook for their critical discussion and suggestions for this manuscript. We are grateful to N. Maria and J. Nguyen for editing of the manuscript, and D. Sun for creating the illustrations for this article. P.A. is a NYSC Robertson Investigator. Work in the Arlotta lab is supported by grants to P.A. the US National Institutes of Health (NS078164 and MH101268), the Stanley Center for Psychiatric Disease of the Broad Institute of MIT and Harvard, and the Harvard Brain Initiative. We apologize to colleagues whose work we could not cite because of space limitations.	Adamo A, 2015, NAT GENET, V47, P132, DOI 10.1038/ng.3169; Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255; Bilimoria PM, 2015, BRAIN RES, V1617, P7, DOI 10.1016/j.brainres.2014.11.032; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen HM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.12; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; de Bartolomeis A, 2014, MOL NEUROBIOL, V49, P484, DOI 10.1007/s12035-013-8534-3; Doherty JL, 2014, GENOME MED, V6, DOI 10.1186/gm546; Ecker C, 2015, LANCET NEUROL, V14, P1121, DOI 10.1016/S1474-4422(15)00050-2; Egbujo CN, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0710-5; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Elsayed M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00468; Falk A, 2016, MOL PSYCHIATR, V21, P1167, DOI 10.1038/mp.2016.89; Flaherty E.K., 2015, BRAIN RES; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708; Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141; Hashimoto-Torii K, 2014, NEURON, V82, P560, DOI 10.1016/j.neuron.2014.03.002; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Heyes S, 2015, PROG NEUROBIOL, V134, P36, DOI 10.1016/j.pneurobio.2015.09.002; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hyman SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003142; Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Larimore J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065069; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lencz T, 2014, MOL PSYCHIATR, V19, P168, DOI 10.1038/mp.2013.166; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madison JM, 2015, MOL PSYCHIATR, V20, P703, DOI 10.1038/mp.2015.7; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Martinez-Cerdeno V., 2016, DEV NEUROBIOL; McCarro SA, 2014, NAT NEUROSCI, V17, P756, DOI 10.1038/nn.3716; Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Mouchlianitis E, 2016, LANCET PSYCHIAT, V3, P451, DOI 10.1016/S2215-0366(15)00540-4; Moyer CE, 2015, NEUROSCI LETT, V601, P46, DOI 10.1016/j.neulet.2014.11.042; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Rigamonti A, 2016, STEM CELL REP, V6, P993, DOI 10.1016/j.stemcr.2016.05.010; Robicsek O, 2013, MOL PSYCHIATR, V18, P1067, DOI 10.1038/mp.2013.67; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896; Sanders SJ, 2014, CURR GENET MED REP, V2, P151, DOI DOI 10.1007/S40142-014-0045-7; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Scholvin J, 2016, IEEE T BIO-MED ENG, V63, P120, DOI 10.1109/TBME.2015.2406113; Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Tian Y, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0075-5; Tieng V, 2014, STEM CELLS DEV, V23, P1535, DOI 10.1089/scd.2013.0442; Tomassy GS, 2016, TRENDS CELL BIOL, V26, P135, DOI 10.1016/j.tcb.2015.09.002; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wen ZX, 2016, CURR OPIN NEUROBIOL, V36, P118, DOI 10.1016/j.conb.2015.11.003; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Woodhams PL, 1996, EXP NEUROL, V140, P68, DOI 10.1006/exnr.1996.0116; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Young-Pearse TL, 2016, CURR OPIN NEUROBIOL, V36, P66, DOI 10.1016/j.conb.2015.10.006; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zikopoulos B, 2013, FRONT HUM NEUROSCI, V7, P1, DOI 10.3389/fnhum.2013.00609	99	159	164	2	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1220	1228		10.1038/nm.4214	http://dx.doi.org/10.1038/nm.4214			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27783065				2022-12-25	WOS:000387302300013
J	Riaz, N; Havel, JJ; Kendall, SM; Makarov, V; Walsh, LA; Desrichard, A; Weinhold, N; Chan, TA				Riaz, Nadeem; Havel, Jonathan J.; Kendall, Sviatoslav M.; Makarov, Vladimir; Walsh, Logan A.; Desrichard, Alexis; Weinhold, Nils; Chan, Timothy A.			Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy	NATURE GENETICS			English	Article							CTLA-4 BLOCKADE; PD-1 BLOCKADE; CELL; NIVOLUMAB; SENSITIVITY	Immune checkpoint blockade has shown significant promise as an anticancer treatment, yet the determinants of response are not completely understood. Here we show that somatic mutations in SERPINB3 and SERPINB4 are associated with survival after anti-CTLA4 immunotherapy in two independent cohorts of patients with melanoma (n = 174). Interestingly, serpins are homologs of the well-known ovalbumin antigen and are associated with autoimmunity. Our findings have implications for the personalization of immunotherapy.	[Riaz, Nadeem; Havel, Jonathan J.; Kendall, Sviatoslav M.; Makarov, Vladimir; Walsh, Logan A.; Desrichard, Alexis; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Riaz, Nadeem; Weinhold, Nils; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Riaz, Nadeem; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.; Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, 1275 York Ave, New York, NY 10021 USA.	chant@mskcc.org	Chan, Timothy A/ABD-5850-2021	Havel, Jonathan/0000-0003-0951-510X; Riaz, Nadeem/0000-0001-9873-5862; Walsh, Logan/0000-0001-8771-2577; Desrichard, Alexis/0000-0002-1335-7813; Kendall, Sviatoslav/0000-0002-5368-5109	Pershing Square Sohn Cancer Research grant; Frederick Adler Chair; Stand Up 2 Cancer; the STARR Cancer Consortium; NIH/NCI Cancer Center Support Grant [P30 CA008748]; Stand Up To Cancer - Cancer Research Institute Cancer Immunology Translational Cancer Research Grant; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Pershing Square Sohn Cancer Research grant(Pershing Square Sohn Cancer Research Alliance); Frederick Adler Chair; Stand Up 2 Cancer; the STARR Cancer Consortium; NIH/NCI Cancer Center Support Grant; Stand Up To Cancer - Cancer Research Institute Cancer Immunology Translational Cancer Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Wolchok, T. Merghoub, J. Yuan, P. Wong, and A. Snyder for collaborative interactions. We thank the Integrated Genomics Operation and the Ludwig Immune Monitoring Facility at Memorial Sloan Kettering for technical assistance. We thank A. Heguy and the Genome Technology Center at New York University and L. Mangarin for assistance with validation sequencing. This work was funded by a Pershing Square Sohn Cancer Research grant (T.A.C.), the Frederick Adler Chair (T.A.C.), Stand Up 2 Cancer (T.A.C.), the STARR Cancer Consortium (T.A.C.), and in part through NIH/NCI Cancer Center Support Grant P30 CA008748. Research supported by a Stand Up To Cancer - Cancer Research Institute Cancer Immunology Translational Cancer Research Grant. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Catanzaro JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4729; El-Rachkidy RG, 2008, J INVEST DERMATOL, V128, P2219, DOI 10.1038/jid.2008.71; Gatto M, 2013, CLIN REV ALLERG IMMU, V45, P267, DOI 10.1007/s12016-013-8353-3; Guan J, 2015, SCI REP-UK, V5, DOI 10.1038/srep07857; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holen E, 1996, CLIN EXP ALLERGY, V26, P1080, DOI 10.1046/j.1365-2222.1996.d01-412.x; Katagiri C, 2006, J CELL BIOL, V172, P983, DOI 10.1083/jcb.200508064; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lysvand H, 2014, BBA-MOL BASIS DIS, V1842, P734, DOI 10.1016/j.bbadis.2014.02.005; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Mine Y, 2008, J AGR FOOD CHEM, V56, P4874, DOI 10.1021/jf8001153; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Munz C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00009; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Sivaprasad U, 2015, J INVEST DERMATOL, V135, P160, DOI 10.1038/jid.2014.353; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Vidalino L, 2009, AUTOIMMUN REV, V9, P108, DOI 10.1016/j.autrev.2009.03.011	24	85	91	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1327	1329		10.1038/ng.3677	http://dx.doi.org/10.1038/ng.3677			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27668655	Green Accepted			2022-12-25	WOS:000386543400008
J	Bird, GH; Mazzola, E; Opoku-Nsiah, K; Lammert, MA; Godes, M; Neuberg, DS; Walensky, LD				Bird, Gregory H.; Mazzola, Emanuele; Opoku-Nsiah, Kwadwo; Lammert, Margaret A.; Godes, Marina; Neuberg, Donna S.; Walensky, Loren D.			Biophysical determinants for cellular uptake of hydrocarbon-stapled peptide helices	NATURE CHEMICAL BIOLOGY			English	Article							PROAPOPTOTIC ACTIVITY; BH3 HELIX; P53; INHIBITION; ACTIVATION; PROTEINS; DELIVERY; AFFINITY; BIMSAHB; COMPLEX	Hydrocarbon-stapled peptides are a class of bioactive alpha-helical ligands developed to dissect and target protein interactions. While there is consensus that stapled peptides can be effective chemical tools for investigating protein regulation, their broader utility for therapeutic modulation of intracellular interactions remains an active area of study. In particular, the design principles for generating cell-permeable stapled peptides are empiric, yet consistent intracellular access is essential to in vivo application. Here, we used an unbiased statistical approach to determine which biophysical parameters dictate the uptake of stapled-peptide libraries. We found that staple placement at the amphipathic boundary combined with optimal hydrophobic and helical content are the key drivers of cellular uptake, whereas excess hydrophobicity and positive charge at isolated amino acid positions can trigger membrane lysis at elevated peptide dosing. Our results provide a design roadmap for maximizing the potential to generate cell-permeable stapled peptides with on-mechanism cellular activity.	[Bird, Gregory H.; Opoku-Nsiah, Kwadwo; Lammert, Margaret A.; Godes, Marina; Walensky, Loren D.] Dana Farber Canc Inst, Linde Program Canc Chem Biol, Dept Pediat Oncol, Boston, MA 02115 USA; [Mazzola, Emanuele; Neuberg, Donna S.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Walensky, LD (corresponding author), Dana Farber Canc Inst, Linde Program Canc Chem Biol, Dept Pediat Oncol, Boston, MA 02115 USA.	loren_walensky@dfci.harvard.edu			NIH grants [1R35CA197583, 1R21CA209358]; Leukemia and Lymphoma Society (LLS) Marshall A. Lichtman Specialized Center of Research project grant; William Lawrence and Blanche Hughes Foundation; Todd J. Schwartz Memorial Fund; Wolpoff Family Foundation; LLS Scholar Award; Dana-Farber/Harvard Cancer Center Support grant [5P30CA006516]; NATIONAL CANCER INSTITUTE [P30CA006516, R21CA209358, R35CA197583] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society (LLS) Marshall A. Lichtman Specialized Center of Research project grant; William Lawrence and Blanche Hughes Foundation; Todd J. Schwartz Memorial Fund; Wolpoff Family Foundation; LLS Scholar Award; Dana-Farber/Harvard Cancer Center Support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Smith for graphics support, S. Rudnicki of the Institute of Chemistry and Cell Biology-Longwood for assistance with IXM screening and analysis, and J. Opferman of St. Jude Children's Research Hospital for the BCL-X<INF>L</INF>-reconstituted p185<SUP>+</SUP>Arf<SUP>-/-</SUP>Mcl-1-deleted B-ALL cells. This research was supported by NIH grants 1R35CA197583 and 1R21CA209358, a Leukemia and Lymphoma Society (LLS) Marshall A. Lichtman Specialized Center of Research project grant, the William Lawrence and Blanche Hughes Foundation, the Todd J. Schwartz Memorial Fund, the Wolpoff Family Foundation, and an LLS Scholar Award to L.D.W.E.M. and D.S.N. are supported in part by the Dana-Farber/Harvard Cancer Center Support grant 5P30CA006516.	Baek S, 2012, J AM CHEM SOC, V134, P103, DOI 10.1021/ja2090367; Barclay LA, 2015, MOL CELL, V57, P873, DOI 10.1016/j.molcel.2015.01.014; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Bird GH, 2014, ACS CHEM BIOL, V9, P831, DOI 10.1021/cb4003305; Bird GH, 2008, METHOD ENZYMOL, V446, P369, DOI 10.1016/S0076-6879(08)01622-4; Bird GH, 2014, NAT STRUCT MOL BIOL, V21, P1058, DOI 10.1038/nsmb.2922; Bird GH, 2014, J CLIN INVEST, V124, P2113, DOI 10.1172/JCI71856; Bird Gregory H, 2011, Curr Protoc Chem Biol, V3, P99, DOI 10.1002/9780470559277.ch110042; Braun CR, 2010, CHEM BIOL, V17, P1325, DOI 10.1016/j.chembiol.2010.09.015; BREIMAN L., 1984, CRC PRESS; Chang YS, 2013, P NATL ACAD SCI USA, V110, pE3445, DOI 10.1073/pnas.1303002110; Chu Q, 2015, MEDCHEMCOMM, V6, P111, DOI 10.1039/c4md00131a; Cohen NA, 2012, CHEM BIOL, V19, P1175, DOI 10.1016/j.chembiol.2012.07.018; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Edwards AL, 2015, ACS CHEM BIOL, V10, P2149, DOI 10.1021/acschembio.5b00214; Edwards AL, 2013, CHEM BIOL, V20, P888, DOI 10.1016/j.chembiol.2013.06.007; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.1093/biomet/28.3-4.321; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Ihaka R., 1996, J COMP GRAPH STAT; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Koss B, 2013, BLOOD, V122, P1587, DOI 10.1182/blood-2012-06-440230; LaBelle JL, 2012, J CLIN INVEST, V122, P2018, DOI 10.1172/JCI46231; LaRochelle JR, 2015, J AM CHEM SOC, V137, P2536, DOI 10.1021/ja510391n; Leshchiner ES, 2015, P NATL ACAD SCI USA, V112, P1761, DOI 10.1073/pnas.1413185112; Li YC, 2014, CELL REP, V9, P1946, DOI 10.1016/j.celrep.2014.10.058; Okamoto T, 2014, ACS CHEM BIOL, V9, P838, DOI 10.1021/cb400638p; Okamoto T, 2013, ACS CHEM BIOL, V8, P297, DOI 10.1021/cb3005403; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; StataCorp, 2013, STATA STAT SOFTW REL; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Sun TL, 2013, BIOPHYS J, V104, P1923, DOI 10.1016/j.bpj.2013.03.039; Takada K, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003808; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Walensky LD, 2014, J MED CHEM, V57, P6275, DOI 10.1021/jm4011675	38	133	137	4	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					845	+		10.1038/NCHEMBIO.2153	http://dx.doi.org/10.1038/NCHEMBIO.2153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27547919	Green Accepted			2022-12-25	WOS:000384248600017
J	Boudreau, A; Purkey, HE; Hitz, A; Robarge, K; Peterson, D; Labadie, S; Kwong, M; Hong, R; Gao, M; Del Nagro, C; Pusapati, R; Ma, SG; Salphati, L; Pang, J; Zhou, AH; Lai, T; Li, YJ; Chen, ZG; Wei, BQ; Yen, I; Sideris, S; McCleland, M; Firestein, R; Corson, L; Vanderbilt, A; Williams, S; Daemen, A; Belvin, M; Eigenbrot, C; Jackson, PK; Malek, S; Hatzivassiliou, G; Sampath, D; Evangelista, M; O'Brien, T				Boudreau, Aaron; Purkey, Hans E.; Hitz, Anna; Robarge, Kirk; Peterson, David; Labadie, Sharada; Kwong, Mandy; Hong, Rebecca; Gao, Min; Del Nagro, Christopher; Pusapati, Raju; Ma, Shuguang; Salphati, Laurent; Pang, Jodie; Zhou, Aihe; Lai, Tommy; Li, Yingjie; Chen, Zhongguo; Wei, Binqing; Yen, Ivana; Sideris, Steve; McCleland, Mark; Firestein, Ron; Corson, Laura; Vanderbilt, Alex; Williams, Simon; Daemen, Anneleen; Belvin, Marcia; Eigenbrot, Charles; Jackson, Peter K.; Malek, Shiva; Hatzivassiliou, Georgia; Sampath, Deepak; Evangelista, Marie; O'Brien, Thomas			Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN LACTATE-DEHYDROGENASE; TUMOR PROGRESSION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CELL-PROLIFERATION; LUNG-CANCER; EXPRESSION; IDENTIFICATION; GLYCOLYSIS; GROWTH; SURVIVAL	Metabolic reprogramming in tumors represents a potential therapeutic target. Herein we used shRNA depletion and a novel lactate dehydrogenase (LDHA) inhibitor, GNE-140, to probe the role of LDHA in tumor growth in vitro and in vivo. In MIA PaCa-2 human pancreatic cells, LDHA inhibition rapidly affected global metabolism, although cell death only occurred after 2 d of continuous LDHA inhibition. Pancreatic cell lines that utilize oxidative phosphorylation (OXPHOS) rather than glycolysis were inherently resistant to GNE-140, but could be resensitized to GNE-140 with the OXPHOS inhibitor phenformin. Acquired resistance to GNE-140 was driven by activation of the AMPK-mTOR-S6K signaling pathway, which led to increased OXPHOS, and inhibitors targeting this pathway could prevent resistance. Thus, combining an LDHA inhibitor with compounds targeting the mitochondrial or AMPK-S6K signaling axis may not only broaden the clinical utility of LDHA inhibitors beyond glycolytically dependent tumors but also reduce the emergence of resistance to LDHA inhibition.	[Boudreau, Aaron; Peterson, David; Pusapati, Raju; Evangelista, Marie] Genentech Inc, Discovery Oncol, San Francisco, CA 94080 USA; [Purkey, Hans E.; Robarge, Kirk; Labadie, Sharada; Wei, Binqing] Genentech Inc, Discovery Chem, San Francisco, CA USA; [Hitz, Anna; Kwong, Mandy; Hong, Rebecca; Gao, Min; Del Nagro, Christopher; Corson, Laura; Belvin, Marcia; Jackson, Peter K.; Hatzivassiliou, Georgia; Sampath, Deepak; O'Brien, Thomas] Genentech Inc, Translat Oncol, San Francisco, CA 94080 USA; [Ma, Shuguang; Salphati, Laurent; Pang, Jodie] Genentech Inc, Drug Metab & Pharmacokinet, San Francisco, CA USA; [Lai, Tommy] WuXi AppTec Co Ltd, Chem, Shanghai, Peoples R China; [Li, Yingjie; Chen, Zhongguo] WuXi AppTec Co Ltd, Struct Biol, Shanghai, Peoples R China; [Yen, Ivana; Sideris, Steve; Malek, Shiva] Genentech Inc, Biochem & Cellular Pharmacol, San Francisco, CA USA; [McCleland, Mark; Firestein, Ron] Genentech Inc, Dept Pathol, San Francisco, CA USA; [Vanderbilt, Alex; Williams, Simon] Genentech Inc, Biomed Imaging, San Francisco, CA USA; [Daemen, Anneleen] Genentech Inc, Bioinformat, San Francisco, CA USA; [Eigenbrot, Charles] Genentech Inc, Struct Biol, San Francisco, CA USA; [Jackson, Peter K.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Stanford University	Evangelista, M (corresponding author), Genentech Inc, Discovery Oncol, San Francisco, CA 94080 USA.; O'Brien, T (corresponding author), Genentech Inc, Translat Oncol, San Francisco, CA 94080 USA.	evangelista.marie@gene.com; obrien.tom@gene.com		Corson, Laura/0000-0003-2772-3375; Jackson, Peter/0000-0002-1742-2539; Malek, Shiva/0000-0002-9526-7968; Purkey, Hans/0000-0002-8570-364X				AITHAL HN, 1985, AM J PHYSIOL, V249, pC111, DOI 10.1152/ajpcell.1985.249.1.C111; Billiard J, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-19; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; BUSCH H, 1957, J BIOL CHEM, V229, P377; Chen J., 2015, Piperidine-dione Derivatives., Patent No. [WO2015140133A1, 2015140133]; COPELAND L, 1994, ARCH BIOCHEM BIOPHYS, V312, P107, DOI 10.1006/abbi.1994.1287; Dragovich PS, 2014, BIOORG MED CHEM LETT, V24, P3764, DOI 10.1016/j.bmcl.2014.06.076; Dragovich PS, 2013, BIOORG MED CHEM LETT, V23, P3186, DOI 10.1016/j.bmcl.2013.04.001; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fauber BP, 2014, BIOORG MED CHEM LETT, V24, P5683, DOI 10.1016/j.bmcl.2014.10.067; Fauber BP, 2013, BIOORG MED CHEM LETT, V23, P5533, DOI 10.1016/j.bmcl.2013.08.060; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Girgis H, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-101; Granchi C, 2011, EUR J MED CHEM, V46, P5398, DOI 10.1016/j.ejmech.2011.08.046; Gray DC, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-61; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Koukourakis MI, 2014, BRIT J CANCER, V110, P2217, DOI 10.1038/bjc.2014.158; Koukourakis MI, 2003, TUMOR BIOL, V24, P199, DOI 10.1159/000074430; Koukourakis MI, 2006, J CLIN ONCOL, V24, P4301, DOI 10.1200/JCO.2006.05.9501; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; NOVOA WB, 1959, J BIOL CHEM, V234, P1143; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Qing GL, 2010, CANCER RES, V70, P10351, DOI 10.1158/0008-5472.CAN-10-0740; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Shirwany NA, 2014, FRONT BIOSCI-LANDMRK, V19, P447, DOI 10.2741/4218; Shitara Y, 2013, TOXICOL SCI, V132, P32, DOI 10.1093/toxsci/kfs330; VanderPorten E, 2013, ANAL BIOCHEM, V441, P115, DOI 10.1016/j.ab.2013.07.003; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Ward RA, 2012, J MED CHEM, V55, P3285, DOI 10.1021/jm201734r; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003	40	123	126	4	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					779	+		10.1038/nchembio.2143	http://dx.doi.org/10.1038/nchembio.2143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27479743				2022-12-25	WOS:000384248600008
J	Spangler, B; Morgan, CW; Fontaine, SD; Vander Wal, MN; Chang, CJ; Wells, JA; Renslo, AR				Spangler, Benjamin; Morgan, Charles W.; Fontaine, Shaun D.; Vander Wal, Mark N.; Chang, Christopher J.; Wells, James A.; Renslo, Adam R.			A reactivity-based probe of the intracellular labile ferrous iron pool	NATURE CHEMICAL BIOLOGY			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ON FLUORESCENT-PROBE; LIVING CELLS; DISPIRO-1,2,4-TRIOXOLANE ANTIMALARIALS; N-ACETYLCYSTEINE; OXIDATIVE STRESS; HEME ALKYLATION; CLINICAL-TRIAL; ARTEMISININ; GLUTATHIONE	Improved methods for studying intracellular reactive Fe(II) are of significant interest for studies of iron metabolism and disease-relevant changes in iron homeostasis. Here we describe a highly selective reactivity-based probe in which a Fenton-type reaction with intracellular labile Fe(II) leads to unmasking of the aminonucleoside puromycin. Puromycin leaves a permanent and dose-dependent mark on treated cells that can be detected with high sensitivity and precision using a high-content, plate-based immunofluorescence assay. Using this new probe and screening approach, we detected alteration of cellular labile Fe(II) in response extracellular iron conditioning, overexpression of iron storage and/or export proteins, and post-translational regulation of iron export. We also used this new tool to demonstrate that labile Fe(II) pools are larger in cancer cells than in nontumorigenic cells.	[Spangler, Benjamin; Morgan, Charles W.; Fontaine, Shaun D.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94143 USA; [Vander Wal, Mark N.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Vander Wal, Mark N.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wells, James A.; Renslo, Adam R.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wells, JA; Renslo, AR (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.; Wells, JA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	jim.wells@ucsf.edu; adam.renslo@ucsf.edu	Wells, Jim A/O-9854-2016	Morgan, Charles/0000-0002-0118-1056; Spangler, Benjamin/0000-0001-9409-1529	US National Institutes of Health (NIH) [AI105106]; NIH [GM 79465]; NIH Research Training Grant in Chemistry and Chemical Biology [T32 GM064337]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, T32GM064337] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Research Training Grant in Chemistry and Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Chen for technical support in automated cell imaging and image analysis with IN Cell Developer software, T. Matsuguchi for assistance with qRT-PCR setup and analysis, H. Shimizu for assistance with the PAMPA assay, and D. Ruggero for helpful comments on the manuscript. A.R.R. is funded by US National Institutes of Health (NIH) grant AI105106. C.J.C. is funded by NIH grant GM 79465. B.S. and C.W.M. acknowledge funding from the NIH Research Training Grant in Chemistry and Chemical Biology (T32 GM064337).	Aron AT, 2015, ACCOUNTS CHEM RES, V48, P2434, DOI 10.1021/acs.accounts.5b00221; Au-Yeung HY, 2013, J AM CHEM SOC, V135, P15165, DOI 10.1021/ja4072964; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Borstnik K, 2002, INT J PARASITOL, V32, P1661, DOI 10.1016/S0020-7519(02)00195-9; Boult J, 2008, CLIN CANCER RES, V14, P379, DOI 10.1158/1078-0432.CCR-07-1054; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; Creek DJ, 2007, J PHARM SCI-US, V96, P2945, DOI 10.1002/jps.20958; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Fernaeus S, 2005, NEUROSCI LETT, V382, P217, DOI 10.1016/j.neulet.2005.03.069; Fontaine SD, 2015, CHEMMEDCHEM, V10, P47, DOI 10.1002/cmdc.201402362; Fontaine SD, 2014, ORG LETT, V16, P5776, DOI 10.1021/ol5028392; Frikke-Schmidt H, 2010, ANAL BIOCHEM, V397, P135, DOI 10.1016/j.ab.2009.09.040; GAO JP, 1993, CANCER CHEMOTH PHARM, V33, P191, DOI 10.1007/BF00686215; Hirayama T, 2013, CHEM SCI, V4, P1250, DOI 10.1039/c2sc21649c; ISHII T, 1987, J CELL PHYSIOL, V133, P330, DOI 10.1002/jcp.1041330217; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kakhlon O, 2002, BIOCHEM J, V363, P431, DOI 10.1042/0264-6021:3630431; KANG YJ, 1994, J CELL PHYSIOL, V161, P589, DOI 10.1002/jcp.1041610323; Kurz T, 2011, INT J BIOCHEM CELL B, V43, P1686, DOI 10.1016/j.biocel.2011.08.016; Mahajan SS, 2011, CHEMMEDCHEM, V6, P415, DOI 10.1002/cmdc.201100002; Martins MM, 2015, CANCER DISCOV, V5, P154, DOI 10.1158/2159-8290.CD-14-0552; Mercer AE, 2007, J BIOL CHEM, V282, P9372, DOI 10.1074/jbc.M610375200; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Mukherjee TK, 2007, J IMMUNOL, V178, P1835, DOI 10.4049/jimmunol.178.3.1835; O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Petrat F, 2002, BIOL CHEM, V383, P489, DOI 10.1515/BC.2002.051; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Tang YQ, 2005, J ORG CHEM, V70, P5103, DOI 10.1021/jo050385+; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Valecha N, 2012, CLIN INFECT DIS, V55, P663, DOI 10.1093/cid/cis475; Valecha N, 2010, CLIN INFECT DIS, V51, P684, DOI 10.1086/655831; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wang XF, 2009, BIOORG MED CHEM LETT, V19, P4542, DOI 10.1016/j.bmcl.2009.07.013; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; YAN CYI, 1995, J BIOL CHEM, V270, P26827, DOI 10.1074/jbc.270.45.26827	45	78	81	4	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					680	+		10.1038/nchembio.2116	http://dx.doi.org/10.1038/nchembio.2116			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27376690	Green Accepted, Green Submitted			2022-12-25	WOS:000382255100008
J	Zhou, KX; Yee, SW; Seiser, EL; van Leeuwen, N; Tavendalel, R; Bennett, AJ; Groves, CJ; Coleman, RL; van der Heijden, AA; Beulens, JW; de Keyser, CE; Zaharenkoll, L; Rotroff', DM; Out, M; Jablonski, KA; Chen, L; Javorsky, M; Zidzik, J; Levin, AM; Williams, LK; Dujic, T; Semiz, S; Kubo, M; Chien, HC; Maeda, S; Witte, JS; Wu, LY; Tkac, I; Kooy, A; van Schaik, RHN; Stehouwer, CDA; Logie, L; Sutherland, C; Klovins, J; Pirags, V; Hofman, A; Stricker, BH; Motsinger-Reif, AA; Wagner, MJ; Innocenti, F; Hart, LM'T; Holman, RR; McCarthy, MI; Hedderson, MM; Palmer, CNA; Florez, JC; Giacomini, KM; Pearson, ER				Zhou, Kaixin; Yee, Sook Wah; Seiser, Eric L.; van Leeuwen, Nienke; Tavendalel, Roger; Bennett, Amanda J.; Groves, Christopher J.; Coleman, Ruth L.; van der Heijden, Amber A.; Beulens, Joline W.; de Keyser, Catherine E.; Zaharenkoll, Linda; Rotroff', Daniel M.; Out, Mattijs; Jablonski, Kathleen A.; Chen, Ling; Javorsky, Martin; Zidzik, Jozef; Levin, Albert M.; Williams, L. Keoki; Dujic, Tanja; Semiz, Sabina; Kubo, Michiaki; Chien, Huan-Chieh; Maeda, Shiro; Witte, John S.; Wu, Longyang; Tkac, Ivan; Kooy, Adriaan; van Schaik, Ron H. N.; Stehouwer, Coen D. A.; Logie, Lisa; Sutherland, Calum; Klovins, Janis; Pirags, Valdis; Hofman, Albert; Stricker, Bruno H.; Motsinger-Reif, Alison A.; Wagner, Michael J.; Innocenti, Federico; Hart, Leen M. 't; Holman, Rory R.; McCarthy, Mark I.; Hedderson, Monique M.; Palmer, Colin N. A.; Florez, Jose C.; Giacomini, Kathleen M.; Pearson, Ewan R.		MetGen Investigators; DPP Investigators; ACCORD Investigators	Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; EXPRESSION; PHARMACOKINETICS; METAANALYSIS; METABOLISM	Metformin is the first-line antidiabetic drug with over 100 million users worldwide, yet its mechanism of action remains unclear(1). Here the Metformin Genetics (MetGen) Consortium reports a three-stage genome-wide association study (GWAS), consisting of 13,123 participants of different ancestries. The C allele of rs8192675 in the intron of SLC2A2, which encodes the facilitated glucose transporter GLUT2, was associated with a 0.17% (P = 6.6 x 10(-14)) greater metformin-induced reduction in hemoglobin A1c (HbA1c) in 10,577 participants of European ancestry. rs8192675 was the top cis expression quantitative trait locus (cis-eQTL) for SLC2A2 in 1,226 human liver samples, suggesting a key role for hepatic GLUT2 in regulation of metformin action. Among obese individuals, C-allele homozygotes at rs8192675 had a 0.33% (3.6 mmol/mol) greater absolute HbA1c reduction than T-allele homozygotes. This was about half the effect seen with the addition of a DPP-4 inhibitor, and equated to a dose difference of 550 mg of metformin, suggesting rs8192675 as a potential biomarker for stratified medicine.	[Zhou, Kaixin; Tavendalel, Roger; Dujic, Tanja; Logie, Lisa; Sutherland, Calum; Palmer, Colin N. A.; Pearson, Ewan R.] Univ Dundee, Sch Med, Dundee, Scotland; [Yee, Sook Wah; Chien, Huan-Chieh; Giacomini, Kathleen M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Seiser, Eric L.; Innocenti, Federico] Univ N Carolina, Eshelman Sch Pharm, Ctr Pharmacogen & Individualized Therapy, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [van Leeuwen, Nienke; Hart, Leen M. 't] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Bennett, Amanda J.; Groves, Christopher J.; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Coleman, Ruth L.; Holman, Rory R.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabetes Trials Unit, Oxford, England; [van der Heijden, Amber A.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice, Amsterdam, Netherlands; [Beulens, Joline W.; Hart, Leen M. 't] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Beulens, Joline W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Keyser, Catherine E.; Hofman, Albert; Stricker, Bruno H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Zaharenkoll, Linda; Klovins, Janis] LGDB, Riga, Latvia; [Zaharenkoll, Linda; Klovins, Janis; Pirags, Valdis] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Rotroff', Daniel M.; Motsinger-Reif, Alison A.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Rotroff', Daniel M.] North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Out, Mattijs; Kooy, Adriaan] Locat Bethesda, Treant Zorggrp, Hoogeveen, Netherlands; [Out, Mattijs; Kooy, Adriaan] Bethesda Diabet Res Ctr, Hoogeveen, Netherlands; [Jablonski, Kathleen A.] George Washington Univ, Biostat Ctr, Rockville, MD USA; [Chen, Ling; Florez, Jose C.] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Chen, Ling; Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Javorsky, Martin; Zidzik, Jozef; Tkac, Ivan] Safarik Univ, Fac Med, Kosice, Slovakia; [Levin, Albert M.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Williams, L. Keoki] Henry Ford Hlth Syst, Ctr Hlth Policy arid Hlth Serv Res, Detroit, MI USA; [Williams, L. Keoki] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Dujic, Tanja; Semiz, Sabina] Univ Sarajevo, Fac Pharm, Sarajevo, Bosnia & Herceg; [Semiz, Sabina] Int Univ Sarajevo, Fac Engn & Nat Sci, Sarajevo, Bosnia & Herceg; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci IMS, Yokohama, Kanagawa, Japan; [Maeda, Shiro] Univ Ryukyus, Grad Sch Med, Dept Adv Genom & Lab Med, Nishihara, Okinawa, Japan; [Maeda, Shiro] Univ Ryukyus Hosp, Div Clin Lab & Blood Transfus, Nishihara, Okinawa, Japan; [Witte, John S.; Wu, Longyang] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Witte, John S.; Giacomini, Kathleen M.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Witte, John S.] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Witte, John S.] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [van Schaik, Ron H. N.] Erasmus Univ, Med Ctr, Dept Clin C;hernistry, Rotterdam, Netherlands; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Res Inst Maastricht, Dept Internal Med & Cardiovasc, Maastricht, Netherlands; [Pirags, Valdis] Univ Latvia, Fac Med, Riga, Latvia; [Pirags, Valdis] Pauls Stradins Clin Univ Hosp, Dept Endocrinol, Riga, Latvia; [Stricker, Bruno H.] Inspeceorate Healthcare, Heerlen, Netherlands; [Wagner, Michael J.] Univ North Carolina Chapel Hill, Ctr Pharrnacogen & Individualized Therapy, Chapel Hill, NC USA; [Hart, Leen M. 't] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford, England; [Hedderson, Monique M.] Kaiser Permanente Nothern Calif, Div Res, Oakland, CA USA; [Florez, Jose C.] Broad Inst, Program Metab, Cambridge, MA USA; [Florez, Jose C.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Florez, Jose C.] Harvard Med Sch, Dept Med, Boston, MA USA	University of Dundee; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; University of Oxford; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Latvian Biomedical Research & Study Centre; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; George Washington University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Pavol Jozef Safarik Kosice; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Sarajevo; RIKEN; University of the Ryukyus; University of the Ryukyus; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Maastricht University Medical Centre (MUMC); University of Latvia; Pauls Stradins Clinical University Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Kaiser Permanente; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Pearson, ER (corresponding author), Univ Dundee, Sch Med, Dundee, Scotland.; Giacomini, KM (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Giacomini, KM (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	kaliriv.giacomini@ucsl.edu; e.z.pearson@dundee.ac.uk	Giacomini, Kathleen/AEF-2452-2022; van Schaik, Ron H.N./G-6816-2013; Dujic, Tanja/AAC-9829-2022; Klovins, Janis/C-5695-2011; 't Hart, Leen/ABG-3185-2021; Palmer, Colin NA/C-7053-2008; Stehouwer, Coen/AAB-3435-2021; Out, Mattijs/P-6963-2016; Pirags, Valdis/AAQ-5492-2020; Javorsky, Martin/AAL-6279-2021; Motsinger-Reif, Alison/I-4167-2018; McCarthy, Mark/M-3763-2015	Dujic, Tanja/0000-0001-9221-1208; 't Hart, Leen/0000-0003-4401-2938; Palmer, Colin NA/0000-0002-6415-6560; Pirags, Valdis/0000-0002-3650-7394; Motsinger-Reif, Alison/0000-0003-1346-2493; Klovins, Janis/0000-0001-8362-5505; Zidzik, Jozef/0000-0002-9863-4217; Logie, Lisa/0000-0003-4955-7427; Zhou, Kaixin/0000-0002-4751-7248; Beulens, Joline/0000-0002-4181-0937; McCarthy, Mark/0000-0002-4393-0510; Pearson, Ewan/0000-0001-9237-8585; Semiz, Sabina/0000-0003-2629-4660; Javorsky, Martin/0000-0003-2316-5847; bennett, amanda/0000-0003-2140-8710; Stehouwer, Coen/0000-0001-8752-3223; Yee, Sook Wah/0000-0001-8121-8746; Coleman, Ruth/0000-0002-5194-8550; Tkac, Ivan/0000-0002-3171-8803; Rotroff, Daniel/0000-0003-0553-3220; Sutherland, Calum/0000-0003-4398-7434	Diabetes UK [10/0004063] Funding Source: Medline; NHLBI NIH HHS [R01 HL110380, R01 HL118267] Funding Source: Medline; NIAID NIH HHS [R01 AI079139] Funding Source: Medline; NIA NIH HHS [RC2 AG036607] Funding Source: Medline; NIDDK NIH HHS [U01 DK048380, U01 DK048407, U01 DK048404, U01 DK048514, U01 DK048485, U01 DK048377, U01 DK048413, U01 DK048412, U01 DK048437, U01 DK048406, U01 DK085545, P30 DK017047, R01 DK078907, U01 DK048387, U01 DK048468, U01 DK048411, U01 DK048397, U01 DK048381, R01 DK072041, U01 DK048434, U01 DK048375, R01 DK064695, U01 DK048443, U01 DK048349, U01 DK048489, U01 DK048400] Funding Source: Medline; NIGMS NIH HHS [R01 GM117163, U19 GM061390] Funding Source: Medline; Wellcome Trust [102820/Z/13/Z, 098381, 090532, 092272, 102820, 085475/Z/08/Z, 085475/B/08/Z, 084727/Z/08/Z] Funding Source: Medline; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110380, R01HL118267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK048404, U01DK048375, U01DK048411, U01DK048400, U01DK048489, R01DK072041, U01DK048349, U01DK048437, U01DK048387, U01DK048468, U01DK048514, U01DK048413, U01DK048434, U01DK048406, U01DK048412, R01DK064695, P30DK017047, U01DK085545, U01DK048380, U01DK048377, U01DK048485, U01DK048443, U01DK048381, U01DK048397, U01DK048407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117163, U19GM061390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036607] Funding Source: NIH RePORTER	Diabetes UK(Diabetes UK); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ait-Omar A, 2011, DIABETES, V60, P2598, DOI 10.2337/db10-1740; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bailey CJ, 2015, CLIN PHARMACOL THER, V98, P170, DOI 10.1002/cpt.144; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bray GA, 2012, DIABETES CARE, V35, P731, DOI 10.2337/dc11-1299; Burcelin R, 2000, DIABETES, V49, P1643, DOI 10.2337/diabetes.49.10.1643; Dahlin A, 2013, MOL PHARMACEUT, V10, P650, DOI 10.1021/mp300429e; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; FANCONI G., 1949, HELVETICA PAEDIATR ACTA, V4, P359; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gong L, 2012, PHARMACOGENET GENOM, V22, P820, DOI 10.1097/FPC.0b013e3283559b22; Hosokawa M, 2002, AM J PHYSIOL-ENDOC M, V282, pE794, DOI 10.1152/ajpendo.00374.2001; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Jablonski KA, 2010, DIABETES, V59, P2672, DOI 10.2337/db10-0543; Kabakchiev B, 2013, GASTROENTEROLOGY, V144, P1488, DOI 10.1053/j.gastro.2013.03.001; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kooy A, 2009, ARCH INTERN MED, V169, P616, DOI 10.1001/archinternmed.2009.20; Liang XM, 2015, MOL PHARMACEUT, V12, P4301, DOI 10.1021/acs.molpharmaceut.5b00501; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; MANZ F, 1987, PEDIATR NEPHROL, V1, P509, DOI 10.1007/BF00849262; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCreight LJ, 2016, DIABETOLOGIA, V59, P426, DOI 10.1007/s00125-015-3844-9; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Pau CT, 2014, J CLIN ENDOCR METAB, V99, P1870, DOI 10.1210/jc.2013-4021; Pawlyk AC, 2014, DIABETES, V63, P2590, DOI 10.2337/db13-1367; Postmus I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6068; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schroder A, 2013, PHARMACOGENOMICS J, V13, P12, DOI 10.1038/tpj.2011.44; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Seyer P, 2013, J CLIN INVEST, V123, P1662, DOI 10.1172/JCI65538; Sherifali D, 2010, DIABETES CARE, V33, P1859, DOI 10.2337/dc09-1727; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Stocker SL, 2013, CLIN PHARMACOL THER, V93, P186, DOI 10.1038/clpt.2012.210; Tkac I, 2013, DIABETES OBES METAB, V15, P189, DOI 10.1111/j.1463-1326.2012.01691.x; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; van Leeuwen N, 2012, DIABETOLOGIA, V55, P1971, DOI 10.1007/s00125-012-2537-x; Xia K, 2012, BIOINFORMATICS, V28, P451, DOI 10.1093/bioinformatics/btr678; Zhou K, 2010, CLIN PHARMACOL THER, V87, P52, DOI 10.1038/clpt.2009.176; Zhou KX, 2014, LANCET DIABETES ENDO, V2, P481, DOI 10.1016/S2213-8587(14)70050-6; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735; Zhou KX, 2009, DIABETES, V58, P1434, DOI 10.2337/db08-0896	51	113	121	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1055	+		10.1038/ng.3632	http://dx.doi.org/10.1038/ng.3632			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27500523	Green Accepted, Green Submitted			2022-12-25	WOS:000382398800017
J	Baer, C; Squadrito, ML; Laoui, D; Thompson, D; Hansen, SK; Kiialainen, A; Hoves, S; Ries, CH; Ooi, CH; De Palma, M				Baer, Caroline; Squadrito, Mario Leonardo; Laoui, Damya; Thompson, Danielle; Hansen, Sarah K.; Kiialainen, Anna; Hoves, Sabine; Ries, Carola H.; Ooi, Chia-Huey; De Palma, Michele			Suppression of microRNA activity amplifies IFN-gamma-induced macrophage activation and promotes anti-tumour immunity	NATURE CELL BIOLOGY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; TIE2-EXPRESSING MONOCYTES; NEGATIVE REGULATION; CANCER; CELLS; DICER; EXPRESSION; RECEPTOR; RNA; GENERATION	Tumour-associated macrophages (TAMs) largely express an alternatively activated (or M2) phenotype, which entails immunosuppressive and tumour-promoting capabilities. Reprogramming TAMs towards a classically activated (M1) phenotype may thwart tumour-associated immunosuppression and unleash anti-tumour immunity. Here we show that conditional deletion of the microRNA (miRNA)-processing enzyme DICER in macrophages prompts M1-like TAM programming, characterized by hyperactive IFN-gamma/STAT1 signalling. This rewiring abated the immunosuppressive capacity of TAMs and fostered the recruitment of activated cytotoxic T lymphocytes (CTLs) to the tumours. CTL-derived IFN-gamma exacerbated M1 polarization of Dicer1-deficient TAMs and inhibited tumour growth. Remarkably, DICER deficiency in TAMs negated the anti-tumoral effects of macrophage depletion by anti-CSF1R antibodies, and enabled complete tumour eradication by PD1 checkpoint blockade or CD40 agonistic antibodies. Finally, genetic rescue of Let-7 miRNA activity in Dicer1-deficient TAMs partly restored their M2-like phenotype and decreased tumour-infiltrating CTLs. These findings suggest that DICER/Let-7 activity opposes IFN-gamma-induced, immunostimulatory M1-like TAM activation, with potential therapeutic implications.	[Baer, Caroline; Squadrito, Mario Leonardo; Laoui, Damya; Thompson, Danielle; Hansen, Sarah K.; De Palma, Michele] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland; [Kiialainen, Anna; Ooi, Chia-Huey] Roche Innovat Ctr Basel Pharmaceut Sci Pharma Res, CH-4070 Basel, Switzerland; [Hoves, Sabine; Ries, Carola H.; Ooi, Chia-Huey] Roche Innovat Ctr Munich Oncol Discovery Pharma, D-82377 Penzberg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Roche Holding	Squadrito, ML; De Palma, M (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland.	mario.squadrito@epfl.ch; michele.depalma@epfl.ch	Squadrito, Mario Leonardo/U-2090-2019; Van Ginderachter, Jo A/H-5473-2013; De Palma, Michele/L-5350-2016	Van Ginderachter, Jo A/0000-0002-4442-7474; De Palma, Michele/0000-0001-9128-5459; Hoves, Sabine/0000-0002-4953-7234; Ooi, Chia-Huey/0000-0001-8678-2901; Laoui, Damya/0000-0002-3373-1403; Squadrito, Mario Leonardo/0000-0002-1188-0299	Fonds National Suisse de la Recherche Scientifique [FNS 31003A-143978, FNS 31003A-165963]; Fondation pour la lutte contre le cancer; FNS [IZK0Z3_160843/1]; Swiss Federal Commission for Scholarships for Foreign Students (Swiss Government Excellence Scholarship) [2015.0430]	Fonds National Suisse de la Recherche Scientifique; Fondation pour la lutte contre le cancer; FNS(Swiss National Science Foundation (SNSF)); Swiss Federal Commission for Scholarships for Foreign Students (Swiss Government Excellence Scholarship)	We thank M. Smyth (QIMR Berghofer, Herston, Australia) for providing MC38-OVA cells; F. Schutz (Swiss Institute of Bioinformatics) for advice on statistical methods; C. Maderna, F. Jammes, L. Giesbrecht, S. Takahashi, C. W. Rmili and A. Bellotti (M.D.P's laboratory) and C. Wolter (Roche) for technical help; the BIOP team at EPFL for advice on image processing and proteome profiler cytokine array analysis; and F. Radtke, T. Petrova and C. Brisken for providing breeding pairs of transgenic mice. This work was supported by grants from the Fonds National Suisse de la Recherche Scientifique (FNS 31003A-143978; FNS 31003A-165963) and Fondation pour la lutte contre le cancer to M.D.P. D.L. was supported by an FNS International Short Visits fellowship (IZK0Z3_160843/1). S.K.H. was supported by the Swiss Federal Commission for Scholarships for Foreign Students (Swiss Government Excellence Scholarship 2015.0430).	Alemdehy MF, 2012, BLOOD, V119, P4723, DOI 10.1182/blood-2011-10-386359; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Banerjee S, 2013, J IMMUNOL, V190, P6542, DOI 10.4049/jimmunol.1202496; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bleckmann A, 2015, MOL ONCOL, V9, P155, DOI 10.1016/j.molonc.2014.07.023; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coffelt SB, 2015, TRENDS IMMUNOL, V36, P198, DOI 10.1016/j.it.2015.02.006; Coffelt SB, 2011, J IMMUNOL, V186, P4183, DOI 10.4049/jimmunol.1002802; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; De Palma M, 2002, METHOD ENZYMOL, V346, P514; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; De Palma M, 2008, CANCER CELL, V14, P299, DOI 10.1016/j.ccr.2008.09.004; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Ellis SL, 2010, J IMMUNOL, V185, P1864, DOI 10.4049/jimmunol.1000900; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jimenez VC, 2014, PHYSIOL GENOMICS, V46, P91, DOI 10.1152/physiolgenomics.00140.2013; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; Kuipers H, 2010, J IMMUNOL, V185, P400, DOI 10.4049/jimmunol.0903912; Lahmar Q, 2016, BBA-REV CANCER, V1865, P23, DOI 10.1016/j.bbcan.2015.06.009; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Mathsyaraja H, 2015, ONCOGENE, V34, P3651, DOI 10.1038/onc.2014.294; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Ooi CH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002415; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Ries CH, 2015, CURR OPIN PHARMACOL, V23, P45, DOI 10.1016/j.coph.2015.05.008; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Sandmann T, 2014, BIOINFORMATICS, V30, P127, DOI 10.1093/bioinformatics/btt592; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sonda N, 2013, IMMUNITY, V38, P1236, DOI 10.1016/j.immuni.2013.06.004; Squadrito ML, 2014, CELL REP, V8, P1432, DOI 10.1016/j.celrep.2014.07.035; Squadrito ML, 2013, TRENDS IMMUNOL, V34, P350, DOI 10.1016/j.it.2013.02.003; Squadrito ML, 2012, CELL REPORTS, V1, P141, DOI 10.1016/j.celrep.2011.12.005; Tannenbaum CS, 1998, J IMMUNOL, V161, P927; Teng GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056709; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Vonderheide RH, 2013, CLIN CANCER RES, V19, P1035, DOI 10.1158/1078-0432.CCR-12-2064; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju162; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zonari E, 2013, BLOOD, V122, P243, DOI 10.1182/blood-2012-08-449306	70	165	173	6	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2016	18	7					790	+		10.1038/ncb3371	http://dx.doi.org/10.1038/ncb3371			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DP9TS	27295554				2022-12-25	WOS:000378840900011
J	Kadoch, C; Williams, RT; Calarco, JP; Miller, EL; Weber, CM; Braun, SMG; Pulice, JL; Chory, EJ; Crabtree, GR				Kadoch, Cigall; Williams, Robert T.; Calarco, Joseph P.; Miller, Erik L.; Weber, Christopher M.; Braun, Simon M. G.; Pulice, John L.; Chory, Emma J.; Crabtree, Gerald R.			Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states	NATURE GENETICS			English	Article							CHROMATIN-REMODELING COMPLEX; COFFIN-SIRIS SYNDROME; NEURAL DEVELOPMENT; SWI/SNF COMPLEXES; SYNOVIAL SARCOMA; HOMEOTIC GENES; CANCER; PRC2; NUCLEOSOME; MUTATIONS	The opposition between Polycomb repressive complexes (PRCs) and BAF (mSWI/SNF) complexes has a critical role in both development and disease. Mutations in the genes encoding BAF subunits contribute to more than 20% of human malignancies, yet the underlying mechanisms remain unclear, owing largely to a lack of assays to assess BAF function in living cells. To address this, we have developed a widely applicable recruitment assay system through which we find that BAF opposes PRC by rapid, ATP-dependent eviction, leading to the formation of accessible chromatin. The reversal of this process results in reassembly of facultative heterochromatin. Surprisingly, BAF-mediated PRC eviction occurs in the absence of RNA polymerase II (Pol II) occupancy, transcription, and replication. Further, we find that tumor-suppressor and oncogenic mutant BAF complexes have different effects on PRC eviction. The results of these studies define a mechanistic sequence underlying the resolution and formation of facultative heterochromatin, and they demonstrate that BAF opposes PRC on a minute-by-minute basis to provide epigenetic plasticity.	[Kadoch, Cigall; Williams, Robert T.; Pulice, John L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kadoch, Cigall; Williams, Robert T.; Pulice, John L.] Harvard Med Sch, Boston, MA 02115 USA; [Kadoch, Cigall; Pulice, John L.] Broad Inst & MIT Harvard, Cambridge, MA 02142 USA; [Calarco, Joseph P.; Miller, Erik L.; Weber, Christopher M.; Braun, Simon M. G.; Chory, Emma J.; Crabtree, Gerald R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Calarco, Joseph P.; Miller, Erik L.; Weber, Christopher M.; Braun, Simon M. G.; Chory, Emma J.; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Calarco, Joseph P.; Miller, Erik L.; Weber, Christopher M.; Braun, Simon M. G.; Chory, Emma J.; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Stanford University; Stanford University	Kadoch, C (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Kadoch, C (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kadoch, C (corresponding author), Broad Inst & MIT Harvard, Cambridge, MA 02142 USA.; Crabtree, GR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Crabtree, GR (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Crabtree, GR (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	cigall_kadoch@dfci.harvard.edu; crabtree@stanford.edu		Pulice, John/0000-0002-2561-9358; Williams, Robert/0000-0002-9509-9327; Weber, Christopher/0000-0002-4285-8131; Braun, Simon/0000-0003-2622-9914; Chory, Emma/0000-0001-8541-9289; Crabtree, Robert/0000-0002-6639-8707	NIH Director's New Innovator Award DP2 [1DP2CA195762-01]; American Cancer Society Scholar Award [RSG-14-051-01-DMC]; Pew Scholar Award; A.P. Giannini Foundation; Alex's Lemonade Stand Foundation (ALSF) Young Investigator Award; NIH SARC Sarcoma SPORE Career Development and SPORE Project [5U54 CA168512-04]; NIH grants [CA163915, NS046789]; CIRM [RB4-05886]; Howard Hughes Medical Institute; SPARS; NATIONAL CANCER INSTITUTE [R01CA163915, U54CA168512, DP2CA195762, F31CA203228, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS046789, R01NS046789] Funding Source: NIH RePORTER	NIH Director's New Innovator Award DP2; American Cancer Society Scholar Award(American Cancer Society); Pew Scholar Award; A.P. Giannini Foundation; Alex's Lemonade Stand Foundation (ALSF) Young Investigator Award; NIH SARC Sarcoma SPORE Career Development and SPORE Project; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Howard Hughes Medical Institute(Howard Hughes Medical Institute); SPARS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to N. Hathaway, O. Bell, L. Chen, and J. Ronan, for insightful comments and technical assistance. We thank M. Alhamadsheh for synthesis of FK1012. We also thank J. Buenrostro and B. Wu for helpful advice and technical assistance with accessibility studies and V. Petkova. C.K. was supported by the NIH Director's New Innovator Award DP2 (1DP2CA195762-01), the American Cancer Society Scholar Award (RSG-14-051-01-DMC), the Pew Scholar Award, the A.P. Giannini Foundation, the Alex's Lemonade Stand Foundation (ALSF) Young Investigator Award, and the NIH SARC Sarcoma SPORE Career Development and SPORE Project (5U54 CA168512-04) awards. G.R.C. is supported by NIH grants (CA163915, NS046789), CIRM RB4-05886, SPARS and the Howard Hughes Medical Institute.	Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Bruijn DRH, 2006, HUM MOL GENET, V15, P2936, DOI 10.1093/hmg/ddl235; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Deciphering Dev. Disord. Study, 2014, NATURE, V519, P223; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Jadhav U, 2016, CELL, V165, P1389, DOI 10.1016/j.cell.2016.04.031; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; KENNISON JA, 1992, NEW BIOL, V4, P91; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kosho T, 2014, AM J MED GENET C, V166, P262, DOI 10.1002/ajmg.c.31407; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Narayanan R, 2015, CELL REP, V13, P1842, DOI 10.1016/j.celrep.2015.10.046; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stanton BZ, 2016, NAT GENET; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Victor MB, 2014, NEURON, V84, P311, DOI 10.1016/j.neuron.2014.10.016; Weinberg P, 2013, GENETICS, V194, P189, DOI 10.1534/genetics.112.148742; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	58	158	160	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					213	222		10.1038/ng.3734	http://dx.doi.org/10.1038/ng.3734			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27941796	Green Submitted, Green Accepted			2022-12-25	WOS:000393148600010
J	Shaw, ND; Brand, H; Kupchinsky, ZA; Bengani, H; Plummer, L; Jones, TI; Erdin, S; Williamson, KA; Rainger, J; Stortchevoi, A; Samocha, K; Curra, BB; Dunican, DS; Collins, RL; Willer, JR; Lek, A; Lek, M; Nassan, M; Pereira, S; Kammin, T; Lucente, D; Silva, A; Seabra, CM; Chiang, C; Ana, Y; Ansari, M; Rainger, JK; Joss, S; Smith, JC; Lippincott, MF; Singh, SS; Patel, N; Jing, JW; Law, JR; Ferraro, N; Verloes, M; Rauch, A; Steindl, K; Zweier, M; Scheer, I; Sato, D; Okamoto, N; Jacobsen, C; Tryggestad, J; Chernausek, S; Schimmenti, LA; Brasseur, B; Cesaretti, C; Garcia-Ortiz, JE; Buitrago, TP; Silva, OP; Hoffman, JD; Muhlbauer, W; Ruprecht, KW; Loeys, BL; Shino, M; Kaind, AM; Cho, CH; Morton, CC; Meehan, RR; van Heyningen, V; Liao, EC; Balasubramanian, R; Hall, JE; Seminara, SB; Macarthur, D; Moore, SA; Yoshiura, K; Gusella, JF; Marsh, JA; Graham, JM; Lin, AE; Katsanis, N; Jones, PL; Crowley, WF; Davis, EE; FitzPatrick, DR; Talkowski, ME				Shaw, Natalie D.; Brand, Harrison; Kupchinsky, Zachary A.; Bengani, Hemant; Plummer, Lacey; Jones, Takako I.; Erdin, Serkan; Williamson, Kathleen A.; Rainger, Joe; Stortchevoi, Alexei; Samocha, Kaitlin; Curra, Benjamin B.; Dunican, Donncha S.; Collins, Ryan L.; Willer, Jason R.; Lek, Angela; Lek, Monkol; Nassan, Malik; Pereira, Shahrin; Kammin, Tammy; Lucente, Diane; Silva, Alexandra; Seabra, Catarina M.; Chiang, Colby; Ana, Yu; Ansari, Morad; Rainger, Jacqueline K.; Joss, Shelagh; Smith, Jill Clayton; Lippincott, Margaret F.; Singh, Sylvia S.; Patel, Nirav; Jing, Jenny W.; Law, Jennifer R.; Ferraro, Nalton; Verloes, Main; Rauch, Anita; Steindl, Katharina; Zweier, Markus; Scheer, Ianina; Sato, Daisuke; Okamoto, Nobuhiko; Jacobsen, Christina; Tryggestad, Jeanie; Chernausek, Steven; Schimmenti, Lisa A.; Brasseur, Benjamin; Cesaretti, Claudia; Garcia-Ortiz, Jose E.; Pineda Buitrago, Tatiana; Perez Silva, Orlando; Hoffman, Jodi D.; Muehlbauer, Wolfgang; Ruprecht, Klaus W.; Loeys, Bart L.; Shino, Masato; Kaind, Angela M.; Cho, Chie-Hee; Morton, Cynthia C.; Meehan, Richard R.; van Heyningen, Veronica; Liao, Eric C.; Balasubramanian, Ravikumar; Hall, Janet E.; Seminara, Stephanie B.; Macarthur, Daniel; Moore, Steven A.; Yoshiura, Koh-ichiro; Gusella, James F.; Marsh, Joseph A.; Graham, John M., Jr.; Lin, Angela E.; Katsanis, Nicholas; Jones, Peter L.; Crowley, William F., Jr.; Davis, Erica E.; FitzPatrick, David R.; Talkowski, Michael E.			SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome	NATURE GENETICS			English	Article							X INACTIVATION; CHROMOSOME; EXPRESSION; DOMAIN; FSHD1; GNRH; METHYLATION; INHERITANCE; HYPOPLASIA; PREDICTION	Arhinia, or absence of the nose, is a rare malformation of unknown etiology that is often accompanied by ocular and reproductive defects. Sequencing of 40 people with arhinia revealed that 84% of probands harbor a missense mutation localized to a constrained region of SMCHD1 encompassing the ATPase domain. SMCHD1 mutations cause facioscapulohumeral muscular dystrophy type 2 (FSHD2) via a trans-acting loss-of function epigenetic mechanism. We discovered shared mutations and comparable DNA hypomethylation patterning between these distinct disorders. CRISPR/Cas9-mediated alteration of smchd1 in zebrafish yielded arhinia-relevant phenotypes. Transcriptome and protein analyses in arhinia probands and controls showed no differences in SMCHD1 mRNA or protein abundance but revealed regulatory changes in genes and pathways associated with craniofacial patterning. Mutations in SMCHD1 thus contribute to distinct phenotypic spectra, from craniofacial malformation and reproductive disorders to muscular dystrophy, which we speculate to be consistent with oligogenic mechanisms resulting in pleiotropic outcomes.	[Shaw, Natalie D.; Brand, Harrison; Plummer, Lacey; Lippincott, Margaret F.; Singh, Sylvia S.; Patel, Nirav; Jing, Jenny W.; Balasubramanian, Ravikumar; Hall, Janet E.; Seminara, Stephanie B.; Crowley, William F., Jr.] Massachusetts Gen Hosp, Dept Med, Reprod Endocrine Unit, Harvard Reprod Endocrine Sci Ctr, Boston, MA 02114 USA; [Shaw, Natalie D.; Brand, Harrison; Plummer, Lacey; Lippincott, Margaret F.; Singh, Sylvia S.; Patel, Nirav; Jing, Jenny W.; Balasubramanian, Ravikumar; Hall, Janet E.; Seminara, Stephanie B.; Crowley, William F., Jr.] Massachusetts Gen Hosp, Dept Med, Reprod Endocrine Unit, NICHD Ctr Excellence Translat Res Fertil & Infert, Boston, MA 02114 USA; [Shaw, Natalie D.; Hall, Janet E.] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; [Brand, Harrison; Erdin, Serkan; Stortchevoi, Alexei; Curra, Benjamin B.; Collins, Ryan L.; Lucente, Diane; Silva, Alexandra; Seabra, Catarina M.; Chiang, Colby; Ana, Yu; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; [Brand, Harrison; Erdin, Serkan; Stortchevoi, Alexei; Curra, Benjamin B.; Collins, Ryan L.; Lucente, Diane; Silva, Alexandra; Seabra, Catarina M.; Chiang, Colby; Ana, Yu; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Brand, Harrison; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Brand, Harrison; Samocha, Kaitlin; Lek, Monkol; Jacobsen, Christina; Liao, Eric C.; Lin, Angela E.; Talkowski, Michael E.] Harvard Med Sch, Boston, MA 02115 USA; [Brand, Harrison; Erdin, Serkan; Samocha, Kaitlin; Lek, Monkol; Morton, Cynthia C.; Macarthur, Daniel; Gusella, James F.; Talkowski, Michael E.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Kupchinsky, Zachary A.; Willer, Jason R.; Katsanis, Nicholas; Davis, Erica E.] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27708 USA; [Bengani, Hemant; Williamson, Kathleen A.; Rainger, Joe; Dunican, Donncha S.; Ansari, Morad; Rainger, Jacqueline K.; Meehan, Richard R.; van Heyningen, Veronica; Marsh, Joseph A.; FitzPatrick, David R.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Jones, Takako I.; Jones, Peter L.] Univ Massachusetts Med Sch, Dept Cell & Dev Biol, Worcester, MA 01655 USA; [Samocha, Kaitlin; Lek, Monkol; Macarthur, Daniel] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Collins, Ryan L.] Harvard Med Sch, Div Med Sci, Program Bioinformat & Integrat Genom, Boston, MA 02115 USA; [Lek, Angela; Gusella, James F.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Nassan, Malik] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Pereira, Shahrin; Kammin, Tammy; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA; [Seabra, Catarina M.] Univ Porto, GABBA Program, Oporto, Portugal; [Joss, Shelagh] South Glasgow Univ Hosp, West Scotland Genet Serv, Glasgow, Lanark, Scotland; [Smith, Jill Clayton] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Fac Med & Human Sci,Inst Human Dev, Manchester, Lancs, England; [Law, Jennifer R.] Univ N Carolina, Div Pediat Endocrinol, Chapel Hill, NC 27514 USA; [Ferraro, Nalton] Boston Childrens Hosp, Dept Oral & Maxillofacial Surg, Boston, MA USA; [Verloes, Main] Robert Debre Hosp, Dept Genet, Paris, France; [Rauch, Anita; Steindl, Katharina; Zweier, Markus] Univ Zurich, Clin Res Prior Program Rare Dis, Inst Med Genet, Schlieren, Switzerland; [Rauch, Anita; Steindl, Katharina; Zweier, Markus] Univ Zurich, Clin Res Prior Program Rare Dis, Radiz Rare Dis Initiat Zurich, Schlieren, Switzerland; [Scheer, Ianina] Childrens Hosp, Dept Diagnost Imaging, Zurich, Switzerland; [Sato, Daisuke] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Osaka, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Osaka, Japan; [Jacobsen, Christina] Boston Childrens Hosp, Div Endocrinol & Genet, Boston, MA 02115 USA; [Tryggestad, Jeanie] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Schimmenti, Lisa A.] Mayo Clin, Dept Otorhinolaryngol, Rochester, MN 55905 USA; [Schimmenti, Lisa A.] Mayo Clin, Dep Clin Genom, Rochester, MN 55905 USA; [Brasseur, Benjamin] Univ Miami, Leonard M Miller Sch Med, DeWitt Daughtry Family Dept Surg, Miami, FL 33146 USA; [Cesaretti, Claudia] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Med Genet Unit, Milan, Italy; [Garcia-Ortiz, Jose E.] Inst Mexicano Seguro Social, Ctr Invest Biomed Occidente, Div Genet, Guadalajara, Mexico; [Pineda Buitrago, Tatiana] San Jose State Univ, Fdn Hosp Infantil, Bogota, Colombia; [Perez Silva, Orlando] Acad Nacl Med Colombia, Bogota, Colombia; [Hoffman, Jodi D.] Tufts Med Ctr, Div Genet, Boston, MA 02111 USA; [Hoffman, Jodi D.] Tufts Med Ctr, Div Maternal Fetal Med, Boston, MA 02111 USA; [Muehlbauer, Wolfgang] ATOS Klin, Dept Plast & Aesthet Surg, Munich, Germany; [Ruprecht, Klaus W.] Univ Hosp Saarland, Dept Ophthalmol, Homburg, Germany; [Loeys, Bart L.] Univ Antwerp, Ctr Med Genet, Antwerp, Belgium; [Loeys, Bart L.] Univ Antwerp Hosp, Antwerp, Belgium; [Shino, Masato] Gunma Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Gunma, Japan; [Kaind, Angela M.] Charite, Biol & Neurobiol, Berlin, Germany; [Kaind, Angela M.] Berlin Inst Hlth, Berlin, Germany; [Cho, Chie-Hee] Univ Hosp Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland; [Liao, Eric C.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Liao, Eric C.] Massachusetts Gen Hosp, Div Plast & Reconstruct Surg, Boston, MA 02114 USA; [Liao, Eric C.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Macarthur, Daniel; Talkowski, Michael E.] Broad Inst MIT & Harvard, Ctr Mendelian Genom, Cambridge, MA 02142 USA; [Moore, Steven A.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Yoshiura, Koh-ichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki, Japan; [Graham, John M., Jr.] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Lin, Angela E.] MassGeneral Hosp Children, Med Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Duke University; University of Edinburgh; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Mayo Clinic; Harvard University; Brigham & Women's Hospital; Universidade do Porto; University of Manchester; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Boston Children's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University Children's Hospital Zurich; Hokkaido University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Harvard University; Boston Children's Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic; Mayo Clinic; University of Miami; IRCCS Ca Granda Ospedale Maggiore Policlinico; Instituto Mexicano del Seguro Social; Tufts Medical Center; Tufts Medical Center; Universitatsklinikum des Saarlandes; University of Antwerp; University of Antwerp; Gunma University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; University of Bern; University Hospital of Bern; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Iowa; Nagasaki University; Cedars Sinai Medical Center	Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Talkowski, ME (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Davis, EE (corresponding author), Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27708 USA.; FitzPatrick, DR (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.; Talkowski, ME (corresponding author), Broad Inst MIT & Harvard, Ctr Mendelian Genom, Cambridge, MA 02142 USA.	erica.davis@duke.edu; david.fitzpatrick@igmm.ed.ac.uk; talkowski@chgr.mgh.harvard.edu	shaw, natalie/C-3761-2019; Loeys, Bart/B-3236-2017; VAN HEYNINGEN, Veronica/GYE-0531-2022; Rauch, Anita/C-5568-2014; Erdin, Serkan/AAE-4288-2019; Cesaretti, Claudia/K-2633-2018; Hall, Janet E/F-3516-2019; Seabra, Catarina/ABA-5591-2020; Wang, Guilin/G-8794-2018; Graham, John M./J-1429-2019; Erdin, Serkan/B-4988-2008	shaw, natalie/0000-0002-0847-9170; Loeys, Bart/0000-0003-3703-9518; Rauch, Anita/0000-0003-2930-3163; Cesaretti, Claudia/0000-0002-6819-0846; Hall, Janet E/0000-0003-4644-3061; Erdin, Serkan/0000-0001-6587-2625; Talkowski, Michael/0000-0003-2889-0992; Moore, Steven/0000-0002-6353-7900; FitzPatrick, David R./0000-0003-4861-969X; Marsh, Joseph/0000-0003-4132-0628; Liao, Eric/0000-0001-6385-7448; Seabra, Catarina/0000-0003-2862-1979; van Heyningen, Veronica/0000-0003-0359-0141; Meehan, Richard/0000-0001-6471-6882; Lippincott, Margaret/0000-0002-3533-1999; Schimmenti, Lisa/0000-0003-3154-4249; , steven/0000-0003-4538-8793; Rainger, Joe/0000-0003-1091-5100; Kaindl, Angela/0000-0001-9454-206X; Ansari, Morad/0000-0002-8905-5379; Collins, Ryan/0000-0003-1268-9995; Samocha, Kaitlin/0000-0002-1704-3352; Willer, Jason/0000-0002-5869-3992; Davis, Erica/0000-0002-2412-8397; MacArthur, Daniel/0000-0002-5771-2290	National Institutes of Health ((NIH)) [R00MH095867, R01HD081256, P01GM061354, T32HD007396, P50HD028138]; MGH Robert and Laura Reynolds Research Scholar Award [R01HD043341]; March of Dimes [FY15-255]; Medical Research Council [MR/M02122X/1]; German Research Foundation [SFB665]; Berlin Institute of Health (BIH) [CRG1]; Medical Research Council (MRC) Human Genetics Unit award [MC_PC_U127574433]; University of Edinburgh Institute of Genomics and Molecular Medicine Translational Initiative Fund;  [K23HD073304-02];  [1SI2ES025429-01];  [P50DK096415];  [R01AR062587];  [U54-NS053672]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD085857, K23HD077043, R01HD081256, P50HD028138, U54HD060848, K23HD073304, T32HD007396, R01HD043341] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG008900, R01HG009141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK096415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH095867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER; MRC [MR/M02122X/1, MC_PC_U127561093, MC_U127527199, MC_PC_U127574433, MC_U127561093, MC_PC_U127527199] Funding Source: UKRI; Medical Research Council [MC_PC_U127574433, MC_PC_U127561093, MC_PC_U127527199, MC_U127561093, MC_U127527199] Funding Source: researchfish; Fight for Sight [1590/91] Funding Source: researchfish	National Institutes of Health ((NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH Robert and Laura Reynolds Research Scholar Award; March of Dimes(March of Dimes); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Research Foundation(German Research Foundation (DFG)); Berlin Institute of Health (BIH); Medical Research Council (MRC) Human Genetics Unit award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh Institute of Genomics and Molecular Medicine Translational Initiative Fund; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight	We thank all participants, family members and clinical staff for their generous contributions of time and materials to this research. We thank T. Gillis, J. Ruliera, C. Hanscom, C. Antolik and M. Anderson for technical assistance. This project was funded by grants from the National Institutes of Health ((NIH) R00MH095867 and R01HD081256 to M.E.T.; P01GM061354 to M.E.T., J.F.G., C.C.M. and E.C.L.; T32HD007396 to H. Brand; P50HD028138 to W.F.C., S.B.S., M.E.T., N.K. and E.E.D.; R01HD043341 and MGH Robert and Laura Reynolds Research Scholar Award to S.B.S.; K23HD073304-02 and 1SI2ES025429-01 to N.D.S.; P50DK096415 to N.K. and R01AR062587 to P.L.J.); the March of Dimes (FY15-255 to M.E.T.); the Medical Research Council (MR/M02122X/1 to J.A.M.); the German Research Foundation (SFB665 to A.M.K.) and the Berlin Institute of Health (BIH-CRG1 to A.M.K.). D.R.F., R.R.M. (MC_PC_U127574433), D.S.D., H. Bengani, K.A.W., J.R., J.K.R. and J.A.M. are funded by program grants from the Medical Research Council (MRC) Human Genetics Unit award to the University of Edinburgh. M.A. is funded by the University of Edinburgh Institute of Genomics and Molecular Medicine Translational Initiative Fund. S.A.M. is supported by U54-NS053672, which funds the Iowa, Paul D. Wellstone Muscular Dystrophy Cooperative Research Center. N.K. is supported as a Distinguished Jean and George Brumley Professor at Duke University, and M.E.T. is supported as the Desmond and Ann Heathwood MGH Research Scholar.	Abraham E, 2009, GEN COMP ENDOCR, V164, P151, DOI 10.1016/j.ygcen.2009.01.012; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; BOSMA JF, 1981, J CRAN GENET DEV BIO, V1, P153; Calandra P, 2016, J MED GENET, V53, P348, DOI 10.1136/jmedgenet-2015-103436; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chassaing N, 2016, GENOME RES, V26, P474, DOI 10.1101/gr.196048.115; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen KL, 2016, BIOCHEM J, V473, P1733, DOI 10.1042/BCJ20160189; Chen KL, 2015, P NATL ACAD SCI USA, V112, pE3535, DOI 10.1073/pnas.1504232112; Cho CH, 2006, ORAL MAXILLOFAC SURG, V10, P106, DOI 10.1007/s10006-006-0680-6; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gendrel AV, 2013, MOL CELL BIOL, V33, P3150, DOI 10.1128/MCB.00145-13; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gordon C. T., 2016, NAT GENET; Hall JG, 2009, BIRTH DEFECTS RES A, V85, P677, DOI 10.1002/bdra.20611; Heffernan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11476; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Jones TI, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0072-6; Jones TI, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-23; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemmers RJLF, 2015, HUM MUTAT, V36, P679, DOI 10.1002/humu.22792; Lemmers RJLF, 2015, HUM MOL GENET, V24, P659, DOI 10.1093/hmg/ddu486; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lindgren AM, 2013, HUM GENET, V132, P537, DOI 10.1007/s00439-013-1263-x; Liu CQ, 2016, HUM MOL GENET, V25, P1382, DOI 10.1093/hmg/ddw020; Mould AW, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-19; Parhar IS, 2002, PROG BRAIN RES, V141, P3; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Schmidt-Sidor B, 2009, FOLIA NEUROPATHOL, V47, P371; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Solomon B. D., GENEREVIEWS; Solomon BD, 2009, AM J MED GENET A, V149A, P2543, DOI 10.1002/ajmg.a.33081; Steven C, 2003, GEN COMP ENDOCR, V133, P27, DOI 10.1016/S0016-6480(03)00144-8; Thiele H, 1996, AM J MED GENET, V63, P310, DOI 10.1002/(SICI)1096-8628(19960503)63:1<310::AID-AJMG51>3.0.CO;2-N; Timberlake AT, 2016, ELIFE, V5, DOI 10.7554/eLife.20125; van den Boogaard ML, 2016, AM J HUM GENET, V98, P1020, DOI 10.1016/j.ajhg.2016.03.013; van den Boogaard ML, 2016, EUR J HUM GENET, V24, P78, DOI 10.1038/ejhg.2015.55; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; Weemaes CMR, 2013, EUR J HUM GENET, V21, P1219, DOI 10.1038/ejhg.2013.40; Whitlock KE, 2006, MOL CELL ENDOCRINOL, V254, P39, DOI 10.1016/j.mce.2006.04.038; Yahyavi M, 2013, HUM MOL GENET, V22, P3250, DOI 10.1093/hmg/ddt179; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	52	82	83	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					238	248		10.1038/ng.3743	http://dx.doi.org/10.1038/ng.3743			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	28067909	Green Accepted, Green Submitted			2022-12-25	WOS:000393148600012
J	Hatch, EM				Hatch, Emily M.			Y chromothripsis?	NATURE CELL BIOLOGY			English	Editorial Material							CHROMOSOME-PULVERIZATION; DNA-DAMAGE; MICRONUCLEI; CELLS	Micronucleation of missegregated chromatin can lead to substantial chromosome rearrangements via chromothripsis. However, the molecular details of micronucleus-based chromothripsis are still unclear. Now, an elegant system that specifically induces missegregation of the Y chromosome provides insight into this process, including a role for non-homologous end joining.	[Hatch, Emily M.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Hatch, EM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	ehatch@fredhutch.org		Hatch, Emily/0000-0002-3393-4075				Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; de Pagter Mirjam S, 2015, Recent Results Cancer Res, V200, P165, DOI 10.1007/978-3-319-20291-4_8; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Holland N, 2008, MUTAT RES-REV MUTAT, V659, P93, DOI 10.1016/j.mrrev.2008.03.007; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; KATO H, 1967, J CELL BIOL, V34, P35, DOI 10.1083/jcb.34.1.35; Lv P., 2017, NAT CELL BIOL, V19, P68; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018618; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	16	3	4	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2017	19	1					12	14		10.1038/ncb3458	http://dx.doi.org/10.1038/ncb3458			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EG9AI	28008180				2022-12-25	WOS:000391349000003
J	Redin, C; Brand, H; Collins, RL; Kammin, T; Mitchell, E; Hodge, JC; Hanscom, C; Pillalamarri, V; Seabra, CM; Abbott, MA; Abdul-Rahman, OA; Aberg, E; Adley, R; Alcaraz-Estrada, SL; Alkuraya, FS; An, Y; Anderson, MA; Antolik, C; Anyane-Yeboa, K; Atkin, JF; Bartell, T; Bernstein, JA; Beyer, E; Blumenthal, I; Bongers, EMHF; Brilstra, EH; Brown, CW; Bruggenwirth, HT; Callewaert, B; Chiang, C; Corning, K; Cox, H; Cuppen, E; Currall, BB; Cushing, T; David, D; Deardorff, MA; Dheedene, A; D'Hooghe, M; de Vries, BBA; Earl, DL; Ferguson, HL; Fisher, H; FitzPatrick, DR; Gerrol, P; Giachino, D; Glessner, JT; Gliem, T; Grady, M; Graham, BH; Griffis, C; Gripp, KW; Gropman, AL; Hanson-Kahn, A; Harris, DJ; Hayden, MA; Hill, R; Hochstenbach, R; Hoffman, JD; Hopkin, RJ; Hubshman, MW; Innes, AM; Irons, M; Irving, M; Jacobsen, JC; Janssens, S; Jewett, T; Johnson, JP; Jongmans, MC; Kahler, SG; Koolen, DA; Korzelius, J; Kroisel, PM; Lacassie, Y; Lawless, W; Lemyre, E; Leppig, K; Levin, AV; Li, HB; Li, H; Liao, EC; Lim, C; Lose, EJ; Lucente, D; Macera, MJ; Manavalan, P; Mandrile, G; Marcelis, CL; Margolin, L; Mason, T; Masser-Frye, D; McClellan, MW; Mendoza, CJZ; Menten, B; Middelkamp, S; Mikami, LR; Moe, E; Mohammed, S; Mononen, T; Mortenson, ME; Moya, G; Nieuwint, AW; Ordulu, Z; Parkash, S; Pauker, SP; Pereira, S; Perrin, D; Phelan, K; Aguilar, REP; Poddighe, PJ; Pregno, G; Raskin, S; Reis, L; Rhead, W; Rita, D; Renkens, I; Roelens, F; Ruliera, J; Rump, P; Schilit, SLP; Shaheen, R; Sparkes, R; Spiegel, E; Stevens, B; Stone, MR; Tagoe, J; Thakuria, JV; van Bon, BW; van de Kamp, J; van Der Burgt, I; van Essen, T; van Ravenswaaij-Arts, CM; van Roosmalen, MJ; Vergult, S; Volker-Touw, CML; Warburton, DP; Waterman, MJ; Wiley, S; Wilson, A; Yerena-de Vega, MDA; Zori, RT; Levy, B; Brunner, HG; de Leeuw, N; Kloosterman, WP; Thorland, EC; Morton, CC; Gusella, JF; Talkowski, ME				Redin, Claire; Brand, Harrison; Collins, Ryan L.; Kammin, Tammy; Mitchell, Elyse; Hodge, Jennelle C.; Hanscom, Carrie; Pillalamarri, Vamsee; Seabra, Catarina M.; Abbott, Mary-Alice; Abdul-Rahman, Omar A.; Aberg, Erika; Adley, Rhett; Alcaraz-Estrada, Sofia L.; Alkuraya, Fowzan S.; An, Yu; Anderson, Mary-Anne; Antolik, Caroline; Anyane-Yeboa, Kwame; Atkin, Joan F.; Bartell, Tina; Bernstein, Jonathan A.; Beyer, Elizabeth; Blumenthal, Ian; Bongers, Ernie M. H. F.; Brilstra, Eva H.; Brown, Chester W.; Bruggenwirth, Hennie T.; Callewaert, Bert; Chiang, Colby; Corning, Ken; Cox, Helen; Cuppen, Edwin; Currall, Benjamin B.; Cushing, Tom; David, Dezso; Deardorff, Matthew A.; Dheedene, Annelies; D'Hooghe, Marc; de Vries, Bert B. A.; Earl, Dawn L.; Ferguson, Heather L.; Fisher, Heather; FitzPatrick, David R.; Gerrol, Pamela; Giachino, Daniela; Glessner, Joseph T.; Gliem, Troy; Grady, Margo; Graham, Brett H.; Griffis, Cristin; Gripp, Karen W.; Gropman, Andrea L.; Hanson-Kahn, Andrea; Harris, David J.; Hayden, Mark A.; Hill, Rosamund; Hochstenbach, Ron; Hoffman, Jodi D.; Hopkin, Robert J.; Hubshman, Monika W.; Innes, A. Micheil; Irons, Mira; Irving, Melita; Jacobsen, Jessie C.; Janssens, Sandra; Jewett, Tamison; Johnson, John P.; Jongmans, Marjolijn C.; Kahler, Stephen G.; Koolen, David A.; Korzelius, Jerome; Kroisel, Peter M.; Lacassie, Yves; Lawless, William; Lemyre, Emmanuelle; Leppig, Kathleen; Levin, Alex V.; Li, Haibo; Li, Hong; Liao, Eric C.; Lim, Cynthia; Lose, Edward J.; Lucente, Diane; Macera, Michael J.; Manavalan, Poornima; Mandrile, Giorgia; Marcelis, Carlo L.; Margolin, Lauren; Mason, Tamara; Masser-Frye, Diane; McClellan, Michael W.; Mendoza, Cinthya J. Zepeda; Menten, Bjorn; Middelkamp, Sjors; Mikami, Liya R.; Moe, Emily; Mohammed, Shehla; Mononen, Tarja; Mortenson, Megan E.; Moya, Graciela; Nieuwint, Aggie W.; Ordulu, Zehra; Parkash, Sandhya; Pauker, Susan P.; Pereira, Shahrin; Perrin, Danielle; Phelan, Katy; Pina Aguilar, Raul E.; Poddighe, Pino J.; Pregno, Giulia; Raskin, Salmo; Reis, Linda; Rhead, William; Rita, Debra; Renkens, Ivo; Roelens, Filip; Ruliera, Jayla; Rump, Patrick; Schilit, Samantha L. P.; Shaheen, Ranad; Sparkes, Rebecca; Spiegel, Erica; Stevens, Blair; Stone, Matthew R.; Tagoe, Julia; Thakuria, Joseph V.; van Bon, Bregje W.; van de Kamp, Jiddeke; van Der Burgt, Ineke; van Essen, Ton; van Ravenswaaij-Arts, Conny M.; van Roosmalen, Markus J.; Vergult, Sarah; Volker-Touw, Catharina M. L.; Warburton, Dorothy P.; Waterman, Matthew J.; Wiley, Susan; Wilson, Anna; Yerena-de Vega, Maria de la Concepcion A.; Zori, Roberto T.; Levy, Brynn; Brunner, Han G.; de Leeuw, Nicole; Kloosterman, Wigard P.; Thorland, Erik C.; Morton, Cynthia C.; Gusella, James F.; Talkowski, Michael E.			The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies	NATURE GENETICS			English	Article							SEVERE MENTAL-RETARDATION; OF-FUNCTION MUTATIONS; DE-NOVO MUTATIONS; CHROMOSOME REARRANGEMENTS; MICRODELETION SYNDROME; INTELLECTUAL DISABILITY; STRUCTURAL VARIATION; DEVELOPMENTAL DELAY; SPECTRUM; EPILEPSY	Despite the clinical significance of balanced chromosomal abnormalities (BCAs), their characterization has largely been restricted to cytogenetic resolution. We explored the landscape of BCAs at nucleotide resolution in 273 subjects with a spectrum of congenital anomalies. Whole-genome sequencing revised 93% of karyotypes and demonstrated complexity that was cryptic to karyotyping in 21 % of BCAs, highlighting the limitations of conventional cytogenetic approaches. At least 33.9% of BCAs resulted in gene disruption that likely contributed to the developmental phenotype, 5.2% were associated with pathogenic genomic imbalances, and 7.3% disrupted topologically associated domains (TADS) encompassing known syndromic loci. Remarkably, BCA breakpoints in eight subjects altered a single TAD encompassing MEF2C, a known driver of 5q14.3 microdeletion syndrome, resulting in decreased MEF2C expression. We propose that sequence-level resolution dramatically improves prediction of clinical outcomes for balanced rearrangements and provides insight into new pathogenic mechanisms, such as altered regulation due to changes in chromosome topology.	[Redin, Claire; Brand, Harrison; Collins, Ryan L.; Hanscom, Carrie; Pillalamarri, Vamsee; Seabra, Catarina M.; Adley, Rhett; An, Yu; Antolik, Caroline; Blumenthal, Ian; Chiang, Colby; Currall, Benjamin B.; Glessner, Joseph T.; Lawless, William; Lucente, Diane; Manavalan, Poornima; Stone, Matthew R.; Waterman, Matthew J.; Wilson, Anna; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; [Redin, Claire; Brand, Harrison; Collins, Ryan L.; Hanscom, Carrie; Pillalamarri, Vamsee; Seabra, Catarina M.; Antolik, Caroline; Glessner, Joseph T.; Stone, Matthew R.; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Ctr Human Genet Res, Psychiatr & Neurodev Genet Unit, Boston, MA 02114 USA; [Redin, Claire; Brand, Harrison; Collins, Ryan L.; Hanscom, Carrie; Pillalamarri, Vamsee; Seabra, Catarina M.; Antolik, Caroline; Glessner, Joseph T.; Innes, A. Micheil; Stone, Matthew R.; Talkowski, Michael E.] Harvard Med Sch, Boston, MA 02115 USA; [Redin, Claire; Brand, Harrison; Collins, Ryan L.; Hanscom, Carrie; Pillalamarri, Vamsee; Seabra, Catarina M.; Antolik, Caroline; Glessner, Joseph T.; Stone, Matthew R.; Morton, Cynthia C.; Gusella, James F.; Talkowski, Michael E.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Collins, Ryan L.] Harvard Med Sch, Div Med Sci, Program Bioinformat & Integrat Gen, Boston, MA USA; [Kammin, Tammy; Currall, Benjamin B.; Ferguson, Heather L.; Gerrol, Pamela; Hayden, Mark A.; Mendoza, Cinthya J. Zepeda; Ordulu, Zehra; Pereira, Shahrin; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA; [Mitchell, Elyse; Hodge, Jennelle C.; Gliem, Troy; Thorland, Erik C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Hodge, Jennelle C.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Hodge, Jennelle C.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Seabra, Catarina M.] Univ Porto, GABBA Program, Porto, Portugal; [Abbott, Mary-Alice] Baystate Med Ctr, Med Genet, Springfield, MA USA; [Abdul-Rahman, Omar A.] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Aberg, Erika; Parkash, Sandhya] IWK Hlth Ctr, Maritime Med Genet Serv, Halifax, NS, Canada; [Alcaraz-Estrada, Sofia L.; Pina Aguilar, Raul E.] ISSSTE, Ctr Med Nacl Noviembre 20, Med Genom Div, Mexico City, DF, Mexico; [Alkuraya, Fowzan S.; Shaheen, Ranad] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia; [An, Yu] Fudan Univ, Shanghai Med Sch, IBS, Shanghai, Peoples R China; [An, Yu] Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai, Peoples R China; [Anderson, Mary-Anne; Ruliera, Jayla] Ctr Human Genet Res DNA & Tissue Culture Res, Boston, MA USA; [Anyane-Yeboa, Kwame; Warburton, Dorothy P.] Columbia Univ, Med Ctr, Div Clin Genet, New York, NY USA; [Atkin, Joan F.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Atkin, Joan F.] Nationwide Childrens Hosp, Div Mol & Human Genet, Columbus, OH USA; [Bartell, Tina] Kaiser Permanente, Dept Genet, Sacramento, CA USA; [Bernstein, Jonathan A.; Hanson-Kahn, Andrea] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Beyer, Elizabeth; Griffis, Cristin; Moe, Emily; Reis, Linda; Rhead, William] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Beyer, Elizabeth; Griffis, Cristin; Moe, Emily; Rhead, William] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Bongers, Ernie M. H. F.; de Vries, Bert B. A.; Jongmans, Marjolijn C.; Koolen, David A.; Marcelis, Carlo L.; van Bon, Bregje W.; van Der Burgt, Ineke; Brunner, Han G.; de Leeuw, Nicole] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Human Genet, Med Ctr, Nijmegen, Netherlands; [Bongers, Ernie M. H. F.; de Vries, Bert B. A.; Jongmans, Marjolijn C.; Koolen, David A.; Marcelis, Carlo L.; van Bon, Bregje W.; van Der Burgt, Ineke; Brunner, Han G.; de Leeuw, Nicole] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, Nijmegen, Netherlands; [Brilstra, Eva H.; Cuppen, Edwin; Hochstenbach, Ron; Korzelius, Jerome; Middelkamp, Sjors; Renkens, Ivo; van Roosmalen, Markus J.; Volker-Touw, Catharina M. L.; Kloosterman, Wigard P.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Genet, Div Biomed Genet, Utrecht, Netherlands; [Brown, Chester W.; Graham, Brett H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Brown, Chester W.; Graham, Brett H.] Texas Childrens Hosp, Dept Genet, Houston, TX 77030 USA; [Bruggenwirth, Hennie T.] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Callewaert, Bert; Dheedene, Annelies; Janssens, Sandra; Menten, Bjorn; Vergult, Sarah] Univ Ghent, Ctr Med Genet, Ghent, Belgium; [Corning, Ken] Greenwood Genet Ctr, Columbia, SC USA; [Cox, Helen] Birmingham Womens Hosp, West Midlands Reg Clin Genet Unit, Birmingham, W Midlands, England; [Currall, Benjamin B.; Schilit, Samantha L. P.; Gusella, James F.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Cushing, Tom] Univ New Mexico, Sch Med, Dept Pediat, Div Pediat Genet, Albuquerque, NM 87131 USA; [David, Dezso] Natl Hlth Inst Doutor Ricardo Jorge, Dept Human Genet, Lisbon, Portugal; [Deardorff, Matthew A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Deardorff, Matthew A.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [D'Hooghe, Marc] Algemeen Ziekenhuis St Jan, Dept Neurol & Child Neurol, Brugge, Belgium; [Earl, Dawn L.] Seattle Childrens, Seattle, WA USA; [Fisher, Heather] Mt Sinai West Hosp, New York, NY USA; [FitzPatrick, David R.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Giachino, Daniela; Mandrile, Giorgia; Pregno, Giulia] Univ Torino, Dept Clin & Biol Sci, Med Genet Unit, Turin, Italy; [Grady, Margo] UW Canc Ctr ProHlth Care, Waukesha, WI USA; [Gripp, Karen W.] Thomas Jefferson Univ, Sidney Kimmel Med Sch, Philadelphia, PA 19107 USA; [Gropman, Andrea L.] Childrens Natl Med Ctr, Div Neurogenet & Dev Pediat, Washington, DC 20010 USA; [Hanson-Kahn, Andrea] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Harris, David J.] Boston Childrens Hosp, Div Genet, Boston, MA USA; [Harris, David J.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Hill, Rosamund] Auckland City Hosp, Dept Neurol, Auckland, New Zealand; [Hoffman, Jodi D.] Boston Med Ctr, Dept Pediat, Div Genet, Boston, MA USA; [Hopkin, Robert J.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Hopkin, Robert J.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Hubshman, Monika W.] Schneider Childrens Med Ctr Israel, Pediat Genet Unit, Petah Tiqwa, Israel; [Hubshman, Monika W.] Raphael Recanati Genet Inst, Rabin Med Ctr, Petah Tiqwa, Israel; [Hubshman, Monika W.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Innes, A. Micheil; Sparkes, Rebecca] Univ Calgary, Cumming Sch Med, Dept Med Genet, Calgary, AB, Canada; [Irons, Mira] Acad Affairs, Amer Board Med Specialties, Chicago, IL USA; [Irving, Melita; Mohammed, Shehla] Guys & St Thomas NHS Fdn Trust, Dept Clin Genet, London, England; [Jacobsen, Jessie C.] Kings Coll London, Div Med & Mol Genet, London, England; [Jacobsen, Jessie C.] Univ Auckland, Ctr Brain Res, Auckland, New Zealand; [Jacobsen, Jessie C.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Jewett, Tamison; Mortenson, Megan E.] Wake Forest Sch Med, Dept Pediat, Winston Salem, NC USA; [Johnson, John P.] Shodair Childrens Hosp, Dept Mol Genet, Helena, MT USA; [Kahler, Stephen G.; Lim, Cynthia] Arkansas Childrens Hosp, Div Genet & Metab, Little Rock, AR USA; [Kroisel, Peter M.] Med Univ Graz, Inst Human Genet, Graz, Austria; [Lacassie, Yves] LSUHSC, Dept Pediat, New Orleans, LA USA; [Lacassie, Yves] Childrens Hosp, New Orleans, LA USA; [Lemyre, Emmanuelle] Univ Montreal, CHU St Justine, Dept Pediat, Montreal, PQ, Canada; [Leppig, Kathleen] Univ Washington, Dept Med, Div Med Genet, Seattle, WA USA; [Leppig, Kathleen] Grp Hlth Cooperat Puget Sound, Clin Genet, Seattle, WA USA; [Levin, Alex V.] Thomas Jefferson Univ, Wills Eye Hosp, Philadelphia, PA 19107 USA; [Li, Haibo; Li, Hong] Nanjing Med Univ, Affiliated Suzhou Hosp, Ctr Reprod & Genet, Suzhou, Peoples R China; [Liao, Eric C.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Liao, Eric C.; Mendoza, Cinthya J. Zepeda; Ordulu, Zehra; Pauker, Susan P.; Schilit, Samantha L. P.; Thakuria, Joseph V.; Morton, Cynthia C.] Harvard Med Sch, Boston, MA USA; [Liao, Eric C.] Massachusetts Gen Hosp, Div Plast & Reconstruct Surg, Boston, MA 02114 USA; [Liao, Eric C.] Harvard Stem Cell Inst, Cambridge, MA USA; [Lose, Edward J.] Virginia G Piper Canc Ctr HonorHlth, Scottsdale, AZ USA; [Lose, Edward J.] UAB, Dept Genet, Birmingham, AL USA; [Macera, Michael J.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, Clin Cytogenet Lab, New York, NY USA; [Margolin, Lauren; Mason, Tamara; Perrin, Danielle] Broad Inst Harvard & MIT, Genom Platform, Cambridge, MA USA; [Masser-Frye, Diane] Rady Childrens Hosp, Dept Genet, San Diego, CA USA; [McClellan, Michael W.] Madigan Army Med Ctr, Dept Obstet & Gynecol, Tacoma, WA 98431 USA; [Mikami, Liya R.; Raskin, Salmo] Pontificia Univ Catolica Parana, Sch Med, Grad Program Hlth Sci, Grp Adv Mol Invest, Curitiba, Parana, Brazil; [Mikami, Liya R.] Ctr Univ Autonomo Brasil Unibrasil, Curitiba, Parana, Brazil; [Mononen, Tarja] Kuopio Univ Hosp, Dept Clin Genet, Kuopio, Finland; [Mortenson, Megan E.] Novant Hlth Derrick L Davis Canc Ctr, Winston Salem, NC USA; [Moya, Graciela] GENOS Lab, Buenos Aires, DF, Argentina; [Nieuwint, Aggie W.; Poddighe, Pino J.; van de Kamp, Jiddeke] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Parkash, Sandhya] Dalhousie Univ, IWK Hlth Ctr, Maritime Med Genet Serv, Dept Pediat, Halifax, NS, Canada; [Pauker, Susan P.] Harvard Vanguard Med Associates, Med Genet, Watertown, MA USA; [Phelan, Katy] Tulane Univ, Sch Med, Dept Pediat, Hayward Genet Program, New Orleans, LA 70112 USA; [Pina Aguilar, Raul E.] Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen, Scotland; [Reis, Linda] Childrens Res Inst, Milwaukee, WI USA; [Rhead, William] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Rita, Debra] Aurora Clin Labs, Midwest Diagnost Pathol, Rosemont, IL USA; [Roelens, Filip] Algemeen Ziekenhuis Delta, Roeselare, Belgium; [Rump, Patrick; van Essen, Ton; van Ravenswaaij-Arts, Conny M.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Spiegel, Erica] Columbia Univ, Med Ctr, Div Maternal Fetal Med, New York, NY USA; [Stevens, Blair] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA; [Tagoe, Julia] Alberta Hlth Serv, Genet Serv, Lethbridge, AB, Canada; [Thakuria, Joseph V.] Massachusetts Gen Hosp, Div Med Genet, Boston, MA 02114 USA; [Waterman, Matthew J.] Eastern Nazarene Coll, Dept Biol, Quincy, MA USA; [Wiley, Susan] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Dev & Behav Pediat, Cincinnati, OH USA; [Yerena-de Vega, Maria de la Concepcion A.] ISSSTE, Ctr Med Nacl Noviembre 20, Lab Genet, Mexico City, DF, Mexico; [Zori, Roberto T.] Univ Florida, Div Pediat Genet & Metab, Gainesville, FL USA; [Levy, Brynn] Columbia Univ, Dept Pathol, New York, NY USA; [Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Brunner, Han G.] Maastricht Univ, Med Ctr, Grow Sch Oncol & Dev Biol, Maastricht, Netherlands; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Morton, Cynthia C.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biol Sci, Div Evolut & Genom Sci, Manchester, Lancs, England; [Brown, Chester W.] Univ Tennessee, Ctr Hlth Sci, Le Bonheur Childrens Hosp, Dept Pediat,Genet Div, Memphis, TN 38163 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Mayo Clinic; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Universidade do Porto; Baystate Medical Center; University of Mississippi; University of Mississippi Medical Center; Dalhousie University; King Faisal Specialist Hospital & Research Center; Fudan University; Fudan University; Columbia University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Kaiser Permanente; Stanford University; Medical College of Wisconsin; Children's Hospital of Wisconsin; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Baylor College of Medicine; Baylor College of Medicine; Erasmus University Rotterdam; Erasmus MC; Ghent University; Greenwood Genetic Center; Birmingham Women's Hospital; Harvard University; Harvard Medical School; University of New Mexico; Instituto Nacional de Saude Dr. Ricardo Jorge; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Seattle Children's Hospital; Mount Sinai West; University of Edinburgh; University of Turin; Jefferson University; Children's National Health System; Stanford University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Auckland City Hospital; Boston Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Calgary; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Auckland; University of Auckland; Wake Forest University; Arkansas Children's Hospital; Medical University of Graz; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Washington; University of Washington Seattle; Group Health Cooperative; Jefferson University; Nanjing Medical University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; University of Alabama System; University of Alabama Birmingham; Columbia University; NewYork-Presbyterian Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rady Childrens Hospital San Diego; Madigan Army Medical Center; Pontificia Universidade Catolica do Parana; Kuopio University Hospital; University of Eastern Finland; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Dalhousie University; Harvard Vanguard Medical Associates; Tulane University; University of Aberdeen; Medical College of Wisconsin; University of Groningen; Columbia University; University of Texas System; University of Texas Health Science Center Houston; Alberta Health Services (AHS); Harvard University; Massachusetts General Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; State University System of Florida; University of Florida; Columbia University; Maastricht University; Maastricht University; Harvard University; Brigham & Women's Hospital; University of Manchester; University of Tennessee System; University of Tennessee Health Science Center	Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Ctr Human Genet Res, Psychiatr & Neurodev Genet Unit, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Talkowski, ME (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA.	talkowski@chgr.mgh.harvard.edu	Koolen, D.A./L-4448-2015; Menten, Björn/B-3072-2013; Hodge, Jennelle/AAW-5082-2020; Marcelis, C.L.M./L-4504-2015; Ordulu, Zehra/ABI-6638-2020; Cuppen, Edwin/F-5696-2011; Mandrile, Gio/AFZ-2487-2022; Piña-Aguilar, Raul Eduardo/C-6639-2008; Giachino, Daniela Francesca/L-9098-2019; Graham, Brett/R-8685-2018; Brilstra, Eva/AAT-3092-2021; van Bon, Bregje/Q-2445-2015; Raskin, Salmo/C-4155-2013; Cuppen, Edwin/H-2389-2016; Seabra, Catarina/ABA-5591-2020; Callewaert, Bert/J-6357-2014	Marcelis, C.L.M./0000-0001-7095-4641; Ordulu, Zehra/0000-0002-3218-1075; Cuppen, Edwin/0000-0002-0400-9542; Mandrile, Gio/0000-0003-0849-2225; Piña-Aguilar, Raul Eduardo/0000-0002-2043-4282; Giachino, Daniela Francesca/0000-0002-3186-6726; Graham, Brett/0000-0001-8451-8154; van Bon, Bregje/0000-0003-2234-0105; Cuppen, Edwin/0000-0002-0400-9542; David, Dezso/0000-0003-2293-590X; Callewaert, Bert/0000-0002-9743-4205; Vergult, Sarah/0000-0002-0816-6262; Seabra, Catarina/0000-0003-2862-1979; Schilit, Samantha/0000-0002-8991-6327; Liao, Eric/0000-0001-6385-7448; Glessner, Joseph/0000-0001-5131-2811; SHAHEEN, RANAD/0000-0002-2590-1759; Korzelius, Jerome/0000-0002-8443-0192; Talkowski, Michael/0000-0003-2889-0992; FitzPatrick, David R./0000-0003-4861-969X; Irving, Melita/0000-0002-2997-4461; Collins, Ryan/0000-0003-1268-9995; Innes, Micheil/0000-0001-9881-5467; Anyane-Yeboa, Kwame/0000-0002-4977-9719	National Institutes of Health [GM061354, MH095867, HD081256]; March of Dimes [6-FY15-255]; European Commission [EMBO ALTF-183-2015]; Bettencourt-Schueller Foundation; Philippe Foundation; Harvard Medical School-Portugal Program in Translational and Clinical Research and Health Information (Fundacao para a Ciencia e a Tecnologia) [HMSP-ICT/0016/2013]; National Science Foundation [DGE1144152]; Fund for Scientific Research-Flanders; Clinical Medicine Science and Technology Projects of Jiangsu Province [BL2013019]; Suzhou Key Medical Center [Szzx201505]; Royal Society of New Zealand (Rutherford Discovery Fellowship); Desmond and Ann Heathwood MGH Research Scholars award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD085857, R01HD081256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH095867, F32MH110124, R00MH095867] Funding Source: NIH RePORTER; MRC [MC_PC_U127561093] Funding Source: UKRI; Medical Research Council [MC_PC_U127561093] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); European Commission(European CommissionEuropean Commission Joint Research Centre); Bettencourt-Schueller Foundation; Philippe Foundation; Harvard Medical School-Portugal Program in Translational and Clinical Research and Health Information (Fundacao para a Ciencia e a Tecnologia); National Science Foundation(National Science Foundation (NSF)); Fund for Scientific Research-Flanders(FWO); Clinical Medicine Science and Technology Projects of Jiangsu Province; Suzhou Key Medical Center; Royal Society of New Zealand (Rutherford Discovery Fellowship)(Royal Society of New Zealand); Desmond and Ann Heathwood MGH Research Scholars award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank all subjects and families who have been enrolled in this study, as well as the countless genetic counselors and clinical geneticists who contributed to the ascertainment of subjects. This study was supported by the National Institutes of Health (grant GM061354 to M.E.T., J.F.G., C.C.M., and E.L.; grants MH095867 and HD081256 to M.E.T.), the March of Dimes (6-FY15-255 to M.E.T.), the European Molecular Biology Organization and the Marie Curie Actions of the European Commission (fellowship EMBO ALTF-183-2015 to C.R.), the Bettencourt-Schueller Foundation (young investigator award to C.R.), the Philippe Foundation (award to C.R.), the Harvard Medical School-Portugal Program in Translational and Clinical Research and Health Information (Fundacao para a Ciencia e a Tecnologia, HMSP-ICT/0016/2013 to C.C.M. and D.D.), the National Science Foundation (NSF Graduate Research Fellowship DGE1144152 to S.L.P.S.), the Fund for Scientific Research-Flanders (B.C. and S.V. are an FWO senior clinical investigator and an FWO postdoctoral researcher, respectively), Clinical Medicine Science and Technology Projects of Jiangsu Province (grant BL2013019 to Haibo Li and Hong Li), the Suzhou Key Medical Center (grant Szzx201505 to Haibo Li and Hong Li), and the Royal Society of New Zealand (Rutherford Discovery Fellowship to J.C.J.). This study was also supported by the Desmond and Ann Heathwood MGH Research Scholars award to M.E.T.	Abyzov A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8256; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Brand H, 2014, AM J HUM GENET, V95, P454, DOI 10.1016/j.ajhg.2014.09.005; Brunetti-Pierri N, 2011, EUR J HUM GENET, V19, P102, DOI 10.1038/ejhg.2010.142; Cardoso C, 2009, NEUROLOGY, V72, P784, DOI 10.1212/01.wnl.0000336339.08878.2d; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Gregori M, 2007, J MED GENET, V44, P750, DOI 10.1136/jmg.2007.052787; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deng Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115692; DeSanto C, 2015, J MED GENET, V52, P754, DOI 10.1136/jmedgenet-2015-103069; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Ellaway CJ, 2013, EUR J HUM GENET, V21, P522, DOI 10.1038/ejhg.2012.208; Engels H, 2009, EUR J HUM GENET, V17, P1592, DOI 10.1038/ejhg.2009.90; Floris C, 2008, EUR J HUM GENET, V16, P696, DOI 10.1038/ejhg.2008.7; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; FUNDERBURK SJ, 1977, AM J HUM GENET, V29, P136; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; JACOBS PA, 1974, ANN HUM GENET, V37, P359, DOI 10.1111/j.1469-1809.1974.tb01843.x; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; lbn-Salem J., 2014, GENOME BIOL, V15, P423; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Lettice LA, 2011, HUM MUTAT, V32, P1492, DOI 10.1002/humu.21615; Lu WN, 2007, PLOS GENET, V3, P830, DOI 10.1371/journal.pgen.0030080; Lupianez DG, 2016, TRENDS GENET, V32, P225, DOI 10.1016/j.tig.2016.01.003; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mcdermott SM, 2014, RNA, V20, P1593, DOI 10.1261/rna.045849.114; MCKUSICK VA, 1993, J MED GENET, V30, P1, DOI 10.1136/jmg.30.1.1; Mencarelli MA, 2009, EUR J MED GENET, V52, P148, DOI 10.1016/j.ejmg.2009.03.004; Meyerson M, 2011, CELL, V144, P9, DOI 10.1016/j.cell.2010.12.025; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Perche O, 2013, AM J MED GENET A, V161, P3072, DOI 10.1002/ajmg.a.36170; Petrovski S, 2016, AM J HUM GENET, V98, P1001, DOI 10.1016/j.ajhg.2016.03.011; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rasmussen MB, 2014, J MED GENET, V51, P605, DOI 10.1136/jmedgenet-2014-102535; Ravel C, 2006, HUM REPROD, V21, P1484, DOI 10.1093/humrep/del024; Rosenfeld JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006568; Saitsu H, 2011, AM J MED GENET A, V155A, P2879, DOI 10.1002/ajmg.a.34289; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schluth-Bolard C, 2013, J MED GENET, V50, P144, DOI 10.1136/jmedgenet-2012-101351; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Tabet AC, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0015-2; Takagi M, 2013, EUR J MED GENET, V56, P526, DOI 10.1016/j.ejmg.2013.05.012; Talkowski ME, 2012, NEW ENGL J MED, V367, P2226, DOI 10.1056/NEJMoa1208594; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; Utami KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090852; Vergult S, 2014, EUR J HUM GENET, V22, P652, DOI 10.1038/ejhg.2013.220; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WARBURTON D, 1980, PEDIATR CLIN N AM, V27, P753; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Xia F, 2014, AM J HUM GENET, V94, P784, DOI 10.1016/j.ajhg.2014.04.006; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; Zweier M, 2011, MOL SYNDROMOL, V2, P164, DOI 10.1159/000337496; Zweier M, 2010, HUM MUTAT, V31, P722, DOI 10.1002/humu.21253	79	153	158	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					36	45		10.1038/ng.3720	http://dx.doi.org/10.1038/ng.3720			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27841880	Green Submitted, Green Accepted			2022-12-25	WOS:000390976600009
J	Raymond, DD; Stewart, SM; Lee, J; Ferdman, J; Bajic, G; Do, KT; Ernandes, MJ; Suphaphiphat, P; Settembre, EC; Dormitzer, PR; Del Giudice, G; Finco, O; Kang, TH; Ippolito, GC; Georgiou, G; Kepler, TB; Haynes, BF; Moody, MA; Liao, HX; Schmidt, AG; Harrison, SC				Raymond, Donald D.; Stewart, Shaun M.; Lee, Jiwon; Ferdman, Jack; Bajic, Goran; Do, Khoi T.; Ernandes, Michael J.; Suphaphiphat, Pirada; Settembre, Ethan C.; Dormitzer, Philip R.; Del Giudice, Giuseppe; Finco, Oretta; Kang, Tae Hyun; Ippolito, Gregory C.; Georgiou, George; Kepler, Thomas B.; Haynes, Barton F.; Moody, M. Anthony; Liao, Hua-Xin; Schmidt, Aaron G.; Harrison, Stephen C.			Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain	NATURE MEDICINE			English	Article							RECEPTOR-BINDING SITE; AFFINITY MATURATION; VIRUS HEMAGGLUTININ; SIALIC-ACID; H1N1; HIV-1; NEUTRALIZATION; SELECTION; ORIGIN	For broad protection against infection by viruses such as influenza or HIV, vaccines should elicit antibodies that bind conserved viral epitopes, such as the receptor-binding site (RBS). RBS-directed antibodies have been described for both HIV1-3 and influenza virus(4-8), and the design of immunogens to elicit them is a goal of vaccine research in both fields. Residues in the RBS of influenza virus hemagglutinin (HA) determine a preference for the avian or human receptor, alpha-2,3-linked sialic acid and alpha-2,6-linked sialic acid, respectively(9,10). Transmission of an avian-origin virus between humans generally requires one or more mutations in the sequences encoding the influenza virus RBS to change the preferred receptor from avian to human(9,11,12), but passage of a human-derived vaccine candidate in chicken eggs can select for reversion to avian receptor preference(13-15). For example, the X-181 strain of the 2009 new pandemic H1N1 influenza virus, derived from the A/California/07/2009 isolate and used in essentially all vaccines since 2009, has arginine at position 226, a residue known to confer preference for an alpha-2,3 linkage in H1 subtype viruses(13,14); the wild-type A/California/07/2009 isolate, like most circulating human H1N1 viruses, has glutamine at position 226. We describe, from three different individuals, RBS-directed antibodies that recognize the avian-adapted H1 strain in current influenza vaccines but not the circulating new pandemic 2009 virus; Arg226 in the vaccine-strain RBS accounts for the restriction. The polyclonal sera of the three donors also reflect this preference. Therefore, when vaccines produced from strains that are never passaged in avian cells become widely available, they may prove more capable of eliciting RBS-directed, broadly neutralizing antibodies than those produced from egg-adapted viruses, extending the established benefits of current seasonal influenza immunizations.	[Raymond, Donald D.; Bajic, Goran; Do, Khoi T.; Ernandes, Michael J.; Schmidt, Aaron G.; Harrison, Stephen C.] Harvard Med Sch, Boston Childrens Hosp, Lab Mol Med, Cambridge, MA 02138 USA; [Stewart, Shaun M.; Ferdman, Jack; Suphaphiphat, Pirada; Settembre, Ethan C.; Dormitzer, Philip R.] Seqirus, 45 Sidney St, Cambridge, MA USA; [Lee, Jiwon; Kang, Tae Hyun; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Ernandes, Michael J.] Harvard Med Sch, Grad Program Virol, Boston, MA USA; [Del Giudice, Giuseppe; Finco, Oretta] Novartis Vaccines & Diagnost, Siena, Italy; [Ippolito, Gregory C.; Georgiou, George] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Haynes, Barton F.; Moody, M. Anthony; Liao, Hua-Xin] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA; [Haynes, Barton F.; Liao, Hua-Xin] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Moody, M. Anthony] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA; [Harrison, Stephen C.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Stewart, Shaun M.] Incyte, Wilmington, DE USA; [Dormitzer, Philip R.] Pfizer Vaccines Res & Dev, Pearl River, NY USA; [Del Giudice, Giuseppe; Finco, Oretta] GSK Vaccines, Siena, Italy	Harvard University; Boston Children's Hospital; CSL; University of Texas System; University of Texas Austin; Harvard University; Harvard Medical School; Novartis; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Boston University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; Incyte; Pfizer; GlaxoSmithKline	Harrison, SC (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Lab Mol Med, Cambridge, MA 02138 USA.; Harrison, SC (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Ippolito, Gregory C./AAR-2930-2021; Moody, M/AAB-6947-2020	Ippolito, Gregory C./0000-0002-7565-7002; Moody, M/0000-0002-3890-5855; Lee, Jiwon/0000-0001-7835-3621; Ernandes, Michael/0000-0001-8218-0145; Bajic, Goran/0000-0003-0480-4324	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI089618, U19AI057234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [U19 AI057234, P01 AI089618] Funding Source: Medline; NIGMS NIH HHS [P41 GM103403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Faenzi E, 2012, VACCINE, V30, P4086, DOI 10.1016/j.vaccine.2012.04.020; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kepler TB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00170; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; KOZLOV JV, 1981, J GEN VIROL, V56, P437, DOI 10.1099/0022-1317-56-2-437; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Lee J, 2016, NAT MED; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Schmidt AG, 2015, CELL REP, V13, P2842, DOI 10.1016/j.celrep.2015.11.063; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; SCHOLTISSEK C, 1978, VIROLOGY, V89, P613, DOI 10.1016/0042-6822(78)90203-9; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Tan YC, 2014, CLIN IMMUNOL, V151, P55, DOI 10.1016/j.clim.2013.12.008; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu Q, 2010, J VIROL, V84, P4936, DOI 10.1128/JVI.02489-09; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	37	73	74	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1465	+		10.1038/nm.4223	http://dx.doi.org/10.1038/nm.4223			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27820604	Green Accepted			2022-12-25	WOS:000389549000024
J	Iotchkova, V; Huang, J; Morris, JA; Jain, D; Barbieri, C; Walter, K; Min, JL; Chen, L; Astle, W; Cocca, M; Deelen, P; Elding, H; Farmaki, AE; Franklin, CS; Franberg, M; Gaunt, TR; Hofman, A; Jiang, T; Kleber, ME; Lachance, G; Luan, J; Malerba, G; Matchan, A; Mead, D; Memari, Y; Ntalla, I; Panoutsopoulou, K; Pazoki, R; Perry, JRB; Rivadeneira, F; Sabater-Lleal, M; Sennblad, B; Shin, SY; Southam, L; Traglia, M; van Dijk, F; van Leeuwen, EM; Zaza, G; Zhang, WH; Amin, N; Butterworth, A; Chambers, JC; Dedoussis, G; Dehghan, A; Franco, OH; Franke, L; Frontini, M; Gambaro, G; Gasparini, P; Hamsten, A; Issacs, A; Kooner, JS; Kooperberg, C; Langenberg, C; Marz, W; Scott, RA; Swertz, MA; Toniolo, D; Uitterlinden, AG; van Duijn, CM; Watkins, H; Zeggini, E; Maurano, MT; Timpson, NJ; Reiner, AP; Auer, PL; Soranzo, N				Iotchkova, Valentina; Huang, Jie; Morris, John A.; Jain, Deepti; Barbieri, Caterina; Walter, Klaudia; Min, Josine L.; Chen, Lu; Astle, William; Cocca, Massimilian; Deelen, Patrick; Elding, Heather; Farmaki, Aliki-Eleni; Franklin, Christopher S.; Franberg, Mattias; Gaunt, Tom R.; Hofman, Albert; Jiang, Tao; Kleber, Marcus E.; Lachance, Genevieve; Luan, Jianan; Malerba, Giovanni; Matchan, Angela; Mead, Daniel; Memari, Yasin; Ntalla, Ioanna; Panoutsopoulou, Kalliope; Pazoki, Raha; Perry, John R. B.; Rivadeneira, Fernando; Sabater-Lleal, Maria; Sennblad, Bengt; Shin, So-Youn; Southam, Lorraine; Traglia, Michela; van Dijk, Freerk; van Leeuwen, Elisabeth M.; Zaza, Gianluigi; Zhang, Weihua; Amin, Najaf; Butterworth, Adam; Chambers, John C.; Dedoussis, George; Dehghan, Abbas; Franco, Oscar H.; Franke, Lude; Frontini, Mattia; Gambaro, Giovanni; Gasparini, Paolo; Hamsten, Anders; Issacs, Aaron; Kooner, Jaspal S.; Kooperberg, Charles; Langenberg, Claudia; Marz, Winfried; Scott, Robert A.; Swertz, Morris A.; Toniolo, Daniela; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Watkins, Hugh; Zeggini, Eleftheria; Maurano, Mathew T.; Timpson, Nicholas J.; Reiner, Alexander P.; Auer, Paul L.; Soranzo, Nicole		UK10K Consortium	Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CAUSES HEREDITARY THROMBOCYTHEMIA; SPLICE DONOR MUTATION; LOW-FREQUENCY; THROMBOPOIETIN GENE; SEQUENCE VARIANTS; RARE VARIANTS; BLOOD-CELL; ANTIPHOSPHOLIPID SYNDROME; SUPER-ENHANCERS	Large-scale whole-genome sequence data sets offer novel opportunities to identify genetic variation underlying human traits. Here we apply genotype imputation based on whole-genome sequence data from the UK1OK and 1000 Genomes Project into 35,981 study participants of European ancestry, followed by association analysis with 20 quantitative cardiometabolic and hematological traits. We describe 17 new associations, including 6 rare (minor allele frequency (MAF) < 1 %) or low-frequency (1% < MAF < 5%) variants with platelet count (PLT), red blood cell indices (MCH and MCV) and HDL cholesterol. Applying fine-mapping analysis to 233 known and new loci associated with the 20 traits, we resolve the associations of 59 loci to credible sets of 20 or fewer variants and describe trait enrichments within regions of predicted regulatory function. These findings improve understanding of the allelic architecture of risk factors for cardiometabolic and hematological diseases and provide additional functional insights with the identification of potentially novel biological targets.	[Iotchkova, Valentina] European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton, England; [Iotchkova, Valentina; Huang, Jie; Barbieri, Caterina; Walter, Klaudia; Chen, Lu; Elding, Heather; Franklin, Christopher S.; Matchan, Angela; Mead, Daniel; Memari, Yasin; Panoutsopoulou, Kalliope; Shin, So-Youn; Southam, Lorraine; Zeggini, Eleftheria; Soranzo, Nicole] Wellcome Trust Sanger Inst, Human Genet, Hinxton, England; [Huang, Jie] Boston VA Res Inst, Boston, MA USA; [Morris, John A.] McGill Univ, Lady Davis Inst Med Res, Ctr Clin Epidemiol, Jewish Gen Hosp, Montreal, PQ, Canada; [Morris, John A.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Jain, Deepti] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Barbieri, Caterina; Traglia, Michela; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, Milan, Italy; [Min, Josine L.; Gaunt, Tom R.; Shin, So-Youn; Timpson, Nicholas J.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Chen, Lu; Frontini, Mattia; Soranzo, Nicole] Univ Cambridge, Dept Hematol, Cambridge, England; [Astle, William; Jiang, Tao; Butterworth, Adam] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Cocca, Massimilian; Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Med Genet, Trieste, Italy; [Cocca, Massimilian; Gasparini, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Deelen, Patrick; van Dijk, Freerk; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Deelen, Patrick; van Dijk, Freerk; Franke, Lude; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Farmaki, Aliki-Eleni; Ntalla, Ioanna; Dedoussis, George] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens, Greece; [Franberg, Mattias; Sabater-Lleal, Maria; Sennblad, Bengt; Hamsten, Anders] Karolinska Inst, Dept Med, Cardiovasc Med Unit, Stockholm, Sweden; [Hofman, Albert; Pazoki, Raha; Rivadeneira, Fernando; van Leeuwen, Elisabeth M.; Amin, Najaf; Dehghan, Abbas; Franco, Oscar H.; Issacs, Aaron; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Kleber, Marcus E.; Marz, Winfried] Heidelberg Univ, Mannheim Med Fac, Med Clin Nephrol Hypertensiol Rheumatol Endocrino, Mannheim, Germany; [Lachance, Genevieve; Perry, John R. B.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Luan, Jianan; Perry, John R. B.; Langenberg, Claudia; Scott, Robert A.] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Inst Metab Sci, Biomedical Campus, Cambridge, England; [Malerba, Giovanni] Univ Verona, Sect Biol & Genet, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Ntalla, Ioanna] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Southam, Lorraine; Watkins, Hugh] Wellcome Trust Ctr Human Genet, Oxford, England; [Zaza, Gianluigi] Univ Verona, Dept Med, Renal Unit, Verona, Italy; [Zhang, Weihua] Imperial Coll London, Dept Epidemiol & Biostat, St Marys Campus, London, England; [Butterworth, Adam; Soranzo, Nicole] Univ Cambridge, Natl Inst Hlth Res Blood & Transplant Unit NIHR B, Cambridge, England; [Gambaro, Giovanni] Catholic Univ, Columbus Gemelli Univ Hosp, Inst Internal Med, Div Nephrol & Dialysis,Renal Program, Rome, Italy; [Gasparini, Paolo] Expt Genet Div, Doha, Qatar; [Kooner, Jaspal S.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Kooperberg, Charles; Reiner, Alexander P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Marz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Marz, Winfried] Synlab Holding Deutschland, Synlab Acad, Mannheim, Germany; [Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study, Groningen, Netherlands; [Watkins, Hugh] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford, England; [Maurano, Mathew T.] NYU, Langone Med Ctr, Inst Syst Genet, New York, NY USA; [Reiner, Alexander P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Auer, Paul L.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Lady Davis Institute; McGill University; McGill University; University of Washington; University of Washington Seattle; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Bristol; University of Cambridge; University of Cambridge; IRCCS Burlo Garofolo; University of Trieste; University of Groningen; University of Groningen; Harokopio University Athens; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Ruprecht Karls University Heidelberg; University of London; King's College London; University of Cambridge; University of Verona; University of London; Queen Mary University London; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Wellcome Centre for Human Genetics; University of Verona; Imperial College London; University of Cambridge; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Imperial College London; Fred Hutchinson Cancer Center; Medical University of Graz; SYNLAB Group; University of Groningen; University of Oxford; New York University; NYU Langone Medical Center; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Milwaukee	Soranzo, N (corresponding author), Wellcome Trust Sanger Inst, Human Genet, Hinxton, England.; Soranzo, N (corresponding author), Univ Cambridge, Dept Hematol, Cambridge, England.; Soranzo, N (corresponding author), Univ Cambridge, Natl Inst Hlth Res Blood & Transplant Unit NIHR B, Cambridge, England.; Reiner, AP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Reiner, AP (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Auer, PL (corresponding author), Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA.	apreiner@uw.edu; pauer@uwm.edu; ns6@sanger.ac.uk	Timpson, Nicholas John/O-7548-2015; Deelen, Patrick/B-3566-2013; Traglia, Michela/AAX-5816-2020; Cocca, Massimiliano/J-2951-2018; Auer, Paul/AAC-5060-2019; Dedoussis, George/AAN-7252-2021; Fox, Laura J/C-6249-2016; van Leeuwen, Elisabeth/G-3382-2017; Gasparini, Paolo/B-6173-2014; Mead, Daniel/AAE-6629-2019; Rivadeneira, Fernando/O-5385-2015; Malerba, Giovanni/T-3278-2019; Franco, Óscar H/ABE-2305-2020; Dehghan, Abbas/ABE-7377-2020; zhang, weihua/GXV-1334-2022; Zaza, Gianluigi/K-3827-2018; Gaunt, Tom R/O-3918-2014; Attrill, Lauren/V-1688-2018; Lleal, Maria Sabater/I-5832-2013; Toniolo, Daniela/AAE-2969-2019; Langenberg, Claudia/ABG-9067-2021; Franke, Lude/P-7036-2016; Dehghan, Abbas/B-9896-2008	Timpson, Nicholas John/0000-0002-7141-9189; Deelen, Patrick/0000-0002-5654-3966; Cocca, Massimiliano/0000-0002-1127-7596; Dedoussis, George/0000-0002-7798-6221; Mead, Daniel/0000-0001-7717-4330; Rivadeneira, Fernando/0000-0001-9435-9441; Franco, Óscar H/0000-0002-4606-4929; Gaunt, Tom R/0000-0003-0924-3247; Lleal, Maria Sabater/0000-0002-0128-379X; Toniolo, Daniela/0000-0001-9545-6032; Langenberg, Claudia/0000-0002-5017-7344; Van Duijn, Cornelia/0000-0002-2374-9204; Astle, William John/0000-0001-8866-6672; Chen, Lu/0000-0002-1083-9729; Panoutsopoulou, Kalliope/0000-0002-5460-8025; Franke, Lude/0000-0002-5159-8802; Zaza, Gianluigi/0000-0002-6004-6196; Pazoki, Raha/0000-0002-5142-2348; Morris, John/0000-0003-2769-8202; Soranzo, Nicole/0000-0003-1095-3852; Huang, Jie/0000-0002-9036-4304; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Watkins, Hugh/0000-0002-5287-9016; Memari, Yasin/0000-0002-1747-542X; Amin, Najaf/0000-0002-8944-1771; Kelly, Kirsten/0000-0003-4234-543X; Gasparini, Paolo/0000-0002-0859-0856; Dehghan, Abbas/0000-0001-6403-016X; s, hema/0000-0002-3440-9475; Walter, Klaudia/0000-0003-4448-0301; Iotchkova, Valentina/0000-0001-5057-0210; Butterworth, Adam/0000-0002-6915-9015; Gambaro, Giovanni/0000-0001-5733-2370	Wellcome Trust [WT091310, WT098051]; European Union [257082, HEALTH-F5-2011-282510]; National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Donor Health and Genomics at the University of Cambridge; NHS Blood and Transplant (NHSBT); NHLBI [R21 HL121422-02]; MRC [MR/L003120/1, MC_UU_12013/3, MC_UU_12015/2, G0601966, MC_UU_12015/1, MC_U106179472, G0700931, G0800270] Funding Source: UKRI; British Heart Foundation [RG/13/13/30194, RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MC_U106179471, MR/L003120/1, MC_UU_12015/2, MC_UU_12015/1, MC_UU_12013/3, MC_U106179472, MC_PC_15018, G0800270] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL121422] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Donor Health and Genomics at the University of Cambridge; NHS Blood and Transplant (NHSBT); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study makes use of data generated by the UK10K Consortium, derived from samples from the ALSPAC and TwinsUK data sets. A full list of the investigators who contributed to the generation of the data is available from http://www.UK1OK.org/. Funding for UK10K was provided by the Wellcome Trust under award WT091310. The research of N.S. is supported by the Wellcome Trust (grants WT098051 and WT091310), the European Union Framework Programme 7 (EPIGENESYS grant 257082 and BLUEPRINT grant HEALTH-F5-2011-282510) and the National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Donor Health and Genomics at the University of Cambridge in partnership with NHS Blood and Transplant (NHSBT). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or NHSBT. P.L.A. was supported by NHLBI R21 HL121422-02. A full list of grant support and acknowledgements can be found in the Supplementary Note and ref. 14.	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Baerenwald DA, 2013, DIABETOLOGIA, V56, P1306, DOI 10.1007/s00125-013-2875-3; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Danjou F, 2015, NAT GENET, V47, P1264, DOI 10.1038/ng.3307; Dasouki MJ, 2013, BLOOD, V122, P3440, DOI 10.1182/blood-2012-12-473538; de Groot PG, 2012, INT J LAB HEMATOL, V34, P223, DOI 10.1111/j.1751-553X.2012.01414.x; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Douvris A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000884; Duan Q, 2013, BIOINFORMATICS, V29, P528, DOI 10.1093/bioinformatics/bts724; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Ghilardi N, 1999, BRIT J HAEMATOL, V107, P310, DOI 10.1046/j.1365-2141.1999.01710.x; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Grand FH, 2004, CANCER RES, V64, P7216, DOI 10.1158/0008-5472.CAN-04-2005; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Iwamoto S, 2015, BIOCHEM SOC T, V43, P1063, DOI 10.1042/BST20150094; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Keller MF, 2014, HUM MOL GENET, V23, P6944, DOI 10.1093/hmg/ddu401; Khan A, 2016, NUCLEIC ACIDS RES, V44, pD164, DOI 10.1093/nar/gkv1002; Kiryluk K, 2014, NAT GENET, V46, P1187, DOI 10.1038/ng.3118; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kondo T, 1998, BLOOD, V92, P1091, DOI 10.1182/blood.V92.4.1091.416a36_1091_1096; Kong YX, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/565369; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Korporaal SJA, 2004, J BIOL CHEM, V279, P52526, DOI 10.1074/jbc.M407407200; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Laurent B, 2012, J CELL SCI, V125, P993, DOI 10.1242/jcs.095877; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Liu K, 2008, HAEMATOLOGICA, V93, P706, DOI 10.3324/haematol.11801; Lutters BCH, 2003, J BIOL CHEM, V278, P33831, DOI 10.1074/jbc.M212655200; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Menicanin D, 2010, STEM CELLS DEV, V19, P1501, DOI 10.1089/scd.2009.0492; Menon MC, 2015, J CLIN INVEST, V125, P208, DOI 10.1172/JCI76902; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Moayyeri A, 2012, J BONE MINER RES, V27, P2170, DOI 10.1002/jbmr.1659; Moroy T, 2015, BLOOD, V126, P2561, DOI 10.1182/blood-2015-06-655043; Monteferrario D, 2014, NEW ENGL J MED, V370, P245, DOI 10.1056/NEJMoa1308130; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Ono Y, 2012, BLOOD, V120, P3812, DOI 10.1182/blood-2012-02-413617; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Polfus LM, 2016, AM J HUM GENET, V99, P481, DOI 10.1016/j.ajhg.2016.06.016; Sanghera DK, 1997, HUM MOL GENET, V6, P311, DOI 10.1093/hmg/6.2.311; Sankaran VG, 2012, GENE DEV, V26, P2075, DOI 10.1101/gad.197020.112; Service S. K., 2014, PLOS GENET, V10; Shavit JA, 1998, GENE DEV, V12, P2164, DOI 10.1101/gad.12.14.2164; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Stevenson WS, 2013, J THROMB HAEMOST, V11, P2039, DOI 10.1111/jth.12368; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Taylor PN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6681; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Timpson NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5871; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Vijai J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6751; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10534; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Williams CM, 2014, PLATELETS, V25, P62, DOI 10.3109/09537104.2012.761686; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003	74	49	49	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1303	1312		10.1038/ng.3668	http://dx.doi.org/10.1038/ng.3668			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27668658	Green Submitted, Green Accepted			2022-12-25	WOS:000386543400005
J	Rosenblatt, DS; Watkins, D; Rajabi, F; Levy, HL				Rosenblatt, David S.; Watkins, David; Rajabi, Farrah; Levy, Harvey L.			Confounding factors in identification of disease-resilient individuals	NATURE BIOTECHNOLOGY			English	Letter									[Rosenblatt, David S.; Watkins, David] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Rosenblatt, David S.; Watkins, David] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Rajabi, Farrah; Levy, Harvey L.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Levy, Harvey L.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA	McGill University; McGill University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Watkins, D (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Watkins, D (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	david.watkins@mcgill.ca			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103484] Funding Source: NIH RePORTER; NIDDK NIH HHS [U24 DK097154] Funding Source: Medline; NIGMS NIH HHS [P41 GM103484] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514; Rajabi F., 2016, SOC INH MET DIS 39 A; ROSENBLATT DS, 1985, LANCET, V1, P1127	3	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1103	1104		10.1038/nbt.3684	http://dx.doi.org/10.1038/nbt.3684			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27824855				2022-12-25	WOS:000387506500017
J	Stefely, JA; Kwiecien, NW; Freiberger, EC; Richards, AL; Jochem, A; Rush, MJP; Ulbrich, A; Robinson, KP; Hutchins, PD; Veling, MT; Guo, X; Kemmerer, ZA; Connors, KJ; Trujillo, EA; Sokol, J; Marx, H; Westphall, MS; Hebert, AS; Pagliarini, DJ; Coon, JJ				Stefely, Jonathan A.; Kwiecien, Nicholas W.; Freiberger, Elyse C.; Richards, Alicia L.; Jochem, Adam; Rush, Matthew J. P.; Ulbrich, Arne; Robinson, Kyle P.; Hutchins, Paul D.; Veling, Mike T.; Guo, Xiao; Kemmerer, Zachary A.; Connors, Kyle J.; Trujillo, Edna A.; Sokol, Jacob; Marx, Harald; Westphall, Michael S.; Hebert, Alexander S.; Pagliarini, David J.; Coon, Joshua J.			Mitochondrial protein functions elucidated by multi-omic mass spectrometry profiling	NATURE BIOTECHNOLOGY			English	Article							ALDEHYDE DEHYDROGENASE GENE; SJOGREN-LARSSON SYNDROME; COENZYME-Q BIOSYNTHESIS; PARA-AMINOBENZOIC ACID; SACCHAROMYCES-CEREVISIAE; HIGH-THROUGHPUT; DISEASE; SCALE; YEAST; PERTURBATIONS	Mitochondrial dysfunction is associated with many human diseases, including cancer and neurodegeneration, that are often linked to proteins and pathways that are not well-characterized. To begin defining the functions of such poorly characterized proteins, we used mass spectrometry to map the proteomes, lipidomes, and metabolomes of 174 yeast strains, each lacking a single gene related to mitochondrial biology. 144 of these genes have human homologs, 60 of which are associated with disease and 39 of which are uncharacterized. We present a multi-omic data analysis and visualization tool that we use to find covariance networks that can predict molecular functions, correlations between profiles of related gene deletions, gene-specific perturbations that reflect protein functions, and a global respiration deficiency response. Using this multi-omic approach, we link seven proteins including Hfd1p and its human homolog ALDH3A1 to mitochondrial coenzyme Q (CoQ) biosynthesis, an essential pathway disrupted in many human diseases. This Resource should provide molecular insights into mitochondrial protein functions.	[Stefely, Jonathan A.; Jochem, Adam; Robinson, Kyle P.; Veling, Mike T.; Guo, Xiao; Kemmerer, Zachary A.; Sokol, Jacob; Pagliarini, David J.] Morgridge Inst Res, Madison, WI 53715 USA; [Stefely, Jonathan A.; Robinson, Kyle P.; Veling, Mike T.; Kemmerer, Zachary A.; Sokol, Jacob; Pagliarini, David J.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Kwiecien, Nicholas W.; Freiberger, Elyse C.; Richards, Alicia L.; Rush, Matthew J. P.; Ulbrich, Arne; Hutchins, Paul D.; Connors, Kyle J.; Trujillo, Edna A.; Marx, Harald; Westphall, Michael S.; Hebert, Alexander S.; Coon, Joshua J.] Genorne Ctr Wisconsin, Madison, WI USA; [Kwiecien, Nicholas W.; Richards, Alicia L.; Rush, Matthew J. P.; Ulbrich, Arne; Hutchins, Paul D.; Guo, Xiao; Connors, Kyle J.; Trujillo, Edna A.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Freiberger, Elyse C.; Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Pagliarini, DJ (corresponding author), Morgridge Inst Res, Madison, WI 53715 USA.; Pagliarini, DJ (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.; Coon, JJ (corresponding author), Genorne Ctr Wisconsin, Madison, WI USA.; Coon, JJ (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.; Coon, JJ (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI USA.	dpagliarini@morgridge.org; jcoon@chem.wisc.edu	Ulbrich, Arne/ABG-8048-2021	Pagliarini, David J./0000-0002-0001-0087; Rush, Matthew/0000-0002-5622-1350; Stefely, Jonathan/0000-0003-3235-1107; Hutchins, Paul/0000-0002-6683-5735	Searle Scholars Award; NIH [T32GM007215, R01DK098672, R01GM112057, R01GM115591, R35GM118110, T32DK007665, T32HG002760]; NIH Ruth L. Kirschstein NRSA [F30AG043282]; DOE Great Lakes Bioenergy Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]; ACS Analytical Chemistry; NSF Graduate Research Fellowship; Society of Analytical Chemists of Pittsburgh; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098672, T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM115591, R35GM118110, T32GM008692, R01GM112057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG043282] Funding Source: NIH RePORTER	Searle Scholars Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Great Lakes Bioenergy Research Center (DOE Office of Science)(United States Department of Energy (DOE)); ACS Analytical Chemistry; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Society of Analytical Chemists of Pittsburgh; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Pagliarini and Coon laboratories for helpful discussions. This work was supported by a Searle Scholars Award and NIH grants R01DK098672, R01GM112057, and R01GM115591 (to D.J.P.); NIH grant R35GM118110 (to J.J.C.); NIH Ruth L. Kirschstein NRSA F30AG043282 (to J.A.S.); DOE Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494 to N.W.K. and A.U.); and ACS Analytical Chemistry and Society of Analytical Chemists of Pittsburgh awards (to A.L.R.); NSF Graduate Research Fellowship and NIH T32GM007215 (to M.T.V.); NIH T32DK007665 (to Z.A.K.); and NIH T32HG002760 (to E.A.T.).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENTLEY R, 1961, BIOCHEM BIOPH RES CO, V5, P443, DOI 10.1016/0006-291X(61)90092-4; BOOTH AN, 1960, J BIOL CHEM, V235, P2649; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DeLaurenzi V, 1996, NAT GENET, V12, P52; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Hebert AS, 2013, MOL CELL PROTEOMICS, V12, P3360, DOI 10.1074/mcp.M113.032011; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jackson Brian, 2011, Human Genomics, V5, P283; KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Kitamura T, 2013, BBA-MOL CELL BIOL L, V1831, P1395, DOI 10.1016/j.bbalip.2013.05.007; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Laredj LN, 2014, BIOCHIMIE, V100, P78, DOI 10.1016/j.biochi.2013.12.006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113; Peterson AC, 2014, ANAL CHEM, V86, P10036, DOI 10.1021/ac5014767; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108; Richards AL, 2015, NAT PROTOC, V10, P701, DOI 10.1038/nprot.2015.040; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Williams EG, 2016, SCIENCE, V352, DOI 10.1126/science.aad0189; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	42	81	82	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1191	+		10.1038/nbt.3683	http://dx.doi.org/10.1038/nbt.3683			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27669165	Green Accepted, Green Submitted			2022-12-25	WOS:000387506500031
J	Webb, S				Webb, Sarah			The cancer bloodhounds	NATURE BIOTECHNOLOGY			English	Editorial Material							MUTATIONS; BLOOD; DNA											Baselga J, 2015, SAN ANT BREAST CANC; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Janku F, 2014, ONCOTARGET, V5, P3607, DOI 10.18632/oncotarget.1964; Scher C., 2016, JAMA ONCOL, DOI [10.1001/jamaoncol.2016.1828(2016), DOI 10.1001/JAMAONCOL.2016.1828]; Schwaederle M, 2016, ONCOTARGET, V7, P9707, DOI 10.18632/oncotarget.7110; Sheridan C, 2016, NAT BIOTECHNOL, V34, P358, DOI 10.1038/nbt0416-359; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219	9	26	26	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1090	1094		10.1038/nbt.3717	http://dx.doi.org/10.1038/nbt.3717			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27824838				2022-12-25	WOS:000387506500013
J	Bentzen, AK; Marquard, AM; Lyngaa, R; Saini, SK; Ramskov, S; Donia, M; Such, L; Furness, AJS; McGranahan, N; Rosenthal, R; Straten, PT; Szallasi, Z; Svane, IM; Swanton, C; Quezada, SA; Jakobsen, SN; Eklund, AC; Hadrup, SR				Bentzen, Amalie Kai; Marquard, Andrea Marion; Lyngaa, Rikke; Saini, Sunil Kumar; Ramskov, Sofie; Donia, Marco; Such, Lina; Furness, Andrew J. S.; McGranahan, Nicholas; Rosenthal, Rachel; Straten, Per Thor; Szallasi, Zoltan; Svane, Inge Marie; Swanton, Charles; Quezada, Sergio A.; Jakobsen, Soren Nyboe; Eklund, Aron Charles; Hadrup, Sine Reker			Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes	NATURE BIOTECHNOLOGY			English	Article							PARALLEL DETECTION; MASS CYTOMETRY; SELF-ANTIGEN; RESPONSES; MELANOMA; GENERATION; DESIGN; SENSITIVITY; RECOGNIZES; BLOCKADE	Identification of the peptides recognized by individual T cells is important for understanding and treating immune-related diseases. Current cytometry-based approaches are limited to the simultaneous screening of 10-100 distinct T-cell specificities in one sample. Here we use peptide-major histocompatibility complex (MHC) multimers labeled with individual DNA barcodes to screen >1,000 peptide specificities in a single sample, and detect low-frequency CD8 T cells specific for virus- or cancer restricted antigens. When analyzing T-cell recognition of shared melanoma antigens before and after adoptive cell therapy in melanoma patients, we observe a greater number of melanoma-specific T-cell populations compared with cytometry-based approaches. Furthermore, we detect neoepitope-specific T cells in tumor-infiltrating lymphocytes and peripheral blood from patients with non-small cell lung cancer. Barcode-labeled pMHC multimers enable the combination of functional T-cell analysis with large-scale epitope recognition profiling for the characterization of T-cell recognition in various diseases, including in small clinical samples.	[Bentzen, Amalie Kai; Lyngaa, Rikke; Saini, Sunil Kumar; Ramskov, Sofie; Such, Lina; Jakobsen, Soren Nyboe; Hadrup, Sine Reker] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, Copenhagen, Denmark; [Marquard, Andrea Marion; Szallasi, Zoltan; Eklund, Aron Charles] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, Lyngby, Denmark; [Donia, Marco; Straten, Per Thor; Svane, Inge Marie] Univ Copenhagen, Herlev Hosp, Dept Hematol, Ctr Canc Immune Therapy, Copenhagen, Denmark; [Donia, Marco; Svane, Inge Marie] Univ Copenhagen, Herlev Hosp, Dept Oncol, Copenhagen, Denmark; [Furness, Andrew J. S.; McGranahan, Nicholas; Rosenthal, Rachel; Swanton, Charles; Quezada, Sergio A.] UCL Canc Inst, CRUK Lung Canc Ctr Excellence, London, England; [Furness, Andrew J. S.; Quezada, Sergio A.] UCL, UCL Canc Inst, Canc Immunol Unit, London, England; [McGranahan, Nicholas; Rosenthal, Rachel; Swanton, Charles] Francis Crick Inst, Translat Canc Therapeut Lab, London, England; [Straten, Per Thor] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark; [Jakobsen, Soren Nyboe] Immudex, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of London; University College London; University of London; University College London; Francis Crick Institute; University of Copenhagen	Hadrup, SR (corresponding author), Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, Copenhagen, Denmark.	sirha@vet.dtu.dk	Hadrup, Sine Reker/P-3388-2014; McGranahan, Nicholas/ABD-6561-2021; Quezada, Sergio/ABF-6466-2020	Hadrup, Sine Reker/0000-0002-5937-4344; McGranahan, Nicholas/0000-0001-9537-4045; Quezada, Sergio/0000-0002-9763-1700; Ramskov, Sofie/0000-0001-9413-8673; Szallasi, Zoltan/0000-0001-5395-7509; Donia, Marco/0000-0003-4966-9752; Bentzen, Amalie Kai/0000-0002-5184-3054; Marquard, Andrea/0000-0003-2928-6017; Swanton, Charles/0000-0002-4299-3018; Eklund, Aron Charles/0000-0003-0861-1001; jakobsen, soren nyboe/0000-0002-2227-8615; Svane, Inge Marie/0000-0002-9451-6037; thor Straten, Per/0000-0002-4731-4969; Saini, Sunil Kumar/0000-0003-3382-9432	Danish Cancer Society [ID:R72-A4531-13-S2]; Lundbeck Foundation Fellowship [R190-2014-4178]; Danish Research Council (FSS) [1331-00283]; Danish Research Council (DFF) [4004-00422]; Familien Erichsens Mindefond; Cancer Research UK [FC001169]; UK Medical Research Council [FC001169, MR/FC001169/1]; Wellcome Trust [FC001169]; Novo Nordisk Foundation [16584]; Cancer Research UK [20466, 12100] Funding Source: researchfish; Lundbeck Foundation [R181-2014-3828] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016584] Funding Source: researchfish; The Danish Cancer Society [R72-A4531] Funding Source: researchfish; Versus Arthritis [20265] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation Fellowship; Danish Research Council (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Danish Research Council (DFF); Familien Erichsens Mindefond; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Cancer Research UK(Cancer Research UK); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society); Versus Arthritis(Versus Arthritis)	We would like to thank U.K. Hansen, A. Burkal and T. Seremet for technical assistance; T. Schumacher, Netherlands Cancer Institute, for scientific discussions and sharing of MHC expression plasmids; and Dr. Altman, NIH Tetramer Core Facility, for sharing expression plasmids HLA-B*1501 and HLA-B*3501. The work was funded by The Danish Cancer Society (ID:R72-A4531-13-S2), The Lundbeck Foundation Fellowship (ID: R190-2014-4178), The Danish Research Council (FSS-ID: 1331-00283 and DFF-ID:4004-00422), Familien Erichsens Mindefond, Cancer Research UK (FC001169), the UK Medical Research Council (FC001169), the Wellcome Trust (FC001169), the UK Medical Research Council (MR/FC001169/1) and the Novo Nordisk Foundation (ID: 16584).	Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Andersen R, 2016, CLIN CANCER RES, V22, P3734, DOI 10.1158/1078-0432.CCR-15-1879; Andersen RS, 2012, NAT PROTOC, V7, P891, DOI 10.1038/nprot.2012.037; Andersen RS, 2012, CANCER RES, V72, P1642, DOI 10.1158/0008-5472.CAN-11-2614; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Chattopadhyay PK, 2012, METHODS, V57, P251, DOI 10.1016/j.ymeth.2012.02.009; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Derre L, 2007, J IMMUNOL, V179, P7635, DOI 10.4049/jimmunol.179.11.7635; Dossinger G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061384; Dolton G, 2014, CLIN EXP IMMUNOL, V177, P47, DOI 10.1111/cei.12339; Frosig TM, 2015, CYTOM PART A, V87A, P967, DOI 10.1002/cyto.a.22689; Frosig TM, 2015, CANCER IMMUNOL IMMUN, V64, P609, DOI 10.1007/s00262-015-1664-x; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Lyngaa R, 2014, CLIN CANCER RES, V20, P1768, DOI 10.1158/1078-0432.CCR-13-2697; Massilamany C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087519; McCutcheon M, 1997, J IMMUNOL METHODS, V210, P149, DOI 10.1016/S0022-1759(97)00182-8; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Stevanovic S, 1999, SEMIN IMMUNOL, V11, P375, DOI 10.1006/smim.1999.0195; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Valmori D, 1998, J IMMUNOL, V160, P1750; van Buuren MM, 2014, J IMMUNOL, V192, P641, DOI 10.4049/jimmunol.1301770; Wieckowski S, 2009, J IMMUNOL, V183, P5397, DOI 10.4049/jimmunol.0901460; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Xu QK, 2009, P NATL ACAD SCI USA, V106, P2289, DOI 10.1073/pnas.0812506106	36	167	222	4	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2016	34	10					1037	1045		10.1038/nbt.3662	http://dx.doi.org/10.1038/nbt.3662			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EA0ZG	27571370	Green Submitted			2022-12-25	WOS:000386317500018
J	Chen, HJ; Wei, ZB; Sun, J; Bhattacharya, A; Savage, DJ; Serda, R; Mackeyev, Y; Curley, SA; Bu, PC; Wang, LH; Chen, SB; Cohen-Gould, L; Huang, E; Shen, XL; Lipkin, SM; Copeland, NG; Jenkins, NA; Shuler, ML				Chen, Huanhuan Joyce; Wei, Zhubo; Sun, Jian; Bhattacharya, Asmita; Savage, David J.; Serda, Rita; Mackeyev, Yuri; Curley, Steven A.; Bu, Pengcheng; Wang, Lihua; Chen, Shuibing; Cohen-Gould, Leona; Huang, Emina; Shen, Xiling; Lipkin, Steven M.; Copeland, Neal G.; Jenkins, Nancy A.; Shuler, Michael L.			A recellularized human colon model identifies cancer driver genes	NATURE BIOTECHNOLOGY			English	Article							TUMOR-SUPPRESSOR; INVASION; MICROENVIRONMENT; PROLIFERATION; HOMOLOG; TISSUES; LATS2	Refined cancer models are needed to bridge the gaps between cell line, animal and clinical research. Here we describe the engineering of an organotypic colon cancer model by recellularization of a native human matrix that contains cell-populated mucosa and an intact muscularis mucosa layer. This ex vivo system recapitulates the pathophysiological progression from APC-mutant neoplasia to submucosal invasive tumor. We used it to perform a Sleeping Beauty transposon mutagenesis screen to identify genes that cooperate with mutant APC in driving invasive neoplasia. We identified 38 candidate invasion-driver genes, 17 of which, including TCF7L2, TWIST2, MSH2, DCC, EPHB1 and EPHB2 have been previously implicated in colorectal cancer progression. Six invasion-driver genes that have not, to our knowledge, been previously described were validated in vitro using cell proliferation, migration and invasion assays and ex vivo using recellularized human colon. These results demonstrate the utility of our organoid model for studying cancer biology.	[Chen, Huanhuan Joyce; Bu, Pengcheng; Shen, Xiling; Shuler, Michael L.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Wei, Zhubo; Copeland, Neal G.; Jenkins, Nancy A.] Houston Methodist Res Inst, Canc Res Program, Houston, TX 77030 USA; [Sun, Jian; Lipkin, Steven M.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Sun, Jian; Lipkin, Steven M.] Weill Cornell Med Coll, Dept Genet Med, New York, NY USA; [Bhattacharya, Asmita] Cornell Univ, Genet Genom & Dev, Ithaca, NY USA; [Savage, David J.; Serda, Rita] Univ Texas Houston, Med Sch Houston, Houston, TX USA; [Mackeyev, Yuri] Rice Univ, Dept Chem, Houston, TX USA; [Curley, Steven A.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Wang, Lihua] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Chen, Shuibing] Weill Cornell Med Coll, Chem Biol Surg, New York, NY USA; [Cohen-Gould, Leona] Weill Cornell Med Coll, Dept Biochem, New York, NY USA; [Huang, Emina] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Huang, Emina] Cleveland Clin, Dept Colorectal Surg, Cleveland, OH 44106 USA	Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Cornell University; Cornell University; University of Texas System; University of Texas Health Science Center Houston; Rice University; Baylor College of Medicine; Cornell University; Cornell University; Cornell University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Shuler, ML (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.; Jenkins, NA (corresponding author), Houston Methodist Res Inst, Canc Res Program, Houston, TX 77030 USA.	njenkins2@houstonmethodist.org; mls50@cornell.edu	Savage, David/ABA-5389-2021; Mackeyev, Yuri/C-9777-2010; Bhattacharya, Asmita/GQR-2455-2022	Mackeyev, Yuri/0000-0003-4456-0563; Bhattacharya, Asmita/0000-0002-5669-8036; Savage, MD, PhD, David/0000-0003-4690-5115; Huang, Emina/0000-0003-2495-4370; Bu, Pengcheng/0000-0002-3208-0354	US National Cancer Institute Physical Sciences-Oncology Center (NCI-PSOC) Young Investigator trans-network grant; US National Institutes of Health (NIH) grant [UH2TR000516]; US National Science Foundation (NSF) grants [NSF-1106153, NSF GRFP-2011131053]; NIH [R01GM095990]; Arnold O. Beckman Postdoctoral fellowship; Welch Foundation grant at Rice University [C-0627]; Cancer Prevention Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE [R01CA157663] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000516, UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114254, R01GM095990] Funding Source: NIH RePORTER; Directorate For Engineering [1350659] Funding Source: National Science Foundation	US National Cancer Institute Physical Sciences-Oncology Center (NCI-PSOC) Young Investigator trans-network grant; US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF) grants(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold O. Beckman Postdoctoral fellowship; Welch Foundation grant at Rice University; Cancer Prevention Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank the members of M.L.S.'s laboratory and N.A.J. and N.G.C.'s laboratory. We also thank H.E. Varmus for providing laboratory resources and helpful discussions. This work was supported by a US National Cancer Institute Physical Sciences-Oncology Center (NCI-PSOC) Young Investigator trans-network grant to H.J.C. and Z.W., US National Institutes of Health (NIH) grant UH2TR000516 to M.L.S., US National Science Foundation (NSF) grants NSF-1106153 to M.L.S. and NSF GRFP-2011131053 to H.J.C., NIH grant R01GM095990 to X.S., an Arnold O. Beckman Postdoctoral fellowship to H.J.C., a Welch Foundation grant C-0627 at Rice University to Y.M. and the Cancer Prevention Research Institute of Texas (CPRIT) (N.G.C. and N.A.J.).	Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Biswas S, 2004, CANCER RES, V64, P4687, DOI 10.1158/0008-5472.CAN-03-3255; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; Chen HJ, 2015, NAT BIOTECHNOL, V33, P656, DOI 10.1038/nbt.3239; Chen HJ, 2012, J CLIN INVEST, V122, P3184, DOI 10.1172/JCI62110; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Copeland NG, 2009, TRENDS GENET, V25, P455, DOI 10.1016/j.tig.2009.08.004; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Funato K, 2011, EXP THER MED, V2, P457, DOI 10.3892/etm.2011.231; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gomes CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041261; Gout S, 2008, CANCER MICROENVIRON, V1, P69, DOI 10.1007/s12307-008-0007-2; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Katoh M, 2013, BRIT J CANCER, V109, P299, DOI 10.1038/bjc.2013.281; Kim MY, 2006, GASTROENTEROLOGY, V131, P1913, DOI 10.1053/j.gastro.2006.10.021; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; LIOTTA LA, 1984, AM J PATHOL, V117, P339; Lohi J, 1996, HISTOCHEM J, V28, P431, DOI 10.1007/BF02331434; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Oshima H, 2015, CANCER RES, V75, P766, DOI 10.1158/0008-5472.CAN-14-2036; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Ruiz-Ponte C, 2001, Hum Mutat, V18, P355, DOI 10.1002/humu.1198; Takeda H, 2015, NAT GENET, V47, P142, DOI 10.1038/ng.3175; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Williams DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016012; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yu H, 2013, WORLD J GASTROENTERO, V19, P2404, DOI 10.3748/wjg.v19.i15.2404	49	70	70	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2016	34	8					845	+		10.1038/nbt.3586	http://dx.doi.org/10.1038/nbt.3586			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2VJ	27398792	Green Submitted, Green Accepted			2022-12-25	WOS:000381339600021
J	Le, HQ; Ghatak, S; Yeung, CYC; Tellkamp, F; Gunschmann, C; Dieterich, C; Yeroslaviz, A; Habermand, B; Pombo, A; Niessen, CM; Wickstrom, SA				Huy Quang Le; Ghatak, Sushmita; Yeung, Ching-Yan Chloe; Tellkamp, Frederik; Guenschmann, Christian; Dieterich, Christoph; Yeroslaviz, Assa; Habermand, Bianca; Pombo, Ana; Niessen, Carien M.; Wickstroem, Sara A.			Mechanical regulation of transcription controls Polycomb-mediated gene silencing during lineage commitment	NATURE CELL BIOLOGY			English	Article							INTEGRIN-LINKED KINASE; RNA-POLYMERASE-II; NUCLEAR ACTIN; GENOME-WIDE; CELL-ADHESION; STEM-CELLS; MYOSIN-II; EXPRESSION; CHROMATIN; TISSUE	Tissue mechanics drive morphogenesis, but how forces are sensed and transmitted to control stem cell fate and self-organization remains unclear. We show that a mechanosensory complex of emerin (Emd), non-muscle myosin IIA (NMIIA) and actin controls gene silencing and chromatin compaction, thereby regulating lineage commitment. Force-driven enrichment of Emd at the outer nuclear membrane of epidermal stem cells leads to defective heterochromatin anchoring to the nuclear lamina and a switch from H3K9me2,3 to H3K27me3 occupancy at constitutive heterochromatin. Emd enrichment is accompanied by the recruitment of NMIIA to promote local actin polymerization that reduces nuclear actin levels, resulting in attenuation of transcription and subsequent accumulation of H3K27me3 at facultative heterochromatin. Perturbing this mechanosensory pathway by deleting NMIIA in mouse epidermis leads to attenuated H3K27me3-mediated silencing and precocious lineage commitment, abrogating morphogenesis. Our results reveal how mechanics integrate nuclear architecture and chromatin organization to control lineage commitment and tissue morphogenesis.	[Huy Quang Le; Ghatak, Sushmita; Yeung, Ching-Yan Chloe; Wickstroem, Sara A.] Max Planck Inst Biol Ageing, Paul Gerson Unna Grp Skin Homeostasis & Ageing, D-50931 Cologne, Germany; [Tellkamp, Frederik; Guenschmann, Christian; Niessen, Carien M.; Wickstroem, Sara A.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Tellkamp, Frederik; Guenschmann, Christian; Niessen, Carien M.] Univ Cologne, Ctr Mol Med Cologne, Dept Dermatol, D-50931 Cologne, Germany; [Dieterich, Christoph] Max Planck Inst Biol Ageing, Computat RNA Biol & Ageing, D-50931 Cologne, Germany; [Yeroslaviz, Assa; Habermand, Bianca] Max Planck Inst Biochem, Computat Biol, D-82152 Martinsried, Germany; [Pombo, Ana] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, D-13092 Berlin, Germany	Max Planck Society; University of Cologne; University of Cologne; Max Planck Society; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Wickstrom, SA (corresponding author), Max Planck Inst Biol Ageing, Paul Gerson Unna Grp Skin Homeostasis & Ageing, D-50931 Cologne, Germany.; Wickstrom, SA (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.	wickstroem@age.mpg.de	Pombo, Ana/A-1045-2010; Tellkamp, Frederik/AAS-1863-2020; Tellkamp, Frederik/D-8027-2014; Yeung, Ching-Yan Chloé/GPX-1457-2022; Dieterich, Christoph/ABF-8459-2021; Habermann, Bianca/N-4886-2016	Pombo, Ana/0000-0002-7493-6288; Tellkamp, Frederik/0000-0002-0473-7320; Tellkamp, Frederik/0000-0002-0473-7320; Yeung, Ching-Yan Chloé/0000-0002-7076-8109; Niessen, Carien M./0000-0002-4892-9391; Yeroslaviz, Assa/0000-0001-9638-4026; Wickstrom, Sara/0000-0001-6383-6292; Le, Huy/0000-0002-0851-9320; Habermann, Bianca/0000-0002-2457-7504	Max Planck Society; Max Planck Forderstiftung; Behrens-Weise Foundation; Deutsche Forschungsgemeinschaft [SFB 829, SPP1782]	Max Planck Society(Max Planck Society); Max Planck Forderstiftung(Max Planck Society); Behrens-Weise Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank A. Antebi, P. Tessarz and R. Wedlich-Soldner for critical reading of the manuscript, M. Schuler for advice on the bioinformatics analyses, T. Bucher and N. Bremicker for technical assistance, P. Zentis for help with image analyses, and the FAGS & Imaging Core Facility of MPI for Biology of Ageing, and CECAD Imaging Facility for support. The Max Planck Genome Centre Cologne is acknowledged for sequencing. This work was supported by the Max Planck Society, the Max Planck Forderstiftung, the Behrens-Weise Foundation (to S.A.W.), and Deutsche Forschungsgemeinschaft through SFB 829 (to C.M.N. and S.A.W) and through SPP1782 (to C.M.N.). The Myh9 mice were kindly provided by the European Mutant Mouse Archive (EMMA).	Arteaga MF, 2013, CANCER CELL, V23, P376, DOI 10.1016/j.ccr.2013.02.014; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Demmerle J, 2012, J BIOL CHEM, V287, P22080, DOI 10.1074/jbc.M111.325308; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dopie J, 2012, P NATL ACAD SCI USA, V109, pE544, DOI 10.1073/pnas.1118880109; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evans ND, 2013, J MECH BEHAV BIOMED, V28, P397, DOI 10.1016/j.jmbbm.2013.04.023; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fedorchak GR, 2014, PROG BIOPHYS MOL BIO, V115, P76, DOI 10.1016/j.pbiomolbio.2014.06.009; FRASER NW, 1978, NATURE, V272, P590, DOI 10.1038/272590a0; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Guilluy C, 2014, NAT CELL BIOL, V16, P376, DOI 10.1038/ncb2927; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munro SA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6125; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Perlman CE, 2007, J APPL PHYSIOL, V103, P1037, DOI 10.1152/japplphysiol.00160.2007; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Radovanac K, 2013, EMBO J, V32, P1409, DOI 10.1038/emboj.2013.90; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Schreiber KH, 2013, CELL, V152, P1365, DOI 10.1016/j.cell.2013.02.015; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Spencer VA, 2011, J CELL SCI, V124, P123, DOI 10.1242/jcs.073197; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swift J, 2014, J CELL SCI, V127, P3005, DOI 10.1242/jcs.149203; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Towbin BD, 2013, TRENDS BIOCHEM SCI, V38, P356, DOI 10.1016/j.tibs.2013.04.004; Treisman R, 2013, TRENDS BIOCHEM SCI, V38, P376, DOI 10.1016/j.tibs.2013.06.004; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Watt FM, 2002, J DERMATOL SCI, V28, P173, DOI 10.1016/S0923-1811(02)00003-8; Wheeler MA, 2008, BIOCHEM SOC T, V36, P1354, DOI 10.1042/BST0361354; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Xu YZ, 2010, MOL BIOL CELL, V21, P811, DOI 10.1091/mbc.E09-06-0534; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	58	246	249	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2016	18	8					864	+		10.1038/ncb3387	http://dx.doi.org/10.1038/ncb3387			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DS5NO	27398909				2022-12-25	WOS:000380829200007
J	Kleinstiver, BP; Tsai, SQ; Prew, MS; Nguyen, NT; Welch, MM; Lopez, JM; McCaw, ZR; Aryee, MJ; Joung, JK				Kleinstiver, Benjamin P.; Tsai, Shengdar Q.; Prew, Michelle S.; Nguyen, Nhu T.; Welch, Moira M.; Lopez, Jose M.; McCaw, Zachary R.; Aryee, Martin J.; Joung, J. Keith			Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells	NATURE BIOTECHNOLOGY			English	Article							OFF-TARGET CLEAVAGE; RNA; SYSTEMS; ENDONUCLEASE; DELIVERY; TALENS; RANGE	The activities and genome-wide specificities of CRISPR-Cas Cpf1 nucleases(1) are not well defined. We show that two Cpf1 nucleases from Acidaminococcus sp. BV3L6 and Lachnospiraceae bacterium ND2006 (AsCpf1 and LbCpf1, respectively) have on-target efficiencies in human cells comparable with those of the widely used Streptococcus pyogenes Cas9 (SpCas9)(2-5). We also report that four to six bases at the 3' end of the short CRISPR RNA (crRNA) used to program Cpf1 nucleases are insensitive to single base mismatches, but that many of the other bases in this region of the crRNA are highly sensitive to single or double substitutions. Using GUIDE-seq and targeted deep sequencing analyses performed with both Cpf1 nucleases, we were unable to detect off-target cleavage for more than half of 20 different crRNAs. Our results suggest that AsCpf1 and LbCpf1 are highly specific in human cells.	[Kleinstiver, Benjamin P.; Tsai, Shengdar Q.; Prew, Michelle S.; Nguyen, Nhu T.; Welch, Moira M.; Lopez, Jose M.; McCaw, Zachary R.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Kleinstiver, Benjamin P.; Tsai, Shengdar Q.; Prew, Michelle S.; Nguyen, Nhu T.; Welch, Moira M.; Lopez, Jose M.; McCaw, Zachary R.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Kleinstiver, Benjamin P.; Tsai, Shengdar Q.; Prew, Michelle S.; Nguyen, Nhu T.; Welch, Moira M.; Lopez, Jose M.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Kleinstiver, Benjamin P.; Tsai, Shengdar Q.; Lopez, Jose M.; Aryee, Martin J.; Joung, J. Keith] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [McCaw, Zachary R.; Aryee, Martin J.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kleinstiver, BP; Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.; Kleinstiver, BP; Joung, JK (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA.; Kleinstiver, BP; Joung, JK (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA.; Kleinstiver, BP; Joung, JK (corresponding author), Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.	bkleinstiver@mgh.harvard.edu; jjoung@mgh.harvard.edu	Aryee, Martin/AAC-8113-2020; Kleinstiver, Benjamin/K-4498-2014; Tsai, Shengdar Q./G-4600-2012	Kleinstiver, Benjamin/0000-0002-5469-0655; Tsai, Shengdar Q./0000-0001-9161-3993; Prew, Michelle/0000-0001-7247-3024; Aryee, Martin/0000-0002-6848-1344; McCaw, Zachary/0000-0002-2006-9828	National Institutes of Health (NIH) Director's Pioneer Award [DP1 GM105378]; NIH [R01 GM107427]; Jim and Ann Orr Research Scholar Award; Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship; Massachusetts General Hospital Collaborative Center for X-Linked Dystonia-Parkinsonism; MGH Tosteson Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378, R01GM107427] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr Research Scholar Award; Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Massachusetts General Hospital Collaborative Center for X-Linked Dystonia-Parkinsonism; MGH Tosteson Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health (NIH) Director's Pioneer Award (DP1 GM105378) and NIH R01 GM107427 to J.K.J., the Jim and Ann Orr Research Scholar Award (to J.K.J.), a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship (to B.P.K.), an award from the Massachusetts General Hospital Collaborative Center for X-Linked Dystonia-Parkinsonism, and an MGH Tosteson Award (to S.Q.T.). New reagents described in this work have been deposited with the non-profit plasmid distribution service Addgene (http://www.addgene.org/crispr-cas).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fagerlund RD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0824-9; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schunder E, 2013, INT J MED MICROBIOL, V303, P51, DOI 10.1016/j.ijmm.2012.11.004; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tsai SQ, 2016, NAT BIOTECHNOL, V34, P483, DOI 10.1038/nbt.3534; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	30	371	417	4	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2016	34	8					869	+		10.1038/nbt.3620	http://dx.doi.org/10.1038/nbt.3620			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2VJ	27347757	Green Accepted, Green Submitted			2022-12-25	WOS:000381339600025
J	Maeda, H; Kowada, T; Kikuta, J; Furuya, M; Shirazaki, M; Mizukami, S; Ishii, M; Kikuchi, K				Maeda, Hiroki; Kowada, Toshiyuki; Kikuta, Junichi; Furuya, Masayuki; Shirazaki, Mai; Mizukami, Shin; Ishii, Masaru; Kikuchi, Kazuya			Real-time intravital imaging of pH variation associated with osteoclast activity	NATURE CHEMICAL BIOLOGY			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; RESISTANT ACID-PHOSPHATASE; BONE-RESORPTION PRODUCTS; IN-VIVO; 2-PHOTON MICROSCOPY; FLUORESCENCE PROBES; CELL-INTERACTIONS; RATIONAL DESIGN; LIVING CELLS; CANCER-CELLS	Intravital imaging by two-photon excitation microscopy (TPEM) has been widely used to visualize cell functions. However, small molecular probes (SMPs), commonly used for cell imaging, cannot be simply applied to intravital imaging because of the challenge of delivering them into target tissues, as well as their undesirable physicochemical properties for TPEM imaging. Here, we designed and developed a functional SMP with an active-targeting moiety, higher photostability, and a fluorescence switch and then imaged target cell activity by injecting the SMP into living mice. The combination of the rationally designed SMP with a fluorescent protein as a reporter of cell localization enabled quantitation of osteoclast activity and time-lapse imaging of its in vivo function associated with changes in cell deformation and membrane fluctuations. Real-time imaging revealed heterogenic behaviors of osteoclasts in vivo and provided insights into the mechanism of bone resorption.	[Maeda, Hiroki; Mizukami, Shin; Kikuchi, Kazuya] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka, Japan; [Kowada, Toshiyuki; Kikuta, Junichi; Mizukami, Shin; Ishii, Masaru; Kikuchi, Kazuya] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Kikuta, Junichi; Furuya, Masayuki; Shirazaki, Mai; Ishii, Masaru] Osaka Univ, Grad Sch Med, Dept Immunol & Cell Biol, Suita, Osaka, Japan; [Kowada, Toshiyuki] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA	Osaka University; Osaka University; Osaka University; Stanford University	Kikuchi, K (corresponding author), Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka, Japan.; Ishii, M; Kikuchi, K (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan.; Ishii, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Immunol & Cell Biol, Suita, Osaka, Japan.	mishii@icb.med.osaka-u.ac.jp; kkikuchi@mls.eng.osaka-u.ac.jp	Mizukami, Shin/AAE-2465-2019; Kowada, Toshiyuki/R-2716-2016; Mizukami, Shin/AAL-4349-2021; Kikuta, Junichi/HHS-8875-2022	Mizukami, Shin/0000-0002-2292-8606; Kowada, Toshiyuki/0000-0002-6623-6505; Mizukami, Shin/0000-0002-2292-8606; 	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25220207, 26102529, 15K12754, 14J00794]; Naito Foundation; Asahi Glass Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [15K12754, 16K13099, 15H00818] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Asahi Glass Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (grant nos. 25220207, 26102529, and 15K12754 to K.K., 14J00794 to H.M.). K.K. and M.I. thank the Naito Foundation for financial support. K.K. and S.M. thank the Asahi Glass Foundation for financial support. K.K. and M.I. also thank the Uehara Memorial Foundation for financial support.	AUBRY JM, 1989, J ORG CHEM, V54, P726, DOI 10.1021/jo00264a046; Auchere F, 2001, EUR J BIOCHEM, V268, P2889, DOI 10.1046/j.1432-1327.2001.02175.x; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Chittajallu DR, 2015, NAT METHODS, V12, P577, DOI 10.1038/nmeth.3363; Ducros M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004418; Entenberg D, 2011, NAT PROTOC, V6, P1500, DOI 10.1038/nprot.2011.376; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Frisch M.J, 2016, GAUSSIAN 16 REV C01; Gabe Y, 2004, J AM CHEM SOC, V126, P3357, DOI 10.1021/ja037944j; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Halleen JM, 1999, J BIOL CHEM, V274, P22907, DOI 10.1074/jbc.274.33.22907; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hilal SH, 1995, QUANT STRUCT-ACT REL, V14, P348, DOI 10.1002/qsar.19950140405; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Johnsson AKE, 2014, CELL REP, V6, P1153, DOI 10.1016/j.celrep.2014.02.024; Jones G, 2003, J PHYS CHEM A, V107, P8429, DOI 10.1021/jp0340212; Karsdal MA, 2005, AM J PATHOL, V166, P467, DOI 10.1016/S0002-9440(10)62269-9; Kavarnos G.J., 1993, FUNDAMENTALS PHOTOIN; Kikuta J, 2013, J CLIN INVEST, V123, P866, DOI 10.1172/JCI65054; Kim HJ, 2013, J AM CHEM SOC, V135, P17969, DOI 10.1021/ja409971k; Komatsu T, 2011, CHEM COMMUN, V47, P10055, DOI 10.1039/c1cc13367e; Kowada T, 2015, CHEM SOC REV, V44, P4953, DOI 10.1039/c5cs00030k; Kowada T, 2011, J AM CHEM SOC, V133, P17772, DOI 10.1021/ja2064582; Kozloff KM, 2010, J BONE MINER RES, V25, P1748, DOI 10.1002/jbmr.66; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Li L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4276; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Loudet A, 2007, CHEM REV, V107, P4891, DOI 10.1021/cr078381n; Miao F, 2013, BIOSENS BIOELECTRON, V50, P42, DOI 10.1016/j.bios.2013.05.060; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Mizuno R, 2014, J EXP MED, V211, P1123, DOI 10.1084/jem.20132112; Mula S, 2008, J ORG CHEM, V73, P2146, DOI 10.1021/jo702346s; Nobis M, 2013, CANCER RES, V73, P4674, DOI 10.1158/0008-5472.CAN-12-4545; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Plumere N, 2012, ANAL CHEM, V84, P2141, DOI 10.1021/ac2020883; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; SILVERTON S, 1994, J CELL BIOCHEM, V56, P367, DOI 10.1002/jcb.240560313; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sunahara H, 2007, J AM CHEM SOC, V129, P5597, DOI 10.1021/ja068551y; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; TAMURA T, 1993, J BONE MINER RES, V8, P953; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Urano Y, 2009, NAT MED, V15, P104, DOI 10.1038/nm.1854; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Wang WG, 2002, CANCER RES, V62, P6278; Wu JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6262; Yao S, 2007, ORG LETT, V9, P5645, DOI 10.1021/ol7026366	56	51	51	2	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2016	12	8					579	+		10.1038/NCHEMBIO.2096	http://dx.doi.org/10.1038/NCHEMBIO.2096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2UW	27272564				2022-12-25	WOS:000380640100003
J	Shin, HY; Willi, M; Yoo, KH; Zeng, XK; Wang, CC; Metser, G; Hennighausen, L				Shin, Ha Youn; Willi, Michaela; Yoo, Kyung Hyun; Zeng, Xianke; Wang, Chaochen; Metser, Gil; Hennighausen, Lothar			Hierarchy within the mammary STAT5-driven Wap super-enhancer	NATURE GENETICS			English	Article							WHEY ACIDIC PROTEIN; DISTAL REGULATORY ELEMENTS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SIGNAL TRANSDUCER; GLAND DEVELOPMENT; CELL IDENTITY; STAT5; PREGNANCY; PROMOTER	Super-enhancers comprise dense transcription factor platforms highly enriched for active chromatin marks. A paucity of functional data led us to investigate the role of super-enhancers in the mammary gland, an organ characterized by exceptional gene regulatory dynamics during pregnancy. ChIP-seq analysis for the master regulator STAT5A, the glucocorticoid receptor, H3K27ac and MED1 identified 440 mammary-specific super-enhancers, half of which were associated with genes activated during pregnancy. We interrogated the Wap super-enhancer, generating mice carrying mutations in STAT5-binding sites within its constituent enhancers. Individually, the most distal site displayed the greatest enhancer activity. However, combinatorial mutation analysis showed that the 1,000-fold induction in gene expression during pregnancy relied on all enhancers. Disabling the binding sites of STAT5, NFIB and ELF5 in the proximal enhancer incapacitated the entire super-enhancer. Altogether, these data suggest a temporal and functional enhancer hierarchy. The identification of mammary-specific super-enhancers and the mechanistic exploration of the Wap locus provide insights into the regulation of cell-type-specific expression of hormone-sensing genes.	[Shin, Ha Youn; Willi, Michaela; Yoo, Kyung Hyun; Zeng, Xianke; Wang, Chaochen; Metser, Gil; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Willi, Michaela] Med Univ Innsbruck, Div Bioinformat, Bioctr, Innsbruck, Austria	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Medical University of Innsbruck	Hennighausen, L (corresponding author), NIDDK, Lab Genet & Physiol, US Natl Inst Hlth, Bethesda, MD 20892 USA.	lotharh@mail.nih.gov	Wang, Chaochen/AAE-6657-2022; Wang, Chaochen/AAO-2998-2021; Shin, Ha Youn/B-1751-2017	Wang, Chaochen/0000-0003-2346-2884; Willi, Michaela/0000-0002-2248-1998; Shin, Ha Youn/0000-0002-8553-2107; Hennighausen, Lothar/0000-0001-8319-9841	IPR of the NIDDK/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK071001, ZIADK061000] Funding Source: NIH RePORTER	IPR of the NIDDK/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Smith from the NIDDK genomics core for never-ending help with next-generation sequencing and C. Liu from the NHLBI transgenic core for generating the CRISPR/Cas9-based mouse mutants. M.W. is a graduate student of the Individual Graduate Partnership Program (GPP) between NIH/NIDDK and the Medical University of Innsbruck. This work was performed in partial fulfillment of the graduation requirements for M.W. We thank K. Kang and S. Oh for discussions in the early stage of this project and Z. Trajanoski for advising M.W. during her graduate studies. This research was funded by the IPR of the NIDDK/NIH.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; BAYNA EM, 1990, NUCLEIC ACIDS RES, V18, P2977, DOI 10.1093/nar/18.10.2977; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; BURDON T, 1991, J BIOL CHEM, V266, P6909; BURDON TG, 1994, MOL ENDOCRINOL, V8, P1528, DOI 10.1210/me.8.11.1528; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fang Z, 2015, EUR J IMMUNOL, V45, P3150, DOI 10.1002/eji.201545713; Gonzalez AJ, 2015, NAT GENET, V47, P1249, DOI 10.1038/ng.3402; Gordon K, 1992, Biotechnology, V24, P425; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; GREENBERG NM, 1991, MOL ENDOCRINOL, V5, P1504, DOI 10.1210/mend-5-10-1504; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; HENNIGHAUSEN LG, 1982, EUR J BIOCHEM, V125, P131, DOI 10.1111/j.1432-1033.1982.tb06660.x; HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Kang K, 2014, MOL CELL BIOL, V34, P464, DOI 10.1128/MCB.00988-13; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lefebvre V., NUCL ACIDS RES; Li P, 2014, IMMUNOL REV, V261, P141, DOI 10.1111/imr.12199; LI S, 1995, MOL CELL BIOL, V15, P2063; LI S, 1994, J BIOL CHEM, V269, P14235; LI S, 1994, MOL ENDOCRINOL, V8, P1328, DOI 10.1210/me.8.10.1328; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114485; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; MCKNIGHT RA, 1995, TRANSGENIC RES, V4, P39, DOI 10.1007/BF01976500; McKnight RA, 1996, MOL REPROD DEV, V44, P179, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;179::AID-MRD6&gt;3.0.CO;2-K; MCKNIGHT RA, 1995, MOL ENDOCRINOL, V9, P717, DOI 10.1210/me.9.6.717; Metser G, 2016, NUCLEIC ACIDS RES, V44, P1052, DOI 10.1093/nar/gkv999; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Ong CT, 2012, EMBO REP, V13, P423, DOI 10.1038/embor.2012.52; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pelish HE, 2015, NATURE, V526, P273, DOI 10.1038/nature14904; Pinz S, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0063-y; PITTIUS CW, 1988, MOL ENDOCRINOL, V2, P1027, DOI 10.1210/mend-2-11-1027; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; RICHARDS DA, 1981, J BIOL CHEM, V256, P526; Robinson GW, 2014, MOL ENDOCRINOL, V28, P758, DOI 10.1210/me.2012-1387; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Thakurela S, 2015, GENOME RES, V25, P1309, DOI 10.1101/gr.190926.115; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Witte S, 2015, TRENDS IMMUNOL, V36, P519, DOI 10.1016/j.it.2015.07.005; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou HF, 2015, CELL HOST MICROBE, V17, P205, DOI 10.1016/j.chom.2014.12.013; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538	78	147	151	1	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					904	+		10.1038/ng.3606	http://dx.doi.org/10.1038/ng.3606			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27376239	Green Accepted			2022-12-25	WOS:000380755100014
J	Yu, L; Wang, GD; Ruan, J; Chen, YB; Yang, CP; Cao, X; Wu, H; Liu, YH; Du, ZL; Wang, XP; Yang, J; Cheng, SC; Zhong, L; Wang, L; Wang, X; Hu, JY; Fang, L; Bai, B; Wang, KL; Yuan, N; Wu, SF; Li, BG; Zhang, JG; Yang, YQ; Zhang, CL; Long, YC; Li, HS; Yang, JY; Irwin, DM; Ryder, OA; Li, Y; Wu, CI; Zhang, YP				Yu, Li; Wang, Guo-Dong; Ruan, Jue; Chen, Yong-Bin; Yang, Cui-Ping; Cao, Xue; Wu, Hong; Liu, Yan-Hu; Du, Zheng-Lin; Wang, Xiao-Ping; Yang, Jing; Cheng, Shao-Chen; Zhong, Li; Wang, Lu; Wang, Xuan; Hu, Jing-Yang; Fang, Lu; Bai, Bing; Wang, Kai-Le; Yuan, Na; Wu, Shi-Fang; Li, Bao-Guo; Zhang, Jin-Guo; Yang, Ye-Qin; Zhang, Cheng-Lin; Long, Yong-Cheng; Li, Hai-Shu; Yang, Jing-Yuan; Irwin, David M.; Ryder, Oliver A.; Li, Ying; Wu, Chung-I; Zhang, Ya-Ping			Genomic analysis of snub-nosed monkeys (Rhinopithecus) identifies genes and processes related to high-altitude adaptation	NATURE GENETICS			English	Article							PHYLOGENETIC ANALYSIS; REVEALS ADAPTATION; POPULATION HISTORY; ADAPTIVE EVOLUTION; WEB SERVER; SEQUENCE; DNA; ANNOTATION; ALIGNMENT; TIBETAN	The snub-nosed monkey genus Rhinopithecus includes five closely related species distributed across altitudinal gradients from 800 to 4,500 m. Rhinopithecus bieti, Rhinopithecus roxellana, and Rhinopithecus strykeri inhabit high-altitude habitats, whereas Rhinopithecus brelichi and Rhinopithecus avunculus inhabit lowland regions. We report the de novo whole-genome sequence of R. bieti and genomic sequences for the four other species. Eight shared substitutions were found in six genes related to lung function, DNA repair, and angiogenesis in the high-altitude snub-nosed monkeys. Functional assays showed that the high-altitude variant of CDT1 ( Ala537Val) renders cells more resistant to UV irradiation, and the high-altitude variants of RNASE4 ( Asn89Lys and Thr128Ile) confer enhanced ability to induce endothelial tube formation in vitro. Genomic scans in the R. bieti and R. roxellana populations identified signatures of selection between and within populations at genes involved in functions relevant to high-altitude adaptation. These results provide valuable insights into the adaptation to high altitude in the snub-nosed monkeys.	[Yu, Li; Wu, Hong; Liu, Yan-Hu; Wang, Xiao-Ping; Yang, Jing; Cheng, Shao-Chen; Zhong, Li; Wang, Lu; Hu, Jing-Yang; Bai, Bing] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresource Yu, Kunming, Peoples R China; [Wang, Guo-Dong; Cao, Xue; Wu, Hong; Wang, Xuan; Hu, Jing-Yang; Wu, Shi-Fang; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Ruan, Jue; Du, Zheng-Lin; Fang, Lu; Wang, Kai-Le; Yuan, Na; Wu, Chung-I] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Ruan, Jue] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China; [Chen, Yong-Bin; Yang, Cui-Ping] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Cao, Xue] Kunming Med Univ, Deparment Lab Anim Sci, Kunming, Peoples R China; [Wu, Hong; Liu, Yan-Hu; Cheng, Shao-Chen; Hu, Jing-Yang] Yunnan Univ, Sch Life Sci, Key Lab Anim Genet Div & Evolut High Educ Yunnan, Kunming, Peoples R China; [Wu, Hong; Hu, Jing-Yang] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Peoples R China; [Li, Bao-Guo] Northwest Univ, Coll Life Sci, Xian, Peoples R China; [Li, Bao-Guo] Shaanxi Acad Sci, Inst Zool, Xian, Peoples R China; [Zhang, Cheng-Lin] Beijing Zoo, Beijing Key Lab Capt Wildlife Technol, Beijing, Peoples R China; [Yang, Ye-Qin] Fanjing Mt Natl Nat Reserve, Fanjing, Guizhou, Peoples R China; [Long, Yong-Cheng] Sun Yat Sen Univ, Inst Primatol & Human Evolut, Guangzhou, Peoples R China; [Li, Hai-Shu] Nujiang Prefecture Forestry Bur, Nujiang, Yunnan, Peoples R China; [Yang, Jing-Yuan] Shennongjia Natl Nat Reserve, Jiangxi, Hubei, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Ryder, Oliver A.] San Diego Zoo Inst Conservat Res, Escondido, CA USA; [Li, Ying] Sichuan Agr Univ, Inst Anim Genet & Breeding, Yaan, Peoples R China; [Wu, Chung-I] Univ Chicago, Dept Ecol & Evolut, Chicago, IL USA	Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming Medical University; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest University Xi'an; Sun Yat Sen University; University of Toronto; Zoological Society of San Diego; Sichuan Agricultural University; University of Chicago	Wu, CI (corresponding author), Yunnan Univ, State Key Lab Conservat & Utilizat Bioresource Yu, Kunming, Peoples R China.; Yu, L (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.; Zhang, YP (corresponding author), Univ Chicago, Dept Ecol & Evolut, Chicago, IL USA.	yuli@ynu.edu.cn; cw16@uchicago.edu; zhangyp@mail.kiz.ac.cn	Zhong, Li/GZM-4358-2022; Zhang, Cheng/GRS-8698-2022; Wang, Kaile/ABF-1390-2021; xiaoping, wang/GRX-3807-2022; Yang, jing/AAB-5204-2019	Zhong, Li/0000-0003-1611-5171; Yang, jing/0000-0003-3223-2618; Ruan, Jue/0000-0003-3713-3192; Wang, Kaile/0000-0003-2249-1026; Irwin, David/0000-0001-6131-4933	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB13000000]; National Nature Science Foundation of China [91131904]; National Program for Support of Top-Notch Young Professionals; State Key Laboratory of Genetic Resources and Evolution [GREKF14-04]; program Innovative Research Team in University of Yunnan Province (IRTSTYN); National Natural Science Foundation of China [81322030, U1502224]; Yunnan Province High-Level Talents Introduced Program [2013HA021]; Yunnan Applied Basic Research Projects [2014FA038]; Animal Branch of the Germplasm Bank of Wild Species, Chinese Academy of Sciences	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Support of Top-Notch Young Professionals; State Key Laboratory of Genetic Resources and Evolution; program Innovative Research Team in University of Yunnan Province (IRTSTYN); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province High-Level Talents Introduced Program; Yunnan Applied Basic Research Projects; Animal Branch of the Germplasm Bank of Wild Species, Chinese Academy of Sciences	We thank Z.G. Wu for collection of the samples used for resequencing. We thank Z.H. Yang and J.Z. Zhang for assisting in data analyses. We thank Y.K. Wu and Y.H. Wang for help with the purification of RNASE4 proteins. We thank Y.C. Long and Z.F. Xiang for providing the photographs of snub-nosed monkeys. This study was supported jointly and equally by the Strategic Priority Research Program of the Chinese Academy of Sciences (to Y.-P.Z., G.-D.W., and Y.-B.C.; XDB13000000) and the National Nature Science Foundation of China (to L.Y.; 91131904). L.Y. was supported by the National Program for Support of Top-Notch Young Professionals, State Key Laboratory of Genetic Resources and Evolution (GREKF14-04) and by the program Innovative Research Team in University of Yunnan Province (IRTSTYN). Y.-B.C. was supported by the National Natural Science Foundation of China (81322030, U1502224), Yunnan Province High-Level Talents Introduced Program 2013HA021, and Yunnan Applied Basic Research Projects (2014FA038). This work was supported by the Animal Branch of the Germplasm Bank of Wild Species, Chinese Academy of Sciences (Large Research Infrastructure Funding).	Ai HS, 2015, NAT GENET, V47, P217, DOI 10.1038/ng.3199; Aldashev AA, 2002, AM J RESP CRIT CARE, V166, P1396, DOI 10.1164/rccm.200204-345OC; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alkorta-Aranburu G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003110; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Di Liddo R, 2010, MOL MED REP, V3, P127, DOI 10.3892/mmr_00000229; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Droma Y, 2008, WILD ENVIRON MED, V19, P22, DOI 10.1580/06-WEME-OR-073.1; Fallone F, 2013, ONCOGENE, V32, P4387, DOI 10.1038/onc.2012.462; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Galen SC, 2015, P NATL ACAD SCI USA, V112, P13958, DOI 10.1073/pnas.1507300112; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Ge RL, 1998, AM J PHYSIOL-HEART C, V274, pH1792, DOI 10.1152/ajpheart.1998.274.5.H1792; Geissmann T, 2011, AM J PRIMATOL, V73, P96, DOI 10.1002/ajp.20894; Gou X, 2014, GENOME RES, V24, P1308, DOI 10.1101/gr.171876.113; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo Y, 2012, MOL MED REP, V6, P631, DOI 10.3892/mmr.2012.964; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hammond EM, 2004, CANCER RES, V64, P6556, DOI 10.1158/0008-5472.CAN-04-1520; Holloway DE, 2001, PROTEIN EXPRES PURIF, V22, P307, DOI 10.1006/prep.2001.1434; Isaacs JS, 2004, J BIOL CHEM, V279, P16128, DOI 10.1074/jbc.M313342200; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Li BG, 2002, INT J PRIMATOL, V23, P1227, DOI 10.1023/A:1021122819845; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HP, 2003, GENETICS, V164, P269; Li M, 2004, INT J PRIMATOL, V25, P861, DOI 10.1023/B:IJOP.0000029126.27618.88; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li SP, 2013, ANGIOGENESIS, V16, P387, DOI 10.1007/s10456-012-9322-9; Liedigk R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037418; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu Z, 2007, MOL ECOL, V16, P3334, DOI 10.1111/j.1365-294X.2007.03383.x; Liu ZJ, 2009, MOL ECOL, V18, P3831, DOI 10.1111/j.1365-294X.2009.04330.x; LONG YC, 1994, PRIMATES, V35, P241, DOI 10.1007/BF02382060; LONG YC, 1996, CHINESE BIODIVERSITY, V4, P145; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mirarab S, 2014, BIOINFORMATICS, V30, pI541, DOI 10.1093/bioinformatics/btu462; Palomera-Sanchez Z, 2011, DNA REPAIR, V10, P119, DOI 10.1016/j.dnarep.2010.10.010; Pasha MAQ, 2001, ANN HUM GENET, V65, P531, DOI 10.1017/S0003480001008879; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Quan GQ, 2002, RES GOLDEN MONKEY; Ravn LS, 2008, PHARMACOGENET GENOM, V18, P525, DOI 10.1097/FPC.0b013e3282fce3bd; Roos Christian, 2007, Vietnamese Journal of Primatology, V1, P41; Ruan J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-711; Sakaguchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046480; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Valour D, 2014, PHYSIOL GENOMICS, V46, P39, DOI 10.1152/physiolgenomics.00091.2013; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang GD, 2014, GENOME BIOL EVOL, V6, P2122, DOI 10.1093/gbe/evu162; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wong CH, 2009, FORENSIC SCI INT, V192, P53, DOI 10.1016/j.forsciint.2009.07.019; Xie P, 2008, CELL SIGNAL, V20, P1671, DOI 10.1016/j.cellsig.2008.05.012; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang JZ, 1997, MOL BIOL EVOL, V14, P527, DOI 10.1093/oxfordjournals.molbev.a025789; Zhang W. T., 2014, CHINESE TEA, V10, P10, DOI DOI 10.1371/J0URNAL.PPAT.1004244; Zhang Z, 1998, J COMPUT BIOL, V5, P197, DOI 10.1089/cmb.1998.5.197; Zhang ZY, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2758; Zhou XM, 2014, NAT GENET, V46, P1303, DOI 10.1038/ng.3137; Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20; Zou ZT, 2015, MOL BIOL EVOL, V32, P2085, DOI 10.1093/molbev/msv091	96	67	78	15	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					947	+		10.1038/ng.3615	http://dx.doi.org/10.1038/ng.3615			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27399969	hybrid			2022-12-25	WOS:000380755100020
J	Weischenfeldt, J; Dubash, T; Drainas, AP; Mardin, BR; Chen, YY; Stutz, AM; Waszak, SM; Bosco, G; Halvorsen, AR; Raeder, B; Efthymiopoulos, T; Erkek, S; Siegl, C; Brenner, H; Brustugun, OT; Dieter, SM; Northcott, PA; Petersen, I; Pfister, SM; Schneider, M; Solberg, SK; Thunissen, E; Weichert, W; Zichner, T; Thomas, R; Peifer, M; Helland, A; Ball, CR; Jechlinger, M; Sotillo, R; Glimm, H; Korbel, JO				Weischenfeldt, Joachim; Dubash, Taronish; Drainas, Alexandros P.; Mardin, Balca R.; Chen, Yuanyuan; Stuetz, Adrian M.; Waszak, Sebastian M.; Bosco, Graziella; Halvorsen, Ann Rita; Raeder, Benjamin; Efthymiopoulos, Theocharis; Erkek, Serap; Siegl, Christine; Brenner, Hermann; Brustugun, Odd Terje; Dieter, Sebastian M.; Northcott, Paul A.; Petersen, Iver; Pfister, Stefan M.; Schneider, Martin; Solberg, Steinar K.; Thunissen, Erik; Weichert, Wilko; Zichner, Thomas; Thomas, Roman; Peifer, Martin; Helland, Aslaug; Ball, Claudia R.; Jechlinger, Martin; Sotillo, Rocio; Glimm, Hanno; Korbel, Jan O.			Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking	NATURE GENETICS			English	Article							SUPER-ENHANCERS; CHROMATIN DOMAINS; CELL IDENTITY; PAIRED-END; LANDSCAPE; MUTATIONS; GENOME; REARRANGEMENTS; EXPRESSION; PROMOTES	Extensive prior research focused on somatic copy-number alterations (SCNAs) affecting cancer genes, yet the extent to which recurrent SCNAs exert their influence through rearrangement of cis-regulatory elements (CREs) remains unclear. Here we present a framework for inferring cancer-related gene overexpression resulting from CRE reorganization (e.g., enhancer hijacking) by integrating SCNAs, gene expression data and information on topologically associating domains (TADS). Analysis of 7,416 cancer genomes uncovered several pan-cancer candidate genes, including IRS4, SMARCA1 and TERT. We demonstrate that IRS4 overexpression in lung cancer is associated with recurrent deletions in cis, and we present evidence supporting a tumor promoting role. We additionally pursued cancer-type-specific analyses and uncovered IGF2 as a target for enhancer hijacking in colorectal cancer. Recurrent tandem duplications intersecting with a TAD boundary mediate de novo formation of a 3D contact domain comprising IGF2 and a lineage-specific super-enhancer, resulting in high-level gene activation. Our framework enables systematic inference of CRE rearrangements mediating dysregulation in cancer.	[Weischenfeldt, Joachim; Drainas, Alexandros P.; Mardin, Balca R.; Stuetz, Adrian M.; Waszak, Sebastian M.; Raeder, Benjamin; Efthymiopoulos, Theocharis; Erkek, Serap; Zichner, Thomas; Korbel, Jan O.] EMBL, Genome Biol Unit, Heidelberg, Germany; [Weischenfeldt, Joachim] Univ Copenhagen, Finsen Lab, Rigshosp, Copenhagen, Denmark; [Weischenfeldt, Joachim] BRIC, Copenhagen, Denmark; [Dubash, Taronish; Siegl, Christine; Dieter, Sebastian M.; Ball, Claudia R.; Glimm, Hanno] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany; [Dubash, Taronish; Siegl, Christine; Dieter, Sebastian M.; Ball, Claudia R.; Glimm, Hanno] German Canc Res Ctr, Div Translat Oncol, Heidelberg, Germany; [Chen, Yuanyuan; Sotillo, Rocio] German Canc Res Ctr, Div Mol Thorac Oncol, Heidelberg, Germany; [Bosco, Graziella; Thomas, Roman; Peifer, Martin] Univ Cologne, Fac Med, Dept Translat Genom, Ctr Integrated Oncol Cologne Bonn, Cologne, Germany; [Halvorsen, Ann Rita; Brustugun, Odd Terje; Helland, Aslaug] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Canc Genet, Oslo, Norway; [Erkek, Serap; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brustugun, Odd Terje; Helland, Aslaug] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Northcott, Paul A.] St Jude Childrens Res Hosp, Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Petersen, Iver] Jena Univ Hosp, Inst Pathol, Jena, Germany; [Schneider, Martin] Heidelberg Univ Clin, Gen Surg, Heidelberg, Germany; [Solberg, Steinar K.] Oslo Univ Hosp, Rikshosp, Dept Cardiothorac Surg, Oslo, Norway; [Thunissen, Erik] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Weichert, Wilko] Tech Univ Munich, Inst Pathol, Munich, Germany; [Weichert, Wilko; Thomas, Roman] Univ Hosp Cologne, Dept Pathol, Cologne, Germany; [Weichert, Wilko; Ball, Claudia R.; Glimm, Hanno] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Heidelberg, Germany; [Peifer, Martin] Univ Cologne, CMMC, Cologne, Germany; [Jechlinger, Martin] EMBL, Cell Biol Unit, Heidelberg, Germany; [Korbel, Jan O.] EMBL EBI, Wellcome Trust Genome Campus, Cambridge, England	European Molecular Biology Laboratory (EMBL); Rigshospitalet; University of Copenhagen; University of Copenhagen; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; University of Oslo; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Oslo; St Jude Children's Research Hospital; Friedrich Schiller University of Jena; Ruprecht Karls University Heidelberg; University of Oslo; National Hospital Norway; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Technical University of Munich; University of Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Korbel, JO (corresponding author), EMBL, Genome Biol Unit, Heidelberg, Germany.; Glimm, H (corresponding author), Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany.; Glimm, H (corresponding author), German Canc Res Ctr, Div Translat Oncol, Heidelberg, Germany.; Glimm, H (corresponding author), German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Heidelberg, Germany.; Korbel, JO (corresponding author), EMBL EBI, Wellcome Trust Genome Campus, Cambridge, England.	hanno.glimm@nct-heidelberg.de; jan.korbel@embl-heidelberg.de	Jechlinger, Martin/AAC-9442-2020; Brenner, Hermann/B-4627-2017; Chen, Yuanyuan/GXG-2130-2022; Helland, Åslaug/H-3910-2015; Brenner, Hermann/ABE-6383-2020; Weischenfeldt, Joachim/O-3681-2015; Pfister, Stefan M/F-6860-2013; Erkek, Serap/AAV-5549-2020; Drainas, Alexandros/GNM-5498-2022; Waszak, Sebastian M./D-7828-2015; Northcott, Paul A/N-4022-2018	Brenner, Hermann/0000-0002-6129-1572; Helland, Åslaug/0000-0002-5520-0275; Brenner, Hermann/0000-0002-6129-1572; Weischenfeldt, Joachim/0000-0002-3917-5524; Pfister, Stefan M/0000-0002-5447-5322; Drainas, Alexandros/0000-0001-9081-9850; Waszak, Sebastian M./0000-0003-3042-9521; Northcott, Paul A/0000-0002-1220-5252; Zichner, Thomas/0000-0001-9848-7598; Peifer, Martin/0000-0002-5243-5503; Raeder, Benjamin/0000-0002-9494-8884; Bosco, Graziella/0000-0001-6601-4518; Ball, Claudia/0000-0002-1749-3791; Erkek, Serap/0000-0003-4439-5203; Jechlinger, Martin/0000-0002-3710-4466; Dieter, Sebastian/0000-0003-1324-7638; Mardin, Balca R/0000-0002-3903-9354; Sotillo, Rocio/0000-0002-0855-7917	Network of Excellence - European Commission [260791]; German Ministry for Science and Education (BMBF) [01KU1505F, 01ZX1303A, 01ZX1406]; European Research Council (ERC) Starting Grant [336045]; Danish Medical Research Council [DFF-4183-00233]; DFG [KFO 227/BA 4806/1-2, KFO 227/GL286/1-1]; Baden-Wurttemberg Stiftung [P-LS-ASII/33]; iMed (Helmholtz Initiative on Personalized Oncology); EU [TRANSCAN-2 ERA-NET]; German Cancer Aid (Colon-Resist-Net); SNSF Early Postdoc Mobility Fellowship [P2ELP3_155365]; EMBO Long-Term Fellowship [ALTF 755-2014]; German Cancer Research Center; Heidelberg School of Oncology	Network of Excellence - European Commission; German Ministry for Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); European Research Council (ERC) Starting Grant(European Research Council (ERC)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DFG(German Research Foundation (DFG)); Baden-Wurttemberg Stiftung; iMed (Helmholtz Initiative on Personalized Oncology); EU(European Commission); German Cancer Aid (Colon-Resist-Net); SNSF Early Postdoc Mobility Fellowship; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); German Cancer Research Center; Heidelberg School of Oncology	This research project was funded in part through Network of Excellence funding by the European Commission (260791 to J.O.K. and A.H.), grants from the German Ministry for Science and Education (BMBF) (01KU1505F to J.O.K. and S.M.P.; 01ZX1303A to R.T. and M.P.; 01ZX1406 to M.P.), a European Research Council (ERC) Starting Grant (336045 to J.O.K.), the Danish Medical Research Council (DFF-4183-00233 to LW.), the DFG (KFO 227/BA 4806/1-2 to C.R.B. and KFO 227/GL286/1-1 to H.G.), the Baden-Wurttemberg Stiftung (P-LS-ASII/33 to C.R.B. and H.G.), iMed (Helmholtz Initiative on Personalized Oncology to H.G.), the EU framework program Horizon2020 (TRANSCAN-2 ERA-NET to H.G.), and the German Cancer Aid (Colon-Resist-Net to C.R.B. and H.G.). S.M.W. received funding through an SNSF Early Postdoc Mobility Fellowship (P2ELP3_155365) and an EMBO Long-Term Fellowship (ALTF 755-2014). T.D. was supported by a scholarship from the German Cancer Research Center. S.M.D. was supported by the Heidelberg School of Oncology. The results reported here are in part based upon data generated by the TCGA Research Network ("URLs"), and we acknowledge the specimen donors as well as the research groups involved in the sampling, sequencing and processing of these data. We are grateful to the NCT Tissue Bank for providing samples in accordance with the regulations of the tissue bank and the approval of the ethics committee of Heidelberg University. We are grateful to the GeneCore, IT, mouse facility and Flow Cytometry core facilities at EMBL for excellent assistance. We thank E. Furlong and B. Klaus for valuable discussions during early stages of this project, N. Sidiropoulos for assistance with Hi -C plots, and N. Habermann for assistance with manuscript formatting and proofreading. pMD2.G and psPAX2 were gifts from D. Trono (EPFL, Lausanne, France).	Ahmad I, 2012, BBA-MOL CELL RES, V1823, P850, DOI 10.1016/j.bbamcr.2012.01.004; Anderson E, 2014, DEVELOPMENT, V141, P3934, DOI 10.1242/dev.108480; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brouwer-Visser J, 2015, CYTOKINE GROWTH F R, V26, P371, DOI 10.1016/j.cytogfr.2015.01.002; Chen J, 2014, CANCER CELL, V26, P160, DOI 10.1016/j.ccr.2014.07.021; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Dekker J, 2015, FEBS LETT, V589, P2877, DOI 10.1016/j.febslet.2015.08.044; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hinsby AM, 2004, J BIOL CHEM, V279, P46438, DOI 10.1074/jbc.M404537200; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Homma Y, 2014, J BIOL CHEM, V289, P26302, DOI 10.1074/jbc.M114.565945; Hoxhaj G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073327; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V209, P17, DOI 10.1016/j.mce.2003.08.003; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mehine M, 2014, FERTIL STERIL, V102, P621, DOI 10.1016/j.fertnstert.2014.06.050; Melton C, 2015, NAT GENET, V47, P710, DOI 10.1038/ng.3332; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Peifer M, 2015, NATURE, V526, P700, DOI 10.1038/nature14980; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Qu BH, 1999, J BIOL CHEM, V274, P31179, DOI 10.1074/jbc.274.44.31179; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Roy N, 2015, GENE DEV, V29, P658, DOI 10.1101/gad.256628.114; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shimwell NJ, 2009, ONCOGENE, V28, P686, DOI 10.1038/onc.2008.417; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Stein LD, 2015, NATURE, V523, P149, DOI 10.1038/523149a; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Uchida T, 2000, MOL CELL BIOL, V20, P126, DOI 10.1128/MCB.20.1.126-138.2000; Valentijn LJ, 2015, NAT GENET, V47, P1411, DOI 10.1038/ng.3438; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xia ZQ, 2014, INT J CLIN EXP MED, V7, P3763; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	76	214	220	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					65	74		10.1038/ng.3722	http://dx.doi.org/10.1038/ng.3722			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27869826	Green Accepted			2022-12-25	WOS:000390976600012
J	Stucki, D; Brites, D; Jeljeli, L; Coscolla, M; Liu, QY; Trauner, A; Fenner, L; Rutaihwa, L; Borrell, S; Luo, T; Gao, Q; Kato-Maeda, M; Ballif, M; Egger, M; Macedo, R; Mardassi, H; Moreno, M; Vilanova, GT; Fyfe, J; Globan, M; Thomas, J; Jamieson, F; Guthrie, JL; Asante-Poku, A; Yeboah-Manu, D; Wampande, E; Ssengooba, W; Joloba, M; Boom, WH; Basu, I; Bower, J; Saraiva, M; Vasconcellos, SEG; Suffys, P; Koch, A; Wilkinson, R; Gail-Bekker, L; Malla, B; Ley, SD; Beck, HP; de Jong, BC; Toit, K; Sanchez-Padilla, E; Bonnet, M; Gil-Brusola, A; Frank, M; Beng, VNP; Eisenach, K; Alani, I; Ndung'u, PW; Revathi, G; Gehre, F; Akter, S; Ntoumi, F; Stewart-Isherwood, L; Ntinginya, NE; Rachow, A; Hoelscher, M; Cirillo, DM; Skenders, G; Hoffner, S; Bakonyte, D; Stakenas, P; Diel, R; Crudu, V; Moldovan, O; Al-Hajoj, S; Otero, L; Barletta, F; Carter, EJ; Diero, L; Supply, P; Comas, I; Niemann, S; Gagneux, S				Stucki, David; Brites, Daniela; Jeljeli, Leila; Coscolla, Mireia; Liu, Qingyun; Trauner, Andrej; Fenner, Lukas; Rutaihwa, Liliana; Borrell, Sonia; Luo, Tao; Gao, Qian; Kato-Maeda, Midori; Ballif, Marie; Egger, Matthias; Macedo, Rita; Mardassi, Helmi; Moreno, Milagros; Tudo Vilanova, Griselda; Fyfe, Janet; Globan, Maria; Thomas, Jackson; Jamieson, Frances; Guthrie, Jennifer L.; Asante-Poku, Adwoa; Yeboah-Manu, Dorothy; Wampande, Eddie; Ssengooba, Willy; Joloba, Moses; Boom, W. Henry; Basu, Indira; Bower, James; Saraiva, Margarida; Vasconcellos, Sidra E. G.; Suffys, Philip; Koch, Anastasia; Wilkinson, Robert; Gail-Bekker, Linda; Malla, Bijaya; Ley, Serej D.; Beck, Hans-Peter; de Jong, Bouke C.; Toit, Kadri; Sanchez-Padilla, Elisabeth; Bonnet, Maryline; Gil-Brusola, Ana; Frank, Matthias; Beng, Veronique N. Penlap; Eisenach, Kathleen; Alani, Issam; Ndung'u, Perpetual Wangui; Revathi, Gunturu; Gehre, Florian; Akter, Suriya; Ntoumi, Francine; Stewart-Isherwood, Lynsey; Ntinginya, Nyanda E.; Rachow, Andrea; Hoelscher, Michael; Cirillo, Daniela Maria; Skenders, Girts; Hoffner, Sven; Bakonyte, Daiva; Stakenas, Petras; Diel, Roland; Crudu, Valeriu; Moldovan, Olga; Al-Hajoj, Sahal; Otero, Larissa; Barletta, Francesca; Carter, E. Jane; Diero, Lameck; Supply, Philip; Comas, Inack; Niemann, Stefan; Gagneux, Sebastien			Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages	NATURE GENETICS			English	Article							PAPUA-NEW-GUINEA; GENETIC DIVERSITY; RESISTANT TUBERCULOSIS; ANTIGENIC VARIATION; GENOMIC DIVERSITY; HIV-INFECTION; SOUTH-AFRICA; POPULATION; PATHOGENS; EVOLUTION	Generalist and specialist species differ in the breadth of their ecological niches. Little is known about the niche width of obligate human pathogens. Here we analyzed a global collection of Mycobacterium tuberculosis lineage 4 clinical isolates, the most geographically widespread cause of human tuberculosis. We show that lineage 4 comprises globally distributed and geographically restricted sublineages, suggesting a distinction between generalists and specialists. Population genomic analyses showed that, whereas the majority of human T cell epitopes were conserved in all sublineages, the proportion of variable epitopes was higher in generalists. Our data further support a European origin for the most common generalist sublineage. Hence, the global success of lineage 4 reflects distinct strategies adopted by different sublineages and the influence of human migration.	[Stucki, David; Brites, Daniela; Coscolla, Mireia; Trauner, Andrej; Fenner, Lukas; Rutaihwa, Liliana; Borrell, Sonia; Ballif, Marie; Malla, Bijaya; Ley, Serej D.; Beck, Hans-Peter; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Stucki, David; Brites, Daniela; Coscolla, Mireia; Trauner, Andrej; Fenner, Lukas; Rutaihwa, Liliana; Borrell, Sonia; Ballif, Marie; Malla, Bijaya; Ley, Serej D.; Beck, Hans-Peter; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Jeljeli, Leila; Niemann, Stefan] Forschungszentrum Borstel, Borstel, Germany; [Jeljeli, Leila; Mardassi, Helmi] Univ Tunis El Manar, Inst Pasteur Tunis, Tunis, Tunisia; [Liu, Qingyun; Gao, Qian] Fudan Univ, Key Lab Med Mol Virol, Minist Educ, Shanghai, Peoples R China; [Liu, Qingyun; Gao, Qian] Fudan Univ, Minist Hlth, Inst Biomed Sci, Shanghai, Peoples R China; [Liu, Qingyun; Gao, Qian] Fudan Univ, Inst Med Microbiol, Sch Basic Med Sci, Shanghai, Peoples R China; [Fenner, Lukas; Ballif, Marie; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Luo, Tao] Sichuan Univ, West China Ctr Med Sci, Sch Basic Med Sci, Laborat Infect & Immun, Chengdu, Peoples R China; [Kato-Maeda, Midori] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Macedo, Rita] Lab Saude Publ, Lisbon, Portugal; [Moreno, Milagros] Hosp Nossa Senhora Paz, Cubal, Angola; [Tudo Vilanova, Griselda] Hosp Clin ISGlobal, Microbiol Serv, Barcelona, Spain; [Fyfe, Janet; Globan, Maria] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Thomas, Jackson] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Jamieson, Frances; Guthrie, Jennifer L.] Publ Hlth Ontario, Toronto, ON, Canada; [Asante-Poku, Adwoa; Yeboah-Manu, Dorothy] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Wampande, Eddie; Ssengooba, Willy; Joloba, Moses] Makerere Univ, Dept Med Microbiol, Kampala, Uganda; [Ssengooba, Willy] Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands; [Boom, W. Henry] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Basu, Indira; Bower, James] Auckland City Hosp, LabPlus, Auckland, New Zealand; [Saraiva, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Saraiva, Margarida] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Vasconcellos, Sidra E. G.; Suffys, Philip] Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Koch, Anastasia; Wilkinson, Robert; Gail-Bekker, Linda] Univ Cape Town, Institute Infect Dis & Mol Med, Cape Town, South Africa; [Koch, Anastasia; Wilkinson, Robert; Gail-Bekker, Linda] Univ Cape Town, Dept Clin Lab Sci, Cape Town, South Africa; [Wilkinson, Robert] Imperial Coll London, Dept Med, London, England; [Wilkinson, Robert] Francis Crick Inst Mill Hill Lab, London, England; [Ley, Serej D.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [de Jong, Bouke C.; Gehre, Florian; Akter, Suriya] Inst Trop Med, Antwerp, Belgium; [Toit, Kadri] Tartu Univ Hosp, United Labs, Mycobacteriol, Tartu, Estonia; [Sanchez-Padilla, Elisabeth; Bonnet, Maryline] Epicentre, Dept Clin Res, Paris, France; [Gil-Brusola, Ana] Univ Hosp La Fe, Dept Microbiol, Valencia, Spain; [Frank, Matthias; Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Beng, Veronique N. Penlap] Univ Yaounde I, Biotechnol Ctr BTC, Inst Lab TB Res LTR, Yaounde, Cameroon; [Eisenach, Kathleen] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Alani, Issam] Fac Med Technol, Dept Med Lab Technol, Baghdad, Iraq; [Ndung'u, Perpetual Wangui] Jomo Kenyatta Univ Agr & Technol, Inst Trop Med & Infect Dis ITROMID, Nairobi, Kenya; [Revathi, Gunturu] Aga Khan Univ Hosp, Dept Pathol, Nairobi, Kenya; [Gehre, Florian] MRC, Fajara, Gambia; [Ntoumi, Francine] Univ Marien Gouabi, Fdn Congolaise Rech Med, Brazzaville, Rep Congo; [Stewart-Isherwood, Lynsey] Univ Witwatersrand, Right Care & Clin HIV Res Unit, Johannesburg, South Africa; [Ntinginya, Nyanda E.] Mbeya Med Res Ctr NIMR MMRC, Natl Inst Med Res, Mbeya, Tanzania; [Rachow, Andrea; Hoelscher, Michael] Univ Munich, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Rachow, Andrea; Hoelscher, Michael] German Ctr Infect Res DZIF, Munich, Germany; [Cirillo, Daniela Maria] IRCCS, San Raffaele Sci Inst, Emerging Bacterial Pathogens Unit, Milan, Italy; [Skenders, Girts] Riga East Univ Hosp, Ctr TB & Lung Dis, Riga, Latvia; [Hoffner, Sven] Publ Hlth Agcy Sweden, Dept Microbiol, WH0 Supranatl TB Reference Lab, Solna, Sweden; [Bakonyte, Daiva; Stakenas, Petras] Vilnius Univ, Inst Biotechnol, Dept Immunol & Cell Biol, Vilnius, Lithuania; [Diel, Roland] Schleswig Holstein Univ Hosp, Inst Epidemiol, Kiel, Germany; [Crudu, Valeriu] Phthysiopneumol Inst, Natl TB Reference Lab, Kishinev, Moldova; [Moldovan, Olga] Marius Nasta Pneumophtisiol Inst, Bucharest, Romania; [Al-Hajoj, Sahal] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh, Saudi Arabia; [Barletta, Francesca] Univ Peruana Cayetano Heredia, Instituto Med Trop Alexander von Humboldt, Mol Epidemiol Unit TB, Lima, Peru; [Carter, E. Jane] Brown Univ, Miriam Hosp, Warren Alpert Sch Med, Providence, RI USA; [Carter, E. Jane; Diero, Lameck] Moi Univ, Sch Med, Eldoret, Kenya; [Supply, Philip] Univ Lille, CNRS, INSERM,U1019,UMR 8204, CHU Lille,Inst Pasteur Lille,Ctr Infect & Immunit, Lille, France; [Comas, Inack] Ilnst Biomed Valencia IBV CSIC, Valencia, Spain; [Comas, Inack] CIBER Epidemiol & Publ Hlth, Madrid, Spain; [Niemann, Stefan] German Ctr Infect Res, Borstel Site, Borstel, Germany	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Forschungszentrum Borstel; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Fudan University; Fudan University; Fudan University; University of Bern; Sichuan University; University of California System; University of California San Francisco; Victorian Infectious Diseases Reference Laboratory; Ifakara Health Institute; University of Ghana; Makerere University; University of Amsterdam; Case Western Reserve University; Auckland City Hospital; Universidade do Minho; Fundacao Oswaldo Cruz; University of Cape Town; University of Cape Town; Imperial College London; Francis Crick Institute; PNG Institute Of Medical Research; Institute of Tropical Medicine (ITM); Eberhard Karls University of Tubingen; University of Yaounde I; University of Arkansas System; University of Arkansas Medical Sciences; Jomo Kenyatta University of Agriculture & Technology; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; University of Munich; German Center for Infection Research; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Riga East University Hospital; Public Health Agency of Sweden; Vilnius University; University of Kiel; Schleswig Holstein University Hospital; "Marius Nasta" Pneumophtisiology Institute; King Faisal Specialist Hospital & Research Center; Universidad Peruana Cayetano Heredia; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Moi University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; German Center for Infection Research	Gagneux, S (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Gagneux, S (corresponding author), Univ Basel, Basel, Switzerland.	sebastien.gagneux@unibas.ch	Niemann, Stefan/C-9327-2011; Comas, Iñaki/AAA-1155-2019; Ssengooba, Willy/ABE-2168-2020; Cirillo, Daniela Maria/AAB-3646-2019; Guthrie, Jennifer/ABE-2378-2021; Gagneux, Sebastien/ABE-7909-2020; suffys, philip/E-3009-2013; AL-Ani, Issam/AAH-9679-2019; Ssengooba, Willy/AAG-1202-2020; Brites, Daniela/AGL-8378-2022; Saraiva, Margarida/E-8781-2011; Gil-Brusola, Ana/ABD-4999-2021; Coscolla, Mireia/ABD-7942-2021; , 罗涛/AHA-1191-2022; Asante-Poku, Adwoa/AAF-5216-2020; Hoelscher, Michael/D-3436-2012; vasconcellos, Sidra E G Ezidio gonçalves/H-9651-2014; de Jong, Bouke/A-3636-2013; Supply, Philip/A-9580-2019; Yeboah-Manu, Dorothy/A-1933-2016	Comas, Iñaki/0000-0001-5504-9408; Ssengooba, Willy/0000-0002-1643-110X; Cirillo, Daniela Maria/0000-0001-6415-1535; Guthrie, Jennifer/0000-0001-8565-203X; Ssengooba, Willy/0000-0002-1643-110X; Brites, Daniela/0000-0002-8090-2287; Saraiva, Margarida/0000-0002-8180-1293; vasconcellos, Sidra E G Ezidio gonçalves/0000-0001-6983-1310; Niemann, Stefan/0000-0002-6604-0684; Gil-Brusola, Ana/0000-0002-4418-3676; Coscolla, Mireia/0000-0003-0752-0538; Macedo, Rita/0000-0003-2184-5136; Beck, Hans-Peter/0000-0001-8326-4834; de Jong, Bouke/0000-0002-1017-4675; Otero, Larissa/0000-0002-8348-4340; AL-Ani, Issam/0000-0002-4084-9442; Gagneux, Sebastien/0000-0001-7783-9048; Skenders, Girts/0000-0002-8514-5991; Mollel, Jackson Thomas/0000-0002-9078-793X; Fenner, Lukas/0000-0003-3309-4835; Wilkinson, Robert/0000-0002-2753-1800; Asante-Poku, Adwoa/0000-0001-8929-193X; Liu, Qingyun/0000-0002-2284-5050; Ley, Serej D./0000-0002-2705-9120; Supply, Philip/0000-0003-3690-3853; Egger, Matthias/0000-0001-7462-5132; Stucki, David/0000-0003-0131-9980; Yeboah-Manu, Dorothy/0000-0002-1663-6287; Rutaihwa, Liliana K/0000-0002-4092-2291; Koch, Anastasia Sideris/0000-0002-5897-4196; Trauner, Andrej/0000-0002-6260-9829; Klaos, Kadri/0000-0002-0055-755X; BEKKER, LINDA-GAIL/0000-0002-0755-4386	Swiss National Science Foundation [310030_166687, 320030_153442]; Swiss HIV Cohort Study grant [740]; European Research Council [309540-EVODRTB]; German Center for Infection Research (DZIF); Novartis Foundation; Natural Science Foundation of China [91631301]; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [5U01-AI069924-05]; TB-PAN-NET project [FP7-223681]; PathoNgenTrace project [FP7-278864-2]; SystemsX.ch; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss HIV Cohort Study grant; European Research Council(European Research Council (ERC)European Commission); German Center for Infection Research (DZIF); Novartis Foundation(Novartis); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); TB-PAN-NET project; PathoNgenTrace project; SystemsX.ch; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Lecher, S. Li and J. Zallet for technical support. Calculations were performed at the sciCORE scientific computing core facility at the University of Basel. This work was supported by the Swiss National Science Foundation (grants 310030_166687 (S.G.) and 320030_153442 (M.E.) and Swiss HIV Cohort Study grant 740 to L.F.), the European Research Council (309540-EVODRTB to S.G.), TB-PAN-NET (FP7-223681 to S.N.), PathoNgenTrace projects (FP7-278864-2 to S.N.), SystemsX.ch (S.G.), the German Center for Infection Research (DZIF; S.N.), the Novartis Foundation (S.G.), the Natural Science Foundation of China (91631301 to Q.G.), and the National Institute of Allergy and Infectious Diseases (5U01-AI069924-05) of the US National Institutes of Health (M.E.).	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Asante-Poku A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003370; Baily S.L., 1993, MASS MIGRATION MODER; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Ballif M, 2012, INT J TUBERC LUNG D, V16, P1100, DOI 10.5588/ijtld.11.0779; BATES JH, 1993, MED CLIN N AM, V77, P1205, DOI 10.1016/S0025-7125(16)30188-2; Bekmurzayeva A, 2013, TUBERCULOSIS, V93, P381, DOI 10.1016/j.tube.2013.03.003; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; Bouakaze C, 2011, J CLIN MICROBIOL, V49, P3292, DOI 10.1128/JCM.00744-11; Brites D, 2015, IMMUNOL REV, V264, P6, DOI 10.1111/imr.12264; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Bryant JM, 2013, LANCET RESP MED, V1, P786, DOI 10.1016/S2213-2600(13)70231-5; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Clark TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083012; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Comas I, 2015, CURR BIOL, V25, P3260, DOI 10.1016/j.cub.2015.10.061; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Coppola M, 2015, CLIN VACCINE IMMUNOL, V22, P1060, DOI 10.1128/CVI.00271-15; Coscolla M, 2015, CELL HOST MICROBE, V18, P538, DOI 10.1016/j.chom.2015.10.008; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Coscolla M, 2013, EMERG INFECT DIS, V19, P969, DOI 10.3201/eid1906.121012; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; de Araujo LS, 2015, TUBERCULOSIS, V95, P751, DOI 10.1016/j.tube.2015.08.002; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Ernst JD, 2008, TUBERCULOSIS, V88, P366, DOI 10.1016/j.tube.2007.11.002; Esparza M, 2015, SCAND J IMMUNOL, V81, P46, DOI 10.1111/sji.12249; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Fenner L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003318; Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Guerra-Assuncao JA, 2015, J INFECT DIS, V211, P1154, DOI 10.1093/infdis/jiu574; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P3795, DOI 10.1128/JCM.01726-14; Juarez MD, 2001, FEMS MICROBIOL LETT, V203, P95, DOI 10.1111/j.1574-6968.2001.tb10826.x; Kay GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7717; Kirzinger MWB, 2012, TRENDS MICROBIOL, V20, P88, DOI 10.1016/j.tim.2011.11.006; Lanzas F, 2013, J CLIN MICROBIOL, V51, P3277, DOI 10.1128/JCM.01122-13; Ley SD, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0307-2; Luo T, 2015, P NATL ACAD SCI USA, V112, P8136, DOI 10.1073/pnas.1424063112; Malla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052297; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Mokrousov I, 2016, MOL PHYLOGENET EVOL, V99, P133, DOI 10.1016/j.ympev.2016.03.020; NAGAI S, 1991, INFECT IMMUN, V59, P372, DOI 10.1128/IAI.59.1.372-382.1991; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Pepperell CS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003543; Perdigao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-991; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stucki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041253; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Vouga M, 2016, CLIN MICROBIOL INFEC, V22, P12, DOI 10.1016/j.cmi.2015.10.010; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wampande EM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-484; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; World Health Organization, 2015, GLOB TUB CONTR SURV; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946	79	200	203	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1535	1543		10.1038/ng.3704	http://dx.doi.org/10.1038/ng.3704			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27798628	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000389011100014
J	Choi, YK; Maki, T; Mandeville, ET; Koh, SH; Hayakawa, K; Arai, K; Kim, YM; Whalen, MJ; Xing, CH; Wang, XY; Kim, KW; Lo, EH				Choi, Yoon Kyung; Maki, Takakuni; Mandeville, Emiri T.; Koh, Seong-Ho; Hayakawa, Kazuhide; Arai, Ken; Kim, Young-Myeong; Whalen, Michael J.; Xing, Changhong; Wang, Xiaoying; Kim, Kyu-Won; Lo, Eng H.			Dual effects of carbon monoxide on pericytes and neurogenesis in traumatic brain injury	NATURE MEDICINE			English	Article							ADULT BRAIN; DISEASE	At low levels, carbon monoxide (CO) has physiological roles as a second messenger and neuromodulator(1,2). Here we assess the effects of CO in a mouse model of traumatic brain injury (TBI). Treatment with CO-releasing molecule (CORM)-3 reduced pericyte death and ameliorated the progression of neurological deficits. In contrast, although treatment with the radical scavenger N-tert-butyl-a-phenylnitrone (PBN) also reduced pericyte death, neurological outcomes were not rescued. As compared to vehicle-treated control and PBN-treated mice, CORM-3-treated mice showed higher levels of phosphorylated neural nitric oxide synthase within neural stem cells (NSCs). Inhibition of nitric oxide synthase diminished the CORM-3-mediated increase in the number of cells that stained positive for both the neuronal marker NeuN and 5-bromo-2'-deoxyuridine (BrdU; a marker for proliferating cells) in vivo, consequently interfering with neurological recovery after TBI. Because NSCs seemed to be in close proximity to pericytes, we asked whether cross-talk between pericytes and NSCs was induced by CORM-3, thereby promoting neurogenesis. In pericyte cultures that were undergoing oxygen and glucose deprivation, conditioned cell culture medium collected after CORM-3 treatment enhanced the in vitro differentiation of NSCs into mature neurons. Taken together, these findings suggest that CO treatment may provide a therapeutic approach for TBI by preventing pericyte death, rescuing cross-talk with NSCs and promoting neurogenesis.	[Choi, Yoon Kyung; Maki, Takakuni; Mandeville, Emiri T.; Koh, Seong-Ho; Hayakawa, Kazuhide; Arai, Ken; Xing, Changhong; Wang, Xiaoying; Lo, Eng H.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Choi, Yoon Kyung; Maki, Takakuni; Mandeville, Emiri T.; Koh, Seong-Ho; Hayakawa, Kazuhide; Arai, Ken; Xing, Changhong; Wang, Xiaoying; Lo, Eng H.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Koh, Seong-Ho] Hanyang Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon, Gangwon Do, South Korea; [Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA USA; [Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul, South Korea	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Hanyang University; Kangwon National University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Seoul National University (SNU)	Choi, YK; Lo, EH (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA.; Choi, YK; Lo, EH (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA.	yoonkyung@kangwon.ac.kr; lo@helix.mgh.harvard.edu	眞木, 崇州/AAO-1160-2020; Kim, Kyu Won/AAJ-7213-2020; Choi, Yoon Kyung/AGX-0481-2022	Choi, Yoon Kyung/0000-0003-0242-9612; Koh, Seong-Ho/0000-0001-5419-5761	US National Institutes of Health; Rappaport Foundation; National Research Foundation of Korea; Global Research Laboratory Program of Korea	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rappaport Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Global Research Laboratory Program of Korea	This work was supported in part by grants from the US National Institutes of Health (K.H., K.A., M.J.W., C.X., X.W. and E.H.L.), the Rappaport Foundation (E.H.L.), the Research Abroad grant from the National Research Foundation of Korea (Y.K.C., S.-H.K., Y.-M.K. and K.-W.K.) and the Global Research Laboratory Program of Korea (K.-WK.). The vector expressing the HIF-1 alpha double mutant was kindly provided by G.L. Semenza (Johns Hopkins University School of Medicine).	Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Chen JJ, 2004, DEV BIOL, V269, P165, DOI 10.1016/j.ydbio.2004.01.024; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Hu XM, 2014, PROG NEUROBIOL, V119, P60, DOI 10.1016/j.pneurobio.2014.06.002; Lo EH, 2014, VASCULAR MECH CNS TR; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Xing C., 2016, PROG NEUROBIOL; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022	17	86	90	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1335	1341		10.1038/nm.4188	http://dx.doi.org/10.1038/nm.4188			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27668935				2022-12-25	WOS:000387302300027
J	Salcini, AE				Salcini, Anna Elisabetta			Dangerous R loops form in the absence of H3K9 methylation	NATURE GENETICS			English	Editorial Material							EMBRYONIC STEM-CELLS; HISTONE; HETEROCHROMATIN; GERMLINE; CANCER	Methylation of histone H3 on lysine 9 (H3K9) is a hallmark of transcriptionally inactive heterochromatin that is deregulated in pathological conditions. A new study shows that complete loss of H3K9 methylation in Caenorhabditis elegans leads to derepression of repetitive elements and formation of DNA:RNA hybrids (R loops), resulting in increased rates of repeat-specific mutation.	[Salcini, Anna Elisabetta] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	University of Copenhagen	Salcini, AE (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark.	lisa.salcini@bric.ku.dk	Salcini, Anna Elisabetta/G-4472-2017	Salcini, Anna Elisabetta/0000-0001-5828-2512				Bulut-Karslioglu A, 2014, MOL CELL, V55, P277, DOI 10.1016/j.molcel.2014.05.029; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Gibert JM, 2007, PLOS GENET, V3, P266, DOI 10.1371/journal.pgen.0030030; Liu S, 2014, GENE DEV, V28, P2041, DOI 10.1101/gad.244848.114; Nestorov P, 2013, CURR TOP DEV BIOL, V104, P243, DOI 10.1016/B978-0-12-416027-9.00008-5; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Robert VJ, 2014, CELL REP, V9, P443, DOI 10.1016/j.celrep.2014.09.018; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Wagner T, 2012, NAT BIOTECHNOL, V30, P622, DOI 10.1038/nbt.2300; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Zeller P, 2016, NAT GENET, V48, P1385, DOI 10.1038/ng.3672	14	0	0	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1299	1300		10.1038/ng.3705	http://dx.doi.org/10.1038/ng.3705			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27787508				2022-12-25	WOS:000386543400003
J	Ernst, RJ; Krogager, TP; Maywood, ES; Zanchi, R; Beranek, V; Elliott, TS; Barry, NP; Hastings, MH; Chin, JW				Ernst, Russell J.; Krogager, Toke P.; Maywood, Elizabeth S.; Zanchi, Roberto; Beranek, Vaclav; Elliott, Thomas S.; Barry, Nicholas P.; Hastings, Michael H.; Chin, Jason W.			Genetic code expansion in the mouse brain	NATURE CHEMICAL BIOLOGY			English	Article							UNNATURAL AMINO-ACIDS; MAMMALIAN-CELLS; SUPRACHIASMATIC NUCLEUS; EXPRESSION; PROTEINS; OSCILLATIONS; CHEMISTRY; TISSUES; MICE; TIME	Site-specific incorporation of non-natural amino acids into proteins, via genetic code expansion with pyrrolysyl tRNA synthetase (PylRS) and tRNA(CUA)(pyl) pairs (and their evolved derivatives) from Methanosarcina sp., forms the basis of powerful approaches to probe and control protein function in cells and invertebrate organisms. Here we demonstrate that adeno-associated viral delivery of these pairs enables efficient genetic code expansion in primary neuronal culture, organotypic brain slices and the brains of live mice.	[Ernst, Russell J.; Krogager, Toke P.; Maywood, Elizabeth S.; Zanchi, Roberto; Beranek, Vaclav; Elliott, Thomas S.; Barry, Nicholas P.; Hastings, Michael H.; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge, England	MRC Laboratory Molecular Biology	Chin, JW (corresponding author), MRC, Mol Biol Lab, Cambridge, England.	chin@mrc-lmb.cam.ac.uk		Hastings, Michael Harvey/0000-0001-8576-6651	Medical Research Council (MRC), UK [MC_U105181009, MC_UP_A024_1008, MC_U105170643]; MRC case studentship (Nikon); MRC [MC_U105170643, MC_UP_A024_1008] Funding Source: UKRI; Medical Research Council [MC_U105170643, MC_UP_A024_1008, 1560461] Funding Source: researchfish	Medical Research Council (MRC), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC case studentship (Nikon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (MRC), UK (MC_U105181009 and MC_UP_A024_1008, to J.W.C., MC_U105170643 to M.H.H.). V.B. is supported by an MRC case studentship (Nikon). We thank the MRC biomedical facility staff at ARES for their help.	Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260; Bianco A, 2012, NAT CHEM BIOL, V8, P748, DOI [10.1038/nchembio.1043, 10.1038/NCHEMBIO.1043]; Brancaccio M, 2013, NEURON, V78, P714, DOI 10.1016/j.neuron.2013.03.011; Buvoli M, 2000, MOL CELL BIOL, V20, P3116, DOI 10.1128/MCB.20.9.3116-3124.2000; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Elliott TS, 2014, NAT BIOTECHNOL, V32, P465, DOI 10.1038/nbt.2860; Fossella JA, 2006, COGN AFFECT BEHAV NE, V6, P1, DOI 10.3758/CABN.6.1.1; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Hancock SM, 2010, J AM CHEM SOC, V132, P14819, DOI 10.1021/ja104609m; Hastings MH, 2005, METHOD ENZYMOL, V393, P579, DOI 10.1016/S0076-6879(05)93030-9; Jaki T, 2011, PHARM STAT, V10, P284, DOI 10.1002/pst.449; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kang JY, 2013, NEURON, V80, P358, DOI 10.1016/j.neuron.2013.08.016; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Lang K, 2012, J AM CHEM SOC, V134, P10317, DOI 10.1021/ja302832g; Li FH, 2013, ANGEW CHEM INT EDIT, V52, P9700, DOI 10.1002/anie.201303477; Lin SX, 2011, J AM CHEM SOC, V133, P20581, DOI 10.1021/ja209008w; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Nguyen DP, 2009, J AM CHEM SOC, V131, P14194, DOI 10.1021/ja906603s; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; Schmied WH, 2014, J AM CHEM SOC, V136, P15577, DOI 10.1021/ja5069728; Uttamapinant C, 2013, NAT PROTOC, V8, P1620, DOI 10.1038/nprot.2013.096; Xue L, 2015, NAT CHEM BIOL, V11, P917, DOI 10.1038/nchembio.1959; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	31	76	76	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					776	+		10.1038/nchembio.2160	http://dx.doi.org/10.1038/nchembio.2160			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27571478	Green Accepted			2022-12-25	WOS:000384248600007
J	Shen, CH; Kim, SH; Trousil, S; Frederick, DT; Piris, A; Yuan, P; Cai, L; Gu, L; Li, M; Lee, JH; Mitra, D; Fisher, DE; Sullivan, RJ; Flaherty, KT; Zheng, B				Shen, Che-Hung; Kim, Sun Hye; Trousil, Sebastian; Frederick, Dennie T.; Piris, Adriano; Yuan, Ping; Cai, Li; Gu, Lei; Li, Man; Lee, Jung Hyun; Mitra, Devarati; Fisher, David E.; Sullivan, Ryan J.; Flaherty, Keith T.; Zheng, Bin			Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; ACQUIRED-RESISTANCE; BLADDER-CANCER; METASTATIC MELANOMA; CELL-PROLIFERATION; GENOMIC LANDSCAPE; EWING SARCOMA; BINDING SITES; B-RAF; MUTATIONS	The protein kinase B-Raf proto-oncogene, serine/threonine kinase (BRAF) is an oncogenic driver and therapeutic target in melanoma. Inhibitors of BRAF (BRAFi) have shown high response rates and extended survival in patients with melanoma who bear tumors that express mutations encoding BRAF proteins mutant at Val600, but a vast majority of these patients develop drug resistance(1,2). Here we show that loss of stromal antigen 2 (STAG2) or STAG3, which encode subunits of the cohesin complex, in melanoma cells results in resistance to BRAFi. We identified loss-of-function mutations in STAG2, as well as decreased expression of STAG2 or STAG3 proteins in several tumor samples from patients with acquired resistance to BRAFi and in BRAFi-resistant melanoma cell lines. Knockdown of STAG2 or STAG3 expression decreased sensitivity of BRAF(Val600Glu)-mutant melanoma cells and xenograft tumors to BRAFi. Loss of STAG2 inhibited CCCTCbinding- factor-mediated expression of dual specificity phosphatase 6 (DUSP6), leading to reactivation of mitogenactivated protein kinase (MAPK) signaling (via the MAPKs ERK1 and ERK2; hereafter referred to as ERK). Our studies unveil a previously unknown genetic mechanism of BRAFi resistance and provide new insights into the tumor suppressor function of STAG2 and STAG3.	[Shen, Che-Hung; Kim, Sun Hye; Trousil, Sebastian; Yuan, Ping; Cai, Li; Li, Man; Lee, Jung Hyun; Mitra, Devarati; Fisher, David E.; Zheng, Bin] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Shen, Che-Hung; Kim, Sun Hye; Trousil, Sebastian; Yuan, Ping; Cai, Li; Li, Man; Lee, Jung Hyun; Mitra, Devarati; Fisher, David E.; Zheng, Bin] Harvard Med Sch, Charlestown, MA 02129 USA; [Frederick, Dennie T.; Fisher, David E.; Sullivan, Ryan J.; Flaherty, Keith T.] Massachusetts Gen Hosp, Ctr Canc, Dept Med Oncol, Boston, MA 02114 USA; [Piris, Adriano] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA; [Piris, Adriano] Harvard Med Sch, Boston, MA USA; [Gu, Lei] Harvard Med Sch, Boston Childrens Hosp, Div Newborn Med, Boston, MA USA; [Shen, Che-Hung] China Med Univ, China Med Univ Hosp, Dept Dermatol, Taichung, Taiwan	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; China Medical University Taiwan; China Medical University Hospital - Taiwan	Zheng, B (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.; Zheng, B (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	bin.zheng@cbrc2.mgh.harvard.edu	Fisher, David/AAH-2878-2019; Gu, Lei/GWQ-6785-2022	Zheng, Bin/0000-0002-0998-7177; Cai, Li/0000-0002-2160-5055	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; V Foundation; Harry J. Lloyd Charitable Trust; Melanoma Research Alliance; US National Institutes of Health (NIH) [P01 CA163222, R01 AR043369, R21 CA175907, R01 CA166717]; NATIONAL CANCER INSTITUTE [R21CA175907, R01CA166717, P01CA163222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; V Foundation; Harry J. Lloyd Charitable Trust; Melanoma Research Alliance; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank K. Swanson, Y. Zhang and G. Zhao for critical comments on the manuscript. We also thank L. Chin (MD Anderson Cancer Center), M. Herlyn (Wistar Institute), C. Pritchard (University of Leicester) and J. Zippin (Weill Cornell Medical College) for providing cell lines. This work is supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (D.E.F.), the V Foundation (B.Z.), the Harry J. Lloyd Charitable Trust (B.Z.), the Melanoma Research Alliance (B.Z.) and the US National Institutes of Health (NIH) grants P01 CA163222 (D.E.F.), R01 AR043369 (D.E.F.), R21 CA175907 (D.E.F.) and R01 CA166717 (B.Z.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Balbas-Martinez C, 2013, NAT GENET, V45, P1464, DOI 10.1038/ng.2799; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Kamata T, 2005, BLOOD, V106, P833, DOI 10.1182/blood-2004-11-4458; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kwong LN, 2015, J CLIN INVEST, V125, P1459, DOI 10.1172/JCI78954; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Moriceau G, 2015, CANCER CELL, V27, P240, DOI 10.1016/j.ccell.2014.11.018; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Ribas A, 2011, NAT REV CLIN ONCOL, V8, P426, DOI 10.1038/nrclinonc.2011.69; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Solomon DA, 2014, BMB REP, V47, P299, DOI 10.5483/BMBRep.2014.47.6.092; Solomon DA, 2013, NAT GENET, V45, P1428, DOI 10.1038/ng.2800; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Thol F, 2014, BLOOD, V123, P914, DOI 10.1182/blood-2013-07-518746; Thota S, 2014, BLOOD, V124, P1790, DOI 10.1182/blood-2014-04-567057; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Xiao TJ, 2011, MOL CELL BIOL, V31, P2174, DOI 10.1128/MCB.05093-11; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; Yuan P, 2013, P NATL ACAD SCI USA, V110, P18226, DOI 10.1073/pnas.1317577110; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	39	52	53	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1056	+		10.1038/nm.4155	http://dx.doi.org/10.1038/nm.4155			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27500726	Green Submitted, Green Accepted			2022-12-25	WOS:000382542800017
J	De Leo, MG; Staiano, L; Vicinanza, M; Luciani, A; Carissimo, A; Mutarelli, M; Di Campli, A; Polishchuk, E; Di Tullio, G; Mona, V; Levtchenko, E; Oltrabella, F; Starborg, T; Santoro, M; di Bernardo, D; Devuyst, O; Lowe, M; Medina, DL; Ballabio, A; De Matteis, MA				De Leo, Maria Giovanna; Staiano, Leopoldo; Vicinanza, Mariella; Luciani, Alessandro; Carissimo, Annamaria; Mutarelli, Margherita; Di Campli, Antonella; Polishchuk, Elena; Di Tullio, Giuseppe; Mona, Valentina; Levtchenko, Elena; Oltrabella, Francesca; Starborg, Tobias; Santoro, Michele; di Bernardo, Diego; Devuyst, Olivier; Lowe, Martin; Medina, Diego L.; Ballabio, Andrea; De Matteis, Maria Antonietta			Autophagosome-lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRL	NATURE CELL BIOLOGY			English	Article							MITOCHONDRIAL-DNA; OCULOCEREBRORENAL SYNDROME; INFLAMMATION; CLATHRIN; PROTEIN; IDENTIFICATION; DYSFUNCTION; TRAFFICKING; BIOGENESIS; EXPRESSION	Phosphoinositides (PtdIns) control fundamental cell processes, and inherited defects of PtdIns kinases or phosphatases cause severe human diseases, including Lowe syndrome due to mutations in OCRL, which encodes a PtdIns(4,5)P-2 5-phosphatase. Here we unveil a lysosomal response to the arrival of autophagosomal cargo in which OCRL plays a key part. We identify mitochondrial DNA and TLR9 as the cargo and the receptor that triggers and mediates, respectively, this response. This lysosome-cargo response is required to sustain the autophagic flux and involves a local increase in PtdIns(4,5)P-2 that is confined in space and time by OCRL. Depleting or inhibiting OCRL leads to an accumulation of lysosomal PtdIns(4,5)P-2, an inhibitor of the calcium channel mucolipin-1 that controls autophagosome-lysosome fusion. Hence, autophagosomes accumulate in OCRL-depleted cells and in the kidneys of Lowe syndrome patients. Importantly, boosting the activity of mucolipin-1 with selective agonists restores the autophagic flux in cells from Lowe syndrome patients.	[De Leo, Maria Giovanna; Staiano, Leopoldo; Vicinanza, Mariella; Carissimo, Annamaria; Mutarelli, Margherita; Polishchuk, Elena; Di Tullio, Giuseppe; Mona, Valentina; Santoro, Michele; di Bernardo, Diego; Medina, Diego L.; Ballabio, Andrea; De Matteis, Maria Antonietta] Telethon Inst Genet & Med TIGEM, I-80078 Naples, Italy; [Luciani, Alessandro; Devuyst, Olivier] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Di Campli, Antonella] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Levtchenko, Elena] Univ Hosp Leuven, Dept Pediat Nephrol & Growth & Regenerat, B-3000 Leuven, Belgium; [Levtchenko, Elena] Katholieke Univ Leuven, B-3000 Leuven, Belgium; [Oltrabella, Francesca; Starborg, Tobias; Lowe, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Ballabio, Andrea] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Ballabio, Andrea] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Ballabio, Andrea] Univ Naples Federico II, Dept Translat Med, Med Genet, I-80131 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Zurich; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); KU Leuven; University Hospital Leuven; KU Leuven; University of Manchester; Baylor College of Medicine; Baylor College of Medicine; University of Naples Federico II	Staiano, L; De Matteis, MA (corresponding author), Telethon Inst Genet & Med TIGEM, I-80078 Naples, Italy.	l.staiano@tigem.it; dematteis@tigem.it	De Matteis, Maria Antonietta/AHE-5161-2022; Levtchenko, Elena/AAO-7125-2020; di Bernardo, Diego/AAF-5881-2021; Mutarelli, Margherita/K-1910-2019; Staiano, Leopoldo/O-9080-2017; Medina, Diego/AAC-9622-2020	De Matteis, Maria Antonietta/0000-0003-0053-3061; di Bernardo, Diego/0000-0002-1911-7407; Staiano, Leopoldo/0000-0001-7017-1516; Medina, Diego/0000-0002-7347-2645; Starborg, Tobias/0000-0002-1091-1487; Carissimo, Annamaria/0000-0003-4636-3969; Devuyst, Olivier/0000-0003-3744-4767; Luciani, Alessandro/0000-0001-7219-3719; Mutarelli, Margherita/0000-0002-2168-5059	Telethon [TGM11CB1]; Italian Association for Cancer Research (AIRC) [IG2013_14761]; European Research Council Advanced Investigator [670881]; Associazione Italiana Sindrome di Lowe (AISLO); Lowe Syndrome Association; USA (LSA) and Programma Operativo Nazionale (PON) [01_00862]; AIRC; Scientific Research, Flanders (F.W.O. Vlaanderen) [1801110N]; UK Lowe Syndrome Trust [NoMU/ML/1010]; Wellcome Trust [088785/Z/09/Z]; Fonds National de la Recherche Scientifique; Fonds de la Recherche Scientifique Medicale (Brussels, Belgium); European Community [305608]; Cystinosis Research Foundation (Irvine, California, USA); Rare Disease Initiative Zurich (RADIZ); Swiss National Science Foundation [310030_146490]	Telethon(Fondazione Telethon); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Research Council Advanced Investigator; Associazione Italiana Sindrome di Lowe (AISLO); Lowe Syndrome Association; USA (LSA) and Programma Operativo Nazionale (PON); AIRC(Fondazione AIRC per la ricerca sul cancro); Scientific Research, Flanders (F.W.O. Vlaanderen)(FWO); UK Lowe Syndrome Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique Medicale (Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); European Community(European Commission); Cystinosis Research Foundation (Irvine, California, USA); Rare Disease Initiative Zurich (RADIZ); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank S. Aydin (UCL Brussels), N. Demoulin (UCL Brussels), M.-C. Gubler (INSEAM Paris), G. Montini (Univ. Bologna), U. Querfeld (Charite Berlin), B. Rudolph (Charite Berlin) and F. Schaeffer (Univ. Heidelberg) for providing renal biopsies from patients with Lowe syndrome and appropriate controls, C. Wilson, F. Emma, C. Settembre, N. B. Pierri and R. Venditti for insightful discussions, G. Diez-Roux for critical reading of the manuscript, the TIGEM Bioinformatics Core and M. Failli for the analysis of the gene expression profiles, the Advanced Microscopy and Imaging Core of TIGEM for the EM analysis, and the Central Proteomics Facility, Sir William Dunn Pathology School, Oxford University. M.A.D.M. acknowledges the support of Telethon (grant TGM11CB1), the Italian Association for Cancer Research (AIRC, grant IG2013_14761), European Research Council Advanced Investigator grant no. 670881 (SYSMET), Associazione Italiana Sindrome di Lowe (AISLO), Lowe Syndrome Association, USA (LSA) and Programma Operativo Nazionale (PON) 01_00862. M.G.D.L. received a Fellowship from AIRC. E. Levtchenko was supported by the fund for Scientific Research, Flanders (F.W.O. Vlaanderen) grant 1801110N. F.O. was supported by a grant from the UK Lowe Syndrome Trust (NoMU/ML/1010) awarded to M.L. T.S. was supported by the Wellcome Trust (088785/Z/09/Z). O.D. was supported by the Fonds National de la Recherche Scientifique and the Fonds de la Recherche Scientifique Medicale (Brussels, Belgium); the European Community's Seventh Framework Programme under grant agreement no. 305608 (EURenOmics); the Cystinosis Research Foundation (Irvine, California, USA); the Rare Disease Initiative Zurich (RADIZ), and the Swiss National Science Foundation project grant 310030_146490 (O.D. and A.L.).	Abe K, 2011, PHYSIOLOGY, V26, P14, DOI 10.1152/physiol.00048.2010; Allmendinger AM, 2014, J RADIOL CASE REP, V8, P1, DOI 10.3941/jrcr.v8i10.1740; Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Benigni A, 2007, ARTHRITIS RHEUM, V56, P1569, DOI 10.1002/art.22524; Brencicova E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00037; Carchman EH, 2013, FASEB J, V27, P4703, DOI 10.1096/fj.13-229476; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen G, 2014, MOL CELL, V54, P362, DOI 10.1016/j.molcel.2014.02.034; Choudhury R, 2009, J BIOL CHEM, V284, P9965, DOI 10.1074/jbc.M807442200; de Carvalho-Neto A, 2009, ARQ NEURO-PSIQUIAT, V67, P305, DOI 10.1590/S0004-282X2009000200027; Di Fruscio G, 2015, AUTOPHAGY, V11, P928, DOI 10.1080/15548627.2015.1043077; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itakura E, 2013, AUTOPHAGY, V9, P917, DOI 10.4161/auto.24109; Jiang P, 2014, MOL BIOL CELL, V25, P1327, DOI 10.1091/mbc.E13-08-0447; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Ladoire S, 2012, AUTOPHAGY, V8, P1175, DOI 10.4161/auto.20353; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Li XZ, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2013.02.016; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mao YX, 2009, EMBO J, V28, P1831, DOI 10.1038/emboj.2009.155; Mehta ZB, 2014, TRAFFIC, V15, P471, DOI 10.1111/tra.12160; Mudaliar H, 2013, AM J PHYSIOL-RENAL, V305, pF143, DOI 10.1152/ajprenal.00398.2012; Nandez R, 2014, ELIFE, V3, DOI 10.7554/eLife.02975; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nikoletopoulou V, 2015, CELL DEATH DIFFER, V22, P398, DOI 10.1038/cdd.2014.204; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Oltrabella F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005058; Pawaria S, 2015, J IMMUNOL, V194, P1403, DOI 10.4049/jimmunol.1402893; Pirruccello M, 2014, ACS CHEM BIOL, V9, P1359, DOI 10.1021/cb500161z; Platt N, 2016, J NEUROCHEM, V136, P74, DOI 10.1111/jnc.13138; Polishchuk Elena V, 2013, Methods Mol Biol, V931, P413, DOI 10.1007/978-1-62703-056-4_20; R Core Team, 2014, R LANG ENV STAT COMP; Ramirez IBR, 2012, HUM MOL GENET, V21, P1744, DOI 10.1093/hmg/ddr608; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Rong YG, 2012, NAT CELL BIOL, V14, P924, DOI 10.1038/ncb2557; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Sridhar S, 2013, EMBO J, V32, P324, DOI 10.1038/emboj.2012.341; Staiano L, 2015, BBA-MOL CELL BIOL L, V1851, P867, DOI 10.1016/j.bbalip.2014.12.001; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; Nguyen TTN, 2013, J BIOL CHEM, V288, P5645, DOI 10.1074/jbc.M112.410126; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; Vicinanza M, 2011, EMBO J, V30, P4970, DOI 10.1038/emboj.2011.354; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wu JY, 2015, J INNATE IMMUN, V7, P623, DOI 10.1159/000430785; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yuan YG, 2012, FREE RADICAL BIO MED, V53, P30, DOI 10.1016/j.freeradbiomed.2012.03.015; Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P11384, DOI 10.1073/pnas.1202194109; Zhang XL, 1998, J BIOL CHEM, V273, P1574, DOI 10.1074/jbc.273.3.1574; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	65	102	103	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2016	18	8					839	+		10.1038/ncb3386	http://dx.doi.org/10.1038/ncb3386			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DS5NO	27398910	Green Accepted, Green Submitted			2022-12-25	WOS:000380829200004
J	Jiang, H; Hegde, S; Knolhoff, BL; Zhu, Y; Herndon, JM; Meyer, MA; Nywening, TM; Hawkins, WG; Shapiro, IM; Weaver, DT; Pachter, JA; Wang-Gillam, A; DeNardo, DG				Jiang, Hong; Hegde, Samarth; Knolhoff, Brett L.; Zhu, Yu; Herndon, John M.; Meyer, Melissa A.; Nywening, Timothy M.; Hawkins, William G.; Shapiro, Irina M.; Weaver, David T.; Pachter, Jonathan A.; Wang-Gillam, Andrea; DeNardo, David G.			Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy	NATURE MEDICINE			English	Article							TUMOR-INFILTRATING MACROPHAGES; SKIN WOUND REPAIR; T-CELLS; DECREASES GROWTH; TISSUE STIFFNESS; FAK; INHIBITION; FIBROSIS; IMPROVES; PYK2	Single-agent immunotherapy has achieved limited clinical benefit to date in patients with pancreatic ductal adenocarcinoma (PDAC). This may be a result of the presence of a uniquely immunosuppressive tumor microenvironment (TME). Critical obstacles to immunotherapy in PDAC tumors include a high number of tumor-associated immunosuppressive cells and a uniquely desmoplastic stroma that functions as a barrier to T cell infiltration. We identified hyperactivated focal adhesion kinase (FAK) activity in neoplastic PDAC cells as an important regulator of the fibrotic and immunosuppressive TME. We found that FAK activity was elevated in human PDAC tissues and correlated with high levels of fibrosis and poor CD8(+) cytotoxic T cell infiltration. Single-agent FAK inhibition using the selective FAK inhibitor VS-4718 substantially limited tumor progression, resulting in a doubling of survival in the p48-Cre; LSL-Kras(G12D); Trp53(flox/+) (KPC) mouse model of human PDAC. This delay in tumor progression was associated with markedly reduced tumor fibrosis and decreased numbers of tumor-infiltrating immunosuppressive cells. We also found that FAK inhibition rendered the previously unresponsive KPC mouse model responsive to T cell immunotherapy and PD-1 antagonists. These data suggest that FAK inhibition increases immune surveillance by overcoming the fibrotic and immunosuppressive PDAC TME and renders tumors responsive to immunotherapy.	[Jiang, Hong; Hegde, Samarth; Knolhoff, Brett L.; Zhu, Yu; Herndon, John M.; Meyer, Melissa A.; Wang-Gillam, Andrea; DeNardo, David G.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Jiang, Hong; Hegde, Samarth; Knolhoff, Brett L.; Zhu, Yu; Herndon, John M.; Meyer, Melissa A.; DeNardo, David G.] Washington Univ, Sch Med, Integrating Commun Canc Environm ICCE Inst, St Louis, MO 63130 USA; [Nywening, Timothy M.; Hawkins, William G.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Hawkins, William G.; Wang-Gillam, Andrea; DeNardo, David G.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63130 USA; [Shapiro, Irina M.; Weaver, David T.; Pachter, Jonathan A.] Verastem Inc, Needham, MA USA; [DeNardo, David G.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	DeNardo, DG (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; DeNardo, DG (corresponding author), Washington Univ, Sch Med, Integrating Commun Canc Environm ICCE Inst, St Louis, MO 63130 USA.; DeNardo, DG (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63130 USA.; DeNardo, DG (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	ddenardo@dom.wustl.edu	Jiang, Hong/AAE-1145-2019	DeNardo, David/0000-0002-3655-5783; Meyer, Melissa/0000-0003-3050-4819; Jiang, Hong/0000-0001-9481-9807; Herndon, John/0000-0002-8378-9654; Hegde, Samarth/0000-0001-6319-0372	Lustgarten Foundation; AACR/PANCAN Award; NCI awards [R01-CA177670, R01-CA203890, R21-CA182701]; BJCIH/Siteman Cancer Center Cancer Frontier Fund; Washington University Clinical and Translational Grant [KL2TR000450]; NATIONAL CANCER INSTITUTE [R01CA177670, T32CA009621, P30CA091842, R21CA182701, F99CA223043, P50CA196510, T32CA113275, R01CA203890] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450] Funding Source: NIH RePORTER	Lustgarten Foundation; AACR/PANCAN Award; NCI awards; BJCIH/Siteman Cancer Center Cancer Frontier Fund; Washington University Clinical and Translational Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	KC (Kras<SUP>G12D</SUP>) cells were obtained from P. Mukherjee (University of North Carolina). HPNE, HPAC, Capan-1, Capan-2, Hs766T, MIA PaCa-2 and SW1990 cells were obtained from K. Lim (Washington University). pBABEpuro K-Ras G12V used to express Kras<SUP>G12V</SUP> was obtained from J. Weber (Washington University). This work was supported by funding awarded to D.G.D. by Lustgarten Foundation, an AACR/PANCAN Award, NCI awards R01-CA177670, R01-CA203890 and R21-CA182701, the BJCIH/Siteman Cancer Center Cancer Frontier Fund, and Washington University Clinical and Translational Grant KL2TR000450 awarded to A.W.G.	Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; Balasubramanian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140273; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Beatty GL, 2015, GASTROENTEROLOGY, V149, P201, DOI 10.1053/j.gastro.2015.04.010; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Chapman NM, 2014, IMMUNOL RES, V59, P23, DOI 10.1007/s12026-014-8527-y; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chapman NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053011; Collins M, 2010, MOL IMMUNOL, V47, P1665, DOI 10.1016/j.molimm.2010.03.009; Crompton BD, 2013, CANCER RES, V73, P2873, DOI 10.1158/0008-5472.CAN-12-1944; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Francois RA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv123; Goedegebuure P, 2011, CURR CANCER DRUG TAR, V11, P734, DOI 10.2174/156800911796191024; Golubovskaya V, 2015, J CANCER RES CLIN, V141, P1613, DOI 10.1007/s00432-015-1924-3; Graves DT, 2014, AM J PHYSIOL-CELL PH, V306, pC887, DOI 10.1152/ajpcell.00098.2014; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Konstantinidou G, 2013, CANCER DISCOV, V3, P444, DOI 10.1158/2159-8290.CD-12-0388; Koppel AC, 2014, AM J PHYSIOL-CELL PH, V306, pC899, DOI 10.1152/ajpcell.00331.2013; Kumper S, 2011, CANCER CELL, V19, P695, DOI 10.1016/j.ccr.2011.05.021; Laklai H, 2016, NAT MED, V22, P497, DOI 10.1038/nm.4082; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Panni RZ, 2013, IMMUNOTHERAPY-UK, V5, P1075, DOI 10.2217/imt.13.102; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Royal RE, 2010, J IMMUNOTHER, V33, P828, DOI 10.1097/CJI.0b013e3181eec14c; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Rustad KC, 2013, DIFFERENTIATION, V86, P87, DOI 10.1016/j.diff.2013.02.003; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sanford DE, 2013, CLIN CANCER RES, V19, P3404, DOI 10.1158/1078-0432.CCR-13-0525; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Sonomura K, 2012, KIDNEY INT, V81, P449, DOI 10.1038/ki.2011.403; Stewart JE, 2015, MOL CARCINOGEN, V54, P9, DOI 10.1002/mc.22070; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Strachan DC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26968; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Tavora B, 2014, NATURE, V514, P112, DOI 10.1038/nature13541; Weischenfeldt J., 2008, COLD SPRING HARB PRO, V12; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; You K, 2015, INT J CLIN EXP MED, V8, P18284; Zhao XK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19276; Zheng DH, 2010, MOL CARCINOGEN, V49, P200, DOI 10.1002/mc.20590; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	56	533	551	14	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					851	+		10.1038/nm.4123	http://dx.doi.org/10.1038/nm.4123			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376576	Green Accepted			2022-12-25	WOS:000381000200010
J	Ryu, D; Mouchiroud, L; Andreux, PA; Katsyuba, E; Moullan, N; Nicolet-dit-Felix, AA; Williams, EG; Jha, P; Lo Sasso, G; Huzard, D; Aebischer, P; Sandi, C; Rinsch, C; Auwerx, J				Ryu, Dongryeol; Mouchiroud, Laurent; Andreux, Penelope A.; Katsyuba, Elena; Moullan, Norman; Nicolet-dit-Felix, Amandine A.; Williams, Evan G.; Jha, Pooja; Lo Sasso, Giuseppe; Huzard, Damien; Aebischer, Patrick; Sandi, Carmen; Rinsch, Chris; Auwerx, Johan			Urolithin A induces mitophagy and prolongs lifespan in C-elegans and increases muscle function in rodents	NATURE MEDICINE			English	Article							ELLAGIC ACID METABOLITES; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; AUTOPHAGY; POMEGRANATE; EXTENSION; UBIQUITIN; FOOD; ELLAGITANNINS; MITOCHONDRIA	The biological effects of urolithins remain poorly characterized, despite wide-spread human exposure via the dietary consumption of their metabolic precursors, the ellagitannins, which are found in the pomegranate fruit, as well as in nuts and berries. We identified urolithin A (UA) as a first-in-class natural compound that induces mitophagy both in vitro and in vivo following oral consumption. In C. elegans, UA prevented the accumulation of dysfunctional mitochondria with age and extended lifespan. Likewise, UA prolonged normal activity during aging in C. elegans, including mobility and pharyngeal pumping, while maintaining mitochondrial respiratory capacity. These effects translated to rodents, where UA improved exercise capacity in two different mouse models of age-related decline of muscle function, as well as in young rats. Our findings highlight the health benefits of urolithin A and its potential application in strategies to improve mitochondrial and muscle function.	[Ryu, Dongryeol; Mouchiroud, Laurent; Andreux, Penelope A.; Katsyuba, Elena; Moullan, Norman; Nicolet-dit-Felix, Amandine A.; Williams, Evan G.; Jha, Pooja; Lo Sasso, Giuseppe; Auwerx, Johan] Ecole Polytech Fed Lausanne, Interfac Inst Bioengn, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Andreux, Penelope A.; Rinsch, Chris] Ecole Polytech Fed Lausanne, Amazentis SA, Innovat Pk,Batiment C, Lausanne, Switzerland; [Huzard, Damien; Sandi, Carmen] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Behav Genet, Lausanne, Switzerland; [Aebischer, Patrick] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Interfac Inst Bioengn, Lab Integrat & Syst Physiol, Lausanne, Switzerland.; Rinsch, C (corresponding author), Ecole Polytech Fed Lausanne, Amazentis SA, Innovat Pk,Batiment C, Lausanne, Switzerland.	contact@amazentis.com; admin.auwerx@epfl.ch	Ryu, Dongryeol/AAQ-3642-2020; Auwerx, Johan/ABE-9307-2021; Williams, Evan/M-7539-2017	Ryu, Dongryeol/0000-0001-5905-6760; Williams, Evan/0000-0002-9746-376X; Jha, Pooja/0000-0002-0293-9287; Auwerx, Johan/0000-0002-5065-5393; Sandi, Carmen/0000-0001-7713-8321	Ecole Polytechnique Federale de Lausanne; Systems X [SysX.ch 2013/153]; Commission for Technology and Innovation (CTI) [15171.1 PFLS-LS]; Fondation Medicale pour la Recherche (FRM)	Ecole Polytechnique Federale de Lausanne; Systems X; Commission for Technology and Innovation (CTI); Fondation Medicale pour la Recherche (FRM)(Fondation pour la Recherche Medicale)	We thank P. Gonczy (Swiss Institute for Experimental Cancer Research, Ecole Polytechnique Federale de Lausanne) for sharing reagents and equipment, the Caenorhabditis Genetics Center for providing worm strains and the Auwerx team members for discussions. We thank the team of the Phenotyping Unit, Center of PhenoGenomics, School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL) for their technical and scientific expertise in the mouse experiments. We thank K.H. Kim (Yonsei University College of Medicine) for providing mRFP-GFP-LC3B reporter and for discussion. We thank G. Yellen (Department of Neurobiology, Harvard Medical School) for providing mitochondrial pHRed-expressing plasmid and D. Kaiserlian (INSERM) for the Mode-K cell line. J.A. is the Nestle Chair in Energy Metabolism. Work in the Auwerx laboratory is supported by the Ecole Polytechnique Federale de Lausanne and Systems X (SysX.ch 2013/153), and was co-financed by the Commission for Technology and Innovation (CTI) (15171.1 PFLS-LS). L.M. was supported by a fellowship from Fondation Medicale pour la Recherche (FRM).	Amato AA, 2014, NEUROLOGY, V83, P2239, DOI 10.1212/WNL.0000000000001070; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; [Anonymous], 2005, GUID IND EST MAX SAF; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Bakkalbasi E, 2009, CRIT REV FOOD SCI, V49, P283, DOI 10.1080/10408390802064404; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Bratic I, 2010, METHODS, V51, P437, DOI 10.1016/j.ymeth.2010.03.003; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Espin JC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/270418; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Cordain L, 2000, AM J CLIN NUTR, V71, P682, DOI 10.1093/ajcn/71.3.682; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Drummond MJ, 2014, J GERONTOL A-BIOL, V69, P1040, DOI 10.1093/gerona/glu004; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Garber K, 2016, NAT BIOTECHNOL, V34, P458, DOI 10.1038/nbt.3557; Gasperotti M, 2015, ACS CHEM NEUROSCI, V6, P1341, DOI 10.1021/acschemneuro.5b00051; Gong GH, 2015, SCIENCE, V350, DOI 10.1126/science.aad2459; Gonzalez-Sarrias A, 2010, MOL NUTR FOOD RES, V54, P311, DOI 10.1002/mnfr.200900152; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Guo SJ, 2015, AUTOPHAGY, V11, P560, DOI 10.1080/15548627.2015.1017181; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Johanningsmeier SD, 2011, ANNU REV FOOD SCI T, V2, P181, DOI 10.1146/annurev-food-030810-153709; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kang I, 2016, MOL NUTR FOOD RES, V60, P1129, DOI 10.1002/mnfr.201500796; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kirienko NV, 2015, P NATL ACAD SCI USA, V112, P1821, DOI 10.1073/pnas.1424954112; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Mouchiroud L, 2011, AGING CELL, V10, P39, DOI 10.1111/j.1474-9726.2010.00640.x; Nunez-Sanchez MA, 2014, MOL NUTR FOOD RES, V58, P1199, DOI 10.1002/mnfr.201300931; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Piwowarski JP, 2015, MOL NUTR FOOD RES, V59, P2168, DOI 10.1002/mnfr.201500264; Robinson S, 2016, CLINICAL NUTRITION AND AGING: SARCOPENIA AND MUSCLE METABOLISM, P3, DOI 10.1155/2012/510801; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Seeram NP, 2007, J AGR FOOD CHEM, V55, P7732, DOI 10.1021/jf071303g; Seeram NP, 2006, J NUTR, V136, P2481, DOI 10.1093/jn/136.10.2481; Tantama M, 2011, J AM CHEM SOC, V133, P10034, DOI 10.1021/ja202902d; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Tomas-Barberan FA, 2014, J AGR FOOD CHEM, V62, P6535, DOI 10.1021/jf5024615; Truchado P, 2012, J AGR FOOD CHEM, V60, P5749, DOI 10.1021/jf203641r; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Wilkinson DS, 2012, METHOD CELL BIOL, V107, P353, DOI 10.1016/B978-0-12-394620-1.00012-6; Xu ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109141; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	63	460	482	34	222	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					879	+		10.1038/nm.4132	http://dx.doi.org/10.1038/nm.4132			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27400265				2022-12-25	WOS:000381000200013
J	Scott, CT; DeFrancesco, L				Scott, Christopher Thomas; DeFrancesco, Laura			Gene therapy's out-of-body experience	NATURE BIOTECHNOLOGY			English	Article							HEMATOPOIETIC STEM; T-CELLS; IMMUNODEFICIENCY; RESISTANCE; INFECTION; VECTORS; CCR5; ADA											Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Burke BP, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.10; Candotti F, 2012, BLOOD, V120, P3635, DOI 10.1182/blood-2012-02-400937; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cesana D, 2014, MOL THER, V22, P774, DOI 10.1038/mt.2014.3; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Gaspar HB, 2006, MOL THER, V14, P505, DOI 10.1016/j.ymthe.2006.06.007; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI [10.1126/scitranslmed.3002716, 10.1126/scitranslmed.3002715]; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Peterson CW, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.7; Qasim W, 2007, ARCH DIS CHILD, V92, P1028, DOI 10.1136/adc.2006.108787; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Shaw KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002594; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Williams DA, 2014, STEM CELL TRANSL MED, V3, P636, DOI 10.5966/sctm.2013-0206; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110	31	9	11	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2016	34	6					600	607		10.1038/nbt.3592	http://dx.doi.org/10.1038/nbt.3592			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DO5TT	27281416				2022-12-25	WOS:000377846400022
J	Garst, AD; Bassalo, MC; Pines, G; Lynch, SA; Halweg-Edwards, AL; Liu, RM; Liang, LY; Wang, ZW; Zeitoun, R; Alexander, WG; Gill, RT				Garst, Andrew D.; Bassalo, Marcelo C.; Pines, Gur; Lynch, Sean A.; Halweg-Edwards, Andrea L.; Liu, Rongming; Liang, Liya; Wang, Zhiwen; Zeitoun, Ramsey; Alexander, William G.; Gill, Ryan T.			Genome-wide mapping of mutations at single-nucleotide resolution for protein, metabolic and genome engineering	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; DIHYDROFOLATE-REDUCTASE; HUMAN-CELLS; CRISPR-CAS9 SYSTEM; DIRECTED EVOLUTION; FURFURAL TOLERANCE; GENES; CODON; OPTIMIZATION; ACTIVATION	Improvements in DNA synthesis and sequencing have underpinned comprehensive assessment of gene function in bacteria and eukaryotes. Genome-wide analyses require high-throughput methods to generate mutations and analyze their phenotypes, but approaches to date have been unable to efficiently link the effects of mutations in coding regions or promoter elements in a highly parallel fashion. We report that CRISPR-Cas9 gene editing in combination with massively parallel oligomer synthesis can enable trackable editing on a genome-wide scale. Our method, CRISPR-enabled trackable genome engineering (CREATE), links each guide RNA to homologous repair cassettes that both edit loci and function as barcodes to track genotype phenotype relationships. We apply CREATE to site saturation mutagenesis for protein engineering, reconstruction of adaptive laboratory evolution experiments, and identification of stress tolerance and antibiotic resistance genes in bacteria. We provide preliminary evidence that CREATE will work in yeast. We also provide a webtool to design multiplex CREATE libraries.	[Garst, Andrew D.; Bassalo, Marcelo C.; Pines, Gur; Lynch, Sean A.; Halweg-Edwards, Andrea L.; Liu, Rongming; Liang, Liya; Wang, Zhiwen; Zeitoun, Ramsey; Gill, Ryan T.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Garst, Andrew D.; Halweg-Edwards, Andrea L.; Alexander, William G.] Muse Biotechnol Inc, Boulder, CO USA; [Bassalo, Marcelo C.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wang, Zhiwen] Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin, Peoples R China; [Wang, Zhiwen] Tianjin Univ, SynBio Res Platform, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin, Peoples R China; [Wang, Zhiwen] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin, Peoples R China	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Tianjin University; Tianjin University; Tianjin University	Gill, RT (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	rtggtr@me.com	, 刘嵘明/AAR-7302-2020; Liu, Rongming/O-5544-2018; liu, rongming/AAZ-8474-2020; Liang, Liya/AAF-4267-2019; Pines, Gur/X-7501-2019; Facility, BioFrontiers Next Generation Sequencing/AAJ-8616-2020	Pines, Gur/0000-0002-1757-6722; Alexander, William/0000-0003-4212-6392	US Department of Energy [DE-SC0008812]; CAPES foundation [0315133]	US Department of Energy(United States Department of Energy (DOE)); CAPES foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work would not have been possible without the insights and efforts of a number of talented individuals. We would like to thank T. Mansell, N. Boyle, K. Fujimori, and H. Chilton for their input, feedback, guidance and contributions to this work. This work was supported by the US Department of Energy (Grant DE-SC0008812) and CAPES foundation (grant #0315133).	Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Basak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051179; Bhabha G, 2013, NAT STRUCT MOL BIOL, V20, P1243, DOI 10.1038/nsmb.2676; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Browning DF, 2004, MOL MICROBIOL, V51, P241, DOI 10.1046/j.1365-2958.2003.03824.x; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chang RL, 2013, SCIENCE, V340, P1220, DOI 10.1126/science.1234012; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fisher MA, 2014, ACS SYNTH BIOL, V3, P30, DOI 10.1021/sb400065q; Foo JL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-81; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Glebes TY, 2015, BIOTECHNOL BIOENG, V112, P129, DOI 10.1002/bit.25325; Ho JM, 2016, ACS SYNTH BIOL, V5, P163, DOI 10.1021/acssynbio.5b00197; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Iwakura M, 2006, J BIOL CHEM, V281, P13234, DOI 10.1074/jbc.M508823200; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mills TY, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-26; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Pines G, 2015, ACS SYNTH BIOL, V4, P604, DOI 10.1021/sb500282v; Raman S, 2014, P NATL ACAD SCI USA, V111, P17803, DOI 10.1073/pnas.1409523111; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Rodriguez-Verdugo A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-50; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Sandoval NR, 2011, METAB ENG, V13, P214, DOI 10.1016/j.ymben.2010.12.001; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shendure J, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0086-2; Smanski MJ, 2014, NAT BIOTECHNOL, V32, P1241, DOI 10.1038/nbt.3063; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368; Stoebel DM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000671; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wang HH, 2012, ACS SYNTH BIOL, V1, P43, DOI 10.1021/sb3000029; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang X, 2013, P NATL ACAD SCI USA, V110, P4021, DOI 10.1073/pnas.1217958110; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Watson M, 2007, FEBS J, V274, P2661, DOI 10.1111/j.1742-4658.2007.05801.x; Wetmore KM, 2015, MBIO, V6, DOI 10.1128/mBio.00306-15; White DG, 1997, J BACTERIOL, V179, P6122, DOI 10.1128/jb.179.19.6122-6126.1997; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Zeitoun RI, 2015, NAT BIOTECHNOL, V33, P631, DOI 10.1038/nbt.3177; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	61	193	278	25	248	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					48	55		10.1038/nbt.3718	http://dx.doi.org/10.1038/nbt.3718			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	27941803				2022-12-25	WOS:000392460800022
J	Gollner, S; Oellerich, T; Agrawal-Singh, S; Schenk, T; Klein, HU; Rohde, C; Pabst, C; Sauer, T; Lerdrup, M; Tavor, S; Stolzel, F; Herold, S; Ehninger, G; Kohler, G; Pan, KT; Urlaub, H; Serve, H; Dugas, M; Spiekermann, K; Vick, B; Jeremias, I; Berdel, WE; Hansen, K; Zelent, A; Wickenhauser, C; Muller, LP; Thiede, C; Muller-Tidow, C				Goellner, Stefanie; Oellerich, Thomas; Agrawal-Singh, Shuchi; Schenk, Tino; Klein, Hans-Ulrich; Rohde, Christian; Pabst, Caroline; Sauer, Tim; Lerdrup, Mads; Tavor, Sigal; Stoelzel, Friedrich; Herold, Sylvia; Ehninger, Gerhard; Koehler, Gabriele; Pan, Kuan-Ting; Urlaub, Henning; Serve, Hubert; Dugas, Martin; Spiekermann, Karsten; Vick, Binje; Jeremias, Irmela; Berdel, Wolfgang E.; Hansen, Klaus; Zelent, Arthur; Wickenhauser, Claudia; Mueller, Lutz P.; Thiede, Christian; Mueller-Tidow, Carsten			Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia	NATURE MEDICINE			English	Article							SOMATIC MUTATIONS; GENE EZH2; CELLS; CANCER; TRANSFORMATION; EXPRESSION; INHIBITOR; THERAPY; PHOSPHORYLATION; DIFFERENTIATION	In acute myeloid leukemia (AML), therapy resistance frequently occurs, leading to high mortality among patients. However, the mechanisms that render leukemic cells drug resistant remain largely undefined. Here, we identified loss of the histone methyltransferase EZH2 and subsequent reduction of histone H3K27 trimethylation as a novel pathway of acquired resistance to tyrosine kinase inhibitors (TKIs) and cytotoxic drugs in AML. Low EZH2 protein levels correlated with poor prognosis in AML patients. Suppression of EZH2 protein expression induced chemoresistance of AML cell lines and primary cells in vitro and in vivo. Low EZH2 levels resulted in derepression of HOX genes, and knockdown of HOXB7 and HOXA9 in the resistant cells was sufficient to improve sensitivity to TKIs and cytotoxic drugs. The endogenous loss of EZH2 expression in resistant cells and primary blasts from a subset of relapsed AML patients resulted from enhanced CDK1-dependent phosphorylation of EZH2 at Thr487. This interaction was stabilized by heat shock protein 90 (HSP9O) and followed by proteasomal degradation of EZH2 in drug-resistant cells. Accordingly, inhibitors of HSP9O, CDK1 and the proteasome prevented EZH2 degradation, decreased HOX gene expression and restored drug sensitivity. Finally, patients with reduced EZH2 levels at progression to standard therapy responded to the combination of bortezomib and cytarabine, concomitant with the re-establishment of EZH2 expression and blast clearance. These data suggest restoration of EZH2 protein as a viable approach to overcome treatment resistance in this AML patient population.	[Goellner, Stefanie; Rohde, Christian; Pabst, Caroline; Mueller, Lutz P.; Mueller-Tidow, Carsten] Univ Hosp Halle Saale, Dept Med Hematol & Oncol 4, Halle, Saale, Germany; [Oellerich, Thomas; Serve, Hubert] Goethe Univ, Dept Med Hematol Oncol 2, Frankfurt, Germany; [Oellerich, Thomas; Serve, Hubert; Spiekermann, Karsten; Vick, Binje; Jeremias, Irmela] German Canc Consortium DKTK, Heidelberg, Germany; [Oellerich, Thomas; Serve, Hubert; Spiekermann, Karsten; Vick, Binje; Jeremias, Irmela] German Canc Res Ctr, Heidelberg, Germany; [Agrawal-Singh, Shuchi; Lerdrup, Mads; Hansen, Klaus] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Agrawal-Singh, Shuchi; Dugas, Martin; Hansen, Klaus] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Schenk, Tino] ICR, Mol Pathol, London, England; [Klein, Hans-Ulrich; Dugas, Martin] Univ Hosp Munster, Inst Med Informat, Munster, Germany; [Sauer, Tim] Univ Hosp Munster, Dept Med A Hematol & Oncol, Munster, Germany; [Tavor, Sigal; Thiede, Christian] Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Stoelzel, Friedrich; Herold, Sylvia; Ehninger, Gerhard] Univ Hosp Carl Gustav Carus, Dept Med Mol Hematol, Dresden, Germany; [Koehler, Gabriele] Univ Munster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany; [Pan, Kuan-Ting; Urlaub, Henning] Max Plank Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt, Gottingen, Germany; [Spiekermann, Karsten] Univ Hosp Munich, Dept Med 3, Munich, Germany; [Vick, Binje; Jeremias, Irmela] Helmholtz Ctr Munich, Res Unit Gene Vectors, Munich, Germany; [Zelent, Arthur; Wickenhauser, Claudia] UMHC, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Wickenhauser, Claudia] Univ Hosp Halle Saale, Dept Pathol, Halle, Saale, Germany; [Schenk, Tino] Univ Hosp Jena, Dept Med Hematol & Oncol 2, Jena, Germany; [Klein, Hans-Ulrich] Brigham & Womens Hosp, Harvard Med Sch, Dept Neurol, Boston, MA USA; [Tavor, Sigal] Assuta Med Ctr, Dept Hematooncol, Tel Aviv, Israel; [Koehler, Gabriele] Klinikum Fulda gAG, Inst Pathol, Fulda, Germany	Martin Luther University Halle Wittenberg; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Copenhagen; University of Copenhagen; University of London; Institute of Cancer Research - UK; University of Munster; University of Munster; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munster; Max Planck Society; University of Gottingen; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Martin Luther University Halle Wittenberg; Friedrich Schiller University of Jena; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Klinikum Fulda	Gollner, S; Muller-Tidow, C (corresponding author), Univ Hosp Halle Saale, Dept Med Hematol & Oncol 4, Halle, Saale, Germany.	stefanie.goellner@uk-halle.de; carsten.mueller-tidow@uk-halle.de	Jeremias, Irmela/Q-5934-2019; Müller-Tidow, Carsten/O-7207-2018; Schenk, Tino/P-4381-2019; Göllner, Stefanie/AAX-3901-2020; Stölzel, Friedrich/AAZ-8613-2021; Müller, Lutz/ABE-2941-2020; Klein, Hans-Ulrich/O-5118-2019	Jeremias, Irmela/0000-0003-1773-7677; Müller-Tidow, Carsten/0000-0002-7166-5232; Schenk, Tino/0000-0003-3430-5876; Klein, Hans-Ulrich/0000-0002-6382-9428; Vick, Binje/0000-0003-1956-2778; Hansen, Klaus/0000-0001-9657-8816; Zelent, Arthur/0000-0002-7968-9888; Serve, Hubert/0000-0001-8472-5516; Lerdrup, Mads/0000-0002-7730-8973; Thiede, Christian/0000-0003-1241-2048	Deutsche Forschungsgemeinschaft [SPP1463, MU1328/9-2, DFG EXC 1003]; German Cancer Aid Foundation [111286]; German Jose-Carreras Leukemia Foundation [DJCLS R 13/04]; state of Sachsen-Anhalt [FZK 28/43]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Aid Foundation; German Jose-Carreras Leukemia Foundation; state of Sachsen-Anhalt	We are grateful to J.H. Song and T.S. Kim (Korea University, Seoul, Republic of Korea) and to S. Chouaib (INSEAM U1186, Gustave Roussy Cancer Campus, Villejuif, France) for providing cell lines. The authors thank D. Wendt-Cousin and A. Kiittner for excellent technical assistance, and K. Agelopoulos and I. Schulze for assistance with exome library preparation and processing. We are grateful to the University of Munster core facilities IFG/IZKF for performing the Affymetrix gene expression arrays and the LIFA for Illumina sequencing of Exome libraries. We thank atelier42 for designing the graphical model of chemoresistance. S.G. and C.M.-T. hold the copyright for the graphic art. The Munster laboratory of W.E.B. was supported by the Deutsche Forschungsgemeinschaft, DFG EXC 1003 Cells in Motion-Cluster of Excellence. This work was further supported by grants from the Deutsche Forschungsgemeinschaft (SPP1463, MU1328/9-2 to C.M.-T.), the German Cancer Aid Foundation (111286 to C.M.-T.), the German Jose-Carreras Leukemia Foundation (DJCLS R 13/04 to C.M.-T.) and the state of Sachsen-Anhalt (FZK 28/43 to C.M.-T.).	Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Armstrong SA, 2003, SEMIN HEMATOL, V40, P268, DOI 10.1016/S0037-1963(03)00196-3; Attar EC, 2013, J CLIN ONCOL, V31, P923, DOI 10.1200/JCO.2012.45.2177; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Chou WC, 2011, BLOOD, V118, P3803, DOI 10.1182/blood-2011-02-339747; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Guglielmelli P, 2011, BLOOD, V118, P5227, DOI 10.1182/blood-2011-06-363424; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Khan SN, 2013, LEUKEMIA, V27, P1301, DOI 10.1038/leu.2013.80; Klein HU, 2014, BIOINFORMATICS, V30, P1154, DOI 10.1093/bioinformatics/btu003; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Krug U, 2011, DTSCH ARZTEBL INT, V108, P863, DOI 10.3238/arztebl.2011.0863; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Metzeler KH, 2011, BLOOD, V118, P6920, DOI 10.1182/blood-2011-08-368225; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pabst C, 2016, BLOOD, V127, P2018, DOI 10.1182/blood-2015-11-683649; Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961; Roboz GJ, 2011, HEMATOL-AM SOC HEMAT, P43, DOI 10.1182/asheducation-2011.1.43; Sashida G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5177; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Stolzel F, 2010, ANN HEMATOL, V89, P653, DOI 10.1007/s00277-009-0889-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Zhang SJ, 2012, BLOOD, V119, P4480, DOI 10.1182/blood-2011-11-390252; Zingg D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7051	44	136	139	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					69	78		10.1038/nm.4247	http://dx.doi.org/10.1038/nm.4247			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27941792	Green Accepted			2022-12-25	WOS:000391646800015
J	Lu, ZG; Xie, JJ; Wu, GJ; Shen, JH; Collins, R; Chen, WN; Kang, XL; Luo, M; Zou, YZ; Huang, LJS; Amatruda, JF; Slone, T; Winick, N; Scherer, PE; Zhang, CC				Lu, Zhigang; Xie, Jingjing; Wu, Guojin; Shen, Jinhui; Collins, Robert; Chen, Weina; Kang, Xunlei; Luo, Min; Zou, Yizhou; Huang, Lily Jun-Shen; Amatruda, James F.; Slone, Tamra; Winick, Naomi; Scherer, Philipp E.; Zhang, Cheng Cheng			Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; CHILDHOOD-CANCER SURVIVOR; TUMOR-SUPPRESSOR GENE; MOLECULAR-MECHANISMS; CALORIE RESTRICTION; ARSENIC TRIOXIDE; ADIPOSE-TISSUE; RETINOIC ACID	New therapeutic approaches are needed to treat leukemia effectively. Dietary restriction regimens, including fasting, have been considered for the prevention and treatment of certain solid tumor types. However, whether and how dietary restriction affects hematopoietic malignancies is unknown. Here we report that fasting alone robustly inhibits the initiation and reverses the leukemic progression of both B cell and T cell acute lymphoblastic leukemia (B-ALL and T-ALL, respectively), but not acute myeloid leukemia (AML), in mouse models of these tumors. Mechanistically, we found that attenuated leptin-receptor (LEPR) expression is essential for the development and maintenance of ALL, and that fasting inhibits ALL development by upregulation of LEPR and its downstream signaling through the protein PR/SET domain 1 (PRDM1). The expression of LEPR signaling-related genes correlated with the prognosis of pediatric patients with pre-B-ALL, and fasting effectively inhibited B-ALL growth in a human xenograft model. Our results indicate that the effects of fasting on tumor growth are cancer-type dependent, and they suggest new avenues for the development of treatment strategies for leukemia.	[Lu, Zhigang; Xie, Jingjing; Wu, Guojin; Shen, Jinhui; Kang, Xunlei; Zhang, Cheng Cheng] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Xie, Jingjing; Zhang, Cheng Cheng] Binzhou Med Univ, BMU, UTSW Joint Taishan Immunol Grp, Yantai, Shandong, Peoples R China; [Collins, Robert; Scherer, Philipp E.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Chen, Weina] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Luo, Min] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Zou, Yizhou] Cent S Univ, Sch Xiangya Med, Dept Immunol, Changsha, Hunan, Peoples R China; [Huang, Lily Jun-Shen; Scherer, Philipp E.] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Amatruda, James F.; Slone, Tamra; Winick, Naomi] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Scherer, Philipp E.] Univ Texas Southwestern Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Binzhou Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Central South University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lu, ZG; Zhang, CC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.; Zhang, CC (corresponding author), Binzhou Med Univ, BMU, UTSW Joint Taishan Immunol Grp, Yantai, Shandong, Peoples R China.	zhigang.lu@utsouthwestern.edu; Alec.Zhang@UTSouthwestern.edu	xie, jing/GRY-1689-2022; Zhang, Cheng/GRS-8698-2022; Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392; Kang, Xunlei/0000-0003-1853-1881; Lu, Zhigang/0000-0002-2880-7848	US National Institutes of Health [1R01CA172268]; Leukemia & Lymphoma Society [1024-14, TRP-6024-14]; CPRIT [RP140402, 1R01HL089966, R01-DK55758, RP140412]; NATIONAL CANCER INSTITUTE [R01CA172268] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055758] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to acknowledge the support by grants from the US National Institutes of Health 1R01CA172268 (C.C.Z.), Leukemia & Lymphoma Society Awards 1024-14 (C.C.Z.) and TRP-6024-14 (C.C.Z.), CPRIT RP140402 (C.C.Z.), 1R01HL089966 (L.J.H.), R01-DK55758 (P.E.S.) and RP140412 (P.E.S.).	Ando S, 2012, NAT REV ENDOCRINOL, V8, P263, DOI 10.1038/nrendo.2011.184; Baskin DG, 1998, DIABETES, V47, P538, DOI 10.2337/diabetes.47.4.538; Bifulco M, 2015, HAEMATOLOGICA, V100, pE118, DOI 10.3324/haematol.2014.122168; Boi M, 2015, LEUKEMIA LYMPHOMA, V56, P1223, DOI 10.3109/10428194.2014.953155; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Butturini AM, 2007, J CLIN ONCOL, V25, P2063, DOI 10.1200/JCO.2006.07.7792; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; Deng M, 2014, BLOOD, V124, P924, DOI 10.1182/blood-2014-01-549162; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Efficace F, 2014, J CLIN ONCOL, V32, P3406, DOI 10.1200/JCO.2014.55.3453; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Hangaishi A, 2010, INT J HEMATOL, V91, P46, DOI 10.1007/s12185-009-0472-5; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kang XL, 2015, NAT CELL BIOL, V17, P665, DOI 10.1038/ncb3158; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Oeffinger KC, 2003, J CLIN ONCOL, V21, P1359, DOI 10.1200/JCO.2003.06.131; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Park J, 2010, AM J PATHOL, V177, P3133, DOI 10.2353/ajpath.2010.100595; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pramanik R, 2013, LEUKEMIA RES, V37, P503, DOI 10.1016/j.leukres.2012.12.013; Ross JA, 2004, J CLIN ONCOL, V22, P3558, DOI 10.1200/JCO.2004.11.152; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Sheng X, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00053; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Sugihara E, 2012, ONCOGENE, V31, P2849, DOI 10.1038/onc.2011.462; Teras LR, 2012, ENERG BALANCE CANCER, V5, P1, DOI 10.1007/978-1-4614-2403-1_1; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Vishalakshi N., 2011, J PROTEOM BIOINFORM, V4, P184; Weigle DS, 1997, J CLIN ENDOCR METAB, V82, P561, DOI 10.1210/jc.82.2.561; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yun JP, 2010, CANCER PREV RES, V3, P1259, DOI 10.1158/1940-6207.CAPR-10-0087; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zheng JK, 2014, BLOOD, V123, P992, DOI 10.1182/blood-2013-04-498469; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095; Zheng JK, 2011, CELL STEM CELL, V9, P119, DOI 10.1016/j.stem.2011.06.003	57	62	67	5	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					79	90		10.1038/nm.4252	http://dx.doi.org/10.1038/nm.4252			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27941793	Green Accepted			2022-12-25	WOS:000391646800016
J	Schmidt, C				Schmidt, Charles			Pancreatic islets find a new transplant home in the omentum	NATURE BIOTECHNOLOGY			English	News Item																			0	16	17	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					8	8		10.1038/nbt0117-8	http://dx.doi.org/10.1038/nbt0117-8			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	28072777				2022-12-25	WOS:000392460800009
J	[Anonymous]				[Anonymous]			BMS in microbiome immuno-oncology deal	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					5	5		10.1038/nbt0117-5a	http://dx.doi.org/10.1038/nbt0117-5a			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	28072775				2022-12-25	WOS:000392460800004
J	Kaminski, MM; Tosic, J; Kresbach, C; Engel, H; Klockenbusch, J; Muller, AL; Pichler, R; Grahammer, F; Kretz, O; Huber, TB; Walz, G; Arnold, SJ; Lienkamp, SS				Kaminski, Michael M.; Tosic, Jelena; Kresbach, Catena; Engel, Hannes; Klockenbusch, Jonas; Mueller, Anna-Lena; Pichler, Roman; Grahammer, Florian; Kretz, Oliver; Huber, Tobias B.; Walz, Gerd; Arnold, Sebastian J.; Lienkamp, Soeren S.			Direct reprogramming of fibroblasts into renal tubular epithelial cells by defined transcription factors	NATURE CELL BIOLOGY			English	Article							HUMAN PLURIPOTENT CELLS; DIRECT CONVERSION; KIDNEY ORGANOIDS; GENERATION; MOUSE; DIFFERENTIATION; EXPRESSION; CISPLATIN; CIRCUITRY; GUDMAP	Direct reprogramming by forced expression of transcription factors can convert one cell type into another. Thus, desired cell types can be generated bypassing pluripotency. However, direct reprogramming towards renal cells remains an unmet challenge. Here, we identify renal cell fate-inducing factors on the basis of their tissue specificity and evolutionarily conserved expression, and demonstrate that combined expression of Emx2, Hnf1b, Hnf4a and Pax8 converts mouse and human fibroblasts into induced renal tubular epithelial cells (iRECs). iRECs exhibit epithelial features, a global gene expression profile resembling their native counterparts, functional properties of differentiated renal tubule cells and sensitivity to nephrotoxic substances. Furthermore, iRECs integrate into kidney organoids and form tubules in decellularized kidneys. Our approach demonstrates that reprogramming factors can be identified by targeted in silico analysis. Renal tubular epithelial cells generated ex vivo by forced expression of transcription factors may facilitate disease modelling, drug and nephrotoxicity testing, and regenerative approaches.	[Kaminski, Michael M.; Tosic, Jelena; Kresbach, Catena; Engel, Hannes; Klockenbusch, Jonas; Mueller, Anna-Lena; Pichler, Roman; Grahammer, Florian; Kretz, Oliver; Huber, Tobias B.; Walz, Gerd; Arnold, Sebastian J.; Lienkamp, Soeren S.] Univ Freiburg, Fac Med, Med Ctr, Div Renal,Dept Med, Hugstetter Str 55, D-79106 Freiburg, Germany; [Tosic, Jelena; Arnold, Sebastian J.] Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, Albertstr 25, D-79104 Freiburg, Germany; [Tosic, Jelena] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Albertstr 19a, D-79104 Freiburg, Germany; [Tosic, Jelena] Univ Freiburg, Fac Biol, Schanzlestr 1, D-79104 Freiburg, Germany; [Kretz, Oliver] Univ Freiburg, Dept Neuroanat, Albertstr 17, D-79104 Freiburg, Germany; [Huber, Tobias B.; Walz, Gerd; Arnold, Sebastian J.; Lienkamp, Soeren S.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Schanzlestr 18, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Arnold, SJ; Lienkamp, SS (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Div Renal,Dept Med, Hugstetter Str 55, D-79106 Freiburg, Germany.; Arnold, SJ (corresponding author), Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, Albertstr 25, D-79104 Freiburg, Germany.; Arnold, SJ; Lienkamp, SS (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Schanzlestr 18, D-79104 Freiburg, Germany.	sebastian.arnold@pharmakol.uni-freiburg.de; soeren.lienkamp@uniklinik-freiburg.de	Lienkamp, Soeren/AAH-6296-2020; Grahammer, Florian/ABB-7775-2021	Lienkamp, Soeren/0000-0003-2963-6865; Huber, Tobias B./0000-0001-7175-5062; Arnold, Sebastian J./0000-0002-2688-9210; Kresbach, Catena/0000-0002-6004-7332; Pichler, Roman/0000-0003-2602-998X; Kaminski, Michael M./0000-0003-0429-7027; Kretz, Oliver/0000-0003-1152-5956; Weckerle, Jelena/0000-0003-3447-9235	Emmy Noether Programme [LI1817/2-1, AR732/1-1]; Projects B07 of the collaborative research initiative KIDGEM [SFB 1140]; German Research Foundation (DFG); BIOSS Centre of Biological Signalling Studies; Excellence Initiative of the German Research Foundation (Spemann Graduate School) [GSC-4];  [SFB 850]	Emmy Noether Programme(German Research Foundation (DFG)); Projects B07 of the collaborative research initiative KIDGEM; German Research Foundation (DFG)(German Research Foundation (DFG)); BIOSS Centre of Biological Signalling Studies; Excellence Initiative of the German Research Foundation (Spemann Graduate School); 	We thank A. Heer, A. Sammarco and B. Joch for excellent technical assistance; the staff of the SFB1140 project Z01 and R. Nitschke (Life Imaging Centre (LIC), Albert-Ludwigs-University Freiburg) for help with confocal microscopy; D. Pfeifer for performing microarrays; M. Follo for FACS analysis; O. Wessely (Cleveland, USA), P. Vize (Calgary, Canada), N. Ueno (National Institute for Basic Biology, Japan) and D. Trono (Lausanne, Switzerland) for generously providing plasmids; M. Kottgen for thoughtful comments on the manuscript. This work was supported by the Emmy Noether Programme to S.S.L. (LI1817/2-1) and S.J.A. (AR732/1-1), Projects B07 of the collaborative research initiative KIDGEM (SFB 1140) to S.S.L. and S.J.A. and project A03 of SFB 850 to S.J.A. by the German Research Foundation (DFG), BIOSS Centre of Biological Signalling Studies, and the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School) to S.J.A.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Bar-Nur O, 2014, NAT METHODS, V11, P1170, DOI [10.1038/nmeth.3142, 10.1038/NMETH.3142]; Buganim Y, 2012, CELL STEM CELL, V11, P373, DOI 10.1016/j.stem.2012.07.019; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Cui SY, 1996, AM J PHYSIOL-RENAL, V271, pF900, DOI 10.1152/ajprenal.1996.271.4.F900; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Giles RH, 2014, NAT PROTOC, V9, P2725, DOI 10.1038/nprot.2014.181; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Heinaniemi M, 2013, NAT METHODS, V10, P577, DOI [10.1038/nmeth.2445, 10.1038/NMETH.2445]; Hendry CE, 2013, J AM SOC NEPHROL, V24, P1424, DOI 10.1681/ASN.2012121143; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jaitovich A, 2010, LIFE SCI, V86, P73, DOI 10.1016/j.lfs.2009.10.019; Kaminski M. M., 2016, NAT PROTOC EXCH; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lang AH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003734; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Legouis D, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0058-4; Lienkamp S, 2010, P NATL ACAD SCI USA, V107, P20388, DOI 10.1073/pnas.1013070107; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Morizane R, 2015, NAT BIOTECHNOL, V33, P1193, DOI 10.1038/nbt.3392; Nagy A, 2003, MANIPULATING MOUSE E, P453; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Nam YJ, 2014, DEVELOPMENT, V141, P4267, DOI 10.1242/dev.114025; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Papadimou E, 2015, STEM CELL REP, V4, P685, DOI 10.1016/j.stemcr.2015.02.002; Pereira CF, 2012, ANN NY ACAD SCI, V1266, P7, DOI 10.1111/j.1749-6632.2012.06508.x; Rackham OJL, 2016, NAT GENET, V48, P331, DOI 10.1038/ng.3487; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; United States Renal Data System, 2014, ANN DAT REP EP KIDN; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; VALENTICH JD, 1979, J CELL PHYSIOL, V100, P291, DOI 10.1002/jcp.1041000210; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Xia Y, 2014, NAT PROTOC, V9, P2693, DOI 10.1038/nprot.2014.182; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564; Yonezawa A, 2005, BIOCHEM PHARMACOL, V70, P1823, DOI 10.1016/j.bcp.2005.09.020; Yu J, 2012, DEVELOPMENT, V139, P1863, DOI 10.1242/dev.074005	58	84	86	4	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2016	18	12					1269	+		10.1038/ncb3437	http://dx.doi.org/10.1038/ncb3437			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	ED8PY	27820600				2022-12-25	WOS:000389134600005
J	Janetzko, J; Trauger, SA; Lazarus, MB; Walker, S				Janetzko, John; Trauger, Sunia A.; Lazarus, Michael B.; Walker, Suzanne			How the glycosyltransferase OGT catalyzes amide bond cleavage	NATURE CHEMICAL BIOLOGY			English	Article							O-GLCNAC TRANSFERASE; METASTABLE BINDING-SITES; PROTEIN; HCF-1; MODELS; FAMILY	The essential human enzyme O-linked beta-N-acetylglucosamine transferase (OGT), known for modulating the functions of nuclear and cytoplasmic proteins through serine and threonine glycosylation, was unexpectedly implicated in the proteolytic maturation of the cell cycle regulator host cell factor-1 (HCF-1). Here we show that HCF-1 cleavage occurs via glycosylation of a glutamate side chain followed by on-enzyme formation of an internal pyroglutamate, which undergoes spontaneous backbone hydrolysis.	[Janetzko, John; Lazarus, Michael B.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Janetzko, John; Lazarus, Michael B.; Walker, Suzanne] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02215 USA; [Trauger, Sunia A.] Harvard Univ, Div Sci, Small Mol Mass Spectrometry, Cambridge, MA 02138 USA; [Lazarus, Michael B.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Icahn School of Medicine at Mount Sinai	Walker, S (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02215 USA.	suzanne_walker@hms.harvard.edu	Janetzko, John/AAQ-2602-2021	Janetzko, John/0000-0003-1604-2515; Lazarus, Michael/0000-0002-6738-2563	National Science and Engineering Research Council (NSERC) of Canada; National Institutes of Health [R01 GM094263]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094263] Funding Source: NIH RePORTER	National Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.J. is a National Science and Engineering Research Council (NSERC) of Canada PGS-M and PGS-D3 fellowship recipient. Funding for this work was provided by a National Institutes of Health grant (R01 GM094263) to S.W. We thank C. Thompson (Bruker Daltonics, Billerica, Massachusetts, USA) for access to and assistance with a SolariX XR 7T q-Q-FT-ICR mass spectrometer. We thank D. Vocadlo (Simon Fraser University, Vancouver, British Columbia, Canada) for providing UDP-5SGlcNAc. X-ray diffraction data were collected at the National Synchrotron Light Source at Brookhaven National Laboratory (Beamline X25).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bhuiyan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136636; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERICKSON BW, 1983, ANN NY ACAD SCI, V421, P167, DOI 10.1111/j.1749-6632.1983.tb18107.x; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Janetzko J, 2014, J BIOL CHEM, V289, P34424, DOI 10.1074/jbc.R114.604405; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; KHAN SA, 1986, BIOCHEMISTRY-US, V25, P5165, DOI 10.1021/bi00366a027; KHAN SA, 1982, J BIOL CHEM, V257, P1864; Kotzler MP, 2016, J BIOL CHEM, V291, P429, DOI 10.1074/jbc.C115.698696; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Mangone M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009020; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meyer V, 2013, PITFALLS ERRORS HPLC, P110; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nalbone JM, 2016, ORG LETT, V18, P1186, DOI 10.1021/acs.orglett.6b00317; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Parker JB, 2014, CELL REP, V9, P967, DOI 10.1016/j.celrep.2014.09.051; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6	34	23	23	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					899	+		10.1038/NCHEMBIO.2173	http://dx.doi.org/10.1038/NCHEMBIO.2173			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27618188	Green Submitted, Green Accepted			2022-12-25	WOS:000386798800007
J	Mironov, GG; Clouthier, CM; Akbar, A; Keillor, JW; Berezovski, MV				Mironov, Gleb G.; Clouthier, Christopher M.; Akbar, Abdullah; Keillor, Jeffrey W.; Berezovski, Maxim V.			Simultaneous analysis of enzyme structure and activity by kinetic capillary electrophoresis-MS	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN CONFORMATIONAL-CHANGES; RELAXATION DISPERSION NMR; MASS SPECTROMETRY; ION MOBILITY; TISSUE TRANSGLUTAMINASE; POPULATION SHIFT; DRUG DISCOVERY; STATES; DYNAMICS; SPECTROSCOPY	To enable the detection of protein conformational isomers, their enzymatic activity and their inhibition in a single experiment, we developed a method based on kinetic capillary electrophoresis coupled on-line with UV detection and ion mobility mass spectrometry (CE-UV-IM-MS). Kinetic CE-UV separated protein conformers and monitored their interconversion dynamics in solution. Ion mobility mass spectrometry analyzed the conformer sizes, exact molecular weights, and structures of an enzyme and of its substrates, inhibitors and corresponding products. This coupled CE-UV-IM-MS system allowed the simultaneous, real-time observation of the effect of small-molecule inhibitors on both the conformational distribution and enzymatic activity of the human tissue transglutaminase TG2. By expanding mass spectrometry profiling of enzymatic reactions beyond proteins and substrates to include protein dynamics, CE-UV-IM-MS opens a new avenue for the modulation and regulation of cellular functions, drug development and protein engineering.	[Mironov, Gleb G.; Clouthier, Christopher M.; Akbar, Abdullah; Keillor, Jeffrey W.; Berezovski, Maxim V.] Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON, Canada	University of Ottawa	Keillor, JW; Berezovski, MV (corresponding author), Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON, Canada.	jkeillor@uottawa.ca; maxim.berezovski@uottawa.ca	Berezovski, Maxim V./F-8961-2012; Berezovski, Maxim V./N-1247-2019	Berezovski, Maxim V./0000-0003-0514-599X; Berezovski, Maxim V./0000-0003-0514-599X	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Ministry of Research and Innovation, Ontario, Canada; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ministry of Research and Innovation, Ontario, Canada(Ministry of Research and Innovation, Ontario); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (M.V.B. and J.W.K.), the Canada Foundation for Innovation (M.V.B.), the Ministry of Research and Innovation, Ontario, Canada (M.V.B.) and by an Ontario Graduate Scholarship (for G.G.M.).	Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Berezovski M, 2002, J AM CHEM SOC, V124, P13674, DOI 10.1021/ja028212e; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bruning JB, 2010, NAT CHEM BIOL, V6, P837, DOI 10.1038/NCHEMBIO.451; Caron NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044159; Clouthier CM, 2012, ANGEW CHEM INT EDIT, V51, P12464, DOI 10.1002/anie.201205575; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Fischetti RF, 2004, CHEM BIOL, V11, P1431, DOI 10.1016/j.chembiol.2004.08.013; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Garman E, 2003, CURR OPIN STRUC BIOL, V13, P545, DOI 10.1016/j.sbi.2003.09.013; Gnaccarini C, 2009, BIOORGAN MED CHEM, V17, P6354, DOI 10.1016/j.bmc.2009.07.031; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Grant BJ, 2010, CURR OPIN STRUC BIOL, V20, P142, DOI 10.1016/j.sbi.2009.12.004; Heegaard NHH, 2003, J CHROMATOGR A, V1004, P51, DOI 10.1016/S0021-9673(03)00719-2; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Hu BH, 2003, J AM CHEM SOC, V125, P14298, DOI 10.1021/ja038593b; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kaddis Catherine S, 2007, Anal Chem, V79, P1778, DOI 10.1021/ac071878c; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Keedy DA, 2014, STRUCTURE, V22, P899, DOI 10.1016/j.str.2014.04.016; Keillor JW, 2008, CAN J CHEM, V86, P271, DOI 10.1139/V08-024; Kempf JG, 2007, J MOL BIOL, V368, P131, DOI 10.1016/j.jmb.2007.01.074; Konijnenberg A, 2013, BBA-PROTEINS PROTEOM, V1834, P1239, DOI 10.1016/j.bbapap.2012.11.013; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Leblanc A, 2001, BIOCHEMISTRY-US, V40, P8335, DOI 10.1021/bi0024097; Lipscomb WN, 1998, NATO ADV SCI I A-LIF, V301, P27; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lubell W.D., 2005, PEPTIDES SCI SYNTHES; Mattevi A, 1996, CURR OPIN STRUC BIOL, V6, P824, DOI 10.1016/S0959-440X(96)80013-3; Mironov GG, 2013, J AM CHEM SOC, V135, P13728, DOI 10.1021/ja407486z; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Nabuchi Y, 2010, ANAL CHEM, V82, P8890, DOI 10.1021/ac101482b; Nguyen HT, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4896220; Nussinov R, 2015, ANNU REV PHARMACOL, V55, P249, DOI 10.1146/annurev-pharmtox-010814-124401; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Roy I, 2013, PROTEIN EXPRES PURIF, V87, P41, DOI 10.1016/j.pep.2012.10.002; Ruschak AM, 2012, P NATL ACAD SCI USA, V109, pE3454, DOI 10.1073/pnas.1213640109; Shi HL, 2012, J PHYS CHEM B, V116, P3344, DOI 10.1021/jp210797x; Smith DP, 2007, J AM SOC MASS SPECTR, V18, P2180, DOI 10.1016/j.jasms.2007.09.017; Smith MJ, 2015, CURR OPIN STRUC BIOL, V32, P39, DOI 10.1016/j.sbi.2015.02.003; STONE SR, 1985, BIOCHEM J, V230, P497, DOI 10.1042/bj2300497; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tang YF, 2006, J MOL BIOL, V355, P1066, DOI 10.1016/j.jmb.2005.10.066; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; WOLYNES PG, 1995, P NATL ACAD SCI USA, V92, P2426, DOI 10.1073/pnas.92.7.2426	52	29	29	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					918	+		10.1038/NCHEMBIO.2170	http://dx.doi.org/10.1038/NCHEMBIO.2170			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27595328				2022-12-25	WOS:000386798800012
J	Yamada, K; Park, HM; Rigel, DF; DiPetrillo, K; Whalen, EJ; Anisowicz, A; Beil, M; Berstler, J; Brocklehurst, CE; Burdick, DA; Caplan, SL; Capparelli, MP; Chen, GJ; Chen, W; Dale, B; Deng, L; Fu, FM; Hamamatsu, N; Harasaki, K; Herr, T; Hoffmann, P; Hu, QY; Huang, WJ; Idamakanti, N; Imase, H; Iwaki, Y; Jain, M; Jeyaseelan, J; Kato, M; Kaushik, VK; Kohls, D; Kunjathoor, V; LaSala, D; Lee, J; Liu, J; Luo, Y; Ma, FP; Mo, RW; Mowbray, S; Mogi, M; Ossola, F; Pandey, P; Patel, SJ; Raghavan, S; Salem, B; Shanado, YH; Trakshel, GM; Turner, G; Wakai, H; Wang, CH; Weldon, S; Wielicki, JB; Xie, XL; Xu, LF; Yagi, YI; Yasoshima, K; Yin, JN; Yowe, D; Zhang, JH; Zheng, G; Monovich, L				Yamada, Ken; Park, Hyi-Man; Rigel, Dean F.; DiPetrillo, Keith; Whalen, Erin J.; Anisowicz, Anthony; Beil, Michael; Berstler, James; Brocklehurst, Cara Emily; Burdick, Debra A.; Caplan, Shari L.; Capparelli, Michael P.; Chen, Guanjing; Chen, Wei; Dale, Bethany; Deng, Lin; Fu, Fumin; Hamamatsu, Norio; Harasaki, Kouki; Herr, Tracey; Hoffmann, Peter; Hu, Qi-Ying; Huang, Waan-Jeng; Idamakanti, Neeraja; Imase, Hidetomo; Iwaki, Yuki; Jain, Monish; Jeyaseelan, Jey; Kato, Mitsunori; Kaushik, Virendar K.; Kohls, Darcy; Kunjathoor, Vidya; LaSala, Daniel; Lee, Jongchan; Liu, Jing; Luo, Yang; Ma, Fupeng; Mo, Ruowei; Mowbray, Sarah; Mogi, Muneto; Ossola, Flavio; Pandey, Pramod; Patel, Sejal J.; Raghavan, Swetha; Salem, Bahaa; Shanado, Yuka H.; Trakshel, Gary M.; Turner, Gordon; Wakai, Hiromichi; Wang, Chunhua; Weldon, Stephen; Wielicki, Jennifer B.; Xie, Xiaoling; Xu, Lingfei; Yagi, Yukiko I.; Yasoshima, Kayo; Yin, Jianning; Yowe, David; Zhang, Ji-Hu; Zheng, Gang; Monovich, Lauren			Small-molecule WNK inhibition regulates cardiovascular and renal function	NATURE CHEMICAL BIOLOGY			English	Article							LOWERS BLOOD-PRESSURE; PROTEIN-KINASES; HYPERTENSION; SPAK; GENE; MUTATIONS; PSEUDOHYPOALDOSTERONISM; PHOSPHORYLATION; COTRANSPORTER; POTASSIUM	The With-No-Lysine (K) (WNK) kinases play a critical role in blood pressure regulation and body fluid and electrolyte homeostasis. Herein, we introduce the first orally bioavailable pan-WNK-kinase inhibitor, WNK463, that exploits unique structural features of the WNK kinases for both affinity and kinase selectivity. In rodent models of hypertension, WNK463 affects blood pressure and body fluid and electrolyte homeostasis, consistent with WNK-kinase-associated physiology and pathophysiology.	[Yamada, Ken; Park, Hyi-Man; Rigel, Dean F.; DiPetrillo, Keith; Whalen, Erin J.; Anisowicz, Anthony; Beil, Michael; Berstler, James; Brocklehurst, Cara Emily; Burdick, Debra A.; Caplan, Shari L.; Capparelli, Michael P.; Chen, Guanjing; Chen, Wei; Dale, Bethany; Deng, Lin; Fu, Fumin; Hamamatsu, Norio; Harasaki, Kouki; Herr, Tracey; Hoffmann, Peter; Hu, Qi-Ying; Huang, Waan-Jeng; Idamakanti, Neeraja; Imase, Hidetomo; Iwaki, Yuki; Jain, Monish; Jeyaseelan, Jey; Kato, Mitsunori; Kaushik, Virendar K.; Kohls, Darcy; Kunjathoor, Vidya; LaSala, Daniel; Lee, Jongchan; Liu, Jing; Luo, Yang; Ma, Fupeng; Mo, Ruowei; Mowbray, Sarah; Mogi, Muneto; Ossola, Flavio; Pandey, Pramod; Patel, Sejal J.; Raghavan, Swetha; Salem, Bahaa; Shanado, Yuka H.; Trakshel, Gary M.; Turner, Gordon; Wakai, Hiromichi; Wang, Chunhua; Weldon, Stephen; Wielicki, Jennifer B.; Xie, Xiaoling; Xu, Lingfei; Yagi, Yukiko I.; Yasoshima, Kayo; Yin, Jianning; Yowe, David; Zhang, Ji-Hu; Zheng, Gang; Monovich, Lauren] Novartis Inst BioMed Res, Cambridge, MA 02139 USA	Novartis	Yamada, K (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.	ken.yamada@novartis.com		Kato, Mitsunori/0000-0002-8426-2504; Turner, Gordon/0000-0001-9156-7499; Yamada, Ken/0000-0001-7899-6192	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE))	The authors acknowledge G. Waters and L.D. Morton for careful reading of this manuscript and K. Gunderson for detailed NMR analysis of WNK463 (Novartis Institutes for BioMedical Research). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Golbang AP, 2005, HYPERTENSION, V46, P295, DOI 10.1161/01.HYP.0000174326.96918.d6; Hoorn EJ, 2012, EXP CELL RES, V318, P1020, DOI 10.1016/j.yexcr.2012.02.029; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kikuchi E, 2015, J AM SOC NEPHROL, V26, P1525, DOI 10.1681/ASN.2014060560; McCormick JA, 2008, HYPERTENSION, V51, P588, DOI 10.1161/HYPERTENSIONAHA.107.103788; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Mori T, 2013, BIOCHEM J, V455, P339, DOI 10.1042/BJ20130597; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; O'Reilly M, 2003, J AM SOC NEPHROL, V14, P2447, DOI 10.1097/01.ASN.0000089830.97681.3B; Ohta A, 2013, BIOCHEM J, V451, P111, DOI 10.1042/BJ20121903; Ohta A, 2009, HUM MOL GENET, V18, P3978, DOI 10.1093/hmg/ddp344; Arroyo JP, 2012, AM J NEPHROL, V35, P379, DOI 10.1159/000337479; Proctor G, 2006, AM J KIDNEY DIS, V48, P674, DOI 10.1053/j.ajkd.2006.06.014; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Roy A, 2015, AM J PHYSIOL-RENAL, V308, pF366, DOI 10.1152/ajprenal.00612.2014; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Sohara E., 2015, NEPHROL DIAL TRANSPL; Takahashi D, 2014, BIOSCIENCE REP, V34, P195, DOI 10.1042/BSR20140047; Uchida S, 2010, PFLUG ARCH EUR J PHY, V460, P695, DOI 10.1007/s00424-010-0848-7; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	28	75	76	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					896	+		10.1038/NCHEMBIO.2168	http://dx.doi.org/10.1038/NCHEMBIO.2168			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27595330				2022-12-25	WOS:000386798800006
J	Zackular, JP; Moore, JL; Jordan, AT; Juttukonda, LJ; Noto, MJ; Nicholson, MR; Crews, JD; Semler, MW; Zhang, Y; Ware, LB; Washington, MK; Chazin, WJ; Caprioli, RM; Skaar, EP				Zackular, Joseph P.; Moore, Jessica L.; Jordan, Ashley T.; Juttukonda, Lillian J.; Noto, Michael J.; Nicholson, Maribeth R.; Crews, Jonathan D.; Semler, Matthew W.; Zhang, Yaofang; Ware, Lorraine B.; Washington, M. Kay; Chazin, Walter J.; Caprioli, Richard M.; Skaar, Eric P.			Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection	NATURE MEDICINE			English	Article							ANTIBIOTIC-ASSOCIATED COLITIS; FECAL CALPROTECTIN; EPIDEMIOLOGY; COMMENSALS	Clostridium difficile is the most commonly reported nosocomial pathogen in the United States and is an urgent public health concern worldwide(1). Over the past decade, incidence, severity and costs associated with C. difficile infection (CDI) have increased dramatically(2). CDI is most commonly initiated by antibiotic-mediated disruption of the gut microbiota; however, non-antibiotic-associated CDI cases are well documented and on the rise(3,4). This suggests that unexplored environmental, nutrient and host factors probably influence CDI. Here we show that excess dietary zinc (Zn) substantially alters the gut microbiota and, in turn, reduces the minimum amount of antibiotics needed to confer susceptibility to CDI. In mice colonized with C. difficile, excess dietary Zn severely exacerbated C. difficile associated disease by increasing toxin activity and altering the host immune response. In addition, we show that the Zn-binding S100 protein calprotectin has antimicrobial effects against C. difficile and is an essential component of the innate immune response to CDI. Taken together, these data suggest that nutrient Zn levels have a key role in determining susceptibility to CDI and severity of disease, and that calprotectin-mediated metal limitation is an important factor in the host immune response to C. difficile.	[Zackular, Joseph P.; Jordan, Ashley T.; Juttukonda, Lillian J.; Noto, Michael J.; Zhang, Yaofang; Ware, Lorraine B.; Washington, M. Kay; Skaar, Eric P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Moore, Jessica L.; Chazin, Walter J.; Caprioli, Richard M.] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Moore, Jessica L.; Caprioli, Richard M.] Vanderbilt Univ, Mass Spectrometry Res Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Noto, Michael J.; Semler, Matthew W.; Ware, Lorraine B.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Nicholson, Maribeth R.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Crews, Jonathan D.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Chazin, Walter J.; Caprioli, Richard M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Caprioli, Richard M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Skaar, Eric P.] US Dept Vet Affairs, Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Baylor College of Medicine; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Skaar, EP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA.; Skaar, EP (corresponding author), US Dept Vet Affairs, Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA.	eric.skaar@vanderbilt.edu	Ware, Lorraine/AAJ-9307-2021	Ware, Lorraine/0000-0002-9429-4702; Nicholson, Maribeth/0000-0003-3941-5599; Zackular, Joseph/0000-0002-3228-3055; Moore, Jessica/0000-0003-2519-6209	US Department of Veterans Affairs (Merit Review Award) [1I01BX002482]; US National Institutes of Health (NIH) [R01 AI101171, P41 GM103391-05]; Vanderbilt Digestive Disease Research Center (VDDRC) [P30DK058404]; NIH-NIDDK [T32DK007673]; NIH-NIAID [F32AI120553]; NIH-NIGMS [T32GM065086]; Thrasher Research Fund Early Career Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101171, F32AI120553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, T32DK007673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103391, T32GM007347, T32GM008320] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002482] Funding Source: NIH RePORTER	US Department of Veterans Affairs (Merit Review Award)(US Department of Veterans Affairs); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research Center (VDDRC); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Thrasher Research Fund Early Career Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank P. Schloss and J. Sorg for critical feedback on this study, and D. Aronoff and S. Walk for providing C. difficile strains. This research was supported by the US Department of Veterans Affairs (Merit Review Award no. 1I01BX002482; E.P.S.), the US National Institutes of Health (NIH) (grant no. R01 AI101171 (E.P.S.) and P41 GM103391-05 (R.M.C.)) and the Vanderbilt Digestive Disease Research Center (VDDRC) (grant no. P30DK058404; E.P.S.). J.P.Z. was supported by NIH-NIDDK grant no. T32DK007673 and NIH-NIAID grant no. F32AI120553. J.L.M. was supported by NIH-NIGMS grant no. T32GM065086. M.R.N. was supported by the Thrasher Research Fund Early Career Award.	Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Chumbler NM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.2, 10.1038/nmicrobiol.2015.2]; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; FEKETY R, 1981, AM J MED, V70, P906, DOI 10.1016/0002-9343(81)90553-2; Fischer W. C., 2004, ANNU REV NUTR, V24, P255, DOI DOI 10.1146/ANNUREV.NUTR.23.011702.073054; Gaddy JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004450; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Hanania A, 2016, INFECT DIS CLIN PRAC, V24, P31, DOI 10.1097/IPC.0000000000000312; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; Hensbergen PJ, 2015, FEBS LETT, V589, P3952, DOI 10.1016/j.febslet.2015.10.027; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Hood MI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003068; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Leffler DA, 2015, NEW ENGL J MED, V373, P287, DOI 10.1056/NEJMc1506004; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Rao K, 2016, INFECT DIS-NOR, V48, P663, DOI 10.1080/23744235.2016.1186832; Rubino JT, 2016, J BIOL INORG CHEM, V21, P185, DOI 10.1007/s00775-015-1319-6; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Schubert AM, 2015, MBIO, V6, DOI 10.1128/mBio.00974-15; Seo SU, 2015, IMMUNITY, V42, P744, DOI 10.1016/j.immuni.2015.03.004; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Theriot CM, 2011, GUT MICROBES, V2, P326, DOI [10.4161/gmic.2.6.19142, 10.4161/gmic.19142]; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; WUST J, 1982, J CLIN MICROBIOL, V16, P1096; Zackular JP, 2015, J BIOL CHEM, V290, P18991, DOI 10.1074/jbc.R115.645085	29	142	145	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1330	1334		10.1038/nm.4174	http://dx.doi.org/10.1038/nm.4174			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27668938	Green Accepted			2022-12-25	WOS:000387302300026
J	Cheng, F; Sun, RF; Hou, XL; Zheng, HK; Zhang, FL; Zhang, YY; Liu, B; Liang, JL; Zhuang, M; Liu, YX; Liu, DY; Wang, XB; Li, PX; Liu, YM; Lin, K; Bucher, J; Zhang, NW; Wang, Y; Wang, H; Deng, J; Liao, YC; Wei, KY; Zhang, XM; Fu, LX; Hu, YY; Liu, JS; Cai, CC; Zhang, SJ; Zhang, SF; Li, F; Zhang, H; Zhang, JF; Guo, N; Liu, ZY; Liu, J; Sun, C; Ma, Y; Zhang, HJ; Cui, Y; Freeling, MR; Borm, T; Bonnema, G; Wu, J; Wang, XW				Cheng, Feng; Sun, Rifei; Hou, Xilin; Zheng, Hongkun; Zhang, Fenglan; Zhang, Yangyong; Liu, Bo; Liang, Jianli; Zhuang, Mu; Liu, Yunxia; Liu, Dongyuan; Wang, Xiaobo; Li, Pingxia; Liu, Yumei; Lin, Ke; Bucher, Johan; Zhang, Ningwen; Wang, Yan; Wang, Hui; Deng, Jie; Liao, Yongcui; Wei, Keyun; Zhang, Xueming; Fu, Lixia; Hu, Yunyan; Liu, Jisheng; Cai, Chengcheng; Zhang, Shujiang; Zhang, Shifan; Li, Fei; Zhang, Hui; Zhang, Jifang; Guo, Ning; Liu, Zhiyuan; Liu, Jin; Sun, Chao; Ma, Yuan; Zhang, Haijiao; Cui, Yang; Freeling, Micheal R.; Borm, Theo; Bonnema, Guusje; Wu, Jian; Wang, Xiaowu			Subgenome parallel selection is associated with morphotype diversification and convergent crop domestication in Brassica rapa and Brassica oleracea	NATURE GENETICS			English	Article							PLANT DOMESTICATION; LEAF DEVELOPMENT; LATERAL ORGANS; AUXIN RESPONSE; ARABIDOPSIS; POLARITY; GROWTH; EVOLUTION; PATHWAYS; KANADI	Brassica species, including crops such as cabbage, turnip and oilseed, display enormous phenotypic variation. Brassica genomes have all undergone a whole-genome triplication (WGT) event with unknown effects on phenotype diversification. We resequenced 199 Brassica rapa and 119 Brassica oleracea accessions representing various morphotypes and identified signals of selection at the mesohexaploid subgenome level. For cabbage morphotypes with their typical leaf-heading trait, we identified four subgenome loci that show signs of parallel selection among subgenomes within B. rapa, as well as four such loci within B. ateracea. Fifteen subgenome loci are under selection and are shared by these two species. We also detected strong subgenome FiaraIlel selection linked to the domestication of the tuberous morphotypes, turnip (B. rapa) and kohlrabi (B. oleracea). Overall, we demonstrated that the mesohexaploidization of the two Brassica genomes contributed to their diversification into heading and tuber-forming morphotypes through convergent subgenome parallel selection of paralogous genes.	[Cheng, Feng; Sun, Rifei; Zhang, Yangyong; Liu, Bo; Liang, Jianli; Zhuang, Mu; Liu, Yunxia; Wang, Xiaobo; Li, Pingxia; Liu, Yumei; Wang, Yan; Wang, Hui; Deng, Jie; Liao, Yongcui; Wei, Keyun; Zhang, Xueming; Fu, Lixia; Hu, Yunyan; Liu, Jisheng; Cai, Chengcheng; Zhang, Shujiang; Zhang, Shifan; Li, Fei; Zhang, Hui; Zhang, Jifang; Guo, Ning; Liu, Zhiyuan; Liu, Jin; Sun, Chao; Ma, Yuan; Zhang, Haijiao; Cui, Yang; Bonnema, Guusje; Wu, Jian; Wang, Xiaowu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom,Minist Agr, Beijing, Peoples R China; [Hou, Xilin] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Zheng, Hongkun; Liu, Dongyuan] Biomarker Technol Corp, Beijing, Peoples R China; [Zhang, Fenglan] BAAFS, BVRC, Beijing, Peoples R China; [Lin, Ke; Bucher, Johan; Zhang, Ningwen; Borm, Theo; Bonnema, Guusje] Univ Wageningen & Res Ctr, Wageningen UR Plant Breeding, Wageningen, Netherlands; [Freeling, Micheal R.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Beijing Academy of Agriculture & Forestry; Wageningen University & Research; University of California System; University of California Berkeley	Bonnema, G; Wu, J; Wang, XW (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom,Minist Agr, Beijing, Peoples R China.; Bonnema, G (corresponding author), Univ Wageningen & Res Ctr, Wageningen UR Plant Breeding, Wageningen, Netherlands.	guusje.bonnema@wur.nl; wujian@caas.cn; wangxiaowu@caas.cn	刘博, 博/AAR-9824-2020; Yongcui, Liao/AAD-9466-2019; Wang, Xiaowu/L-2579-2019; hu, yunyan/AAE-5630-2019	Cai, Chengcheng/0000-0002-8780-8963; Sun, Chao/0000-0001-6869-9944	National Program on Key Basic Research Projects (973 Program) [2012CB113900, 2013CB127000]; National High-Technology R&D Program of China [2012AA100201]; National Program on Key Research Project [2016YFD0100307]; National Natural Science Foundation of China (NSFC) [31301771, 31272179, 31301784]; Program for Strategic Scientific Alliances between China and the Netherlands; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops; Ministry of Agriculture, China; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences; European Community [NUE-CROPS FP7-CP-IP 222645]; Technological Top Institute (TTI) Green Genetics; Rijk Zwaan; Bejo Zaden	National Program on Key Basic Research Projects (973 Program)(National Basic Research Program of China); National High-Technology R&D Program of China(National High Technology Research and Development Program of China); National Program on Key Research Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for Strategic Scientific Alliances between China and the Netherlands; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops; Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs); Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences; European Community(European Commission); Technological Top Institute (TTI) Green Genetics; Rijk Zwaan; Bejo Zaden	This study was funded by National Program on Key Basic Research Projects (973 Program: 2012CB113900 to Xiaowu Wang and F.C. and 2013CB127000 to Xiaowu Wang), the National High-Technology R&D Program of China (2012AA100201 to J.W.), a National Program on Key Research Project (2016YFD0100307) and the National Natural Science Foundation of China (NSFC grants 31301771 to EC., 31272179 to J.W. and 31301784 to J. Liang). Research was supported by the Program for Strategic Scientific Alliances between China and the Netherlands, the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, the Ministry of Agriculture, China, and the Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences. The authors gratefully acknowledge funding from the European Community under the Seventh Framework Programme for Research, Technological Development and Demonstration Activities, for Integrated Project NUE-CROPS FP7-CP-IP 222645. B. oleracea resequencing data and analyses were funded by a grant from the Technological Top Institute (TTI) Green Genetics, Rijk Zwaan and Bejo Zaden.	Arias T, 2014, AM J BOT, V101, P86, DOI 10.3732/ajb.1300312; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Barkoulas M, 2007, CURR OPIN PLANT BIOL, V10, P660, DOI 10.1016/j.pbi.2007.07.012; Beuchat J, 2010, NEW PHYTOL, V188, P23, DOI 10.1111/j.1469-8137.2010.03387.x; Bonnema G., 2011, Genetics, genomics and breeding of vegetable brassicas, P81; Boswell V. R., 1949, OUR VEGETABLE TRAVEL, V96, P145; Bowman JL, 2002, TRENDS GENET, V18, P134, DOI 10.1016/S0168-9525(01)02601-4; Braybrook SA, 2010, PLANT CELL, V22, P1006, DOI 10.1105/tpc.110.073924; Byrne ME, 2005, CURR OPIN PLANT BIOL, V8, P59, DOI 10.1016/j.pbi.2004.11.009; Cheng F, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.24; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Cheng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036442; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Fuller DQ, 2014, P NATL ACAD SCI USA, V111, P6147, DOI 10.1073/pnas.1308937110; Gazzarrini S, 2003, ANN BOT-LONDON, V91, P605, DOI 10.1093/aob/mcg064; Gepts P, 2014, CURR OPIN PLANT BIOL, V18, P51, DOI 10.1016/j.pbi.2014.02.001; Hake S, 2004, ANNU REV CELL DEV BI, V20, P125, DOI 10.1146/annurev.cellbio.20.031803.093824; Hovav R, 2008, GENETICS, V179, P1725, DOI 10.1534/genetics.108.089656; Husbands AY, 2009, GENE DEV, V23, P1986, DOI 10.1101/gad.1819909; Izhaki A, 2007, PLANT CELL, V19, P495, DOI 10.1105/tpc.106.047472; Kelley DR, 2012, DEVELOPMENT, V139, P1105, DOI 10.1242/dev.067918; Kidner CA, 2007, CURR OPIN PLANT BIOL, V10, P13, DOI 10.1016/j.pbi.2006.11.013; Kwak M, 2012, ANN BOT-LONDON, V110, P1573, DOI 10.1093/aob/mcs207; Lenser T, 2013, TRENDS PLANT SCI, V18, P704, DOI 10.1016/j.tplants.2013.08.007; Li J, 2009, PLANTA, V229, P593, DOI 10.1007/s00425-008-0854-6; Li Wanlong, 2006, Functional & Integrative Genomics, V6, P300, DOI 10.1007/s10142-005-0015-y; Lin ZW, 2012, NAT GENET, V44, P720, DOI 10.1038/ng.2281; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Liu ZY, 2011, J EXP BOT, V62, P4367, DOI 10.1093/jxb/err167; Manju R. V., 1995, Indian Journal of Experimental Biology, V33, P1; Mouchel CF, 2006, NATURE, V443, P458, DOI 10.1038/nature05130; Nagaharu U., 1935, JPN J BOT, V7, P389, DOI DOI 10.1038/35036519; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Piazza P, 2005, NEW PHYTOL, V167, P693, DOI 10.1111/j.1469-8137.2005.01466.x; Prakash S., 1980, OPERA BOT, V55, P1, DOI DOI 10.1016/B978-1-891127-79-3.50001-9; Pritchard JK, 2000, GENETICS, V155, P945; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Santuari L, 2011, CURR BIOL, V21, P1918, DOI 10.1016/j.cub.2011.10.002; Scacchi E, 2009, DEVELOPMENT, V136, P2059, DOI 10.1242/dev.035444; Stamm P, 2010, J EXP BOT, V61, P2889, DOI 10.1093/jxb/erq147; TAJIMA F, 1983, GENETICS, V105, P437; Tang HB, 2013, P NATL ACAD SCI USA, V110, P15824, DOI 10.1073/pnas.1305213110; Tang HB, 2012, GENETICS, V190, P1563, DOI 10.1534/genetics.111.137349; Townsley BT, 2012, ANNU REV PLANT BIOL, V63, P535, DOI 10.1146/annurev-arplant-042811-105524; Vavilov NI, 1922, J GENET, V12, P47, DOI 10.1007/BF02983073; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang JP, 2015, COMPEND PL GENOME, P121, DOI 10.1007/978-3-662-47901-8_11; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wu FJ, 2007, PLANT CELL, V19, P914, DOI 10.1105/tpc.106.048637; Wu G, 2008, P NATL ACAD SCI USA, V105, P16392, DOI 10.1073/pnas.0803997105; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yu XH, 2000, SCI CHINA SER C, V43, P321, DOI 10.1007/BF02879292; Zhang NW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114241; Zhao JJ, 2005, THEOR APPL GENET, V110, P1301, DOI 10.1007/s00122-005-1967-y	55	186	204	10	177	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1218	1224		10.1038/ng.3634	http://dx.doi.org/10.1038/ng.3634			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27526322				2022-12-25	WOS:000384391600017
J	Das, S; Forer, L; Schonherr, S; Sidore, C; Locke, AE; Kwong, A; Vrieze, SI; Chew, EY; Levy, S; McGue, M; Schlessinger, D; Stambolian, D; Loh, PR; Iacono, WG; Swaroop, A; Scott, LJ; Cucca, F; Kronenberg, F; Boehnke, M; Abecasis, GR; Fuchsberger, C				Das, Sayantan; Forer, Lukas; Schoenherr, Sebastian; Sidore, Carlo; Locke, Adam E.; Kwong, Alan; Vrieze, Scott I.; Chew, Emily Y.; Levy, Shawn; McGue, Matt; Schlessinger, David; Stambolian, Dwight; Loh, Po-Ru; Iacono, William G.; Swaroop, Anand; Scott, Laura J.; Cucca, Francesco; Kronenberg, Florian; Boehnke, Michael; Abecasis, Goncalo R.; Fuchsberger, Christian			Next-generation genotype imputation service and methods	NATURE GENETICS			English	Article							ASSOCIATION; PROTECTION; THOUSANDS; MAPREDUCE	Genotype imputation is a key component of genetic association studies, where it increases power, facilitates meta-analysis, and aids interpretation of signals. Genotype imputation is computationally demanding and, with current tools, typically requires access to a high-performance computing cluster and to a reference panel of sequenced genomes. Here we describe improvements to imputation machinery that reduce computational requirements by more than an order of magnitude with no loss of accuracy in comparison to standard imputation tools. We also describe a new web-based service for imputation that facilitates access to new reference panels and greatly improves user experience and productivity.	[Das, Sayantan; Sidore, Carlo; Locke, Adam E.; Kwong, Alan; Scott, Laura J.; Boehnke, Michael; Abecasis, Goncalo R.; Fuchsberger, Christian] Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; [Forer, Lukas; Schoenherr, Sebastian; Kronenberg, Florian; Fuchsberger, Christian] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Sidore, Carlo; Cucca, Francesco] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Sidore, Carlo; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy; [Vrieze, Scott I.] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Chew, Emily Y.] NEI, Clin Trials Branch, Div Epidemiol & Clin Applicat, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [McGue, Matt; Iacono, William G.] Univ Minnesota, Dept Psychol, Minneapolis, MN USA; [Schlessinger, David] NIA, Genet Lab, US Natl Inst Hlth, Baltimore, MD 21224 USA; [Stambolian, Dwight] Univ Penn, Dept Genet, Philadelphia, PA USA; [Loh, Po-Ru] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Loh, Po-Ru] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Fuchsberger, Christian] Univ Lubeck, European Acad Bolzano Bozen EURAC, Ctr Biomed, Bolzano, Italy	University of Michigan System; University of Michigan; Medical University of Innsbruck; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari; University of Colorado System; University of Colorado Boulder; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); HudsonAlpha Institute for Biotechnology; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); European Academy of Bozen-Bolzano	Abecasis, GR; Fuchsberger, C (corresponding author), Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA.; Fuchsberger, C (corresponding author), Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria.; Fuchsberger, C (corresponding author), Univ Lubeck, European Acad Bolzano Bozen EURAC, Ctr Biomed, Bolzano, Italy.	goncalo@umich.edu; christian.fuchsberger@eurac.edu	Forer, Lukas/AAX-9577-2021; Schoenherr, Sebastian/ABB-3366-2020; Kronenberg, Florian/B-1736-2008; Sidore, Carlo/AAV-7967-2020; Schoenherr, Sebastian/W-8761-2019; Locke, Adam/K-2000-2019; Forer, Lukas/ABE-6007-2020; Fuchsberger, Christian/ABD-7127-2021	Forer, Lukas/0000-0003-2139-7329; Kronenberg, Florian/0000-0003-2229-1120; Sidore, Carlo/0000-0001-7504-7477; Schoenherr, Sebastian/0000-0001-5909-9226; Locke, Adam/0000-0001-6227-198X; Fuchsberger, Christian/0000-0002-5918-8947; Swaroop, Anand/0000-0002-1975-1141; Levy, Shawn/0000-0002-1369-5740; CUCCA, Francesco/0000-0002-7414-1995	National Institutes of Health [HG007022, HL117626, HG000376, R01DA037904]; Austrian Science Fund (FWF) [J-3401]; European Community [602133]; Intramural Research Program of the National Institute on Aging, National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000489, ZIAEY000546] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL117626, R01HL117626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007022, R56HG000376, R01HG000376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA009367, R01AA009367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005147, R01DA037904, U01DA024417, R37DA005147, R01DA036216, R01DA024417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Community(European Commission); Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors gratefully acknowledge D. Hinds for assistance with minimac3 code optimizations and A.L. Williams for providing HAPI-UR. We acknowledge support from National Institutes of Health grants HG007022 and HL117626 (G.R.A.), HG000376 (M.B.), and R01DA037904 (S.I.V.), Austrian Science Fund (FWF) grant J-3401 (C.F.), and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 602133 (L.F. and S.S.). This work was also supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health (D. Schlessinger).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dean J, 2004, USENIX ASSOCIATION PROCEEDINGS OF THE SIXTH SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION (OSDE '04), P137; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; McCarthy S., 2016, NAT GENET; Paul JS, 2012, BIOINFORMATICS, V28, P2008, DOI 10.1093/bioinformatics/bts314; Pistis G, 2015, EUR J HUM GENET, V23, P975, DOI 10.1038/ejhg.2014.216; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Schonherr S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-200; Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243	27	1413	1422	9	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1284	1287		10.1038/ng.3656	http://dx.doi.org/10.1038/ng.3656			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27571263	Green Accepted			2022-12-25	WOS:000384391600026
J	Hai, Y; Christianson, DW				Hai, Yang; Christianson, David W.			Histone deacetylase 6 structure and molecular basis of catalysis and inhibition	NATURE CHEMICAL BIOLOGY			English	Article							HDAC INHIBITORS; ACETYLATION; BINDING; SUBSTRATE; METABOLISM; AGGRESOME; MECHANISM; PROTEINS; DOMAINS; CHIMERA	Histone deacetylase 6 (HDAC6) is a critical target for drug design because of its role in oncogenic transformation and cancer metastasis, and is unique among all histone deacetylases in that it contains tandem catalytic domains designated CD1 and CD2. We now report the crystal structures of CD2 from Homo sapiens HDAC6 and of CD1 and CD2 from Danio rerio HDAC6. We correlated these structures with activity measurements using 13 different substrates. The catalytic activity of CD2 from both species exhibited broad substrate specificity, whereas that of CD1 was highly specific for substrates bearing C-terminal acetyllysine residues. Crystal structures of substrate complexes yielded unprecedented snapshots of the catalytic mechanism. Additionally, crystal structures of complexes with eight different inhibitors, including belinostat and panobinostat (currently used in cancer chemotherapy), the macrocyclic tetrapeptide HC toxin, and the HDAC6-specific inhibitor N-hydroxy-4-(2-((2-hydroxyethyl)(phenyl)amino)-2-oxoethyl) benzamide, revealed surprising new insight regarding changes in Zn2+ coordination and isozyme-specific inhibition.	[Hai, Yang; Christianson, David W.] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; [Christianson, David W.] Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA; [Christianson, David W.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	University of Pennsylvania; Harvard University; Harvard University	Christianson, DW (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.; Christianson, DW (corresponding author), Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA.; Christianson, DW (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	chris@sas.upenn.edu	Hai, Yang/N-6388-2015	Hai, Yang/0000-0002-2039-5367	National Institutes of Health (NIH) [GM49758]; Radcliffe Institute for Advanced Study at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049758] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radcliffe Institute for Advanced Study at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Marmorstein, B.S. Cooperman, X. Li, and M. Chen for helpful discussions, the National Institutes of Health (NIH) for grant GM49758 to D.W.C. in support of this research, and V. Stojanoff, D. Neau, and J. Nix for assistance with synchrotron data collection. For synchrotron access, we are grateful to the Northeastern Collaborative Access Team beamline 24-ID-E at the Advanced Photon Source, Argonne National Laboratory; the Structural Molecular Biology Program beamline 14-1 at the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory; and the Molecular Biology Consortium beamline 4.2.2 at the Advanced Light Source, Lawrence Berkeley National Laboratory. Finally, D.W.C. thanks the Radcliffe Institute for Advanced Study at Harvard University for the Elizabeth S. and Richard M. Cashin Fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; BROSCH G, 1995, PLANT CELL, V7, P1941, DOI 10.1105/tpc.7.11.1941; Burli RW, 2013, J MED CHEM, V56, P9934, DOI 10.1021/jm4011884; Center RJ, 1998, PROTEIN SCI, V7, P1612, DOI 10.1002/pro.5560070715; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; CHRISTIANSON DW, 1989, ACCOUNTS CHEM RES, V22, P62, DOI 10.1021/ar00158a003; CHRISTIANSON DW, 1987, P NATL ACAD SCI USA, V84, P1512, DOI 10.1073/pnas.84.6.1512; CHRISTIANSON DW, 1985, P NATL ACAD SCI USA, V82, P6840, DOI 10.1073/pnas.82.20.6840; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Decroos C, 2014, ACS CHEM BIOL, V9, P2157, DOI 10.1021/cb5003762; Decroos C, 2013, BIOORGAN MED CHEM, V21, P4530, DOI 10.1016/j.bmc.2013.05.045; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Gantt ML, 2016, BIOCHEMISTRY-US, V55, P820, DOI 10.1021/acs.biochem.5b01327; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hildmann C, 2004, J BACTERIOL, V186, P2328, DOI 10.1128/JB.186.8.2328-2339.2004; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim B, 2015, PROTEIN SCI, V24, P354, DOI 10.1002/pro.2623; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JH, 2013, P NATL ACAD SCI USA, V110, P15704, DOI 10.1073/pnas.1313893110; LIANG TC, 1987, BIOCHEMISTRY-US, V26, P7603, DOI 10.1021/bi00398a011; Lombardi PM, 2011, CURR OPIN STRUC BIOL, V21, P735, DOI 10.1016/j.sbi.2011.08.004; Ma N, 2016, CURR TOP MED CHEM, V16, P415, DOI 10.2174/1568026615666150813145629; Marmorstein R, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018762; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Norvell A, 2010, SCIENCE, V327, P964, DOI 10.1126/science.1187159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Yuan H, 2012, J BIOL CHEM, V287, P42428, DOI 10.1074/jbc.R112.372300; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	60	260	263	8	176	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					741	+		10.1038/nchembio.2134	http://dx.doi.org/10.1038/nchembio.2134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27454933	Green Accepted			2022-12-25	WOS:000382255100017
J	Kim, D; Kim, J; Hur, JK; Been, KW; Yoon, SH; Kim, JS				Kim, Daesik; Kim, Jungeun; Hur, Junho K.; Been, Kyung Wook; Yoon, Sun-heui; Kim, Jin-Soo			Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells	NATURE BIOTECHNOLOGY			English	Article							RNA-GUIDED ENDONUCLEASES; OFF-TARGET CLEAVAGE; CRISPR-CAS SYSTEM; DIGENOME-SEQ; NUCLEASES; RIBONUCLEOPROTEINS; VECTORS; TALENS; SITES	Programmable clustered regularly interspaced short palindromic repeats (CRISPR) Cpf1 endonucleases are single-RNA-guided (crRNA) enzymes that recognize thymidine-rich protospacer-adjacent motif (PAM) sequences and produce cohesive double-stranded breaks (DSBs). Genome editing with CRISPR-Cpf1 endonucleases could provide an alternative to CRISPR-Cas9 endonucleases, but the determinants of targeting specificity are not well understood. Using mismatched crRNAs we found that Cpf1 could tolerate single or double mismatches in the 3' PAM-distal region, but not in the 5' PAM-proximal region. Genome-wide analysis of cleavage sites in vitro for eight Cpf1 nucleases using Digenome-seq revealed that there were 6 (LbCpf1) and 12 (AsCpf1) cleavage sites per crRNA in the human genome, fewer than are present for Cas9 nucleases (>90). Most Cpf1 off-target cleavage sites did not produce mutations in cells. We found mismatches in either the 3' PAM-distal region or in the PAM sequence of 12 off-target sites that were validated in vivo. Off-target effects were completely abrogated by using preassembled, recombinant Cpf1 ribonucleoproteins.	[Kim, Daesik; Kim, Jungeun; Hur, Junho K.; Been, Kyung Wook; Kim, Jin-Soo] Inst Basic Sci IBS, Ctr Genome Engn, Seoul, South Korea; [Kim, Daesik; Kim, Jungeun; Been, Kyung Wook; Yoon, Sun-heui; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU)	Kim, JS (corresponding author), Inst Basic Sci IBS, Ctr Genome Engn, Seoul, South Korea.; Kim, JS (corresponding author), Seoul Natl Univ, Dept Chem, Seoul, South Korea.	jskim01@snu.ac.kr	Hur, Junho/ADK-0757-2022; Kim, Daesik/AFH-7798-2022; KIM, Jin-Soo/M-6918-2013	Hur, Junho/0000-0003-3794-1149; KIM, Jin-Soo/0000-0003-4847-1306	 [IBS-R021-D1]		This work was supported by IBS-R021-D1. We thank F. Zhang (MIT) for providing human codon-optimized Cpf1 expression plasmids.	Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	28	403	449	9	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2016	34	8					863	+		10.1038/nbt.3609	http://dx.doi.org/10.1038/nbt.3609			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2VJ	27272384				2022-12-25	WOS:000381339600024
J	Walerych, D; Lisek, K; Sommaggio, R; Piazza, S; Ciani, Y; Dalla, E; Rajkowska, K; Gaweda-Walerych, K; Ingallina, E; Tonelli, C; Morelli, MJ; Amato, A; Eterno, V; Zambelli, A; Rosato, A; Amati, B; Wisniewski, JR; Del Sal, G				Walerych, Dawid; Lisek, Kamil; Sommaggio, Roberta; Piazza, Silvano; Ciani, Yari; Dalla, Emiliano; Rajkowska, Katarzyna; Gaweda-Walerych, Katarzyna; Ingallina, Eleonora; Tonelli, Claudia; Morelli, Marco J.; Amato, Angela; Eterno, Vincenzo; Zambelli, Alberto; Rosato, Antonio; Amati, Bruno; Wisniewski, Jacek R.; Del Sal, Giannino			Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer	NATURE CELL BIOLOGY			English	Article							NEGATIVE BREAST-CANCER; TRANSCRIPTION FACTOR; GENE-EXPRESSION; WIDE ANALYSIS; SOLID TUMORS; IN-VIVO; KAPPA-B; CELLS; PROTEIN; PATHWAY	In cancer, the tumour suppressor gene TP53 undergoes frequent missense mutations that endow mutant p53 proteins with oncogenic properties. Until now, a universal mutant p53 gain-of-function program has not been defined. By means of multi-omics: proteome, DNA interactome (chromatin immunoprecipitation followed by sequencing) and transcriptome (RNA sequencing/microarray) analyses, we identified the proteasome machinery as a common target of p53 missense mutants. The mutant p53-proteasome axis globally affects protein homeostasis, inhibiting multiple tumour-suppressive pathways, including the anti-oncogenic KSRP-microRNA pathway. In cancer cells, p53 missense mutants cooperate with Nrf2 (NFE2L2) to activate proteasome gene transcription, resulting in resistance to the proteasome inhibitor carfilzomib. Combining the mutant p53-inactivating agent APR-246 (PRIMA-1MET) with the proteasome inhibitor carfilzomib is effective in overcoming chemoresistance in triple-negative breast cancer cells, creating a therapeutic opportunity for treatment of solid tumours and metastasis with mutant p53.	[Walerych, Dawid; Lisek, Kamil; Piazza, Silvano; Ciani, Yari; Dalla, Emiliano; Rajkowska, Katarzyna; Gaweda-Walerych, Katarzyna; Ingallina, Eleonora; Del Sal, Giannino] Lab Nazl CIB, Area Sci Pk Padriciano, I-34149 Trieste, Italy; [Lisek, Kamil; Ingallina, Eleonora; Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, I-34127 Trieste, Italy; [Sommaggio, Roberta; Rosato, Antonio] Univ Padua, Dept Surg Oncol & Gastroenterol, I-35128 Padua, Italy; [Gaweda-Walerych, Katarzyna] Polish Acad Sci, Mossakowski Med Res Ctr, Neurogenet Lab, PL-02106 Warsaw, Poland; [Tonelli, Claudia; Amati, Bruno] European Inst Oncol IEO, Dept Expt Oncol, I-20141 Milan, Italy; [Morelli, Marco J.; Amati, Bruno] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, I-20139 Milan, Italy; [Amato, Angela; Eterno, Vincenzo; Zambelli, Alberto] IRCCS Salvatore Maugeri Fdn, Lab Expt Oncol & Pharmacogen, I-27100 Pavia, Italy; [Zambelli, Alberto] Azienda Osped Papa Giovanni XXIII, Unit Med Oncol, I-24127 Bergamo, Italy; [Rosato, Antonio] Ist Oncol Veneto IOV IRCCS, I-35128 Padua, Italy; [Wisniewski, Jacek R.] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Biochem Prote Grp, D-82152 Martinsried, Germany	University of Trieste; University of Padua; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; IRCCS European Institute of Oncology (IEO); Istituto Italiano di Tecnologia - IIT; Istituti Clinici Scientifici Maugeri IRCCS; ASST Papa Giovanni XXIII; IRCCS Istituto Oncologico Veneto (IOV); Max Planck Society	Del Sal, G (corresponding author), Lab Nazl CIB, Area Sci Pk Padriciano, I-34149 Trieste, Italy.; Del Sal, G (corresponding author), Univ Trieste, Dipartimento Sci Vita, I-34127 Trieste, Italy.	delsal@lncib.it	Amato, Angela/T-1221-2019; Zambelli, Alberto/HGB-1572-2022; Amati, Bruno/AAM-3418-2020; Dalla, Emiliano/AAH-3039-2020; Rosato, Antonio/E-8626-2010; Gaweda-Walerych, Katarzyna/HII-5614-2022; Lisek, Kamil/J-5785-2016; Gaweda-Walerych, Katarzyna/I-6970-2016; Sommaggio, Roberta/Q-6119-2016; Morelli, Marco/AAN-1879-2020	Zambelli, Alberto/0000-0002-1374-1831; Dalla, Emiliano/0000-0002-4687-6011; Rosato, Antonio/0000-0002-5263-8386; Gaweda-Walerych, Katarzyna/0000-0001-8670-1200; Lisek, Kamil/0000-0002-2406-8830; Sommaggio, Roberta/0000-0002-5682-5867; Morelli, Marco/0000-0003-1862-667X; Ciani, Yari/0000-0002-9635-2830; Tonelli, Claudia/0000-0002-5626-3403; Amato, Angela/0000-0002-1932-1299; Amati, Bruno/0000-0002-2958-1799; DEL SAL, GIANNINO/0000-0003-2185-6003; Piazza, Silvano/0000-0002-7156-5434; Walerych, Dawid/0000-0002-8440-1375	European Research Council (ERC); Italian Health Ministry; Italian Association for Cancer Research (AIRC); Italian Association for Cancer Research (AIRC) Special Program Molecular Clinical Oncology '5 per mille' [10016]; Italian Ministry of Health [RF-2011-02346976]; AIRC/FIRC fellowship; Polish Academy of Sciences; FEBS postdoctoral fellowship	European Research Council (ERC)(European Research Council (ERC)European Commission); Italian Health Ministry(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Association for Cancer Research (AIRC) Special Program Molecular Clinical Oncology '5 per mille'(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); AIRC/FIRC fellowship(Fondazione AIRC per la ricerca sul cancro); Polish Academy of Sciences; FEBS postdoctoral fellowship	We thank A. Testa for reading and editing the manuscript, and A. Kuczynski, L. Collavin, F. Mantovani, A. Rustighi and colleagues from LNCIB for helpful comments and discussions. We acknowledge K. Wiman and U. Bjorklund from Aprea for sharing the APR-246 compound and discussing the administration protocol. We thank D. D. Zhang for the gift of the Nrf2 expression vector. This work was supported by the European Research Council (ERC), the Italian Health Ministry and the Italian Association for Cancer Research (AIRC) to B.A. and the Italian Association for Cancer Research (AIRC) Special Program Molecular Clinical Oncology '5 per mille' (grant no. 10016) and the Italian Ministry of Health (RF-2011-02346976), to G.D.S.; Y.C. was supported by the AIRC/FIRC fellowship; K.G.-W. was supported by the Polish Academy of Sciences; D.W. was a recipient of the FEBS postdoctoral fellowship.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Ali A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3667; Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Ben-Nissan G, 2014, BIOMOLECULES, V4, P862, DOI 10.3390/biom4030862; Bikkavilli RK, 2010, J CELL SCI, V123, P1352, DOI 10.1242/jcs.056176; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Bykov VJN, 2014, FEBS LETT, V588, P2622, DOI 10.1016/j.febslet.2014.04.017; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Desideri E, 2015, CANCER LETT, V356, P217, DOI 10.1016/j.canlet.2014.02.023; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Di Minin G, 2014, MOL CELL, V56, P617, DOI 10.1016/j.molcel.2014.10.013; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Eldridge AG, 2010, CELL DEATH DIFFER, V17, P4, DOI 10.1038/cdd.2009.82; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Garibaldi F., 2016, ONCOGENE; Girardini JE, 2014, PHARMACOL RES, V79, P75, DOI 10.1016/j.phrs.2013.11.003; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; Huang ZB, 2014, FUTURE ONCOL, V10, P1795, DOI [10.2217/fon.14.30, 10.2217/FON.14.30]; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Johnson DE, 2015, ENDOCR-RELAT CANCER, V22, pT1, DOI 10.1530/ERC-14-0005; Kalo E, 2012, J CELL SCI, V125, P5578, DOI 10.1242/jcs.106815; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kollareddy M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8389; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lehmann S, 2012, J CLIN ONCOL, V30, P3633, DOI 10.1200/JCO.2011.40.7783; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Listerman I, 2013, CANCER RES, V73, P2817, DOI 10.1158/0008-5472.CAN-12-3082; Liu K, 2015, INT J ONCOL, V46, P2526, DOI 10.3892/ijo.2015.2949; Martynova E, 2012, ONCOTARGET, V3, P132; Masciarelli S, 2014, ONCOGENE, V33, P1601, DOI 10.1038/onc.2013.106; Moschonas A, 2008, MOL CELL BIOL, V28, P6208, DOI 10.1128/MCB.00611-08; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Polotskaia A, 2015, P NATL ACAD SCI USA, V112, pE1220, DOI 10.1073/pnas.1416318112; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Subramanian M, 2015, ONCOGENE, V34, P1094, DOI 10.1038/onc.2014.46; Tonelli C, 2015, ONCOTARGET, V6, P24611, DOI 10.18632/oncotarget.5232; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Turner N, 2013, CANCER TREAT REV, V39, P541, DOI 10.1016/j.ctrv.2012.12.001; Vangala JR, 2014, J BIOL CHEM, V289, P12612, DOI 10.1074/jbc.M113.542829; Walerych D, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00289; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232; Wang Michael, 2011, Oncology (Williston Park), V25 Suppl 2, P19; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; Wisniewski JR, 2014, J PROTEOMICS, V109, P322, DOI 10.1016/j.jprot.2014.07.012; Wisniewski JR, 2012, ANAL CHEM, V84, P2631, DOI 10.1021/ac300006b; Xu HM, 2012, BBA-MOL CELL RES, V1823, P818, DOI 10.1016/j.bbamcr.2012.01.002; Younger ST, 2015, NUCLEIC ACIDS RES, V43, P4447, DOI 10.1093/nar/gkv284; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	70	149	152	3	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2016	18	8					897	+		10.1038/ncb3380	http://dx.doi.org/10.1038/ncb3380			32	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DS5NO	27347849	Green Submitted			2022-12-25	WOS:000380829200010
J	Yamada, K; Mito, F; Matsuoka, Y; Ide, S; Shikimachi, K; Fujiki, A; Kusakabe, D; Ishida, Y; Enoki, M; Tada, A; Ariyoshi, M; Yamasaki, T; Yamato, M				Yamada, Ken-ichi; Mito, Fumiya; Matsuoka, Yuta; Ide, Satsuki; Shikimachi, Kazushige; Fujiki, Ayano; Kusakabe, Daiki; Ishida, Yuma; Enoki, Masataka; Tada, Arisa; Ariyoshi, Miyuki; Yamasaki, Toshihide; Yamato, Mayumi			Fluorescence probes to detect lipid-derived radicals	Nature Chemical Biology			English	Article							HEPATOCELLULAR-CARCINOMA; CHEMICAL HEPATOCARCINOGENESIS; OXIDATIVE STRESS; PEROXIDATION; CELLS; NITROXIDES; SPIN; DNA; PROLIFERATION; PATHOGENESIS	Lipids and their metabolites are easily oxidized in chain reactions initiated by lipid radicals, forming lipid peroxidation products that include the electrophiles 4-hydroxynonenal and malondialdehyde. These markers can bind cellular macromolecules, causing inflammation, apoptosis and other damage. Methods to detect and neutralize the initiating radicals would provide insights into disease mechanisms and new therapeutic approaches. We describe the first high-sensitivity, specific fluorescence probe for lipid radicals, 2,2,6-trimethyl-4-(4-nitrobenzo[1,2,5]oxadiazol-7-ylamino)-6-pentylpiperidine-1-oxyl (NBD-Pen). NBD-Pen directly detected lipid radicals in living cells by turn-on fluorescence. In a rat model of hepatic carcinoma induced by diethylnitrosamine (DEN), NBD-Pen detected lipid radical generation within 1 h of DEN administration. The lipid radical scavenging moiety of NBD-Pen decreased inflammation, apoptosis and oxidative stress markers at 24 h after DEN, and liver tumor development at 12 weeks. Thus, we have developed a novel fluorescence probe that provides imaging information about lipid radical generation and potential therapeutic benefits in vivo.	[Yamada, Ken-ichi; Mito, Fumiya; Matsuoka, Yuta; Ide, Satsuki; Shikimachi, Kazushige; Fujiki, Ayano; Kusakabe, Daiki; Ishida, Yuma; Enoki, Masataka; Tada, Arisa; Ariyoshi, Miyuki; Yamasaki, Toshihide] Kyushu Univ, Fac Pharmaceut Sci, Phys Chem Life Sci Lab, Fukuoka, Japan; [Yamada, Ken-ichi] PRESTOSTOSTO, Japan Sci & Technol Agcy, Saitama, Japan; [Yamato, Mayumi] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka, Japan; [Yamasaki, Toshihide] Aix Marseille Univ, Inst Chim Radicalaire, Campus St Jerome, Marseille, France	Kyushu University; Japan Science & Technology Agency (JST); Kyushu University; UDICE-French Research Universities; Aix-Marseille Universite	Yamada, K (corresponding author), Kyushu Univ, Fac Pharmaceut Sci, Phys Chem Life Sci Lab, Fukuoka, Japan.; Yamada, K (corresponding author), PRESTOSTOSTO, Japan Sci & Technol Agcy, Saitama, Japan.	kenyamada@phar.kyushu-u.ac.jp	Yamada, Ken-ichi/E-6318-2012	Yamada, Ken-ichi/0000-0003-2100-8477	JST PRESTO; JSPS KAKENHI [24390011, 24659020]; Platform Project for Supporting in Drug Discovery and Life Science Research from AMED, Japan; Suzuken Memorial Foundation, Nagoya, Japan; Suntory Foundation for Life Sciences, Kyoto, Japan	JST PRESTO(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform Project for Supporting in Drug Discovery and Life Science Research from AMED, Japan; Suzuken Memorial Foundation, Nagoya, Japan; Suntory Foundation for Life Sciences, Kyoto, Japan	This work was supported in part by JST PRESTO, by JSPS KAKENHI grant number 24390011 and 24659020, by the Platform Project for Supporting in Drug Discovery and Life Science Research from AMED, Japan, by the Suzuken Memorial Foundation, Nagoya, Japan, and by the Suntory Foundation for Life Sciences, Kyoto, Japan. We appreciate the technical support provided by the Research Support Center, Graduate School of Medical Sciences, Kyushu University.	Abbas K, 2014, FREE RADICAL BIO MED, V71, P281, DOI 10.1016/j.freeradbiomed.2014.03.019; Bagryanskaya EG, 2014, CHEM REV, V114, P5011, DOI 10.1021/cr4000946; BARTSCH H, 1989, FREE RADICAL BIO MED, V7, P637, DOI 10.1016/0891-5849(89)90144-5; Blair IA, 2008, J BIOL CHEM, V283, P15545, DOI 10.1074/jbc.R700051200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blinco JP, 2008, J ORG CHEM, V73, P6763, DOI 10.1021/jo801099w; Blinco JP, 2011, AUST J CHEM, V64, P373, DOI 10.1071/CH10442; Bognar B, 2006, J HETEROCYCLIC CHEM, V43, P81, DOI 10.1002/jhet.5570430113; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Factor VM, 2000, P NATL ACAD SCI USA, V97, P2196, DOI 10.1073/pnas.040428797; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hebels DGAJ, 2010, TOXICOL SCI, V116, P194, DOI 10.1093/toxsci/kfq121; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Jia M, 2009, ANAL CHEM, V81, P8033, DOI 10.1021/ac901374m; Krishna MC, 1996, J BIOL CHEM, V271, P26026, DOI 10.1074/jbc.271.42.26026; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; LIN S, 1991, PHOTOCHEM PHOTOBIOL, V54, P361, DOI 10.1111/j.1751-1097.1991.tb02028.x; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Mito F, 2011, FREE RADICAL RES, V45, P1103, DOI 10.3109/10715762.2011.595410; Nagata H, 2009, HEPATOLOGY, V49, P1944, DOI 10.1002/hep.22860; Nakae D, 1997, CANCER RES, V57, P1281; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Niki E, 2014, BBA-GEN SUBJECTS, V1840, P809, DOI 10.1016/j.bbagen.2013.03.020; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Parola M, 1998, J CLIN INVEST, V102, P1942, DOI 10.1172/JCI1413; Pollack M, 2006, CHEM RES TOXICOL, V19, P1074, DOI 10.1021/tx0600503; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Soresi M, 2006, WORLD J GASTROENTERO, V12, P2563, DOI 10.3748/wjg.v12.i16.2563; Thaler S, 2011, ACTA OPHTHALMOL, V89, pE555, DOI 10.1111/j.1755-3768.2011.02180.x; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; WAGNER BA, 1994, BIOCHEMISTRY-US, V33, P4449, DOI 10.1021/bi00181a003; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yamada KI, 2006, FREE RADICAL BIO MED, V40, P2040, DOI 10.1016/j.freeradbiomed.2006.01.031; Yamasaki T, 2013, ASIAN J ORG CHEM, V2, P388, DOI 10.1002/ajoc.201300011; Yamasaki T, 2011, J ORG CHEM, V76, P4144, DOI 10.1021/jo200361p; Yamasaki T, 2011, J ORG CHEM, V76, P435, DOI 10.1021/jo101961m; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z	43	36	40	5	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2016	12	8					608	+		10.1038/NCHEMBIO.2105	http://dx.doi.org/10.1038/NCHEMBIO.2105			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2UW	27294322				2022-12-25	WOS:000380640100007
J	Galanos, P; Vougas, K; Walter, D; Polyzos, A; Maya-Mendoza, A; Haagensen, EJ; Kokkalis, A; Roumelioti, FM; Gagos, S; Tzetis, M; Canovas, B; Igea, A; Ahuja, AK; Zellweger, R; Havaki, S; Kanavakis, E; Kletsas, D; Roninson, IB; Garbis, SD; Lopes, M; Nebreda, A; Thanos, D; Blow, JJ; Townsend, P; Sorensen, CS; Bartek, J; Gorgoulis, VG				Galanos, Panagiotis; Vougas, Konstantinos; Walter, David; Polyzos, Alexander; Maya-Mendoza, Apolinar; Haagensen, Emma J.; Kokkalis, Antonis; Roumelioti, Fani-Marlen; Gagos, Sarantis; Tzetis, Maria; Canovas, Begona; Igea, Ana; Ahuja, Akshay K.; Zellweger, Ralph; Havaki, Sofia; Kanavakis, Emanuel; Kletsas, Dimitris; Roninson, Igor B.; Garbis, Spiros D.; Lopes, Massimo; Nebreda, Angel; Thanos, Dimitris; Blow, J. Julian; Townsend, Paul; Sorensen, Claus Storgaard; Bartek, Jiri; Gorgoulis, Vassilis G.			Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASES; NF-KAPPA-B; DNA-DAMAGE; FORK REVERSAL; MUTANT P53; S PHASE; CANCER; CELL; PROTEIN; SENESCENCE	The cyclin-dependent kinase inhibitor p21(WAF1/CIP1) (p21) is a cell-cycle checkpoint effector and inducer of senescence, regulated by p53. Yet, evidence suggests that p21 could also be oncogenic, through a mechanism that has so far remained obscure. We report that a subset of atypical cancerous cells strongly expressing p21 showed proliferation features. This occurred predominantly in p53-mutant human cancers, suggesting p53-independent upregulation of p21 selectively in more aggressive tumour cells. Multifaceted phenotypic and genomic analyses of p21-inducible, p53-null, cancerous and near-normal cellular models showed that after an initial senescence-like phase, a subpopulation of p21-expressing proliferating cells emerged, featuring increased genomic instability, aggressiveness and chemoresistance. Mechanistically, sustained p21 accumulation inhibited mainly the CRL4-CDT2 ubiquitin ligase, leading to deregulated origin licensing and replication stress. Collectively, our data reveal the tumour-promoting ability of p21 through deregulation of DNA replication licensing machinery-an unorthodox role to be considered in cancer treatment, since p21 responds to various stimuli including some chemotherapy drugs.	[Galanos, Panagiotis; Havaki, Sofia; Gorgoulis, Vassilis G.] Univ Athens, Sch Med, Dept Histol & Embryol, Mol Carcinogenesis Grp, 75 Mikras Asias Str, GR-11527 Athens, Greece; [Vougas, Konstantinos; Polyzos, Alexander; Kokkalis, Antonis; Roumelioti, Fani-Marlen; Gagos, Sarantis; Thanos, Dimitris; Gorgoulis, Vassilis G.] Acad Athens, Biomed Res Fdn, 4 Soranou Ephessiou St, GR-11527 Athens, Greece; [Walter, David; Sorensen, Claus Storgaard] Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark; [Maya-Mendoza, Apolinar; Bartek, Jiri] Danish Canc Soc, Res Ctr, Genome Integr Unit, Strandblvd 49, DK-2100 Copenhagen, Denmark; [Haagensen, Emma J.; Blow, J. Julian] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dow St, Dundee DD1 5EH, Scotland; [Kanavakis, Emanuel] Univ Athens, Sch Med, Dept Med Genet, Thivon & Levadias Str, GR-11527 Athens, Greece; [Canovas, Begona; Igea, Ana; Nebreda, Angel] Barcelona Inst Sci & Technol, IRB Barcelona, Barcelona 08028, Spain; [Ahuja, Akshay K.; Zellweger, Ralph; Lopes, Massimo] Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Kanavakis, Emanuel] Aghia Sophia Childrens Hosp, Res Inst Study Genet & Malignant Disorders Child, Thivon Str, GR-11527 Athens, Greece; [Kletsas, Dimitris] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Lab Cell Proliferat & Ageing, POB 60228, GR-15310 Athens, Greece; [Roninson, Igor B.] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Ctr Targeted Therapeut, Coker Life Sci Bldg,715 Sumter St, Columbia, SC 29208 USA; [Garbis, Spiros D.] Univ Southampton, Ctr Proteome Res, Inst Life Sci, Canc Unit,Fac Med, Univ Rd Southampton, Southampton SO17 1BJ, Hants, England; [Garbis, Spiros D.] Univ Southampton, Ctr Proteome Res, Inst Life Sci, Clin Expt Sci Unit,Fac Med, Univ Rd Southampton, Southampton SO17 1BJ, Hants, England; [Nebreda, Angel] ICREA, Barcelona 08010, Spain; [Townsend, Paul; Gorgoulis, Vassilis G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Inst Canc Sci, Wilmslow Rd, Manchester M20 4QL, Lancs, England; [Bartek, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc 77900, Czech Republic; [Galanos, Panagiotis; Vougas, Konstantinos; Bartek, Jiri] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, SE-17177 Stockholm, Sweden	Athens Medical School; National & Kapodistrian University of Athens; Academy of Athens; University of Copenhagen; Danish Cancer Society; University of Dundee; Athens Medical School; National & Kapodistrian University of Athens; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Zurich; The Aghia Sophia Children's Hospital; National Centre of Scientific Research "Demokritos"; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Southampton; University of Southampton; ICREA; University of Manchester; Palacky University Olomouc; Karolinska Institutet	Gorgoulis, VG (corresponding author), Univ Athens, Sch Med, Dept Histol & Embryol, Mol Carcinogenesis Grp, 75 Mikras Asias Str, GR-11527 Athens, Greece.; Gorgoulis, VG (corresponding author), Acad Athens, Biomed Res Fdn, 4 Soranou Ephessiou St, GR-11527 Athens, Greece.; Bartek, J (corresponding author), Danish Canc Soc, Res Ctr, Genome Integr Unit, Strandblvd 49, DK-2100 Copenhagen, Denmark.; Gorgoulis, VG (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Inst Canc Sci, Wilmslow Rd, Manchester M20 4QL, Lancs, England.; Bartek, J (corresponding author), Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc 77900, Czech Republic.; Bartek, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, SE-17177 Stockholm, Sweden.	jb@cancer.dk; vgorg@med.uoa.gr	Igea, Ana/K-8082-2017; Thanos, Dimitris/AAE-5720-2019; Garbis, Spiros D/L-3099-2013; Nebreda, Angel Rodriguez/R-9594-2019; Cánovas, Begoña/AAB-7741-2019; Blow, J. Julian/B-3977-2009; Townsend, Paul/AAF-8234-2020; Tzetis, Maria/K-5220-2012; Gorgoulis, Vassilis/AAD-3630-2019; Galanos, Panagiotis/AAR-7690-2021; Roninson, Igor/K-1310-2017	Igea, Ana/0000-0002-6658-4518; Garbis, Spiros D/0000-0002-1050-0805; Cánovas, Begoña/0000-0002-2546-0295; Blow, J. Julian/0000-0002-9524-5849; Tzetis, Maria/0000-0002-6810-2922; Gorgoulis, Vassilis/0000-0001-9001-4112; Galanos, Panagiotis/0000-0003-1403-4685; Roninson, Igor/0000-0002-9211-1327; Lopes, Massimo/0000-0003-3847-8133; Townsend, Paul/0000-0001-8956-9508; Kletsas, Dimitris/0000-0002-9828-3963; Haagensen, Emma/0000-0001-7420-9809; Vougas, Konstantinos/0000-0002-8873-4740; Walter, David/0000-0003-4363-0339; GAGOS, SARANTIS/0000-0003-4907-7706; Maya-Mendoza, Apolinar/0000-0001-7452-9896; Sorensen, Claus/0000-0001-6022-9710	Wessex Cancer Trust; Medical Research, UK; University of Southampton 'Annual Adventures in Research' fund; European Union's Seventh Framework Programme 'INsPiRE'; European Union's Seventh Framework Programme 'INTEGER'; Greek GSRT programmes of Excellence I (Aristeia I - 'STOCHAGEN'); Greek GSRT programmes of Excellence II (Aristeia II - 'TransProFeat CDC6'); Greek GSRT Cooperation programme ('NoisePlus'); Hellenic Association for Molecular Cancer Research (HAMCR); Research Institute for the Study of Genetic and Malignant Diseases in Childhood; 'Aghia Sophia' Children's Hospital, Athens, Greece; Danish National Research Foundation (Center of excellence project CARD); Lundbeck Foundation; Danish Council for Independent Research; ICREA Funding Source: Custom; Lundbeck Foundation [R93-2011-8990] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002290, NNF15OC0016584] Funding Source: researchfish; The Danish Cancer Society [R124-A7785] Funding Source: researchfish	Wessex Cancer Trust; Medical Research, UK; University of Southampton 'Annual Adventures in Research' fund; European Union's Seventh Framework Programme 'INsPiRE'; European Union's Seventh Framework Programme 'INTEGER'; Greek GSRT programmes of Excellence I (Aristeia I - 'STOCHAGEN'); Greek GSRT programmes of Excellence II (Aristeia II - 'TransProFeat CDC6'); Greek GSRT Cooperation programme ('NoisePlus'); Hellenic Association for Molecular Cancer Research (HAMCR); Research Institute for the Study of Genetic and Malignant Diseases in Childhood; 'Aghia Sophia' Children's Hospital, Athens, Greece; Danish National Research Foundation (Center of excellence project CARD); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); ICREA(ICREA); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	We would like to thank A. Kotsinas, K. Evangelou, T. Liloglou and A. Georgakilas for their valuable support to this work. We would like to thank A. Dutta for providing the vectors with the wt and PIP mutated domain of p21, G. Blandino for the H1299 p21 Ponasterone-ON cells and Z. Lygerou for the secondary antibodies employed in the IF analyses. We thank R. Allsopp, D. Coates, the Wessex Cancer Trust and Medical Research, UK, and the University of Southampton 'Annual Adventures in Research' fund for their support of the proteomics infrastructure and its use for this study. We are also indebted to the PRIDE team for the proteomics data processing repository assistance. This work received funding from the European Union's Seventh Framework Programmes 'INsPiRE' and 'INTEGER', the Greek GSRT programmes of Excellence I (Aristeia I - 'STOCHAGEN'), the Greek GSRT programmes of Excellence II (Aristeia II - 'TransProFeat CDC6'), the Greek GSRT Cooperation programme ('NoisePlus'), the Hellenic Association for Molecular Cancer Research (HAMCR), and partial funding from the Research Institute for the Study of Genetic and Malignant Diseases in Childhood, 'Aghia Sophia' Children's Hospital, Athens, Greece, the Danish National Research Foundation (Center of excellence project CARD), the Lundbeck Foundation and the Danish Council for Independent Research.	Abbas T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012914; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; [Anonymous], 2013, PRACT ASSESS RES EVA; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bates S, 1998, ONCOGENE, V17, P1691, DOI 10.1038/sj.onc.1202104; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Beck H, 2010, J CELL BIOL, V188, P629, DOI 10.1083/jcb.200905059; Benson EK, 2014, ONCOGENE, V33, P3959, DOI 10.1038/onc.2013.378; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Budhavarapu VN, 2012, CELL CYCLE, V11, P2030, DOI 10.4161/cc.20643; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cha HH, 1998, J BIOL CHEM, V273, P1998, DOI 10.1074/jbc.273.4.1998; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Delehouze C, 2014, ONCOGENE, V33, P5675, DOI 10.1038/onc.2013.513; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Evangelou K, 2013, CELL DEATH DIFFER, V20, P1485, DOI 10.1038/cdd.2013.76; Georgakopoulou EA, 2013, AGING-US, V5, P37; Gibbs E, 1997, J BIOL CHEM, V272, P2373; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Gorgoulis VG, 2003, EMBO J, V22, P1567, DOI 10.1093/emboj/cdg157; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Holland AJ, 2012, NAT MED, V18, P1630, DOI 10.1038/nm.2988; Iraqui I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002976; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Liontos M, 2009, AM J PATHOL, V175, P376, DOI 10.2353/ajpath.2009.081160; Murfuni I, 2013, ONCOGENE, V32, P610, DOI 10.1038/onc.2012.80; Neelsen KJ, 2015, NAT REV MOL CELL BIO, V16, P207, DOI 10.1038/nrm3935; Neelsen KJ, 2013, GENE DEV, V27, P2537, DOI 10.1101/gad.226373.113; Neelsen KJ, 2014, METHODS MOL BIOL, V1094, P177, DOI 10.1007/978-1-62703-706-8_15; Neelsen KJ, 2013, J CELL BIOL, V200, P699, DOI 10.1083/jcb.201212058; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Ottaviani D, 2014, TRENDS GENET, V30, P85, DOI 10.1016/j.tig.2014.01.001; Papachristou EK, 2013, J PROTEOME RES, V12, P2078, DOI 10.1021/pr301067r; Pateras IS, 2009, MOL CANCER RES, V7, P1902, DOI 10.1158/1541-7786.MCR-09-0317; Peart MJ, 2010, CELL CYCLE, V9, P3956, DOI 10.4161/cc.9.19.13162; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petrakis TG, 2016, SEMIN CANCER BIOL, V37-38, P3, DOI 10.1016/j.semcancer.2015.12.002; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Porter ACG, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-3; Ramirez-Gonzalez Ricardo H, 2013, F1000Res, V2, P248, DOI 10.12688/f1000research.2-248.v1; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rosai J. R., 2011, ACKERMANS SURG PATHO; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Sideridou M, 2011, J CELL BIOL, V195, P1123, DOI 10.1083/jcb.201108121; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Velimezi G, 2013, NAT CELL BIOL, V15, P967, DOI 10.1038/ncb2795; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Wu Y, 2008, J BIOL CHEM, V283, P14883, DOI 10.1074/jbc.M801097200; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zhang CZ, 2013, GENE DEV, V27, P2513, DOI 10.1101/gad.229559.113	75	173	178	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2016	18	7					777	+		10.1038/ncb3378	http://dx.doi.org/10.1038/ncb3378			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DP9TS	27323328	Green Accepted			2022-12-25	WOS:000378840900010
J	Leung, LC; Mourrain, P				Leung, Louis C.; Mourrain, Philippe			DRUG DISCOVERY Zebrafish uncover novel antipsychotics	NATURE CHEMICAL BIOLOGY			English	News Item									[Leung, Louis C.; Mourrain, Philippe] Stanford Univ, Stanford Ctr Sleep Sci & Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University	Mourrain, P (corresponding author), Stanford Univ, Stanford Ctr Sleep Sci & Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	mourrain@stanford.edu	Mourrain, Philippe/N-4671-2017					Bruni G, 2016, NAT CHEM BIOL, V12, P559, DOI [10.1038/NCHEMBIO.2097, 10.1038/nchembio.2097]; Hyman SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003142; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Martineau PR, 2013, METHODS, V62, P292, DOI 10.1016/j.ymeth.2013.05.002; Rennekamp AJ, 2016, NAT CHEM BIOL, V12, P552, DOI [10.1038/NCHEMBIO.2089, 10.1038/nchembio.2089]	5	11	11	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					468	469		10.1038/nchembio.2114	http://dx.doi.org/10.1038/nchembio.2114			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27315534				2022-12-25	WOS:000378087500001
J	Modjarrad, K; Moorthy, VS; Ben Embarek, P; Van Kerkhove, M; Kim, J; Kieny, MP				Modjarrad, Kayvon; Moorthy, Vasee S.; Ben Embarek, Peter; Van Kerkhove, Maria; Kim, Jerome; Kieny, Marie-Paule			A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation	NATURE MEDICINE			English	Article							EAST RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS INFECTION; MOUSE MODEL; GENERATION	As part of the World Health Organization (WHO) R&D Blueprint initiative, leading stakeholders on Middle East respiratory syndrome coronavirus (MERS-CoV) convened to agree on strategic public-health goals and global priority research activities that are needed to combat MERS-CoV.	[Modjarrad, Kayvon] US Mil HIV Res Program, Walter Reed Army Inst Res, Silver Spring, MD USA; [Moorthy, Vasee S.; Ben Embarek, Peter; Kieny, Marie-Paule] WHO, Geneva, Switzerland; [Van Kerkhove, Maria] Inst Pasteur, Ctr Global Hlth, Paris, France; [Kim, Jerome] Int Vaccine Inst, Seoul, South Korea	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; International Vaccine Institute	Moorthy, VS (corresponding author), WHO, Geneva, Switzerland.	moorthyv@who.int	Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019	Kieny, Marie-Paule/0000-0002-5943-6488; Moorthy, Vasee/0000-0002-6535-2854	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Agrawal AS, 2015, J VIROL, V89, P3659, DOI 10.1128/JVI.03427-14; Arabi Y, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1490-9; Ben Embarek Peter K, 2015, Wkly Epidemiol Rec, V90, P245; Cohen J, 2016, SCIENCE, V351, P16, DOI 10.1126/science.351.6268.16; Drosten C, 2015, CLIN INFECT DIS, V60, P369, DOI 10.1093/cid/ciu812; Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14; Falzarano D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004250; Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; Middleton D, 2014, EMERG INFECT DIS, V20, P372, DOI 10.3201/eid2003.131159; Modjarrad K., VIRUS RES IN PRESS; Modjarrad K, 2016, J VIRUS ERAD, V2, P1; Ng DL, 2016, AM J PATHOL, V186, P652, DOI 10.1016/j.ajpath.2015.10.024; Park SW, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.41.30042; Pas SD, 2015, J CLIN VIROL, V69, P81, DOI 10.1016/j.jcv.2015.05.022; Reusken CBEM, 2015, EMERG INFECT DIS, V21, P1422, DOI 10.3201/eid2108.150481; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712; Warren T., 2015, IDWEEK SAN DIEGO; World Health Organization, 2015, WHOMERSLAB151; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111	21	42	43	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					701	705		10.1038/nm.4131	http://dx.doi.org/10.1038/nm.4131			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27387881	Green Published, Bronze			2022-12-25	WOS:000379366900004
J	Nestl, BM; Geinitz, C; Popa, S; Rizek, S; Haselbeck, RJ; Stephen, R; Noble, MA; Fischer, MP; Ralph, EC; Hau, HT; Man, H; Omar, M; Turkenburg, JP; van Dien, S; Culler, SJ; Grogan, G; Hauer, B				Nestl, Bettina M.; Geinitz, Christopher; Popa, Stephanie; Rizek, Sari; Haselbeck, Robert J.; Stephen, Rosary; Noble, Michael A.; Fischer, Max-Philipp; Ralph, Erik C.; Hau, Hoi Ting; Man, Henry; Omar, Muhiadin; Turkenburg, Johan P.; van Dien, Stephen; Culler, Stephanie J.; Grogan, Gideon; Hauer, Bernhard			Structural and functional insights into asymmetric enzymatic dehydration of alkenols	NATURE CHEMICAL BIOLOGY			English	Article							TERTIARY ALCOHOLS; CASTELLANIELLA-DEFRAGRANS; CATALYZED DEHYDRATION; REGIOSELECTIVE DEHYDRATION; 1,3-PROPANEDIOL PRODUCTION; METHIONINE RESIDUES; BETA-MYRCENE; DEGRADATION; OLEFINS; REDUCTION	The asymmetric dehydration of alcohols is an important process for the direct synthesis of alkenes. We report the structure and substrate specificity of the bifunctional linalool dehydratase isomerase (LinD) from the bacterium Castellaniella defragrans that catalyzes in nature the hydration of b-myrcene to linalool and the subsequent isomerization to geraniol. Enzymatic kinetic resolutions of truncated and elongated aromatic and aliphatic tertiary alcohols (C5-C15) that contain a specific signature motif demonstrate the broad substrate specificity of LinD. The three-dimensional structure of LinD from Castellaniella defragrans revealed a pentamer with active sites at the protomer interfaces. Furthermore, the structure of LinD in complex with the product geraniol provides initial mechanistic insights into this bifunctional enzyme. Site-directed mutagenesis confirmed active site amino acid residues essential for its dehydration and isomerization activity. These structural and mechanistic insights facilitate the development of hydrating catalysts, enriching the toolbox for novel bond-forming biocatalysis.	[Nestl, Bettina M.; Geinitz, Christopher; Fischer, Max-Philipp; Hauer, Bernhard] Univ Stuttgart, Inst Tech Biochem, Stuttgart, Germany; [Popa, Stephanie; Hau, Hoi Ting; Man, Henry; Omar, Muhiadin; Turkenburg, Johan P.; Grogan, Gideon] Univ York, Dept Chem, York Struct Biol Lab, York, N Yorkshire, England; [Rizek, Sari; Haselbeck, Robert J.; Stephen, Rosary; Noble, Michael A.; Ralph, Erik C.; van Dien, Stephen; Culler, Stephanie J.] Genomatica Inc, San Diego, CA USA	University of Stuttgart; University of York - UK	Hauer, B (corresponding author), Univ Stuttgart, Inst Tech Biochem, Stuttgart, Germany.	bernhard.hauer@itb.uni-stuttgart.de		Popa, Steph/0000-0002-3424-4674; Nestl, Bettina/0000-0003-1282-195X; Turkenburg, Johan/0000-0001-6992-6838	European Union's Horizon research and innovation programme (EmPowerPutida) [635536]; Biotechnology and Biological Sciences Research Council [1359511, BB/P005578/1] Funding Source: researchfish; BBSRC [BB/P005578/1] Funding Source: UKRI	European Union's Horizon research and innovation programme (EmPowerPutida); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project has received funding from the European Union's Horizon 2020 research and innovation programme (EmPowerPutida) under grant agreement no. 635536 (to B.H.). This work was supported by the Diamond Light Source for access to beamlines I02 and I04 under proposed number mx-9948 (to G.G.).	Alvarez-Manzaneda EJ, 2004, TETRAHEDRON LETT, V45, P4453, DOI 10.1016/j.tetlet.2004.04.058; Biebl H, 1999, APPL MICROBIOL BIOT, V52, P289, DOI 10.1007/s002530051523; Brodkorb D, 2010, J BIOL CHEM, V285, P30436, DOI 10.1074/jbc.M109.084244; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Foss S, 1998, SYST APPL MICROBIOL, V21, P237, DOI 10.1016/S0723-2020(98)80028-3; Frija LMT, 2012, TETRAHEDRON, V68, P7414, DOI 10.1016/j.tet.2012.06.083; Fujiwara T, 2013, FEBS LETT, V587, P840, DOI 10.1016/j.febslet.2013.02.007; Gao JH, 2009, AM J TRANSL RES, V1, P312; Harmer MA, 2001, APPL CATAL A-GEN, V221, P45, DOI 10.1016/S0926-860X(01)00794-3; Heyen U, 2000, APPL ENVIRON MICROB, V66, P3004, DOI 10.1128/AEM.66.7.3004-3009.2000; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang W, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0473-6; Jin JF, 2011, CHEM COMMUN, V47, P2502, DOI 10.1039/c0cc04153j; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KANTAM ML, 1993, SYNTHETIC COMMUN, V23, P45, DOI 10.1080/00397919308020399; KANTAM ML, 1993, TETRAHEDRON LETT, V34, P1185, DOI 10.1016/S0040-4039(00)77523-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lakshminarasimhan M, 2010, J BIOL CHEM, V285, P29651, DOI 10.1074/jbc.M110.147934; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Liu JZ, 2016, APPL BIOCHEM BIOTECH, V179, P1073, DOI 10.1007/s12010-016-2051-6; Luddeke F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-192; Luddeke F, 2012, APPL ENVIRON MICROB, V78, P2128, DOI 10.1128/AEM.07226-11; Luddeke F, 2011, Z NATURFORSCH C, V66, P409; Manabe K, 2002, J AM CHEM SOC, V124, P11971, DOI 10.1021/ja026241j; Marliere P., 2014, WO patent, Patent No. [2014184345 A1, 2014184345]; Marmulla R, 2016, BMC BIOCHEM, V17, DOI 10.1186/s12858-016-0062-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; OVERMAN LE, 1976, J AM CHEM SOC, V98, P2901, DOI 10.1021/ja00426a038; POSNER GH, 1991, TETRAHEDRON LETT, V32, P6489, DOI 10.1016/0040-4039(91)80200-P; Raju S, 2015, ACS CATAL, V5, P281, DOI 10.1021/cs501511x; Resch V, 2015, CATAL SCI TECHNOL, V5, P1385, DOI 10.1039/c4cy00692e; Schwartz BD, 2006, EUR J ORG CHEM, V2006, P3181, DOI 10.1002/ejoc.200600246; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Stadtman ER, 2002, MOL CELL BIOCHEM, V234, P3, DOI 10.1023/A:1015916831583; Toh T, 2006, BIOCHEM BIOPH RES CO, V347, P1021, DOI 10.1016/j.bbrc.2006.07.034; TONG IT, 1991, APPL ENVIRON MICROB, V57, P3541, DOI 10.1128/AEM.57.12.3541-3546.1991; TURBEK CS, 1992, FEMS MICROBIOL LETT, V94, P187, DOI 10.1111/j.1574-6968.1992.tb05312.x; Volkov A, 2010, J BIOL CHEM, V285, P10353, DOI 10.1074/jbc.M109.081851; Weidenweber S, 2016, FEBS LETT, V590, P1375, DOI 10.1002/1873-3468.12165; WILLIMANN L, 1952, HELV CHIM ACTA, V35, P2401, DOI 10.1002/hlca.19520350728; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wuensch C, 2013, ANGEW CHEM INT EDIT, V52, P2293, DOI 10.1002/anie.201207916; Zhang X, 2016, ORG CHEM FRONT, V3, P701, DOI 10.1039/c6qo00069j	48	21	21	3	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2017	13	3					275	+		10.1038/NCHEMBIO.2271	http://dx.doi.org/10.1038/NCHEMBIO.2271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL2DY	28068311	Green Accepted			2022-12-25	WOS:000394431500009
J	Maric, HM; Hausrat, TJ; Neubert, F; Dalbyl, NO; Doose, S; Sauer, M; Kneussel, M; Stromgaard, K				Maric, Hans Michael; Hausrat, Torben Johann; Neubert, Franziska; Dalbyl, Nils Ole; Doose, Soeren; Sauer, Markus; Kneussel, Matthias; Stromgaard, Kristian			Gephyrin-binding peptides visualize postsynaptic sites and modulate neurotransmission	NATURE CHEMICAL BIOLOGY			English	Article							GAMMA-AMINOBUTYRIC-ACID; GABA(A) RECEPTOR SUBTYPES; ISCHEMIC BRAIN-DAMAGE; PROTEIN-KINASE-C; GLYCINE RECEPTOR; INHIBITORY SYNAPSES; HIPPOCAMPAL-NEURONS; GABAERGIC SYNAPSES; MOLECULAR-BASIS; NERVOUS-SYSTEM	gamma-Aminobutyric acid type A and glycine receptors are the major mediators of fast synaptic inhibition in the human central nervous system and are established drug targets. However, all drugs targeting these receptors bind to the extracellular ligand-binding domain of the receptors, which inherently is associated with perturbation of the basic physiological action. Here we pursue a fundamentally different approach, by instead targeting the intracellular receptor-gephyrin interaction. First, we defined the gephyrin peptide-binding consensus sequence, which facilitated the development of gephyrin super-binding peptides and later effective affinity probes for the isolation of native gephyrin. Next, we demonstrated that fluorescent super-binding peptides could be used to directly visualize inhibitory postsynaptic sites for the first time in conventional and super-resolution microscopy. Finally, we demonstrate that the gephyrin super-binding peptides act as acute intracellular modulators of fast synaptic inhibition by modulating receptor clustering, thus being conceptually novel modulators of inhibitory neurotransmission.	[Maric, Hans Michael; Dalbyl, Nils Ole; Stromgaard, Kristian] Univ Copenhagen, Dept Drug Design & Pharmacol, Ctr Biopharmaceut, Copenhagen, Denmark; [Hausrat, Torben Johann; Kneussel, Matthias] Univ Med Ctr Hamburg Eppendorf, Dept Mol Neurogenet, Ctr Mol Neurobiol, ZMNH, Hamburg, Germany; [Neubert, Franziska; Doose, Soeren; Sauer, Markus] Univ Wurzburg, Dept Biotechnol & Biophys, Bioctr, Wurzburg, Germany	University of Copenhagen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Maric, HM; Stromgaard, K (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Ctr Biopharmaceut, Copenhagen, Denmark.	kristian.stromgaard@sund.ku.dk	Sauer, Markus/C-4378-2017; Maric, Hans Michael/AAQ-8205-2020	Sauer, Markus/0000-0002-1692-3219; Maric, Hans Michael/0000-0002-2719-4752; Dalby, Nils Ole/0000-0002-1901-4205; Stromgaard, Kristian/0000-0003-2206-4737; Kneussel, Matthias/0000-0003-4900-366X; Doose, Soren/0000-0002-6983-1182	Lundbeck Foundation [R118-A11469]; German Research Foundation [SFB/TRR166]; Lundbeck Foundation [R118-2012-11469] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); German Research Foundation(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden)	We thank P. Breiden for her excellent technical assistance. We thank C. Geis and C. Sommer (Hans-Berger Department of Neurology, Jena University Hospital, Jena, Germany) for providing primary cultures of mouse hippocampal neurons. H.M.M. was supported by the Lundbeck Foundation (R118-A11469). S.D. and M.S. acknowledge funding by the German Research Foundation (SFB/TRR166).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bach A, 2010, ORG BIOMOL CHEM, V8, P4281, DOI 10.1039/c0ob00025f; Brady ML, 2015, DEV NEUROBIOL, V75, P1241, DOI 10.1002/dneu.22280; Choii G, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.5; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Craig AM, 1996, J NEUROSCI, V16, P3166; Defeudis FV, 2002, PHARMACOL RES, V46, P565, DOI 10.1016/S1043-6618(02)00233-5; Dejanovic BL, 2014, NEUROBIOL DIS, V67, P88, DOI 10.1016/j.nbd.2014.02.001; Dejanovic B, 2015, EMBO MOL MED, V7, P1580, DOI 10.15252/emmm.201505323; Dejanovic B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001908; Dejanovic B, 2014, J NEUROSCI, V34, P7763, DOI 10.1523/JNEUROSCI.0531-14.2014; Ehmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5650; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Flores CE, 2015, P NATL ACAD SCI USA, V112, pE65, DOI 10.1073/pnas.1411170112; Fritschy JM, 2014, EUR J NEUROSCI, V39, P1845, DOI 10.1111/ejn.12534; Gross GG, 2016, NAT METHODS, V13, P673, DOI 10.1038/nmeth.3894; Gross GG, 2013, NEURON, V78, P971, DOI 10.1016/j.neuron.2013.04.017; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hines RM, 2012, CURR OPIN NEUROBIOL, V22, P552, DOI 10.1016/j.conb.2011.10.007; Kiewert C, 2008, BRAIN RES, V1201, P143, DOI 10.1016/j.brainres.2008.01.052; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kneussel M, 2016, TRENDS NEUROSCI, V39, P170, DOI 10.1016/j.tins.2016.01.002; Kowalczyk S, 2013, EUR J NEUROSCI, V37, P544, DOI 10.1111/ejn.12078; Kuhse J, 2012, J BIOL CHEM, V287, P30952, DOI 10.1074/jbc.M112.349597; Linsalata AE, 2014, J COMP NEUROL, V522, P921, DOI 10.1002/cne.23453; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Maric HM, 2015, ANGEW CHEM INT EDIT, V54, P490, DOI 10.1002/anie.201409043; Maric HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6767; Maric HM, 2014, ACS CHEM BIOL, V9, P2554, DOI 10.1021/cb500303a; Maric HM, 2011, J BIOL CHEM, V286, P42105, DOI 10.1074/jbc.M111.303412; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Oh WC, 2016, SCIENCE, V353, P1037, DOI 10.1126/science.aaf5206; Petrini EM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4921; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Sander B, 2013, ACTA CRYSTALLOGR D, V69, P2050, DOI 10.1107/S0907444913018714; Sauer M, 2013, J CELL SCI, V126, P3505, DOI 10.1242/jcs.123612; Sigal YM, 2015, CELL, V163, P493, DOI 10.1016/j.cell.2015.08.033; Specht CG, 2013, NEURON, V79, P308, DOI 10.1016/j.neuron.2013.05.013; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tretter V, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00023; Tretter V, 2011, J BIOL CHEM, V286, P37702, DOI 10.1074/jbc.M111.291336; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; Wang CY, 2015, MOL CELL BIOL, V35, P1712, DOI 10.1128/MCB.01332-14; Werner C, 2016, BRAIN, V139, P365, DOI 10.1093/brain/awv324; Zhang X., 2013, US patent, Patent No. [20150374705 A1, 20150374705]; Zheng Chan-Ying, 2011, Commun Integr Biol, V4, P104, DOI 10.4161/cib.4.1.14172	51	28	28	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					153	160		10.1038/NCHEMBIO.2246	http://dx.doi.org/10.1038/NCHEMBIO.2246			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27893705				2022-12-25	WOS:000393533000009
J	Greenberg, MVC; Glaser, J; Borsos, M; El Marjou, F; Walter, M; Teissandier, A; Bourc'his, D				Greenberg, Maxim V. C.; Glaser, Juliane; Borsos, Mate; El Marjou, Fatima; Walter, Marius; Teissandier, Aurelie; Bourc'his, Deborah			Transient transcription in the early embryo sets an epigenetic state that programs postnatal growth	NATURE GENETICS			English	Article							DE-NOVO METHYLATION; CPG ISLAND METHYLATION; DNA METHYLATION; MAMMALIAN DEVELOPMENT; PREIMPLANTATION EMBRYOS; CHROMATIN-STRUCTURE; H2A UBIQUITYLATION; MOUSE DEVELOPMENT; STEM-CELLS; HISTONE H3	The potential for early embryonic events to program epigenetic states that influence adult physiology remains an important question in health and development. Using the imprinted Zdbf2 locus as a paradigm for the early programming of phenotypes, we demonstrate here that chromatin changes that occur in the pluripotent embryo can be dispensable for embryogenesis but instead signal essential regulatory information in the adult. The Liz (long isoform of Zdbf2) transcript is transiently expressed in early embryos and embryonic stem cells (ESCs). This transcription locally promotes de novo DNA methylation upstream of the Zdbf2 promoter, which antagonizes Polycomb-mediated repression of Zdbf2. Strikingly, mouse embryos deficient for Liz develop normally but fail to activate Zdbf2 in the postnatal brain and show indelible growth reduction, implying a crucial role for a Liz dependent epigenetic switch. This work provides evidence that transcription during an early embryonic timeframe can program a stable epigenetic state with later physiological consequences.	[Greenberg, Maxim V. C.; Glaser, Juliane; Borsos, Mate; Walter, Marius; Teissandier, Aurelie; Bourc'his, Deborah] PSL Res Univ, CNRS, Inst Curie, INSERM, Paris, France; [El Marjou, Fatima] CNRS, Inst Curie, Paris, France; [Teissandier, Aurelie] Ecole Mines, Paris, France; [Borsos, Mate] Strasbourg Univ, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg		deborah.bourchis@curie.fr	Greenberg, Maxim/AAE-5213-2020	Greenberg, Maxim/0000-0001-9935-8763; Bourc'his, Deborah/0000-0001-9499-7291; aurelie, teissandier/0000-0002-9836-9089	ANR 'Investissements d'Avenir' program [ANR-10-EQPX-03, ANR-10-INBS-09-08]; Canceropole Ile-de-France; ERC (ERC-Cog EpiRepro); ANR [ABS4NGS-ANR-11-BINF-0001]; ARC; EMBO [LTF 457-2013]; DIM Biotherapy, Ile-de-France; Ecole Polytechnique	ANR 'Investissements d'Avenir' program(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); ERC (ERC-Cog EpiRepro); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); EMBO(European Molecular Biology Organization (EMBO)); DIM Biotherapy, Ile-de-France; Ecole Polytechnique	We would like to thank members of the Bourc'his laboratory for insightful experimental and conceptual input; E. Heard, R. Margueron, J. Barau and R. Duffle for 'critical advice on the manuscript; M. Weber for the DNMT3-mutant embryos; and C. Jouhanneau and the Institut Curie Animal Facility for excellent mouse husbandry. High-throughput sequencing was performed by the ICGex NGS platform of the Institut Curie supported by grants from the ANR 'Investissements d'Avenir' program (ANR-10-EQPX-03, Equipex and ANR-10-INBS-09-08, France Genomique Consortium) and from Canceropole Ile-de-France. The laboratory of D.B. is part of the Laboratoire d'Excellence (LABEX) entitled DEEP (11-LBX0044). This research was supported by grants from the ERC (ERC-Cog EpiRepro) and the ANR (ABS4NGS-ANR-11-BINF-0001). M.V.C.G. was supported by ARC and EMBO (LTF 457-2013) postdoctoral fellowships. J.G. was a recipient of a PhD fellowship from DIM Biotherapy, Ile-de-France. M.W. was the recipient of a PhD fellowship from the Ecole Polytechnique.	Auclair G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0545-5; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Borsos M, 2016, GENE DEV, V30, P611, DOI 10.1101/gad.273805.115; Boulard M, 2015, NAT GENET, V47, P479, DOI 10.1038/ng.3272; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Charalambous Marika, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P3, DOI 10.1097/MED.0b013e328013daa2; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Duffie R, 2014, GENE DEV, V28, P463, DOI 10.1101/gad.232058.113; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Faust C, 1998, DEVELOPMENT, V125, P4495; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Galonska C, 2015, CELL STEM CELL, V17, P462, DOI 10.1016/j.stem.2015.07.005; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; Greenberg MVC, 2015, CURR OPIN GENET DEV, V31, P42, DOI 10.1016/j.gde.2015.04.005; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Guo X, 2015, NATURE, V517, P640, DOI 10.1038/nature13899; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jeffery L, 2004, J BIOL CHEM, V279, P49479, DOI 10.1074/jbc.M409070200; Jermann P, 2014, P NATL ACAD SCI USA, V111, pE3415, DOI 10.1073/pnas.1400672111; Kobayashi H, 2012, FEBS LETT, V586, P827, DOI 10.1016/j.febslet.2012.01.059; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Kobayashi H, 2009, GENOMICS, V93, P461, DOI 10.1016/j.ygeno.2008.12.012; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; Schmidt CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052629; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Walter M, 2016, ELIFE, V5, DOI 10.7554/eLife.11418; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Zheng H, 2016, MOL CELL, V63, P1066, DOI 10.1016/j.molcel.2016.08.032	49	51	51	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					110	118		10.1038/ng.3718	http://dx.doi.org/10.1038/ng.3718			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27841881				2022-12-25	WOS:000390976600016
J	North, TE; Goessling, W				North, Trista E.; Goessling, Wolfram			Haematopoietic stem cells show their true colours	NATURE CELL BIOLOGY			English	Editorial Material							AORTIC ENDOTHELIUM; CLONAL-TRACKING; IN-VIVO; DYNAMICS	Delineating the behaviour of haematopoietic stem cells (HSCs) in vivo has thus far proven challenging. Two studies in zebrafish and mouse models now track HSCs in vivo using fate mapping with multicolour approaches to provide further insights into clonal events that regulate blood development, HSC function and differentiation during homeostasis and stress conditions.	[North, Trista E.] Harvard Med Sch, Harvard Stem Cell Inst, Dept Pathol, Beth Israel Deaconess Med Ctr, CLS 536,3 Blackfan Circle, Boston, MA 02115 USA; [Goessling, Wolfram] Harvard Med Sch, Harvard Stem Cell Inst, Brigham & Womens Hosp, Genet & Gastroenterol Div, NRB 458,77 Ave Louis Pasteur, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	North, TE (corresponding author), Harvard Med Sch, Harvard Stem Cell Inst, Dept Pathol, Beth Israel Deaconess Med Ctr, CLS 536,3 Blackfan Circle, Boston, MA 02115 USA.	tnorth@bidmc.harvard.edu; wgoessling@partners.org	North, Trista/ABG-4789-2020	North, Trista/0000-0003-1249-563X				Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Henninger J, 2017, NAT CELL BIOL, V19, P17, DOI 10.1038/ncb3444; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kim S, 2014, CELL STEM CELL, V14, P473, DOI 10.1016/j.stem.2013.12.012; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Wu CF, 2014, CELL STEM CELL, V14, P486, DOI 10.1016/j.stem.2014.01.020; Yu VWC, 2016, CELL, V167, P1310, DOI 10.1016/j.cell.2016.10.045	14	2	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2017	19	1					10	12		10.1038/ncb3459	http://dx.doi.org/10.1038/ncb3459			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EG9AI	28008181				2022-12-25	WOS:000391349000002
J	Youssef, HM; Eggert, K; Kopplu, R; Alqudah, AM; Poursarebani, N; Fazeli, A; Sakuma, S; Tagiri, A; Rutten, T; Govind, G; Lundqvist, U; Graner, A; Komatsuda, T; Sreenivasulu, N; Schnurbusch, T				Youssef, Helmy M.; Eggert, Kai; Kopplu, Ravi; Alqudah, Ahmad M.; Poursarebani, Naser; Fazeli, Arash; Sakuma, Shun; Tagiri, Akemi; Rutten, Twan; Govind, Geetha; Lundqvist, Udda; Graner, Andreas; Komatsuda, Takao; Sreenivasulu, Nese; Schnurbusch, Thorsten			VRS2 regulates hormone-mediated inflorescence patterning in barley	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; AUXIN BIOSYNTHESIS; GENES; CYTOKININ; DOMESTICATION; GIBBERELLINS; MORPHOLOGY; HOMOLOG; RICE; CELL	Plant architecture has clear agronomic and economic implications for crops such as wheat and barley, as it is a critical factor for determining grain yield. Despite this, only limited molecular information is available about how grain-bearing inflorescences, called spikes, are formed and maintain their regular, distichous pattern. Here we elucidate the molecular and hormonal role of Six-rowed spike 2 (Vrs2), which encodes a SHORT INTERNODES (SHI) transcriptional regulator during barley inflorescence and shoot development. We show that Vrs2 is specifically involved in floral organ patterning and phase duration by maintaining hormonal homeostasis and gradients during normal spike development and similarly influences plant stature traits. Furthermore, we establish a link between the SHI protein family and sucrose metabolism during organ growth and development that may have implications for deeper molecular insights into inflorescence and plant architecture in crops.	[Youssef, Helmy M.; Eggert, Kai; Kopplu, Ravi; Alqudah, Ahmad M.; Poursarebani, Naser; Sakuma, Shun; Rutten, Twan; Govind, Geetha; Graner, Andreas; Sreenivasulu, Nese; Schnurbusch, Thorsten] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Youssef, Helmy M.] Cairo Univ, Fac Agr, Giza, Egypt; [Fazeli, Arash] Ilam Univ, Dept Agron & Plant Breeding, Fac Agr, Ilam, Iran; [Sakuma, Shun] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa, Japan; [Tagiri, Akemi; Komatsuda, Takao] NIAS, Tsukuba, Ibaraki, Japan; [Govind, Geetha] Reliance Corp Pk, Reliance R&D Ctr, Ghansoli, Navi Mumbai, India; [Lundqvist, Udda] Nord Genet Resource Ctr NordGen, Alnarp, Sweden; [Sreenivasulu, Nese] IRRI, Grain Qual & Nutr Ctr, Manila, Philippines	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Egyptian Knowledge Bank (EKB); Cairo University; Yokohama City University; National Institute of Agrobiological Sciences - Japan; CGIAR; International Rice Research Institute (IRRI)	Youssef, HM; Schnurbusch, T (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany.; Youssef, HM (corresponding author), Cairo Univ, Fac Agr, Giza, Egypt.	Youssef@ipk-gatersleben.de; thor@ipk-gatersleben.de	Govind, Geetha/AAB-3203-2021; Sakuma, Shun/C-5719-2019; Sakuma, Shun/AAH-6260-2020; Sreenivasulu, Nese/E-8600-2011; Koppolu, Ravi/AAJ-6633-2021; Schnurbusch, Thorsten/B-2249-2009; Alqudah, Ahmad M./I-7062-2012	Govind, Geetha/0000-0003-0450-0814; Sakuma, Shun/0000-0003-1622-5346; Sakuma, Shun/0000-0003-1622-5346; Sreenivasulu, Nese/0000-0002-3998-038X; Schnurbusch, Thorsten/0000-0002-5267-0677; Alqudah, Ahmad M./0000-0002-0436-9724; Tagiri, Akemi/0000-0002-6445-2335; Rutten, Twan/0000-0001-5891-6503; Graner, Andreas/0000-0003-3246-6393; Youssef, Helmy/0000-0003-4957-4040; Koppolu, Ravi/0000-0001-8566-9501	Genomics for Agricultural Innovation Program of the Ministry of Agriculture, Forestry, and Fisheries of Japan [TRS1002]; HEISENBERG Program of the German Research Foundation (DFG) [SCHN 768/8-1, SCHN 768/9-1]	Genomics for Agricultural Innovation Program of the Ministry of Agriculture, Forestry, and Fisheries of Japan; HEISENBERG Program of the German Research Foundation (DFG)(German Research Foundation (DFG))	We thank the US Department of Agriculture-Agricultural Research Service (USDA-ARS); the National Small Grains Collection, Aberdeen (ID); the Nordic Genetic Resources Center (NordGen), Alnarp, Sweden; and the IPK Genebank, Germany, for providing the mutants and germ plasm for haplotype analysis. We thank J. Thiel for help with the quantitative real-time PCR analyses; S. Beier and M. Mascher for bioinformatics support; the IBGSC for prepublication access to barley sequence information of chromosome 5H; and S. Konig, I. Walde, H. Ibrahim, C. Trautewig, M. Piirschel, K. Lipfert, H. Ernst, B. Kettig, D. Bohmert and Y.A.T. Moya for excellent technical support. We also would like to thank the anonymous reviewers for their constructive and supportive evaluations while improving this manuscript. This work was supported by grants from the Genomics for Agricultural Innovation Program of the Ministry of Agriculture, Forestry, and Fisheries of Japan, grant TRS1002, to T.K. and the HEISENBERG Program of the German Research Foundation (DFG), grants SCHN 768/8-1 and SCHN 768/9-1, to.T.S.	Baylis T, 2013, NEW PHYTOL, V197, P737, DOI 10.1111/nph.12084; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Boden SA, 2014, PLANT CELL, V26, P1557, DOI 10.1105/tpc.114.123794; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Eklund DM, 2010, PLANT CELL, V22, P349, DOI 10.1105/tpc.108.064816; Eklund DM, 2010, DEVELOPMENT, V137, P1275, DOI 10.1242/dev.039594; El-Showk S, 2013, DEVELOPMENT, V140, P1373, DOI 10.1242/dev.086371; Eveland AL, 2014, GENOME RES, V24, P431, DOI 10.1101/gr.166397.113; Fridborg I, 2001, PLANT PHYSIOL, V127, P937, DOI 10.1104/pp.010388; Gaillochet C, 2015, CURR OPIN PLANT BIOL, V23, P91, DOI 10.1016/j.pbi.2014.11.002; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; King RW, 2006, PLANT PHYSIOL, V141, P498, DOI 10.1104/pp.106.076760; Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110; Kuusk S, 2006, PLANT J, V47, P99, DOI 10.1111/j.1365-313X.2006.02774.x; Matsoukas IG, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00218; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Rao NN, 2008, P NATL ACAD SCI USA, V105, P3646, DOI 10.1073/pnas.0709059105; Staldal V, 2012, PLANT MOL BIOL, V78, P545, DOI 10.1007/s11103-012-9888-z; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Wang Q, 2014, PLANT CELL, V26, P2068, DOI 10.1105/tpc.114.123059; Wang Y, 2014, PLANT CELL, V26, P2055, DOI 10.1105/tpc.114.123083; Yuo T, 2012, J EXP BOT, V63, P5223, DOI 10.1093/jxb/ers182; Zhang DB, 2014, ANNU REV PLANT BIOL, V65, P553, DOI 10.1146/annurev-arplant-050213-040104; Zhang R, 2008, J INTEGR PLANT BIOL, V50, P1070, DOI 10.1111/j.1744-7909.2008.00729.x; Zhu HF, 2005, PLANT MOL BIOL, V59, P581, DOI 10.1007/s11103-005-0183-0	29	82	88	6	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					157	161		10.1038/ng.3717	http://dx.doi.org/10.1038/ng.3717			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27841879				2022-12-25	WOS:000390976600023
J	Faltas, BM; Prandi, D; Tagawa, ST; Molina, AM; Nanus, DM; Sternberg, C; Rosenberg, J; Mosquera, JM; Robinson, B; Elemento, O; Sboner, A; Beltran, H; Demichelis, F; Rubin, MA				Faltas, Bishoy M.; Prandi, Davide; Tagawa, Scott T.; Molina, Ana M.; Nanus, David M.; Sternberg, Cora; Rosenberg, Jonathan; Mosquera, Juan Miguel; Robinson, Brian; Elemento, Olivier; Sboner, Andrea; Beltran, Himisha; Demichelis, Francesca; Rubin, Mark A.			Clonal evolution of chemotherapy-resistant urothelial carcinoma	NATURE GENETICS			English	Article							CELL-ADHESION MOLECULE; PHASE-III TRIAL; SOMATIC ERCC2 MUTATIONS; LUNG-CANCER CELLS; CISPLATIN; APOPTOSIS; APOBEC3B; TARGETS; GROWTH; L1-CAM	Chemotherapy-resistant urothelial carcinoma has no uniformly curative therapy. Understanding how selective pressure from chemotherapy directs the evolution of urothelial carcinoma and shapes its clonal architecture is a central biological question with clinical implications. To address this question, we performed whole-exome sequencing and clonality analysis of 72 urothelial carcinoma samples, including 16 matched sets of primary and advanced tumors prospectively collected before and after chemotherapy. Our analysis provided several insights: (i) chemotherapy-treated urothelial carcinoma is characterized by intrapatient mutational heterogeneity, and the majority of mutations are not shared; (ii) both branching evolution and metastatic spread are very early events in the natural history of urothelial carcinoma; (iii) chemotherapy-treated urothelial carcinoma is enriched with clonal mutations involving L1 cell adhesion molecule (L1CAM) and integrin signaling pathways; and (iv) APOBEC-induced mutagenesis is clonally enriched in chemotherapy-treated urothelial carcinoma and continues to shape the evolution of urothelial carcinoma throughout its lifetime.	[Faltas, Bishoy M.; Tagawa, Scott T.; Molina, Ana M.; Nanus, David M.; Mosquera, Juan Miguel; Robinson, Brian; Elemento, Olivier; Sboner, Andrea; Beltran, Himisha; Demichelis, Francesca; Rubin, Mark A.] Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York Presbyterian Hosp, New York, NY 10065 USA; [Faltas, Bishoy M.; Tagawa, Scott T.; Molina, Ana M.; Nanus, David M.; Beltran, Himisha] Weill Cornell Med, Div Hematol & Med Oncol, Dept Med, New York, NY USA; [Faltas, Bishoy M.; Tagawa, Scott T.; Nanus, David M.; Beltran, Himisha; Rubin, Mark A.] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Prandi, Davide; Demichelis, Francesca] Univ Trento, Ctr Integrat Biol, Trento, Italy; [Sternberg, Cora] San Camillo Forlanini Hosp, Dept Med Oncol, Rome, Italy; [Rosenberg, Jonathan] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Mosquera, Juan Miguel; Robinson, Brian; Sboner, Andrea; Rubin, Mark A.] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA; [Elemento, Olivier; Sboner, Andrea; Demichelis, Francesca] Weill Cornell Med, Inst Computat Biomed, New York, NY 10065 USA	Cornell University; NewYork-Presbyterian Hospital; Cornell University; Cornell University; University of Trento; Azienda Ospedaliera San Camillo-Forlanini; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	Demichelis, F; Rubin, MA (corresponding author), Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York Presbyterian Hosp, New York, NY 10065 USA.; Rubin, MA (corresponding author), Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.; Demichelis, F (corresponding author), Univ Trento, Ctr Integrat Biol, Trento, Italy.; Rubin, MA (corresponding author), Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA.	f.demichelis@unitn.it; rubinma@med.cornell.edu	Demichelis, Francesca/J-9829-2016; Faltas, Bishoy Morris/J-5739-2019	Demichelis, Francesca/0000-0002-8266-8631; Faltas, Bishoy Morris/0000-0002-6432-1693; Tagawa, Scott/0000-0003-2777-8587; Rubin, Mark/0000-0002-8321-9950; Prandi, Davide/0000-0001-9885-6074	Translational Research Program at WCMC Pathology and Laboratory Medicine; Conquer Cancer Foundation; John and Elizabeth Leonard Family Foundation Young Investigator Award; NIH/NCATS [KL2TR000458]; Early Detection Research Network US NCI [5U01 CA111275-09]; Damon Runyon Cancer Research Foundation Clinical Investigator Award [CI-67-13]; European Research Council [ERC-CoG 648670]; NATIONAL CANCER INSTITUTE [P30CA008748, U01CA111275] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000458, UL1TR002384, KL2TR002385] Funding Source: NIH RePORTER	Translational Research Program at WCMC Pathology and Laboratory Medicine; Conquer Cancer Foundation; John and Elizabeth Leonard Family Foundation Young Investigator Award; NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Early Detection Research Network US NCI; Damon Runyon Cancer Research Foundation Clinical Investigator Award; European Research Council(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We would like to thank our patients and their families for participation in this study. We would like to thank B. Sleckman for constructive review of the manuscript. We would also like to acknowledge D. Scherr and C. Barbieri for contributing samples, our research and clinical pathology fellows J. Fontugne, M. Kossai, C. Pauli, K. Hennrick and K. Park for their assistance during rapid autopsies, and S.S. Chae and D. Wilkes for technical assistance and constructive comments. We would also like to thank T.Y. MacDonald, J. Padilla and T. Fedrizzi for technical assistance. Work was partially supported by the Translational Research Program at WCMC Pathology and Laboratory Medicine. This work was supported by a Conquer Cancer Foundation and the John and Elizabeth Leonard Family Foundation Young Investigator Award (B.M.F.), NIH/NCATS KL2TR000458 (B.M.F.), Early Detection Research Network US NCI 5U01 CA111275-09 (J.M.M., M.A.R. and F.D.), Damon Runyon Cancer Research Foundation Clinical Investigator Award CI-67-13 (H.B.), and H2020 European Research Council ERC-CoG 648670 (F.D.).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Argyris EG, 2007, VIROLOGY, V367, P440, DOI 10.1016/j.virol.2007.06.010; Bellmunt J, 2012, SEMIN ONCOL, V39, P598, DOI 10.1053/j.seminoncol.2012.08.007; Bellmunt J, 2009, J CLIN ONCOL, V27, P4454, DOI 10.1200/JCO.2008.20.5534; Burgett M.E., 2016, ONCOTARGET; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; Cho S, 2016, MABS-AUSTIN, V8, P414, DOI 10.1080/19420862.2015.1125067; Choi EJ, 2016, ONCOTARGET, V7, P3496, DOI 10.18632/oncotarget.6510; Clark PE, 2013, J NATL COMPR CANC NE, V11, P446, DOI 10.6004/jnccn.2013.0059; Damiano JS, 2002, CURR CANCER DRUG TAR, V2, P37, DOI 10.2174/1568009023334033; Eke I, 2015, SEMIN CANCER BIOL, V31, P65, DOI 10.1016/j.semcancer.2014.07.009; Faltas BM, 2015, EXPERT OPIN THER TAR, V19, P515, DOI 10.1517/14728222.2014.987662; Gast D, 2008, EXP CELL RES, V314, P2411, DOI 10.1016/j.yexcr.2008.04.004; Golubovskaya VM, 2014, FRONT BIOSCI-LANDMRK, V19, P687, DOI 10.2741/4236; Greco C, 2010, CANCER RES, V70, P7674, DOI 10.1158/0008-5472.CAN-09-4482; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hodkinson PS, 2006, CELL DEATH DIFFER, V13, P1776, DOI 10.1038/sj.cdd.4401849; Hoopes JI, 2016, CELL REP, V14, P1273, DOI 10.1016/j.celrep.2016.01.021; Howlader N, 2013, SEER CANC STAT REV 1; Kiefel H, 2012, CELL ADHES MIGR, V6, P374, DOI 10.4161/cam.20832; Kim J, 2016, NAT GENET, V48, P600, DOI 10.1038/ng.3557; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Lipinski KA, 2016, TRENDS CANCER, V2, P49, DOI 10.1016/j.trecan.2015.11.003; Liu D, 2016, JAMA ONCOL, V2, P1094, DOI 10.1001/jamaoncol.2016.1056; Maiuthed A, 2014, ANTICANCER RES, V34, P7111; Meier B, 2014, GENOME RES, V24, P1624, DOI 10.1101/gr.175547.114; Min JK, 2010, CLIN CANCER RES, V16, P3571, DOI 10.1158/1078-0432.CCR-09-3075; Muerkoester SS, 2009, INT J ONCOL, V34, P243, DOI 10.3892/ijo_00000146; Murkoster SS, 2007, ONCOGENE, V26, P2759, DOI 10.1038/sj.onc.1210076; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Plimack ER, 2015, EUR UROL, V68, P959, DOI 10.1016/j.eururo.2015.07.009; Prandi D, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0439-6; Rezaee M, 2013, RADIAT RES, V179, P323, DOI 10.1667/RR3185.1; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Schafer H, 2012, CANCER LETT, V319, P66, DOI 10.1016/j.canlet.2011.12.035; Schultze A, 2010, EXPERT OPIN INV DRUG, V19, P777, DOI 10.1517/13543784.2010.489548; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Shain KH, 2001, MOL CANCER THER, V1, P69; Sternberg CN, 2006, EUR J CANCER, V42, P50, DOI 10.1016/j.ejca.2005.08.032; Sternberg CN, 2001, J CLIN ONCOL, V19, P2638, DOI 10.1200/JCO.2001.19.10.2638; Stoeck A, 2007, GYNECOL ONCOL, V104, P461, DOI 10.1016/j.ygyno.2006.08.038; Szikriszt B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0963-7; Tsutsumi S, 2011, J SURG ONCOL, V103, P669, DOI 10.1002/jso.21880; Van Allen EM, 2014, CANCER DISCOV, V4, P1140, DOI 10.1158/2159-8290.CD-14-0623; van Boxtel R, 2013, CELL DEATH DIFFER, V20, P1219, DOI 10.1038/cdd.2013.81; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Voura EB, 2001, MOL BIOL CELL, V12, P2699, DOI 10.1091/mbc.12.9.2699; Wei LS, 2015, INT J CLIN EXP MED, V8, P8599; Weidle UH, 2009, ANTICANCER RES, V29, P4919; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yoon H, 2012, CANCER LETT, V316, P70, DOI 10.1016/j.canlet.2011.10.024; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zhang H, 2002, CANCER, V95, P896, DOI 10.1002/cncr.10751; Zheng Y, 2012, INT J MOL MED, V30, P884, DOI 10.3892/ijmm.2012.1065; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	64	164	169	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1490	1499		10.1038/ng.3692	http://dx.doi.org/10.1038/ng.3692			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27749842	Green Submitted, Green Accepted			2022-12-25	WOS:000389011100009
J	Smalley, E				Smalley, Eric			Medtronic automated insulin delivery device gets FDA nod	NATURE BIOTECHNOLOGY			English	News Item																			0	12	12	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1220	1220		10.1038/nbt1216-1220	http://dx.doi.org/10.1038/nbt1216-1220			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27926704				2022-12-25	WOS:000390185300006
J	Zhang, JH; McCastlain, K; Yoshihara, H; Xu, BS; Chang, YC; Churchman, ML; Wul, G; Li, YJ; Wei, L; Iacobucci, I; Liu, Y; Qu, CX; Wen, J; Edmonsonl, M; Payne-Turner, D; Kaufmann, KB; Takayanagi, S; Wienholds, E; Waanders, E; Ntziachristos, P; Bakogianni, S; Wang, JJ; Aifantis, I; Roberts, KG; Ma, J; Song, GC; Easton, J; Mulder, HL; Chen, X; Newman, S; Ma, XT; Rusch, M; Gupta, P; Boggs, K; Vadodaria, B; Dalton, J; Liu, YL; Valentine, ML; Ding, L; Lu, C; Fulton, RS; Fulton, L; Tabib, Y; Ochoa, K; Devidas, M; Pei, DQ; Cheng, C; Yang, J; Evans, WE; Relling, MV; Pui, CH; Jeha, S; Harvey, RC; Chen, IML; Willman, CL; Marcucci, G; Bloomfield, CD; Kohlschmidt, J; Mrozek, K; Paietta, E; Tallman, MS; Stock, W; Foster, MC; Racevskis, J; Rowe, JM; Luger, S; Kornblau, SM; Shurtleff, SA; Raimondi, SC; Mardis, ER; Wilson, RK; Dick, JE; Hunger, SP; Loh, ML; Downing, JR; Mullighan, CG				Zhang, Jinghui; McCastlain, Kelly; Yoshihara, Hiroki; Xu, Beisi; Chang, Yunchao; Churchman, Michelle L.; Wul, Gang; Li, Yongjin; Wei, Lei; Iacobucci, Ilaria; Liu, Yu; Qu, Chunxu; Wen, Ji; Edmonsonl, Michael; Payne-Turner, Debbie; Kaufmann, Kerstin B.; Takayanagi, Shin-ichiro; Wienholds, Erno; Waanders, Esme; Ntziachristos, Panagiotis; Bakogianni, Sofia; Wang, Jingjing; Aifantis, Iannis; Roberts, Kathryn G.; Ma, Jing; Song, Guangchun; Easton, John; Mulder, Heather L.; Chen, Xiang; Newman, Scott; Ma, Xiaotu; Rusch, Michael; Gupta, Pankaj; Boggs, Kristy; Vadodaria, Bhavin; Dalton, James; Liu, Yanling; Valentine, Marcus L.; Ding, Li; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda; Tabib, Yashodhan; Ochoa, Kerri; Devidas, Meenakshi; Pei, Deqing; Cheng, Cheng; Yang, Jun; Evans, William E.; Relling, Mary V.; Pui, Ching-Hon; Jeha, Sima; Harvey, Richard C.; Chen, I-Ming L.; Willman, Cheryl L.; Marcucci, Guido; Bloomfield, Clara D.; Kohlschmidt, Jessica; Mrozek, Krzysztof; Paietta, Elisabeth; Tallman, Martin S.; Stock, Wendy; Foster, Matthew C.; Racevskis, Janis; Rowe, Jacob M.; Luger, Selina; Kornblau, Steven M.; Shurtleff, Sheila A.; Raimondi, Susana C.; Mardis, Elaine R.; Wilson, Richard K.; Dick, John E.; Hunger, Stephen P.; Loh, Mignon L.; Downing, James R.; Mullighan, Charles G.		St Jude Childrens Res Hosp-Washing	Deregulation of DUX4 and ERG in acute lymphoblastic leukemia	NATURE GENETICS			English	Article							ETS-RELATED GENE; HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR ERG; MYELOID-LEUKEMIA; YOUNG-ADULTS; FUSION; IKZF1; EXPRESSION; CHILDHOOD; DELETION	Chromosomal rearrangements deregulating hematopoietic transcription factors are common in acute lymphoblastic leukemia (ALL). Here we show that deregulation of the homeobox transcription factor gene DUX4 and the ETS transcription factor gene ERG is a hallmark of a subtype of B-progenitor ALL that comprises up to 7% of B-ALL. DUX4 rearrangement and overexpression was present in all cases and was accompanied by transcriptional deregulation of ERG, expression of a novel ERG isoform, ERGalt, and frequent ERG deletion. ERGalt uses a non-canonical first exon whose transcription was initiated by DUX4 binding. ERGalt retains the DNA-binding and transactivation domains of ERG, but it inhibits wild-type ERG transcriptional activity and is transforming. These results illustrate a unique paradigm of transcription factor deregulation in leukemia in which DUX4 deregulation results in loss of function of ERG, either by deletion or induced expression of an isoform that is a dominant-negative inhibitor of wild-type ERG function.	[Zhang, Jinghui; Xu, Beisi; Wul, Gang; Li, Yongjin; Liu, Yu; Qu, Chunxu; Wen, Ji; Edmonsonl, Michael; Easton, John; Mulder, Heather L.; Chen, Xiang; Newman, Scott; Ma, Xiaotu; Rusch, Michael; Gupta, Pankaj; Boggs, Kristy; Vadodaria, Bhavin] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [McCastlain, Kelly; Yoshihara, Hiroki; Chang, Yunchao; Churchman, Michelle L.; Wei, Lei; Iacobucci, Ilaria; Payne-Turner, Debbie; Waanders, Esme; Roberts, Kathryn G.; Ma, Jing; Song, Guangchun; Dalton, James; Liu, Yanling; Shurtleff, Sheila A.; Raimondi, Susana C.; Downing, James R.; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kaufmann, Kerstin B.; Takayanagi, Shin-ichiro; Wienholds, Erno; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Kaufmann, Kerstin B.; Takayanagi, Shin-ichiro; Wienholds, Erno; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Takayanagi, Shin-ichiro] Kyowa Hakko Kirin Co Ltd, Oncol Res Labs, Tokyo, Japan; [Waanders, Esme] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands; [Waanders, Esme] Radboud Ctr Mol Life Sci, Nijmegen, Netherlands; [Ntziachristos, Panagiotis; Bakogianni, Sofia; Wang, Jingjing; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Aifantis, Iannis] Howard Hughes Med Inst, New York, NY USA; [Valentine, Marcus L.] St Jude Childrens Res Hosp, Cytogenet Core Facil, 332 N Lauderdale St, Memphis, TN 38105 USA; [Ding, Li; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda; Tabib, Yashodhan; Ochoa, Kerri; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, McDonnell Genome Inst, St Louis, MO USA; [Devidas, Meenakshi] Univ Florida, Colleges Med Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA; [Pei, Deqing; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Yang, Jun; Evans, William E.; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Pui, Ching-Hon; Jeha, Sima] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Harvey, Richard C.; Chen, I-Ming L.; Willman, Cheryl L.] Univ New Mexico, Dept Pathol, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Marcucci, Guido] City Hope Natl Med Ctr, Gehr Leukemia Ctr, Dept Hematol & Hematopoiet Cell Transplan, Duarte, CA USA; [Bloomfield, Clara D.; Kohlschmidt, Jessica; Mrozek, Krzysztof] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Paietta, Elisabeth] Montefiore Med Ctr, North Div, Ctr Canc, 111 E 210th St, Bronx, NY 10467 USA; [Tallman, Martin S.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA; [Stock, Wendy] Univ Chicago, Med Ctr, Hematol Oncol Sect, Chicago, IL 60637 USA; [Foster, Matthew C.] Univ North Carolina Chapel Hill, Div Hematol Oncol, Chapel Hill, NC USA; [Racevskis, Janis] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med Oncol, New York, NY USA; [Rowe, Jacob M.] Shaare Zedek Med Ctr, Dept Hematol, Jerusalem, Israel; [Luger, Selina] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Kornblau, Steven M.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Hunger, Stephen P.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Hunger, Stephen P.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Loh, Mignon L.] Univ Calif San Francisco, Dept Pediat, Benioff Childrens Hosp, San Francisco, CA USA; [Ntziachristos, Panagiotis] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Kyowa Kirin Ltd; Radboud University Nijmegen; New York University; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Washington University (WUSTL); State University System of Florida; University of Florida; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of New Mexico; City of Hope; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; University of Chicago; University of Chicago Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Montefiore Medical Center; Yeshiva University; Hebrew University of Jerusalem; Shaare Zedek Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; Northwestern University; Feinberg School of Medicine	Zhang, JH (corresponding author), St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Mullighan, CG (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jinghui.zhang@stjude.org; charles.mullighan@stjude.org	Relling, Mary/N-5032-2018; Rusch, Michael/AAG-1998-2019; Jeha, Sima C/N-8163-2018; LI, YONGJIN/E-1688-2011; Waanders, Esmé/P-5464-2014; Zhang, Jing/GWZ-7332-2022; Chen, Xiang/N-2524-2018; WANG, JINGYI/GSJ-1241-2022; Cheng, Cheng/N-8075-2018; wang, jing/GRS-7509-2022; McCastlain, Kelly/O-3366-2018; Xu, Beisi/C-8560-2009; Mardis, Elaine/W-2202-2019; Wilson, Richard K./AAF-4139-2019; Mullighan, Charles/H-3253-2011; Mrózek, Krzysztof/A-3142-2008; Raimondi, Susana C/N-8166-2018; Devidas, Meenakshi/H-1170-2019; Pui, Ching-Hon/N-8076-2018; Evans, William E./C-2069-2012; Downing, James R./N-8102-2018; Ntziachristos, Panagiotis/CAG-2071-2022	Rusch, Michael/0000-0002-5363-1848; Waanders, Esmé/0000-0002-2466-953X; Chen, Xiang/0000-0002-2499-8261; McCastlain, Kelly/0000-0001-7868-3049; Xu, Beisi/0000-0003-0099-858X; Wilson, Richard K./0000-0002-1992-1358; Mullighan, Charles/0000-0002-1871-1850; Devidas, Meenakshi/0000-0002-1099-3478; Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322; Kaufmann, Kerstin B./0000-0001-5013-6123; Wen, Ji/0000-0002-3327-5591; Easton, John/0000-0003-4503-6608; Loh, Mignon/0000-0003-4099-4700; Yoshihara, Hiroki/0000-0001-5128-4515; Dick, John/0000-0002-9527-8317; Wu, Gang/0000-0002-1678-5864	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; Stand Up to Cancer Innovative Research Grant; St. Baldrick's Foundation Scholar Award; St. Baldrick's Consortium Award; Leukemia and Lymphoma Society Specialized Center of Research grant; Lady Tata Memorial Trust Award; Leukemia and Lymphoma Society Special Fellow Award; Alex's Lemonade Stand Foundation Young Investigator Awards; American Society of Hematology Scholar Awards; Dutch Cancer Society Fellowship [KUN2012-5366]; St. Luke's Life Science Institute grant; National Cancer Institute [P30 CA021765, U10 CA180820, CA180827, CA196172, U10 CA180861, U24 CA196171, CA145707, U01 CA157937, R00 CA188293, U10 CA98543, U10 CA98413, U24 CA114766]; National Institute of General Medical Sciences [P50 GM115279]; National Cancer Institute, US National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [P30CA021765, U24CA114766, U10CA180899, U10CA180861, U24CA196172, U10CA180850, U24CA196171, RC1CA145707, P30CA016058, P30CA118100, U10CA180820, U10CA180827, P30CA008748, U10CA180886, U10CA098543, U10CA098413, U01CA157937, R00CA188293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115279] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Stand Up to Cancer Innovative Research Grant; St. Baldrick's Foundation Scholar Award; St. Baldrick's Consortium Award; Leukemia and Lymphoma Society Specialized Center of Research grant(Leukemia and Lymphoma Society); Lady Tata Memorial Trust Award; Leukemia and Lymphoma Society Special Fellow Award(Leukemia and Lymphoma Society); Alex's Lemonade Stand Foundation Young Investigator Awards; American Society of Hematology Scholar Awards; Dutch Cancer Society Fellowship(KWF Kankerbestrijding); St. Luke's Life Science Institute grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital, by a Stand Up to Cancer Innovative Research Grant and a St. Baldrick's Foundation Scholar Award (to C.G.M.), by a St. Baldrick's Consortium Award (to S.P.H.), by a Leukemia and Lymphoma Society Specialized Center of Research grant (to S.P.H. and C.G.M.), by a Lady Tata Memorial Trust Award (to I.I.), by a Leukemia and Lymphoma Society Special Fellow Award and Alex's Lemonade Stand Foundation Young Investigator Awards (to K.G.R.), by American Society of Hematology Scholar Awards (to C.G.M., P.N. and K.G.R.), by Dutch Cancer Society Fellowship KUN2012-5366 (to E. Waanders), by a St. Luke's Life Science Institute grant (to H.Y.), by National Cancer Institute grants P30 CA021765 (St. Jude Cancer Center Support Grant), U10 CA180820 (ECOG-ACRIN Operations), and CA180827 and CA196172 (to E.P.); U10 CA180861 (to C.D.B. and G.M.); U24 CA196171 (The Alliance NCTN Biorepository and Biospecimen Resource); CA145707 (to C.L.W. and C.G.M.); U01 CA157937 (to C.L.W. and S.P.H.), R00 CA188293 (to P.N.); and grants to the Children's Oncology Group: U10 CA98543 (Chair's grant and supplement to support the COG ALL TARGET project), U10 CA98413 (Statistical Center) and U24 CA114766 (Specimen Banking); and by National Institute of General Medical Sciences grant P50 GM115279 (to J.Z., J.Y., W.E.E., M.V.R., M.L.L. and C.G.M.). This project has been funded in whole or in part by federal funds from the National Cancer Institute, US National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.	Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Carmichael CL, 2012, P NATL ACAD SCI USA, V109, P15437, DOI 10.1073/pnas.1213454109; Clappier E, 2014, LEUKEMIA, V28, P70, DOI 10.1038/leu.2013.277; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Iacobucci I, 2016, CANCER CELL, V29, P186, DOI 10.1016/j.ccell.2015.12.013; Italiano A, 2012, GENE CHROMOSOME CANC, V51, P207, DOI 10.1002/gcc.20945; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kneissl S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046667; Kruse EA, 2009, P NATL ACAD SCI USA, V106, P13814, DOI 10.1073/pnas.0906556106; Lilljebjorn H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11790; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2013, SEMIN HEMATOL, V50, P314, DOI 10.1053/j.seminhematol.2013.10.001; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Ng AP, 2010, BLOOD, V115, P3966, DOI 10.1182/blood-2009-09-242107; PRASAD DDK, 1994, ONCOGENE, V9, P3717; Rainis L, 2005, CANCER RES, V65, P7596, DOI 10.1158/0008-5472.CAN-05-0147; RAO VN, 1987, SCIENCE, V237, P635, DOI 10.1126/science.3299708; REDDY ESP, 1991, ONCOGENE, V6, P2285; Russell LJ, 2014, J CLIN ONCOL, V32, P1453, DOI 10.1200/JCO.2013.51.3242; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Salek-Ardakani S, 2009, CANCER RES, V69, P4665, DOI 10.1158/0008-5472.CAN-09-0075; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; van der Veer A, 2014, BLOOD, V123, P1691, DOI 10.1182/blood-2013-06-509794; Yasuda T, 2016, NAT GENET, V48, P569, DOI 10.1038/ng.3535; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Young JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003947; Zaliova M, 2014, LEUKEMIA, V28, P182, DOI 10.1038/leu.2013.282; Zou JH, 2005, MOL CELL BIOL, V25, P6235, DOI 10.1128/MCB.25.14.6235-6246.2005	33	161	165	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1481	1489		10.1038/ng.3691	http://dx.doi.org/10.1038/ng.3691			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27776115	Green Accepted, Green Submitted			2022-12-25	WOS:000389011100008
J	Akcay, G; Belmonte, MA; Aquila, B; Chuaqui, C; Hird, AW; Lamb, ML; Rawlins, PB; Su, N; Tentarelli, S; Grimster, NP; Su, QB				Akcay, Gizem; Belmonte, Matthew A.; Aquila, Brian; Chuaqui, Claudio; Hird, Alexander W.; Lamb, Michelle L.; Rawlins, Philip B.; Su, Nancy; Tentarelli, Sharon; Grimster, Neil P.; Su, Qibin			Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-PROTEIN INTERACTIONS; BCL-2 FAMILY-MEMBERS; STRUCTURE-BASED DESIGN; SMALL-MOLECULE; RATIONAL DESIGN; RESIDENCE TIME; CANCER; DISCOVERY; RESISTANCE; STRATEGY	Targeted covalent inhibition of disease-associated proteins has become a powerful methodology in the field of drug discovery, leading to the approval of new therapeutics. Nevertheless, current approaches are often limited owing to their reliance on a cysteine residue to generate the covalent linkage. Here we used aryl boronic acid carbonyl warheads to covalently target a noncatalytic lysine side chain, and generated to our knowledge the first reversible covalent inhibitors for Mcl-1, a protein-protein interaction (PPI) target that has proven difficult to inhibit via traditional medicinal chemistry strategies. These covalent binders exhibited improved potency in comparison to noncovalent congeners, as demonstrated in biochemical and cell-based assays. We identified Lys234 as the residue involved in covalent modification, via point mutation. The covalent binders discovered in this study will serve as useful starting points for the development of Mcl-1 therapeutics and probes to interrogate Mcl-1-dependent biological phenomena.	[Akcay, Gizem; Belmonte, Matthew A.; Aquila, Brian; Chuaqui, Claudio; Hird, Alexander W.; Lamb, Michelle L.; Tentarelli, Sharon; Grimster, Neil P.; Su, Qibin] AstraZeneca, Oncol Innovat Med Unit, Waltham, MA 02451 USA; [Rawlins, Philip B.] AstraZeneca, Discovery Sci, Cambridge, Cambs, England; [Su, Nancy] AstraZeneca, Discovery Sci, Waltham, MA USA	AstraZeneca; AstraZeneca; AstraZeneca	Grimster, NP; Su, QB (corresponding author), AstraZeneca, Oncol Innovat Med Unit, Waltham, MA 02451 USA.	neil.grimster@astrazeneca.com; qibin.su@astrazeneca.com		Tentarelli, Sharon/0000-0003-2968-8120	AstraZeneca	AstraZeneca(AstraZeneca)	We thank P. Ross for protein mass spectrometry assistance, E. Code and K. Jacques for advice and help for the preparation of Mcl-1 K234A mutant, A. Shapiro and J. Breen for discussion of the kinetic data obtained from time-dependent TR-FRET binding experiments, R. Chen for helpful discussions, and M. Vasbinder for proofreading the manuscript and helpful discussions. We thank the AstraZeneca PostDoc Program for funding this project.	Anscombe E, 2015, CHEM BIOL, V22, P1159, DOI 10.1016/j.chembiol.2015.07.018; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; Bandyopadhyay A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7561; Barf T, 2012, J MED CHEM, V55, P6243, DOI 10.1021/jm3003203; Basu D, 2015, BIOORGAN MED CHEM, V23, P2767, DOI 10.1016/j.bmc.2015.04.038; Belmar J, 2015, PHARMACOL THERAPEUT, V145, P76, DOI 10.1016/j.pharmthera.2014.08.003; Belmonte MA, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.3428.3428; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Booher RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108371; Bruncko M., 2008, 7-nonsubstituted Indole Mcl-1 Inhibitors, Patent No. [WO2008130970Al, 2008130970]; Bruncko M, 2015, J MED CHEM, V58, P2180, DOI 10.1021/jm501258m; Cal PMSD, 2015, CHEM-EUR J, V21, P8182, DOI 10.1002/chem.201500127; Cal PMSD, 2012, J AM CHEM SOC, V134, P10299, DOI 10.1021/ja303436y; Choi S, 2010, NAT CHEM BIOL, V6, P133, DOI [10.1038/NCHEMBIO.281, 10.1038/nchembio.281]; Cohen NA, 2012, CHEM BIOL, V19, P1175, DOI 10.1016/j.chembiol.2012.07.018; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Finlay MRV, 2014, J MED CHEM, V57, P8249, DOI 10.1021/jm500973a; Fischer PM, 2005, DRUG DES REV ONLINE, V2, P179; Fletcher S, 2006, J R SOC INTERFACE, V3, P215, DOI 10.1098/rsif.2006.0115; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Gasteiger J., 1990, TETRAHEDRON COMPUT M, V3, P537, DOI DOI 10.1016/0898-5529(90)90156-3; Hajduk PJ, 2006, J MED CHEM, V49, P6972, DOI 10.1021/jm060511h; Kenny PW, 2005, METH PRIN MED CHEM, V22, P271, DOI 10.1002/3527603743.ch11; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Lee CU, 2012, ANGEW CHEM INT EDIT, V51, P8699, DOI 10.1002/anie.201203341; Mah R, 2014, BIOORG MED CHEM LETT, V24, P33, DOI 10.1016/j.bmcl.2013.10.003; Mukherjee H, 2015, ACS CHEM BIOL, V10, P855, DOI 10.1021/cb500872g; Muppidi A, 2012, J AM CHEM SOC, V134, P14734, DOI 10.1021/ja306864v; Palve V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111927; Rudolph J, 2014, ANGEW CHEM INT EDIT, V53, P3777, DOI 10.1002/anie.201400233; Serafimova IM, 2012, NAT CHEM BIOL, V8, P471, DOI [10.1038/NCHEMBIO.925, 10.1038/nchembio.925]; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Smith AJT, 2009, J MED CHEM, V52, P225, DOI 10.1021/jm800498e; Tanaka Y, 2013, J MED CHEM, V56, P9635, DOI 10.1021/jm401170c; Touzeau C, 2016, LEUKEMIA, V30, P761, DOI 10.1038/leu.2015.184; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Way JC, 2000, CURR OPIN CHEM BIOL, V4, P40, DOI 10.1016/S1367-5931(99)00049-6; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Wenzel SS, 2013, LEUKEMIA, V27, P1381, DOI 10.1038/leu.2012.367; Williams MM, 2015, ONCOTARGET, V6, P3519, DOI 10.18632/oncotarget.2792; Yamanaka K, 2005, MOL CANCER THER, V4, P1689, DOI 10.1158/1535-7163.MCT-05-0064; Yancey D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074561; Zinzalla G, 2009, FUTURE MED CHEM, V1, P65, DOI [10.4155/fmc.09.12, 10.4155/FMC.09.12]	51	111	112	4	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					931	+		10.1038/NCHEMBIO.2174	http://dx.doi.org/10.1038/NCHEMBIO.2174			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27595327				2022-12-25	WOS:000386798800014
J	DeFrancesco, L				DeFrancesco, Laura			Zika pipeline progresses	NATURE BIOTECHNOLOGY			English	News Item																		2014, NAT BIOTECHNOL, V32, P849; 2016, NAT MED, V22, P1101; 2016, CELL, V165, P1238; 2016, SCIENCE, V354, P237; 2016, NATURE, V536, P474	5	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1084	1086		10.1038/nbt1116-1084b	http://dx.doi.org/10.1038/nbt1116-1084b			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27824828				2022-12-25	WOS:000387506500007
J	Horiuchi, D; Camarda, R; Zhou, AY; Yau, C; Momcilovic, O; Balakrishnan, S; Corella, AN; Eyob, H; Kessenbrock, K; Lawson, DA; Marsh, LA; Anderton, BN; Rohrberg, J; Kunder, R; Bazarov, AV; Yaswen, P; McManus, MT; Rugo, HS; Werb, Z; Goga, A				Horiuchi, Dai; Camarda, Roman; Zhou, Alicia Y.; Yau, Christina; Momcilovic, Olga; Balakrishnan, Sanjeev; Corella, Alexandra N.; Eyob, Henok; Kessenbrock, Kai; Lawson, Devon A.; Marsh, Lindsey A.; Anderton, Brittany N.; Rohrberg, Julia; Kunder, Ratika; Bazarov, Alexey V.; Yaswen, Paul; McManus, Michael T.; Rugo, Hope S.; Werb, Zena; Goga, Andrei			PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression	NATURE MEDICINE			English	Article							C-MYC; DEPENDENT PHOSPHORYLATION; CANCER; GROWTH; ACTIVATION; P27(KIP1); PHOSPHATASE; BINDING; CELLS; CYCLE	Triple-negative breast cancer (TNBC), in which cells lack expression of the estrogen receptor (ER), the progesterone receptor (PR) and the ERBB2 (also known as HER2) receptor, is the breast cancer subtype with the poorest outcomes. No targeted therapy is available against this subtype of cancer owing to a lack of validated molecular targets. We previously reported that signaling involving MYC-an essential, pleiotropic transcription factor that regulates the expression of hundreds of genes-is disproportionally higher in triple-negative (TN) tumors than in receptor-positive (RP) tumors(2). Direct inhibition of the oncogenic transcriptional activity of MYC has been challenging to achieve(3). Here, by conducting a shRNA screen targeting the kinome, we identified PIM1, a non-essential serine-threonine kinase, in a synthetic lethal interaction with MYC. PIM1 expression was higher in TN tumors than in RP tumors and was associated with poor prognosis in patients with hormone-and HER2-negative tumors. Small-molecule PIM kinase inhibitors halted the growth of human TN tumors with elevated MYC expression in patient-derived tumor xenograft (PDX) and MYC-driven transgenic mouse models of breast cancer by inhibiting the oncogenic transcriptional activity of MYC and restoring the function of the endogenous cell cycle inhibitor, p27. Our findings warrant clinical evaluation of PIM kinase inhibitors in patients with TN tumors that have elevated MYC expression.	[Horiuchi, Dai; Camarda, Roman; Zhou, Alicia Y.; Momcilovic, Olga; Balakrishnan, Sanjeev; Corella, Alexandra N.; Eyob, Henok; Anderton, Brittany N.; Rohrberg, Julia; Goga, Andrei] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Horiuchi, Dai; Werb, Zena; Goga, Andrei] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Horiuchi, Dai; Marsh, Lindsey A.; Kunder, Ratika] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA; [Horiuchi, Dai; Marsh, Lindsey A.; Kunder, Ratika] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Yau, Christina] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Yau, Christina] Buck Inst Res Aging, Canc & Dev Therapeut Program, Novato, CA USA; [Kessenbrock, Kai; Lawson, Devon A.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Bazarov, Alexey V.; Yaswen, Paul] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA USA; [McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Rugo, Hope S.; Goga, Andrei] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Zhou, Alicia Y.] Color Genom, Burlingame, CA USA; [Balakrishnan, Sanjeev] Dovetail Genom, Santa Cruz, CA USA; [Corella, Alexandra N.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Corella, Alexandra N.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA; [Eyob, Henok] Boston Consulting Grp Inc, Summit, NJ USA; [Kessenbrock, Kai] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA; [Lawson, Devon A.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Anderton, Brittany N.] Univ Calif Davis, Biol Educ Res Grp, Davis, CA 95616 USA; [Bazarov, Alexey V.] Cypre Inc, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of California System; University of California San Francisco; Buck Institute for Research on Aging; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Boston Consulting Group (BCG); University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Davis	Horiuchi, D; Goga, A (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.; Horiuchi, D; Goga, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Horiuchi, D (corresponding author), Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA.; Horiuchi, D (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	dai.horiuchi@northwestern.edu; andrei.goga@ucsf.edu	mcmanus, michael/AAB-1239-2020; Kunder, Ratika/AFQ-3698-2022; Kessenbrock, Kai/B-6936-2011	mcmanus, michael/0000-0003-3013-6569; Corella, Alexandra/0000-0002-5435-0335; Rohrberg, Julia/0000-0001-6965-3905; Zhou, Alicia/0000-0003-0388-8909	US National Institutes of Health [K99CA175700, R00CA175700, 5T32DK007418, K99CA181490, ES019458, U01CA168370, P30DK63720, R01CA180039, R01CA170447]; Susan G. Komen Foundation [PDF15331114]; UCSF Program for Breakthrough Biomedical Research; California Breast Cancer Research Program [17lB-0024]; CDMRP Breast Cancer Research Program [W81XWH-12-1-0272, W81XWH-16-1-0603]; LLS Scholar Award; V-Foundation Award; Breast Cancer Research Foundation; Northwestern Medicine Catalyst Funds; NATIONAL CANCER INSTITUTE [R01CA180039, T32CA108462, R00CA175700, K22CA190511, R01CA170447, K99CA175700, U01CA168370, R00CA181490, K99CA181490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, T32DK007418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008568] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); UCSF Program for Breakthrough Biomedical Research; California Breast Cancer Research Program; CDMRP Breast Cancer Research Program; LLS Scholar Award; V-Foundation Award; Breast Cancer Research Foundation; Northwestern Medicine Catalyst Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the US National Institutes of Health (K99CA175700 (D.H.), R00CA175700 (D.H.), 5T32DK007418 (R.C.), K99CA181490 (K.K.), ES019458 (P.Y. and Z.W.), U01CA168370 (M.T.M.), P30DK63720 (M.T.M.), R01CA180039 (Z.W.) and R01CA170447 (A.G.)), the Susan G. Komen Foundation (PDF15331114; J.R.), the UCSF Program for Breakthrough Biomedical Research (M.T.M.), an Innovative, Developmental, and Exploratory Award from the California Breast Cancer Research Program (17lB-0024; A.G.), an Era of Hope Scholar Award from the CDMRP Breast Cancer Research Program (W81XWH-12-1-0272 and W81XWH-16-1-0603; both to AG.), an LLS Scholar Award (A.G.), a V-Foundation Award (A.G.), the Breast Cancer Research Foundation (H.S.R. and A.G.) and the Northwestern Medicine Catalyst Funds (D.H.). The authors thank A. Welm for her guidance with the use of the patient derived orthotopic tumor xenograft models, J.W. Smyth for his assistance with the generation of the transgenic breast cancer cell lines, and D.B. Udy, C.L. Hueschen and A. Vasilopoulos for their assistance with microscopy. We thank S. Samson, C. Baas, H. Klein-Connolly and D. Roth for consumer advocacy support and feedback related to this project, and J.M. Bishop for his insights into the project and his mentorship to D.H.	Bachmann M, 2006, INT J BIOCHEM CELL B, V38, P430, DOI 10.1016/j.biocel.2005.10.010; Bazarov AV, 2009, CELL CYCLE, V8, P3373, DOI 10.4161/cc.8.20.9856; Braso-Maristany F, 2016, NAT MED, V22, P1303, DOI 10.1038/nm.4198; Burger MT, 2015, J MED CHEM, V58, P8373, DOI 10.1021/acs.jmedchem.5b01275; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kirschner AN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju407; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lu J, 2013, BLOOD, V122, P1610, DOI 10.1182/blood-2013-01-481457; Malinen M, 2013, MOL CELL ENDOCRINOL, V365, P270, DOI 10.1016/j.mce.2012.10.028; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Mohanty AR, 2012, J BIOL CHEM, V287, P21757, DOI 10.1074/jbc.M112.346254; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Mukhopadhyay R, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2477; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Sato M, 2015, ONCOTARGET, V6, P3292, DOI 10.18632/oncotarget.3203; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Wang J, 2012, ONCOGENE, V31, P1794, DOI 10.1038/onc.2011.371; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388	38	106	112	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1321	1329		10.1038/nm.4213	http://dx.doi.org/10.1038/nm.4213			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27775705	Green Accepted			2022-12-25	WOS:000387302300025
J	Pasakarnis, L; Frei, E; Caussinus, E; Affolter, M; Brunner, D				Pasakarnis, Laurynas; Frei, Erich; Caussinus, Emmanuel; Affolter, Markus; Brunner, Damian			Amnioserosa cell constriction but not epidermal actin cable tension autonomously drives dorsal closure	NATURE CELL BIOLOGY			English	Article							NONMUSCLE MYOSIN-II; APICAL CONSTRICTION; DROSOPHILA-MELANOGASTER; EPITHELIAL TISSUES; GAL4 LINES; MORPHOGENESIS; FORCES; DYNAMICS; OSCILLATIONS; CONTRACTIONS	Tissue morphogenesis requires coordination of multiple force-producing components. During dorsal closure in fly embryogenesis, an epidermis opening closes. A tensioned epidermal actin/MyosinII cable, which surrounds the opening, produces a force that is thought to combine with another MyosinII force mediating apical constriction of the amnioserosa cells that fill the opening. A model proposing that each force could autonomously drive dorsal closure was recently challenged by a model in which the two forces combine in a ratchet mechanism. Acute force elimination via selective MyosinII depletion in one or the other tissue shows that the amnioserosa tissue autonomously drives dorsal closure while the actin/MyosinII cable cannot. These findings exclude both previous models, although a contribution of the ratchet mechanism at dorsal closure onset remains likely. This shifts the current view of dorsal closure being a combinatorial force-component system to a single tissue-driven closure event.	[Pasakarnis, Laurynas; Frei, Erich; Caussinus, Emmanuel; Brunner, Damian] Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Affolter, Markus] Univ Basel, Growth & Dev, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	University of Zurich; University of Basel	Brunner, D (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	damian.brunner@imls.uzh.ch	Brunner, Damian/F-2024-2011	Brunner, Damian/0000-0001-5250-492X; Affolter, Markus/0000-0002-5171-0016	University of Zurich; Swiss initiative in Systems Biology, SystemsX.ch (MorphogenetiX); Cantons Basel-Stadt and Basel-Land; SNSF	University of Zurich; Swiss initiative in Systems Biology, SystemsX.ch (MorphogenetiX); Cantons Basel-Stadt and Basel-Land; SNSF(Swiss National Science Foundation (SNSF))	We thank C. Lehner and M. Daellenbach for critical reading of the manuscript. We are grateful to W Boll for providing help with the microscopy. We thank A. Trenner and W Boll for support in generating mCherry-Zipper. We also thank the many people providing fly strains. L.P. was supported in part by a grant from the University of Zurich and, together with E.C., by the Swiss initiative in Systems Biology, SystemsX.ch (MorphogenetiX). M.A. acknowledges funding from the Cantons Basel-Stadt and Basel-Land and from the SNSF. D.B. acknowledges financial support from the University of Zurich.	Abreu-Blanco MT, 2011, J CELL BIOL, V193, P455, DOI 10.1083/jcb.201011018; Azevedo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023964; Blanchard GB, 2010, DEVELOPMENT, V137, P2743, DOI 10.1242/dev.045872; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Chatterjee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034063; David DJV, 2013, DEVELOPMENT, V140, P4719, DOI 10.1242/dev.098491; David DJV, 2010, DEVELOPMENT, V137, P1645, DOI 10.1242/dev.044107; Ducuing A., 2016, NAT CELL BIOL; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Eltsov M, 2015, NAT CELL BIOL, V17, P605, DOI 10.1038/ncb3159; Fischer SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095695; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Franke JD, 2010, DEV BIOL, V345, P117, DOI 10.1016/j.ydbio.2010.06.028; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; Gorfinkiel N, 2007, J CELL SCI, V120, P3289, DOI 10.1242/jcs.010850; Gorfinkiel N, 2009, DEVELOPMENT, V136, P1889, DOI 10.1242/dev.030866; Herranz H, 2001, DEVELOPMENT, V128, P4837; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Igaki T, 2000, P NATL ACAD SCI USA, V97, P662, DOI 10.1073/pnas.97.2.662; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; Jayasinghe AK, 2013, BIOPHYS J, V105, P255, DOI 10.1016/j.bpj.2013.05.027; Kaltschmidt JA, 2002, NAT CELL BIOL, V4, P937, DOI 10.1038/ncb882; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Lee A, 2004, MOL BIOL CELL, V15, P3285, DOI 10.1091/mbc.E04-01-0057; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Ma XY, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036004; Machado PF, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0200-y; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mizuno T, 2002, DEVELOPMENT, V129, P1215; Narasimha M, 2004, CURR BIOL, V14, P381, DOI 10.1016/j.cub.2004.02.033; Peralta XG, 2007, BIOPHYS J, V92, P2583, DOI 10.1529/biophysj.106.094110; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rodriguez-Diaz A, 2008, HFSP J, V2, P220, DOI 10.2976/1.2955565; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Saias L, 2015, DEV CELL, V33, P611, DOI 10.1016/j.devcel.2015.03.016; Sandler AD, 2010, PEDIATR CLIN N AM, V57, P879, DOI 10.1016/j.pcl.2010.07.009; Saravanan S, 2013, MOL BIOL CELL, V24, P2350, DOI 10.1091/mbc.E12-12-0868; Scuderi A, 2005, DEV DYNAM, V232, P791, DOI 10.1002/dvdy.20306; Sepp KJ, 1999, GENETICS, V151, P1093; Sokolow A, 2012, BIOPHYS J, V102, P969, DOI 10.1016/j.bpj.2012.01.027; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Takaesu NT, 2002, GENESIS, V34, P16, DOI 10.1002/gene.10109; Wada A, 2007, DEV BIOL, V301, P340, DOI 10.1016/j.ydbio.2006.09.020; Wang QM, 2012, BIOPHYS J, V103, P2265, DOI 10.1016/j.bpj.2012.09.036; Watkins SE, 2014, CLIN PLAST SURG, V41, P149, DOI 10.1016/j.cps.2013.12.003; Wells AR, 2014, MOL BIOL CELL, V25, P3552, DOI 10.1091/mbc.E14-07-1190; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29	53	53	53	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1161	+		10.1038/ncb3420	http://dx.doi.org/10.1038/ncb3420			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27749821				2022-12-25	WOS:000387165600010
J	Yamaura, K; Kiyonaka, S; Numata, T; Inoue, R; Hamachi, I				Yamaura, Kei; Kiyonaka, Shigeki; Numata, Tomohiro; Inoue, Ryuji; Hamachi, Itaru			Discovery of allosteric modulators for GABA(A) receptors by ligand-directed chemistry	NATURE CHEMICAL BIOLOGY			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; FLUORESCENT SENSOR; BENZODIAZEPINE BINDING; CLASSICAL BENZODIAZEPINES; PROTEIN; SUBTYPES; SITE; AFFINITY; SUBUNITS; IDENTIFICATION	The fast inhibitory actions of gamma-aminobutyric acid (GABA) are mainly mediated by GABA(A) receptors (GABA(A)Rs) in the brain. The existence of multiple ligand-binding sites and a lack of structural information have hampered the efficient screening of drugs capable of acting on GABA(A)Rs. We have developed semisynthetic fluorescent biosensors for orthosteric and allosteric GABA(A)R ligands on live cells via coupling of affinity-based chemical labeling reagents to a bimolecular fluorescence quenching and recovery system. These biosensors were amenable to the high-throughput screening of a chemical library, leading to the discovery of new small molecules capable of interacting with GABA(A)Rs. Electrophysiological measurements revealed that one hit, 4,4',4 ''-(4-propyl-[1H]-pyrazole-1,3,5-triyl) trisphenol (PPT), was a novel negative allosteric modulator capable of strongly suppressing GABA-induced chloride currents. Thus, these semisynthetic biosensors represent versatile platforms for screening drugs to treat GABA(A)R-related neurological disorders, and this strategy can be extended to structurally complicated membrane proteins.	[Yamaura, Kei; Kiyonaka, Shigeki; Hamachi, Itaru] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto, Japan; [Kiyonaka, Shigeki] Kyoto Univ, Dept Technol & Ecol, Hall Global Environm Studies, Kyoto, Japan; [Numata, Tomohiro; Inoue, Ryuji] Fukuoka Univ, Sch Med, Dept Physiol, Jonan Ku, Fukuoka, Japan; [Hamachi, Itaru] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Kyoto University; Kyoto University; Fukuoka University; Japan Science & Technology Agency (JST)	Kiyonaka, S; Hamachi, I (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto, Japan.; Kiyonaka, S (corresponding author), Kyoto Univ, Dept Technol & Ecol, Hall Global Environm Studies, Kyoto, Japan.; Hamachi, I (corresponding author), Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan.	kiyonaka@sbchem.kyoto-u.ac.jp; ihamachi@sbchem.kyoto-u.ac.jp	Numata, Tomohiro/AAW-2453-2020; yamaura, kei/AAN-8730-2020; Kiyonaka, Shigeki/AAM-7303-2021; Numata, Tomohiro/AAC-2330-2021	Numata, Tomohiro/0000-0002-5719-4884; yamaura, kei/0000-0001-6913-5155; Numata, Tomohiro/0000-0002-5719-4884	Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST) of Molecular Technologies; JSPS KAKENHI [JP15H01637]; SUNBOR Grant from Suntory Foundation for Life Sciences	Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST) of Molecular Technologies; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SUNBOR Grant from Suntory Foundation for Life Sciences	We thank S. Moss (Tufts University) for GABA<INF>A</INF>R constructs. The pCAGGS vector was provided by the RIKEN BRC through the National Bio-Resource Project of the MEXT, Japan. We thank Y. Yasueda (Kyoto University) and E. Kusaka (Kyoto University) for excellent technical assistance. This work was funded by the Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST) of Molecular Technologies and JSPS KAKENHI (JP15H01637) to I.H. and by a SUNBOR Grant from Suntory Foundation for Life Sciences to S.K.	Atack JR, 2006, NEUROPHARMACOLOGY, V51, P1023, DOI 10.1016/j.neuropharm.2006.04.018; Atack JR, 2010, J PHARMACOL EXP THER, V332, P17, DOI 10.1124/jpet.109.157909; Barnard EA, 1998, PHARMACOL REV, V50, P291; Boileau AJ, 1998, MOL PHARMACOL, V53, P295, DOI 10.1124/mol.53.2.295; Brun MA, 2012, J AM CHEM SOC, V134, P7676, DOI 10.1021/ja3002277; Brun MA, 2009, J AM CHEM SOC, V131, P5873, DOI 10.1021/ja900149e; Chebib M, 2000, J MED CHEM, V43, P1427, DOI 10.1021/jm9904349; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Cho S, 2011, BIOCHEM BIOPH RES CO, V413, P637, DOI 10.1016/j.bbrc.2011.09.026; Da Settimo F, 2007, CURR MED CHEM, V14, P2680, DOI 10.2174/092986707782023190; Davies PA, 1997, BRIT J PHARMACOL, V120, P899, DOI 10.1038/sj.bjp.0700987; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Fujishima SH, 2012, J AM CHEM SOC, V134, P3961, DOI 10.1021/ja2108855; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Iqbal F, 2011, BIOORG MED CHEM LETT, V21, P4252, DOI 10.1016/j.bmcl.2011.05.067; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Lukovic E, 2008, J AM CHEM SOC, V130, P12821, DOI 10.1021/ja8046188; Marvin JS, 1998, J AM CHEM SOC, V120, P7, DOI 10.1021/ja972993f; Masharina A, 2012, J AM CHEM SOC, V134, P19026, DOI 10.1021/ja306320s; Mayer-Wrangowski SC, 2015, ANGEW CHEM INT EDIT, V54, P4379, DOI 10.1002/anie.201410148; Middendorp SJ, 2014, ACS CHEM BIOL, V9, P1846, DOI 10.1021/cb500186a; Miki T, 2014, CHEM BIOL, V21, P1013, DOI 10.1016/j.chembiol.2014.07.013; MOHLER H, 1980, P NATL ACAD SCI-BIOL, V77, P1666, DOI 10.1073/pnas.77.3.1666; Mortensen M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5454; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oakley S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032070; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PUIA G, 1991, MOL PHARMACOL, V39, P691; Quirk K, 1996, NEUROPHARMACOLOGY, V35, P1331, DOI 10.1016/S0028-3908(96)00061-5; Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/nchembio.917, 10.1038/NCHEMBIO.917]; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Sakaguchi R, 2010, ANGEW CHEM INT EDIT, V49, P2150, DOI 10.1002/anie.200903951; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; Schneider R, 2013, J AM CHEM SOC, V135, P6838, DOI 10.1021/ja4030484; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Sigel E, 1998, MOL PHARMACOL, V54, P1097, DOI 10.1124/mol.54.6.1097; Simard JR, 2009, J AM CHEM SOC, V131, P18478, DOI 10.1021/ja907795q; Simard JR, 2009, J AM CHEM SOC, V131, P13286, DOI 10.1021/ja902010p; SLANY A, 1995, MOL PHARMACOL, V48, P385; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Takikawa K, 2014, ANGEW CHEM INT EDIT, V53, P13439, DOI 10.1002/anie.201407181; Tamura T, 2014, ACS CHEM BIOL, V9, P2708, DOI 10.1021/cb500661v; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tsukiji S, 2009, NAT CHEM BIOL, V5, P341, DOI 10.1038/nchembio.157; WAFFORD KA, 1993, MOL PHARMACOL, V43, P240; Wang HX, 2011, J AM CHEM SOC, V133, P12220, DOI 10.1021/ja204422r; Wruss J, 2009, J AM CHEM SOC, V131, P5478, DOI 10.1021/ja807917t; Yang MY, 2012, ANGEW CHEM INT EDIT, V51, P7674, DOI 10.1002/anie.201204029; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]	55	38	39	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					822	+		10.1038/NCHEMBIO.2150	http://dx.doi.org/10.1038/NCHEMBIO.2150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27526031				2022-12-25	WOS:000384248600014
J	Chandra, V; Hannan, Z; Xu, HZ; Mandal, M				Chandra, Vishnu; Hannan, Zain; Xu, Huizhong; Mandal, Maumita			Single-molecule analysis reveals multi-state folding of a guanine riboswitch	NATURE CHEMICAL BIOLOGY			English	Article							ADENINE-SENSING RIBOSWITCH; APTAMER DOMAIN; MECHANICAL FORCE; RNA-POLYMERASE; BINDING; RESOLUTION; DYNAMICS; ADHESION; RIBOZYME	Guanine-responsive riboswitches undergo ligand-dependent structural rearrangements to control gene expression by transcription termination. While the molecular basis for ligand recognition is well established, the associated structural rearrangements and the kinetics involved in the formation of the aptamer domain are less well understood. Using high-resolution optical tweezers, we followed the folding trajectories of a single molecule of the xpt-pbuX guanine aptamer from Bacillus subtilis. We report a rapid six-state conformational rearrangement, in which three of the states are guanine dependent, during the transition from the linear to the native receptor conformation. The folding completes in <1 s. The force-dependent equilibrium kinetics and the mutational data indicated that the flexible J2-J3 junction undergoes a ligand-dependent conformational switching, which triggers the formation of the long-range tertiary interactions and the P1 helix. In the absence of the right ligand, the junction failed to initiate the series of conformational rearrangements required for the riboswitch activities.	[Chandra, Vishnu; Hannan, Zain; Mandal, Maumita] Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Xu, Huizhong; Mandal, Maumita] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Mandal, Maumita] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Chandra, Vishnu] Rutgers New Jersey Med Sch, Newark, NJ USA; [Hannan, Zain] Swarthmore Coll, Dept Chem, Swarthmore, PA 19081 USA; [Mandal, Maumita] Single Mol & RNA Biol Inst, Pittsburgh, PA USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Swarthmore College	Mandal, M (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.; Mandal, M (corresponding author), Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA.; Mandal, M (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.; Mandal, M (corresponding author), Single Mol & RNA Biol Inst, Pittsburgh, PA USA.	maumita.mandal@gmail.com		Chandra, Vishnu/0000-0002-6580-0792; Xu, Huizhong/0000-0002-6224-7813	NSF CAREER [CHE-1151815]; Single-Molecule and RNA Biology Institute	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Single-Molecule and RNA Biology Institute	We would like to thank S. Kumar for technical assistance with the RNA preparation for ITC experiments and B. Plaut for writing Matlab codes. We gratefully acknowledge. S. Smith for helping us with the mini-tweezers. We also acknowledge the Protein Data Bank for letting us use the 3D structure of xpt-pbuX guanine riboswitch aptamer (ID: 4FE5) for illustration purpose. This research was generously supported by NSF CAREER (CHE-1151815) awarded to M.M. and support from Single-Molecule and RNA Biology Institute.	Allner O, 2013, RNA, V19, P916, DOI 10.1261/rna.037549.112; Batey RT, 2012, Q REV BIOPHYS, V45, P345, DOI 10.1017/S0033583512000078; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Brenner MD, 2010, BIOCHEMISTRY-US, V49, P1596, DOI 10.1021/bi9019912; Buck J, 2007, P NATL ACAD SCI USA, V104, P15699, DOI 10.1073/pnas.0703182104; Buck J, 2010, NUCLEIC ACIDS RES, V38, P4143, DOI 10.1093/nar/gkq138; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Frieda KL, 2012, SCIENCE, V338, P397, DOI 10.1126/science.1225722; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Lee MK, 2010, P NATL ACAD SCI USA, V107, P9192, DOI 10.1073/pnas.1001195107; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Neupane K, 2011, NUCLEIC ACIDS RES, V39, P7677, DOI 10.1093/nar/gkr305; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P5262, DOI 10.1093/nar/gkm565; Onoa B, 2003, SCIENCE, V299, P1892, DOI 10.1126/science.1081338; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Savinov A, 2014, BBA-GENE REGUL MECH, V1839, P1030, DOI 10.1016/j.bbagrm.2014.04.005; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2012, CURR OPIN STRUC BIOL, V22, P279, DOI 10.1016/j.sbi.2012.04.005; Smith SB, 2003, METHOD ENZYMOL, V361, P134; St-Pierre P, 2014, BBA-GENE REGUL MECH, V1839, P1005, DOI 10.1016/j.bbagrm.2014.05.015; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1	31	19	20	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					194	201		10.1038/NCHEMBIO.2252	http://dx.doi.org/10.1038/NCHEMBIO.2252			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27941758				2022-12-25	WOS:000393533000015
J	Hong, SG; Zhou, WJ; Fang, B; Lu, WY; Loro, E; Damle, M; Ding, GL; Jager, J; Zhang, SS; Zhang, YX; Feng, D; Chug, QW; Dill, BD; Molina, H; Khurana, TS; Rabinowitz, JD; Lazar, MA; Sun, Z				Hong, Sungguan; Zhou, Wenjun; Fang, Bin; Lu, Wenyun; Loro, Emanuele; Damle, Manashree; Ding, Guolian; Jager, Jennifer; Zhang, Sisi; Zhang, Yuxiang; Feng, Dan; Chug, Qingwei; Dill, Brian D.; Molina, Henrik; Khurana, Tejvir S.; Rabinowitz, Joshua D.; Lazar, Mitchell A.; Sun, Zheng			Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion	NATURE MEDICINE			English	Article							PURINE NUCLEOTIDE CYCLE; HUMAN SKELETAL-MUSCLE; ACID CYCLE; OXIDATIVE CAPACITY; DIABETES-MELLITUS; FUEL SELECTION; RESISTANCE; METABOLISM; EXPRESSION; MITOCHONDRIA	Type 2 diabetes and insulin resistance are associated with reduced glucose utilization in the muscle and poor exercise performance. Here we find that depletion of the epigenome modifier histone deacetylase 3 (HDAC3) specifically in skeletal muscle causes severe systemic insulin resistance in mice but markedly enhances endurance and resistance to muscle fatigue, despite reducing muscle force. This seemingly paradoxical phenotype is due to lower glucose utilization and greater lipid oxidation in HDAC3-depleted muscles, a fuel switch caused by the activation of anaplerotic reactions driven by AMP deaminase 3 (Ampd3) and catabolism of branched-chain amino acids. These findings highlight the pivotal role of amino acid catabolism in muscle fatigue and type 2 diabetes pathogenesis. Further, as genome occupancy of HDAC3 in skeletal muscle is controlled by the circadian clock, these results delineate an epigenomic regulatory mechanism through which the circadian clock governs skeletal muscle bioenergetics. These findings suggest that physical exercise at certain times of the day or pharmacological targeting of HDAC3 could potentially be harnessed to alter systemic fuel metabolism and exercise performance.	[Hong, Sungguan; Zhou, Wenjun; Ding, Guolian; Sun, Zheng] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Fang, Bin; Damle, Manashree; Jager, Jennifer; Zhang, Yuxiang; Feng, Dan; Chug, Qingwei; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Fang, Bin; Damle, Manashree; Jager, Jennifer; Zhang, Yuxiang; Feng, Dan; Chug, Qingwei; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Lu, Wenyun; Zhang, Sisi; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Loro, Emanuele; Khurana, Tejvir S.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Loro, Emanuele; Khurana, Tejvir S.] Univ Penn, Penn Muscle Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ding, Guolian] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Dill, Brian D.; Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, 1230 York Ave, New York, NY 10021 USA; [Sun, Zheng] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Princeton University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University; Rockefeller University; Baylor College of Medicine	Sun, Z (corresponding author), Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA.; Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.; Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.; Sun, Z (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	lazar@mail.med.upenn.edu; zheng.sun@bcm.edu	Lazar, Mitchell A/AAF-3738-2019; Ding, Guolian/GXG-7578-2022; Zhou, Wenjun/H-2824-2016; Loro, Emanuele/J-5212-2019; Rabinowitz, Joshua/GPP-4019-2022	Ding, Guolian/0000-0002-0099-9980; Zhou, Wenjun/0000-0003-4042-4329; Loro, Emanuele/0000-0002-0822-4514; Rabinowitz, Joshua/0000-0002-1247-4727; Dill, Brian/0000-0002-4532-3044; Jager, Jennifer/0000-0003-3740-9742; Feng, Dan/0000-0001-5926-8894	Leona M. and Harry B. Helmsley Charitable Trust; NIH [CA211437, DK043806, DK099443]; NATIONAL CANCER INSTITUTE [R50CA211437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK099443, U2CDK059637, K99DK099443, U24DK059637, R37DK043806, P30DK019525] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Burden (New York University) for MLC-Cre mice, J. Hogenesch (University of Pennsylvania) for processed data from circaDB, M. Birnbaum and J. Baur (University of Pennsylvania) for helpful discussion, S. Guo (Texas A&M University) for help with the EPS procedure, P. Zhang (Baylor College of Medicine) for adenoviral plasmids, S. Hui and J. Park (Princeton University) for analysis of metabolomics data, V. Narkar (University of Texas Health Science Center) for the immunostaining protocol, M. Goncalves and C. Lanzillotta (University of Pennsylvania) for technical assistance. We thank the Penn Diabetes Center (DK19525) Functional Genomics Core for nucleotide sequencing, the Mouse Metabolic Phenotyping Core for clamp experiments, the Penn Muscle Institute Muscle Physiology Assessment Core for muscle contraction study, and the Princeton/Penn Regional Metabolomics Core for flux and lipid analysis. We thank the Baylor Diabetes Center (DK079638) Metabolism Core for Seahorse analysis and Vanderbilt MMPC (DK59637) for lipidomics analysis. The Rockefeller Proteomics Resource Center is supported by the Leona M. and Harry B. Helmsley Charitable Trust. This work was supported by NIH grants CA211437 (W.L.), DK043806 (M.A.L.) and DK099443 (Z.S.).	Arinze IJ, 2005, BIOCHEM MOL BIOL EDU, V33, P165, DOI 10.1002/bmb.2005.494033032469; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Bowtell JL, 2007, SPORTS MED, V37, P1071, DOI 10.2165/00007256-200737120-00005; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Cheng J, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-96; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Dube JJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE882, DOI 10.1152/ajpendo.00769.2007; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gibala MJ, 2000, ACTA PHYSIOL SCAND, V168, P657, DOI 10.1046/j.1365-201x.2000.00717.x; Gineviciene V, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-58; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Harfmann BD, 2015, J BIOL RHYTHM, V30, P84, DOI 10.1177/0748730414561638; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hawley JA, 1997, SPORTS MED, V24, P73, DOI 10.2165/00007256-199724020-00001; Holloszy JO, 2013, DIABETES, V62, P1036, DOI 10.2337/db12-1107; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Kang S, 2016, TRENDS CELL BIOL, V26, P341, DOI 10.1016/j.tcb.2016.01.002; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lau P, 2011, DIABETOLOGIA, V54, P1169, DOI 10.1007/s00125-011-2046-3; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Loro E, 2015, AM J PHYSIOL-REG I, V309, pR835, DOI 10.1152/ajpregu.00505.2014; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mayeuf-Louchart A, 2015, DIABETES OBES METAB, V17, P39, DOI 10.1111/dom.12517; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Operti MG, 1998, MUSCLE NERVE, V21, P401; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003; Paoli A, 2015, EXERC SPORT SCI REV, V43, P153, DOI 10.1249/JES.0000000000000050; Phinney Stephen D, 2004, Nutr Metab (Lond), V1, P2, DOI 10.1186/1743-7075-1-2; RANDLE PJ, 1963, LANCET, V1, P785; Samant SA, 2015, J BIOL CHEM, V290, P15559, DOI 10.1074/jbc.M115.653048; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; She PX, 2010, J APPL PHYSIOL, V108, P941, DOI 10.1152/japplphysiol.01248.2009; Sun Z, 2011, COLD SH Q B, V76, P49, DOI 10.1101/sqb.2011.76.011494; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Templeman NM, 2012, AM J PHYSIOL-REG I, V303, pR101, DOI 10.1152/ajpregu.00511.2011; VANDENBERGHE G, 1992, PROG NEUROBIOL, V39, P547, DOI 10.1016/0301-0082(92)90006-Z; Wagenmakers AJM, 1998, EXERCISE SPORT SCI R, V26, P287; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wong KE, 2015, DIABETES, V64, P1532, DOI 10.2337/db14-0827; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	60	60	64	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					223	234		10.1038/nm.4245	http://dx.doi.org/10.1038/nm.4245			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	27991918	Green Accepted			2022-12-25	WOS:000393729000014
J	Kathayat, RS; Elvira, PD; Dickinson, BC				Kathayat, Rahul S.; Elvira, Pablo D.; Dickinson, Bryan C.			A fluorescent probe for cysteine depalmitoylation reveals dynamic APT signaling	NATURE CHEMICAL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITION; PROTEIN THIOESTERASE; RAS LOCALIZATION; PALMITOYLATION; ACYLATION; PSD-95	Hundreds of human proteins are modified by reversible palmitoylation of cysteine residues (S-palmitoylation), but the regulation of depalmitoylation is poorly understood. Here, we develop 'depalmitoylation probes' (DPPs), small-molecule fluorophores, to monitor the endogenous activity levels of 'erasers' of S-palmitoylation, acylprotein thioesterases (APTs). Live-cell analysis with DPPs reveals rapid growth-factor-mediated inhibition of the depalmitoylation activity of APTs, exposing a novel regulatory mechanism of dynamic lipid signaling.	[Kathayat, Rahul S.; Elvira, Pablo D.; Dickinson, Bryan C.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA	University of Chicago	Dickinson, BC (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	Dickinson@uchicago.edu	Kathayat, Rahul Singh/Y-5617-2019	Kathayat, Rahul Singh/0000-0002-9159-2413	University of Chicago; National Institute of General Medical Sciences of the National Institutes of Health [R35 GM119840]; University of Chicago Medicine Comprehensive Cancer Center [P30CA14599]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119840] Funding Source: NIH RePORTER	University of Chicago(University of Chicago); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Chicago Medicine Comprehensive Cancer Center; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Chicago, the National Institute of General Medical Sciences of the National Institutes of Health (R35 GM119840) to B.C.D., the University of Chicago Medicine Comprehensive Cancer Center (P30CA14599), and a "Catalyst Award" to B.C.D. from the Chicago Biomedical Consortium, with support from the Searle Funds at The Chicago Community Trust. We thank). Pu (University of Chicago) and D. Dammeier (University of Chicago) for technical assistance, and C. He (University of Chicago), A. Mukherje (National Institutes of Health), Y. Krishnan (University of Chicago), and J. Lewis (University of Chicago) for supplying materials and equipment.	Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Chan P, 2016, NAT CHEM BIOL, V12, P282, DOI [10.1038/nchembio.2036, 10.1038/NCHEMBIO.2036]; Creaser SP, 2002, J AM CHEM SOC, V124, P2444, DOI 10.1021/ja017671x; Davda D, 2014, MEDCHEMCOMM, V5, P268, DOI 10.1039/c3md00333g; Dekker FJ, 2011, BIOORGAN MED CHEM, V19, P1376, DOI 10.1016/j.bmc.2010.11.025; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Eisenberg S, 2013, BIOCHEM SOC T, V41, P79, DOI 10.1042/BST20120268; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Gormer K, 2012, CHEMBIOCHEM, V13, P1017, DOI 10.1002/cbic.201200078; Hernandez JL, 2013, CURR OPIN CHEM BIOL, V17, P20, DOI 10.1016/j.cbpa.2012.11.023; Kong E, 2013, J BIOL CHEM, V288, P9112, DOI 10.1074/jbc.M112.421073; Lee JH, 2010, J AM CHEM SOC, V132, P1216, DOI 10.1021/ja9090676; Lin DTS, 2015, ELIFE, V4, DOI 10.7554/eLife.11306; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Peng T, 2016, CURR OPIN CHEM BIOL, V30, P77, DOI 10.1016/j.cbpa.2015.11.008; Ponimaskin E, 2008, J NEUROSCI, V28, P8897, DOI 10.1523/JNEUROSCI.2171-08.2008; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; Zhang MM, 2010, P NATL ACAD SCI USA, V107, P8627, DOI 10.1073/pnas.0912306107; Zheng BH, 2013, J AM CHEM SOC, V135, P7082, DOI 10.1021/ja311416v	25	49	50	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					150	152		10.1038/NCHEMBIO.2262	http://dx.doi.org/10.1038/NCHEMBIO.2262			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27992880	Green Accepted			2022-12-25	WOS:000393533000008
J	Lun, XK; Zanotelli, VRT; Wade, JD; Schapiro, D; Tognetti, M; Dobberstein, N; Bodenmiller, B				Lun, Xiao-Kang; Zanotelli, Vito R. T.; Wade, James D.; Schapiro, Denis; Tognetti, Marco; Dobberstein, Nadine; Bodenmiller, Bernd			Influence of node abundance on signaling network state and dynamics analyzed by mass cytometry	NATURE BIOTECHNOLOGY			English	Article							KRAS GENE AMPLIFICATION; TYROSINE KINASE; BREAST-CANCER; ERBB FAMILY; OVEREXPRESSION; PATHWAY; ERK; ACTIVATION; PHOSPHORYLATION; PROLIFERATION	Signaling networks are key regulators of cellular function. Although the concentrations of signaling proteins are perturbed in disease states, such as cancer, and are modulated by drug therapies, our understanding of how such changes shape the properties of signaling networks is limited. Here we couple mass-cytometry-based single-cell analysis with overexpression of tagged signaling proteins to study the dependence of signaling relationships and dynamics on protein node abundance. Focusing on the epidermal growth factor receptor (EGFR) signaling network in HEK293T cells, we analyze 20 signaling proteins during a 1-h EGF stimulation time course using a panel of 35 antibodies. Data analysis with BP-R-2, a measure that quantifies complex signaling relationships, reveals abundance-dependent network states and identifies novel signaling relationships. Further, we show that upstream signaling proteins have abundance-dependent effects on downstream signaling dynamics. Our approach elucidates the influence of node abundance on signal transduction networks and will further our understanding of signaling in health and disease.	[Lun, Xiao-Kang; Zanotelli, Vito R. T.; Wade, James D.; Schapiro, Denis; Tognetti, Marco; Dobberstein, Nadine; Bodenmiller, Bernd] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Lun, Xiao-Kang; Tognetti, Marco] ETH, Life Sci Zurich Grad Sch, Mol Life Sci PhD Program, Zurich, Switzerland; [Lun, Xiao-Kang; Zanotelli, Vito R. T.; Schapiro, Denis; Tognetti, Marco] Univ Zurich, Zurich, Switzerland; [Zanotelli, Vito R. T.; Schapiro, Denis] ETH, Life Sci Zurich Grad Sch, Syst Biol PhD Program, Zurich, Switzerland; [Wade, James D.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Wade, James D.] Emory Univ, Atlanta, GA 30322 USA; [Tognetti, Marco] ETH, Inst Biochem, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University System of Georgia; Georgia Institute of Technology; Emory University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bodenmiller, B (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	bernd.bodenmiller@imls.uzh.ch	Schapiro, Denis/AAH-6010-2021; Lun, Xiaokang/S-3115-2019	Schapiro, Denis/0000-0002-9391-5722; Lun, Xiaokang/0000-0003-0534-469X; Tognetti, Marco/0000-0002-2379-1525; Zanotelli, Vito Riccardo Tomaso/0000-0001-7268-311X	Bodenmiller laboratory; Swiss National Science Foundation (SNSF) [316030-139220]; SNSF Assistant Professorship [PP00P3-144874]; Swiss Cancer League grant; European Research Council (ERC) under the European Union's Seventh Framework Programme (FP)/ERC [336921]; National Science Foundation Graduate Research Fellowship [DGE-1650044]; Institute of International Education; Forschungskredit of the University of Zurich Fellowship [FK-74419-01-01]; PhosphonetPPM SystenisX grant	Bodenmiller laboratory; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF Assistant Professorship; Swiss Cancer League grant; European Research Council (ERC) under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Institute of International Education; Forschungskredit of the University of Zurich Fellowship; PhosphonetPPM SystenisX grant	We would like to thank the Bodenmiller laboratory for support and fruitful discussions, the Lehner laboratory and the Mosimann laboratory for sharing equipment. We would especially like to thank A.-C. Gingras, Lunenfeld-Tanenbaum Research Institute, for sharing the pDEST vectors used in this study. This work was supported by the Swiss National Science Foundation (SNSF) R'Equip grant 316030-139220, a SNSF Assistant Professorship grant PP00P3-144874, a Swiss Cancer League grant, the PhosphonetPPM SystenisX grant, and funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 336921. The work of J.D.W. was supported by a National Science Foundation Graduate Research Fellowship under grant no. DGE-1650044 and a Whitaker International Fellowship awarded by the Institute of International Education. The work of D.S. is supported by the Forschungskredit of the University of Zurich Fellowship under grant no. FK-74419-01-01.	Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Cepero V, 2010, CANCER RES, V70, P7580, DOI 10.1158/0008-5472.CAN-10-0436; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Eralp Y, 2008, ANN ONCOL, V19, P669, DOI 10.1093/annonc/mdm522; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Han T, 2015, J HEPATOL, V63, P651, DOI 10.1016/j.jhep.2015.03.036; Hendriks RW, 2014, NAT REV CANCER, V14, P219, DOI 10.1038/nrc3702; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Krishnaswamy S, 2014, SCIENCE, V346, P1079, DOI 10.1126/science.1250689; Lee YK, 2010, CANCER LETT, V292, P228, DOI 10.1016/j.canlet.2009.12.005; Little AS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001752; Mann T.M., 2008, CIRC RES, V103, P813; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nyati MK, 2006, NAT REV CANCER, V6, P876, DOI 10.1038/nrc1953; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Oliva JL, 2005, GROWTH FACTORS, V23, P245, DOI 10.1080/08977190500366043; Perfetto L, 2016, NUCLEIC ACIDS RES, V44, pD548, DOI 10.1093/nar/gkv1048; Rahman MT, 2013, INT J MOL SCI, V14, P13748, DOI 10.3390/ijms140713748; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Redell MS, 2013, BLOOD, V121, P1083, DOI 10.1182/blood-2012-04-421925; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Seong HA, 2010, J BIOL CHEM, V285, P2397, DOI 10.1074/jbc.M109.064295; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sundqvist A, 2013, ONCOGENE, V32, P3606, DOI 10.1038/onc.2012.370; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Tewari M, 2004, MOL CELL, V13, P469, DOI 10.1016/S1097-2765(04)00033-4; Valtorta E, 2013, INT J CANCER, V133, P1259, DOI 10.1002/ijc.28106; Wang MC, 2015, PROTEOMICS, V15, P3163, DOI 10.1002/pmic.201400441; Wei ZZ, 2014, CELL MOL NEUROBIOL, V34, P881, DOI 10.1007/s10571-014-0067-4; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Xu Y, 2014, SIGSIM-PADS'14: PROCEEDINGS OF THE 2014 ACM CONFERENCE ON SIGSIM PRINCIPLES OF ADVANCED DISCRETE SIMULATION, P39; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595	50	24	24	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2017	35	2					164	172		10.1038/nbt.3770	http://dx.doi.org/10.1038/nbt.3770			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EK7BP	28092656	Green Accepted			2022-12-25	WOS:000394080800022
J	Bonder, MJ; Luijk, R; Zhernakova, DV; Moed, M; Deelen, P; Vermaat, M; van Iterson, M; van Dijk, F; van Galen, M; Bot, J; Slieker, RC; Jhamai, PM; Verbiest, M; Suchiman, HED; Verkerk, M; van der Breggen, R; van Rooij, J; Lakenberg, N; Arindrarto, W; Kielbasa, SM; Jonkers, I; van 't Hof, P; Nooren, I; Beekman, M; Deelen, J; van Heemst, D; Zhernakova, A; Tigchelaar, EF; Swertz, MA; Hofman, A; Uitterlinden, AG; Pool, R; van Dongen, J; Hottenga, JJ; Stehouwer, CDA; van der Kallen, CJH; Schalkwijk, CG; van den Berg, LH; van Zwet, EW; Mei, HL; Li, Y; Lemire, M; Hudson, TJ; Slagboom, PE; Wijmenga, C; Veldink, JH; van Greevenbroek, MMJ; van Duijn, CM; Boomsma, DI; Isaacs, A; Jansen, R; van Meurs, JBJ; 't Hoen, PAC; Franke, L; Heijmans, BT				Bonder, Marc Jan; Luijk, Rene; Zhernakova, Dania V.; Moed, Matthijs; Deelen, Patrick; Vermaat, Martijn; van Iterson, Maarten; van Dijk, Freerk; van Galen, Michiel; Bot, Jan; Slieker, Roderick C.; Jhamai, P. Mila; Verbiest, Michael; Suchiman, H. Eka D.; Verkerk, Marijn; van der Breggen, Ruud; van Rooij, Jeroen; Lakenberg, Nico; Arindrarto, Wibowo; Kielbasa, Szymon M.; Jonkers, Iris; van 't Hof, Peter; Nooren, Irene; Beekman, Marian; Deelen, Joris; van Heemst, Diana; Zhernakova, Alexandra; Tigchelaar, Ettje F.; Swertz, Morris A.; Hofman, Albert; Uitterlinden, Andre G.; Pool, Rene; van Dongen, Jenny; Hottenga, Jouke J.; Stehouwer, Coen D. A.; van der Kallen, Carla J. H.; Schalkwijk, Casper G.; van den Berg, Leonard H.; van Zwet, Erik W.; Mei, Hailiang; Li, Yang; Lemire, Mathieu; Hudson, Thomas J.; Slagboom, P. Eline; Wijmenga, Cisca; Veldink, Jan H.; van Greevenbroek, Marleen M. J.; van Duijn, Cornelia M.; Boomsma, Dorret I.; Isaacs, Aaron; Jansen, Rick; van Meurs, Joyce B. J.; 't Hoen, Peter A. C.; Franke, Lude; Heijmans, Bastiaan T.		BIOS Consortium	Disease variants alter transcription factor levels and methylation of their binding sites	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; SUSCEPTIBILITY LOCI; ARCHITECTURE; PROTEINS; DNA; FAMILY	Most disease-associated genetic variants are noncoding, making it challenging to design experiments to understand their functional consequences(1,2). Identification of expression quantitative trait loci (eQTLs) has been a powerful approach to infer the downstream effects of disease-associated variants, but most of these variants remain unexplained(3,4). The analysis of DNA methylation, a key component of the epigenome(5,6), offers highly complementary data on the regulatory potential of genomic regions(7,8). Here we show that disease-associated variants have widespread effects on DNA methylation in trans that likely reflect differential occupancy of trans binding sites by cis-regulated transcription factors. Using multiple omics data sets from 3,841 Dutch individuals, we identified 1,907 established trait-associated SNPs that affect the methylation levels of 10,141 different CpG sites in trans (false discovery rate (FDR) < 0.05). These included SNPs that affect both the expression of a nearby transcription factor (such as NFKB1, CTCF and NKX2-3) and methylation of its respective binding site across the genome. Trans methylation QTLs effectively expose the downstream effects of disease-associated variants.	[Bonder, Marc Jan; Zhernakova, Dania V.; Deelen, Patrick; van Dijk, Freerk; Jonkers, Iris; Zhernakova, Alexandra; Tigchelaar, Ettje F.; Swertz, Morris A.; Li, Yang; Wijmenga, Cisca; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Luijk, Rene; Moed, Matthijs; van Iterson, Maarten; Slieker, Roderick C.; Suchiman, H. Eka D.; van der Breggen, Ruud; Lakenberg, Nico; Beekman, Marian; Deelen, Joris; Slagboom, P. Eline; Heijmans, Bastiaan T.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Mol Epidemiol Sect, Leiden, Netherlands; ['t Hoen, Peter A. C.; Franke, Lude; Heijmans, Bastiaan T.] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Vermaat, Martijn; 't Hoen, Peter A. C.] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands; [Bot, Jan; Nooren, Irene] SURFsara, Amsterdam, Netherlands; [Jhamai, P. Mila; Verkerk, Marijn; van Rooij, Jeroen; Uitterlinden, Andre G.; van Meurs, Joyce B. J.] ErasmusMC, Dept Internal Med, Rotterdam, Netherlands; [Arindrarto, Wibowo; van Zwet, Erik W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Med Stat Sect, Leiden, Netherlands; [Kielbasa, Szymon M.; van 't Hof, Peter; Mei, Hailiang] Leiden Univ, Med Ctr, Sequence Anal Support Core, Leiden, Netherlands; [van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Hofman, Albert] ErasmusMC, Dept Epidemiol, Rotterdam, Netherlands; [Pool, Rene; van Dongen, Jenny; Hottenga, Jouke J.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [van der Kallen, Carla J. H.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Stehouwer, Coen D. A.; van der Kallen, Carla J. H.; Schalkwijk, Casper G.; van Greevenbroek, Marleen M. J.; Isaacs, Aaron] Maastricht Univ, Med Ctr, Sch Cardiovasc Dis CARIM, Maastricht, Netherlands; [van den Berg, Leonard H.; Veldink, Jan H.] Univ Med Ctr Utrecht, Dept Neurol Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Lemire, Mathieu; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [van Duijn, Cornelia M.; Isaacs, Aaron] ErasmusMC, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Isaacs, Aaron] Maastricht Univ, Maastricht Ctr Syst Biol MaCSBio, Maastricht, Netherlands; [Jansen, Rick] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Neurosci Campus Amsterdam, Amsterdam, Netherlands	University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University; Utrecht University; Utrecht University Medical Center; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER		lude@ludesign.nl; bas.heijmans@lumc.nl	Kiełbasa, Szymon M./K-2792-2019; Hoen, Peter A 't/D-3950-2018; Stehouwer, Coen/AAB-3435-2021; Pool, René/AFO-8147-2022; Wijmenga, Cisca/AAE-7719-2019; Zhernakova, Alexandra/ABA-9372-2020; Boomsma, Dorret I/AAX-4470-2020; Kiełbasa, Szymon/G-1636-2018; Li, Yang/HGT-8446-2022; Deelen, Patrick/B-3566-2013; Beekman, Marian/L-3004-2019; Suchiman, H. Eka D./F-5024-2017; Deelen, Joris/H-3201-2019; Zhernakova, Daria/M-5619-2016; Franke, Lude/P-7036-2016	Hoen, Peter A 't/0000-0003-4450-3112; Pool, René/0000-0001-5579-0933; Wijmenga, Cisca/0000-0002-5635-1614; Kiełbasa, Szymon/0000-0003-2805-6535; Li, Yang/0000-0003-4022-7341; Deelen, Patrick/0000-0002-5654-3966; Beekman, Marian/0000-0003-0585-6206; Suchiman, H. Eka D./0000-0002-7168-5516; Deelen, Joris/0000-0003-4483-3701; Zhernakova, Daria/0000-0001-6531-3890; Jansen, Rick/0000-0002-3333-6737; Bonder, Marc Jan/0000-0002-8431-3180; Arindrarto, Wibowo/0000-0003-0499-0948; Slieker, Roderick/0000-0003-0961-9152; Van Duijn, Cornelia/0000-0002-2374-9204; Schalkwijk, Casper G/0000-0003-0190-2690; Franke, Lude/0000-0002-5159-8802; van der Kallen, Carla/0000-0003-1468-8793; van Meurs, Joyce/0000-0001-6245-2123; van Greevenbroek, Marleen/0000-0002-2989-1631; Stehouwer, Coen/0000-0001-8752-3223; van Dongen, Jenny/0000-0003-2063-8741	BBMRI-NL; Dutch government [NWO 184.021.007]; Dutch Research Council [ZonMW-VIDI 917.14.374]; ERC Starting Grant [637640]; FP7 [259867]; SURF Cooperative	BBMRI-NL; Dutch government; Dutch Research Council; ERC Starting Grant; FP7; SURF Cooperative	This work was performed within the framework of the Biobank-Based Integrative Omics Studies (BIOS) consortium funded by BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184.021.007). Samples were contributed by LifeLines, the Leiden Longevity Study, the Netherlands Twin Registry (NTR), the Rotterdam Study, the Genetic Research in Isolated Populations program, the CODAM study and the PAN study. We thank the participants of all aforementioned biobanks and acknowledge the contributions of the investigators to this study (Supplementary Note). This work was carried out on the Dutch national e-infrastructure with the support of SURF Cooperative. L.F. is supported by a grant from the Dutch Research Council (ZonMW-VIDI 917.14.374) and is supported by FP7/2007-2013, grant agreement 259867 and by an ERC Starting Grant, grant agreement 637640 (ImmRisk).	Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Huan TX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005035; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Lemire M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7326; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mill J, 2013, NAT REV GENET, V14, P585, DOI 10.1038/nrg3405; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Qiu ZJ, 2015, MOL CELL BIOL, V35, P224, DOI 10.1128/MCB.00553-14; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Sasai N, 2009, INT J DEV BIOL, V53, P323, DOI 10.1387/ijdb.082652ns; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; van Greevenbroek MMJ, 2011, EUR J CLIN INVEST, V41, P372, DOI 10.1111/j.1365-2362.2010.02418.x; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willemsen G, 2013, TWIN RES HUM GENET, V16, P271, DOI 10.1017/thg.2012.140; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yao C, 2015, CIRCULATION, V131, P536, DOI 10.1161/CIRCULATIONAHA.114.010696; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	33	231	233	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					131	138		10.1038/ng.3721	http://dx.doi.org/10.1038/ng.3721			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27918535	Green Published, Green Submitted			2022-12-25	WOS:000390976600019
J	Debelouchina, GT; Gerecht, K; Muir, TW				Debelouchina, Galia T.; Gerecht, Karola; Muir, Tom W.			Ubiquitin utilizes an acidic surface patch to alter chromatin structure	NATURE CHEMICAL BIOLOGY			English	Article							HISTONE H2B; HYDROGEN-EXCHANGE; 2-DIMENSIONAL NMR; HUMAN-CELLS; UBIQUITYLATION; METHYLATION; MONOUBIQUITYLATION; TRANSCRIPTION; CHROMOSOMES; ELONGATION	Ubiquitylation of histone H2B, associated with gene activation, leads to chromatin decompaction through an unknown mechanism. We used a hydrogen-deuterium exchange strategy coupled with NMR spectroscopy to map the ubiquitin surface responsible for its structural effects on chromatin. Our studies revealed that a previously uncharacterized acidic patch on ubiquitin comprising residues Glu16 and G1u18 is essential for decompaction. These residues mediate promiscuous electrostatic interactions with the basic histone proteins, potentially positioning the ubiquitin moiety as a dynamic 'wedge' that prevents the intimate association of neighboring nucleosomes. Using two independent crosslinking strategies and an oligomerization assay, we also showed that ubiquitin-ubiquitin contacts occur in the chromatin environment and are important for the solubilization of the chromatin polymers. Our work highlights a novel, chromatin-related aspect of the 'ubiquitin code' and sheds light on how the information-rich ubiquitin modification can orchestrate different biochemical outcomes using distinct surface features.	[Debelouchina, Galia T.; Gerecht, Karola; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Gerecht, Karola] Tech Univ Munich, Dept Chem, Garching, Germany	Princeton University; Technical University of Munich	Muir, TW (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	muir@princeton.edu	Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344	US National Institutes of Health [R01-GM107047]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107047] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Muller, I. Pelczer, B. Fierz, L. Guerra, N. Shah, S. Kilic, M. Holt, U. Nguyen, J. Boa and K. Jani for stimulating discussions and help regarding the preparation of materials. This work was funded by US National Institutes of Health grant R01-GM107047 to T.W.M.	Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Braun S, 2012, EMBO REP, V13, P619, DOI 10.1038/embor.2012.78; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Fuchs G, 2014, GENOME RES, V24, P1572, DOI 10.1101/gr.176487.114; GALARDY RE, 1973, NATURE-NEW BIOL, V242, P127, DOI 10.1038/newbio242127a0; Going CC, 2016, J AM SOC MASS SPECTR, V27, P1019, DOI 10.1007/s13361-016-1350-z; Holt MT, 2015, P NATL ACAD SCI USA, V112, P10365, DOI 10.1073/pnas.1504483112; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Joti Y, 2012, NUCLEUS-PHILA, V3, P404, DOI 10.4161/nucl.21222; Kato H, 2009, J AM CHEM SOC, V131, P15104, DOI 10.1021/ja9070078; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Machida S, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160090; Maeshima K, 2016, EMBO J, V35, P1115, DOI 10.15252/embj.201592660; Maeshima K, 2014, CHROMOSOMA, V123, P225, DOI 10.1007/s00412-014-0460-2; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; PAN YQ, 1992, BIOCHEMISTRY-US, V31, P11405, DOI 10.1021/bi00161a019; PATERSON Y, 1990, SCIENCE, V249, P755, DOI 10.1126/science.1697101; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raschke TM, 1998, CURR OPIN BIOTECH, V9, P80, DOI 10.1016/S0958-1669(98)80088-8; Roscoe BP, 2013, J MOL BIOL, V425, P1363, DOI 10.1016/j.jmb.2013.01.032; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Shah NH, 2012, J AM CHEM SOC, V134, P11338, DOI 10.1021/ja303226x; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; ZHANG YZ, 1995, PROTEIN SCI, V4, P804; Zheng CY, 2005, J BIOL CHEM, V280, P33552, DOI 10.1074/jbc.M507241200; Zhou LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10589; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	44	62	63	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					105	110		10.1038/NCHEMBIO.2235	http://dx.doi.org/10.1038/NCHEMBIO.2235			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27870837	Green Accepted			2022-12-25	WOS:000393267200020
J	Drysdale, AT; Grosenick, L; Downar, J; Dunlop, K; Mansouri, F; Meng, Y; Fetcho, RN; Zebley, B; Oathes, DJ; Etkin, A; Schatzberg, AF; Sudheimer, K; Keller, J; Mayberg, HS; Gunning, FM; Alexopoulos, GS; Fox, MD; Pascual-Leone, A; Voss, HU; Casey, BJ; Dubin, MJ; Liston, C				Drysdale, Andrew T.; Grosenick, Logan; Downar, Jonathan; Dunlop, Katharine; Mansouri, Farrokh; Meng, Yue; Fetcho, Robert N.; Zebley, Benjamin; Oathes, Desmond J.; Etkin, Amit; Schatzberg, Alan F.; Sudheimer, Keith; Keller, Jennifer; Mayberg, Helen S.; Gunning, Faith M.; Alexopoulos, George S.; Fox, Michael D.; Pascual-Leone, Alvaro; Voss, Henning U.; Casey, B. J.; Dubin, Marc J.; Liston, Conor			Resting-state connectivity biomarkers define neurophysiological subtypes of depression	NATURE MEDICINE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTRINSIC FUNCTIONAL CONNECTIVITY; DEFAULT MODE NETWORK; PREFRONTAL CORTEX; MAJOR DEPRESSION; DENDRITIC MORPHOLOGY; HEAD MOTION; AMYGDALA; ANTIDEPRESSANT; ORGANIZATION	Biomarkers have transformed modern medicine but remain largely elusive in psychiatry, partly because there is a weak correspondence between diagnostic labels and their neurobiological substrates. Like other neuropsychiatric disorders, depression is not a unitary disease, but rather a heterogeneous syndrome that encompasses varied, co-occurring symptoms and divergent responses to treatment. By using functional magnetic resonance imaging (fMRI) in a large multisite sample (n = 1,188), we show here that patients with depression can be subdivided into four neurophysiological subtypes ('biotypes') defined by distinct patterns of dysfunctional connectivity in limbic and frontostriatal networks. Clustering patients on this basis enabled the development of diagnostic classifiers (biomarkers) with high (82-93%) sensitivity and specificity for depression subtypes in multisite validation (n = 711) and out-of-sample replication (n = 477) data sets. These biotypes cannot be differentiated solely on the basis of clinical features, but they are associated with differing clinical-symptom profiles. They also predict responsiveness to transcranial magnetic stimulation therapy (n = 154). Our results define novel subtypes of depression that transcend current diagnostic boundaries and may be useful for identifying the individuals who are most likely to benefit from targeted neurostimulation therapies.	[Drysdale, Andrew T.; Meng, Yue; Fetcho, Robert N.; Dubin, Marc J.; Liston, Conor] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10017 USA; [Drysdale, Andrew T.; Gunning, Faith M.; Alexopoulos, George S.; Dubin, Marc J.; Liston, Conor] Weill Cornell Med Coll, Dept Psychiat, New York, NY 10017 USA; [Drysdale, Andrew T.; Liston, Conor] Weill Cornell Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10017 USA; [Grosenick, Logan] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Grosenick, Logan] Stanford Univ, Ctr Mind Brain & Computat, Stanford, CA 94305 USA; [Grosenick, Logan] Columbia Univ, Med Ctr, Dept Stat, New York, NY USA; [Downar, Jonathan; Dunlop, Katharine] Toronto Western Hosp, Dept Psychiat, Toronto, ON, Canada; [Zebley, Benjamin] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY USA; [Oathes, Desmond J.] Univ Penn, Perelman Sch Med, Ctr Neuromodulat Depress & Stress, Philadelphia, PA USA; [Oathes, Desmond J.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA USA; [Etkin, Amit; Schatzberg, Alan F.; Sudheimer, Keith; Keller, Jennifer] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Etkin, Amit] Stanford Univ, Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA 94305 USA; [Mayberg, Helen S.] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA; [Gunning, Faith M.; Alexopoulos, George S.] Weill Cornell Med Coll, Inst Geriatr Psychiat, New York, NY USA; [Fox, Michael D.; Pascual-Leone, Alvaro] Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA USA; [Fox, Michael D.; Pascual-Leone, Alvaro] Harvard Med Sch, Boston, MA USA; [Voss, Henning U.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Casey, B. J.] Yale Univ, Dept Psychol, New Haven, CT USA	Cornell University; Cornell University; Cornell University; Stanford University; Stanford University; Columbia University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Emory University; Cornell University; Harvard University; Harvard Medical School; Cornell University; Yale University	Liston, C (corresponding author), Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10017 USA.; Liston, C (corresponding author), Weill Cornell Med Coll, Dept Psychiat, New York, NY 10017 USA.; Liston, C (corresponding author), Weill Cornell Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10017 USA.	col2004@med.cornell.edu	, Conor Liston/GQH-8931-2022; Oathes, Desmond/AAW-3048-2021; Fox, Michael D./AAZ-3928-2020; Oathes, Desmond/X-4088-2019; Pascual-Leone, Alvaro/AAC-5101-2019; Downar, Jonathan/I-9002-2016; Dubin, Marc/L-8915-2013; Voss, Henning/C-2194-2009; Etkin, Amit/ABD-5761-2021	Fox, Michael D./0000-0001-8848-6399; Oathes, Desmond/0000-0001-7346-2669; Pascual-Leone, Alvaro/0000-0001-8975-0382; Downar, Jonathan/0000-0002-5140-174X; Dubin, Marc/0000-0002-5542-2978; Voss, Henning/0000-0003-2811-2074; Dunlop, Katharine/0000-0003-4366-7692; Fetcho, Robert/0000-0002-4557-4177; Sudheimer, Keith/0000-0002-9909-0063	NIMH; NIDA; Autism Speaks; NINDS; NIH COBRE grant [1P20RR021938-01A2]; Dana Foundation; Hartwell Foundation; International Mental Health Research Organization; Klingenstein-Simons Foundations; NIMH [R00 MH097822, R01 MH109685, P50 MH077083]; HHMI; NARSAD; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH097822, R01MH109685, R21MH099196, P50MH077083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS083741] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Autism Speaks; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH COBRE grant; Dana Foundation; Hartwell Foundation; International Mental Health Research Organization; Klingenstein-Simons Foundations; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HHMI(Howard Hughes Medical Institute); NARSAD(NARSAD); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank all investigators who volunteered to share MRI data via the 1000 Functional Connectomes Project (http://fcon_1000.projects.nitrc.org/index.html), which was supported by grants from the NIMH, NIDA, Autism Speaks, NINDS and HHMI. Principal investigators from sites that provided data used here include: R.L. Buckner (Harvard-MGH), F.X. Castellanos (NYU), A.C. Evans (ICBM), B. Leventhal (Nathan Kline Institute), S.J. Li (Medical College of Wisconsin), M.J. Lowe (Cleveland Clinic), H.M. Mayberg (Emory), M.P. Milham (Nathan Kline Institute), V. Riedl (Munchen), C. Sorg (Munchen), A. Villringer (Leipzig) and Y.F. Zang (Beijing Normal University). We also thank the following investigators at the University of New Mexico who provided public access to MRI data from patients diagnosed with schizophrenia through the Center of Biomedical Research Excellence in Brain Function and Mental Illness (COBRE): C. Aine, V. Calhoun, J. Canive, F. Hanlon, R. Jung, K. Kiehl, A. Mayer, N. Perrone-Bizzozero, J. Stephen and C. Tesche, who were supported by NIH COBRE grant 1P20RR021938-01A2. We also thank D. Fair (OHSU) and J. Power (NIMH, Weill Cornell) for providing comments on the data analysis, as well as members of the Liston Lab and Sackler Institute, for their helpful comments on the manuscript. H.S.M. was supported by a grant from the NIMH (P50 MH077083). C.L. was supported by grants from the Dana Foundation, Hartwell Foundation, International Mental Health Research Organization, Klingenstein-Simons Foundations, NARSAD and NIMH (R00 MH097822, R01 MH109685).	Baker JT, 2014, JAMA PSYCHIAT, V71, P109, DOI 10.1001/jamapsychiatry.2013.3469; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen CH, 2007, BIOL PSYCHIAT, V62, P407, DOI 10.1016/j.biopsych.2006.09.018; Clementz BA, 2016, AM J PSYCHIAT, V173, P373, DOI 10.1176/appi.ajp.2015.14091200; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Downar J, 2014, BIOL PSYCHIAT, V76, P176, DOI 10.1016/j.biopsych.2013.10.026; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Ferenczi EA, 2016, SCIENCE, V351, DOI 10.1126/science.aac9698; Fox MD, 2012, BIOL PSYCHIAT, V72, P595, DOI 10.1016/j.biopsych.2012.04.028; GEORGE MS, 1995, NEUROREPORT, V6, P1853, DOI 10.1097/00001756-199510020-00008; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Gourley SL, 2013, J NEUROSCI, V33, P3107, DOI 10.1523/JNEUROSCI.2138-12.2013; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hastie T., 2009, UNSUPERVISED LEARNIN; Hill SK, 2013, AM J PSYCHIAT, V170, P1275, DOI 10.1176/appi.ajp.2013.12101298; Huang YZ, 2008, CEREB CORTEX, V18, P563, DOI 10.1093/cercor/bhm087; Insel TR, 2015, SCIENCE, V348, P499, DOI 10.1126/science.aab2358; Knutson B, 2008, BIOL PSYCHIAT, V63, P686, DOI 10.1016/j.biopsych.2007.07.023; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liston C, 2014, BIOL PSYCHIAT, V76, P517, DOI 10.1016/j.biopsych.2014.01.023; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nielsen JA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00599; Oathes DJ, 2015, BIOL PSYCHIAT, V77, P385, DOI 10.1016/j.biopsych.2014.08.006; Pankevich DE, 2014, NEURON, V84, P546, DOI 10.1016/j.neuron.2014.10.007; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Plitt M, 2015, NEUROIMAGE-CLIN, V7, P359, DOI 10.1016/j.nicl.2014.12.013; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Rosa MJ, 2015, NEUROIMAGE, V105, P493, DOI 10.1016/j.neuroimage.2014.11.021; Salvadore G, 2009, BIOL PSYCHIAT, V65, P289, DOI 10.1016/j.biopsych.2008.08.014; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	59	971	1001	36	386	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					28	38		10.1038/nm.4246	http://dx.doi.org/10.1038/nm.4246			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27918562	Green Accepted			2022-12-25	WOS:000391646800011
J	Zakas, PM; Brown, HC; Knight, K; Meeks, SL; Spencer, HT; Gaucher, EA; Doering, CB				Zakas, Philip M.; Brown, Harrison C.; Knight, Kristopher; Meeks, Shannon L.; Spencer, H. Trent; Gaucher, Eric A.; Doering, Christopher B.			Enhancing the pharmaceutical properties of protein drugs by ancestral sequence reconstruction	NATURE BIOTECHNOLOGY			English	Article							A2 SUBUNIT DISSOCIATION; COAGULATION-FACTOR-VIII; HIGH-LEVEL EXPRESSION; EVOLUTIONARY HISTORY; IDENTIFICATION; DOMAIN	Optimization of a protein's pharmaceutical properties is usually carried out by rational design and/or directed evolution. Here we test an alternative approach based on ancestral sequence reconstruction. Using available genomic sequence data on coagulation factor VIII and predictive models of molecular evolution, we engineer protein variants with improved activity, stability, and biosynthesis potential and reduced inhibition by anti-drug antibodies. In principle, this approach can be applied to any protein drug based on a conserved gene sequence.	[Zakas, Philip M.; Brown, Harrison C.; Spencer, H. Trent; Doering, Christopher B.] Emory Univ, Laney Grad Sch, Program Mol & Syst Pharmacol, Atlanta, GA 30322 USA; [Knight, Kristopher; Meeks, Shannon L.; Spencer, H. Trent; Doering, Christopher B.] Emory Univ, Sch Med, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA; [Gaucher, Eric A.] Georgia Inst Technol, Inst Bioengn & Biosci, Sch Biol, Atlanta, GA 30332 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Doering, CB (corresponding author), Emory Univ, Laney Grad Sch, Program Mol & Syst Pharmacol, Atlanta, GA 30322 USA.; Doering, CB (corresponding author), Emory Univ, Sch Med, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA.	cdoerin@emory.edu	Doering, Christopher/W-2064-2019	Meeks, Shannon/0000-0002-3683-8644	National Institutes of Health/National Heart, Lung, and Blood Institute for the Translational Research Centers in Thrombotic and Hemostatic Disorders [U54 HL112309]; Bayer Hemophilia Awards Program; Bayer HealthCare; Children's Healthcare of Atlanta; Georgia Institute of Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL135969, R01HL137128, U54HL112309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute for the Translational Research Centers in Thrombotic and Hemostatic Disorders; Bayer Hemophilia Awards Program; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Children's Healthcare of Atlanta; Georgia Institute of Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health/National Heart, Lung, and Blood Institute for the Translational Research Centers in Thrombotic and Hemostatic Disorders (U54 HL112309 to H.T.S., S.L.M., and C.B.D.), the Bayer Hemophilia Awards Program, Bayer HealthCare (C.B.D.) as well as a research partnership between Children's Healthcare of Atlanta and the Georgia Institute of Technology (C.B.D. and E.A.G.). We also thank E.T. Parker (Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University, Atlanta, Georgia, USA) for technical assistance with the in vivo mouse studies.	Brown HC, 2011, J BIOL CHEM, V286, P24451, DOI 10.1074/jbc.M111.238758; Doering CB, 2004, J BIOL CHEM, V279, P6546, DOI 10.1074/jbc.M312451200; Doering CB, 2002, J BIOL CHEM, V277, P38345, DOI 10.1074/jbc.M206959200; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Harms MJ, 2013, P NATL ACAD SCI USA, V110, P11475, DOI 10.1073/pnas.1303930110; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; Kratzer JT, 2014, P NATL ACAD SCI USA, V111, P3763, DOI 10.1073/pnas.1320393111; Leong L, 2015, BLOOD, V125, P392, DOI 10.1182/blood-2014-02-555656; Markovitz RC, 2013, BLOOD, V121, P2785, DOI 10.1182/blood-2012-09-456582; Merkl R, 2016, BIOL CHEM, V397, P1, DOI 10.1515/hsz-2015-0158; Parker ET, 2006, J BIOL CHEM, V281, P13922, DOI 10.1074/jbc.M513124200; Pipe SW, 1999, BLOOD, V93, P176, DOI 10.1182/blood.V93.1.176.401k07_176_183; Risso VA, 2013, J AM CHEM SOC, V135, P2899, DOI 10.1021/ja311630a; Sabatino DE, 2009, BLOOD, V114, P4562, DOI 10.1182/blood-2009-05-220327; Wilson C, 2015, SCIENCE, V347, P882, DOI 10.1126/science.aaa1823; Zakas PM, 2015, J THROMB HAEMOST, V13, P72, DOI 10.1111/jth.12755; Zakas PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049481; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	19	57	61	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					35	37		10.1038/nbt.3677	http://dx.doi.org/10.1038/nbt.3677			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	27669166	Green Accepted			2022-12-25	WOS:000392460800020
J	[Anonymous]				[Anonymous]			First mitochondrial DNA transfer go-ahead	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					7	7		10.1038/nbt0117-7	http://dx.doi.org/10.1038/nbt0117-7			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	28072791	Bronze			2022-12-25	WOS:000392460800008
J	Love, MI; Hogenesch, JB; Irizarry, RA				Love, Michael I.; Hogenesch, John B.; Irizarry, Rafael A.			Modeling of RNA-seq fragment sequence bias reduces systematic errors in transcript abundance estimation	NATURE BIOTECHNOLOGY			English	Article							EXPRESSION; QUANTIFICATION; NORMALIZATION; GENES	We find that current computational methods for estimating transcript abundance from RNA-seq data can lead to hundreds of false-positive results. We show that these systematic errors stem largely from a failure to model fragment GC content bias. Sample-specific biases associated with fragment sequence features lead to misidentification of transcript isoforms. We introduce alpine, a method for estimating sample-specific bias-corrected transcript abundance. By incorporating fragment sequence features, alpine greatly increases the accuracy of transcript abundance estimates, enabling a fourfold reduction in the number of false positives for reported changes in expression compared with Cufflinks. Using simulated data, we also show that alpine retains the ability to discover true positives, similar to other approaches. The method is available as an R/Bioconductor package that includes data visualization tools useful for bias discovery.	[Love, Michael I.; Irizarry, Rafael A.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Love, Michael I.; Irizarry, Rafael A.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hogenesch, John B.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Dept Pharmacol, Philadelphia, PA 19104 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Pennsylvania Medicine	Irizarry, RA (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.; Irizarry, RA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	rafa@jimmy.harvard.edu		Love, Michael/0000-0001-8401-0545	NIH [5T32CA009337-35, HG005220]; National Institute of Neurological Disorders and Stroke [5R01NS054794-08]; Defense Advanced Research Projects Agency [DARPA-D12AP00025]; NATIONAL CANCER INSTITUTE [T32CA009337] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful for helpful suggestions from Y. Benjamini, W. Huber, N. Lahens, L. Pinello, C. Meyer, R. Petro, Z. Xu, and Y. Li. M.I.L. was supported by NIH grant 5T32CA009337-35. J.B.H. was supported by NIH R01 grant HG005220, the National Institute of Neurological Disorders and Stroke (5R01NS054794-08 to J.B.H.), the Defense Advanced Research Projects Agency (DARPA-D12AP00025, to John Harer, Duke University). R.A.I. was supported by NIH R01 grant HG005220.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Frazee AC, 2015, BIOINFORMATICS, V31, P2778, DOI 10.1093/bioinformatics/btv272; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hayer KE, 2015, BIOINFORMATICS, V31, P3938, DOI 10.1093/bioinformatics/btv488; Hron T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0724-z; Katz Y, 2015, BIOINFORMATICS, V31, P2400, DOI 10.1093/bioinformatics/btv034; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Lahens NF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r86; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Leek JT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku864; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li JJ, 2011, P NATL ACAD SCI USA, V108, P19867, DOI 10.1073/pnas.1113972108; Li J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r50; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; Li W, 2012, BIOINFORMATICS, V28, P2914, DOI 10.1093/bioinformatics/bts559; Nicolae M, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-9; Patro R, 2015, BIORXIV; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290	30	68	68	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1287	1291		10.1038/nbt.3682	http://dx.doi.org/10.1038/nbt.3682			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27669167	Green Submitted, Green Accepted			2022-12-25	WOS:000390185300020
J	Festuccia, N; Dubois, A; Vandormael-Pournin, S; Tejeda, EG; Mouren, A; Bessonnard, S; Mueller, F; Proux, C; Cohen-Tannoudji, M; Navarro, P				Festuccia, Nicola; Dubois, Agnes; Vandormael-Pournin, Sandrine; Tejeda, Elena Gallego; Mouren, Adrien; Bessonnard, Sylvain; Mueller, Florian; Proux, Caroline; Cohen-Tannoudji, Michel; Navarro, Pablo			Mitotic binding of Esrrb marks key regulatory regions of the pluripotency network	NATURE CELL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; SELF-RENEWAL; LYSINE-9 METHYLATION; GENE-EXPRESSION; FATE DECISIONS; GENOME-WIDE; DNA-BINDING; ES CELLS; CYCLIN-A	Pluripotent mouse embryonic stem cells maintain their identity throughout virtually infinite cell divisions. This phenomenon, referred to as self-renewal, depends on a network of sequence-specific transcription factors (TFs) and requires daughter cells to accurately reproduce the gene expression pattern of the mother. However, dramatic chromosomal changes take place in mitosis, generally leading to the eviction of TFs from chromatin. Here, we report that Esrrb, a major pluripotency TF, remains bound to key regulatory regions during mitosis. We show that mitotic Esrrb binding is highly dynamic, driven by specific recognition of its DNA-binding motif and is associated with early transcriptional activation of target genes after completion of mitosis. These results indicate that Esrrb may act as a mitotic bookmarking factor, opening another perspective to molecularly understand the role of sequence-specific TFs in the epigenetic control of self-renewal, pluripotency and genome reprogramming.	[Festuccia, Nicola; Dubois, Agnes; Tejeda, Elena Gallego; Mouren, Adrien; Navarro, Pablo] CNRS, Inst Pasteur, UMR 3738, Epigenet Stem Cells,Dept Dev & Stem Cell Biol, 25 Rue Docteur Roux, F-75015 Paris, France; [Dubois, Agnes; Bessonnard, Sylvain; Cohen-Tannoudji, Michel] CNRS, UMR 3738, Inst Pasteur, Mouse Funct Genet,Dept Dev & Stem Cell Biol, 25 Rue Docteur Roux, F-75015 Paris, France; [Mueller, Florian] CNRS, UMR 3691, Imaging & Modelling, Dept Cell Biol & Infect,Inst Pasteur, 25 Rue Docteur Roux, F-75015 Paris, France; [Proux, Caroline] Inst Pasteur, Transcriptome & EpiGenome, BioM, Ctr Innovat & Technol Res, 28 Rue Docteur Roux, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Navarro, P (corresponding author), CNRS, Inst Pasteur, UMR 3738, Epigenet Stem Cells,Dept Dev & Stem Cell Biol, 25 Rue Docteur Roux, F-75015 Paris, France.	pnavarro@pasteur.fr	Mueller, Florian/C-9075-2012	Mueller, Florian/0000-0002-9622-4396; Cohen-Tannoudji, Michel/0000-0002-6405-2657	Institut Pasteur, CNRS; ANR Laboratoire d'Excellence Revive (Investissement d'Avenir) [ANR-10-LABX-73]; EMBO Long Term Fellowship [ALTF 876-2013]; Marie-Curie Intra-European Fellowship [EFIMB - 626705]	Institut Pasteur, CNRS; ANR Laboratoire d'Excellence Revive (Investissement d'Avenir)(French National Research Agency (ANR)); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Marie-Curie Intra-European Fellowship(European Commission)	We are grateful to I. Chambers for allowing N.F. and P.N. to pursue observations made initially in his laboratory on the chromosomal retention of Esrrb during mitosis. We are grateful to A. Rada-Iglesias, G. Cecere, S. Tajbakhsh, M. Yaniv and members of our laboratory for critical reading of the manuscript. We acknowledge B. Jagla for running the iRNA-Seq pipeline and P. Clerc for assistance with fluorescence microscopy. P.N. acknowledges financial support to the Institut Pasteur, CNRS and the ANR Laboratoire d'Excellence Revive (Investissement d'Avenir; ANR-10-LABX-73). N.F was funded by an EMBO Long Term Fellowship (ALTF 876-2013) and a Marie-Curie Intra-European Fellowship (EFIMB - 626705).	Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Bulut-Karslioglu A, 2014, MOL CELL, V55, P277, DOI 10.1016/j.molcel.2014.05.029; Caravaca JM, 2013, GENE DEV, V27, P251, DOI 10.1101/gad.206458.112; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dalton S, 2015, TRENDS CELL BIOL, V25, P592, DOI 10.1016/j.tcb.2015.07.007; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Faast R, 2004, ONCOGENE, V23, P491, DOI 10.1038/sj.onc.1207133; Farla P, 2004, J STRUCT BIOL, V147, P50, DOI 10.1016/j.jsb.2004.01.002; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Gearhart MD, 2003, J MOL BIOL, V327, P819, DOI 10.1016/S0022-2836(03)00183-9; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Kadauke S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-6; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lerner J., 2016, NUCL ACIDS RES; Madsen JGS, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1365; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Mueller F, 2013, CRIT REV BIOCHEM MOL, V48, P492, DOI 10.3109/10409238.2013.833891; Mueller F, 2012, METHODS MOL BIOL, V833, P153, DOI 10.1007/978-1-61779-477-3_11; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Sauer M, 2008, NUCLEIC ACIDS RES, V36, P1900, DOI 10.1093/nar/gkn044; Sela Y, 2012, STEM CELLS, V30, P1097, DOI 10.1002/stem.1078; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Verdeguer F, 2010, NAT MED, V16, P106, DOI 10.1038/nm.2068; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xing HY, 2008, NAT CELL BIOL, V10, P1318, DOI 10.1038/ncb1790; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zaidi SK, 2003, P NATL ACAD SCI USA, V100, P14852, DOI 10.1073/pnas.2533076100; Zaret KS, 2014, DEV CELL, V29, P132, DOI 10.1016/j.devcel.2014.04.019	60	72	73	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1139	+		10.1038/ncb3418	http://dx.doi.org/10.1038/ncb3418			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27723719	Green Submitted			2022-12-25	WOS:000387165600008
J	Kim, KD; Tanizawa, H; Iwasaki, O; Noma, K				Kim, Kyoung-Dong; Tanizawa, Hideki; Iwasaki, Osamu; Noma, Ken-ichi			Transcription factors mediate condensin recruitment and global chromosomal organization in fission yeast	NATURE GENETICS			English	Article							3D GENOME ARCHITECTURE; NON-SMC SUBUNITS; CHROMATIN INTERACTIONS; CELL-CYCLE; CENTROMERIC LOCALIZATION; REGULATORY LANDSCAPE; MITOTIC CHROMOSOMES; DROSOPHILA GENOME; PLURIPOTENT CELLS; COHESIN COMPLEX	It is becoming clear that structural-maintenance-of-chromosomes (SMC) complexes such as condensin and cohesin are involved in three-dimensional genome organization, yet their exact roles in functional organization remain unclear. We used chromatin interaction analysis by paired-end tag sequencing (ChIA-PET) to comprehensively identify genome-wide associations mediated by condensin and cohesin in fission yeast. We found that although cohesin and condensin often bind;to the same loci, they direct different association networks and generate small and larger chromatin domains, respectively. Cohesin mediates associations between loci positioned within 100 kb of each other; condensin can drive longer-range associations. Moreover, condensin, but not cohesin, connects cell cycle-regulated genes bound by mitotic transcription factors. This study describes the different functions of condensin and cohesin in genome organization and how specific transcription factors function in condensin loading, cell cycle-dependent genome organization and mitotic chromosome organization to support faithful chromosome segregation.	[Kim, Kyoung-Dong; Tanizawa, Hideki; Iwasaki, Osamu; Noma, Ken-ichi] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	The Wistar Institute	Noma, K (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	noma@wistar.org	Tanizawa, Hideki/Z-1107-2019	Tanizawa, Hideki/0000-0002-2573-2473	G. Harold and Leila Y. Mathers Charitable Foundation; NIH Director's New Innovator Award Program of the National Institutes of Health [DP2-OD004348]; Cancer Center Support Grant (CCSG) [P30CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004348] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; NIH Director's New Innovator Award Program of the National Institutes of Health; Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the Wistar Institute genomics and bioinformatics facilities for high-throughput sequencing and genomic data analyses; the Wistar imaging facility for microscopic analysis; and the Yeast Genetic Resource Center (YGRC) for fission yeast strains. We also thank L. Showe, P. Lieberman and R. Locke for critically reading the manuscript, and S. Shaffer for editorial assistance. This work was supported by the G. Harold and Leila Y. Mathers Charitable Foundation and the NIH Director's New Innovator Award Program of the National Institutes of Health under award number (DP2-OD004348 to K.N.). Support for shared resources used in this study was provided by Cancer Center Support Grant (CCSG) P30CA010815 to the Wistar Institute.	ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Alonso-Nunez ML, 2005, MOL BIOL CELL, V16, P2003, DOI 10.1091/mbc.E04-06-0442; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dowen JM, 2013, STEM CELL REP, V1, P371, DOI 10.1016/j.stemcr.2013.09.002; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Feng SH, 2014, MOL CELL, V55, P694, DOI 10.1016/j.molcel.2014.07.008; Fullwood Melissa J, 2010, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2115s89; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Grob S, 2014, MOL CELL, V55, P678, DOI 10.1016/j.molcel.2014.07.009; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haeusler RA, 2008, GENE DEV, V22, P2204, DOI 10.1101/gad.1675908; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Hirano M, 2001, EMBO J, V20, P3238, DOI 10.1093/emboj/20.12.3238; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Iwasaki O, 2015, MOL CELL, V59, P755, DOI 10.1016/j.molcel.2015.07.007; Iwasaki O, 2010, MOL BIOL CELL, V21, P254, DOI 10.1091/mbc.E09-09-0790; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kim KD, 2013, J CELL SCI, V126, P5271, DOI 10.1242/jcs.133678; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Li L, 2015, MOL CELL, V58, P216, DOI 10.1016/j.molcel.2015.02.023; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Mizuguchi T, 2014, NATURE, V516, P432, DOI 10.1038/nature13833; Nakazawa N, 2008, J CELL BIOL, V180, P1115, DOI 10.1083/jcb.200708170; Nakazawa N, 2015, GENES CELLS, V20, P481, DOI 10.1111/gtc.12239; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Petit CS, 2005, J CELL SCI, V118, P5731, DOI 10.1242/jcs.02687; Phanstiel DH, 2015, BIOINFORMATICS, V31, P3092, DOI 10.1093/bioinformatics/btv336; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rodley CDM, 2009, FUNGAL GENET BIOL, V46, P879, DOI 10.1016/j.fgb.2009.07.006; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Schmidt CK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r52; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Sutani T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8815; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; Takayama Y, 2007, NUCLEIC ACIDS RES, V35, P3223, DOI 10.1093/nar/gkm213; Tanaka A, 2012, MOL CELL, V48, P532, DOI 10.1016/j.molcel.2012.09.011; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; Xiao TJ, 2011, MOL CELL BIOL, V31, P2174, DOI 10.1128/MCB.05093-11; Yamazaki H, 2012, GENE DEV, V26, P241, DOI 10.1101/gad.177873.111; Yoshimura SH, 2002, CURR BIOL, V12, P508, DOI 10.1016/S0960-9822(02)00719-4; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	63	48	49	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1242	1252		10.1038/ng.3647	http://dx.doi.org/10.1038/ng.3647			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27548313	Green Accepted			2022-12-25	WOS:000384391600020
J	Pan, M; Reid, MA; Lowman, XH; Kulkarni, RP; Tran, TQ; Liu, XJ; Yang, Y; Hernandez-Davies, JE; Rosales, KK; Li, HQ; Hugo, W; Song, CY; Xu, XD; Schones, DE; Ann, DK; Gradinaru, V; Lo, RS; Locasale, JW; Kong, M				Pan, Min; Reid, Michael A.; Lowman, Xazmin H.; Kulkarni, Rajan P.; Tran, Thai Q.; Liu, Xiaojing; Yang, Ying; Hernandez-Davies, Jenny E.; Rosales, Kimberly K.; Li, Haiqing; Hugo, Willy; Song, Chunying; Xu, Xiangdong; Schones, Dustin E.; Ann, David K.; Gradinaru, Viviana; Lo, Roger S.; Locasale, Jason W.; Kong, Mei			Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation	NATURE CELL BIOLOGY			English	Article							CANCER STEM-CELLS; HUMAN PANCREATIC-CANCER; DISTINCT POPULATIONS; PYRUVATE-CARBOXYLASE; LUNG-CANCER; METHYLATION; HYPOXIA; GROWTH; GENE; PROLIFERATION	Poorly organized tumour vasculature often results in areas of limited nutrient supply and hypoxia. Despite our understanding of solid tumour responses to hypoxia, how nutrient deprivation regionally affects tumour growth and therapeutic response is poorly understood. Here, we show that the core region of solid tumours displayed glutamine deficiency compared with other amino acids. Low glutamine in tumour core regions led to dramatic histone hypermethylation due to decreased alpha-ketoglutarate levels, a key cofactor for the Jumonji-domain-containing histone demethylases. Using patient-derived (V600E)BRAF melanoma cells, we found that low-glutamine-induced histone hypermethylation resulted in cancer cell dedifferentiation and resistance to BRAF inhibitor treatment, which was largely mediated by methylation on H3K27, as knockdown of the H3K27-specific demethylase KDM6B and the methyltransferase EZH2 respectively reproduced and attenuated the low-glutamine effects in vitro and in vivo. Thus, intratumoral regional variation in the nutritional microenvironment contributes to tumour heterogeneity and therapeutic response.	[Pan, Min; Reid, Michael A.; Lowman, Xazmin H.; Tran, Thai Q.; Yang, Ying; Hernandez-Davies, Jenny E.; Rosales, Kimberly K.; Kong, Mei] City Hope Canc Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Kulkarni, Rajan P.; Gradinaru, Viviana] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Kulkarni, Rajan P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Liu, Xiaojing; Locasale, Jason W.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Li, Haiqing] City Hope Canc Ctr, Beckman Res Inst, Dept Informat Sci, Duarte, CA 91010 USA; [Hugo, Willy; Song, Chunying; Lo, Roger S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Hugo, Willy; Song, Chunying; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Xu, Xiangdong] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Schones, Dustin E.; Ann, David K.] City Hope Canc Ctr, Beckman Res Inst, Dept Diabet & Metab Dis, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Duke University; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California San Diego; City of Hope; Beckman Research Institute of City of Hope	Kong, M (corresponding author), City Hope Canc Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	mekong@coh.org	Locasale, Jason W/ABE-6505-2020; Yang, Ying/I-8380-2019	Locasale, Jason W/0000-0002-7766-3502; Reid, Michael/0000-0001-6222-9538; Liu, Xiaojing/0000-0002-4231-6017; Hugo, Willy/0000-0002-1426-7190	National Institutes of Health (NIH)/National Cancer Institute (NCI) [R01CA183989]; Caltech-City of Hope Biomedical Initiative Pilot Grant; American Cancer Society [RSG-16-085-01-TBE]; Stand up to Cancer Philip A. Sharp Innovation in Collaboration Award; DNA Damage Response and Oncogenic Signaling (DDROS) Training Program at City of Hope; NIH/NCI [P30CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572, R00CA168997, R01CA183989] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001882, KL2TR000122] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Caltech-City of Hope Biomedical Initiative Pilot Grant; American Cancer Society(American Cancer Society); Stand up to Cancer Philip A. Sharp Innovation in Collaboration Award; DNA Damage Response and Oncogenic Signaling (DDROS) Training Program at City of Hope; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank members of the Kong laboratory for helpful comments on the manuscript. This work was supported by National Institutes of Health (NIH)/National Cancer Institute (NCI) grant R01CA183989 (to M.K.), Caltech-City of Hope Biomedical Initiative Pilot Grant (to M.K. and V.G.), American Cancer Society Research Scholar RSG-16-085-01-TBE (to M.K.) and Stand up to Cancer Philip A. Sharp Innovation in Collaboration Award. M.K. is the Pew Scholar in the Biomedical Sciences and the V scholar in Cancer Research. X.H.L. is supported by the DNA Damage Response and Oncogenic Signaling (DDROS) Training Program at City of Hope. Research reported here includes work carried out in Core Facilities supported by the NIH/NCI under grant number P30CA33572.	Aoki H, 2015, J INVEST DERMATOL, V135, P1829, DOI 10.1038/jid.2015.83; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; CONTI F, 1994, J HISTOCHEM CYTOCHEM, V42, P717, DOI 10.1177/42.6.7910617; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gonzalez ME, 2014, P NATL ACAD SCI USA, V111, P3098, DOI 10.1073/pnas.1308953111; He XL, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0422-1; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; KWON BS, 1991, P NATL ACAD SCI USA, V88, P9228, DOI 10.1073/pnas.88.20.9228; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Li KK, 2012, MED RES REV, V32, P815, DOI 10.1002/mrr.20228; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mao Q, 2013, J CANCER RES CLIN, V139, P211, DOI 10.1007/s00432-012-1310-3; McCabe MT, 2014, EPIGENOMICS-UK, V6, P341, DOI [10.2217/EPI.14.23, 10.2217/epi.14.23]; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; MORTL M, 1984, BIOCHIM BIOPHYS ACTA, V776, P237, DOI 10.1016/0005-2736(84)90213-X; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Muz B, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.82; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; ROBERTS E, 1949, CANCER RES, V9, P350; Samanta D, 2014, P NATL ACAD SCI USA, V111, pE5429, DOI 10.1073/pnas.1421438111; Sargiannidou I, 2015, ANN NEUROL, V78, P303, DOI 10.1002/ana.24441; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yuan Y, 2012, ACS CHEM BIOL, V7, P1152, DOI 10.1021/cb300139y; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zucchi I, 2008, P NATL ACAD SCI USA, V105, P16940, DOI 10.1073/pnas.0808978105	56	189	194	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2016	18	10					1090	1101		10.1038/ncb3410	http://dx.doi.org/10.1038/ncb3410			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DY2ZX	27617932	Green Accepted			2022-12-25	WOS:000384961700008
J	Yun, S; Budatha, M; Dahlman, JE; Coon, BG; Cameron, RT; Langer, R; Anderson, DG; Baillie, G; Schwartz, MA				Yun, Sanguk; Budatha, Madhusudhan; Dahlman, James E.; Coon, Brian G.; Cameron, Ryan T.; Langer, Robert; Anderson, Daniel G.; Baillie, George; Schwartz, Martin A.			Interaction between integrin alpha(5) and PDE4D regulates endothelial inflammatory signalling	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; EXTRACELLULAR-MATRIX; SHEAR-STRESS; NLRP3 INFLAMMASOME; SMOOTH-MUSCLE; WALL SHEAR; ATHEROSCLEROSIS; FLOW; CELLS	Atherosclerosis is primarily a disease of lipid metabolism and inflammation; however, it is also closely associated with endothelial extracellular matrix (ECM) remodelling, with fibronectin accumulating in the laminin collagen basement membrane. To investigate how fibronectin modulates inflammation in arteries, we replaced the cytoplasmic tail of the fibronectin receptor integrin alpha(5) with that of the collagen/laminin receptor integrin alpha(2). This chimaera suppressed inflammatory signalling in endothelial cells on fibronectin and in knock-in mice. Fibronectin promoted inflammation by suppressing anti-inflammatory cAMP. cAMP was activated through endothelial prostacyclin secretion; however, this was ECM-independent. Instead, cells on fibronectin suppressed cAMP via enhanced phosphodiesterase (PDE) activity, through direct binding of integrin alpha(5) to phosphodiesterase-4D5 (PDE4D5), which induced PP2A-dependent dephosphorylation of PDE4D5 on the inhibitory site Ser651. In vivo knockdown of PDE4D5 inhibited inflammation at athero-prone sites. These data elucidate a molecular mechanism linking ECM remodelling and inflammation, thereby identifying a new class of therapeutic targets.	[Yun, Sanguk; Budatha, Madhusudhan; Coon, Brian G.; Schwartz, Martin A.] Yale Univ, Yale Cardiovasc Res Ctr, Dept Internal Med, New Haven, CT 06520 USA; [Dahlman, James E.; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Dahlman, James E.; Langer, Robert; Anderson, Daniel G.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Dahlman, James E.; Langer, Robert; Anderson, Daniel G.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cameron, Ryan T.; Baillie, George] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Schwartz, Martin A.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Schwartz, Martin A.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Glasgow; Massachusetts Institute of Technology (MIT); Yale University; Yale University	Schwartz, MA (corresponding author), Yale Univ, Yale Cardiovasc Res Ctr, Dept Internal Med, New Haven, CT 06520 USA.; Schwartz, MA (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.; Schwartz, MA (corresponding author), Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA.	martin.schwartz@yale.edu		schwartz, martin/0000-0002-2071-1243	Yale Mouse Phenotypic Center [U24 DK059635]; National Institutes of Health [5R01HL75092]; MRC [MR/J007412/1]; Medical Research Council [MR/J007412/1] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635] Funding Source: NIH RePORTER	Yale Mouse Phenotypic Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Yamada (NIH, USA), D. Calderwood (Yale University, USA), H. Kim (POSTECH, Korea) and A. Jayaraman (Texas A&M University, USA) for providing reagents, and J. Hwa (Yale University, USA) for advice on prostacyclin experiments. Lipid analysis was done by the Yale Mouse Phenotypic Center, supported by a U24 DK059635 grant. This work was funded by a National Institutes of Health grant 5R01HL75092 to M.A.S. G.B. is funded by an MRC project grant (MR/J007412/1). We are grateful to R. Webber and N. Copeland for maintaining the mouse colonies used in this study.	Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; Babaev VR, 2008, ATHEROSCLEROSIS, V197, P534, DOI 10.1016/j.atherosclerosis.2007.08.015; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Bao XP, 1999, ARTERIOSCL THROM VAS, V19, P996, DOI 10.1161/01.ATV.19.4.996; Bollyky PL, 2012, CURR DIABETES REP, V12, P471, DOI 10.1007/s11892-012-0297-0; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Chiu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043040; Conway DE, 2013, J CELL SCI, V126, P5101, DOI 10.1242/jcs.138313; Dahlman JE, 2014, NAT NANOTECHNOL, V9, P648, DOI [10.1038/NNANO.2014.84, 10.1038/nnano.2014.84]; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Fetalvero KM, 2007, PROSTAG OTH LIPID M, V82, P109, DOI 10.1016/j.prostaglandins.2006.05.011; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; Frangos SG, 1999, ARCH SURG-CHICAGO, V134, P1142, DOI 10.1001/archsurg.134.10.1142; Funk SD, 2010, CIRC RES, V106, P1394, DOI 10.1161/CIRCRESAHA.109.210286; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; Ghosh S, 2015, ARTERIOSCL THROM VAS, V35, P1712, DOI 10.1161/ATVBAHA.115.305513; GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018; GRANT DS, 1990, ANN NY ACAD SCI, V588, P61, DOI 10.1111/j.1749-6632.1990.tb13197.x; Hahn C, 2008, ARTERIOSCL THROM VAS, V28, P2101, DOI 10.1161/ATVBAHA.108.165951; Hahn C, 2009, CIRC RES, V104, P995, DOI 10.1161/CIRCRESAHA.108.186486; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Kakolyris Stelios, 1995, In Vivo (Attiki), V9, P35; KHACHIGIAN LM, 1995, J CLIN INVEST, V96, P1169, DOI 10.1172/JCI118106; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Madamanchi A, 2014, ADV EXP MED BIOL, V819, P41, DOI 10.1007/978-94-017-9153-3_3; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; McCormick K, 2014, CURR OPIN GENET DEV, V27, P20, DOI 10.1016/j.gde.2014.02.001; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Muzaffar S, 2012, J CELL PHYSIOL, V227, P1941, DOI 10.1002/jcp.22922; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Netherton SJ, 2005, MOL PHARMACOL, V67, P263, DOI 10.1124/mol.104.004853; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289; Orr AW, 2008, CIRC RES, V103, P671, DOI 10.1161/CIRCRESAHA.108.182097; Orr AW, 2007, J CELL BIOL, V176, P719, DOI 10.1083/jcb.200609008; Orr AW, 2005, J CELL BIOL, V169, P191, DOI 10.1083/jcb.200410073; Papageorgiou AP, 2012, IMMUNOBIOLOGY, V217, P503, DOI 10.1016/j.imbio.2011.07.011; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Pullamsetti SS, 2011, CIRCULATION, V123, P1194, DOI 10.1161/CIRCULATIONAHA.110.941484; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; Sokolowska M, 2015, J IMMUNOL, V194, P5472, DOI 10.4049/jimmunol.1401343; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Stitham J, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00024; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Tan MH, 2004, BLOOD, V104, P11, DOI 10.1182/blood-2003-09-3363; Thompson WJ, 2002, BIOCHEM PHARMACOL, V63, P797, DOI 10.1016/S0006-2952(01)00914-5; Tsai MC, 2009, CIRC RES, V105, P471, DOI 10.1161/CIRCRESAHA.109.193656; Wang C, 2013, ARTERIOSCL THROM VAS, V33, P2130, DOI 10.1161/ATVBAHA.113.301826; Wang JJ, 2010, AM J PHYSIOL-HEART C, V298, pH1146, DOI 10.1152/ajpheart.00252.2009; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yurdagul A, 2014, ARTERIOSCL THROM VAS, V34, P1362, DOI 10.1161/ATVBAHA.114.303863; Yurdagul A, 2013, MOL BIOL CELL, V24, P398, DOI 10.1091/mbc.E12-07-0513; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502	63	60	61	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2016	18	10					1043	1053		10.1038/ncb3405	http://dx.doi.org/10.1038/ncb3405			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DY2ZX	27595237	Green Published, Green Accepted			2022-12-25	WOS:000384961700004
J	Kim, JH; Han, GC; Seo, JY; Park, I; Park, W; Jeong, HW; Lee, SH; Bae, SH; Seong, J; Yum, MK; Hann, SH; Kwon, YG; Seo, D; Choi, MH; Kong, YY				Kim, Ji-Hoon; Han, Gi-Chan; Seo, Ji-Yun; Park, Inkuk; Park, Wookjin; Jeong, Hyun-Woo; Lee, Su Hyeon; Bae, Sung-hwan; Seong, Jinwoo; Yum, Min-Kyu; Hann, Sang-Hyeon; Kwon, Young-Guen; Seo, Daekwan; Choi, Man Ho; Kong, Young-Yun			Sex hormones establish a reserve pool of adult muscle stem cells	NATURE CELL BIOLOGY			English	Article							ESTROGEN-RECEPTOR-ALPHA; HUMAN SKELETAL-MUSCLE; PROGENITOR CELLS; SATELLITE CELLS; ANDROGEN RECEPTOR; MIND BOMB-1; NOTCH ACTIVATION; TESTOSTERONE; EXPRESSION; MOUSE	Quiescent satellite cells, known as adult muscle stem cells, possess a remarkable ability to regenerate skeletal muscle following injury throughout life. Although they mainly originate from multipotent stem/progenitor cells of the somite, the mechanism underlying the establishment of quiescent satellite cell populations is unknown. Here, we show that sex hormones induce Mind bomb 1 (Mib1) expression in myofibres at puberty, which activates Notch signalling in cycling juvenile satellite cells and causes them to be converted into adult quiescent satellite cells. Myofibres lacking Mib1 fail to send Notch signals to juvenile satellite cells, leading to impaired cell cycle exit and depletion. Our findings reveal that the hypothalamic-pituitary-gonadal axis drives Mibi expression in the myofibre niche. Moreover, the same axis regulates the re-establishment of quiescent satellite cell populations following injury. Our data show that sex hormones establish adult quiescent satellite cell populations by regulating the myofibre niche at puberty and re-establish them during regeneration.	[Kim, Ji-Hoon; Han, Gi-Chan; Seo, Ji-Yun; Park, Inkuk; Park, Wookjin; Jeong, Hyun-Woo; Bae, Sung-hwan; Seong, Jinwoo; Yum, Min-Kyu; Hann, Sang-Hyeon; Seo, Daekwan; Kong, Young-Yun] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Lee, Su Hyeon; Choi, Man Ho] Korea Inst Sci & Technol, Mat & Life Sci Res Div, Seoul 136791, South Korea; [Kwon, Young-Guen] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120752, South Korea; [Seo, Daekwan] Inst for Basic Sci Korea, Ctr RNA Res, Seoul 151742, South Korea	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Yonsei University; Institute for Basic Science - Korea (IBS)	Kong, YY (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea.	ykong@snu.ac.kr		Jeong, Hyun-Woo/0000-0002-6976-6739; Yum, Min Kyu/0000-0002-7163-1825	Basic Science Research Program of the Ministry of Science, ICT and Future of the National Research Foundation - Korean government [NRF-2014R1A2A1A10052675]; Bio and Medical Technology Development Program of the Ministry of Science, ICT and Future of the National Research Foundation - Korean government [NRF-2011-0019269]; Korea Mouse Phenotyping Project of the Ministry of Science, ICT and Future of the National Research Foundation - Korean government [NRF-2014M3A9D5A01073930]; SNU-Yonsei Research Cooperation Program through Seoul National University	Basic Science Research Program of the Ministry of Science, ICT and Future of the National Research Foundation - Korean government; Bio and Medical Technology Development Program of the Ministry of Science, ICT and Future of the National Research Foundation - Korean government; Korea Mouse Phenotyping Project of the Ministry of Science, ICT and Future of the National Research Foundation - Korean government; SNU-Yonsei Research Cooperation Program through Seoul National University	We thank S. Kato and Y. Imai for providing Ar<SUP>f/y</SUP> mice, J.-S. Kang for suggesting useful methods for this study, and S.-K. Lee for helpful comments for manuscript preparation. This work was supported by grants from the Basic Science Research Program (NRF-2014R1A2A1A10052675), the Bio and Medical Technology Development Program (NRF-2011-0019269) and the Korea Mouse Phenotyping Project (NRF-2014M3A9D5A01073930) of the Ministry of Science, ICT and Future of the National Research Foundation, funded by the Korean government, and by the SNU-Yonsei Research Cooperation Program through Seoul National University.	Bao JQ, 2013, GENESIS, V51, P481, DOI 10.1002/dvg.22389; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Brown D, 2009, J ENDOCRINOL, V201, P129, DOI 10.1677/JOE-08-0476; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Carson JA, 2002, J APPL PHYSIOL, V93, P242, DOI 10.1152/japplphysiol.01212.2001; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chambon C, 2010, P NATL ACAD SCI USA, V107, P14327, DOI 10.1073/pnas.1009536107; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Doumit ME, 1996, ENDOCRINOLOGY, V137, P1385, DOI 10.1210/en.137.4.1385; Dupont S, 2000, DEVELOPMENT, V127, P4277; Ebling FJP, 2005, REPRODUCTION, V129, P675, DOI 10.1530/rep.1.00367; EDELSTEIN MC, 1990, CONTRACEPTION, V42, P209, DOI 10.1016/0010-7824(90)90104-4; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gunther S, 2013, CELL STEM CELL, V13, P590, DOI 10.1016/j.stem.2013.07.016; Jeong HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036359; Jeong HW, 2009, J CLIN INVEST, V119, P3290, DOI 10.1172/JCI38416; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P25, DOI 10.1007/s004180050003; Kalbe C, 2007, HISTOCHEM CELL BIOL, V127, P95, DOI 10.1007/s00418-006-0224-z; Kim YW, 2008, BLOOD, V112, P4628, DOI 10.1182/blood-2008-03-148999; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; LUCAS LA, 1980, J ENDOCRINOL, V87, P37, DOI 10.1677/joe.0.0870037; Maatta Jorma A, 2013, Bonekey Rep, V2, P440, DOI 10.1038/bonekey.2013.174; Mourikis P, 2012, DEVELOPMENT, V139, P4536, DOI 10.1242/dev.084756; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Neal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037950; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Rios AC, 2011, NATURE, V473, P532, DOI 10.1038/nature09970; SAFRANSKI TJ, 1993, BIOL REPROD, V48, P669, DOI 10.1095/biolreprod48.3.669; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Sinha-Hikim I, 2004, J CLIN ENDOCR METAB, V89, P5245, DOI 10.1210/jc.2004-0084; Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Valdez DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097334; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Velders M, 2012, FASEB J, V26, P1909, DOI 10.1096/fj.11-194779; Weiser MJ, 2009, ENDOCRINOLOGY, V150, P1817, DOI 10.1210/en.2008-1355; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wierman ME, 2007, ADV PHYSIOL EDUC, V31, P26, DOI 10.1152/advan.00086.2006; Wiik A, 2009, HISTOCHEM CELL BIOL, V131, P181, DOI 10.1007/s00418-008-0512-x; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yoo YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037258; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Yoon MJ, 2008, MOL CELL BIOL, V28, P4794, DOI 10.1128/MCB.00436-08; Zenclussen ML, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00032	60	44	45	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2016	18	9					930	940		10.1038/ncb3401	http://dx.doi.org/10.1038/ncb3401			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DU7TF	27548913				2022-12-25	WOS:000382416800004
J	Gibson, WJ; Hoivik, EA; Halle, MK; Taylor-Weiner, A; Cherniack, AD; Berg, A; Holst, F; Zack, TI; Werner, HMJ; Staby, KM; Rosenberg, M; Stefansson, IM; Kusonmano, K; Chevalier, A; Mauland, KK; Trovik, J; Krakstad, C; Giannakis, M; Hodis, E; Woie, K; Bjorge, L; Vintermyr, OK; Wala, JA; Lawrence, MS; Getz, G; Carter, SL; Beroukhim, R; Salvesen, HB				Gibson, William J.; Hoivik, Erling A.; Halle, Mari K.; Taylor-Weiner, Amaro; Cherniack, Andrew D.; Berg, Anna; Holst, Frederik; Zack, Travis I.; Werner, Henrica M. J.; Staby, Kjersti M.; Rosenberg, Mara; Stefansson, Ingunn M.; Kusonmano, Kanthida; Chevalier, Aaron; Mauland, Karen K.; Trovik, Jone; Krakstad, Camilla; Giannakis, Marios; Hodis, Eran; Woie, Kathrine; Bjorge, Line; Vintermyr, Olav K.; Wala, Jeremiah A.; Lawrence, Michael S.; Getz, Gad; Carter, Scott L.; Beroukhim, Rameen; Salvesen, Helga B.			The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis	NATURE GENETICS			English	Article							ESTROGEN-RECEPTOR; BREAST-CANCER; PANCREATIC-CANCER; MUTATIONS; HYPERPLASIA; THERAPY; REVEALS; ARID1A; ADENOCARCINOMA; INSTABILITY	Recent studies have detailed the genomic landscape of primary endometrial cancers, but the evolution of these cancers into metastases has not been characterized. We performed whole-exome sequencing of 98 tumor biopsies including complex atypical hyperplasias, primary tumors and paired abdominopelvic metastases to survey the evolutionary landscape of endometrial cancer. We expanded and reanalyzed The Cancer Genome Atlas ( TCGA) data, identifying new recurrent alterations in primary tumors, including mutations in the estrogen receptor cofactor gene NRIP1 in 12% of patients. We found that likely driver events were present in both primary and metastatic tissue samples, with notable exceptions such as ARID1A mutations. Phylogenetic analyses indicated that the sampled metastases typically arose from a common ancestral subclone that was not detected in the primary tumor biopsy. These data demonstrate extensive genetic heterogeneity in endometrial cancers and relative homogeneity across metastatic sites.	[Gibson, William J.; Taylor-Weiner, Amaro; Cherniack, Andrew D.; Holst, Frederik; Zack, Travis I.; Rosenberg, Mara; Chevalier, Aaron; Giannakis, Marios; Hodis, Eran; Wala, Jeremiah A.; Lawrence, Michael S.; Getz, Gad; Carter, Scott L.; Beroukhim, Rameen] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Gibson, William J.; Holst, Frederik; Zack, Travis I.; Wala, Jeremiah A.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gibson, William J.; Zack, Travis I.; Giannakis, Marios; Hodis, Eran; Wala, Jeremiah A.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Gibson, William J.; Zack, Travis I.; Hodis, Eran; Wala, Jeremiah A.; Beroukhim, Rameen] Harvard Med Sch, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; [Hoivik, Erling A.; Halle, Mari K.; Berg, Anna; Holst, Frederik; Werner, Henrica M. J.; Mauland, Karen K.; Trovik, Jone; Woie, Kathrine; Bjorge, Line; Salvesen, Helga B.] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway; [Hoivik, Erling A.; Halle, Mari K.; Berg, Anna; Holst, Frederik; Werner, Henrica M. J.; Kusonmano, Kanthida; Mauland, Karen K.; Trovik, Jone; Krakstad, Camilla; Bjorge, Line; Salvesen, Helga B.] Haukeland Hosp, Dept Gynecol & Obstet, Bergen, Norway; [Staby, Kjersti M.; Stefansson, Ingunn M.; Vintermyr, Olav K.] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Stefansson, Ingunn M.; Vintermyr, Olav K.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Kusonmano, Kanthida] Univ Bergen, Computat Biol Unit, Bergen, Norway; [Krakstad, Camilla] Univ Bergen, Dept Biomed, Bergen, Norway; [Carter, Scott L.] Brigham & Womens Hosp, Broad Inst, Dana Farber Canc Inst, Joint Ctr Canc Precis Med, 75 Francis St, Boston, MA 02115 USA; [Carter, Scott L.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Carter, Scott L.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Kusonmano, Kanthida] King Mongkuts Univ Technol, Bioinformat & Syst Biol Program, Computat Biol Unit, Sch Bioresources & Technol, Bangkok, Thailand	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; King Mongkuts University of Technology North Bangkok; King Mongkuts University of Technology Thonburi	Carter, SL; Beroukhim, R (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Beroukhim, R (corresponding author), Harvard Med Sch, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA.; Hoivik, EA (corresponding author), Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway.; Hoivik, EA (corresponding author), Haukeland Hosp, Dept Gynecol & Obstet, Bergen, Norway.; Carter, SL (corresponding author), Brigham & Womens Hosp, Broad Inst, Dana Farber Canc Inst, Joint Ctr Canc Precis Med, 75 Francis St, Boston, MA 02115 USA.; Carter, SL (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.; Carter, SL (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	erling.hoivik@uib.no; scarter@broadinstitute.org; rameen_beroukhim@dfci.harvard.edu	Holst, Frederik/H-3149-2019; Kusonmano, Kanthida/AAQ-2802-2020; Werner, henrica/ABG-1235-2021; Giannakis, Marios/Z-4908-2019; Cherniack, Andrew D./AAY-8132-2020; Krakstad, Camilla/AAB-5138-2020; Lawrence, Michael/AAC-8202-2020; Halle, Mari K/AAT-4856-2020; Bjorge, Line/C-1307-2017; salvesen, Helga B/C-1187-2017; Cherniack, Andrew/AAC-5310-2019; Bjorge, Line/AAD-6179-2021	Holst, Frederik/0000-0002-5928-2175; Werner, henrica/0000-0001-5186-8369; Cherniack, Andrew D./0000-0003-0470-0111; Krakstad, Camilla/0000-0002-0174-8139; Bjorge, Line/0000-0002-0240-2770; salvesen, Helga B/0000-0002-4438-8831; Bjorge, Line/0000-0002-0240-2770; Halle, Mari K/0000-0002-2660-8271; Rosenberg, Mara/0000-0001-6400-3161	Research Council of Norway; Norwegian Cancer Society, Helse Vest; University of Bergen; Bergen Research Foundation; National Institutes of Health [T32GM007753, 5R01CA188228, 1F30CA192725]; Novartis Institutes for Biomedical Research; NATIONAL CANCER INSTITUTE [R01CA188228, F30CA192725] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society, Helse Vest; University of Bergen; Bergen Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institutes for Biomedical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Valen, B. Edvardsen, K. Madissoo, R. Kopperud and B. Nordanger for excellent technical assistance. This study was supported by the Research Council of Norway, the Norwegian Cancer Society, Helse Vest, the University of Bergen, the Bergen Research Foundation, the National Institutes of Health (award numbers T32GM007753, 5R01CA188228 and 1F30CA192725) and the Novartis Institutes for Biomedical Research.	Abedalthagafi MS, 2015, CANCER GENET-NY, V208, P345, DOI 10.1016/j.cancergen.2015.03.005; Berg A, 2015, ONCOTARGET, V6, P1327, DOI 10.18632/oncotarget.2675; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hayes MP, 2006, CLIN CANCER RES, V12, P5932, DOI 10.1158/1078-0432.CCR-06-1375; Hong B, 2015, CURR OPIN GENET DEV, V30, P25, DOI 10.1016/j.gde.2014.12.004; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Mao TL, 2013, AM J SURG PATHOL, V37, P1342, DOI 10.1097/PAS.0b013e3182889dc3; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Novetsky AP, 2013, GYNECOL ONCOL, V128, P470, DOI 10.1016/j.ygyno.2012.10.026; Ren Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03042; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Rosell M, 2014, CANCER RES, V74, P5469, DOI 10.1158/0008-5472.CAN-13-3429; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Stachler MD, 2015, NAT GENET, V47, P1047, DOI 10.1038/ng.3343; Torres-Martin M, 2015, CANCER GENET-NY, V208, P327, DOI 10.1016/j.cancergen.2015.03.012; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Veeraraghavan J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5577; Werner HMJ, 2013, MODERN PATHOL, V26, P428, DOI 10.1038/modpathol.2012.174; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Wik E, 2014, GYNECOL ONCOL, V134, P599, DOI 10.1016/j.ygyno.2014.06.026; WOODRUFF JD, 1994, AM J OBSTET GYNECOL, V170, P1213; Wright JD, 2012, LANCET, V379, P1352, DOI 10.1016/S0140-6736(12)60442-5; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhao SM, 2013, P NATL ACAD SCI USA, V110, P2916, DOI 10.1073/pnas.1222577110; Zhu S, 2011, THEOR POPUL BIOL, V79, P220, DOI 10.1016/j.tpb.2011.03.002	53	136	141	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					848	+		10.1038/ng.3602	http://dx.doi.org/10.1038/ng.3602			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27348297	Green Submitted, Green Accepted			2022-12-25	WOS:000380755100007
J	Banh, RS; Iorio, C; Marcotte, R; Xu, Y; Cojocari, D; Rahman, AA; Pawling, J; Zhang, W; Sinha, A; Rose, CM; Isasa, M; Zhang, S; Wu, R; Virtanen, C; Hitomi, T; Habu, T; Sidhu, SS; Koizumi, A; Wilkins, SE; Kislinger, T; Gygi, SP; Schofield, CJ; Dennis, JW; Wouters, BG; Neel, BG				Banh, Robert S.; Iorio, Caterina; Marcotte, Richard; Xu, Yang; Cojocari, Dan; Rahman, Anas Abdel; Pawling, Judy; Zhang, Wei; Sinha, Ankit; Rose, Christopher M.; Isasa, Marta; Zhang, Shuang; Wu, Ronald; Virtanen, Carl; Hitomi, Toshiaki; Habu, Toshiyuki; Sidhu, Sachdev S.; Koizumi, Akio; Wilkins, Sarah E.; Kislinger, Thomas; Gygi, Steven P.; Schofield, Christopher J.; Dennis, James W.; Wouters, Bradly G.; Neel, Benjamin G.			PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia	NATURE CELL BIOLOGY			English	Article							TYROSINE-PHOSPHATASE 1B; INSULIN SENSITIVITY; PROTEIN; CANCER; INHIBITION; GROWTH; CELLS; QUANTIFICATION; CATEGORIES; EXPRESSION	Tumours exist in a hypoxic microenvironment and must limit excessive oxygen consumption. Hypoxia-inducible factor (HIF) controls mitochondrial oxygen consumption, but how/if tumours regulate non-mitochondrial oxygen consumption (NMOC) is unknown. Protein-tyrosine phosphatase-1B (PTP1B) is required for Her2/Neu-driven breast cancer (BC) in mice, although the underlying mechanism and human relevance remain unclear. We found that PTP1B-deficient HER2(+) xenografts have increased hypoxia, necrosis and impaired growth. In vitro, PTP1B deficiency sensitizes HER2(+) BC lines to hypoxia by increasing NMOC by alpha-KG-dependent dioxygenases (alpha-KGDDs). The moyamoya disease gene product RNF213, an E3 ligase, is negatively regulated by PTP1B in HER2(+) BC cells. RNF213 knockdown reverses the effects of PTP1B deficiency on alpha-KGDDs, NMOC and hypoxia-induced death of HER2(+) BC cells, and partially restores tumorigenicity. We conclude that PTP1B acts via RNF213 to suppress alpha-KGDD activity and NMOC. This PTP1B/RNF213/alpha-KGDD pathway is critical for survival of HER2(+) BC, and possibly other malignancies, in the hypoxic tumour microenvironment.	[Banh, Robert S.; Xu, Yang; Cojocari, Dan; Sinha, Ankit; Wu, Ronald; Kislinger, Thomas; Wouters, Bradly G.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Banh, Robert S.; Iorio, Caterina; Marcotte, Richard; Xu, Yang; Cojocari, Dan; Sinha, Ankit; Wu, Ronald; Virtanen, Carl; Kislinger, Thomas; Wouters, Bradly G.; Neel, Benjamin G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Banh, Robert S.; Xu, Yang; Zhang, Shuang; Neel, Benjamin G.] NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Rahman, Anas Abdel; Pawling, Judy; Dennis, James W.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Rahman, Anas Abdel] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Dept Genet, Riyadh 12713, Saudi Arabia; [Zhang, Wei; Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Rose, Christopher M.; Isasa, Marta; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Hitomi, Toshiaki; Koizumi, Akio] Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Kyoto 6068501, Japan; [Habu, Toshiyuki] Kyoto Univ, Inst Radiat, Ctr Biol, Dept Radiat Syst Biol, Kyoto 6068501, Japan; [Wilkins, Sarah E.; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; New York University; NYU Langone Medical Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; King Faisal Specialist Hospital & Research Center; University of Toronto; Harvard University; Harvard Medical School; Kyoto University; Kyoto University; University of Oxford	Neel, BG (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada.; Neel, BG (corresponding author), NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.	Benjamin.Neel@nyumc.org	Xu, Yang/CAG-8877-2022; Cojocari, Dan/AAK-6850-2020; Wouters, Bradly/T-1525-2017; Habu, Toshiyuki/ABC-6644-2021; Dennis, James/E-7268-2013; Kislinger, Thomas/A-5934-2008; Abdel Rahman, Anas/AEC-1515-2022	Xu, Yang/0000-0003-1670-6131; Cojocari, Dan/0000-0002-2614-071X; Wouters, Bradly/0000-0002-8187-592X; Habu, Toshiyuki/0000-0003-4131-3938; Abdel Rahman, Anas/0000-0002-9527-9424; Kislinger, Thomas/0000-0003-3525-5540; Sinha, Ankit/0000-0002-9113-2599; Zhang, Wei/0000-0001-5813-240X; Rose, Christopher/0000-0002-7502-3368; Wu, Ronald/0000-0002-8712-6663	NIH [R37 CA49152, GM96745]; Canadian Institutes of Health Research (CIHR) [120593]; CIHR [62975, 136956, 133615]; Terry Fox New Frontiers Research Program [PPG09-02005]; Cancer Research-UK; Wellcome Trust; Kiban Kenkyu [A-25253047]; Princess Margaret Cancer Foundation; Ontario Ministry of Health and Long Term Care; Canada Research Chair programme; Canadian Breast Cancer Foundation; CIHR; Ontario Graduate Scholarship; MITACS-Accelerate internship; Medical Biophysics Excellence Award; Kirsti Piia Callum Memorial Fellowship; NATIONAL CANCER INSTITUTE [R37CA049152, R01CA049152] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/D011523/1] Funding Source: researchfish; BBSRC [BB/D011523/1] Funding Source: UKRI; Grants-in-Aid for Scientific Research [15K07044] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Terry Fox New Frontiers Research Program; Cancer Research-UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Kiban Kenkyu; Princess Margaret Cancer Foundation(University of Toronto); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Canada Research Chair programme(Canada Research Chairs); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); MITACS-Accelerate internship; Medical Biophysics Excellence Award; Kirsti Piia Callum Memorial Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank G. Keller and T. W. Mak (Princess Margaret Cancer Center) for helpful comments on the manuscript. This work was funded by NIH grant R37 CA49152 and Canadian Institutes of Health Research (CIHR) grant 120593 (to B.G.N.), CIHR grant 62975 (to J.W.D.), CIHR grant 136956 (to S.S.S.), CIHR grant 133615 (to T.K.), Terry Fox New Frontiers Research Program PPG09-02005 (to B.G.W.), Cancer Research-UK and the Wellcome Trust (to S.E.W. and C.J.S), NIH grant GM96745 (to S.P.G.) and Kiban Kenkyu grant A-25253047 to A.K. Work in the Ned and Wouters laboratories was partially supported by the Princess Margaret Cancer Foundation and the Ontario Ministry of Health and Long Term Care. B.G.N. and J.W.D. are Canada Research Chairs, Tier 1, and B.G.W. is a Senior Investigator of the Ontario Institute for Cancer Research. T.K. is supported by the Canada Research Chair programme (Tier 2). R.M. was partially supported by a Post-doctoral Fellowship Grant, and R.S.B. by a Doctoral Fellowship Grant, both from the Canadian Breast Cancer Foundation. W.Z. was supported by a CIHR Post-doctoral Fellowship Grant. D.C. was supported by an Ontario Graduate Scholarship. A.A.R. was supported by a MITACS-Accelerate internship. A.S. was supported by the Medical Biophysics Excellence Award and the Kirsti Piia Callum Memorial Fellowship.	Anso E, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-7; Balavenkatraman KK, 2011, MOL CANCER RES, V9, P1377, DOI 10.1158/1541-7786.MCR-11-0198; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bettaieb A, 2013, J BIOL CHEM, V288, P17360, DOI 10.1074/jbc.M112.441469; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gentile A, 2008, ONCOGENE, V27, P5590, DOI 10.1038/onc.2008.173; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hewitson KS, 2005, PHILOS T R SOC A, V363, P807, DOI 10.1098/rsta.2004.1540; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Kim JS, 2016, J STROKE, V18, P2, DOI 10.5853/jos.2015.01627; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Kuiper C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00359; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lutterman J, 1998, PEDIATRICS, V101, P57, DOI 10.1542/peds.101.1.57; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McDonough MA, 2005, J AM CHEM SOC, V127, P7680, DOI 10.1021/ja050841b; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Rahman AMA, 2015, GLYCOBIOLOGY, V25, P225, DOI 10.1093/glycob/cwu105; Rahman AMA, 2014, ANAL CHIM ACTA, V845, P53, DOI 10.1016/j.aca.2014.06.012; Rahman AMA, 2013, ACS CHEM BIOL, V8, P2053, DOI 10.1021/cb4004173; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Senko MW, 2013, ANAL CHEM, V85, P11710, DOI 10.1021/ac403115c; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Sinha A, 2014, BIOCHEM BIOPH RES CO, V445, P694, DOI 10.1016/j.bbrc.2013.12.070; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; van den Beucken T, 2009, J BIOL CHEM, V284, P24204, DOI 10.1074/jbc.M109.006510; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weinberg DG, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1151; WIENER JR, 1994, J NATL CANCER I, V86, P372, DOI 10.1093/jnci/86.5.372; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wu X, 2012, MOL CELL BIOL, V32, P3872, DOI 10.1128/MCB.00751-12; Yan L, 2010, EXPERT OPIN THER PAT, V20, P1219, DOI 10.1517/13543776.2010.510836; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	59	73	73	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2016	18	7					803	+		10.1038/ncb3376	http://dx.doi.org/10.1038/ncb3376			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DP9TS	27323329	Green Submitted, Green Accepted			2022-12-25	WOS:000378840900012
J	Peng, YJ				Peng, Yaojin			The morality and ethics governing CRISPR-Cas9 patents in China	NATURE BIOTECHNOLOGY			English	Editorial Material							IMMUNITY; RNA; DNA		[Peng, Yaojin] Maastricht Univ, Inst Globalizat & Int Regulat, NL-6200 MD Maastricht, Netherlands	Maastricht University	Peng, YJ (corresponding author), Maastricht Univ, Inst Globalizat & Int Regulat, NL-6200 MD Maastricht, Netherlands.	yaojin.peng@hotmail.com						Bosley KS, 2015, NAT BIOTECHNOL, V33, P478, DOI 10.1038/nbt.3227; Chen X., 2002, COMMUNICATION; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; European Patent Office, 2013, EUR PAT CONV; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Legal Affairs Department of the State Intellectual Property Office PRC, 2001, EXPL NEWL AD PAT LAW, P26; Li W, 2014, NAT BIOTECHNOL, V32, P1001, DOI 10.1038/nbt.3031; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; May A. P., 2016, US Patent No, Patent No. [9,260,752, 9260752]; Ministry of Health of the PRC, 2007, MEAS ETH REV BIOM RE; Ministry of Science and Technology and Ministry of Health of the PRC, 2003, ETH GUID HUM EMBR ST; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; State Intellectual Property Office PRC, 2010, GUID PAT EX 2; State Intellectual Property Office PRC, 2010, GUID PAT EX 2; Suzhou Tangshan Bio-Tech Co. Ltd, 2014, Chinese Patent application, Patent No. [201310610085.0, 201310610085]; Webber P, 2014, NAT BIOTECHNOL, V32, P331, DOI 10.1038/nbt.2843; World Intellectual Property Organization, 2004, WIPO INT PROP HDB PO; Zhang F., 2014, US Patent, Patent No. [8,697,359, 8697359]; Zhang Q., 2008, STRATEGY PRACTICE IN, P26; Zhang Q., 2008, STRATEGY PRACTICE IN, P61	24	11	11	3	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2016	34	6					616	619		10.1038/nbt.3590	http://dx.doi.org/10.1038/nbt.3590			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DO5TT	27281418				2022-12-25	WOS:000377846400024
J	Liu, F; Somarowthu, S; Pyle, AM				Liu, Fei; Somarowthu, Srinivas; Pyle, Anna Marie			Visualizing the secondary and tertiary architectural domains of lnc RNA RepA	NATURE CHEMICAL BIOLOGY			English	Article							LONG NONCODING RNAS; XIST RNA; X-CHROMOSOME; A-REPEAT; SHAPE; GENE; REVEALS; ULTRACENTRIFUGATION; PROTEINS; INSIGHTS	Long noncoding RNAs (lncRNAs) are important for gene expression, but little is known about their structures. RepA is a 1.6-kb mouse lncRNA comprising the same sequence as the 59 region of Xist, including A and F repeats. It has been proposed to facilitate the initiation and spread of X-chromosome inactivation, although its exact role is poorly understood. To gain insight into the molecular mechanism of RepA and Xist, we determined a complete phylogenetically validated secondary-structural map of RepA through SHAPE and DMS chemical probing of a homogeneously folded RNA in vitro. We combined UV-cross-linking experiments with RNA modeling methods to produce a three-dimensional model of RepA functional domains demonstrating that tertiary architecture exists within lncRNA molecules and occurs within specific functional modules. This work provides a foundation for understanding of the evolution and functional properties of RepA and Xist and offers a framework for exploring architectural features of other lncRNAs.	[Liu, Fei; Somarowthu, Srinivas; Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Liu, Fei; Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Pyle, Anna Marie] Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA; [Somarowthu, Srinivas] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	Yale University; Howard Hughes Medical Institute; Yale University; Drexel University	Pyle, AM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Pyle, AM (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Pyle, AM (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	anna.pyle@yale.edu			National Institutes of Health [R01GM50313]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge M. Simon (Yale University) for sharing the in vivo DMS probing data of Xist and E. Jagdmann for the synthesis of 1M7. We thank T. Dickey, C. Zhao, O. Fedorova, and all other members of the Pyle laboratory for constructive discussion and critical reading of the manuscript. This project was supported by the National Institutes of Health (R01GM50313). A.M.P. is supported as an Investigator, and F.L. is supported as a Postdoctoral Fellow, of the Howard Hughes Medical Institute.	BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chen CK, 2016, SCIENCE, V354, P468, DOI 10.1126/science.aae0047; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Duszczyk MM, 2011, RNA, V17, P1973, DOI 10.1261/rna.2747411; Duszczyk MM, 2008, NUCLEIC ACIDS RES, V36, P7068, DOI 10.1093/nar/gkn776; Fang R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005668; Fernandez-Luna MT, 2008, RNA BIOL, V5, P20, DOI 10.4161/rna.5.1.5974; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Galupa R, 2015, CURR OPIN GENET DEV, V31, P57, DOI 10.1016/j.gde.2015.04.002; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Harris ME, 2009, METHOD ENZYMOL, V468, P127, DOI 10.1016/S0076-6879(09)68007-1; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Low JT, 2010, METHODS, V52, P150, DOI 10.1016/j.ymeth.2010.06.007; Lu ZP, 2016, CELL, V165, P1267, DOI 10.1016/j.cell.2016.04.028; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; McGinnis JL, 2009, METHOD ENZYMOL, V468, P67, DOI 10.1016/S0076-6879(09)68004-6; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; Monfort A, 2015, CELL REP, V12, P554, DOI 10.1016/j.celrep.2015.06.067; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Novikova IV, 2013, METHODS, V63, P170, DOI 10.1016/j.ymeth.2013.07.030; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; Pyle AM, 2007, TRENDS BIOCHEM SCI, V32, P138, DOI 10.1016/j.tibs.2007.01.005; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Ramachandran S, 2013, BIOCHEMISTRY-US, V52, P596, DOI 10.1021/bi300756s; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Somarowthu S, 2015, MOL CELL, V58, P353, DOI 10.1016/j.molcel.2015.03.006; Su LHJ, 2003, J MOL BIOL, V334, P639, DOI 10.1016/j.jmb.2003.09.071; Takamoto K, 2004, J MOL BIOL, V343, P1195, DOI 10.1016/j.jmb.2004.08.080; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Weinberg Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-3; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang L, 2014, TRENDS BIOCHEM SCI, V39, P35, DOI 10.1016/j.tibs.2013.10.002; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	50	78	79	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2017	13	3					282	+		10.1038/NCHEMBIO.2272	http://dx.doi.org/10.1038/NCHEMBIO.2272			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL2DY	28068310	Green Accepted			2022-12-25	WOS:000394431500010
J	Papapetrou, EP				Papapetrou, Eirini P.			Patient-derived induced pluripotent stem cells in cancer research and precision oncology	NATURE MEDICINE			English	Article							COPY NUMBER; HEMATOPOIETIC PROGENITORS; GENOMIC INSTABILITY; ORGANOID CULTURES; GENE-EXPRESSION; SOMATIC-CELLS; DISEASE; MODEL; GENERATION; DIFFERENTIATION	Together with recent advances in the processing and culture of human tissue, bioengineering, xenotransplantation and genome editing, Induced pluripotent stem cells (iPSCs) present a range of new opportunities for the study of human cancer. Here we discuss the main advantages and limitations of iPSC modeling, and how the method intersects with other patient-derived models of cancer, such as organoids, organson- chips and patient-derived xenografts (PDXs). We highlight the opportunities that iPSC models can provide beyond those offered by existing systems and animal models and present current challenges and crucial areas for future improvements toward wider adoption of this technology.	[Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Dept Med Hematol & Med Oncol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Papapetrou, EP (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.; Papapetrou, EP (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Papapetrou, EP (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.; Papapetrou, EP (corresponding author), Icahn Sch Med Mt Sinai, Dept Med Hematol & Med Oncol, New York, NY 10029 USA.	eirini.papapetrou@mssm.edu		Papapetrou, Eirini/0000-0001-7002-417X	US National Institutes of Health (NIH) [R00 DK087923, R01 HL121570]; Lawrence Ellison Foundation; Damon Runyon Cancer Research Foundation; Edward Evans Foundation; Taub Foundation for MDS research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK087923] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Ellison Foundation(Lawrence Ellison Foundation); Damon Runyon Cancer Research Foundation; Edward Evans Foundation; Taub Foundation for MDS research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	E.P.P. is supported by US National Institutes of Health (NIH) grants R00 DK087923 and R01 HL121570; by the Lawrence Ellison Foundation; by the Damon Runyon Cancer Research Foundation; by the Edward Evans Foundation; and by the Taub Foundation for MDS research.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Antony-Debre I, 2015, BLOOD, V125, P930, DOI 10.1182/blood-2014-06-585513; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Burridge PW, 2016, NAT MED, V22, P547, DOI 10.1038/nm.4087; Burrows CK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005793; Cao LS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7653; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Chen KG, 2014, CELL STEM CELL, V14, P13, DOI 10.1016/j.stem.2013.12.005; Chen YJ, 2015, CELL STEM CELL, V17, P233, DOI 10.1016/j.stem.2015.06.001; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Choi J, 2015, NAT BIOTECHNOL, V33, P1173, DOI 10.1038/nbt.3388; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Corominas-Faja B, 2013, CELL CYCLE, V12, P3109, DOI 10.4161/cc.26173; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Day CP, 2015, CELL, V163, P39, DOI 10.1016/j.cell.2015.08.068; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; Eggert US, 2013, NAT CHEM BIOL, V9, P206, DOI 10.1038/nchembio.1206; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Engle SJ, 2014, J BIOL CHEM, V289, P4562, DOI 10.1074/jbc.R113.529156; Engle SJ, 2013, CELL STEM CELL, V12, P669, DOI 10.1016/j.stem.2013.05.011; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Feraud O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149291; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Gandre-Babbe S, 2013, BLOOD, V121, P4925, DOI 10.1182/blood-2013-01-478412; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Garbes L, 2013, HUM MOL GENET, V22, P398, DOI 10.1093/hmg/dds437; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Giobbe GG, 2015, NAT METHODS, V12, P637, DOI [10.1038/nmeth.3411, 10.1038/NMETH.3411]; Gould SE, 2015, NAT MED, V21, P431, DOI 10.1038/nm.3853; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guo SQ, 2014, CELL, V156, P649, DOI 10.1016/j.cell.2014.01.020; Guye P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10243; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HENDERSON E, 1977, VIROLOGY, V76, P152, DOI 10.1016/0042-6822(77)90292-6; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hosoi M, 2014, EXP HEMATOL, V42, P816, DOI 10.1016/j.exphem.2014.03.010; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; Hu KJ, 2011, BLOOD, V117, pE109, DOI 10.1182/blood-2010-07-298331; Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ingber DE, 2016, CELL, V164, P1105, DOI 10.1016/j.cell.2016.02.049; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim J, 2015, EMBO J, V34, P739, DOI 10.15252/embj.201490736; Kim J, 2013, CELL REP, V3, P2088, DOI 10.1016/j.celrep.2013.05.036; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kotini AG, 2015, NAT BIOTECHNOL, V33, P646, DOI 10.1038/nbt.3178; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Krijger PHL, 2016, CELL STEM CELL, V18, P597, DOI 10.1016/j.stem.2016.01.007; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Kyttala A, 2016, STEM CELL REP, V6, P200, DOI 10.1016/j.stemcr.2015.12.009; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee DF, 2015, CELL, V161, P240, DOI 10.1016/j.cell.2015.02.045; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Majumder B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7169; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Maqsood MI, 2013, CELL BIOL INT, V37, P1038, DOI 10.1002/cbin.10137; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Morizane R, 2015, NAT BIOTECHNOL, V33, P1193, DOI 10.1038/nbt.3392; Muller LUW, 2012, BLOOD, V119, P5449, DOI 10.1182/blood-2012-02-408674; Mulero-Navarro S, 2015, CELL REP, V13, P504, DOI 10.1016/j.celrep.2015.09.019; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Ogawa M, 2015, NAT BIOTECHNOL, V33, P853, DOI 10.1038/nbt.3294; Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005; Papapetrou EP, 2016, SCIENCE, V353, P991, DOI 10.1126/science.aai7626; Papapetrou EP, 2011, NAT PROTOC, V6, P1251, DOI 10.1038/nprot.2011.374; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Passier R, 2016, CELL STEM CELL, V18, P309, DOI [10.1016/j.stem.2016.02.011, 10.1016/j.stem.2016.02.013]; Peterson SE, 2014, J BIOL CHEM, V289, P4578, DOI 10.1074/jbc.R113.516419; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Rowe RG, 2016, CELL STEM CELL, V18, P707, DOI 10.1016/j.stem.2016.05.016; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Soyombo AA, 2013, STEM CELL REP, V1, P336, DOI 10.1016/j.stemcr.2013.08.004; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Stricker SH, 2013, GENE DEV, V27, P654, DOI 10.1101/gad.212662.112; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tapia N, 2016, CELL STEM CELL, V19, P298, DOI 10.1016/j.stem.2016.06.017; Terrenoire C, 2013, J GEN PHYSIOL, V141, P61, DOI 10.1085/jgp.201210899; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vaira V, 2010, P NATL ACAD SCI USA, V107, P8352, DOI 10.1073/pnas.0907676107; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; van den Berg CW, 2015, DEVELOPMENT, V142, P3231, DOI 10.1242/dev.123810; Varela C, 2012, J CLIN INVEST, V122, P569, DOI 10.1172/JCI46268; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu J, 2016, CELL, V165, P1572, DOI 10.1016/j.cell.2016.05.043; Ye ZH, 2014, STEM CELLS, V32, P269, DOI 10.1002/stem.1545; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Zeltner N, 2015, CURR OPIN CELL BIOL, V37, P102, DOI 10.1016/j.ceb.2015.10.008; Zhang X, 2013, ONCOGENE, V32, P2249, DOI 10.1038/onc.2012.237	128	88	92	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1392	1401		10.1038/nm.4238	http://dx.doi.org/10.1038/nm.4238			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27923030	Green Accepted			2022-12-25	WOS:000389549000016
J	Rawat, N; Pumphrey, MO; Liu, SX; Zhang, XF; Tiwari, VK; Ando, K; Trick, HN; Bockus, WW; Akhunov, E; Anderson, JA; Gill, BS				Rawat, Nidhi; Pumphrey, Michael O.; Liu, Sixin; Zhang, Xiaofei; Tiwari, Vijay K.; Ando, Kaori; Trick, Harold N.; Bockus, William W.; Akhunov, Eduard; Anderson, James A.; Gill, Bikram S.			Wheat Fhb1 encodes a chimeric lectin with agglutinin domains and a pore-forming toxin-like domain conferring resistance to Fusarium head blight	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; MAJOR QTL; GENE; DEOXYNIVALENOL; GRAMINEARUM; CLONING; BARLEY	Fusarium head blight (FHB), caused by Fusarium graminearum, is a devastating disease of wheat and barley that leads to reduced yield and mycotoxin contamination of grain, making it unfit for human consumption. FHB is a global problem, with outbreaks in the United States, Canada, Europe, Asia and South America. In the United States alone, total direct and secondary economic losses from 1993 to 2001 owing to FHB were estimated at $7.67 billion(1). Fhb1 is the most consistently reported quantitative trait locus (QTL) for FHB resistance breeding. Here we report the map-based cloning of Fhb1 from a Chinese wheat cultivar Sumai 3. By mutation analysis, gene silencing and transgenic overexpression, we show that a pore-forming toxin-like (PFT) gene at Fhb1 confers FHB resistance. PFT is predicted to encode a chimeric lectin with two agglutinin domains and an ETX/MTX2 toxin domain. Our discovery identifies a new type of durable plant resistance gene conferring quantitative disease resistance to plants against Fusarium species.	[Rawat, Nidhi; Tiwari, Vijay K.; Gill, Bikram S.] Kansas State Univ, Dept Plant Pathol, Wheat Genet Resource Ctr, Throckmorton Hall, Manhattan, KS 66506 USA; [Pumphrey, Michael O.; Ando, Kaori] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Liu, Sixin] USDA ARS, Natl Ctr Cool & Cold Water Aquaculture, Kearneysville, WV USA; [Zhang, Xiaofei; Anderson, James A.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Trick, Harold N.; Bockus, William W.; Akhunov, Eduard] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Rawat, Nidhi; Tiwari, Vijay K.] Univ Maryland, Plant Sci & Landscape Architecture Dept, College Pk, MD 20742 USA	Kansas State University; Washington State University; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; Kansas State University; University System of Maryland; University of Maryland College Park	Gill, BS (corresponding author), Kansas State Univ, Dept Plant Pathol, Wheat Genet Resource Ctr, Throckmorton Hall, Manhattan, KS 66506 USA.	bsgill@ksu.edu	Anderson, James/AAI-2477-2021; Pumphrey, Michael/V-8830-2019; Rawat, Nidhi/AAN-5564-2021; Tiwari, Vijay/AAD-7197-2021	Anderson, James/0000-0003-4655-6517; Rawat, Nidhi/0000-0003-4820-0020; Trick, Harold/0000-0001-5255-5575; zhang, xiaofei/0000-0003-4516-9179; Pumphrey, Michael/0000-0001-7524-9634	US Wheat and Barley Scab Initiative (USDA-ARS) [59-0206-2-088]; US National Science Foundation [IIP-1338897]	US Wheat and Barley Scab Initiative (USDA-ARS)(United States Department of Agriculture (USDA)); US National Science Foundation(National Science Foundation (NSF))	This work was supported by US Wheat and Barley Scab Initiative (USDA-ARS grant 59-0206-2-088) and US National Science Foundation grant contract (IIP-1338897). We thank G. Bai for (USDA-ARS, Manhattan, Kansas) providing seeds of wheat cultivars and landraces for association studies and S. McCormick (USDA-ARS, Peoria, Illinois) for providing purified DON for inoculation experiments. We thank A. Akhunova, R. Matniyazov, S. Sehgal, S. Simsek, K. Benson, B. Friebe, D. Wilson, J.W. Raupp, N. Tyagi, U.M. Quraishi and L. Jiarui for technical support. We acknowledge help from student workers C. McDaniel, K. Madden and R. Clay-Pettis. This is contribution 16-147-J from the Kansas Agricultural Experiment Station.	Anderson J. A., 2011, P 2011 NAT FUS HEAD; Bai GH, 2003, FUSARIUM HEAD BLIGHT OF WHEAT & BARLEY, P296; Bartos J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-155; Bernardo AN, 2012, MOL BREEDING, V29, P477, DOI 10.1007/s11032-011-9565-y; Berthiller F, 2005, J AGR FOOD CHEM, V53, P3421, DOI 10.1021/jf047798g; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Hao CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046444; Jin F, 2013, CROP SCI, V53, P2006, DOI 10.2135/cropsci2012.09.0531; Lannoo N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00397; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Lin Fan-Yun, 2008, Yichuan, V30, P1608, DOI 10.3724/SP.J.1005.2008.01608; Liu SX, 2008, CEREAL RES COMMUN, V36, P195, DOI 10.1556/CRC.36.2008.Suppl.B.15; Liu Sixin, 2006, Functional & Integrative Genomics, V6, P83, DOI 10.1007/s10142-005-0007-y; Ma LL, 2010, MOL BIOL REP, V37, P785, DOI 10.1007/s11033-009-9606-3; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Mesterhazy A, 2002, EUR J PLANT PATHOL, V108, P675, DOI 10.1023/A:1020631114063; Nganje W. E., 2004, 538 N DAK STAT U; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Pumphrey M. O., 2007, THESIS; Puthoff DP, 2005, MOL PLANT PATHOL, V6, P411, DOI 10.1111/J.1364-3703.2005.00289.X; Schweiger W, 2013, MOL PLANT PATHOL, V14, P772, DOI 10.1111/mpp.12048; Stack RW, 1997, CEREAL RES COMMUN, V25, P667; Thanabalu T, 1996, GENE, V170, P85, DOI 10.1016/0378-1119(95)00836-5; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; VANEEUWIJK FA, 1995, THEOR APPL GENET, V90, P221, DOI 10.1007/BF00222205; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Yu JB, 2008, PHYTOPATHOLOGY, V98, P87, DOI 10.1094/PHYTO-98-1-0087	28	195	215	3	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1576	1580		10.1038/ng.3706	http://dx.doi.org/10.1038/ng.3706			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27776114				2022-12-25	WOS:000389011100020
J	Corradin, O; Cohen, AJ; Luppino, JM; Bayles, IM; Schumacher, FR; Scacheri, PC				Corradin, Olivia; Cohen, Andrea J.; Luppino, Jennifer M.; Bayles, Ian M.; Schumacher, Fredrick R.; Scacheri, Peter C.			Modeling disease risk through analysis of physical interactions between genetic variants within chromatin regulatory circuitry	NATURE GENETICS			English	Article							CELL IDENTITY; SUPER-ENHANCERS; EXPRESSION; TRANSCRIPTION; LOCUS; ELEMENTS; IDENTIFICATION; HERITABILITY; IMPUTATION; MODULATE	SNPs associated with disease susceptibility often reside in enhancer clusters, or super-enhancers. Constituents of these enhancer clusters cooperate to regulate target genes and often extend beyond the linkage disequilibrium (LD) blocks containing risk SNPs identified in genome-wide association studies (GWAS). We identified 'outside variants', defined as SNPs in weak LD with GWAS risk SNPs that physically interact with risk SNPs as part of a target gene's regulatory circuitry. These outside variants further explain variation in target gene expression beyond that explained by GWAS-associated SNPs. Additionally, the clinical risk associated with GWAS SNPs is considerably modified by the genotype of outside variants. Collectively, these findings suggest a potential model in which outside variants and GWAS SNPs that physically interact in 3D chromatin collude to influence target transcript levels as well as clinical risk. This model offers an additional hypothesis for the source of missing heritability for complex traits.	[Corradin, Olivia; Cohen, Andrea J.; Luppino, Jennifer M.; Bayles, Ian M.; Scacheri, Peter C.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Corradin, Olivia] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Schumacher, Fredrick R.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Scacheri, Peter C.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Case Western Reserve University; Case Western Reserve University	Scacheri, PC (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.; Scacheri, PC (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	peter.scacheri@case.edu	Schumacher, Fredrick/R-6043-2019	Schumacher, Fredrick/0000-0002-3073-7463; Corradin, Olivia/0000-0002-9484-0873; Luppino, Jennifer/0000-0002-2078-7619	NIH [R01CA160356, R01CA143237, 1R01CA193677, P50CA150964, T32GM008056]; NATIONAL CANCER INSTITUTE [R01CA143237, R01CA193677, R01CA160356, R01CA204279, P50CA150964] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000441, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056, T32GM007250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Tesar, T. LaFramboise, A. Lager and J. Morrow for helpful comments and discussion. This research was supported by NIH grants R01CA160356, R01CA143237, 1R01CA193677 and P50CA150964 (P.C.S.) and T32GM008056 (O.C.).	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Alcina A, 2013, J MED GENET, V50, P25, DOI 10.1136/jmedgenet-2012-101085; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Biancolella M, 2014, HUM MOL GENET, V23, P2198, DOI 10.1093/hmg/ddt584; Bothma JP, 2015, ELIFE, V4, DOI 10.7554/eLife.07956; Bryois J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004461; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fortini BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111914; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Glubb DM, 2015, AM J HUM GENET, V96, P5, DOI 10.1016/j.ajhg.2014.11.009; Guenther CA, 2014, NAT GENET, V46, P748, DOI 10.1038/ng.2991; Guo C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7069; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; He HL, 2015, P NATL ACAD SCI USA, V112, P6128, DOI 10.1073/pnas.1506255112; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ing-Simmons E, 2015, GENOME RES, V25, P504, DOI 10.1101/gr.184986.114; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Lam DD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004935; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Puig-Kroger A, 2006, J CELL BIOCHEM, V98, P744, DOI 10.1002/jcb.20813; Roman TS, 2015, AM J HUM GENET, V97, P801, DOI 10.1016/j.ajhg.2015.10.016; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shaw AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092556; Spieler D, 2014, GENOME RES, V24, P592, DOI 10.1101/gr.166751.113; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wiersma EJ, 1999, J BIOL CHEM, V274, P4858, DOI 10.1074/jbc.274.8.4858; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Zaitlen N, 2010, GENET EPIDEMIOL, V34, P537, DOI 10.1002/gepi.20507	61	36	36	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1313	1320		10.1038/ng.3674	http://dx.doi.org/10.1038/ng.3674			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27643537	Green Accepted			2022-12-25	WOS:000386543400006
J	Halldorsson, BV; Hardarson, MT; Kehr, B; Styrkarsdottir, U; Gylfason, A; Thorleifsson, G; Zink, F; Jonasdottir, A; Jonasdottir, A; Sulem, P; Masson, G; Thorsteinsdottir, U; Helgason, A; Kong, A; Gudbjartsson, DF; Stefansson, K				Halldorsson, Bjarni V.; Hardarson, Marteinn T.; Kehr, Birte; Styrkarsdottir, Unnur; Gylfason, Arnaldur; Thorleifsson, Gudrnar; Zink, Florian; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Sulem, Patrick; Masson, Gisli; Thorsteinsdottir, Unnur; Helgason, Agnar; Kong, Augustine; Gudbjartsson, Daniel F.; Stefansson, Kari			The rate of meiotic gene conversion varies by sex and age	NATURE GENETICS			English	Article							RECOMBINATION HOT-SPOTS; CROSSOVER; NONCROSSOVER; POPULATIONS; MECHANISMS; ANEUPLOIDY; EVOLUTION; INSIGHTS; MUTATION; MAP	Meiotic recombination involves a combination of gene conversion and crossover events that, along with mutations, produce germline genetic diversity. Here we report the discovery of 3,176 SNP and 61 indel gene conversions. Our estimate of the non crossover (NCO) gene conversion rate (G) is 7.0 for SNPs and 5.8 for indels per megabase per generation, and the GC bias is 67.6%. For indels, we demonstrate a 65.6% preference for the shorter allele. NCO gene conversions from mothers are longer than those from fathers, and G is 2.17 times greater in mothers. Notably, G increases with the age of mothers, but not the age of fathers. A disproportionate number of NCO gene conversions in older mothers occur outside double-strand break (DSB) regions and in regions with relatively low GC content. This points to age-related changes in the mechanisms of meiotic gene conversion in oocytes.	[Halldorsson, Bjarni V.; Hardarson, Marteinn T.; Kehr, Birte; Styrkarsdottir, Unnur; Gylfason, Arnaldur; Thorleifsson, Gudrnar; Zink, Florian; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Sulem, Patrick; Masson, Gisli; Thorsteinsdottir, Unnur; Helgason, Agnar; Kong, Augustine; Gudbjartsson, Daniel F.; Stefansson, Kari] IdeCODE Genet Amgen Inc, Reykjavik, Iceland; [Halldorsson, Bjarni V.] Reykjavik Univ, Sch Sci & Engn, Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland; [Helgason, Agnar] Univ Iceland, Dept Anthropol, Reykjavik, Iceland; [Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland	Reykjavik University; University of Iceland; University of Iceland; University of Iceland	Halldorsson, BV; Stefansson, K (corresponding author), IdeCODE Genet Amgen Inc, Reykjavik, Iceland.; Halldorsson, BV (corresponding author), Reykjavik Univ, Sch Sci & Engn, Reykjavik, Iceland.; Stefansson, K (corresponding author), Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland.	bjarnih@decode.is; kstefans@decode.is	Helgason, Agnar/K-1522-2015; Kehr, Birte/AAU-4853-2020; Stefansson, Kari/AAE-7187-2019	Kehr, Birte/0000-0002-3417-7504; Masson, Gisli/0000-0003-0493-8242; Halldorsson, Bjarni/0000-0003-0756-0767; Helgason, Agnar/0000-0002-8545-3767; Kong, Augustine/0000-0001-8193-5438; Styrkarsdottir, Unnur/0000-0001-8146-8278	NIH (NIDA) [R01-DA017932]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017932] Funding Source: NIH RePORTER	NIH (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the NIH (NIDA) (R01-DA017932).	Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Assis R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002508; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Campbell CL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7260; Cole F, 2014, NAT GENET, V46, P1072, DOI 10.1038/ng.3068; de Boer E, 2015, GENE DEV, V29, P1721, DOI 10.1101/gad.265561.115; de Villena FPM, 2001, MAMM GENOME, V12, P318, DOI 10.1007/s003350020005; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galtier N, 2001, GENETICS, V159, P907; Glemin S, 2015, GENOME RES, V25, P1215, DOI 10.1101/gr.185488.114; Goldmann JM, 2016, NAT GENET, V48, P935, DOI 10.1038/ng.3597; Gudbjartsson DF, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.11; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Haber J., 2013, GENOME STABILITY; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hodges CA, 2005, NAT GENET, V37, P1351, DOI 10.1038/ng1672; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kong A, 2014, NAT GENET, V46, P11, DOI 10.1038/ng.2833; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lachance J, 2014, AM J HUM GENET, V95, P408, DOI 10.1016/j.ajhg.2014.09.008; Lam I, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016634; Leland S, 2009, P NATL ACAD SCI USA, V106, P12776, DOI 10.1073/pnas.0903075106; Leushkin EV, 2013, EVOLUTION, V67, P2604, DOI 10.1111/evo.12129; Martin HC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8846; Martini E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002305; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Narasimhan V. M., 2016, DIRECT MULTIGENERATI; Odenthal-Hesse L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004106; Padhukasahasram B., 2013, EUR J HUM GENET; Palamara PF, 2015, AM J HUM GENET, V97, P775, DOI 10.1016/j.ajhg.2015.10.006; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; Subramanian VV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000263; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tsaponina O, 2014, MOL CELL, V55, P615, DOI 10.1016/j.molcel.2014.06.025; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; Weng KA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004607; Williams AL, 2015, ELIFE, V4, DOI 10.7554/eLife.04637; Wong WSW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10486	49	46	46	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1377	1384		10.1038/ng.3669	http://dx.doi.org/10.1038/ng.3669			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27643539	Green Accepted			2022-12-25	WOS:000386543400014
J	Yun, S; Reynolds, RP; Masiulis, I; Eisch, AJ				Yun, Sanghee; Reynolds, Ryan P.; Masiulis, Irene; Eisch, Amelia J.			Re-evaluating the link between neuropsychiatric disorders and dysregulated adult neurogenesis	NATURE MEDICINE			English	Article							DEEP-BRAIN-STIMULATION; DENTATE GRANULE CELLS; NEURAL PROGENITOR CELLS; HIPPOCAMPAL NEUROGENESIS; PATTERN SEPARATION; ENVIRONMENTAL ENRICHMENT; VENTRAL HIPPOCAMPUS; DRUG-ADDICTION; ANIMAL-MODEL; MICE IMPAIRS	People diagnosed with neuropsychiatric disorders such as depression, anxiety, addiction or schizophrenia often have dysregulated memory, mood, pattern separation and/or reward processing. These symptoms are indicative of a disrupted function of the dentate gyrus (DG) subregion of the brain, and they improve with treatment and remission. The dysfunction of the DG is accompanied by structural maladaptations, including dysregulation of adult-generated neurons. An increasing number of studies using modern inducible approaches to manipulate new neurons show that the behavioral symptoms in animal models of neuropsychiatric disorders can be produced or exacerbated by the inhibition of DG neurogenesis. Thus, here we posit that the connection between neuropsychiatric disorders and dysregulated DG neurogenesis is beyond correlation or epiphenomenon, and that the regulation of adult generated DG neurogenesis merits continued and focused attention in the ongoing effort to develop novel treatments for neuropsychiatric disorders.	[Yun, Sanghee; Reynolds, Ryan P.; Eisch, Amelia J.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Masiulis, Irene; Eisch, Amelia J.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Eisch, Amelia J.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Eisch, Amelia J.] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Eisch, AJ (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA.; Eisch, AJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.; Eisch, AJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.; Eisch, AJ (corresponding author), Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.	eischa@email.chop.edu	Yun, Sanghee/AAL-7543-2020	Yun, Sanghee/0000-0001-7505-0836; Reynolds, Ryan/0000-0002-3781-0766; Eisch, Amelia/0000-0001-6476-5385	US National Institutes of Health [DA023701, DA023555, MH107945]; US National Aeronautics and Space Administration [NNX15AE09G];  [NIMH T32-MH076690]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107945, T32MH076690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290, K02DA023555, R21DA023701] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants to A.J.E. from the US National Institutes of Health (DA023701, DA023555, MH107945) and the US National Aeronautics and Space Administration (NNX15AE09G). S.Y. was funded by a postdoctoral institutional training grant (NIMH T32-MH076690, Basic Science Training Program in the Neurobiology of Mental Illness, PI, C. Tamminga).	Ahmed AIA, 2013, J CLIN PSYCHOPHARM, V33, P55, DOI 10.1097/JCP.0b013e31827c0117; Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Alia-Klein N, 2011, ARCH GEN PSYCHIAT, V68, P283, DOI 10.1001/archgenpsychiatry.2011.10; Allen KM, 2016, AUST NZ J PSYCHIAT, V50, P473, DOI 10.1177/0004867415589793; Altman J., 1975, HIPPOCAMPUS STRUCTUR, P95, DOI [10.1007/978-1-4684-2976-3_5, DOI 10.1007/978-1-4684-2976-3_5]; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Amrein I, 2004, EUR J NEUROSCI, V20, P3342, DOI 10.1111/j.1460-9568.2004.03795.x; Arruda-Carvalho M, 2011, J NEUROSCI, V31, P15113, DOI 10.1523/JNEUROSCI.3432-11.2011; Bagot RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8062; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Bayer R, 2015, DRUG ALCOHOL DEPEN, V156, P139, DOI 10.1016/j.drugalcdep.2015.09.005; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; Bedard A, 2011, NEUROGENESIS IN THE ADULT BRAIN II: CLINICAL IMPLICATIONS, P1, DOI 10.1007/978-4-431-53945-2_1; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Bergmann O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018994; Boldrini M, 2013, NEUROPSYCHOPHARMACOL, V38, P1068, DOI 10.1038/npp.2013.5; Boldrini M, 2012, BIOL PSYCHIAT, V72, P562, DOI 10.1016/j.biopsych.2012.04.024; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bremner JD, 2007, NEUROIMAG CLIN N AM, V17, P523, DOI 10.1016/j.nic.2007.07.003; Brown ES, 1999, NEUROPSYCHOPHARMACOL, V21, P474, DOI 10.1016/S0893-133X(99)00054-8; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Bystritsky A, 2006, MOL PSYCHIATR, V11, P805, DOI 10.1038/sj.mp.4001852; Cameron H.A., 2007, HDB CONT NEUROPHARMA; Canales JJ, 2010, BEHAV PHARMACOL, V21, P379, DOI 10.1097/FBP.0b013e32833e16b6; Castilla-Ortega E, 2016, NEUROSCI BIOBEHAV R, V66, P15, DOI 10.1016/j.neubiorev.2016.03.030; Chauvet C, 2009, NEUROPSYCHOPHARMACOL, V34, P2767, DOI 10.1038/npp.2009.127; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Culpepper L, 2004, J CLIN PSYCHIAT, V65, P742; Danielson NB, 2016, NEURON, V90, P101, DOI 10.1016/j.neuron.2016.02.019; Das T, 2014, SCHIZOPHR RES, V159, P193, DOI 10.1016/j.schres.2014.05.006; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Dichter GS, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-19; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Drew MR, 2010, BEHAV NEUROSCI, V124, P446, DOI 10.1037/a0020081; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Elvsashagen T, 2013, BIPOLAR DISORD, V15, P167, DOI 10.1111/bdi.12046; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fattore L, 2016, NEUROSCI BIOBEHAV R, V65, P341, DOI 10.1016/j.neubiorev.2016.04.006; Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Geuze E, 2005, MOL PSYCHIATR, V10, P160, DOI 10.1038/sj.mp.4001579; Gilpin N.W., 2015, BRAIN REWARD STRESS; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Hagihara H, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/318596; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Hayes JP, 2011, J PSYCHIATR RES, V45, P660, DOI 10.1016/j.jpsychires.2010.10.007; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; Henn FA, 2004, BIOL PSYCHIAT, V56, P146, DOI 10.1016/j.biopsych.2004.04.011; Hill AS, 2015, NEUROPSYCHOPHARMACOL, V40, P2368, DOI 10.1038/npp.2015.85; Ikrar T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00204; Johnston ST, 2016, NEUROBIOL LEARN MEM, V129, P60, DOI 10.1016/j.nlm.2015.10.013; Jonas P, 2015, STRUCTURE FUNCTION P; Kang EC, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019026; Keilhoff G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/832757; Kempermann G., 2006, ADULT NEUROGENSIS ST; Kempermann G, 2011, NEUROGENESIS IN THE ADULT BRAIN I: NEUROBIOLOGY, P271, DOI 10.1007/978-4-431-53933-9_11; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Koob GF, 2005, NEUROBIOLOGY ADDICTI; Kropff E, 2015, CURR OPIN NEUROBIOL, V35, P21, DOI 10.1016/j.conb.2015.06.002; Lacar Benjamin, 2014, F1000Prime Rep, V6, P8, DOI 10.12703/P6-8; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lehmann ML, 2013, J NEUROSCI, V33, P2961, DOI 10.1523/JNEUROSCI.3878-12.2013; Lemaire V, 2012, J NEUROSCI, V32, P3101, DOI 10.1523/JNEUROSCI.4731-11.2012; Lepousez G, 2015, NEURON, V86, P387, DOI 10.1016/j.neuron.2015.01.002; Lerner TN, 2016, CELL, V164, P1136, DOI 10.1016/j.cell.2016.02.027; Levone BR, 2015, NEUROBIOL STRESS, V1, P147, DOI 10.1016/j.ynstr.2014.11.003; Liberzon I., 2016, NEUROBIOLOGY PTSD BR; Liu KY, 2016, HIPPOCAMPUS, V26, P705, DOI 10.1002/hipo.22561; Lopez-Rojas J, 2016, NEUROSCI BIOBEHAV R, V64, P167, DOI 10.1016/j.neubiorev.2016.02.021; Lucassen PJ, 2013, MOL PSYCHIATR, V18, P396, DOI 10.1038/mp.2012.39; Lucassen PJ, 2010, NEUROPHARMACOLOGY, V58, P940, DOI 10.1016/j.neuropharm.2010.01.012; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Mackey S, 2013, NEUROSCI BIOBEHAV R, V37, P300, DOI 10.1016/j.neubiorev.2012.12.003; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mandyam CD, 2012, TRENDS NEUROSCI, V35, P250, DOI 10.1016/j.tins.2011.12.005; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Manji Husseini K, 2003, World Psychiatry, V2, P136; Marvel CL, 2004, PSYCHIAT CLIN N AM, V27, P19, DOI 10.1016/S0193-953X(03)00106-0; McAvoy KM, 2016, NEURON, V91, P1356, DOI 10.1016/j.neuron.2016.08.009; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mongiat LA, 2011, EUR J NEUROSCI, V33, P1055, DOI 10.1111/j.1460-9568.2011.07603.x; Moore GJ, 2000, LANCET, V356, P1241, DOI 10.1016/S0140-6736(00)02793-8; Morishita T, 2014, NEUROTHERAPEUTICS, V11, P475, DOI 10.1007/s13311-014-0282-1; Mouchlianitis E, 2016, LANCET PSYCHIAT, V3, P451, DOI 10.1016/S2215-0366(15)00540-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mustroph ML, 2011, EUR J NEUROSCI, V34, P1161, DOI 10.1111/j.1460-9568.2011.07828.x; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Narayan VA, 2016, NAT REV DRUG DISCOV, V15, P71, DOI 10.1038/nrd.2015.20; Niibori Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2261; Noonan MA, 2008, J NEUROSCI, V28, P2516, DOI 10.1523/JNEUROSCI.4661-07.2008; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; O'Leary OF, 2014, TRENDS PHARMACOL SCI, V35, P675, DOI 10.1016/j.tips.2014.09.011; Otten M, 2015, J AFFECT DISORDERS, V174, P113, DOI 10.1016/j.jad.2014.11.001; Peng ZW, 2013, BEHAV BRAIN RES, V244, P1, DOI 10.1016/j.bbr.2013.01.032; Petrik D, 2012, FASEB J, V26, P3148, DOI 10.1096/fj.11-201426; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Platel JC, 2013, CELL MOL LIFE SCI, V70, P3591, DOI 10.1007/s00018-013-1262-z; Player MJ, 2013, NEUROPSYCHOPHARMACOL, V38, P2101, DOI 10.1038/npp.2013.126; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Scharfman H. E., 2011, DENTATE GYRUS COMPRE; Schoenfeld TJ, 2015, NEUROPSYCHOPHARMACOL, V40, P113, DOI 10.1038/npp.2014.230; Seo DO, 2015, J NEUROSCI, V35, P11330, DOI 10.1523/JNEUROSCI.0483-15.2015; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Solinas M, 2010, PROG NEUROBIOL, V92, P572, DOI 10.1016/j.pneurobio.2010.08.002; Song J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018937; Song J, 2013, NAT NEUROSCI, V16, P1728, DOI 10.1038/nn.3572; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Suthana N, 2014, NEUROIMAGE, V85, P996, DOI 10.1016/j.neuroimage.2013.07.066; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Sweeney P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10188; Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38; Tannenholz L, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00147; Temprana SG, 2015, NEURON, V85, P116, DOI 10.1016/j.neuron.2014.11.023; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; Toni N, 2011, EUR J NEUROSCI, V33, P1062, DOI 10.1111/j.1460-9568.2011.07604.x; Tsai CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9373; Vaidya V. A., 2007, CNS & Neurological Disorders-Drug Targets, V6, P358, DOI 10.2174/187152707783220910; van Dijk RM, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00022; Vivar Carmen, 2013, Curr Top Behav Neurosci, V15, P189, DOI 10.1007/7854_2012_220; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; Wadiche JI, 2015, NEURON, V85, P3, DOI 10.1016/j.neuron.2014.12.047; Walker AK, 2015, MOL PSYCHIATR, V20, P500, DOI 10.1038/mp.2014.34; Walton NM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.56; WEST MJ, 1988, BRAIN RES, V448, P167, DOI 10.1016/0006-8993(88)91114-6; Wosiski-Kuhn M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00096; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yang SM, 2015, J NEUROSCI, V35, P15379, DOI 10.1523/JNEUROSCI.2345-15.2015; Yu EP, 2013, J NEUROSCI, V33, P2947, DOI 10.1523/JNEUROSCI.1868-12.2013; Zhai TY, 2014, BEHAV BRAIN RES, V272, P209, DOI 10.1016/j.bbr.2014.06.054	148	80	81	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1239	1247		10.1038/nm.4218	http://dx.doi.org/10.1038/nm.4218			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27783068	Green Accepted			2022-12-25	WOS:000387302300015
J	Bailey, SD; Desai, K; Kron, KJ; Mazrooei, P; Sinnott-Armstrong, NA; Treloar, AE; Dowar, M; Thu, KL; Cescon, DW; Silvester, J; Yang, SYC; Wu, X; Pezo, RC; Haibe-Kains, B; Mak, TW; Bedard, PL; Pugh, TJ; Sallari, RC; Lupien, M				Bailey, Swneke D.; Desai, Kinjal; Kron, Ken J.; Mazrooei, Parisa; Sinnott-Armstrong, Nicholas A.; Treloar, Aislinn E.; Dowar, Mark; Thu, Kelsie L.; Cescon, David W.; Silvester, Jennifer; Yang, S. Y. Cindy; Wu, Xue; Pezo, Rossanna C.; Haibe-Kains, Benjamin; Mak, Tak W.; Bedard, Philippe L.; Pugh, Trevor J.; Sallari, Richard C.; Lupien, Mathieu			Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; TERT PROMOTER; CHROMATIN; MUTATIONS; LANDSCAPE; TRANSCRIPTION; REVEAL	Sustained expression of the estrogen receptor-alpha (ESR1) drives two-thirds of breast cancer and defines the ESR1-positive subtype. ESR1 engages enhancers upon estrogen stimulation to establish an oncogenic expression program(1). Somatic copy number alterations involving the ESR1 gene occur in approximately 1% of ESR1-positive breast cancers(2-5), suggesting that other mechanisms underlie the persistent expression of ESR1. We report significant enrichment of somatic mutations within the set of regulatory elements (SRE) regulating ESR1 in 7% of ESR1-positive breast cancers. These mutations regulate ESRI expression by modulating transcription factor binding to the DNA. The SRE includes a recurrently mutated enhancer whose activity is also affected by rs9383590, a functional inherited single-nucleotide variant (SNV) that accounts for several breast cancer risk associated loci. Our work highlights the importance of considering the combinatorial activity of regulatory elements as a single unit to delineate the impact of noncoding genetic alterations on single genes in cancer.	[Bailey, Swneke D.; Kron, Ken J.; Mazrooei, Parisa; Treloar, Aislinn E.; Dowar, Mark; Cescon, David W.; Yang, S. Y. Cindy; Wu, Xue; Pezo, Rossanna C.; Haibe-Kains, Benjamin; Bedard, Philippe L.; Pugh, Trevor J.; Lupien, Mathieu] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Bailey, Swneke D.; Kron, Ken J.; Mazrooei, Parisa; Treloar, Aislinn E.; Yang, S. Y. Cindy; Haibe-Kains, Benjamin; Mak, Tak W.; Pugh, Trevor J.; Lupien, Mathieu] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Desai, Kinjal] Norris Cotton Canc Ctr, Dartmouth Med Sch, Dept Genet, Lebanon, NH USA; [Sinnott-Armstrong, Nicholas A.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Thu, Kelsie L.; Cescon, David W.; Silvester, Jennifer; Mak, Tak W.] Univ Hlth Network, Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Haibe-Kains, Benjamin] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Bedard, Philippe L.] Univ Toronto, Dept Med, Div Med Oncol, Toronto, ON, Canada; [Sallari, Richard C.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lupien, Mathieu] Ontario Inst Canc Res, Toronto, ON, Canada; [Wu, Xue] Geneseeq Technol Inc, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Dartmouth College; Norris Cotton Cancer Center; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; Massachusetts Institute of Technology (MIT); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Geneseeq Technology Inc.	Lupien, M (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Lupien, M (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Lupien, M (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.	mlupien@uhnres.utoronto.ca	Pugh, Trevor/Y-2535-2019; Haibe-Kains, Benjamin/D-3702-2011	Pugh, Trevor/0000-0002-8073-5888; Haibe-Kains, Benjamin/0000-0002-7684-0079; Thu, Kelsie/0000-0001-9262-7238; Bedard, Philippe/0000-0002-6771-2999; Silvester, Jennifer/0000-0001-6087-4066; Lupien, Mathieu/0000-0003-0929-9478	National Cancer Institute (NCI) at the National Institute of Health (NIH) [R01CA155004]; Princess Margaret Cancer Foundation; Canadian Cancer Society [CCSRI702922]; Susan G. Komen Foundation [CCR15332792]; Gattuso-Slaight Personalized Cancer Medicine Fund/PMCF; Ontario Institute for Cancer Research (OICR); Canadian Institute of Health Research (CIHR); Prostate Cancer Canada (PCC) [RS2014-04]; Canadian Breast Cancer Foundation (CBCF); Knudson; CIHR; NATIONAL CANCER INSTITUTE [R01CA155004] Funding Source: NIH RePORTER	National Cancer Institute (NCI) at the National Institute of Health (NIH); Princess Margaret Cancer Foundation(University of Toronto); Canadian Cancer Society(Canadian Cancer Society (CCS)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Gattuso-Slaight Personalized Cancer Medicine Fund/PMCF; Ontario Institute for Cancer Research (OICR); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Prostate Cancer Canada (PCC); Canadian Breast Cancer Foundation (CBCF); Knudson; CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Razak, C. Elser, D. Cescon, D. Warr, E. Amir, L. Siu, N. Leighl and S. Sridhar for their involvement in recruiting the IMPACT and COMPACT samples used in this study. We also thank M. Lemaire for helpful discussions. We thank R. Rottapel and O. Kent for use of and help with the Glomax Multi-Detection system. We acknowledge the ENCODE consortium and the ENCODE production laboratories that generated the data sets provided by the ENCODE Data Coordination Center used in the manuscript. We also acknowledge the Cancer Genome Project, for making all the breast cancer and liver cancer called mutations publicly available, and the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), for making the genotyping and expression data from primary breast tumors data available. We acknowledge the Princess Margaret Genomics Centre and the Bioinformatics group for providing the infrastructure assisting us with the targeted sequencing and analysis of the ESR1 SRE. Supported by the National Cancer Institute (NCI) at the National Institute of Health (NIH) (R01CA155004 to M.L.), the Princess Margaret Cancer Foundation (T.J.P. and M.L.), The Canadian Cancer Society (CCSRI702922 to M.L.), the Susan G. Komen Foundation (CCR15332792 to T.J.P.) and the Gattuso-Slaight Personalized Cancer Medicine Fund/PMCF (B.H.-K.). M.L. is funded by a young investigator award from the Ontario Institute for Cancer Research (OICR), a new investigator salary award from the Canadian Institute of Health Research (CIHR) and a Movember Rising Star award from Prostate Cancer Canada (PCC) (RS2014-04). K.J.K. and R.C.P. are supported by Canadian Breast Cancer Foundation (CBCF) postdoctoral fellowships. S.D.B. is supported by a Knudson and CIHR postdoctoral fellowship.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bailey SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7186; Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Brown LA, 2008, NAT GENET, V40, P806, DOI 10.1038/ng0708-806; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dunbier AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001382; Dunning AM, 2016, NAT GENET, V48, P374, DOI 10.1038/ng.3521; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Frietze S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r52; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Horlings HM, 2008, NAT GENET, V40, P807, DOI 10.1038/ng0708-807; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Polak P, 2014, NAT BIOTECHNOL, V32, P71, DOI 10.1038/nbt.2778; Reis-Filho JS, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809b; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Taberlay PC, 2014, GENOME RES, V24, P1421, DOI 10.1101/gr.163485.113; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Vincent-Salomon A, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809a; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Yamamoto-Ibusuki M, 2015, EUR J HUM GENET, V23, P949, DOI 10.1038/ejhg.2014.219; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	36	53	53	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1260	1266		10.1038/ng.3650	http://dx.doi.org/10.1038/ng.3650			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27571262	Green Accepted			2022-12-25	WOS:000384391600022
J	Briggs, DC; Yoshida-Moriguchi, T; Zheng, TQ; Venzke, D; Anderson, ME; Strazzulli, A; Moracci, M; Yu, LP; Hohenester, E; Campbell, KP				Briggs, David C.; Yoshida-Moriguchi, Takako; Zheng, Tianqing; Venzke, David; Anderson, Mary E.; Strazzulli, Andrea; Moracci, Marco; Yu, Liping; Hohenester, Erhard; Campbell, Kevin P.			Structural basis of laminin binding to the LARGE glycans on dystroglycan	NATURE CHEMICAL BIOLOGY			English	Article							ALPHA-DYSTROGLYCAN; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; REVEALS; DOMAIN; IDENTIFICATION; GLYCOSYLATION; DYSTROPHIN; HEPARIN; LIGAND	Dystroglycan is a highly glycosylated extracellular matrix receptor with essential functions in skeletal muscle and the nervous system. Reduced matrix binding by alpha-dystroglycan (alpha-DG) due to perturbed glycosylation is a pathological feature of several forms of muscular dystrophy. Like-acetylglucosaminyltransferase (LARGE) synthesizes the matrix-binding heteropolysaccharide [-glucuronic acid-beta 1,3-xylose-alpha 1,3-](n). Using a dual exoglycosidase digestion, we confirm that this polysaccharide is present on native alpha-DG from skeletal muscle. The atomic details of matrix binding were revealed by a high-resolution crystal structure of laminin-G-like (LG) domains 4 and 5 (LG4 and LG5) of laminin-alpha 2 bound to a LARGE-synthesized oligosaccharide. A single glucuronic acid-beta 1,3-xylose disaccharide repeat straddles a Ca2+ ion in the LG4 domain, with oxygen atoms from both sugars replacing Ca2+-bound water molecules. The chelating binding mode accounts for the high affinity of this protein-carbohydrate interaction. These results reveal a previously uncharacterized mechanism of carbohydrate recognition and provide a structural framework for elucidating the mechanisms underlying muscular dystrophy.	[Briggs, David C.; Hohenester, Erhard] Imperial Coll London, Dept Life Sci, London, England; [Yoshida-Moriguchi, Takako; Zheng, Tianqing; Venzke, David; Anderson, Mary E.; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Zheng, Tianqing; Venzke, David; Anderson, Mary E.; Campbell, Kevin P.] Univ Iowa, Dept Physiol & Mol Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Zheng, Tianqing; Venzke, David; Anderson, Mary E.; Campbell, Kevin P.] Univ Iowa, Dept Neurol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Zheng, Tianqing; Venzke, David; Anderson, Mary E.; Campbell, Kevin P.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Strazzulli, Andrea; Moracci, Marco] Natl Res Council Italy, Inst Biosci & Bioresources, Naples, Italy; [Yu, Liping] Univ Iowa, Med Nucl Magnet Resonance Facil, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA	Imperial College London; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Iowa	Hohenester, E (corresponding author), Imperial Coll London, Dept Life Sci, London, England.; Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.; Campbell, KP (corresponding author), Univ Iowa, Dept Physiol & Mol Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.; Campbell, KP (corresponding author), Univ Iowa, Dept Neurol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.; Campbell, KP (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	e.hohenester@imperial.ac.uk; kevin-campbell@uiowa.edu	Strazzulli, Andrea/E-1343-2017; Zheng, Tianqing/C-6679-2017; Moracci, Marco/B-8444-2015; Strazzulli, Andrea/P-5145-2016	Campbell, Kevin/0000-0003-2066-5889; Moracci, Marco/0000-0002-9846-2531; Briggs, David/0000-0002-9793-7339; Yu, Liping/0000-0003-3536-6427; Venzke, David/0000-0001-8180-9562; Strazzulli, Andrea/0000-0002-9690-149X	Wellcome Trust Senior Investigator Award [101748/Z/13/Z]; Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant [1U54NS053672]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER	Wellcome Trust Senior Investigator Award(Wellcome Trust); Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S.G. Withers (University of British Columbia) for a gift of T. maritima beta-glucuronidase and C.M. Blaumueller for critical reading of the manuscript. The IIH6 antibody was obtained from the Developmental Studies Hybridoma Bank, University of Iowa. We acknowledge Diamond Light Source for time on beamlines I02 and I04-1 under proposal MX9424. This work was funded by a Wellcome Trust Senior Investigator Award to E.H. (101748/Z/13/Z) and a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant to K.P.C. (1U54NS053672).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Beedle AM, 2007, J BIOL CHEM, V282, P16713, DOI 10.1074/jbc.C700061200; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELUCAS L, 1975, CARBOHYD RES, V41, P19, DOI 10.1016/S0008-6215(00)87003-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; Goddeeris MM, 2013, NATURE, V503, P136, DOI 10.1038/nature12605; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Le BV, 2011, J MOL BIOL, V414, P231, DOI 10.1016/j.jmb.2011.09.048; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Moracci M, 2000, J BIOL CHEM, V275, P22082, DOI 10.1074/jbc.M910392199; Nagae M, 2014, INT J MOL SCI, V15, P3768, DOI 10.3390/ijms15033768; Nyberg NT, 2005, MAGN RESON CHEM, V43, P971, DOI 10.1002/mrc.1698; Paracuellos P, 2015, STRUCTURE, V23, P2133, DOI 10.1016/j.str.2015.09.004; Reissner C, 2014, J BIOL CHEM, V289, P27585, DOI 10.1074/jbc.M114.595413; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Salleh HM, 2006, CARBOHYD RES, V341, P49, DOI 10.1016/j.carres.2005.10.005; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; Sheckler LR, 2006, J BIOL CHEM, V281, P22896, DOI 10.1074/jbc.M603464200; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Stetefeld J, 2004, STRUCTURE, V12, P503, DOI 10.1016/j.str.2004.02.001; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; Wright KM, 2012, NEURON, V76, P931, DOI 10.1016/j.neuron.2012.10.009; Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	60	63	70	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					810	+		10.1038/NCHEMBIO.2146	http://dx.doi.org/10.1038/NCHEMBIO.2146			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27526028	Green Accepted, Green Submitted			2022-12-25	WOS:000384248600012
J	Clarke, VE; Harmanci, AS; Bai, HW; Youngblood, MW; Lee, TI; Baranoski, JF; Ercan-Sencicek, AG; Abraham, BJ; Weintraub, AS; Hnisz, D; Simon, M; Krischek, B; Erson-Omay, EZ; Henegariu, O; Carrion-Grant, G; Mishra-Gorur, K; Duran, D; Goldmann, JE; Schramm, J; Goldbrunner, R; Piepmeier, JM; Vortmeyer, AO; Gunel, JM; Bilguvar, K; Yasuno, K; Young, RA; Gunel, M				Clarke, Victoria E.; Harmanci, Akdes Serin; Bai, Hanwen; Youngblood, Mark W.; Lee, Tong Ihn; Baranoski, Jacob F.; Ercan-Sencicek, A. Gulhan; Abraham, Brian J.; Weintraub, Abraham S.; Hnisz, Denes; Simon, Matthias; Krischek, Boris; Erson-Omay, E. Zeynep; Henegariu, Octavian; Carrion-Grant, Geneive; Mishra-Gorur, Ketu; Duran, Daniel; Goldmann, Johanna E.; Schramm, Johannes; Goldbrunner, Roland; Piepmeier, Joseph M.; Vortmeyer, Alexander O.; Gunel, Jennifer Molitemo; Bilguvar, Kaya; Yasuno, Katsuhito; Young, Richard A.; Gunel, Murat			Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; SUPER-ENHANCERS; CELL IDENTITY; AKT1; TRAF7; KLF4; SMO	RNA polymerase II mediates the transcription of all protein-coding genes in eukaryotic cells, a process that is fundamental to life. Genomic mutations altering this enzyme have not previously been linked to any pathology in humans, which is a testament to its indispensable role in cell biology. On the basis of a combination of next-generation genomic analyses of 775 meningiomas, we report that recurrent somatic p.Gln403Lys or p.Leu438_His439del mutations in POLR2A, which encodes the catalytic subunit of RNA polymerase II (ref. 1), hijack this essential enzyme and drive neoplasia. POLR2A mutant tumors show dysregulation of key meningeal identity genes(2,3), including WNT6 and ZIC1/ZIC4. In addition to mutations in POLR2A, NF2, SMARCB1,TRAF7, KLF4, AKT1, PIK3CA, and SMO4-8, we also report somatic mutations in AKT3, PIK3R1, PRKAR1A, and SUFU in meningiomas. Our results identify a role for essential transcriptional machinery in driving tumorigenesis and define mutually exclusive meningioma subgroups with distinct clinical and pathological features.	[Clarke, Victoria E.; Harmanci, Akdes Serin; Bai, Hanwen; Youngblood, Mark W.; Baranoski, Jacob F.; Erson-Omay, E. Zeynep; Henegariu, Octavian; Carrion-Grant, Geneive; Mishra-Gorur, Ketu; Duran, Daniel; Bilguvar, Kaya; Gunel, Murat] Yale Sch Med, Yale Program Brain Tumor Res, New Haven, CT 06510 USA; [Clarke, Victoria E.; Harmanci, Akdes Serin; Ercan-Sencicek, A. Gulhan; Erson-Omay, E. Zeynep; Henegariu, Octavian; Carrion-Grant, Geneive; Mishra-Gorur, Ketu; Duran, Daniel; Piepmeier, Joseph M.; Gunel, Jennifer Molitemo; Yasuno, Katsuhito; Gunel, Murat] Yale Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; [Clarke, Victoria E.; Bai, Hanwen; Youngblood, Mark W.; Baranoski, Jacob F.; Henegariu, Octavian; Mishra-Gorur, Ketu; Duran, Daniel; Bilguvar, Kaya; Gunel, Murat] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lee, Tong Ihn; Abraham, Brian J.; Weintraub, Abraham S.; Hnisz, Denes; Goldmann, Johanna E.; Young, Richard A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Ercan-Sencicek, A. Gulhan; Henegariu, Octavian; Mishra-Gorur, Ketu; Gunel, Murat] Yale Sch Med, Yale Program Neurogenet, New Haven, CT 06510 USA; [Simon, Matthias] Univ Bonn, Sch Med, Dept Neurosurg, Bonn, Germany; [Krischek, Boris] Univ Hosp Cologne, Dept Gen Neurosurg, Cologne, Germany; [Henegariu, Octavian; Mishra-Gorur, Ketu; Gunel, Murat] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA; [Schramm, Johannes] Univ Bonn, Sch Med, Fac Med, Bonn, Germany; [Vortmeyer, Alexander O.] Yale Sch Med, Dept Pathol, New Haven, CT USA; [Bilguvar, Kaya] Yale Sch Med, Yale Ctr Genome Anal, Orange, CT USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA USA; [Gunel, Murat] Yale Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Yale University; University of Bonn; University of Cologne; Yale University; University of Bonn; Yale University; Massachusetts Institute of Technology (MIT); Yale University	Gunel, M (corresponding author), Yale Sch Med, Yale Program Brain Tumor Res, New Haven, CT 06510 USA.; Gunel, M (corresponding author), Yale Sch Med, Dept Neurosurg, New Haven, CT 06510 USA.; Gunel, M (corresponding author), Yale Sch Med, Dept Genet, New Haven, CT 06510 USA.; Gunel, M (corresponding author), Yale Sch Med, Yale Program Neurogenet, New Haven, CT 06510 USA.; Gunel, M (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.; Gunel, M (corresponding author), Yale Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06510 USA.	murat.gunel@yale.edu	Abraham, Brian/C-2230-2019; Hnisz, Denes/AAE-9592-2019; Young, Richard A/F-6495-2012; Yasuno, Katsuhito/E-1960-2012	Abraham, Brian/0000-0001-8085-3027; Hnisz, Denes/0000-0002-6256-1693; Young, Richard A/0000-0001-8855-8647; Youngblood, Mark/0000-0002-1044-8015; Duran, Daniel/0000-0001-6888-252X; Yasuno, Katsuhito/0000-0002-3606-532X	Gregory M. Kiez and Mehmet Kutman Foundation; Yale School of Medicine; NIH [T32GM00720, F30CA183530-03]; Austrian Science Fund (FWF) [J3490]; Gilead Sciences, Inc.; Yale University; NATIONAL CANCER INSTITUTE [P30CA016359, F30CA183530] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001862, TL1TR001864, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, T32GM007205] Funding Source: NIH RePORTER	Gregory M. Kiez and Mehmet Kutman Foundation; Yale School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Gilead Sciences, Inc.(Gilead Sciences); Yale University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the patients and their families who have contributed to this study. This work was supported by the Gregory M. Kiez and Mehmet Kutman Foundation, the Yale School of Medicine, the NIH (Medical Scientist Training Program grant T32GM00720 to V.E.C. and M.W.Y.; NIH/NCI NRSA F30CA183530-03 to V.E.C.), and the Austrian Science Fund (FWF; Erwin Schrodinger Fellowship J3490 to D.H.). Partial funding for sequencing of the tumor samples was provided through a research agreement between Gilead Sciences, Inc., and Yale University. We gratefully acknowledge T. Boggon for constructive comments regarding the structure of RNA polymerase II and N. Ivanova for providing expertise on the maintenance of mouse embryonic stem cells.	Aavikko M, 2012, AM J HUM GENET, V91, P520, DOI 10.1016/j.ajhg.2012.07.015; Abedalthagafi M, 2016, NEURO-ONCOLOGY, V18, P649, DOI 10.1093/neuonc/nov316; Bhagwat AS, 2015, TRENDS CANCER, V1, P53, DOI 10.1016/j.trecan.2015.07.001; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Choe Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086025; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; Kampjarvi K, 2012, BRIT J CANCER, V107, P1761, DOI 10.1038/bjc.2012.428; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kotani T, 2012, VITAM HORM, V88, P273, DOI 10.1016/B978-0-12-394622-5.00012-2; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Ostrom QT, 2013, NEUROONCOL S2, V15, piil; Reuss DE, 2013, ACTA NEUROPATHOL, V125, P351, DOI 10.1007/s00401-013-1093-x; Rifat Y, 2010, DEV BIOL, V345, P237, DOI 10.1016/j.ydbio.2010.07.017; Santi L, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/487480; Schmitz U, 2001, BRIT J CANCER, V84, P199, DOI 10.1054/bjoc.2000.1583; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; WINTZERITH M, 1992, NUCLEIC ACIDS RES, V20, P910, DOI 10.1093/nar/20.4.910; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043005	25	177	178	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1253	1259		10.1038/ng.3651	http://dx.doi.org/10.1038/ng.3651			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27548314	Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000384391600021
J	Wang, ZH; Zhang, XJ; Ji, YX; Zhang, P; Deng, KQ; Gong, J; Ren, SX; Wang, XH; Chen, I; Wang, H; Gao, C; Yokota, T; Ang, YS; Li, S; Cass, A; Vondriska, TM; Li, GP; Deb, A; Srivastava, D; Yang, HT; Xiao, XS; Li, HL; Wang, YB				Wang, Zhihua; Zhang, Xiao-Jing; Ji, Yan-Xiao; Zhang, Peng; Deng, Ke-Qiong; Gong, Jun; Ren, Shuxun; Wang, Xinghua; Chen, Iris; Wang, He; Gao, Chen; Yokota, Tomohiro; Ang, Yen Sin; Li, Shen; Cass, Ashley; Vondriska, Thomas M.; Li, Guangping; Deb, Arjun; Srivastava, Deepak; Yang, Huang-Tian; Xiao, Xinshu; Li, Hongliang; Wang, Yibin			The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy	NATURE MEDICINE			English	Article							HISTONE METHYLATION; GENE-EXPRESSION; HEART; BINDING; MTOR; RAPTOR; IDENTIFICATION; REPRESSION; REGULATOR; CHROMATIN	Epigenetic reprogramming is a critical process of pathological gene induction during cardiac hypertrophy and remodeling, but the underlying regulatory mechanisms remain to be elucidated. Here we identified a heart-enriched long noncoding (Inc)RNA, named cardiac-hypertrophy-associated epigenetic regulator (Chaer), which is necessary for the development of cardiac hypertrophy. Mechanistically, Chaer directly interacts with the catalytic subunit of polycomb repressor complex 2 (PRC2). This interaction, which is mediated by a 66-mer motif in Chaer, interferes with PRC2 targeting to genomic loci, thereby inhibiting histone H3 lysine 27 methylation at the promoter regions of genes involved in cardiac hypertrophy. The interaction between Chaer and PRC2 is transiently induced after hormone or stress stimulation in a process involving mammalian target of rapamycin complex 1, and this interaction is a prerequisite for epigenetic reprogramming and induction of genes involved in hypertrophy. Inhibition of Chaer expression in the heart before, but not after, the onset of pressure overload substantially attenuates cardiac hypertrophy and dysfunction. Our study reveals that stress-induced pathological gene activation in the heart requires a previously uncharacterized IncRNA-dependent epigenetic checkpoint.	[Wang, Zhihua; Zhang, Xiao-Jing; Ji, Yan-Xiao; Zhang, Peng; Deng, Ke-Qiong; Gong, Jun; Li, Hongliang] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China; [Wang, Zhihua; Zhang, Xiao-Jing; Ji, Yan-Xiao; Zhang, Peng; Deng, Ke-Qiong; Gong, Jun; Li, Hongliang] Wuhan Univ, Anim Expt Ctr, Anim Biosafety Level Lab 3, Wuhan, Peoples R China; [Wang, Zhihua; Zhang, Xiao-Jing; Ji, Yan-Xiao; Zhang, Peng; Deng, Ke-Qiong; Gong, Jun; Li, Hongliang] Wuhan Univ, Med Res Inst, Sch Med, Wuhan, Peoples R China; [Wang, Zhihua; Ren, Shuxun; Chen, Iris; Wang, He; Gao, Chen; Yokota, Tomohiro; Vondriska, Thomas M.; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; [Wang, Xinghua; Li, Guangping] Tianjin Med Univ, Hosp 2, Tianjin Inst Cardiol, Dept Cardiol, Tianjin, Peoples R China; [Ang, Yen Sin] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Ang, Yen Sin] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Li, Shen; Deb, Arjun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA; [Li, Shen; Deb, Arjun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA; [Cass, Ashley; Xiao, Xinshu] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Dept Integrat Biol & Physiol,Coll Life Sci, Los Angeles, CA 90095 USA; [Cass, Ashley; Xiao, Xinshu] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA USA; [Yang, Huang-Tian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Yang, Huang-Tian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Mol Cardiol, Shanghai, Peoples R China; [Yang, Huang-Tian] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China	Wuhan University; Wuhan University; Wuhan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tianjin Medical University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Li, HL (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Anim Expt Ctr, Anim Biosafety Level Lab 3, Wuhan, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Med Res Inst, Sch Med, Wuhan, Peoples R China.; Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA.; Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA.; Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA.	lihl@whu.edu.cn; yibinwang@mednet.ucla.edu	Wang, Zhihua/AAM-1486-2021; wang, xinghua/AAE-4659-2022	Wang, Yibin/0000-0003-0852-0767; Yokota, Tomohiro/0000-0003-2540-3810; Srivastava, Deepak/0000-0002-3480-5953; Wang, Zhihua/0000-0002-1800-2384; Xiao, Xinshu/0000-0002-9362-8029	US National Institute of Health (NIH) [HL070079, HL103205, HL108186, HL110667, HL115238, R01HG006264, U01HG007013]; University of California at Los Angeles CTSI-Cardiovascular Pilot Team research grant [UL1TR000124]; National Science Fund for Distinguished Young Scholars [81425005]; Key Project of the National Natural Science Foundation [81330005, 81630011]; National Science and Technology Support Project [2013YQ030923-05, 2014BAI02B01, 2015BAI08801]; American Heart Association Western States Affiliate Postdoctoral Fellowship [15POST24970034]; UCLA Eli and Edythe Broad Center Predoctoral Fellowship in Stem Cell Science; China Scholarship Council [201406280042]; Jennifer S. Buchwald Graduate Fellowship in Physiology; NIH [T90DE022734]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL110667, R01HL070079, R01HL123295, R01HL114437, R01HL108186, R01HL137241, R01HL115238, R01HL122737, R01HL129178, R01HL103205, R01HL129639] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006264, U01HG007013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE022734] Funding Source: NIH RePORTER	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Los Angeles CTSI-Cardiovascular Pilot Team research grant; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Project of the National Natural Science Foundation; National Science and Technology Support Project; American Heart Association Western States Affiliate Postdoctoral Fellowship(American Heart Association); UCLA Eli and Edythe Broad Center Predoctoral Fellowship in Stem Cell Science; China Scholarship Council(China Scholarship Council); Jennifer S. Buchwald Graduate Fellowship in Physiology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the US National Institute of Health (NIH) (grant no. HL070079 (Y.W.), HL103205 (Y.W.), HL108186 (Y.W.), HL110667 (Y.W.), HL115238 (T.M.V.), R01HG006264 (X.X.) and U01HG007013 (X.X.)), the University of California at Los Angeles CTSI-Cardiovascular Pilot Team research grant UL1TR000124 (Y.W., X.X. and T.M.V.), the National Science Fund for Distinguished Young Scholars (grant no. 81425005; H.L.), the Key Project of the National Natural Science Foundation (grant no. 81330005 and 81630011; both to H.L.), the National Science and Technology Support Project (grant no. 2013YQ030923-05, 2014BAI02B01 and 2015BAI08801; all to H.L.) and an American Heart Association Western States Affiliate Postdoctoral Fellowship (15POST24970034; Z.W.). C.G. was a recipient of the UCLA Eli and Edythe Broad Center Predoctoral Fellowship in Stem Cell Science. H.W. was supported by the China Scholarship Council (award no. 201406280042) and was a recipient of a Jennifer S. Buchwald Graduate Fellowship in Physiology. A.C. was supported by NIH predoctoral training grant T90DE022734. The authors wish to acknowledge outstanding technical support from H. Pu and Core support from the UCLA Cardiovascular Research Laboratories and the Division of Molecular Medicine at UCLA.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Angrisano T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106024; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Friedrichs F, 2009, GENOME RES, V19, P395, DOI 10.1101/gr.076653.108; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Han P, 2014, NATURE, V514, P102, DOI 10.1038/nature13596; Ishii N, 2006, J HUM GENET, V51, P1087, DOI 10.1007/s10038-006-0070-9; Jiang F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152767; Joh RI, 2014, BBA-GENE REGUL MECH, V1839, P1385, DOI 10.1016/j.bbagrm.2014.06.006; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kaneda R, 2009, GENES CELLS, V14, P69, DOI 10.1111/j.1365-2443.2008.01252.x; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kang S, 2011, J BIOL CHEM, V286, P18465, DOI 10.1074/jbc.M110.200022; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kumarswamy R, 2014, CIRC RES, V114, P1569, DOI 10.1161/CIRCRESAHA.114.303915; Kurian L, 2015, CIRCULATION, V131, P1278, DOI 10.1161/CIRCULATIONAHA.114.013303; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956; Li FP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-168; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Li Q, 2015, P NATL ACAD SCI USA, V112, P899, DOI 10.1073/pnas.1420695112; Li Y, 2014, ARCH BIOCHEM BIOPHYS, V558, P79, DOI 10.1016/j.abb.2014.06.023; Liu LT, 2016, CARDIOVASC RES, V111, P56, DOI 10.1093/cvr/cvw078; Liu XQ, 2015, EXP CELL RES, V335, P123, DOI 10.1016/j.yexcr.2015.04.012; Liu ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066666, 10.1371/journal.pone.0055618]; Marketou ME, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5720758; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Matkovich SJ, 2014, P NATL ACAD SCI USA, V111, P12264, DOI 10.1073/pnas.1410622111; Monnier P, 2013, P NATL ACAD SCI USA, V110, P20693, DOI 10.1073/pnas.1310201110; Ounzain S, 2015, EUR HEART J, V36, P353, DOI 10.1093/eurheartj/ehu180; Papait R, 2013, P NATL ACAD SCI USA, V110, P20164, DOI 10.1073/pnas.1315155110; Peters T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150236; Sala V, 2012, MOL MED, V18, P938, DOI 10.2119/molmed.2011.00512; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shende P, 2016, CARDIOVASC RES, V109, P103, DOI 10.1093/cvr/cvv252; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Viereck J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1475; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang K, 2014, CIRC RES, V114, P1377, DOI 10.1161/CIRCRESAHA.114.302476; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wang ZH, 2015, CIRC RES, V116, P235, DOI 10.1161/CIRCRESAHA.114.305490; Wu L, 2013, BIOCHEMISTRY-US, V52, P9519, DOI 10.1021/bi401085h; Xu N, 2015, J PATHOL, V235, P672, DOI 10.1002/path.4480; Yang T, 2013, BIOCHEM BIOPH RES CO, V436, P578, DOI 10.1016/j.bbrc.2013.05.079	54	257	269	0	83	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1131	1139		10.1038/nm.4179	http://dx.doi.org/10.1038/nm.4179			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27618650	Green Accepted, Green Submitted			2022-12-25	WOS:000384872500016
J	Tang, Y; Feinberg, T; Keller, ET; Li, XY; Weiss, SJ				Tang, Yi; Feinberg, Tamar; Keller, Evan T.; Li, Xiao-Yan; Weiss, Stephen J.			Snail/Slug binding interactions with YAP/TAZ control skeletal stem cell self-renewal and differentiation	NATURE CELL BIOLOGY			English	Article							HIPPO SIGNALING PATHWAY; MESENCHYMAL PROGENITORS; MULTIPLE FUNCTIONS; NUCLEAR IMPORT; BONE MASS; OSTEOBLAST; SLUG; EXPRESSION; OSTERIX; GROWTH	Bone-marrow-derived skeletal stem/stromal cell (SSC) self-renewal and function are critical to skeletal development, homeostasis and repair. Nevertheless, the mechanisms controlling SSC behaviour, particularly bone formation, remain ill-defined. Using knockout mouse models that target the zinc-finger transcription factors Snail or Slug, or Snail and Slug combined, a regulatory,axis has been uncovered wherein Snail and Slug cooperatively control SSC self-renewal, osteoblastogenesis and bone formation. Mechanistically, Snail/Slug regulate SSC function by forming complexes with the transcriptional co-activators YAP and TAZ in tandem with the inhibition of the Hippo-pathway-dependent regulation of YAP/TAZ signalling cascades. In turn, the Snail/Slug-YAP/TAZ axis activates a series of YAP/TAZ/TEAD and Runx2 downstream targets that control SSC homeostasis and osteogenesis. Together, these results demonstrate that SSCs mobilize Snail/Slug-YAP/TAZ complexes to control stem cell function.	[Tang, Yi; Feinberg, Tamar; Li, Xiao-Yan; Weiss, Stephen J.] Univ Michigan, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Tang, Yi; Feinberg, Tamar; Li, Xiao-Yan; Weiss, Stephen J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Keller, Evan T.] Univ Michigan, Dept Pathol, Dept Urol, Ann Arbor, MI 48109 USA; [Keller, Evan T.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Tang, Y; Weiss, SJ (corresponding author), Univ Michigan, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA.; Tang, Y; Weiss, SJ (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	yitang@umich.edu; sjweiss@umich.edu	Keller, Evan T/M-1446-2016	Keller, Evan T/0000-0002-7592-7535	Breast Cancer Research Foundation; NIH [R01-1AR065524, P01-CA093900]; NATIONAL CANCER INSTITUTE [P01CA093900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. N. Olson (University of Texas Southwestern, USA) for providing YAP<SUP>+/-</SUP>/TAZ<SUP>+/-</SUP> mice. This work was supported by a grant from the Breast Cancer Research Foundation (S.J.W.). Work performed in this study was also supported by NIH Grant R01-1AR065524 (S.J.W.) and by P01-CA093900 (E.T.K).	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Perez-Mancera PA, 2007, HUM MOL GENET, V16, P2972, DOI 10.1093/hmg/ddm278; Baffle R., 2013, ONCOGENE, V32, P3381; Barrallo-Gimeno A, 2009, TRENDS GENET, V25, P248, DOI 10.1016/j.tig.2009.04.001; Bianco P, 2015, DEVELOPMENT, V142, P1023, DOI 10.1242/dev.102210; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Chen Y, 2013, BIOCHEM BIOPH RES CO, V435, P356, DOI 10.1016/j.bbrc.2013.04.086; Chen Y, 2013, J BONE MINER RES, V28, P1412, DOI 10.1002/jbmr.1871; Choi S, 2014, ACTA CRYSTALLOGR D, V70, P1050, DOI 10.1107/S1399004714000972; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; de Frutos CA, 2009, EMBO J, V28, P686, DOI 10.1038/emboj.2009.23; Desgrosellier JS, 2014, DEV CELL, V30, P295, DOI 10.1016/j.devcel.2014.06.005; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Galli GG, 2015, MOL CELL, V60, P328, DOI 10.1016/j.molcel.2015.09.001; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Horvay K, 2015, EMBO J, V34, P1319, DOI 10.15252/embj.201490881; Hwang WL, 2014, NAT CELL BIOL, V16, P268, DOI 10.1038/ncb2910; Isern J, 2014, ELIFE, V3, DOI 10.7554/eLife.03696; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kfoury Y, 2015, CELL STEM CELL, V16, P239, DOI 10.1016/j.stem.2015.02.019; Lin YS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4070; Liu YL, 2010, BONE, V47, P916, DOI 10.1016/j.bone.2010.07.022; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; Mingot JM, 2009, J CELL SCI, V122, P1452, DOI 10.1242/jcs.041749; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Oram KF, 2003, ANAT REC PART A, V271A, P189, DOI 10.1002/ar.a.10027; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park SJ, 2010, BONE, V46, P1498, DOI 10.1016/j.bone.2010.02.027; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao H, 2015, NAT CELL BIOL, V17, P386, DOI 10.1038/ncb3139; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	57	133	138	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2016	18	9					917	929		10.1038/ncb3394	http://dx.doi.org/10.1038/ncb3394			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DU7TF	27479603	Green Accepted			2022-12-25	WOS:000382416800003
J	Liang, XH; Shen, W; Sun, H; Migawa, MT; Vickers, TA; Crooke, ST				Liang, Xue-hai; Shen, Wen; Sun, Hong; Migawa, Michael T.; Vickers, Timothy A.; Crooke, Stanley T.			Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames	NATURE BIOTECHNOLOGY			English	Article							MAMMALIAN-CELLS; GENE-THERAPY; INITIATION; EUKARYOTES; MECHANISMS; EXPRESSION; MODEL	Increasing the levels of therapeutic proteins in vivo remains challenging. Antisense oligonucleotides (ASOs) are often used to downregulate gene expression(1) or to modify RNA splicing(2,3,) but antisense technology has not previously been used to directly increase the production of selected proteins. Here we used a class of modified ASOs that bind to mRNA sequences in upstream open reading frames (uORFs) to specifically increase the amounts of protein translated from a downstream primary ORF (pORF). Using ASO treatment, we increased the amount of proteins expressed from four genes by 30-150% in a dose-dependent manner in both human and mouse cells. Notably, systemic treatment of mice with ASO resulted in an similar to 80% protein increase of LRPPRC. The ASO-mediated increase in protein expression was sequence-specific, occurred at the level of translation and was dependent on helicase activity. We also found that the type of RNA modification and the position of modified nucleotides in ASOs affected translation of a pORF. ASOs are a useful class of therapeutic agents with broad utility.	[Liang, Xue-hai; Shen, Wen; Sun, Hong; Vickers, Timothy A.; Crooke, Stanley T.] Ionis Pharmaceut Inc, Dept Core Antisense Res, Carlsbad, CA 92010 USA; [Migawa, Michael T.] Ionis Pharmaceut Inc, Dept Med Chem, Carlsbad, CA USA	Ionis Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.	Liang, XH (corresponding author), Ionis Pharmaceut Inc, Dept Core Antisense Res, Carlsbad, CA 92010 USA.	lliang@ionisph.com			Ionis Pharmaceuticals	Ionis Pharmaceuticals	This work was supported by Ionis Pharmaceuticals internal funding. We thank M. Ramesh for technique assistance; H. Murray and C.L. De Hoyos for help in the animal study; S. Damle for microarray data processing and deposition; T. Reigle for help in figure preparation; and F. Bennett, E. Swayze, W. Lima and S. Wang for discussions.	Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Bleriot Y, 2004, TETRAHEDRON, V60, P6813, DOI 10.1016/j.tet.2004.06.009; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; CHIANG MY, 1991, J BIOL CHEM, V266, P18162; Crooke S.T, 2008, ANTISENSE DRUG TECHN, P3; Deng Y, 2014, GENE, V538, P217, DOI 10.1016/j.gene.2013.12.019; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; Hoyng SA, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00032; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1980, CELL, V22, P7, DOI 10.1016/0092-8674(80)90148-8; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Liang XH, 2003, P NATL ACAD SCI USA, V100, P7521, DOI 10.1073/pnas.1332001100; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liang XH, 2015, NUCLEIC ACIDS RES, V43, P2927, DOI 10.1093/nar/gkv143; Liang XH, 2013, BBA-GENE REGUL MECH, V1829, P455, DOI 10.1016/j.bbagrm.2013.01.011; Liang XH, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1121; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Meng LY, 2015, NATURE, V518, P409, DOI 10.1038/nature13975; Mourich DV, 2014, NUCLEIC ACID THER, V24, P114, DOI 10.1089/nat.2013.0449; Pearson S, 2004, NAT BIOTECHNOL, V22, P3, DOI 10.1038/nbt0104-3; Pichon X, 2012, CURR PROTEIN PEPT SC, V13, P294, DOI 10.2174/138920312801619475; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Seth PP, 2010, J ORG CHEM, V75, P1569, DOI 10.1021/jo902560f; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; Wethmar K, 2014, WIRES RNA, V5, P765, DOI 10.1002/wrna.1245; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359	34	87	96	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2016	34	8					875	+		10.1038/nbt.3589	http://dx.doi.org/10.1038/nbt.3589			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2VJ	27398791				2022-12-25	WOS:000381339600026
J	Walsh, TA; Bevan, SA; Gachotte, DJ; Larsen, CM; Moskal, WA; Merlo, PAO; Sidorenko, LV; Hampton, RE; Stoltz, V; Pareddy, D; Anthony, GI; Bhaskar, PB; Marri, PR; Clark, LM; Chen, W; Adu-Peasah, PS; Wensing, ST; Zirkle, R; Metz, JG				Walsh, Terence A.; Bevan, Scott A.; Gachotte, Daniel J.; Larsen, Cory M.; Moskal, William A.; Merlo, P. A. Owens; Sidorenko, Lyudmila V.; Hampton, Ronnie E.; Stoltz, Virginia; Pareddy, Dayakar; Anthony, Geny I.; Bhaskar, Pudota B.; Marri, Pradeep R.; Clark, Lauren M.; Chen, Wei; Adu-Peasah, Patrick S.; Wensing, Steven T.; Zirkle, Ross; Metz, James G.			Canola engineered with a microalgal polyketide synthase-like system produces oil enriched in docosahexaenoic acid	NATURE BIOTECHNOLOGY			English	Article							POLYUNSATURATED FATTY-ACIDS; BRASSICA-NAPUS; AGROBACTERIUM-TUMEFACIENS; ARABIDOPSIS-THALIANA; TRANSGENIC PLANTS; EXPRESSION; GENE; PROMOTER; DNA; TRANSFORMATION	Dietary omega-3 long-chain polyunsaturated fatty acids (LC-PUFAs), docosahexaenoic acid (DHA, C22:6) and eicosapentaenoic acid (EPA, C20:5) are usually derived from marine fish. Although production of both EPA and DHA has been engineered into land plants, including Arabidopsis, Camelina sativa and Brassica juncea, neither has been produced in commercially relevant amounts in a widely grown crop. We report expression of a microalgal polyketide synthase-like PUFA synthase system, comprising three multidomain polypeptides and an accessory enzyme, in canola (Brassica napus) seeds. This transgenic enzyme system is expressed in the cytoplasm, and synthesizes DHA and EPA de novo from malonyl-CoA without substantially altering plastidial fatty acid production. Furthermore, there is no significant impact of DHA and EPA production on seed yield in either the greenhouse or the field. Canola oil processed from field-grown grain contains 3.7% DHA and 0.7% EPA, and can provide more than 600 mg of omega-3 LC-PUFAs in a 14 g serving.	[Walsh, Terence A.; Bevan, Scott A.; Gachotte, Daniel J.; Larsen, Cory M.; Moskal, William A.; Merlo, P. A. Owens; Sidorenko, Lyudmila V.; Hampton, Ronnie E.; Stoltz, Virginia; Pareddy, Dayakar; Anthony, Geny I.; Bhaskar, Pudota B.; Marri, Pradeep R.; Clark, Lauren M.; Chen, Wei; Adu-Peasah, Patrick S.; Wensing, Steven T.] Dow AgroSci LLC, Res & Dev, Indianapolis, IN 46268 USA; [Zirkle, Ross] DSM Nutr Prod LLC, Columbia, MD USA; [Metz, James G.] DSM Nutr Prod LLC, Boulder, CO USA; [Metz, James G.] Metz Consultancy, Longmont, CO USA	Dow Chemical Company; DSM NV; DSM NV	Walsh, TA (corresponding author), Dow AgroSci LLC, Res & Dev, Indianapolis, IN 46268 USA.	tawalsh@dow.com	Walsh, Terence A/K-1863-2012	Walsh, Terence A/0000-0003-2640-8189; Pudota, Bala/0000-0003-2576-101X				Abedi E, 2014, FOOD SCI NUTR, V2, P443, DOI 10.1002/fsn3.121; [Anonymous], 2013, OFFICIAL METHODS REC; Apt K.E., 2010, US patent application, Patent No. [20100266564A1, 20100266564]; Ayele M, 2005, GENOME RES, V15, P487, DOI 10.1101/gr.3176505; Barclay W, 2005, SINGLE CELL OILS; BARKER RF, 1983, PLANT MOL BIOL, V2, P335, DOI 10.1007/BF01578595; BUSTOS MM, 1991, EMBO J, V10, P1469, DOI 10.1002/j.1460-2075.1991.tb07667.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Copp JN, 2006, APPL ENVIRON MICROB, V72, P2298, DOI 10.1128/AEM.72.4.2298-2305.2006; DEBLOCK M, 1989, PLANT PHYSIOL, V91, P694, DOI 10.1104/pp.91.2.694; DESILVA J, 1990, PLANT MOL BIOL, V14, P537, DOI 10.1007/BF00027499; Dietz-Pfeilstetter A, 2010, PLANT SCI, V179, P164, DOI 10.1016/j.plantsci.2010.04.015; Fourmann M, 1998, THEOR APPL GENET, V96, P852, DOI 10.1007/s001220050812; Frankel E.N., 2005, LIPID OXIDATION; Gudynaite-Savitch L, 2009, PLANT BIOTECHNOL J, V7, P472, DOI 10.1111/j.1467-7652.2009.00416.x; Hauvermale A, 2006, LIPIDS, V41, P739, DOI 10.1007/s11745-006-5025-6; HEPBURN AG, 1985, J GEN MICROBIOL, V131, P2961; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; HOFFMAN LM, 1985, EMBO J, V4, P883, DOI 10.1002/j.1460-2075.1985.tb03714.x; Jones PJH, 2014, AM J CLIN NUTR, V100, P88, DOI 10.3945/ajcn.113.081133; KREBBERS E, 1988, PLANT PHYSIOL, V87, P859, DOI 10.1104/pp.87.4.859; Kridl J. C., 1991, Seed Science Research, V1, P209, DOI 10.1017/S0960258500000921; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lau W, 2015, SCIENCE, V349, P1224, DOI 10.1126/science.aac7202; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mayerhofer R, 2005, GENETICS, V171, P1977, DOI 10.1534/genetics.105.049098; Metz JG, 2009, PLANT PHYSIOL BIOCH, V47, P472, DOI 10.1016/j.plaphy.2009.02.002; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Napier JA, 2014, CURR OPIN PLANT BIOL, V19, P68, DOI 10.1016/j.pbi.2014.04.001; Naqvi S, 2010, TRENDS PLANT SCI, V15, P48, DOI 10.1016/j.tplants.2009.09.010; Peremarti A, 2010, PLANT MOL BIOL, V73, P363, DOI 10.1007/s11103-010-9628-1; Petrie J.R., 2015, US patent application, Patent No. [20150374654A1, 20150374654]; Petrie JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085061; Petrie JR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035214, 10.1371/journal.pone.0049165]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ruiz-Lopez N, 2014, PLANT J, V77, P198, DOI 10.1111/tpj.12378; Salem N, 2015, CURR OPIN CLIN NUTR, V18, P147, DOI 10.1097/MCO.0000000000000145; Schwender J, 2015, PLANT PHYSIOL, V168, P828, DOI 10.1104/pp.15.00385; Shulse CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020146; Smith MA, 2003, PLANTA, V217, P507, DOI 10.1007/s00425-003-1015-6; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Ullrich KK, 2015, CURR OPIN BIOTECH, V32, P61, DOI 10.1016/j.copbio.2014.11.011; Verdaguer B, 1998, PLANT MOL BIOL, V37, P1055, DOI 10.1023/A:1006004819398; Weaver C.A., 2012, US patent application, Patent No. [8309796B2, 8309796]; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Weng H, 2004, PLANT MOL BIOL REP, V22, P289, DOI 10.1007/BF02773139; Wu GH, 2005, NAT BIOTECHNOL, V23, P1013, DOI 10.1038/nbt1107; Xue ZX, 2013, NAT BIOTECHNOL, V31, P734, DOI 10.1038/nbt.2622; Yalpani N, 2001, PLANT CELL, V13, P1401	51	63	64	6	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2016	34	8					881	+		10.1038/nbt.3585	http://dx.doi.org/10.1038/nbt.3585			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2VJ	27398790				2022-12-25	WOS:000381339600027
J	Chen, RD; Gao, BQ; Liu, X; Ruan, FY; Zhang, Y; Lou, JZ; Feng, KP; Wunsch, C; Li, SM; Dai, JG; Sun, F				Chen, Ridao; Gao, Bingquan; Liu, Xiao; Ruan, Feiying; Zhang, Yong; Lou, Jizhong; Feng, Keping; Wunsch, Carsten; Li, Shu-Ming; Dai, Jungui; Sun, Fei			Molecular insights into the enzyme promiscuity of an aromatic prenyltransferase	NATURE CHEMICAL BIOLOGY			English	Article							CATALYTIC PROMISCUITY; ASPERGILLUS-TERREUS; STRUCTURAL BASIS; PRENYLATION; SYNTHASE; BUTYROLACTONE; BIOSYNTHESIS; PURIFICATION; MECHANISM	Aromatic prenyltransferases (aPTases) transfer prenyl moieties from isoprenoid donors to various aromatic acceptors, some of which have the rare property of extreme enzymatic promiscuity toward both a variety of prenyl donors and a large diversity of acceptors. In this study, we discovered a new aPTase, AtaPT, from Aspergillus terreus that exhibits unprecedented promiscuity toward diverse aromatic acceptors and prenyl donors and also yields products with a range of prenylation patterns. Systematic crystallographic studies revealed various discrete conformations for ligand binding with donor-dependent acceptor specificity and multiple binding sites within a spacious hydrophobic substrate-binding pocket. Further structure-guided mutagenesis of active sites at the substrate-binding pocket is responsible for altering the specificity and promiscuity toward substrates and the diversity of product prenylations. Our study reveals the molecular mechanism underlying the promiscuity of AtaPT and suggests an efficient protein engineering strategy to generate new prenylated derivatives in drug discovery applications.	[Chen, Ridao; Ruan, Feiying; Feng, Keping; Dai, Jungui] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China; [Chen, Ridao; Liu, Xiao; Ruan, Feiying; Feng, Keping; Dai, Jungui] Peking Union Med Coll, Beijing, Peoples R China; [Gao, Bingquan; Sun, Fei] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing, Peoples R China; [Gao, Bingquan; Sun, Fei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Yong; Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing, Peoples R China; [Wunsch, Carsten; Li, Shu-Ming] Philipps Univ Marburg, Inst Pharmazeut Biol & Biotechnol, Marburg, Germany; [Liu, Xiao] Beijing Univ Chinese Med, Modern Res Ctr Tradit Chinese Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Philipps University Marburg; Beijing University of Chinese Medicine	Dai, JG (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China.; Dai, JG (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Sun, F (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing, Peoples R China.; Sun, F (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	jgdai@imm.ac.cn; feisun@sun5.ibp.ac.cn	Sun, Fei/C-4190-2015; Sun, Fei/AAR-3186-2020	Sun, Fei/0000-0002-0351-5144; Sun, Fei/0000-0002-0351-5144; , Xiao Liu/0000-0001-9701-0675	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08030202]; National Basic Research Program (973 Program) of Ministry of Science and Technology of China [2014CB910700, 2014CB910202]; National Natural Science Foundation of China [81302667]; Deutsche Forschungsgemeinschaft [Li844/4-1]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program (973 Program) of Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank S. Huang and J. He for their on-site assistance with the crystallographic data collection at the SSRF beamline BL17U. This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08030202) to F.S., the National Basic Research Program (973 Program) of Ministry of Science and Technology of China (2014CB910700) to F.S. and (2014CB910202) to J.L., the National Natural Science Foundation of China (81302667) to R.C. and the Deutsche Forschungsgemeinschaft (Li844/4-1) to S.-M.L. The computational resources were provided by the National Supercomputing Center in Tianjin and the HPC-Service Station at the Center for Biological Imaging of the Institute of Biophysics of the Chinese Academy of Sciences.	Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241; Brandt W, 2009, PHYTOCHEMISTRY, V70, P1758, DOI 10.1016/j.phytochem.2009.09.001; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chen DW, 2015, ANGEW CHEM INT EDIT, V54, P12678, DOI 10.1002/anie.201506505; Cheng W, 2014, SCIENCE, V343, P878, DOI 10.1126/science.1246774; Chooi YH, 2012, J AM CHEM SOC, V134, P9428, DOI 10.1021/ja3028636; Cuetos A, 2016, ANGEW CHEM INT EDIT, V55, P3144, DOI 10.1002/anie.201510554; Ding YS, 2010, J AM CHEM SOC, V132, P12733, DOI 10.1021/ja1049302; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Gao BQ, 2015, ACTA CRYSTALLOGR F, V71, P889, DOI 10.1107/S2053230X15008882; Guo CJ, 2015, CHEM SCI, V6, P5913, DOI 10.1039/c5sc01058f; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Jost M, 2010, J AM CHEM SOC, V132, P17849, DOI 10.1021/ja106817c; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kremer A, 2007, MICROBIOL-SGM, V153, P3409, DOI 10.1099/mic.0.2007/009019-0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Li SM, 2010, NAT PROD REP, V27, P57, DOI 10.1039/b909987p; Li SM, 2009, APPL MICROBIOL BIOT, V84, P631, DOI 10.1007/s00253-009-2128-z; MARKOVITS J, 1989, CANCER RES, V49, P5111; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Mori T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10849; NITTA K, 1983, CHEM PHARM BULL, V31, P1528; Pavese JM, 2014, AM J CLIN NUTR, V100, p431S, DOI 10.3945/ajcn.113.071290; Pockrandt D, 2014, APPL MICROBIOL BIOT, V98, P4987, DOI 10.1007/s00253-014-5509-x; Rudolft JD, 2013, J AM CHEM SOC, V135, P1895, DOI 10.1021/ja310734n; Saleh O, 2009, PHYTOCHEMISTRY, V70, P1728, DOI 10.1016/j.phytochem.2009.05.009; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Schuller JM, 2012, J MOL BIOL, V422, P87, DOI 10.1016/j.jmb.2012.05.033; Shen Y, 2012, CHEM PHARM BULL, V60, P1437, DOI 10.1248/cpb.c12-00616; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Yin SQ, 2013, APPL MICROBIOL BIOT, V97, P1649, DOI 10.1007/s00253-012-4130-0; Yu X, 2013, CHEM BIOL, V20, P1492, DOI 10.1016/j.chembiol.2013.10.007; Yu X, 2012, METHOD ENZYMOL, V516, P259, DOI 10.1016/B978-0-12-394291-3.00005-8; Zhou K, 2015, J NAT PROD, V78, P2229, DOI 10.1021/acs.jnatprod.5b00422	37	68	73	7	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					226	234		10.1038/NCHEMBIO.2263	http://dx.doi.org/10.1038/NCHEMBIO.2263			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27992881				2022-12-25	WOS:000393533000019
J	Himburg, HA; Doan, PL; Quarmyne, M; Yan, X; Sasine, J; Zhao, LM; Hancock, GV; Kan, J; Pohl, KA; Tran, E; Chao, NJ; Harris, JR; Chute, JP				Himburg, Heather A.; Doan, Phuong L.; Quarmyne, Mamle; Yan, Xiao; Sasine, Joshua; Zhao, Liman; Hancock, Grace V.; Kan, Jenny; Pohl, Katherine A.; Tran, Evelyn; Chao, Nelson J.; Harris, Jeffrey R.; Chute, John P.			Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms	NATURE MEDICINE			English	Article							STEM-CELL NICHE; BONE-MARROW; SELF-RENEWAL; LYMPHOID PROGENITORS; OXIDATIVE STRESS; WNT; MAINTENANCE; DIFFERENTIATION; RECONSTITUTION; ENGRAFTMENT	The role of osteolineage cells in regulating hematopoietic stem cell (HSC) regeneration following myelosuppression is not well understood. Here we show that deletion of the pro-apoptotic genes Bak and Bax in osterix (Osx, also known as Sp7 transcription factor 7)-expressing cells in mice promotes HSC regeneration and hematopoietic radioprotection following total body irradiation. These mice showed increased bone marrow (BM) levels of the protein dickkopf-1 (Dkk1), which was produced in Osx-expressing BM cells. Treatment of irradiated HSCs with Dkk1 in vitro increased the recovery of both long-term repopulating HSCs and progenitor cells, and systemic administration of Dkk1 to irradiated mice increased hematopoietic recovery and improved survival. Conversely, inducible deletion of one allele of Dkk1 in Osx-expressing cells in adult mice inhibited the recovery of BM stem and progenitor cells and of complete blood counts following irradiation. Dkk1 promoted hematopoietic regeneration via both direct effects on HSCs, in which treatment with Dkk1 decreased the levels of mitochondria! reactive oxygen species and suppressed senescence, and indirect effects on BM endothelial cells, in which treatment with Dkk1 induced epidermal growth factor (EGF) secretion. Accordingly, blockade of the EGF receptor partially abrogated Dkk1-mediated hematopoietic recovery. These data identify Dkk1 as a regulator of hematopoietic regeneration and demonstrate paracrine cross-talk between BM osteolineage cells and endothelial cells in regulating hematopoietic reconstitution following injury.	[Himburg, Heather A.; Quarmyne, Mamle; Yan, Xiao; Sasine, Joshua; Zhao, Liman; Kan, Jenny; Pohl, Katherine A.; Tran, Evelyn; Chute, John P.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90024 USA; [Doan, Phuong L.; Chao, Nelson J.; Harris, Jeffrey R.] Duke Univ, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA; [Quarmyne, Mamle; Yan, Xiao] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Hancock, Grace V.] Univ Calif Los Angeles, Dept Cell & Dev Biol, Los Angeles, CA USA; [Chute, John P.] Univ Calif Los Angeles, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA; [Chute, John P.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Duke University; Duke University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Chute, JP (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90024 USA.; Chute, JP (corresponding author), Univ Calif Los Angeles, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA.; Chute, JP (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.	jchute@mednet.ucla.edu	Doan, Phuong L./Q-2093-2019	Doan, Phuong L./0000-0003-1361-2068; Sasine, Joshua/0000-0001-9866-462X; Tran, Evelyn/0000-0002-3731-5255; Himburg, Heather/0000-0002-9676-6371	NHLBI [HL-086998-05]; NIAID [AI-067769-11, AI-107333]; California Institute for Regenerative Medicine Leadership Award [LA1-08014]; NIAID Centers for Medical Countermeasures Against Radiation (CMCR) Pilot Award [2U19AI067773-11]; NATIONAL CANCER INSTITUTE [K08CA184552] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067769, U19AI067773, U19AI067798, U01AI107333] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); California Institute for Regenerative Medicine Leadership Award; NIAID Centers for Medical Countermeasures Against Radiation (CMCR) Pilot Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Vainio (University of Oulu) for the Dkk1<SUP>FL/+</SUP> mice. This work was supported, in part, by NHLBI grant HL-086998-05 (J.P.C.), NIAID grants AI-067769-11 (J.P.C.) and AI-107333 (J.P.C.), the California Institute for Regenerative Medicine Leadership Award LA1-08014 (J.P.C.) and the NIAID Centers for Medical Countermeasures Against Radiation (CMCR) Pilot Award 2U19AI067773-11 (H.A.H.).	Boudousquie C, 2014, J IMMUNOL, V193, P2784, DOI 10.4049/jimmunol.1400465; Brault V, 2001, DEVELOPMENT, V128, P1253; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Cho J, 2014, J CLIN INVEST, V124, P3159, DOI 10.1172/JCI61636; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doan PL, 2013, NAT MED, V19, P295, DOI 10.1038/nm.3070; Doan PL, 2013, STEM CELLS, V31, P327, DOI 10.1002/stem.1275; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Famili F, 2016, STEM CELL REP, V6, P652, DOI 10.1016/j.stemcr.2016.04.009; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Huang J, 2012, NAT MED, V18, P1778, DOI 10.1038/nm.2984; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Ishikawa ET, 2012, P NATL ACAD SCI USA, V109, P9071, DOI 10.1073/pnas.1120358109; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kim IG, 2014, BIOCHEM BIOPH RES CO, V443, P49, DOI 10.1016/j.bbrc.2013.11.038; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lento W, 2014, GENE DEV, V28, P995, DOI 10.1101/gad.231944.113; Li WS, 2013, BLOOD, V121, P4063, DOI 10.1182/blood-2012-12-473470; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Luis TC, 2012, LEUKEMIA, V26, P414, DOI 10.1038/leu.2011.387; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Min JK, 2011, J CLIN INVEST, V121, P1882, DOI 10.1172/JCI42556; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Olson TS, 2013, BLOOD, V121, P5238, DOI 10.1182/blood-2012-10-463414; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Varnum-Finney B, 2011, J CLIN INVEST, V121, P1207, DOI 10.1172/JCI43868; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	60	48	50	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					91	99		10.1038/nm.4251	http://dx.doi.org/10.1038/nm.4251			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27918563	Green Accepted			2022-12-25	WOS:000391646800017
J	Patrick, EM; Srinivasan, S; Jankowsky, E; Comstock, MJ				Patrick, Eric M.; Srinivasan, Sukanya; Jankowsky, Eckhard; Comstock, Matthew J.			The RNA helicase Mtr4p is a duplex-sensing translocase	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEAR-RNA; RIBOSOMAL-RNA; BOX PROTEIN; ARCH DOMAIN; EXOSOME; DEGRADATION; TRAMP; MECHANISM; POLYADENYLATION; COORDINATION	The conserved Saccharomyces cerevisiae Ski2-like RNA helicase Mtr4p plays essential roles in eukaryotic nuclear RNA processing. RNA helicase activity of Mtr4p is critical for biological functions of the enzyme, but the molecular basis for RNA unwinding is not understood. Here, single-molecule high-resolution optical trapping measurements reveal that Mtr4p unwinds RNA duplexes by 3'-to-5' translocation on the loading strand, that strand separation occurs in discrete steps of 6 base pairs and that a single Mtr4p molecule performs consecutive unwinding steps. We further show that RNA unwinding by Mtr4p requires interaction with upstream RNA duplex. Inclusion of Mtr4p within the TRAMP complex increases the rate constant for unwinding initiation but does not change the characteristics of Mtr4p's helicase mechanism. Our data indicate that Mtr4p utilizes a previously unknown unwinding mode that combines aspects of canonical translocating helicases and non-canonical duplex-sensing helicases, thereby restricting directional translocation to duplex regions.	[Patrick, Eric M.; Comstock, Matthew J.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Srinivasan, Sukanya; Jankowsky, Eckhard] Case Western Univ, Ctr RNA Mol Biol, Cleveland, OH USA; [Srinivasan, Sukanya; Jankowsky, Eckhard] Case Western Univ, Dept Biochem, Cleveland, OH USA	Michigan State University; Case Western Reserve University; Case Western Reserve University	Comstock, MJ (corresponding author), Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA.	mjcomsto@msu.edu	Srinivasan, Sukanya/ABE-7326-2021	Jankowsky, Eckhard/0000-0001-7677-7412	US National Science Foundation [MCB-1514706]; US National Institutes of Health [R01 GM118088, GM099720]	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Comstock and Jankowsky laboratories for scientific discussion. Funding was provided by US National Science Foundation grant MCB-1514706 (to M.J.C.) and US National Institutes of Health grants R01 GM118088 and GM099720 (to E.J.).	Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Beran RKF, 2006, J MOL BIOL, V358, P974, DOI 10.1016/j.jmb.2006.02.078; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Bernstein Jade, 2012, World J Biol Chem, V3, P7, DOI 10.4331/wjbc.v3.i1.7; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023; Cisse II, 2012, NAT STRUCT MOL BIOL, V19, P623, DOI 10.1038/nsmb.2294; Comstock MJ, 2015, SCIENCE, V348, P352, DOI 10.1126/science.aaa0130; Comstock MJ, 2011, NAT METHODS, V8, P335, DOI 10.1038/NMETH.1574; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Jia HJ, 2012, P NATL ACAD SCI USA, V109, P7292, DOI 10.1073/pnas.1201085109; Jia HJ, 2011, CELL, V145, P890, DOI 10.1016/j.cell.2011.05.010; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Johnson SJ, 2013, RNA BIOL, V10, P33, DOI 10.4161/rna.22101; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lange H, 2011, PLANT J, V68, P51, DOI 10.1111/j.1365-313X.2011.04675.x; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148090; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu SX, 2014, CELL, V157, P702, DOI 10.1016/j.cell.2014.02.034; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Putnam AA, 2013, BBA-GENE REGUL MECH, V1829, P884, DOI 10.1016/j.bbagrm.2013.02.002; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Qi Z, 2013, ELIFE, V2, DOI 10.7554/eLife.00334; Qu XH, 2012, P NATL ACAD SCI USA, V109, P14458, DOI 10.1073/pnas.1208950109; Schmidt K, 2013, WIRES RNA, V4, P217, DOI 10.1002/wrna.1155; Schneider C, 2013, TRENDS BIOCHEM SCI, V38, P485, DOI 10.1016/j.tibs.2013.06.013; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sloan KE, 2014, RNA, V20, P540, DOI 10.1261/rna.043471.113; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Taylor LL, 2014, NUCLEIC ACIDS RES, V42, P13861, DOI 10.1093/nar/gku1208; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; Tinoco I, 2004, BIOCHEM SOC T, V32, P757, DOI 10.1042/BST0320757; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165	48	13	14	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					99	104		10.1038/NCHEMBIO.2234	http://dx.doi.org/10.1038/NCHEMBIO.2234			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27870836				2022-12-25	WOS:000393267200019
J	Terajima, H; Yoshitane, H; Ozaki, H; Suzuki, Y; Shimba, S; Kuroda, S; Iwasaki, W; Fukada, Y				Terajima, Hideki; Yoshitane, Hikari; Ozaki, Haruka; Suzuki, Yutaka; Shimba, Shigeki; Kuroda, Shinya; Iwasaki, Wataru; Fukada, Yoshitaka			ADARB 1 catalyzes circadian A-to-I editing and regulates RNA rhythm	NATURE GENETICS			English	Article							POSTTRANSCRIPTIONAL REGULATION; ABUNDANCE; CLOCK; BRAIN	It has been proposed that the CLOCK-ARNTL (BMAL1) complex drives circadian transcription of thousands of genes, including Per and Cry family genes that encode suppressors of CLOCK-ARNTL-dependent transcription(1-3). However, recent studies demonstrated that 70-80% of circadian-oscillating mRNAs have no obvious rhythms in their de novo transcription(4,5), indicating the potential importance of post-transcriptional regulation. Our CLOCK-ChIP-seq analysis identified rhythmic expression of adenosine deaminase, RNA-specific, B1 (Adarbl, also known as Adar2), an adenosine-to-inosine (A-to-I) RNA-editing enzyme. RNA-seq showed circadian rhythms of ADARB1-mediated A-to-I editing in a variety of transcripts. In Adarbl-knockout mice, rhythms of large populations of mRNA were attenuated, indicating a profound impact of ADARB1-mediated A-to-I editing on RNA rhythms. Furthermore, Adarb1-knockout mice exhibited short-period rhythms in locomotor activity and gene expression. These phenotypes were associated with abnormal accumulation of CRY2. The present study identifies A-to-I RNA editing as a key mechanism of post-transcriptional regulation in the circadian clockwork.	[Terajima, Hideki; Yoshitane, Hikari; Kuroda, Shinya; Iwasaki, Wataru; Fukada, Yoshitaka] Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo, Japan; [Ozaki, Haruka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Chiba, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan; [Shimba, Shigeki] Nihon Univ, Sch Pharm, Dept Hlth Sci, Chiba, Japan; [Ozaki, Haruka] RIKEN, Adv Ctr Comp & Commun, Bioinformat Res Unit, Saitama, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Nihon University; RIKEN	Yoshitane, H; Fukada, Y (corresponding author), Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo, Japan.	stane@mail.ecc.u-tokyo.ac.jp; sfukada@mail.ecc.u-tokyo.ac.jp	吉孝, 深田/G-5090-2014; Iwasaki, Wataru/O-4917-2014	Iwasaki, Wataru/0000-0002-9169-9245; Yoshitane, Hikari/0000-0001-6319-3354; Terajima, Hideki/0000-0002-6241-8002; Ozaki, Haruka/0000-0002-1606-2762	MEXT of Japan; Japan Prize foundation; Uchang Cho Institute of Science; JSPS research fellowship for young scientists	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Prize foundation(Japan Prize Foundation); Uchang Cho Institute of Science; JSPS research fellowship for young scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank K. Yugi, Y. Sugiura and T. Kokaji for their help with metabolic analysis, contributed to the manuscript. and we thank T. Nakagawa for his help with RNA-seq data analysis. We also thank J. Nakano for critical comments on the manuscript. Computations were partially performed on the NIG supercomputer at ROIS National Institute of Genetics. Adarb1<SUP>-/-</SUP>Gria2<SUP>R/R</SUP> mice were obtained from MMRRC 8U42OD010924-13. This work was partially supported by Grants-in-Aid for Scientific Research and Innovative Areas Genome Science from MEXT of Japan (to H.Y., W.I. and Y.F.), by the Japan Prize foundation (to H.Y.) and by Uchang Cho Institute of Science (to H.Y.). H.T. is supported by a JSPS research fellowship for young scientists.	Barbon A, 2003, MOL BRAIN RES, V117, P168, DOI 10.1016/S0169-328X(03)00317-6; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Huang H, 2012, NEURON, V73, P304, DOI 10.1016/j.neuron.2011.11.022; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Jepson JEC, 2011, J BIOL CHEM, V286, P8325, DOI 10.1074/jbc.M110.186817; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kiran AM, 2013, NUCLEIC ACIDS RES, V41, pD258, DOI 10.1093/nar/gks961; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kojima S, 2015, BIOCHEMISTRY-US, V54, P124, DOI 10.1021/bi500707c; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Lim C, 2013, NAT NEUROSCI, V16, P1544, DOI 10.1038/nn.3543; Liscovitch N, 2014, RNA BIOL, V11, P1448, DOI 10.4161/15476286.2014.992286; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Du NH, 2014, ELIFE, V3, DOI 10.7554/eLife.02510; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Vesely C, 2012, GENOME RES, V22, P1468, DOI 10.1101/gr.133025.111; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wang QD, 2000, J NEUROCHEM, V74, P1290; Wulff BE, 2011, NAT REV GENET, V12, P81, DOI 10.1038/nrg2915; Yoshitane H, 2014, MOL CELL BIOL, V34, P1776, DOI 10.1128/MCB.01465-13	34	52	54	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					146	151		10.1038/ng.3731	http://dx.doi.org/10.1038/ng.3731			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27893733				2022-12-25	WOS:000390976600021
J	Jarret, A; McFarland, AP; Horner, SM; Kell, A; Schwerk, J; Hong, M; Badil, S; Joslyn, RC; Baker, DP; Carrington, M; Hagedorn, CH; Gale, M; Savan, R				Jarret, Abigail; McFarland, Adelle P.; Horner, Stacy M.; Kell, Alison; Schwerk, Johannes; Hong, MeeAe; Badil, Samantha; Joslyn, Rochelle C.; Baker, Darren P.; Carrington, Mary; Hagedorn, Curt H.; Gale, Michael, Jr.; Savan, Ram			Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling	NATURE MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR MESSENGER-RNA; GENETIC-VARIATION; HCV INFECTION; IFN THERAPY; III IFN; EXPRESSION; IL28B; LIVER; ALPHA	Hepatitis C virus (HCV) infects 200 million people globally, and 60-80% of cases persist as a chronic infection that will progress to cirrhosis and liver cancer in 2-10% of patients(1-3). We recently demonstrated that HCV induces aberrant expression of two host microRNAs (miRNAs), miR-208b and miR-499a-5p, encoded by myosin genes in infected hepatocytes(4). These miRNAs, along with AU-rich-element-mediated decay, suppress IFNL2 and IFNL3, members of the type III interferon (IFN) gene family, to support viral persistence. In this study, we show that miR-208b and miR-499a-5p also dampen type I IFN signaling in HCV-infected hepatocytes by directly down-regulating expression of the type I IFN receptor chain, IFNAR1. Inhibition of these miRNAs by using miRNA inhibitors during HCV infection increased expression of IFNAR1. Additionally, inhibition rescued the antiviral response to exogenous type I IFN, as measured by a marked increase in IFN-stimulated genes and a decrease in HCV load. Treatment of HCV-infected hepatocytes with type I IFN increased expression of myosins over HCV infection alone. Since these miRNAs can suppress type III IFN family members, these data collectively define a novel cross-regulation between type I and III IFNs during HCV infection.	[Jarret, Abigail; McFarland, Adelle P.; Horner, Stacy M.; Kell, Alison; Schwerk, Johannes; Hong, MeeAe; Badil, Samantha; Joslyn, Rochelle C.; Gale, Michael, Jr.; Savan, Ram] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA USA; [Carrington, Mary] Frederick Natl Lab Canc Res, Canc & Inflammat Program, Expt Immunol Lab, Leidos Biomed Res Frederick, Frederick, MD USA; [Carrington, Mary] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA; [Hagedorn, Curt H.] Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA; [Hagedorn, Curt H.] Univ Arkansas Med Sci, Genet Program, Little Rock, AR 72205 USA; [Hagedorn, Curt H.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [McFarland, Adelle P.] Univ Washington, Dept Microbiol, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Horner, Stacy M.] Duke Univ, Med Ctr, Ctr Virol, Dept Mol Genet & Microbiol, Durham, NC USA; [Baker, Darren P.] Sanofi Genzyme, Cambridge, MA USA	University of Washington; University of Washington Seattle; Biogen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Washington; University of Washington Seattle; Duke University; Sanofi-Aventis; Genzyme Corporation	Savan, R (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	savanram@uw.edu	Schwerk, Johannes/AAN-2937-2020	McFarland, Adelle/0000-0001-7534-1158; Kell, Alison/0000-0001-5550-1038; Schwerk, Johannes/0000-0002-5964-7162; Savan, Ram/0000-0002-3087-1355; Horner, Stacy/0000-0002-9351-7409	NATIONAL CANCER INSTITUTE [ZIABC010791, R21CA148068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108765, U19AI040035, R01AI060389, R01AI118916, R56AI060389] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA148068, HHSN261200800001E] Funding Source: Medline; NIAID NIH HHS [R01 AI118916, R01 AI108765, N01AI40035, R56 AI060389, R01 AI060389] Funding Source: Medline; CCR NIH HHS [HHSN261200800001C] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CCR NIH HHS		Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Chandra PK, 2014, AM J PATHOL, V184, P214, DOI 10.1016/j.ajpath.2013.10.005; de Castellarnau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031016; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Eldrup AB, 2004, J MED CHEM, V47, P5284, DOI 10.1021/jm040068f; Fukuda R, 1996, J GASTROENTEROL, V31, P806, DOI 10.1007/BF02358606; Fukuda R, 1997, J HEPATOL, V26, P455, DOI 10.1016/S0168-8278(97)80407-2; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gonzalez G, 2007, J VIROL METHODS, V145, P14, DOI 10.1016/j.jviromet.2007.04.013; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jayasekera CR, 2014, NEW ENGL J MED, V370, P1869, DOI 10.1056/NEJMp1400160; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Liu SH, 2011, ANTIVIR RES, V89, P54, DOI 10.1016/j.antiviral.2010.11.004; Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050; Mathai J, 1999, J INTERF CYTOK RES, V19, P1011, DOI 10.1089/107999099313226; McFarland AP, 2014, NAT IMMUNOL, V15, P72, DOI 10.1038/ni.2758; Morita K, 1999, J MED VIROL, V58, P359, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;359::AID-JMV7&gt;3.0.CO;2-S; Morita K, 1998, J CLIN GASTROENTEROL, V26, P135, DOI 10.1097/00004836-199803000-00010; Muir AJ, 2014, J HEPATOL, V61, P1238, DOI 10.1016/j.jhep.2014.07.022; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Pearlman BL, 2012, LANCET INFECT DIS, V12, P717, DOI 10.1016/S1473-3099(12)70060-9; Pedergnana V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038578; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Schwerk J, 2015, CURR OPIN VIROL, V12, P75, DOI 10.1016/j.coviro.2015.02.006; Sheahan T, 2014, CELL HOST MICROBE, V15, P190, DOI 10.1016/j.chom.2014.01.007; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Welzel TM, 2009, HEPATOLOGY, V49, P1847, DOI 10.1002/hep.22877; Zeuzem S, 2011, J HEPATOL, V54, pS538, DOI 10.1016/S0168-8278(11)61362-7	41	33	34	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1475	+		10.1038/nm.4211	http://dx.doi.org/10.1038/nm.4211			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27841874	Green Accepted			2022-12-25	WOS:000389549000026
J	Aumeier, C; Schaedel, L; Gaillard, J; John, K; Blanchoin, L; Thery, M				Aumeier, Charlotte; Schaedel, Laura; Gaillard, Jeremie; John, Karin; Blanchoin, Laurent; Thery, Manuel			Self-repair promotes microtubule rescue	NATURE CELL BIOLOGY			English	Article							DYNAMIC INSTABILITY; IN-VITRO; TRANSITION FREQUENCIES; CELL-MIGRATION; GTP HYDROLYSIS; TUBULIN; PROTEINS; ENDS; POLARITY; KATANIN	The dynamic instability of microtubules is characterized by slow growth phases stochastically interrupted by rapid depolymerizations called catastrophes. Rescue events can arrest the depolymerization and restore microtubule elongation. However, the origin of these rescue events remains unexplained. Here we show that microtubule lattice self-repair, in structurally damaged sites, is responsible for the rescue of microtubule growth. Tubulin photo-conversion in cells revealed that free tubulin dimers can incorporate along the shafts of microtubules, especially in regions where microtubules cross each other, form bundles or become bent due to mechanical constraints. These incorporation sites appeared to act as effective rescue sites ensuring microtubule rejuvenation. By securing damaged microtubule growth, the self-repair process supports a mechanosensitive growth by specifically promoting microtubule assembly in regions where they are subjected to physical constraints.	[Aumeier, Charlotte; Schaedel, Laura; Gaillard, Jeremie; Blanchoin, Laurent; Thery, Manuel] Univ Grenoble Alpes, CytoMorpho Lab, Biosci & Biotechnol Inst Grenoble, CEA,INRA,CNRS,UMR5168, F-38054 Grenoble, France; [John, Karin] Univ Grenoble Alpes, CNRS, Lab Interdisciplinaire Phys, F-38402 St Martin Dheres, France; [Blanchoin, Laurent; Thery, Manuel] Univ Paris Diderot, INSERM, CytoMorpho Lab, Hop St Louis,Inst Univ Hematol,UMRS1160, F-75010 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Blanchoin, L; Thery, M (corresponding author), Univ Grenoble Alpes, CytoMorpho Lab, Biosci & Biotechnol Inst Grenoble, CEA,INRA,CNRS,UMR5168, F-38054 Grenoble, France.; Blanchoin, L; Thery, M (corresponding author), Univ Paris Diderot, INSERM, CytoMorpho Lab, Hop St Louis,Inst Univ Hematol,UMRS1160, F-75010 Paris, France.	laurent.blanchoin@cea.fr; manuel.thery@cea.fr		John, Karin/0000-0003-1678-6880; Aradilla Zapata, Laura/0000-0002-7317-3696; Aumeier, Charlotte/0000-0002-0629-1721	HFSP [RGY0088/2012]; ANR [ANR-12-BSV5-0014]; ERC [310472]	HFSP(Human Frontier Science Program); ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission)	We thank G. Montagnac for sharing his unpublished data on tubulin photo activation in cells; and F. Perez and C. Pous for sharing their unpublished data on the microtubule rescue by CLIP170. This work has been supported by HFSP (RGY0088/2012), ANR funding (ANR-12-BSV5-0014) and ERC (Starting Grant 310472).	Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Akhtar N, 2013, NAT CELL BIOL, V15, P17, DOI 10.1038/ncb2646; Al-Bassam J, 2010, DEV CELL, V19, P245, DOI 10.1016/j.devcel.2010.07.016; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; Billger MA, 1996, BIOCHEMISTRY-US, V35, P13656, DOI 10.1021/bi9616965; Bowne-Anderson H, 2013, BIOESSAYS, V35, P452, DOI 10.1002/bies.201200131; Charafeddine RA, 2015, J INVEST DERMATOL, V135, P2309, DOI 10.1038/jid.2015.94; Davis LJ, 2002, BIOPHYS J, V82, P2916, DOI 10.1016/S0006-3495(02)75632-4; Diaz-Valencia JD, 2011, BIOPHYS J, V100, P2440, DOI 10.1016/j.bpj.2011.03.062; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Doodhi H, 2014, CURR BIOL, V24, P322, DOI 10.1016/j.cub.2014.01.005; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Gardner MK, 2013, CURR OPIN CELL BIOL, V25, P14, DOI 10.1016/j.ceb.2012.09.006; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Komarova YA, 2002, J CELL SCI, V115, P3527; KOWALSKI RJ, 1993, J BIOL CHEM, V268, P9847; Labbe JC, 2003, CURR BIOL, V13, P707, DOI 10.1016/S0960-9822(03)00251-3; Mimori-Kiyosue Y, 2011, CYTOSKELETON, V68, P603, DOI 10.1002/cm.20540; Portran D, 2013, CYTOSKELETON, V70, P12, DOI 10.1002/cm.21081; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Schaedel L, 2015, NAT MATER, V14, P1156, DOI [10.1038/NMAT4396, 10.1038/nmat4396]; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; Stiess M, 2010, SCIENCE, V327, P704, DOI 10.1126/science.1182179; Tropini C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030103; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Wadsworth P, 1999, CELL MOTIL CYTOSKEL, V42, P48, DOI 10.1002/(SICI)1097-0169(1999)42:1<48::AID-CM5>3.3.CO;2-#; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WALKER RA, 1989, J CELL BIOL, V108, P931, DOI 10.1083/jcb.108.3.931; Ward A, 2015, NAT MATER, V14, P583, DOI [10.1038/NMAT4222, 10.1038/nmat4222]; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wightman R, 2007, PLANT J, V52, P742, DOI 10.1111/j.1365-313X.2007.03271.x; Winans AM, 2016, ELIFE, V5, DOI 10.7554/eLife.12387; Yi JS, 2013, J CELL BIOL, V202, P779, DOI 10.1083/jcb.201301004; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206; Zhang Q, 2013, CURR BIOL, V23, P2191, DOI 10.1016/j.cub.2013.09.018	45	85	85	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2016	18	10					1054	1064		10.1038/ncb3406	http://dx.doi.org/10.1038/ncb3406			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DY2ZX	27617929	Green Accepted			2022-12-25	WOS:000384961700005
J	Mondal, M; Casals, F; Xu, T; Dall'Olio, GM; Pybus, M; Netea, MG; Comas, D; Laayouni, H; Li, QB; Majumder, PP; Bertranpetit, J				Mondal, Mayukh; Casals, Ferran; Xu, Tina; Dall'Olio, Giovanni M.; Pybus, Marc; Netea, Mihai G.; Comas, David; Laayouni, Hafid; Li, Qibin; Majumder, Partha P.; Bertranpetit, Jaume			Genomic analysis of Andamanese provides insights into ancient human migration into Asia and adaptation	NATURE GENETICS			English	Article							POPULATION HISTORY; POSITIVE SELECTION; GENETIC-VARIATION; WIDE ASSOCIATION; SEQUENCE; NEANDERTHAL; COMPONENTS; ADMIXTURE; DISTINCT; MODEL	To shed light on the peopling of South Asia and the origins of the morphological adaptations found there, we analyzed whole-genome sequences from 10 Andamanese individuals and compared them with sequences for 60 individuals from mainland Indian populations with different ethnic histories and with publicly available data from other populations. We show that all Asian and Pacific populations share a single origin and expansion out of Africa, contradicting an earlier proposal of two independent waves of migration(1-4). We also show that populations from South and Southeast Asia harbor a small proportion of ancestry from an unknown extinct hominin, and this ancestry is absent from Europeans and East Asians. The footprints of adaptive selection in the genomes of the Andamanese show that the characteristic distinctive phenotypes of this population (including very short stature) do not reflect an ancient African origin but instead result from strong natural selection on genes related to human body size.	[Mondal, Mayukh; Pybus, Marc; Comas, David; Laayouni, Hafid; Bertranpetit, Jaume] Univ Pompeu Fabra, Inst Biol Evolutiva UPF CSIC, Barcelona, Spain; [Casals, Ferran] Univ Pompeu Fabra, Serv Genom, Barcelona, Spain; [Xu, Tina] BGI Shenzhen, Shenzhen, Peoples R China; [Dall'Olio, Giovanni M.] GlaxoSmithKline, GSK R&D, Computat Biol Target Sci, Stevenage, Herts, England; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Laayouni, Hafid] Univ Autonoma Barcelona, Dept Genet Microbiol, Bellaterra, Spain; [Majumder, Partha P.] Natl Inst BioMed Gen, Kalyani, W Bengal, India; [Bertranpetit, Jaume] Univ Cambridge, Dept Archaeol & Anthropol, Leverhulrne Ctr Human Evolutionary Studies, Cambridge, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Pompeu Fabra University; Beijing Genomics Institute (BGI); GlaxoSmithKline; Radboud University Nijmegen; Autonomous University of Barcelona; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); University of Cambridge	Bertranpetit, J (corresponding author), Univ Pompeu Fabra, Inst Biol Evolutiva UPF CSIC, Barcelona, Spain.; Majumder, PP (corresponding author), Natl Inst BioMed Gen, Kalyani, W Bengal, India.; Bertranpetit, J (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Leverhulrne Ctr Human Evolutionary Studies, Cambridge, England.	jaume.bertanpetit@upf.edu; ppm1@nibrng.ac.in	Mondal, Mayukh/M-5476-2015; Laayouni, Hafid/AAA-9254-2019; Netea, Mihai/N-5155-2014; Bertranpetit, Jaume/F-8550-2012; Casals, Ferran/H-4347-2015; Comas, David/D-5382-2014	Mondal, Mayukh/0000-0003-0122-0323; Laayouni, Hafid/0000-0003-1297-5078; Bertranpetit, Jaume/0000-0003-0100-0590; Casals, Ferran/0000-0002-8941-0369; Comas, David/0000-0002-5075-0956; Pybus, Marc/0000-0002-6195-5738	Ministerio de Economia y Competitividad (Spain) [PRI-PIBIN-2011-0942, FU2013-43726-P]; Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement de la Generalitat de Catalunya [GRC 2014 SGR866]	Ministerio de Economia y Competitividad (Spain); Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya)	J. Nye and C. Tyler-Smith kindly corrected the manuscript in depth. Thanks are given to R.A. Foley for discussion and inspiring input for Figure 3. Our main funding was provided by the joint Spain-India bilateral grant PRI-PIBIN-2011-0942 from the Ministerio de Economia y Competitividad (Spain). Complementary funding was provided by grant BFU2013-43726-P from the Ministerio de Economia y Competitividad (Spain), with the support of Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement de la Generalitat de Catalunya (GRC 2014 SGR866).	Abbi A, 2009, LANG SCI, V31, P791, DOI 10.1016/j.langsci.2008.02.002; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Basu A, 2016, P NATL ACAD SCI USA, V113, P1594, DOI 10.1073/pnas.1513197113; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Brown, 1922, ANDAMAN ISLANDERS ST; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Coon C. S., 1966, LIVING RACES MAN; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dass F. A. M., 1937, THE ANDAMAN ISLANDS; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huxley T. H, 1870, J ETHNOLOGICAL SOC L, V2, P404, DOI DOI 10.2307/3014371; Juyal G, 2014, HUM GENET, V133, P1273, DOI 10.1007/s00439-014-1462-0; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Molnar Stephen., 2015, HUMAN VARIATION RACE; Montgomery SH, 2013, J HUM EVOL, V65, P750, DOI 10.1016/j.jhevol.2013.08.006; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pybus M, 2015, BIOINFORMATICS, V31, P3946, DOI 10.1093/bioinformatics/btv493; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; TAJIMA F, 1989, GENETICS, V123, P585; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Zoledziewska M, 2015, NAT GENET, V47, P1352, DOI 10.1038/ng.3403	53	79	79	3	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1066	+		10.1038/ng.3621	http://dx.doi.org/10.1038/ng.3621			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	DU7MQ	27455350	Green Accepted			2022-12-25	WOS:000382398800019
J	Payumo, AY; McQuade, LE; Walker, WJ; Yamazoe, S; Chen, JK				Payumo, Alexander Y.; McQuade, Lindsey E.; Walker, Whitney J.; Yamazoe, Sayumi; Chen, James K.			Tbx16 regulates hox gene activation in mesodermal progenitor cells	NATURE CHEMICAL BIOLOGY			English	Article							CAUSES SPONDYLOCOSTAL DYSOSTOSIS; NO-TAIL; ZEBRAFISH; SPADETAIL; FATE; WNT; MUTATION; BMP; IDENTIFICATION; MORPHOGENESIS	The transcription factor T-box 16 (Tbx16, or Spadetail) is an essential regulator of paraxial mesoderm development in zebrafish (Danio rerio). Mesodermal progenitor cells (MPCs) fail to differentiate into trunk somites in tbx16 mutants and instead accumulate within the tailbud in an immature state. However, the mechanisms by which Tbx16 controls mesoderm patterning have remained enigmatic. We describe here the use of photoactivatable morpholino oligonucleotides to determine the Tbx16 transcriptome in MPCs. We identified 124 Tbx16-regulated genes that were expressed in zebrafish gastrulae, including several developmental signaling proteins and regulators of gastrulation, myogenesis and somitogenesis. Unexpectedly, we observed that a loss of Tbx16 function precociously activated posterior hox genes in MPCs, and overexpression of a single posterior hox gene was sufficient to disrupt MPC migration. Our studies support a model in which Tbx16 regulates the timing of collinear hox gene activation to coordinate the anterior-posterior fates and positions of paraxial MPCs.	[Payumo, Alexander Y.; McQuade, Lindsey E.; Walker, Whitney J.; Yamazoe, Sayumi; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Chen, James K.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [McQuade, Lindsey E.] Univ Illinois, Coll Pharm, Chicago, IL USA; [Yamazoe, Sayumi] Genentech Inc, Discovery Chem, San Francisco, CA 94080 USA	Stanford University; Stanford University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Roche Holding; Genentech	Chen, JK (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Chen, JK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	jameschen@stanford.edu	Chen, James/G-9972-2011	Chen, James/0000-0002-9220-8436	NIH [DP1 HD075622, R01 GM087292, R01 GM108952, P50 GM107615]; A.P. Giannini Foundation Fellowship for Medical Research; Japan Society for the Promotion of Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, R01GM108952, R01GM087292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A.P. Giannini Foundation Fellowship for Medical Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Crumpton, B. Gomez and O. Herman of the Stanford Shared FACS Facility for technical assistance with flow cytometry, Z. Weng of the Stanford Sequencing Service Center for assistance with RNA library sequencing, I. Yanai and F. Wagner for assistance with sequence-read processing, S. Amacher (Ohio State University) for tbx16<SUP>b104/+</SUP> zebrafish, M. Lardelli (University of Adelaide), G. Lieschke (Monash University) and H. Okamoto (RIKEN Brain Science Institute) for plasmids, and K. Mruk for helpful discussions. This work was supported by the NIH (DP1 HD075622, R01 GM087292 and R01 GM108952 to J.K.C.; P50 GM107615 to the Stanford Center for Systems Biology), an A.P. Giannini Foundation Fellowship for Medical Research (L.E.M.) and a Japan Society for the Promotion of Science Fellowship (S.Y.).	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Bouldin CM, 2015, DEVELOPMENT, V142, P2499, DOI 10.1242/dev.124024; Denans N, 2015, ELIFE, V4, DOI 10.7554/eLife.04379; Eckalbar WL, 2012, WIRES DEV BIOL, V1, P401, DOI 10.1002/wdev.34; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Fior R, 2012, DEVELOPMENT, V139, P4656, DOI 10.1242/dev.078923; Garnett AT, 2009, DEVELOPMENT, V136, P749, DOI 10.1242/dev.024703; Griffin KJP, 2002, NAT CELL BIOL, V4, P821, DOI 10.1038/ncb862; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Harvey SA, 2010, DEVELOPMENT, V137, P1127, DOI 10.1242/dev.046318; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; HO RK, 1992, DEVELOPMENT, P65; Holley SA, 2006, GENE DEV, V20, P1831, DOI 10.1101/gad.1453706; Hubaud A, 2014, NAT REV MOL CELL BIO, V15, P709, DOI 10.1038/nrm3891; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Jung-Hwan Kim, 2011, International Journal of Service Science, Management, Engineering, and Technology, V2, P1, DOI 10.4018/jssmet.2011070101; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1989, NATURE, V337, P358, DOI 10.1038/337358a0; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Mallo M, 2009, INT J DEV BIOL, V53, P1469, DOI 10.1387/ijdb.072276mm; Manning AJ, 2015, DEV BIOL, V406, P172, DOI 10.1016/j.ydbio.2015.09.001; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Martin BL, 2012, DEV CELL, V22, P223, DOI 10.1016/j.devcel.2011.11.001; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; Mich JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103661; Montavon T, 2014, SEMIN CELL DEV BIOL, V34, P76, DOI 10.1016/j.semcdb.2014.06.005; Mueller RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-492; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Neave B, 1997, MECH DEVELOP, V62, P183, DOI 10.1016/S0925-4773(97)00659-X; O'Neill K, 2013, DEV BIOL, V375, P117, DOI 10.1016/j.ydbio.2012.12.002; Payumo AY, 2015, ACS CHEM BIOL, V10, P1466, DOI 10.1021/cb5010178; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Row RH, 2009, DEV BIOL, V329, P55, DOI 10.1016/j.ydbio.2009.02.016; Sato T, 2006, GENESIS, V44, P136, DOI 10.1002/gene.20196; Scaal M, 2016, SEMIN CELL DEV BIOL, V49, P83, DOI 10.1016/j.semcdb.2015.11.003; Shestopalov IA, 2007, NAT CHEM BIOL, V3, P650, DOI 10.1038/nchembio.2007.30; Shestopalov IA, 2012, NAT CHEM BIOL, V8, P270, DOI [10.1038/nchembio.772, 10.1038/NCHEMBIO.772]; Sparrow DB, 2006, AM J HUM GENET, V78, P28, DOI 10.1086/498879; Sparrow DB, 2008, HUM MOL GENET, V17, P3761, DOI 10.1093/hmg/ddn272; Szeto DP, 2006, GENE DEV, V20, P1923, DOI 10.1101/gad.1435306; THISSE B, ZFIN DIRECT DATA SUB; Turnpenny PD, 2003, J MED GENET, V40, P333, DOI 10.1136/jmg.40.5.333; Warga RM, 2013, DEV BIOL, V383, P75, DOI 10.1016/j.ydbio.2013.08.018; Warga RM, 1999, DEVELOPMENT, V126, P827; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wells S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021559; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053; Yabe T, 2012, DEV BIOL, V370, P213, DOI 10.1016/j.ydbio.2012.07.029; Yamamoto A, 1998, DEVELOPMENT, V125, P3389; Yamazoe S, 2014, ANGEW CHEM INT EDIT, V53, P10114, DOI 10.1002/anie.201405355; Yamazoe S, 2012, ANGEW CHEM INT EDIT, V51, P6908, DOI 10.1002/anie.201201690; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	56	10	10	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					694	+		10.1038/nchembio.2124	http://dx.doi.org/10.1038/nchembio.2124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27376691	Green Accepted			2022-12-25	WOS:000382255100010
J	Ren, AM; Vusurovic, N; Gebetsberger, J; Gao, P; Juen, M; Kreutz, C; Micura, R; Patel, DJ				Ren, Aiming; Vusurovic, Nikola; Gebetsberger, Jennifer; Gao, Pu; Juen, Michael; Kreutz, Christoph; Micura, Ronald; Patel, Dinshaw J.			Pistol ribozyme adopts a pseudoknot fold facilitating site-specific in-line cleavage	NATURE CHEMICAL BIOLOGY			English	Article							SELF-CLEAVING RIBOZYMES; DELTA VIRUS RIBOZYME; VARKUD SATELLITE RIBOZYME; CRYSTAL-STRUCTURE; TWISTER RIBOZYME; HAIRPIN RIBOZYME; STRUCTURAL BASIS; RNA; CATALYSIS; STATE	The field of small self-cleaving nucleolytic ribozymes has been invigorated by the recent discovery of the twister, twister-sister, pistol and hatchet ribozymes. We report the crystal structure of a pistol ribozyme termed env25, which adopts a compact tertiary architecture stabilized by an embedded pseudoknot fold. The G-U cleavage site adopts a splayed-apart conformation with in-line alignment of the modeled 2'-O of G for attack on the adjacent to-be-cleaved P-O5' bond. Highly conserved residues G40 (N1 position) and A32 (N3 and 2'-OH positions) are aligned to act as a general base and a general acid, respectively, to accelerate cleavage chemistry, with their roles confirmed by cleavage assays on variants, and an increased pK(a) of 4.7 for A32. Our structure of the pistol ribozyme defined how the overall and local topologies dictate the in-line alignment at the G-U cleavage site, with cleavage assays on variants revealing key residues that participate in acid-base-catalyzed cleavage chemistry.	[Ren, Aiming] Zhejiang Univ, Inst Life Sci, Hangzhou, Zhejiang, Peoples R China; [Ren, Aiming; Gao, Pu; Patel, Dinshaw J.] Mem Sloan Kettering Canc, Struct Biol Program, New York, NY USA; [Vusurovic, Nikola; Gebetsberger, Jennifer; Juen, Michael; Kreutz, Christoph; Micura, Ronald] Leopold Franzens Univ, Inst Organ Chem, Innsbruck, Austria; [Vusurovic, Nikola; Gebetsberger, Jennifer; Juen, Michael; Kreutz, Christoph; Micura, Ronald] Ctr Mol Biosci CMBI, Innsbruck, Austria	Zhejiang University; Memorial Sloan Kettering Cancer Center; University of Innsbruck	Patel, DJ (corresponding author), Mem Sloan Kettering Canc, Struct Biol Program, New York, NY USA.; Micura, R (corresponding author), Leopold Franzens Univ, Inst Organ Chem, Innsbruck, Austria.; Micura, R (corresponding author), Ctr Mol Biosci CMBI, Innsbruck, Austria.	ronald.micura@uibk.ac.at; pateld@mskcc.org	Kreutz, Christoph/AAH-2302-2019		National Institute of General Medical Sciences from US National Institutes of Health (NIH) [P41 GM103403]; US DOE [DE-AC02-06CH11357]; Zhejiang University; Thousand Young Talents Plan of China; US NIH [1 U19 CA179564]; Memorial Sloan-Kettering Cancer Center Core Grant [P30 CA008748]; Austrian Science Fund FWF [P27947, I1040, P26550, P28725]; Swiss National Foundation SNF; Austrian Science Fund (FWF) [P 27947, I 1040] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748, U19CA179564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from US National Institutes of Health (NIH); US DOE(United States Department of Energy (DOE)); Zhejiang University; Thousand Young Talents Plan of China; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan-Kettering Cancer Center Core Grant; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Swiss National Foundation SNF(Swiss National Science Foundation (SNSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge assistance by staff at Northeastern Collaborative Access Team (NE-CAT) beamlines at the Advanced Photon Source and the experimental station 14-1 at the Stanford Synchrotron Radiation Light Source. X-ray diffraction studies were conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by a grant from the National Institute of General Medical Sciences (P41 GM103403) from the US National Institutes of Health (NIH). Use of the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the US DOE under contract DE-AC02-06CH11357. A.R. was supported in part by new faculty start-up funds from Zhejiang University and the Thousand Young Talents Plan of China. The research was supported by US NIH grant 1 U19 CA179564 to D.J.P., by the Memorial Sloan-Kettering Cancer Center Core Grant (P30 CA008748), and the Austrian Science Fund FWF (P27947, I1040 to R.M., P26550, P28725 to C.K.), and the Swiss National Foundation SNF (Early Postdoc.Mobility to J.G.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BUZAYAN JM, 1986, NATURE, V323, P349, DOI 10.1038/323349a0; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Cochrane JC, 2008, ACCOUNTS CHEM RES, V41, P1027, DOI 10.1021/ar800050c; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Doherty EA, 2000, ANNU REV BIOCHEM, V69, P597, DOI 10.1146/annurev.biochem.69.1.597; Eiler D, 2014, P NATL ACAD SCI USA, V111, P13028, DOI 10.1073/pnas.1414571111; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlacher MD, 2006, J AM CHEM SOC, V128, P4453, DOI 10.1021/ja0588454; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Ferre-D'Amare AR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003574; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Gaines CS, 2016, J AM CHEM SOC, V138, P3058, DOI 10.1021/jacs.5b12061; Harris KA, 2015, RNA, V21, P1852, DOI 10.1261/rna.052514.115; HUTCHINS CJ, 1986, NUCLEIC ACIDS RES, V14, P3627, DOI 10.1093/nar/14.9.3627; Jeong S, 2003, BIOCHEMISTRY-US, V42, P7727, DOI 10.1021/bi034627g; Jimenez RM, 2015, TRENDS BIOCHEM SCI, V40, P648, DOI 10.1016/j.tibs.2015.09.001; Kapinos LE, 2011, CHEM-EUR J, V17, P8156, DOI 10.1002/chem.201003544; Ke AL, 2004, NATURE, V429, P201, DOI 10.1038/nature02522; Kirk SR, 2001, BIOORGAN MED CHEM, V9, P2295, DOI 10.1016/S0968-0896(01)00123-7; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Kosutic M, 2015, ANGEW CHEM INT EDIT, V54, P15128, DOI 10.1002/anie.201506601; Lilley DMJ, 2011, PHILOS T R SOC B, V366, P2910, DOI 10.1098/rstb.2011.0132; Lilley DMJ, 2004, RNA, V10, P151, DOI 10.1261/rna.5217104; Liu YJ, 2014, NAT CHEM BIOL, V10, P739, DOI [10.1038/nchembio.1587, 10.1038/NCHEMBIO.1587]; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Mir A, 2016, BIOCHEMISTRY-US, V55, P633, DOI 10.1021/acs.biochem.5b01139; Mir A, 2015, BIOCHEMISTRY-US, V54, P6369, DOI 10.1021/acs.biochem.5b00824; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perreault J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002031; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; Ren AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6534; Roth A, 2014, NAT CHEM BIOL, V10, P56, DOI [10.1038/nchembio.1386, 10.1038/NCHEMBIO.1386]; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Suslov NB, 2015, NAT CHEM BIOL, V11, P840, DOI 10.1038/nchembio.1929; Watson PY, 2012, NAT CHEM BIOL, V8, P963, DOI [10.1038/nchembio.1095, 10.1038/NCHEMBIO.1095]; Webb CHT, 2011, RNA BIOL, V8, P719, DOI 10.4161/rna.8.5.16226; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Weinberg Z, 2015, NAT CHEM BIOL, V11, P606, DOI [10.1038/NCHEMBIO.1846, 10.1038/nchembio.1846]; Wilcox JL, 2013, BIOCHEMISTRY-US, V52, P7470, DOI 10.1021/bi400768q; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Wunderlich C., 2015, THESIS	44	53	57	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					702	+		10.1038/nchembio.2125	http://dx.doi.org/10.1038/nchembio.2125			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27398999	Green Accepted			2022-12-25	WOS:000382255100011
J	Cha, PH; Cho, YH; Lee, SK; Lee, J; Jeong, WJ; Moon, BS; Yun, JH; Yang, JS; Choi, S; Yoon, J; Kim, HY; Kim, MY; Kaduwal, S; Lee, W; Min, DS; Kim, H; Han, G; Choi, KY				Cha, Pu-Hyeon; Cho, Yong-Hee; Lee, Sang-Kyu; Lee, JaeHeon; Jeong, Woo-Jeong; Moon, Byoung-San; Yun, Ji-Hye; Yang, Jee Sun; Choi, Sooho; Yoon, Juyong; Kim, Hyun-Yi; Kim, Mi-Yeon; Kaduwal, Saluja; Lee, Weontae; Min, Do Sik; Kim, Hoguen; Han, Gyoonhee; Choi, Kang-Yell			Small-molecule binding of the axin RGS domain promotes beta-catenin and Ras degradation	NATURE CHEMICAL BIOLOGY			English	Article							COLORECTAL-CANCER; WNT/BETA-CATENIN; K-RAS; MULTIPLE MUTATIONS; ACTIVATION; APC; PATHWAY; INHIBITION; STABILITY; CELLS	Both the Wnt/beta-catenin and Ras pathways are aberrantly activated in most human colorectal cancers (CRCs) and interact cooperatively in tumor promotion. Inhibition of these signaling may therefore be an ideal strategy for treating CRC. We identified KY1220, a compound that destabilizes both beta-catenin and Ras, via targeting the Wnt/beta-catenin pathway, and synthesized its derivative KYA1797K. KYA1797K bound directly to the regulators of G-protein signaling domain of axin, initiating beta-catenin and Ras degradation through enhancement of the beta-catenin destruction complex activating GSK3 beta. KYA1797K effectively suppressed the growth of CRCs harboring APC and KRAS mutations, as shown by various in vitro studies and by in vivo studies using xenograft and transgenic mouse models of tumors induced by APC and KRAS mutations. Destabilization of both beta-catenin and Ras via targeting axin is a potential therapeutic strategy for treatment of CRC and other type cancers activated Wnt/beta-catenin and Ras pathways.	[Cha, Pu-Hyeon; Cho, Yong-Hee; Lee, Sang-Kyu; Lee, JaeHeon; Jeong, Woo-Jeong; Moon, Byoung-San; Yun, Ji-Hye; Yang, Jee Sun; Choi, Sooho; Yoon, Juyong; Kim, Hyun-Yi; Kim, Mi-Yeon; Kaduwal, Saluja; Lee, Weontae; Min, Do Sik; Han, Gyoonhee; Choi, Kang-Yell] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul, South Korea; [Cha, Pu-Hyeon; Cho, Yong-Hee; Lee, Sang-Kyu; Lee, JaeHeon; Jeong, Woo-Jeong; Moon, Byoung-San; Yang, Jee Sun; Yoon, Juyong; Kim, Hyun-Yi; Kim, Mi-Yeon; Kaduwal, Saluja; Han, Gyoonhee; Choi, Kang-Yell] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea; [Yun, Ji-Hye; Choi, Sooho; Lee, Weontae] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul, South Korea; [Min, Do Sik] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Pusan, South Korea; [Kim, Hoguen] Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University; Pusan National University; Yonsei University; Yonsei University Health System	Choi, KY (corresponding author), Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul, South Korea.; Choi, KY (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea.	kychoi@yonsei.ac.kr	LEE, WEON TAE/AAQ-9088-2021; cha, puhyeon/ABA-7719-2020; Moon, Byoung-San/AAK-1554-2020	Kim, Mi-Yeon/0000-0002-7929-865X; Lee, Weontae/0000-0003-2347-1262; Yoon, Juyong/0000-0002-6617-0083	National Research Foundation of Korea (NRF) grant - Korean Government (MSIP) [2016R1A5A1004694, 2015R1A2A1A05001873]; NRF	National Research Foundation of Korea (NRF) grant - Korean Government (MSIP); NRF	We thank B. Vogelstein, K.W. Kinzler, J.-W. Oh, N.-C. Ha and E.-h. Jho for providing cells and reagents. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (grants 2016R1A5A1004694, 2015R1A2A1A05001873). Y.-H.C. and S.C. were supported by a BK21 studentship from the NRF.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chung DC, 2000, GASTROENTEROLOGY, V119, P854, DOI 10.1053/gast.2000.16507; DAbaco GM, 1996, MOL CELL BIOL, V16, P884; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Guardavaccaro D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002921; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hawk ET, 2005, J CLIN ONCOL, V23, P378, DOI 10.1200/JCO.2005.08.097; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jeon SH, 2007, J BIOL CHEM, V282, P14482, DOI 10.1074/jbc.M611129200; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Kim MY, 2010, NEUROSCIENCE, V170, P8, DOI 10.1016/j.neuroscience.2010.07.020; Kim S, 2010, J BIOL CHEM, V285, P36420, DOI 10.1074/jbc.M110.137471; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Luo FJ, 2009, INT J EXP PATHOL, V90, P558, DOI 10.1111/j.1365-2613.2009.00667.x; Mo HB, 1999, J NUTR, V129, P804, DOI 10.1093/jn/129.4.804; Moon BS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt373; Park KS, 2006, J CELL SCI, V119, P819, DOI 10.1242/jcs.02779; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tortora G, 2007, DRUG RESIST UPDATE, V10, P81, DOI 10.1016/j.drup.2007.03.003; Waldner MJ, 2010, MOL ASPECTS MED, V31, P171, DOI 10.1016/j.mam.2010.02.005; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhang B, 2003, CLIN CANCER RES, V9, P3073	40	59	60	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2016	12	8					593	+		10.1038/NCHEMBIO.2103	http://dx.doi.org/10.1038/NCHEMBIO.2103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2UW	27294323				2022-12-25	WOS:000380640100005
J	Thalji, NK; Ivanciu, L; Davidson, R; Gimotty, PA; Krishnaswamy, S; Camire, RM				Thalji, Nabil K.; Ivanciu, Lacramioara; Davidson, Robert; Gimotty, Phyllis A.; Krishnaswamy, Sriram; Camire, Rodney M.			A rapid pro-hemostatic approach to overcome direct oral anticoagulants	NATURE MEDICINE			English	Article							FACTOR-XA INHIBITOR; PROTHROMBIN COMPLEX CONCENTRATE; SYMPTOMATIC VENOUS THROMBOEMBOLISM; CATALYZED PROTEASE INACTIVATION; FACTOR PATHWAY INHIBITOR; COAGULATION-FACTOR XA; ACTIVATED FACTOR-VII; IN-VIVO; ANTITHROMBIN-III; ATRIAL-FIBRILLATION	Direct inhibitors of coagulation factor Xa (FXa) or thrombin are promising oral anticoagulants that are becoming widely adopted. The ability to reverse their anticoagulant effects is important when serious bleeding occurs or urgent medical procedures are needed. Here, using experimental mouse models of hemostasis, we show that a variant coagulation factor, FXa(I16L), rapidly restores hemostasis in the presence of the anticoagulant effects of these inhibitors. The ability of FXa(I16L) to reverse the anticoagulant effects of FXa inhibitor depends, at least in part, on the ability of the active site inhibitor to hinder antithrombin-dependent FXa inactivation, paradoxically allowing uninhibited FXa to persist in plasma. Because of its inherent catalytic activity, FXa(I16L) is more potent (by >50-fold) in the hemostasis models tested than a noncatalytic antidote that is currently in clinical development. FXa(I16L) also reduces the anticoagulant-associated bleeding in vivo that is induced by the thrombin inhibitor dabigatran. FXa(I16L) may be able to fill an important unmet clinical need for a rapid, pro-hemostatic agent to reverse the effects of several new anticoagulants.	[Thalji, Nabil K.; Ivanciu, Lacramioara; Davidson, Robert; Krishnaswamy, Sriram; Camire, Rodney M.] Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA; [Thalji, Nabil K.; Ivanciu, Lacramioara; Davidson, Robert; Camire, Rodney M.] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Thalji, Nabil K.; Ivanciu, Lacramioara; Krishnaswamy, Sriram; Camire, Rodney M.] Univ Penn, Dept Pediat, Perelman Sch Med, Div Hematol, Philadelphia, PA 19104 USA; [Gimotty, Phyllis A.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Camire, RM (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA.; Camire, RM (corresponding author), Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA.; Camire, RM (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Div Hematol, Philadelphia, PA 19104 USA.	rcamire@mail.med.upenn.edu	Gimotty, Phyllis/GWZ-4136-2022; Krishnaswamy, Sriram/Z-4380-2019	Gimotty, Phyllis/0000-0002-3850-9799; 	US National Institutes of Health (NIH) [F30 HL-120487, T32 HL-007439, T32 GM-007170, P01 HL-74124]; Penn-CHOP Blood Center for Patient Care and Discovery; Pfizer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, T32HL007439, F30HL120487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn-CHOP Blood Center for Patient Care and Discovery; Pfizer(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the US National Institutes of Health (NIH) grants F30 HL-120487 (N.K.T.), T32 HL-007439 (N.K.T.), T32 GM-007170 (N.K.T.) and P01 HL-74124 (R.M.C. and S.K.), the Penn-CHOP Blood Center for Patient Care and Discovery (P.A.G.) and research funding from Pfizer (R.M.C.). We are grateful to V. Arruda (Children's Hospital of Philadelphia and University of Pennsylvania) and L. Brass (University of Pennsylvania) for useful suggestions and critical review of the manuscript.	Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Ansell JE, 2016, J THROMB THROMBOLYS, V41, P248, DOI 10.1007/s11239-015-1288-1; Ansell JE, 2014, NEW ENGL J MED, V371, P2141, DOI 10.1056/NEJMc1411800; Bajaj MS, 2001, THROMB HAEMOSTASIS, V86, P959; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Bunce MW, 2011, BLOOD, V117, P290, DOI 10.1182/blood-2010-08-300756; Camire RM, 2000, BIOCHEMISTRY-US, V39, P14322, DOI 10.1021/bi001074q; CONARD J, 1983, HAEMOSTASIS, V13, P363; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; Crowther M, 2015, ARTERIOSCL THROM VAS, V35, P1736, DOI 10.1161/ATVBAHA.114.303402; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; Di Nisio M, 2005, NEW ENGL J MED, V353, P1028, DOI 10.1056/NEJMra044440; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Esmon CT, 2004, J THROMB HAEMOST, V2, P209, DOI 10.1046/j.1538-7933.2003.00537.x; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Fox BD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7498; Furugohri T, 2008, J THROMB HAEMOST, V6, P1542, DOI 10.1111/j.1538-7836.2008.03064.x; GITEL SN, 1984, J BIOL CHEM, V259, P6890; Glund S, 2015, LANCET, V386, P680, DOI 10.1016/S0140-6736(15)60732-2; Godier A, 2012, ANESTHESIOLOGY, V116, P94, DOI 10.1097/ALN.0b013e318238c036; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; GREEN RA, 1987, AM J VET RES, V48, P496; Herrmann R, 2014, THROMB HAEMOSTASIS, V111, P989, DOI 10.1160/TH13-07-0607; Huntington JA, 2013, J THROMB HAEMOST, V11, P254, DOI 10.1111/jth.12252; Husted S, 2016, DRUG SAFETY, V39, P5, DOI 10.1007/s40264-015-0357-x; Ivanciu L, 2014, BLOOD, V124, P1705, DOI 10.1182/blood-2014-03-565010; Ivanciu L, 2011, NAT BIOTECHNOL, V29, P1028, DOI 10.1038/nbt.1995; Izaguirre G, 2014, J BIOL CHEM, V289, P34049, DOI 10.1074/jbc.M114.611707; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4901, DOI 10.1021/bi00667a023; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lin HF, 1997, BLOOD, V90, P3962, DOI 10.1182/blood.V90.10.3962; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Mark C, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.3636.3636; MORITA T, 1986, J BIOL CHEM, V261, P4015; Mueck W, 2014, CLIN PHARMACOKINET, V53, P1, DOI 10.1007/s40262-013-0100-7; Neyman M, 2008, BLOOD, V112, P1101, DOI 10.1182/blood-2008-04-152959; OLSON ST, 1986, J BIOL CHEM, V261, P3151; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Parry TJ, 2011, BLOOD COAGUL FIBRIN, V22, P720, DOI 10.1097/MBC.0b013e32834cb30e; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; Perzborn E, 2014, THROMB RES, V133, P671, DOI 10.1016/j.thromres.2014.01.017; Perzborn E, 2013, THROMB HAEMOSTASIS, V110, P162, DOI 10.1160/TH12-12-0907; Perzborn E, 2010, ARTERIOSCL THROM VAS, V30, P376, DOI 10.1161/ATVBAHA.110.202978; Pinto DJP, 2007, J MED CHEM, V50, P5339, DOI 10.1021/jm070245n; Samama MM, 2011, CLIN CHEM LAB MED, V49, P761, DOI 10.1515/CCLM.2011.134; Samama MM, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-11; Scaglione F, 2013, CLIN PHARMACOKINET, V52, P69, DOI 10.1007/s40262-012-0030-9; Schiele F, 2013, BLOOD, V121, P3554, DOI 10.1182/blood-2012-11-468207; Schlachterman A, 2005, J THROMB HAEMOST, V3, P2730, DOI 10.1111/j.1538-7836.2005.01639.x; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Siegal DM, 2014, DRUG DISCOV TODAY, V19, P1465, DOI 10.1016/j.drudis.2014.05.013; Smith SA, 2008, J THROMB HAEMOST, V6, P1750, DOI 10.1111/j.1538-7836.2008.03104.x; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; Toso R, 2008, J BIOL CHEM, V283, P18627, DOI 10.1074/jbc.M802205200; Turecek PL, 2004, HAEMOPHILIA, V10, P3, DOI 10.1111/j.1365-2516.2004.00934.x; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Whinna HC, 2008, THROMB RES, V122, pS64, DOI 10.1016/S0049-3848(08)70022-7; Yeh CH, 2015, ARTERIOSCL THROM VAS, V35, P1056, DOI 10.1161/ATVBAHA.115.303397	63	27	27	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					924	+		10.1038/nm.4149	http://dx.doi.org/10.1038/nm.4149			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27455511				2022-12-25	WOS:000381000200018
J	Wang, MX; Carver, JJ; Phelan, VV; Sanchez, LM; Garg, N; Peng, Y; Nguyen, DD; Watrous, J; Kapono, CA; Luzzatto-Knaan, T; Porto, C; Bouslimani, A; Melnik, AV; Meehan, MJ; Liu, WT; Criisemann, M; Boudreau, PD; Esquenazi, E; Sandoval-Calderon, M; Kersten, RD; Pace, LA; Quinn, RA; Duncan, KR; Hsu, CC; Floros, DJ; Gavilan, RG; Kleigrewe, K; Northen, T; Dutton, RJ; Parrot, D; Carlson, EE; Aigle, B; Michelsen, CF; Jelsbak, L; Sohlenkamp, C; Pevzner, P; Edlund, A; McLean, J; Piel, J; Murphy, BT; Gerwick, L; Liaw, CC; Yang, YL; Humpf, HU; Maansson, M; Keyzers, RA; Sims, AC; Johnson, AR; Sidebottom, AM; Sedio, BE; Klitgaard, A; Larson, CB; Boya, CA; Torres-Mendoza, D; Gonzalez, DJ; Silva, DB; Marques, LM; Demarque, DP; Pociute, E; O'Neill, EC; Briand, E; Helfrich, EJN; Granatosky, EA; Glukhov, E; Ryffel, F; Houson, H; Mohimani, H; Kharbush, JJ; Zeng, Y; Vorholt, JA; Kurita, KL; Charusanti, P; McPhail, KL; Nielsen, KF; Vuong, L; Elfeki, M; Traxler, MF; Engene, N; Koyama, N; Vining, OB; Baric, R; Silva, RR; Mascuch, SJ; Tomasi, S; Jenkins, S; Macherla, V; Hoffman, T; Agarwal, V; Williams, PG; Dai, JQ; Neupane, R; Gurr, J; Rodriguez, AMC; Lamsa, A; Zhang, C; Dorrestein, K; Duggan, BM; Almaliti, J; Allard, PM; Phapale, P; Nothias, LF; Alexandrovr, T; Litaudon, M; Wolfender, JL; Kyle, JE; Metz, TO; Peryea, T; Nguyen, DT; VanLeer, D; Shinn, P; Jadhav, A; Muller, R; Waters, KM; Shi, WY; Liu, XT; Zhang, LX; Knight, R; Jensen, PR; Palsson, BO; Pogliano, K; Linington, RG; Gutierrez, M; Lopes, NP; Gerwick, WH; Moore, BS; Dorrestein, PC; Bandeira, N				Wang, Mingxun; Carver, Jeremy J.; Phelan, Vanessa V.; Sanchez, Laura M.; Garg, Neha; Peng, Yao; Don Duy Nguyen; Watrous, Jeramie; Kapono, Clifford A.; Luzzatto-Knaan, Tal; Porto, Carla; Bouslimani, Amina; Melnik, Alexey V.; Meehan, Michael J.; Liu, Wei -Ting; Criisemann, Max; Boudreau, Paul D.; Esquenazi, Eduardo; Sandoval-Calderon, Mario; Kersten, Roland D.; Pace, Laura A.; Quinn, Robert A.; Duncan, Katherine R.; Hsu, Cheng-Chih; Floros, Dimitrios J.; Gavilan, Ronnie G.; Kleigrewe, Karin; Northen, Trent; Dutton, Rachel J.; Parrot, Delphine; Carlson, Erin E.; Aigle, Bertrand; Michelsen, Charlotte F.; Jelsbak, Lars; Sohlenkamp, Christian; Pevzner, Pavel; Edlund, Anna; McLean, Jeffrey; Piel, Jorn; Murphy, Brian T.; Gerwick, Lena; Liaw, Chih-Chuang; Yang, Yu-Liang; Humpf, Hans-Ulrich; Maansson, Maria; Keyzers, Robert A.; Sims, Amy C.; Johnson, Andrew R.; Sidebottom, Ashley M.; Sedio, Brian E.; Klitgaard, Andreas; Larson, Charles B.; Boya P, Cristopher A.; Torres-Mendoza, Daniel; Gonzalez, David J.; Silva, Denise B.; Marques, Lucas M.; Demarque, Daniel P.; Pociute, Egle; O'Neill, Ellis C.; Briand, Enora; Helfrich, Eric J. N.; Granatosky, Eve A.; Glukhov, Evgenia; Ryffel, Florian; Houson, Hailey; Mohimani, Hosein; Kharbush, Jenan J.; Zeng, Yi; Vorholt, Julia A.; Kurita, Kenji L.; Charusanti, Pep; McPhail, Kerry L.; Nielsen, Kristian Fog; Vuong, Lisa; Elfeki, Maryam; Traxler, Matthew F.; Engene, Niclas; Koyama, Nobuhiro; Vining, Oliver B.; Baric, Ralph; Silva, Ricardo R.; Mascuch, Samantha J.; Tomasi, Sophie; Jenkins, Stefan; Macherla, Venkat; Hoffman, Thomas; Agarwal, Vinayak; Williams, Philip G.; Dai, Jingqui; Neupane, Ram; Gurr, Joshua; Rodriguez, Andres M. C.; Lamsa, Anne; Zhang, Chen; Dorrestein, Kathleen; Duggan, Brendan M.; Almaliti, Jehad; Allard, Pierre-Marie; Phapale, Prasad; Nothias, Louis-Felix; Alexandrovr, Theodore; Litaudon, Marc; Wolfender, Jean-Luc; Kyle, Jennifer E.; Metz, Thomas O.; Peryea, Tyler; Dac-Trung Nguyen; VanLeer, Danielle; Shinn, Paul; Jadhav, Ajit; Muller, Rolf; Waters, Katrina M.; Shi, Wenyuan; Liu, Xueting; Zhang, Lixin; Knight, Rob; Jensen, Paul R.; Palsson, Bernhard O.; Pogliano, Kit; Linington, Roger G.; Gutierrez, Marcelino; Lopes, Norberto P.; Gerwick, William H.; Moore, Bradley S.; Dorrestein, Pieter C.; Bandeira, Nuno			Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking	NATURE BIOTECHNOLOGY			English	Article							GENE-CLUSTER; GENOME; DEREPLICATION; METABOLOMICS; IDENTIFICATION; REPOSITORY; DISCOVERY; RESOURCE; EXTRACTS	The potential of the diverse chemistries present in natural products (NP) for biotechnology and medicine remains untapped because NP databases are not searchable with raw data and the NP community has no way to share data other than in published papers. Although mass spectrometry (MS) techniques are well-suited to high-throughput characterization of NP, there is a pressing need for an infrastructure to enable sharing and curation of data. We present Global Natural Products Social Molecular Networking (GNPS; http://gnps.ucsd.edu), an open-access knowledge base for community-wide organization and sharing of raw, processed or identified tandem mass (MS/MS) spectrometry data. In GNPS, crowdsourced curation of freely available community-wide reference MS libraries will underpin improved annotations. Data-driven social-networking should facilitate identification of spectra and foster collaborations. We also introduce the concept of 'living data' through continuous reanalysis of deposited data.	[Wang, Mingxun; Carver, Jeremy J.; Pevzner, Pavel] Univ Calif San Diego, Comp Sci & Engn, La Jolla, CA 92093 USA; [Wang, Mingxun; Carver, Jeremy J.; Pevzner, Pavel; Mohimani, Hosein; Bandeira, Nuno] Univ Calif San Diego, Ctr Computat Mass Spectrometry, La Jolla, CA USA; [Phelan, Vanessa V.; Sanchez, Laura M.; Garg, Neha; Watrous, Jeramie; Luzzatto-Knaan, Tal; Porto, Carla; Bouslimani, Amina; Melnik, Alexey V.; Meehan, Michael J.; Pace, Laura A.; Gonzalez, David J.; Koyama, Nobuhiro; Dorrestein, Kathleen; Duggan, Brendan M.; Almaliti, Jehad; Gerwick, William H.; Moore, Bradley S.; Dorrestein, Pieter C.; Bandeira, Nuno] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Collaborat Mass Spectrometry Innovat Ctr, La Jolla, CA USA; [Peng, Yao; Don Duy Nguyen; Kapono, Clifford A.; Hsu, Cheng-Chih; Floros, Dimitrios J.; Zeng, Yi] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA USA; [Liu, Wei -Ting] Stanford Univ, Dept Microbiol & Immunol, Palo Alto, CA 94304 USA; [Criisemann, Max; Boudreau, Paul D.; Duncan, Katherine R.; Kleigrewe, Karin; Gerwick, Lena; Larson, Charles B.; O'Neill, Ellis C.; Briand, Enora; Glukhov, Evgenia; Kharbush, Jenan J.; Mascuch, Samantha J.; Jensen, Paul R.; Gerwick, William H.; Moore, Bradley S.; Dorrestein, Pieter C.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA USA; [Esquenazi, Eduardo; Pociute, Egle; Houson, Hailey; Vuong, Lisa; Macherla, Venkat] Sirenas Marine Discovery, San Diego, CA USA; [Sandoval-Calderon, Mario; Sohlenkamp, Christian] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca, Morelos, Mexico; [Kersten, Roland D.] Salk Inst Biol Studies, La Jolla, CA USA; [Quinn, Robert A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Duncan, Katherine R.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Gavilan, Ronnie G.; Sedio, Brian E.; Boya P, Cristopher A.; Torres-Mendoza, Daniel; Gutierrez, Marcelino] INDICASAT, Ctr Drug Discovery & Biodivers, City Of Knowledge, Panama; [Northen, Trent; Jenkins, Stefan] Lawrence Berkeley Natl Lab, Genome Dynam, Berkeley, CA USA; [Dutton, Rachel J.] Harvard, FAS Ctr Syst Biol, Cambridge, MA USA; [Parrot, Delphine; Tomasi, Sophie] Univ Rennes 1, Prod Nat Synth Chim Med, Rennes, France; [Carlson, Erin E.] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA; [Aigle, Bertrand] Univ Lorraine, Dynam Genomes & Adaptat Microbienne, Vandoeuvre Les Nancy, France; [Michelsen, Charlotte F.; Jelsbak, Lars; Maansson, Maria; Klitgaard, Andreas; Nielsen, Kristian Fog] Tech Univ Denmark, Dept Syst Biol, Lyngby, Denmark; [Edlund, Anna] J Craig Venter Inst, Microbial & Environm Genom, La Jolla, CA USA; [Edlund, Anna; McLean, Jeffrey; Shi, Wenyuan] UC Los Angeles, Sch Dent, Los Angeles, CA USA; [McLean, Jeffrey] Univ Washington, Dept Periodont, Seattle, WA 98195 USA; [Piel, Jorn; Helfrich, Eric J. N.; Ryffel, Florian; Vorholt, Julia A.] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Murphy, Brian T.; Elfeki, Maryam] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL USA; [Liaw, Chih-Chuang] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Yang, Yu-Liang] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan; [Humpf, Hans-Ulrich] Univ Munster, Inst Food Chem, Munster, Germany; [Keyzers, Robert A.] Victoria Univ Wellington, Sch Chem & Phys Sci, Wellington, New Zealand; [Keyzers, Robert A.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand; [Sims, Amy C.; Baric, Ralph] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Johnson, Andrew R.; Sidebottom, Ashley M.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Sedio, Brian E.] Smithsonian Trop Res Inst, Ancon, Panama; [Larson, Charles B.; Gonzalez, David J.; Dorrestein, Pieter C.; Bandeira, Nuno] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA USA; [Silva, Denise B.; Marques, Lucas M.; Demarque, Daniel P.; Silva, Ricardo R.; Rodriguez, Andres M. C.; Lopes, Norberto P.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Sao Paulo, Brazil; [Silva, Denise B.] Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Campo Grande, Brazil; [Briand, Enora] Univ Rennes 1, CNRS, UMR 6553, ECOBIO, Rennes, France; [Granatosky, Eve A.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Kurita, Kenji L.; Linington, Roger G.] UC Santa Cruz, PBSci Chem & Biochem Dept, Santa Cruz, CA USA; [Charusanti, Pep; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA USA; [McPhail, Kerry L.; Vining, Oliver B.] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Traxler, Matthew F.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA USA; [Engene, Niclas] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Hoffman, Thomas; Muller, Rolf] Helmholtz Inst Pharmaceut Res Saarland, Dept Pharmaceut Biotechnol, Saarbrucken, Germany; [Agarwal, Vinayak; Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Oceans & Human Hlth, La Jolla, CA USA; [Williams, Philip G.; Dai, Jingqui; Neupane, Ram; Gurr, Joshua] Univ Hawaii Manoa, Dept Chem, Honolulu, HI 96822 USA; [Lamsa, Anne; Pogliano, Kit] Univ Calif San Diego, Div Biol Sci, La Jolla, CA USA; [Zhang, Chen] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA USA; [Allard, Pierre-Marie; Wolfender, Jean-Luc] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland; [Phapale, Prasad; Alexandrovr, Theodore] European Mol Biol Lab, Struct & Computat Biol, Heidelberg, Germany; [Nothias, Louis-Felix; Litaudon, Marc] Univ Paris Saclay, Labex CEBA, ICSN, CNRS,UPR 2301, Gif Sur Yvette, France; [Kyle, Jennifer E.; Metz, Thomas O.; Waters, Katrina M.] Pacific NW Natl Lab, Biol Sci, Richland, WA 99352 USA; [Peryea, Tyler; Dac-Trung Nguyen; VanLeer, Danielle; Shinn, Paul; Jadhav, Ajit] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Liu, Xueting] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Universidad Nacional Autonoma de Mexico; Salk Institute; California State University System; San Diego State University; UHI Millennium Institute; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Harvard University; Universite de Rennes; University of Minnesota System; University of Minnesota Twin Cities; Universite de Lorraine; Technical University of Denmark; J. Craig Venter Institute; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Sun Yat Sen University; Academia Sinica - Taiwan; University of Munster; Victoria University Wellington; Victoria University Wellington; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Indiana University System; Indiana University Bloomington; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California San Diego; Universidade de Sao Paulo; Universidade Federal de Mato Grosso do Sul; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; University of Notre Dame; University of California System; University of California Santa Cruz; University of California System; University of California San Diego; Oregon State University; University of California System; University of California Berkeley; State University System of Florida; Florida International University; Helmholtz Association; Helmholtz-Center for Infection Research; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Geneva; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Pacific Northwest National Laboratory; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Chinese Academy of Sciences; Institute of Microbiology, CAS; University of California System; University of California San Diego	Bandeira, N (corresponding author), Univ Calif San Diego, Ctr Computat Mass Spectrometry, La Jolla, CA USA.; Dorrestein, PC; Bandeira, N (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Collaborat Mass Spectrometry Innovat Ctr, La Jolla, CA USA.; Dorrestein, PC (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA USA.; Dorrestein, PC; Bandeira, N (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA USA.	pdorrestein@ucsd.edu; bandeira@ucsd.edu	Sims, Amy C/HGD-6501-2022; Briand, Enora/P-6074-2016; Jean-Luc, Wolfender JLW/EWV-1043-2022; Keyzers, Robert Alexander/K-2144-2015; Jean-Luc, Wolfender JLW/O-2163-2018; Zhang, Chen/B-5163-2018; Sanchez, Laura/AAT-8338-2020; Briand, Enora/AAS-8520-2020; Wang, Mingxun/HGV-1545-2022; Marques, Lucas Maciel Mauriz/N-2235-2017; PHAPALE, PRASAD/AAC-1409-2020; Gutiérrez, Marcelino/V-8134-2019; Vorholt, Julia/K-3514-2016; Carlson, Erin/AAU-9079-2020; da Silva, Ricardo/F-8354-2019; O'Neill, Ellis Charles/N-3805-2014; Aigle, Bertrand/AAN-8229-2021; Parrot, Delphine/ABD-9203-2021; Dorrestein, Pieter/ABF-2930-2020; Porto, Carla/AAP-2161-2020; Glukhov, Evgenia/ABB-2769-2020; Duggan, Brendan M./I-9258-2019; almaliti, jehad/R-7507-2016; Humpf, Hans-Ulrich/AAV-4845-2020; Kharbush, Jenan/ABE-6132-2020; SHI, wen/GPW-9531-2022; Demarque, Daniel Pecoraro/K-7325-2014; Porto, Carla/D-6888-2013; Jelsbak, Lars/B-6195-2013; Liaw, Chih-Chuang/AAG-9682-2021; Sohlenkamp, Christian/C-6219-2018; Agarwal, Vinayak/L-5688-2017; Sophie, Tomasi/ABF-6796-2021; Garg, Neha/L-3120-2018; Müller, Rolf/B-1559-2008; Fapesp, Biota/F-8655-2017; Allard, Pierre-Marie/ABD-1433-2021; Traxler, Matthew/AAL-7315-2021; Phapale, Prasad/AAR-9912-2020; da Silva, Denise Brentan/G-1460-2012; Nielsen, Kristian Fog/C-7233-2011; Lopes, Norberto P/C-7148-2012; Torres-Mendoza, Daniel/AAU-7741-2020; Linington, Roger/ABD-5582-2021; Duncan, Katherine R./M-9460-2016	Sims, Amy C/0000-0003-0178-4225; Briand, Enora/0000-0001-8996-0072; Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Keyzers, Robert Alexander/0000-0002-7658-7421; Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Zhang, Chen/0000-0003-4805-0392; Sanchez, Laura/0000-0001-9223-7977; Wang, Mingxun/0000-0001-7647-6097; Marques, Lucas Maciel Mauriz/0000-0001-6286-8698; PHAPALE, PRASAD/0000-0002-9487-597X; Gutiérrez, Marcelino/0000-0003-1423-3772; Vorholt, Julia/0000-0002-6011-4910; Carlson, Erin/0000-0001-8287-8893; da Silva, Ricardo/0000-0001-6378-0479; O'Neill, Ellis Charles/0000-0002-5941-2806; Porto, Carla/0000-0001-8331-2760; Duggan, Brendan M./0000-0002-7034-8374; almaliti, jehad/0000-0002-3562-0846; Demarque, Daniel Pecoraro/0000-0002-3576-5148; Porto, Carla/0000-0001-8331-2760; Jelsbak, Lars/0000-0002-5759-9769; Sohlenkamp, Christian/0000-0002-9962-2859; Garg, Neha/0000-0002-2760-7123; Müller, Rolf/0000-0002-1042-5665; Fapesp, Biota/0000-0002-9887-8449; Allard, Pierre-Marie/0000-0003-3389-2191; Phapale, Prasad/0000-0002-9487-597X; da Silva, Denise Brentan/0000-0003-0872-2756; Nielsen, Kristian Fog/0000-0002-5848-0911; Lopes, Norberto P/0000-0002-8159-3658; Linington, Roger/0000-0003-1818-4971; Sandoval-Calderon, Mario/0000-0001-7888-4334; Northen, Trent/0000-0001-8404-3259; Klitgaard, Andreas/0000-0002-2533-570X; Gavilan, Ronnie/0000-0003-1437-5607; jensen, paul/0000-0003-2349-1888; Helfrich, Eric Jan Nikolaus/0000-0001-8751-3279; Aigle, Bertrand/0000-0001-5266-5926; Zhang, Lixin/0000-0003-0894-9520; Jadhav, Ajit/0000-0001-7955-1451; Pogliano, Kit/0000-0002-7868-3345; Neupane, Ram/0000-0002-9310-7426; Tomasi, Sophie/0000-0001-9827-527X; Sedio, Brian/0000-0002-1723-9822; Humpf, Hans-Ulrich/0000-0003-3296-3058; Duncan, Katherine R./0000-0002-3670-4849; Phelan, Vanessa/0000-0001-7156-9294; Kharbush, Jenan/0000-0002-9963-098X; Nguyen, Dac-Trung/0000-0003-2591-9948; McPhail, Kerry/0000-0003-2076-1002; Waters, Katrina/0000-0003-4696-5396; Murphy, Brian/0000-0002-1372-3887; Caraballo, Mauricio/0000-0001-5499-2728; Williams, Philip/0000-0001-8987-0683; Boya P., Cristopher A./0000-0002-8093-596X; Traxler, Matthew/0000-0001-8430-595X; Crusemann, Max/0000-0001-6660-2715; Edlund, Anna/0000-0002-3394-4804; Charusanti, Pep/0000-0003-0009-6615; Bandeira, Nuno/0000-0001-8385-3655; Torres-Mendoza, Daniel/0000-0002-3540-4238; Moore, Bradley/0000-0002-4652-1253; Pace, Laura/0000-0002-3311-8342; Knight, Rob/0000-0002-0975-9019; Hsu, Cheng-Chih/0000-0002-2892-5326	US National Institutes of Health (NIH) [5P41GM103484-07, GM094802, AI095125, GM097509, S10RR029121, UL1RR031980, GM085770, U01TW0007401, U01AI12316-01]; National Institute of Allergy and Infectious Diseases (NIAID), NIH; Department of Health and Human Services [HHSN272200800060C]; NIH [K01 GM103809, T32 GM075762, K99DE024543, 1F32GM089044, 5R21AI085540, U01TW006634-06]; NIH IRACDA [K12 GM068524]; United States-Israel Binational Agricultural Research and Development Fund Vaadia-BARD [FI-494-13]; Science without Borders Program from CNPq; Sao Paulo Research Foundation (FAPESP) [2014/01651-8, 2012/18031-7]; German Academic Exchange Service (DAAD); Deutsche Forschungsgemeinschaft (D.F.G.); Marie Curie IOF Fellowship within the 7th European Community Framework Program (FP7-PEOPLE-IOF) [301244-CYANOMIC]; Ministry of Science and Technology of Taiwan [MOST103-2628-B-110-001-MY3]; Novo Nordisk Foundation; National Program on Key Basic Research Project [2013BC734000]; National Natural Science Foundation of China [81102369, 31125002]; INSA grant, Rennes; FAPESP [2012/18031-7, 2014/01884-2, 2014/18052-0, 2013/16496-5, 2014/50265-3]; CAPES/PNPD; CNPq-INCT_if; Notre Dame Chemistry-Biochemistry-Biology Interface (CBBI) program; National Institutes of Health [1R01DE023810-01, 1R01GM095373]; Villum Foundation [VKR023113]; Augustinus Foundation [13-4656]; Aase & Ejnar Danielsens Foundation [10-001120]; UC MEXUS-CONACYT Collaborative Grant [CN-12-552]; NSF [DEB 1010816]; Smithsonian Institution Grand Challenges Award; DFG (Forschergruppe 854); SNF [IZLSZ3_149025]; Danish Council for Independent Research, Technology, and Production Sciences [09-064967]; Agilent Thought Leader Program; NIH/NIAID [U19-AI106772]; Department of Defense [W81XWH-13-1-0171]; Oregon Sea Grant [NA10OAR4170059/R/BT-48]; NSF; Research Corporation for Science Advancement (Cottrell Scholar Award); Indiana University Quantitative Chemical Biology trainee fellowship; Danish Research Council for Technology and Production Science; Sapere Aude [116262]; FNS [200020_146200];  [CNPq-PQ 480 306385/2011-2]; FOGARTY INTERNATIONAL CENTER [U01TW006634, U19TW007401] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [U41AT008718] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029121, UL1RR031980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095125, U01AI124316, R21AI085540, U19AI106772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE024543, R01DE020102, R01DE023810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094802, R01GM097509, K01GM103809, F32GM089044, R01GM085770, K12GM068524, R01GM095373, P41GM103484, T32GM075762] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; Villum Fonden [00007262] Funding Source: researchfish; NNF Center for Biosustainability [Network Reconstruction] Funding Source: researchfish; Division Of Chemistry [1532310] Funding Source: National Science Foundation	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH IRACDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development Fund Vaadia-BARD; Science without Borders Program from CNPq; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft (D.F.G.)(German Research Foundation (DFG)); Marie Curie IOF Fellowship within the 7th European Community Framework Program (FP7-PEOPLE-IOF); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); INSA grant, Rennes; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq-INCT_if; Notre Dame Chemistry-Biochemistry-Biology Interface (CBBI) program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Villum Foundation(Villum Fonden); Augustinus Foundation; Aase & Ejnar Danielsens Foundation; UC MEXUS-CONACYT Collaborative Grant(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSF(National Science Foundation (NSF)); Smithsonian Institution Grand Challenges Award; DFG (Forschergruppe 854)(German Research Foundation (DFG)); SNF; Danish Council for Independent Research, Technology, and Production Sciences(Det Frie Forskningsrad (DFF)); Agilent Thought Leader Program; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense(United States Department of Defense); Oregon Sea Grant; NSF(National Science Foundation (NSF)); Research Corporation for Science Advancement (Cottrell Scholar Award); Indiana University Quantitative Chemical Biology trainee fellowship; Danish Research Council for Technology and Production Science; Sapere Aude; FNS(Swiss National Science Foundation (SNSF)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Novo Nordisk Fonden(Novo Nordisk Foundation); Villum Fonden(Villum Fonden); NNF Center for Biosustainability; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was partially supported by US National Institutes of Health (NIH) grants 5P41GM103484-07, GM094802, AI095125, GM097509, S10RR029121, UL1RR031980, GM085770, U01TW0007401, and U01AI12316-01; N.B. was also partially supported as an Alfred P. Sloan Fellow. In addition, this work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), NIH, and the Department of Health and Human Services, under Contract Number HHSN272200800060C. V.V.P. is supported by the NIH grant K01 GM103809. L.M.S. is supported by NIH IRACDA K12 GM068524 award. T.L.-K. is supported by the United States-Israel Binational Agricultural Research and Development Fund Vaadia-BARD No. FI-494-13. C.P. is supported by Science without Borders Program from CNPq. A.M.C.R. is supported by Sao Paulo Research Foundation (FAPESP) grant#2014/01651-8, 2012/18031-7. K.K. was supported by a fellowship within the Postdoc-Programme of the German Academic Exchange Service (DAAD). M.C. was supported by a Deutsche Forschungsgemeinschaft (D.F.G.) postdoctoral fellowship. E.B. is supported by a Marie Curie IOF Fellowship within the 7th European Community Framework Program (FP7-PEOPLE-2011-IOF, grant number 301244-CYANOMIC). C.-C.L. was supported by a grant from the Ministry of Science and Technology of Taiwan (MOST103-2628-B-110-001-MY3). P.C. and B.O.P. were supported by the Novo Nordisk Foundation. Lixin Zhang and Xueting Liu are supported by the National Program on Key Basic Research Project (2013BC734000) and the National Natural Science Foundation of China (81102369 and 31125002). D.P. is supported by an INSA grant, Rennes. R.R.S. is supported by FAPESP grant#2014/01884-2. D.P.D. is supported by FAPESP grant#2014/18052-0. L.M.M. is supported by FAPESP grant#2013/16496-5. D.B.S. is supported by FAPESP grant#2012/18031-7. N.P.L. is supported by FAPESP(2014/50265-3), CAPES/PNPD, CNPq-PQ 480 306385/2011-2, and CNPq-INCT_if. E.A.G. is supported by the Notre Dame Chemistry-Biochemistry-Biology Interface (CBBI) program and NIH T32 GM075762. W.S. and J.S.M. are supported by grants from the National Institutes of Health 1R01DE023810-01 and 1R01GM095373. A.E. is supported by a grant from the NIH K99DE024543. C.F.M. and L.J. are supported by the Villum Foundation VKR023113, the Augustinus Foundation 13-4656, and the Aase & Ejnar Danielsens Foundation 10-001120. M.S.-C. was supported by UC MEXUS-CONACYT Collaborative Grant CN-12-552. M.F.T. was supported by NIH grant 1F32GM089044. Contributions by B.E.S. were supported by NSF grant DEB 1010816 and a Smithsonian Institution Grand Challenges Award. E.J.N.H. and J.P. are supported by the DFG (Forschergruppe 854) and by SNF grant IZLSZ3_149025. K.F.N. and A.K. are supported by the Danish Council for Independent Research, Technology, and Production Sciences (09-064967) and the Agilent Thought Leader Program. A.C.S. and R.S.B. were supported by NIH/NIAID U19-AI106772. B.T.M. and M.E. were supported under Department of Defense grant #W81XWH-13-1-0171. Contributions by O.B.V. and K.L.M. were supported by Oregon Sea Grant NA10OAR4170059/R/BT-48, NIH 5R21AI085540, and U01TW006634-06. E.E.C., A.M.S., and A.R.J. were supported by an NSF CAREER Award, a Pew Biomedical Scholar Award (E.E.C.), a Sloan Research Fellow Award (E.E.C.), the Research Corporation for Science Advancement (Cottrell Scholar Award; E.E.C.) and an Indiana University Quantitative Chemical Biology trainee fellowship (A.R.J.). M.M. was supported by the Danish Research Council for Technology and Production Science with Sapere Aude (116262). P.-M. A.; was supported by FNS for fellowship on Subside (200020_146200). We thank V. Paul, R. Taylor, L. Aluwihare, F. Rohwer, B. Pullman, J. Fang, M. Overgaard, M. Katze, R.D. Smith, S.K. Mazmanian, W. Fenical, E. Macagno, X. He, and C. Neubauer for feedback and support for their laboratory personnel to contribute to the work. We thank B. Gust and co-workers at the University of Tuebingen for assisting us to obtain Streptomyces sp. DSM5940.	Anderton CR, 2016, J AM SOC MASS SPECTR, V27, P556, DOI 10.1007/s13361-015-1324-6; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bandeira N, 2007, P NATL ACAD SCI USA, V104, P6140, DOI 10.1073/pnas.0701130104; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertin MJ, 2015, J NAT PROD, V78, P493, DOI 10.1021/np5009762; Blunt JW, MARINLIT DATABASE MA; Boudreau PD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133297; Bouslimani A, 2014, NAT PROD REP, V31, P718, DOI 10.1039/c4np00044g; Cha JY, 2016, ISME J, V10, P119, DOI 10.1038/ismej.2015.95; Nguyen DD, 2013, P NATL ACAD SCI USA, V110, pE2611, DOI 10.1073/pnas.1303471110; Duhrkop K, 2015, P NATL ACAD SCI USA, V112, P12580, DOI 10.1073/pnas.1509788112; Duncan KR, 2015, CHEM BIOL, V22, P460, DOI 10.1016/j.chembiol.2015.03.010; Engel P, 2015, APPL ENVIRON MICROB, V81, P1502, DOI 10.1128/AEM.03283-14; Guthals A, 2012, MOL BIOSYST, V8, P2535, DOI 10.1039/c2mb25085c; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Ito T, 2014, J ANTIBIOT, V67, P353, DOI 10.1038/ja.2014.12; Kersten RD, 2013, P NATL ACAD SCI USA, V110, pE4407, DOI 10.1073/pnas.1315492110; Kildgaard S, 2014, MAR DRUGS, V12, P3681, DOI 10.3390/md12063681; Kleigrewe K, 2015, J NAT PROD, V78, P1671, DOI 10.1021/acs.jnatprod.5b00301; Klitgaard A, 2015, ANAL CHEM, V87, P6520, DOI 10.1021/acs.analchem.5b01934; Laatsch H., 2011, ANTIBASE 2012 NATURA; Lamsa A, 2012, MOL MICROBIOL, V84, P486, DOI 10.1111/j.1365-2958.2012.08038.x; Lang G, 2008, J NAT PROD, V71, P1595, DOI 10.1021/np8002222; Liaimer A, 2015, P NATL ACAD SCI USA, V112, P1862, DOI 10.1073/pnas.1419543112; Little JL, 2012, J AM SOC MASS SPECTR, V23, P179, DOI 10.1007/s13361-011-0265-y; Liu WT, 2014, J ANTIBIOT, V67, P99, DOI 10.1038/ja.2013.99; Liu YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136241; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; Mascuch SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119668; Matsuda F, 2010, PLANT PHYSIOL, V152, P566, DOI 10.1104/pp.109.148031; Moree WJ, 2012, P NATL ACAD SCI USA, V109, P13811, DOI 10.1073/pnas.1206855109; Nonejuie P, 2013, P NATL ACAD SCI USA, V110, P16169, DOI 10.1073/pnas.1311066110; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Purves K, 2016, METABOLITES, V6, DOI 10.3390/metabo6010002; Sawada Y, 2012, PHYTOCHEMISTRY, V82, P38, DOI 10.1016/j.phytochem.2012.07.007; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sidebottom AM, 2013, ACS CHEM BIOL, V8, P2009, DOI 10.1021/cb4002798; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sud M, 2016, NUCLEIC ACIDS RES, V44, pD463, DOI 10.1093/nar/gkv1042; The National Institute of Standards and Technology, NIST STAND REF DAT 1; UCHIDA K, 1975, J ANTIBIOT, V28, P266, DOI 10.7164/antibiotics.28.266; Vizcaino MI, 2015, NAT CHEM, V7, P411, DOI [10.1038/NCHEM.2221, 10.1038/nchem.2221]; Vizcaino MI, 2014, J AM CHEM SOC, V136, P9244, DOI 10.1021/ja503450q; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Winnikoff JR, 2014, J ANTIBIOT, V67, P105, DOI 10.1038/ja.2013.120; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s	54	1691	1706	51	543	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2016	34	8					828	837		10.1038/nbt.3597	http://dx.doi.org/10.1038/nbt.3597			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2VJ	27504778	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-25	WOS:000381339600019
J	Witteveen, JS; Willemsen, MH; Dombroski, TCD; van Bakel, NHM; Nillesen, WM; van Hulten, JA; Jansen, EJR; Verkaik, D; Veenstra-Knol, HE; van Ravenswaaij-Arts, CMA; Wassink-Ruiter, JSK; Vincent, M; David, A; Le Caignec, C; Schieving, J; Gilissen, C; Foulds, N; Rump, P; Strom, T; Cremer, K; Zink, AM; Engels, H; de Munnik, SA; Visser, JE; Brunner, HG; Martens, GJM; Pfundt, R; Kleefstra, T; Kolk, SM				Witteveen, Josefine S.; Willemsen, Marjolein H.; Dombroski, Thais C. D.; van Bakel, Nick H. M.; Nillesen, Willy M.; van Hulten, Josephus A.; Jansen, Eric J. R.; Verkaik, Dave; Veenstra-Knol, Hermine E.; van Ravenswaaij-Arts, Conny M. A.; Wassink-Ruiter, Jolien S. Klein; Vincent, Marie; David, Albert; Le Caignec, Cedric; Schieving, Jolanda; Gilissen, Christian; Foulds, Nicola; Rump, Patrick; Strom, Tim; Cremer, Kirsten; Zink, Alexander M.; Engels, Hartmut; de Munnik, Sonja A.; Visser, Jasper E.; Brunner, Han G.; Martens, Gerard J. M.; Pfundt, Rolph; Kleefstra, Tjitske; Kolk, Sharon M.			Haploinsufficiency of MeCP2-interacting transcriptional co-repressor SIN3A causes mild intellectual disability by affecting the development of cortical integrity	NATURE GENETICS			English	Article							DEVELOPING CEREBRAL-CORTEX; 15Q24 MICRODELETION SYNDROME; HISTONE DEACETYLASE COMPLEX; EMBRYONIC STEM-CELLS; NEURAL STEM; NEURODEVELOPMENTAL DISORDERS; DEVELOPING NEOCORTEX; RETT-SYNDROME; HUMAN BRAIN; MECP2	Numerous genes are associated with neurodevelopmental disorders such as intellectual disability and autism spectrum disorder ( ASD), but their dysfunction is often poorly characterized. Here we identified dominant mutations in the gene encoding the transcriptional repressor and MeCP2 interactor switch-insensitive 3 family member A ( SIN3A; chromosome 15q24.2) in individuals who, in addition to mild intellectual disability and ASD, share striking features, including facial dysmorphisms, microcephaly and short stature. This phenotype is highly related to that of individuals with atypical 15q24 microdeletions, linking SIN3A to this microdeletion syndrome. Brain magnetic resonance imaging showed subtle abnormalities, including corpus callosum hypoplasia and ventriculomegaly. Intriguingly, in vivo functional knockdown of Sin3a led to reduced cortical neurogenesis, altered neuronal identity and aberrant corticocortical projections in the developing mouse brain. Together, our data establish that haploinsufficiency of SIN3A is associated with mild syndromic intellectual disability and that SIN3A can be considered to be a key transcriptional regulator of cortical brain development.	[Witteveen, Josefine S.; Dombroski, Thais C. D.; van Bakel, Nick H. M.; van Hulten, Josephus A.; Jansen, Eric J. R.; Visser, Jasper E.; Martens, Gerard J. M.; Kolk, Sharon M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol, Nijmegen, Netherlands; [Willemsen, Marjolein H.; Nillesen, Willy M.; Verkaik, Dave; Gilissen, Christian; de Munnik, Sonja A.; Brunner, Han G.; Pfundt, Rolph; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands; [Veenstra-Knol, Hermine E.; van Ravenswaaij-Arts, Conny M. A.; Wassink-Ruiter, Jolien S. Klein; Rump, Patrick] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Vincent, Marie; David, Albert; Le Caignec, Cedric] Ctr Hosp Univ Nantes, Serv Genet Med, Nantes, France; [Le Caignec, Cedric] INSERM, Fac Med, UMRS 957, Lab Physiopathol Resorpt Osseuse & Therapie Tumeu, Nantes, France; [Schieving, Jolanda; Visser, Jasper E.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands; [Foulds, Nicola] Southampton Univ Hosp, Natl Hlth Serv Fdn Trust, Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Foulds, Nicola] Univ Southampton, Dept Human Genet & Genom Med, Fac Med, Southampton, Hants, England; [Strom, Tim] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Strom, Tim] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Cremer, Kirsten; Zink, Alexander M.; Engels, Hartmut] Univ Bonn, Inst Human Genet, Bonn, Germany; [Visser, Jasper E.] Amphia Hosp Breda, Dept Neurol, Berda, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Radboud University Nijmegen; University of Southampton; University of Southampton; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Bonn; Amphia Hospital	Kolk, SM (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol, Nijmegen, Netherlands.; Kleefstra, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands.	tjitske.kleefstra@radboudumc.nl; s.kolk@ncmls.ru.nl	Martens, Gerard JM/D-1925-2010; Gilissen, Christian/E-5246-2012; Visser, Jasper/GWN-0963-2022; Pfundt, Rolph/L-4576-2015; Visser, Jasper E/D-9237-2013; Kleefstra, Tjitske/G-2619-2012; Kolk, Sharon M/A-9055-2011; Willemsen, Marjolein/R-5958-2019; Vincent, Marie/K-7342-2018	Gilissen, Christian/0000-0003-1693-9699; Visser, Jasper/0000-0002-9896-3416; Kolk, Sharon M/0000-0003-2116-5456; Martens, Gerard/0000-0003-1761-4570; Vincent, Marie/0000-0003-1010-5618	Science without Borders, CAPES-Brasil [BEX 12044/13-0]; Netherlands Organization for Health Research and Development, ZonMw [907-00-365]; Dutch Brain Foundation [HsN F2014(1)-16]; German Ministry of Research and Education (German Mental Retardation Network) as part of the National Genome Research Network [01GS08164, 01GS08167, 01GS08163]	Science without Borders, CAPES-Brasil; Netherlands Organization for Health Research and Development, ZonMw(Netherlands Organization for Health Research and Development); Dutch Brain Foundation; German Ministry of Research and Education (German Mental Retardation Network) as part of the National Genome Research Network	We thank laboratory members and colleagues for critically reading this manuscript and members of the various laboratories for helpful editing and discussions. We express thanks to W. Hendriks (Radboud University) for sharing plasmids and N. Nadif Kasri (Radboud University Medical Center) for kindly providing antibody to mouse Ki-67. We are grateful for the mouse Sin3a cDNA clone from R. Floyd and B.D. Hendrich (Wellcome Trust Centre for Stem Cell Research and MRC Centre for Stem Cell Biology and Regenerative Medicine). We thank the Radboud Institute for Molecular Life Sciences microscopy platform (see URLs) for excellent support and maintenance of the equipment. We are grateful to the families and subjects participating in this study for their involvement. This work was supported by funding from Science without Borders, CAPES-Brasil (BEX 12044/13-0) to T.C.D.D., complemented by extra support from the Educational Institute of Biosciences at Radboud University, by grants from the Netherlands Organization for Health Research and Development, ZonMw (grant 907-00-365) to T.K., by the Dutch Brain Foundation (HsN F2014(1)-16) to J.E.V. and by the German Ministry of Research and Education (grants 01GS08164, 01GS08167 and 01GS08163 German Mental Retardation Network) to H.E. and T.S., as part of the National Genome Research Network.	Andrieux J, 2009, AM J MED GENET A, V149A, P2813, DOI 10.1002/ajmg.a.33097; Baltus GA, 2009, J BIOL CHEM, V284, P6998, DOI 10.1074/jbc.M807670200; Bansal N, 2016, ADV CANCER RES, V130, P113, DOI 10.1016/bs.acr.2016.01.006; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bielen H, 2014, DEV NEUROBIOL, V74, P772, DOI 10.1002/dneu.22168; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; Borrell V, 2012, DEV NEUROBIOL, V72, P955, DOI 10.1002/dneu.22013; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Damen D, 2013, BIOL CHEM, V394, P1595, DOI 10.1515/hsz-2013-0193; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Deriziotis P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5954; Evsyukova I, 2013, ANNU REV CELL DEV BI, V29, P299, DOI 10.1146/annurev-cellbio-101512-122400; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fox PT, 2005, HUM BRAIN MAPP, V25, P185, DOI 10.1002/hbm.20141; Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789; Gajan A, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0053-9; Gallagher SJ, 2013, DEV BIOL, V373, P83, DOI 10.1016/j.ydbio.2012.10.009; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guerrini R, 2014, LANCET NEUROL, V13, P710, DOI 10.1016/S1474-4422(14)70040-7; Hatanaka Y, 2009, J COMP NEUROL, V514, P215, DOI 10.1002/cne.22021; Huang TN, 2014, NAT NEUROSCI, V17, P240, DOI 10.1038/nn.3626; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Jansen S., 2016, CLIN GENET; Ji QH, 2014, J CELL SCI, V127, P4679, DOI 10.1242/jcs.154245; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kim Y, 2005, BIOL PSYCHIAT, V57, P107, DOI 10.1016/j.biopsych.2004.10.025; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kleefstra T, 2014, NEUROPHARMACOLOGY, V80, P83, DOI 10.1016/j.neuropharm.2013.12.025; Kolk SM, 2006, MOL CELL NEUROSCI, V32, P199, DOI 10.1016/j.mcn.2006.01.016; Kolk SM, 2009, J NEUROSCI, V29, P12542, DOI 10.1523/JNEUROSCI.2521-09.2009; Kolk SM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00037; Krishnan K, 2015, P NATL ACAD SCI USA, V112, pE4782, DOI 10.1073/pnas.1506499112; Kyrylenko S, 2000, BIOCHEM BIOPH RES CO, V275, P455, DOI 10.1006/bbrc.2000.3325; Laguesse S, 2015, CELL TISSUE RES, V359, P17, DOI 10.1007/s00441-014-1979-5; Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065; LaMonica BE, 2012, CURR OPIN NEUROBIOL, V22, P747, DOI 10.1016/j.conb.2012.03.006; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lugtenberg D., 2016, EUR J HUM GENET; Magoulas PL, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-2; McDonel P, 2012, DEV BIOL, V363, P62, DOI 10.1016/j.ydbio.2011.12.019; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Mefford HC, 2012, J MED GENET, V49, P110, DOI 10.1136/jmedgenet-2011-100499; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Namba T, 2014, NEURON, V81, P814, DOI 10.1016/j.neuron.2013.12.015; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nascimento EM, 2011, NAT CELL BIOL, V13, P1395, DOI 10.1038/ncb2385; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; North HA, 2009, DEVELOPMENT, V136, P2467, DOI 10.1242/dev.034405; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Palumbo O, 2014, AM J MED GENET A, V164, P828, DOI 10.1002/ajmg.a.36363; Paul LK, 2011, J NEURODEV DISORD, V3, P3, DOI 10.1007/s11689-010-9059-y; Pollock A, 2014, CELL REP, V7, P1184, DOI 10.1016/j.celrep.2014.04.003; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; Saha N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2428-5; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Samuelsson L, 2015, EUR J MED GENET, V58, P111, DOI 10.1016/j.ejmg.2014.12.006; Schoch H, 2014, NEUROPHARMACOLOGY, V80, P53, DOI 10.1016/j.neuropharm.2014.01.003; Schubert D, 2015, MOL PSYCHIATR, V20, P795, DOI 10.1038/mp.2014.147; Shoemaker LD, 2010, BIOESSAYS, V32, P197, DOI 10.1002/bies.200900114; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Suzuki DE, 2011, IN VITRO CELL DEV-AN, V47, P492, DOI 10.1007/s11626-011-9426-3; Swaminathan A, 2010, MECH DEVELOP, V127, P96, DOI 10.1016/j.mod.2009.10.003; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Vignoli A, 2010, EPILEPSY BEHAV, V17, P489, DOI 10.1016/j.yebeh.2010.01.024; Willemsen MH, 2014, CLIN GENET, V85, P101, DOI 10.1111/cge.12244; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Xu D, 2014, CELL REP, V6, P104, DOI 10.1016/j.celrep.2013.12.016; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhang W, 2014, J NEUROSCI, V34, P2754, DOI 10.1523/JNEUROSCI.4900-12.2014; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	84	43	45	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					877	+		10.1038/ng.3619	http://dx.doi.org/10.1038/ng.3619			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27399968	Green Published			2022-12-25	WOS:000380755100011
J	Erasmus, JH; Auguste, AJ; Kaelber, JT; Luo, H; Rossi, SL; Fenton, K; Leal, G; Kim, DY; Chiu, W; Wang, T; Frolov, I; Nasar, F; Weaver, SC				Erasmus, Jesse H.; Auguste, Albert J.; Kaelber, Jason T.; Luo, Huanle; Rossi, Shannan L.; Fenton, Karla; Leal, Grace; Kim, Dal Y.; Chiu, Wah; Wang, Tian; Frolov, Ilya; Nasar, Farooq; Weaver, Scott C.			A chikungunya fever vaccine utilizing an insect-specific virus platform	NATURE MEDICINE			English	Article							FORMALDEHYDE INACTIVATION; NONHUMAN-PRIMATES; DENDRITIC CELLS; EILAT VIRUS; ANTIGEN; IMMUNOGENICITY; ALPHAVIRUSES; REPLICATION; DISEASE; ATTENUATION	Traditionally, vaccine development involves tradeoffs between immunogenicity and safety. Live-attenuated vaccines typically offer rapid and durable immunity but have reduced safety when compared to inactivated vaccines. In contrast, the inability of inactivated vaccines to replicate enhances safety at the expense of immunogenicity, often necessitating multiple doses and boosters. To overcome these tradeoffs, we developed the insect-specific alphavirus, Eilat virus (EILV), as a vaccine platform. To address the chikungunya fever (CHIKF) pandemic, we used an EILV cDNA clone to design a chimeric virus containing the chikungunya virus (CHIKV) structural proteins. The recombinant EILV/CHIKV was structurally identical at 10 A to wild-type CHIKV, as determined by single-particle cryo-electron microscopy, and it mimicked the early stages of CHIKV replication in vertebrate cells from attachment and entry to viral RNA delivery. Yet the recombinant virus remained completely defective for productive replication, providing a high degree of safety. A single dose of EILV/CHIKV produced in mosquito cells elicited rapid (within 4 d) and long-lasting (>290 d) neutralizing antibodies that provided complete protection in two different mouse models. In nonhuman primates, EILV/CHIKV elicited rapid and robust immunity that protected against viremia and telemetrically monitored fever. Our EILV platform represents the first structurally native application of an insect-specific virus in preclinical vaccine development and highlights the potential application of such viruses in vaccinology.	[Erasmus, Jesse H.; Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Erasmus, Jesse H.; Auguste, Albert J.; Luo, Huanle; Rossi, Shannan L.; Fenton, Karla; Leal, Grace; Wang, Tian; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Erasmus, Jesse H.; Auguste, Albert J.; Luo, Huanle; Rossi, Shannan L.; Fenton, Karla; Leal, Grace; Wang, Tian; Weaver, Scott C.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Auguste, Albert J.; Rossi, Shannan L.; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Kaelber, Jason T.; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kaelber, Jason T.; Chiu, Wah] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Kim, Dal Y.; Frolov, Ilya] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Nasar, Farooq] US Army, Med Res Inst Infect Dis, Div Virol, Frederick, MD 21701 USA; [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Medical Branch Galveston	Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	sweaver@utmb.edu	Erasmus, Jesse/J-8792-2019; Weaver, Scott C/D-6490-2011; Nasar, Farooq/C-7659-2019	Erasmus, Jesse/0000-0003-1612-2697; Weaver, Scott C/0000-0001-8016-8556; Nasar, Farooq/0000-0003-3658-9649; KIM, Dal Young/0000-0003-1756-3128; Auguste, Albert/0000-0001-9048-0041; Frolov, Ilya/0000-0002-8548-2517; Kaelber, Jason/0000-0001-9426-1030	NIH [AI120942, P41GM103832]; Welch Foundation; UTMB Technology Commercialization Program; UTMB McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI120942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); UTMB Technology Commercialization Program; UTMB McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Klages and W Lawrence for their technical assistance with the nonhuman primate study, V. Popov and F. Murphy for providing electron microscopy training and discussion, N. Dobias and the UTMB research histology core for assistance with tissue preparations, O. Escaffre for confocal microscopy assistance, and C. Mire for critically reading the manuscript. Support for this work came from NIH grants AI120942 (to S.C.W.), a Welch Foundation grant (to WC.), and a grant from the UTMB Technology Commercialization Program. J.H.E. is supported by a UTMB McLaughlin Fellowship. Electron microscopy was supported by NIH grant P41GM103832 (to WC.). The views expressed in this article are those of the authors and do not reflect the official policy or position of the US Department of Defense, or the Department of the Army.	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; [Anonymous], 2005, CUTTER INCIDENT AM 1; Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; CARDOSO AI, 1995, VIROLOGY, V212, P255, DOI 10.1006/viro.1995.1479; Delrue I, 2009, VET RES, V40, DOI 10.1051/vetres/2009047; Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681; Engering AJ, 1997, ADV EXP MED BIOL, V417, P183; Erasmus JH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004119; Eyden B., 1996, ORGANELLES TUMOR DIA; Fan YC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004167; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Frolova E, 2006, J VIROL, V80, P4122, DOI 10.1128/JVI.80.8.4122-4134.2006; Gardner CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002719; Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Kuhn RJ, 1996, J VIROL, V70, P7900, DOI 10.1128/JVI.70.11.7900-7909.1996; Kumar M, 2012, VACCINE, V30, P6142, DOI 10.1016/j.vaccine.2012.07.072; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268; LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4; Li CL, 2015, INT J DISTRIB SENS N, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060; NAKAO E, 1973, B WORLD HEALTH ORGAN, V48, P559; Nasar F, 2015, J VIROL, V89, P1404, DOI 10.1128/JVI.01856-14; Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109; Paessler S, 2003, J VIROL, V77, P9278, DOI 10.1128/JVI.77.17.9278-9286.2003; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Roy CJ, 2014, J INFECT DIS, V209, P1891, DOI 10.1093/infdis/jiu014; Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137; Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sun SY, 2013, ELIFE, V2, DOI 10.7554/eLife.00435; Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062; Weaver Scott C, 2016, Antiviral Res, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; WHITE A, 1972, APPL MICROBIOL, V23, P951, DOI 10.1128/AEM.23.5.951-952.1972; Whittembury A, 2009, VACCINE, V27, P5974, DOI 10.1016/j.vaccine.2009.07.082; Wilton T, 2014, J VIROL, V88, P11955, DOI 10.1128/JVI.01809-14	44	73	74	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					192	199		10.1038/nm.4253	http://dx.doi.org/10.1038/nm.4253			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	27991917	Bronze, Green Accepted			2022-12-25	WOS:000393729000011
J	Lee, JC; Biasci, D; Roberts, R; Gearry, RB; Mansfield, JC; Ahmad, T; Prescotts, NJ; Satsangi, J; Wilson, DC; Jostins, L; Anderson, CA; Traherne, JA; Lyons, PA; Parkes, M; Smith, KGC				Lee, James C.; Biasci, Daniele; Roberts, Rebecca; Gearry, Richard B.; Mansfield, John C.; Ahmad, Tariq; Prescotts, Natalie J.; Satsangi, Jack; Wilson, David C.; Jostins, Luke; Anderson, Carl A.; Traherne, James A.; Lyons, Paul A.; Parkes, Miles; Smith, Kenneth G. C.		UK IBD Genetics Consortium	Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; ULCERATIVE-COLITIS; QUANTITATIVE TRAITS; RISK; VARIANTS; PREDICTION; PHENOTYPES; SEVERITY	For most immune-mediated diseases, the main determinant of patient well-being is not the diagnosis itself but instead the course that the disease takes over time (prognosis)(1-3). Prognosis may vary substantially between patients for reasons that are poorly understood. Familial studies support a genetic contribution to prognosis(4-6), but little evidence has been found for a proposed association between prognosis and the burden of susceptibility variants(7-13). To better characterize how genetic variation influences disease prognosis, we performed a within cases genome-wide association study in two cohorts of patients with Crohn's disease. We identified four genome-wide significant loci, none of which showed any association with disease susceptibility. Conversely, the aggregated effect of all 170 disease susceptibility loci was not associated with disease prognosis. Together, these data suggest that the genetic contribution to prognosis in Crohn's disease is largely independent of the contribution to disease susceptibility and point to a biology of prognosis that could provide new therapeutic opportunities.	[Lee, James C.; Biasci, Daniele; Lyons, Paul A.; Parkes, Miles; Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Dept Med, Cambridge, England; [Roberts, Rebecca; Gearry, Richard B.] Univ Otago, Dept Med, Christchurch, New Zealand; [Mansfield, John C.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Ahmad, Tariq] Univ Exeter, Sch Med, Exeter, Devon, England; [Prescotts, Natalie J.] Kings Coll London, Fac Life Sci & Med, Dept Med & Mol Genet, London, England; [Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Gastrointestinal Unit,Div Med Sci, Edinburgh, Midlothian, Scotland; [Wilson, David C.] Univ Edinburgh, Royal Hosp Sick Children, Coll Med & Vet Med, Paediat Gastroenterol & Nutr Child Life & Hlth, Edinburgh, Midlothian, Scotland; [Jostins, Luke] Univ Oxford, Wellcome Trust Ctr Human Genet, Headington, England; [Anderson, Carl A.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Traherne, James A.] Univ Cambridge, Dept Pathol, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Otago; Newcastle University - UK; University of Exeter; University of London; King's College London; University of Edinburgh; University of Edinburgh; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Cambridge	Lee, JC; Smith, KGC (corresponding author), Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Dept Med, Cambridge, England.	jc165@cam.ac.uk; kgcs2@cam.ac.uk	Gearry, Richard B/H-3959-2019; Lee, James/ABD-5920-2020; Prescott, Natalie J/F-6490-2011; Barclay, Murray Lindsay/D-9000-2012; Prescott, Natalie/AHE-5121-2022	Gearry, Richard B/0000-0002-2298-5141; Lee, James/0000-0001-5711-9385; Prescott, Natalie J/0000-0002-5901-7371; Barclay, Murray Lindsay/0000-0003-2944-8338; Prescott, Natalie/0000-0002-5901-7371; Simmons, Alison/0000-0003-3454-0710; Parkes, Miles/0000-0002-6467-0631; Smith, Kenneth/0000-0003-3829-4326; Anderson, Carl/0000-0003-1719-7009; Biasci, Daniele/0000-0003-3148-8152	NIHR Biomedical Research Centres in Cambridge and Guy's and St Thomas'; Crohn's and Colitis UK (Medical Research Award) [M/14/2]; Evelyn Trust [17/07]; Medical Research Council [MR/L019027/1]; Wellcome Trust Intermediate Clinical Fellowship [105920/Z/14/Z]; Marie Curie PhD Fellowship (TranSVIR) [FP7-PEOPLE-ITN-2008 238756]; Wellcome Trust University Award [094491/Z/10/Z]; European Research Council [695551]; Wellcome Trust [098051, WT091310]; MRC [G0800675, MR/M00533X/1, MR/L019027/1, MC_UU_00008/7, G0600329, G0800759, MC_UU_12010/7] Funding Source: UKRI; Medical Research Council [MC_UU_00008/7, MR/M00533X/1, G0800759, G0800675, MC_UU_12010/7, G0600329] Funding Source: researchfish; Medical Research Foundation [C0482] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-026, NF-SI-0514-10109] Funding Source: researchfish; Versus Arthritis [20406] Funding Source: researchfish; Wellcome Trust [102974/Z/13/Z] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M11-1, M14-5, M14-2] Funding Source: researchfish; Chief Scientist Office [ETM/137] Funding Source: researchfish	NIHR Biomedical Research Centres in Cambridge and Guy's and St Thomas'; Crohn's and Colitis UK (Medical Research Award); Evelyn Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); Marie Curie PhD Fellowship (TranSVIR); Wellcome Trust University Award(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); Crohn&quot;s and Colitis UK; Chief Scientist Office	We thank L. Hildyard, E. Gray and other members of the Wellcome Trust Sanger Institute DNA team for their help with sample coordination and A. Groff and C. Weiner for critical reading of the manuscript. This work was supported by NIHR Biomedical Research Centres in Cambridge and Guy's and St Thomas' (in particular, J. Todd and the NIHR Cambridge BRC Genomics Theme), Crohn's and Colitis UK (Medical Research Award M/14/2), the Evelyn Trust (17/07), and the Medical Research Council (programme grant MR/L019027/1). J.C.L. is supported by a Wellcome Trust Intermediate Clinical Fellowship (105920/Z/14/Z), and D.B. is supported by a Marie Curie PhD Fellowship (TranSVIR FP7-PEOPLE-ITN-2008 238756). N.J.P. is supported by a Wellcome Trust University Award (094491/Z/10/Z), and J.A.T. is supported by the European Research Council (695551). C.A.A. is supported by the Wellcome Trust (098051). K.G.C.S. is an NIHR Senior Investigator. This study makes use of data generated by the UK10K Consortium, derived from samples from the ALSPAC and DTR cohorts. A full list of the investigators who contributed to the generation of the data is available from http://www.UK10K.org. Funding for UK10K was provided by the Wellcome Trust (WT091310).	Ananthakrishnan AN, 2014, AM J GASTROENTEROL, V109, P395, DOI 10.1038/ajg.2013.464; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CANDORE G, 1995, HUM IMMUNOL, V42, P289, DOI 10.1016/0198-8859(94)00103-W; Chataway J, 2001, J NEUROL NEUROSUR PS, V71, P757, DOI 10.1136/jnnp.71.6.757; Chibnik LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024380; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; EGEA E, 1991, J EXP MED, V173, P531, DOI 10.1084/jem.173.3.531; Franceschi C, 2005, MECH AGEING DEV, V126, P351, DOI 10.1016/j.mad.2004.08.028; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Hehlio T, 2003, GUT, V52, P558, DOI 10.1136/gut.52.4.558; Hilven K, 2015, MULT SCLER J, V21, P1670, DOI 10.1177/1352458514568174; Jawaheer D, 2004, ARTHRITIS RHEUM-US, V50, P736, DOI 10.1002/art.20066; Jensen CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010003; Jess T, 2007, INFLAMM BOWEL DIS, V13, P481, DOI 10.1002/ibd.20036; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jung C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052223; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Mabbott NA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-632; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; MODICA MA, 1990, J IMMUNOGENET, V17, P101; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Pincus T, 1995, BRIT J RHEUMATOL, V34, P59; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Sands BE, 2003, AM J GASTROENTEROL, V98, P2712, DOI 10.1016/S0002-9270(03)01707-6; Satsangi J, 1996, GUT, V38, P738, DOI 10.1136/gut.38.5.738; Scott IC, 2015, J RHEUMATOL, V42, P1131, DOI 10.3899/jrheum.141211; Vallot C, 2015, CELL STEM CELL, V16, P533, DOI 10.1016/j.stem.2015.03.016; Van Gestel S, 2000, BEHAV GENET, V30, P141, DOI 10.1023/A:1001907321955; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Weersma RK, 2009, GUT, V58, P388, DOI 10.1136/gut.2007.144865; Wei Z, 2013, AM J HUM GENET, V92, P1008, DOI 10.1016/j.ajhg.2013.05.002; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133	33	150	151	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					262	268		10.1038/ng.3755	http://dx.doi.org/10.1038/ng.3755			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	28067912	Green Submitted, Green Accepted			2022-12-25	WOS:000393148600015
J	Cramer, SL; Saha, A; Liu, JY; Tadi, S; Tiziani, S; Yan, WP; Triplett, K; Lamb, C; Alters, SE; Rowlinson, S; Zhang, YJ; Keating, MJ; Huang, P; DiGiovanni, J; Georgiou, G; Stone, E				Cramer, Shiro L.; Saha, Achinto; Liu, Jinyun; Tadi, Surendar; Tiziani, Stefano; Yan, Wupeng; Triplett, Kendra; Lamb, Candice; Alters, Susan E.; Rowlinson, Scott; Zhang, Yan Jessie; Keating, Michael J.; Huang, Peng; DiGiovanni, John; Georgiou, George; Stone, Everett			Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth	NATURE MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; PROSTATE-CANCER; THIOREDOXIN REDUCTASE; EFFECTIVE ELIMINATION; MEDIATED MECHANISMS; OXIDATIVE STRESS; CARCINOMA-CELLS; CURCUMIN; PATHWAY; GLUTATHIONE	Cancer cells experience higher oxidative stress from reactive oxygen species (ROS) than do non-malignant cells because of genetic alterations and abnormal growth; as a result, maintenance of the antioxidant glutathione (GSH) is essential for their survival and proliferation(1-3). Under conditions of elevated ROS, endogenous L-cysteine (L-Cys) production is insufficient for GSH synthesis. This necessitates uptake of L-Cys that is predominantly in its disulfide form, L-cystine (CSSC), via the xCT(-) transporter. We show that administration of an engineered and pharmacologically optimized human cyst(e)inase enzyme mediates sustained depletion of the extracellular L-Cys and CSSC pool in mice and non-human primates. Treatment with this enzyme selectively causes cell cycle arrest and death in cancer cells due to depletion of intracellular GSH and ensuing elevated ROS; yet this treatment results in no apparent toxicities in mice even after months of continuous treatment. Cyst(e)inase suppressed the growth of prostate carcinoma allografts, reduced tumor growth in both prostate and breast cancer xenografts and doubled the median survival time of TCL1-Tg:p53(-/-) mice, which develop disease resembling human chronic lymphocytic leukemia. It was observed that enzyme-mediated depletion of the serum L-Cys and CSSC pool suppresses the growth of multiple tumors, yet is very well tolerated for prolonged periods, suggesting that cyst(e)inase represents a safe and effective therapeutic modality for inactivating antioxidant cellular responses in a wide range of malignancies(4,5).	[Cramer, Shiro L.; Triplett, Kendra; Lamb, Candice; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Saha, Achinto; DiGiovanni, John] Univ Texas Austin, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Saha, Achinto; DiGiovanni, John] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA; [Liu, Jinyun; Huang, Peng] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Tadi, Surendar; Tiziani, Stefano] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Yan, Wupeng; Triplett, Kendra; Lamb, Candice; Zhang, Yan Jessie; Georgiou, George; Stone, Everett] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Alters, Susan E.; Rowlinson, Scott] Aeglea Biotherapeut, Austin, TX USA; [Keating, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.; Georgiou, G; Stone, E (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	gg@che.utexas.edu; stonesci@utexas.edu	Saha, Achinto/K-1041-2019	Saha, Achinto/0000-0002-4810-551X; Liu, Jinyun/0000-0002-4763-2684	College of Natural Sciences; Office of the Executive Vice President and Provost; Institute for Cellular and Molecular Biology at the University of Texas at Austin; National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Welch Foundation [F-1778]; NIH [1 R01 GM104896, 1 R01 CA172724, 1 R01 CA154754, 1 RO1 CA189623]; NCI [P30 CA54174]; Aeglea Biotherapeutics; NATIONAL CANCER INSTITUTE [R01CA189623, R01CA154754, P30CA054174, R01CA172724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104896] Funding Source: NIH RePORTER	College of Natural Sciences; Office of the Executive Vice President and Provost; Institute for Cellular and Molecular Biology at the University of Texas at Austin; National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Aeglea Biotherapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. Lowe (Aeglea Biotherapeutics), O. Paley, and M. Bonem for assistance with various aspects of this work and data interpretation and to L. Beltran and S. Carbajal for their expert technical assistance. Instrumentation and technical assistance for parts of this work were provided by the Macromolecular Crystallography Facility, with financial support from the College of Natural Sciences, the Office of the Executive Vice President and Provost, and the Institute for Cellular and Molecular Biology at the University of Texas at Austin. Diffraction data was collected at the Advanced Light Source at the Berkeley Center for Structural Biology which is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231. This work was supported by funding from: Welch Foundation F-1778 (Y.J.Z.), NIH 1 R01 GM104896 (Y.J.Z.), NIH 1 R01 CA172724 (P.H.), NIH 1 R01 CA154754 (G.G., ES.), NIH 1 RO1 CA189623 (E.S., J.D. and G.G.), NCI P30 CA54174 (S. Tiziani) and Aeglea Biotherapeutics.	Afanas'ev I, 2011, AGING DIS, V2, P219; Belalcazar A. D., 2014, ISRN BIOCH, V2013, DOI DOI 10.1155/2013/637897; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Chaiswing L, 2012, FREE RADICAL BIO MED, V52, P452, DOI 10.1016/j.freeradbiomed.2011.10.489; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Doxsee DW, 2007, PROSTATE, V67, P162, DOI 10.1002/pros.20508; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Foye W. O., 2007, FOYES PRINCIPLES MED; Ghislat G, 2012, J BIOL CHEM, V287, P38625, DOI 10.1074/jbc.M112.365767; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Holl M, 2016, MOL CARCINOGEN, V55, P27, DOI 10.1002/mc.22255; Huang SF, 2010, J MOL BIOL, V396, P708, DOI 10.1016/j.jmb.2009.11.058; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kanai M, 2013, CANCER CHEMOTH PHARM, V71, P1521, DOI 10.1007/s00280-013-2151-8; Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2; KATO S, 1993, NEUROSCIENCE, V57, P473, DOI 10.1016/0306-4522(93)90080-Y; Kim JK, 2009, IEEE PHOTONIC TECH L, V21, P21, DOI 10.1109/LPT.2008.2007912; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lee WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10420; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu Haibo, 2011, Wei Sheng Yan Jiu, V40, P283; Liu J, 2014, LEUKEMIA, V28, P118, DOI 10.1038/leu.2013.125; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; Narang VS, 2003, ANTICANCER RES, V23, P4571; Olsen LF, 2013, REDOX REP, V18, P245, DOI 10.1179/1351000213Y.0000000059; Pader I, 2014, P NATL ACAD SCI USA, V111, P6964, DOI 10.1073/pnas.1317320111; Persa C, 2006, EXP EYE RES, V83, P817, DOI 10.1016/j.exer.2006.04.001; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; Saha A, 2016, ONCOTARGET, V7, P25194, DOI 10.18632/oncotarget.7535; Sanchez Y, 2010, J PHARMACOL EXP THER, V335, P114, DOI 10.1124/jpet.110.168344; Shiozaki A., 2014, J GASTROENTEROL BOK, V49, P1; Stone E, 2012, ACS CHEM BIOL, V7, P1822, DOI 10.1021/cb300335j; Takeuchi S, 2013, NEUROSURGERY, V72, P33, DOI 10.1227/NEU.0b013e318276b2de; Timmerman L. A., 2013, CANCER CELL, V24, P853; Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; You XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023788; Zhang W, 2005, CANCER RES, V65, P1554, DOI 10.1158/0008-5472.CAN-04-1554; Zhang W, 2015, MOL MED REP, V12, P7374, DOI 10.3892/mmr.2015.4364; Zhang W, 2012, NAT CELL BIOL, V14, P276, DOI 10.1038/ncb2432; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049683	48	261	266	8	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					120	127		10.1038/nm.4232	http://dx.doi.org/10.1038/nm.4232			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27869804	Green Accepted			2022-12-25	WOS:000391646800021
J	Ly, P; Teitz, LS; Kim, DH; Shoshani, O; Skaletsky, H; Fachinetti, D; Page, DC; Cleveland, DW				Ly, Peter; Teitz, Levi S.; Kim, Dong H.; Shoshani, Ofer; Skaletsky, Helen; Fachinetti, Daniele; Page, David C.; Cleveland, Don W.			Selective Y centromere inactivation triggers chromosome shattering in micronuclei and repair by non-homologous end joining	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; HUMAN-CELLS; CENP-B; REARRANGEMENTS; CHROMOTHRIPSIS; SEQUENCE; PULVERIZATION; CONSEQUENCES; PROTEINS; SYSTEM	Chromosome missegregation into a micronucleus can cause complex and localized genomic rearrangements(1,2) known as chromothripsis(3), but the underlying mechanisms remain unresolved. Here we developed an inducible Y centromere-selective inactivation strategy by exploiting a CENP-A/histone H3 chimaera to directly examine the fate of missegregated chromosomes in otherwise diploid human cells. Using this approach, we identified a temporal cascade of events that are initiated following centromere inactivation involving chromosome missegregation, fragmentation, and re-ligation that span three consecutive cell cycles. Following centromere inactivation, a micronucleus harbouring the Y chromosome is formed in the first cell cycle. Chromosome shattering, producing up to 53 dispersed fragments from a single chromosome, is triggered by premature micronuclear condensation prior to or during mitotic entry of the second cycle. Lastly, canonical non-homologous end joining (NHEJ), but not homology-dependent repair, is shown to facilitate re-ligation of chromosomal fragments in the third cycle. Thus, initial errors in cell division can provoke further genomic instability through fragmentation of micronuclear DNAs coupled to NHEJ-mediated reassembly in the subsequent interphase.	[Ly, Peter; Kim, Dong H.; Shoshani, Ofer; Fachinetti, Daniele; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Ly, Peter; Kim, Dong H.; Shoshani, Ofer; Fachinetti, Daniele; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Teitz, Levi S.; Page, David C.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA; [Teitz, Levi S.; Skaletsky, Helen; Page, David C.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Skaletsky, Helen; Page, David C.] Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Fachinetti, Daniele] PSL Res Univ, Inst Curie, CNRS, UMR144, F-75005 Paris, France	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.; Cleveland, DW (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Kim, Dong Hyun/0000-0002-8762-1496; Ly, Peter/0000-0001-8946-7069; /0000-0001-9920-3411; Fachinetti, Daniele/0000-0002-8795-6771; Cleveland, Don/0000-0002-1934-3682; Shoshani, Ofer/0000-0001-8918-9935	NIH [GM029513, HG007852]; Ludwig Institute for Cancer Research; Howard Hughes Medical Institute; Cancer Cell Biology Training Grant from the NCI [5T32CA067754-18]; Hope Funds for Cancer Research [HFCR-14-06-06]; NATIONAL CANCER INSTITUTE [T32CA067754, P30CA023100] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, R35GM122476, R01GM074150, R37GM029513, R01GM029513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Cell Biology Training Grant from the NCI; Hope Funds for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Jepsen and the UC San Diego IGM Genomics Center (MCC P30 CA023100) for DNA library preparation and sequencing, A. Shiau, S. Dowdy, E. Hatch, M. Hetzer, X. Wu and T. Pyntikova (Whitehead Institute, USA) for providing reagents, D. Jenkins, I. Goyal and Y. Sun for technical assistance, and the UC San Diego School of Medicine Microscopy Core (NINDS P30 NS047101) for shared use of equipment. This work was funded by a grant from the NIH (GM029513) to D.W.C., who receives salary support from the Ludwig Institute for Cancer Research. D.C.P. is supported by the Howard Hughes Medical Institute and NIH (HG007852). P.L. was supported by a Cancer Cell Biology Training Grant from the NCI (5T32CA067754-18) and a Postdoctoral Fellowship from the Hope Funds for Cancer Research (HFCR-14-06-06).	Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; Fachinetti D, 2015, DEV CELL, V33, P314, DOI 10.1016/j.devcel.2015.03.020; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Hinchcliffe EH, 2016, NAT CELL BIOL, V18, P668, DOI 10.1038/ncb3348; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Holland AJ, 2012, NAT MED, V18, P1630, DOI 10.1038/nm.2988; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; KATO H, 1968, J NATL CANCER I, V40, P165; Klare K, 2015, J CELL BIOL, V210, P11, DOI 10.1083/jcb.201412028; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Leach NT, 2004, MUTAT RES-FUND MOL M, V554, P89, DOI 10.1016/j.mrfmmm.2004.03.004; Logsdon GA, 2015, J CELL BIOL, V208, P521, DOI 10.1083/jcb.201412011; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; Mardin BR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156505; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Orth JD, 2012, MOL BIOL CELL, V23, P567, DOI 10.1091/mbc.E11-09-0781; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Sabatinos SA, 2015, MOL BIOL CELL, V26, P3439, DOI 10.1091/mbc.E15-05-0318; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tan EH, 2015, ELIFE, V4, DOI 10.7554/eLife.06516; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	40	135	140	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2017	19	1					68	75		10.1038/ncb3450	http://dx.doi.org/10.1038/ncb3450			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EG9AI	27918550	Green Accepted, Green Submitted			2022-12-25	WOS:000391349000010
J	Dejong, CA; Chen, GM; Li, HX; Johnston, CW; Edwards, MR; Rees, PN; Skinnider, MA; Webster, ALH; Magarvey, NA				Dejong, Chris A.; Chen, Gregory M.; Li, Haoxin; Johnston, Chad W.; Edwards, Mclean R.; Rees, Philip N.; Skinnider, Michael A.; Webster, Andrew L. H.; Magarvey, Nathan A.			Polyketide and nonribosomal peptide retro-biosynthesis and global gene cluster matching	NATURE CHEMICAL BIOLOGY			English	Article							NATURAL-PRODUCT DISCOVERY; STRUCTURE ELUCIDATION; ANTIBIOTICS; PREDICTION; GENOMICS; SEQUENCE; MINIMUM; CULTURE; SEARCH; LOGIC	Polyketides (PKs) and nonribosomal peptides (NRPs) are profoundly important natural products, forming the foundations of many therapeutic regimes. Decades of research have revealed over 11,000 PK and NRP structures, and genome sequencing is uncovering new PK and NRP gene clusters at an unprecedented rate. However, only similar to 10% of PK and NRPs are currently associated with gene clusters, and it is unclear how many of these orphan gene clusters encode previously isolated molecules. Therefore, to efficiently guide the discovery of new molecules, we must first systematically de-orphan emergent gene clusters from genomes. Here we provide to our knowledge the first comprehensive retro-biosynthetic program, generalized retro-biosynthetic assembly prediction engine (GRAPE), for PK and NRP families and introduce a computational pipeline, global alignment for natural products cheminformatics (GARLIC), to uncover how observed biosynthetic gene clusters relate to known molecules, leading to the identification of gene clusters that encode new molecules.	[Dejong, Chris A.; Chen, Gregory M.; Li, Haoxin; Johnston, Chad W.; Edwards, Mclean R.; Rees, Philip N.; Skinnider, Michael A.; Webster, Andrew L. H.; Magarvey, Nathan A.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Dejong, Chris A.; Chen, Gregory M.; Li, Haoxin; Johnston, Chad W.; Edwards, Mclean R.; Rees, Philip N.; Skinnider, Michael A.; Webster, Andrew L. H.; Magarvey, Nathan A.] McMaster Univ, Dept Chem & Chem Biol, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University	Magarvey, NA (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.; Magarvey, NA (corresponding author), McMaster Univ, Dept Chem & Chem Biol, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	magarv@mcmaster.ca		Johnston, Chad/0000-0002-1988-709X; Skinnider, Michael/0000-0002-2168-1621	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 371576-2014]; Joint Programme Initiative on Antimicrobial Resistance through the Canadian Institutes of Health Research (CIHR) [138739]; CIHR; Canada Research Chairs Program [950228183]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Joint Programme Initiative on Antimicrobial Resistance through the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	This work was funded through an Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery grant (RGPIN 371576-2014) (N.A.M.) and a Joint Programme Initiative on Antimicrobial Resistance funded through the Canadian Institutes of Health Research (CIHR) (grant 138739) (N.A.M.). C.W.J. is funded through a CIHR Doctoral Research Award. N.A.M. is supported by the Canada Research Chairs Program (grant 950228183). We thank J. Cao for rendering trees, A. Luo for curating sugar genes and structures, and B. Furman for valuable communications.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson E, 1987, SMILES LINE NOTATION; [Anonymous], 2014, SCIPY OPEN SOURCE SC; Bachmann BO, 2010, NAT CHEM BIOL, V6, P390, DOI 10.1038/nchembio.377; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Barsby T, 2001, ORG LETT, V3, P437, DOI 10.1021/ol006942q; Callahan B, 2009, P NATL ACAD SCI USA, V106, P19410, DOI 10.1073/pnas.0902364106; Challis GL, 2004, CURR OPIN STRUC BIOL, V14, P748, DOI 10.1016/j.sbi.2004.10.005; Desjardine K, 2007, J NAT PROD, V70, P1850, DOI 10.1021/np070209r; DOBASHI K, 1988, J ANTIBIOT, V41, P1533, DOI 10.7164/antibiotics.41.1533; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/NCHEMBIO.1659, 10.1038/nchembio.1659]; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fisher R.A.Y., 1948, FRANK STAT TABLES BI; GAUDIANO G, 1966, TETRAHEDRON LETT, P3559; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Ishida K, 2010, J AM CHEM SOC, V132, P13966, DOI 10.1021/ja105003g; Jensen PR, 2014, J IND MICROBIOL BIOT, V41, P203, DOI 10.1007/s10295-013-1353-8; Johnston CW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9421; Khayatt BI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062136; Lincke T, 2010, ANGEW CHEM INT EDIT, V49, P2011, DOI 10.1002/anie.200906114; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; POWELL MJD, 1964, COMPUT J, V7, P155, DOI 10.1093/comjnl/7.2.155; Rahman SA, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-12; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; SHEEHAN JC, 1968, J AM CHEM SOC, V90, P462, DOI 10.1021/ja01004a043; Skinnider MA, 2015, NUCLEIC ACIDS RES, V43, P9645, DOI 10.1093/nar/gkv1012; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; Vizcaino MI, 2015, NAT CHEM, V7, P411, DOI [10.1038/NCHEM.2221, 10.1038/nchem.2221]; Walsh CT, 2013, ANGEW CHEM INT EDIT, V52, P7098, DOI 10.1002/anie.201208344; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; WEBER JM, 1990, J BACTERIOL, V172, P2372, DOI 10.1128/jb.172.5.2372-2383.1990; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437	34	80	84	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1007	+		10.1038/nchembio.2188	http://dx.doi.org/10.1038/nchembio.2188			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27694801				2022-12-25	WOS:000388582900008
J	Heppert, JK; Goldstein, B				Heppert, Jennifer K.; Goldstein, Bob			Remodelling germ cells by intercellular cannibalism	NATURE CELL BIOLOGY			English	Editorial Material							CAENORHABDITIS-ELEGANS	Work from the early 1980s reported strange lobes protruding from Caenorhabditis elegans germ cell precursors. However, the fate and potential significance of these lobes remained unexplored for decades. Now, neighbouring endodermal cells are shown to sever and digest these lobes, in an unexpected process of 'intercellular cannibalism', which could play an important part in regulating primordial germ cells.	[Heppert, Jennifer K.; Goldstein, Bob] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Goldstein, B (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	bobg@e-mail.unc.edu		Heppert, Jennifer/0000-0001-8602-414X; Goldstein, Bob/0000-0001-6961-675X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083071] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083071] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdu Y, 2016, NAT CELL BIOL, V18, P1302, DOI 10.1038/ncb3439; Han C, 2014, NEURON, V81, P544, DOI 10.1016/j.neuron.2013.11.021; Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Smelick C, 2005, AGEING RES REV, V4, P67, DOI 10.1016/j.arr.2004.09.002; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Unal E, 2011, COLD SH Q B, V76, P73, DOI 10.1101/sqb.2011.76.011379	11	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2016	18	12					1267	1268		10.1038/ncb3449	http://dx.doi.org/10.1038/ncb3449			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	ED8PY	27897161	Green Accepted			2022-12-25	WOS:000389134600004
J	Skjoedt, ML; Snoek, T; Kildegaard, KR; Arsovska, D; Eichenberger, M; Goedecke, TJ; Rajkumar, AS; Zhang, J; Kristensen, M; Lehka, BJ; Siedler, S; Borodina, I; Jensen, MK; Keasling, JD				Skjoedt, Mette L.; Snoek, Tim; Kildegaard, Kanchana R.; Arsovska, Dushica; Eichenberger, Michael; Goedecke, Tobias J.; Rajkumar, Arun S.; Zhang, Jie; Kristensen, Mette; Lehka, Beata J.; Siedler, Solvej; Borodina, Irina; Jensen, Michael K.; Keasling, Jay D.			Engineering prokaryotic transcriptional activators as metabolite biosensors in yeast	NATURE CHEMICAL BIOLOGY			English	Article							GENE-EXPRESSION; MUCONIC ACID; PROTEIN; OPTIMIZATION; EVOLUTION; BIOLOGY; PATHWAY; SYSTEM; CIRCUITS; SENSORS	Whole-cell biocatalysts have proven a tractable path toward sustainable production of bulk and fine chemicals. Yet the screening of libraries of cellular designs to identify best-performing biocatalysts is most often a low-throughput endeavor. For this reason, the development of biosensors enabling real-time monitoring of production has attracted attention. Here we applied systematic engineering of multiple parameters to search for a general biosensor design in the budding yeast Saccharomyces cerevisiae based on small-molecule binding transcriptional activators from the prokaryote superfamily of LysR-type transcriptional regulators (LTTRs). We identified a design supporting LTTR-dependent activation of reporter gene expression in the presence of cognate small-molecule inducers. As proof of principle, we applied the biosensors for in vivo screening of cells producing naringenin or cis, cis-muconic acid at different levels, and found that reporter gene output correlated with production. The transplantation of prokaryotic transcriptional activators into the eukaryotic chassis illustrates the potential of a hitherto untapped biosensor resource useful for biotechnological applications.	[Skjoedt, Mette L.; Snoek, Tim; Kildegaard, Kanchana R.; Arsovska, Dushica; Goedecke, Tobias J.; Rajkumar, Arun S.; Zhang, Jie; Kristensen, Mette; Siedler, Solvej; Borodina, Irina; Jensen, Michael K.; Keasling, Jay D.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark; [Eichenberger, Michael] Evolva SA, Reinach, Switzerland; [Eichenberger, Michael] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Lehka, Beata J.] Evolva Biotech AS, Copenhagen, Denmark; [Lehka, Beata J.] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Keasling, Jay D.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	Technical University of Denmark; Technical University of Darmstadt; Roskilde University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Jensen, MK (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark.	mije@biosustain.dtu.dk	Keasling, Jay D/J-9162-2012; Rajkumar, Arun S./AAH-9004-2021	Keasling, Jay D/0000-0003-4170-6088; Rajkumar, Arun S./0000-0003-0895-5189; Kildegaard, Kanchana Rueksomtawin/0000-0001-9885-380X; Borodina, Irina/0000-0002-8452-1393; Snoek, Tim/0000-0002-5395-9034; Zhang, Jie/0000-0003-4119-9442; Eichenberger, Michael/0000-0003-4749-4135; Jensen, Michael Krogh/0000-0001-7574-4707	Novo Nordisk Foundation; European Union Seventh Framework Programme (FP7-KBBE-7-single-stage) [613745]; Lundbeck Foundation [R140-2013-13496, R77-2010-6772] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011335, NNF10CC1016517, NNF13SA0009311, NNF13SA0006019] Funding Source: researchfish; NNF Center for Biosustainability [Bacterial Synthetic Biology, iLoop, Yeast Metabolic Engineering, Synthetic Biology Tools for Yeast] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Union Seventh Framework Programme (FP7-KBBE-7-single-stage); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	This work was supported by the Novo Nordisk Foundation and by the European Union Seventh Framework Programme (FP7-KBBE-2013-7-single-stage) under grant agreement no. 613745, Promys (M.E. & S.S.). We acknowledge A. Koza and E. Ozdemir for technical assistance.	Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Bundy BM, 2002, P NATL ACAD SCI USA, V99, P7693, DOI 10.1073/pnas.102605799; Chen WN, 2013, APPL BIOCHEM BIOTECH, V171, P44, DOI 10.1007/s12010-013-0334-8; Choi JH, 2015, ACS SYNTH BIOL, V4, P400, DOI 10.1021/sb500254g; Collier LS, 1998, J BACTERIOL, V180, P2493, DOI 10.1128/JB.180.9.2493-2501.1998; Curran KA, 2013, METAB ENG, V15, P55, DOI 10.1016/j.ymben.2012.10.003; Eckert-Boulet N, 2012, YEAST, V29, P323, DOI 10.1002/yea.2912; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Esvelt KM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.66; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Folcher M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt405; Galloway KE, 2013, SCIENCE, V341, P1358, DOI 10.1126/science.1235005; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gupta RK, 2003, FEMS YEAST RES, V4, P305, DOI 10.1016/S1567-1356(03)00174-0; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jensen NB, 2014, FEMS YEAST RES, V14, P238, DOI 10.1111/1567-1364.12118; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Kildegaard KR, 2014, METAB ENG, V26, P57, DOI 10.1016/j.ymben.2014.09.004; Kim T, 2015, ANGEW CHEM INT EDIT, V54, P5933, DOI 10.1002/anie.201412204; Koopman F, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-155; Laishram RS, 2007, GENE DEV, V21, P1258, DOI 10.1101/gad.1520507; Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012; Lee ME, 2013, NUCLEIC ACIDS RES, V41, P10668, DOI 10.1093/nar/gkt809; LEE N, 1987, P NATL ACAD SCI USA, V84, P8814, DOI 10.1073/pnas.84.24.8814; LI WZ, 1991, MOL CELL BIOL, V11, P666, DOI 10.1128/MCB.11.2.666; MacLean AA, 2006, APPL ENVIRON MICROB, V72, P5403, DOI 10.1128/AEM.00580-06; MacLean AM, 2011, MICROBIOL-SGM, V157, P2522, DOI 10.1099/mic.0.050542-0; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; McIsaac RS, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1402; Michener JK, 2012, METAB ENG, V14, P306, DOI 10.1016/j.ymben.2012.04.004; Mikkelsen MD, 2012, METAB ENG, V14, P104, DOI 10.1016/j.ymben.2012.01.006; Naesby M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-45; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; Opekarova M, 1997, FEMS MICROBIOL LETT, V152, P261, DOI 10.1111/j.1574-6968.1997.tb10437.x; Peng HL, 1999, J BACTERIOL, V181, P2302, DOI 10.1128/JB.181.7.2302-2306.1999; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PFEIFER K, 1987, CELL, V49, P9, DOI 10.1016/0092-8674(87)90750-1; Raman S, 2014, P NATL ACAD SCI USA, V111, P17803, DOI 10.1073/pnas.1409523111; Rikhvanov E. G., 2003, Mikrobiologiya, V72, P616; Rogers JK, 2016, P NATL ACAD SCI USA, V113, P2388, DOI 10.1073/pnas.1600375113; SHADEL GS, 1991, J BACTERIOL, V173, P568, DOI 10.1128/jb.173.2.568-574.1991; Siedler S, 2014, METAB ENG, V21, P2, DOI 10.1016/j.ymben.2013.10.011; Stanton BC, 2014, ACS SYNTH BIOL, V3, P880, DOI 10.1021/sb5002856; Stanton BC, 2014, NAT CHEM BIOL, V10, P99, DOI 10.1038/nchembio.1411; Suastegui M., 2016, ANGEW CHEM, V128, P2414; Teo WS, 2015, BIOTECHNOL J, V10, P315, DOI 10.1002/biot.201400159; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang BJ, 2015, NUCLEIC ACIDS RES, V43, P1955, DOI 10.1093/nar/gku1388; Wang M, 2016, BIOTECHNOL BIOENG, V113, P206, DOI 10.1002/bit.25676; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Zhang HR, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0319-0	54	126	133	3	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					951	+		10.1038/NCHEMBIO.2177	http://dx.doi.org/10.1038/NCHEMBIO.2177			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27642864	Green Published			2022-12-25	WOS:000386798800017
J	Zhang, TH; Kwiatkowski, N; Olson, CM; Dixon-Clarke, SE; Abraham, BJ; Greifenberg, AK; Ficarro, SB; Elkins, JM; Liang, YK; Hannett, NM; Manz, T; Hao, MF; Bartkowiak, B; Greenleaf, AL; Marto, JA; Geyer, M; Bullock, AN; Young, RA; Gray, NS				Zhang, Tinghu; Kwiatkowski, Nicholas; Olson, Calla M.; Dixon-Clarke, Sarah E.; Abraham, Brian J.; Greifenberg, Ann K.; Ficarro, Scott B.; Elkins, Jonathan M.; Liang, Yanke; Hannett, Nancy M.; Manz, Theresa; Hao, Mingfeng; Bartkowiak, Bartlomiej; Greenleaf, Arno L.; Marto, Jarrod A.; Geyer, Matthias; Bullock, Alex N.; Young, Richard A.; Gray, Nathanael S.			Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							RNA-POLYMERASE-II; ACUTE LYMPHOBLASTIC-LEUKEMIA; C-TERMINAL DOMAIN; SUPER-ENHANCERS; P-TEFB; TRANSCRIPTION; KINASE; PHOSPHORYLATION; EXPRESSION; COMPLEX	Cyclin-dependent kinases 12 and 13 (CDK12 and CDK13) play critical roles in the regulation of gene transcription. However, the absence of CDK12 and CDK13 inhibitors has hindered the ability to investigate the consequences of their inhibition in healthy cells and cancer cells. Here we describe the rational design of a first-in-class CDK12 and CDK13 covalent inhibitor, THZ531. Co-crystallization of THZ531 with CDK12-cyclin K indicates that THZ531 irreversibly targets a cysteine located outside the kinase domain. THZ531 causes a loss of gene expression with concurrent loss of elongating and hyperphosphorylated RNA polymerase II. In particular, THZ531 substantially decreases the expression of DNA damage response genes and key super-enhancer-associated transcription factor genes. Coincident with transcriptional perturbation, THZ531 dramatically induced apoptotic cell death. Small molecules capable of specifically targeting CDK12 and CDK13 may thus help identify cancer subtypes that are particularly dependent on their kinase activities.	[Zhang, Tinghu; Kwiatkowski, Nicholas; Olson, Calla M.; Ficarro, Scott B.; Liang, Yanke; Manz, Theresa; Hao, Mingfeng; Marto, Jarrod A.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zhang, Tinghu; Kwiatkowski, Nicholas; Olson, Calla M.; Ficarro, Scott B.; Liang, Yanke; Hao, Mingfeng; Marto, Jarrod A.; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kwiatkowski, Nicholas; Abraham, Brian J.; Hannett, Nancy M.; Young, Richard A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Dixon-Clarke, Sarah E.; Elkins, Jonathan M.; Bullock, Alex N.] Univ Oxford, Struct Genom Consortium, Oxford, England; [Greifenberg, Ann K.; Geyer, Matthias] Univ Bonn, Inst Innate Immun, Dept Struct Immunol, Bonn, Germany; [Greifenberg, Ann K.; Geyer, Matthias] Ctr Adv European Studies & Res, Bonn, Germany; [Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02115 USA; [Manz, Theresa] Univ Saarland, Dept Pharm, Pharmaceut & Med Chem, Saarbrucken, Germany; [Bartkowiak, Bartlomiej; Greenleaf, Arno L.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Oxford; University of Bonn; Center of Advanced European Studies & Research (CAESAR); Harvard University; Dana-Farber Cancer Institute; Saarland University; Duke University; Massachusetts Institute of Technology (MIT)	Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Gray, NS (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Young, RA (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	young@wi.mit.edu; Nathanael_Gray@dfci.harvard.edu	Abraham, Brian/C-2230-2019; Young, Richard A/F-6495-2012	Abraham, Brian/0000-0001-8085-3027; Young, Richard A/0000-0001-8855-8647; Geyer, Matthias/0000-0002-7718-5002; Elkins, Jon/0000-0003-2858-8929	National Institutes of Health [HG002668, CA109901, 5 R01 CA179483-02 C]; Koch Institute and Dana-Farber/Harvard Cancer Center Bridge Grant; DFG [GE 976/9-1]; Hope Funds for Cancer Research Grillo-Marxuach Family Fellowship; NDM Prize Studentship; Medical Research Council; AbbVie; Bayer; Boehringer Ingelheim; Genome Canada through Ontario Genomics Institute Grant [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; NATIONAL CANCER INSTITUTE [R01CA179483, P30CA014051, P01CA109901] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; Medical Research Council [1092716] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koch Institute and Dana-Farber/Harvard Cancer Center Bridge Grant; DFG(German Research Foundation (DFG)); Hope Funds for Cancer Research Grillo-Marxuach Family Fellowship; NDM Prize Studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AbbVie(AbbVie); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Genome Canada through Ontario Genomics Institute Grant(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. George, K. Wong, P. Hammerman, J. Bradner and members of the Gray and Young laboratories for helpful discussions. We thank P. Wisniewski and C. Zollo from the Whitehead FACS facility for help with FACS instruments. We thank J. Love, T. Volkert, and S. Gupta from the Whitehead Genome Core for help with genomics experiments. The authors would like to thank Diamond Light Source for beamtime (proposal mx8421), and the staff of Beamline I03 for assistance with data collection. We thank W. Massefski from the Dana-Farber NMR lab for help in collecting NMR data for the manuscript. M.G. is a member of the DFG excellence cluster ImmunoSensation. This work was supported by the National Institutes of Health (HG002668 and CA109901 to R.A.Y. and 5 R01 CA179483-02 C to N.S.G.), the Koch Institute and Dana-Farber/Harvard Cancer Center Bridge Grant (N.K., N.S.G., R.A.Y.), the DFG (GE 976/9-1 to M.G.), the Hope Funds for Cancer Research Grillo-Marxuach Family Fellowship (B.J.A.), and a NDM Prize Studentship, funded in part by the Medical Research Council (S.E.D.-C.). The SGC is a registered charity (no. 1097737) that receives funds from AbbVie, Bayer, Boehringer Ingelheim, Genome Canada through Ontario Genomics Institute Grant OGI-055, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and Wellcome Trust Grant 092809/Z/10/Z.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; [Anonymous], PYMOL MOL GRAPH SYST; Askenazi M, 2009, NAT METHODS, V6, P240, DOI 10.1038/nmeth0409-240; Bajrami I, 2014, CANCER RES, V74, P287, DOI 10.1158/0008-5472.CAN-13-2541; Bartkowiak B, 2015, BBA-GENE REGUL MECH, V1849, P1179, DOI 10.1016/j.bbagrm.2015.07.010; Bartkowiak B, 2015, J BIOL CHEM, V290, P1786, DOI 10.1074/jbc.M114.612226; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bennett CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001448; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Bosken CA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4505; Bowman EA, 2014, NUCLEUS-PHILA, V5, P224, DOI 10.4161/nucl.29347; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chen HH, 2006, MOL CELL BIOL, V26, P2736, DOI 10.1128/MCB.26.7.2736-2745.2006; Chen HH, 2007, BIOCHEM BIOPH RES CO, V354, P735, DOI 10.1016/j.bbrc.2007.01.049; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Davidson L, 2014, GENE DEV, V28, P342, DOI 10.1101/gad.231274.113; Eifler TT, 2015, MOL CELL BIOL, V35, P468, DOI 10.1128/MCB.01157-14; Ekumi KM, 2015, NUCLEIC ACIDS RES, V43, P2575, DOI 10.1093/nar/gkv101; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Ficarro SB, 2009, ANAL CHEM, V81, P3440, DOI 10.1021/ac802720e; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Greifenberg AK, 2016, CELL REP, V14, P320, DOI 10.1016/j.celrep.2015.12.025; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Joshi PM, 2014, J BIOL CHEM, V289, P9247, DOI 10.1074/jbc.M114.551143; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Liang K, 2015, MOL CELL BIOL, V35, P928, DOI 10.1128/MCB.01426-14; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lolli G, 2004, STRUCTURE, V12, P2067, DOI 10.1016/j.str.2004.08.013; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Sanso M, 2013, TRANSCR-AUSTIN, V4, P146, DOI 10.4161/trns.25146; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winsor TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060909; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.biochem.60.1.689; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	58	177	189	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					876	+		10.1038/nchembio.2166	http://dx.doi.org/10.1038/nchembio.2166			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27571479	Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000384248600021
J	Kahsai, AW; Wisler, JW; Lee, J; Ahn, S; Cahill, TJ; Dennison, SM; Staus, DP; Thomsen, ARB; Anasti, KM; Pani, B; Wingler, LM; Desai, H; Bompiani, KM; Strachan, RT; Qin, XX; Alam, SM; Sullenger, BA; Lefkowitz, RJ				Kahsai, Alem W.; Wisler, James W.; Lee, Jungmin; Ahn, Seungkirl; Cahill, Thomas J., III; Dennison, S. Moses; Staus, Dean P.; Thomsen, Alex R. B.; Anasti, Kara M.; Pani, Biswaranjan; Wingler, Laura M.; Desai, Hemant; Bompiani, Kristin M.; Strachan, Ryan T.; Qin, Xiaoxia; Alam, S. Munir; Sullenger, Bruce A.; Lefkowitz, Robert J.			Conformationally selective RNA aptamers allosterically modulate the beta(2)-adrenoceptor	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; ADRENERGIC-RECEPTOR; HEALTHY-VOLUNTEERS; CRYSTAL-STRUCTURE; DRUG DISCOVERY; NOBEL LECTURE; GENERATION; COMPLEX; LIGANDS	G-protein-coupled receptor (GPCR) ligands function by stabilizing multiple, functionally distinct receptor conformations. This property underlies the ability of 'biased agonists' to activate specific subsets of a given receptor's signaling profile. However, stabilizing distinct active GPCR conformations to enable structural characterization of mechanisms underlying GPCR activation remains difficult. These challenges have accentuated the need for receptor tools that allosterically stabilize and regulate receptor function through unique, previously unappreciated mechanisms. Here, using a highly diverse RNA library combined with advanced selection strategies involving state-of-the-art next-generation sequencing and bioinformatics analyses, we identify RNA aptamers that bind a prototypical GPCR, the. 2-adrenoceptor (beta(2)AR). Using biochemical, pharmacological, and biophysical approaches, we demonstrate that these aptamers bind with nanomolar affinity at defined surfaces of the receptor, allosterically stabilizing active, inactive, and ligand-specific receptor conformations. The discovery of RNA aptamers as allosteric GPCR modulators significantly expands the diversity of ligands available to study the structural and functional regulation of GPCRs.	[Kahsai, Alem W.; Wisler, James W.; Lee, Jungmin; Ahn, Seungkirl; Cahill, Thomas J., III; Staus, Dean P.; Thomsen, Alex R. B.; Pani, Biswaranjan; Wingler, Laura M.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lee, Jungmin] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Cahill, Thomas J., III; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Dennison, S. Moses; Anasti, Kara M.; Alam, S. Munir] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Desai, Hemant] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Bompiani, Kristin M.; Sullenger, Bruce A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Bompiani, Kristin M.; Sullenger, Bruce A.] Duke Univ, Med Ctr, Duke Translat Res Inst, Durham, NC USA; [Bompiani, Kristin M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Strachan, Ryan T.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Qin, Xiaoxia] Duke Univ, Genome Sequencing & Anal Core Resource, Durham, NC USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC USA	Duke University; Harvard University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC USA.	lefko001@receptor-biol.duke.edu	Pani, Biswaranjan/GLT-9217-2022; Wingler, Laura/ABA-4466-2020; Lefkowitz, Robert/AAW-2649-2021; Alam, S. Munir/AAC-6711-2019	Wingler, Laura/0000-0002-3688-5088; Thomsen, Alex/0000-0003-1638-8911	US National Institutes of Health [HL16037, R01HL65222]; NHLBI grant of the National Institutes of Health [F30HL129803]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, T32HL007101, F30HL129803, R01HL065222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI grant of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.J.L. is an investigator with the Howard Hughes Medical Institute (HHMI). This work was supported in part by grants from the US National Institutes of Health to R.J.L. (HL16037) and to B.A.S. (R01HL65222). We gratefully acknowledge B. Kobilka (Stanford University, Stanford, CA) and G. Skiniotis (University of Michigan, Ann Arbor, Michigan) for stimulating ideas and helpful discussions; we are also grateful to S. Rajagopal and J.C. Snyder of Duke University for discussions and critical reading of the manuscript; we thank O. Fedrigo and N. Hoang at the Genome Sequencing and Analysis Core Resource (Duke University) for library preparation support and quality control analysis and for performing next-generation DNA sequencing; we also acknowledge the use of transmission electron microscopy at the Shared Materials Instrumentation Facility (Duke University). T.J.C. is supported by an NHLBI grant of the National Institutes of Health (F30HL129803). We also thank X. Chen (Changzhou University, Jiangsu, China) for the supply of BI167107; A.K. Shukla (IIT, Kanpur, India), E. Pratico (Duke University), J. Kim (Duke University), and K. Xiao (University of Pittsburg) for valuable assistance with reagents; X. Jiang and W. Capel for excellent technical assistance; and D. Addison and Q. Lennon for secretarial assistance.	Adams JJ, 2014, CURR OPIN STRUC BIOL, V24, P1, DOI 10.1016/j.sbi.2013.11.003; Bompiani KM, 2012, J THROMB HAEMOST, V10, P870, DOI 10.1111/j.1538-7836.2012.04679.x; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Daniels DA, 2002, ANAL BIOCHEM, V305, P214, DOI 10.1006/abio.2002.5663; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ghosh E, 2015, NAT REV MOL CELL BIO, V16, P69, DOI 10.1038/nrm3933; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; HOFFMAN BB, 1982, ANNU REV PHYSIOL, V44, P475, DOI 10.1146/annurev.ph.44.030182.002355; Ivetac A, 2010, CHEM BIOL DRUG DES, V76, P201, DOI 10.1111/j.1747-0285.2010.01012.x; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Kahsai AW, 2014, NAT PROTOC, V9, P1301, DOI 10.1038/nprot.2014.075; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kobilka B, 2013, ANGEW CHEM INT EDIT, V52, P6380, DOI 10.1002/anie.201302116; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lee G, 2014, ACS CHEM NEUROSCI, V5, P559, DOI 10.1021/cn500041k; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; Lincoff AM, 2016, LANCET, V387, P349, DOI 10.1016/S0140-6736(15)00515-2; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Oberthur D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7923; Ozer A, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.34; Peisley Alys, 2015, Methods Mol Biol, V1335, P29, DOI 10.1007/978-1-4939-2914-6_3; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pratico ED, 2013, NUCLEIC ACID THER, V23, P35, DOI 10.1089/nat.2012.0388; Que-Gewirth NS, 2007, GENE THER, V14, P283, DOI 10.1038/sj.gt.3302900; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ratner M, 2014, NAT BIOTECHNOL, V32, P701, DOI 10.1038/nbt0814-701; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Soergel DG, 2013, J CLIN PHARMACOL, V53, P892, DOI 10.1002/jcph.111; Staus DP, 2014, MOL PHARMACOL, V85, P472, DOI 10.1124/mol.113.089516; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Tesmer JJG, 2016, METHODS MOL BIOL, V1380, P151, DOI 10.1007/978-1-4939-3197-2_12; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vinkenborg JL, 2011, NAT CHEM BIOL, V7, P519, DOI [10.1038/NCHEMBIO.609, 10.1038/nchembio.609]; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Wang J., 2013, CHINESE J ORG CHEM, V33, P634; Weichert D, 2014, P NATL ACAD SCI USA, V111, P10744, DOI 10.1073/pnas.1410415111; Weiss DR, 2013, ACS CHEM BIOL, V8, P1018, DOI 10.1021/cb400103f; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Williams R J, 1995, Methods Mol Biol, V41, P63; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Zhou JH, 2015, CHEM BIOL, V22, P379, DOI 10.1016/j.chembiol.2015.01.005	54	53	54	3	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					709	+		10.1038/nchembio.2126	http://dx.doi.org/10.1038/nchembio.2126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27398998	Green Submitted, Green Accepted			2022-12-25	WOS:000382255100012
J	Tillberg, PW; Chen, F; Piatkevich, KD; Zhao, YX; Yu, CC; English, BP; Gao, LY; Martorell, A; Suk, HJ; Yoshida, F; DeGennaro, EM; Roossien, DH; Gong, GY; Seneviratne, U; Tannenbaum, SR; Desimone, R; Cai, DW; Boyden, ES				Tillberg, Paul W.; Chen, Fei; Piatkevich, Kiryl D.; Zhao, Yongxin; Yu, Chih-Chieh (Jay); English, Brian P.; Gao, Linyi; Martorell, Anthony; Suk, Ho-Jun; Yoshida, Fumiaki; DeGennaro, Ellen M.; Roossien, Douglas H.; Gong, Guanyu; Seneviratne, Uthpala; Tannenbaum, Steven R.; Desimone, Robert; Cai, Dawen; Boyden, Edward S.			Protein-retention expansion microscopy of cells and tissues labeled using standard fluorescent proteins and antibodies	NATURE BIOTECHNOLOGY			English	Article							CELLULAR STRUCTURES; ANTIGEN RETRIEVAL; SENSITIVITY	Expansion microscopy (ExM) enables imaging of preserved specimens with nanoscale precision on diffraction-limited instead of specialized super-resolution microscopes. ExM works by physically separating fluorescent probes after anchoring them to a swellable gel. The first ExM method did not result in the retention of native proteins in the gel and relied on custom-made reagents that are not widely available. Here we describe protein retention ExM (proExM), a variant of ExM in which proteins are anchored to the swellable gel, allowing the use of conventional fluorescently labeled antibodies and streptavidin, and fluorescent proteins. We validated and demonstrated the utility of proExM for multicolor super-resolution (similar to 70 nm) imaging of cells and mammalian tissues on conventional microscopes.	[Tillberg, Paul W.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Tillberg, Paul W.; Chen, Fei; Piatkevich, Kiryl D.; Zhao, Yongxin; Yu, Chih-Chieh (Jay); Suk, Ho-Jun; Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA; [Chen, Fei; Yu, Chih-Chieh (Jay); Gao, Linyi; Gong, Guanyu; Seneviratne, Uthpala; Tannenbaum, Steven R.; Boyden, Edward S.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [English, Brian P.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Martorell, Anthony; DeGennaro, Ellen M.; Desimone, Robert; Boyden, Edward S.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Suk, Ho-Jun] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Yoshida, Fumiaki] Osaka Univ, Sch Med, Suita, Osaka, Japan; [Yoshida, Fumiaki; DeGennaro, Ellen M.; Desimone, Robert; Boyden, Edward S.] MIT, McGovern Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Roossien, Douglas H.; Cai, Dawen] Univ Michigan, Sch Med, Ann Arbor, MI USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Osaka University; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan	Boyden, ES (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), MIT, McGovern Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	esb@media.mit.edu	Chen, Fei/HGE-5690-2022; Yoshida, Fumiaki/AAL-2140-2021; Gong, Guanyu/ABA-1935-2021; English, Brian P/O-8156-2016; Zhao, Yongxin/AAE-3708-2020; Cai, Dawen/Q-3354-2017	Chen, Fei/0000-0003-2308-3649; Gong, Guanyu/0000-0002-5791-0916; English, Brian P/0000-0002-4037-6294; Zhao, Yongxin/0000-0003-4188-5725; Cai, Dawen/0000-0003-4471-2061; Roossien, Douglas/0000-0003-1184-2919; DeGennaro, Ellen/0000-0001-5506-6451; Yu, Chih-Chieh (Jay)/0000-0001-8713-0446; Gao, Alex/0000-0002-3579-0327	MIT Media Lab; MIT Brain and Cognitive Sciences Department; New York Stem Cell Foundation-Robertson Investigator Award; National Institutes of Health (NIH) Transformative Award [1R01GM104948]; NIH Director's Pioneer Award [1DP1NS087724, NIH 1R01EY023173, NIH 1U01MH106011]; MIT McGovern Institute; Open Philanthropy Project; National Science Foundation fellowship; Poitras Fellowship; Integrative Neuronal Systems [T32 GM007484]; Hertz Fellowship; Howard Hughes Medical Institute; MIT McGovern Institute MINT program; NATIONAL EYE INSTITUTE [R01EY023173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484, R01GM104948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS087724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029639] Funding Source: NIH RePORTER	MIT Media Lab; MIT Brain and Cognitive Sciences Department; New York Stem Cell Foundation-Robertson Investigator Award; National Institutes of Health (NIH) Transformative Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT McGovern Institute; Open Philanthropy Project; National Science Foundation fellowship(National Science Foundation (NSF)); Poitras Fellowship; Integrative Neuronal Systems; Hertz Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); MIT McGovern Institute MINT program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We acknowledge N. Pak for assistance with perfusions. For funding, E.S.B. acknowledges the MIT Media Lab, the MIT Brain and Cognitive Sciences Department, the New York Stem Cell Foundation-Robertson Investigator Award, National Institutes of Health (NIH) Transformative Award 1R01GM104948, NIH Director's Pioneer Award 1DP1NS087724, NIH 1R01EY023173 and NIH 1U01MH106011, the MIT McGovern Institute, and the Open Philanthropy Project. F.C. acknowledges the National Science Foundation fellowship and Poitras Fellowship. A.M. was supported by T32 GM007484, Integrative Neuronal Systems, P.W.T. acknowledges the Hertz Fellowship. B.P.E. was supported by the Howard Hughes Medical Institute. E.S.B. and S.R.T. acknowledge the MIT McGovern Institute MINT program.	Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; Bossi M, 2008, NANO LETT, V8, P2463, DOI 10.1021/nl801471d; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Dedecker P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126008; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; English B. P., 2015, SPIE NANOSCI ENG; HACKSTADT T, 1988, INFECT IMMUN, V56, P802, DOI 10.1128/IAI.56.4.802-807.1988; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hunt NCA, 1996, J CLIN PATHOL, V49, P767, DOI 10.1136/jcp.49.9.767; JEKEL PA, 1983, ANAL BIOCHEM, V134, P347, DOI 10.1016/0003-2697(83)90308-1; Jimenez N, 2012, TRAFFIC, V13, P926, DOI 10.1111/j.1600-0854.2012.01363.x; Kakimoto K, 2008, J MOL HISTOL, V39, P389, DOI 10.1007/s10735-008-9177-y; Kroon D.-J., B SPLINEGRID IMAGE P; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/NMETH.1447, 10.1038/nmeth.1447]; Randall KJ, 2008, TOXICOL PATHOL, V36, P795, DOI 10.1177/0192623308322311; Rego EH, 2012, P NATL ACAD SCI USA, V109, pE135, DOI 10.1073/pnas.1107547108; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Seneviratne U, 2016, P NATL ACAD SCI USA, V113, P4152, DOI 10.1073/pnas.1521318113; Sniegowski JA, 2005, BIOCHEM BIOPH RES CO, V332, P657, DOI 10.1016/j.bbrc.2005.04.166; Vedaldi A., 2010, P INT C MULT, P1469, DOI [10.1145/1873951.1874249, DOI 10.1145/1873951.1874249]; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819	28	275	289	30	167	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2016	34	9					987	+		10.1038/nbt.3625	http://dx.doi.org/10.1038/nbt.3625			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DW0RE	27376584	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000383348500026
J	Yu, HJ; Takeuchi, H; Takeuchi, M; Liu, Q; Kantharia, J; Haltiwanger, RS; Li, HL				Yu, Hongjun; Takeuchi, Hideyuki; Takeuchi, Megumi; Liu, Qun; Kantharia, Joshua; Haltiwanger, Robert S.; Li, Huilin			Structural analysis of Notch-regulating Rumi reveals basis for pathogenic mutations	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN O-GLUCOSYLTRANSFERASE; GLCNAC TRANSFERASE; DIFFRACTION; PATHWAY; GLYCOSYLATION; GLUCOSYLATION; MOLECULES; EVOLUTION; COMPLEX; GLUCOSE	Rumi O-glucosylates the EGF repeats of a growing list of proteins essential in metazoan development, including Notch. Rumi is essential for Notch signaling, and Rumi dysregulation is linked to several human diseases. Despite Rumi's critical roles, it is unknown how Rumi glucosylates a serine of many but not all EGF repeats. Here we report crystal structures of Drosophila Rumi as binary and ternary complexes with a folded EGF repeat and/or donor substrates. These structures provide insights into the catalytic mechanism and show that Rumi recognizes structural signatures of the EGF motif, the U-shaped consensus sequence,C-X-S-X-(P/A)-C and a conserved hydrophobic region. We found that five Rumi mutations identified in cancers and Dowling-Degos disease are clustered around the enzyme active site and adversely affect its activity. Our study suggests that loss of Rumi activity may underlie these diseases, and the mechanistic insights may facilitate the development of modulators of Notch signaling.	[Yu, Hongjun; Liu, Qun; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Takeuchi, Hideyuki; Takeuchi, Megumi; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Kantharia, Joshua; Li, Huilin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Li, HL (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.; Haltiwanger, RS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.; Li, HL (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	rhalti@uga.edu; hli@bnl.gov	Takeuchi, Hideyuki/AAZ-9210-2020; Liu, Qun/A-8757-2011	Liu, Qun/0000-0002-1179-290X; Yu, Hongjun/0000-0002-1483-2962; Li, Huilin/0000-0001-8085-8928	NIH [GM061126, AG029979]; SBU-BNL; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886, DE-AC02-06CH11357]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029979] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBU-BNL; US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Li and Haltiwanger labs for critical comments on this work, as well as S. Singh Johar for technical assistance. The work was supported by the NIH (grants GM061126 (to R.S.H.) and AG029979 (to H.L.)) and SBU-BNL (seed grant to R.S.H. and H.L.). We acknowledge access to beamlines X25, X29 and X4A at NSLS, Brookhaven National Laboratory and LRL-CAT at APS, Argonne National Laboratory, and we thank the staff at these beamlines. NSLS and APS were supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract nos. DE-AC02-98CH10886 and DE-AC02-06CH11357, respectively. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. The results published here are in part based on data generated by the TCGA Research Network (http://cancergenome.nih.gov/). H.L. dedicates this work to the loving memory of his son Paul J. Li.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Basmanav FB, 2014, AM J HUM GENET, V94, P135, DOI 10.1016/j.ajhg.2013.12.003; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen CI, 2012, EMBO J, V31, P3183, DOI 10.1038/emboj.2012.143; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Haltom AR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004795; Hanneken S, 2011, HAUTARZT, V62, P842, DOI 10.1007/s00105-011-2222-x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jonusiene V, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0438-y; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lariviere L, 2005, J MOL BIOL, V352, P139, DOI 10.1016/j.jmb.2005.07.007; Lariviere L, 2003, J MOL BIOL, V330, P1077, DOI 10.1016/S0022-2836(03)00635-1; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mauerer A, 2010, DERMATOLOGY, V221, P206, DOI 10.1159/000316091; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Ramkumar N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005551; Rampias T, 2014, NAT MED, V20, P1199, DOI 10.1038/nm.3678; Rana NA, 2011, CURR OPIN STRUC BIOL, V21, P583, DOI 10.1016/j.sbi.2011.08.008; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Thakurdas SM, 2016, HEPATOLOGY, V63, P550, DOI 10.1002/hep.28024; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valero-Gonzalez J, 2016, NAT CHEM BIOL, V12, P240, DOI [10.1038/NCHEMBIO.2019, 10.1038/nchembio.2019]; Vasudevan D, 2014, GLYCOCONJUGATE J, V31, P417, DOI 10.1007/s10719-014-9556-4; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Yu HJ, 2015, NAT CHEM BIOL, V11, P847, DOI 10.1038/nchembio.1927	52	25	25	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					735	+		10.1038/nchembio.2135	http://dx.doi.org/10.1038/nchembio.2135			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27428513	Green Submitted, Green Accepted			2022-12-25	WOS:000382255100016
J	Adriaens, C; Standaert, L; Barra, J; Latil, M; Verfaillie, A; Kalev, P; Boeckx, B; Wijnhoven, PWG; Radaelli, E; Vermi, W; Leucci, E; Lapouge, G; Beck, B; van den Oord, J; Nakagawa, S; Hirose, T; Sablina, AA; Lambrechts, D; Aerts, S; Blanpain, C; Marine, JC				Adriaens, Carmen; Standaert, Laura; Barra, Jasmine; latil, MathilDe; Verfaillie, Annelien; Kalev, Peter; Boeckx, Bram; Wijnhoven, Paul W. G.; Radaelli, Enrico; Vermi, William; Leucci, Eleonora; Lapouge, Gaelle; Beck, Benjamin; van den Oord, Joost; Nakagawa, Shinichi; Hirose, Tetsuro; Sablina, Anna A.; Lambrechts, Diether; Aerts, Stein; Blanpain, Cedric; Marine, Jean-Christophe			p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity	NATURE MEDICINE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; NONCODING RNA NEAT1; MOUSE SKIN; GENOME STABILITY; CANCER; MICE; ACTIVATION; EXPRESSION; CARCINOMA	In a search for mediators of the p53 tumor suppressor pathway, which induces pleiotropic and often antagonistic cellular responses, we identified the long noncoding RNA (lncRNA) NEAT1. NEAT1 is an essential architectural component of paraspeckle nuclear bodies, whose pathophysiological relevance remains unclear. Activation of p53, pharmacologically or by oncogene-induced replication stress, stimulated the formation of paraspeckles in mouse and human cells. Silencing Neat1 expression in mice, which prevents paraspeckle formation, sensitized preneoplastic cells to DNA-damage-induced cell death and impaired skin tumorigenesis. We provide mechanistic evidence that NEAT1 promotes ATR signaling in response to replication stress and is thereby engaged in a negative feedback loop that attenuates oncogene-dependent activation of p53. NEAT1 targeting in established human cancer cell lines induced synthetic lethality with genotoxic chemotherapeutics, including PARP inhibitors, and nongenotoxic activation of p53. This study establishes a key genetic link between NEAT1 paraspeckles, p53 biology and tumorigenesis and identifies NEAT1 as a promising target to enhance sensitivity of cancer cells to both chemotherapy and p53 reactivation therapy.	[Adriaens, Carmen; Standaert, Laura; Barra, Jasmine; Leucci, Eleonora; Marine, Jean-Christophe] Katholieke Univ Leuven, VIB, Ctr Biol Dis, Lab Mol Canc Biol, Leuven, Belgium; [Adriaens, Carmen; Standaert, Laura; Barra, Jasmine; Leucci, Eleonora; Marine, Jean-Christophe] Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Canc Biol, Leuven, Belgium; [latil, MathilDe; Lapouge, Gaelle; Beck, Benjamin; Blanpain, Cedric] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Brussels, Belgium; [Verfaillie, Annelien; Aerts, Stein] Katholieke Univ Leuven, Lab Computat Biol, Ctr Human Genet, Leuven, Belgium; [Kalev, Peter; Sablina, Anna A.] Katholieke Univ Leuven, Lab Mech Cell Transformat, VIB, Ctr Biol Dis, Leuven, Belgium; [Kalev, Peter; Sablina, Anna A.] Katholieke Univ Leuven, Lab Mech Cell Transformat, Ctr Human Genet, Leuven, Belgium; [Boeckx, Bram; Lambrechts, Diether] Katholieke Univ Leuven, VIB, Vesalius Res Ctr, Leuven, Belgium; [Boeckx, Bram; Lambrechts, Diether] Katholieke Univ Leuven, Lab Translat Genet, Dept Oncol, Leuven, Belgium; [Wijnhoven, Paul W. G.] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge, England; [Radaelli, Enrico] Katholieke Univ Leuven, Mouse Histopathol Core Facil, VIB, Ctr Biol Dis, Leuven, Belgium; [Vermi, William] Univ Brescia, Dept Mol & Translat Med, Sect Pathol, Brescia, Italy; [Vermi, William] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [van den Oord, Joost] Katholieke Univ Leuven, Dept Pathol, Lab Translat Cell & Tissue Res, Leuven, Belgium; [van den Oord, Joost] UZ Leuven, Leuven, Belgium; [Nakagawa, Shinichi] RIKEN, RNA Biol Lab, Wako, Saitama, Japan; [Nakagawa, Shinichi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Hirose, Tetsuro] Hokkaido Univ, Inst Genet Med, Sapporo, Hokkaido, Japan; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, Brussels, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Universite Libre de Bruxelles; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Brescia; Washington University (WUSTL); KU Leuven; KU Leuven; RIKEN; Hokkaido University; Hokkaido University; Universite Libre de Bruxelles; WELBIO	Marine, JC (corresponding author), Katholieke Univ Leuven, VIB, Ctr Biol Dis, Lab Mol Canc Biol, Leuven, Belgium.; Marine, JC (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Canc Biol, Leuven, Belgium.	jeanchristophe.marine@cme.vib-kuleuven.be	Nakagawa, Shinichi/I-4192-2014; Sablina, Anna/P-2818-2019; Latil, Mathilde/E-2011-2017; Hirose, Tetsuro/P-7367-2018; Marine, Jean-Christophe/K-3292-2016; Sablina, Anna/B-2217-2017; Aerts, Stein/A-1100-2009; Blanpain, Cedric/ABD-8392-2021; Lambrechts, Diether/AAJ-3167-2020; Leucci, Eleonora/G-4938-2011	Nakagawa, Shinichi/0000-0002-6806-7493; Sablina, Anna/0000-0001-9526-4014; Hirose, Tetsuro/0000-0003-1068-5464; Marine, Jean-Christophe/0000-0003-2433-9837; Sablina, Anna/0000-0001-9526-4014; Aerts, Stein/0000-0002-8006-0315; Lambrechts, Diether/0000-0002-3429-302X; Leucci, Eleonora/0000-0002-2898-748X; Standaert, Laura/0000-0003-1208-4160; Adriaens, Carmen/0000-0001-5186-2741; Barra, Jasmine/0000-0002-2400-1257; Beck, Benjamin/0000-0001-8162-7566; VERMI, WILLIAM/0000-0002-2291-2997	Interuniversitaire Attractiepolen (IUAP); Fund for Scientific Research Flanders (FWO); Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 15378]; Ministero Salute [RF-2010-2315888]; Institute for Science, Innovation and Technology (IWT) scholarship; Hercules grant [AKUL/09/037]	Interuniversitaire Attractiepolen (IUAP); Fund for Scientific Research Flanders (FWO)(FWO); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Salute(Ministry of Health, Italy); Institute for Science, Innovation and Technology (IWT) scholarship(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Hercules grant	We thank O. Van Goethem, G. Bervoets and S. Peeters for excellent technical assistance; E. Bonomi and M. Bugatti (Fondazione Beretta) for ISH analysis of human cancer samples; and S. Jackson for helpful comments on the manuscript and for imaging facility access. Imaging was done on a Nikon A1 confocal microscope acquired through a Hercules grant type 1 (AKUL/09/037) to W. Annaert. This work was supported by Interuniversitaire Attractiepolen (IUAP), an Institute for Science, Innovation and Technology (IWT) scholarship to C.A. and a Fund for Scientific Research Flanders (FWO) scholarship to L.S. W.V. is supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, IG 15378) and by Ministero Salute (RF-2010-2315888).	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arun G, 2016, GENE DEV, V30, P34, DOI 10.1101/gad.270959.115; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blume CJ, 2015, LEUKEMIA, V29, P2015, DOI 10.1038/leu.2015.119; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Britton S, 2014, NUCLEIC ACIDS RES, V42, P9047, DOI 10.1093/nar/gku601; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Cha H, 2010, CANCER RES, V70, P4112, DOI 10.1158/0008-5472.CAN-09-4244; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dobbelstein M, 2015, NAT REV DRUG DISCOV, V14, P405, DOI 10.1038/nrd4553; Ferriss JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030550; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Guo S, 2015, INT J CLIN EXP PATHO, V8, P5395; Ha K, 2011, DNA REPAIR, V10, P252, DOI 10.1016/j.dnarep.2010.11.009; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Herrmann C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks543; Huang BY, 2009, MOL CANCER RES, V7, P1497, DOI 10.1158/1541-7786.MCR-09-0144; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Khoo KH, 2014, NAT REV DRUG DISCOV, V13, DOI 10.1038/nrd4288; Krietsch J, 2012, NUCLEIC ACIDS RES, V40, P10287, DOI 10.1093/nar/gks798; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Li Z, 2016, TUMOR BIOL, V37, P673, DOI 10.1007/s13277-015-3843-y; Llopis A, 2012, CELL CYCLE, V11, P3627, DOI 10.4161/cc.21917; Marin-Bejar O, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r104; Mastrocola AS, 2013, J BIOL CHEM, V288, P24731, DOI 10.1074/jbc.M113.497974; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Nakagawa S, 2014, DEVELOPMENT, V141, P4618, DOI 10.1242/dev.110544; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Rulten SL, 2014, NUCLEIC ACIDS RES, V42, P307, DOI 10.1093/nar/gkt835; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Specks J, 2015, MOL CELL BIOL, V35, P2910, DOI 10.1128/MCB.00475-15; Standaert L, 2014, RNA, V20, P1844, DOI 10.1261/rna.047332.114; Sullivan KD, 2012, NAT CHEM BIOL, V8, P646, DOI [10.1038/nchembio.965, 10.1038/NCHEMBIO.965]; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wickramasinghe VO, 2016, MOL CELL, V61, P496, DOI 10.1016/j.molcel.2016.02.001; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Yamazaki Tomohiro, 2015, Front Biosci (Elite Ed), V7, P1; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	62	288	298	2	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					861	+		10.1038/nm.4135	http://dx.doi.org/10.1038/nm.4135			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376578				2022-12-25	WOS:000381000200011
J	Alvarez, MJ; Shen, Y; Giorgi, FM; Lachmann, A; Ding, BB; Ye, BH; Califano, A				Alvarez, Mariano J.; Shen, Yao; Giorgi, Federico M.; Lachmann, Alexander; Ding, B. Belinda; Ye, B. Hilda; Califano, Andrea			Functional characterization of somatic mutations in cancer using network-based inference of protein activity	NATURE GENETICS			English	Article							GENE SET ENRICHMENT; TRANSCRIPTION FACTOR ACTIVITY; DIFFERENTIAL EXPRESSION; REGULATORY PROGRAMS; SMALL MOLECULES; PATHWAYS; IDENTIFICATION; PROGRESSION; DISEASE	Identifying the multiple dysregulated oncoproteins that contribute to tumorigenesis in a given patient is crucial for developing personalized treatment plans. However, accurate inference of aberrant protein activity in biological samples is still challenging as genetic alterations are only partially predictive and direct measurements of protein activity are generally not feasible. To address this problem we introduce and experimentally validate a new algorithm, virtual inference of protein activity by enriched regulon analysis ( VIPER), for accurate assessment of protein activity from gene expression data. We used VIPER to evaluate the functional relevance of genetic alterations in regulatory proteins across all samples in The Cancer Genome Atlas ( TCGA). In addition to accurately infer aberrant protein activity induced by established mutations, we also identified a fraction of tumors with aberrant activity of druggable oncoproteins despite a lack of mutations, and vice versa. In vitro assays confirmed that VIPER-inferred protein activity outperformed mutational analysis in predicting sensitivity to targeted inhibitors.	[Alvarez, Mariano J.; Shen, Yao; Giorgi, Federico M.; Lachmann, Alexander; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Alvarez, Mariano J.; Shen, Yao] DarwinHealth Inc, New York, NY 11040 USA; [Ding, B. Belinda; Ye, B. Hilda] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Motor Neuron Ctr, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Columbia Initiat Stem Cells, New York, NY 10027 USA	Columbia University; Yeshiva University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Alvarez, MJ; Califano, A (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.; Alvarez, MJ (corresponding author), DarwinHealth Inc, New York, NY 11040 USA.; Califano, A (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Motor Neuron Ctr, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Columbia Initiat Stem Cells, New York, NY 10027 USA.	malvarez@darwinhealth.com; ac2248@cumc.columbia.edu	Lachmann, Alexander/AAF-1940-2020; Giorgi, Federico M./AAD-5797-2020	Lachmann, Alexander/0000-0002-1982-7652; Giorgi, Federico M./0000-0002-7325-9908; Califano, Andrea/0000-0003-4742-3679	National Institutes of Health (NIH) Roadmap National Centers for Biomedical Computing [5U54CA121852]; NIH Library of Integrated Network-based Cellular Signatures program [1U01CA164184]; National Cancer Institute (NCI) Cancer Target Discovery and Development program [1U01CA168426]; NIH [S10OD012351, S10OD021764, R01CA85573]; Lauri Strauss Leukemia Foundation; NATIONAL CANCER INSTITUTE [U01CA168426, U01CA164184, P30CA013330, U54CA121852, R01CA085573, R35CA197745] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012351, S10OD021764] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Roadmap National Centers for Biomedical Computing; NIH Library of Integrated Network-based Cellular Signatures program; National Cancer Institute (NCI) Cancer Target Discovery and Development program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lauri Strauss Leukemia Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Riekhof for critical insight and help with drafting the manuscript. This work was supported by the National Institutes of Health (NIH) Roadmap National Centers for Biomedical Computing (5U54CA121852), the NIH Library of Integrated Network-based Cellular Signatures program (1U01CA164184), the National Cancer Institute (NCI) Cancer Target Discovery and Development program (1U01CA168426), and the NIH instrumentation grants (S10OD012351 and S10OD021764). Additional support was from NIH (R01CA85573) to B.H.Y. and a fellowship grant from the Lauri Strauss Leukemia Foundation to B.B.D. The results published here are in whole or part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI as of January 2011.	Abatangelo L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-275; Adjibade P, 2014, SEMIN CELL DEV BIOL, V34, P15, DOI 10.1016/j.semcdb.2014.05.013; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alvarez MJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r143; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Benaglia T, 2009, J STAT SOFTW, V32, P1; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Boorsma A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003112; Bozovic A, 2013, CLIN BIOCHEM, V46, P444, DOI 10.1016/j.clinbiochem.2012.09.024; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen JC, 2014, CELL, V159, P402, DOI 10.1016/j.cell.2014.09.021; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Dudoit S, 2003, BIOTECHNIQUES, P45; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kundaje A, 2007, ANN NY ACAD SCI, V1115, P178, DOI 10.1196/annals.1407.020; Kushwaha R, 2015, STEM CELLS, V33, P367, DOI 10.1002/stem.1870; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MacConaill LE, 2014, J MOL DIAGN, V16, P660, DOI 10.1016/j.jmoldx.2014.06.004; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; R Development Core Team, 2012, R LANG ENV STAT COMP; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Rodriguez JA, 2014, SEMIN CANCER BIOL, V27, P11, DOI 10.1016/j.semcancer.2014.03.005; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang K, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P264; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wolf-Yadlin A, 2009, CURR OPIN CHEM BIOL, V13, P398, DOI 10.1016/j.cbpa.2009.06.027; Yoruk E, 2011, IEEE ACM T COMPUT BI, V8, P592, DOI 10.1109/TCBB.2010.87	62	323	327	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					838	+		10.1038/ng.3593	http://dx.doi.org/10.1038/ng.3593			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27322546	Green Accepted, Green Published			2022-12-25	WOS:000380755100006
J	Goldmann, JM; Wong, WSW; Pinelli, M; Farrah, T; Bodian, D; Stittrich, AB; Glusman, G; Vissers, LELM; Hoischen, A; Roach, JC; Vockley, JG; Veltman, JA; Solomon, BD; Gilissen, C; Niederhuber, JE				Goldmann, Jakob M.; Wong, Wendy S. W.; Pinelli, Michele; Farrah, Terry; Bodian, Dale; Stittrich, Anna B.; Glusman, Gustavo; Vissers, Lisenka E. L. M.; Hoischen, Alexander; Roach, Jared C.; Vockley, Joseph G.; Veltman, Joris A.; Solomon, Benjamin D.; Gilissen, Christian; Niederhuber, John E.			Parent-of-origin-specific signatures of de novo mutations	NATURE GENETICS			English	Article							CHROMATIN ORGANIZATION; GERMLINE MUTATION; HUMAN CANCER; GENOME; RATES; PATTERNS; CLUSTERS; DISEASE; HUMANS; READS	De novo mutations (DNMs) originating in gametogenesis are an important source of genetic variation. We use a data set of 7,216 autosomal DNMs with resolved parent of origin from whole-genome sequencing of 816 parent-offspring trios to investigate differences between maternally and paternally derived DNMs and study the underlying mutational mechanisms. Our results show that the number of DNMs in offspring increases not only with paternal age, but also with maternal age, and that some genome regions show enrichment for maternally derived DNMs. We identify parent-of-origin-specific mutation signatures that become more pronounced with increased parental age, pointing to different mutational mechanisms in spermatogenesis and oogenesis. Moreover, we find DNMs that are spatially clustered to have a unique mutational signature with no significant differences between parental alleles, suggesting a different mutational mechanism. Our findings provide insights into the molecular mechanisms that underlie mutagenesis and are relevant to disease and evolution in humans(1).	[Goldmann, Jakob M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands; [Wong, Wendy S. W.; Bodian, Dale; Vockley, Joseph G.; Solomon, Benjamin D.; Niederhuber, John E.] Inova Hlth Syst, ITMI, Falls Church, VA 22042 USA; [Pinelli, Michele] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Farrah, Terry; Stittrich, Anna B.; Glusman, Gustavo; Roach, Jared C.] Inst Syst Biol, Seattle, WA USA; [Vissers, Lisenka E. L. M.; Hoischen, Alexander; Veltman, Joris A.; Gilissen, Christian] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Human Genet, Nijmegen, Netherlands; [Vockley, Joseph G.] Virginia Commonwealth Univ, Sch Med, Dept Pediat, Richmond, VA USA; [Solomon, Benjamin D.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Clin Genet, Maastricht, Netherlands; [Solomon, Benjamin D.] Inova Hlth Syst, Inova Childrens Hosp, Dept Pediat, Falls Church, VA USA; [Solomon, Benjamin D.; Niederhuber, John E.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Radboud University Nijmegen; Inova Health System; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Institute for Systems Biology (ISB); Radboud University Nijmegen; Virginia Commonwealth University; Maastricht University; Inova Fairfax Hospital; Inova Health System; Johns Hopkins University	Niederhuber, JE (corresponding author), Inova Hlth Syst, ITMI, Falls Church, VA 22042 USA.; Gilissen, C (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Human Genet, Nijmegen, Netherlands.; Niederhuber, JE (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	John.Niederhuber@inova.org	Goldmann, Jakob M/K-5948-2013; Hoischen, Alexander/AGF-7293-2022; Gilissen, Christian/E-5246-2012; Vissers, Lisenka ELM/A-2598-2015; Hoischen, Alexander/D-1282-2013; Pinelli, Michele/A-1584-2010; Veltman, Joris A/F-5128-2010	Goldmann, Jakob M/0000-0002-8514-573X; Hoischen, Alexander/0000-0002-8072-4476; Gilissen, Christian/0000-0003-1693-9699; Vissers, Lisenka ELM/0000-0001-6470-5497; Hoischen, Alexander/0000-0002-8072-4476; Pinelli, Michele/0000-0002-5927-1185; Veltman, Joris A/0000-0002-3218-8250; Solomon, Benjamin/0000-0002-8826-1023; Glusman, Gustavo/0000-0001-8060-5955; wong, wendy/0000-0001-9850-3797	Inova Health System, a nonprofit healthcare system in Northern Virginia; Netherlands Organization for Scientific Research [918-15-667, 916-14-043, SH-271-13]; European Research Council (ERC) [DENOVO 281964]; German Academic Exchange Service DAAD; German Research Foundation DFG	Inova Health System, a nonprofit healthcare system in Northern Virginia; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)); German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation DFG(German Research Foundation (DFG))	We thank all the clinical, laboratory, information technology, and informatics staff for their support on this research project, especially R. Haridas and R. Smith for Sanger sequencing. We would like to thank D. Aguiar and S. Istrail for helpful discussions on their HapCompass software. We would also like to express our gratitude to the participating individuals and their families. The ITMI was supported by the Inova Health System, a nonprofit healthcare system in Northern Virginia. This work was partly financially supported by grants from the Netherlands Organization for Scientific Research (918-15-667 to J.A.V., 916-14-043 to C.G., and SH-271-13 to C.G. and J.A.V.), the European Research Council (ERC Starting grant DENOVO 281964 to J.A.V.), the German Academic Exchange Service DAAD (postdoctoral grant to A.B.S.), and the German Research Foundation DFG (Postdoc grant to A.B.S.).	Acuna-Hidalgo R, 2015, AM J HUM GENET, V97, P67, DOI 10.1016/j.ajhg.2015.05.008; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2011, PLOS BIOL, V9, DOI [10.1371/journal.pbio.1001046, DOI 10.1371/JOURNAL.PBIO.1001046]; Bodian DL, 2016, GENET MED, V18, P221, DOI 10.1038/gim.2015.111; Bodian DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094554; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Chan K, 2015, ANNU REV GENET, V49, P243, DOI 10.1146/annurev-genet-112414-054714; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Forster P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2898; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Glusman G, 2011, BIOINFORMATICS, V27, P3216, DOI 10.1093/bioinformatics/btr540; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Makova KD, 2015, NAT REV GENET, V16, P213, DOI 10.1038/nrg3890; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Pettersen HS, 2015, DNA REPAIR, V25, P60, DOI 10.1016/j.dnarep.2014.11.006; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Visser I, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i07; White S, 2012, EUR J HUM GENET, V20, P348, DOI 10.1038/ejhg.2011.204; Wong WSW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10486	40	153	156	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					935	+		10.1038/ng.3597	http://dx.doi.org/10.1038/ng.3597			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27322544				2022-12-25	WOS:000380755100018
J	Jiang, Y; Woosley, AN; Sivalingam, N; Natarajan, S; Howe, PH				Jiang, Yong; Woosley, Alec N.; Sivalingam, Nageswaran; Natarajan, Sneha; Howe, Philip H.			Cathepsin-B-mediated cleavage of Disabled-2 regulates TGF-beta-induced autophagy	NATURE CELL BIOLOGY			English	Article							TO-MESENCHYMAL TRANSITION; PROMOTES; CANCER; DAB2; PHOSPHORYLATION; METASTASIS; COMPLEXES; NECROSIS; DEATH; GENE	Transforming growth factor-beta (TGF-beta) induces the expression of Disabled-2 (Dab2), an endocytic adaptor and tumour suppressor, concomitant with the induction of an epithelial-mesenchymal transition (EMT) in mammary epithelial cells. Here we show that following TGF-beta-mediated EMT, sustained TGF-beta treatment leads to proteolytic degradation of Dab2 by cathepsin B (CTSB), loss of the mesenchymal phenotype and induction of autophagy. CTSB inhibition or expression of a CTSB-resistant Dab2 mutant maintains Dab2 expression and shifts long-term TGF-beta-treated cells from autophagy to apoptosis. We further show that Dab2 interacts with Beclin-1 to promote casein-kinase-2-mediated phosphorylation of Beclin-1, preventing Beclin-1-Vps34 interaction and subsequent autophagosome assembly. Thus, CTSB-mediated degradation of Dab2 allows Beclin-1-Vps34 induction of autophagy, whereas sustained Dab2 expression prevents autophagy and promotes apoptosis by stabilizing the pro-apoptotic Bim protein. In vivo studies suggest that Dab2-mediated regulation of autophagy modulates chemotherapeutic resistance and tumour metastasis.	[Jiang, Yong; Woosley, Alec N.; Sivalingam, Nageswaran; Howe, Philip H.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Sivalingam, Nageswaran; Howe, Philip H.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Natarajan, Sneha] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	Medical University of South Carolina; Medical University of South Carolina; Cleveland Clinic Foundation	Howe, PH (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.; Howe, PH (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.	howep@musc.edu	Sivalingam, Nageswaran/J-5135-2019	Sivalingam, Nageswaran/0000-0001-8998-8622	Flow Cytometry & Cell Sorting, Molecular Imaging, Small Animal Imaging, and the Gene Targeting and Knockout Shared Resources, Hollings Cancer Center, Medical University of South Carolina [P30CA138313]; National Institute of General Medicine [P30GM103331]; National Cancer Institute [CA555536, CA154664]; NATIONAL CANCER INSTITUTE [P30CA138313, R01CA055536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER	Flow Cytometry & Cell Sorting, Molecular Imaging, Small Animal Imaging, and the Gene Targeting and Knockout Shared Resources, Hollings Cancer Center, Medical University of South Carolina; National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Hussey, B. Howley, T. Smith and other members of our laboratory for helpful comments and critical insights. We are very grateful to B. Levine (Center for Autophagy Research, University of Texas Southwestern Medical Center, USA) for providing us with Beclin-1 constructs. The work was supported in part by the Flow Cytometry & Cell Sorting, Molecular Imaging, Small Animal Imaging, and the Gene Targeting and Knockout Shared Resources, Hollings Cancer Center, Medical University of South Carolina (P30CA138313). Our study used the services of the MUSC Center for Oral Health Research (COHR), which is partially supported by the National Institute of General Medicine grant P30GM103331. This work was also supported by grants CA555536 and CA154664 from the National Cancer Institute to P.H.H.	Avalos Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/603980; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dote H, 2004, CLIN CANCER RES, V10, P2082, DOI 10.1158/1078-0432.CCR-03-0236; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jiang Y, 2012, EMBO J, V31, P2336, DOI 10.1038/emboj.2012.83; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Linebaugh BE, 1999, EUR J BIOCHEM, V264, P100, DOI 10.1046/j.1432-1327.1999.00582.x; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MORT JS, 1984, ARTHRITIS RHEUM, V27, P509, DOI 10.1002/art.1780270505; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Podgorski I, 2003, BIOCHEM SOC SYMP, V70, P263, DOI 10.1042/bss0700263; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sinha AA, 2001, PROSTATE, V49, P172, DOI 10.1002/pros.1132; Sloane B F, 1990, Semin Cancer Biol, V1, P137; Suzuki HI, 2010, AUTOPHAGY, V6, P645, DOI 10.4161/auto.6.5.12046; Werle B, 1997, BRIT J CANCER, V75, P1137, DOI 10.1038/bjc.1997.196; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	28	43	46	4	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2016	18	8					851	+		10.1038/ncb3388	http://dx.doi.org/10.1038/ncb3388			38	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DS5NO	27398911	Green Accepted			2022-12-25	WOS:000380829200006
J	Porter, EB; Polaski, JT; Morck, MM; Batey, RT				Porter, Ely B.; Polaski, Jacob T.; Morck, Makenna M.; Batey, Robert T.			Recurrent RNA motifs as scaffolds for genetically encodable small-molecule biosensors	NATURE CHEMICAL BIOLOGY			English	Article							SELECTIVE 2'-HYDROXYL ACYLATION; FLUORESCENT BIOSENSORS; GENE-REGULATION; FOLDING MOTIF; IN-VITRO; DI-GMP; RIBOSWITCHES; BINDING; APTAMERS; RESOLUTION	Allosteric RNA devices are increasingly being viewed as important tools capable of monitoring enzyme evolution, optimizing engineered metabolic pathways, facilitating gene discovery and regulators of nucleic acid-based therapeutics. A key bottleneck in the development of these platforms is the availability of small-molecule-binding RNA aptamers that robustly function in the cellular environment. Although aptamers can be raised against nearly any desired target through in vitro selection, many cannot easily be integrated into devices or do not reliably function in a cellular context. Here, we describe a new approach using secondary-and tertiary-structural scaffolds derived from biologically active riboswitches and small ribozymes. When applied to the neurotransmitter precursors 5-hydroxytryptophan and 3,4-dihydroxyphenylalanine, this approach yielded easily identifiable and characterizable aptamers predisposed for coupling to readout domains to allow engineering of nucleic acid-sensory devices that function in vitro and in the cellular context.	[Porter, Ely B.; Polaski, Jacob T.; Morck, Makenna M.; Batey, Robert T.] Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA; [Porter, Ely B.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Morck, Makenna M.] Stanford Univ, Dept Biochem, Palo Alto, CA 94304 USA	University of Colorado System; University of Colorado Boulder; Massachusetts Institute of Technology (MIT); Stanford University	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625; Polaski, Jacob/0000-0001-6570-1789; Morck, Makenna/0000-0001-7561-892X	National Science Foundation [NSF 1150834]; National Institutes of Health [R01 GM073850, T32 GM008759]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103, R01GM073850, T32GM008759] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank B. Suess (Technical University Darmstadt) and A. Heckel (Goethe University Frankfurt) for the kind gift of alpha-methyl-5-hydroxy-L-tryptophan, R. Knight and J. Shorenstein for useful discussions about bioinformatics analysis of selections, A. Lambowitz (University of Texas at Austin) for the generous gift of the GsI reverse transcriptase, M. Yarus for the amino acid column labeling protocol, D. McKay and J. Trausch for crystallographic support, and A. Young and A. Palmer for assistance with microscopy. J. Kieft, J. Pfingsten and M. Matyjasik provided critical feedback on the manuscript. This work was supported by grants to R.T.B. from the National Science Foundation (NSF 1150834) and the National Institutes of Health (R01 GM073850) and a predoctoral training grant in Signaling and Cellular Regulation (T32 GM008759).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Berens C, 2001, BIOORGAN MED CHEM, V9, P2549, DOI 10.1016/S0968-0896(01)00063-3; Berens C, 2015, BIOTECHNOL J, V10, P246, DOI 10.1002/biot.201300498; Buck J, 2010, NUCLEIC ACIDS RES, V38, P4143, DOI 10.1093/nar/gkq138; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carothers JM, 2010, NUCLEIC ACIDS RES, V38, P2736, DOI 10.1093/nar/gkq082; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Darmostuk M, 2015, BIOTECHNOL ADV, V33, P1141, DOI 10.1016/j.biotechadv.2015.02.008; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Davis JH, 2002, P NATL ACAD SCI USA, V99, P11616, DOI 10.1073/pnas.182095699; de la Pena M, 2009, RNA, V15, P1949, DOI 10.1261/rna.1889509; Ditzler MA, 2013, NUCLEIC ACIDS RES, V41, P1873, DOI 10.1093/nar/gks1190; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards Andrea L., 2009, V535, P135, DOI 10.1007/978-1-59745-557-2_9; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filonov GS, 2014, J AM CHEM SOC, V136, P16299, DOI 10.1021/ja508478x; Garst AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003533; Garst AD, 2012, J MOL BIOL, V423, P17, DOI 10.1016/j.jmb.2012.06.038; Gilbert Sunny D., 2009, V540, P97, DOI 10.1007/978-1-59745-558-9_8; Hodak JH, 2005, P NATL ACAD SCI USA, V102, P10505, DOI 10.1073/pnas.0408645102; Illangasekare M, 2010, RNA, V16, P2370, DOI 10.1261/rna.2385310; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kellenberger CA, 2015, J AM CHEM SOC, V137, P6432, DOI 10.1021/jacs.5b00275; Kellenberger CA, 2013, J AM CHEM SOC, V135, P4906, DOI 10.1021/ja311960g; Ketterer S, 2016, NUCLEIC ACIDS RES, V44, P5983, DOI 10.1093/nar/gkw465; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; Majerfeld I, 2005, NUCLEIC ACIDS RES, V33, P5482, DOI 10.1093/nar/gki861; Majerfeld I, 2005, J MOL EVOL, V61, P226, DOI 10.1007/s00239-004-0360-9; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Marshall KA, 2000, METHOD ENZYMOL, V318, P193; McKeague M., 2012, J NUCLEIC ACIDS, V2012, DOI DOI 10.1155/2012/748913; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mohr S, 2013, RNA, V19, P958, DOI 10.1261/rna.039743.113; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nakayama S, 2012, CHEM COMMUN, V48, P9059, DOI 10.1039/c2cc34379g; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Peselis A, 2014, WIRES RNA, V5, P803, DOI 10.1002/wrna.1247; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Ponchon L, 2007, NAT METHODS, V4, P571, DOI 10.1038/NMETH1058; Romanini DW, 2012, ACS SYNTH BIOL, V1, P602, DOI 10.1021/sb3000904; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schutze T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029604; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Sharma V, 2008, J AM CHEM SOC, V130, P16310, DOI 10.1021/ja805203w; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Stojanovic MN, 2004, J AM CHEM SOC, V126, P9266, DOI 10.1021/ja032013t; Su YC, 2016, J AM CHEM SOC, V138, P7040, DOI 10.1021/jacs.6b01621; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Weinberg Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-3; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wittmann A, 2011, MOL BIOSYST, V7, P2419, DOI 10.1039/c1mb05070b; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008	59	62	64	3	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2017	13	3					295	+		10.1038/NCHEMBIO.2278	http://dx.doi.org/10.1038/NCHEMBIO.2278			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL2DY	28092358	Green Accepted			2022-12-25	WOS:000394431500013
J	Maji, B; Moore, CL; Zetsche, B; Volz, SE; Zhang, F; Shoulders, MD; Choudhary, A				Maji, Basudeb; Moore, Christopher L.; Zetsche, Bernd; Volz, Sara E.; Zhang, Feng; Shoulders, Matthew D.; Choudhary, Amit			Multidimensional chemical control of CRISPR-Cas9	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN-CELLS; TRANSCRIPTION FACTORS; CAS9; PROTEIN; METHODOLOGY; MODULATION; ACTIVATION; DOMAINS; COMPLEX; SYSTEM	Cas9-based technologies have transformed genome engineering and the interrogation of genomic functions, but methods to control such technologies across numerous dimensions including dose, time, specificity, and mutually exclusive modulation of multiple genes are still lacking. We conferred such multidimensional controls to diverse Cas9 systems by leveraging small-molecule-regulated protein degron domains. Application of our strategy to both Cas9-mediated genome editing and transcriptional activities opens new avenues for systematic genome interrogation.	[Maji, Basudeb; Moore, Christopher L.; Zetsche, Bernd; Volz, Sara E.; Zhang, Feng; Shoulders, Matthew D.; Choudhary, Amit] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Maji, Basudeb; Choudhary, Amit] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Maji, Basudeb; Choudhary, Amit] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Moore, Christopher L.; Shoulders, Matthew D.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Zetsche, Bernd; Volz, Sara E.; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zetsche, Bernd; Volz, Sara E.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Zetsche, Bernd; Volz, Sara E.; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Shoulders, MD; Choudhary, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Choudhary, A (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Choudhary, A (corresponding author), Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA.; Shoulders, MD (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	mshoulde@mit.edu; achoud@broadinstitute.org	Macrae, Rhiannon/AAX-1536-2020		NIH [1DP2GM119162, 1R21A1126239-01]; Edward Mallinckrodt, Jr. Foundation; Burroughs Wellcome Fund; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI126239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM119162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NIH (Director's New Innovator Award 1DP2GM119162 to M.D.S.; grant 1R21A1126239-01 to A.C.), the Edward Mallinckrodt, Jr. Foundation (Faculty Scholar Award to M.D.S.), and the Burroughs Wellcome Fund (Career Award at the Scientific Interface to A.C.). C.L.M. acknowledges the National Science Foundation for a Graduate Research Fellowship. We are grateful to B. Harvey (NIDA) and to I. Slaymaker, EA. Ran, and B. Wagner (Broad Institute) for helpful discussions. J.K. Joung (Harvard Medical School, Boston, Massachusetts, USA) provided U20S. eGFP-PEST cells. This work is dedicated to Professor Stuart L. Schreiber on the occasion of his 60th birthday.	Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Gantz VM, 2016, BIOESSAYS, V38, P50, DOI 10.1002/bies.201500102; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Miyazaki Y, 2012, J AM CHEM SOC, V134, P3942, DOI 10.1021/ja209933r; Moore CL, 2016, ACS CHEM BIOL, V11, P200, DOI 10.1021/acschembio.5b00740; Nguyen DP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12009; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nunez JK, 2016, ACS CHEM BIOL, V11, P681, DOI 10.1021/acschembio.5b01019; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Shoulders MD, 2013, J AM CHEM SOC, V135, P8129, DOI 10.1021/ja402756p; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	25	96	99	6	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					9	11		10.1038/nchembio.2224	http://dx.doi.org/10.1038/nchembio.2224			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27820801	Green Accepted, Green Published			2022-12-25	WOS:000393267200005
J	Weldon, C; Behm-Ansmant, I; Hurley, LH; Burleys, GA; Branlant, C; Eperon, IC; Dominguez, C				Weldon, Carika; Behm-Ansmant, Isabelle; Hurley, Laurence H.; Burleys, Glenn A.; Branlant, Christiane; Eperon, Ian C.; Dominguez, Cyril			Identification of G-quadruplexes in long functional RNAs using 7-deazaguanine RNA	NATURE CHEMICAL BIOLOGY			English	Article							BCL-X; PROTEIN; TRANSLATION; SEQUENCES; BIOLOGY; SERVER	RNA G-quadruplex (G4) structures are thought to affect biological processes, including translation and pre-mRNA splicing, but it is not possible at present to demonstrate that they form naturally at specific sequences in long functional RNA molecules. We developed a new strategy, footprinting of long 7-deazaguanine-substituted RNAs (FOLDeR), that allows the formation of G4s to be confirmed in long RNAs and under functional conditions.	[Weldon, Carika; Eperon, Ian C.; Dominguez, Cyril] Univ Leicester, Leicester Inst Struct & Chem Biol, Leicester, Leics, England; [Weldon, Carika; Eperon, Ian C.; Dominguez, Cyril] Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England; [Behm-Ansmant, Isabelle; Branlant, Christiane] Univ Lorraine, Biopole, CNRS, IMoPA Ingn Mol & Physiopathol Articulaire,UMR 736, Vandoeuvre Les Nancy, France; [Hurley, Laurence H.] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA; [Hurley, Laurence H.] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Hurley, Laurence H.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Burleys, Glenn A.] Univ Strathclyde, Dept Pure & Appl Chem, Glasgow, Lanark, Scotland	University of Leicester; University of Leicester; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Arizona; University of Arizona; University of Arizona; University of Strathclyde	Eperon, IC; Dominguez, C (corresponding author), Univ Leicester, Leicester Inst Struct & Chem Biol, Leicester, Leics, England.; Eperon, IC; Dominguez, C (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England.	eci@le.ac.uk; cd180@le.ac.uk	Eperon, Ian C./E-8799-2011; Dominguez, Cyril/H-3347-2019	Eperon, Ian C./0000-0002-4903-1911; Dominguez, Cyril/0000-0003-3575-8922; Weldon, Carika/0000-0001-8859-2669; Behm-Ansmant, Isabelle/0000-0001-8909-0660; Branlant, Christiane/0000-0003-4728-5499	Medical Research Council Career Development Award [G1000526]; Bank of Butterfield Foundation in Bermuda; Lorraine University [UMR 7365]; European Alternative Splicing Network of Excellence (EURASNET, FP6 life sciences, genomics and biotechnology for health) [LSHG-CT-2005-518238]; CNRS; Medical Research Council [G1000526] Funding Source: researchfish; MRC [G1000526] Funding Source: UKRI	Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bank of Butterfield Foundation in Bermuda; Lorraine University; European Alternative Splicing Network of Excellence (EURASNET, FP6 life sciences, genomics and biotechnology for health); CNRS(Centre National de la Recherche Scientifique (CNRS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council Career Development Award (G1000526) to CD. and a Sir Dudley Spurling Post Graduate Scholarship from the Bank of Butterfield Foundation in Bermuda to C.W. This work was also funded by CNRS and Lorraine University (UMR 7365 and previously 7214) and the European Alternative Splicing Network of Excellence (EURASNET, FP6 life sciences, genomics and biotechnology for health; LSHG-CT-2005-518238).	Agarwala P, 2015, ORG BIOMOL CHEM, V13, P5570, DOI 10.1039/c4ob02681k; Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Huang H, 2014, NAT CHEM BIOL, V10, P686, DOI [10.1038/NCHEMBIO.1561, 10.1038/nchembio.1561]; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kwok CK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3971; Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Munroe SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137893; MURCHIE AIH, 1992, NUCLEIC ACIDS RES, V20, P49, DOI 10.1093/nar/20.1.49; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Ribeiro MM, 2015, HUM GENET, V134, P37, DOI 10.1007/s00439-014-1485-6; Smith LD, 2014, CELL REP, V9, P193, DOI 10.1016/j.celrep.2014.08.051; Warner KD, 2014, NAT STRUCT MOL BIOL, V21, P658, DOI 10.1038/nsmb.2865; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Zizza P, 2016, NUCLEIC ACIDS RES, V44, P1579, DOI 10.1093/nar/gkv1122; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	25	40	40	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					18	20		10.1038/NCHEMBIO.2228	http://dx.doi.org/10.1038/NCHEMBIO.2228			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27820800	Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000393267200008
J	Braso-Maristany, F; Filosto, S; Catchpole, S; Marlow, R; Quist, J; Francesch-Domenech, E; Plumb, DA; Zakka, L; Gazinska, P; Liccardi, G; Meier, P; Gris-Oliver, A; Cheang, MCU; Perdrix-Rosell, A; Shafat, M; Noel, E; Patel, N; McEachern, K; Scaltriti, M; Castel, P; Noor, F; Buus, R; Mathew, S; Watkins, J; Serra, V; Marra, P; Grigoriadis, A; Tutt, AN				Braso-Maristany, Fara; Filosto, Simone; Catchpole, Steven; Marlow, Rebecca; Quist, Jelmar; Francesch-Domenech, Erika; Plumb, Darren A.; Zakka, Leila; Gazinska, Patrycja; Liccardi, Gianmaria; Meier, Pascal; Gris-Oliver, Albert; Cheang, Maggie Chon U.; Perdrix-Rosell, Anna; Shafat, Manar; Noel, Elodie; Patel, Nirmesh; McEachern, Kristen; Scaltriti, Maurizio; Castel, Pau; Noor, Farzana; Buus, Richard; Mathew, Sumi; Watkins, Johnathan; Serra, Violeta; Marra, Pierfrancesco; Grigoriadis, Anita; Tutt, Andrew N.			PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer	NATURE MEDICINE			English	Article							MOLECULAR CHARACTERIZATION; PRECLINICAL MODELS; C-MYC; PHOSPHORYLATION; ACTIVATION; TRANSCRIPTION; PROGRESSION; SUBTYPES; PATHWAYS; SURVIVAL	Triple-negative breast cancers (TNBCs) have poor prognosis and lack targeted therapies. Here we identified increased copy number and expression of the PIM1 proto-oncogene in genomic data sets of patients with TNBC. TNBC cells, but not nonmalignant mammary epithelial cells, were dependent on PIM1 for proliferation and protection from apoptosis. PIM1 knockdown reduced expression of the anti-apoptotic factor BCL2, and dynamic BH3 profiling of apoptotic priming revealed that PIM1 prevents mitochondrial-mediated apoptosis in TNBC cell lines. In TNBC tumors and their cellular models, PIM1 expression was associated with several transcriptional signatures involving the transcription factor MYC, and PIM1 depletion in TNBC cell lines decreased, in a MYC-dependent manner, cell population growth and expression of the MYC target gene MCL1. Treatment with the pan-PIM kinase inhibitor AZD1208 impaired the growth of both cell line and patient-derived xenografts and sensitized them to standard-of-care chemotherapy. This work identifies PIM1 as a malignant-cell-selective target in TNBC and the potential use of PIM1 inhibitors for sensitizing TNBC to chemotherapy-induced apoptotic cell death.	[Braso-Maristany, Fara; Filosto, Simone; Catchpole, Steven; Marlow, Rebecca; Quist, Jelmar; Francesch-Domenech, Erika; Plumb, Darren A.; Zakka, Leila; Gazinska, Patrycja; Perdrix-Rosell, Anna; Shafat, Manar; Noel, Elodie; Patel, Nirmesh; Noor, Farzana; Mathew, Sumi; Watkins, Johnathan; Marra, Pierfrancesco; Grigoriadis, Anita; Tutt, Andrew N.] Kings Coll London, Guys Hosp, Fac Life Sci & Med, Breast Canc Now Res Unit,Div Canc Studies, London, England; [Quist, Jelmar; Grigoriadis, Anita] Kings Coll London, Fac Life Sci & Med, Div Canc Studies, Canc Bioinformat, London, England; [Liccardi, Gianmaria; Meier, Pascal; Cheang, Maggie Chon U.; Buus, Richard; Tutt, Andrew N.] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England; [Gris-Oliver, Albert; Serra, Violeta] Vall dHebron Inst Oncol, Expt Therapeut Grp, Barcelona, Spain; [McEachern, Kristen] AstraZeneca, Oncol iMed, Waltham, MA USA; [Scaltriti, Maurizio; Castel, Pau] Mem Sloan Kettering Canc Ctr, HOPP, 1275 York Ave, New York, NY 10021 USA; [Scaltriti, Maurizio] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Vall d'Hebron Institut d'Oncologia (VHIO); AstraZeneca; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Tutt, AN (corresponding author), Kings Coll London, Guys Hosp, Fac Life Sci & Med, Breast Canc Now Res Unit,Div Canc Studies, London, England.; Tutt, AN (corresponding author), Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England.	andrew.tutt@icr.ac.uk	Watkins, Johnathan/ABI-8343-2020; Serra, Violeta/AAG-8328-2019; Gris Oliver, Albert/AAL-6783-2021; Miquel, Josep Maria/AAG-3508-2019; Castel, Pau/AAL-5791-2020	Watkins, Johnathan/0000-0001-8370-6022; Gris Oliver, Albert/0000-0003-1802-9541; Castel, Pau/0000-0002-4972-4347; Tutt, Andrew/0000-0001-8715-2901; Serra, Violeta/0000-0001-6620-1065; Cheang, Maggie Chon U/0000-0001-5718-2501; Shafat, Manar/0000-0002-3493-9089; Grigoriadis, Anita/0000-0003-3434-201X; Braso Maristany, Fara/0000-0001-5440-9643; Filosto, Simone/0000-0002-7854-998X; Buus, Richard/0000-0002-3386-3465; Meier, Pascal/0000-0003-2760-6523	Breast Cancer Now at King's College London; Institute of Cancer Research London; National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; US National Institutes of Health [P30 CA008748]; Breast Cancer Research Foundation; 'GHD-pink' research via the FERO Foundation; Experimental Cancer Medicine Centre at King's College London; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; Biotechnology and Biological Sciences Research Council [BB/L021684/1] Funding Source: researchfish; Medical Research Council [G1000089, MR/M019217/1] Funding Source: researchfish; Worldwide Cancer Research [14-1328] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; BBSRC [BB/L021684/1] Funding Source: UKRI; MRC [G1000089, MR/M019217/1] Funding Source: UKRI	Breast Cancer Now at King's College London; Institute of Cancer Research London; National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; 'GHD-pink' research via the FERO Foundation; Experimental Cancer Medicine Centre at King's College London; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the Breast Cancer Now funding (A.N.T.) at King's College London and the Institute of Cancer Research London, the National Institute for Health Research Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, the US National Institutes of Health grant P30 CA008748 (M.S.) and the Breast Cancer Research Foundation (M.S.). The PDX studies were supported by a 'GHD-pink' research support via the FERO Foundation (VS.). Patient samples and data were provided by King's Health Partners Cancer Biobank, London, UK, which is supported by the Experimental Cancer Medicine Centre at King's College London and the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award. We thank S. Swift, S. Utting and M. Ferrao for technical and administrative assistance, AstraZeneca for providing AZD1208, D. Huszar (AstraZeneca) for providing information on the use of AZD1208, H. Mirza (King's College London) for his support with the bioinformatics analysis, J. Hurst (The Institute of Cancer Research London) for helping with the NanoString nCounter PanCancer Pathway analysis, M. Dowsett (Institute of Cancer Research and Royal Marsden Hospital National Institute for Health Research comprehensive Biomedical Research Centre London) for providing staff and infrastructure support for the NanoString NCounter work, T. Tenev (Institute of Cancer Research) for providing MDA-MB-231 containing the BCL2 pTIPZ overexpression vector and the Guy's Hospital Pharmacy for providing the chemotherapeutic drugs.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Balko JM, 2014, CANCER DISCOV, V4, P232, DOI 10.1158/2159-8290.CD-13-0286; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Canbay E, 2003, CELL BIOL INT, V27, P477, DOI 10.1016/S1065-6995(03)00039-8; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Rinaldis E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-643; Garcia PD, 2014, CLIN CANCER RES, V20, P1834, DOI 10.1158/1078-0432.CCR-13-2062; Gazinska P, 2013, MODERN PATHOL, V26, P955, DOI 10.1038/modpathol.2012.244; Grigoriadis A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-619; Horiuchi D., 2016, NAT MED; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Keeton EK, 2014, BLOOD, V123, P905, DOI 10.1182/blood-2013-04-495366; Kirschner AN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju407; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Labisso WL, 2012, CELL CYCLE, V11, P1593, DOI 10.4161/cc.20008; LAIRD PW, 1993, NUCLEIC ACIDS RES, V21, P4750, DOI 10.1093/nar/21.20.4750; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Magnuson NS, 2010, FUTURE ONCOL, V6, P1461, DOI 10.2217/FON.10.106; Malinen M, 2013, MOL CELL ENDOCRINOL, V365, P270, DOI 10.1016/j.mce.2012.10.028; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; McEachern K. A., 2014, 56 ASH ANN M EXP SAN; Miura K, 2013, ONCOGENE, V32, P5292, DOI 10.1038/onc.2012.571; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Morton JP, 2013, MOL ONCOL, V7, P248, DOI 10.1016/j.molonc.2013.02.015; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Raab M. S., 2013, 55 ASH ANN M EXP NEW; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Turner NC, 2013, CLIN CANCER RES, V19, P6380, DOI 10.1158/1078-0432.CCR-13-0915; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	48	144	151	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1303	1313		10.1038/nm.4198	http://dx.doi.org/10.1038/nm.4198			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27775704	Green Submitted, Green Accepted			2022-12-25	WOS:000387302300023
J	Broix, L; Jagline, H; Ivanova, EL; Schmucker, S; Drouot, N; Clayton-Smith, J; Pagnamenta, AT; Metcalfe, KA; Isidor, B; Louvier, UW; Poduri, A; Taylor, JC; Tilly, P; Poirier, K; Saillour, Y; Lebrun, N; Stemmelen, T; Rudolf, G; Muraca, G; Saintpierre, B; Elmorjani, A; Moise, M; Weirauch, NB; Guerrini, R; Boland, A; Olaso, R; Masson, C; Tripathy, R; Keays, D; Beldjord, C; Nguyen, L; Godin, J; Kini, U; Nischke, P; Deleuze, JF; Bahi-Buisson, N; Sumara, I; Hinckelmann, MV; Chelly, J				Broix, Loic; Jagline, Helene; Ivanova, Ekaterina L.; Schmucker, Stephane; Drouot, Nathalie; Clayton-Smith, Jill; Pagnamenta, Alistair T.; Metcalfe, Kay A.; Isidor, Bertrand; Louvier, Ulrike Walther; Poduri, Annapurna; Taylor, Jenny C.; Tilly, Peggy; Poirier, Karine; Saillour, Yoann; Lebrun, Nicolas; Stemmelen, Tristan; Rudolf, Gabrielle; Muraca, Giuseppe; Saintpierre, Benjamin; Elmorjani, Adrienne; Moise, Martin; Weirauch, Nathalie Bednarek; Guerrini, Renzo; Boland, Anne; Olaso, Robert; Masson, Cecile; Tripathy, Ratna; Keays, David; Beldjord, Cherif; Nguyen, Laurent; Godin, Juliette; Kini, Usha; Nischke, Patrick; Deleuze, Jean-Francois; Bahi-Buisson, Nadia; Sumara, Izabela; Hinckelmann, Maria-Victoria; Chelly, Jamel		Deciphering Dev Disorders Study	Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia	NATURE GENETICS			English	Article							UBIQUITIN LIGASE NEDD4L; CORTICAL DEVELOPMENT; NEURONAL MIGRATION; C2 DOMAIN; FILAMIN-A; MALFORMATIONS; NEOCORTEX; PHOSPHORYLATION; ACTIVATION; MECHANISMS	Neurodevelopmental disorders with periventricular nodular heterotopia (PNH) are etiologically heterogeneous, and their genetic causes remain in many cases unknown. Here we show that missense mutations in NEDD4L mapping to the HECT domain of the encoded E3 ubiquitin ligase lead to PNH associated with toe syndactyly, cleft palate and neurodevelopmental delay. Cellular and expression data showed sensitivity of PNH-associated mutants to proteasome degradation. Moreover, an in utero electroporation approach showed that PNH-related mutants and excess wild-type NEDD4L affect neurogenesis, neuronal positioning and terminal translocation. Further investigations, including rapamycin-based experiments, found differential deregulation of pathways involved. Excess wild-type NEDD4L leads to disruption of Dab1 and mTORC1 pathways, while PNH-related mutations are associated with deregulation of mTORC1 and AKT activities. Altogether, these data provide insights into the critical role of NEDD4L in the regulation of mTOR pathways and their contributions in cortical development.	[Broix, Loic; Jagline, Helene; Ivanova, Ekaterina L.; Schmucker, Stephane; Drouot, Nathalie; Tilly, Peggy; Stemmelen, Tristan; Rudolf, Gabrielle; Godin, Juliette; Sumara, Izabela; Hinckelmann, Maria-Victoria; Chelly, Jamel] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Broix, Loic; Jagline, Helene; Ivanova, Ekaterina L.; Schmucker, Stephane; Drouot, Nathalie; Tilly, Peggy; Stemmelen, Tristan; Rudolf, Gabrielle; Godin, Juliette; Sumara, Izabela; Hinckelmann, Maria-Victoria; Chelly, Jamel] CNRS, U7104, Illkirch Graffenstaden, France; [Broix, Loic; Jagline, Helene; Ivanova, Ekaterina L.; Schmucker, Stephane; Drouot, Nathalie; Tilly, Peggy; Stemmelen, Tristan; Rudolf, Gabrielle; Godin, Juliette; Sumara, Izabela; Hinckelmann, Maria-Victoria; Chelly, Jamel] INSERM, U964, Illkirch Graffenstaden, France; [Broix, Loic; Jagline, Helene; Ivanova, Ekaterina L.; Schmucker, Stephane; Drouot, Nathalie; Tilly, Peggy; Stemmelen, Tristan; Rudolf, Gabrielle; Godin, Juliette; Sumara, Izabela; Hinckelmann, Maria-Victoria; Chelly, Jamel] Univ Strasbourg, Illkirch Graffenstaden, France; [Broix, Loic; Poirier, Karine; Saillour, Yoann; Lebrun, Nicolas; Muraca, Giuseppe; Saintpierre, Benjamin; Elmorjani, Adrienne] Paris Descartes Univ, CNRS, INSERM, Inst Cochin,U1016,U8104, Paris, France; [Clayton-Smith, Jill; Metcalfe, Kay A.] Cent Manchester Univ Hosp NHS Trust, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester, Lancs, England; [Pagnamenta, Alistair T.; Taylor, Jenny C.] Univ Oxford, Wellcome Trust Ctr Human Genet, NIHR Biomed Res Ctr, Oxford, England; [Isidor, Bertrand] Univ Hosp Nantes, Serv Genet Med, Nantes, France; [Louvier, Ulrike Walther] Univ Hosp Montpellier, Unite Neuropediat & Epileptol Infantile, Montpellier, France; [Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Div Epilepsy & Clin Neurophysiol, Epilepsy Genet Program, Boston, MA USA; [Moise, Martin; Nguyen, Laurent] Univ Liege, Grappe Interdisciplinaire Genoproteom Appl Neuros, Liege, Belgium; [Weirauch, Nathalie Bednarek] Univ Hosp Reims, Hop Maison Blanche, Reims, France; [Guerrini, Renzo] Univ Florence, A Meyer Childrens Hosp, Paediat Neurol Unit, Florence, Italy; [Boland, Anne; Olaso, Robert; Deleuze, Jean-Francois] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Masson, Cecile; Nischke, Patrick] Paris Descartes Univ, Inst Imagine, Bioinformat Platform, Paris, France; [Tripathy, Ratna; Keays, David] Inst Mol Pathol, Vienna, Austria; [Beldjord, Cherif] Hop Cochin, Lab Biochim & Genet Mol, Paris, France; [Kini, Usha] Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford, England; [Bahi-Buisson, Nadia] Paris Descartes Univ, Hop Necker Enfants Malades, INSERM, Inst Imagine,U1163, Paris, France; [Chelly, Jamel] Hop Univ Strasbourg, Hop Civil Strasbourg, Serv Diagnost Genet, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Manchester; University of Oxford; Wellcome Centre for Human Genetics; Nantes Universite; CHU de Nantes; Universite de Montpellier; CHU de Montpellier; Harvard University; Boston Children's Hospital; University of Liege; CHU de Reims; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Oxford University Hospitals NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chelly, J (corresponding author), Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France.; Chelly, J (corresponding author), CNRS, U7104, Illkirch Graffenstaden, France.; Chelly, J (corresponding author), INSERM, U964, Illkirch Graffenstaden, France.; Chelly, J (corresponding author), Univ Strasbourg, Illkirch Graffenstaden, France.	chelly@igbmc.fr	POIRIER, Karine/N-3009-2018; Chelly, Jamel/J-7528-2015; wei, wei/HHR-8613-2022; Isidor, Bertrand/AAJ-3456-2021; Olaso, Robert/AAC-4162-2019; Godin, Juliette/I-1677-2017; Bahi-Buisson, Nadia/H-5207-2017	POIRIER, Karine/0000-0002-7928-2906; Chelly, Jamel/0000-0002-0939-8719; Isidor, Bertrand/0000-0001-6480-126X; Godin, Juliette/0000-0001-6559-1065; Sumara, Izabela/0000-0002-5968-3358; Broix, Loic/0000-0002-8231-370X; Moise, Martin/0000-0003-3874-2213; STEMMELEN, Tristan/0000-0002-4382-1277; Bahi-Buisson, Nadia/0000-0002-5352-0929; Saillour, Yoann/0000-0002-5110-9239; Guerrini, Renzo/0000-0002-7272-7079; Nguyen, Laurent/0000-0002-8560-3008; Taylor, Jenny/0000-0003-3602-5704; Rudolf, Gabrielle/0000-0002-2050-3911	Strasbourg University; Agence Nationale de la Recherche [ANR-10-IDEX-0002-02]; Fondation pour la Recherche Medicale (FRM within the program Equipe FRM) [DEQ20130326477]; Fondation Maladies Rares; Fondation NRJ-Institut de France; Agence National de Recherche (ANR Blanc) [1103 01, R11039KK, ANR E-Rare-012-01, E10107KP, ANR-13-BSV-0009-01]; European Union [241995, 602531]; National Institute of Neurological Disorders and Stroke; Epilepsy Phenome/Genome Project [NS053998, NS077364, NS077274, NS077303, NS077276]; NIHR Biomedical Research Centre Oxford; UK Department of Health's NIHR Biomedical Research Centre;  [ANR-10-LABX-0030-INRT]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS077274, U01NS077276, U01NS077364, U01NS077303, U01NS053998] Funding Source: NIH RePORTER	Strasbourg University; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM within the program Equipe FRM); Fondation Maladies Rares; Fondation NRJ-Institut de France(Fondation de France); Agence National de Recherche (ANR Blanc)(French National Research Agency (ANR)); European Union(European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Epilepsy Phenome/Genome Project; NIHR Biomedical Research Centre Oxford(National Institute for Health Research (NIHR)); UK Department of Health's NIHR Biomedical Research Centre; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the patients and their families for their participation. We thank D. Rotin and C. Jiang (The Hospital for Sick Children) for kindly providing human V5-tagged Nedd4-2 constructs (pcDNA3.1-nV5 wild type, CS and Y971A constructs) and L. Lindner, M. Ruff, M. Macias and F. Francis for their thoughtful comments and help. We thank investigators from the Epi4K Consortium and the Epilepsy Phenome/Genome Project for contributing NEDD4L-related genotype and phenotype data. This work was supported by funding from Strasbourg University and grant ANR-10-LABX-0030-INRT, a French State Fund managed by the Agence Nationale de la Recherche under the frame program Investissements d'Avenir ANR-10-IDEX-0002-02, the Fondation pour la Recherche Medicale (FRM funding within the framework of the program Equipe FRM; J.C-DEQ20130326477), the Fondation Maladies Rares, the Fondation NRJ-Institut de France, Agence National de Recherche (ANR Blanc 1103 01, project R11039KK; ANR E-Rare-012-01, project E10107KP; ANR-13-BSV-0009-01) and European Union FP7 project GENECODYS (grant 241995) and DESIRE (grant agreement 602531), and funding provided from the National Institute of Neurological Disorders and Stroke to the Epi4k Consortium and the Epilepsy Phenome/Genome Project (NS053998, NS077364, NS077274, NS077303 and NS077276). This study was also supported in part by the NIHR Biomedical Research Centre Oxford with funding from the UK Department of Health's NIHR Biomedical Research Centre funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health.	Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Boase NA, 2015, GENE, V557, P113, DOI 10.1016/j.gene.2014.12.020; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Carabalona A, 2012, HUM MOL GENET, V21, P1004, DOI 10.1093/hmg/ddr531; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Conti V, 2013, BRAIN, V136, P3378, DOI 10.1093/brain/awt249; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Garrone NF, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-26; Goel P, 2015, GENE, V557, P1, DOI 10.1016/j.gene.2014.11.051; Guerrini R, 2014, LANCET NEUROL, V13, P710, DOI 10.1016/S1474-4422(14)70040-7; Honda T, 2016, CEREB CORTEX, V26, P3219, DOI 10.1093/cercor/bhv162; Hsia HE, 2014, P NATL ACAD SCI USA, V111, P13205, DOI 10.1073/pnas.1400737111; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Jansen LA, 2015, BRAIN, V138, P1613, DOI 10.1093/brain/awv045; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Lian GW, 2012, J NEUROSCI, V32, P7672, DOI 10.1523/JNEUROSCI.0894-12.2012; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Mirzaa GM, 2015, LANCET NEUROL, V14, P1182, DOI 10.1016/S1474-4422(15)00278-1; Moon UY, 2015, CELL REP, V12, P965, DOI 10.1016/j.celrep.2015.07.013; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Sekine K, 2012, NEURON, V76, P353, DOI 10.1016/j.neuron.2012.07.020; Sekine K, 2011, J NEUROSCI, V31, P9426, DOI 10.1523/JNEUROSCI.0650-11.2011; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yu JSL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8212	37	63	68	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1349	1358		10.1038/ng.3676	http://dx.doi.org/10.1038/ng.3676			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27694961	Green Accepted			2022-12-25	WOS:000386543400011
J	Chen, YJ; Mahieu, NG; Huang, XJ; Singh, M; Crawford, PA; Johnson, SL; Gross, RW; Schaefer, J; Patti, GJ				Chen, Ying-Jr; Mahieu, Nathaniel G.; Huang, Xiaojing; Singh, Manmilan; Crawford, Peter A.; Johnson, Stephen L.; Gross, Richard W.; Schaefer, Jacob; Patti, Gary J.			Lactate metabolism is associated with mammalian mitochondria	NATURE CHEMICAL BIOLOGY			English	Article							MASS-SPECTROMETRY; OXIDATION COMPLEX; SKELETAL-MUSCLE; TUMOR-CELLS; DEHYDROGENASE; SHUTTLE; BRAIN; LDH	It is well established that lactate secreted by fermenting cells can be oxidized or used as a gluconeogenic substrate by other cells and tissues. It is generally assumed, however, that within the fermenting cell itself, lactate is produced to replenish NAD+ and then is secreted. Here we explore the possibility that cytosolic lactate is metabolized by the mitochondria of fermenting mammalian cells. We found that fermenting HeLa and H460 cells utilize exogenous lactate carbon to synthesize a large percentage of their lipids. Using high-resolution mass spectrometry, we found that both C-13 and 2-H-2 labels from enriched lactate enter the mitochondria. The lactate dehydrogenase (LDH) inhibitor oxamate decreased respiration of isolated mitochondria incubated in lactate, but not of isolated mitochondria incubated in pyruvate. Additionally, transmission electron microscopy (TEM) showed that LDHB localizes to the mitochondria. Taken together, our results demonstrate a link between lactate metabolism and the mitochondria of fermenting mammalian cells.	[Chen, Ying-Jr; Mahieu, Nathaniel G.; Singh, Manmilan; Schaefer, Jacob; Patti, Gary J.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Huang, Xiaojing; Johnson, Stephen L.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Huang, Xiaojing; Crawford, Peter A.] Sanford Burnham Prebys Med Discovery Inst, Orlando, FL USA; [Gross, Richard W.; Patti, Gary J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Sanford Burnham Prebys Medical Discovery Institute; Washington University (WUSTL)	Patti, GJ (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.; Patti, GJ (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	gjpattij@wustl.edu	Huang, Xiaojing/GOV-3212-2022	Huang, Xiaojing/0000-0003-0107-0783; Crawford, Peter/0000-0001-8597-4426	National Institutes of Health [R01 ES022181, R21 CA191097-01A1, R01 HL118639-03, R01 DK091538, R01 EB002058]; Alfred P. Sloan Foundation; Camille & Henry Dreyfus Foundation; Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [R21CA191097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Camille & Henry Dreyfus Foundation; Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funding from the National Institutes of Health grants R01 ES022181 (G.J.P.), R21 CA191097-01A1 (G.J.P.), R01 HL118639-03 (R.W.G.), R01 DK091538 (P.A.C.), and R01 EB002058 (J.S.), as well as grants from the Alfred P. Sloan Foundation (G.J.P.), the Camille & Henry Dreyfus Foundation (G.J.P.), and the Pew Scholars Program in the Biomedical Sciences (G.J.P.). We thank W. Beatty at Washington University's Molecular Microbiology Imaging Facility for acquiring the TEM images.	Bonvento G, 2005, J CEREBR BLOOD F MET, V25, P1394, DOI 10.1038/sj.jcbfm.9600127; BRANDT RB, 1987, ARCH BIOCHEM BIOPHYS, V259, P412, DOI 10.1016/0003-9861(87)90507-8; Brooks GA, 1999, P NATL ACAD SCI USA, V96, P1129, DOI 10.1073/pnas.96.3.1129; Brooks GA, 2000, MED SCI SPORT EXER, V32, P790, DOI 10.1097/00005768-200004000-00011; BUCHER T, 1958, ANGEW CHEM INT EDIT, V70, P552, DOI 10.1002/ange.19580701707; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chen YJ, 2014, BIOCHEMISTRY-US, V53, P4755, DOI 10.1021/bi500763u; CHIARETTI B, 1979, CANCER RES, V39, P2195; CORI CF, 1946, ANNU REV BIOCHEM, V15, P193, DOI 10.1146/annurev.bi.15.070146.001205; DAWSON DM, 1964, SCIENCE, V143, P929, DOI 10.1126/science.143.3609.929; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Elustondo PA, 2013, J BIOL CHEM, V288, P25309, DOI 10.1074/jbc.M113.476648; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; GREENHOUSE WVV, 1977, CANCER RES, V37, P4173; Hashimoto T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002915; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; Huang XJ, 2014, ANAL CHEM, V86, P1632, DOI 10.1021/ac403384n; Ivanisevic J, 2013, ANAL CHEM, V85, P6876, DOI 10.1021/ac401140h; Kane DA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00366; Kennedy BWC, 2012, J AM CHEM SOC, V134, P4969, DOI 10.1021/ja300222e; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Mahieu NG, 2016, BIOINFORMATICS, V32, P268, DOI 10.1093/bioinformatics/btv564; MARKERT CL, 1975, SCIENCE, V189, P102, DOI 10.1126/science.1138367; Nelson D. L., 2008, LEHNINGER PRINCIPLES, V5th, P926; Nielsen HB, 2002, J APPL PHYSIOL, V92, P1677, DOI 10.1152/japplphysiol.00028.2001; O'Donnell JM, 2004, AM J PHYSIOL-HEART C, V286, pH2237, DOI 10.1152/ajpheart.01113.2003; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Schugar RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074806; SHAW CR, 1963, P NATL ACAD SCI USA, V50, P211, DOI 10.1073/pnas.50.2.211; SJODIN B, 1976, Acta Physiologica Scandinavica Supplementum, P1; Stueber D, 2006, J POLYM SCI POL PHYS, V44, P2760, DOI 10.1002/polb.20931; TAKASU T, 1969, J NEUROL NEUROSUR PS, V32, P175, DOI 10.1136/jnnp.32.3.175; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35	36	150	150	4	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					937	+		10.1038/NCHEMBIO.2172	http://dx.doi.org/10.1038/NCHEMBIO.2172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27618187	Green Accepted			2022-12-25	WOS:000386798800015
J	Parrales, A; Ranjan, A; Iyer, SV; Padhye, S; Weir, SJ; Roy, A; Iwakuma, T				Parrales, Alejandro; Ranjan, Atul; Iyer, Swathi V.; Padhye, Subhash; Weir, Scott J.; Roy, Anuradha; Iwakuma, Tomoo			DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway	NATURE CELL BIOLOGY			English	Article							STATIN USE; WILD-TYPE; CANCER; CHAPERONE; CHIP; MDM2; STABILIZATION; DEGRADATION; HSP40; METAANALYSIS	Stabilization of mutant p53 (mutp53) in tumours greatly contributes to malignant progression. However, little is known about the underlying mechanisms and therapeutic approaches to destabilize mutp53. Here, through high-throughput screening we identify statins, cholesterol-lowering drugs, as degradation inducers for conformational or misfolded p53 mutants with minimal effects on wild-type p53 (wtp53) and DNA contact mutants. Statins preferentially suppress mutp53-expressing cancer cell growth. Specific reduction of mevalonate-5-phosphate by statins or mevalonate kinase knockdown induces CHIP ubiquitin ligase-mediated nuclear export, ubiquitylation, and degradation of mutp53 by impairing interaction of mutp53 with DNAJA1, a Hsp40 family member. Knockdown of DNAJA1 also induces CHIP-mediated mutp53 degradation, while its overexpression antagonizes statin-induced mutp53 degradation. Our study reveals that DNAJA1 controls the fate of misfolded mutp53, provides insights into potential strategies to deplete mutp53 through the mevalonate pathway-DNAJA1 axis, and highlights the significance of p53 status in impacting statins' efficacy on cancer therapy.	[Parrales, Alejandro; Ranjan, Atul; Iyer, Swathi V.; Iwakuma, Tomoo] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA; [Padhye, Subhash] Abeda Inamdar Senior Coll, Dept Chem, Pune 411001, Maharashtra, India; [Weir, Scott J.] Univ Kansas, Med Ctr, Inst Advancing Med Innovat, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Roy, Anuradha] Univ Kansas, High Throughput Screening Lab, Lawrence, KS 66047 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas	Iwakuma, T (corresponding author), Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA.	tiwakuma@kumc.edu		Iyer, Swathi/0000-0001-5686-2978; Roy, Anuradha/0000-0002-1057-1443; Weir, Scott/0000-0002-8020-434X	NIH [R01-CA174735-01A1, P30-GM103495, P30-CA168524-02]; Lead Development and Optimization Shared Resource; NATIONAL CANCER INSTITUTE [R01CA174735, P30CA168524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103495, P20GM113117] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lead Development and Optimization Shared Resource; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Vogelstein (Johns Hopkins Medicine, USA), D. R. Welch (University of Kansas Medical Center, USA), S. Anant (University of Kansas Medical Center, USA), D. A. Dixon (University of Kansas Medical Center, USA), J. Lewis-Wambi (University of Kansas Medical Center, USA), S. Thomas (University of Kansas Medical Center, USA), T. Komiya (University of Kansas Medical Center, USA) and G. Lozano (MD Anderson Cancer Center, USA) for providing cell lines. We also thank A. K. Godwin, S. Hyter, R. Perez, N. K. Sharma, R. Pradhan, M. Danley, T. Izumi and R. Stein for technical assistance and helpful discussion. Research reported in this publication was supported by NIH R01-CA174735-01A1 (T.I.), P30-GM103495 (T.I.) and P30-CA168524-02 (T.I.) grants, and utilized the Lead Development and Optimization Shared Resource.	Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Altwairgi AK, 2015, ONCOL REP, V33, P1019, DOI 10.3892/or.2015.3741; Baandrup L, 2015, BRIT J CANCER, V112, P157, DOI 10.1038/bjc.2014.574; Bisgaier CL, 1997, J LIPID RES, V38, P2502; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Edkins Adrienne L, 2015, Subcell Biochem, V78, P219, DOI 10.1007/978-3-319-11731-7_11; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gandelman K., 2011, BIOEQUIV BIOAVAILAB, V3, P62; Hiraki M, 2015, CHEM BIOL, V22, P1206, DOI 10.1016/j.chembiol.2015.07.016; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Kota P, 2009, P NATL ACAD SCI USA, V106, P11073, DOI 10.1073/pnas.0900746106; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Levav-Cohen Yaara, 2014, Subcell Biochem, V85, P161, DOI 10.1007/978-94-017-9211-0_9; Li D, 2011, MOL CANCER RES, V9, P577, DOI 10.1158/1541-7786.MCR-10-0534; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Masciarelli S, 2014, ONCOGENE, V33, P1601, DOI 10.1038/onc.2013.106; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Moon H, 2014, TRENDS ENDOCRIN MET, V25, P188, DOI 10.1016/j.tem.2013.12.007; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rivlin N, 2015, SEMIN CANCER BIOL, V32, P10, DOI 10.1016/j.semcancer.2013.12.006; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Shimoyama S, 2011, CANCER CHEMOTH PHARM, V67, P729, DOI 10.1007/s00280-011-1583-2; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Varley JM, 1997, ONCOGENE, V14, P865, DOI 10.1038/sj.onc.1201041; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Yue XT, 2015, ELIFE, V4, DOI 10.7554/eLife.08401; Zhang XL, 2014, BRIT J CLIN PHARMACO, V77, P458, DOI 10.1111/bcp.12210; Zhong SL, 2015, CANCER TREAT REV, V41, P554, DOI 10.1016/j.ctrv.2015.04.005; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	34	137	140	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1233	+		10.1038/ncb3427	http://dx.doi.org/10.1038/ncb3427			46	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27775703	Green Accepted, Green Submitted			2022-12-25	WOS:000387165600016
J	Spivakov, M; Fraser, P				Spivakov, Mikhail; Fraser, Peter			Defining cell type with chromatin profiling	NATURE BIOTECHNOLOGY			English	Editorial Material							EPIGENETIC HETEROGENEITY; STATE	Enhancer cytometry outperforms gene expression profiling in identifying hematopoietic cell subtypes.	[Spivakov, Mikhail; Fraser, Peter] Babraham Inst, Nucl Dynam Programme, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Spivakov, M (corresponding author), Babraham Inst, Nucl Dynam Programme, Cambridge, England.	mikhail.spivakov@babraham.ac.uk; peter.fraser@babraham.ac.uk		Spivakov, Mikhail/0000-0002-0383-3943; Fraser, Peter/0000-0002-0041-1227				Angermueller C, 2016, NAT METHODS, V13, P229, DOI 10.1038/nmeth.3728; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/NMETH.3035, 10.1038/nmeth.3035]	12	2	2	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1126	1128		10.1038/nbt.3724	http://dx.doi.org/10.1038/nbt.3724			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27824844				2022-12-25	WOS:000387506500023
J	Li, Y; Xu, M; Ding, X; Yan, C; Song, ZQ; Chen, LW; Huang, XH; Wang, X; Jian, YL; Tang, GH; Tang, CY; Di, YT; Mu, SZ; Liu, XZ; Liu, K; Li, T; Wang, YC; Miao, L; Guo, WX; Hao, XJ; Yang, CL				Li, Yang; Xu, Meng; Ding, Xiao; Yan, Chen; Song, Zhiqin; Chen, Lianwan; Huang, Xiahe; Wang, Xin; Jian, Youli; Tang, Guihua; Tang, Changyong; Di, Yingtong; Mu, Shuzhen; Liu, Xuezhao; Liu, Kai; Li, Ting; Wang, Yingchun; Miao, Long; Guo, Weixiang; Hao, Xiaojiang; Yang, Chonglin			Protein kinase C controls lysosome biogenesis independently of mTORC1	NATURE CELL BIOLOGY			English	Article							ANTIGEN-PRESENTATION; TFEB; AUTOPHAGY; ACTIVATION; INHIBITION; CLEARANCE; DEGRADATION; MECHANISMS; CASCADES; SIGNALS	Lysosomes respond to environmental cues by controlling their own biogenesis, but the underlying mechanisms are poorly understood. Here we describe a protein kinase C (PKC)-dependent and mTORC1-independent mechanism for regulating lysosome biogenesis, which provides insights into previously reported effects of PKC on lysosomes. By identifying lysosome-inducing compounds we show that PKC couples activation of the TFEB transcription factor with inactivation of the ZKSCAN3 transcriptional repressor through two parallel signalling cascades. Activated PKC inactivates GSK3 beta, leading to reduced phosphorylation, nuclear translocation and activation of TFEB, while PKC activates JNK and p38 MAPK, which phosphorylate ZKSCAN3, leading to its inactivation by translocation out of the nucleus. PKC activation may therefore mediate lysosomal adaptation to many extracellular cues. PKC activators facilitate clearance of aggregated proteins and lipid droplets in cell models and ameliorate amyloid beta plaque formation in APP/PS1 mouse brains. Thus, PKC activators are viable treatment options for lysosome-related disorders.	[Li, Yang; Xu, Meng; Huang, Xiahe; Wang, Xin; Jian, Youli; Tang, Changyong; Liu, Xuezhao; Liu, Kai; Li, Ting; Wang, Yingchun; Guo, Weixiang; Yang, Chonglin] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, 1 West Beichen Rd, Beijing 100101, Peoples R China; [Xu, Meng; Liu, Xuezhao; Liu, Kai] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China; [Ding, Xiao; Tang, Guihua; Di, Yingtong; Hao, Xiaojiang] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources Western, Kunming 650021, Peoples R China; [Yan, Chen; Song, Zhiqin; Mu, Shuzhen; Hao, Xiaojiang] Key Lab Chem Nat Prod Guizhou Prov, Guiyang 550002, Peoples R China; [Ding, Xiao; Yan, Chen; Mu, Shuzhen; Hao, Xiaojiang] Chinese Acad Sci, Guiyang 550002, Peoples R China; [Chen, Lianwan; Miao, Long] Chinese Acad Sci, Inst Biophys, Beijing Key Lab Noncoding RNA, Key Lab RNA Biol, 15 Datun Rd, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS	Yang, CL (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, 1 West Beichen Rd, Beijing 100101, Peoples R China.; Hao, XJ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources Western, Kunming 650021, Peoples R China.; Hao, XJ (corresponding author), Key Lab Chem Nat Prod Guizhou Prov, Guiyang 550002, Peoples R China.; Hao, XJ (corresponding author), Chinese Acad Sci, Guiyang 550002, Peoples R China.	haoxj@mail.kib.ac.cn; clyang@genetics.ac.cn	Xu, Meng/X-9026-2019; Tang, Gui-Hua/ABE-7668-2020	Xu, Meng/0000-0001-9366-5746; Tang, Gui-Hua/0000-0002-8831-7154; Li, Yang/0000-0002-6286-2939; Ding, Xiao/0000-0002-3287-7611; Miao, Long/0000-0002-0562-6681; Liu, Kai/0000-0002-8014-2310	National Science Foundation of China [31230043, 21432010]; National Basic Research Program of China [2013CB910102]; Chinese Academy of Sciences [KJZD-EW-L08]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank X. C. Wang (Institute of Biophysics, China), S. M. Ferguson (Yale University, USA), S. C. Lin (Xiamen University, China), L. Yu (School of Life Sciences, Tsinghua University, China) and Z. H. Xu (Institute of Genetics and Developmental Biology, China) for experimental materials; A. Ballabio, X. C. Wang and J. R. Speakman for constructive suggestions and critical reading of the manuscript; and I. Hanson for proofreading services. This research was supported by grants 31230043 (to C.Yang) and 21432010 (to X.Hao and C.Yang) from the National Science Foundation of China, 2013CB910102 (to C.Yang) from the National Basic Research Program of China, and KJZD-EW-L08 (to C.Yang) from the Chinese Academy of Sciences.	Balakumar P, 2014, CELL SIGNAL, V26, P2147, DOI 10.1016/j.cellsig.2014.06.011; Chauhan S, 2013, MOL CELL, V50, P16, DOI 10.1016/j.molcel.2013.01.024; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Ferguson SM, 2015, CURR OPIN CELL BIOL, V35, P59, DOI 10.1016/j.ceb.2015.04.014; Ferron M, 2013, GENE DEV, V27, P955, DOI 10.1101/gad.213827.113; GOTTA H, 1984, Z NATURFORSCH B, V39, P683; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; HASLER CM, 1992, CANCER RES, V52, P202; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Larocca MC, 2002, CELL SIGNAL, V14, P641, DOI 10.1016/S0898-6568(02)00003-7; Liu DF, 2005, P NATL ACAD SCI USA, V102, P123, DOI 10.1073/pnas.0405737102; Loegering Daniel J, 2011, Enzyme Res, V2011, P537821, DOI 10.4061/2011/537821; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Majewski M, 2007, INT IMMUNOL, V19, P719, DOI 10.1093/intimm/dxm034; Marchand B, 2015, J BIOL CHEM, V290, P5592, DOI 10.1074/jbc.M114.616714; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Polito VA, 2014, EMBO MOL MED, V6, P1142, DOI 10.15252/emmm.201303671; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Samie M, 2015, NAT IMMUNOL, V16, P729, DOI 10.1038/ni.3196; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016907; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Stretton C, 2015, BIOCHEM J, V470, P207, DOI 10.1042/BJ20150404; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799; Wang WY, 2015, P NATL ACAD SCI USA, V112, pE1373, DOI 10.1073/pnas.1419669112; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	47	200	207	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2016	18	10					1065	1077		10.1038/ncb3407	http://dx.doi.org/10.1038/ncb3407			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DY2ZX	27617930				2022-12-25	WOS:000384961700006
J	Traxler, EA; Yao, Y; Wang, YD; Woodard, KJ; Kurita, R; Nakamura, Y; Hughes, JR; Hardison, RC; Blobel, GA; Li, CL; Weiss, MJ				Traxler, Elizabeth A.; Yao, Yu; Wang, Yong-Dong; Woodard, Kaitly J.; Kurita, Ryo; Nakamura, Yukio; Hughes, Jim R.; Hardison, Ross C.; Blobel, Gerd A.; Li, Chunliang; Weiss, Mitchell J.			A genome-editing strategy to treat beta-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition	NATURE MEDICINE			English	Article							SICKLE-CELL-DISEASE; GAMMA-GLOBIN GENE; FETAL-HEMOGLOBIN; EPSILON-GLOBIN; BINDING; DELETION; ANEMIA; REGION; NFE3	Disorders resulting from mutations in the hemoglobin subunit beta gene (HBB; which encodes beta-globin), mainly sickle cell disease (SCD) and beta-thalassemia, become symptomatic postnatally as fetal gamma-globin expression from two paralogous genes, hemoglobin subunit gamma 1 (HBG1) and HBG2, decreases and adult beta-globin expression increases, thereby shifting red blood cell (RBC) hemoglobin from the fetal (referred to as HbF or alpha 2 gamma 2) to adult (referred to as HbA or alpha 2 beta 2) form. These disorders are alleviated when postnatal expression of fetal gamma-globin is maintained. For example, in hereditary persistence of fetal hemoglobin (HPFH), a benign genetic condition, mutations attenuate gamma-globin-to-beta-globin switching, causing high-level HbF expression throughout life. Co-inheritance of HPFH with beta-thalassemia- or SCD-associated gene mutations alleviates their clinical manifestations. Here we performed CRISPR-Cas9-mediated genome editing of human blood progenitors to mutate a 13-nt sequence that is present in the promoters of the HBG1 and HBG2 genes, thereby recapitulating a naturally occurring HPFH-associated mutation. Edited progenitors produced RBCs with increased HbF levels that were sufficient to inhibit the pathological hypoxia-induced RBC morphology found in SCD. Our findings identify a potential DNA target for genome-editing-mediated therapy of beta-hemoglobinopathies.	[Traxler, Elizabeth A.; Yao, Yu; Woodard, Kaitly J.; Weiss, Mitchell J.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Traxler, Elizabeth A.] Univ Penn, Perelman Sch Med, Med Scientist Training Program, Philadelphia, PA 19104 USA; [Wang, Yong-Dong] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Kurita, Ryo; Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Nakamura, Yukio] Univ Tsukuba, Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Hughes, Jim R.] Univ Oxford, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford, England; [Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Li, Chunliang] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; St Jude Children's Research Hospital; RIKEN; University of Tsukuba; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; St Jude Children's Research Hospital	Weiss, MJ (corresponding author), St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA.	mitch.weiss@stjude.org	Weiss, Mitchell J/W-9814-2018; , chunliang.li@stjude.org/P-4373-2018; Nakamura, Yukio/A-5263-2016; Hardison, Ross C/G-1142-2010	Weiss, Mitchell J/0000-0003-2460-3036; , chunliang.li@stjude.org/0000-0002-5938-5510; Nakamura, Yukio/0000-0001-8056-4946; Hardison, Ross C/0000-0003-4084-7516	US National Institutes of Health [4R01HL119479, 2R56DK0658, P30CA021765-37, F30DK102291]; American Lebanese Syrian Associated Charities; Assisi Foundation of Memphis; Wellcome Strategic Award; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065806, R24DK106766, F30DK102291] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12009/15] Funding Source: researchfish; MRC [MC_UU_12009/15] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Assisi Foundation of Memphis; Wellcome Strategic Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to P. Mead, G. Neale, S. Olsen, C. Sherr and Y. Yasui for valuable discussions and technical expertise. DNA sequencing studies were performed at the Hartwell Center, St. Jude Children's Research Hospital (SJCRH). FISH studies were performed by the SJCRH Cytogenetics Resource. Lentivirus was produced by the SJCRH Hematology Department Vector Core Facility. Allophycocyanin (APC)-conjugated anti-Band3 was a gift from X. An (New York Blood Center). The all-in-one expression plasmid spCas9 (BB)-2A-GFP (PX458, Addgene plasmid #48138) and lentiCRISPRv2 (Addgene plasmid #52961) were gifts from F. Zhang (Broad Institute). We thank D. Phillips for his support and encouragement. Support was provided by the US National Institutes of Health (grant no. 4R01HL119479 (G.A.B.), 2R56DK0658 (R.C.H.) and P30CA021765-37 (C.L.), and fellowship no. F30DK102291 (E.A.T.)), the American Lebanese Syrian Associated Charities (M.J.W.), the Assisi Foundation of Memphis (M.J.W.) and a Wellcome Strategic Award (J.R.H.). We thank our patients with SCD, who contributed samples for this study.	Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; de Vasconcellos JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106924; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Forget BG, 1998, ANN NY ACAD SCI, V850, P38, DOI 10.1111/j.1749-6632.1998.tb10460.x; GILMAN JG, 1988, NUCLEIC ACIDS RES, V16, P10635, DOI 10.1093/nar/16.22.10635; Hoban MD, 2016, BLOOD, V127, P839, DOI 10.1182/blood-2015-09-618587; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; KIDOGUCHI K, 1978, BLOOD, V52, P1115; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Liberati C, 2001, J BIOL CHEM, V276, P41700, DOI 10.1074/jbc.M102987200; MANTOVANI R, 1989, NUCLEIC ACIDS RES, V17, P6681, DOI 10.1093/nar/17.16.6681; Palstra RJ, 2008, ADV GENET, V61, P107, DOI 10.1016/S0065-2660(07)00004-1; RONCHI AE, 1995, J BIOL CHEM, V270, P21934, DOI 10.1074/jbc.270.37.21934; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; SUPERTIFURGA G, 1988, EMBO J, V7, P3099, DOI 10.1002/j.1460-2075.1988.tb03176.x; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Zhu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033013	21	211	233	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					987	+		10.1038/nm.4170	http://dx.doi.org/10.1038/nm.4170			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27525524	Green Accepted			2022-12-25	WOS:000382542800008
J	Zhou, HJ; Qin, LF; Zhang, HF; Tang, WW; Ji, WD; He, Y; Liang, XL; Wang, ZR; Yuan, QY; Vortmeyer, A; Toomre, D; Fuh, G; Yan, MH; Kluger, MS; Wu, DQ; Min, W				Zhou, Huanjiao Jenny; Qin, Lingfeng; Zhang, Haifeng; Tang, Wenwen; Ji, Weidong; He, Yun; Liang, Xiaoling; Wang, Zongren; Yuan, Qianying; Vortmeyer, Alexander; Toomre, Derek; Fuh, Germaine; Yan, Minghong; Kluger, Martin S.; Wu, Dianqing; Min, Wang			Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation	NATURE MEDICINE			English	Article							CELL-CELL; VASCULAR DEVELOPMENT; 2-HIT MECHANISM; MOUSE MODEL; ANGIOGENESIS; MUTATIONS; DISEASE; TIE2; GENE; PROTEINS	Cerebral cavernous malformations (CCMs) are vascular malformations that affect the central nervous system and result in cerebral hemorrhage, seizure and stroke. CCMs arise from loss-of-function mutations in one of three genes: KRIT1 (also known as CCM1), CCM2 or PDCD10 (also known as CCM3). PDCD10 mutations in humans often result in a more severe form of the disease relative to mutations in the other two CCM genes, and PDCD10-knockout mice show severe defects, the mechanistic basis for which is unclear. We have recently reported that CCM3 regulates exocytosis mediated by the UNC13 family of exocytic regulatory proteins. Here, in investigating the role of endothelial cell exocytosis in CCM disease progression, we found that CCM3 suppresses UNC13B- and vesicle-associated membrane protein 3 (VAMP3)-dependent exocytosis of angiopoietin 2 (ANGPT2) in brain endothelial cells. CCM3 deficiency in endothelial cells augments the exocytosis and secretion of ANGPT2, which is associated with destabilized endothelial cell junctions, enlarged lumen formation and endothelial cell-pericyte dissociation. UNC13B deficiency, which blunts ANGPT2 secretion from endothelial cells, or treatment with an ANGPT2-neutralizing antibody normalizes the defects in the brain and retina caused by endothelial-cell-specific CCM3 deficiency, including the disruption of endothelial cell junctions, vessel dilation and pericyte dissociation. Thus, enhanced secretion of ANGPT2 in endothelial cells contributes to the progression of CCM disease, providing a new therapeutic approach for treating this devastating pathology.	[Zhou, Huanjiao Jenny; Qin, Lingfeng; Zhang, Haifeng; Tang, Wenwen; He, Yun; Yuan, Qianying; Vortmeyer, Alexander; Kluger, Martin S.; Wu, Dianqing; Min, Wang] Yale Univ, Sch Med, Dept Pathol, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06510 USA; [Zhou, Huanjiao Jenny; Ji, Weidong; Wang, Zongren; Min, Wang] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Guangzhou, Guangdong, Peoples R China; [Tang, Wenwen; Yuan, Qianying; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Ji, Weidong; Min, Wang] Guangzhou Darron Medsci, Guangzhou, Guangdong, Peoples R China; [He, Yun] Sun Yat Sen Univ Med Sci, Sch Publ Hlth, Dept Toxicol, Guangzhou, Guangdong, Peoples R China; [Liang, Xiaoling] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Toomre, Derek] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Fuh, Germaine] Genentech Inc, Dept Antibody Engn, San Francisco, CA USA; [Yan, Minghong] Genentech Inc, Dept Mol Oncol, San Francisco, CA USA; [Kluger, Martin S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Yale University; Sun Yat Sen University; Yale University; Sun Yat Sen University; Sun Yat Sen University; Yale University; Roche Holding; Genentech; Roche Holding; Genentech; Yale University	Wu, DQ; Min, W (corresponding author), Yale Univ, Sch Med, Dept Pathol, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06510 USA.; Min, W (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Guangzhou, Guangdong, Peoples R China.; Wu, DQ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.; Min, W (corresponding author), Guangzhou Darron Medsci, Guangzhou, Guangdong, Peoples R China.	dan.wu@yale.edu; wang.min@yale.edu	Yuan, Qianying/AAC-2375-2019; yuan, qianying/E-9114-2018; ji, weidong/AAX-7397-2020	Qin, Lingfeng/0000-0002-5381-6826; WANG, ZONGREN/0000-0002-4925-7232	US National Institutes of Health (NIH) [R01 HL109420, HL115148, GM109487]; National Natural Science Foundation of China [91539110]; Scientific Grants of Guangdong [2015B020225002, 2015A050502018]; American Heart Association [13SDG17110045, 14SDG20490020]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109420, R01HL136507, R01HL115148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109487] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Grants of Guangdong; American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Unc13B-deficient mice were a gift from N. Brose (Max Planck Institute of Experimental Medicine, Germany). We thank J. Pober, R. Liu and T. Manes for reagents and discussion. This work was partly supported by US National Institutes of Health (NIH) grants R01 HL109420 (W.M.), HL115148 (W.M.), GM109487 (D.W.), National Natural Science Foundation of China (no. 91539110) (W.M.), Scientific Grants of Guangdong (no. 2015B020225002 and 2015A050502018) (W.M.), American Heart Association grant 13SDG17110045 (H.Z.) and 14SDG20490020 (W.T.).	Abraham S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8286; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boulday G, 2009, DIS MODEL MECH, V2, P168, DOI 10.1242/dmm.001263; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241; Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Chang WG, 2013, CARDIOVASC RES, V100, P492, DOI 10.1093/cvr/cvt215; Cunningham K, 2011, HUM MOL GENET, V20, P3198, DOI 10.1093/hmg/ddr225; Cuttano R, 2016, EMBO MOL MED, V8, P6, DOI 10.15252/emmm.201505433; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Denier C, 2006, ANN NEUROL, V60, P550, DOI 10.1002/ana.20947; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Gingras AR, 2012, J CELL BIOL, V199, P39, DOI 10.1083/jcb.201205109; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kluger MS, 2013, ARTERIOSCL THROM VAS, V33, P489, DOI 10.1161/ATVBAHA.112.300893; Kumpers P, 2009, CRIT CARE, V13, DOI 10.1186/cc7866; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Li SQ, 2011, MOL VIS, V17, P3566; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marchi S, 2015, EMBO MOL MED, V7, P1403, DOI 10.15252/emmm.201505316; McDonald DA, 2011, HUM MOL GENET, V20, P211, DOI 10.1093/hmg/ddq433; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Pouwels J, 2012, J CELL SCI, V125, P3271, DOI 10.1242/jcs.093641; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sako K, 2009, J BIOL CHEM, V284, P5592, DOI 10.1074/jbc.M806928200; Shenkar R, 2015, GENET MED, V17, P188, DOI 10.1038/gim.2014.97; Sigurbjornsdottir S, 2014, NAT REV MOL CELL BIO, V15, P665, DOI 10.1038/nrm3871; Song YJ, 2013, DEV CELL, V25, P507, DOI 10.1016/j.devcel.2013.05.002; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Tanriover G, 2013, CLIN NEUROL NEUROSUR, V115, P438, DOI 10.1016/j.clineuro.2012.06.023; Thomson BR, 2014, J CLIN INVEST, V124, P4320, DOI 10.1172/JCI77162; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Yoruk B, 2012, DEV BIOL, V362, P121, DOI 10.1016/j.ydbio.2011.12.006; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang Y, 2013, DEV CELL, V27, P215, DOI 10.1016/j.devcel.2013.09.021; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhou HJ, 2014, ARTERIOSCL THROM VAS, V34, P603, DOI 10.1161/ATVBAHA.113.303053; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178	60	72	73	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1033	+		10.1038/nm.4169	http://dx.doi.org/10.1038/nm.4169			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27548575	Green Accepted			2022-12-25	WOS:000382542800014
J	Grintsevich, EE; Yesilyurt, HG; Rich, SK; Hung, RJ; Terman, JR; Reisler, E				Grintsevich, Elena E.; Yesilyurt, Hunkar Gizem; Rich, Shannon K.; Hung, Ruei-Jiun; Terman, Jonathan R.; Reisler, Emil			F-actin dismantling through a redox-driven synergy between Mical and cofilin	NATURE CELL BIOLOGY			English	Article							MEDIATED AXONAL REPULSION; CYTOSKELETON DYNAMICS; CELL MOTILITY; MONOOXYGENASE DOMAIN; CROSS-LINKING; DROSOPHILA; PLEXIN; PROTEIN; ADF/COFILIN; GUIDANCE	Numerous cellular functions depend on actin filament (F-actin) disassembly. The best-characterized disassembly proteins, the ADF (actin-depolymerizing factor)/cofilins (encoded by the twinstar gene in Drosophila), sever filaments and recycle monomers to promote actin assembly. Cofilin is also a relatively weak actin disassembler, posing questions about mechanisms of cellular F-actin destabilization. Here we uncover a key link to targeted F-actin disassembly by finding that F-actin is efficiently dismantled through a post-translational-mediated synergism between cofilin and the actin-oxidizing enzyme Mical. We find that Mical-mediated oxidation of actin improves cofilin binding to filaments, where their combined effect dramatically accelerates F-actin disassembly compared with either effector alone. This synergism is also necessary and sufficient for F-actin disassembly in vivo, magnifying the effects of both Mical and cofilin on cellular remodelling, axon guidance and Semaphorin-Plexin repulsion. Mical and cofilin, therefore, form a redox-dependent synergistic pair that promotes F-actin instability by rapidly dismantling F-actin and generating post-translationally modified actin that has altered assembly properties.	[Grintsevich, Elena E.; Reisler, Emil] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Yesilyurt, Hunkar Gizem; Rich, Shannon K.; Hung, Ruei-Jiun; Terman, Jonathan R.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Yesilyurt, Hunkar Gizem; Rich, Shannon K.; Hung, Ruei-Jiun; Terman, Jonathan R.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Yesilyurt, Hunkar Gizem; Rich, Shannon K.; Hung, Ruei-Jiun; Terman, Jonathan R.] Univ Texas Southwestern Med Ctr Dallas, Neurosci Grad Program, Dallas, TX 75390 USA; [Reisler, Emil] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles	Reisler, E (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Terman, JR (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.; Terman, JR (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.; Terman, JR (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Neurosci Grad Program, Dallas, TX 75390 USA.; Reisler, E (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	jonathan.terman@utsouthwestern.edu; reisler@mbi.ucla.edu			US Public Health Service [GM077190, NS073968]; Welch Foundation [I-1749]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073968] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Kramer, M. Quinlan and M. Rosen for comments, G. Marriott (UC Berkeley, USA) for the gift of kabiramide C, and J. Merriam (UCLA, USA), the Bloomington Stock Center, the Kyoto Drosophila Genetic Resource Center, the Vienna Drosophila Resource Center, and FlyTrap for flies. This work was supported by US Public Health Service grants to E.R. (GM077190) and J.R.T. (NS073968) and a Welch Foundation grant (I-1749) to J.R.T.	Aggarwal PK, 2015, DIABETES, V64, P1743, DOI 10.2337/db14-0719; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Alqassim SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep22176; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bobkov AA, 2002, J MOL BIOL, V323, P739, DOI 10.1016/S0022-2836(02)01008-2; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Bribian A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5265; Brieher W, 2013, MOL BIOL CELL, V24, P2299, DOI 10.1091/mbc.E12-09-0694; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Chin SM, 2016, J MOL BIOL, V428, P1604, DOI 10.1016/j.jmb.2016.03.006; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Giridharan SSP, 2014, ANTIOXID REDOX SIGN, V20, P2059, DOI 10.1089/ars.2013.5487; Grintsevich EE, 2008, J MOL BIOL, V377, P395, DOI 10.1016/j.jmb.2007.12.073; Grintsevich EE, 2014, CYTOSKELETON, V71, P472, DOI 10.1002/cm.21184; Grintsevich EE, 2010, BIOCHEMISTRY-US, V49, P3919, DOI 10.1021/bi1002663; Gurel PS, 2014, CURR BIOL, V24, P156, DOI 10.1016/j.cub.2013.12.018; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Hou ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep07890; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Huang ZY, 2007, DEVELOPMENT, V134, P2337, DOI 10.1242/dev.004242; Hung RJ, 2013, NAT CELL BIOL, V15, P1445, DOI 10.1038/ncb2871; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Hung RJ, 2011, CYTOSKELETON, V68, P415, DOI 10.1002/cm.20527; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Johnson RI, 2008, J CELL BIOL, V180, P1191, DOI 10.1083/jcb.200706108; Kim E, 2002, BIOCHEMISTRY-US, V41, P86, DOI 10.1021/bi0113824; Kirilly D, 2009, NAT NEUROSCI, V12, P1497, DOI 10.1038/nn.2415; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Lee BC, 2013, MOL CELL, V51, P397, DOI 10.1016/j.molcel.2013.06.019; Lundquist MR, 2014, CELL, V156, P563, DOI 10.1016/j.cell.2013.12.035; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McDonald CA, 2013, BIOCHEMISTRY-US, V52, P6076, DOI 10.1021/bi4008462; Muhlrad A, 2006, FEBS J, V273, P1488, DOI 10.1111/j.1742-4658.2006.05169.x; Myster F, 2015, J VIROL, V89, P3630, DOI 10.1128/JVI.03634-14; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Ngo KX, 2015, ELIFE, V4, DOI 10.7554/eLife.04806; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Schmidt EF, 2008, J NEUROSCI, V28, P2287, DOI 10.1523/JNEUROSCI.5646-07.2008; Schottenfeld-Roames J, 2014, CURR BIOL, V24, P1756, DOI 10.1016/j.cub.2014.06.029; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stephan D, 2012, J NEUROSCI, V32, P16080, DOI 10.1523/JNEUROSCI.3116-12.2012; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Sutherland JD, 1999, CURR OPIN CELL BIOL, V11, P142, DOI 10.1016/S0955-0674(99)80018-0; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Tilney LG, 2005, P NATL ACAD SCI USA, V102, P18785, DOI 10.1073/pnas.0509437102; Van Battum EY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5317; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vanoni MA, 2013, INT J MOL SCI, V14, P6920, DOI 10.3390/ijms14046920; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Vitali T, 2016, ARCH BIOCHEM BIOPHYS, V593, P24, DOI 10.1016/j.abb.2016.01.016; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Wilson C, 2016, CYTOSKELETON, V73, P577, DOI 10.1002/cm.21315; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Witherden DA, 2012, IMMUNITY, V37, P314, DOI 10.1016/j.immuni.2012.05.026; Wu H, 2016, PROTEIN EXPRES PURIF, V127, P116, DOI 10.1016/j.pep.2016.05.008; Yang TH, 2012, NEURON, V74, P108, DOI 10.1016/j.neuron.2011.12.034; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhou YP, 2011, CELL MOL LIFE SCI, V68, P4033, DOI 10.1007/s00018-011-0787-2; Zucchini D, 2011, ARCH BIOCHEM BIOPHYS, V515, P1, DOI 10.1016/j.abb.2011.08.004	69	69	69	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2016	18	8					876	+		10.1038/ncb3390	http://dx.doi.org/10.1038/ncb3390			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DS5NO	27454820	Green Accepted, Green Submitted			2022-12-25	WOS:000380829200008
J	Xu, Y; Phoon, CKL; Berno, B; D'Souza, K; Hoedt, E; Zhang, GA; Neubert, TA; Epand, RM; Ren, MD; Schlame, M				Xu, Yang; Phoon, Colin K. L.; Berno, Bob; D'Souza, Kenneth; Hoedt, Esthelle; Zhang, Guoan; Neubert, Thomas A.; Epand, Richard M.; Ren, Mindong; Schlame, Michael			Loss of protein association causes cardiolipin degradation in Barth syndrome	NATURE CHEMICAL BIOLOGY			English	Article							PLURIPOTENT STEM-CELL; RESPIRATORY-CHAIN; FATTY-ACIDS; MITOCHONDRIAL; MODEL; TURNOVER; ARRANGEMENT; DEFICIENCY; METABOLISM; COMPLEXES	Cardiolipin is a specific mitochondrial phospholipid that has a high affinity for proteins and that stabilizes the assembly of supercomplexes involved in oxidative phosphorylation. We found that sequestration of cardiolipin in protein complexes is critical to protect it from degradation. The turnover of cardiolipin is slower by almost an order of magnitude than the turnover of other phospholipids. However, in subjects with Barth syndrome, cardiolipin is rapidly degraded via the intermediate monolysocardiolipin. Treatments that induce supercomplex assembly decrease the turnover of cardiolipin and the concentration of monolyso-cardiolipin, whereas dissociation of supercomplexes has the opposite effect. Our data suggest that cardiolipin is uniquely protected from normal lipid turnover by its association with proteins, but this association is compromised in subjects with Barth syndrome, leading cardiolipin to become unstable, which in turn causes the accumulation of monolyso-cardiolipin.	[Xu, Yang; Ren, Mindong; Schlame, Michael] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Phoon, Colin K. L.] NYU, Dept Pediat, New York, NY 10016 USA; [Berno, Bob; Epand, Richard M.] McMaster Univ, Dept Chem, Hamilton, ON, Canada; [D'Souza, Kenneth; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Hoedt, Esthelle; Zhang, Guoan; Neubert, Thomas A.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY USA; [Hoedt, Esthelle; Zhang, Guoan; Neubert, Thomas A.] NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY USA; [Ren, Mindong; Schlame, Michael] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; McMaster University; McMaster University; New York University; New York University; New York University	Schlame, M (corresponding author), NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA.; Schlame, M (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	michael.schlame@med.nyu.edu	Phoon, Colin K/C-9270-2009; , Richard/R-2316-2019	, Richard/0000-0002-9602-9558; neubert, Thomas/0000-0001-7049-2088	National Institutes of Health [1R01GM115593, RR027990]; National Institutes of Health (NINDs core center grant) [NS050276]; Barth Syndrome Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NINDs core center grant); Barth Syndrome Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by the National Institutes of Health (grant 1R01GM115593 to M.S., Shared Instrumentation Grant RR027990 to T.A.N., and NINDS core center grant NS050276 to T.A.N.). Funds were also provided by the Barth Syndrome Foundation (to C.K.L.P. and R.M.E.). Mouse embryonic stem cells with and without tafazzin knockout were obtained from Z. Khuchua (Cincinnati Children's Hospital, Cincinnati, Ohio, USA).	Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davidescu M, 2012, J BIOENERG BIOMEMBR, V44, P51, DOI 10.1007/s10863-012-9411-x; Dudek J, 2013, STEM CELL RES, V11, P806, DOI 10.1016/j.scr.2013.05.005; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HELLERSTEIN MK, 1991, J CLIN INVEST, V87, P1841, DOI 10.1172/JCI115206; Hofer A, 2014, HUM MOL GENET, V23, P2400, DOI 10.1093/hmg/ddt631; KELLEHER JK, 1992, AM J PHYSIOL, V262, pE118, DOI 10.1152/ajpendo.1992.262.1.E118; KHARROUBI AT, 1992, AM J PHYSIOL, V263, pE667, DOI 10.1152/ajpendo.1992.263.4.E667; LANDRISCINA C, 1976, LIPIDS, V11, P61, DOI 10.1007/BF02532585; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macchioni L, 2014, J BIOENERG BIOMEMBR, V46, P389, DOI 10.1007/s10863-014-9577-5; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888; Pereira DSA, 2009, BIOCHEM J, V417, P717, DOI DOI 10.1042/BJ20080805; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Soustek MS, 2011, HUM GENE THER, V22, P865, DOI 10.1089/hum.2010.199; Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; Valianpour F, 2003, J LIPID RES, V44, P560, DOI 10.1194/jlr.M200217-JLR200; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wahjudi PN, 2011, J LIPID RES, V52, P2226, DOI 10.1194/jlr.M015966; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274; Xu Y, 2014, CHEM PHYS LIPIDS, V179, P17, DOI 10.1016/j.chemphyslip.2013.10.005; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487; Zhang GA, 2011, J PROTEOME RES, V10, P2546, DOI 10.1021/pr200016n; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	52	81	82	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2016	12	8					641	+		10.1038/NCHEMBIO.2113	http://dx.doi.org/10.1038/NCHEMBIO.2113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2UW	27348092	Green Accepted			2022-12-25	WOS:000380640100012
J	Chaveroux, C; Bruhat, A; Carraro, V; Jousse, C; Averous, J; Maurin, AC; Parry, L; Mesclon, F; Muranishi, Y; Cordelier, P; Meulle, A; Baril, P; Thi, AD; Ravassard, P; Mallet, J; Fafournoux, P				Chaveroux, Cedric; Bruhat, Alain; Carraro, Valerie; Jousse, Celine; Averous, Julien; Maurin, Anne-Catherine; Parry, Laurent; Mesclon, Florent; Muranishi, Yuki; Cordelier, Pierre; Meulle, Aline; Baril, Patrick; Anh Do Thi; Ravassard, Philippe; Mallet, Jacques; Fafournoux, Pierre			Regulating the expression of therapeutic transgenes by controlled intake of dietary essential amino acids	NATURE BIOTECHNOLOGY			English	Article							APOPTOSIS-INDUCING LIGAND; GENE-THERAPY; PROTEIN-KINASE; TRAIL; TRANSLATION; STRESS; CELL; PHOSPHORYLATION; TRANSCRIPTION; REINITIATION	Widespread application of gene therapy will depend on the development of simple methods to regulate the expression of therapeutic genes. Here we harness an endogenous signaling pathway to regulate therapeutic gene expression through diet. The GCN2-eIF2 alpha signaling pathway is specifically activated by deficiencies in any essential amino acid (EAA); EAA deficiency leads to rapid expression of genes regulated by ATF4-binding cis elements. We found that therapeutic genes under the control of optimized amino acid response elements (AAREs) had low basal expression and high induced expression. We applied our system to regulate the expression of TNFSF10 (TRAIL) in the context of glioma therapy and found that intermittent activation of this gene by EEA-deficient meals retained its therapeutic efficacy while abrogating its toxic effects on normal tissue. The GCN2-eIF2 alpha pathway is expressed in many tissues, including the brain, and is highly specific to EAA deficiency. Our system may be particularly well suited for intermittent regulation of therapeutic transgenes over short or long time periods.	[Chaveroux, Cedric; Bruhat, Alain; Carraro, Valerie; Jousse, Celine; Averous, Julien; Maurin, Anne-Catherine; Parry, Laurent; Mesclon, Florent; Muranishi, Yuki; Fafournoux, Pierre] Univ Clermont Ferrand 1, Ctr Clermont Theix, Genes Nutrients Team, INRA,UMR Nutr Humaine 1019, F-63122 St Genes Champanelle, France; [Cordelier, Pierre; Meulle, Aline] Univ Toulouse, CRCT, INSERM, UPS, Toulouse, France; [Baril, Patrick; Fafournoux, Pierre] Univ Orleans, CNRS, UPR4301, Ctr Biophys Mol, Orleans, France; [Baril, Patrick; Fafournoux, Pierre] INSERM, Orleans, France; [Anh Do Thi; Ravassard, Philippe; Mallet, Jacques] Univ Paris 06, CNRS UMR7225, INSERM U1127, Biotechnol & Biotherapy Team,ICM, Paris, France; [Mallet, Jacques] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	INRAE; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California San Francisco	Fafournoux, P (corresponding author), Univ Clermont Ferrand 1, Ctr Clermont Theix, Genes Nutrients Team, INRA,UMR Nutr Humaine 1019, F-63122 St Genes Champanelle, France.; Fafournoux, P (corresponding author), Univ Orleans, CNRS, UPR4301, Ctr Biophys Mol, Orleans, France.; Fafournoux, P (corresponding author), INSERM, Orleans, France.	pierre.fafournoux@clermont.inra.fr	Cordelier, Pierre/D-1150-2014	Cordelier, Pierre/0000-0003-2096-7967; ravassard, philippe/0000-0002-0393-9262; Chaveroux, Cedric/0000-0002-4116-3354; BARIL, Patrick/0000-0001-8290-9899; Maurin, Anne-Catherine/0000-0002-4400-8704	'Programmes Emergence' of 'Agence Nationale de la Recherche' [ANR-12-EMMA-0024, ANR-12-BSV2-0025-03]	'Programmes Emergence' of 'Agence Nationale de la Recherche'(French National Research Agency (ANR))	We thank K. Shah (Harvard Medical School) for Gli36-Luc cells, D. Ron and H. Harding (Institute of Metabolic Science, Cambridge, UK) for GCN2<SUP>-/-</SUP> and PERK<SUP>-/-</SUP> MEFs, J.C. Bell (Ottawa health research institute, Canada) for PKR<SUP>-/-</SUP> MEFs, M. Petera for statistical analysis assistance, and A. Terrisse and A Teygnie for animal care and technical assistance. This study was supported by 'Programmes Emergence' (ANR-12-EMMA-0024) and (ANR-12-BSV2-0025-03) of 'Agence Nationale de la Recherche'.	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Agha-Mohammadi S, 2000, J CLIN INVEST, V105, P1177, DOI 10.1172/JCI10027; Bartus RT, 2014, MOL THER, V22, P487, DOI 10.1038/mt.2013.281; Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530; Benitez JA, 2008, CURR MED CHEM, V15, P729, DOI 10.2174/092986708783955491; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Carraro V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015716; Chaveroux C, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0549; Chaveroux C, 2010, BIOCHIMIE, V92, P736, DOI 10.1016/j.biochi.2010.02.020; CROSBY JS, 1994, MOL CELL BIOL, V14, P3906, DOI 10.1128/MCB.14.6.3906; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Ezzine S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt797; Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022; Griffith TS, 2009, CURR GENE THER, V9, P9, DOI 10.2174/156652309787354612; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hingtgen S, 2008, MOL CANCER THER, V7, P3575, DOI 10.1158/1535-7163.MCT-08-0640; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kim CY, 2011, EXP MOL MED, V43, P580, DOI 10.3858/emm.2011.43.10.065; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Maurin AC, 2014, CELL REP, V6, P438, DOI 10.1016/j.celrep.2014.01.006; Misra Sanjukta, 2013, J Assoc Physicians India, V61, P127; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Nagane M, 2007, J NEUROSURG, V106, P407, DOI 10.3171/jns.2007.106.3.407; Naidoo J, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/595410; Nesterov A, 2002, ONCOGENE, V21, P1135, DOI 10.1038/sj.onc.1205151; Nitsch R, 2000, LANCET, V356, P827, DOI 10.1016/S0140-6736(00)02659-3; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Pines M, 2015, MOLECULES, V20, P573, DOI 10.3390/molecules20010573; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Seol JY, 2003, CANCER GENE THER, V10, P540, DOI 10.1038/sj.cgt.7700597; Shah K, 2003, ONCOGENE, V22, P6865, DOI 10.1038/sj.onc.1206748; Sheridan C, 2011, NAT BIOTECHNOL, V29, P121, DOI 10.1038/nbt.1769; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Volkmann X, 2007, HEPATOLOGY, V46, P1498, DOI 10.1002/hep.21846; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517	43	11	12	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2016	34	7					746	+		10.1038/nbt.3582	http://dx.doi.org/10.1038/nbt.3582			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2TT	27272383				2022-12-25	WOS:000381335400029
J	Contreras, JL				Contreras, Jorge L.			The president says patients should own their genetic data. He's wrong	NATURE BIOTECHNOLOGY			English	Letter									[Contreras, Jorge L.] Univ Utah, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah	Contreras, JL (corresponding author), Univ Utah, Salt Lake City, UT USA.	jorge.contreras@law.utah.edu		Contreras, Jorge/0000-0002-7899-3060				Department of Homeland Security, 2015, FED REGISTER, V80, P53942; Hirschfeld D, 2016, NY TIMES, pA15; Skloot R, 2011, IMMORTAL LIFE HENRIE	3	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2016	34	6					585	586		10.1038/nbt.3608	http://dx.doi.org/10.1038/nbt.3608			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DO5TT	27281407				2022-12-25	WOS:000377846400013
J	Bertocchi, C; Wang, Y; Ravasio, A; Hara, Y; Wu, Y; Sailov, T; Baird, MA; Davidson, MW; Zaidel-Bar, R; Toyama, Y; Ladoux, B; Mege, RM; Kanchanawong, P				Bertocchi, Cristina; Wang, Yilin; Ravasio, Andrea; Hara, Yusuke; Wu, Yao; Sailov, Talgat; Baird, Michelle A.; Davidson, Michael W.; Zaidel-Bar, Ronen; Toyama, Yusuke; Ladoux, Benoit; Mege, Rene-Marc; Kanchanawong, Pakorn			Nanoscale architecture of cadherin-based cell adhesions	NATURE CELL BIOLOGY			English	Article							ALPHA-CATENIN; VINCULIN; ACTIN; MICROSCOPY; TENSION; COMPLEX; BINDING; CONTRACTILITY; ORGANIZATION; ASSOCIATION	Multicellularity in animals requires dynamic maintenance of cell-cell contacts. Intercellularly ligated cadherins recruit numerous proteins to form supramolecular complexes that connect with the actin cytoskeleton and support force transmission. However, the molecular organization within such structures remains unknown. Here we mapped protein organization in cadherin-based adhesions by super-resolution microscopy, revealing a multi -compartment nanoscale architecture, with the plasma -membrane-proximal cadherin-catenin compartment segregated from the actin cytoskeletal compartment, bridged by an interface zone containing vinculin. Vinculin position is determined by alpha-catenin, and following activation, vinculin can extend similar to 30 nm to bridge the cadherin-catenin and actin compartments, while modulating the nanoscale positions of the actin regulators zyxin and VASP. Vinculin conformational activation requires tension and tyrosine phosphorylation, regulated by Abl kinase and PTP1B phosphatase. Such modular architecture provides a structural framework for mechanical and biochemical signal integration by vinculin, which may differentially engage cadherin-catenin complexes with the actomyosin machinery to regulate cell adhesions.	[Bertocchi, Cristina; Wang, Yilin; Ravasio, Andrea; Hara, Yusuke; Wu, Yao; Sailov, Talgat; Zaidel-Bar, Ronen; Toyama, Yusuke; Ladoux, Benoit; Kanchanawong, Pakorn] Mechanobiol Inst, Singapore 117411, Singapore; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Zaidel-Bar, Ronen; Kanchanawong, Pakorn] Natl Univ Singapore, Dept Biomed Engn, Singapore 117583, Singapore; [Toyama, Yusuke] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Toyama, Yusuke] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Ladoux, Benoit; Mege, Rene-Marc] Univ Paris Diderot, Inst Jacques Monod, CNRS UMR 7592, Paris, France; [Wang, Yilin] South Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China; [Sailov, Talgat] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Baird, Michelle A.] NHLBI, NIH, Bethesda, MD 20892 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; National University of Singapore; National University of Singapore; National University of Singapore; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Southern University of Science & Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kanchanawong, P (corresponding author), Mechanobiol Inst, Singapore 117411, Singapore.; Kanchanawong, P (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Singapore 117583, Singapore.	biekp@nus.edu.sg	Bertocchi, Cristina/GSJ-6994-2022; Ravasio, Andrea/H-6722-2012; Kanchanawong, Pakorn/M-1315-2017; Hara, Yusuke/AAQ-1000-2021; Toyama, Yusuke/H-8023-2012; Hara, Yusuke/B-7916-2010	Bertocchi, Cristina/0000-0003-0907-1318; Ravasio, Andrea/0000-0001-7835-5133; Kanchanawong, Pakorn/0000-0001-8765-3861; Hara, Yusuke/0000-0002-2005-7704; Toyama, Yusuke/0000-0003-3230-1062; Hara, Yusuke/0000-0002-2005-7704; Ladoux, Benoit/0000-0003-2086-1556; Mege, Rene-Marc/0000-0001-8128-5543; Zaidel-Bar, Ronen/0000-0002-1374-5007	Singapore National Research Foundation Fellowship [NRF-NRFF-2011-04, NRF-RF2009-RF001-074, NRF2012NRF-CRP001-084]; Mechanobiology Institute; National University of Singapore Startup Grants; Singapore Ministry of Education Tier 2 grant [MOE2015-T2-1-116]; European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC [617233]; Institut Universitaire de France; USPC-NUS; CNRS; Human Frontier Science Program [RGP0040/2012]; Agence Nationale de la Recherche [ANR 2010 Blan1515]	Singapore National Research Foundation Fellowship(National Research Foundation, Singapore); Mechanobiology Institute; National University of Singapore Startup Grants(National University of Singapore); Singapore Ministry of Education Tier 2 grant(Ministry of Education, Singapore); European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Institut Universitaire de France; USPC-NUS; CNRS(Centre National de la Recherche Scientifique (CNRS)); Human Frontier Science Program(Human Frontier Science Program); Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank C. Ajo-Franklin (Lawrence Berkeley National Laboratory), G. Shtengel and H. Hess (Howard Hughes Medical Institute, Janelia Research Campus) for generous help with super-resolution microscopy instrumentation and analysis. We thank H. Chen (Protein Expression Facility, Mechanobiology Institute, Singapore) for generation of mutant constructs, H. T. Ong and A. Sathe (Mechanobiology Institute) for assistance with FRET analysis, C. Zhang (Mechanobiology Institute) for assistance with 3D graphical model, and J. Yan (National University of Singapore) for critical reading of the manuscript. P.K., C.B., Y.Wang, A.R., T.S. and R.Z.-B. are supported by Singapore National Research Foundation Fellowship awarded to P.K. (NRF-NRFF-2011-04), R.Z.-B. (NRF-RF2009-RF001-074), and Competitive Research Programme (NRF2012NRF-CRP001-084) to P.K. and R.Z.-B. Y.T. is supported by Mechanobiology Institute and National University of Singapore Startup Grants, and a Singapore Ministry of Education Tier 2 grant (MOE2015-T2-1-116). B.L. is supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013/ERC grant agreement no. 617233), the Mechanobiology Institute, and the Institut Universitaire de France, and USPC-NUS funding. B.L. and R.-M.M. are also supported by CNRS, the Human Frontier Science Program (grant RGP0040/2012) and Agence Nationale de la Recherche (ANR 2010 Blan1515).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Ajo-Franklin CM, 2005, BIOPHYS J, V89, P2759, DOI 10.1529/biophysj.105.066738; Bays JL, 2014, J CELL BIOL, V205, P251, DOI 10.1083/jcb.201309092; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Bertocchi Cristina, 2013, Critical Reviews in Biomedical Engineering, V41, P281; Bertocchi Cristina, 2012, J Signal Transduct, V2012, P125295, DOI 10.1155/2012/125295; Quang BAT, 2013, CURR BIOL, V23, P2197, DOI 10.1016/j.cub.2013.09.015; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Hara Y, 2016, CURR BIOL, V26, P2388, DOI 10.1016/j.cub.2016.07.003; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kim TJ, 2015, CURR BIOL, V25, P218, DOI 10.1016/j.cub.2014.11.017; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Leckband DE, 2014, ANNU REV CELL DEV BI, V30, P291, DOI 10.1146/annurev-cellbio-100913-013212; Lecuit T, 2015, NAT CELL BIOL, V17, P533, DOI 10.1038/ncb3136; Leerberg JM, 2014, CURR BIOL, V24, P1689, DOI 10.1016/j.cub.2014.06.028; Liu JR, 2015, P NATL ACAD SCI USA, V112, pE4864, DOI 10.1073/pnas.1512025112; MILAM LM, 1985, J MOL BIOL, V184, P543, DOI 10.1016/0022-2836(85)90301-8; NAGAFUCHI A, 1994, DEV GROWTH DIFFER, V36, P59; Nagar B, 2002, CANCER RES, V62, P4236; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Paszek MJ, 2012, NAT METHODS, V9, DOI [10.1038/nmeth.2077, 10.1038/NMETH.2077]; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; Shtengel G, 2014, METHOD CELL BIOL, V123, P273, DOI 10.1016/B978-0-12-420138-5.00015-X; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Strale PO, 2015, J CELL BIOL, V210, P333, DOI 10.1083/jcb.201410111; Sumida GM, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-48; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Wu Y, 2015, DEV CELL, V32, P139, DOI 10.1016/j.devcel.2014.12.003; Xu G, 2002, J BIOL CHEM, V277, P49989, DOI 10.1074/jbc.M206454200; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; YONEMURA S, 1995, J CELL SCI, V108, P127; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zaidel-Bar R, 2013, J CELL SCI, V126, P373, DOI 10.1242/jcs.111559	51	87	88	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2017	19	1					28	37		10.1038/ncb3456	http://dx.doi.org/10.1038/ncb3456			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EG9AI	27992406	Green Accepted			2022-12-25	WOS:000391349000006
J	Kaczmarska, Z; Ortega, E; Goudarzi, A; Huang, H; Kim, S; Marquez, JA; Zhao, YM; Khochbin, S; Panne, D				Kaczmarska, Zuzanna; Ortega, Esther; Goudarzi, Afsaneh; Huang, He; Kim, Sunjoo; Marquez, Jose A.; Zhao, Yingming; Khochbin, Saadi; Panne, Daniel			Structure of p300 in complex with acyl-CoA variants	NATURE CHEMICAL BIOLOGY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; HISTONE ACETYLTRANSFERASE; POSTTRANSLATIONAL MODIFICATION; TRANSCRIPTIONAL COACTIVATOR; LYSINE PROPIONYLATION; YEATS DOMAIN; CROTONYLATION; ACETYLATION; COENZYME; IDENTIFICATION	Histone acetylation plays an important role in transcriptional activation. Histones are also modified by chemically diverse acylations that are frequently deposited by p300, a transcriptional coactivator that uses a number of different acyl-CoA cofactors. Here we report that while p300 is a robust acetylase, its activity gets weaker with increasing acyl-CoA chain length. Crystal structures of p300 in complex with propionyl-, crotonyl-, or butyryl-CoA show that the aliphatic portions of these cofactors are bound in the lysine substrate-binding tunnel in a conformation that is incompatible with substrate transfer. Lysine substrate binding is predicted to remodel the acyl-CoA ligands into a conformation compatible with acyl-chain transfer. This remodeling requires that the aliphatic portion of acyl-CoA be accommodated in a hydrophobic pocket in the enzymes active site. The size of the pocket and its aliphatic nature exclude long-chain and charged acyl-CoA variants, presumably explaining the cofactor preference for p300.	[Kaczmarska, Zuzanna; Ortega, Esther; Marquez, Jose A.; Panne, Daniel] European Mol Biol Lab, Grenoble, France; [Goudarzi, Afsaneh; Khochbin, Saadi] Univ Grenoble Alpes, Inst Albert Bonniot, Grenoble, France; [Huang, He; Kim, Sunjoo; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Chicago	Panne, D (corresponding author), European Mol Biol Lab, Grenoble, France.	panne@embl.fr	Goudarzi, Afsaneh/R-1332-2019; Khochbin, Saadi/M-8090-2013; Panne, Daniel/I-8368-2017; Ortega, Esther/AAB-1836-2020	Goudarzi, Afsaneh/0000-0002-0972-5994; Khochbin, Saadi/0000-0002-0455-0857; Panne, Daniel/0000-0001-9158-5507; Kaczmarska, Zuzanna/0000-0002-7668-1442	FRISBI [ANR-10-INSB-05-02]; EMBL Interdisciplinary Postdoc Programme under Marie Sklodowska-Curie actions [291772]; ANR [15-CE12-0005-02]; Worldwide Cancer Research foundation [16-0280]; INCa; Fondation pour la Recherche Medicale; Fondation ARC; NIH [GM105933, DK107868, GM115961]; GOAL [ANR-10-LABX-49-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105933, R01GM115961] Funding Source: NIH RePORTER	FRISBI; EMBL Interdisciplinary Postdoc Programme under Marie Sklodowska-Curie actions; ANR(French National Research Agency (ANR)); Worldwide Cancer Research foundation; INCa(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation ARC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GOAL; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of ESRF and EMBL-Grenoble for assistance and support in using beamlines ID29, 23-1 and 23-2 and the HTX facility. We thank L. Signor (IBS, Grenoble) and P. Phapale (EMBL) for MS analysis. This work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GOAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). Z.K. was supported by a fellowship from the EMBL Interdisciplinary Postdoc Programme under Marie Sklodowska-Curie actions Cofund (grant agreement number 291772). This work was supported by the ANR Grant Episperm3 (ANR-15-CE12-0005-02) to S. Khochbin and D.P. and the Worldwide Cancer Research foundation (grant #16-0280) to D.P. Work in S. Khochbin's laboratory is supported by INCa, Fondation pour la Recherche Medicale and Fondation ARC. Work in Y.Zfs laboratory is supported by NIH grants GM105933, DK107868 and GM115961.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Andrews FH, 2016, NAT CHEM BIOL, V12, P396, DOI 10.1038/nchembio.2065; Bao XC, 2014, ELIFE, V3, DOI 10.7554/eLife.02999; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Carvalho PC, 2008, GENET MOL RES, V7, P342, DOI 10.4238/vol7-2gmr426; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; Dai LZ, 2014, NAT CHEM BIOL, V10, P365, DOI [10.1038/NCHEMBIO.1497, 10.1038/nchembio.1497]; Delvecchio M, 2013, NAT STRUCT MOL BIOL, V20, P1040, DOI 10.1038/nsmb.2642; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Flynn EM, 2015, STRUCTURE, V23, P1801, DOI 10.1016/j.str.2015.08.004; Garcia B, 2014, 62 ANN AM SOC MASS S; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Goudarzi A, 2016, MOL CELL, V62, P169, DOI 10.1016/j.molcel.2016.03.014; Gould TA, 2004, MOL MICROBIOL, V53, P1135, DOI 10.1111/j.1365-2958.2004.04211.x; HOSOKAWA Y, 1986, ANAL BIOCHEM, V153, P45, DOI 10.1016/0003-2697(86)90058-8; Huang H, 2015, CHEM REV, V115, P2376, DOI 10.1021/cr500491u; Janke R, 2015, ANNU REV CELL DEV BI, V31, P473, DOI 10.1146/annurev-cellbio-100814-125544; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Karukurichi KR, 2011, BIOORG CHEM, V39, P42, DOI 10.1016/j.bioorg.2010.10.004; KING MT, 1985, ANAL BIOCHEM, V146, P173, DOI 10.1016/0003-2697(85)90412-9; Leemhuis H, 2008, CHEMBIOCHEM, V9, P499, DOI 10.1002/cbic.200700556; Li YY, 2016, MOL CELL, V62, P181, DOI 10.1016/j.molcel.2016.03.028; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Maksimoska J, 2014, BIOCHEMISTRY-US, V53, P3415, DOI 10.1021/bi500380f; Moellering RE, 2013, SCIENCE, V341, P549, DOI 10.1126/science.1238327; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Ringel AE, 2016, ACTA CRYSTALLOGR D, V72, P841, DOI 10.1107/S2059798316007907; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rousseaux S, 2015, CELL J, V17, P1; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Smith BC, 2007, J BIOL CHEM, V282, P37256, DOI 10.1074/jbc.M707878200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Watson WT, 2002, MOL CELL, V9, P685, DOI 10.1016/S1097-2765(02)00480-X; Xie ZY, 2016, MOL CELL, V62, P194, DOI 10.1016/j.molcel.2016.03.036; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Yang C, 2013, J AM CHEM SOC, V135, P7791, DOI 10.1021/ja311636b; Yu-Ying Y, 2011, BIOORG MED CHEM LETT, V21, P4976, DOI 10.1016/j.bmcl.2011.05.060; Yuan H, 2013, BIOPOLYMERS, V99, P98, DOI 10.1002/bip.22128; Zhang XL, 2014, J PHYS CHEM B, V118, P2009, DOI 10.1021/jp409778e; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]	50	79	81	3	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					21	29		10.1038/NCHEMBIO.2217	http://dx.doi.org/10.1038/NCHEMBIO.2217			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27820805	Green Submitted, Green Accepted			2022-12-25	WOS:000393267200009
J	Protze, SI; Liu, J; Nussinovitch, U; Ohana, L; Backx, PH; Gepstein, L; Keller, GM				Protze, Stephanie I.; Liu, Jie; Nussinovitch, Udi; Ohana, Lily; Backx, Peter H.; Gepstein, Lior; Keller, Gordon M.			Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; HEART; EXPRESSION; GENE; BMP; DIFFERENTIATION; PROGENITORS; MOUSE; GENERATION; TRANSIENT	The sinoatrial node (SAN) is the primary pacemaker of the heart and controls heart rate throughout life. Failure of SAN function due to congenital disease or aging results in slowing of the heart rate and inefficient blood circulation, a condition treated by implantation of an electronic pacemaker. The ability to produce pacemaker cells in vitro could lead to an alternative, biological pacemaker therapy in which the failing SAN is replaced through cell transplantation. Here we describe a transgene-independent method for the generation of SAN-like pacemaker cells (SANLPCs) from human pluripotent stem cells by stage-specific manipulation of developmental signaling pathways. SANLPCs are identified as NKX2-5(-) cardiomyocytes that express markers of the SAN lineage and display typical pacemaker action potentials, ion current profiles and chronotropic responses. When transplanted into the apex of rat hearts, SANLPCs are able to pace the host tissue, demonstrating their capacity to function as a biological pacemaker.	[Protze, Stephanie I.; Keller, Gordon M.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada; [Protze, Stephanie I.; Keller, Gordon M.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Protze, Stephanie I.; Keller, Gordon M.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Liu, Jie; Ohana, Lily; Backx, Peter H.] York Univ, Dept Biol, Toronto, ON, Canada; [Liu, Jie; Ohana, Lily; Backx, Peter H.] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Liu, Jie; Ohana, Lily; Backx, Peter H.] Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Nussinovitch, Udi; Gepstein, Lior] Technion Israel Inst Technol, Rappaport Fac Med, Sohnis Lab Cardiac Electrophysiol & Regenerat Med, Haifa, Israel; [Nussinovitch, Udi; Gepstein, Lior] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Nussinovitch, Udi] Technion Israel Inst Technol, Dept Internal Med A, Rappaport Fac Med, Haifa, Israel; [Nussinovitch, Udi; Gepstein, Lior] Technion Israel Inst Technol, Rambam Hlth Care Campus, Haifa, Israel; [Gepstein, Lior] Technion Israel Inst Technol, Dept Cardiol, Haifa, Israel	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Keller, GM (corresponding author), Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada.; Keller, GM (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Keller, GM (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	gkeller@uhnresearch.ca		Keller, Gordon/0000-0001-9309-9297; Protze, Stephanie/0000-0002-7993-3780	Canadian Institute of Health Research (CIHR) [MOP-84524, MOP-83453]; European Research Council Ideas-Program (ERC) [ERC-2010-StG-260830-Cardio-iPS]; Technion-UHN International Centre for Cardiovascular Innovation collaboration; Banting postdoctoral fellowship	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); European Research Council Ideas-Program (ERC)(European Research Council (ERC)); Technion-UHN International Centre for Cardiovascular Innovation collaboration; Banting postdoctoral fellowship	We would like to thank members of the Keller laboratory for experimental advice and critical comments on the manuscript, M. Gagliardi for assistance with largescale tissue culture experiments for the in vivo rat heart transplantation studies, A. Elefanty and E. Stanley (Monash University, Victoria, AU) for providing the HES3-NKX2-5<SUP>gfp/w</SUP> reporter cell line, G. Daley (Harvard Medical School, Boston) for providing the MSC-iPS1 cell line, R. Hamilton (Sick Kids, Toronto, ON, Canada) for assistance in obtaining fetal tissue samples, R. Li (UHN, Toronto, ON, Canada) for use of the MEA apparatus and the Sick Kids/UHN Flow Cytometry Facility for assistance with cell sorting. This work was supported by grants from Canadian Institute of Health Research (CIHR, MOP-84524 to G.M.K. and MOP-83453 to P.H.B.) and the European Research Council Ideas-Program (ERC, ERC-2010-StG-260830-Cardio-iPS to L.G.) as well as by donors to Toronto General and Western Hospital Foundation including Joyce Mason and the supporters of the Technion-UHN International Centre for Cardiovascular Innovation collaboration. S.I.P. was supported by a Banting postdoctoral fellowship.	Barron M, 2000, DEV DYNAM, V218, P383, DOI 10.1002/(SICI)1097-0177(200006)218:2<383::AID-DVDY11>3.0.CO;2-P; Birket MJ, 2015, NAT BIOTECHNOL, V33, P970, DOI 10.1038/nbt.3271; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Christoffels VM, 2009, CIRC-ARRHYTHMIA ELEC, V2, P195, DOI 10.1161/CIRCEP.108.829341; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Horsthuis T, 2009, CIRC RES, V105, P61, DOI 10.1161/CIRCRESAHA.108.192443; Hu YF, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008681; Ionta V, 2015, STEM CELL REP, V4, P129, DOI 10.1016/j.stemcr.2014.11.004; Jung JJ, 2014, STEM CELL REP, V2, P592, DOI 10.1016/j.stemcr.2014.03.006; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Katsu K, 2013, DEV BIOL, V374, P71, DOI 10.1016/j.ydbio.2012.11.027; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Keren-Politansky A, 2009, DEV BIOL, V335, P374, DOI 10.1016/j.ydbio.2009.09.012; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li R, 2012, GENE THER, V19, P588, DOI 10.1038/gt.2012.33; Liu J, 2016, ADV DRUG DELIVER REV, V96, P253, DOI 10.1016/j.addr.2015.12.023; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Mesirca P, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00019; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Mommersteeg MTM, 2010, CARDIOVASC RES, V87, P92, DOI 10.1093/cvr/cvq033; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Opthof T, 2000, CARDIOVASC RES, V45, P177, DOI 10.1016/S0008-6363(99)00322-3; Piedra ME, 2002, DEVELOPMENT, V129, P3431; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Rosen MR, 2004, CARDIOVASC RES, V64, P12, DOI 10.1016/j.cardiores.2004.05.012; Rosenthal N, 2000, CURR OPIN CELL BIOL, V12, P742, DOI 10.1016/S0955-0674(00)00162-9; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Sizarov A, 2011, CIRC-ARRHYTHMIA ELEC, V4, P532, DOI 10.1161/CIRCEP.111.963421; von Steinburg SP, 2013, PEERJ, V1, DOI 10.7717/peerj.82; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Witty AD, 2014, NAT BIOTECHNOL, V32, P1026, DOI 10.1038/nbt.3002; Xavier-Neto J, 1999, DEVELOPMENT, V126, P2677; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894	42	208	217	5	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					56	68		10.1038/nbt.3745	http://dx.doi.org/10.1038/nbt.3745			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	27941801				2022-12-25	WOS:000392460800023
J	Tsanov, KM; Pearson, DS; Wu, Z; Han, A; Triboulet, R; Seligson, MT; Powers, JT; Osborne, JK; Kane, S; Gygi, SP; Gregory, RI; Daley, GQ				Tsanov, Kaloyan M.; Pearson, Daniel S.; Wu, Zhaoting; Han, Areum; Triboulet, Robinson; Seligson, Marc T.; Powers, John T.; Osborne, Jihan K.; Kane, Susan; Gygi, Steven P.; Gregory, Richard I.; Daley, George Q.			LIN28 phosphorylation by MAPK/ERK couples signalling to the post-transcriptional control of pluripotency	NATURE CELL BIOLOGY			English	Article							LIN-28; MICRORNA; RNA; DIFFERENTIATION; TRANSLATION; METABOLISM; CELLS	Signalling and post-transcriptional gene control are both critical for the regulation of pluripotency(1,2), yet how they are integrated to influence cell identity remains poorly understood. LIN28 (also known as LIN28A), a highly conserved RNA-binding protein, has emerged as a central post-transcriptional regulator of cell fate through blockade of let-7 microRNA biogenesis and direct modulation of mRNA translation(3). Here we show that LIN28 is phosphorylated by MAPK/ERK in pluripotent stem cells, which increases its levels via post-translational stabilization. LIN28 phosphorylation had little impact on let-7 but enhanced the effect of LIN28 on its direct mRNA targets, revealing a mechanism that uncouples LIN28's let-7-dependent and -independent activities. We have linked this mechanism to the induction of pluripotency by somatic cell reprogramming and the transition from naive to primed pluripotency. Collectively, our findings indicate that MAPK/ERK directly impacts LIN28, defining an axis that connects signalling, post-transcriptional gene control, and cell fate regulation.	[Tsanov, Kaloyan M.; Pearson, Daniel S.; Wu, Zhaoting; Han, Areum; Seligson, Marc T.; Powers, John T.; Osborne, Jihan K.; Daley, George Q.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Tsanov, Kaloyan M.; Pearson, Daniel S.; Wu, Zhaoting; Han, Areum; Seligson, Marc T.; Powers, John T.; Osborne, Jihan K.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Tsanov, Kaloyan M.; Pearson, Daniel S.; Wu, Zhaoting; Han, Areum; Triboulet, Robinson; Seligson, Marc T.; Powers, John T.; Osborne, Jihan K.; Gregory, Richard I.; Daley, George Q.] Harvard Med Sch, Harvard Stem Cell Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Tsanov, Kaloyan M.; Pearson, Daniel S.; Wu, Zhaoting; Han, Areum; Seligson, Marc T.; Powers, John T.; Osborne, Jihan K.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Triboulet, Robinson; Gregory, Richard I.] Boston Childrens Hosp, Stem Cell Program, Div Hematol Oncol, Boston, MA 02115 USA; [Kane, Susan] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Daley, GQ (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Harvard Med Sch, Harvard Stem Cell Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Tsanov, Kaloyan M/J-6852-2012; Powers, John/AAO-1018-2020; /AAD-2039-2020	/0000-0001-9007-4844	NIH [NIH-P30-HD 18655]; NIGMS [T32GM007753, R01GM086386, R01GM107536]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086386, T32GM007753, R01GM107536] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Sharp, L. Cantley, G. Ruvkun, and members of the Daley laboratory for invaluable discussions, A. D. L. Angeles for critical feedback on the manuscript, X. Wu/Yi Zhang's laboratory and R. Rubio/DFCI CCCB for assistance with RNA-seq, and R. Tomaino at the Taplin Biological Mass Spectrometry Core for assistance with mass spectrometry. Bioanalyser analysis was performed in the BCH IDDRC Molecular Genetics Core, which is supported by NIH (NIH-P30-HD 18655). Sequencing analysis was conducted on the Orchestra High Performance Computing Cluster at Harvard Medical School. K.M.T. was an HHMI International Student Research Fellow and a Herchel Smith Graduate Fellow. D.S.P. was supported by a grant from NIGMS (T32GM007753). R.I.G. was supported by a grant from NIGMS (R01GM086386). G.Q.D. is an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research, and was supported by a grant from NIGMS (R01GM107536).	Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Cai N, 2012, J MOL CELL BIOL, V4, P262, DOI 10.1093/jmcb/mjs031; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Kim SK, 2014, CELL STEM CELL, V15, P735, DOI 10.1016/j.stem.2014.10.016; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Tan FE, 2014, P NATL ACAD SCI USA, V111, pE1740, DOI 10.1073/pnas.1320873111; Vadla B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002588; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang LX, 2014, BBA-MOL CELL RES, V1843, P1188, DOI 10.1016/j.bbamcr.2014.03.001; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Ye J, 2014, CELL STEM CELL, V15, P271, DOI 10.1016/j.stem.2014.08.010; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009	29	44	46	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2017	19	1					60	67		10.1038/ncb3453	http://dx.doi.org/10.1038/ncb3453			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EG9AI	27992407	Green Accepted, Green Submitted			2022-12-25	WOS:000391349000009
J	Giddings, LV; Miller, H				Giddings, L. Val; Miller, Henry			US National Academies report misses the mark	NATURE BIOTECHNOLOGY			English	Letter									[Giddings, L. Val] ITIF, Washington, DC 20005 USA; [Miller, Henry] Stanford Univ, Hoover Inst, Stanford, CA 94305 USA	Stanford University	Giddings, LV (corresponding author), ITIF, Washington, DC 20005 USA.	vgiddings@itif.org						Brookes G, 2015, GM CROPS FOOD, V6, P13, DOI 10.1080/21645698.2015.1022310; Canola Council of Canada, 2001, AGR EC ASS TRANSG CA; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Cary T, 2014, CROP SCI, V54, P1419, DOI [10.2135/cropsci2013.10.0665, DOI 10.2135/CROPSCI2013.10.0665]; Conko G, 2016, NAT BIOTECHNOL, V34, P493, DOI 10.1038/nbt.3568; Fernandez W., 2009, 13 ICABR C RAV IT 18; Fischer J., 2009, 112009 CURT U TECHN; Giddings L.V, SCI PROGR; Giddings L.V. U.S., 2016, INNOVATION FILES; Gomez-Barbero M., 2008, JRC TECHNICAL REPORT; Gouse M., 2012, AgBioForum, V15, P163; Gusta M., 2011, AgBioForum, V14, P1; Hakim D, 2016, NY TIMES; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; National Academies of Sciences Engineering and Medicine., 2016, GEN ENG CROPS EXP FU; National Research Council, 1989, FIELD TEST GEN MOD O; Powell M., 2011, J PUBLIC DELIBERATIO, V7, P4; Raney T, 2006, CURR OPIN BIOTECH, V17, P174, DOI 10.1016/j.copbio.2006.02.009; Rowe G, 2008, PUBLIC UNDERST SCI, V17, P419, DOI 10.1177/0963662506075351; White House, 2012, NAT BIOEC BLUEPR	20	3	3	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1226	1228		10.1038/nbt.3746	http://dx.doi.org/10.1038/nbt.3746			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27926716				2022-12-25	WOS:000390185300008
J	Osuna, CE; Lim, SY; Deleage, C; Griffin, BD; Stein, D; Schroeder, LT; Omange, RW; Best, K; Luo, M; Hraber, PT; Andersen-Elyard, H; Ojeda, EFC; Huang, S; Vanlandingham, DL; Higgs, S; Perelson, AS; Estes, JD; Safronetz, D; Lewis, MG; Whitney, JB				Osuna, Christa E.; Lim, So-Yon; Deleage, Claire; Griffin, Bryan D.; Stein, Derek; Schroeder, Lukas T.; Omange, Robert Were; Best, Katharine; Luo, Ma; Hraber, Peter T.; Andersen-Elyard, Hanne; Ojeda, Erwing Fabian Cardozo; Huang, Scott; Vanlandingham, Dana L.; Higgs, Stephen; Perelson, Alan S.; Estes, Jacob D.; Safronetz, David; Lewis, Mark G.; Whitney, James B.			Zika viral dynamics and shedding in rhesus and cynomolgus macaques	NATURE MEDICINE			English	Article							NATURAL-KILLER-CELLS; SEXUAL TRANSMISSION; VIRUS-INFECTION; DENGUE VIRUS; OUTBREAK; SERUM; EXPRESSION; MOSQUITOS; RESPONSES; MEMORY	Infection with Zika virus has been associated with serious neurological complications and fetal abnormalities. However, the dynamics of viral infection, replication and shedding are poorly understood. Here we show that both rhesus and cynomolgus macaques are highly susceptible to infection by lineages of Zika virus that are closely related to, or are currently circulating in, the Americas. After subcutaneous viral inoculation, viral RNA was detected in blood plasma as early as 1 d after infection. Viral RNA was also detected in saliva, urine, cerebrospinal fluid (CSF) and semen, but transiently in vaginal secretions. Although viral RNA during primary infection was cleared from blood plasma and urine within 10 d, viral RNA was detectable in saliva and seminal fluids until the end of the study, 3 weeks after the resolution of viremia in the blood. The control of primary Zika virus infection in the blood was correlated with rapid innate and adaptive immune responses. We also identified Zika RNA in tissues, including the brain and male and female reproductive tissues, during early and late stages of infection. Re-infection of six animals 45 d after primary infection with a heterologous strain resulted in complete protection, which suggests that primary Zika virus infection elicits protective immunity. Early invasion of Zika virus into the nervous system of healthy animals and the extent and duration of shedding in saliva and semen underscore possible concern for additional neurologic complications and nonarthropod-mediated transmission in humans.	[Osuna, Christa E.; Lim, So-Yon; Whitney, James B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA; [Deleage, Claire; Estes, Jacob D.] Frederick Natl Lab Canc Res, Leidos Biomed Res, Frederick, MD USA; [Griffin, Bryan D.; Stein, Derek; Schroeder, Lukas T.; Omange, Robert Were; Luo, Ma; Safronetz, David] Natl Microbiol Lab, Winnipeg, MB, Canada; [Best, Katharine; Hraber, Peter T.; Ojeda, Erwing Fabian Cardozo; Perelson, Alan S.] Los Alamos Natl Lab, Los Alamos, NM USA; [Andersen-Elyard, Hanne; Lewis, Mark G.] Bioqual, Rockville, MD USA; [Huang, Scott; Vanlandingham, Dana L.; Higgs, Stephen] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA; [Whitney, James B.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Los Alamos National Laboratory; BIOQUAL Inc.; Kansas State University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Whitney, JB (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA.; Whitney, JB (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA.	jwhitne2@bidmc.harvard.edu	Perelson, Alan S/Z-1959-2019; Omange, Were/F-1454-2016	Perelson, Alan S/0000-0002-2455-0002; Hraber, Peter/0000-0002-2920-4897; Osuna, Christa/0000-0003-2761-2456; Griffin, Bryan D/0000-0002-7950-1873; Omange, Were/0000-0002-0421-110X; Cardozo Ojeda, Erwing/0000-0001-8690-9896; Elyard, Hanne/0000-0003-1103-9608	National Cancer Institute ( NIH Contract) [HHSN261200800001E]; NIH [AI028433, OD0110995]; Public Health Agency of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI028433, U24AI126683, R01AI028433] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095, R24OD010976] Funding Source: NIH RePORTER	National Cancer Institute ( NIH Contract); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Agency of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Finneyfrock, Z. Pippin, A. Dodson and A. Cook for their expert animal husbandry and care, and J. Guedj for suggestions about the model simulations. CD38 antibodies were obtained from the NIH Nonhuman Primate Reagent Resource supported by HHSN272200900037C and OD010976. The data presented in this study are tabulated in the main paper and in the supplementary materials. This work was supported in part by federal funds from the National Cancer Institute ( NIH Contract HHSN261200800001E). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products or organizations imply endorsement by the US Government. A.S.P. acknowledges support from NIH grants AI028433 and OD0110995. D.S. acknowledges support from the Public Health Agency of Canada.	Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416; Banerjee S, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0130; Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901; BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6; Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021; Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; Deleage Claire, 2016, Pathog Immun, V1, P68; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Donaldson MM, 2012, J IMMUNOL METHODS, V386, P10, DOI 10.1016/j.jim.2012.08.011; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Fukuhara M, 2013, J VIROL, V87, P701, DOI 10.1128/JVI.01453-12; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; GUBLER DJ, 1976, AM J TROP MED HYG, V25, P146, DOI 10.4269/ajtmh.1976.25.146; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; HARRISON RM, 1980, J MED PRIMATOL, V9, P265; Kuhrt D, 2011, J IMMUNOL METHODS, V363, P166, DOI 10.1016/j.jim.2010.09.017; Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887; Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9; Millon P., 2015, EPIDEMIOLOGIE SYNDRO; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002; Townsend Peterson A, 2016, PLOS CURR; Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4; Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x; Whitney JB, 2009, AIDS, V23, P1453, DOI 10.1097/QAD.0b013e32832b43d9	54	205	209	0	39	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1448	+		10.1038/nm.4206	http://dx.doi.org/10.1038/nm.4206			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27694931	Green Accepted, Green Submitted			2022-12-25	WOS:000389549000022
J	Roy, A; Kundu, M; Jana, M; Mishra, RK; Yung, YN; Luan, CH; Gonzalez, FJ; Pahan, K				Roy, Avik; Kundu, Madhuchhanda; Jana, Malabendu; Mishra, Rama K.; Yung, Yeni; Luan, Chi-Hao; Gonzalez, Frank J.; Pahan, Kalipada			Identification and characterization of PPAR alpha ligands in the hippocampus	NATURE CHEMICAL BIOLOGY			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; RAT HIPPOCAMPUS; UP-REGULATION; BODY-WEIGHT; MOUSE MODEL; OLEOYLETHANOLAMIDE; EXPRESSION; NEURONS; BRAIN; METABOLISM	Peroxisome proliferator-activated receptor-alpha (PPAR alpha) regulates hepatic fatty acid catabolism and mediates the metabolic response to starvation. Recently we found that PPAR alpha is constitutively activated in nuclei of hippocampal neurons and controls plasticity via direct transcriptional activation of CREB. Here we report the discovery of three endogenous PPAR alpha ligands3- hydroxy-(2,2)-dimethyl butyrate, hexadecanamide, and 9-octadecenamide-in mouse brain hippocampus. Mass spectrometric detection of these compounds in mouse hippocampal nuclear extracts, in silico interaction studies, time-resolved FRET analyses, and thermal shift assay results clearly indicated that these three compounds served as ligands of PPAR alpha. Site-directed mutagenesis studies further revealed that PPAR alpha Y464 and Y314 are involved in binding these hippocampal ligands. Moreover, these ligands activated PPAR alpha and upregulated the synaptic function of hippocampal neurons. These results highlight the discovery of hippocampal ligands of PPAR alpha capable of modulating synaptic functions.	[Roy, Avik; Kundu, Madhuchhanda; Jana, Malabendu; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Mishra, Rama K.] Northwestern Univ, Med & Synthet Chem Core, Ctr Mol Innovat & Drug Discovery, Evanston, IL USA; [Yung, Yeni] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Luan, Chi-Hao] Northwestern Univ, High Throughput Anal Lab, Evanston, IL USA; [Luan, Chi-Hao] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Pahan, Kalipada] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL 60612 USA	Rush University; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.; Pahan, K (corresponding author), Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL 60612 USA.	kalipada_pahan@rush.edu		Gonzalez, Frank/0000-0002-7990-2140	Chicago Biomedical Consortium; US National Institutes of Health [AG050431, NS83054]; Veterans Affairs [1I01BX003033-01]; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050431] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003033] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank ChemCore at the Northwestern University Center for Molecular Innovation and Drug Discovery, which is funded by the Chicago Biomedical Consortium. This study was supported by grants from the US National Institutes of Health (AG050431 and NS83054) and a merit award (1I01BX003033-01) from Veterans Affairs to K.P.	Cabrero A, 2002, J BIOL CHEM, V277, P10100, DOI 10.1074/jbc.M110321200; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P8027, DOI 10.1073/pnas.0903038106; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chen L, 2015, ONCOTARGET, V6, P42530, DOI 10.18632/oncotarget.6466; Cluny NL, 2009, NEUROGASTROENT MOTIL, V21, P420, DOI 10.1111/j.1365-2982.2008.01248.x; Corbett GT, 2015, P NATL ACAD SCI USA, V112, P8445, DOI 10.1073/pnas.1504890112; Dasgupta S, 2003, J BIOL CHEM, V278, P22424, DOI 10.1074/jbc.M301789200; Fanelli F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-8; Fang X, 2007, PROSTAG OTH LIPID M, V82, P175, DOI 10.1016/j.prostaglandins.2006.05.002; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gocke AR, 2009, J IMMUNOL, V182, P4479, DOI 10.4049/jimmunol.0713927; Gorini A, 1999, NEUROCHEM RES, V24, P617, DOI 10.1023/A:1021008306414; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Huitron-Resendiz S, 2001, EXP NEUROL, V172, P235, DOI 10.1006/exnr.2001.7792; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jana M, 2007, NEUROCHEM RES, V32, P2015, DOI 10.1007/s11064-007-9340-y; KAINU T, 1994, NEUROREPORT, V5, P2481, DOI 10.1097/00001756-199412000-00019; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; Melis M, 2013, CNS NEUROL DISORD-DR, V12, P70, DOI 10.2174/1871527311312010012; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Narala VR, 2010, J BIOL CHEM, V285, P22067, DOI 10.1074/jbc.M109.085118; Raso GM, 2013, PHARMACOL RES, V76, P67, DOI 10.1016/j.phrs.2013.07.007; Roy AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085011; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Roy A, 2015, CELL METAB, V22, P253, DOI 10.1016/j.cmet.2015.05.022; Roy A, 2015, J NEUROIMMUNE PHARM, V10, P30, DOI 10.1007/s11481-014-9582-9; Roy A, 2013, CELL REP, V4, P724, DOI 10.1016/j.celrep.2013.07.028; Saha RN, 2007, FREE RADICAL BIO MED, V42, P1866, DOI 10.1016/j.freeradbiomed.2007.03.022; Saha RN, 2009, J IMMUNOL, V183, P2068, DOI 10.4049/jimmunol.0801892	38	47	48	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1075	+		10.1038/NCHEMBIO.2204	http://dx.doi.org/10.1038/NCHEMBIO.2204			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27748752	Green Accepted			2022-12-25	WOS:000388582900017
J	Bender, S; Gronych, J; Warnatz, HJ; Hutter, B; Grobner, S; Ryzhova, M; Pfaff, E; Hovestadt, V; Weinberg, F; Halbach, S; Kool, M; Northcott, PA; Sturm, D; Bjerke, L; Zichner, T; Stutz, AM; Schramm, K; Huang, B; Buchhalter, I; Heinold, M; Risch, T; Worst, BC; van Tilburg, CM; Weber, UD; Zapatka, M; Raeder, B; Milford, D; Heiland, S; von Kalle, C; Previti, C; Lawerenz, C; Kulozik, AE; Unterberg, A; Witt, O; von Deimling, A; Capper, D; Truffaux, N; Grill, J; Jabado, N; Sehested, AM; Sumerauer, D; Hmida-Ben Brahim, D; Trabelsi, S; Ng, HK; Zagzag, D; Allen, JC; Karajannis, MA; Gottardo, NG; Jones, C; Korbel, J; Schmidt, S; Wolf, S; Reifenberger, G; Felsberg, J; Brors, B; Herold-Mende, C; Lehrach, H; Brummer, T; Korshunov, A; Eils, R; Yaspo, ML; Pfister, SM; Lichter, P; Jones, DTW				Bender, Sebastian; Gronych, Jan; Warnatz, Hans-Joerg; Hutter, Barbara; Groebner, Susanne; Ryzhova, Marina; Pfaff, Elke; Hovestadt, Volker; Weinberg, Florian; Halbach, Sebastian; Kool, Marcel; Northcott, Paul A.; Sturm, Dominik; Bjerke, Lynn; Zichner, Thomas; Stutz, Adrian M.; Schramm, Kathrin; Huang, Bingding; Buchhalter, Ivo; Heinold, Michael; Risch, Thomas; Worst, Barbara C.; van Tilburg, Cornelis M.; Weber, Ursula D.; Zapatka, Marc; Raeder, Benjamin; Milford, David; Heiland, Sabine; von Kalle, Christof; Previti, Christopher; Lawerenz, Chris; Kulozik, Andreas E.; Unterberg, Andreas; Witt, Olaf; von Deimling, Andreas; Capper, David; Truffaux, Nathalene; Grill, Jacques; Jabado, Nada; Sehested, Astrid M.; Sumerauer, David; Hmida-Ben Brahim, Dorra; Trabelsi, Saoussen; Ng, Ho-Keung; Zagzag, David; Allen, Jeffrey C.; Karajannis, Matthias A.; Gottardo, Nicholas G.; Jones, Chris; Korbel, Jan; Schmidt, Sabine; Wolf, Stephan; Reifenberger, Guido; Felsberg, Jorg; Brors, Benedikt; Herold-Mende, Christel; Lehrach, Hans; Brummer, Tilman; Korshunov, Andrey; Eils, Roland; Yaspo, Marie-Laure; Pfister, Stefan M.; Lichter, Peter; Jones, David T. W.		Int Canc Genome Consortium	Recurrent MET fusion genes represent a drug target in pediatric glioblastoma	NATURE MEDICINE			English	Article							LARGE-CELL LYMPHOMA; GENOMIC LANDSCAPE; MUTATIONS; REARRANGEMENT; INHIBITION; TRANSCRIPT; RESISTANCE; REVEALS; GLIOMA; TUMORS	Pediatric glioblastoma is one of the most common and most deadly brain tumors in childhood. Using an integrative genetic analysis of 53 pediatric glioblastomas and five in vitro model systems, we identified previously unidentified gene fusions involving the MET oncogene in similar to 10% of cases. These MET fusions activated mitogen-activated protein kinase (MAPK) signaling and, in cooperation with lesions compromising cell cycle regulation, induced aggressive glial tumors in vivo. MET inhibitors suppressed MET tumor growth in xenograft models. Finally, we treated a pediatric patient bearing a MET-fusion-expressing glioblastoma with the targeted inhibitor crizotinib. This therapy led to substantial tumor shrinkage and associated relief of symptoms, but new treatment-resistant lesions appeared, indicating that combination therapies are likely necessary to achieve a durable clinical response.	[Bender, Sebastian; Groebner, Susanne; Pfaff, Elke; Kool, Marcel; Northcott, Paul A.; Sturm, Dominik; Worst, Barbara C.; Pfister, Stefan M.; Jones, David T. W.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Bender, Sebastian; Pfaff, Elke; Sturm, Dominik; Worst, Barbara C.; van Tilburg, Cornelis M.; Kulozik, Andreas E.; Witt, Olaf; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany; [Bender, Sebastian; Gronych, Jan; Groebner, Susanne; Pfaff, Elke; Hovestadt, Volker; Kool, Marcel; Northcott, Paul A.; Sturm, Dominik; Schramm, Kathrin; Worst, Barbara C.; van Tilburg, Cornelis M.; Weber, Ursula D.; Zapatka, Marc; von Deimling, Andreas; Capper, David; Brors, Benedikt; Korshunov, Andrey; Pfister, Stefan M.; Lichter, Peter; Jones, David T. W.] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Gronych, Jan; Hovestadt, Volker; Schramm, Kathrin; Weber, Ursula D.; Zapatka, Marc; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Warnatz, Hans-Joerg; Risch, Thomas; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Berlin, Germany; [Hutter, Barbara; Buchhalter, Ivo; Heinold, Michael; Brors, Benedikt] German Canc Res Ctr, Div Appl Bioinformat, Heidelberg, Germany; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, Moscow, Russia; [Weinberg, Florian; Halbach, Sebastian; Brummer, Tilman] Univ Freiburg, Inst Mol Med & Cell Res IMMZ, Fac Med, Freiburg, Germany; [Weinberg, Florian; Brummer, Tilman] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Freiburg, Germany; [Bjerke, Lynn; Jones, Chris] Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England; [Bjerke, Lynn; Jones, Chris] Inst Canc Res, Div Canc Therapeut, Sutton, Surrey, England; [Zichner, Thomas; Stutz, Adrian M.; Raeder, Benjamin; Korbel, Jan] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Huang, Bingding; Buchhalter, Ivo; Lawerenz, Chris; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [van Tilburg, Cornelis M.; Brors, Benedikt] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Milford, David; Heiland, Sabine] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany; [von Kalle, Christof] German Canc Res Ctr, Div Translat Oncol, Heidelberg, Germany; [von Kalle, Christof; Previti, Christopher; Schmidt, Sabine; Wolf, Stephan] German Canc Res Ctr, Genom & Prote Core Facil, Heidelberg, Germany; [Unterberg, Andreas; Herold-Mende, Christel] Univ Heidelberg Hosp, Dept Neurosurg, Heidelberg, Germany; [Witt, Olaf] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, Heidelberg, Germany; [von Deimling, Andreas; Capper, David; Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, Heidelberg, Germany; [von Deimling, Andreas; Capper, David; Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Truffaux, Nathalene; Grill, Jacques] CNRS, UMR 8203, Lab Vectorol & Therapeut Anticanc, Villejuif, France; [Truffaux, Nathalene; Grill, Jacques] Univ Paris Sud, Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Jabado, Nada] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Sehested, Astrid M.] Rigshosp, Dept Pediat Hematol & Oncol, Copenhagen, Denmark; [Sumerauer, David] Charles Univ Prague, Fac Med 2, Dept Pediat Hematol & Oncol, Prague, Czech Republic; [Sumerauer, David] Univ Hosp Motol, Prague, Czech Republic; [Hmida-Ben Brahim, Dorra; Trabelsi, Saoussen] Farhat Hached Hosp, Dept Cytogenet & Reprod Biol, Sousse, Tunisia; [Ng, Ho-Keung] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Zagzag, David] NYU, Dept Pathol, Sch Med, 550 1St Ave, New York, NY 10016 USA; [Zagzag, David] NYU, Dept Neurosurg, Sch Med, 550 1St Ave, New York, NY 10016 USA; [Allen, Jeffrey C.; Karajannis, Matthias A.] NYU, Dept Pediat, Langone Med Ctr, New York, NY 10016 USA; [Gottardo, Nicholas G.] Princess Margaret Hosp Children, Dept Pediat Oncol & Haematol, Perth, WA, Australia; [Gottardo, Nicholas G.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Gottardo, Nicholas G.] Univ Western Australia, Sch Pediat & Child Hlth, Perth, WA, Australia; [Stutz, Adrian M.; Reifenberger, Guido; Felsberg, Jorg] Heinrich Heine Univers Dusseldorf, Dept Neuropathol, Dusseldorf, Germany; [Brummer, Tilman] Univ Freiburg, Med Ctr, Comprehens Canc Ctr Freiburg CCCF, Freiburg, Germany; [Brummer, Tilman] DKTK, Standort Freiburg, Germany; [Eils, Roland] Heidelberg Univ, IPMB, Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, BioQuant Ctr, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; University of Freiburg; University of Freiburg; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; McGill University; McGill University; McGill University; Rigshospitalet; University of Copenhagen; Charles University Prague; Motol University Hospital; Universite de Sousse; Hopital Farhat Hached; Chinese University of Hong Kong; New York University; New York University; New York University; NYU Langone Medical Center; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Freiburg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Pfister, SM; Jones, DTW (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany.; Pfister, SM (corresponding author), Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany.; Pfister, SM; Lichter, P; Jones, DTW (corresponding author), German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany.; Lichter, P (corresponding author), German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany.	s.pfister@dkfz.de; peter.lichter@dkfz.de; david.jones@dkfz.de	Zapatka, Marc/G-9896-2013; Jones, David T. W./Z-1963-2019; Kulozik, Andreas/AAO-2432-2020; Northcott, Paul A/N-4022-2018; Sturm, Dominik/AAL-3689-2020; Grill, Jacques/R-8093-2019; Capper, David/I-8500-2014; Jones, Chris/ABE-6059-2021; Ng, Ho Keung/I-3952-2015; Brummer, Tilman/AAA-9428-2020; Jones, David TW/G-9588-2013; Ryzhova, Marina/G-4178-2014; Halbach, Sebastian/G-4021-2012; Brummer, Tilman/B-6218-2016; Jabado, Nada/AAN-4026-2020; Brors, Benedikt/E-5620-2013; Eils, Roland/B-6121-2009; Pfister, Stefan M/F-6860-2013; von Deimling, Andreas/F-7774-2013; Reifenberger, Guido/AAE-3599-2019; Karajannis, Matthias A/H-8845-2019	Zapatka, Marc/0000-0001-8287-5967; Northcott, Paul A/0000-0002-1220-5252; Sturm, Dominik/0000-0003-0250-1696; Capper, David/0000-0003-1945-497X; Jones, Chris/0000-0001-8118-2296; Brummer, Tilman/0000-0003-4387-7905; Jones, David TW/0000-0002-2036-5141; Ryzhova, Marina/0000-0001-7206-6365; Halbach, Sebastian/0000-0002-6827-8178; Brummer, Tilman/0000-0003-4387-7905; Brors, Benedikt/0000-0001-5940-3101; Eils, Roland/0000-0002-0034-4036; Pfister, Stefan M/0000-0002-5447-5322; von Deimling, Andreas/0000-0002-5863-540X; Karajannis, Matthias A/0000-0002-7151-6528; Gottardo, Nicholas/0000-0002-1082-6776; Buchhalter, Ivo/0000-0003-0764-5832; trabelsi, saoussen/0000-0002-2789-7167; Hovestadt, Volker/0000-0002-3480-6649; Raeder, Benjamin/0000-0002-9494-8884; Hutter, Barbara/0000-0002-9034-0329; Allen, Jeffrey/0000-0001-9957-6664; Gronych, Jan/0000-0003-0557-679X; Zichner, Thomas/0000-0001-9848-7598; Korshunov, Andrey/0000-0002-5257-3623	PedBrain Tumor Project; German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A, 0315416C, 01GS0883, 031A425A, 01ZX1302]; German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); German Cancer Consortium (DKTK, INFORM project); Max Planck Society (Munich, Germany); European Union (FP7) [262055]; Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC) [HA-305]; German Research Foundation (DFG) [LA2983/2-1]; EDM Foundation; Lemos Foundation; New York University Langone Human Specimen Resource Center, Laura and Isaac Perlmutter Cancer Center; Cancer Center Support Grant from the National Cancer Institute, US National Institutes of Health [P30 CA16087]; National Center for the Advancement of Translational Science (NCATS), US National Institutes of Health [UL 1 T12000038]; Making Headway Foundation; Dr. Mildred Scheel Foundation Scholarship; NHS; ICR; Cancer Research UK [13982, 11736] Funding Source: researchfish; The Brain Tumour Charity [16/193, 6/78] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER	PedBrain Tumor Project; German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); German Cancer Consortium (DKTK, INFORM project); Max Planck Society (Munich, Germany)(Max Planck Society); European Union (FP7)(European Commission); Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC); German Research Foundation (DFG)(German Research Foundation (DFG)); EDM Foundation; Lemos Foundation; New York University Langone Human Specimen Resource Center, Laura and Isaac Perlmutter Cancer Center; Cancer Center Support Grant from the National Cancer Institute, US National Institutes of Health; National Center for the Advancement of Translational Science (NCATS), US National Institutes of Health; Making Headway Foundation; Dr. Mildred Scheel Foundation Scholarship; NHS; ICR; Cancer Research UK(Cancer Research UK); The Brain Tumour Charity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	For technical support and expertise, we thank A. Wittmann, L. Sieber, C. Xanthopoulos, D. Sohn and N. Mack, the DKFZ Genomics and Proteomics Core Facility, the DKFZ Center for Preclinical Research, R. Kabbe (Division of Theoretical Bioinformatics, DKFZ), M. Bieg and M. Schlesner (Division of Applied Bioinformatics, DKFZ), C. Jager-Schmidt (Data Management Group, DKFZ), S. Ruffer and T. Giese from the Heidelberg University Hospital, M. Rabenstein from the NCT Heidelberg, S. Thamm, D. Balzereit, S. Dokel, M. Linser, A. Kovacsovics and V. Amstislayskiy from the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin, the tissue bank of the National Center for Tumor Diseases (NCT, Heidelberg), and the Department of Oncogenomics (University of Amsterdam). Ntv-a; Cdkn2a<SUP>-/-</SUP>; Pten<SUP>fl/fl</SUP> mice were kindly provided by E. Holland (Fred Hutchinson Cancer Research Center). This work was principally supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants #01KU1201A, MedSys #0315416C, NGFNplus #01GS0883 and e:Med Joint Research Projects SYS-GLIO #031A425A and CancerTelSys #01ZX1302). Additional support came from the German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the German Cancer Consortium (DKTK, INFORM project), the Max Planck Society (Munich, Germany), the European Union (FP7/2007-2013, grant ESGI #262055), the Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC, grant number HA-305), the German Research Foundation (DFG, grant LA2983/2-1), the EDM and the Lemos Foundations, the New York University Langone Human Specimen Resource Center, Laura and Isaac Perlmutter Cancer Center, supported in part by the Cancer Center Support Grant, P30 CA16087 from the National Cancer Institute, US National Institutes of Health, UL 1 T12000038 from the National Center for the Advancement of Translational Science (NCATS), US National Institutes of Health, and grants from the Making Headway Foundation. J. Gronych was supported by a Dr. Mildred Scheel Foundation Scholarship. The authors acknowledge NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden and the ICR as well as the project (Ministry of Health, Czech Republic) for conceptual development of research organization 00064203 (University Hospital Motol, Prague, Czech Republic).	Bao ZS, 2014, GENOME RES, V24, P1765, DOI 10.1101/gr.165126.113; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chi AS, 2012, J CLIN ONCOL, V30, pE30, DOI 10.1200/JCO.2011.38.4586; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Diamond JR, 2013, J CLIN ONCOL, V31, pE254, DOI 10.1200/JCO.2012.46.4289; Dias-Santagata D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017948; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; GRECO A, 1995, MOL CELL BIOL, V15, P6118; Hernandez L, 1999, BLOOD, V94, P3265; Jones C, 2014, NAT REV CANCER, V14, P651, DOI 10.1038/nrc3811; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Korshunov A, 2015, ACTA NEUROPATHOL, V129, P669, DOI 10.1007/s00401-015-1405-4; Lai AZ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004839; Laser-Azogui A, 2014, ONCOGENE, V33, P1788, DOI 10.1038/onc.2013.138; Louis, 2016, WHO CLASSIFICATION G; Mak HHL, 2007, ONCOGENE, V26, P7213, DOI 10.1038/sj.onc.1210522; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Navis AC, 2015, ACTA NEUROPATHOL, V130, P131, DOI 10.1007/s00401-015-1420-5; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shin Clifford H, 2015, Genes Cancer, V6, P9; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Truffaux N, 2015, NEURO-ONCOLOGY, V17, P953, DOI 10.1093/neuonc/nou330; Weber RG, 2007, ONCOGENE, V26, P1088, DOI 10.1038/sj.onc.1209851; Worst BC, 2016, EUR J CANCER, V65, P91, DOI 10.1016/j.ejca.2016.06.009; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611	33	128	134	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1314	1320		10.1038/nm.4204	http://dx.doi.org/10.1038/nm.4204			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27748748				2022-12-25	WOS:000387302300024
J	Ducuing, A; Vincent, S				Ducuing, Antoine; Vincent, Stephan			The actin cable is dispensable in directing dorsal closure dynamics but neutralizes mechanical stress to prevent scarring in the Drosophila embryo	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; EPITHELIAL MORPHOGENESIS; DILATED CARDIOMYOPATHY; FORCES; EXPRESSION; MOVEMENT; ADHESION; ZASP; PDZ; CYPHER/ZASP	The actin cable is a supracellular structure that embryonic epithelia produce to close gaps. However, the action of the cable remains debated. Here, we address the function of the cable using Drosophila dorsal closure, a paradigm to understand wound healing. First, we show that the actin cytoskeleton protein Zasp52 is specifically required for actin cable formation. Next, we used Zasp52 loss of function to dissect the mechanism of action of the cable. Surprisingly, closure dynamics are perfect in Zasp52 mutants: the cable is therefore dispensable for closure, even in the absence of the amnioserosa. Conversely, we observed that the cable protects cellular geometries from robust morphogenetic forces that otherwise interfere with closure: the absence of cable results in defects in epithelial organization that lead to morphogenetic scarring. We propose that the cable prevents morphogenetic scarring by stabilizing cellular interactions rather than by acting on closure dynamics.	[Ducuing, Antoine; Vincent, Stephan] Univ Lyon, LBMC, UMR5239, CNRS,Ecole Normale Super Lyon,SFR Biosci Lyon Ger, F-69007 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet	Vincent, S (corresponding author), Univ Lyon, LBMC, UMR5239, CNRS,Ecole Normale Super Lyon,SFR Biosci Lyon Ger, F-69007 Lyon, France.	stephane.vincent11@ens-lyon.fr			Centre National de la Recherche Scientifique; COOPERA grant from Region Rhone-Alpes; Fonds Recherche, ENS de Lyon	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); COOPERA grant from Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Fonds Recherche, ENS de Lyon	We thank the ARTHRO-TOOLS and PLATIM facilities of the UMS3444 and Bloomington and the Developmental Studies Hybridoma Bank for reagents. We thank F. Schock, McGill University, for providing the Zasp Delta mutant, B. Mollereau's group and M. Grammont's group for laboratory space and equipment and P. Joncour for running one-way ANOVA and pairwise t-tests in R for Fig. 6f,j. This work was supported by a Chair from the Centre National de la Recherche Scientifique and a COOPERA grant from the Region Rhone-Alpes to S.V. and the Fonds Recherche, ENS de Lyon.	Abate A, 2012, IEEE ACM T COMPUT BI, V9, P1607, DOI 10.1109/TCBB.2012.126; Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200; Belacortu Y, 2011, DEV DYNAM, V240, P2379, DOI 10.1002/dvdy.22753; BEMENT WM, 1993, J CELL BIOL, V121, P565, DOI 10.1083/jcb.121.3.565; Brock J, 1996, J CELL BIOL, V135, P1097, DOI 10.1083/jcb.135.4.1097; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Danjo Y, 1998, J CELL SCI, V111, P3323; Davidson LA, 2002, CELL MOTIL CYTOSKEL, V53, P163, DOI 10.1002/cm.10070; Ducuing A, 2015, J CELL BIOL, V208, P239, DOI 10.1083/jcb.201410042; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Gates J, 2007, DEVELOPMENT, V134, P2027, DOI 10.1242/dev.02849; Gettings M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000390; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Katzemich A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003342; Katzemich A, 2011, GENE EXPR PATTERNS, V11, P484, DOI 10.1016/j.gep.2011.08.004; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Laplante C, 2006, DEVELOPMENT, V133, P3255, DOI 10.1242/dev.02492; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Li JJ, 2013, J CELL SCI, V126, P5005, DOI 10.1242/jcs.133421; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mateus R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051766; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Pasakarnis L., 2016, NAT CELL BIOL; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; Peralta XG, 2007, BIOPHYS J, V92, P2583, DOI 10.1529/biophysj.106.094110; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Rodriguez-Diaz A, 2008, HFSP J, V2, P220, DOI 10.2976/1.2955565; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Stronach B, 2014, GENE EXPR PATTERNS, V15, P67, DOI 10.1016/j.gep.2014.05.002; Strudwick Xanthe L, 2012, Cells, V1, P1313, DOI 10.3390/cells1041313; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Verma S, 2012, MOL BIOL CELL, V23, P4601, DOI 10.1091/mbc.E12-08-0574; Vincent S, 2008, DEVELOPMENT, V135, P2767, DOI 10.1242/dev.017814; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	46	52	52	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1149	+		10.1038/ncb3421	http://dx.doi.org/10.1038/ncb3421			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27749820				2022-12-25	WOS:000387165600009
J	Sheridan, C				Sheridan, Cormac			CAR-T cells forge ahead, Novartis reorganizes	NATURE BIOTECHNOLOGY			English	News Item																		2015, NAT BIOTECHNOL, V33, P571; 2010, BLOOD, V116, P4099; 2016, BLOOD, V128, P1688; 2016, NAT BIOTECHNOL, V34, P793; 2014, NAT BIOTECHNOL, V32, P604; 2016, NAT BIOTECHNOL, V34, P12	6	3	3	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1079	1081		10.1038/nbt1116-1079	http://dx.doi.org/10.1038/nbt1116-1079			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27824842				2022-12-25	WOS:000387506500003
J	Turpin, W; Espin-Garcia, O; Xu, W; Silverberg, MS; Kevans, D; Smith, MI; Guttman, DS; Griffiths, A; Panaccione, R; Otley, A; Xu, LZ; Shestopaloff, K; Moreno-Hagelsieb, G; Paterson, AD; Croitoru, K				Turpin, Williams; Espin-Garcia, Osvaldo; Xu, Wei; Silverberg, Mark S.; Kevans, David; Smith, Michelle I.; Guttman, David S.; Griffiths, Anne; Panaccione, Remo; Otley, Anthony; Xu, Lizhen; Shestopaloff, Konstantin; Moreno-Hagelsieb, Gabriel; Paterson, Andrew D.; Croitoru, Kenneth		GEM Project Res Consortium	Association of host genome with intestinal microbial composition in a large healthy cohort	NATURE GENETICS			English	Article							GUT MICROBIOTA; WIDE ASSOCIATION; CROHNS-DISEASE; METAGENOME; GENOTYPE; IBD	Intestinal microbiota is known to be important in health and disease. Its composition is influenced by both environmental and host factors. Few large-scale studies have evaluated the association between host genetic variation and the composition of microbiota. We recruited a cohort of 1,561 healthy individuals, of whom 270 belong in 123 families, and found that almost one-third of fecal bacterial taxa were heritable. In addition, we identified 58 SNPs associated with the relative abundance of 33 taxa in 1,098 discovery subjects. Among these, four loci were replicated in a second cohort of 463 subjects: rs62171178 (nearest gene UBR3) associated with Rikenellaceae, rs1394174 (CNTN6) associated with Faecalibacterium, rs59846192 (DMRTB1) associated with Lachnospira, and rs28473221 (SALL3) associated with Eubacterium. After correction for multiple testing, 6 of the 58 associations remained significant, one of which replicated. These results identify associations between specific genetic variants and the gut microbiome.	[Turpin, Williams; Silverberg, Mark S.; Kevans, David; Smith, Michelle I.; Croitoru, Kenneth] Mt Sinai Hosp, Zane Cohen Ctr Digest Dis, Toronto, ON, Canada; [Turpin, Williams; Silverberg, Mark S.; Kevans, David; Croitoru, Kenneth] Univ Toronto, Div Gastroenterol, Dept Med, Toronto, ON, Canada; [Espin-Garcia, Osvaldo; Silverberg, Mark S.; Smith, Michelle I.; Croitoru, Kenneth] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Espin-Garcia, Osvaldo; Xu, Wei; Xu, Lizhen; Shestopaloff, Konstantin; Paterson, Andrew D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada; [Guttman, David S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada; [Griffiths, Anne] Hosp Sick Children, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Toronto, ON, Canada; [Panaccione, Remo] Univ Calgary, Div Gastroenterol & Hepatol, Inflammatory Bowel Dis Clin, Calgary, AB, Canada; [Otley, Anthony] IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Xu, Lizhen; Paterson, Andrew D.] Hosp Sick Children, Res Inst, Genet & Genome Biol, Toronto, ON, Canada; [Moreno-Hagelsieb, Gabriel] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada; [Paterson, Andrew D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Calgary; Dalhousie University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Wilfrid Laurier University; University of Toronto	Croitoru, K (corresponding author), Mt Sinai Hosp, Zane Cohen Ctr Digest Dis, Toronto, ON, Canada.; Croitoru, K (corresponding author), Univ Toronto, Div Gastroenterol, Dept Med, Toronto, ON, Canada.; Croitoru, K (corresponding author), Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.; Paterson, AD (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada.; Paterson, AD (corresponding author), Hosp Sick Children, Res Inst, Genet & Genome Biol, Toronto, ON, Canada.; Paterson, AD (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.	andrew.paterson@sickkids.ca; kcroitoru@mtsinai.on.ca	Paterson, Andrew/AAQ-7511-2020; Panaccione, Remo/ABC-1140-2021; Paterson, Andrew D/A-4088-2011; Williams, Turpin/H-3255-2019; Silverberg, Mark/B-4183-2008; Guttman, David S/A-7839-2011	Paterson, Andrew/0000-0002-9169-118X; Panaccione, Remo/0000-0002-5247-940X; Paterson, Andrew D/0000-0002-9169-118X; Williams, Turpin/0000-0001-9364-5868; Guttman, David S/0000-0001-8479-3869; Otley, Anthony/0000-0002-7371-9302; Vallance, Bruce/0000-0003-1345-6747; Jacobson, Kevan/0000-0001-7269-8557; Moreno-Hagelsieb, Gabriel/0000-0002-2457-4450; Kevans, David/0000-0002-9720-0273	Crohn's and Colitis Canada; Canadian Institutes of Health Research (CIHR) [CMF108031]; Helmsley Charitable Trust; Postdoctoral Fellowship Research Award from CIHR Fellowship/Canadian Association of Gastroenterology (CAG)/Ferring Pharmaceuticals, Inc.; Department of Medicine, Mount Sinai Hospital, Toronto; Gale and Graham Wright Chair in Digestive Diseases; CIHR/CAG/Abbvie IBD Fellowship Award; CIHR STAGE fellowship; Ontario Graduate Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Crohn's and Colitis Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Helmsley Charitable Trust; Postdoctoral Fellowship Research Award from CIHR Fellowship/Canadian Association of Gastroenterology (CAG)/Ferring Pharmaceuticals, Inc.; Department of Medicine, Mount Sinai Hospital, Toronto; Gale and Graham Wright Chair in Digestive Diseases; CIHR/CAG/Abbvie IBD Fellowship Award; CIHR STAGE fellowship; Ontario Graduate Scholarship(Ontario Graduate Scholarship); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the GEM Global Project Office, C. Bravi, D. Couchman, N. Ganeswaren, A. Keludjian, K. Ow, R. Caplan, M. Greaves, A. Craig-Neil, A. Olteanu, N. Allam, A. Garrioch, D. Ng, V. Onay, and I. Yeadon, for administrative support. We thank D. Cvitkovitch for his helpful scientific discussion of the project. All authors disclose no potential conflicts (financial, professional, or personal) that are relevant to the manuscript. This study was supported by grants from Crohn's and Colitis Canada, Canadian Institutes of Health Research (CIHR) grant CMF108031 and the Helmsley Charitable Trust. W.T. is the recipient of a Postdoctoral Fellowship Research Award from CIHR Fellowship/Canadian Association of Gastroenterology (CAG)/Ferring Pharmaceuticals, Inc., and a fellowship from the Department of Medicine, Mount Sinai Hospital, Toronto. M.S.S. is supported in part by the Gale and Graham Wright Chair in Digestive Diseases. D.K. is the recipient of a CIHR/CAG/Abbvie IBD Fellowship Award. L.X. is the recipient of a CIHR STAGE fellowship. K.S. is the recipient of an Ontario Graduate Scholarship.	Ashida H, 2014, NAT REV MICROBIOL, V12, P399, DOI 10.1038/nrmicro3259; Chang YJ, 2010, STAND GENOMIC SCI, V3, P1, DOI 10.4056/sigs.1002553; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Davenport ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140301; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kevans D, 2016, J CROHNS COLITIS, V10, P209, DOI 10.1093/ecco-jcc/jjv197; Liang CY, 2013, J BIOL CHEM, V288, P723, DOI 10.1074/jbc.M112.401323; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	24	251	263	5	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1413	1417		10.1038/ng.3693	http://dx.doi.org/10.1038/ng.3693			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27694960				2022-12-25	WOS:000386543400018
J	[Anonymous]				[Anonymous]			3D cancer cells library	NATURE BIOTECHNOLOGY			English	News Item																		2009, NATURE, V459, P262; 2015, CELL, V161, P933	2	0	0	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1086	1086		10.1038/nbt1116-1086	http://dx.doi.org/10.1038/nbt1116-1086			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27824833				2022-12-25	WOS:000387506500009
J	Lewis, AK; Dunleavy, KM; Senkow, TL; Her, C; Horn, BT; Jersett, MA; Mahling, R; McCarthy, MR; Perell, GT; Valley, CC; Karim, CB; Gao, JL; Pomerantz, WCK; Thomas, DD; Cembran, A; Hinderliter, A; Sachs, JN				Lewis, Andrew K.; Dunleavy, Katie M.; Senkow, Tiffany L.; Her, Cheng; Horn, Benjamin T.; Jersett, Mark A.; Mahling, Ryan; McCarthy, Megan R.; Perell, Gabriella T.; Valley, Christopher C.; Karim, Christine B.; Gao, Jiali; Pomerantz, William C. K.; Thomas, David D.; Cembran, Alessandro; Hinderliter, Anne; Sachs, Jonathan N.			Oxidation increases the strength of the methionine-aromatic interaction	NATURE CHEMICAL BIOLOGY			English	Article							MOLECULAR-DYNAMICS; TERMINAL METHIONINES; SALT BRIDGES; CALMODULIN; SULFUR; RESIDUES; STABILITY; ALGORITHM; PEPTIDES; PROTEINS	Oxidation of methionine disrupts the structure and function of a range of proteins, but little is understood about the chemistry that underlies these perturbations. Using quantum mechanical calculations, we found that oxidation increased the strength of the methionine-aromatic interaction motif, a driving force for protein folding and protein-protein interaction, by 0.5-1.4 kcal/mol. We found that non-hydrogen-bonded interactions between dimethyl sulfoxide (a methionine analog) and aromatic groups were enriched in both the Protein Data Bank and Cambridge Structural Database. Thermal denaturation and NMR spectroscopy experiments on model peptides demonstrated that oxidation of methionine stabilized the interaction by 0.5-0.6 kcal/mol. We confirmed the biological relevance of these findings through a combination of cell biology, electron paramagnetic resonance spectroscopy and molecular dynamics simulations on (i) calmodulin structure and dynamics, and (ii) lymphotoxin-a binding to TNFR1. Thus, the methionine-aromatic motif was a determinant of protein structural and functional sensitivity to oxidative stress.	[Lewis, Andrew K.; Senkow, Tiffany L.; Valley, Christopher C.; Sachs, Jonathan N.] Univ Minnesota Twin Cities, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Dunleavy, Katie M.; Horn, Benjamin T.; Jersett, Mark A.; Mahling, Ryan; Cembran, Alessandro; Hinderliter, Anne] Univ Minnesota, Dept Chem & Biochem, Duluth, MN 55812 USA; [Her, Cheng; McCarthy, Megan R.; Karim, Christine B.; Thomas, David D.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Perell, Gabriella T.; Gao, Jiali; Pomerantz, William C. K.] Univ Minnesota Twin Cities, Dept Chem, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sachs, JN (corresponding author), Univ Minnesota Twin Cities, Dept Biomed Engn, Minneapolis, MN 55455 USA.; Cembran, A; Hinderliter, A (corresponding author), Univ Minnesota, Dept Chem & Biochem, Duluth, MN 55812 USA.	cembran@d.umn.edu; ahinderl@d.umn.edu; jnsachs@umn.edu	Cembran, Alessandro/B-1561-2016	Cembran, Alessandro/0000-0002-9868-4994; Karim, Christine/0000-0002-7321-7695; Held, Tiffany/0000-0001-5903-8079; Thomas, David D./0000-0002-8822-2040	US National Institutes of Health (NIH) [R01 GM107175]; NIH [R37 AG26160]; US National Science Foundation (NSF)-CAREER [CHE-1352091]; NSF-CAREER [MCB-0845676]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026160, R37AG026160] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF)-CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF-CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants to J.N.S. (US National Institutes of Health (NIH) R01 GM107175), D.D.T. (NIH R37 AG26160), W.C.K.P. (US National Science Foundation (NSF)-CAREER CHE-1352091) and A.H. (NSF-CAREER MCB-0845676). This work was carried out in part using computing resources at the University of Minnesota Supercomputing Institute. EPR spectroscopy and CD experiments were performed at the Biophysical Spectroscopy Center, University of Minnesota. We thank J.F. Evans for discussion and guidance regarding the principal component analysis of our CD data.	Anbanandam A, 2005, BIOCHEMISTRY-US, V44, P9486, DOI 10.1021/bi0504963; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Arakawa T, 2007, BIOPHYS CHEM, V131, P62, DOI 10.1016/j.bpc.2007.09.004; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Balog EM, 2009, BIOCHEMISTRY-US, V48, P3005, DOI 10.1021/bi802117k; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bartlett RK, 2003, BIOCHEMISTRY-US, V42, P3231, DOI 10.1021/bi026956z; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Boschek CB, 2008, BIOCHEMISTRY-US, V47, P131, DOI 10.1021/bi701352w; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Butterfield SM, 2002, J AM CHEM SOC, V124, P9751, DOI 10.1021/ja026668q; Cramer C.J., 2013, ESSENTIALS COMPUTATI; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Etemadi N, 2013, FEBS J, V280, P5283, DOI 10.1111/febs.12419; Fealey ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046748; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gao J, 1998, BIOPHYS J, V74, P1115, DOI 10.1016/S0006-3495(98)77830-0; Gao J, 2001, BIOPHYS J, V80, P1791, DOI 10.1016/S0006-3495(01)76149-8; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Hoshi T, 2001, J PHYSIOL-LONDON, V531, P1, DOI 10.1111/j.1469-7793.2001.0001j.x; Ilardi EA, 2014, J MED CHEM, V57, P2832, DOI 10.1021/jm401375q; Jas GS, 2002, PROTEINS, V48, P257, DOI 10.1002/prot.10133; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; JIMENEZ MA, 1994, J MOL BIOL, V242, P487; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim G, 2014, BBA-GEN SUBJECTS, V1840, P901, DOI 10.1016/j.bbagen.2013.04.038; Klein JC, 2008, P NATL ACAD SCI USA, V105, P12867, DOI 10.1073/pnas.0802286105; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MORGAN RS, 1978, INT J PEPT PROT RES, V11, P209; MORGAN RS, 1980, INT J PEPT PROT RES, V15, P177; Mukherjea P, 1996, PROTEIN SCI, V5, P468; MULLIKEN RS, 1955, J CHEM PHYS, V23, P1833, DOI 10.1063/1.1740588; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pranata J, 1997, BIOORG CHEM, V25, P213, DOI 10.1006/bioo.1997.1064; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Sacksteder CA, 2006, BIOPHYS J, V91, P1480, DOI 10.1529/biophysj.106.086033; Scott J, 2002, NEW J CHEM, V26, P1822, DOI 10.1039/b204221e; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; SHECHTER Y, 1975, BIOCHEMISTRY-US, V14, P4497, DOI 10.1021/bi00691a025; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; VASQUEZ M, 1987, BIOPOLYMERS, V26, P351, DOI 10.1002/bip.360260305; VIGUERA AR, 1995, BIOCHEMISTRY-US, V34, P8771, DOI 10.1021/bi00027a028; Yin D, 2000, CHEM RES TOXICOL, V13, P103, DOI 10.1021/tx990142a; Zauhar RJ, 2000, BIOPOLYMERS, V53, P233, DOI 10.1002/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.3.CO;2-W; Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993	59	45	45	1	52	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					860	+		10.1038/NCHEMBIO.2159	http://dx.doi.org/10.1038/NCHEMBIO.2159			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27547920	Green Accepted			2022-12-25	WOS:000384248600019
J	Miyake, Y; Keusch, JJ; Wang, LL; Saito, M; Hess, D; Wang, XN; Melancon, BJ; Helquist, P; Gut, H; Matthias, P				Miyake, Yasuyuki; Keusch, Jeremy J.; Wang, Longlong; Saito, Makoto; Hess, Daniel; Wang, Xiaoning; Melancon, Bruce J.; Helquist, Paul; Gut, Heinz; Matthias, Patrick			Structural insights into HDAC6 tubulin deacetylation and its selective inhibition	NATURE CHEMICAL BIOLOGY			English	Article							2 CATALYTIC DOMAINS; HISTONE DEACETYLASE; ALPHA-TUBULIN; HDAC6-MEDIATED DEACETYLATION; TRICHOSTATIN-A; IN-VIVO; MICROTUBULE; ACETYLATION; ACETYLTRANSFERASE; AGGRESOME	We report crystal structures of zebrafish histone deacetylase 6 (HDAC6) catalytic domains in tandem or as single domains in complex with the (R) and (S) enantiomers of trichostatin A (TSA) or with the HDAC6-specific inhibitor nexturastat A. The tandem domains formed, together with the inter-domain linker, an ellipsoid-shaped complex with pseudo-twofold symmetry. We identified important active site differences between both catalytic domains and revealed the binding mode of HDAC6 selective inhibitors. HDAC inhibition assays with (R)-and (S)-TSA showed that (R)-TSA was a broad-range inhibitor, whereas (S)-TSA had moderate selectivity for HDAC6. We identified a uniquely positioned a-helix and a flexible tryptophan residue in the loop joining a-helices H20 to H21 as critical for deacetylation of the physiologic substrate tubulin. Using single-molecule measurements and biochemical assays we demonstrated that HDAC6 catalytic domain 2 deacetylated a-tubulin lysine 40 in the lumen of microtubules, but that its preferred substrate was unpolymerized tubulin.	[Miyake, Yasuyuki; Keusch, Jeremy J.; Wang, Longlong; Saito, Makoto; Hess, Daniel; Gut, Heinz; Matthias, Patrick] Friedrich Miescher Inst Biomed Res FMI, Basel, Switzerland; [Wang, Xiaoning; Melancon, Bruce J.; Helquist, Paul] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Matthias, Patrick] Univ Basel, Fac Sci, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Notre Dame; University of Basel	Matthias, P (corresponding author), Friedrich Miescher Inst Biomed Res FMI, Basel, Switzerland.; Matthias, P (corresponding author), Univ Basel, Fac Sci, Basel, Switzerland.	patrick.matthias@fmi.ch	Saito, Makoto/GLR-4232-2022; wang, xiaoning/B-9133-2015; Miyake, Yasuyuki/AAS-1504-2021	wang, xiaoning/0000-0001-7877-9964; Miyake, Yasuyuki/0000-0001-6250-0260; Saito, Makoto/0000-0001-8619-5176; Wang, Longlong/0000-0001-5279-1885	Novartis Research Foundation; Nakajima Foundation; Ara Parseghian Medical Research Foundation; National Institutes of Health [1R01NS092653]; Warren Family Center for Drug Discovery and Development; Department of Chemistry and Biochemisry; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092653] Funding Source: NIH RePORTER	Novartis Research Foundation; Nakajima Foundation; Ara Parseghian Medical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Warren Family Center for Drug Discovery and Development; Department of Chemistry and Biochemisry; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Spector and A. Roll-Mecak for sharing information about total internal reflection fluorescence microscopy experiments and discussions, S. Weiler and U. Schopf and U. Rass for helpful discussions, K. Verhey for a technical suggestion, L. Gelman for help with microscopy analysis, and D. Klein and J. Seebacher for mass spectrometry analysis to identify domain boundaries. Part of this work was performed at beamlines X10SA and X06DA of the Swiss Light Source. We thank G. Matthias, C. Cao and M. Regenass for helpful technical assistance, and O. Truee, R.G. Clerc and all the members of the Matthias laboratory for fruitful discussions. This work was supported by the Novartis Research Foundation and M. S. was also partly supported by a Fellowship from the Nakajima Foundation. Work performed at the University of Notre Dame is supported by the Ara Parseghian Medical Research Foundation, the National Institutes of Health (1R01NS092653), the Warren Family Center for Drug Discovery and Development and the Department of Chemistry and Biochemisry. X.W., B.J.M. and P.H. thank J. Zajicek and J. Pontius for NMR microscopy support and discussion.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ageta-Ishihara N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3532; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037; Bergman JA, 2012, J MED CHEM, V55, P9891, DOI 10.1021/jm301098e; BLACK MM, 1989, J NEUROSCI, V9, P358; Blanc E., 2011, BUSTER VERSION 2 11; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Carbajal A, 2013, BIOCHEM J, V449, P643, DOI 10.1042/BJ20121439; Cosner CC, 2013, EUR J ORG CHEM, V2013, P162, DOI 10.1002/ejoc.201201233; Cosner CC, 2011, ORG LETT, V13, P3564, DOI 10.1021/ol200964m; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; CUEVA JG, 2012, CURR BIOL, V22, P1066, DOI [DOI 10.1016/j.cub.2012.05.012, DOI 10.1016/J.CUB.2012.05.012]; de Zoeten EF, 2011, MOL CELL BIOL, V31, P2066, DOI 10.1128/MCB.05155-11; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kormendi V, 2012, J BIOL CHEM, V287, P41569, DOI 10.1074/jbc.C112.421222; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lawson JLD, 2013, BIOCHEM SOC T, V41, P1736, DOI 10.1042/BST20130239; Lombardi PM, 2011, CURR OPIN STRUC BIOL, V21, P735, DOI 10.1016/j.sbi.2011.08.004; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nahhas F, 2007, MOL CELL BIOCHEM, V303, P221, DOI 10.1007/s11010-007-9478-6; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; Santo L, 2012, BLOOD, V119, P2579, DOI 10.1182/blood-2011-10-387365; Scholz C, 2015, NAT BIOTECHNOL, V33, P415, DOI 10.1038/nbt.3130; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Seidel C, 2015, EPIGENOMICS-UK, V7, P103, DOI [10.2217/EPI.14.69, 10.2217/epi.14.69]; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Silvestri L, 2012, J CHEM INF MODEL, V52, P2215, DOI 10.1021/ci300160y; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; YOSHIDA M, 1990, J ANTIBIOT, V43, P1101, DOI 10.7164/antibiotics.43.1101; Yu I, 2015, J BIOL CHEM, V290, P17163, DOI 10.1074/jbc.R115.637447; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhao ZQ, 2010, PROTEIN PEPTIDE LETT, V17, P555, DOI 10.2174/092986610791112620; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813; Ziolkowska NE, 2013, METHODS MOL BIOL, V1046, P323, DOI 10.1007/978-1-62703-538-5_19; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	60	175	180	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					748	+		10.1038/nchembio.2140	http://dx.doi.org/10.1038/nchembio.2140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27454931				2022-12-25	WOS:000382255100018
J	Davies, RW; Flint, J; Myers, S; Mott, R				Davies, Robert W.; Flint, Jonathan; Myers, Simon; Mott, Richard			Rapid genotype imputation from sequence without reference panels	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; DISCOVERY; FRAMEWORK	Inexpensive genotyping methods are essential for genetic studies requiring large sample sizes. In human studies, array-based microarrays and high-density haplotype reference panels allow efficient genotype imputation for this purpose. However, these resources are typically unavailable in non-human settings. Here we describe a method ( STITCH) for imputation based only on sequencing read data, without requiring additional reference panels or array data. We demonstrate its applicability even in settings of extremely low sequencing coverage, by accurately imputing 5.7 million SNPs at a mean r(2) value of 0.98 in 2,073 outbred laboratory mice ( 0.15x sequencing coverage). In a sample of 11,670 Han Chinese ( 1.7x coverage), we achieve accuracy similar to that of alternative approaches that require a reference panel, demonstrating that our approach can work for genetically diverse populations. Our method enables straightforward progression from low-coverage sequence to imputed genotypes, overcoming barriers that at present restrict the application of genome-wide association study technology outside humans.	[Davies, Robert W.; Myers, Simon; Mott, Richard] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Flint, Jonathan] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA USA; [Myers, Simon] Univ Oxford, Dept Stat, Oxford, England; [Mott, Richard] UCL, UCL Genet Inst, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California Los Angeles; University of Oxford; University of London; University College London	Davies, RW (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	rwdavies@well.ox.ac.uk	Myers, Simon R/A-6792-2015	Myers, Simon R/0000-0002-2585-9626; Mott, Richard/0000-0002-1022-9330	Wellcome Trust [097308/Z/11/Z, WT090532/Z/09/Z, WT083573/Z/07/Z, WT089269/Z/09/Z, WT098387/Z/12/Z];  [098387/Z/12/Z]	Wellcome Trust(Wellcome TrustEuropean Commission); 	R.W.D. is supported by a grant from the Wellcome Trust (097308/Z/11/Z). S.M. is supported by Investigator Award 098387/Z/12/Z. This work was funded by the Wellcome Trust (WT090532/Z/09/Z, WT083573/Z/07/Z, WT089269/Z/09/Z and WT098387/Z/12/Z).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Didion JP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-34; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang BE, 2011, BIOINFORMATICS, V27, P727, DOI 10.1093/bioinformatics/btq719; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nicod J, 2016, NAT GENET, V48, P912, DOI 10.1038/ng.3595; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Sargolzaei M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-478; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714; VanRaden PM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0243-7; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085	27	77	81	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					965	+		10.1038/ng.3594	http://dx.doi.org/10.1038/ng.3594			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27376236	Green Submitted, Green Accepted			2022-12-25	WOS:000380755100023
J	Yano, K; Yamamoto, E; Aya, K; Takeuchi, H; Lo, PC; Hu, L; Yamasaki, M; Yoshida, S; Kitano, H; Hirano, K; Matsuoka, M				Yano, Kenji; Yamamoto, Eiji; Aya, Koichiro; Takeuchi, Hideyuki; Lo, Pei-ching; Hu, Li; Yamasaki, Masanori; Yoshida, Shinya; Kitano, Hidemi; Hirano, Ko; Matsuoka, Makoto			Genome-wide association study using whole-genome sequencing rapidly identifies new genes influencing agronomic traits in rice	NATURE GENETICS			English	Article							GRAIN-SIZE; PHOTOPERIOD SENSITIVITY; LINKAGE DISEQUILIBRIUM; NATURAL VARIATION; GREEN-REVOLUTION; COMPLEX TRAITS; MAGIC MAIZE; ARABIDOPSIS; REVEALS; SELECTION	A genome-wide association study ( GWAS) can be a powerful tool for the identification of genes associated with agronomic traits in crop species, but it is often hindered by population structure and the large extent of linkage disequilibrium. In this study, we identified agronomically important genes in rice using GWAS based on whole-genome sequencing, followed by the screening of candidate genes based on the estimated effect of nucleotide polymorphisms. Using this approach, we identified four new genes associated with agronomic traits. Some genes were undetectable by standard SNP analysis, but we detected them using gene-based association analysis. This study provides fundamental insights relevant to the rapid identification of genes associated with agronomic traits using GWAS and will accelerate future efforts aimed at crop improvement.	[Yano, Kenji; Aya, Koichiro; Takeuchi, Hideyuki; Lo, Pei-ching; Hu, Li; Kitano, Hidemi; Hirano, Ko; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi, Japan; [Yamamoto, Eiji] NARO Inst Vegetable & Tea Sci, Tsu, Mie, Japan; [Yamasaki, Masanori] Kobe Univ, Grad Sch Agr Sci, Food Resources Educ & Res Ctr, Kasai, Hyogo, Japan; [Yoshida, Shinya] Hyogo Prefectural Res Ctr Agr Forestry & Fisherie, Kasai, Hyogo, Japan	Nagoya University; Kobe University	Matsuoka, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi, Japan.; Yamamoto, E (corresponding author), NARO Inst Vegetable & Tea Sci, Tsu, Mie, Japan.	yame@affrc.go.jp; makoto@agr.nagoya-u.ac.jp	Yamasaki, Masanori/C-5193-2018	Yamasaki, Masanori/0000-0001-7759-3965; Yamamoto, Eiji/0000-0002-3095-6455; Yano, Kenji/0000-0002-2428-9748	Japan Society for the Promotion of Science [26252001]; Council for Science, Technology and Innovation (CSTI); Cross-Ministerial Strategic Innovation Promotion Program (SIP); "Technologies for Creating Next-Generation Agriculture, Forestry and Fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO);  [16J08722]; Grants-in-Aid for Scientific Research [15H04436] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science, Technology and Innovation (CSTI); Cross-Ministerial Strategic Innovation Promotion Program (SIP); "Technologies for Creating Next-Generation Agriculture, Forestry and Fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science through a Grant in Aid for Scientific Research (A) (26252001), Council for Science, Technology and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP), "Technologies for Creating Next-Generation Agriculture, Forestry and Fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO), and by Grant in Aid for JSPS Fellows Grant Number 16J08722.	Abrash EB, 2011, PLANT CELL, V23, P2864, DOI 10.1105/tpc.111.086637; Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Asano K, 2011, P NATL ACAD SCI USA, V108, P11034, DOI 10.1073/pnas.1019490108; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Chen XM, 2002, DEVELOPMENT, V129, P1085; Dell'Acqua M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0716-z; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Ebana K, 2008, BREEDING SCI, V58, P281, DOI 10.1270/jsbbs.58.281; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Ferrari R, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.06.005; Fujino K, 2010, MOL GENET GENOMICS, V284, P137, DOI 10.1007/s00438-010-0555-2; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hashimoto Z, 2004, THEOR APPL GENET, V109, P1586, DOI 10.1007/s00122-004-1794-6; Hazzouri KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9824; Holland JB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0713-2; Huang XH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7258; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2013, TRENDS GENET, V29, P225, DOI 10.1016/j.tig.2012.12.001; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ivanov DK, 2015, J GERONTOL A-BIOL, V70, P1470, DOI 10.1093/gerona/glv047; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jorgenson E, 2006, NAT REV GENET, V7, P885, DOI 10.1038/nrg1962; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Lipka AE, 2015, CURR OPIN PLANT BIOL, V24, P110, DOI 10.1016/j.pbi.2015.02.010; Ma XY, 2013, CANCER EPIDEM BIOMAR, V22, P467, DOI 10.1158/1055-9965.EPI-12-1365; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Matsubara K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00193; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayerle J, 2013, JAMA-J AM MED ASSOC, V309, P1912, DOI 10.1001/jama.2013.4350; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Ozawa K, 2012, METHODS MOL BIOL, V847, P51, DOI 10.1007/978-1-61779-558-9_5; Platt A, 2010, GENETICS, V186, P1045, DOI 10.1534/genetics.110.121665; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Ren GD, 2012, CURR BIOL, V22, P695, DOI 10.1016/j.cub.2012.02.052; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Shin J.-H., 2006, J STAT SOFTWARE, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Takahashi Y, 2011, GENES GENET SYST, V86, P175, DOI 10.1266/ggs.86.175; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Vilhjalmsson BJ, 2013, NAT REV GENET, V14, P1, DOI 10.1038/nrg3382; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Woolston C, 2014, NATURE, V514, pS49, DOI 10.1038/514S49a; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	73	331	351	33	332	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					927	+		10.1038/ng.3596	http://dx.doi.org/10.1038/ng.3596			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27322545				2022-12-25	WOS:000380755100017
J	Rodrigues, MJ; Windeisen, V; Zhang, Y; Guedez, G; Weber, S; Strohmeier, M; Hanes, JW; Royant, A; Evans, G; Sinning, I; Ealick, SE; Begley, TP; Tews, I				Rodrigues, Matthew J.; Windeisen, Volker; Zhang, Yang; Guedez, Gabriela; Weber, Stefan; Strohmeier, Marco; Hanes, Jeremiah W.; Royant, Antoine; Evans, Gwyndaf; Sinning, Irmgard; Ealick, Steven E.; Begley, Tadhg P.; Tews, Ivo			Lysine relay mechanism coordinates intermediate transfer in vitamin B6 biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							PYRIDOXAL 5'-PHOSPHATE SYNTHASE; PARASITE PLASMODIUM-FALCIPARUM; INTERSUBUNIT CROSS-TALK; PLP-SYNTHASE; MACROMOLECULAR CRYSTALLOGRAPHY; CHROMOPHORIC INTERMEDIATE; 5-PHOSPHATE SYNTHASE; STRUCTURAL INSIGHTS; PHOSPHATE SYNTHASE; BACILLUS-SUBTILIS	Substrate channeling has emerged as a common mechanism for enzymatic intermediate transfer. A conspicuous gap in knowledge concerns the use of covalent lysine imines in the transfer of carbonyl-group-containing intermediates, despite their wide use in enzymatic catalysis. Here we show how imine chemistry operates in the transfer of covalent intermediates in pyridoxal 5'-phosphate biosynthesis by the Arabidopsis thaliana enzyme Pdx1. An initial ribose 5-phosphate lysine imine is converted to the chromophoric I-320 intermediate, simultaneously bound to two lysine residues and partially vacating the active site, which creates space for glyceraldehyde 3-phosphate to bind. Crystal structures show how substrate binding, catalysis and shuttling are coupled to conformational changes around strand beta(6) of the Pdx1 (beta alpha)(8)-barrel. The dual-specificity active site and imine relay mechanism for migration of carbonyl intermediates provide elegant solutions to the challenge of coordinating a complex sequence of reactions that follow a path of over 20 angstrom between substrate- and product-binding sites.	[Rodrigues, Matthew J.; Windeisen, Volker; Tews, Ivo] Univ Southampton, Biol Sci, Southampton, Hants, England; [Rodrigues, Matthew J.; Evans, Gwyndaf] Diamond Light Source, Harwell Sci & Innovat Campus, Harwell, Berks, England; [Windeisen, Volker; Guedez, Gabriela; Weber, Stefan; Strohmeier, Marco; Sinning, Irmgard; Tews, Ivo] Heidelberg Univ Biochem Ctr BZH, Heidelberg, Germany; [Zhang, Yang; Hanes, Jeremiah W.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Hanes, Jeremiah W.] Pacific Biosci, Menlo Pk, CA USA; [Royant, Antoine] Univ Grenoble Alpes, CNRS, Inst Biol Struct, CEA, Grenoble, France; [Royant, Antoine] European Synchrotron Radiat Facil, Grenoble, France; [Begley, Tadhg P.] Texas A&M Univ, Dept Chem, College Stn, TX USA	University of Southampton; Diamond Light Source; Ruprecht Karls University Heidelberg; Cornell University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF); Texas A&M University System; Texas A&M University College Station	Tews, I (corresponding author), Univ Southampton, Biol Sci, Southampton, Hants, England.; Tews, I (corresponding author), Heidelberg Univ Biochem Ctr BZH, Heidelberg, Germany.	ivo.tews@soton.ac.uk	Tews, Ivo/A-2750-2010; Evans, Gwyndaf/R-5524-2016; Rodrigues, Matthew/ABB-7514-2021; Royant, Antoine/G-3684-2012; Guédez, Gabriela/O-2180-2019	Tews, Ivo/0000-0002-4704-1139; Evans, Gwyndaf/0000-0002-6079-2201; Royant, Antoine/0000-0002-1919-8649; Guédez, Gabriela/0000-0002-3711-8470; Rodrigues, Matthew/0000-0003-1243-903X	European Commission [VITBIOMAL-012158]; Deutsche Forschungsgemeinschaft (DFG) [TE368]; NIH [DK44083]; Robert A. Welch Foundation [A-0034]; ESRF [Mx1461, Mx1732]; RADDAM; Diamond Light Source [Mx8891]; University of Southampton; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044083, R37DK044083] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); ESRF; RADDAM; Diamond Light Source; University of Southampton; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W.J. Anderson, H. Clarke, C. Phippen (Southampton), A. Wessling and N. Kwak (Heidelberg), for their experimental contributions; T. Fitzpatrick (Geneva, Switzerland) for the generous gift of the expression plasmid for Arabidopsis Pdx1.3; S. Findlow and C. Holes at the Macromolecular Crystallisation Facility, Centre for Biological Sciences, and P. Horton and S. Coles at the Southampton Diffraction Centre, Chemistry, both University of Southampton; J. Kopp and C. Siegmann from the crystallization platform of the Cluster of Excellence CellNetworks, Heidelberg; staff at the Diamond Light Source and the European Synchrotron Radiation Facility for access and excellent user support without which this project would not have been possible; P. Carpentier, M. Weik, G. Gotthard and D. von Stetten at ESRF for support during data collection and online spectroscopy and D. Flot and G. Leonard for flexible access to the ESRF beamlines; A. Douangamath, P. Aller, R. Owen and M. Walsh for support at Diamond beamlines; B. Kappes (Erlangen) and P. Macheroux (Graz) for critical discussions; and L. Kinsland for assistance in preparation of the manuscript. This work was supported in parts by grants by the European Commission (VITBIOMAL-012158) and by the Deutsche Forschungsgemeinschaft (DFG) (TE368) to I. T., by the NIH (DK44083) and by the Robert A. Welch Foundation (A-0034) to T.P.B., by ESRF Mx1461, Mx1732, RADDAM and Diamond Light Source Mx8891 to I.T. M.J.R. was supported by a joint studentship between Diamond Light Source and the University of Southampton.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Borshchevskiy V, 2014, ACTA CRYSTALLOGR D, V70, P2675, DOI 10.1107/S1399004714017295; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Das S, 1997, NATURE, V385, P29, DOI 10.1038/385029a0; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; Derrer B, 2010, FEBS LETT, V584, P4169, DOI 10.1016/j.febslet.2010.09.013; Dubnovitsky AP, 2005, PROTEIN SCI, V14, P1498, DOI 10.1110/ps.051397905; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Foadi J, 2013, ACTA CRYSTALLOGR D, V69, P1617, DOI 10.1107/S0907444913012274; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Gildea RJ, 2014, ACTA CRYSTALLOGR D, V70, P2652, DOI 10.1107/S1399004714017039; Guedez G, 2012, STRUCTURE, V20, P172, DOI 10.1016/j.str.2011.11.015; Hanes JW, 2008, NAT CHEM BIOL, V4, P425, DOI 10.1038/nchembio.93; Hanes JW, 2008, J AM CHEM SOC, V130, P3043, DOI 10.1021/ja076604l; Hanes JW, 2008, ANGEW CHEM INT EDIT, V47, P2102, DOI 10.1002/anie.200704390; Ho MC, 2009, NATURE, V459, P393, DOI 10.1038/nature07938; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; McCarthy AA, 2009, J SYNCHROTRON RADIAT, V16, P803, DOI 10.1107/S0909049509035377; McGeehan J, 2009, J SYNCHROTRON RADIAT, V16, P163, DOI 10.1107/S0909049509001629; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P1; Moccand C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016042; Mooney S, 2010, PHYTOCHEMISTRY, V71, P495, DOI 10.1016/j.phytochem.2009.12.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Neuwirth M, 2009, FEBS LETT, V583, P2179, DOI 10.1016/j.febslet.2009.06.009; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; PARES S, 1994, P NATL ACAD SCI USA, V91, P4850, DOI 10.1073/pnas.91.11.4850; Pearson AR, 2009, BIOCHEM SOC T, V37, P378, DOI 10.1042/BST0370378; Percudani R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-273; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Raschle T, 2007, J BIOL CHEM, V282, P6098, DOI 10.1074/jbc.M610614200; Raschle T, 2009, J BIOL CHEM, V284, P7706, DOI 10.1074/jbc.M804728200; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Reeksting SB, 2013, BIOCHEM J, V449, P175, DOI 10.1042/BJ20120925; Robinson GC, 2016, P NATL ACAD SCI USA, V113, pE5821, DOI 10.1073/pnas.1608125113; Smith AM, 2015, J BIOL CHEM, V290, P5226, DOI 10.1074/jbc.M114.626382; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; von Stetten D, 2015, ACTA CRYSTALLOGR D, V71, P15, DOI 10.1107/S139900471401517X; Wakatsuki S, 1998, J SYNCHROTRON RADIAT, V5, P215, DOI 10.1107/S0909049597018785; Wallner S, 2009, BIOCHEMISTRY-US, V48, P1928, DOI 10.1021/bi801887r; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu N, 2001, J AM CHEM SOC, V123, P6465, DOI 10.1021/ja010219t; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y; Zeldin OB, 2013, J APPL CRYSTALLOGR, V46, P1225, DOI 10.1107/S0021889813011461; Zeldin OB, 2013, J SYNCHROTRON RADIAT, V20, P49, DOI 10.1107/S0909049512044706; ZHANG XF, 2010, 2 INT C E BUS INF SY, V1, P1, DOI DOI 10.3969/J.ISSN.1009-7937.2010.01.009; Zhu JH, 2005, J BIOL CHEM, V280, P27914, DOI 10.1074/jbc.M503642200	58	13	13	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2017	13	3					290	+		10.1038/NCHEMBIO.2273	http://dx.doi.org/10.1038/NCHEMBIO.2273			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL2DY	28092359	Green Submitted, Green Accepted			2022-12-25	WOS:000394431500011
J	Oller, J; Mendez-Barbero, N; Ruiz, EJ; Villahoz, S; Renard, M; Canelas, LI; Briones, AM; Alberca, R; Lozano-Vidal, N; Hurle, MA; Milewicz, D; Evangelista, A; Salaices, M; Nistal, JF; Jimenez-Borreguero, LJ; De Backer, J; Campanero, MR; Redondo, JM				Oller, Jorge; Mendez-Barbero, Nerea; Josue Ruiz, E.; Villahoz, Silvia; Renard, Marjolijn; Canelas, Lizet I.; Briones, Ana M.; Alberca, Rut; Lozano-Vidal, Noelia; Hurle, Maria A.; Milewicz, Dianna; Evangelista, Arturo; Salaices, Mercedes; Nistal, J. Francisco; Jesus Jimenez-Borreguero, Luis; De Backer, Julie; Campanero, Miguel R.; Miguel Redondo, Juan			Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome	NATURE MEDICINE			English	Article							ANGIOTENSIN-II; ANEURYSM FORMATION; INFLAMMATORY ANEURYSM; THORACIC AORTA; IN-VIVO; SYNTHASE; EXPRESSION; DISSECTIONS; DISINTEGRIN; PROGRESSION	Heritable thoracic aortic aneurysms and dissections (TAAD), including Marfan syndrome (MFS), currently lack a cure, and causative mutations have been identified for only a fraction of affected families. Here we identify the metalloproteinase ADAMTS1 and inducible nitric oxide synthase (NOS2) as therapeutic targets in individuals with TAAD. We show that Adamts1 is a major mediator of vascular homeostasis, given that genetic haploinsufficiency of Adamts1 in mice causes TAAD similar to MFS. Aortic nitric oxide and Nos2 levels were higher in Adamts1-deficient mice and in a mouse model of MFS (hereafter referred to as MFS mice), and Nos2 inactivation protected both types of mice from aortic pathology. Pharmacological inhibition of Nos2 rapidly reversed aortic dilation and medial degeneration in young Adamts1-deficient mice and in young or old MFS mice. Patients with MFS showed elevated NOS2 and decreased ADAMTS1 protein levels in the aorta. These findings uncover a possible causative role for the ADAMTS1 NOS2 axis in human TAAD and warrant evaluation of NOS2 inhibitors for therapy.	[Oller, Jorge; Mendez-Barbero, Nerea; Josue Ruiz, E.; Villahoz, Silvia; Canelas, Lizet I.; Alberca, Rut; Lozano-Vidal, Noelia; Miguel Redondo, Juan] CNIC, Gene Regulat Cardiovasc Remodeling & Inflammat Gr, Madrid, Spain; [Renard, Marjolijn] Ghent Univ Hosp, Ctr Med Genet Ghent, Ghent, Belgium; [Briones, Ana M.; Salaices, Mercedes; De Backer, Julie] Univ Autonoma Madrid, Dept Pharmacol, Fac Med, Madrid, Spain; [Hurle, Maria A.; Nistal, J. Francisco] Univ Cantabria, Hosp Univ Marques de Valdecilla, IDIVAL, Cardiovasc Surg,Fac Med, Santander, Spain; [Hurle, Maria A.; Nistal, J. Francisco] Univ Cantabria, Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med,Dept Physiol & Pharmacol, Santander, Spain; [Milewicz, Dianna] Univ Texas Houston, Div Med Genet, Houston, TX USA; [Evangelista, Arturo] Hosp Valle De Hebron, Serv Cardiol, Barcelona, Spain; [Jesus Jimenez-Borreguero, Luis] Ctr Nacl Invest Cardiovasc, Madrid, Spain; [Jesus Jimenez-Borreguero, Luis] Hosp la Princesa, Madrid, Spain; [Campanero, Miguel R.] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Canc Biol, Madrid, Spain; [Miguel Redondo, Juan] Ctr Invest Biomed RED Enfermedades Cardiovasc CIB, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Ghent University; Ghent University Hospital; Autonomous University of Madrid; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; University of Texas System; University of Texas Health Science Center Houston; Hospital Universitari Vall d'Hebron; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital de La Princesa; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Redondo, JM (corresponding author), CNIC, Gene Regulat Cardiovasc Remodeling & Inflammat Gr, Madrid, Spain.; Campanero, MR (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Canc Biol, Madrid, Spain.; Redondo, JM (corresponding author), Ctr Invest Biomed RED Enfermedades Cardiovasc CIB, Madrid, Spain.	mcampanero@iib.uam.es; jmredondo@cnic.es	Redondo, Juan Miguel/H-6351-2015; De Backer, Julie/B-2897-2014; Mendez-Barbero, Nerea/AAV-4643-2020; Campanero, Miguel R/A-4052-2013; Jimenez-Borreguero, Luis Jesus/L-8107-2014	Redondo, Juan Miguel/0000-0001-5779-9122; De Backer, Julie/0000-0001-8878-1507; Mendez-Barbero, Nerea/0000-0003-1620-3067; Campanero, Miguel R/0000-0003-1410-8621; Briones, Ana/0000-0001-8218-5579; Salaices Sanchez, Mercedes/0000-0003-3323-1692; Lozano-Vidal, Noelia/0000-0003-4115-0227; Jimenez-Borreguero, Luis Jesus/0000-0001-5870-237X; Oller Pedrosa, Jorge/0000-0002-2224-2954; Hurle, Maria Amor/0000-0002-7710-1358	Spanish Ministerio de Economia, Industria y Competitividad (MINECO); Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO award) [SEV-2015-0505]; MINECO [SAF2013-45258P, SAF2012-34296, SAF2015-636333R]; Fundacion La Marato (TV3 grant) [20151331, 20151330]; CSIC; CIBERCV of Ministerio de Sanidad [B16/11/00264]; Red de Investigacion Cardiovascular (RIC) of Ministerio de Sanidad [RD12/0042/0022, RD12/0042/0021, RD12/0042/0024, RD12/0042/0056, RD12/0042/0018]; Marie Sklodowska-Curie fellowship; FPI fellowships [BES 2010-034552, SVP-2013-067777]	Spanish Ministerio de Economia, Industria y Competitividad (MINECO)(Spanish Government); Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO award)(Spanish Government); MINECO(Spanish Government); Fundacion La Marato (TV3 grant); CSIC; CIBERCV of Ministerio de Sanidad; Red de Investigacion Cardiovascular (RIC) of Ministerio de Sanidad; Marie Sklodowska-Curie fellowship; FPI fellowships	We thank B. Ibanez and G. Egea for reagents, S. Bartlett for English language editing, A.G. Arroyo, S. Lamas, J. Alegre-Cebollada and J. Ruiz-Cabello for critical reading of the manuscript and advice, and S. Pocock and J. Vazquez for advice on statistics. We also thank the CNIC histology facility, C. Velasco, A.V. Alonso and L. Flores for technical support. CNIC is supported by the Spanish Ministerio de Economia, Industria y Competitividad (MINECO) and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). Support was also provided by grants from MINECO (grants SAF2013-45258P (M.R.C.), SAF2012-34296 (J.M.R.) and SAF2015-636333R (J.M.R.)), Fundacion La Marato (TV3 grants 20151331 (J.M.R.) and 20151330 (A.E.)), CSIC (M.R.C.), the CIBERCV of Ministerio de Sanidad (grant CB16/11/00264; J.M.R.) and the Red de Investigacion Cardiovascular (RIC) of Ministerio de Sanidad (grants RD12/0042/0022 (J.M.R.), RD12/0042/0021 (A.E.), RD12/0042/0024 (KS.), RD12/0042/0056 (J.L.J.-B.) and RD12/0042/0018 (J.F.N.)), and by a Marie Sklodowska-Curie fellowship (E.J.R.) and FPI fellowships BES 2010-034552 (J.O.) and SVP-2013-067777 (S.V.). The cost of this publication has been paid in part with FEDER funds.	Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; Biddinger A, 1997, J VASC SURG, V25, P506, DOI 10.1016/S0741-5214(97)70261-1; Chen XF, 2013, CURR OPIN PHARMACOL, V13, P180, DOI 10.1016/j.coph.2013.01.002; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Cook JR, 2015, ARTERIOSCL THROM VAS, V35, P911, DOI 10.1161/ATVBAHA.114.305150; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; De Backer J, 2015, CURR PHARM DESIGN, V21, P4061, DOI 10.2174/1381612821666150826093152; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; Escolano A, 2014, EMBO J, V33, P1117, DOI 10.1002/embj.201386369; Esteban V, 2011, J EXP MED, V208, P2125, DOI 10.1084/jem.20110503; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forteza A, 2016, EUR HEART J, V37, P978, DOI 10.1093/eurheartj/ehv575; Fukuda S, 2000, CIRCULATION, V101, P2532, DOI 10.1161/01.CIR.101.21.2532; Gahllo EM, 2014, J CLIN INVEST, V124, P448, DOI 10.1172/JCI69666; Gao YX, 2016, SCI CHINA LIFE SCI, V59, P59, DOI 10.1007/s11427-015-4959-4; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gillis E, 2013, CIRC RES, V113, P327, DOI 10.1161/CIRCRESAHA.113.300675; Girardi LN, 1997, ANN THORAC SURG, V64, P251, DOI 10.1016/S0003-4975(97)00458-X; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hubmacher D, 2011, CELL MOL LIFE SCI, V68, P3137, DOI 10.1007/s00018-011-0780-9; Johanning JM, 2002, ANN VASC SURG, V16, P65, DOI 10.1007/s10016-001-0139-z; Johanning JM, 2001, J VASC SURG, V33, P579, DOI 10.1067/mva.2001.111805; Karimi A, 2016, CAN J CARDIOL, V32, P26, DOI 10.1016/j.cjca.2015.11.004; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Lacro RV, 2014, NEW ENGL J MED, V371, P2061, DOI 10.1056/NEJMoa1404731; Le Goff C, 2011, HUM MOL GENET, V20, pR163, DOI 10.1093/hmg/ddr361; Lee JK, 2001, ARTERIOSCL THROM VAS, V21, P1393, DOI 10.1161/hq0901.095750; Lee NV, 2005, J BIOL CHEM, V280, P34796, DOI 10.1074/jbc.M506980200; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; Mendez-Barbero N, 2013, EMBO MOL MED, V5, P1901, DOI 10.1002/emmm.201302842; Milleron O, 2015, EUR HEART J, V36, P2160, DOI 10.1093/eurheartj/ehv151; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; O'Sullivan S, 2014, BBA-MOL CELL RES, V1843, P603, DOI 10.1016/j.bbamcr.2013.12.006; Oller J, 2015, MOL CELL BIOL, V35, P3409, DOI 10.1128/MCB.00494-15; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pfeilschifter J, 2001, PFLUG ARCH EUR J PHY, V442, P479, DOI 10.1007/s004240100586; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; Ren PP, 2013, ANN THORAC SURG, V95, P570, DOI 10.1016/j.athoracsur.2012.10.084; Renard M, 2013, INT J CARDIOL, V165, P314, DOI 10.1016/j.ijcard.2011.08.079; Roth M, 2002, J THORAC CARDIOV SUR, V123, P822, DOI 10.1067/mtc.2002.121291; Sadamasa N, 2003, STROKE, V34, P2980, DOI 10.1161/01.STR.0000102556.55600.3B; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Segura A. M., CIRCULATION, V98, P11331; Segura AM, 1998, CIRCULATION, V98, pII331; Shindo T, 2000, J CLIN INVEST, V105, P1345, DOI 10.1172/JCI8635; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; Tang CH, 2007, J BIOL CHEM, V282, P25406, DOI 10.1074/jbc.M701001200; Thai SNM, 2002, MECH DEVELOP, V115, P181, DOI 10.1016/S0925-4773(02)00115-6; Van Doren SR, 2015, MATRIX BIOL, V44-46, P224, DOI 10.1016/j.matbio.2015.01.005; Wu ZY, 2016, AM J TRANSL RES, V8, P1426; Zhang J, 2003, J VASC SURG, V38, P360, DOI 10.1016/S0741-5214(03)00148-4	58	92	93	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					200	212		10.1038/nm.4266	http://dx.doi.org/10.1038/nm.4266			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28067899	Green Submitted			2022-12-25	WOS:000393729000012
J	Dunford, A; Weinstock, DM; Savova, V; Schumacher, SE; Cleary, JP; Yoda, A; Sullivan, TJ; Hess, JM; Gimelbrant, AA; Beroukhim, R; Lawrence, MS; Getz, G; Lane, AA				Dunford, Andrew; Weinstock, David M.; Savova, Virginia; Schumacher, Steven E.; Cleary, John P.; Yoda, Akinori; Sullivan, Timothy J.; Hess, Julian M.; Gimelbrant, Alexander A.; Beroukhim, Rameen; Lawrence, Michael S.; Getz, Gad; Lane, Andrew A.			Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; H3K27ME3 DEMETHYLASE UTX; CHROMOSOME INACTIVATION; Y-CHROMOSOME; SOMATIC MUTATIONS; MOSAIC LOSS; EXPRESSION; DISPARITIES; DISORDERS; EVOLUTION	There is a striking and unexplained male predominance across many cancer types. A subset of X-chromosome genes can escape X-inactivation, which would protect females from complete functional loss by a single mutation. To identify putative 'escape from X-inactivation tumor-suppressor' (EXITS) genes, we examined somatic alterations from >4,100 cancers across 21 tumor types for sex bias. Six of 783 non-pseudoautosomal region (PAR) X-chromosome genes (ATRX, CNKSR2, DDX3X, KDM5C, KDM6A, and MAGEC3) harbored loss-of-function mutations more frequently in males (based on a false discovery rate < 0.1), in comparison to zero of 18,055 autosomal and PAR genes (Fisher's exact P < 0.0001). Male-biased mutations in genes that escape X-inactivation were observed in combined analysis across many cancers and in several individual tumor types, suggesting a generalized phenomenon. We conclude that biallelic expression of EXITS genes in females explains a portion of the reduced cancer incidence in females as compared to males across a variety of tumor types.	[Dunford, Andrew; Weinstock, David M.; Schumacher, Steven E.; Sullivan, Timothy J.; Hess, Julian M.; Gimelbrant, Alexander A.; Beroukhim, Rameen; Getz, Gad; Lane, Andrew A.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Weinstock, David M.; Cleary, John P.; Yoda, Akinori; Beroukhim, Rameen; Lane, Andrew A.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Savova, Virginia; Schumacher, Steven E.; Gimelbrant, Alexander A.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Savova, Virginia; Gimelbrant, Alexander A.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Lawrence, Michael S.; Getz, Gad] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA; [Lawrence, Michael S.; Getz, Gad] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lane, AA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA USA.; Lane, AA (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	andrew_lane@dfci.harvard.edu	Lawrence, Michael/AAC-8202-2020	Gimelbrant, Alexander/0000-0001-6986-0285; Lane, Andrew/0000-0001-7380-0226	National Cancer Institute [K08CA181340]; American Society of Hematology Scholar Award; V Foundation Scholar Award; Stand Up to Cancer Innovative Research Grant; NATIONAL CANCER INSTITUTE [K08CA181340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114864] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Hematology Scholar Award; V Foundation Scholar Award; Stand Up to Cancer Innovative Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank C. Sievers and B. Bernstein for helpful discussions, Z. Herbert and the Molecular Biology Core Facilities at the Dana-Farber Cancer Institute for assistance with RNA-seq, and T. Golub for facilitating the project. This work was supported by National Cancer Institute grant K08CA181340 (A.A.L.), an American Society of Hematology Scholar Award (A.A.L.), and a V Foundation Scholar Award (A.A.L.). G.G. is the Paul C. Zamecnik, MD, Chair in Oncology at Massachusetts General Hospital. D.M.W. is a Leukemia and Lymphoma Society Scholar and is supported by a Stand Up to Cancer Innovative Research Grant.	Al Nadaf S, 2012, CHROMOSOMA, V121, P71, DOI 10.1007/s00412-011-0343-8; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Berletch JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005079; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chaligne R, 2015, GENOME RES, V25, P488, DOI 10.1101/gr.185926.114; Chaligne R, 2014, FEBS LETT, V588, P2514, DOI 10.1016/j.febslet.2014.06.023; Cook MB, 2009, CANCER EPIDEM BIOMAR, V18, P1174, DOI 10.1158/1055-9965.EPI-08-1118; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Cotton AM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r122; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dubrow R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-325; Duijf PHG, 2013, INT J CANCER, V132, P2316, DOI 10.1002/ijc.27924; Dumanski JP, 2015, SCIENCE, V347, P81, DOI 10.1126/science.1262092; Edgren G, 2012, EUR J EPIDEMIOL, V27, P187, DOI 10.1007/s10654-011-9647-5; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jiang L, 2015, NAT GENET, V47, P1061, DOI 10.1038/ng.3358; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Miyake N, 2013, AM J MED GENET A, V161, P2234, DOI 10.1002/ajmg.a.36072; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pinto EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7302; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sayres MAW, 2013, MOL BIOL EVOL, V30, P781, DOI 10.1093/molbev/mss267; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Veiga LCS, 2012, BRAZ J MED BIOL RES, V45, P172, DOI 10.1590/S0100-879X2012007500004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talebizadeh Z, 2006, GENOMICS, V88, P675, DOI 10.1016/j.ygeno.2006.07.016; Vaags AK, 2014, ANN NEUROL, V76, P758, DOI 10.1002/ana.24274; Van der Meulen J, 2015, BLOOD, V125, P13, DOI 10.1182/blood-2014-05-577270; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Wu H, 2014, NEURON, V81, P103, DOI 10.1016/j.neuron.2013.10.051; Yang C, 2011, HUM GENET, V130, P175, DOI 10.1007/s00439-011-0994-9; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang LJ, 2007, CHINESE MED J-PEKING, V120, P2002, DOI 10.1097/00029330-200711020-00012	49	181	183	4	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					10	16		10.1038/ng.3726	http://dx.doi.org/10.1038/ng.3726			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27869828	Green Submitted, Green Accepted			2022-12-25	WOS:000390976600006
J	Jarchum, I				Jarchum, Irene			Photosynthesis gets a boost	NATURE BIOTECHNOLOGY			English	Editorial Material														Jarchum, Irene/0000-0002-5453-0299				Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878	1	0	1	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					30	30		10.1038/nbt.3764	http://dx.doi.org/10.1038/nbt.3764			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	28072773	Bronze			2022-12-25	WOS:000392460800018
J	Piraner, DI; Abedi, MH; Moser, BA; Lee-Gosselin, A; Shapiro, MG				Piraner, Dan I.; Abedi, Mohamad H.; Moser, Brittany A.; Lee-Gosselin, Audrey; Shapiro, Mikhail G.			Tunable thermal bioswitches for in vivo control of microbial therapeutics	NATURE CHEMICAL BIOLOGY			English	Article							LACTIC-ACID BACTERIA; ESCHERICHIA-COLI; GENE-EXPRESSION; RECOMBINANT PROTEINS; FOCUSED ULTRASOUND; TET REPRESSOR; TISSUE-DAMAGE; E. COLI; TEMPERATURE; MICROORGANISMS	Temperature is a unique input signal that could be used by engineered microbial therapeutics to sense and respond to host conditions or spatially targeted external triggers such as focused ultrasound. To enable these possibilities, we present two families of tunable, orthogonal, temperature-dependent transcriptional repressors providing switch-like control of bacterial " gene expression at thresholds spanning the biomedically relevant range of 32-46 degrees C. We integrate these molecular bioswitches into thermal logic circuits and demonstrate their utility in three in vivo microbial therapy scenarios, including spatially precise activation using focused ultrasound, modulation of activity in response to a host fever, and self-destruction after fecal elimination to prevent environmental escape. This technology provides a critical capability for coupling endogenous or applied thermal signals to cellular function in basic research, biomedical and industrial applications.	[Piraner, Dan I.; Abedi, Mohamad H.; Moser, Brittany A.; Lee-Gosselin, Audrey; Shapiro, Mikhail G.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Piraner, Dan I.; Abedi, Mohamad H.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Shapiro, MG (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	mikhail@caltech.edu		Shapiro, Mikhail/0000-0002-0291-4215; Moser, Brittany/0000-0001-8720-5989; Piraner, Dan/0000-0003-3857-9487; Abedi, Mohamad/0000-0001-9717-6288	NIH [T32GM007616]; NSF; Paul and Daisy Soros Fellowship for New Americans; DARPA Young Faculty Award [D14AP00050]; Weston Havens Foundation; Burroughs Wellcome Career Award at the Scientific Interface; Heritage Medical Research Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Paul and Daisy Soros Fellowship for New Americans; DARPA Young Faculty Award; Weston Havens Foundation; Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); Heritage Medical Research Institute	The authors thank J. Szablowski for assistance with focused ultrasound, A. Mukherjee, J. Bois and A. Gluhovsky for helpful discussions, and S. Zemsky, R. Rezvani, Y. Rang and G. Ha for experimental assistance. DIP. was supported by the NIH fellowship for Predoctoral Training in Biology and Chemistry (T32GM007616). M.H.A. was supported by an NSF graduate research fellowship and the Paul and Daisy Soros Fellowship for New Americans. This work was supported by a DARPA Young Faculty Award (D14AP00050), the Weston Havens Foundation, a Burroughs Wellcome Career Award at the Scientific Interface and the Heritage Medical Research Institute (M.G.S.).	Al-Bataineh O, 2012, CANCER TREAT REV, V38, P346, DOI 10.1016/j.ctrv.2011.08.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Archer EJ, 2012, ACS SYNTH BIOL, V1, P451, DOI 10.1021/sb3000595; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; Chan CTY, 2016, NAT CHEM BIOL, V12, P82, DOI [10.1038/NCHEMBIO.1979, 10.1038/nchembio.1979]; Chao YP, 2002, BIOTECHNOL BIOENG, V79, P1, DOI 10.1002/bit.10304; Claesen J, 2015, ACS SYNTH BIOL, V4, P358, DOI 10.1021/sb500258b; Courbet A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3601; Daniel C, 2011, TRENDS BIOTECHNOL, V29, P499, DOI 10.1016/j.tibtech.2011.05.002; Danino T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3519; de Marco A, 2005, CELL STRESS CHAPERON, V10, P329, DOI 10.1379/CSC-139R.1; Deckers R, 2009, P NATL ACAD SCI USA, V106, P1175, DOI 10.1073/pnas.0806936106; Elias WJ, 2013, NEW ENGL J MED, V369, P640, DOI 10.1056/NEJMoa1300962; Inda ME, 2014, P NATL ACAD SCI USA, V111, P3579, DOI 10.1073/pnas.1317147111; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Fite BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035509; Ford TJ, 2015, CURR OPIN CHEM BIOL, V28, P20, DOI 10.1016/j.cbpa.2015.05.012; Gallagher RR, 2015, NUCLEIC ACIDS RES, V43, P1945, DOI 10.1093/nar/gku1378; Grammel M, 2013, NAT CHEM BIOL, V9, P475, DOI 10.1038/nchembio.1296; Handley A, 2015, MOL CELL, V58, P621, DOI 10.1016/j.molcel.2015.04.024; Hoynes-O'Connor A, 2015, NUCLEIC ACIDS RES, V43, P6166, DOI 10.1093/nar/gkv499; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Hurme R, 1996, J BIOL CHEM, V271, P12626, DOI 10.1074/jbc.271.21.12626; Hurme R, 1997, CELL, V90, P55, DOI 10.1016/S0092-8674(00)80313-X; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; JENSEN PR, 1993, EUR J BIOCHEM, V211, P181, DOI 10.1111/j.1432-1033.1993.tb19885.x; Kortmann J, 2011, NUCLEIC ACIDS RES, V39, P2855, DOI 10.1093/nar/gkq1252; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; McCabe KM, 2011, APPL ENVIRON MICROB, V77, P2863, DOI 10.1128/AEM.01915-10; McDannold N, 2004, MAGN RESON MED, V51, P913, DOI 10.1002/mrm.20060; McDannold NJ, 2000, RADIOLOGY, V216, P517, DOI 10.1148/radiology.216.2.r00au42517; Mimee M, 2015, CELL SYST, V1, P62, DOI 10.1016/j.cels.2015.06.001; NATORI Y, 1988, BIOCHIMIE, V70, P1765, DOI 10.1016/0300-9084(88)90036-3; Neupert J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn545; Nistala Goutam J, 2010, J Biol Eng, V4, P4, DOI 10.1186/1754-1611-4-4; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Pritchard MT, 2004, METHODS, V32, P54, DOI 10.1016/S1046-2023(03)00187-7; Rudaya AY, 2005, AM J PHYSIOL-REG I, V289, pR1244, DOI 10.1152/ajpregu.00370.2005; Satija R., 2015, DESIGN TOOLBOX RNA T; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Sussman R., 1962, CR HEBD ACAD SCI, V24, P1517; Ter Haar G, 2007, INT J HYPERTHER, V23, P89, DOI 10.1080/02656730601186138; Tey SK, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.11; Thiesen B, 2008, INT J HYPERTHER, V24, P467, DOI 10.1080/02656730802104757; Valdez-Cruz NA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-18; Waldminghaus T, 2008, BIOL CHEM, V389, P1319, DOI 10.1515/BC.2008.150; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Wilson CJ, 2007, CELL MOL LIFE SCI, V64, P3, DOI 10.1007/s00018-006-6296-z; WISSMANN A, 1991, GENETICS, V128, P225; Zhao K, 2005, J BIOL CHEM, V280, P17758, DOI 10.1074/jbc.M500393200	53	104	106	7	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					75	80		10.1038/NCHEMBIO.2233	http://dx.doi.org/10.1038/NCHEMBIO.2233			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27842069				2022-12-25	WOS:000393267200016
J	Hayer, A; Shao, L; Chung, MY; Joubert, LM; Yang, HW; Tsai, FC; Bisaria, A; Betzig, E; Meyer, T				Hayer, Arnold; Shao, Lin; Chung, Mingyu; Joubert, Lydia-Marie; Yang, Hee Won; Tsai, Feng-Chiao; Bisaria, Anjali; Betzig, Eric; Meyer, Tobias			Engulfed cadherin fingers are polarized junctional structures between collectively migrating endothelial cells	NATURE CELL BIOLOGY			English	Article							VE-CADHERIN; MYOSIN-II; ACTIN POLYMERIZATION; F-ACTIN; LAMELLIPODIA; PROTEINS; DYNAMICS; RHOA; CA2+; ACTIVATION	The development and maintenance of tissues requires collective cell movement, during which neighbouring cells coordinate the polarity of their migration machineries. Here, we ask how polarity signals are transmitted from one cell to another across symmetrical cadherin junctions, during collective migration. We demonstrate that collectively migrating endothelial cells have polarized VE-cadherin-rich membrane protrusions, 'cadherin fingers', which leading cells extend from their rear and follower cells engulf at their front, thereby generating opposite membrane curvatures and asymmetric recruitment of curvature-sensing proteins. In follower cells, engulfment of cadherin fingers occurs along with the formation of a lamellipodia-like zone with low actomyosin contractility, and requires VE-cadherin/catenin complexes and Arp2/3-driven actin polymerization. Lateral accumulation of cadherin fingers in follower cells precedes turning, and increased actomyosin contractility can initiate cadherin finger extension as well as engulfment by a neighbouring cell, to promote follower behaviour. We propose that cadherin fingers serve as guidance cues that direct collective cell migration.	[Hayer, Arnold; Chung, Mingyu; Yang, Hee Won; Tsai, Feng-Chiao; Bisaria, Anjali; Meyer, Tobias] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Shao, Lin; Betzig, Eric] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Joubert, Lydia-Marie] Stanford Univ, Sch Med, Cell Sci Imaging Facil, Stanford, CA 94305 USA; [Tsai, Feng-Chiao] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10051, Taiwan; [Tsai, Feng-Chiao] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 10051, Taiwan	Stanford University; Howard Hughes Medical Institute; Stanford University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hayer, A; Meyer, T (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	arnoldh@stanford.edu; tobias1@stanford.edu	Hayer, Arnold/W-8863-2019	Hayer, Arnold/0000-0001-7808-8880; Joubert, Lydia-Marie/0000-0002-4709-007X; Tsai, Feng-Chiao/0000-0001-9615-6023; Yang, Hee Won/0000-0002-0000-8091; Meyer, Tobias/0000-0003-4339-3804; Chung, Mingyu/0000-0003-1718-6203; Bisaria, Anjali/0000-0002-9709-9558	Swiss National Science Foundation; Human Frontiers Science Program Organization; NIH grants [GM063702, MH095087]; Stanford Shared FACS Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063702, R01GM030179, P50GM107615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095087] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers Science Program Organization(Human Frontier Science Program); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Shared FACS Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank G. Crabtree, M. Lin and X. Liu for providing constructs, M. Teruel for reagents to generate Giardia-diced siRNA, and the Stanford Shared FACS Facility for support. E. Wagner and M. Glotzer generously provided constructs and advice for local Rho activation. We are grateful to S. Collins, D. Garbett, A. Suvrathan, G. Dey and M. Galic for helpful discussions and comments on the manuscript. A.H. was supported by postdoctoral fellowships from the Swiss National Science Foundation and from the Human Frontiers Science Program Organization. This work was supported by NIH grants GM063702 and MH095087.	Abu Taha A, 2014, MOL BIOL CELL, V25, P245, DOI 10.1091/mbc.E13-07-0404; Ando K, 2013, J CELL BIOL, V202, P901, DOI 10.1083/jcb.201301115; Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Asokan SB, 2014, DEV CELL, V31, P747, DOI 10.1016/j.devcel.2014.10.024; Bajar BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20889; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; Brevier J, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016005; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Collins C, 2015, CURR OPIN CELL BIOL, V36, P62, DOI 10.1016/j.ceb.2015.07.004; Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Das T, 2015, NAT CELL BIOL, V17, P276, DOI 10.1038/ncb3115; Dorland YL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12210; Edelstein A., 2010, CURR PROTOC MOL BIOL, V14, P20; Etienne-Manneville S, 2014, CURR OPIN CELL BIOL, V30, P51, DOI 10.1016/j.ceb.2014.06.004; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110; Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Galic M, 2012, NAT CELL BIOL, V14, P874, DOI 10.1038/ncb2533; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Haeger A, 2015, TRENDS CELL BIOL, V25, P556, DOI 10.1016/j.tcb.2015.06.003; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; Hoelzle MK, 2012, MOL BIOL CELL, V23, P310, DOI 10.1091/mbc.E11-08-0719; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Khalil AA, 2010, INTEGR BIOL-UK, V2, P568, DOI 10.1039/c0ib00052c; Lou SS, 2015, J CELL BIOL, V209, P275, DOI 10.1083/jcb.201409001; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Matthews HK, 2012, DEV CELL, V23, P371, DOI 10.1016/j.devcel.2012.06.003; Mayor R, 2016, NAT REV MOL CELL BIO, V17, P97, DOI 10.1038/nrm.2015.14; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Ng MR, 2012, J CELL BIOL, V199, P545, DOI 10.1083/jcb.201207148; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peglion F, 2014, NAT CELL BIOL, V16, P639, DOI 10.1038/ncb2985; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Phng LK, 2015, DEV CELL, V32, P123, DOI 10.1016/j.devcel.2014.11.017; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Theveneau E., 2013, NATURE, V15, P1; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Tsai FC, 2012, CURR BIOL, V22, P837, DOI 10.1016/j.cub.2012.03.037; van Geemen D, 2014, ARTERIOSCL THROM VAS, V34, P2059, DOI 10.1161/ATVBAHA.114.304180; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Wagner E, 2016, J CELL BIOL, V213, P641, DOI 10.1083/jcb.201603025; Wilson CW, 2013, BLOOD, V122, P3678, DOI 10.1182/blood-2013-02-483156; Wollman R, 2012, NAT CELL BIOL, V14, P1261, DOI 10.1038/ncb2614; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007; YONEMURA S, 1995, J CELL SCI, V108, P127; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43	63	122	122	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2016	18	12					1311	+		10.1038/ncb3438	http://dx.doi.org/10.1038/ncb3438			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	ED8PY	27842057	Green Accepted			2022-12-25	WOS:000389134600009
J	Miroshnikova, YA; Mouw, JK; Barnes, JM; Pickup, MW; Lakins, JN; Kim, Y; Lobo, K; Persson, AI; Reis, GF; McKnight, TR; Holland, EC; Phillips, JJ; Weaver, VM				Miroshnikova, Yekaterina A.; Mouw, Janna K.; Barnes, J. Matthew; Pickup, Michael W.; Lakins, Johnathan N.; Kim, Youngmi; Lobo, Khadjia; Persson, Anders I.; Reis, Gerald F.; McKnight, Tracy R.; Holland, Eric C.; Phillips, Joanna J.; Weaver, Valerie M.			Tissue mechanics promote IDH1-dependent HIF1 alpha-tenascin C feedback to regulate glioblastoma aggression	NATURE CELL BIOLOGY			English	Article							MESENCHYMAL TRANSITION; MALIGNANT GLIOMA; EXPRESSION; HYPOXIA; IDH1; 2-HYDROXYGLUTARATE; INHIBITION; MUTATIONS; PATHWAYS; BIOLOGY	Increased overall survival for patients with glioma brain tumours is associated with mutations in the metabolic regulator isocitrate dehydrogenase 1 (IDH1). Gliomas develop within a mechanically challenged microenvironment that is characterized by a dense extracellular matrix (ECM) that compromises vascular integrity to induce hypoxia and activate HIF1 alpha. We found that glioma aggression and patient prognosis correlate with HIF1 alpha levels and the stiffness of a tenascin C (TNC)-enriched ECM. Gain-and loss-of-function xenograft manipulations demonstrated that a mutant IDH1 restricts glioma aggression by reducing HIF1 alpha-dependent TNC expression to decrease ECM stiffness and mechanosignalling. Recurrent IDH1-mutant patient gliomas had a stiffer TNC-enriched ECM that our studies attributed to reduced miR-203 suppression of HIF1 alpha and TNC mediated via a tension-dependent positive feedback loop. Thus, our work suggests that elevated ECM stiffness can independently foster glioblastoma aggression and contribute to glioblastoma recurrence via bypassing the protective activity of IDH1 mutational status.	[Miroshnikova, Yekaterina A.; Mouw, Janna K.; Barnes, J. Matthew; Pickup, Michael W.; Lakins, Johnathan N.; Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Kim, Youngmi; Holland, Eric C.] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Human Biol & Solid Tumor Translat Res, Dept Neurosurg, Seattle, WA 98109 USA; [Kim, Youngmi; Holland, Eric C.] Univ Washington, Alvord Brain Tumor Ctr, Seattle, WA 98195 USA; [Lobo, Khadjia; McKnight, Tracy R.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, Magnet Resonance Sci Ctr, San Francisco, CA 94143 USA; [Persson, Anders I.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Persson, Anders I.; Phillips, Joanna J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94158 USA; [Persson, Anders I.; Phillips, Joanna J.] Univ Calif San Francisco, Helen Diller Family Canc Res Ctr, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; [Persson, Anders I.; Phillips, Joanna J.] Univ Calif San Francisco, Helen Diller Family Canc Res Ctr, UCSF Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Reis, Gerald F.; Phillips, Joanna J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, UCSF Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA.; Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.; Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Weaver, VM (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Weaver, VM (corresponding author), Univ Calif San Francisco, UCSF Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA.	Valerie.Weaver@ucsf.edu		Mouw, Janna K/0000-0002-9846-8466; Persson, Anders/0000-0003-3868-0577; Weaver, Valerie marie/0000-0003-4786-6752	US National Institutes of Health NCI R01 grants [CA138818-01A1, CA192914-01, CA174929-01, 2R01CA085482-11A1]; US National Institutes of Health NCI U54 grants [CA163155-01, CA143836-01]; US National Institutes of Health NCI [F31CA180422-01A1]; NSF [GRFP 1144247]; US DOD BCRP grant [W81XWH-07-1-0538]; NINDS [R01 N5081117, R21 N5088114]; NBTS; NATIONAL CANCER INSTITUTE [U01CA202241, U54CA143836, R01CA174929, P50CA097257, U54CA210184, T32CA108462, U01CA168878, R01CA192914, U54CA163155, F31CA180422, R01CA138818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088114, R01NS081117] Funding Source: NIH RePORTER	US National Institutes of Health NCI R01 grants; US National Institutes of Health NCI U54 grants; US National Institutes of Health NCI; NSF(National Science Foundation (NSF)); US DOD BCRP grant; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NBTS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Lu for the B20 mouse experiment with input from G. Bergers; C. Cowdrey and A. Shai for tissue collection support; and I. Acerbi for IRB paperwork. Animal handling and tissue preparation was supported by L. Korets and N. Korets. This work was supported by US National Institutes of Health NCI R01 grants CA138818-01A1, CA192914-01, CA174929-01, and 2R01CA085482-11A1 (V.M.W.), U54 grants CA163155-01 and CA143836-01 (V.M.W.), US National Institutes of Health NCI F31CA180422-01A1 (Y.A.M.), NSF GRFP 1144247 (Y.A.M.), US DOD BCRP grant W81XWH-07-1-0538 (J.K.M.), NINDS R01 N5081117 (J.J.P.), NINDS R21 N5088114 and NBTS (A.I.P.).	Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Chang JH, 2016, INT J RADIAT ONCOL, V94, P412, DOI 10.1016/j.ijrobp.2015.10.001; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Chesnelong C, 2014, NEURO-ONCOLOGY, V16, P686, DOI 10.1093/neuonc/not243; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Koperek O, 2013, VIRCHOWS ARCH, V463, P795, DOI 10.1007/s00428-013-1484-3; Kriegel A. J., 2013, JOVE-J VIS EXP, V81, P50785; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lakins Johnathon N, 2012, Methods Mol Biol, V916, P317, DOI 10.1007/978-1-61779-980-8_24; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li R, 2015, ONCOTARGET, V6, P7318, DOI 10.18632/oncotarget.3440; Liao HZ, 2015, ONCOTARGET, V6, P8914, DOI 10.18632/oncotarget.3563; Le LTN, 2016, J CELL BIOL, V212, P707, DOI 10.1083/jcb.201507054; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Marucci G, 2015, PATHOLOGICA, V107, P1; Masson N, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-3; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Miroshnikova YA, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/2/026013; Mouw JK, 2014, NAT MED, V20, P360, DOI 10.1038/nm.3497; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Tarhonskaya H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4423; Turcan S, 2013, ONCOTARGET, V4, P1729, DOI 10.18632/oncotarget.1412; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; Vordermark D, 2005, CLIN CANCER RES, V11, P3966, DOI 10.1158/1078-0432.CCR-05-0097; Wade A, 2013, FEBS J, V280, P2399, DOI 10.1111/febs.12109; Wierenga ATJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093494; Williams SC, 2011, ACTA NEUROPATHOL, V121, P279, DOI 10.1007/s00401-010-0790-y; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9	46	164	167	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2016	18	12					1336	+		10.1038/ncb3429	http://dx.doi.org/10.1038/ncb3429			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	ED8PY	27820599	Green Accepted			2022-12-25	WOS:000389134600011
J	Newberry, RW; Raines, RT				Newberry, Robert W.; Raines, Ronald T.			A prevalent intraresidue hydrogen bond stabilizes proteins	NATURE CHEMICAL BIOLOGY			English	Article							ALPHA-DIALKYLATED GLYCINES; CENTER-DOT-O; STRUCTURAL VERSATILITY; BACKBONE; THIOAMIDES; PEPTIDES; DYNAMICS; PATTERN	Current limitations in de novo protein structure prediction and design suggest an incomplete understanding of the interactions that govern protein folding. Here we demonstrate that previously unappreciated hydrogen bonds occur within proteins between the amide proton and carbonyl oxygen of the same residue. Quantum calculations, infrared spectroscopy, and nuclear magnetic resonance spectroscopy show that these interactions share hallmark features of canonical hydrogen bonds. Biophysical analyses demonstrate that selective attenuation or enhancement of these C5 hydrogen bonds affects the stability of synthetic beta-sheets. These interactions are common, affecting approximately 5% of all residues and 94% of proteins, and their cumulative impact provides several kilocalories per mole of conformational stability to a typical protein. C5 hydrogen bonds especially stabilize the flat beta-sheets of the amyloid state, which is linked with Alzheimer's disease and other neurodegenerative disorders. Inclusion of these interactions in computational force fields would improve models of protein folding, function, and dysfunction.	[Newberry, Robert W.; Raines, Ronald T.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Raines, Ronald T.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Raines, RT (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.; Raines, RT (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	rtraines@wisc.edu	Newberry, Robert W./I-8089-2019; Raines, Ronald T./A-5009-2013	Newberry, Robert W./0000-0002-2020-2641; Raines, Ronald T./0000-0001-7164-1719	NIH [R01 AR044276, R01 GM044783, P41 GM103399, S10 RR013790, T32 GM008349]; NSF [CHE-1124944, CHE-0840494, BIR-9512577]; ACS Division of Organic Chemistry Graduate Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044783, P41GM103399, T32GM008349] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ACS Division of Organic Chemistry Graduate Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G.J. Bartlett, I.C. Tanrikulu, and L.L. Kiessling for discussions, and W.M. Westler, T. Zhang, and M.T. Zanni for assistance with spectroscopy. This work was supported by grants R01 AR044276 (NIH), R01 GM044783 (NIH), and CHE-1124944 (NSF). R.W.N. was supported by Biotechnology Training Grant T32 GM008349 (NIH) and by an ACS Division of Organic Chemistry Graduate Fellowship. The National Magnetic Resonance Facility at Madison is supported by grant P41 GM103399 (NIH). High-performance computing is supported by grant CHE-0840494 (NSF). The Biophysics Instrumentation Facility at the University of Wisconsin-Madison was established with grants BIR-9512577 (NSF) and S10 RR013790 (NIH).	AVIGNON M, 1969, BIOPOLYMERS, V8, P69, DOI 10.1002/bip.1969.360080107; Bartlett GJ, 2016, PROTEIN SCI, V25, P887, DOI 10.1002/pro.2896; Bartlett GJ, 2010, NAT CHEM BIOL, V6, P615, DOI [10.1038/NCHEMBIO.406, 10.1038/nchembio.406]; BENEDETTI E, 1988, BIOPOLYMERS, V27, P357, DOI 10.1002/bip.360270302; Blanco S, 2004, J AM CHEM SOC, V126, P11675, DOI 10.1021/ja048317c; BURGESS AW, 1973, BIOPOLYMERS, V12, P2177, DOI 10.1002/bip.1973.360120920; Cheng PN, 2013, J AM CHEM SOC, V135, P5477, DOI 10.1021/ja3088407; Choudhary A, 2009, J AM CHEM SOC, V131, P7244, DOI 10.1021/ja901188y; Clauss AD, 2014, CHEM EDUC RES PRACT, V15, P417, DOI 10.1039/c4rp00057a; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; Culik RM, 2012, J AM CHEM SOC, V134, P8026, DOI 10.1021/ja301681v; DADO GP, 1993, J AM CHEM SOC, V115, P4228, DOI 10.1021/ja00063a046; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Dian BC, 2002, J CHEM PHYS, V117, P10688, DOI 10.1063/1.1521132; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Florez AIG, 2016, ANGEW CHEM INT EDIT, V55, P3295, DOI 10.1002/anie.201510983; Fu YW, 2006, J AM CHEM SOC, V128, P15948, DOI 10.1021/ja065303t; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Hinderaker MP, 2003, PROTEIN SCI, V12, P1188, DOI 10.1110/ps.0241903; Huang R, 2009, J PHYS CHEM B, V113, P5661, DOI 10.1021/jp9014299; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Newberry RW, 2013, J AM CHEM SOC, V135, P7843, DOI 10.1021/ja4033583; Ohnishi S, 2006, J AM CHEM SOC, V128, P16338, DOI 10.1021/ja066008b; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rowland RS, 1996, J PHYS CHEM-US, V100, P7384, DOI 10.1021/jp953141+; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheiner S, 2005, J PHYS CHEM B, V109, P16132, DOI 10.1021/jp053416d; Shi ZS, 2006, CHEM REV, V106, P1877, DOI 10.1021/cr040433a; Skinner JJ, 2012, PROTEIN SCI, V21, P996, DOI 10.1002/pro.2081; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U; TONIOLO C, 1988, BIOPOLYMERS, V27, P373, DOI 10.1002/bip.360270303; TONIOLO C, 1980, CRC CR REV BIOCH MOL, V9, P1, DOI 10.3109/10409238009105471; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; ZIMMERMAN SS, 1977, MACROMOLECULES, V10, P1, DOI 10.1021/ma60055a001	45	70	70	2	56	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1084	+		10.1038/NCHEMBIO.2206	http://dx.doi.org/10.1038/NCHEMBIO.2206			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27748749	Green Accepted			2022-12-25	WOS:000388582900018
J	Agnihotri, S; Jalali, S; Wilson, MR; Danesh, A; Li, M; Klironomos, G; Krieger, JR; Mansouri, A; Khan, O; Mamatjan, Y; Landon-Brace, N; Tung, T; Dowar, M; Li, TT; Bruce, JP; Burrell, KE; Tonge, PD; Alamsahebpour, A; Krischek, B; Agarwalla, PK; Bi, WL; Dunn, IF; Beroukhim, R; Fehlings, MG; Bril, V; Pagnotta, SM; Iavarone, A; Pugh, TJ; Aldape, KD; Zadeh, G				Agnihotri, Sameer; Jalali, Shahrzad; Wilson, Mark R.; Danesh, Arnavaz; Li, Mira; Klironomos, George; Krieger, Jonathan R.; Mansouri, Alireza; Khan, Osaama; Mamatjan, Yasin; Landon-Brace, Natalie; Tung, Takyee; Dowar, Mark; Li, Tiantian; Bruce, Jeffrey P.; Burrell, Kelly E.; Tonge, Peter D.; Alamsahebpour, Amir; Krischek, Boris; Agarwalla, Pankaj Kumar; Bi, Wenya Linda; Dunn, Ian F.; Beroukhim, Rameen; Fehlings, Michael G.; Bril, Vera; Pagnotta, Stefano M.; Iavarone, Antonio; Pugh, Trevor J.; Aldape, Kenneth D.; Zadeh, Gelareh			The genomic landscape of schwannoma	NATURE GENETICS			English	Article							DRIVER MUTATIONS; GENE-EXPRESSION; CANCER; TUMORS; CLASSIFICATION; ADENOCARCINOMA; ESTABLISHMENT; COMPLEXITY; RESISTANCE; INHIBITORS	Schwannomas are common peripheral nerve sheath tumors that can cause debilitating morbidities. We performed an integrative analysis to determine genomic aberrations common to sporadic schwannomas. Exome sequence analysis with validation by targeted DNA sequencing of 125 samples uncovered, in addition to expected NF2 disruption, recurrent mutations in ARID1A, ARID1B and DDR1. RNA sequencing identified a recurrent in-frame SH3PXD2A-HTRA1 fusion in 12/125 (10%) cases, and genomic analysis demonstrated the mechanism as resulting from a balanced 19-Mb chromosomal inversion on chromosome 10q. The fusion was associated with male gender predominance, occurring in one out of every six men with schwannoma. Methylation profiling identified distinct molecular subgroups of schwannomas that were associated with anatomical location. Expression of the SH3PXD2A-HTRA1 fusion resulted in elevated phosphorylated ERK, increased proliferation, increased invasion and in vivo tumorigenesis. Targeting of the MEK-ERK pathway was effective in fusion-positive Schwann cells, suggesting a possible therapeutic approach for this subset of tumors.	[Agnihotri, Sameer; Jalali, Shahrzad; Wilson, Mark R.; Li, Mira; Klironomos, George; Mansouri, Alireza; Khan, Osaama; Mamatjan, Yasin; Landon-Brace, Natalie; Tung, Takyee; Burrell, Kelly E.; Tonge, Peter D.; Alamsahebpour, Amir; Aldape, Kenneth D.; Zadeh, Gelareh] Univ Hlth Network, Princess Margaret Canc Ctr, MacFeeters Hamilton Ctr Neurooncol Res, Toronto, ON, Canada; [Danesh, Arnavaz; Dowar, Mark; Li, Tiantian; Bruce, Jeffrey P.; Pugh, Trevor J.; Aldape, Kenneth D.; Zadeh, Gelareh] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Krieger, Jonathan R.] Hosp Sick Children, SPARC Bioctr, Toronto, ON, Canada; [Krischek, Boris] Univ Hosp Cologne, Dept Neurosurg, Cologne, Germany; [Agarwalla, Pankaj Kumar; Bi, Wenya Linda; Dunn, Ian F.; Beroukhim, Rameen] Harvard Med Sch, Boston, MA USA; [Agarwalla, Pankaj Kumar; Bi, Wenya Linda; Beroukhim, Rameen] Broad Inst MIT & Harvard, Cambridge, MA USA; [Agarwalla, Pankaj Kumar] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Agarwalla, Pankaj Kumar; Bi, Wenya Linda; Beroukhim, Rameen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bi, Wenya Linda; Dunn, Ian F.; Beroukhim, Rameen] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fehlings, Michael G.; Zadeh, Gelareh] Univ Hlth Network, Dept Neurosurg, Toronto, ON, Canada; [Bril, Vera] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Bril, Vera] Univ Toronto, Elizabeth Raab Neurofibromatosis Program, Toronto, ON, Canada; [Pagnotta, Stefano M.] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Pagnotta, Stefano M.; Iavarone, Antonio] Columbia Univ, Dept Pathol & Cell Biol & Neurol, New York, NY USA; [Pugh, Trevor J.; Aldape, Kenneth D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Aldape, Kenneth D.] Maryland Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Aldape, Kenneth D.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cologne; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Sannio; Columbia University; University of Toronto; University of Texas System; UTMD Anderson Cancer Center; University of Toronto	Aldape, KD; Zadeh, G (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, MacFeeters Hamilton Ctr Neurooncol Res, Toronto, ON, Canada.; Aldape, KD; Zadeh, G (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Zadeh, G (corresponding author), Univ Hlth Network, Dept Neurosurg, Toronto, ON, Canada.; Aldape, KD (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Aldape, KD (corresponding author), Maryland Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.; Aldape, KD (corresponding author), Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada.	kaldape@uhnresearch.ca; gelareh.zadeh@uhn.ca	Mamatjan, Yasin/ABD-2527-2021; AGNIHOTRI, SAMEER/HHS-2255-2022; Pugh, Trevor/Y-2535-2019; BRIL, vera/ABA-6509-2020	Mamatjan, Yasin/0000-0002-8807-2927; AGNIHOTRI, SAMEER/0000-0001-6584-3795; Pugh, Trevor/0000-0002-8073-5888; Mansouri, Alireza/0000-0002-7442-7539; Iavarone, Antonio/0000-0002-0683-4634; Fehlings, Michael/0000-0002-5722-6364; LANDON-BRACE, NATALIE/0000-0001-7021-8716; PAGNOTTA, Stefano Maria/0000-0002-8298-9777	Canadian Institute of Health Research (CIHR); Princess Margaret Cancer Foundation; Wilkins Family Chair in Brain Tumor Research; CIHR; Terry Fox Research Institute; MacFeeters-Hamilton Neuro-Oncology Research Program	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Princess Margaret Cancer Foundation(University of Toronto); Wilkins Family Chair in Brain Tumor Research; CIHR(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute; MacFeeters-Hamilton Neuro-Oncology Research Program	This work was supported by the Canadian Institute of Health Research (CIHR) post-doctoral fellowship (S.A.). The contributions of T.J.P., K.D.A. and G.Z. to this project were supported by the Princess Margaret Cancer Foundation. We thank the staff of the Princess Margaret Genomics Centre (N. Winegarden, J. Tsao and N. Khuu) and Bioinformatics Services (C. Virtanen and Z. Lu) for their expertise in generating the sequencing data used in this study. G.Z. is supported by the Wilkins Family Chair in Brain Tumor Research, CIHR grants, and The Terry Fox Research Institute. K.D.A. is supported by funding from the MacFeeters-Hamilton Neuro-Oncology Research Program. The human immortalized Schwann cells were a gift from A. Hoke (The Johns Hopkins School of Medicine, Baltimore, Maryland, USA).	Abul-Kasim K, 2008, NEURORADIOLOGY, V50, P301, DOI 10.1007/s00234-007-0345-7; Agnihotri S, 2014, J NEUROSURG, V121, P1434, DOI 10.3171/2014.6.JNS131433; AL-Shudifat AR, 2014, J NEUROL NEUROSUR PS, V85, P106, DOI 10.1136/jnnp-2013-305168; Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Bandopadhayay P, 2016, NAT GENET, V48, P273, DOI 10.1038/ng.3500; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Blakeley JO, 2016, NEURO-ONCOLOGY, V18, P624, DOI 10.1093/neuonc/nov200; Brastianos PK, 2014, NAT GENET, V46, P161, DOI 10.1038/ng.2868; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Burger KL, 2014, PROSTATE, V74, P134, DOI 10.1002/pros.22735; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cleven AHG, 2016, MODERN PATHOL, V29, P582, DOI 10.1038/modpathol.2016.45; DAIMARU Y, 1985, AM J SURG PATHOL, V9, P434, DOI 10.1097/00000478-198506000-00005; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; Dorak M. Tevfik, 2012, Frontiers in Genetics, V3, P268, DOI 10.3389/fgene.2012.00268; Gao MS, 2013, J MED CHEM, V56, P3281, DOI 10.1021/jm301824k; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gu L, 2010, ENDOCR-RELAT CANCER, V17, P481, DOI 10.1677/ERC-09-0328; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; He XP, 2010, CANCER RES, V70, P3109, DOI 10.1158/0008-5472.CAN-09-3557; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hung G, 2002, INT J ONCOL, V20, P475; Hung G, 1999, INT J ONCOL, V14, P409; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koppikar P, 2008, CLIN CANCER RES, V14, P7682, DOI 10.1158/1078-0432.CCR-08-1328; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Lehmann HC, 2012, STEM CELLS DEV, V21, P423, DOI 10.1089/scd.2010.0513; Lu SM, 2001, P NATL ACAD SCI USA, V98, P1410, DOI 10.1073/pnas.031581398; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Milligan BD, 2012, J NEUROSURG, V116, P598, DOI 10.3171/2011.11.JNS11811; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Nigro A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.98; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Piotrowski A, 2014, NAT GENET, V46, P182, DOI 10.1038/ng.2855; Plotkin SR, 2009, NEW ENGL J MED, V361, P358, DOI 10.1056/NEJMoa0902579; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Rohrich M, 2016, ACTA NEUROPATHOL, V131, P877, DOI 10.1007/s00401-016-1540-6; Sabha N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039412; Sim JCH, 2015, INTRACTABLE RARE DIS, V4, P17, DOI 10.5582/irdr.2014.01021; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Torres-Martin M, 2013, INT J ONCOL, V42, P848, DOI 10.3892/ijo.2013.1798; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647	58	72	73	2	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1339	1348		10.1038/ng.3688	http://dx.doi.org/10.1038/ng.3688			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27723760				2022-12-25	WOS:000386543400010
J	Huarte, M				Huarte, Maite			p53 partners with RNA in the DNA damage response	NATURE GENETICS			English	Editorial Material							EVOLUTION; GENOMICS	Stabilization of p53 protein is a key step in the cellular response to DNA damage. A new study describes a long noncoding RNA, DINO, transcribed from the CDKN1A promoter region that induces stabilization of p53 protein and promotes efficient activation of p53 target genes in response to DNA damage.	[Huarte, Maite] Univ Navarra, Dept Gene Therapy & Regulat Gene Express, Ctr Appl Med Res CIMA, Pamplona, Spain; [Huarte, Maite] Inst Hlth Res Navarra IdiSNA, Pamplona, Spain	University of Navarra	Huarte, M (corresponding author), Univ Navarra, Dept Gene Therapy & Regulat Gene Express, Ctr Appl Med Res CIMA, Pamplona, Spain.; Huarte, M (corresponding author), Inst Hlth Res Navarra IdiSNA, Pamplona, Spain.	maitehuarte@unav.es	Huarte, Maite/J-6903-2014	Huarte, Maite/0000-0003-3753-6493				Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Grossi E, 2016, BBA-GENE REGUL MECH, V1859, P200, DOI 10.1016/j.bbagrm.2015.07.011; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Schmitt AM, 2016, NAT GENET, V48, P1370, DOI 10.1038/ng.3673; Ulitsky I, 2016, NAT REV GENET, V17, P601, DOI 10.1038/nrg.2016.85; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020	8	8	10	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1298	1299		10.1038/ng.3702	http://dx.doi.org/10.1038/ng.3702			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27787509				2022-12-25	WOS:000386543400002
J	Ni, T; Li, XY; Lu, N; An, T; Liu, ZP; Fu, R; Lv, WC; Zhang, YW; Xu, XJ; Rowe, RG; Lin, YS; Scherer, A; Feinberg, T; Zheng, XQ; Chen, BA; Liu, XS; Guo, QL; Wu, ZQ; Weiss, SJ				Ni, Ting; Li, Xiao-Yan; Lu, Na; An, Teng; Liu, Zhi-Ping; Fu, Rong; Lv, Wen-Cong; Zhang, Yi-Wei; Xu, Xiao-Jun; Rowe, R. Grant; Lin, Yong-Shun; Scherer, Amanda; Feinberg, Tamar; Zheng, Xiao-Qi; Chen, Bao-An; Liu, X. Shirley; Guo, Qing-Long; Wu, Zhao-Qiu; Weiss, Stephen J.			Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN REPRESSION; MAMMARY-GLAND; STEM-CELLS; TRANSCRIPTION FACTORS; SNAIL1 EXPRESSION; METASTASIS; INVASION; MICE; DEGRADATION	The zinc-finger transcription factor Snail1 is inappropriately expressed in breast cancer and associated with poor prognosis. While interrogating human databases, we uncovered marked decreases in relapse-free survival of breast cancer patients expressing high Snail1 levels in tandem with wild-type, but not mutant, p53. Using a Snail1 conditional knockout model of mouse breast cancer that maintains wild-type p53, we find that Snail1 plays an essential role in tumour progression by controlling the expansion and activity of tumour-initiating cells in preneoplastic glands and established tumours, whereas it is not required for normal mammary development. Growth and survival of preneoplastic as well as neoplastic mammary epithelial cells is dependent on the formation of a Snail1/HDAC1/p53 tri-molecular complex that deacetylates active p53, thereby promoting its proteasomal degradation. Our findings identify Snail1 as a molecular bypass that suppresses the anti-proliferative and pro-apoptotic effects exerted by wild-type p53 in breast cancer.	[Ni, Ting; Lu, Na; An, Teng; Fu, Rong; Lv, Wen-Cong; Zhang, Yi-Wei; Xu, Xiao-Jun; Guo, Qing-Long; Wu, Zhao-Qiu] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Basic Med, State Key Lab Nat Med,Jiangsu Prov Key Lab Carcin, Nanjing 210009, Jiangsu, Peoples R China; [Li, Xiao-Yan; Rowe, R. Grant; Lin, Yong-Shun; Scherer, Amanda; Feinberg, Tamar; Weiss, Stephen J.] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Inst Life Sci, Ann Arbor, MI 48109 USA; [Liu, Zhi-Ping] Gannan Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Ganzhou 341000, Peoples R China; [Zheng, Xiao-Qi] Shanghai Normal Univ, Dept Math, Shanghai 200234, Peoples R China; [Chen, Bao-An] Southeast Univ, Sch Med, Affiliated Zhongda Hosp, Dept Hematol & Oncol, Nanjing 210009, Jiangsu, Peoples R China; [Liu, X. Shirley] Harvard Univ, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Harvard Sch Publ Hlth, Boston, MA 02115 USA	China Pharmaceutical University; University of Michigan System; University of Michigan; Gannan Medical University; Shanghai Normal University; Southeast University - China; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health	Wu, ZQ (corresponding author), China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Basic Med, State Key Lab Nat Med,Jiangsu Prov Key Lab Carcin, Nanjing 210009, Jiangsu, Peoples R China.; Weiss, SJ (corresponding author), Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Inst Life Sci, Ann Arbor, MI 48109 USA.	zqwu@cpu.edu.cn; sjweiss@umich.edu	Liu, Zhiping/O-3510-2019	Liu, Zhiping/0000-0002-5109-4153	Breast Cancer Research Foundation (BCRF); China Pharmaceutical University; National Natural Science Foundation of China [NSFC 81572745, 91539115]; Jiangsu Province Innovative Research Team; State Key Laboratory of Natural Medicines [SKLNMZZJQ201604]; Changjiang Scholar and Innovative Research Team [IRT1193]; US National Institutes of Health [U01 CA180980]; NATIONAL CANCER INSTITUTE [U01CA180980, R01CA071699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	Breast Cancer Research Foundation (BCRF); China Pharmaceutical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Innovative Research Team; State Key Laboratory of Natural Medicines; Changjiang Scholar and Innovative Research Team; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant from the Breast Cancer Research Foundation (BCRF) to S.J.W. as well as the Startup Fund from China Pharmaceutical University, the National Natural Science Foundation of China (NSFC 81572745 and 91539115), and the Jiangsu Province Innovative Research Team and State Key Laboratory of Natural Medicines (SKLNMZZJQ201604) to Z.-Q.W. Additional support was provided by the Changjiang Scholar and Innovative Research Team (IRT1193) to Q.-L.G. and the US National Institutes of Health (U01 CA180980) to X.S.L. We thank M.-D. Lai (China Pharmaceutical University, China) for critically reviewing this manuscript, W. Gu (Columbia University, USA) and P.-C. Yang (Academia Sinica, Taiwan) for providing HA-tagged p53 WT and mutant plasmids, R. Weinberg (Massachusetts Institute of Technology, USA) for sharing human mammary epithelial cells (HMLEs), A. Cano (Universidad Autonoma de Madrid, Spain) for Snaill mutants, Y. Kang and L. Wan (Princeton University, USA) for sharing protocols of mouse mammary epithelial cell isolation, B. Gyorffy (Hungarian Academy of Sciences, Hungary) for assistance with the human breast cancer databases and R. Kuick (University of Michigan, USA) for helpful discussions.	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Beck B, 2015, CELL STEM CELL, V16, P67, DOI 10.1016/j.stem.2014.12.002; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen Q, 2014, GENE DEV, V28, P432, DOI 10.1101/gad.233676.113; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Choi S, 2014, ACTA CRYSTALLOGR D, V70, P1050, DOI 10.1107/S1399004714000972; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gajula RP, 2013, MOL CANCER RES, V11, P1387, DOI 10.1158/1541-7786.MCR-13-0218-T; Geradts J, 2011, HUM PATHOL, V42, P1125, DOI 10.1016/j.humpath.2010.11.004; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2014, MOL ONCOL, V8, P508, DOI 10.1016/j.molonc.2013.12.018; Horvay K, 2015, EMBO J, V34, P1319, DOI 10.15252/embj.201490881; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jiao BW, 2012, CELL, V149, P630, DOI 10.1016/j.cell.2012.02.056; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kang GY, 2013, J BIOL CHEM, V288, P32506, DOI 10.1074/jbc.M113.479840; Kim J, 2014, EMBO REP, V15, P1062, DOI 10.15252/embr.201438587; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lan LX, 2015, EMBO J, V34, P1493, DOI 10.15252/embj.201489004; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Lim SO, 2010, FEBS LETT, V584, P2231, DOI 10.1016/j.febslet.2010.04.006; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lin YS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4070; Mak AS, 2014, CELL ADHES MIGR, V8, P8, DOI DOI 10.4161/CAM.27841; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Muenst S, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/902042; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Perez-Mancera PA, 2005, HUM MOL GENET, V14, P3449, DOI 10.1093/hmg/ddi373; Piccinin S, 2012, CANCER CELL, V22, P404, DOI 10.1016/j.ccr.2012.08.003; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Pyun BJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.43; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shiota M, 2008, ONCOGENE, V27, P5543, DOI 10.1038/onc.2008.176; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Tran HD, 2014, CANCER RES, V74, P6330, DOI 10.1158/0008-5472.CAN-14-0923; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Villarejo A, 2014, J BIOL CHEM, V289, P930, DOI 10.1074/jbc.M113.528026; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wan LL, 2014, CANCER CELL, V26, P92, DOI 10.1016/j.ccr.2014.04.027; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wu ZQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4998; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	70	68	69	5	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1221	+		10.1038/ncb3425	http://dx.doi.org/10.1038/ncb3425			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27749822	Green Accepted			2022-12-25	WOS:000387165600015
J	Waldorf, KMA; Stencel-Baerenwald, JE; Kapur, RP; Studholme, C; Boldenow, E; Vornhagen, J; Baldessari, A; Dighe, MK; Thiel, J; Merillat, S; Armistead, B; Tisoncik-Go, J; Green, RR; Davis, MA; Dewey, EC; Fairgrieve, MR; Gatenby, JC; Richards, T; Garden, GA; Diamond, MS; Juul, SE; Grant, RF; Kuller, L; Shaw, DWW; Ogle, J; Gough, GM; Lee', W; English, C; Hevner, RF; Dobyns, WB; Gale, M; Rajagopa, L				Waldorf, Kristina M. Adams; Stencel-Baerenwald, Jennifer E.; Kapur, Raj P.; Studholme, Colin; Boldenow, Erica; Vornhagen, Jay; Baldessari, Audrey; Dighe, Manjiri K.; Thiel, Jeff; Merillat, Sean; Armistead, Blair; Tisoncik-Go, Jennifer; Green, Richard R.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gatenby, J. Christopher; Richards, Todd; Garden, Gwenn A.; Diamond, Michael S.; Juul, Sandra E.; Grant, Richard F.; Kuller, LaRene; Shaw, Dennis W. W.; Ogle, Jason; Gough, G. Michael; Lee', Wonsok; English, Chris; Hevner, Robert F.; Dobyns, William B.; Gale, Michael, Jr.; Rajagopa, Lakshmi			Fetal brain lesions after sub-cutaneous inoculation of Zika virus in a pregnant nonhuman primate	NATURE MEDICINE			English	Article							ENCEPHALITIS; INFECTION; MACAQUE; DAMAGE; CELLS	We describe the development of fetal brain lesions after Zika virus (ZIKV) inoculation in a pregnant pigtail macaque. Periventricular lesions developed within 10 d and evolved asymmetrically in the occipital-parietal lobes. Fetal autopsy revealed ZIKV in the brain and significant cerebral white matter hypoplasia, periventricular white matter gliosis, and axonal and ependymal injury. Our observation of ZIKV-associated fetal brain lesions in a nonhuman primate provides a model for therapeutic evaluation.	[Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Stencel-Baerenwald, Jennifer E.; Tisoncik-Go, Jennifer; Green, Richard R.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Stencel-Baerenwald, Jennifer E.; Tisoncik-Go, Jennifer; Green, Richard R.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gale, Michael, Jr.] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA; [Kapur, Raj P.; Garden, Gwenn A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kapur, Raj P.] Seattle Childrens Hosp, Dept Pathol, Seattle, WA USA; [Studholme, Colin; Boldenow, Erica; Juul, Sandra E.; Dobyns, William B.; Rajagopa, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Studholme, Colin] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Studholme, Colin; Dighe, Manjiri K.; Thiel, Jeff; Gatenby, J. Christopher; Richards, Todd; Shaw, Dennis W. W.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Boldenow, Erica; Vornhagen, Jay; Merillat, Sean; Armistead, Blair; Rajagopa, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA; [Armistead, Blair; Rajagopa, Lakshmi] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Baldessari, Audrey; Grant, Richard F.; Kuller, LaRene; Ogle, Jason; Gough, G. Michael; Lee', Wonsok; English, Chris] Washington Natl Primate Res Ctr, Seattle, WA USA; [Garden, Gwenn A.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO USA; [Shaw, Dennis W. W.] Seattle Childrens Hosp, Dept Radiol, Seattle, WA USA; [Hevner, Robert F.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Hevner, Robert F.; Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Boldenow, Erica] Calvin Coll, Dept Biol, Grand Rapids, MI 49506 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Calvin University	Waldorf, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Gale, M (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; Gale, M (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.; Rajagopa, L (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Rajagopa, L (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA.; Rajagopa, L (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	adamsk@uw.edu; mgale@uw.edu; lakshmi.rajagopal@seattlechildrens.org	Dobyns, William/AAI-2768-2020; Dighe, Manjiri/D-9294-2018; Diamond, Michael/AAH-1733-2019; Garden, Gwenn/CAF-9344-2022; Vornahgen, Jay/AAI-1887-2019; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; Dighe, Manjiri/0000-0003-0047-5148; Diamond, Michael/0000-0002-8791-3165; Vornahgen, Jay/0000-0002-1685-302X; Gale, Michael/0000-0002-6332-7436; Garden, Gwenn/0000-0002-8753-6515; Davis, Michael/0000-0002-5406-4128; Green, Richard/0000-0001-8851-7204	University of Washington Department of Obstetrics and Gynecology; US National Institutes of Health (NIH) [R01AI100989, AI104002, AI083019, R01EB017133, R01NS055064, R01NS061957]; NIH [T32 HD007233, T32 AI07509]; Office of Research Infrastructure Programs (ORIP) of the NIH [P51OD010425]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100989, R01AI104002, T32AI007509, U19AI083019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055064, R01NS061957] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	University of Washington Department of Obstetrics and Gynecology; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research Infrastructure Programs (ORIP) of the NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Seattle Genomics Core Laboratory of the Washington National Primate Research Center Systems Biology Division for sequence analysis and the Center for Innate Immunity and Immune Disease immuno-informatics core group for bioinformatics support. We would like to acknowledge J. Hamanishi for technical assistance with preparation of the figures and L. Brandao (neuroradiologist at the Clinica Felippe Mattoso) for providing images and clinical information from a child with congenital ZIKV syndrome. We thank R. Tesh (University of Texas Medical Branch at Galveston-World Reference Center for Emerging Viruses and Arboviruses) for providing viral seed stocks. We thank A. Powers (US Centers for Disease Control and Prevention) for technical guidance for the qPCR experiments and C. Hughes for administrative assistance. We also thank M.-T. Little for technical editing. This work was supported by funding from the University of Washington Department of Obstetrics and Gynecology (K.M.A.W.) and the US National Institutes of Health (NIH) (grant no. R01AI100989 (L.R. and K.M.A.W.), AI104002 (M.G.), AI083019 (M.G.), R01EB017133 (C.S.), R01NS055064 (C.S.) and R01NS061957 (C.S)). The NIH training grants T32 HD007233 and T32 AI07509 provided support for E.B. and respectively. This project was also supported by the Office of Research Infrastructure Programs (ORIP) of the NIH through grant no. P51OD010425 to the Washington National Primate Research Center (A.B., R.F.G., L.K., J.O., G.M.G., W.L. and C.E.). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health or other funders. The funders had no role in study design, data collection and analysis, the decision to publish or preparation of the manuscript.	Brasil R, 2016, N ENGL J MED; Bruce AG, 2013, J VIROL, V87, P13676, DOI 10.1128/JVI.02331-13; CONRAD S, 1995, AM J PRIMATOL, V36, P15, DOI 10.1002/ajp.1350360103; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; HADDAD J, 1990, NEUROPEDIATRICS, V21, P215, DOI 10.1055/s-2008-1071500; Lennartsson F, 2014, INVEST OPHTH VIS SCI, V55, P8278, DOI 10.1167/iovs.14-14913; Leonard JR, 2000, AM J ROENTGENOL, V174, P1651, DOI 10.2214/ajr.174.6.1741651; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Nakgoi K, 2014, AM J PRIMATOL, V76, P97, DOI 10.1002/ajp.22213; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Putaporntip C, 2010, MOL ECOL, V19, P3466, DOI 10.1111/j.1365-294X.2010.04756.x; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Sourisseau M, 2013, GASTROENTEROLOGY, V145, P966, DOI 10.1053/j.gastro.2013.07.026; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x; Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58	19	177	179	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1256	1259		10.1038/nm.4193	http://dx.doi.org/10.1038/nm.4193			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27618651	Bronze, Green Accepted			2022-12-25	WOS:000387302300017
J	Zheng, WY; Umitsu, M; Jagan, I; Tran, CW; Ishiyama, N; BeGora, M; Araki, K; Ohashi, PS; Ikura, M; Muthuswamy, SK				Zheng, Weiyue; Umitsu, Masataka; Jagan, Ishaan; Tran, Charles W.; Ishiyama, Noboru; BeGora, Michael; Araki, Kiyomi; Ohashi, Pamela S.; Ikura, Mitsuhiko; Muthuswamy, Senthil K.			An interaction between Scribble and the NADPH oxidase complex controls M1 macrophage polarization and function	NATURE CELL BIOLOGY			English	Article							PROMOTES MAMMARY TUMORIGENESIS; CHRONIC GRANULOMATOUS-DISEASE; NF-KAPPA-B; CELL POLARITY; PROTEIN SCRIBBLE; BREAST-CANCER; ACTIVATION; LOCALIZATION; SUPEROXIDE; LEUKOCYTES	The polarity protein Scribble (SCRIB) regulates apical-basal polarity, directional migration and tumour suppression in Drosophila and mammals(1-6). Here we report that SCRIB is an important regulator of myeloid cell functions including bacterial infection and inflammation. SCRIB interacts directly with the NADPH oxidase (NOX) complex in a PSD95/Dlg/ZO-1 (PDZ)-domain-dependent manner and is required for NOX-induced reactive oxygen species (ROS) generation in culture and in vivo. On bacterial infection, SCRIB localized to phagosomes in a leucine-rich repeat-dependent manner and promoted ROS production within phagosomes to kill bacteria. Unexpectedly, SCRIB loss promoted M1 macrophage polarization and inflammation. Thus, SCRIB uncouples ROS-dependent bacterial killing activity from M1 polarization and inflammatory functions of macrophages. Modulating the SCRIB-NOX pathway can therefore identify ways to manage infection and inflammation with implications for chronic inflammatory diseases, sepsis and cancer.	[Zheng, Weiyue; Umitsu, Masataka; Jagan, Ishaan; Tran, Charles W.; Ishiyama, Noboru; BeGora, Michael; Araki, Kiyomi; Ohashi, Pamela S.; Ikura, Mitsuhiko; Muthuswamy, Senthil K.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Zheng, Weiyue; Umitsu, Masataka; Jagan, Ishaan; Tran, Charles W.; Ishiyama, Noboru; BeGora, Michael; Araki, Kiyomi; Ohashi, Pamela S.; Ikura, Mitsuhiko; Muthuswamy, Senthil K.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Jagan, Ishaan] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02115 USA; [Tran, Charles W.; Ohashi, Pamela S.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Umitsu, Masataka] Osaka Univ, Inst Prot Res, Osaka 5650871, Japan	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Toronto; Osaka University	Muthuswamy, SK (corresponding author), Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Muthuswamy, SK (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada.	smuthusw@bidmc.harvard.edu	Muthuswamy, Senthil K/AGY-2834-2022; Tran, Charles/AAL-4841-2021	Muthuswamy, Senthil K/0000-0001-6564-9634; Ikura, Mitsuhiko/0000-0002-9524-1303; Ohashi, Pamela S./0000-0003-2915-9317	DOD Breast Cancer Research Program [CA098830, BC075024]; Rita Allen Foundation; Lee K Margaret Lau Chair for breast cancer research; Campbell Family Institute for Breast cancer research; Uehara Memorial Foundation; Naito Foundation; Terry Fox Foundation EIRR21 at CIHR; JSPS postdoctoral fellowship for research abroad; Ontario Ministry of Health and Long Term Care	DOD Breast Cancer Research Program(United States Department of Defense); Rita Allen Foundation; Lee K Margaret Lau Chair for breast cancer research; Campbell Family Institute for Breast cancer research; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Terry Fox Foundation EIRR21 at CIHR; JSPS postdoctoral fellowship for research abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	We would like to thank S. Courtneidge (Oregon Health and Science University, USA) for Tks5, NOXA1 and NoxO1 cDNA, I. Harris for assistance with ROS assays, G. M. C. Gasmi-Seabrook for assistance with NMR experiments, P. B. Stathopulos for assistance in structural modelling and its analysis, and members of the Muthuswamy laboratory for critical discussions. This work was supported by CA098830, BC075024, Era of Hope Scholar award from DOD Breast Cancer Research Program; Rita Allen Foundation, Lee K Margaret Lau Chair for breast cancer research and Campbell Family Institute for Breast cancer research to S.K.M. M.U. received fellowships from The Uehara Memorial Foundation, The Naito Foundation, and the Terry Fox Foundation EIRR21 at CIHR, and a JSPS postdoctoral fellowship for research abroad. This was also funded in part by the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the OMOHLTC.	Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; Baker L, 2016, J CELL SCI, V129, P2307, DOI 10.1242/jcs.185413; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; BRIGGS RT, 1975, J CELL BIOL, V67, P566, DOI 10.1083/jcb.67.3.566; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DINAUER MC, 1992, ANNU REV MED, V43, P117, DOI 10.1146/annurev.med.43.1.117; Elsum IA, 2014, ONCOGENE, V33, P5523, DOI 10.1038/onc.2013.498; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feigin ME, 2014, CANCER RES, V74, P3180, DOI 10.1158/0008-5472.CAN-13-3415; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Han W, 2013, J IMMUNOL, V190, P4786, DOI 10.4049/jimmunol.1201809; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; Lam GY, 2011, CELL HOST MICROBE, V10, P627, DOI 10.1016/j.chom.2011.11.005; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; NISHINAKA Y, 1993, BIOCHEM BIOPH RES CO, V193, P554, DOI 10.1006/bbrc.1993.1659; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Pearson HB, 2011, J CLIN INVEST, V121, P4257, DOI 10.1172/JCI58509; Rieber N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/252460; Sattler M, 1999, BLOOD, V93, P2928; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sheng KC, 2010, J IMMUNOL, V184, P2863, DOI 10.4049/jimmunol.0903458; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Wilson C, 2015, J CELL SCI, V128, P2989, DOI 10.1242/jcs.168567; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	38	30	31	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1244	+		10.1038/ncb3413	http://dx.doi.org/10.1038/ncb3413			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27694890				2022-12-25	WOS:000387165600017
J	Hodgson, L; Spiering, D; Sabouri-Ghomi, M; Dagliyan, O; DerMardirossian, C; Danuser, G; Hahn, KM				Hodgson, Louis; Spiering, Desiree; Sabouri-Ghomi, Mohsen; Dagliyan, Onur; DerMardirossian, Celine; Danuser, Gaudenz; Hahn, Klaus M.			FRET binding antenna reports spatiotemporal dynamics of GDI-Cdc42 GTPase interactions	NATURE CHEMICAL BIOLOGY			English	Article							DISSOCIATION INHIBITOR; RHO GTPASES; PHOSPHORYLATION; RAC; ACTIVATION; MEMBRANE; CDC42; COMPLEX; CELLS	Guanine-nucleotide dissociation inhibitors (GDIs) are negative regulators of Rho family GTPases that sequester the GTPases away from the membrane. Here we ask how GDI-Cdc42 interaction regulates localized Cdc42 activation for cell motility. The sensitivity of cells to overexpression of Rho family pathway components led us to a new biosensor, GDI.Cdc42 FLARE, in which Cdc42 is modified with a fluorescence resonance energy transfer (FRET) 'binding antenna' that selectively reports Cdc42 binding to endogenous GDIs. Similar antennae could also report GDI-Rac1 and GDI-RhoA interaction. Through computational multiplexing and simultaneous imaging, we determined the spatiotemporal dynamics of GDI-Cdc42 interaction and Cdc42 activation during cell protrusion and retraction. This revealed remarkably tight coordination of GTPase release and activation on a time scale of 10 s, suggesting that GDI-Cdc42 interactions are a critical component of the spatiotemporal regulation of Cdc42 activity, and not merely a mechanism for global sequestration of an inactivated pool of signaling molecules.	[Hodgson, Louis; Spiering, Desiree] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Hodgson, Louis; Spiering, Desiree] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA; [Hodgson, Louis; Dagliyan, Onur; Hahn, Klaus M.] Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Hodgson, Louis; Dagliyan, Onur; Hahn, Klaus M.] Univ North Carolina Chapel Hill, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA; [Sabouri-Ghomi, Mohsen; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [DerMardirossian, Celine] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Danuser, Gaudenz] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School	Hodgson, L (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.; Hodgson, L (corresponding author), Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA.; Hodgson, L; Hahn, KM (corresponding author), Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27599 USA.; Hodgson, L; Hahn, KM (corresponding author), Univ North Carolina Chapel Hill, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA.; Danuser, G (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.; Danuser, G (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	louis.hodgson@einstein.yu.edu; Gaudenz.Danuser@UTSouthwestern.edu; khahn@med.unc.edu	Dagliyan, Onur/N-5683-2019	Dagliyan, Onur/0000-0003-1825-1011; Hodgson, Louis/0000-0001-9188-7580; Hahn, Klaus/0000-0002-1970-7562; Danuser, Gaudenz/0000-0001-8583-2014	National Institute of General Medical Sciences [P01-GM103723, T-R01 GM090317, GM099837]; National Cancer Institute [CA181838]; NATIONAL CANCER INSTITUTE [R21CA181838, P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099837, R01GM090317, P01GM103723] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Institute of General Medical Sciences (P01-GM103723 and T-R01 GM090317 to G.D. and K.M.H.; GM099837 to C.D.) and the National Cancer Institute (CA181838 to L.H.) for funding. O.D. is a Howard Hughes Medical Institute International Student Research Fellow. Mammalian expression cDNA constructs for Myc-WASP and HA-Tiam1 were gifts from D. Cox (Departments of Anatomy and Structural Biology and Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York, USA). Myc-Intersectin1L was a gift from H. Bourne (Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California, USA). Myc-mDia2 was from S. Narumiya (Department of Pharmacology, University of Kyoto, Kyoto, Japan). PAK1 was from Y. Wu (Department of Genetics and Genome Sciences, University of Connecticut Health Center, Farmington, Connecticut, USA).	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; CHUANG TH, 1993, J BIOL CHEM, V268, P26206; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dovas A, 2010, J BIOL CHEM, V285, P23294, DOI 10.1074/jbc.M109.098129; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron B., 1994, INTRO BOOTSTRAP; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Ellis S, 2000, CURR BIOL, V10, P1387, DOI 10.1016/S0960-9822(00)00777-6; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; Hodgson L., 2010, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1411s46, DOI 10.1002/0471143030.CB1411S46]; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Qiao J, 2008, AM J PHYSIOL-CELL PH, V295, pC1161, DOI 10.1152/ajpcell.00139.2008; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Shen FM, 2006, CYTOM PART A, V69A, P563, DOI 10.1002/cyto.a.20283; Spiering D, 2013, METHOD CELL BIOL, V114, P593, DOI 10.1016/B978-0-12-407761-4.00025-7; Spiering D, 2012, METHODS MOL BIOL, V827, P215, DOI 10.1007/978-1-61779-442-1_15; TAKAI Y, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P338; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Toutchkine A, 2007, ORG LETT, V9, P2775, DOI 10.1021/ol070780h; Tsukada Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000223; Ugolev Y, 2008, J BIOL CHEM, V283, P22257, DOI 10.1074/jbc.M800734200; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	45	34	34	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					802	+		10.1038/NCHEMBIO.2145	http://dx.doi.org/10.1038/NCHEMBIO.2145			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27501396	Green Submitted, Green Accepted			2022-12-25	WOS:000384248600011
J	Lindeboom, RGH; Supek, F; Lehner, B				Lindeboom, Rik G. H.; Supek, Fran; Lehner, Ben			The rules and impact of nonsense-mediated mRNA decay in human cancers	NATURE GENETICS			English	Article							EXON JUNCTION COMPLEX; BETA-GLOBIN GENE; EXPRESSION; MUTATIONS; CODONS; DROSOPHILA; PROTEIN; UPF1	Premature termination codons (PTCs) cause a large proportion of inherited human genetic diseases. PTC-containing transcripts can be degraded by an mRNA surveillance pathway termed nonsense-mediated mRNA decay (NMD). However, the efficiency of NMD varies; it is inefficient when a PTC is located downstream of the last exon junction complex (EJC). We used matched exome and transcriptome data from 9,769 human tumors to systematically elucidate the rules of NMD targeting in human cells. An integrated model incorporating multiple rules beyond the canonical EJC model explains approximately three-fourths of the non-random variance in NMD efficiency across thousands of PTCs. We also show that dosage compensation may sometimes mask the effects of NMD. Applying the NMD model identifies signatures of both positive and negative selection on NMD-triggering mutations in human tumors and provides a classification for tumor-suppressor genes.	[Lindeboom, Rik G. H.; Supek, Fran; Lehner, Ben] Barcelona Inst Sci & Technol, CRG, EMBL CRG Syst Biol Unit, Barcelona, Spain; [Lindeboom, Rik G. H.; Supek, Fran; Lehner, Ben] UPF, Barcelona, Spain; [Supek, Fran] Rudjer Boskovic Inst, Dept Elect, Zagreb, Croatia; [Lehner, Ben] ICREA, Barcelona, Spain; [Lindeboom, Rik G. H.] Radboud Inst Mol Life Sci, Dept Mol Biol, Nijmegen, Netherlands	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Rudjer Boskovic Institute; ICREA	Supek, F; Lehner, B (corresponding author), Barcelona Inst Sci & Technol, CRG, EMBL CRG Syst Biol Unit, Barcelona, Spain.; Supek, F; Lehner, B (corresponding author), UPF, Barcelona, Spain.; Supek, F (corresponding author), Rudjer Boskovic Inst, Dept Elect, Zagreb, Croatia.; Lehner, B (corresponding author), ICREA, Barcelona, Spain.	fran.supek@crg.eu; ben.lehner@crg.eu	Lehner, Ben/ABH-6562-2020; Lehner, Ben/L-3413-2014; Supek, Fran/B-2359-2012	Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124; Supek, Fran/0000-0002-7811-6711; Lindeboom, Rik/0000-0002-3660-504X	European Research Council (ERC) Consolidator grant [616434]; Spanish Ministry of Economy and Competitiveness ('Centro de Excelencia Severo Ochoa') [BFU2011-26206, SEV-2012-0208]; AXA Research Fund; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR); FP7 project 4DCellFate [277899]; EMBL-CRG Systems Biology Program; FP7 grant MAESTRA [ICT-2013-612944]; FP7 grant InnoMol [FP7-REGPOT-2012-2013-1-316289]; ICREA Funding Source: Custom	European Research Council (ERC) Consolidator grant(European Research Council (ERC)); Spanish Ministry of Economy and Competitiveness ('Centro de Excelencia Severo Ochoa')(Spanish Government); AXA Research Fund(AXA Research Fund); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); FP7 project 4DCellFate; EMBL-CRG Systems Biology Program; FP7 grant MAESTRA; FP7 grant InnoMol; ICREA(ICREA)	This work was supported by a European Research Council (ERC) Consolidator grant (616434), the Spanish Ministry of Economy and Competitiveness (BFU2011-26206 and 'Centro de Excelencia Severo Ochoa 2013-2017' SEV-2012-0208), the AXA Research Fund, the Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), FP7 project 4DCellFate (277899) and the EMBL-CRG Systems Biology Program. F.S. was also supported by FP7 grants MAESTRA (ICT-2013-612944) and InnoMol (FP7-REGPOT-2012-2013-1-316289).	Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Buhler M, 2004, NUCLEIC ACIDS RES, V32, P3304, DOI 10.1093/nar/gkh651; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Fiorini F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8581; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gutmann DH, 1999, ONCOGENE, V18, P4450, DOI 10.1038/sj.onc.1202829; HALL GW, 1994, BLOOD, V83, P2031; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Kurosaki T, 2014, GENE DEV, V28, P1900, DOI 10.1101/gad.245506.114; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Longman D, 2007, GENE DEV, V21, P1075, DOI 10.1101/gad.417707; Malone JH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r28; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; MAQUAT LE, 1995, RNA, V1, P453; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; McFarland CD, 2014, P NATL ACAD SCI USA, V111, P15138, DOI 10.1073/pnas.1404341111; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Rivas MA, 2015, SCIENCE, V348, P666, DOI 10.1126/science.1261877; Romao L, 2000, BLOOD, V96, P2895; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Supek F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001004; Tani H, 2012, RNA BIOL, V9, P1370, DOI 10.4161/rna.22360; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826; Zhang ZG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.101	41	220	225	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1112	1118		10.1038/ng.3664	http://dx.doi.org/10.1038/ng.3664			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27618451	Green Accepted			2022-12-25	WOS:000384391600006
J	Wang, XL; Wang, HW; Liu, SX; Ferjani, A; Li, JS; Yan, JB; Yang, XH; Qin, F				Wang, Xianglan; Wang, Hongwei; Liu, Shengxue; Ferjani, Ali; Li, Jiansheng; Yan, Jianbing; Yang, Xiaohong; Qin, Feng			Genetic variation in ZmVPP1 contributes to drought tolerance in maize seedlings	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; H+-TRANSLOCATING PYROPHOSPHATASE; QUANTITATIVE TRAIT LOCI; ARABIDOPSIS-THALIANA; POSTDOMESTICATION SPREAD; TRANSPOSABLE ELEMENT; STRESS RESPONSES; AGRONOMIC TRAITS; STOMATAL CLOSURE; COLD TOLERANCE	Maize production is threatened by drought stress worldwide. Identification of the genetic components underlying drought tolerance in maize is of great importance. Here we report a genome-wide association study (GWAS) of maize drought tolerance at the seedling stage that identified 83 genetic variants, which were resolved to 42 candidate genes. The peak GWAS signal showed that the natural variation in ZmVPP1, encoding a vacuolar-type H+ pyrophosphatase, contributes most significantly to the trait. Further analysis showed that a 366-bp insertion in the promoter, containing three MYB cis elements, confers drought inducible expression of ZmVPP1 in drought-tolerant genotypes. Transgenic maize with enhanced ZmVPP1 expression exhibits improved drought tolerance that is most likely due to enhanced photosynthetic efficiency and root development. Taken together, this information provides important genetic insights into the natural variation of maize drought tolerance. The identified loci or genes can serve as direct targets for both genetic engineering and selection for maize trait improvement.	[Wang, Xianglan; Wang, Hongwei; Liu, Shengxue; Qin, Feng] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China; [Wang, Xianglan; Wang, Hongwei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ferjani, Ali] Tokyo Gakugei Univ, Dept Biol, Tokyo, Japan; [Li, Jiansheng; Yang, Xiaohong] China Agr Univ, Natl Maize Improvement Ctr China, Beijing Key Lab Crop Genet Improvement, Beijing, Peoples R China; [Yan, Jianbing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tokyo Gakugei University; China Agricultural University; Huazhong Agricultural University	Qin, F (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China.; Yang, XH (corresponding author), China Agr Univ, Natl Maize Improvement Ctr China, Beijing Key Lab Crop Genet Improvement, Beijing, Peoples R China.	yxiaohong@cau.edu.cn; qinfeng@ibcas.ac.cn		Wang, Hongwei/0000-0001-6005-9352; Qin, Feng/0000-0001-9134-4711	National High-Tech Research and Development Program of China [2012AA10A306-4]; National Basic Research Program of China [2012CB114302-4]; Chinese Academy of Sciences [XDA08010206]; National Natural Science Foundation of China [31471505]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors would like to thank T. Komori (Japan Tobacco, Inc.) for kindly providing us with the maize transformation plasmids pSBI and pSBII. Y. Ma helped in maize transformation vector construction. We would also like to thank S. Li and Z. Li for their excellent technical support in maize transformation and seed propagation. This research was supported by grants from the National High-Tech Research and Development Program of China (2012AA10A306-4), the National Basic Research Program of China (2012CB114302-4), Chinese Academy of Sciences grant (XDA08010206), and the National Natural Science Foundation of China (31471505) to F.Q.	Bak G, 2013, PLANT CELL, V25, P2202, DOI 10.1105/tpc.113.110411; Boyer JS, 2013, GLOB FOOD SECUR-AGR, V2, P139, DOI 10.1016/j.gfs.2013.08.002; Chen ZZ, 2006, MOL CELL BIOL, V26, P6902, DOI 10.1128/MCB.00433-06; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Ferjani A, 2011, PLANT CELL, V23, P2895, DOI 10.1105/tpc.111.085415; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang CH, 2012, PLANT SIGNAL BEHAV, V7, P428, DOI 10.4161/psb.19192; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; Kriegel A, 2015, PLANT CELL, V27, P3383, DOI 10.1105/tpc.15.00733; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Li YB, 2014, NAT GENET, V46, P398, DOI 10.1038/ng.2923; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Mao HD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9326; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Mitsuya S, 2005, PLANTA, V222, P1001, DOI 10.1007/s00425-005-0043-9; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Negi NP, 2015, PLANT CELL REP, V34, P1109, DOI 10.1007/s00299-015-1770-4; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Pennisi E, 2008, SCIENCE, V320, P171, DOI 10.1126/science.320.5873.171; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Runkel ED, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003346; Semagn K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-313; Setter TL, 2011, J EXP BOT, V62, P701, DOI 10.1093/jxb/erq308; Sivankalyani V, 2015, TRANSGENIC RES, V24, P237, DOI 10.1007/s11248-014-9840-x; STITT M, 1989, PLANT PHYSIOL, V89, P628, DOI 10.1104/pp.89.2.628; Thirunavukkarasu N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1182; Vainonen JP, 2012, BIOCHEM J, V442, P573, DOI 10.1042/BJ20111739; Voitsik AM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-85; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Xue YD, 2013, THEOR APPL GENET, V126, P2587, DOI 10.1007/s00122-013-2158-x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang Q, 2013, P NATL ACAD SCI USA, V110, P16969, DOI 10.1073/pnas.1310949110; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; You J, 2013, J EXP BOT, V64, P569, DOI 10.1093/jxb/ers349; Yu CQ, 2011, NATURE, V470, P307, DOI 10.1038/470307a; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang XX, 2008, PLANT MOL BIOL, V68, P131, DOI 10.1007/s11103-008-9357-x; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	48	246	271	28	304	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1233	1241		10.1038/ng.3636	http://dx.doi.org/10.1038/ng.3636			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27526320				2022-12-25	WOS:000384391600019
J	He, J; Zhang, X; Wei, YB; Sun, XL; Chen, YP; Deng, J; Jin, YB; Gan, YZ; Hu, X; Jia, RL; Xu, CH; Hou, ZH; Leong, YA; Zhu, L; Feng, JH; An, Y; Jia, Y; Li, C; Liu, X; Ye, H; Ren, LM; Li, R; Yao, HH; Li, YH; Chen, S; Zhang, XW; Su, Y; Guo, JP; Shen, N; Morand, EF; Yu, D; Li, ZG				He, Jing; Zhang, Xia; Wei, Yunbo; Sun, Xiaolin; Chen, Yaping; Deng, Jun; Jin, Yuebo; Gan, Yuzhou; Hu, Xin; Jia, Rulin; Xu, Chuanhui; Hou, Zhaohua; Leong, Yew Ann; Zhu, Lei; Feng, Jinhong; An, Yuan; Jia, Yuan; Li, Chun; Liu, Xu; Ye, Hua; Ren, Limin; Li, Ru; Yao, Haihong; Li, Yuhui; Chen, Shi; Zhang, Xuewu; Su, Yin; Guo, Jianping; Shen, Nan; Morand, Eric F.; Yu, Di; Li, Zhanguo			Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus	NATURE MEDICINE			English	Article							EXPRESSION; RESPONSES; THERAPY; TH17	Systemic lupus erythematosus (SLE) is a potentially life-threatening autoimmune disease characterized by altered balance of activity between effector and regulatory CD4(+) T cells. The homeostasis of CD4(+) T cell subsets is regulated by interleukin (IL)-2, and reduced production of IL-2 by T cells is observed in individuals with SLE. Here we report that treatment with low-dose recombinant human IL-2 selectively modulated the abundance of regulatory T (T-reg) cells, follicular helper T (T-FH) cells and IL-17-producing helper T (T(H)17) cells, but not T(H)1 or T(H)2 cells, accompanied by marked reductions of disease activity in patients with SLE.	[He, Jing; Zhang, Xia; Sun, Xiaolin; Jin, Yuebo; Gan, Yuzhou; Jia, Rulin; Xu, Chuanhui; Zhu, Lei; An, Yuan; Jia, Yuan; Li, Chun; Liu, Xu; Ye, Hua; Ren, Limin; Li, Ru; Yao, Haihong; Li, Yuhui; Chen, Shi; Zhang, Xuewu; Su, Yin; Guo, Jianping; Li, Zhanguo] Peking Univ Peoples Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [Wei, Yunbo; Hou, Zhaohua; Feng, Jinhong; Yu, Di] Shandong Acad Sci, Shandong Anal & Test Ctr, Lab Immunol Environm & Hlth, Jinan, Peoples R China; [Chen, Yaping; Hu, Xin; Leong, Yew Ann; Yu, Di] Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Lab Mol Immunomodulat,Infect & Immun Program, Clayton, Vic, Australia; [Deng, Jun; Shen, Nan; Yu, Di] Shanghai Jiao Tong Univ, Shanghai Renji Hosp, China Australia Ctr Personalised Immunol, Sch Med, Shanghai, Peoples R China; [Morand, Eric F.; Yu, Di] Monash Univ, Monash Hlth, Ctr Inflammatory Dis, Sch Clin Sci, Clayton, Vic, Australia	Peking University; Qilu University of Technology; Monash University; Shanghai Jiao Tong University; Monash University	Yu, D; Li, ZG (corresponding author), Peking Univ Peoples Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China.; Yu, D (corresponding author), Shandong Acad Sci, Shandong Anal & Test Ctr, Lab Immunol Environm & Hlth, Jinan, Peoples R China.; Yu, D (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Lab Mol Immunomodulat,Infect & Immun Program, Clayton, Vic, Australia.; Yu, D (corresponding author), Shanghai Jiao Tong Univ, Shanghai Renji Hosp, China Australia Ctr Personalised Immunol, Sch Med, Shanghai, Peoples R China.; Yu, D (corresponding author), Monash Univ, Monash Hlth, Ctr Inflammatory Dis, Sch Clin Sci, Clayton, Vic, Australia.	di.yu@monash.edu; li99@bjmu.edu.cn	Sun, Xiaolin/AAD-8492-2022; Hou, Zhaohua/A-1046-2018; Wei, Yunbo/AHE-8248-2022; Shen, Nan/AGK-6807-2022; Morand, Eric F/I-4718-2013; Morand, Eric/AAT-3259-2021; Yu, Di/C-2163-2009	Sun, Xiaolin/0000-0001-9709-1532; Hou, Zhaohua/0000-0003-3093-0279; Morand, Eric F/0000-0002-9507-3338; Morand, Eric/0000-0002-9507-3338; Yu, Di/0000-0003-1721-8922; Shen, Nan/0000-0002-5875-4417; Leong, Yew Ann/0000-0002-0999-7084; Xu, Chuanhui/0000-0002-3222-7168; Deng, Jun/0000-0002-8916-6503; Li, Zhanguo/0000-0002-2590-6242	National Sci-Tech Support Program [2014BAI07B01]; National Basic Research Program of China 973 Program [2014CB541903, 2014CB541901, 2010CB529104]; National Natural Science Foundation of China (NSFC) [81373117, 31570880, 31530020, 81429003, 81471601]; Beijing Key Laboratory for Rheumatism and Immune Diagnosis [BZ0135]; Peking-Tsinghua Center for Life Sciences; Priority Research Program of the Shandong Academy of Sciences; Shandong Province Taishan Scholar Program; Australian National Health and Medical Research Council (NHMRC) [GNT1085509]	National Sci-Tech Support Program; National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Key Laboratory for Rheumatism and Immune Diagnosis; Peking-Tsinghua Center for Life Sciences; Priority Research Program of the Shandong Academy of Sciences; Shandong Province Taishan Scholar Program; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by the National Sci-Tech Support Program (grant no. 2014BAI07B01; Z.L.), the National Basic Research Program of China 973 Program (grant no. 2014CB541903 (D.Y.), 2014CB541901 (N.S.) and 2010CB529104 (Z.L.)), the National Natural Science Foundation of China (NSFC) (grant no. 81373117 (J.H.), 31570880 (J.H.), 31530020 (Z.L.), 81429003 (D.Y.) and 81471601 (X.S.)), the Beijing Key Laboratory for Rheumatism and Immune Diagnosis (grant no. BZ0135; Z.L.), the Peking-Tsinghua Center for Life Sciences (Z.L.), the Priority Research Program of the Shandong Academy of Sciences (D.Y.), the Shandong Province Taishan Scholar Program (D.Y.) and the Australian National Health and Medical Research Council (NHMRC) Fellowship GNT1085509 (D.Y.).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Castela E, 2014, JAMA DERMATOL, V150, P748, DOI 10.1001/jamadermatol.2014.504; Choi JY, 2015, ARTHRITIS RHEUMATOL, V67, P988, DOI 10.1002/art.39020; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Furie RA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1143, DOI 10.1002/art.24698; Hartemann A, 2013, LANCET DIABETES ENDO, V1, P295, DOI 10.1016/S2213-8587(13)70113-X; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoes JN, 2007, ANN RHEUM DIS, V66, P1560, DOI 10.1136/ard.2007.072157; Humrich JY, 2015, ANN RHEUM DIS, V74, P791, DOI 10.1136/annrheumdis-2014-206506; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lieberman LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740619; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shin MS, 2011, CURR OPIN RHEUMATOL, V23, P444, DOI 10.1097/BOR.0b013e328349a255; Vincent FB, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4277; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499	27	332	369	5	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					991	+		10.1038/nm.4148	http://dx.doi.org/10.1038/nm.4148			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27500725				2022-12-25	WOS:000382542800009
J	Li, S; Garrett-Bakelman, FE; Chung, SS; Sanders, MA; Hricik, T; Rapaport, F; Patel, J; Dillon, R; Vijay, P; Brown, AL; Perl, AE; Cannon, J; Bullinger, L; Luger, S; Becker, M; Lewis, ID; To, LB; Delwel, R; Lowenberg, B; Dohner, H; Guzman, ML; Hassane, DC; Roboz, GJ; Grimwade, D; Valk, PJM; D'Andrea, RJ; Carroll, M; Park, CY; Neuberg, D; Levine, R; Melnick, AM; Mason, CE				Li, Sheng; Garrett-Bakelman, Francine E.; Chung, Stephen S.; Sanders, Mathijs A.; Hricik, Todd; Rapaport, Franck; Patel, Jay; Dillon, Richard; Vijay, Priyanka; Brown, Anna L.; Perl, Alexander E.; Cannon, Joy; Bullinger, Lars; Luger, Selina; Becker, Michael; Lewis, Ian D.; To, Luen Bik; Delwel, Ruud; Lowenberg, Bob; Doehner, Hartmut; Guzman, Monica L.; Hassane, Duane C.; Roboz, Gail J.; Grimwade, David; Valk, Peter J. M.; D'Andrea, Richard J.; Carroll, Martin; Park, Christopher Y.; Neuberg, Donna; Levine, Ross; Melnick, Ari M.; Mason, Christopher E.			Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia	NATURE MEDICINE			English	Article							CLONAL EVOLUTION; DNA METHYLATION; MUTATIONS RESULT; TET2 FUNCTION; CHEMOTHERAPY; CTCF; AML	Genetic heterogeneity contributes to clinical outcome and progression of most tumors, but little is known about allelic diveisity for epigenetic compartments, and almost no data exist for acute myeloid leukemia (AML). We examined epigenetic heterogeneity as assessed by cytosine methylation within defined genomic loci with four CpGs (epialleles), somatic mutations, and transcriptomes of AML patient samples at serial time points. We observed that epigenetic allele burden is linked to inferior outcome and varies considerably during disease progression. Epigenetic and genetic allelic burden and patterning followed different patterns and kinetics during disease progression. We observed a subset of AMLs with high epiallele and low somatic mutation burden at diagnosis, a subset with high somatic mutation and lower epiallele burdens at diagnosis, and a subset with a mixed profile, suggesting distinct modes of tumor heterogeneity. Genes linked to promoter-associated epiallele shifts during tumor progression showed increased single-cell transcriptional variance and differential expression, suggesting functional impact on gene regulation. Thus, genetic and epigenetic heterogeneity can occur with distinct kinetics likely to affect the biological and clinical features of tumors.	[Li, Sheng; Mason, Christopher E.] Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA; [Li, Sheng; Mason, Christopher E.] Weill Cornell Med, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al Sa, New York, NY 10065 USA; [Garrett-Bakelman, Francine E.; Guzman, Monica L.; Hassane, Duane C.; Roboz, Gail J.; Melnick, Ari M.] Weill Cornell Med, Div Hematol Med Oncol, Dept Med, New York, NY 10065 USA; [Chung, Stephen S.; Hricik, Todd; Rapaport, Franck; Patel, Jay; Levine, Ross] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Sanders, Mathijs A.; Delwel, Ruud; Lowenberg, Bob; Valk, Peter J. M.] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; [Dillon, Richard; Grimwade, David] Kings Coll London, Dept Med & Mol Genet, Fac Life Sci & Med, London, England; [Vijay, Priyanka] Weill Cornell Med, Triinst Training Program Computat Biol & Med, New York, NY USA; [Brown, Anna L.; Lewis, Ian D.; D'Andrea, Richard J.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Brown, Anna L.; Lewis, Ian D.; D'Andrea, Richard J.] Univ South Australia, Adelaide, SA, Australia; [Brown, Anna L.; D'Andrea, Richard J.] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Brown, Anna L.; Lewis, Ian D.; To, Luen Bik; D'Andrea, Richard J.] SA Pathol, Dept Hematol, Adelaide, SA, Australia; [Brown, Anna L.; Lewis, Ian D.; To, Luen Bik; D'Andrea, Richard J.] Royal Adelaide Hosp, Adelaide, SA, Australia; [Perl, Alexander E.; Cannon, Joy; Luger, Selina; Carroll, Martin] Univ Penn, Div Hematol & Oncol, Philadelphia, PA 19104 USA; [Bullinger, Lars; Doehner, Hartmut; Guzman, Monica L.] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Becker, Michael] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Lewis, Ian D.; To, Luen Bik] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Park, Christopher Y.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Park, Christopher Y.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Mason, Christopher E.] Feil Family Brain & Mind Res Inst, New York, NY USA; [Li, Sheng] Weill Cornell Med, Dept Neurosurg, New York, NY USA	Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; University of London; King's College London; Cornell University; Centre for Cancer Biology; SA Pathology; University of South Australia; University of South Australia; SA Pathology; Royal Adelaide Hospital; University of Pennsylvania; Ulm University; University of Rochester; University of Adelaide; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Cornell University	Mason, CE (corresponding author), Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA.; Mason, CE (corresponding author), Weill Cornell Med, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al Sa, New York, NY 10065 USA.; Melnick, AM (corresponding author), Weill Cornell Med, Div Hematol Med Oncol, Dept Med, New York, NY 10065 USA.; Mason, CE (corresponding author), Feil Family Brain & Mind Res Inst, New York, NY USA.	amm2014@med.cornell.edu; chm2042@med.cornell.edu	Melnick, Ari/AAA-5763-2020; levine, ross/AAE-7658-2019; Valk, Peter/AAX-2823-2020; Döhner, Hartmut/C-8933-2016; Hassane, Duane/AAA-3456-2021; Mason, Christopher/HCH-3977-2022; Patel, Jay/HDM-6251-2022; Bullinger, Lars/AAL-7965-2020	Döhner, Hartmut/0000-0003-2116-5536; Brown, Anna/0000-0002-9023-0138; Dillon, Richard/0000-0001-9333-5296; Hassane, Duane/0000-0002-0719-9572; D'Andrea, Richard/0000-0002-4915-4612; Bullinger, Lars/0000-0002-5890-5510; Rapaport, Franck/0000-0001-6553-2110	Starr Cancer Consortium [I4-A442, I7-A765, I9-A9-071]; Irma T. Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; Bert L. and N. Kuggie Vallee Foundation; WorldQuant Foundation; Pershing Square Sohn Cancer Research Alliance; NASA [NNX14AH50G]; LLS SCOR [7006-13]; NCI [K08CA169055]; American Society of Hematology award under the ASH-AMFDP partnership [ASHAMFDP-20121]; Robert Wood Johnson Foundation; ASH/EHA TRTH; Doris Duke Medical Foundation; Leukemia and Lymphoma Society Translational Research Program; Geoffrey Beene Cancer Center; Leukaemia and Lymphoma Research award; German Research Foundation (DFG) [SFB 1074]; DFG Heisenberg-Stipendium [BU 1339/3-1]; Australian National Health and Medical Research Council; Royal Adelaide Hospital Contributing Haematologists Fund; US National Institutes of Health [R01CA102031, R01NS076465]; Leukemia Fighters funding; NATIONAL CANCER INSTITUTE [R21CA176362, R01CA198089, K08CA169055, R01CA172546, R01CA102031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1151054] Funding Source: researchfish	Starr Cancer Consortium; Irma T. Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; Bert L. and N. Kuggie Vallee Foundation; WorldQuant Foundation; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); NASA(National Aeronautics & Space Administration (NASA)); LLS SCOR; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Hematology award under the ASH-AMFDP partnership; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); ASH/EHA TRTH; Doris Duke Medical Foundation(Doris Duke Charitable Foundation (DDCF)); Leukemia and Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Geoffrey Beene Cancer Center; Leukaemia and Lymphoma Research award; German Research Foundation (DFG)(German Research Foundation (DFG)); DFG Heisenberg-Stipendium(German Research Foundation (DFG)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Royal Adelaide Hospital Contributing Haematologists Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Fighters funding; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative	We thank J. Phillips, J. Ishii, L. Wang, J. Busuttil, T. Lee, P. Zumbo, J. Gandara, and A. Zeilemaker for technical support; C. Sheridan for technical support, assistance with organization, and maintenance of sample database and banking; M. Perugini, D. Iarossi, and I.S. Tiong for assistance with clinical database management; and Y. Neelamraju, Z. Li, J. Glass, and M.R. De Massy for data annotation and management. Next-generation sequencing protocols and sequencing were performed by the Weill Cornell Medicine Epigenomics Core and the New York Genome Center. We thank A. Viale from the Integrated Genomics Operation and N. Socci from the bioinformatics core at Memorial Sloan Kettering Cancer Center for sequencing services. We thank the South Australian Cancer Research Biobank for access to clinical samples. We thank F. Michor for recommendations regarding data analyses. This work was supported by Starr Cancer Consortium grant I4-A442 (A.M.M., R.L., and C.E.M.), STARR Cancer Consortium grant I7-A765 and I9-A9-071 (C.E.M.), the Irma T. Hirschl and Monique Weill-Caulier Charitable Trusts, Bert L. and N. Kuggie Vallee Foundation and the WorldQuant Foundation, Pershing Square Sohn Cancer Research Alliance, and NASA (NNX14AH50G) (C.E.M.); LLS SCOR 7006-13 (A.M.M.); NCI K08CA169055 (F.E.G.-B.); an American Society of Hematology (ASHAMFDP-20121) award under the ASH-AMFDP partnership with the Robert Wood Johnson Foundation and ASH/EHA TRTH (F.E.G.-B.); a Doris Duke Medical Foundation, Leukemia and Lymphoma Society Translational Research Program, and Geoffrey Beene Cancer Center (C.Y.P.); a Leukaemia and Lymphoma Research award (D.G. and R. Dillon); German Research Foundation (DFG) grant SFB 1074 (project B3; K.D. and L.B.); DFG Heisenberg-Stipendium BU 1339/3-1 (L.B.); an Australian National Health and Medical Research Council and the Royal Adelaide Hospital Contributing Haematologists Fund financial support (R.J.D., A.L.B., and I.D.L.); US National Institutes of Health R01CA102031 (G.J.R. and M.L.G.) and R01NS076465 (C.E.M. and A.M.M.); and Leukemia Fighters funding (G.J.R., M.L.G., and D.C.H.).	Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Chambwe N, 2014, BLOOD, V123, P1699, DOI 10.1182/blood-2013-07-509885; Chou WC, 2011, LEUKEMIA, V25, P246, DOI 10.1038/leu.2010.267; De S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003137; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Garrett-Bakelman FE, 2015, JOVE-J VIS EXP, DOI 10.3791/52246; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kemp CJ, 2014, CELL REP, V7, P1020, DOI 10.1016/j.celrep.2014.04.004; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kronke J, 2013, BLOOD, V122, P100, DOI 10.1182/blood-2013-01-479188; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Landau DA, 2014, LEUKEMIA, V28, P34, DOI 10.1038/leu.2013.248; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0472-5; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Mroz EA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001786; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pan H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7921; Parkin B, 2013, BLOOD, V121, P369, DOI 10.1182/blood-2012-04-427039; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Rampal R, 2014, CELL REP, V9, P1841, DOI 10.1016/j.celrep.2014.11.004; Roboz GJ, 2012, CURR OPIN ONCOL, V24, P711, DOI 10.1097/CCO.0b013e328358f62d; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Tawana K, 2015, BLOOD, V126, P1214, DOI 10.1182/blood-2015-05-647172; TESTA JR, 1979, CANCER RES, V39, P3619; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	48	219	224	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					792	799		10.1038/nm.4125	http://dx.doi.org/10.1038/nm.4125			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27322744	Green Accepted			2022-12-25	WOS:000379366900018
J	D'Lima, NG; Ma, J; Winkler, L; Chu, Q; Loh, KH; Corpuz, EO; Budnik, BA; Lykke-Andersen, J; Saghatelian, A; Slavoff, SA				D'Lima, Nadia G.; Ma, Jiao; Winkler, Lauren; Chu, Qian; Loh, Ken H.; Corpuz, Elizabeth O.; Budnik, Bogdan A.; Lykke-Andersen, Jens; Saghatelian, Alan; Slavoff, Sarah A.			A human microprotein that interacts with the mRNA decapping complex	NATURE CHEMICAL BIOLOGY			English	Article							P-BODY FORMATION; PROCESSING BODIES; REFERENCE GENOME; MAMMALIAN-CELLS; P53 MUTATIONS; IN-VIVO; DECAY; IDENTIFICATION; TRANSLATION; DISCOVERY	Proteomic detection of non-annotated microproteins indicates the translation of hundreds of small open reading frames (smORFs) in human cells, but whether these microproteins are functional or not is unknown. Here, we report the discovery and characterization of a 7-kDa human microprotein we named non-annotated P-body dissociating polypeptide (NoBody). NoBody interacts with mRNA decapping proteins, which remove the 5' cap from mRNAs to promote 5'-to-3' decay. Decapping proteins participate in mRNA turnover and nonsense-mediated decay (NMD). NoBody localizes to mRNA-decay-associated RNA-protein granules called P-bodies. Modulation of NoBody levels reveals that its abundance is anticorrelated with cellular P-body numbers and alters the steady-state levels of a cellular NMD substrate. These results implicate NoBody as a novel component of the mRNA decapping complex and demonstrate potential functionality of a newly discovered microprotein.	[D'Lima, Nadia G.; Winkler, Lauren; Slavoff, Sarah A.] Yale Univ, Dept Chem & Chem Biol, Inst Chem Biol, New Haven, CT USA; [Ma, Jiao; Chu, Qian; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Peptide Biol Lab, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Loh, Ken H.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Corpuz, Elizabeth O.; Lykke-Andersen, Jens] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Budnik, Bogdan A.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Yale University; Salk Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Harvard University	Slavoff, SA (corresponding author), Yale Univ, Dept Chem & Chem Biol, Inst Chem Biol, New Haven, CT USA.; Saghatelian, A (corresponding author), Salk Inst Biol Studies, Clayton Fdn Peptide Biol Lab, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	asaghatelian@salk.edu; sarah.slavoff@yale.edu	slavoff, sarah/HIK-2036-2022; Budnik, Bogdan/AAH-9987-2019; Budnik, Bogdan/AGG-8824-2022	Budnik, Bogdan/0000-0003-3622-2003; Chu, Qian/0000-0001-6550-6975; Lykke-Andersen, Jens/0000-0003-1821-0754; Slavoff, Sarah/0000-0002-4443-2070	George E. Hewitt Foundation for medical research Postdoctoral Fellowship; NIH [R01 GM102491]; NCI Cancer Center Support Grant P30 [CA014195 MASS]; The Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; Yale University West Campus start-up funds; American Cancer Society Institutional Research Grant Individual Award for New Investigators from the Yale Cancer Center [IRG-58-012-57]; NIH Ruth L. Kirchstein postdoctoral fellowship [1F32GM099408]; Anderson Endowed Postdoctoral Fellowship in the Biological Sciences; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118069, R01GM102491, F32GM099408] Funding Source: NIH RePORTER	George E. Hewitt Foundation for medical research Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant P30; The Leona M. and Harry B. Helmsley Charitable Trust; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; Yale University West Campus start-up funds; American Cancer Society Institutional Research Grant Individual Award for New Investigators from the Yale Cancer Center; NIH Ruth L. Kirchstein postdoctoral fellowship; Anderson Endowed Postdoctoral Fellowship in the Biological Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Ting for the generous use of her Zeiss Axio Observer inverted confocal microscope. This study was supported by a George E. Hewitt Foundation for medical research Postdoctoral Fellowship (Q.C.), NIH (R01 GM102491, A.S.), the NCI Cancer Center Support Grant P30 (CA014195 MASS core, A.S.), The Leona M. and Harry B. Helmsley Charitable Trust grant (#2012-PG-MED002, A.S.), and Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals (A.S.). S.A.S. was supported by Yale University West Campus start-up funds, an American Cancer Society Institutional Research Grant Individual Award for New Investigators from the Yale Cancer Center (IRG-58-012-57) and a NIH Ruth L. Kirchstein postdoctoral fellowship (1F32GM099408). N.G.D. was supported by an Anderson Endowed Postdoctoral Fellowship in the Biological Sciences.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Fillman C, 2005, CURR OPIN CELL BIOL, V17, P326, DOI 10.1016/j.ceb.2005.04.002; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009; LEHMAN TA, 1991, CANCER RES, V51, P4090; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Li Y, 2011, RNA, V17, P419, DOI 10.1261/rna.2439811; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Martin L, 2014, CANCER RES, V74, P3104, DOI 10.1158/0008-5472.CAN-13-2235; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Nickless A, 2014, NAT MED, V20, P961, DOI 10.1038/nm.3620; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Peng XX, 2015, NUCLEIC ACIDS RES, V43, pD737, DOI 10.1093/nar/gku1110; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Saghatelianr A, 2015, NAT CHEM BIOL, V11, P909, DOI 10.1038/nchembio.1964; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Slavoff SA, 2014, J BIOL CHEM, V289, P10950, DOI 10.1074/jbc.C113.533968; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Storz G, 2014, ANNU REV BIOCHEM, V83, P753, DOI 10.1146/annurev-biochem-070611-102400; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Vanderperre B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070698; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	37	143	148	6	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					174	180		10.1038/NCHEMBIO.2249	http://dx.doi.org/10.1038/NCHEMBIO.2249			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27918561	Green Accepted, Green Submitted			2022-12-25	WOS:000393533000012
J	Kagan, VE; Mao, GW; Qu, F; Angeli, JPF; Doll, S; St Croix, C; Dar, HH; Liu, B; Tyurin, VA; Ritov, VB; Kapralov, AA; Amoscato, AA; Jiang, JF; Anthonymuthu, T; Mohammadyani, D; Yang, Q; Proneth, B; Klein-Seetharaman, J; Watkins, S; Bahar, H; Greenberger, J; Mallampalli, RK; Stockwell, BR; Tyurina, YY; Conrad, M; Bayir, H				Kagan, Valerian E.; Mao, Gao Wei; Qu, Feng; Angeli, Jose Pedro Friedmann; Doll, Sebastian; St Croix, Claudette; Dar, Haider Hussain; Liu, Bing; Tyurin, Vladimir A.; Ritov, Vladimir B.; Kapralov, Alexandr A.; Amoscato, Andrew A.; Jiang, Jianfei; Anthonymuthu, Tamil; Mohammadyani, Dariush; Yang, Qin; Proneth, Bettina; Klein-Seetharaman, Judith; Watkins, Simon; Bahar, Hiet; Greenberger, Joel; Mallampalli, Rama K.; Stockwell, Brent R.; Tyurina, Yulia Y.; Conrad, Marcus; Bayir, Hulya			Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis	NATURE CHEMICAL BIOLOGY			English	Article							GLUTATHIONE-PEROXIDASE 4; VITAMIN-E ACTION; LIPID-PEROXIDATION; AMINOPHOSPHOLIPID ASYMMETRY; MOLECULAR-BASIS; DEATH; LIPOXYGENASE; OXIDATION; MECHANISM; PROBE	Enigmatic lipid peroxidation products have been claimed as the proximate executioners of ferroptosis-a specialized death program triggered by insufficiency of glutathione peroxidase 4 (GPX4). Using quantitative redox lipidomics, reverse genetics, bioinformatics and systems biology, we discovered that ferroptosis involves a highly organized oxygenation center, wherein oxidation in endoplasmic-reticulum-associated compartments occurs on only one class of phospholipids (phosphatidylethanolamines (PEs)) and is specific toward two fatty acyls-arachidonoyl (AA) and adrenoyl (AdA). Suppression of AA or AdA esterification into PE by genetic or pharmacological inhibition of acyl-CoA synthase 4 (ACSL4) acts as a specific antiferroptotic rescue pathway. Lipoxygenase (LOX) generates doubly and triply-oxygenated (15-hydroperoxy)-diacylated PE species, which act as death signals, and tocopherols and tocotrienols (vitamin E) suppress LOX and protect against ferroptosis, suggesting a homeostatic physiological role for vitamin E. This oxidative PE death pathway may also represent a target for drug discovery.	[Kagan, Valerian E.; Mao, Gao Wei; Qu, Feng; Dar, Haider Hussain; Tyurin, Vladimir A.; Ritov, Vladimir B.; Kapralov, Alexandr A.; Amoscato, Andrew A.; Jiang, Jianfei; Mohammadyani, Dariush; Tyurina, Yulia Y.; Bayir, Hulya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.; Greenberger, Joel] Univ Pittsburgh, Dept Radiat Oncol, Pittsburgh, PA 15260 USA; [Mao, Gao Wei; Anthonymuthu, Tamil; Yang, Qin; Bayir, Hulya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Angeli, Jose Pedro Friedmann; Doll, Sebastian; Proneth, Bettina; Conrad, Marcus] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [St Croix, Claudette; Watkins, Simon] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA; [Liu, Bing; Bahar, Hiet] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Klein-Seetharaman, Judith] Univ Warwick, Div Metab & Vasc Hlth, Coventry, W Midlands, England; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Stockwell, Brent R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Warwick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Columbia University	Kagan, VE; Bayir, H (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA.; Kagan, VE (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.; Kagan, VE (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.; Kagan, VE (corresponding author), Univ Pittsburgh, Dept Radiat Oncol, Pittsburgh, PA 15260 USA.; Bayir, H (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA.; Conrad, M (corresponding author), Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany.	kagan@pitt.edu; marcus.conrad@helmholtz-muenchen.de; bayihx@ccm.upmc.edu	Angeli, J Pedro Friedmann/ABG-6270-2020; Anthonymuthu, Tamil/I-5534-2019; Watkins, Simon/ABG-2590-2021; St Croix, Claudette/AAA-3338-2022; Stockwell, Brent R/AAE-7200-2019; Dar, Haider/AAE-3582-2021; Proneth, Bettina/AGZ-9097-2022; Conrad, Marcus/E-8792-2015; DAR, HILAL/HHM-3664-2022; Liu, Bing/G-1899-2012	Angeli, J Pedro Friedmann/0000-0001-7706-1379; Watkins, Simon/0000-0003-4092-1552; Stockwell, Brent R/0000-0002-3532-3868; Conrad, Marcus/0000-0003-1140-5612; Tyurina, Yulia/0000-0003-0287-2091; Amoscato, Andrew/0000-0002-1340-9150; Kagan, Valerian E./0000-0002-7245-1885; Liu, Bing/0000-0002-7257-2441; Doll, Sebastian/0000-0002-8933-5362; Greenberger, Joel/0000-0003-2271-7566; Yang, Qin/0000-0001-8690-4809; Tyurin, Vladimir/0000-0002-3474-1697; Kapralov, Oleksandr/0000-0002-3006-916X; Dar, Haider H./0000-0001-9586-7288	US National Institutes of Health [P01HL114453, U19AI068021, N5076511, N5061817, P41GM103712, ES020693]; Human Frontier Science Program [HFSP-RGP0013/2014]; Deutsche Forschungsgemeinschaft [CO 291/2-3, CO 291/5-1]; NATIONAL CANCER INSTITUTE [R35CA209896] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081784, P01HL114453, R01HL097376, R01HL098174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084604, R01NS061817, R01NS076511] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Ruzicka (Thermo Fisher Scientific) for help in obtaining MS<SUP>3</SUP> spectra of PE oxidation products using tribrid Fusion Lumos. Supported by the US National Institutes of Health (P01HL114453 to R.K.M., U19AI068021 to J.G., N5076511 to V.E.K., N5061817 to H.B., P41GM103712 to I.B. and ES020693 to Y.Y.T.), the Human Frontier Science Program (HFSP-RGP0013/2014), and the Deutsche Forschungsgemeinschaft (CO 291/2-3 and CO 291/5-1) to M.C.	Allocati N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.570; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; ARAI H, 1995, LIPIDS, V30, P135, DOI 10.1007/BF02538266; Askari B, 2007, DIABETES, V56, P1143, DOI 10.2337/db06-0267; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Byrne JM, 2015, SCIENCE, V347, P1473, DOI 10.1126/science.aaa4834; Carlson BA, 2016, REDOX BIOL, V9, P22, DOI 10.1016/j.redox.2016.05.003; Chen LJ, 2015, J BIOL CHEM, V290, P28097, DOI 10.1074/jbc.M115.680090; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dixon SJ, 2015, ACS CHEM BIOL, V10, P1604, DOI 10.1021/acschembio.5b00245; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S., 2016, NAT CHEM BIOL; Drummen GPC, 2002, FREE RADICAL BIO MED, V33, P473, DOI 10.1016/S0891-5849(02)00848-1; Garreta A, 2013, FASEB J, V27, P4811, DOI 10.1096/fj.13-235952; Golej DL, 2011, J LIPID RES, V52, P782, DOI 10.1194/jlr.M013292; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Kuch EM, 2014, BBA-MOL CELL BIOL L, V1841, P227, DOI 10.1016/j.bbalip.2013.10.018; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Li B, 2015, FREE RADICAL BIO MED, V82, P187, DOI 10.1016/j.freeradbiomed.2015.01.020; Massey KA, 2011, BIOCHEM SOC T, V39, P1240, DOI 10.1042/BST0391240; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; Noguchi N, 2002, BIOL CHEM, V383, P619, DOI 10.1515/BC.2002.064; O'Donnell VB, 2012, BLOOD, V120, P1985, DOI 10.1182/blood-2012-04-402826; Orrenius S, 2005, NAT CHEM BIOL, V1, P188, DOI 10.1038/nchembio0905-188; SCHROEDER F, 1980, BIOCHIM BIOPHYS ACTA, V599, P254, DOI 10.1016/0005-2736(80)90072-3; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Sen CK, 2000, J BIOL CHEM, V275, P13049, DOI 10.1074/jbc.275.17.13049; SESSIONS A, 1981, FEBS LETT, V134, P75, DOI 10.1016/0014-5793(81)80554-6; Soh N, 2007, ORG BIOMOL CHEM, V5, P3762, DOI 10.1039/b713223a; Suardiaz R, 2016, J CHEM THEORY COMPUT, V12, P2079, DOI 10.1021/acs.jctc.5b01236; Toppo S, 2009, BBA-GEN SUBJECTS, V1790, P1486, DOI 10.1016/j.bbagen.2009.04.007; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Wortmann M, 2013, CIRC RES, V113, P408, DOI 10.1161/CIRCRESAHA.113.279984; Xiao Y, 2012, J LIPID RES, V53, P1610, DOI 10.1194/jlr.M027185; Yamanaka K, 2012, RSC ADV, V2, P7894, DOI 10.1039/c2ra20816d; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010	43	902	949	40	520	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					81	90		10.1038/NCHEMBIO.2238	http://dx.doi.org/10.1038/NCHEMBIO.2238			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27842066	Green Accepted			2022-12-25	WOS:000393267200017
J	Rose, JC; Huang, PS; Camp, ND; Ye, J; Leidal, AM; Goreshnik, I; Trevillian, BM; Dickinson, MS; Cunningham-Bryant, D; Debnath, J; Baker, D; Wolf-Yadlin, A; Maly, DJ				Rose, John C.; Huang, Po-Ssu; Camp, Nathan D.; Ye, Jordan; Leidal, Andrew M.; Goreshnik, Inna; Trevillian, Bridget M.; Dickinson, Miles S.; Cunningham-Bryant, Daniel; Debnath, Jayanta; Baker, David; Wolf-Yadlin, Alejandro; Maly, Dustin J.			A computationally engineered RAS rheostat reveals RAS-ERK signaling dynamics	NATURE CHEMICAL BIOLOGY			English	Article							RAF-1; PHOSPHORYLATION; ACTIVATION; MUTATIONS; COOPERATE; GROWTH; BRAF; INHIBITOR; FEEDBACK; KINASES	Synthetic protein switches controlled with user-defined inputs are powerful tools for studying and controlling dynamic cellular processes. To date, these approaches have relied primarily on intermolecular regulation. Here we report a computationally guided framework for engineering intramolecular regulation of protein function. We utilize this framework to develop chemically inducible activator of RAS (CIAR), a single-component RAS rheostat that directly activates endogenous RAS in response to a small molecule. Using CIAR, we show that direct RAS activation elicits markedly different RAS-ERK signaling dynamics from growth factor stimulation, and that these dynamics differ among cell types. We also found that the clinically approved RAF inhibitor vemurafenib potently primes cells to respond to direct wild-type RAS activation. These results demonstrate the utility of CIAR for quantitatively interrogating RAS signaling. Finally, we demonstrate the general utility of our approach in design of intramolecularly regulated protein tools by applying it to the Rho family of guanine nucleotide exchange factors.	[Rose, John C.; Trevillian, Bridget M.; Dickinson, Miles S.; Cunningham-Bryant, Daniel; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Huang, Po-Ssu; Goreshnik, Inna; Baker, David; Maly, Dustin J.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Huang, Po-Ssu; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Camp, Nathan D.; Wolf-Yadlin, Alejandro] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Ye, Jordan; Leidal, Andrew M.; Debnath, Jayanta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Ye, Jordan; Leidal, Andrew M.; Debnath, Jayanta] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Huang, Po-Ssu] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Stanford University	Maly, DJ (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.; Maly, DJ (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	maly@chem.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Huang, Possu/0000-0002-7948-2895; Debnath, Jayanta/0000-0002-8745-4069; Camp, Nathan/0000-0002-1216-5262; Rose, John/0000-0003-1810-4337; Cunningham-Bryant, Daniel/0000-0003-0756-475X; Maly, Dustin/0000-0003-0094-0177; Leidal, Andrew/0000-0002-4001-3266	US National Institutes of Health (NIH) [R01GM086858, R01CA126792, F30CA189793]; National Science Foundation CAREER award [CHE-0954242]; US Department of Defense Breast Cancer Research Program (BCRP) [W81XWH-11-1-0130]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA126792, F30CA189793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086858, T32GM007266] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER award(National Science Foundation (NSF)); US Department of Defense Breast Cancer Research Program (BCRP)(United States Department of Defense); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	E. Campeau (Zenith Epigenetics) provided the pLenti_CMV_GFP_Puro (658-5) plasmid, and M. Meyerson (Dana-Farber Cancer Institute) provided pBABEpuroCRAF. This research was supported by US National Institutes of Health (NIH) grants R01GM086858 (D.J.M.), R01CA126792 (J.D.) and F30CA189793 (J.C.R.), a National Science Foundation CAREER award CHE-0954242 (D.J.M.), the US Department of Defense Breast Cancer Research Program (BCRP) (W81XWH-11-1-0130) and the Howard Hughes Medical Institute (P.-S.H. and D.B.).	Ambroggio XI, 2006, CURR OPIN STRUC BIOL, V16, P525, DOI 10.1016/j.sbi.2006.05.014; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Buskirk AR, 2005, CHEM BIOL, V12, P151, DOI 10.1016/j.chembiol.2004.11.012; Callahan MK, 2014, CANCER IMMUNOL RES, V2, P70, DOI 10.1158/2326-6066.CIR-13-0160; Courcelles M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.25; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Dueber JE, 2007, NAT BIOTECHNOL, V25, P660, DOI 10.1038/nbt1308; Goreshnik I, 2010, J AM CHEM SOC, V132, P938, DOI 10.1021/ja907886v; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Karginov AV, 2010, NAT BIOTECHNOL, V28, P743, DOI 10.1038/nbt.1639; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/nmeth.1428, 10.1038/NMETH.1428]; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; Marquette A, 2011, NAT STRUCT MOL BIOL, V18, P584, DOI 10.1038/nsmb.2022; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; McPhillips F, 2006, CARCINOGENESIS, V27, P729, DOI 10.1093/carcin/bgi289; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tarcic G, 2012, FASEB J, V26, P1582, DOI 10.1096/fj.11-194654; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Vomastek T, 2008, MOL CELL BIOL, V28, P6954, DOI 10.1128/MCB.00925-08; Wixler V, 1996, FEBS LETT, V385, P131, DOI 10.1016/0014-5793(96)00363-8; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Zhang BH, 2001, J BIOL CHEM, V276, P31620, DOI 10.1074/jbc.M102808200; Zhou XX, 2012, SCIENCE, V338, P810, DOI 10.1126/science.1226854; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	50	13	13	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					119	126		10.1038/NCHEMBIO.2244	http://dx.doi.org/10.1038/NCHEMBIO.2244			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27870838	Green Accepted, Green Submitted			2022-12-25	WOS:000393267200022
J	Faber, ZJ; Chen, X; Gedman, AL; Boggs, K; Cheng, JJ; Ma, J; Radtke, I; Chao, JR; Walsh, MP; Song, GC; Andersson, AK; Dang, JJ; Dong, L; Liu, Y; Huether, R; Call, ZL; Mulder, H; Wu, G; Edmonson, M; Rusch, M; Qu, CX; Li, YJ; Vadodaria, B; Wang, JM; Hedlund, E; Cao, XY; Yergeau, D; Nakitandwe, J; Pounds, SB; Shurtleff, S; Fulton, RS; Fulton, LL; Easton, J; Parganas, E; Pui, CH; Rubnitz, JE; Dingo, L; Mardis, ER; Wilson, RK; Gruber, TA; Mullighan, CG; Schlenk, RF; Paschka, P; Dohner, K; Dohner, H; Bullinger, L; Zhang, JH; Klco, JM; Downing, JR				Faber, Zachary J.; Chen, Xiang; Gedman, Amanda Larson; Boggs, Kristy; Cheng, Jinjun; Ma, Jing; Radtke, Ina; Chao, Jyh-Rong; Walsh, Michael P.; Song, Guangchun; Andersson, Anna K.; Dang, Jinjun; Dong, Li; Liu, Yu; Huether, Robert; Call, Zhongling; Mulder, Heather; Wu, Gang; Edmonson, Michael; Rusch, Michael; Qu, Chunxu; Li, Yongjin; Vadodaria, Bhavin; Wang, Jianmin; Hedlund, Erin; Cao, Xueyuan; Yergeau, Donald; Nakitandwe, Joy; Pounds, Stanley B.; Shurtleff, Sheila; Fulton, Robert S.; Fulton, Lucinda L.; Easton, John; Parganas, Evan; Pui, Ching-Hon; Rubnitz, Jeffrey E.; Dingo, Li; Mardis, Elaine R.; Wilson, Richard K.; Gruber, Tanja A.; Mullighan, Charles G.; Schlenk, Richard F.; Paschka, Peter; Doehner, Konstanze; Doehner, Hartmut; Bullinger, Lars; Zhang, Jinghui; Klco, Jeffery M.; Downing, James R.			The genomic landscape of core-binding factor acute myeloid leukemias	NATURE GENETICS			English	Article							SOMATIC MUTATIONS; GENE-EXPRESSION; CYCLIN D2; C-KIT; TRANSCRIPTION FACTOR; CLONAL EVOLUTION; ZBTB7A MUTATIONS; COHESIN COMPLEX; FUSION GENE; AML	Acute myeloid leukemia (AML) comprises a heterogeneous group of leukemias frequently defined by recurrent cytogenetic abnormalities, including rearrangements involving the core binding factor (CBF) transcriptional complex. To better understand the genomic landscape of CBF-AMLs, we analyzed both pediatric (n = 87) and adult (n = 78) samples, including cases with RUNX1-RUNX1 T1 (n = 85) or CBFB-MYH11 (n = 80) rearrangements, by whole-genome or whole-exome sequencing. In addition to known mutations in the Ras pathway, we identified recurrent stabilizing mutations in CCND2, suggesting a previously unappreciated cooperating pathway in CBF-AML. Outside of signaling alterations, RUNX1-RUNXIT1 and CBFB-MYH11 AMLs demonstrated remarkably different spectra of cooperating mutations, as RUNX1-RUNX1T1 cases harbored recurrent mutations in DHX15 and ZBTB7A, as well as an enrichment of mutations in epigenetic regulators, including ASXL2 and the cohesin complex. This detailed analysis provides insights into the pathogenesis and development of CBF-AML, while highlighting dramatic differences in the landscapes of cooperating mutations for these related AML subtypes.	[Faber, Zachary J.; Gedman, Amanda Larson; Cheng, Jinjun; Radtke, Ina; Walsh, Michael P.; Song, Guangchun; Call, Zhongling; Nakitandwe, Joy; Shurtleff, Sheila; Parganas, Evan; Mullighan, Charles G.; Klco, Jeffery M.; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Chen, Xiang; Boggs, Kristy; Liu, Yu; Huether, Robert; Mulder, Heather; Wu, Gang; Edmonson, Michael; Rusch, Michael; Qu, Chunxu; Li, Yongjin; Vadodaria, Bhavin; Wang, Jianmin; Hedlund, Erin; Yergeau, Donald; Easton, John; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol & Bioinformat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Cao, Xueyuan; Pounds, Stanley B.] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Fulton, Robert S.; Fulton, Lucinda L.; Dingo, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, McDonnell Genome Inst, St Louis, MO USA; [Pui, Ching-Hon; Rubnitz, Jeffrey E.; Gruber, Tanja A.] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Schlenk, Richard F.; Paschka, Peter; Doehner, Konstanze; Doehner, Hartmut; Bullinger, Lars] Univ Ulm, Dept Internal Med 3, Ulm, Germany; [Andersson, Anna K.] Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Washington University (WUSTL); St Jude Children's Research Hospital; Ulm University; Lund University	Klco, JM; Downing, JR (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Zhang, JH (corresponding author), St Jude Childrens Res Hosp, Dept Computat Biol & Bioinformat, 332 N Lauderdale St, Memphis, TN 38105 USA.; Bullinger, L (corresponding author), Univ Ulm, Dept Internal Med 3, Ulm, Germany.	lars.bullinger@uniklinik-ulm.de; jinghui.zhang@stjude.org; jeffery.klco@stjude.org; james.downing@stjude.org	Zhang, Jing/GWZ-7332-2022; Döhner, Hartmut/C-8933-2016; Pui, Ching-Hon/N-8076-2018; Mardis, Elaine/W-2202-2019; LI, YONGJIN/E-1688-2011; Chen, Xiang/N-2524-2018; Schlenk, Richard/AAG-3218-2019; wang, jian/GVS-0711-2022; Bullinger, Lars/AAL-7965-2020; Mullighan, Charles/H-3253-2011; Klco, Jeffery/M-9717-2018; Rubnitz, Jeffrey E/N-2619-2018; Wu, Gang/M-8012-2014; Wilson, Richard K./AAF-4139-2019; Gruber, Tanja/AAH-1248-2021; Downing, James R./N-8102-2018; Rusch, Michael/AAG-1998-2019; Pounds, Stanley B/N-2480-2018	Döhner, Hartmut/0000-0003-2116-5536; Pui, Ching-Hon/0000-0003-0303-5658; Chen, Xiang/0000-0002-2499-8261; Mullighan, Charles/0000-0002-1871-1850; Klco, Jeffery/0000-0003-2961-6960; Rubnitz, Jeffrey E/0000-0001-9885-3527; Wu, Gang/0000-0002-1678-5864; Wilson, Richard K./0000-0002-1992-1358; Rusch, Michael/0000-0002-5363-1848; Pounds, Stanley B/0000-0002-9167-2114; Faber, Zachary/0000-0003-4517-2212; Hagstrom-Andersson, Anna/0000-0002-2904-1311; Easton, John/0000-0003-4503-6608; Bullinger, Lars/0000-0002-5890-5510	St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital; US National Institutes of Health [P30 CA021765, K08 HL116605]; Burroughs Wellcome Fund; German Bundesministerium fur Bildung and Forschung (BMBF) [01GI9981, 01KG0605]; Deutsche Krebshilfe [111911]; Deutsche Forschungsgemeinschaft (DFG) [DO 704/3-1]; DFG [SFB 1074]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL116605] Funding Source: NIH RePORTER	St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); German Bundesministerium fur Bildung and Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank all the patients and their parents from the St. Jude Children's Research Hospital (USA) and the adult patients and their families from the German Austrian AML Study Group (AMLSG). We thank the Tissue Resources Laboratory, the Flow Cytometry and Cell Sorting Core, and the Clinical Applications of Core Technology Laboratories of the Hartwell Center for Bioinformatics and Biotechnology of St. Jude Children's Research Hospital. This work was funded by the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project, the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital and grants from the US National Institutes of Health (P30 CA021765 and K08 HL116605 (J.M.K.)). C.G.M. is a Pew Scholar in Biomedical Sciences and a St. Baldrick's Scholar. J.M.K. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. This study was supported in part by grants 01GI9981 and 01KG0605 from the German Bundesministerium fur Bildung and Forschung (BMBF), grant 111911 from the Deutsche Krebshilfe and grant DO 704/3-1 from the Deutsche Forschungsgemeinschaft (DFG). K.D., H.D. and L.B. are supported by the Collaborative Research Center SFB 1074 funded by the DFG. L.B. is a Heisenberg Professor of the DFG (BU 1339/8-1).	Abdel-Wahab O, 2013, J EXP MED, V210, P2641, DOI 10.1084/jem.20131141; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; Bacher U, 2006, BLOOD, V107, P3847, DOI 10.1182/blood-2005-08-3522; Boissel N, 2006, LEUKEMIA, V20, P965, DOI 10.1038/sj.leu.2404188; Bose T, 2010, J CELL BIOL, V189, P201, DOI 10.1083/jcb.200912129; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Bowen DT, 2005, BLOOD, V106, P2113, DOI 10.1182/blood-2005-03-0867; Bullinger L, 2007, BLOOD, V110, P1291, DOI 10.1182/blood-2006-10-049783; Cai XW, 2015, CELL STEM CELL, V17, P165, DOI 10.1016/j.stem.2015.06.002; Care RS, 2003, BRIT J HAEMATOL, V121, P775, DOI 10.1046/j.1365-2141.2003.04362.x; Castilla LH, 1999, NAT GENET, V23, P144, DOI 10.1038/13776; Chen BB, 2012, BLOOD, V119, P3132, DOI 10.1182/blood-2011-06-358911; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Combs DJ, 2006, MOL CELL BIOL, V26, P523, DOI 10.1128/MCB.26.2.523-534.2006; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dolnik A, 2012, BLOOD, V120, pE83, DOI 10.1182/blood-2011-12-401471; Downing JR, 1999, BRIT J HAEMATOL, V106, P296, DOI 10.1046/j.1365-2141.1999.01377.x; Duployez N, 2016, BLOOD, V127, P2451, DOI 10.1182/blood-2015-12-688705; Edelmann J, 2012, BLOOD, V120, P4783, DOI 10.1182/blood-2012-04-423517; Farrar JE, 2016, CANCER RES, V76, P2197, DOI 10.1158/0008-5472.CAN-15-1015; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Haferlach C, 2010, LEUKEMIA, V24, P1065, DOI 10.1038/leu.2010.22; Hartmann L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11733; He J, 2016, BLOOD, V127, P3004, DOI 10.1182/blood-2015-08-664649; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Inoue D, 2013, J CLIN INVEST, V123, P4627, DOI 10.1172/JCI70739; Jiang L, 2015, NAT GENET, V47, P1061, DOI 10.1038/ng.3358; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Krauth MT, 2014, LEUKEMIA, V28, P1449, DOI 10.1038/leu.2014.4; Kuchenbauer F, 2006, BRIT J HAEMATOL, V134, P616, DOI 10.1111/j.1365-2141.2006.06229.x; Kuhn MWM, 2012, BLOOD, V119, pE67, DOI 10.1182/blood-2011-09-380444; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Lavallee VP, 2016, BLOOD, V127, P2498, DOI 10.1182/blood-2016-03-703868; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; Mayas RM, 2010, P NATL ACAD SCI USA, V107, P10020, DOI 10.1073/pnas.0906022107; Micol JB, 2014, BLOOD, V124, P1445, DOI 10.1182/blood-2014-04-571018; Mirzaa GM, 2014, NAT GENET, V46, P510, DOI 10.1038/ng.2948; Nanri T, 2005, LEUKEMIA, V19, P1673, DOI 10.1038/sj.leu.2403889; Nanri T, 2005, LEUKEMIA, V19, P1361, DOI 10.1038/sj.leu.2403803; Olsson L, 2016, BRIT J HAEMATOL, V174, P292, DOI 10.1111/bjh.14056; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Paschka P, 2013, BLOOD, V121, P170, DOI 10.1182/blood-2012-05-431486; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Schessl C, 2005, J CLIN INVEST, V115, P2159, DOI 10.1172/JCI24225; Sood R, 2016, LEUKEMIA, V30, P501, DOI 10.1038/leu.2015.141; Tie F, 2012, MOL CELL BIOL, V32, P2323, DOI 10.1128/MCB.06392-11; Valk PJM, 2004, HAEMATOLOGICA, V89, P106; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Yuan YZ, 2001, P NATL ACAD SCI USA, V98, P10398, DOI 10.1073/pnas.171321298; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	63	151	161	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1551	1556		10.1038/ng.3709	http://dx.doi.org/10.1038/ng.3709			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27798625	Green Accepted			2022-12-25	WOS:000389011100016
J	Rainkumar, N; Omelchenko, T; Silva-Gagliardi, NF; McGlade, CJ; Wijnholds, J; Anderson, KV				Rainkumar, Nitya; Omelchenko, Tatiana; Silva-Gagliardi, Nancy F.; McGlade, C. Jane; Wijnholds, Jan; Anderson, Kathryn V.			Crumbs2 promotes cell ingression during the epithelial-to-mesenchymal transition at gastrulation	NATURE CELL BIOLOGY			English	Article							PRIMITIVE STREAK; MOUSE EMBRYO; APICAL MEMBRANE; RENAL FIBROSIS; STEM-CELLS; PROTEIN; DROSOPHILA; POLARITY; CRB2; MUTATIONS	During gastrulation of the mouse embryo, individual cells ingress in an apparently stochastic pattern during the epithelial-to-mesenchymal transition (EMT). Here we define a critical role of the apical protein Crumbs2 (CRB2) in the gastrulation EMT. Static and live imaging show that ingressing cells in Crumbs2 mutant embryos become trapped at the primitive streak, where they continue to express the epiblast transcription factor SOX2 and retain thin E-cadherin-containing connections to the epiblast surface that trap them at the streak. CRB2 is distributed in a complex anisotropic pattern on apical cell edges, and the level of CRB2 on a cell edge is inversely correlated with the level of myosin IIB. The data suggest that the distributions of CRB2 and myosin IIB define which cells will ingress, and we propose that cells with high apical CRB2 are basally extruded from the epiblast by neighbouring cells with high levels of apical myosin.	[Rainkumar, Nitya; Anderson, Kathryn V.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA; [Rainkumar, Nitya] Cornell Univ, Weill Cornell Grad Sch Med Sci, Program Biochem & Struct Biol Cell & Dev Biol & M, 1300 York Ave, New York, NY 10065 USA; [Omelchenko, Tatiana] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cell Biol Program, 1275 York Ave, New York, NY 10065 USA; [Silva-Gagliardi, Nancy F.; McGlade, C. Jane] Univ Toronto, Arthur & Sonia Labatt Brain Tumor Res Ctr, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Silva-Gagliardi, Nancy F.; McGlade, C. Jane] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada; [Wijnholds, Jan] Leiden Univ, Med Ctr, Dept Ophthalmol, NL-2333 ZA Leiden, Netherlands; [Rainkumar, Nitya] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; MRC Laboratory Molecular Biology; University of London; University College London	Anderson, KV (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	k-anderson@ski.mskcc.org	Wijnholds, Jan/V-3896-2018	Wijnholds, Jan/0000-0003-0099-460X; Ramkumar, Nitya/0000-0002-4086-4562	NIH [R37 HD03455]; MSKCC Cancer Center Support Grant [P30 CA008748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD035455] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC Cancer Center Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the MSKCC Molecular Cytology and Mouse Genetics Core Facilities for valuable technical support. We thank the Hadjantonakis laboratory for the X-linked GFP and GFP-GPI strains. We thank M. Lewandoski for Brachyury-Cre mice. We thank J. Zallen, A.-K. Hadjantonakis, A. Hall, I. Migeotte, H. Kakkar and members of the Anderson laboratory for their helpful suggestions. The work was supported by NIH R37 HD03455 to K.V.A. and the MSKCC Cancer Center Support Grant (P30 CA008748).	Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; Alves CH, 2013, HUM MOL GENET, V22, P35, DOI 10.1093/hmg/dds398; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Arcila ME, 2015, CLIN CANCER RES, V21, P1935, DOI 10.1158/1078-0432.CCR-14-2124; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Campbell K, 2009, J CELL SCI, V122, P2604, DOI 10.1242/jcs.047183; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Ebarasi L, 2015, AM J HUM GENET, V96, P153, DOI 10.1016/j.ajhg.2014.11.014; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Fletcher GC, 2012, CURR BIOL, V22, P1116, DOI 10.1016/j.cub.2012.04.020; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Herion NJ, 2014, BIRTH DEFECTS RES A, V100, P608, DOI 10.1002/bdra.23283; Ishiuchi T, 2011, NAT CELL BIOL, V13, P860, DOI 10.1038/ncb2274; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.000885; Lemmers C, 2002, J BIOL CHEM, V277, P25408, DOI 10.1074/jbc.M202196200; Letizia A, 2013, J CELL SCI, V126, P2157, DOI 10.1242/jcs.122382; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Migeotte I, 2011, DEVELOPMENT, V138, P3011, DOI 10.1242/dev.059766; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Ramkumar N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005551; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Roper K, 2012, DEV CELL, V23, P939, DOI 10.1016/j.devcel.2012.09.013; Rozbicki E, 2015, NAT CELL BIOL, V17, P397, DOI 10.1038/ncb3138; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Slattum G, 2009, J CELL BIOL, V186, P693, DOI 10.1083/jcb.200903079; Slattum GM, 2014, NAT REV CANCER, V14, P495, DOI 10.1038/nrc3767; Slavotinek A, 2015, AM J HUM GENET, V96, P162, DOI 10.1016/j.ajhg.2014.11.013; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; Voiculescu O, 2014, ELIFE, V3, DOI 10.7554/eLife.01817; Whiteman EL, 2014, MOL CELL BIOL, V34, P43, DOI 10.1128/MCB.00999-13; Williams M, 2012, DEV DYNAM, V241, P270, DOI 10.1002/dvdy.23711; Xiao ZJ, 2011, DEV DYNAM, V240, P2646, DOI 10.1002/dvdy.22778; Zou J, 2012, DEV CELL, V22, P1261, DOI 10.1016/j.devcel.2012.03.007	53	49	51	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2016	18	12					1281	+		10.1038/ncb3442	http://dx.doi.org/10.1038/ncb3442			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	ED8PY	27870829	Green Accepted, Green Submitted			2022-12-25	WOS:000389134600006
J	Loh, PR; Danecek, P; Palamara, PF; Fuchsberger, C; Reshef, YA; Finucane, HK; Schoenherr, S; Forer, L; McCarthy, S; Abecasis, GR; Durbin, R; Price, AL				Loh, Po-Ru; Danecek, Petr; Palamara, Pier Francesco; Fuchsberger, Christian; Reshef, Yakir A.; Finucane, Hilary K.; Schoenherr, Sebastian; Forer, Lukas; McCarthy, Shane; Abecasis, Goncalo R.; Durbin, Richard; Price, Alkes L.			Reference-based phasing using the Haplotype Reference Consortium panel	NATURE GENETICS			English	Article							GENETIC EPIDEMIOLOGY RESEARCH; AGING GERA COHORT; GENOTYPE IMPUTATION; LINKAGE DISEQUILIBRIUM; ADULT HEALTH; DATA SETS; INFERENCE; RECONSTRUCTION; ASSOCIATION; SEQ	Haplotype phasing is a fundamental problem in medical and population genetics. Phasing is generally performed via statistical phasing in a genotyped cohort, an approach that can yield high accuracy in very large cohorts but attains lower accuracy in smaller cohorts. Here we instead explore the paradigm of reference-based phasing. We introduce a new phasing algorithm, Eagle2, that attains high accuracy across a broad range of cohort sizes by efficiently leveraging information from large external reference panels (such as the Haplotype Reference Consortium; HRC) using a new data structure based on the positional Burrows-Wheeler transform. We demonstrate that Eagle2 attains a similar to 20x speedup and similar to 10% increase in accuracy compared to reference-based phasing using SHAPEIT2. On European ancestry samples, Eagle2 with the HRC panel achieves >2x the accuracy of 1000 Genomes-based phasing. Eagle2 is open source and freely available for HRC-based phasing via the Sanger Imputation Service and the Michigan Imputation Server.	[Loh, Po-Ru; Palamara, Pier Francesco; Finucane, Hilary K.; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Loh, Po-Ru; Palamara, Pier Francesco; Price, Alkes L.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Danecek, Petr; McCarthy, Shane; Durbin, Richard] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Fuchsberger, Christian] Univ Lubeck, European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy; [Fuchsberger, Christian; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Reshef, Yakir A.] Harvard Univ, Dept Comp Sci, Cambridge, MA 02138 USA; [Finucane, Hilary K.] MIT, Dept Math, Cambridge, MA 02139 USA; [Schoenherr, Sebastian; Forer, Lukas] Med Univ Innsbruck, Dept Med GenetMol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute; European Academy of Bozen-Bolzano; University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Medical University of Innsbruck; Harvard University; Harvard T.H. Chan School of Public Health	Loh, PR (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.; Loh, PR (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA.	loh@hsph.harvard.edu; aprice@hsph.harvard.edu	Durbin, Richard/AAE-7178-2019; Forer, Lukas/ABE-6007-2020; Schoenherr, Sebastian/ABB-3366-2020; Fuchsberger, Christian/ABD-7127-2021; Schoenherr, Sebastian/W-8761-2019; Forer, Lukas/AAX-9577-2021	Durbin, Richard/0000-0002-9130-1006; Fuchsberger, Christian/0000-0002-5918-8947; Schoenherr, Sebastian/0000-0001-5909-9226; Forer, Lukas/0000-0003-2139-7329; McCarthy, Shane/0000-0002-2715-4187; Palamara, Pier Francesco/0000-0002-7999-1972	US National Institutes of Health [R01 HG006399, R01 MH101244, HG007022, HL117626]; Wellcome Trust [WT098051]; Austrian Science Fund (FWF) [J-3401]; Fannie and John Hertz Foundation; NCRR [1S10RR028832-01]; Netherlands Scientific Organization [NWO 480-05-003];  [F32 HG007805]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399, F32HG007805, R01HG007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER; Medical Research Council [MC_qA137853, G0801823] Funding Source: researchfish; MRC [G0801823] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Fannie and John Hertz Foundation; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Netherlands Scientific Organization; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to S. Linderman, N. Patterson, L. O'Connor, A. Gusev, and B. van de Geijn for helpful discussions. This research was conducted using the UK Biobank Resource. P.L., P.P., and A.L.P. were supported by US National Institutes of Health grants R01 HG006399 and R01 MH101244 and fellowship F32 HG007805. P.D., S.M., R.D., and the Sanger Institute HRC server were supported by Wellcome Trust grant WT098051. C.F., G.R.A., and the Michigan Imputation Server were supported by the Austrian Science Fund (FWF) grant J-3401 and US National Institutes of Health grants HG007022 and HL117626. H.K.F. was supported by the Fannie and John Hertz Foundation. Computational analyses were performed on the Orchestra High Performance Compute Cluster at Harvard Medical School, which is partially supported by grant NCRR 1S10RR028832-01, and on the Lisa Genetic Cluster Computer hosted by SURFsara and financially supported by the Netherlands Scientific Organization (NWO 480-05-003, principal investigator D. Posthuma) along with a supplement from the Dutch Brain Foundation and the VU University Amsterdam.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Das S., NAT GENET; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; He D, 2013, J COMPUT BIOL, V20, P80, DOI 10.1089/cmb.2012.0091; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kumasaka N, 2016, NAT GENET, V48, P206, DOI 10.1038/ng.3467; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Li N, 2003, GENETICS, V165, P2213; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; McCarthy S., NAT GENET; O'Connell J, 2016, NAT GENET, V48, P817, DOI 10.1038/ng.3583; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sharp K, 2016, BIOINFORMATICS, V32, P1974, DOI 10.1093/bioinformatics/btw065; Snyder MW, 2015, NAT REV GENET, V16, P344, DOI 10.1038/nrg3903; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013	30	674	680	4	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1443	1448		10.1038/ng.3679	http://dx.doi.org/10.1038/ng.3679			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27694958	Green Submitted, Green Accepted			2022-12-25	WOS:000386543400023
J	de Saint Germain, A; Clave, G; Badet-Denisot, MA; Pillot, JP; Cornu, D; Le Caer, JP; Burger, M; Pelissier, F; Retailleau, P; Turnbull, C; Bonhomme, S; Chory, J; Rameau, C; Boyer, FD				de Saint Germain, Alexandre; Clave, Guillaume; Badet-Denisot, Marie-Ange; Pillot, Jean-Paul; Cornu, David; Le Caer, Jean-Pierre; Burger, Marco; Pelissier, Frank; Retailleau, Pascal; Turnbull, Colin; Bonhomme, Sandrine; Chory, Joanne; Rameau, Catherine; Boyer, Francois-Didier			An histidine covalent receptor and butenolide complex mediates strigolactone perception	NATURE CHEMICAL BIOLOGY			English	Article							ACTS DOWNSTREAM; ARABIDOPSIS; PROTEIN; RESPONSES; KARRIKIN; PEA; INHIBITION; DWARF14; GENES; HORMONES	Strigolactone plant hormones control plant architecture and are key players in both symbiotic and parasitic interactions. They contain an ABC tricyclic lactone connected to a butenolide group, the D ring. The DWARF14 (D14) strigolactone receptor belongs to the superfamily of alpha/beta-hydrolases, and is known to hydrolyze the bond between the ABC lactone and the D ring. Here we characterized the binding and catalytic functions of RAMOSUS3 (RMS3), the pea (Pisum sativum) ortholog of rice (Oryza sativa) D14 strigolactone receptor. Using new profluorescent probes with strigolactone-like bioactivity, we found that RMS3 acts as a single-turnover enzyme that explains its apparent low enzymatic rate. We demonstrated the formation of a covalent RMS3-D-ring complex, essential for bioactivity, in which the D ring was attached to histidine 247 of the catalytic triad. These results reveal an undescribed mechanism of plant hormone reception in which the receptor performs an irreversible enzymatic reaction to generate its own ligand.	[de Saint Germain, Alexandre; Pillot, Jean-Paul; Bonhomme, Sandrine; Rameau, Catherine; Boyer, Francois-Didier] INRA, Inst Jean Pierre Bourgin, Versailles, France; [de Saint Germain, Alexandre; Pillot, Jean-Paul; Bonhomme, Sandrine; Rameau, Catherine; Boyer, Francois-Didier] AgroParisTech, Inst Jean Pierre Bourgin, Versailles, France; [de Saint Germain, Alexandre; Pillot, Jean-Paul; Bonhomme, Sandrine; Rameau, Catherine; Boyer, Francois-Didier] CNRS, Inst Jean Pierre Bourgin, Versailles, France; [de Saint Germain, Alexandre; Pillot, Jean-Paul; Bonhomme, Sandrine; Rameau, Catherine; Boyer, Francois-Didier] Univ Paris Saclay, Inst Jean Pierre Bourgin, Versailles, France; [de Saint Germain, Alexandre; Burger, Marco; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [de Saint Germain, Alexandre; Burger, Marco; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Clave, Guillaume; Badet-Denisot, Marie-Ange; Le Caer, Jean-Pierre; Pelissier, Frank; Retailleau, Pascal; Boyer, Francois-Didier] CNRS UPR2301, Inst Chim Subst Nat, Gif Sur Yvette, France; [Clave, Guillaume; Badet-Denisot, Marie-Ange; Le Caer, Jean-Pierre; Pelissier, Frank; Retailleau, Pascal; Boyer, Francois-Didier] Univ Paris 11, Inst Chim Subst Nat, Gif Sur Yvette, France; [Clave, Guillaume; Badet-Denisot, Marie-Ange; Le Caer, Jean-Pierre; Pelissier, Frank; Retailleau, Pascal; Boyer, Francois-Didier] Univ Paris Saclay, Inst Chim Subst Nat, Gif Sur Yvette, France; [Cornu, David] CNRS, Inst Biol Integrat Cellule, Gif Sur Yvette, France; [Cornu, David] CEA, Inst Biol Integrat Cellule, Gif Sur Yvette, France; [Cornu, David] Univ Paris Saclay, Inst Biol Integrat Cellule, Gif Sur Yvette, France; [Turnbull, Colin] Imperial Coll London, Div Cell & Mol Biol, London, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Howard Hughes Medical Institute; Salk Institute; Salk Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Imperial College London	Rameau, C; Boyer, FD (corresponding author), INRA, Inst Jean Pierre Bourgin, Versailles, France.; Rameau, C; Boyer, FD (corresponding author), AgroParisTech, Inst Jean Pierre Bourgin, Versailles, France.; Rameau, C; Boyer, FD (corresponding author), CNRS, Inst Jean Pierre Bourgin, Versailles, France.; Rameau, C; Boyer, FD (corresponding author), Univ Paris Saclay, Inst Jean Pierre Bourgin, Versailles, France.; Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.; Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.; Boyer, FD (corresponding author), CNRS UPR2301, Inst Chim Subst Nat, Gif Sur Yvette, France.; Boyer, FD (corresponding author), Univ Paris 11, Inst Chim Subst Nat, Gif Sur Yvette, France.; Boyer, FD (corresponding author), Univ Paris Saclay, Inst Chim Subst Nat, Gif Sur Yvette, France.	chory@salk.edu; catherine.rameau@versailles.inra.fr; francois-didier.boyer@cnrs.fr	Bürger, Marco/G-9576-2011; Bonhomme, Sandrine/AAF-5961-2021; Turnbull, Colin/B-4742-2008	Bürger, Marco/0000-0002-4877-6276; Turnbull, Colin/0000-0001-6635-1418; de Saint Germain, Alexandre/0000-0003-2814-7234; Clave, Guillaume/0000-0001-6401-0935; badet-denisot, marie-ange/0000-0003-3417-6330	Institut National de la Recherche Agronomique (INRA); Agence Nationale de la Recherche [ANR-12-BSV6-004-01]; Stream COST Action [FA1206]; US National Institutes of Health [R01 GM094428]; Howard Hughes Medical Institute; Catharina Foundation; Labex Saclay Plant Sciences-SPS [ANR-10-LABX-0040-SPS]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094428] Funding Source: NIH RePORTER	Institut National de la Recherche Agronomique (INRA); Agence Nationale de la Recherche(French National Research Agency (ANR)); Stream COST Action; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Catharina Foundation; Labex Saclay Plant Sciences-SPS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Novaretti for plant bioassays, A.E. Stewart for helpful discussion, S.K. Lin for technical assistance, J.-P. Andrieu for the assistance and access to amino acids determination facility, U. Pedmale for technical advice, and B.C. Willige, C. Bourbousse, J. Woodson, U. Pedmale, A. Seluzicki and D. O'Keefe for their comments on the manuscript. We are grateful to the Institut National de la Recherche Agronomique (INRA), the Agence Nationale de la Recherche (contract ANR-12-BSV6-004-01) and the Stream COST Action FA1206 for financial support. A.d.S.G. and J. C. were partially supported by a grant to J.C. from US National Institutes of Health (R01 GM094428). J.C. is funded as an investigator of the Howard Hughes Medical Institute. A.d.S.G. was partially supported by a grant from Catharina Foundation to the Salk Institute. The Institut Jean-Pierre Bourgin benefits from the support of the Labex Saclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS).	Abe S, 2014, P NATL ACAD SCI USA, V111, P18084, DOI 10.1073/pnas.1410801111; Alves-Carvalho S, 2015, PLANT J, V84, P1, DOI 10.1111/tpj.12967; Arumingtyas EL, 1992, PISUM GENET, V24, P17; Beveridge CA, 1996, PLANT PHYSIOL, V110, P859, DOI 10.1104/pp.110.3.859; Beveridge CA, 2009, PLANT PHYSIOL, V151, P985, DOI 10.1104/pp.109.143909; Boyer FD, 2014, MOL PLANT, V7, P675, DOI 10.1093/mp/sst163; Boyer FD, 2012, PLANT PHYSIOL, V159, P1524, DOI 10.1104/pp.112.195826; Braun N, 2012, PLANT PHYSIOL, V158, P225, DOI 10.1104/pp.111.182725; Brewer PB, 2013, MOL PLANT, V6, P18, DOI 10.1093/mp/sss130; Chevalier F, 2014, PLANT CELL, V26, P1134, DOI 10.1105/tpc.114.122903; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conn CE, 2015, SCIENCE, V349, P540, DOI 10.1126/science.aab1140; de Saint Germain A, 2013, CURR OPIN PLANT BIOL, V16, P583, DOI 10.1016/j.pbi.2013.06.007; DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720; Dun EA, 2013, MOL PLANT, V6, P128, DOI 10.1093/mp/sss131; Fenaille F, 2003, J AM SOC MASS SPECTR, V14, P215, DOI 10.1016/S1044-0305(02)00911-X; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Guo YX, 2013, P NATL ACAD SCI USA, V110, P8284, DOI 10.1073/pnas.1306265110; Gutjahr C, 2015, SCIENCE, V350, P1521, DOI 10.1126/science.aac9715; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Karimi M, 2007, PLANT PHYSIOL, V145, P1183, DOI 10.1104/pp.107.110411; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopez-Obando M, 2016, PLANTA, V243, P1441, DOI 10.1007/s00425-016-2481-y; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Rameau C., 1997, Pisum Genetics, V29, P7; Scaffidi A, 2014, PLANT PHYSIOL, V165, P1221, DOI 10.1104/pp.114.240036; Schwarz R, 1979, ATLAS PROTEIN SEQUEN, P353, DOI DOI 10.2307/2408678; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S0108767307043930, 10.1107/S2053229614024218]; Shi W, 2012, CHEM COMMUN, V48, P8732, DOI 10.1039/c2cc33366j; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Sun WC, 1998, BIOORG MED CHEM LETT, V8, P3107, DOI 10.1016/S0960-894X(98)00578-2; Sun XD, 2011, MOL PLANT, V4, P116, DOI 10.1093/mp/ssq055; Symons G. M., 1997, Pisum Genetics, V29, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toh S, 2015, SCIENCE, V350, P203, DOI 10.1126/science.aac9476; Toh S, 2014, CHEM BIOL, V21, P988, DOI 10.1016/j.chembiol.2014.07.005; Tsuchiya Y, 2015, SCIENCE, V349, P864, DOI 10.1126/science.aab3831; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Wallner ES, 2016, PLANTA, V243, P1339, DOI 10.1007/s00425-016-2478-6; Waters MT, 2015, PLANT CELL, V27, P1925, DOI 10.1105/tpc.15.00146; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Yang Y, 2008, PLANT PHYSIOL, V147, P1034, DOI 10.1104/pp.108.118224; Zhao LH, 2015, CELL RES, V25, P1219, DOI 10.1038/cr.2015.122; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19	52	168	173	0	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					787	+		10.1038/nchembio.2147	http://dx.doi.org/10.1038/nchembio.2147			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27479744	Green Accepted, Green Submitted			2022-12-25	WOS:000384248600009
J	Fujimura, KE; Sitarik, AR; Haystad, S; Lin, DL; Levan, S; Fadrosh, D; Panzer, AR; LaMere, B; Rackaityte, E; Lukacs, NW; Wegienka, G; Boushey, HA; Ownby, DR; Zoratti, EM; Levin, AM; Johnson, CC; Lynch, SV				Fujimura, Kei E.; Sitarik, Alexandra R.; Haystad, Suzanne; Lin, Din L.; Levan, Sophia; Fadrosh, Douglas; Panzer, Ariane R.; LaMere, Brandon; Rackaityte, Elze; Lukacs, Nicholas W.; Wegienka, Ganesa; Boushey, Homer A.; Ownby, Dennis R.; Zoratti, Edward M.; Levin, Albert M.; Johnson, Christine C.; Lynch, Susan V.			Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation	NATURE MEDICINE			English	Article							ACID	Gut microbiota bacterial depletions and altered metabolic activity at 3 months are implicated in childhood atopy and asthma(1). We hypothesized that compositionally distinct human neonatal gut microbiota (NGM) exist, and are differentially related to relative risk (RR) of childhood atopy and asthma. Using stool samples (n = 298; aged 1-11 months) from a US birth cohort and 16S rRNA sequencing, neonates (median age, 35 d) were divisible into three microbiota composition states (NGM1-3). Each incurred a substantially different RR for multisensitized atopy at age 2 years and doctor-diagnosed asthma at age 4 years. The highest risk group, labeled NGM3, showed lower relative abundance of certain bacteria (for example, Bifidobacterium, Akkermansia and Faecalibacterium), higher relative abundance of particular fungi (Candida and Rhodotorula) and a distinct fecal metabolome enriched for pro-inflammatory metabolites. Ex vivo culture of human adult peripheral T cells with sterile fecal water from NGM3 subjects increased the proportion of CD4(+) cells producing interleukin (IL)-4 and reduced the relative abundance of CD4(+)CD25(+)FOXP3(+) cells. 12,13-DiHOME, enriched in NGM3 versus lower-risk NGM states, recapitulated the effect of NGM3 fecal water on relative CD4(+)CD25(+)FOXP3(+) cell abundance. these findings suggest that neonatal gut microbiome dysbiosis might promote CD4(+) T cell dysfunction associated with childhood atopy.	[Fujimura, Kei E.; Lin, Din L.; Levan, Sophia; Fadrosh, Douglas; Panzer, Ariane R.; LaMere, Brandon; Rackaityte, Elze; Lynch, Susan V.] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA USA; [Sitarik, Alexandra R.; Haystad, Suzanne; Wegienka, Ganesa; Levin, Albert M.; Johnson, Christine C.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Lukacs, Nicholas W.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Boushey, Homer A.] Univ Calif San Francisco, Dept Med, Pulm Crit Care Allergy & Sleep Med, San Francisco, CA USA; [Ownby, Dennis R.] Augusta Univ, Sect Allergy Immunol, Augusta, GA USA; [Zoratti, Edward M.] Henry Ford Hlth Syst, Div Allergy & Immunol, Dept Internal Med, Detroit, MI USA	University of California System; University of California San Francisco; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University System of Georgia; Augusta University; Henry Ford Health System; Henry Ford Hospital	Lynch, SV (corresponding author), Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA USA.; Johnson, CC (corresponding author), Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA.	cjohnso1@hfhs.org; susan.lynch@ucsf.edu	Lukacs, Nicholas W/ABH-5583-2020	Sitarik, Alexandra/0000-0001-8957-389X	US National Institutes of Health; National Institute of Allergy and Infectious Diseases [P01 AI089473-01]; Alfred P. Sloan Foundation [2013-6-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI089473] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the US National Institutes of Health and National Institute of Allergy and Infectious Diseases P01 AI089473-01 (C.C.J., D.R.O., H.A.B., N.W.L., S.V.L., G.W., and E.M.Z.) and the Alfred P. Sloan Foundation 2013-6-03 (S.V.L.). We thank C. Arrieta and B. Finlay for graciously sharing sequencing data from the CHILD study.	Aichbhaumik N, 2008, CLIN EXP ALLERGY, V38, P1787, DOI 10.1111/j.1365-2222.2008.03079.x; Amagai Y, 2015, J DERMATOL SCI, V79, P30, DOI 10.1016/j.jdermsci.2015.03.010; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Havstad S, 2014, J ALLERGY CLIN IMMUN, V134, P722, DOI 10.1016/j.jaci.2014.01.022; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Morin C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0653-y; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Weichert S, 2013, NUTR RES, V33, P831, DOI 10.1016/j.nutres.2013.07.009	12	534	558	7	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1187	1191		10.1038/nm.4176	http://dx.doi.org/10.1038/nm.4176			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27618652	Green Submitted, Green Accepted			2022-12-25	WOS:000384872500022
J	Guo, HY; Ahmed, M; Zhang, F; Yao, CQ; Li, SD; Liang, Y; Hua, JJ; Soares, F; Sun, YF; Langstein, J; Li, YC; Poon, C; Bailey, SD; Desai, K; Fei, T; Li, QY; Sendorek, DH; Fraser, M; Prensner, JR; Pugh, TJ; Pomerantz, M; Bristow, RG; Lupien, M; Feng, FY; Boutros, PC; Freedman, ML; Walsh, MJ; He, HSHS				Guo, Haiyang; Ahmed, Musaddeque; Zhang, Fan; Yao, Cindy Q.; Li, SiDe; Liang, Yi; Hua, Junjie; Soares, Fraser; Sun, Yifei; Langstein, Jens; Li, Yuchen; Poon, Christine; Bailey, Swneke D.; Desai, Kinjal; Fei, Teng; Li, Qiyuan; Sendorek, Dorota H.; Fraser, Michael; Prensner, John R.; Pugh, Trevor J.; Pomerantz, Mark; Bristow, Robert G.; Lupien, Mathieu; Feng, Felix Y.; Boutros, Paul C.; Freedman, Matthew L.; Walsh, Martin J.; He, Housheng Hansen			Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCI; RANGE INTERACTION; CHROMATIN STATE; ANNOTATION; 8Q24; TRANSCRIPTION; BREAST; PCAT-1; PROGRESSION; ASSOCIATION	Long noncoding RNAs (IncRNAs) represent an attractive class of candidates to mediate cancer risk. Through integrative analysis of the IncRNA transcriptome with genomic data and SNP data from prostate cancer genome-wide association studies (GWAS), we identified 45 candidate IncRNAs associated with risk to prostate cancer. We further evaluated the mechanism underlying the top hit, PCAT1, and found that a risk-associated variant at rs7463708 increases binding of ONECUT2, a novel androgen receptor (AR)-interacting transcription factor, at a distal enhancer that loops to the PCAT1 promoter, resulting in upregulation of PCAT1 upon prolonged androgen treatment. In addition, PCAT1 interacts with AR and LSD1 and is required for their recruitment to the enhancers of GNMT and DHCR24, two androgen late-response genes implicated in prostate cancer development and progression. PCAT1 promotes prostate cancer cell proliferation and tumor growth in vitro and in vivo. These findings suggest that modulating IncRNA expression is an important mechanism for risk-associated SNPs in promoting prostate transformation.	[Guo, Haiyang; Ahmed, Musaddeque; Liang, Yi; Hua, Junjie; Soares, Fraser; Langstein, Jens; Li, Yuchen; Poon, Christine; Bailey, Swneke D.; Fraser, Michael; Pugh, Trevor J.; Bristow, Robert G.; Lupien, Mathieu; He, Housheng Hansen] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Zhang, Fan; Li, SiDe; Sun, Yifei; Walsh, Martin J.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Yao, Cindy Q.; Sendorek, Dorota H.; Lupien, Mathieu; Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Hua, Junjie; Bristow, Robert G.; Lupien, Mathieu; Boutros, Paul C.; He, Housheng Hansen] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Langstein, Jens] German Canc Res Ctr, Heidelberg, Germany; [Desai, Kinjal] Norris Cotton Canc Ctr, Dartmouth Med Sch, Dept Genet, Lebanon, NH USA; [Fei, Teng; Pomerantz, Mark; Freedman, Matthew L.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Dept Med Oncol, Boston, MA 02115 USA; [Li, Qiyuan] Xiamen Univ, Coll Med, Xiamen, Peoples R China; [Prensner, John R.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI USA; [Feng, Felix Y.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Feng, Felix Y.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Feng, Felix Y.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Feng, Felix Y.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Freedman, Matthew L.] Eli & Edythe L Broad Inst, Cambridge, MA USA; [Walsh, Martin J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Prensner, John R.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Icahn School of Medicine at Mount Sinai; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); Dartmouth College; Norris Cotton Cancer Center; Harvard University; Dana-Farber Cancer Institute; Xiamen University; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Toronto; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Harvard University; Boston Children's Hospital	He, HSHS (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; He, HSHS (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	hansenhe@uhnresearch.ca	Hua, Junjie Tony/AAH-2163-2021; He, Hansen/ABD-8439-2020; Pugh, Trevor/Y-2535-2019	He, Hansen/0000-0003-2898-3363; Pugh, Trevor/0000-0002-8073-5888; guo, haiyang/0000-0001-5503-6922; /0000-0003-4914-1157; FEI, TENG/0000-0001-9620-0450; Soares, Fraser/0000-0002-3977-7939; Lupien, Mathieu/0000-0003-0929-9478; Prensner, John/0000-0002-7024-636X; Bristow, Robert/0000-0002-8553-9544; Ahmed, Musaddeque/0000-0002-5076-1102; Boutros, Paul/0000-0003-0553-7520	Princess Margaret Cancer Foundation; Canada Foundation for Innovation; Ontario Research Fund [CFI32372, CFI32383]; NSERC discovery grant [498706]; WICC Ontario 20th Anniversary Prostate Cancer Innovation Grant of the CCS [703800]; CIHR transitional operating grant [142246]; Prostate Cancer Canada [RS2014-01, RS2014-04, RS2016-1022]; ICS-IG Maud Menten New Principal Investigator Prize [ICS-145381]; OMIR Early Researcher Award; OICR; CIHR; Canadian Cancer Society Research Scientist Award; Terry Fox Research Institute New Investigator Award; CIHR New Investigator Award; Prostate Cancer Foundation (Challenge Award); NIH [R01CA193910, 5RO1CA154903, 5RO1HL103967]; CIHR Graduate Student Fellowship; CIHR Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA193910] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103967] Funding Source: NIH RePORTER	Princess Margaret Cancer Foundation(University of Toronto); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); WICC Ontario 20th Anniversary Prostate Cancer Innovation Grant of the CCS; CIHR transitional operating grant(Canadian Institutes of Health Research (CIHR)); Prostate Cancer Canada; ICS-IG Maud Menten New Principal Investigator Prize; OMIR Early Researcher Award; OICR; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Scientist Award; Terry Fox Research Institute New Investigator Award; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Prostate Cancer Foundation (Challenge Award); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR Graduate Student Fellowship(Canadian Institutes of Health Research (CIHR)); CIHR Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Brown, X.S. Liu, D. Borges-Rivera and R.A. Young for discussion, as well as the Princess Margaret Genomic Centre for high-throughput sequencing support. The work was supported by the Princess Margaret Cancer Foundation (to H.H.H., M.L., T.J.P. and R.G.B.), the Canada Foundation for Innovation and the Ontario Research Fund (CFI32372 to H.H.H. and CFI32383 to T.J.P.), NSERC discovery grant (498706 to H.H.H.), the WICC Ontario 20th Anniversary Prostate Cancer Innovation Grant of the CCS (703800 to H.H.H.), and a CIHR transitional operating grant (142246 to H.H.H.) and Movember Rising Star awards from Prostate Cancer Canada (RS2014-01 to P.C.B., RS2014-04 to M.L. and RS2016-1022 to H.H.H.). H.H.H. holds an ICS-IG Maud Menten New Principal Investigator Prize (ICS-145381) and an OMIR Early Researcher Award. M.L. holds a young investigator award from the OICR and a new investigator salary award from the CIHR. R.G.B. is a recipient of a Canadian Cancer Society Research Scientist Award. P.C.B. is supported by a Terry Fox Research Institute New Investigator Award and a CIHR New Investigator Award. M.L.F. is supported by the Prostate Cancer Foundation (Challenge Award) and an NIH grant (R01CA193910). J.H. is a CIHR Graduate Student Fellowship recipient. S.D.B. is a CIHR Postdoctoral Fellowship recipient. M.J.W. is supported by grants 5RO1CA154903 and 5RO1HL103967 from the NIH. We acknowledge the ENCODE Consortium and the ENCODE production laboratories that generated the data sets provided by the ENCODE Data Coordination Center used in the manuscript. The results shown here are in whole or part based upon data generated by the TCGA Research Network.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Al Olama AA, 2015, HUM MOL GENET, V24, P5589, DOI 10.1093/hmg/ddv203; Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bailey SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7186; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai CM, 2014, CELL REP, V9, P1618, DOI 10.1016/j.celrep.2014.11.008; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Eeles R, 2014, NAT REV UROL, V11, P18, DOI 10.1038/nrurol.2013.266; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Han Y, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv431; Han Y, 2015, HUM MOL GENET, V24, P5603, DOI 10.1093/hmg/ddv269; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kim T, 2014, P NATL ACAD SCI USA, V111, P4173, DOI 10.1073/pnas.1400350111; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Popadin K, 2013, AM J HUM GENET, V93, P1015, DOI 10.1016/j.ajhg.2013.10.022; Prensner JR, 2014, NEOPLASIA, V16, P900, DOI 10.1016/j.neo.2014.09.001; Prensner JR, 2014, CANCER RES, V74, P1651, DOI 10.1158/0008-5472.CAN-13-3159; Prensner JR, 2013, NAT GENET, V45, P1392, DOI 10.1038/ng.2771; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robbins C, 2007, GENOME RES, V17, P1717, DOI 10.1101/gr.6782707; Romanuik TL, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-43; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Song YH, 2011, MODERN PATHOL, V24, P1272, DOI 10.1038/modpathol.2011.76; Sun YN, 2014, MOL CELL BIOCHEM, V390, P19, DOI 10.1007/s11010-013-1950-x; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yao LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6114; Zhang XY, 2014, TRENDS GENET, V30, P140, DOI 10.1016/j.tig.2014.02.006; Zhang XY, 2012, GENOME RES, V22, P1437, DOI 10.1101/gr.135665.111	59	155	158	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1142	1150		10.1038/ng.3637	http://dx.doi.org/10.1038/ng.3637			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27526323				2022-12-25	WOS:000384391600009
J	Pijacka, W; Moraes, DJA; Ratcliffe, LEK; Nightingale, AK; Hart, EC; da Silva, MP; Machado, BH; McBryde, FD; Abdala, AP; Ford, AP; Paton, JFR				Pijacka, Wioletta; Moraes, Davi J. A.; Ratcliffe, Laura E. K.; Nightingale, Angus K.; Hart, Emma C.; da Silva, Melina P.; Machado, Benedito H.; McBryde, Fiona D.; Abdala, Ana P.; Ford, Anthony P.; Paton, Julian F. R.			Purinergic receptors in the carotid body as a new drug target for controlling hypertension	NATURE MEDICINE			English	Article							BLOOD-PRESSURE; ARTERIOVENOUS ANASTOMOSIS; ARTERIAL CHEMORECEPTORS; SYMPATHETIC ACTIVITY; THERAPEUTIC TARGET; P2X3 RECEPTORS; TASK CHANNELS; ATP; RAT; RESPONSES	In view of the high proportion of individuals with resistance to antihypertensive medication and/or poor compliance or tolerance of this medication, new drugs to treat hypertension are urgently needed. Here we show that peripheral chemoreceptors generate aberrant signaling that contributes to high blood pressure in hypertension. We discovered that purinergic receptor P2X3 (P2rx3, also known as P2x3) mRNA expression is upregulated substantially in chemoreceptive petrosal sensory neurons in rats with hypertension. These neurons generate both tonic drive and hyperreflexia in hypertensive (but not normotensive) rats, and both phenomena are normalized by the blockade of P2X3 receptors. Antagonism of P2X3 receptors also reduces arterial pressure and basal sympathetic activity and normalizes carotid body hyperreflexia in conscious rats with hypertension; no effect was observed in rats without hypertension. We verified P2X3 receptor expression in human carotid bodies and observed hyperactivity of carotid bodies in individuals with hypertension. These data support the identification of the P2X3 receptor as a potential new target for the control of human hypertension.	[Pijacka, Wioletta; Hart, Emma C.; McBryde, Fiona D.; Abdala, Ana P.; Paton, Julian F. R.] Univ Bristol, Biomed Sci, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England; [Moraes, Davi J. A.; da Silva, Melina P.; Machado, Benedito H.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, Ribeirao Preto, SP, Brazil; [Ratcliffe, Laura E. K.] Univ Bristol, Clin Res & Imaging Ctr, CardioNomics Res Grp, Bristol, Avon, England; [Nightingale, Angus K.] Univ Hosp Bristol Natl Hlth Serv Fdn Trust, Bristol Heart Inst, Dept Cardiol, CardioNomics Grp, Bristol, Avon, England; [McBryde, Fiona D.] Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand; [Ford, Anthony P.] Afferent Pharmaceut, San Mateo, CA USA	University of Bristol; Universidade de Sao Paulo; University of Bristol; University of Bristol; University of Auckland	Paton, JFR (corresponding author), Univ Bristol, Biomed Sci, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England.	Julian.F.R.Paton@Bristol.ac.uk	Sheikh, Ana Paula Abdala/G-9104-2014; DA SILVA MORAES, MELINA PIRES/Z-2379-2019; Paton, Julian/AAM-2121-2020; Nightingale, Angus/O-5205-2019; Machado, Benedito Honorio/B-5139-2013; Pijacka, Wioletta/C-7151-2012; Hart, Emma/ABF-7649-2020; Moraes, Davi/AAG-6248-2019	Sheikh, Ana Paula Abdala/0000-0001-6566-9205; Nightingale, Angus/0000-0001-9435-726X; Pijacka, Wioletta/0000-0002-3203-7356; McBryde, Fiona/0000-0002-5687-9101; Hart, Emma/0000-0002-4534-9586	British Heart Foundation [RG/12/6/29670]; Afferent Pharmaceuticals; James Tudor Foundation; National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease at the University Hospitals Bristol National Health Service Foundation Trust; University of Bristol; 'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' FAPESP [2013/06077-5, 2013/10484-5]; University of Bristol's Wolfson Bioimaging Facility BBSRC Alert 13 capital grant [BB/L014181/1]; Marie Curie International Research Staff Exchange Scheme within the 7th European Community Framework Program [612280]; National Institute for Health Research (NIHR); BBSRC [BB/L014181/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L014181/1] Funding Source: researchfish; National Center for Complementary & Integrative Health [R01AT008632] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Afferent Pharmaceuticals; James Tudor Foundation; National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease at the University Hospitals Bristol National Health Service Foundation Trust; University of Bristol; 'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Bristol's Wolfson Bioimaging Facility BBSRC Alert 13 capital grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie International Research Staff Exchange Scheme within the 7th European Community Framework Program; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We wish to thank J.-C. Isner (School of Biological Sciences, University of Bristol) for his expertise on software used for analyzing aspects of some of the in vivo cardiovascular data. Technical support from P. Chappell (mechanical workshop) and D. Carr (electronic workshop) is appreciated. The research support of the British Heart Foundation RG/12/6/29670 (J.F.R.P.), Afferent Pharmaceuticals (A.P.F. & J.F.R.P.) and the James Tudor Foundation (J.F.R.P.) are acknowledged. This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease at the University Hospitals Bristol National Health Service Foundation Trust and the University of Bristol (A.K.N. & J.F.R.P.). Studies in situ were supported by grants from 'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' FAPESP Thematic Project 2013/06077-5 (B.H.M.) and research grant 2013/10484-5 (D.J.A.M.). The University of Bristol's Wolfson Bioimaging Facility BBSRC Alert 13 capital grant BB/L014181/1 is acknowledged. This project also received funding from the Marie Curie International Research Staff Exchange Scheme within the 7th European Community Framework Program under grant agreement no. 612280. This article presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR or the Department of Health.	Abdala AP, 2012, J PHYSIOL-LONDON, V590, P4269, DOI 10.1113/jphysiol.2012.237800; Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; Adriaensen D, 2015, AUTON NEUROSCI-BASIC, V191, P39, DOI 10.1016/j.autneu.2015.04.006; Brown MJ, 2008, CIRCULATION, V118, P773, DOI 10.1161/CIRCULATIONAHA.108.787630; Buckler KJ, 2015, PFLUG ARCH EUR J PHY, V467, P1013, DOI 10.1007/s00424-015-1689-1; Burchell AE, 2014, HYPERTENSION, V64, P6, DOI 10.1161/HYPERTENSIONAHA.114.02925; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Burnstock Geoffrey, 2009, Handb Exp Pharmacol, P333, DOI 10.1007/978-3-540-79090-7_10; CARDENAS H, 1981, NEUROSCI LETT, V24, P29, DOI 10.1016/0304-3940(81)90354-2; Carey RM, 2013, HYPERTENSION, V61, P673, DOI [10.1161/HYPERTENSIONAHA.111.00241, 10.1161/HYPERTENSIONAHA.111.00601]; CLARKE JA, 1993, ADV EXP MED BIOL, V337, P3; COMROE JH, 1953, HARVEY LECT, V48, P110; Daly DM, 2014, J PHYSIOL-LONDON, V592, P537, DOI 10.1113/jphysiol.2013.262634; Deiteren A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123810; Evans AM, 2012, ADV EXP MED BIOL, V758, P81, DOI 10.1007/978-94-007-4584-1_11; Fan J, 2009, J NEUROSCI RES, V87, P2757, DOI 10.1002/jnr.22107; Ford AP, 2015, AUTON NEUROSCI-BASIC, V191, P16, DOI 10.1016/j.autneu.2015.04.005; Ford AP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00267; Ford Anthony P D W, 2011, Handb Exp Pharmacol, P485, DOI 10.1007/978-3-642-16499-6_22; Gerevich Z, 2007, J BIOL CHEM, V282, P33949, DOI 10.1074/jbc.M705840200; Gever JR, 2010, BRIT J PHARMACOL, V160, P1387, DOI 10.1111/j.1476-5381.2010.00796.x; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hansen RR, 2012, EUR J PHARMACOL, V688, P27, DOI 10.1016/j.ejphar.2012.05.008; Heusser K, 2010, HYPERTENSION, V55, P619, DOI 10.1161/HYPERTENSIONAHA.109.140665; Kahlin J, 2014, EXP PHYSIOL, V99, P1089, DOI 10.1113/expphysiol.2014.078873; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li Jianhua, 2014, J Mod Physiol Res, V1, P1; Liu M, 2001, J PHARMACOL EXP THER, V296, P1043; Lloyd A, 2003, PHARMACOECONOMICS, V21, P33, DOI 10.2165/00019053-200321001-00004; Lobo MD, 2015, LANCET, V385, P1634, DOI 10.1016/S0140-6736(14)62053-5; McBryde FD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3395; Moraes DJA, 2014, HYPERTENSION, V63, P1309, DOI 10.1161/HYPERTENSIONAHA.113.02283; NAKAYAMA K, 1961, DIS CHEST, V40, P595; Narkiewicz K, 1998, CIRCULATION, V97, P943; Nurse CA, 2014, J PHYSIOL-LONDON, V592, P3419, DOI 10.1113/jphysiol.2013.269829; Patel NK, 2011, NEUROLOGY, V76, P405, DOI 10.1212/WNL.0b013e3182088108; Paton JFR, 2013, HYPERTENSION, V61, P5, DOI 10.1161/HYPERTENSIONAHA.111.00064; Plump A, 2010, NAT REV DRUG DISCOV, V9, P823, DOI 10.1038/nrd3315; Prasad M, 2001, J PHYSIOL-LONDON, V537, P667; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Rong WF, 2003, J NEUROSCI, V23, P11315; Schiavuzzo JG, 2015, NEUROSCIENCE, V285, P24, DOI 10.1016/j.neuroscience.2014.11.020; Schultz HD, 2015, EXP PHYSIOL, V100, P124, DOI 10.1113/expphysiol.2014.079517; SOMERS VK, 1988, HYPERTENSION, V11, P608, DOI 10.1161/01.HYP.11.6.608; SOMERS VK, 1991, J CLIN INVEST, V87, P1953, DOI 10.1172/JCI115221; Tan ZY, 2010, CIRC RES, V106, P536, DOI 10.1161/CIRCRESAHA.109.206946; WELSH MJ, 1978, J CLIN INVEST, V61, P708, DOI 10.1172/JCI108983; Yuan GX, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005846; Zhang M, 2000, J PHYSIOL-LONDON, V525, P143, DOI 10.1111/j.1469-7793.2000.t01-1-00143.x; Zoccal DB, 2008, J PHYSIOL-LONDON, V586, P3253, DOI 10.1113/jphysiol.2008.154187	59	104	110	3	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1151	1159		10.1038/nm.4173	http://dx.doi.org/10.1038/nm.4173			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27595323	Green Accepted, Green Submitted			2022-12-25	WOS:000384872500018
J	Albers, SC; Berklund, AM; Graff, GD				Albers, Stevan C.; Berklund, Annabelle M.; Graff, Gregory D.			The rise and fall of innovation in biofuels	NATURE BIOTECHNOLOGY			English	Editorial Material									[Albers, Stevan C.] Colorado State Univ, Cell & Mol Biol Grad Program, Ft Collins, CO 80523 USA; [Albers, Stevan C.] CSU Ventures, Ft Collins, CO USA; [Berklund, Annabelle M.] Colorado State Univ, Dept Econ, Ft Collins, CO 80523 USA; [Graff, Gregory D.] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA; [Graff, Gregory D.] Chalmers, Dept Technol Management & Econ, Gothenburg, Sweden	Colorado State University; Colorado State University; Colorado State University; Chalmers University of Technology	Graff, GD (corresponding author), Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA.; Graff, GD (corresponding author), Chalmers, Dept Technol Management & Econ, Gothenburg, Sweden.	gregory.graff@colostate.edu		Graff, Gregory/0000-0002-9140-0901	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004041] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG004041] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2013, ECONOMIST; Bracmort K., 2015, RENEWABLE FUEL STAND; Bubela T, 2013, NAT BIOTECHNOL, V31, P202, DOI 10.1038/nbt.2521; Ewing M, 2009, ENVIRON SCI POLICY, V12, P520, DOI 10.1016/j.envsci.2008.10.002; Guo H, 2007, INTELLECTUAL PROPERT; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Hu AG, 2009, J DEV ECON, V90, P57, DOI 10.1016/j.jdeveco.2008.11.004; Qiu HG, 2012, RENEW SUST ENERG REV, V16, P3095, DOI 10.1016/j.rser.2012.02.036; REN, 2015, REN 2015 GLOB STAT R; Robbins M, 2011, NATURE, V474, pS22, DOI 10.1038/474S022a; Schnepf R., 2013, R40155 CRS; United States Environmental Protection Agency, 2019, APPR PATHW REN FUEL; US Energy Information Administration (EIA), 2015, ANN EN OUTL 2015 PRO; Von Braun Joachim, 2008, BIOFUELS INT FOOD PR; Zilberman D., 2014, CHOICES Q, V1; Zilberman D, 2013, AM J AGR ECON, V95, P275, DOI 10.1093/ajae/aas037	16	38	39	4	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2016	34	8					814	822		10.1038/nbt.3644	http://dx.doi.org/10.1038/nbt.3644			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	DT2VJ	27504772				2022-12-25	WOS:000381339600015
J	Collard, F; Baldin, F; Gerin, I; Bolsee, J; Noel, G; Graff, J; Veiga-da-Cunha, M; Stroobant, V; Vertommen, D; Houddane, A; Rider, MH; Linster, CL; Van Schaftingen, E; Bommer, GT				Collard, Francois; Baldin, Francesca; Gerin, Isabelle; Bolsee, Jennifer; Noel, Gaetane; Graff, Julie; Veiga-da-Cunha, Maria; Stroobant, Vincent; Vertommen, Didier; Houddane, Amina; Rider, Mark H.; Linster, Carole L.; Van Schaftingen, Emile; Bommer, Guido T.			A conserved phosphatase destroys toxic glycolytic side products in mammals and yeast	NATURE CHEMICAL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; FRUCTOSE 2,6-BISPHOSPHATE; ESCHERICHIA-COLI; PYRUVATE-KINASE; GENE DISRUPTION; IDENTIFICATION; EVOLUTIONARY; METABOLISM; ACTIVATION	Metabolic enzymes are very specific. However, most of them show weak side activities toward compounds that are structurally related to their physiological substrates, thereby producing side products that may be toxic. In some cases, 'metabolite repair enzymes' eliminating side products have been identified. We show that mammalian glyceraldehyde 3-phosphate dehydrogenase and pyruvate kinase, two core glycolytic enzymes, produce 4-phosphoerythronate and 2-phospho-L-lactate, respectively. 4-Phosphoerythronate strongly inhibits an enzyme of the pentose phosphate pathway, whereas 2-phospho-L-lactate inhibits the enzyme producing the glycolytic activator fructose 2,6-bisphosphate. We discovered that a single, widely conserved enzyme, known as phosphoglycolate phosphatase (PGP) in mammals, dephosphorylates both 4-phosphoerythronate and 2-phospho-L-lactate, thereby preventing a block in the pentose phosphate pathway and glycolysis. Its yeast ortholog, Pho13, similarly dephosphorylates 4-phosphoerythronate and 2-phosphoglycolate, a side product of pyruvate kinase. Our work illustrates how metabolite repair enzymes can make up for the limited specificity of metabolic enzymes and permit high flux in central metabolic pathways.	[Collard, Francois; Baldin, Francesca; Gerin, Isabelle; Bolsee, Jennifer; Noel, Gaetane; Graff, Julie; Veiga-da-Cunha, Maria; Van Schaftingen, Emile; Bommer, Guido T.] Walloon Excellence Lifesci & Biotechnol WELBIO, Brussels, Belgium; [Collard, Francois; Baldin, Francesca; Gerin, Isabelle; Bolsee, Jennifer; Noel, Gaetane; Graff, Julie; Veiga-da-Cunha, Maria; Van Schaftingen, Emile; Bommer, Guido T.] Catholic Univ Louvain, Physiol Chem Lab, de Duve Inst, Brussels, Belgium; [Stroobant, Vincent] Ludwig Inst Canc Res, Brussels, Belgium; [Vertommen, Didier; Houddane, Amina; Rider, Mark H.] Catholic Univ Louvain, de Duve Inst, Prot Phosphorylat Unit, Brussels, Belgium; [Linster, Carole L.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg	WELBIO; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; University of Luxembourg	Van Schaftingen, E; Bommer, GT (corresponding author), Walloon Excellence Lifesci & Biotechnol WELBIO, Brussels, Belgium.; Van Schaftingen, E; Bommer, GT (corresponding author), Catholic Univ Louvain, Physiol Chem Lab, de Duve Inst, Brussels, Belgium.	emile.vanschaftingen@uclouvain.be; guido.bommer@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020; Bommer, Guido/A-8425-2011	Van Schaftingen, Emile/0000-0002-6199-7647; Bommer, Guido/0000-0001-6898-4884; Linster, Carole/0000-0001-7143-0719; Vertommen, Didier/0000-0001-7648-8282	WELBIO [CR-2015A-09]; Belgian National Science Fund [T.0120.14, J.0044.14]; Training Fund for Research in Industry and Agriculture; Belgian Cancer Foundation [2010-155, 2014-298]; Interuniversity Attraction Pole [IAP-P7.43]; European Union [276814]; European Union (EURO-CDG); Horizon 2020 [E-RARE-3: EURO-CDG2]; de Duve Institute; Universite Catholique de Louvain;  [F.R.S.-FNRS FRFC 2.5025.12]	WELBIO(WELBIO); Belgian National Science Fund; Training Fund for Research in Industry and Agriculture; Belgian Cancer Foundation; Interuniversity Attraction Pole(Belgian Federal Science Policy Office); European Union(European Commission); European Union (EURO-CDG); Horizon 2020; de Duve Institute; Universite Catholique de Louvain; 	Funding was provided from WELBIO (CR-2015A-09 to E.V.S.), the Belgian National Science Fund (T.0120.14 to E.V.S. and J.0044.14 to G.T.B.), the Training Fund for Research in Industry and Agriculture (to F.B. and J.B.), the Belgian Cancer Foundation (2010-155 to G.T.B. and 2014-298 to E.V.S.), the Interuniversity Attraction Pole (IAP-P7.43 to E.V.S.), the European Union Seventh Framework Programme (FP7/2007-2013 grant no. 276814 to C.L.L. and EURO-CDG to E.V.S.) and Horizon 2020 (E-RARE-3: EURO-CDG2 to E.V.S.), the de Duve Institute and the Universite Catholique de Louvain. We would like to thank E.R. Fearon (University of Michigan), F. Zhang (Massachusetts Institute of Technology), V. Delcenserie (University of Liege), G. Daube (University of Liege), L. Novellasdemunt and R. Bartrons (University of Barcelona) for reagents, R. Gemayel (Catholic University of Leuven) for help with yeast experiments, C. Jager and C. Singh (University of Luxembourg) for help with the GC/MS analysis, P. Sonveaux (Universite Catholique de Louvain) and P. E. Porporato (Universite Catholique de Louvain) for help with the Seahorse XF bioanalyzer (grant F.R.S.-FNRS FRFC 2.5025.12) and A.D. Hanson, L. Hue, J.-F. Collet and A. Peracchi for critical reading of the manuscript.	Amberg D., 2005, J METHODS YEAST GENE; ASH DE, 1984, ARCH BIOCHEM BIOPHYS, V228, P31, DOI 10.1016/0003-9861(84)90043-2; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; BoschiMuller S, 1997, J BIOL CHEM, V272, P15106, DOI 10.1074/jbc.272.24.15106; Bracher A, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.2, 10.1038/nplants.2014.2]; Brachmann CB, 1998, YEAST, V14, P115; Collard F, 2010, J BIOL CHEM, V285, P29826, DOI 10.1074/jbc.M110.152629; CORBIER C, 1992, BIOCHEMISTRY-US, V31, P12532, DOI 10.1021/bi00164a033; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Delcenserie V, 2007, SYST APPL MICROBIOL, V30, P381, DOI 10.1016/j.syapm.2007.01.004; Delgado FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067590; Delpierre G, 2000, DIABETES, V49, P1627, DOI 10.2337/diabetes.49.10.1627; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Dixon HBF, 1997, ADV INORG CHEM, V44, P191; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fiehn O, 2011, J BIOL CHEM, V286, P23637, DOI 10.1074/jbc.R110.173617; Gerin I, 2014, BIOCHEM J, V458, P439, DOI 10.1042/BJ20130841; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; ISHII Y, 1964, J BIOCHEM-TOKYO, V56, P111, DOI 10.1093/oxfordjournals.jbchem.a127952; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; Jaeger C, 2015, AM J PATHOL, V185, P1699, DOI 10.1016/j.ajpath.2015.02.016; KANEKO Y, 1989, MOL GEN GENET, V220, P133, DOI 10.1007/BF00260867; Kim SR, 2015, APPL ENVIRON MICROB, V81, P1601, DOI 10.1128/AEM.03474-14; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; LEBLOND DJ, 1976, BIOCHIM BIOPHYS ACTA, V438, P108, DOI 10.1016/0005-2744(76)90227-8; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; Maliekal P, 2006, GLYCOBIOLOGY, V16, P165, DOI 10.1093/glycob/cwj050; Manzano A, 1999, GENE, V229, P83, DOI 10.1016/S0378-1119(99)00037-2; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Ndubuisil MI, 2002, BIOCHEMISTRY-US, V41, P7841, DOI 10.1021/bi0255064; Notebaart RA, 2014, P NATL ACAD SCI USA, V111, P11762, DOI 10.1073/pnas.1406102111; Novellasdemunt L, 2013, BIOCHEM J, V452, P531, DOI 10.1042/BJ20121886; NOWAK T, 1970, J BIOL CHEM, V245, P6057; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pasti C, 2003, BIOORGAN MED CHEM, V11, P1207, DOI 10.1016/S0968-0896(02)00650-8; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; ROSE ZB, 1986, J BIOL CHEM, V261, P996; Rzem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119540; Schoneberg T, 2013, BIOL CHEM, V394, P977, DOI 10.1515/hsz-2013-0130; Schwarte S, 2007, PLANT PHYSIOL, V144, P1580, DOI 10.1104/pp.107.099192; Seifried A, 2014, J BIOL CHEM, V289, P3416, DOI 10.1074/jbc.M113.503359; Stefani M, 1997, CELL MOL LIFE SCI, V53, P141, DOI 10.1007/PL00000585; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; Tawfik DS, 2014, CURR OPIN CHEM BIOL, V21, P73, DOI 10.1016/j.cbpa.2014.05.008; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P897, DOI 10.1042/bj1920897; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Zhu CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047584	52	62	63	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2016	12	8					601	+		10.1038/NCHEMBIO.2104	http://dx.doi.org/10.1038/NCHEMBIO.2104			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2UW	27294321				2022-12-25	WOS:000380640100006
J	Huang, LL; Khusnutdinova, A; Nocek, B; Brown, G; Xu, XH; Cui, H; Petit, P; Flick, R; Zallot, R; Balmant, K; Ziemak, MJ; Shanklin, J; de Crecy-Lagard, V; Fiehn, O; Gregory, JF; Joachimiak, A; Savchenko, A; Yakunin, AF; Hanson, AD				Huang, Lili; Khusnutdinova, Anna; Nocek, Boguslaw; Brown, Greg; Xu, Xiaohui; Cui, Hong; Petit, Pierre; Flick, Robert; Zallot, Remi; Balmant, Kelly; Ziemak, Michael J.; Shanklin, John; de Crecy-Lagard, Valerie; Fiehn, Oliver; Gregory, Jesse F., III; Joachimiak, Andrzej; Savchenko, Alexei; Yakunin, Alexander F.; Hanson, Andrew D.			A family of metal-dependent phosphatases implicated in metabolite damage-control	NATURE CHEMICAL BIOLOGY			English	Article							ACYL CARRIER PROTEIN; PANTOTHENATE KINASE; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; PYROCOCCUS-FURIOSUS; DIRECTED-OVERFLOW; DNA-DAMAGE; ENZYME; FRUCTOSE; ACID	DUF89 family proteins occur widely in both prokaryotes and eukaryotes, but their functions are unknown. Here we define three DUF89 subfamilies (I, II, and III), with subfamily II being split into stand-alone proteins and proteins fused to pantothenate kinase (PanK). We demonstrated that DUF89 proteins have metal-dependent phosphatase activity against reactive phosphoesters or their damaged forms, notably sugar phosphates (subfamilies II and III), phosphopantetheine and its S-sulfonate or sulfonate (subfamily II-PanK fusions), and nucleotides (subfamily I). Genetic and comparative genomic data strongly associated DUF89 genes with phosphoester metabolism. The crystal structure of the yeast (Saccharomyces cerevisiae) subfamily III protein YMR027W revealed a novel phosphatase active site with fructose 6-phosphate and Mg2+ bound near conserved signature residues Asp254 and Asn255 that are critical for activity. These findings indicate that DUF89 proteins are previously unrecognized hydrolases whose characteristic in vivo function is to limit potentially harmful buildups of normal or damaged phosphometabolites.	[Huang, Lili; Gregory, Jesse F., III] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL USA; [Khusnutdinova, Anna; Brown, Greg; Xu, Xiaohui; Cui, Hong; Petit, Pierre; Flick, Robert; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Nocek, Boguslaw; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom & Struct Biol Ctr, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Zallot, Remi; de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Balmant, Kelly] Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL USA; [Ziemak, Michael J.; Hanson, Andrew D.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Shanklin, John] Brookhaven Natl Lab, Biol Environm & Climate Sci Dept, Upton, NY 11973 USA; [Fiehn, Oliver] Univ Calif Davis, Metabol Core, UC Davis Genome Ctr, Davis, CA 95616 USA	State University System of Florida; University of Florida; University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Energy (DOE); Brookhaven National Laboratory; University of California System; University of California Davis	Yakunin, AF (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.; Hanson, AD (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.	a.iakounine@utoronto.ca; adha@ufl.edu	Hanson, Andrew D/B-6415-2013; Balmant, Kelly/P-8658-2019; Zallot, Rémi/J-9645-2019; de Crecy-Lagard, Valerie/AAN-8995-2020; Khusnutdinova, Anna/AAU-8164-2020; ZALLOT, Rémi/D-3933-2014	Hanson, Andrew D/0000-0003-2585-9340; Zallot, Rémi/0000-0002-7317-1578; ZALLOT, Rémi/0000-0002-7317-1578; Yakunin, Alexander/0000-0003-0813-6490; Shanklin, John/0000-0002-6774-8043; Joachimiak, Andrzej/0000-0003-2535-6209	US National Science Foundation [MCB-1153413, IOS-1025398, MCB-1153491]; Genome Canada; Ontario Genomics Institute [2009 OGI ABC 1405]; Ontario Research Fund [ORF-GL2-01-004]; NSERC Strategic Network grant IBN; National Institutes of Health [GM094585]; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; C.V. Griffin Sr. Foundation; US Department of Energy, Office of Basic Energy Sciences [DOE KC0304000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Genome Canada(Genome Canada); Ontario Genomics Institute; Ontario Research Fund; NSERC Strategic Network grant IBN; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); C.V. Griffin Sr. Foundation; US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Science Foundation grants MCB-1153413 and IOS-1025398 (to A.D.H.) and MCB-1153491 (to O.F.); by Genome Canada, the Ontario Genomics Institute (2009 OGI ABC 1405), the Ontario Research Fund (ORF-GL2-01-004), and NSERC Strategic Network grant IBN (to A.F.Y.); by National Institutes of Health grant GM094585 and the US Department of Energy, Office of Biological and Environmental Research, contract DE-AC02-06CH11357 (to A.J.); and by the C.V. Griffin Sr. Foundation (to A.D.H.). J.S. was supported by US Department of Energy, Office of Basic Energy Sciences, grant DOE KC0304000. We thank J.E. Cronan and H.W. Park for enzymes, K. Kodama of Ikeda Corp. of America for pantetheine-S-sulfonate, S. Gerdes for bioinformatic help, E. van Schaftingen for advice on metabolism, and J.D. Rabinowitz for pilot metabolomics.	ABIKO Y, 1967, J BIOCHEM, V61, P290, DOI 10.1093/oxfordjournals.jbchem.a128547; Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bitto E, 2005, ACTA CRYSTALLOGR F, V61, P630, DOI 10.1107/S1744309105017690; Broadwater JA, 1999, PROTEIN EXPRES PURIF, V15, P314, DOI 10.1006/prep.1998.1016; Chaudhuri B, 1997, GENETICS, V145, P75; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Dauter Z, 1996, P NATL ACAD SCI USA, V93, P8836, DOI 10.1073/pnas.93.17.8836; DONALDSON IA, 1993, BIOCHEM J, V291, P179, DOI 10.1042/bj2910179; Dupureur CM, 2008, CURR OPIN CHEM BIOL, V12, P250, DOI 10.1016/j.cbpa.2008.01.012; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fortpied J, 2005, BIOCHEM J, V388, P795, DOI 10.1042/BJ20041976; Frelin O, 2015, BIOCHEM J, V466, P137, DOI 10.1042/BJ20141237; Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gerdes S, 2012, J EXP BOT, V63, P5379, DOI 10.1093/jxb/ers208; Gerin I, 2014, BIOCHEM J, V458, P439, DOI 10.1042/BJ20130841; Goyer A, 2013, BIOCHEM J, V454, P533, DOI 10.1042/BJ20130516; Hagen WR, 2000, J BIOL INORG CHEM, V5, P527, DOI 10.1007/s007750050013; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Hernick M, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P547; Hogbom M, 2005, MOL CELL PROTEOMICS, V4, P827, DOI 10.1074/mcp.T400023-MCP200; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Levi B, 2003, J NUTR BIOCHEM, V14, P49, DOI 10.1016/S0955-2863(02)00254-1; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; Lu Z, 2008, P NATL ACAD SCI USA, V105, P5687, DOI 10.1073/pnas.0710800105; LUKENS L, 1963, METHOD ENZYMOL, V6, P671, DOI 10.1016/0076-6879(63)06236-4; MIDELFORT CF, 1976, BIOCHEMISTRY-US, V15, P2178, DOI 10.1021/bi00655a023; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; NAKAMURA H, 1972, CHEM PHARM BULL, V20, P2008; Niehaus TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1584-3; OLIVARES JA, 1988, METHOD ENZYMOL, V158, P205, DOI 10.1016/0076-6879(88)58057-6; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perry JJP, 2015, CELL REP, V10, P1288, DOI 10.1016/j.celrep.2015.01.054; PIERPOINT WS, 1955, BIOCHEM J, V61, P368, DOI 10.1042/bj0610368; Reaves ML, 2013, NATURE, V500, P237, DOI 10.1038/nature12445; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Rothmann M, 2013, J AM CHEM SOC, V135, P5962, DOI 10.1021/ja400795m; SMITH JL, 1994, SCIENCE, V264, P1427, DOI 10.1126/science.8197456; Stanford M., 1962, J BIOL CHEM, V238, P235; Suhre Karsten, 2007, V396, P31; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thomas J, 2005, J BIOL CHEM, V280, P34675, DOI 10.1074/jbc.M505736200; Tilton GB, 2006, PLANT MOL BIOL, V61, P629, DOI 10.1007/s11103-006-0037-4; Weinberg MV, 2004, J BACTERIOL, V186, P7888, DOI 10.1128/JB.186.23.7888-7895.2004; YOSHIOKA M, 1971, CHEM PHARM BULL, V19, P178	59	28	30	0	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2016	12	8					621	+		10.1038/NCHEMBIO.2108	http://dx.doi.org/10.1038/NCHEMBIO.2108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2UW	27322068	Green Accepted, Green Submitted			2022-12-25	WOS:000380640100009
J	Muller, M; Auslander, S; Spinnler, A; Auslander, D; Sikorski, J; Folcher, M; Fussenegger, M				Muller, Marius; Auslander, Simon; Spinnler, Andrea; Auslander, David; Sikorski, Julian; Folcher, Marc; Fussenegger, Martin			Designed cell consortia as fragrance-programmable analog-to-digital converters	NATURE CHEMICAL BIOLOGY			English	Article							CONTROLLED TRANSGENE EXPRESSION; MAMMALIAN-CELLS; SYNTHETIC CIRCUITS; LIVING CELLS; CANCER-CELLS; LOGIC GATES; MICE; SYSTEM; HOMEOSTASIS; PRINCIPLES	Synthetic biology advances the rational engineering of mammalian cells to achieve cell-based therapy goals. Synthetic gene networks have nearly reached the complexity of digital electronic circuits and enable single cells to perform programmable arithmetic calculations or to provide dynamic remote control of transgenes through electromagnetic waves. We designed a synthetic multilayered gaseous-fragrance-programmable analog-to-digital converter (ADC) allowing for remote control of digital gene expression with 2-bit AND-, OR- and NOR-gate logic in synchronized cell consortia. The ADC consists of multiple sampling-and-quantization modules sensing analog gaseous fragrance inputs; a gas-to-liquid transducer converting fragrance intensity into diffusible cell-to-cell signaling compounds; a digitization unit with a genetic amplifier circuit to improve the signal-to-noise ratio; and recombinase-based digital expression switches enabling 2-bit processing of logic gates. Synthetic ADCs that can remotely control cellular activities with digital precision may enable the development of novel biosensors and may provide bioelectronic interfaces synchronizing analog metabolic pathways with digital electronics.	[Muller, Marius; Auslander, Simon; Spinnler, Andrea; Auslander, David; Sikorski, Julian; Folcher, Marc; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Fussenegger, Martin] Univ Basel, Fac Sci, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.; Fussenegger, M (corresponding author), Univ Basel, Fac Sci, Basel, Switzerland.	fussenegger@bsse.ethz.ch			European Research Council (ERC) [321381]; National Centre of Competence in Research (NCCR) for Molecular Systems Engineering	European Research Council (ERC)(European Research Council (ERC)); National Centre of Competence in Research (NCCR) for Molecular Systems Engineering	We thank T. Horn, E. Montani, T. Lopes and V. Jaeggin for their support with microscopy and flow cytometry. We thank F. Sedlmayer, V. Viswam, S. Burgel and P. Buchmann for their generous advice and O. Chepurny and G. Holz (Department of Physiology and Neuroscience, New York University School of Medicine, New York, USA), H. Matsunami (Department of Molecular Genetics and Microbiology, Duke University Medical Center, North Carolina, USA), H. Ye (Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China) and W. Bacchus (Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland) for providing plasmids and genetic components. This work was supported by a European Research Council (ERC) advanced grant (ProNet, no. 321381) and in part by funding from the National Centre of Competence in Research (NCCR) for Molecular Systems Engineering awarded to M.F.	Auslander D, 2014, MOL CELL, V55, P397, DOI 10.1016/j.molcel.2014.06.007; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Auslander S, 2012, METAB ENG, V14, P252, DOI 10.1016/j.ymben.2011.06.003; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Boorsma M, 2000, NAT BIOTECHNOL, V18, P429, DOI 10.1038/74493; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Clark B, 2006, CURR BIOL, V16, pR585, DOI 10.1016/j.cub.2006.07.007; Dreosti E, 2011, NAT NEUROSCI, V14, P951, DOI 10.1038/nn.2841; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/nmeth.2996, 10.1038/NMETH.2996]; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Folcher M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6392; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gitzinger M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1251; Gitzinger M, 2009, P NATL ACAD SCI USA, V106, P10638, DOI 10.1073/pnas.0901501106; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Kemmer C, 2011, J CONTROL RELEASE, V150, P23, DOI 10.1016/j.jconrel.2010.11.016; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Lapique N, 2014, NAT CHEM BIOL, V10, P1020, DOI 10.1038/nchembio.1680; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Morel M, 2016, P NATL ACAD SCI USA, V113, P8133, DOI 10.1073/pnas.1604391113; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Nern A, 2011, P NATL ACAD SCI USA, V108, P14198, DOI 10.1073/pnas.1111704108; Nissim L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.99; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Riccione KA, 2012, ACS SYNTH BIOL, V1, P389, DOI 10.1021/sb300044r; Rossger K, 2014, METAB ENG, V21, P81, DOI 10.1016/j.ymben.2013.11.003; Roquet N, 2016, SCIENCE, V353, P363, DOI 10.1126/science.aad8559; Tubio MR, 2010, J BIOL CHEM, V285, P14990, DOI 10.1074/jbc.M109.099689; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Rubens JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11658; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saxena P, 2016, P NATL ACAD SCI USA, V113, P1244, DOI 10.1073/pnas.1514383113; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Schukur L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4964; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stanley SA, 2012, SCIENCE, V336, P604, DOI 10.1126/science.1216753; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; TOHE A, 1985, NUCLEIC ACIDS RES, V13, P4267, DOI 10.1093/nar/13.12.4267; Weber W, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng069; Weber W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm466; Weber W, 2007, CURR OPIN BIOTECH, V18, P399, DOI 10.1016/j.copbio.2007.09.002; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Yang L, 2014, NAT METHODS, V11, P1261, DOI [10.1038/nmeth.3147, 10.1038/NMETH.3147]; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535	51	32	37	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2017	13	3					309	+		10.1038/NCHEMBIO.2281	http://dx.doi.org/10.1038/NCHEMBIO.2281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL2DY	28092361				2022-12-25	WOS:000394431500015
J	Schneider, C; Oellerich, T; Baldauf, HM; Schwarz, SM; Thomas, D; Flick, R; Bohnenberger, H; Kaderali, L; Stegmann, L; Cremer, A; Martin, M; Lohmeyer, J; Michaelis, M; Hornung, V; Schliemann, C; Berdel, WE; Hartmann, W; Wardelmann, E; Comoglio, F; Hansmann, ML; Yakunin, AF; Geisslinger, G; Strobel, P; Ferreiros, N; Serve, H; Keppler, OT; Cinatl, J				Schneider, Constanze; Oellerich, Thomas; Baldauf, Hanna-Mari; Schwarz, Sarah-Marie; Thomas, Dominique; Flick, Robert; Bohnenberger, Hanibal; Kaderali, Lars; Stegmann, Lena; Cremer, Anjali; Martin, Margarethe; Lohmeyer, Julian; Michaelis, Martin; Hornung, Veit; Schliemann, Christoph; Berdel, Wolfgang E.; Hartmann, Wolfgang; Wardelmann, Eva; Comoglio, Federico; Hansmann, Martin-Leo; Yakunin, Alexander F.; Geisslinger, Gerd; Stroebel, Philipp; Ferreiros, Nerea; Serve, Hubert; Keppler, Oliver T.; Cinatl, Jindrich, Jr.			SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia	NATURE MEDICINE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; RESTRICTION FACTOR SAMHD1; HIV-1 INFECTION; TRIPHOSPHOHYDROLASE; CELLS; VPX; TRIPHOSPHATES; METABOLISM; ACTIVATION; PROTEIN	The nucleoside analog cytarabine (Ara-C) is an essential component of primary and salvage chemotherapy regimens for acute myeloid leukemia (AML). After cellular uptake, Ara-C is converted into its therapeutically active triphosphate metabolite, Ara-CTP, which exerts antileukemic effects, primarily by inhibiting DNA synthesis in proliferating cells'. Currently, a substantial fraction of patients with AML fail to respond effectively to Ara-C therapy, and reliable biomarkers for predicting the therapeutic response to Ara-C are lacking(2,3). SAMHD1 is a deoxynucleoside triphosphate (dNTP) triphosphohydrolase that cleaves physiological dNTPs into deoxyribonucleosides and inorganic triphosphate(4,5). Although it has been postulated that SAMHD1 sensitizes cancer cells to nucleoside-analog derivatives through the depletion of competing dNTPs6, we show here that SAMHD1 reduces Ara-C cytotoxicity in AML cells. Mechanistically, dGTP-activated SAMHD1 hydrolyzes Ara-CTP, which results in a drastic reduction of Ara-CTP in leukemic cells. Loss of SAMHD1 activity through genetic depletion, mutational inactivation of its triphosphohydrolase activity or proteasomal degradation using specialized, virus-like particles(7,8) potentiates the cytotoxicity of Ara-C in AML cells. In mouse models of retroviral AML transplantation, as well as in retrospective analyses of adult patients with AML, the response to Ara-C-containing therapy was inversely correlated with SAMHD1 expression. These results identify SAMHD1 as a potential biomarker for the stratification of patients with AML who might best respond to Ara-C-based therapy and as a target for treating Ara-C-refractory AML.	[Schneider, Constanze; Baldauf, Hanna-Mari; Schwarz, Sarah-Marie; Stegmann, Lena; Martin, Margarethe; Keppler, Oliver T.; Cinatl, Jindrich, Jr.] Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany; [Oellerich, Thomas; Cremer, Anjali; Serve, Hubert] Goethe Univ Frankfurt, Dept Med Hematol & Oncol 2, Frankfurt, Germany; [Oellerich, Thomas; Comoglio, Federico] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England; [Oellerich, Thomas; Serve, Hubert] German Canc Res Ctr, German Canc Consortium Partner Site, Heidelberg, Germany; [Baldauf, Hanna-Mari; Keppler, Oliver T.] Ludwig Maximilian Univ Munich, Dept Virol, Max von Pettenkofer Inst, Munich, Germany; [Thomas, Dominique; Geisslinger, Gerd; Ferreiros, Nerea] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Flick, Robert; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Bohnenberger, Hanibal; Stroebel, Philipp] Univ Med Ctr, Inst Pathol, Gottingen, Germany; [Kaderali, Lars] Univ Med Greifswald, Inst Bioinformat, Greifswald, Germany; [Michaelis, Martin] Univ Kent, Ctr Mol Proc & Sch Biosci, Canterbury, Kent, England; [Hornung, Veit] Univ Hosp Bonn, Inst Mol Med, Bonn, Germany; [Hornung, Veit] Ludwig Maximilian Univ Munich, Gene Ctr, Munich, Germany; [Hornung, Veit] Ludwig Maximilian Univ Munich, Dept Biochem, Munich, Germany; [Schliemann, Christoph; Berdel, Wolfgang E.] Univ Hosp Munster, Dept Med Hematol A, Oncol, Munster, Germany; [Hartmann, Wolfgang; Wardelmann, Eva] Univ Hosp Munster, Gerhard Domagk Inst Pathol, Munster, Germany; [Hansmann, Martin-Leo] Goethe Univ Frankfurt, Senckenberg Inst Pathol, Frankfurt, Germany; [Geisslinger, Gerd] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; University of Cambridge; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; Goethe University Frankfurt; University of Toronto; University of Gottingen; Greifswald Medical School; University of Kent; University of Bonn; University of Munich; University of Munich; University of Munster; University of Munster; Goethe University Frankfurt; Fraunhofer Gesellschaft	Keppler, OT; Cinatl, J (corresponding author), Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany.; Keppler, OT (corresponding author), Ludwig Maximilian Univ Munich, Dept Virol, Max von Pettenkofer Inst, Munich, Germany.	keppler@mvp.uni-muenchen.de; Cinatl@em.uni-frankfurt.de	Bohnenberger, Hanibal/F-2317-2013; Hornung, Veit/C-3565-2012; Hartmann, Wolfgang/G-1893-2017	Hornung, Veit/0000-0002-4150-194X; Hartmann, Wolfgang/0000-0002-7609-5021; Comoglio, Federico/0000-0002-8970-6610; Michaelis, Martin/0000-0002-5710-5888; Kaderali, Lars/0000-0002-2359-2294; Serve, Hubert/0000-0001-8472-5516	EMBO long-term fellowship [1305-2015, LITCOFUND2013/GA-2013-609409]; Deutsche Forschungsgemeinschaft grant [DFG EXC 1003]; Medical Faculty of the University of Frankfurt; Hilfe fur krebskranke Kinder Frankfurt e.V.; Frankfurter Stiftung fur krebskranke Kinder; LOEWE Program of the State of Hessia (LOEWE Center for Translational Medicine and Pharmacology, Frankfurt); Jose Carreras Leukamie-Stiftung; Deutsche Forschungsgemeinschaft [KE 742/4-1, 1039/Z01]; NSERC Strategic Network grant IBN; Kent Cancer Trust; LMU Munich	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft grant(German Research Foundation (DFG)); Medical Faculty of the University of Frankfurt; Hilfe fur krebskranke Kinder Frankfurt e.V.; Frankfurter Stiftung fur krebskranke Kinder; LOEWE Program of the State of Hessia (LOEWE Center for Translational Medicine and Pharmacology, Frankfurt); Jose Carreras Leukamie-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSERC Strategic Network grant IBN; Kent Cancer Trust; LMU Munich	This study is dedicated to the memory of Professor Werner Reutter. We are grateful to T. Gramberg (Institute of Clinical and Molecular Virology, FAU Erlangen Nurnberg, Erlangen, Germany) for providing a codon-optimized SAMHD1 expression construct and I. Jeremias (Department of Gene Vectors, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Munich, Germany) for providing AML-393. We thank S. Grothe, Y. Voges and K. Lehr for technical assistance, and A. Ruggieri for graphical artwork. We are grateful to R. Zehner for short tandem repeat (STR) profiling. We acknowledge logistic support by N. Herold for LC-MS/MS analyses in the period September to November 2014 as scientific staff in the laboratory of O.T.K. at Goethe University. F.C. is supported by an EMBO long-term fellowship (1305-2015 and Marie Curie Actions LITCOFUND2013/GA-2013-609409). The WEBs laboratory is supported by the Deutsche Forschungsgemeinschaft grant DFG EXC 1003 (H.S.). This work was supported in part by the Medical Faculty of the University of Frankfurt (O.T.K.), Hilfe fur krebskranke Kinder Frankfurt e.V. (J.C.), the Frankfurter Stiftung fur krebskranke Kinder (J.C.), by the LOEWE Program of the State of Hessia (LOEWE Center for Translational Medicine and Pharmacology, Frankfurt)(G.G. and H.S.), the Jose Carreras Leukamie-Stiftung (J.C.), the Deutsche Forschungsgemeinschaft (KE 742/4-1 (O.T.K.), SFB 1039/Z01 (G.G.)), the NSERC Strategic Network grant IBN (M. Michaelis), the Kent Cancer Trust (M. Michaelis) and the LMU Munich (O.T.K.).	Arnold LH, 2015, ANTIMICROB AGENTS CH, V59, P186, DOI 10.1128/AAC.03903-14; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Ballana E, 2014, ANTIMICROB AGENTS CH, V58, P4804, DOI 10.1128/AAC.03145-14; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Dombret H, 2016, BLOOD, V127, P53, DOI 10.1182/blood-2015-08-604520; EARLY AP, 1982, CANCER RES, V42, P1587; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huber AD, 2014, ANTIMICROB AGENTS CH, V58, P4915, DOI 10.1128/AAC.02745-14; Koharudin LMI, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.591958; Kohnken R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0446-6; Komanduri KV, 2016, ANNU REV MED, V67, P59, DOI 10.1146/annurev-med-051914-021329; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lamba JK, 2009, PHARMACOGENOMICS, V10, P1657, DOI [10.2217/pgs.09.118, 10.2217/PGS.09.118]; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Lowenberg B, 2011, NEW ENGL J MED, V364, P1027, DOI 10.1056/NEJMoa1010222; Merati Miesha, 2015, JAAD Case Rep, V1, P227, DOI 10.1016/j.jdcr.2015.05.003; Rentoft M, 2016, P NATL ACAD SCI USA, V113, P4723, DOI 10.1073/pnas.1519128113; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796	25	84	85	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					250	255		10.1038/nm.4255	http://dx.doi.org/10.1038/nm.4255			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	27991919	Green Accepted			2022-12-25	WOS:000393729000017
J	Hahm, E; Wei, CL; Fernandez, I; Li, J; Tardi, NJ; Tracy, M; Wadhwani, S; Cao, YX; Peev, V; Zloza, A; Lusciks, J; Hayek, SS; O'Connor, C; Bitzer, M; Gupta, V; Sever, S; Sykes, DB; Scadden, DT; Reiser, J				Hahm, Eunsil; Wei, Changli; Fernandez, Isabel; Li, Jing; Tardi, Nicholas J.; Tracy, Melissa; Wadhwani, Shikha; Cao, Yanxia; Peev, Vasil; Zloza, Andrew; Lusciks, Jevgenijs; Hayek, Salim S.; O'Connor, Christopher; Bitzer, Markus; Gupta, Vineet; Sever, Sanja; Sykes, David B.; Scadden, David T.; Reiser, Jochen			Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease	NATURE MEDICINE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; SOLUBLE UROKINASE RECEPTOR; PLASMINOGEN-ACTIVATOR RECEPTOR; IDIOPATHIC NEPHROTIC SYNDROME; HEMATOPOIETIC STEM-CELLS; HUMANIZED MOUSE MODELS; GLOMERULAR-DISEASE; MICE; PODOCYTES; PERMEABILITY	Excess levels of protein in urine (proteinuria) is a hallmark of kidney disease that typically occurs in conjunction with diabetes, hypertension, gene mutations, toxins or infections but may also be of unknown cause (idiopathic)(1). Systemic soluble urokinase plasminogen activator receptor (suPAR) is a circulating factor implicated in the onset and progression of chronic kidney disease (CKD)(2), such as focal segmental glomeruloscierosis (FSGS)(3,4). The cellular source(s) of elevated suPAR associated with future and progressing kidney disease is unclear, but is likely extra-renal, as the pathological uPAR is circulating and FSGS can recur even after a damaged kidney is replaced with a healthy donor organ. Here we report that bone marrow (BM) Gr-1(lo) immature myeloid cells are responsible for the elevated, pathological levels of suPAR, as evidenced by BM chimera and BM ablation and cell transfer studies. A marked increase of Gr-1(lo) myeloid cells was commonly found in the BM of proteinuric animals having high suPAR, and these cells efficiently transmit proteinuria when transferred to healthy mice. In accordance with the results seen in suPAR-associated proteinuric animal models, in which kidney damage is caused not by local podocyte-selective injury but more likely by systemic insults, a humanized xenograft model of FSGS resulted in an expansion of Gr-1(lo) cells in the BM, leading to high plasma suPAR and proteinuric kidney disease. Together, these results identify suPAR as a functional connection between the BM and the kidney, and they implicate BM immature myeloid cells as a key contributor to glomerular dysfunction.	[Hahm, Eunsil; Wei, Changli; Fernandez, Isabel; Li, Jing; Tardi, Nicholas J.; Tracy, Melissa; Wadhwani, Shikha; Cao, Yanxia; Peev, Vasil; Zloza, Andrew; Lusciks, Jevgenijs; Gupta, Vineet; Reiser, Jochen] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Zloza, Andrew; Lusciks, Jevgenijs] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Zloza, Andrew] Rutgers Canc Inst New Jersey, Div Surg Oncol Res Sect, Sect Surg Oncol, New Brunswick, NJ USA; [Zloza, Andrew] Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA; [Hayek, Salim S.] Emory Univ, Sch Med, Emory Clin Cardiovasc Res Inst, Div Cardiol, Atlanta, GA 30322 USA; [O'Connor, Christopher; Bitzer, Markus] Univ Michigan, Dept Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Sever, Sanja] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Sykes, David B.; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Ct Regenerat Med, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Sykes, David B.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Rush University; Rush University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Emory University; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Reiser, J (corresponding author), Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA.	Jochen_Reiser@rush.edu	Hayek, Salim S./E-6932-2013	Hayek, Salim S./0000-0003-0180-349X; Hahm, Eunsil/0000-0002-0343-7473; Bitzer, Markus/0000-0002-3711-2984; Zloza, Andrew/0000-0001-8844-6493	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK101350, R01DK106051, R01DK107984, R01DK084195]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100449, R01DK084195, R01DK106051, R01DK101350, R01DK107984] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A.S. Shaw (Washington University School of Medicine) for the Racl transgenic mice; S. Shankland (University of Washington) for providing the nephrotoxic serum (NTS); A. Finnegan (Rush University Medical Center) for reagents and advice; B. Samelko (ne Tryniszewska) (Rush University Medical Center) for technical assistance; and S. Mangos (Rush University Medical Center) for help with manuscript revisions. This research was supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK101350 (J.R.), R01DK106051(J.R.), R01DK107984(V.G.) and R01DK084195(V.G.).	Alfano M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13647; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Bertelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111285; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Brehm MA, 2010, CURR OPIN ENDOCRINOL, V17, P120, DOI 10.1097/MED.0b013e328337282f; Cathelin D, 2014, J AM SOC NEPHROL, V25, P1662, DOI 10.1681/ASN.2013040425; Cravedi P, 2013, AM J TRANSPLANT, V13, P266, DOI 10.1111/ajt.12045; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Delville M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008538; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; Fogo AB, 2015, NAT REV NEPHROL, V11, P76, DOI 10.1038/nrneph.2014.216; Gallon L, 2012, NEW ENGL J MED, V366, P1648, DOI 10.1056/NEJMc1202500; Hayek SS, 2015, NEW ENGL J MED, V373, P1916, DOI 10.1056/NEJMoa1506362; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Huang J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-81; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Kistler AD, 2013, J BIOL CHEM, V288, P36598, DOI 10.1074/jbc.M113.488122; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; Kopp JB, 1996, LAB INVEST, V74, P991; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Niu HT, 2013, BLOOD, V121, P1986, DOI 10.1182/blood-2012-05-433755; Papeta N, 2010, J CLIN INVEST, V120, P4055, DOI 10.1172/JCI43721; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Savin VJ, 1996, NEW ENGL J MED, V334, P878, DOI 10.1056/NEJM199604043341402; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Sellier-Leclerc AL, 2007, J AM SOC NEPHROL, V18, P2732, DOI 10.1681/ASN.2006121346; Shi X, 2013, INFECT IMMUN, V81, P2197, DOI 10.1128/IAI.01280-12; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Spinale JM, 2015, KIDNEY INT, V87, P564, DOI 10.1038/ki.2014.346; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu HY, 2013, MOL CELL BIOL, V33, P4755, DOI 10.1128/MCB.00730-13; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007	40	94	99	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					100	106		10.1038/nm.4242	http://dx.doi.org/10.1038/nm.4242			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27941791	Green Accepted			2022-12-25	WOS:000391646800018
J	Middlebrooks, CD; Banday, AR; Matsuda, K; Udquim, KI; Onabajo, OO; Paquin, A; Figueroa, JD; Zhu, B; Koutros, S; Kubo, M; Shuin, T; Freedman, ND; Kogevinas, M; Malats, N; Chanock, SJ; Garcia-Closas, M; Silverman, DT; Rothman, N; Prokunina-Olsson, L				Middlebrooks, Candace D.; Banday, A. Rouf; Matsuda, Konichi; Udquim, Krizia-Ivana; Onabajo, Olusegun O.; Paquin, Ashley; Figueroa, Jonine D.; Zhu, Bin; Koutros, Stella; Kubo, Michiaki; Shuin, Taro; Freedman, Neal D.; Kogevinas, Manolis; Malats, Nuria; Chanock, Stephen J.; Garcia-Closas, Montserrat; Silverman, Debra T.; Rothman, Nathaniel; Prokunina-Olsson, Ludmila			Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DELETION POLYMORPHISM; CYTIDINE DEAMINASES; DNA; INTERFERON; HYPERMUTATION; MUTAGENESIS; EXPRESSION; SURVIVAL; ENZYMES	High rates of APOBEC-signature mutations are found in many tumors, but factors affecting this mutation pattern are not well understood. Here we explored the contribution of two common germline variants in the APOBEC3 region. SNP rs1014971 was associated with bladder cancer risk, increased APOBEC3B expression, and enrichment with APOBEC-signature mutations in bladder tumors. In contrast, a 30-kb deletion that eliminates APOBEC3B and creates an APOBEC3A-APOBEC3B chimera was not important in bladder cancer, whereas it was associated with breast cancer risk and enrichment with APOBEC-signature mutations in breast tumors. In vitro, APOBEC3B expression was predominantly induced by treatment with a DNA-damaging drug in bladder cancer cell lines, and APOBEC3A expression was induced as part of the antiviral interferon-stimulated response in breast cancer cell lines. These findings suggest a tissue-specific role of environmental oncogenic triggers, particularly in individuals with germline APOBEC3 risk variants.	[Middlebrooks, Candace D.; Banday, A. Rouf; Udquim, Krizia-Ivana; Onabajo, Olusegun O.; Paquin, Ashley; Prokunina-Olsson, Ludmila] NCI, Lab Translat Gen, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Matsuda, Konichi] Univ Tokyo, Mol Med Lab, Ctr Human Genome, Inst Med Sci, Tokyo, Japan; [Figueroa, Jonine D.] Univ Edinburgh, Sch Med, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Zhu, Bin; Koutros, Stella; Freedman, Neal D.; Chanock, Stephen J.; Garcia-Closas, Montserrat; Silverman, Debra T.; Rothman, Nathaniel] NCI, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Kubo, Michiaki] RIKEN, Inst Phys & Chem Res, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Shuin, Taro] Kochi Univ, Sch Med, Dept Urol, Kochi, Japan; [Kogevinas, Manolis] Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain; [Kogevinas, Manolis] Hosp del Mar, Res Inst IMIM, Barcelona, Spain; [Kogevinas, Manolis] Ctr Invest Biomed Red CIBER, Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Malats, Nuria] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Tokyo; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); RIKEN; Kochi University; ISGlobal; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Centro Nacional de Investigaciones Oncologicas (CNIO)	Prokunina-Olsson, L (corresponding author), NCI, Lab Translat Gen, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA.	prokuninal@mail.nih.gov	Garcia-Closas, Montserrat/AAZ-6930-2021; Figueroa, Jonine/AFK-2752-2022; Figueroa, Jonine/GWD-1322-2022; BANDAY, ABDUL R/A-9555-2014; Banday, A. Rouf/AAB-9082-2022; Freedman, Neal David/B-9741-2015; Figueroa, Jonine/AAG-1065-2022; Kogevinas, Manolis/C-3918-2017; ZHU, BIN/GLQ-8199-2022; Koutros, Stella/W-5788-2019; Prokunina-Olsson, Ludmila/A-8240-2019; Prokunina-Olsson, Ludmila/V-7960-2019; Malats, Nuria/H-7041-2015	Garcia-Closas, Montserrat/0000-0003-1033-2650; Figueroa, Jonine/0000-0002-5100-623X; Figueroa, Jonine/0000-0002-5100-623X; Freedman, Neal David/0000-0003-0074-1098; Figueroa, Jonine/0000-0002-5100-623X; Kogevinas, Manolis/0000-0002-9605-0461; Koutros, Stella/0000-0001-5294-5485; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; BANDAY, ABDUL ROUF/0000-0002-1521-340X; Malats, Nuria/0000-0003-2538-3784	federal funds from the Intramural Research Program (IRP), Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institutes of Health Genes, Environment, and Health Initiative (GEI) [HG-06-033-NCI-01, RO1HL091172-01]; NIH [HHSN268200782096C]; NCI [N02-CP-11015]; Ministry of Education, Culture, Sports, Science and Technology of the Japanese government;  [U01HG004438]; NATIONAL CANCER INSTITUTE [R01CA089715, R01CA034627] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438, ZIAHG200331] Funding Source: NIH RePORTER	federal funds from the Intramural Research Program (IRP), Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; National Institutes of Health Genes, Environment, and Health Initiative (GEI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Breast Cancer Association Consortium (BCAC) for access to summary results for the association between rs1014971 and breast cancer risk. The results presented here are in part based upon data generated by the TCGA Research Network. The study was supported by federal funds from the Intramural Research Program (IRP), Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (contract HHSN261200800001E). The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was funded with National Institutes of Health Genes, Environment, and Health Initiative (GEI) grants HG-06-033-NCI-01 and RO1HL091172-01, U01HG004438, and NIH HHSN268200782096C. The Spanish Bladder Cancer Study (SBCS) was funded with intramural contract NCI N02-CP-11015. FIS/Spain 98/1274, FIS/Spain 00/0745, PI061614, and G03/174, Fundacio Marato TV3, Red Tematica Investigation Cooperativa en Cancer (RTICC), Consolider ONCOBIO, EU-FP7-201663; and RO1-CA089715 and CA34627. The Biobank Japan Project was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government. The funders did not have a role in study design, data collection and analysis, writing, or submission of the manuscript.	Akre MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155391; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Caval V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6129; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Dziegielewski J, 2001, BIOCHEMISTRY-US, V40, P704, DOI 10.1021/bi002181n; Figueroa JD, 2014, HUM MOL GENET, V23, P1387, DOI 10.1093/hmg/ddt519; Garcia-Closas M, 2013, CANCER RES, V73, P2211, DOI 10.1158/0008-5472.CAN-12-2388; Gohler S, 2016, J CANCER RES CLIN, V142, P273, DOI 10.1007/s00432-015-2038-7; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Land AM, 2013, J BIOL CHEM, V288, P17253, DOI 10.1074/jbc.M113.458661; Long JR, 2013, JNCI-J NATL CANCER I, V105, P573, DOI 10.1093/jnci/djt018; Machiela MJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0755-5; Matsuda K, 2015, HUM MOL GENET, V24, P1177, DOI 10.1093/hmg/ddu512; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Mullane SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27702; Mussil B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073641; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nowarski R, 2013, CANCER RES, V73, P3494, DOI 10.1158/0008-5472.CAN-13-0728; Plimack ER, 2015, EUR UROL, V68, P959, DOI 10.1016/j.eururo.2015.07.009; Qi GN, 2014, TUMOR BIOL, V35, P5723, DOI 10.1007/s13277-014-1758-7; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Reid E, 2014, J INTERF CYTOK RES, V34, P649, DOI 10.1089/jir.2014.0066; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Saraconi G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0417-z; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; STRANDER H, 1966, ANN MED EXP BIOL FEN, V44, P265; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wang Z, 2014, J VIROL, V88, P1308, DOI 10.1128/JVI.03091-13; Waters CE, 2015, ONCOTARGET, V6, P3409, DOI 10.18632/oncotarget.2636; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Xuan D, 2013, CARCINOGENESIS, V34, P2240, DOI 10.1093/carcin/bgt185	48	100	101	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1330	1338		10.1038/ng.3670	http://dx.doi.org/10.1038/ng.3670			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27643540	Green Accepted			2022-12-25	WOS:000386543400009
J	Ramos-Espiritu, L; Kleinboelting, S; Navarrete, FA; Alvau, A; Visconti, PE; Valsecchi, F; Starkov, A; Manfredi, G; Buck, H; Adura, C; Zippin, JH; van den Heuvel, J; Glickman, JF; Steegborn, C; Levin, LR; Buck, J				Ramos-Espiritu, Lavoisier; Kleinboelting, Silke; Navarrete, Felipe A.; Alvau, Antonio; Visconti, Pablo E.; Valsecchi, Federica; Starkov, Anatoly; Manfredi, Giovanni; Buck, Hannes; Adura, Carolina; Zippin, Jonathan H.; van den Heuvel, Joop; Glickman, J. Fraser; Steegborn, Clemens; Levin, Lonny R.; Buck, Jochen			Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; MEDIATED SIGNAL-TRANSDUCTION; MOUSE SPERM CAPACITATION; INS-1E INSULINOMA CELLS; CRYSTAL-STRUCTURE; MAMMALIAN SPERM; BICARBONATE; CAMP; MITOCHONDRIA; CALCIUM	The prototypical second messenger cAMP regulates a wide variety of physiological processes. It can simultaneously mediate diverse functions by acting locally in independently regulated microdomains. In mammalian cells, two types of adenylyl cyclase generate cAMP: G-protein-regulated transmembrane adenylyl cyclases and bicarbonate-, calcium-and ATP-regulated soluble adenylyl cyclase (sAC). Because each type of cyclase regulates distinct microdomains, methods to distinguish between them are needed to understand cAMP signaling. We developed a mass-spectrometry-based adenylyl cyclase assay, which we used to identify a new sAC-specific inhibitor, LRE1. LRE1 bound to the bicarbonate activator binding site and inhibited sAC via a unique allosteric mechanism. LRE1 prevented sAC-dependent processes in cellular and physiological systems, and it will facilitate exploration of the therapeutic potential of sAC inhibition.	[Ramos-Espiritu, Lavoisier; Buck, Hannes; Levin, Lonny R.; Buck, Jochen] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Ramos-Espiritu, Lavoisier; Glickman, J. Fraser] Rockefeller Univ, High Throughput Screening & Spect Resource Ctr, 1230 York Ave, New York, NY 10021 USA; [Kleinboelting, Silke; Steegborn, Clemens] Univ Bayreuth, Dept Biochem, Bayreuth, Germany; [Navarrete, Felipe A.; Alvau, Antonio; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Valsecchi, Federica; Starkov, Anatoly; Manfredi, Giovanni] Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY USA; [Zippin, Jonathan H.] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA; [van den Heuvel, Joop] Helmholtz Zentrum Infekt Forsch, Braunschweig, Germany	Cornell University; Rockefeller University; University of Bayreuth; University of Massachusetts System; University of Massachusetts Amherst; Cornell University; Cornell University; Helmholtz Association; Helmholtz-Center for Infection Research	Levin, LR (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA.	llevin@med.cornell.edu	Levin, Lonny R/A-7215-2011; Glickman, Joseph/H-3021-2013; Starkov, Anatoly/B-2688-2012	Levin, Lonny/0000-0002-5204-6356; Glickman, Joseph/0000-0002-6706-4039; Starkov, Anatoly/0000-0002-1334-4828	Helmsley Trust; US National Institutes of Health (NIH) grants [GM107442, EY025810]; Weill Cornell Medicine Clinical and Translational Sciences Center; NIH National Center for Advancing Translational Sciences grant [UL1TR00457]; NIH grants [HD38082, HD44044, R01GM088999, K08 CA160657]; Melanoma Research Alliance Team Science and Clinique Clinical Scholars Awards; Deutsche Forschungsgemeinschaft grant [STE1701/11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038082, R01HD044044] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K08CA160657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384, UL1TR000457] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY025810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107442, R01GM088999] Funding Source: NIH RePORTER	Helmsley Trust; US National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell Medicine Clinical and Translational Sciences Center; NIH National Center for Advancing Translational Sciences grant; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance Team Science and Clinique Clinical Scholars Awards; Deutsche Forschungsgemeinschaft grant(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Warren and The Milstein Synthetic Chemistry Core Facility at Weill Cornell Medical College, and S.S. Gross and Q. Chen. C.S. and S.K. thank the Berliner Elektronenspeicherring-Gesellschaft fur Synchrotronstrahlung (BESSY) staff and the Helmholtz Protein Sample Production Facility (PSPF) for technical assistance. L.R.-E. and J.F.G. thank the High-Throughput and Spectroscopy Resource Center staff, the Helmsley Trust for funding the rapid-fire automated solid phase extraction time of flight mass spectrometry instrument, and Agilent staff, especially P. Rye and L. Frick, for technical assistance. This work was supported, in whole or in part, by US National Institutes of Health (NIH) grants GM107442 and EY025810 and by the Weill Cornell Medicine Clinical and Translational Sciences Center, NIH National Center for Advancing Translational Sciences grant UL1TR00457 (to L.R.L. and J.B.); NIH grants HD38082 and HD44044 (to P.E.V.), R01GM088999 (to G.M.), and K08 CA160657 (to J.H.Z.); Melanoma Research Alliance Team Science and Clinique Clinical Scholars Awards (to J.H.Z.); and Deutsche Forschungsgemeinschaft grant STE1701/11 (to C.S.).	Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Appukuttan A, 2012, CARDIOVASC RES, V93, P340, DOI 10.1093/cvr/cvr306; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/NCHEM.1243, 10.1038/nchem.1243]; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bitterman JL, 2013, J PHARMACOL EXP THER, V347, P589, DOI 10.1124/jpet.113.208496; BRAUN T, 1990, P SOC EXP BIOL MED, V194, P58; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; Chen J, 2013, BRAIN RES, V1518, P1, DOI 10.1016/j.brainres.2013.04.027; Chen X, 2014, AM J RESP CELL MOL, V51, P750, DOI 10.1165/rcmb.2013-0542OC; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Conley JM, 2013, J PHARMACOL EXP THER, V347, P276, DOI 10.1124/jpet.113.207449; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; De Rasmo D, 2015, BBA-MOL CELL RES, V1853, P183, DOI 10.1016/j.bbamcr.2014.10.016; Desman G, 2014, BBA-MOL BASIS DIS, V1842, P2636, DOI 10.1016/j.bbadis.2014.08.016; Di Benedetto G, 2013, CELL METAB, V17, P965, DOI 10.1016/j.cmet.2013.05.003; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Flacke JP, 2013, J BIOL CHEM, V288, P3126, DOI 10.1074/jbc.M112.403279; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Kleinboelting S, 2016, J BIOL CHEM, V291, P9776, DOI 10.1074/jbc.M115.708255; Kleinboelting S, 2014, ACTA CRYSTALLOGR F, V70, P467, DOI 10.1107/S2053230X14004014; Kleinboelting S, 2014, P NATL ACAD SCI USA, V111, P3727, DOI 10.1073/pnas.1322778111; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Kumar S, 2009, J BIOL CHEM, V284, P14760, DOI 10.1074/jbc.M900925200; Lee YS, 2011, J BIOL CHEM, V286, P41353, DOI 10.1074/jbc.M111.284679; Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008; Levin LR, 2015, ANNU REV PHYSIOL, V77, P347, DOI 10.1146/annurev-physiol-021014-071821; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Manfredi G., 2014, BIOCH BIOPHYS ACTA B, V1842, P2555; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Navarrete FA, 2015, J CELL PHYSIOL, V230, P1758, DOI 10.1002/jcp.24873; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Ramos LS, 2008, J GEN PHYSIOL, V132, P329, DOI 10.1085/jgp.200810044; Saalau-Bethell SM, 2014, CHEMMEDCHEM, V9, P823, DOI 10.1002/cmdc.201300480; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; Schmid A, 2007, J GEN PHYSIOL, V130, P99, DOI 10.1085/jgp.200709784; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Steegborn C, 2014, BBA-MOL BASIS DIS, V1842, P2535, DOI 10.1016/j.bbadis.2014.08.012; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tian G, 2011, DIABETES, V60, P1535, DOI 10.2337/db10-1087; Tresguerres M, 2010, PFLUG ARCH EUR J PHY, V460, P953, DOI 10.1007/s00424-010-0865-6; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Visconti PE, 1999, DEV BIOL, V214, P429, DOI 10.1006/dbio.1999.9428; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; ZANOTTI A, 1980, ARCH BIOCHEM BIOPHYS, V201, P255, DOI 10.1016/0003-9861(80)90510-X; Zippin JH, 2013, J BIOL CHEM, V288, P33283, DOI 10.1074/jbc.M113.510073	57	49	50	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					838	+		10.1038/NCHEMBIO.2151	http://dx.doi.org/10.1038/NCHEMBIO.2151			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27547922	Green Submitted, Green Accepted			2022-12-25	WOS:000384248600016
J	Zhang, YF; Xu, JK; Ruan, YC; Yu, MK; O'Laughlin, M; Wise, H; Chen, D; Tian, L; Shi, DF; Wang, JL; Chen, SH; Feng, JQ; Chow, DHK; Xie, XH; Zheng, LZ; Huang, L; Huang, S; Leung, K; Lu, N; Zhao, L; Li, HF; Zhao, DW; Guo, X; Chan, KM; Witte, F; Chan, HC; Zheng, YF; Qin, L				Zhang, Yifeng; Xu, Jiankun; Ruan, Ye Chun; Yu, Mei Kuen; O'Laughlin, Micheal; Wise, Helen; Chen, Di; Tian, Li; Shi, Dufang; Wang, Jiali; Chen, Sihui; Feng, Jian Q.; Chow, Dick Ho Kiu; Xie, Xinhui; Zheng, Lizhen; Huang, Le; Huang, Shuo; Leung, Kwoksui; Lu, Na; Zhao, Lan; Li, Huafang; Zhao, Dewei; Guo, Xia; Chan, Kaiming; Witte, Frank; Chan, Hsiao Chang; Zheng, Yufeng; Qin, Ling			Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats	NATURE MEDICINE			English	Article							GENE-RELATED PEPTIDE; TRAUMATIC BRAIN-INJURY; IN-VITRO; VIVO; OSTEOPOROSIS; ALLOYS; DIFFERENTIATION; OSTEOARTHRITIS; INNERVATION; EXPRESSION	Orthopedic implants containing biodegradable magnesium have been used for fracture repair with considerable efficacy; however, the underlying mechanisms by which these implants improve fracture healing remain elusive. Here we show the formation of abundant new bone at peripheral cortical sites after intramedullary implantation of a pin containing ultrapure magnesium into the intact distal femur in rats. This response was accompanied by substantial increases of neuronal calcitonin gene-related polypeptide-alpha (CGRP) in both the peripheral cortex of the femur and the ipsilateral dorsal root ganglia (DRG). Surgical removal of the periosteum, capsaicin denervation of sensory nerves or knockdown in vivo of the CGRP-receptor-encoding genes Cakrl or Ramp1 substantially reversed the magnesium-induced osteogenesis that we observed in this model. Overexpression of these genes, however, enhanced magnesium-induced osteogenesis. We further found that an elevation of extracellular magnesium induces magnesium transporter 1 (MAGT1)-dependent and transient receptor potential cation channel, subfamily M, member 7 (TRPM7)-dependent magnesium entry, as well as an increase in intracellular adenosine triphosphate (ATP) and the accumulation of terminal synaptic vesicles in isolated rat DRG neurons. In isolated rat periosteum-derived stem cells, CGRP induces CALCRL- and RAMP1-dependent activation of cAMP-responsive element binding protein 1 (CREB1) and SP7 (also known as osterix), and thus enhances osteogenic differentiation of these stem cells. Furthermore, we have developed an innovative, magnesium containing intramedullary nail that facilitates femur fracture repair in rats with ovariectomy-induced osteoporosis. Taken together, these findings reveal a previously undefined role of magnesium in promoting CGRP-mediated osteogenic differentiation, which suggests the therapeutic potential of this ion in orthopedics.	[Zhang, Yifeng; Xu, Jiankun; O'Laughlin, Micheal; Tian, Li; Shi, Dufang; Wang, Jiali; Chen, Sihui; Chow, Dick Ho Kiu; Xie, Xinhui; Zheng, Lizhen; Huang, Le; Huang, Shuo; Leung, Kwoksui; Li, Huafang; Chan, Kaiming; Qin, Ling] Chinese Univ Hong Kong, Dept Orthoped & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China; [Ruan, Ye Chun; Yu, Mei Kuen; Chan, Hsiao Chang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Wise, Helen] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Di; Zhao, Lan] Rush Univ, Dept Biochem, Chicago, IL 60612 USA; [Feng, Jian Q.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Lu, Na] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Zhao, Dewei] Dalian Univ, Dept Orthoped, Zhongshan Hosp, Dalian, Peoples R China; [Guo, Xia] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Witte, Frank] Charite, Julius Wolff Inst, Berlin, Germany; [Witte, Frank] Charite, Ctr Musculoskeletal Surg, Berlin, Germany; [Witte, Frank] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Zheng, Yufeng] Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing, Peoples R China; [Qin, Ling] Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Translat Med Res & Dev Ctr, Shenzhen, Peoples R China; [Zhang, Yifeng] Nanjing Univ, Dept Sports Med & Adult Reconstruct Surg, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Rush University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Hong Kong University of Science & Technology; Dalian University; Hong Kong Polytechnic University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Peking University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Nanjing University	Qin, L (corresponding author), Chinese Univ Hong Kong, Dept Orthoped & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China.; Zheng, YF (corresponding author), Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing, Peoples R China.; Qin, L (corresponding author), Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Translat Med Res & Dev Ctr, Shenzhen, Peoples R China.	yfzheng@pku.edu.cn; lingqin@cuhk.edu.hk	Zheng, Yufeng/A-4146-2010; Ruan, Ye Chun/T-7531-2019; Qin, Ling/J-9047-2018; Zheng, Y.F./AAE-6697-2021; RUAN, Ye Chun/T-5919-2017; Chan, Hsiao Chang/E-1507-2016; Li, Huafang/D-5486-2013; Zheng, Yufeng/GQA-7172-2022; Chen, Di/AAJ-3665-2021; Chow, Dick Ho Kiu/C-6547-2014; Witte, Frank/D-9294-2014	Zheng, Yufeng/0000-0002-7402-9979; Ruan, Ye Chun/0000-0002-4266-6789; Qin, Ling/0000-0001-6173-6167; RUAN, Ye Chun/0000-0002-4266-6789; Zheng, Yufeng/0000-0002-7402-9979; Chow, Dick Ho Kiu/0000-0002-2836-3255; Zhao, Lan/0000-0003-0865-2006; Witte, Frank/0000-0001-9154-6217	Hong Kong RGC Collaborative Research Fund [C4028-14GF]; General Research Fund [14112714, 14114415]; NSFC/RGC [N_CUHK449/13, 51361165101]; Innovation and Technology Fund [ITS/350/13]; SMART Program; National Basic Research Program of China (973 Program) [2012CB619102, 2012CB944903, 2013CB967401]; National Natural Science Foundation of China [51225101, 51431002]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054465, R21AR067935, R01AR062136] Funding Source: NIH RePORTER	Hong Kong RGC Collaborative Research Fund; General Research Fund; NSFC/RGC(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Innovation and Technology Fund; SMART Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We acknowledge Li Ka Shing Institute of Health Sciences (LiHS) for providing a harmonious working environment. This work was supported by Hong Kong RGC Collaborative Research Fund (2014/2015, C4028-14GF to L.Q.), General Research Fund (no. 14112714, 14114415 to L.Q.), NSFC/RGC (N_CUHK449/13 to L.Q.; 51361165101 to Y.Z.), Innovation and Technology Fund (no. ITS/350/13 to L.Q.), SMART Program to K.C., L.Q., H.C.C. and Y.C.R. (Lui Che Woo Institute of Innovative Medicine in Faculty of Medicine, the Chinese University of Hong Kong), National Basic Research Program of China (973 Program, no. 2012CB619102 to Y.Z., no.2012CB944903 to H.C.C. and Y.C.R. and no. 2013CB967401 to H.C.C.), National Natural Science Foundation of China (no. 51225101; no. 51431002 to Y.Z.). We thank B. Hesse for collecting and analyzing the mu XRF data. We thank G. Wu and J. Lu for help with scanning electron microscopy analysis.	Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; BRENNER SL, 1980, J BIOL CHEM, V255, P841; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Castaneda-Corral G, 2011, NEUROSCIENCE, V178, P196, DOI 10.1016/j.neuroscience.2011.01.039; Castiglioni S, 2013, NUTRIENTS, V5, P3022, DOI 10.3390/nu5083022; Chaya A, 2015, J ORAL MAXIL SURG, V73, P295, DOI 10.1016/j.joms.2014.09.007; Cheung WH, 2012, J ORTHOP RES, V30, P129, DOI 10.1002/jor.21487; Chokshi R, 2012, CHANNELS, V6, P362, DOI 10.4161/chan.21628; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; Ding YX, 2010, BONE, V46, P1591, DOI 10.1016/j.bone.2010.02.022; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Fu SC, 2012, OSTEOARTHR CARTILAGE, V20, P1409, DOI 10.1016/j.joca.2012.08.006; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018; Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015; Hayes JS, 2010, EXPERT REV MED DEVIC, V7, P843, DOI [10.1586/erd.10.53, 10.1586/ERD.10.53]; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Kuhlmann J, 2013, ACTA BIOMATER, V9, P8714, DOI 10.1016/j.actbio.2012.10.008; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Li HF, 2013, ACTA BIOMATER, V9, P8561, DOI 10.1016/j.actbio.2013.01.029; Li L, 2007, J ORTHOP RES, V25, P1204, DOI 10.1002/jor.20406; Li R, 2001, J BONE MINER RES, V16, P1505; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Madsen JE, 1998, CLIN ORTHOP RELAT R, P230; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McDonald AC, 2003, BONE, V33, P788, DOI 10.1016/S8756-3282(03)00244-8; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Minardi S, 2015, BIOMATERIALS, V62, P128, DOI 10.1016/j.biomaterials.2015.05.011; Mrak E, 2010, J CELL PHYSIOL, V225, P701, DOI 10.1002/jcp.22266; Naot D, 2008, BONE, V43, P813, DOI 10.1016/j.bone.2008.07.003; Niedermair T, 2014, MATRIX BIOL, V38, P22, DOI 10.1016/j.matbio.2014.06.007; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Qin L, 1999, ANAT RECORD, V255, P380; Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001; Seeman E, 2007, OSTEOPOROSIS INT, V18, P123, DOI 10.1007/s00198-006-0296-6; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Sturmer EK, 2006, J BONE MINER RES, V21, P89, DOI 10.1359/JBMR.050913; Tang J, 2013, J ORTHOP TRANSL, V1, P41, DOI 10.1016/j.jot.2013.06.003; Tian G, 2013, ACTA PHARMACOL SIN, V34, P1467, DOI 10.1038/aps.2013.41; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707; Wang XY, 2009, SPINE, V34, P2363, DOI 10.1097/BRS.0b013e3181b04e52; Weizbauer A, 2016, J BIOMED MATER RES B, V104, P525, DOI 10.1002/jbm.b.33422; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028; Xia W, 2014, P NATL ACAD SCI USA, V111, P17863, DOI 10.1073/pnas.1420645111; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/nmat2542, 10.1038/NMAT2542]; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhang XP, 2008, CLIN ORTHOP RELAT R, V466, P1777, DOI 10.1007/s11999-008-0312-6; Zhang ZH, 2010, BIOMED PHARMACOTHER, V64, P430, DOI 10.1016/j.biopha.2009.06.009; Zhao DW, 2016, BIOMATERIALS, V81, P84, DOI 10.1016/j.biomaterials.2015.11.038; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	58	456	470	45	505	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1160	1169		10.1038/nm.4162	http://dx.doi.org/10.1038/nm.4162			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27571347	Green Accepted			2022-12-25	WOS:000384872500019
J	Hore, V; Vinuela, A; Buil, A; Knight, J; McCarthy, MI; Small, K; Marchini, J				Hore, Victoria; Vinuela, Ana; Buil, Alfonso; Knight, Julian; McCarthy, Mark I.; Small, Kerrin; Marchini, Jonathan			Tensor decomposition for multiple-tissue gene expression experiments	NATURE GENETICS			English	Article							IDENTIFICATION; REGULATOR; PHENOTYPES; THOUSANDS; COMPONENT; HUMANS; FUSION; EQTLS; LOCI; RNA	Genome-wide association studies of gene expression traits and other cellular phenotypes have successfully identified links between genetic variation and biological processes. The majority of discoveries have uncovered cis-expression quantitative trait locus (eQTL) effects via mass univariate testing of SNPs against gene expression in single tissues. Here we present a Bayesian method for multiple-tissue experiments focusing on uncovering gene networks linked to genetic variation. Our method decomposes the 3D array (or tensor) of gene expression measurements into a set of latent components. We identify sparse gene networks that can then be tested for association against genetic variation across the genome. We apply our method to a data set of 845 individuals from the TwinsUK cohort with gene expression measured via RNA-seq analysis in adipose, lymphoblastoid cell lines (LCLs) and skin. We uncover several gene networks with a genetic basis and clear biological and statistical significance. Extensions of this approach will allow integration of different omics, environmental and phenotypic data sets.	[Hore, Victoria; Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford, England; [Vinuela, Ana; Small, Kerrin] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Buil, Alfonso] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Knight, Julian; McCarthy, Mark I.; Marchini, Jonathan] Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	University of Oxford; University of London; King's College London; University of Geneva; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Marchini, J (corresponding author), Univ Oxford, Dept Stat, Oxford, England.; Marchini, J (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	marchini@stats.ox.ac.uk	Marchini, Jonathan/ABE-9024-2020; Viñuela, Ana/L-5015-2019; Knight, Julian Charles/W-2399-2019; McCarthy, Mark/M-3763-2015	Marchini, Jonathan/0000-0003-0610-8322; Viñuela, Ana/0000-0003-3771-8537; Knight, Julian Charles/0000-0002-0377-5536; McCarthy, Mark/0000-0002-4393-0510; Small, Kerrin/0000-0003-4566-0005	Wellcome Trust; European Community; NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; European Union [259749]; EPSRC through Life Sciences Interface program of the University of Oxford's Doctoral Training Center; ERC [617306]; MRC [MR/L01999X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1104931] Funding Source: researchfish; Medical Research Council [MR/L01999X/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; European Union(European Commission); EPSRC through Life Sciences Interface program of the University of Oxford's Doctoral Training Center(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to A. Dahl, W. Kretzschmar, K. Sharp, L. Elliot and S. Myers for helpful discussions about the method and interpretation of the results. The TwinsUK cohort was funded by the Wellcome Trust and the European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust and the NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. SNP genotyping was performed by the Wellcome Trust Sanger Institute and National Eye Institute via NIH/CIDR. A.V. and A.B. were supported by European Union Framework Programme 7 grant EuroBATS (259749). V.H. acknowledges the EPSRC for funding through a studentship at the Life Sciences Interface program of the University of Oxford's Doctoral Training Center. J.M. acknowledges support from the ERC (grant 617306).	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Brown AA, 2014, ELIFE, V3, DOI 10.7554/eLife.01381; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Groves AR, 2012, NEUROIMAGE, V63, P365, DOI 10.1016/j.neuroimage.2012.06.038; Groves AR, 2011, NEUROIMAGE, V54, P2198, DOI 10.1016/j.neuroimage.2010.09.073; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hoff PD, 2011, COMPUT STAT DATA AN, V55, P530, DOI 10.1016/j.csda.2010.05.020; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huan TX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7601; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Khan S. A., 2014, PREPRINT; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Lemire M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7326; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu CX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-661; Lucas J, 2006, BAYESIAN INFERENCE FOR GENE EXPRESSION AND PROTEOMICS, P155; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Melchjorsen J, 2009, J INTERF CYTOK RES, V29, P199, DOI 10.1089/jir.2008.0050; MITCHELL TJ, 1988, J AM STAT ASSOC, V83, P1023, DOI 10.2307/2290129; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pai AA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004857; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Yao C, 2015, CIRCULATION, V131, P536, DOI 10.1161/CIRCULATIONAHA.114.010696; Yener B, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-63; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	42	85	85	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1094	+		10.1038/ng.3624	http://dx.doi.org/10.1038/ng.3624			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27479908	Green Submitted, Green Accepted			2022-12-25	WOS:000382398800024
J	Ku, T; Swaney, J; Park, JY; Albanese, A; Murray, E; Cho, JH; Park, YG; Mangena, V; Chen, JP; Chung, KH				Ku, Taeyun; Swaney, Justin; Park, Jeong-Yoon; Albanese, Alexandre; Murray, Evan; Cho, Jae Hun; Park, Young-Gyun; Mangena, Vamsi; Chen, Jiapei; Chung, Kwanghun			Multiplexed and scalable super-resolution imaging of three-dimensional protein localization in size-adjustable tissues	NATURE BIOTECHNOLOGY			English	Article							ARRAY TOMOGRAPHY; CONNECTOME; MICROSCOPY; CLARITY; BRAIN	The biology of multicellular organisms is coordinated across multiple size scales, from the subnanoscale of molecules to the macroscale, tissue-wide interconnectivity of cell populations. Here we introduce a method for super-resolution imaging of the multiscale organization of intact tissues. The method, called magnified analysis of the proteome (MAP), linearly expands entire organs fourfold while preserving their overall architecture and three-dimensional proteome organization. MAP is based on the observation that preventing crosslinking within and between endogenous proteins during hydrogel-tissue hybridization allows for natural expansion upon protein denaturation and dissociation. The expanded tissue preserves its protein content, its fine subcellular details, and its organ-scale intercellular connectivity. We use off-the-shelf antibodies for multiple rounds of immunolabeling and imaging of a tissue's magnified proteome, and our experiments demonstrate a success rate of 82% (100/122 antibodies tested). We show that specimen size can be reversibly modulated to image both inter-regional connections and fine synaptic architectures in the mouse brain.	[Ku, Taeyun; Park, Jeong-Yoon; Albanese, Alexandre; Murray, Evan; Park, Young-Gyun; Chung, Kwanghun] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ku, Taeyun; Park, Jeong-Yoon; Park, Young-Gyun; Chung, Kwanghun] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Swaney, Justin; Cho, Jae Hun; Chung, Kwanghun] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Park, Jeong-Yoon] Yonsei Univ, Coll Med, Spine & Spinal Cord Inst, Dept Neurosurg,Gangnam Severance Hosp, Seoul, South Korea; [Murray, Evan; Chung, Kwanghun] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Mangena, Vamsi] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Chen, Jiapei] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chung, Kwanghun] Broad Inst Harvard Univ & MIT, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Yonsei University; Yonsei University Health System; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Chung, KH (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Chung, KH (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Chung, KH (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Chung, KH (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Chung, KH (corresponding author), Broad Inst Harvard Univ & MIT, Cambridge, MA USA.	khchung@mit.edu	Chung, Kwanghun/H-7714-2014; Park, Young-Gyun/AAS-5614-2021; Ku, Taeyun/T-7080-2019	Chung, Kwanghun/0000-0002-8167-3340; Albanese, Alexandre/0000-0001-7093-574X; Ku, Taeyun/0000-0001-9447-7579; Park, Jeong Yoon/0000-0002-3728-7784; Chen, Jiapei/0000-0002-8205-8593	Chung laboratory; Burroughs Wellcome Fund Career Awards at the Scientific Interface; Searle Scholars Program; Packard award in Science and Engineering; JPB Foundation (PIIF); JPB Foundation (PNDRF); NIH [1-U01-NS090473-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP2ES027992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090473] Funding Source: NIH RePORTER	Chung laboratory; Burroughs Wellcome Fund Career Awards at the Scientific Interface(Burroughs Wellcome Fund); Searle Scholars Program; Packard award in Science and Engineering; JPB Foundation (PIIF); JPB Foundation (PNDRF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the entire Chung laboratory for support and helpful discussions. K.C. was supported by Burroughs Wellcome Fund Career Awards at the Scientific Interface, the Searle Scholars Program, Packard award in Science and Engineering, JPB Foundation (PIIF and PNDRF) and NIH (1-U01-NS090473-01). Resources that may help enable general users to establish the methodology are freely available online (http://www.chunglabresources.org). K.C. is a co-founder of LifeCanvas Technologies, a startup that aims to help the research community adopt technologies developed by the Chung Laboratory.	Agaton C, 2004, ELECTROPHORESIS, V25, P1280, DOI 10.1002/elps.200405846; Albanese A, 2016, ELIFE, V5, DOI 10.7554/eLife.13367; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/NMETH.2481, 10.1038/nmeth.2481]; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/nmeth.2482, 10.1038/NMETH.2482]; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Economon MN, 2016, ELIFE, V5, DOI 10.7554/eLife.10566; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Hanash S, 2004, MOL CELL PROTEOMICS, V3, P298, DOI 10.1074/mcp.R400004-MCP200; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/nmeth.2476, 10.1038/NMETH.2476]; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Kay KR, 2013, NAT PROTOC, V8, P1366, DOI 10.1038/nprot.2013.078; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Kim SY, 2015, P NATL ACAD SCI USA, V112, pE6274, DOI 10.1073/pnas.1510133112; KOSAKA T, 1986, J COMP NEUROL, V249, P242, DOI 10.1002/cne.902490209; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Maglione M, 2013, NAT NEUROSCI, V16, P790, DOI 10.1038/nn.3403; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Murray E, 2015, CELL, V163, P1500, DOI 10.1016/j.cell.2015.11.025; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; PUCHTLER H, 1985, HISTOCHEMISTRY, V82, P201, DOI 10.1007/BF00501395; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sung HW, 1996, BIOMATERIALS, V17, P1405, DOI 10.1016/0142-9612(96)87282-6; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yuan A, 2015, MOL PSYCHIATR, V20, P986, DOI [10.1038/mp.2015.45, 10.1038/mp.2015.99]	35	198	201	13	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2016	34	9					973	+		10.1038/nbt.3641	http://dx.doi.org/10.1038/nbt.3641			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DW0RE	27454740	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000383348500024
J	Meyer, RS; Choi, JY; Sanches, M; Plessis, A; Flowers, JM; Amas, J; Dorph, K; Barretto, A; Gross, B; Fuller, DQ; Bimpong, IK; Ndjiondjop, MN; Hazzouri, KM; Gregorio, GB; Purugganan, MD				Meyer, Rachel S.; Choi, Jae Young; Sanches, Michelle; Plessis, Anne; Flowers, Jonathan M.; Amas, Junrey; Dorph, Katherine; Barretto, Annie; Gross, Briana; Fuller, Dorian Q.; Bimpong, Isaac Kofi; Ndjiondjop, Marie-Noelle; Hazzouri, Khaled M.; Gregorio, Glenn B.; Purugganan, Michael D.			Domestication history and geographical adaptation inferred from a SNP map of African rice	NATURE GENETICS			English	Article							ORYZA-GLABERRIMA; SEVERE BOTTLENECK; SALT TOLERANCE; GENOME; PROGRAM; SATIVA; MODEL; ASSOCIATION; DEMOGRAPHY; FREQUENCY	African rice (Oryza glaberrima Steud.) is a cereal crop species closely related to Asian rice (Oryza sativa L.) but was independently domesticated in West Africa similar to 3,000 years ago(1-3). African rice is rarely grown outside sub-Saharan Africa but is of global interest because of its tolerance to abiotic stresses(4,5). Here we describe a map of 2.32 million SNPs of African rice from whole-genome resequencing of 93 landraces. Population genomic analysis shows a population bottleneck in this species that began similar to 13,000-15,000 years ago with effective population size reaching its minimum value similar to 3,500 years ago, suggesting a protracted period of population size reduction likely commencing with predomestication management and/or cultivation. Genome-wide association studies (GWAS) for six salt tolerance traits identify 11 significant loci, 4 of which are within similar to 300 kb of genomic regions that possess signatures of positive selection, suggesting adaptive geographical divergence for salt tolerance in this species.	[Meyer, Rachel S.; Choi, Jae Young; Sanches, Michelle; Plessis, Anne; Flowers, Jonathan M.; Dorph, Katherine; Purugganan, Michael D.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Meyer, Rachel S.; Flowers, Jonathan M.; Hazzouri, Khaled M.; Purugganan, Michael D.] New York Univ Abu Dhabi, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates; [Amas, Junrey; Barretto, Annie; Gregorio, Glenn B.] Int Rice Res Inst, Genet & Biotechnol Div, Plant Breeding, Los Banos, Philippines; [Gross, Briana] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Fuller, Dorian Q.] UCL, Inst Archaeol, London, England; [Bimpong, Isaac Kofi] AfricaRice Sahel Stn, St Louis, Senegal; [Ndjiondjop, Marie-Noelle] AfricaRice Ctr, Cotonou, Benin	New York University; CGIAR; International Rice Research Institute (IRRI); University of Minnesota System; University of Minnesota Duluth; University of London; University College London; CGIAR; Africa Rice Center; CGIAR; Africa Rice Center	Purugganan, MD (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.; Purugganan, MD (corresponding author), New York Univ Abu Dhabi, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates.	mp132@nyu.edu	Fuller, Dorian/AAF-7400-2019; Fuller, Dorian Q/C-1908-2008	Fuller, Dorian/0000-0002-4859-080X; Fuller, Dorian Q/0000-0002-4859-080X; Hazzouri, Khaled/0000-0002-9346-3906; Choi, Jae Young/0000-0002-0238-8980	National Science Foundation Plant Genome Research Program [IOS-1126971]; Zegar Family Foundation; New York University Abu Dhabi Research Institute; National Science Foundation Plant Genome Postdoctoral Fellowship [IOS-1202803]; NERC [NE/K003402/1] Funding Source: UKRI; Natural Environment Research Council [NE/K003402/1] Funding Source: researchfish	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Zegar Family Foundation; New York University Abu Dhabi Research Institute; National Science Foundation Plant Genome Postdoctoral Fellowship; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We would like to thank E. Septiningsih for critical discussions. We are grateful to M. Sock and B. Fonton for field assistance, to International Rice Research Institute staff for phenotyping assistance, and to J. Maritz and Z. Joly-Lopez for laboratory assistance. We thank the US Department of Agriculture and International Rice Research Institute for providing germplasm. This work was funded in part by grants from the National Science Foundation Plant Genome Research Program (IOS-1126971), the Zegar Family Foundation and the New York University Abu Dhabi Research Institute to M.D.P., as well as by a National Science Foundation Plant Genome Postdoctoral Fellowship (IOS-1202803) to R.S.M.	Agnoun Y., 2012, International Journal of Biology, V4, P158; Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Carney J, 1996, TECHNOL CULT, V37, P5, DOI 10.2307/3107200; Carney J., 2002, BLACK RICE AFRICAN O; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Platten JD, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-32; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eichhorn B., 2014, ARCHAEOLOGY AFRICAN; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Falush D, 2003, GENETICS, V164, P1567; Fischer G., 2008, GLOBAL AGROECOLOGICA; Flowers JM, 2015, PLANT CELL, V27, P2353, DOI 10.1105/tpc.15.00492; Fritz S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046213; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2014, PUBL INST ARCHAEOL, V61, P17; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Hazzouri KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9824; Horie T, 2011, J BIOSCI BIOENG, V111, P346, DOI 10.1016/j.jbiosc.2010.10.014; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; International Rice Research Institute, 2014, STAND EV SYST RIC; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kahle D, 2013, R J, V5, P144; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; LEWONTIN RC, 1973, GENETICS, V74, P175; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Linares OF, 2002, P NATL ACAD SCI USA, V99, P16360, DOI 10.1073/pnas.252604599; Manning K, 2014, QUATERNARY SCI REV, V101, P28, DOI 10.1016/j.quascirev.2014.07.003; Matlon P., 1998, IMPACT RICE RES, P382; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Murray S.S., 2007, FIELDS CHANGE PROGR, P53; Nabholz B, 2014, MOL ECOL, V23, P2210, DOI 10.1111/mec.12738; PEARSON GA, 1966, SOIL SCI, V102, P151, DOI 10.1097/00010694-196609000-00003; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Porteres R., 1976, ORIGINS AFRICAN PLAN, P409, DOI DOI 10.1515/9783110806373.409; Porteres R, 1970, PAPERS AFRICAN PREHI, P43; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ruan SL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-34; Sahi C, 2006, PHYSIOL PLANTARUM, V127, P1, DOI 10.1111/j.1399-3054.2005.00610.x; Sarla N, 2005, CURR SCI INDIA, V89, P955; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team R.D.C., 2015, R LANG ENV STAT COMP; Temudo MP, 2011, HUM ECOL, V39, P309, DOI 10.1007/s10745-011-9404-0; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Thomas CG, 2015, GENOME RES, V25, P667, DOI 10.1101/gr.187237.114; Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461; Tjallingii R, 2008, NAT GEOSCI, V1, P670, DOI 10.1038/ngeo289; Turner S., 2018, BIORXIV, V3, P731, DOI [10.21105/joss.00731, DOI 10.1101/005165, DOI 10.1101/005165.V1, 10.1101/005165]; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Willcox G, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P92; Wu JZ, 2003, PLANT J, V36, P720, DOI 10.1046/j.1365-313X.2003.01903.x; Yang TY, 2014, PLANT PHYSIOL, V166, P945, DOI 10.1104/pp.114.246520; Zach B, 2003, VEG HIST ARCHAEOBOT, V12, P187, DOI 10.1007/s00334-003-0016-5; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	67	116	121	27	151	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1083	+		10.1038/ng.3633	http://dx.doi.org/10.1038/ng.3633			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27500524	Green Submitted			2022-12-25	WOS:000382398800022
J	Hupalo, DN; Luo, ZP; Melnikov, A; Sutton, PL; Rogov, P; Escalante, A; Vallejo, AF; Herrera, S; Arevalo-Herrera, M; Fan, Q; Wang, Y; Cui, LW; Lucas, CM; Durand, S; Sanchez, JF; Baldeviano, GC; Lescano, AG; Laman, M; Barnadas, C; Barry, A; Mueller, I; Kazura, JW; Eapen, A; Kanagaraj, D; Valecha, N; Ferreira, MU; Roobsoong, W; Nguitragool, W; Sattabonkot, J; Gamboa, D; Kosek, M; Vinetz, JM; Gonzalez-Ceron, L; Birren, BW; Daniel, DE; Jane, JM				Hupalo, Daniel N.; Luo, Zunping; Melnikov, Alexandre; Sutton, Patrick L.; Rogov, Peter; Escalante, Ananias; Vallejo, Andres F.; Herrera, Socrates; Arevalo-Herrera, Myriam; Fan, Qi; Wang, Ying; Cui, Liwang; Lucas, Carmen M.; Durand, Salomon; Sanchez, Juan F.; Baldeviano, G. Christian; Lescano, Andres G.; Laman, Moses; Barnadas, Celine; Barry, Alyssa; Mueller, Ivo; Kazura, James W.; Eapen, Alex; Kanagaraj, Deena; Valecha, Neena; Ferreira, Marcelo U.; Roobsoong, Wanlapa; Nguitragool, Wang; Sattabonkot, Jetsumon; Gamboa, Dionicia; Kosek, Margaret; Vinetz, Joseph M.; Gonzalez-Ceron, Lilia; Birren, Bruce W.; Neafsey, Daniel E.; Carlton, Jane M.			Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax	NATURE GENETICS			English	Article							ADAPTIVE PROTEIN EVOLUTION; MALARIA PARASITES; GENETIC DIVERSITY; MULTIGENE FAMILY; ORIGIN; SEQUENCES; SELECTION; ALIGNMENT; REVEALS; FORMAT	Plasmodium vivax is a major public health burden, responsible for the majority of malaria infections outside Africa. We explored the impact of demographic history and selective pressures on the P. vivax genome by sequencing 182 clinical isolates sampled from 11 countries across the globe, using hybrid selection to overcome human DNA contamination. We confirmed previous reports of high genomic diversity in P. vivax relative to the more virulent Plasmodium falciparum species; regional populations of P. vivax exhibited greater diversity than the global P. falciparum population, indicating a large and/or stable population. Signals of natural selection suggest that P. vivax is evolving in response to antimalarial drugs and is adapting to regional differences in the human host and the mosquito vector. These findings underline the variable epidemiology of this parasite species and highlight the breadth of approaches that may be required to eliminate P. vivax globally.	[Luo, Zunping; Sutton, Patrick L.; Carlton, Jane M.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Melnikov, Alexandre; Rogov, Peter; Birren, Bruce W.; Neafsey, Daniel E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Escalante, Ananias] Temple Univ, Dept Biol, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA; [Vallejo, Andres F.; Herrera, Socrates; Arevalo-Herrera, Myriam] Caucaseco Sci Res Ctr, Cali, Colombia; [Arevalo-Herrera, Myriam] Univ Valle, Fac Hlth, Cali, Colombia; [Fan, Qi] Dalian Inst Biotechnol, Dalian, Liaoning, Peoples R China; [Wang, Ying] Third Mil Med Univ, Chongqing, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Lucas, Carmen M.; Durand, Salomon; Sanchez, Juan F.; Baldeviano, G. Christian; Lescano, Andres G.] US Naval Med Res Unit 6, Callao, Peru; [Laman, Moses] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Barnadas, Celine] Papua New Guinea Inst Med Res, Vector Borne Dis Unit, Goroka, Papua N Guinea; [Barnadas, Celine] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic, Australia; [Barry, Alyssa; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Div Populat Hlth & Immun, Parkville, Vic, Australia; [Barry, Alyssa; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Carlton, Vic, Australia; [Mueller, Ivo] Inst Global Hlth ISGLOBAL, Barcelona, Spain; [Kazura, James W.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Eapen, Alex; Kanagaraj, Deena] Indian Council Med Res, Natl Inst Malaria Res Field Unit, Natl Inst Epidemiol Campus, Madras, Tamil Nadu, India; [Valecha, Neena] Indian Council Med Res, Natl Inst Malaria Res, New Delhi, India; [Ferreira, Marcelo U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil; [Roobsoong, Wanlapa; Sattabonkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok, Thailand; [Nguitragool, Wang] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Gamboa, Dionicia; Vinetz, Joseph M.] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Gamboa, Dionicia; Vinetz, Joseph M.] Univ Peruana Cayetano Heredia, Dept Ciencias Celulares Mol, Lima, Peru; [Kosek, Margaret] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Vinetz, Joseph M.] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA; [Gonzalez-Ceron, Lilia] Natl Inst Publ Hlth, Reg Ctr Res Publ Hlth, Tapachula, Chiapas, Mexico	New York University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Universidad del Valle; Army Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); PNG Institute Of Medical Research; PNG Institute Of Medical Research; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; ISGlobal; Case Western Reserve University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Universidade de Sao Paulo; Mahidol University; Mahidol University; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Diego; Instituto Nacional de Salud Publica	Jane, JM (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.; Daniel, DE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.	neafsey@broadinstitute.org; jane.carlton@nyu.edu	GONZALEZ, LILIA/T-2127-2019; Luo, Zunping/HCH-4924-2022; Lescano, Andres G./M-9849-2019; Ferreira, Marcelo U/G-8289-2011; durand, salomon/G-7804-2018; Lescano, Andres G/B-8479-2008	Lescano, Andres G./0000-0001-9779-633X; Ferreira, Marcelo U/0000-0002-5293-9090; durand, salomon/0000-0002-5923-8879; Lescano, Andres G/0000-0001-9779-633X; Barry, Alyssa/0000-0002-1189-2310; Nguitragool, Wang/0000-0002-5484-7130; Vallejo, Andres Felipe/0000-0002-4688-0598; Kosek, Margaret/0000-0001-6340-4852; Roobsoong, Wanlapa/0000-0002-1789-0439; Gamboa, Dionicia/0000-0002-1420-7729; Laman, Moses/0000-0003-0964-805X; Hupalo, Daniel/0000-0001-7816-2948; GONZALEZ-CERON, LILIA/0000-0002-2347-5581	National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) International Centers of Excellence for Malaria Research [U19AI089676, U19AI089681, K24AI068903, D43TW007120, U19AI089672]; Sao Paulo Research Foundation [2009/52729-9]; National Council for Science and Technology Mexico [29005-M SALUD-2004-119]; National Institute of Public Health Mexico [476191]; Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council Independent Medical Research Institutes Infrastructure Support Scheme (NHMRC IRIISS) [5U19AI089702]; Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System; US NIH [D43TW007393]; NIH [U19AI089686, T32AI007180]; Bill and Melinda Gates Foundation; NIAID, NIH, US Department of Health and Human Services [HHSN272200900018C]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil; NHMRC senior research fellowship [1043345]; FOGARTY INTERNATIONAL CENTER [D43TW007120, D43TW007393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI068903, U19AI089676, T32AI007180, U19AI089686, U19AI089681, U19AI089702] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) International Centers of Excellence for Malaria Research; Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Science and Technology Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Public Health Mexico; Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council Independent Medical Research Institutes Infrastructure Support Scheme (NHMRC IRIISS)(National Health and Medical Research Council (NHMRC) of Australia); Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIAID, NIH, US Department of Health and Human Services; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NHMRC senior research fellowship(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge J. Bochicchio and S. Chapman for project management, A. Gnirke for technical support, and members of the Broad Institute Genomics Platform and NYU's Genomics Core for data generation. We thank F. Santillan and P. Michon for technical assistance and MR4 for providing us with malaria parasites deposited by W.E. Collins. The following grants supported this work: National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) International Centers of Excellence for Malaria Research U19AI089676 to J.M.C.; U19AI089681, K24AI068903 and D43TW007120 to J.M.V.; U19AI089672 to L.C.; Sao Paulo Research Foundation 2009/52729-9 to M.U.F.; National Council for Science and Technology Mexico 29005-M SALUD-2004-119 and National Institute of Public Health Mexico project 476191 to L.G.-C.; Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Medical Research Institutes Infrastructure Support Scheme (NHMRC IRIISS) to A.B. and I.M.; 5U19AI089702 to S.H. and M.A.-H.; Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System and US NIH grant D43TW007393 to A.G.L.; NIH U19AI089686 to J.W.K.; and Bill and Melinda Gates Foundation grant to J.S. Sequencing and analysis work at the Broad Institute was supported by federal funds from the NIAID, NIH, US Department of Health and Human Services, under contract HHSN272200900018C. M.U.F. is supported by a senior research scholarship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil, I.M. is supported by NHMRC senior research fellowship 1043345 and D.N.H. is supported by NIH training grant T32AI007180. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official policy or position of the US Department of the Navy, the US Department of Defense, the US government or the National Institutes of Health.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Anthony TG, 2007, MOL BIOCHEM PARASIT, V156, P117, DOI 10.1016/j.molbiopara.2007.07.008; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Arisue N, 2007, J MOL EVOL, V65, P82, DOI 10.1007/s00239-006-0253-1; Baniecki ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003539; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2015, AM J TROP MED HYG, V93, P87, DOI 10.4269/ajtmh.15-0049; Carter R, 2003, TRENDS PARASITOL, V19, P214, DOI 10.1016/S1471-4922(03)00070-9; Chuquiyauri R, 2015, AM J TROP MED HYG, V93, P801, DOI 10.4269/ajtmh.15-0232; Culleton R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029137; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Daniels RF, 2015, P NATL ACAD SCI USA, V112, P7067, DOI 10.1073/pnas.1505691112; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lacroix C, 2008, TRENDS PARASITOL, V24, P431, DOI 10.1016/j.pt.2008.07.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4346; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melnikov A, 2011, GENOME BIOL, V12, DOI [10.1186/gb-2011-12-8-R73, 10.1186/gb-2011-12-8-r73]; Menard D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002489; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Molina-Cruz A, 2014, MEM I OSWALDO CRUZ, V109, P662, DOI 10.1590/0074-0276130553; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373; Pacheco MA, 2012, INFECT GENET EVOL, V12, P978, DOI 10.1016/j.meegid.2012.02.009; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rice BL, 2014, MOL PHYLOGENET EVOL, V78, P172, DOI 10.1016/j.ympev.2014.05.013; Rodrigues PT, 2014, AM J TROP MED HYG, V90, P1102, DOI 10.4269/ajtmh.13-0588; Rubio JM, 1999, AM J TROP MED HYG, V60, P183, DOI 10.4269/ajtmh.1999.60.183; Schousboe ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004196; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tachibana SI, 2012, NAT GENET, V44, P1051, DOI 10.1038/ng.2375; Taylor JE, 2013, MOL BIOL EVOL, V30, P2050, DOI 10.1093/molbev/mst104; Thompson J, 2007, CELL MICROBIOL, V9, P1466, DOI 10.1111/j.1462-5822.2006.00885.x; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	49	114	118	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					953	+		10.1038/ng.3588	http://dx.doi.org/10.1038/ng.3588			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27348298	Green Accepted			2022-12-25	WOS:000380755100021
J	Lukjanenko, L; Jung, MJ; Hegde, N; Perruisseau-Carrier, C; Migliavacca, E; Rozo, M; Karaz, S; Jacot, G; Schmidt, M; Li, LJ; Metairon, S; Raymond, F; Lee, U; Sizzano, F; Wilson, DH; Dumont, NA; Palini, A; Fassler, R; Steiner, P; Descombes, P; Rudnicki, MA; Fan, CM; von Maltzahn, J; Feige, JN; Bentzinger, CF				Lukjanenko, Laura; Jung, M. Juliane; Hegde, Nagabhooshan; Perruisseau-Carrier, Claire; Migliavacca, Eugenia; Rozo, Michelle; Karaz, Sonia; Jacot, Guillaume; Schmidt, Manuel; Li, Liangji; Metairon, Sylviane; Raymond, Frederic; Lee, Umji; Sizzano, Federico; Wilson, David H.; Dumont, Nicolas A.; Palini, Alessio; Faessler, Reinhard; Steiner, Pascal; Descombes, Patrick; Rudnicki, Michael A.; Fan, Chen-Ming; von Maltzahn, Julia; Feige, Jerome N.; Bentzinger, C. Florian			Loss of fibronectin from the aged stem cell niche affects the regenerative capacity of skeletal muscle in mice	NATURE MEDICINE			English	Article							SELF-RENEWAL; EXTRACELLULAR-MATRIX; REJUVENATION; PROLIFERATION; STRENGTH; SURVIVAL; MOUSE; SKIN; FAK	Age-related changes in the niche have long been postulated to impair the function of somatic stem cells. Here we demonstrate that the aged stem cell niche in skeletal muscle contains substantially reduced levels of fibronectin (FN), leading to detrimental consequences for the function and maintenance of muscle stem cells (MuSCs). Deletion of the gene encoding FN from young regenerating muscles replicates the aging phenotype and leads to a loss of MuSC numbers. By using an extracellular matrix (ECM) library screen and pathway profiling, we characterize FN as a preferred adhesion substrate for MuSCs and demonstrate that integrin-mediated signaling through focal adhesion kinase and the p38 mitogen-activated protein kinase pathway is strongly de-regulated in MuSCs from aged mice because of insufficient attachment to the niche. Reconstitution of FN levels in the aged niche remobilizes stem cells and restores youth-like muscle regeneration. Taken together, we identify the loss of stem cell adhesion to FN in the niche ECM as a previously unknown aging mechanism.	[Lukjanenko, Laura; Hegde, Nagabhooshan; Perruisseau-Carrier, Claire; Migliavacca, Eugenia; Karaz, Sonia; Jacot, Guillaume; Metairon, Sylviane; Raymond, Frederic; Lee, Umji; Sizzano, Federico; Palini, Alessio; Steiner, Pascal; Descombes, Patrick; Feige, Jerome N.; Bentzinger, C. Florian] Ecole Polytech Fed Lausanne, NIHS, Campus Ecole Polytech Fed Lausanne,Innovat Pk, Lausanne, Switzerland; [Lukjanenko, Laura] Ecole Polytech Fed Lausanne, Doctoral Program Biotechnol & Bioengn, Lausanne, Switzerland; [Jung, M. Juliane; Schmidt, Manuel; von Maltzahn, Julia] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Rozo, Michelle; Li, Liangji; Fan, Chen-Ming] Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA; [Wilson, David H.; Dumont, Nicolas A.; Rudnicki, Michael A.] Ottawa Hosp, Res Inst, Regenerat Med Program, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada; [Wilson, David H.; Dumont, Nicolas A.; Rudnicki, Michael A.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, Martinsried, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Carnegie Institution for Science; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Max Planck Society	Feige, JN; Bentzinger, CF (corresponding author), Ecole Polytech Fed Lausanne, NIHS, Campus Ecole Polytech Fed Lausanne,Innovat Pk, Lausanne, Switzerland.	jerome.feige@rd.nestle.com; florian.bentzinger@rd.nestle.com	Li, Liangji/AAM-7800-2021; Bentzinger, C. Florian/A-1151-2015; von Maltzahn, Julia/AFP-2284-2022; von Maltzahn, Julia/A-6689-2017	Bentzinger, C. Florian/0000-0003-0422-9622; von Maltzahn, Julia/0000-0001-7674-1487; von Maltzahn, Julia/0000-0001-7674-1487; Jacot, Guillaume/0000-0001-5821-2717; Wilson, David/0000-0001-8322-0380; Li, Liangji/0000-0002-6635-4800; Raymond, Frederic/0000-0002-6148-6898; Lee, Umji/0000-0003-0758-0979	German Research Foundation (DFG) [MA-3975/2-1]; Government of the Ontario Ministry of Research and Innovation (MRI) [ORF-RE05-084]; National Institutes of Health [HD075345, AR060042]; Fondation Suisse de Recherche sur les Maladies Musculaires (FSRMM); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD075345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060042] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Government of the Ontario Ministry of Research and Innovation (MRI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Suisse de Recherche sur les Maladies Musculaires (FSRMM); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Ritchie for help with mouse husbandry. We are grateful to the NIHS community for fruitful discussions and support, in particular to the Aging and Stem Cells groups, and to E. Rolland and E. Baetge. We thank C. Poser for excellent technical assistance. ROSA26-CreER<SUP>T2</SUP> mice were provided by F. Stewart (Technische Universitat Dresden, Germany) as a kind gift to M.A.R. J.V.M. and M.J.J. were supported by a grant from the German Research Foundation (DFG) (grant MA-3975/2-1). M.A.R. holds the Canada Research Chair in Molecular Genetics and is supported by a grant from the Government of the Ontario Ministry of Research and Innovation (MRI) (grant ORF-RE05-084). M.R. and C.M.F. are supported by the National Institutes of Health grants (grants HD075345 and AR060042). C.F.B. is supported by the Fondation Suisse de Recherche sur les Maladies Musculaires (FSRMM).	Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410; Brafman DA, 2009, INTEGR BIOL, V1, P513, DOI 10.1039/b912926j; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; D'Souza DM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12506; Fujimaki S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/592915; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lukjanenko L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071084; Lv HW, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0083-4; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Muller M, 2011, INT ORTHOP, V35, P165, DOI 10.1007/s00264-010-1166-6; Plath T, 2000, J CELL BIOL, V150, P1467, DOI 10.1083/jcb.150.6.1467; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rozo M., 2016, NAT MED; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Siegel AL, 2009, STEM CELLS, V27, P2527, DOI 10.1002/stem.178; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sousa-Victor P, 2015, TRENDS ENDOCRIN MET, V26, P287, DOI 10.1016/j.tem.2015.03.006; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Tierney MT, 2016, CELL REP, V14, P1940, DOI 10.1016/j.celrep.2016.01.072; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Tigges J, 2014, MECH AGEING DEV, V138, P26, DOI 10.1016/j.mad.2014.03.004; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; WATTERS JM, 1993, ANN SURG, V218, P380, DOI 10.1097/00000658-199309000-00017	46	141	142	5	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					897	+		10.1038/nm.4126	http://dx.doi.org/10.1038/nm.4126			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376579	Green Accepted			2022-12-25	WOS:000381000200015
J	Wirnsberger, G; Zwolanek, F; Asaoka, T; Kozieradzki, I; Tortola, L; Wimmer, RA; Kavirayani, A; Fresser, F; Baier, G; Langdon, WY; Ikeda, F; Kuchler, K; Penninger, JM				Wirnsberger, Gerald; Zwolanek, Florian; Asaoka, Tomoko; Kozieradzki, Ivona; Tortola, Luigi; Wimmer, Reiner A.; Kavirayani, Anoop; Fresser, Friedrich; Baier, Gottfried; Langdon, Wallace Y.; Ikeda, Fumiyo; Kuchler, Karl; Penninger, Josef M.			Inhibition of CBLB protects from lethal Candida albicans sepsis	NATURE MEDICINE			English	Article							C-TYPE LECTIN; CHRONIC MUCOCUTANEOUS CANDIDIASIS; INNATE IMMUNE-RESPONSE; CELL ANTIGEN RECEPTOR; SYK TYROSINE 317; HOST-DEFENSE; FUNGAL-INFECTIONS; GENETIC SUSCEPTIBILITY; ASPERGILLUS-FUMIGATUS; NEGATIVE REGULATION	Fungal infections claim an estimated 1.5 million lives each year. Mechanisms that protect from fungal infections are still elusive. Recognition of fungal pathogens relies on C-type lectin receptors (CLRs) and their downstream signaling kinase SYK. Here we report that the E3 ubiquitin ligase CBLB controls proximal CLR signaling in macrophages and dendritic cells. We show that CBLB associates with SYK and ubiquitinates SYK, dectin-1, and dectin-2 after fungal recognition. Functionally, CBLB deficiency results in increased inflammasome activation, enhanced reactive oxygen species production, and increased fungal killing. Genetic deletion of Cblb protects mice from morbidity caused by cutaneous infection and markedly improves survival after a lethal systemic infection with Candida albicans. On the basis of these findings, we engineered a cell-permeable CBLB inhibitory peptide that protects mice from lethal C. albicans infections. We thus describe a key role for Cblb in the regulation of innate antifungal immunity and establish a novel paradigm for the treatment of fungal sepsis.	[Wirnsberger, Gerald; Asaoka, Tomoko; Kozieradzki, Ivona; Tortola, Luigi; Wimmer, Reiner A.; Ikeda, Fumiyo; Penninger, Josef M.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria; [Zwolanek, Florian; Kuchler, Karl] Med Univ Vienna, MFPL, Dept Med Biochem, Vienna, Austria; [Kavirayani, Anoop] VBCF, Vienna, Austria; [Fresser, Friedrich; Baier, Gottfried] Med Univ Innsbruck, Div Translat Cell Genet, Dept Pharmacol & Genet, Innsbruck, Austria; [Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA, Australia	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Innsbruck; University of Western Australia	Penninger, JM (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria.; Kuchler, K (corresponding author), Med Univ Vienna, MFPL, Dept Med Biochem, Vienna, Austria.	karl.kuchler@meduniwien.ac.at; josef.penninger@imba.oeaw.ac.at	Ikeda, Fumiyo/AAD-3770-2020; kuchler, karl/AAL-6937-2020; Penninger, Josef M/I-6860-2013	Ikeda, Fumiyo/0000-0003-0407-2768; kuchler, karl/0000-0003-2719-5955; Penninger, Josef M/0000-0002-8194-3777; Tortola, Luigi/0000-0002-8480-2080; Baier, Gottfried/0000-0002-2085-8325; Asaoka, Tomoko/0000-0001-5141-2353; Kavirayani, Anoop/0000-0003-3874-3101	consolidator ERC grant; EC FP7 project 'FUNGITECT'; FWF project [P-25333]; Marie-Curie Innovative Training Networks' ImResFun grant [MC-ITN-606786]; Advanced ERC grant; Era of Hope/Innovator Award; Helmsley foundation VEO-IBD network grant; Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 25044] Funding Source: researchfish	consolidator ERC grant; EC FP7 project 'FUNGITECT'; FWF project(Austrian Science Fund (FWF)); Marie-Curie Innovative Training Networks' ImResFun grant; Advanced ERC grant; Era of Hope/Innovator Award; Helmsley foundation VEO-IBD network grant; Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank all members of the Penninger laboratory for helpful discussions and technical support. We thank all members of the IMP-IMBA Biooptics service facility, especially G. Schmauss and T. Lendl, for assistance in cell sorting and image quantification. We also thank A. Piszczek and M. Zeba from the Vienna Biocenter Core Facilities (VBCF) for excellent histopathology services, and K. Mechtler, R. Imre, and M. Madalinski from the Protein Biochemistry facility for providing excellent mass spectrometry and peptide synthesis services. This work was supported by a consolidator ERC grant (F.I.), the EC FP7 project 'FUNGITECT' (K.K.), the FWF project P-25333 (K.K.), a Marie-Curie Innovative Training Networks' ImResFun grant (contract MC-ITN-606786; K.K.), an Advanced ERC grant (J.M.P.), an 'Era of Hope/Innovator Award' (J.M.P.), a Helmsley foundation VEO-IBD network grant (J.M.P.), and the Austrian Academy of Sciences (J.M.P.).	Aratani Y, 2002, MED MYCOL, V40, P557, DOI 10.1080/mmy.40.6.557.563; Armstrong-James D, 2014, TRENDS MICROBIOL, V22, P120, DOI 10.1016/j.tim.2014.01.001; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Bergholdt R, 2005, J LEUKOCYTE BIOL, V77, P579, DOI 10.1189/jlb.0904524; Bourgeois Christelle, 2009, V470, P125, DOI 10.1007/978-1-59745-204-5_11; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Deng ZH, 2015, NAT IMMUNOL, V16, P642, DOI 10.1038/ni.3155; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kosoy R, 2004, GENES IMMUN, V5, P232, DOI 10.1038/sj.gene.6364057; Lanternier F, 2013, CURR OPIN PEDIATR, V25, P736, DOI 10.1097/MOP.0000000000000031; Loeser S, 2007, CELL CYCLE, V6, P2478, DOI 10.4161/cc.6.20.4797; Marr KA, 2003, INFECT IMMUN, V71, P5280, DOI 10.1128/IAI.71.9.5280-5286.2003; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Paolino M, 2011, J IMMUNOL, V186, P2138, DOI 10.4049/jimmunol.1003390; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Plantinga TS, 2012, MED MYCOL, V50, P785, DOI 10.3109/13693786.2012.690902; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; QIAN QF, 1994, J IMMUNOL, V152, P5000; Qu XJ, 2004, BLOOD, V103, P1779, DOI 10.1182/blood-2003-07-2260; Ramirez-Ortiz ZG, 2008, INFECT IMMUN, V76, P2123, DOI 10.1128/IAI.00047-08; Ravikumar S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01322; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Smeekens SP, 2013, EMBO MOL MED, V5, P805, DOI 10.1002/emmm.201201678; Smeekens SP, 2011, EUR J IMMUNOL, V41, P2915, DOI 10.1002/eji.201141418; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Stevens DA, 2012, CLIN DERMATOL, V30, P657, DOI 10.1016/j.clindermatol.2011.09.018; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van der Graaf CAA, 2003, NETH J MED, V61, P365; Wallner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065178; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Whibley N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004456; Wirnsberger G, 2014, NAT GENET, V46, P1028, DOI 10.1038/ng.3070; Yankee TM, 1999, J IMMUNOL, V163, P5827; Zhang J, 2004, J IMMUNOL, V173, P1811, DOI 10.4049/jimmunol.173.3.1811; Zheng J, 2015, EUR J IMMUNOL, V45, P2834, DOI 10.1002/eji.201445344; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017; Zou W, 2009, J BIOL CHEM, V284, P18833, DOI 10.1074/jbc.M109.012385; Zwolanek F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004525	56	69	72	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					915	+		10.1038/nm.4134	http://dx.doi.org/10.1038/nm.4134			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27428901	Green Accepted			2022-12-25	WOS:000381000200017
J	Xiao, Y; Tang, J; Guo, H; Zhao, YX; Tang, R; Ouyang, S; Zeng, QM; Rappleye, CA; Rajaram, MVS; Schlesinger, LS; Tao, LJ; Brown, GD; Langdon, WY; Li, BT; Zhang, J				Xiao, Yun; Tang, Juan; Guo, Hui; Zhao, Yixia; Tang, Rong; Ouyang, Song; Zeng, Qiuming; Rappleye, Chad A.; Rajaram, Murugesan V. S.; Schlesinger, Larry S.; Tao, Lijian; Brown, Gordon D.; Langdon, Wallace Y.; Li, Belinda T.; Zhang, Jian			Targeting CBLB as a potential therapeutic approach for disseminated candidiasis	NATURE MEDICINE			English	Article							C-TYPE LECTIN; PATTERN-RECOGNITION RECEPTOR; CELL-ACTIVATION THRESHOLD; HOST-DEFENSE; ASPERGILLUS-FUMIGATUS; TYROSINE KINASE; CUTTING EDGE; FC-RECEPTOR; DECTIN-1; INDUCTION	Disseminated candidiasis has become one of the leading causes of hospital-acquired blood stream infections with high mobility and mortality. However, the molecular basis of host defense against disseminated candidiasis remains elusive, and treatment options are limited. Here we report that the E3 ubiquitin ligase CBLB directs polyubiquitination of dectin-1 and dectin-2, two key pattern-recognition receptors for sensing Candida albicans, and their downstream kinase SYK, thus inhibiting dectin-1-and dectin-2-mediated innate immune responses. CBLB deficiency or inactivation protects mice from systemic infection with a lethal dose of C. albicans, and deficiency of dectin-1, dectin-2, or both in Cblb(-/-) mice abrogates this protection. Notably, silencing the Cblb gene in vivo protects mice from lethal systemic C. albicans infection. Our data reveal that CBLB is crucial for homeostatic control of innate immune responses mediated by dectin-1 and dectin-2. Our data also indicate that CBLB represents a potential therapeutic target for protection from disseminated candidiasis.	[Xiao, Yun; Tang, Juan; Guo, Hui; Zhao, Yixia; Tang, Rong; Ouyang, Song; Zeng, Qiuming; Rappleye, Chad A.; Rajaram, Murugesan V. S.; Schlesinger, Larry S.; Li, Belinda T.; Zhang, Jian] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Xiao, Yun; Tang, Juan; Tang, Rong; Tao, Lijian] Cent S Univ, Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Xiao, Yun] Guangzhou Med Univ, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Zhao, Yixia] Cent S Univ, Xiangya Hosp, Dept Cardiol, Changsha, Hunan, Peoples R China; [Ouyang, Song; Zeng, Qiuming] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Ouyang, Song] Univ South China, Hosp Changsha 1, Dept Neurol, Changsha, Hunan, Peoples R China; [Rappleye, Chad A.] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, MRC Ctr Med Mycol, Aberdeen Fungal Grp, Aberdeen, Scotland; [Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia	University System of Ohio; Ohio State University; Central South University; Guangzhou Medical University; Central South University; Central South University; University of South China; University System of Ohio; Ohio State University; University of Aberdeen; University of Western Australia	Zhang, J (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	jian.zhang@osumc.edu	Rajaram, Murugesan/E-5203-2013	Rajaram, Murugesan/0000-0002-1515-1122; Zhang, Jian/0000-0002-9523-5296; Rappleye, Chad/0000-0001-7880-5958	US National Institutes of Health [R01 AI090901, R01 AI123253, R21 AI117547]; American Heart Association (AHA Great Rivers Associate Grant-in-Aid grant) [16GRNT26990004]; Ohio State University College of Medicine; Wellcome Trust; MRC [MR/N006364/1] Funding Source: UKRI; Medical Research Council [MR/N006364/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123253, R21AI117547, R01AI090901] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA Great Rivers Associate Grant-in-Aid grant); Ohio State University College of Medicine(Ohio State University); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.M. Penninger (University of Toronto) for providing Cblb<SUP>-/-</SUP> mice, Y. Iwakura (Tokyo University of Science) for providing Clec4n<SUP>-/-</SUP> mice, S. Lipkowitz (National Cancer Institute, US National Institutes of Health) for providing Cblb constructs, X. Lin (MD Anderson Cancer Center) for providing the antibody to mouse dectin-3 and Card9<SUP>-/-</SUP> bone marrow cells, P.R. Sundstrom (Dartmouth University) for providing the C. albicans cap1 mutant, and L.D. Chaves (University at Buffalo) for flow cytometric analysis of myeloid cells in the kidneys. We also thank A. Lovett-Racke (Ohio State University) for her advice on in vivo Cblb-knockdown experiments. This work was supported by the US National Institutes of Health (grants R01 AI090901, R01 AI123253, and R21 AI117547; all to J.Z.), the American Heart Association (AHA Great Rivers Associate Grant-in-Aid grant 16GRNT26990004; J.Z.), a start-up fund from the Ohio State University College of Medicine (J.Z.), and the Wellcome Trust (G.D.B.).	Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bahn YS, 2001, J BACTERIOL, V183, P3211, DOI 10.1128/JB.183.10.3211-3223.2001; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Dupre-Crochet S, 2013, J LEUKOCYTE BIOL, V94, P657, DOI 10.1189/jlb.1012544; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Goodridge HS, 2012, TRAFFIC, V13, P1062, DOI 10.1111/j.1600-0854.2012.01382.x; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Guo H, 2012, CELL REPORTS, V1, P472, DOI 10.1016/j.celrep.2012.04.008; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Kojo S, 2009, P NATL ACAD SCI USA, V106, P17847, DOI 10.1073/pnas.0904078106; Li DD, 2004, J IMMUNOL, V173, P7135, DOI 10.4049/jimmunol.173.12.7135; Lin Q, 2010, MOL CELL BIOL, V30, P1541, DOI 10.1128/MCB.00013-10; Liu QJ, 2014, CELL CYCLE, V13, P1875, DOI 10.4161/cc.29213; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Nicola AM, 2008, CURR OPIN MICROBIOL, V11, P313, DOI 10.1016/j.mib.2008.05.011; Oksvold MP, 2008, MOL IMMUNOL, V45, P925, DOI 10.1016/j.molimm.2007.08.002; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Qiao GL, 2008, MOL CELL BIOL, V28, P2470, DOI 10.1128/MCB.01505-07; Qiao GL, 2014, CELL REP, V6, P709, DOI 10.1016/j.celrep.2014.01.012; Qiao GL, 2013, J IMMUNOL, V191, P632, DOI 10.4049/jimmunol.1202068; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Rivera A, 2011, J EXP MED, V208, P369, DOI 10.1084/jem.20100906; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Smeekens SP, 2015, CYTOKINE, V71, P215, DOI 10.1016/j.cyto.2014.10.013; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Swamydas M., 2015, CURR PROTOC IMMUNOL, V110; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Wirnsberger G, 2014, NAT GENET, V46, P1028, DOI 10.1038/ng.3070; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zhang J, 2002, J IMMUNOL, V169, P2236, DOI 10.4049/jimmunol.169.5.2236; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	49	59	60	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					906	+		10.1038/nm.4141	http://dx.doi.org/10.1038/nm.4141			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27428899	Green Submitted, Green Accepted			2022-12-25	WOS:000381000200016
J	Caviglia, S; Brankatschk, M; Fischer, EJ; Eaton, S; Luschnig, S				Caviglia, Sara; Brankatschk, Marko; Fischer, Elisabeth J.; Eaton, Suzanne; Luschnig, Stefan			Staccato/Unc-13-4 controls secretory lysosome-mediated lumen fusion during epithelial tube anastomosis	NATURE CELL BIOLOGY			English	Article							TRACHEAL FUSION; CELLULAR MECHANISMS; VESSEL FUSION; RAB GTPASES; DROSOPHILA; TRAFFICKING; EXPRESSION; PROTEINS; EFFECTOR; MUNC13-4	A crucial yet ill-defined step during the development of tubular networks, such as the vasculature, is the formation of connections (anastomoses) between pre-existing lumenized tubes. By studying tracheal tube anastomosis in Drosophila melanogaster, we uncovered a key role of secretory lysosome-related organelle (LRO) trafficking in lumen fusion. We identified the conserved calcium-binding protein Unc-13-4/Staccato (Stac) and the GTPase Rab39 as critical regulators of this process. Stac and Rab39 accumulate on dynamic vesicles, which form exclusively in fusion tip cells, move in a dynein-dependent manner, and contain late-endosomal, lysosomal, and SNARE components characteristic of LROs. The GTPase Arl3 is necessary and sufficient for Stac LRO formation and promotes Stac-dependent intracellular fusion of juxtaposed apical plasma membranes, thereby forming a transcellular lumen. Concomitantly, calcium is released locally from ER exit sites and apical membrane-associated calcium increases. We propose that calcium-dependent focused activation of LRO exocytosis restricts lumen fusion to appropriate domains within tip cells.	[Caviglia, Sara; Fischer, Elisabeth J.; Luschnig, Stefan] Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Caviglia, Sara; Fischer, Elisabeth J.; Luschnig, Stefan] Univ Zurich, PhD Program Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Brankatschk, Marko; Eaton, Suzanne] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Luschnig, Stefan] Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany; [Luschnig, Stefan] Univ Munster, Cells Motion Cluster Excellence EXC CiM 1003, D-48149 Munster, Germany; [Caviglia, Sara] Univ Copenhagen, Danish Stem Cell Ctr DanStem, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark	University of Zurich; University of Zurich; Max Planck Society; University of Munster; University of Munster; University of Copenhagen	Caviglia, S; Luschnig, S (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Caviglia, S; Luschnig, S (corresponding author), Univ Zurich, PhD Program Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Luschnig, S (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.; Luschnig, S (corresponding author), Univ Munster, Cells Motion Cluster Excellence EXC CiM 1003, D-48149 Munster, Germany.; Caviglia, S (corresponding author), Univ Copenhagen, Danish Stem Cell Ctr DanStem, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	sara.caviglia@sund.ku; luschnig@uni-muenster.de	Eaton, Suzanne/D-7698-2017; Luschnig, Stefan E/A-7253-2010	Eaton, Suzanne/0000-0002-8319-284X; Luschnig, Stefan E/0000-0002-0634-3368; Caviglia, Sara/0000-0001-9832-2566	University of Zurich; Swiss National Science Foundation (SNF) [31003A_141093_1]; Kanton Zurich; 'Cells-in-Motion' Cluster of Excellence [EXC 1003-CiM]; University of Munster	University of Zurich; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Kanton Zurich; 'Cells-in-Motion' Cluster of Excellence; University of Munster	We are indebted to D. Forster for isolating the stac<SUP>3B20</SUP> mutant. We thank M. Trost for generating dys-Gal4, J. Shah for generating Stac-sGFP, J. Glashauser for generating UAS-palm-mKate2, M. Robinson for advice on statistics, and W. Backer for technical help. J. Bressan, M. Crameri, G. Gut, Z. Kabakci, T. Kohlbrenner, S. Re, J. Shah and M. Whitehead contributed experimental results. We thank M. Affolter, H. Chanut-Delalande (University Paul Sabatier, Toulouse, France), D. Brunner, C. Lehner (University of Zurich, Switzerland), B. Dong, S. Hayashi (Riken Center for Developmental Biology, Kobe, Japan), G. Jefferis (University of Cambridge, UK), L. Jiang (Oakland University, USA), H. Kramer (UT Southwestern, USA), T. Littleton (MIT, USA), P. Tomancak (Max-Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany), the Bloomington and Kyoto Drosophila stock centres, and the Developmental Studies Hybridoma Bank for providing fly stocks and reagents. We thank B. Dong and S. Hayashi for communication of unpublished work. We are indebted to C. Lehner for continuous support and discussions. S.C. was supported by a Forschungskredit fellowship of the University of Zurich. Work in S.L.'s laboratory was supported by the Swiss National Science Foundation (SNF 31003A_141093_1), the University of Zurich, the Kanton Zurich, the 'Cells-in-Motion' Cluster of Excellence (EXC 1003-CiM), and the University of Munster.	Allen MJ, 1999, J NEUROSCI, V19, P9374; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Andrews NW, 2014, TRENDS CELL BIOL, V24, P734, DOI 10.1016/j.tcb.2014.07.008; Becker CE, 2009, J BIOL CHEM, V284, P34531, DOI 10.1074/jbc.M109.046102; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Caviglia S, 2014, SEMIN CELL DEV BIOL, V31, P82, DOI 10.1016/j.semcdb.2014.03.018; Caviglia S, 2013, DEVELOPMENT, V140, P1240, DOI 10.1242/dev.087874; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dong B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2347; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Dunst S, 2015, DEV CELL, V33, P351, DOI 10.1016/j.devcel.2015.03.022; Ejsmont RK, 2009, NAT METHODS, V6, P435, DOI [10.1038/NMETH.1334, 10.1038/nmeth.1334]; Elstak Edo D, 2012, Commun Integr Biol, V5, P64; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Forster D, 2010, CURR BIOL, V20, P62, DOI 10.1016/j.cub.2009.11.062; Gervais L, 2012, DEV BIOL, V362, P187, DOI 10.1016/j.ydbio.2011.11.018; Gervais L, 2010, CURR BIOL, V20, P359, DOI 10.1016/j.cub.2009.12.043; Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jazwinska A, 2004, GENE EXPR PATTERNS, V4, P413, DOI 10.1016/j.modgep.2004.01.003; Jiang L, 2003, MOL CELL BIOL, V23, P5625, DOI 10.1128/MCB.23.16.5625-5637.2003; Jiang L, 2007, DEV BIOL, V311, P487, DOI 10.1016/j.ydbio.2007.08.049; Jiang L, 2010, MECH DEVELOP, V127, P265, DOI 10.1016/j.mod.2010.03.003; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; Kanamori T, 2013, SCIENCE, V340, P1475, DOI 10.1126/science.1234879; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Kohl J, 2014, P NATL ACAD SCI USA, V111, pE3805, DOI 10.1073/pnas.1411087111; Laulagnier K, 2011, MOL BIOL CELL, V22, P2068, DOI 10.1091/mbc.E11-03-0193; Lee M, 2003, DEVELOPMENT, V130, P5989, DOI 10.1242/dev.00806; Lee S, 2002, DEVELOPMENT, V129, P1509; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; Melom JE, 2013, J NEUROSCI, V33, P1169, DOI 10.1523/JNEUROSCI.3920-12.2013; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Sarov M, 2016, ELIFE, V5, DOI 10.7554/eLife.12068; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Siekmann AF, 2013, EXP CELL RES, V319, P1255, DOI 10.1016/j.yexcr.2013.01.019; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Strilic B, 2010, CURR BIOL, V20, P2003, DOI 10.1016/j.cub.2010.09.061; Tanaka H, 2004, DEV BIOL, V274, P413, DOI 10.1016/j.ydbio.2004.07.035; TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; van Weering JRT, 2014, SEMIN CELL DEV BIOL, V31, P40, DOI 10.1016/j.semcdb.2014.03.015; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Watzlich D, 2013, EMBO REP, V14, P465, DOI 10.1038/embor.2013.37; Witze ES, 2013, DEV CELL, V26, P645, DOI 10.1016/j.devcel.2013.08.019; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang L, 2009, DEV BIOL, V336, P201, DOI 10.1016/j.ydbio.2009.09.040; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	68	21	22	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2016	18	7					727	+		10.1038/ncb3374	http://dx.doi.org/10.1038/ncb3374			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DP9TS	27323327				2022-12-25	WOS:000378840900006
J	Huang, BH; Faucette, AN; Pawlitz, MD; Pei, B; Goyert, JW; Zhou, JZ; El-Hage, NG; Deng, J; Lin, J; Yao, FY; Dewar, RS; Jassal, JS; Sandberg, ML; Dai, J; Cols, M; Shen, C; Polin, LA; Nichols, RA; Jones, TB; Bluth, MH; Puder, KS; Gonik, B; Nayak, NR; Puscheck, E; Wei, WZ; Cerutti, A; Colonna, M; Chen, K				Huang, Bihui; Faucette, Azure N.; Pawlitz, Michael D.; Pei, Bo; Goyert, Joshua W.; Zhou, Jordan Zheng; El-Hage, Nadim G.; Deng, Jie; Lin, Jason; Yao, Fayi; Dewar, Robert S., III; Jassal, Japnam S.; Sandberg, Maxwell L.; Dai, Jing; Cols, Montserrat; Shen, Cong; Polin, Lisa A.; Nichols, Ronald A.; Jones, Theodore B.; Bluth, Martin H.; Puder, Karoline S.; Gonik, Bernard; Nayak, Nihar R.; Puscheck, Elizabeth; Wei, Wei-Zen; Cerutti, Andrea; Colonna, Marco; Chen, Kang			Interleukin-33-induced expression of PIBF1 by decidual B cells protects against preterm labor	NATURE MEDICINE			English	Article							INDUCED BLOCKING FACTOR; REGULATORY T-CELLS; PROGESTERONE; PREGNANCY; LIPOPOLYSACCHARIDE; AUTOIMMUNE; IMMUNITY; IL-10; BLOOD	Preterm birth (PTB) is a leading cause of neonatal death worldwide(1). Intrauterine and systemic infection and inflammation cause 30-40% of spontaneous preterm labor (PTL)(2), which precedes PTB. Although antibody production is a major immune defense mechanism against infection, and B cell dysfunction has been implicated in pregnancy complications associated with PTL3,4, the functions of B cells in pregnancy are not well known(5-8). We found that choriodecidua of women undergoing spontaneous PTL harbored functionally altered B cell populations. B cell-deficient mice were markedly more susceptible than wild-type (WT) mice to PTL after inflammation, but B cells conferred interleukin (IL)-10-independent protection against PTL. B cell deficiency in mice resulted in a lower uterine level of active progesterone-induced blocking factor 1 (PIBF1), and therapeutic administration of PIBF1 mitigated PTL and uterine inflammation in B cell-deficient mice. B cells are a significant producer of PIBF1 in human choriodecidua and mouse uterus in late gestation. PIBF1 expression by B cells is induced by the mucosal alarmin IL-33 (ref. 9). Human PTL was associated with diminished expression of the alpha-chain of IL-33 receptor on choriodecidual B cells and a lower level of active PIBF1 in late gestation choriodecidua. These results define a vital regulatory cascade involving IL-33, decidual B cells and PIBF1 in safeguarding term pregnancy and suggest new therapeutic approaches based on IL-33 and PIBF1 to prevent human PTL.	[Huang, Bihui; Faucette, Azure N.; Pawlitz, Michael D.; Pei, Bo; Goyert, Joshua W.; Zhou, Jordan Zheng; El-Hage, Nadim G.; Lin, Jason; Yao, Fayi; Dewar, Robert S., III; Jassal, Japnam S.; Dai, Jing; Nichols, Ronald A.; Jones, Theodore B.; Puder, Karoline S.; Gonik, Bernard; Nayak, Nihar R.; Puscheck, Elizabeth; Chen, Kang] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA; [Sandberg, Maxwell L.] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Cols, Montserrat; Shen, Cong] Union Coll, Leadership Med Program, Schenectady, NY 12308 USA; [Polin, Lisa A.; Wei, Wei-Zen; Chen, Kang] Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA; [Polin, Lisa A.; Chen, Kang] Wayne State Univ, Dept Oncol, Detroit, MI 48202 USA; [Nichols, Ronald A.; Jones, Theodore B.] Beaumont Dearborn Hosp, Dept Obstet & Gynecol Med Ed, Dearborn, MI USA; [Bluth, Martin H.] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Cerutti, Andrea] Catalan Inst Res & Adv Studies, Barcelona Biomed Res Pk, Barcelona, Spain; [Cerutti, Andrea] Inst Hosp Mar Invest Med, Program Inflammatory & Cardiovasc Disorders, Barcelona, Spain; [Cerutti, Andrea] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Cerutti, Andrea; Colonna, Marco; Chen, Kang] NIAID, Mucosal Immunol Studies Team, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Faucette, Azure N.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Faucette, Azure N.] CUNY, Kingsborough Community Coll, Dept Biol, Brooklyn, NY USA	Wayne State University; Yale University; Union College; Memorial Sloan Kettering Cancer Center; Wayne State University; Wayne State University; ICREA; Pompeu Fabra University; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL); City University of New York (CUNY) System	Chen, K (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA.; Chen, K (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.; Chen, K (corresponding author), Wayne State Univ, Dept Oncol, Detroit, MI 48202 USA.; Chen, K (corresponding author), NIAID, Mucosal Immunol Studies Team, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kang@wayne.edu	dai, jing/GVS-5395-2022	Huang, Bihui/0000-0003-3084-7096; Goyert, Joshua/0000-0003-3820-970X; Pawlitz, Michael/0000-0002-7001-5676; Zhou, Jordan/0000-0001-6047-9285; Cerutti, Andrea/0000-0003-3026-4704	Burroughs Wellcome Fund; US National Institutes of Health [U01AI95776, R21AI122256, P30CA22453]; American Congress of Obstetricians and Gynecologists; Wayne State University (Perinatal Initiative); Wayne State University Office of the Vice President for Research; NATIONAL CANCER INSTITUTE [P30CA022453, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122256, U01AI095776] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Congress of Obstetricians and Gynecologists; Wayne State University (Perinatal Initiative); Wayne State University Office of the Vice President for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	We thank the European Conditional Mouse Mutagenesis Program and Barry Rosen (Wellcome Trust Sanger Institute) for mouse 1133 targeting vectors, the NIAID Mucosal Immunology Studies Team (MIST) mouse core for generating the Il33<SUP>-/-</SUP> lacZ reporter mice, and M. Treadwell (University of Michigan at Ann Arbor) and X. Xu (Bristol-Myers Squibb) for discussion of the manuscript. This study was supported by grants from the Burroughs Wellcome Fund (Preterm Birth Initiative), US National Institutes of Health (U01AI95776 MIST Young Investigator Award, R21AI122256, P30CA22453), American Congress of Obstetricians and Gynecologists and Wayne State University (Perinatal Initiative) (to K.C.). A.N.F. was partially supported by a fellowship from the Wayne State University Office of the Vice President for Research.	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; BHAT NM, 1995, J REPROD IMMUNOL, V28, P53, DOI 10.1016/0165-0378(94)00907-O; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Candando KM, 2014, IMMUNOL REV, V259, P259, DOI 10.1111/imr.12176; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Frank HG, 2006, PATHOLOGY HUMAN PLAC, P191, DOI [10.1007/0-387-26742-5_9, DOI 10.1007/0-387-26742-5_9]; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gonzalez-Arenas A, 2014, J STEROID BIOCHEM, V144, P463, DOI 10.1016/j.jsbmb.2014.09.007; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Hudic I, 2015, J REPROD IMMUNOL, V109, P36, DOI 10.1016/j.jri.2015.02.006; Jensen F, 2012, HYPERTENSION, V59, P861, DOI 10.1161/HYPERTENSIONAHA.111.188276; Lachmann M, 2004, INT J CANCER, V112, P51, DOI 10.1002/ijc.20326; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Martin NT, 2016, NAT IMMUNOL, V17, P122, DOI 10.1038/ni.3370; Matthiesen L, 2005, CHEM IMMUNOL ALLERGY, V89, P49, DOI 10.1159/000087912; MEDINA KL, 1994, P NATL ACAD SCI USA, V91, P5382, DOI 10.1073/pnas.91.12.5382; Moffett A, 2015, HUM REPROD, V30, P1519, DOI 10.1093/humrep/dev098; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Muzzio DO, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.122366; Parekh VV, 2003, J IMMUNOL, V170, P5897, DOI 10.4049/jimmunol.170.12.5897; Polgar B, 2003, J IMMUNOL, V171, P5956, DOI 10.4049/jimmunol.171.11.5956; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2014, SEMIN FETAL NEONAT M, V19, P15, DOI 10.1016/j.siny.2013.10.004; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sattler S, 2014, J AUTOIMMUN, V50, P107, DOI 10.1016/j.jaut.2014.01.032; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Szekeres-Bartho J, 2010, AM J REPROD IMMUNOL, V64, P77, DOI 10.1111/j.1600-0897.2010.00833.x; SZEKERESBARTHO J, 1985, AM J REPROD IM MIC, V9, P15; Thaxton JE, 2009, J IMMUNOL, V183, P1144, DOI 10.4049/jimmunol.0900788; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Trundley A, 2004, TISSUE ANTIGENS, V63, P1, DOI 10.1111/j.1399-0039.2004.00170.x; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Zimmer JP, 1998, AM J REPROD IMMUNOL, V40, P57	40	55	60	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					128	135		10.1038/nm.4244	http://dx.doi.org/10.1038/nm.4244			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27918564	Green Accepted			2022-12-25	WOS:000391646800022
J	Lazarus, RA; Scheiflinger, F				Lazarus, Robert A.; Scheiflinger, Friedrich			Mining ancient proteins for next-generation drugs	NATURE BIOTECHNOLOGY			English	Editorial Material							HEMOPHILIA-A		[Lazarus, Robert A.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Scheiflinger, Friedrich] Shire, Res EU, Vienna, Austria	Roche Holding; Genentech	Lazarus, RA (corresponding author), Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA.	lazarus.bob@gene.com; fritz.scheiflinger@shire.com	Scheiflinger, Friedrich/AAO-6307-2020					Arruda VR, 2016, J THROMB HAEMOST, V14, P1121, DOI 10.1111/jth.13331; Carter P. J., 2011, CELL RES, V317, P1261; Gomperts E, 2015, EXPERT REV HEMATOL, V8, P427, DOI 10.1586/17474086.2015.1040758; Griswold KE, 2016, CURR OPIN STRUC BIOL, V39, P79, DOI 10.1016/j.sbi.2016.06.003; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Merkl R, 2016, BIOL CHEM, V397, P1, DOI 10.1515/hsz-2015-0158; Morfini M, 2016, EXPERT OPIN EMERG DR, V21, P301, DOI 10.1080/14728214.2016.1220536; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Tarantino M. D., 2016, HAEMOPHILIA; Zakas PM, 2017, NAT BIOTECHNOL, V35, P35, DOI 10.1038/nbt.3677	10	6	6	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					28	29		10.1038/nbt.3762	http://dx.doi.org/10.1038/nbt.3762			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	28072785				2022-12-25	WOS:000392460800017
J	Eppinga, RN; Hagemeijer, Y; Burgess, S; Hinds, DA; Stefansson, K; Gudbjartsson, DF; van Veldhuisen, DJ; Munroe, PB; Verweij, N; van der Harst, P				Eppinga, Ruben N.; Hagemeijer, Yanick; Burgess, Stephen; Hinds, David A.; Stefansson, Kari; Gudbjartsson, Daniel F.; van Veldhuisen, Dirk J.; Munroe, Patricia B.; Verweij, Niek; van der Harst, Pim			Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality	NATURE GENETICS			English	Article							CORONARY-ARTERY-DISEASE; PLACEBO-CONTROLLED TRIAL; WIDE ASSOCIATION; RISK-FACTOR; UK BIOBANK; FOLLOW-UP; OUTCOMES; HYPERTENSION; IVABRADINE; FAILURE	Resting heart rate is a heritable trait correlated with life span. Little is known about the genetic contribution to resting heart rate and its relationship with mortality. We performed a genome-wide association discovery and replication analysis starting with 19.9 million genetic variants and studying up to 265,046 individuals to identify 64 loci associated with resting heart rate (P < 5 x 10(-8)); 46 of these were novel. We then used the genetic variants identified to study the association between resting heart rate and all-cause mortality. We observed that a genetically predicted resting heart rate increase of 5 beats per minute was associated with a 20% increase in mortality risk (hazard ratio 1.20, 95% confidence interval 1.11-1.28, P = 8.20 x 10(-7)) translating to a reduction in life expectancy of 2.9 years for males and 2.6 years for females. Our findings provide evidence for shared genetic predictors of resting heart rate and all-cause mortality.	[Eppinga, Ruben N.; Hagemeijer, Yanick; van Veldhuisen, Dirk J.; Verweij, Niek; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Burgess, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Hinds, David A.] 23andMe Inc, Mountain View, CA USA; [Stefansson, Kari; Gudbjartsson, Daniel F.] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Munroe, Patricia B.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Dept Clin Pharmacol, London, England; [Munroe, Patricia B.] Queen Mary Univ London, NIHR Barts Cardiovasc Biomed Res Unit, London, England; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van der Harst, Pim] Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands	University of Groningen; University of Cambridge; University of Iceland; University of Iceland; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Groningen	van der Harst, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.; van der Harst, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.; van der Harst, P (corresponding author), Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands.	p.van.der.harst@umcg.nl	Stefansson, Kari/AAE-7187-2019; Verweij, Niek/A-4499-2017; Verweij, Niek/ABC-6249-2021; Hagemeijer, Yanick/AAL-7611-2020	Verweij, Niek/0000-0002-4303-7685; Hagemeijer, Yanick/0000-0001-6036-3741; Gudbjartsson, Daniel/0000-0002-5222-9857; Hinds, David/0000-0002-4911-803X; Burgess, Stephen/0000-0001-5365-8760	Netherlands organization for health research and development (ZonMw) [90.700.441]; Wellcome Trust [100114]; NIHR Cardiovascular Biomedical Research Unit at Barts; London School of Medicine and Dentistry, Queen Mary University of London; Netherlands Heart Institute; Marie Sklodowska-Curie Global Fellowship [661395]; Medical Research Council [MC_qA137853] Funding Source: researchfish	Netherlands organization for health research and development (ZonMw)(Netherlands Organization for Health Research and Development); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Cardiovascular Biomedical Research Unit at Barts; London School of Medicine and Dentistry, Queen Mary University of London; Netherlands Heart Institute; Marie Sklodowska-Curie Global Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was conducted using the UK Biobank Resource. This project is supported by the Netherlands organization for health research and development (ZonMw grant 90.700.441). S.B. is supported by the Wellcome Trust (grant 100114). P.B.M. acknowledges support from the NIHR Cardiovascular Biomedical Research Unit at Barts and the London School of Medicine and Dentistry, Queen Mary University of London. N.V. is supported by Netherlands Heart Institute and Marie Sklodowska-Curie Global Fellowship (grant 661395).	Aladin AI, 2016, AM J HYPERTENS, V29, P251, DOI 10.1093/ajh/hpv095; AZBEL MY, 1994, P NATL ACAD SCI USA, V91, P12453, DOI 10.1073/pnas.91.26.12453; Bangalore S, 2012, JAMA-J AM MED ASSOC, V308, P1340, DOI 10.1001/jama.2012.12559; Bohm M, 2015, AM J MED, V128, P219, DOI 10.1016/j.amjmed.2014.09.016; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; Caetano J, 2015, EUR J INTERN MED, V26, P217, DOI 10.1016/j.ejim.2015.02.009; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Davies G, 2016, MOL PSYCHIATR, V21, P758, DOI 10.1038/mp.2016.45; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430; GILLUM RF, 1991, AM HEART J, V121, P172, DOI 10.1016/0002-8703(91)90970-S; Grassi G, 1998, J HYPERTENS, V16, P1635, DOI 10.1097/00004872-199816110-00010; Greenland P, 1999, AM J EPIDEMIOL, V149, P853; Jiang XJ, 2015, HEART, V101, P44, DOI 10.1136/heartjnl-2014-305685; Kanai M., 2016, J HUM GENET; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Kolloch R, 2008, EUR HEART J, V29, P1327, DOI 10.1093/eurheartj/ehn123; Kristal-Boneh E, 2000, EUR HEART J, V21, P116, DOI 10.1053/euhj.1999.1741; Lane JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10889; Levine HJ, 1997, J AM COLL CARDIOL, V30, P1104; Messerli FH, 1998, JAMA-J AM MED ASSOC, V279, P1903, DOI 10.1001/jama.279.23.1903; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Reunanen A, 2000, J INTERN MED, V247, P231, DOI 10.1046/j.1365-2796.2000.00602.x; Schmidt-Nielsen K., 1975, ANIMAL PHYSL ADAPTAT; Siva N, 2015, LANCET, V385, P103, DOI 10.1016/S0140-6736(14)62453-3; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Xu CJ, 2014, GENET EPIDEMIOL, V38, P281, DOI 10.1002/gepi.21797	32	88	88	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1557	1563		10.1038/ng.3708	http://dx.doi.org/10.1038/ng.3708			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27798624	Green Submitted			2022-12-25	WOS:000389011100017
J	Kato, AS; Burris, KD; Gardinier, KM; Gernert, DL; Porter, WJ; Reel, J; Ding, CJ; Tu, Y; Schober, DA; Lee, MR; Heinz, BA; Fitch, TE; Gleason, SD; Catlow, JT; Yu, H; Fitzjohn, SM; Pasqui, F; Wang, H; Qian, YW; Sher, E; Zwart, R; Wafford, KA; Rasmussen, K; Ornstein, PL; Isaac, JTR; Nisenbaum, ES; Bredt, DS; Witkin, JM				Kato, Akihiko S.; Burris, Kevin D.; Gardinier, Kevin M.; Gernert, Douglas L.; Porter, Warren J.; Reel, Jon; Ding, Chunjin; Tu, Yuan; Schober, Douglas A.; Lee, Matthew R.; Heinz, Beverly A.; Fitch, Thomas E.; Gleason, Scott D.; Catlow, John T.; Yu, Hong; Fitzjohn, Stephen M.; Pasqui, Francesca; Wang, He; Qian, Yuewei; Sher, Emanuele; Zwart, Ruud; Wafford, Keith A.; Rasmussen, Kurt; Ornstein, Paul L.; Isaac, John T. R.; Nisenbaum, Eric S.; Bredt, David S.; Witkin, Jeffrey M.			Forebrain-selective AMPA-receptor antagonism guided by TARP gamma-8 as an antiepileptic mechanism	NATURE MEDICINE			English	Article							AUXILIARY SUBUNITS; NEUROTRANSMITTER RECEPTORS; SYNAPTIC PLASTICITY; CORNICHON PROTEINS; KAINATE RECEPTORS; DISCOVERY; EXPRESSION; PERAMPANEL; SEIZURE; FAMILY	Pharmacological manipulation of specific neural circuits to optimize therapeutic index is an unrealized goal in neurology and psychiatry. AMPA receptors are important for excitatory synaptic transmission(1), and their antagonists are antiepileptic(2). Although efficacious, AMPA-receptor antagonists, including perampanel (Fycompa), the only approved antagonist for epilepsy, induce dizziness and motor impairment(3,4). We hypothesized that blockade of forebrain AMPA receptors without blocking cerebellar AMPA receptors would be antiepileptic and devoid of motor impairment. Taking advantage of an AMPA receptor auxiliary protein, TARP gamma-8, which is selectively expressed in the forebrain and modulates the pharmacological properties of AMPA receptors(5), we discovered that LY3130481 selectively antagonized recombinant and native AMPA receptors containing gamma-8, but not gamma-2 (cerebellum) or other TARP members. Two amino acid residues unique to gamma-8 determined this selectivity. We also observed antagonism of AMPA receptors expressed in hippocampal, but not cerebellar, tissue from an patient with epilepsy. Corresponding to this selective activity, LY3130481 prevented multiple seizure types in rats and mice and without motor side effects. These findings demonstrate the first rationally discovered molecule targeting specific neural circuitries for therapeutic advantage.	[Kato, Akihiko S.; Burris, Kevin D.; Gardinier, Kevin M.; Gernert, Douglas L.; Porter, Warren J.; Reel, Jon; Ding, Chunjin; Tu, Yuan; Schober, Douglas A.; Heinz, Beverly A.; Fitch, Thomas E.; Gleason, Scott D.; Catlow, John T.; Yu, Hong; Wang, He; Qian, Yuewei; Rasmussen, Kurt; Ornstein, Paul L.; Nisenbaum, Eric S.; Bredt, David S.; Witkin, Jeffrey M.] Eli Lilly & Co, Lilly Res Lab, Indianapolis, IN 46285 USA; [Lee, Matthew R.] Eli Lilly & Co, Appl Mol Evolut, San Diego, CA USA; [Fitzjohn, Stephen M.; Pasqui, Francesca; Sher, Emanuele; Zwart, Ruud; Wafford, Keith A.; Isaac, John T. R.] Eli Lilly & Co, Lilly UK, Windlesham, Surrey, England; [Yu, Hong; Bredt, David S.] Janssen PRD, San Diego, CA USA; [Fitzjohn, Stephen M.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England; [Ornstein, Paul L.] Roosevelt Univ, Coll Pharm, Schaumburg, IL USA; [Isaac, John T. R.] Wellcome Trust Res Labs, London, England	Eli Lilly; Eli Lilly; Eli Lilly; University of Bristol	Kato, AS; Witkin, JM (corresponding author), Eli Lilly & Co, Lilly Res Lab, Indianapolis, IN 46285 USA.	katoak@lilly.com; jwitkin@lilly.com		Wafford, Keith/0000-0003-4537-4690; Fitzjohn, Stephen/0000-0002-3859-7530				Burgess DL, 2001, GENOMICS, V71, P339, DOI 10.1006/geno.2000.6440; Cokic B, 2008, NEUROPHARMACOLOGY, V54, P1062, DOI 10.1016/j.neuropharm.2008.02.012; Eusebi F, 2009, PROG NEUROBIOL, V88, P32, DOI 10.1016/j.pneurobio.2009.01.008; French JA, 2012, NEUROLOGY, V79, P589, DOI 10.1212/WNL.0b013e3182635735; Gardinier KM, 2016, J MED CHEM, V59, P4753, DOI 10.1021/acs.jmedchem.6b00125; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gill MB, 2011, J NEUROSCI, V31, P6928, DOI 10.1523/JNEUROSCI.6271-10.2011; Gleason SD, 2015, CNS NEUROL DISORD-DR, V14, P612, DOI 10.2174/1871527314666150429114818; Harkin A, 2002, PHYSIOL BEHAV, V77, P65, DOI 10.1016/S0031-9384(02)00810-7; Hibi S, 2012, J MED CHEM, V55, P10584, DOI 10.1021/jm301268u; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kaminski RM, 2007, NEUROPHARMACOLOGY, V52, P895, DOI 10.1016/j.neuropharm.2006.10.007; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Kott S, 2007, J NEUROSCI, V27, P3780, DOI 10.1523/JNEUROSCI.4185-06.2007; Maher MP, 2016, J PHARMACOL EXP THER, V357, P394, DOI 10.1124/jpet.115.231712; Miledi R, 2002, P NATL ACAD SCI USA, V99, P13238, DOI 10.1073/pnas.192445299; Miledi Ricardo, 2006, V322, P347; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Phillips KG, 2012, NEUROPHARMACOLOGY, V62, P1359, DOI 10.1016/j.neuropharm.2011.04.006; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SUZUKI F, 1995, NEUROSCIENCE, V64, P665, DOI 10.1016/0306-4522(94)00463-F; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2012, J PHYSIOL-LONDON, V590, P2217, DOI 10.1113/jphysiol.2011.221101; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Twele F, 2015, NEUROPHARMACOLOGY, V95, P234, DOI 10.1016/j.neuropharm.2015.03.014; Witkin JM, 2016, J PHARMACOL EXP THER, V358, P502, DOI 10.1124/jpet.116.234419; Zwart R, 2014, J PHARMACOL EXP THER, V351, P124, DOI 10.1124/jpet.114.212779	34	52	52	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1496	+		10.1038/nm.4221	http://dx.doi.org/10.1038/nm.4221			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27820603	Green Submitted			2022-12-25	WOS:000389549000029
J	Maibaum, J; Liao, SM; Vulpetti, A; Ostermann, N; Randl, S; Rudisser, S; Lorthiois, E; Erbel, P; Kinzel, B; Kolb, FA; Barbieri, S; Wagner, J; Durand, C; Fettis, K; Dussauge, S; Hughes, N; Delgado, O; Hommel, U; Gould, T; Mac Sweeney, A; Gerhartz, B; Cumin, F; Flohr, S; Schubart, A; Jaffee, B; Harrison, R; Risitano, AM; Eder, J; Anderson, K				Maibaum, Jurgen; Liao, Sha-Mei; Vulpetti, Anna; Ostermann, Nils; Randl, Stefan; Rudisser, Simon; Lorthiois, Edwige; Erbel, Paul; Kinzel, Bernd; Kolb, Fabrice A.; Barbieri, Samuel; Wagner, Julia; Durand, Corinne; Fettis, Kamal; Dussauge, Solene; Hughes, Nicola; Delgado, Omar; Hommel, Ulrich; Gould, Ty; Mac Sweeney, Aengus; Gerhartz, Bernd; Cumin, Frederic; Flohr, Stefanie; Schubart, Anna; Jaffee, Bruce; Harrison, Richard; Risitano, Antonio Maria; Eder, Jorg; Anderson, Karen			Small-molecule factor D inhibitors targeting the alternative complement pathway	NATURE CHEMICAL BIOLOGY			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; MAXIMUM-LIKELIHOOD; WATER SUPPRESSION; DIFFRACTION DATA; ACTIVE-SITE; ACTIVATION; BINDING; REFINEMENT; EXPRESSION; GENERATION	Complement is a key component of the innate immune system, recognizing pathogens and promoting their elimination. Complement component 3 (C3) is the central component of the system. Activation of C3 can be initiated by three distinct routes-the classical, the lectin and the alternative pathways-with the alternative pathway also acting as an amplification loop for the other two pathways. The protease factor D (FD) is essential for this amplification process, which, when dysregulated, predisposes individuals to diverse disorders including age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH). Here we describe the identification of potent and selective small-molecule inhibitors of FD. These inhibitors efficiently block alternative pathway (AP) activation and prevent both C3 deposition onto, and lysis of, PNH erythrocytes. Their oral administration inhibited lipopolysaccharide-induced AP activation in FD-humanized mice. These data demonstrate the feasibility of inhibiting the AP with small-molecule antagonists and support the development of FD inhibitors for the treatment of complement-mediated diseases.	[Maibaum, Jurgen; Vulpetti, Anna; Ostermann, Nils; Rudisser, Simon; Lorthiois, Edwige; Erbel, Paul; Kinzel, Bernd; Barbieri, Samuel; Wagner, Julia; Durand, Corinne; Fettis, Kamal; Dussauge, Solene; Hughes, Nicola; Hommel, Ulrich; Gerhartz, Bernd; Cumin, Frederic; Flohr, Stefanie; Schubart, Anna; Eder, Jorg] Novartis Pharma AG, Novartis Inst BioMed Res, Novartis Campus, Basel, Switzerland; [Liao, Sha-Mei; Delgado, Omar; Gould, Ty; Jaffee, Bruce; Anderson, Karen] Novartis Inst BioMed Res, Cambridge, MA USA; [Randl, Stefan] Evonik Japan Co, Shinjuku Ku, Tokyo, Japan; [Kolb, Fabrice A.] Roche Innovat Ctr Basel, Pharma Res & Early Dev, Basel, Switzerland; [Mac Sweeney, Aengus] Actelion Pharmaceut Ltd, Drug Discovery Dept, Allschwil, Switzerland; [Harrison, Richard] Cardiff Univ, Sch Med, Inst Infect & Immun, Henry Wellcome Bldg,Heath Pk, Cardiff, S Glam, Wales; [Risitano, Antonio Maria] Univ Naples Federico II, Dept Clin Med & Surg, Div Hematol, Naples, Italy	Novartis; Novartis; Roche Holding; Actelion Pharmaceuticals Ltd; Cardiff University; University of Naples Federico II	Maibaum, J (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Novartis Campus, Basel, Switzerland.	juergen_klaus.maibaum@novartis.com; karen.anderson@novartis.com		Harrison, Richard Alexander/0000-0002-2408-6043; Rudisser, Simon/0000-0002-1107-6196; Schubart, Anna/0000-0003-4253-0600; Wagner, Julia/0000-0002-5019-6932; Vulpetti, Anna/0000-0002-3114-8679; Fettis, Kamal/0000-0001-5908-792X				[Anonymous], 2002, PYMOL MOL GRAPH SYST; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Cole LB, 1998, ACTA CRYSTALLOGR D, V54, P711, DOI 10.1107/S0907444997010457; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira VP, 2007, BLOOD, V110, P2190, DOI 10.1182/blood-2007-04-083170; FISHELSON Z, 1987, J IMMUNOL, V138, P3392; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; Harris CL, 2002, J IMMUNOL METHODS, V268, P245, DOI 10.1016/S0022-1759(02)00207-7; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; IKARI N, 1983, IMMUNOLOGY, V49, P685; Jagle U, 2007, GENESIS, V45, P659, DOI 10.1002/dvg.20342; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAM CM, 1987, J BIOL CHEM, V262, P3444; LESAVRE PH, 1978, J EXP MED, V148, P1498, DOI 10.1084/jem.148.6.1498; Loyet KM, 2014, J PHARMACOL EXP THER, V351, P527, DOI 10.1124/jpet.114.215921; Maeda H, 2005, ANGEW CHEM INT EDIT, V44, P2922, DOI 10.1002/anie.200500114; MIN HY, 1986, NUCLEIC ACIDS RES, V14, P8879; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Morikis D, 2002, BIOCHEM SOC T, V30, P1026, DOI 10.1042/BST0301026; Murray CW, 2010, CURR OPIN STRUC BIOL, V20, P497, DOI 10.1016/j.sbi.2010.04.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Risitano AM, 2013, ADV EXP MED BIOL, V735, P155, DOI 10.1007/978-1-4614-4118-2_10; Risitano AM, 2009, BLOOD, V113, P4094, DOI 10.1182/blood-2008-11-189944; Ristau T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093459; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Skolnik S, 2010, J PHARM SCI-US, V99, P3246, DOI 10.1002/jps.22080; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Volanakis JE, 1996, PROTEIN SCI, V5, P553; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Zipfel PF, 2015, MOL IMMUNOL, V67, P21, DOI 10.1016/j.molimm.2015.03.012; Zipfel PF, 2006, MOL IMMUNOL, V43, P97, DOI 10.1016/j.molimm.2005.06.015	50	50	51	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1105	+		10.1038/NCHEMBIO.2208	http://dx.doi.org/10.1038/NCHEMBIO.2208			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27775713				2022-12-25	WOS:000388582900021
J	Zeltner, N; Fattahi, F; Dubois, NC; Saurat, N; Lafaille, F; Shang, L; Zimmer, B; Tchieu, J; Soliman, MA; Lee, G; Casanova, JL; Studer, L				Zeltner, Nadja; Fattahi, Faranak; Dubois, Nicole C.; Saurat, Nathalie; Lafaille, Fabien; Shang, Lei; Zimmer, Bastian; Tchieu, Jason; Soliman, Mohamed A.; Lee, Gabsang; Casanova, Jean-Laurent; Studer, Lorenz			Capturing the biology of disease severity in a PSC-based model of familial dysautonomia	NATURE MEDICINE			English	Article							PLURIPOTENT STEM-CELLS; MOUSE MODEL; INDUCTION; DIFFERENTIATION; SPECIFICATION; EXPRESSION; VARIANTS; MUTATION; GANGLIA; RESCUE	Familial dysautonomia (FD) is a debilitating disorder that affects derivatives of the neural crest (NC). For unknown reasons, people with FD show marked differences in disease severity despite carrying an identical, homozygous point mutation in IKBKAP, encoding I kappa B kinase complex-associated protein. Here we present disease-related phenotypes in human pluripotent stem cells (PSCs) that capture FD severity. Cells from individuals with severe but not mild disease show impaired specification of NC derivatives, including autonomic and sensory neurons. In contrast, cells from individuals with severe and mild FD show defects in peripheral neuron survival, indicating that neurodegeneration is the main culprit for cases of mild FD. Although genetic repair of the FD-associated mutation reversed early developmental NC defects, sensory neuron specification was not restored, indicating that other factors may contribute to disease severity. Whole-exome sequencing identified candidate modifier genes for individuals with severe FD. Our study demonstrates that PSC-based modeling is sensitive in recapitulating disease severity, which presents an important step toward personalized medicine.	[Zeltner, Nadja; Fattahi, Faranak; Saurat, Nathalie; Zimmer, Bastian; Tchieu, Jason; Soliman, Mohamed A.; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Zeltner, Nadja; Fattahi, Faranak; Saurat, Nathalie; Zimmer, Bastian; Tchieu, Jason; Soliman, Mohamed A.; Studer, Lorenz] Sloan Kettering Inst, Ctr Stem Cell Biol, New York, NY 10065 USA; [Fattahi, Faranak] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Dubois, Nicole C.] Icahn Sch Med Mt Sinai, Dev & Regenerat Biol, New York, NY 10029 USA; [Lafaille, Fabien; Shang, Lei; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Soliman, Mohamed A.] Weill Cornell Med Coll, New York, NY USA; [Lee, Gabsang] Johns Hopkins Univ, Inst Cell Engn, Baltimore, MD USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Icahn School of Medicine at Mount Sinai; Rockefeller University; Cornell University; Johns Hopkins University	Zeltner, N; Studer, L (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.; Zeltner, N; Studer, L (corresponding author), Sloan Kettering Inst, Ctr Stem Cell Biol, New York, NY 10065 USA.	zeltnern@gmail.com; studerl@mskcc.org	Casanova, Jean-Laurent/I-3418-2017; Studer, Lorenz/ABH-1491-2021; Tchieu, Jason/AAG-1551-2020	Studer, Lorenz/0000-0003-0741-7987; Tchieu, Jason/0000-0002-9793-9836; Saurat, Nathalie/0000-0002-6439-5166; Casanova, Jean-Laurent/0000-0002-7782-4169; Zimmer, Bastian/0000-0003-0004-4890; Lee, Gabsang/0000-0002-5052-5927	NCI Cancer Center Support Grant (CCSG) [P30 CA08748]; Swiss National Science Foundation; US National Institutes of Health [P30CA08748]; New York State Stem Cell Science (NYSTEM) [C026446, C026447]; Tri-institutional Stem Cell Initiative (Starr Foundation); Robertson Investigator Award from New York Stem Cell Foundation; Maryland Stem Cell Research Funding (MSCRF/TEDCO); Adrienne Helis Malvin Medical Research Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant (CCSG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science (NYSTEM); Tri-institutional Stem Cell Initiative (Starr Foundation); Robertson Investigator Award from New York Stem Cell Foundation; Maryland Stem Cell Research Funding (MSCRF/TEDCO); Adrienne Helis Malvin Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J.-F. Brunet (Ecole Normale Superieure) for providing us with the PHOX2A antibody, S. Irion and M. Tomishima for critical review of the manuscript, A. Hudon for general help, H. Ralph (Weill Cornell Cell Screening Core) for image quantification and the Bioinformatics, Integrated Genomics Operations (funded by the NCI Cancer Center Support Grant (CCSG, P30 CA08748), Cycle for Survival and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology) and Flow Cytometry Core Facilities at Sloan Kettering Institute. This work was supported by the Swiss National Science Foundation (N.Z.); the US National Institutes of Health (P30CA08748), New York State Stem Cell Science (NYSTEM) (C026446 and C026447) and the Tri-institutional Stem Cell Initiative (Starr Foundation) (L.S.); and a Robertson Investigator Award from New York Stem Cell Foundation, Maryland Stem Cell Research Funding (MSCRF/TEDCO) and the Adrienne Helis Malvin Medical Research Foundation (G.L.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Axelrod FB, 2002, J PEDIATR-US, V141, P518, DOI 10.1067/mpd.2002.127088; AXELROD FB, 1981, PEDIATRICS, V67, P517; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Dietrich P, 2012, HUM MOL GENET, V21, P5078, DOI 10.1093/hmg/dds354; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong JL, 2002, AM J MED GENET, V110, P253, DOI 10.1002/ajmg.10450; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Grundy D, 2007, CURR OPIN GASTROEN, V23, P121, DOI 10.1097/MOG.0b013e3280287a23; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098; Itan Y, 2016, NAT METHODS, V13, P109, DOI 10.1038/nmeth.3739; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Itan Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-256; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Morini E, 2016, HUM MOL GENET, V25, P1116, DOI 10.1093/hmg/ddv634; Oh Y, 2016, CELL STEM CELL, V19, P95, DOI 10.1016/j.stem.2016.05.002; Ooi YH, 2009, INVEST OPHTH VIS SCI, V50, P4237, DOI 10.1167/iovs.08-2312; PEARSON J, 1978, J NEUROL SCI, V39, P47, DOI 10.1016/0022-510X(78)90187-9; PEARSON J, 1978, J NEUROL SCI, V35, P77, DOI 10.1016/0022-510X(78)90103-X; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wainger BJ, 2015, NAT NEUROSCI, V18, P17, DOI 10.1038/nn.3886; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zeltner N, 2015, CURR OPIN CELL BIOL, V37, P102, DOI 10.1016/j.ceb.2015.10.008; Zeltner N, 2014, JOVE-J VIS EXP, DOI 10.3791/51609	42	34	34	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1421	+		10.1038/nm.4220	http://dx.doi.org/10.1038/nm.4220			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27841875	Green Accepted			2022-12-25	WOS:000389549000019
J	Becher, I; Werner, T; Doce, C; Zaal, EA; Togel, I; Khan, CA; Rueger, A; Muelbaier, M; Salzer, E; Berkers, CR; Fitzpatrick, PF; Bantscheff, M; Savitski, MM				Becher, Isabelle; Werner, Thilo; Doce, Carola; Zaal, Esther A.; Toegel, Ina; Khan, Crystal A.; Rueger, Anne; Muelbaier, Marcel; Salzer, Elsa; Berkers, Celia R.; Fitzpatrick, Paul F.; Bantscheff, Marcus; Savitski, Mikhail M.			Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat	NATURE CHEMICAL BIOLOGY			English	Article							MASS-SPECTROMETRY; ACTIVE-SITE; SHIFT ASSAY; DRUG; IDENTIFICATION; ENGAGEMENT; BIOSYNTHESIS; ACTIVATION; COMPLEXES; CELLS	We describe a two-dimensional thermal proteome profiling strategy that can be combined with an orthogonal chemo-proteomics approach to enable comprehensive target profiling of the marketed histone deacetylase inhibitor panobinostat. The N-hydroxycinnamide moiety is identified as critical for potent and tetrahydrobiopterin-competitive inhibition of phenylalanine hydroxylase leading to increases in phenylalanine and decreases in tyrosine levels. These findings provide a rationale for adverse clinical observations and suggest repurposing of the drug for treatment of tyrosinemia.	[Becher, Isabelle; Werner, Thilo; Doce, Carola; Toegel, Ina; Rueger, Anne; Muelbaier, Marcel; Salzer, Elsa; Bantscheff, Marcus; Savitski, Mikhail M.] Cellzome GmbH, Heidelberg, Germany; [Becher, Isabelle; Savitski, Mikhail M.] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Zaal, Esther A.; Berkers, Celia R.] Univ Utrecht, Biomol Mass Spectrometry & Prote, Utrecht, Netherlands; [Khan, Crystal A.; Fitzpatrick, Paul F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	GlaxoSmithKline; Cellzome GmbH; European Molecular Biology Laboratory (EMBL); Utrecht University; University of Texas System; University of Texas Health San Antonio	Bantscheff, M; Savitski, MM (corresponding author), Cellzome GmbH, Heidelberg, Germany.; Savitski, MM (corresponding author), European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany.	marcus.x.bantscheff@gsk.com; mikhail.savitski@embl.de	Bantscheff, Marcus/AAQ-2903-2021	Bantscheff, Marcus/0000-0002-8343-8977; Becher, Isabelle/0000-0001-7170-2235; Berkers, Celia/0000-0003-0746-8565; Olivas, Crystal/0000-0001-7805-914X; Wagner, Anne/0000-0001-7078-2878	Welch Foundation [AQ-1245]; VENI grant from the Netherlands Organization for Scientific Research [722.013.009]	Welch Foundation(The Welch Foundation); VENI grant from the Netherlands Organization for Scientific Research	We thank J. Stuhlfauth for cell culture; M. Jundt, K. Kammerer, M. Klos-Hudak, M. Paulmann and T. Rudi for expert technical assistance; and G. Drewes for helpful suggestions. We also thank W.F. Mueller for providing cells for metabolomics experiments. P.F.F. acknowledges support from the Welch Foundation (grant AQ-1245). C.R.B. was supported by a VENI grant (project 722.013.009) from the Netherlands Organization for Scientific Research.	Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Bailey H, 2015, J BLOOD MED, V6, P269, DOI 10.2147/JBM.S69140; Bantscheff M, 2012, BIOORGAN MED CHEM, V20, P1973, DOI 10.1016/j.bmc.2011.11.003; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Becher I, 2013, ACS CHEM BIOL, V8, P599, DOI 10.1021/cb3005879; Daubner SC, 1999, BIOCHEMISTRY-US, V38, P4448, DOI 10.1021/bi983012u; DEGROOT LJ, 1977, METABOLISM, V26, P665, DOI 10.1016/0026-0495(77)90088-9; DIAMOND A, 1994, ACTA PAEDIATR, V83, P89, DOI 10.1111/j.1651-2227.1994.tb13462.x; Dittmann A, 2014, METHODS MOL BIOL, V1156, P279, DOI 10.1007/978-1-4939-0685-7_19; Drewes G., 2009, Patent No. [US20090238808 Al, 20090238808]; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Hosoda F, 2015, ONCOGENE, V34, P1196, DOI 10.1038/onc.2014.57; Huber KVM, 2015, NAT METHODS, V12, P1055, DOI [10.1038/NMETH.3590, 10.1038/nmeth.3590]; Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Novartis, 2016, FAR PRESCR INF; Pootoolal J, 2002, P NATL ACAD SCI USA, V99, P8962, DOI 10.1073/pnas.102285099; Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652; Robers MB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10091; Roberts KM, 2014, BIOCHEMISTRY-US, V53, P7846, DOI 10.1021/bi501183x; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Savitski MM, 2013, J PROTEOME RES, V12, P3586, DOI 10.1021/pr400098r; Savitski MM, 2010, J AM SOC MASS SPECTR, V21, P1668, DOI 10.1016/j.jasms.2010.01.012; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Simon GM, 2013, NAT CHEM BIOL, V9, P200, DOI 10.1038/nchembio.1211; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; van Vliet D, 2015, JIMD REP, V18, P117, DOI 10.1007/8904_2014_358; Werner T, 2012, ANAL CHEM, V84, P7188, DOI 10.1021/ac301553x; Younes A, 2012, J CLIN ONCOL, V30, P2197, DOI 10.1200/JCO.2011.38.1350; Zhang SN, 2015, BIOCHEMISTRY-US, V54, P5167, DOI 10.1021/acs.biochem.5b00616; Ziegler S, 2013, ANGEW CHEM INT EDIT, V52, P2744, DOI 10.1002/anie.201208749	31	121	127	8	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					908	+		10.1038/NCHEMBIO.2185	http://dx.doi.org/10.1038/NCHEMBIO.2185			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27669419				2022-12-25	WOS:000386798800010
J	Caubit, X; Gubellini, P; Andrieux, J; Roubertoux, PL; Metwaly, M; Jacq, B; Fatmi, A; Had-Aissouni, L; Kwan, KY; Salin, P; Carlier, M; Lieden, A; Rudd, E; Shinawi, M; Vincent-Delorme, C; Cuisset, JM; Lemaitre, MP; Abderrehamane, F; Duban, B; Lemaitre, JF; Woolf, AS; Bockenhauer, D; Severac, D; Dubois, E; Zhu, Y; Sestan, N; Garratt, AN; Goff, LKL; Fasano, L				Caubit, Xavier; Gubellini, Paolo; Andrieux, Joris; Roubertoux, Pierre L.; Metwaly, Mehdi; Jacq, Bernard; Fatmi, Ahmed; Had-Aissouni, Laurence; Kwan, Kenneth Y.; Salin, Pascal; Carlier, Michele; Lieden, Agne; Rudd, Eva; Shinawi, Marwan; Vincent-Delorme, Catherine; Cuisset, Jean-Marie; Lemaitre, Marie-Pierre; Abderrehamane, Fatimetou; Duban, Benedicte; Lemaitre, Jean-Francois; Woolf, Adrian S.; Bockenhauer, Detlef; Severac, Dany; Dubois, Emeric; Zhu, Ying; Sestan, Nenad; Garratt, Alistair N.; Goff, Lydia Kerkerian-Le; Fasano, Laurent			TSHZ3 deletion causes an autism syndrome and defects in cortical projection neurons	NATURE GENETICS			English	Article							MICRODELETION SYNDROME; SPECTRUM DISORDER; LAMINAR IDENTITY; DIFFERENTIATION; GENES; BEHAVIOR; SATB2; ABNORMALITIES; SPECIFICATION; TEASHIRT-3	TSHZ3, which encodes a zinc-finger transcription factor, was recently positioned as a hub gene in a module of the genes with the highest expression in the developing human neocortex, but its functions remained unknown. Here we identify TSHZ3 as the critical region for a syndrome associated with heterozygous deletions at 19q12-q13.11, which includes autism spectrum disorder (ASD). In Tshz3-null mice, differentially expressed genes include layer-specific markers of cerebral cortical projection neurons (CPNs), and the human orthologs of these genes are strongly associated with ASD. Furthermore, mice heterozygous for Tshz3 show functional changes at synapses established by CPNs and exhibit core ASD-like behavioral abnormalities. These findings highlight essential roles for Tshz3 in CPN development and function, whose alterations can account for ASD in the newly defined TSHZ3 deletion syndrome.	[Caubit, Xavier; Gubellini, Paolo; Metwaly, Mehdi; Jacq, Bernard; Fatmi, Ahmed; Had-Aissouni, Laurence; Salin, Pascal; Goff, Lydia Kerkerian-Le; Fasano, Laurent] Aix Marseille Univ, CNRS, IBDM, Marseille, France; [Andrieux, Joris; Abderrehamane, Fatimetou] CHRU Lille, Hop Jeanne Flandre, Inst Genet Med, Lille, France; [Roubertoux, Pierre L.] Aix Marseille Univ, INSERM, GMGF, Marseille, France; [Kwan, Kenneth Y.; Zhu, Ying; Sestan, Nenad] Yale Sch Med, Dept Neurosci, New Haven, CT USA; [Kwan, Kenneth Y.] Univ Michigan, Dept Human Genet, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Carlier, Michele] Aix Marseille Univ, CNRS, LPC, Marseille, France; [Lieden, Agne; Rudd, Eva] Karolinska Univ, Hosp Solna, Clin Genet Unit, Stockholm, Sweden; [Shinawi, Marwan] Washington Univ, Sch Med, Dept Pediat, Div Genet & Genom Med, St Louis, MO USA; [Vincent-Delorme, Catherine] CHRU Lille, Hop Jeanne Flandre, Serv Genet Clin, Lille, France; [Cuisset, Jean-Marie; Lemaitre, Marie-Pierre] CHRU Lille, Serv Neuropediat, Hop Salengro, Lille, France; [Duban, Benedicte; Lemaitre, Jean-Francois] UCL, GHICL, Hop St Vincent de Paul, Ctr Cytogenet, Lille, France; [Woolf, Adrian S.] Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Woolf, Adrian S.] Royal Manchester Childrens Hosp, Manchester, Lancs, England; [Woolf, Adrian S.] St Marys Hosp, Manchester, Lancs, England; [Bockenhauer, Detlef] UCL, Inst Child Hlth, London, England; [Severac, Dany; Dubois, Emeric] MGX Montpellier GenomiX, Inst Genom Fonct, Montpellier, France; [Garratt, Alistair N.] Charite, Inst Cell Biol & Neurobiol, Ctr Anat, Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Yale University; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Karolinska Institutet; Karolinska University Hospital; Washington University (WUSTL); Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; University of Manchester; Royal Manchester Children's Hospital; University of Manchester; University of London; University College London; Universite de Montpellier; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fasano, L (corresponding author), Aix Marseille Univ, CNRS, IBDM, Marseille, France.	laurent.fasano@univ-amu.fr	Garratt, Alistair/AAG-2715-2021; Kwan, Kenneth/AAI-2841-2021; Garratt, Alistair/HGC-0774-2022; Bockenhauer, Detlef/AAF-6495-2020; Zhu, Ying/T-2268-2019; Woolf, Adrian S./AAZ-1075-2020; Had, laurence/ABB-8867-2021; Fasano, Laurent/AFL-9580-2022; Fasano, Laurent/AAH-1688-2022	Kwan, Kenneth/0000-0003-4711-071X; Bockenhauer, Detlef/0000-0001-5878-941X; Woolf, Adrian S./0000-0001-5541-1358; Fasano, Laurent/0000-0003-2307-8428; Fasano, Laurent/0000-0003-2307-8428; shinawi, Marwan/0000-0003-1329-4100; Zhu, Ying/0000-0002-6594-3734; Kerkerian-Le Goff, Lydia/0000-0002-7951-3479; Metwaly, Mehdi/0000-0002-4331-8284; Dubois, Emeric/0000-0002-6052-4178	CNRS; Aix-Marseille University; INSERM; Federation pour la Recherche sur le Cerveau (FRC); National Institutes of Health [MH103339, MH106934, MH106874]; Simons Foundation; Kavli Foundation; Medical Research Council [MR/L002744/1]; Manchester Biomedical Research Centre; NIHR Greater Manchester Clinical Research Network; German Federal Ministry for Education and Research (BMBF, NGFN-plus, Alzheimer Disease Integrative Genomics) [PNA-01GS08127-3a]; French National Research Agency through the 'Investments for the Future' program (France-Biolmaging) [ANR-10-INSB-04-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106934, U01MH103339, U01MH106874] Funding Source: NIH RePORTER; MRC [MR/L002744/1] Funding Source: UKRI	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Federation pour la Recherche sur le Cerveau (FRC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Kavli Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Greater Manchester Clinical Research Network; German Federal Ministry for Education and Research (BMBF, NGFN-plus, Alzheimer Disease Integrative Genomics); French National Research Agency through the 'Investments for the Future' program (France-Biolmaging)(French National Research Agency (ANR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Galdi, V. Vanoosten and C. Scajola who assisted with behavioral testing. This work was supported by funding from CNRS and Aix-Marseille University to L.K.-L.G., L.F. and M.C.; INSERM and Aix-Marseille University to P.L.R.; Federation pour la Recherche sur le Cerveau (FRC) to L.F.; National Institutes of Health grants MH103339, MH106934 and MH106874, the Simons Foundation and the Kavli Foundation to N.S.; and the Medical Research Council (MR/L002744/1), the Manchester Biomedical Research Centre and the NIHR Greater Manchester Clinical Research Network to A.S.W. Funding for A.N.G. was provided by a grant from the German Federal Ministry for Education and Research (BMBF, NGFN-plus, Alzheimer Disease Integrative Genomics; PNA-01GS08127-3a). Microscopy was performed at the imaging platform of IBDM, supported by the French National Research Agency through the 'Investments for the Future' program (France-Biolmaging, ANR-10-INSB-04-01).	Adalat S, 2010, PEDIATR NEPHROL, V25, P2247, DOI 10.1007/s00467-010-1578-y; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Ariani F, 2008, AM J HUM GENET, V83, P89, DOI 10.1016/j.ajhg.2008.05.015; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Bailey A, 1998, HUM MOL GENET, V7, P571; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bodria M., 2015, G ITAL NEFROL S64, V32; Brandt T, 2012, AM J MED GENET A, V158A, P1170, DOI 10.1002/ajmg.a.35267; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Caubit X, 2005, J COMP NEUROL, V486, P76, DOI 10.1002/cne.20500; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; Caubit X, 2010, J NEUROSCI, V30, P9465, DOI 10.1523/JNEUROSCI.1765-10.2010; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chowdhury S, 2014, AM J MED GENET A, V164, P62, DOI 10.1002/ajmg.a.36201; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Delmonte S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00430; Forzano F, 2012, EUR J MED GENET, V55, P429, DOI 10.1016/j.ejmg.2012.03.002; Gana S, 2012, EUR J HUM GENET, V20, P852, DOI 10.1038/ejhg.2012.19; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Handrigan GR, 2013, J MED GENET, V50, P163, DOI 10.1136/jmedgenet-2012-101288; Hoerder-Suabedissen A, 2013, P NATL ACAD SCI USA, V110, P3555, DOI 10.1073/pnas.1218510110; Hussman JP, 2011, MOL AUTISM, V2, DOI [10.1186/2040-2392-2-1, 10.1186/2040-2392-2-18]; Irie F, 2012, P NATL ACAD SCI USA, V109, P5052, DOI 10.1073/pnas.1117881109; Jenkins D, 2010, NEPHROL DIAL TRANSPL, V25, P54, DOI 10.1093/ndt/gfp453; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kulharya AS, 1998, AM J MED GENET, V77, P391, DOI 10.1002/(SICI)1096-8628(19980605)77:5<391::AID-AJMG7>3.3.CO;2-V; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Leone DP, 2015, CEREB CORTEX, V25, P3406, DOI 10.1093/cercor/bhu156; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; MAKANJUOLA ROA, 1977, PSYCHOPHARMACOLOGY, V52, P271, DOI 10.1007/BF00426711; Malan V, 2009, J MED GENET, V46, P635, DOI 10.1136/jmg.2008.062034; Mefford H., 2016, GENEREVIEWS; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Novara F, 2010, CLIN GENET, V78, P471, DOI 10.1111/j.1399-0004.2010.01413.x; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Portmann T, 2014, CELL REP, V7, P1077, DOI 10.1016/j.celrep.2014.03.036; Rosenfeld JA, 2010, GENET MED, V12, P694, DOI 10.1097/GIM.0b013e3181f0c5f3; Rosenfeld JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006568; Roubertoux PL, 2015, NEUROMETHODS, V100, P335, DOI 10.1007/978-1-4939-2250-5_14; Schuurs-Hoeijmakers JHM, 2009, J MED GENET, V46, P421, DOI 10.1136/jmg.2009.066910; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Sohur US, 2014, CEREB CORTEX, V24, P293, DOI 10.1093/cercor/bhs342; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; Varlinskaya EI, 2002, ALCOHOL CLIN EXP RES, V26, P1502, DOI 10.1097/01.ALC.0000034033.95701.E3; Venegas-Vega C, 2014, MOL CYTOGENET, V7, DOI 10.1186/s13039-014-0061-z; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013	64	37	39	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1359	1369		10.1038/ng.3681	http://dx.doi.org/10.1038/ng.3681			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	EA3XU	27668656	Green Accepted			2022-12-25	WOS:000386543400012
J	Egelie, KJ; Graff, GD; Strand, SP; Johansen, B				Egelie, Knut J.; Graff, Gregory D.; Strand, Sabina P.; Johansen, Berit			The emerging patent landscape of CRISPR-Cas gene editing technology	NATURE BIOTECHNOLOGY			English	Editorial Material							INTELLECTUAL PROPERTY; ESCHERICHIA-COLI; RNA; DNA; IDENTIFICATION; ENDONUCLEASE; PROKARYOTES; INNOVATION; REPEATS; HISTORY	Early views on the control of the CRISPR-Cas disruptive enabling technology and access for follow-on commercial applications.	[Egelie, Knut J.; Johansen, Berit] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway; [Graff, Gregory D.] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA; [Graff, Gregory D.] Chalmers, Dept Technol Management & Econ, Gothenburg, Sweden; [Egelie, Knut J.; Strand, Sabina P.] Norwegian Univ Sci & Technol, Technol Transfer Off, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Colorado State University; Chalmers University of Technology; Norwegian University of Science & Technology (NTNU)	Egelie, KJ (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway.; Egelie, KJ (corresponding author), Norwegian Univ Sci & Technol, Technol Transfer Off, Trondheim, Norway.	knut.egelie@ntnu.no		Graff, Gregory/0000-0002-9140-0901				*ASS U TECHN MAN, 2007, 9 POINTS CONS LIC U; AXEL R, 2002, Patent No. 6455275; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Bubela T, 2013, NAT BIOTECHNOL, V31, P202, DOI 10.1038/nbt.2521; Chi-Ham CL, 2010, NAT BIOTECHNOL, V28, P32, DOI 10.1038/nbt0110-32; Cohen Stanley N, 1980, US Patent, Patent No. [4,237,224, 4237224]; Colaianni A, 2009, MILBANK Q, V87, P683, DOI 10.1111/j.1468-0009.2009.00575.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cook-Deegan R, 2010, ANNU REV GENOM HUM G, V11, P383, DOI 10.1146/annurev-genom-082509-141811; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doudna J. A., 2014, US patent, Patent No. 20140068797; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Esmond RW, 2014, NANOTECHNOL LAW BUS, V11, P15; FELDMAN M. P., 2007, INTELLECTUAL PROPERT, V1 and 2, P1797; FELDMAN MP, 2007, INTELLECTUAL PROPERT, V2, P1797; Fore Joe Jr, 2006, J Biomed Discov Collab, V1, P7, DOI 10.1186/1747-5333-1-7; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Graff GD, 2013, NAT BIOTECHNOL, V31, P404, DOI 10.1038/nbt.2568; Grushkin D, 2016, NAT BIOTECHNOL, V34, P13, DOI 10.1038/nbt0116-13; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lei Z, 2009, NAT BIOTECHNOL, V27, P36, DOI 10.1038/nbt0109-36; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MORROW JF, 1974, P NATL ACAD SCI USA, V71, P1743, DOI 10.1073/pnas.71.5.1743; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; Robinson D., 2005, INTELLECTUAL PROPERT, V17, P12; Sheridan C, 2014, NAT BIOTECHNOL, V32, P599, DOI 10.1038/nbt0714-599; Sherkow JS, 2015, NAT BIOTECHNOL, V33, P256, DOI 10.1038/nbt.3160; Tuschl T., 2014, EU patent, Patent No. 2028278; van Erp PBG, 2015, CURR OPIN VIROL, V12, P85, DOI 10.1016/j.coviro.2015.03.011; Van Overwalle G, 2006, NAT REV GENET, V7, P143, DOI 10.1038/nrg1765; WALSH JP, 2003, PATENTS KNOWLEDGE BA, P285, DOI DOI 10.1017/CBO9780511493232.010; WEINER C, 1987, SCI TECHNOL HUM VAL, V12, P50, DOI 10.1177/016224398701200105; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang F., 2014, US Patent, Patent No. [8,697,359, 8697359]	40	51	56	6	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2016	34	10					1025	1032		10.1038/nbt.3692	http://dx.doi.org/10.1038/nbt.3692			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EA0ZG	27727218	Bronze			2022-12-25	WOS:000386317500014
J	Gao, RL; Davis, A; McDonald, TO; Sei, E; Shi, XQ; Wang, Y; Tsai, PC; Casasent, A; Waters, J; Zhang, H; Meric-Bernstam, F; Michor, F; Navin, NE				Gao, Ruli; Davis, Alexander; McDonald, Thomas O.; Sei, Emi; Shi, Xiuqing; Wang, Yong; Tsai, Pei-Ching; Casasent, Anna; Waters, Jill; Zhang, Hong; Meric-Bernstam, Funda; Michor, Franziska; Navin, Nicholas E.			Punctuated copy number evolution and clonal stasis in triple-negative breast cancer	NATURE GENETICS			English	Article							TUMOR EVOLUTION; SINGLE; REARRANGEMENT; CHEMOTHERAPY; INSTABILITY; MODEL	Aneuploidy is a hallmark of breast cancer; however, knowledge of how these complex genomic rearrangements evolve during tumorigenesis is limited. In this study, we developed a highly multiplexed single-nucleus sequencing method to investigate copy number evolution in patients with triple-negative breast cancer. We sequenced 1,000 single cells from tumors in 12 patients and identified 1-3 major clonal subpopulations in each tumor that shared a common evolutionary lineage. For each tumor, we also identified a minor subpopulation of non-clonal cells that were classified as metastable, pseudodiploid or chromazemic. Phylogenetic analysis and mathematical modeling suggest that these data are unlikely to be explained by the gradual accumulation of copy number events over time. In contrast, our data challenge the paradigm of gradual evolution, showing. that the majority of copy number aberrations are acquired at the earliest stages of tumor evolution, in short punctuated bursts, followed by stable clonal expansions that form the tumor mass.	[Gao, Ruli; Davis, Alexander; Sei, Emi; Wang, Yong; Tsai, Pei-Ching; Casasent, Anna; Waters, Jill; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Davis, Alexander; Casasent, Anna; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [McDonald, Thomas O.; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [McDonald, Thomas O.; Michor, Franziska] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Shi, Xiuqing] Chinese Acad Med Sci, Peking Union Med Coll, Dept Med Oncol, Canc Hosp & Inst, Beijing, Peoples R China; [Zhang, Hong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.; Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA.; Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	nnavin@mdanderson.org		Gao, Ruli/0000-0002-1137-4564; Davis, Alexander/0000-0002-1797-2303; Casasent, Anna/0000-0002-7857-179X	Lefkofsky Family Foundation; NCI [1RO1CA169244-01]; American Cancer Society [129098-RSG-16-092-01-TBG]; Moonshot Knowledge Gap Award; Center for Genetics and Genomics; NIH [CA016672, UL1TR000371]; Rosalie B. Hite Fellowship; Center for Genetics and Genomics Postdoctoral Fellowship; Nellie B. Connally Breast Cancer Research Endowment; Susan Komen [SAC10006]; CPRIT [RP110584]; M.D. Anderson Cancer Center Support grant (NIH/NCI) [P30CA016672]; Dana-Farber Cancer Institute Physical Science Oncology Center [U54CA193461-01]; NATIONAL CANCER INSTITUTE [R21CA174397, R01CA169244, U54CA193461, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	Lefkofsky Family Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Moonshot Knowledge Gap Award; Center for Genetics and Genomics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosalie B. Hite Fellowship; Center for Genetics and Genomics Postdoctoral Fellowship; Nellie B. Connally Breast Cancer Research Endowment; Susan Komen(Susan G. Komen Breast Cancer Foundation); CPRIT; M.D. Anderson Cancer Center Support grant (NIH/NCI); Dana-Farber Cancer Institute Physical Science Oncology Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank M. Edgerton, J. Kendall, M. Wigler and J. Hicks for their support and discussions. We are also very grateful to the patients with breast cancer at M.D. Anderson for generously donating their tumor tissues to our research studies. This work was supported by a grant from the Lefkofsky Family Foundation. N.E.N. is a Nadia's Gift Foundation Damon Runyon-Rachleff Innovator (DRR-25-13). This work is also supported by grants to N.E.N. from the NCI (1RO1CA169244-01) and the American Cancer Society (129098-RSG-16-092-01-TBG). N.E.N. is a T.C. Hsu Endowed Scholar, an AAAS Wachtel Scholar and an Andrew Sabin Family Fellow. The study is also supported by the Moonshot Knowledge Gap Award and the Center for Genetics and Genomics. This study was supported by the M.D. Anderson Sequencing Core Facility grant (CA016672) and the Flow Cytometry Facility grant (CA016672) from the NIH. Additional funding support includes the Rosalie B. Hite Fellowship (A.C.); a Center for Genetics and Genomics Postdoctoral Fellowship (R.G.); NIH UL1TR000371 (F.M.-B.); the Nellie B. Connally Breast Cancer Research Endowment (F.M.-B.), Susan Komen SAC10006 (F.M.-B.), CPRIT RP110584 (F.M.-B.) and the M.D. Anderson Cancer Center Support grant (NIH/NCI P30CA016672). F.M. gratefully acknowledges support from the Dana-Farber Cancer Institute Physical Science Oncology Center (U54CA193461-01).	Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Bushati N, 2011, NUCLEIC ACIDS RES, V39, P7380, DOI 10.1093/nar/gkr462; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DePinho RA, 2004, NAT GENET, V36, P932, DOI 10.1038/ng0904-932; Eldredge N., 1972, P82; EXCOFFIER L, 1992, GENETICS, V131, P479; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Foo J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004350; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hoglund M, 2002, CANCER RES, V62, P2675; Knouse KA, 2014, P NATL ACAD SCI USA, V111, P13409, DOI 10.1073/pnas.1415287111; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Leber B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000915; Ling SP, 2015, P NATL ACAD SCI USA, V112, pE6496, DOI 10.1073/pnas.1519556112; Lips EH, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0642-8; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Navin NE, 2010, MOL ONCOL, V4, P267, DOI 10.1016/j.molonc.2010.04.010; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Reynolds A.P., 2006, J MATH MODEL ALGORIT, V5, P475, DOI [DOI 10.1007/S10852-005-9022-1, 10.1007/s10852-005-9022-1]; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Williams MJ, 2016, NAT GENET, V48, P238, DOI 10.1038/ng.3489; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886	38	259	265	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1119	1130		10.1038/ng.3641	http://dx.doi.org/10.1038/ng.3641			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27526321	Green Accepted, Green Submitted			2022-12-25	WOS:000384391600007
J	Kodo, K; Ong, SG; Jahanbani, F; Termglinchan, V; Hirono, K; InanlooRahatloo, K; Ebert, AD; Shukla, P; Abilez, OJ; Churko, JM; Karakikes, I; Jung, G; Ichida, F; Wu, SM; Snyder, MP; Bernstein, D; Wu, JC				Kodo, Kazuki; Ong, Sang-Ging; Jahanbani, Fereshteh; Termglinchan, Vittavat; Hirono, Keiichi; InanlooRahatloo, Kolsoum; Ebert, Antje D.; Shukla, Praveen; Abilez, Oscar J.; Churko, Jared M.; Karakikes, Ioannis; Jung, Gwanghyun; Ichida, Fukiko; Wu, Sean M.; Snyder, Michael P.; Bernstein, Daniel; Wu, Joseph C.			iPSC-derived cardiomyocytes reveal abnormal TGF-beta signalling in left ventricular non-compaction cardiomyopathy	NATURE CELL BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; DILATED CARDIOMYOPATHY; CHAMBER DEVELOPMENT; HEART-DISEASE; TBX20; MUTATIONS; NONCOMPACTION; MICE; MYOCARDIUM; ACTIVATION	Left ventricular non-compaction (LVNC) is the third most prevalent cardiomyopathy in children and its pathogenesis has been associated with the developmental defect of the embryonic myocardium. We show that patient-specific induced pluripotent stem Cell-derived cardiomyocytes (iPSC-CMs) generated from LVNC patients carrying a mutation in the cardiac transcription factor TBX20 recapitulate a key aspect of the pathological phenotype at the single-cell level and this was associated with perturbed transforming growth factor beta (TGF-beta) signalling. LVNC iPSC-CMs have decreased proliferative capacity due to abnormal activation of TGF-beta signalling, TBX20 regulates the expression of TGF-beta signalling modifiers including one known to be a genetic cause of LVNC, PRDM16, and genome editing of PRDM16 caused proliferation defects in iPSC-CMs. Inhibition of TGF-beta signalling and genome correction of the TBX20 mutation were sufficient to reverse the disease phenotype. Our study demonstrates that iPSC-CMs are a useful tool for the exploration of pathological mechanisms underlying poorly understood cardiomyopathies including LVNC.	[Kodo, Kazuki; Ong, Sang-Ging; Termglinchan, Vittavat; InanlooRahatloo, Kolsoum; Ebert, Antje D.; Shukla, Praveen; Abilez, Oscar J.; Churko, Jared M.; Karakikes, Ioannis; Jung, Gwanghyun; Wu, Sean M.; Bernstein, Daniel; Wu, Joseph C.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Kodo, Kazuki; Ong, Sang-Ging; Termglinchan, Vittavat; InanlooRahatloo, Kolsoum; Ebert, Antje D.; Shukla, Praveen; Abilez, Oscar J.; Churko, Jared M.; Karakikes, Ioannis; Wu, Sean M.; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Jahanbani, Fereshteh; Snyder, Michael P.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Termglinchan, Vittavat; Ebert, Antje D.; Churko, Jared M.; Karakikes, Ioannis; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Hirono, Keiichi; Ichida, Fukiko] Toyama Univ, Dept Pediat, Toyama, Toyama 9308555, Japan; [Jung, Gwanghyun; Bernstein, Daniel] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Toyama; Stanford University	Bernstein, D; Wu, JC (corresponding author), Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.; Wu, JC (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA.; Wu, JC (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Bernstein, D (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	danb@stanford.edu; joewu@stanford.edu	Abilez, Oscar J./B-5014-2012; Inanloorahatloo, kolsoum/D-7701-2017; Wu, Joseph/H-1067-2013	Abilez, Oscar J./0000-0002-9991-400X; Inanloorahatloo, kolsoum/0000-0002-5316-8259; Bernstein, Daniel/0000-0001-7761-5853; Wu, Joseph/0000-0002-6068-8041; Wu, Sean/0000-0002-0000-3821; Snyder, Michael/0000-0003-0784-7987; Karakikes, Ioannis/0000-0002-4348-600X	Neuroscience Microscopy Service (NMS); FACS Core at the Institute for Stem Cell Biology and Regenerative Medicine, Stanford University; Uehara Memorial Foundation Research Fellowship; American Heart Association [15POST25160016, 15POST22940013]; NIH [K99HL130416, K18 HL11708301, R01 HL113006, R01 HL130020, R01 126527, R01 128170, R01 HL123968, R24 HL117756]; Ministry of Education, Culture, Sports, Science and Technology in Japan; National Institutes of Health [P01 GM099130]; Children's Cardiomyopathy Foundation; AHA Established Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL117756, R01HL128170, R01HL126527, R01HL113006, R01HL123968, R01HL130020, U01HL099776, K99HL130416, F32HL126348, K01HL130608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099130] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [DP1LM012179] Funding Source: NIH RePORTER	Neuroscience Microscopy Service (NMS); FACS Core at the Institute for Stem Cell Biology and Regenerative Medicine, Stanford University; Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cardiomyopathy Foundation; AHA Established Investigator Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank N. Sun, S. Hu and J. Lee for their help with functional assessments; H. Yamagishi (Keio University, Japan) for providing plasmid; A. B. Glick (Pennsylvania State University, USA) for providing dominant-negative TGFBRII overexpression adeno virus; B. Huber, B. Patlolla and G. Berry for their help with analysing the in vivo study. We are grateful for the support provided by the Neuroscience Microscopy Service (NMS), and FACS Core at the Institute for Stem Cell Biology and Regenerative Medicine, Stanford University. This work is supported by the Uehara Memorial Foundation Research Fellowship, American Heart Association Postdoctoral Fellowship 15POST25160016 (K.K.), American Heart Association Postdoctoral Fellowship 15POST22940013 and NIH K99HL130416 (S.-G.O.), The Ministry of Education, Culture, Sports, Science and Technology in Japan (F.I.), National Institutes of Health P01 GM099130 (M.P.S.), NIH K18 HL11708301, Children's Cardiomyopathy Foundation (D.B.), AHA Established Investigator Award, NIH R01 HL113006, NIH R01 HL130020, NIH R01 126527, NIH R01 128170, NIH R01 HL123968 and NIH R24 HL117756 (J.C.W.).	Akli S, 1999, CIRC RES, V85, P319, DOI 10.1161/01.RES.85.4.319; Arndt AK, 2013, AM J HUM GENET, V93, P67, DOI 10.1016/j.ajhg.2013.05.015; Bartram U, 2001, CIRCULATION, V103, P2745; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Brooks G, 1998, CARDIOVASC RES, V39, P301, DOI 10.1016/S0008-6363(98)00125-4; Burridge PW, 2016, NAT MED, V22, P547, DOI 10.1038/nm.4087; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Chakraborty S, 2012, DEV BIOL, V363, P234, DOI 10.1016/j.ydbio.2011.12.034; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507; Churko Jared M, 2013, Methods Mol Biol, V1036, P81, DOI 10.1007/978-1-62703-511-8_7; D'Amato G, 2016, NAT CELL BIOL, V18, P7, DOI 10.1038/ncb3280; Davis J, 2016, CELL, V165, P1147, DOI 10.1016/j.cell.2016.04.002; DiMichele LA, 2009, CIRC RES, V104, P1201, DOI 10.1161/CIRCRESAHA.109.195941; ENGELMANN GL, 1992, MECH DEVELOP, V38, P85, DOI 10.1016/0925-4773(92)90001-Z; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Hammer S, 2008, J CELL BIOCHEM, V104, P1022, DOI 10.1002/jcb.21686; Hauck L, 2007, CIRC RES, V100, P50, DOI 10.1161/01.RES.0000254704.92532.b9; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Kitamura R, 2007, CIRC RES, V101, P78, DOI 10.1161/CIRCRESAHA.106.147264; Kohli SK, 2008, EUR HEART J, V29, P89, DOI 10.1093/eurheartj/ehm481; Kosaka Y, 2012, MOL CELL BIOL, V32, P5089, DOI 10.1128/MCB.00829-12; Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010; Liu CX, 2008, EUR J MED GENET, V51, P580, DOI 10.1016/j.ejmg.2008.09.001; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matsa E, 2016, PHYSIOL REV, V96, P1093, DOI 10.1152/physrev.00036.2015; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; Oechslin E, 2011, EUR HEART J, V32, P1446, DOI 10.1093/eurheartj/ehq508; Posch MG, 2010, J MED GENET, V47, P230, DOI 10.1136/jmg.2009.069997; Qian L, 2008, P NATL ACAD SCI USA, V105, P19833, DOI 10.1073/pnas.0808705105; Sakabe NJ, 2012, HUM MOL GENET, V21, P2194, DOI 10.1093/hmg/dds034; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Sen-Chowdhry S, 2008, CURR OPIN CARDIOL, V23, P171, DOI 10.1097/HCO.0b013e3282fdc939; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Takahata M, 2009, J BIOL CHEM, V284, P3334, DOI 10.1074/jbc.M808989200; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Wang YM, 2014, J AM COLL CARDIOL, V64, P451, DOI 10.1016/j.jacc.2014.04.057; Warner DR, 2007, BBA-MOL CELL RES, V1773, P814, DOI 10.1016/j.bbamcr.2007.03.016; Wu HD, 2015, CELL STEM CELL, V17, P89, DOI 10.1016/j.stem.2015.04.020	44	98	102	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2016	18	10					1031	1042		10.1038/ncb3411	http://dx.doi.org/10.1038/ncb3411			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DY2ZX	27642787	Green Accepted			2022-12-25	WOS:000384961700003
J	Bruner, KM; Murray, AJ; Pollack, RA; Soliman, MG; Laskey, SB; Capoferri, AA; Lai, J; Strain, MC; Lada, SM; Hoh, R; Ho, YC; Richman, DD; Deeks, SG; Siliciano, JD; Siliciano, RF				Bruner, Katherine M.; Murray, Alexandra J.; Pollack, Ross A.; Soliman, Mary G.; Laskey, Sarah B.; Capoferri, Adam A.; Lai, Jun; Strain, Matthew C.; Lada, Steven M.; Hoh, Rebecca; Ho, Ya-Chi; Richman, Douglas D.; Deeks, Steven G.; Siliciano, Janet D.; Siliciano, Robert F.			Defective proviruses rapidly accumulate during acute HIV-1 infection	NATURE MEDICINE			English	Article							CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; VIRUS TYPE-1 INFECTION; IN-VIVO; LATENT RESERVOIR; INTEGRATION; GENOME; RECOMBINATION; HYPERMUTATION; QUANTITATION	Although antiretroviral therapy (ART) suppresses viral replication to clinically undetectable levels, human immunodeficiency virus type 1 (HIV-1) persists in CD4(+) T cells in a latent form that is not targeted by the immune system or by ART(1-5). This latent reservoir is a major barrier to curing individuals of HIV-1 infection. Many individuals initiate ART during chronic infection, and in this setting, most proviruses are defective6. However, the dynamics of the accumulation and the persistence of defective proviruses during acute HIV-1 infection are largely unknown. Here we show that defective proviruses accumulate rapidly within the first few weeks of infection to make up over 93% of all proviruses, regardless of how early ART is initiated. By using an unbiased method to amplify near-full-length proviral genomes from HIV-1-infected adults treated at different stages of infection, we demonstrate that early initiation of ART limits the size of the reservoir but does not profoundly affect the proviral landscape. This analysis allows us to revise our understanding of the composition of proviral populations and estimate the true reservoir size in individuals who were treated early versus late in infection. Additionally, we demonstrate that common assays for measuring the reservoir do not correlate with reservoir size, as determined by the number of genetically intact proviruses. These findings reveal hurdles that must be overcome to successfully analyze future HIV-1 cure strategies.	[Bruner, Katherine M.; Murray, Alexandra J.; Pollack, Ross A.; Soliman, Mary G.; Laskey, Sarah B.; Capoferri, Adam A.; Lai, Jun; Ho, Ya-Chi; Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Capoferri, Adam A.; Siliciano, Robert F.] Howard Hughes Med Inst, Baltimore, MD 21250 USA; [Strain, Matthew C.; Richman, Douglas D.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Lada, Steven M.; Richman, Douglas D.] Vet Affairs VA San Diego Healthcare Syst, San Diego, CA USA; [Hoh, Rebecca; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA	Johns Hopkins University; Howard Hughes Medical Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Francisco; University of California System; University of California San Diego	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Siliciano, RF (corresponding author), Howard Hughes Med Inst, Baltimore, MD 21250 USA.	rsiliciano@jhmi.edu	Capoferri, Adam/AAM-9484-2021; Bruner, Katherine/AAN-7693-2021	Bender, Alexandra/0000-0002-6980-3878; Deeks, Steven/0000-0001-6371-747X; Ho, Ya-Chi/0000-0002-7046-0147	Genomics and Sequencing Core at the UCSD Center for AIDS Research [P30AI036214]; Pendleton Charitable Trust; VA San Diego Healthcare System; Veterans Medical Research Foundation; Martin Delaney CARE and DARE Collaboratories (US National Institutes of Health (NIH)) [AI096113, 1U19AI096109]; ARCHE Collaborative Research Grant from the Foundation for AIDS Research [amFAR 108165-50-RGRL]; Johns Hopkins Center for AIDS Research [P30AI094189]; NIH [43222, R21AI113147-02]; Howard Hughes Medical Institute; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, P30AI036214, R01AI043222, R33AI104283, R21AI113147, U19AI096113, U19AI096109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752, T32GM007309] Funding Source: NIH RePORTER	Genomics and Sequencing Core at the UCSD Center for AIDS Research; Pendleton Charitable Trust; VA San Diego Healthcare System(US Department of Veterans Affairs); Veterans Medical Research Foundation; Martin Delaney CARE and DARE Collaboratories (US National Institutes of Health (NIH)); ARCHE Collaborative Research Grant from the Foundation for AIDS Research; Johns Hopkins Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the study participants who have made this research possible. We also thank G. Laird for critical advice and discussion, L. Alston, H. McHugh and D. Xu for assistance with study participants, V. Walker-Sperling for providing the Ba-L virus, C. Pohlmeyer for providing a sample from a viremic subject, and all of the members of the Siliciano laboratory for valuable discussion and advice. This work was supported by the Genomics and Sequencing Core at the UCSD Center for AIDS Research (P30AI036214 (D.D.R.)), the Pendleton Charitable Trust (D.D.R.), the VA San Diego Healthcare System (D.D.R.), the Veterans Medical Research Foundation (D.D.R.), the Martin Delaney CARE and DARE Collaboratories (US National Institutes of Health (NIH) grants AI096113 (M.C.S., D.D.R. and R.F.S.) and 1U19AI096109 (S.G.D. and R.F.S.)), an ARCHE Collaborative Research Grant from the Foundation for AIDS Research (amFAR 108165-50-RGRL (R.F.S.)), the Johns Hopkins Center for AIDS Research grant P30AI094189 (R.F.S.), the NIH grants 43222 (R.F.S.) and R21AI113147-02 (J.D.S.), the Howard Hughes Medical Institute (R.F.S.), and the Bill and Melinda Gates Foundation (R.F.S.).	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Bosque A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002288; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Delviks-Frankenberry K, 2011, VIRUSES-BASEL, V3, P1650, DOI 10.3390/v3091650; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Harper MS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005254; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hwang CK, 2001, P NATL ACAD SCI USA, V98, P12209, DOI 10.1073/pnas.221289898; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Kearney MF, 2016, J VIROL, V90, P1369, DOI 10.1128/JVI.02139-15; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Kim M, 2014, NAT PROTOC, V9, P2755, DOI 10.1038/nprot.2014.188; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Massanella M., 2015, BIO-PROTOCOL, V5, pe1492; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Rosenbloom DIS, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv123; Rouzioux C, 2014, METHODS MOL BIOL, V1087, P261, DOI 10.1007/978-1-62703-670-2_21; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yu H, 1998, J BIOL CHEM, V273, P28384, DOI 10.1074/jbc.273.43.28384; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	43	419	422	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1043	+		10.1038/nm.4156	http://dx.doi.org/10.1038/nm.4156			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27500724	Green Accepted			2022-12-25	WOS:000382542800015
J	Lesch, BJ; Silber, SJ; McCarrey, JR; Page, DC				Lesch, Bluma J.; Silber, Sherman J.; McCarrey, John R.; Page, David C.			Parallel evolution of male germline epigenetic poising and somatic development in animals	NATURE GENETICS			English	Article							GENE REGULATORY NETWORKS; EMBRYONIC STEM-CELLS; NK HOMEOBOX GENES; RNA-SEQ; TRANSCRIPTION FACTORS; EXPRESSION PATTERNS; CHROMATIN-STRUCTURE; POSITIVE SELECTION; MOUSE SPERMATOZOA; CEREBRAL-CORTEX	Changes in gene regulation frequently underlie changes in morphology during evolution, and differences in chromatin state have been linked with changes in anatomical structure and gene expression across evolutionary time. Here we assess the relationship between evolution of chromatin state in germ cells and evolution of gene regulatory programs governing somatic development. We examined the poised ( H3K4me3/H3K27me3 bivalent) epigenetic state in male germ cells from five mammalian and one avian species. We find that core genes poised in germ cells from multiple amniote species are ancient regulators of morphogenesis that sit at the top of transcriptional hierarchies controlling somatic tissue development, whereas genes that gain poising in germ cells from individual species act downstream of core poised genes during development in a species-specific fashion. We propose that critical regulators of animal development gained an epigenetically privileged state in germ cells, manifested in amniotes by H3K4me3/H3K27me3 poising, early in metazoan evolution.	[Lesch, Bluma J.; Page, David C.] Whitehead Inst, Cambridge, MA 02142 USA; [Silber, Sherman J.] St Lukes Hosp, Infertil Ctr St Louis, St Louis, MO USA; [McCarrey, John R.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Page, David C.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Page, David C.] Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Saint Luke's Hospital - Missouri; University of Texas System; University of Texas at San Antonio (UTSA); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Page, DC (corresponding author), Whitehead Inst, Cambridge, MA 02142 USA.; Page, DC (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Page, DC (corresponding author), Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu		/0000-0001-9920-3411	HHMI award; Hope Funds for Cancer Research postdoctoral fellowship; Burroughs-Wellcome Career Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER	HHMI award; Hope Funds for Cancer Research postdoctoral fellowship; Burroughs-Wellcome Career Award(Burroughs Wellcome Fund); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Skaletsky for statistical advice and analysis; R. Young for advice on ChIP-seq analysis and critical reading of the manuscript; and P. Reddien for critical reading of the manuscript. This project was funded by an HHMI award to D.C.P., by a Hope Funds for Cancer Research postdoctoral fellowship to B.J.L., and by a Burroughs-Wellcome Career Award to B.J.L.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arda HE, 2013, DEV CELL, V25, P5, DOI 10.1016/j.devcel.2013.03.016; Arendt D, 1999, DEVELOPMENT, V126, P2309; Arico JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001391; Arthur RK, 2014, GENOME RES, V24, P1115, DOI 10.1101/gr.162008.113; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Barrow KM, 2005, DEV DYNAM, V233, P1535, DOI 10.1002/dvdy.20482; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Bult CJ, 2016, NUCLEIC ACIDS RES, V44, pD840, DOI 10.1093/nar/gkv1211; Caceres M, 2007, CEREB CORTEX, V17, P2312, DOI 10.1093/cercor/bhl140; Capra JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0025; Chan J, 2001, MOL CARCINOGEN, V31, P16, DOI 10.1002/mc.1033; Chen CY, 2002, NEUROSCI LETT, V319, P67, DOI 10.1016/S0304-3940(01)02555-1; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Das R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-685; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; El-Sharnouby S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003842; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fortunato S, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-14; Fortunato SAV, 2014, NATURE, V514, P620, DOI 10.1038/nature13881; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Hou ZC, 2012, GENOME BIOL EVOL, V4, P713, DOI 10.1093/gbe/evs045; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Ihara M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004317; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Krol AJ, 2011, DEVELOPMENT, V138, P2783, DOI 10.1242/dev.063834; Kurimoto K, 2015, CELL STEM CELL, V16, P517, DOI 10.1016/j.stem.2015.03.002; LAM DMK, 1970, P NATL ACAD SCI USA, V65, P192, DOI 10.1073/pnas.65.1.192; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Lesch BJ, 2014, DEVELOPMENT, V141, P3619, DOI 10.1242/dev.113027; Lesch BJ, 2013, P NATL ACAD SCI USA, V110, P16061, DOI 10.1073/pnas.1315204110; Liu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21198; Liu Y, 2011, NUCLEIC ACIDS RES, V39, P1408, DOI 10.1093/nar/gkq956; Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08084; LONGO FJ, 1990, BIOL REPROD, V42, P553, DOI 10.1095/biolreprod42.3.553; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McGhee SA, 2010, DIS MARKERS, V29, P151, DOI [10.1155/2010/397291, 10.3233/DMA-2010-0740]; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitra A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-557; Noordermeer D, 2014, ELIFE, V3, DOI 10.7554/eLife.02557; Oberdick J., 2013, HDB CEREBELLUM CEREB, P127; OLIVA R, 1988, DEV BIOL, V125, P332, DOI 10.1016/0012-1606(88)90216-3; Olivieri G, 1999, J HISTOCHEM CYTOCHEM, V47, P855, DOI 10.1177/002215549904700702; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Ozawa M, 2012, BMC DEV BIOL, V12, P1, DOI 10.1186/1471-213X-12-33; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036; Rebollo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044253; Reilly SK, 2015, SCIENCE, V347, P1155, DOI 10.1126/science.1260943; Richardson L, 2014, NUCLEIC ACIDS RES, V42, pD835, DOI 10.1093/nar/gkt1155; Sachs M, 2013, CELL REP, V3, P1777, DOI 10.1016/j.celrep.2013.04.032; Saudemont A, 2008, DEV BIOL, V317, P430, DOI 10.1016/j.ydbio.2008.02.013; Sheng GJ, 2012, ANN NY ACAD SCI, V1271, P97, DOI 10.1111/j.1749-6632.2012.06726.x; SHEPHERD RW, 1981, GAMETE RES, V4, P487, DOI 10.1002/mrd.1120040602; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Siklenka K, 2015, SCIENCE, V350, DOI 10.1126/science.aab2006; Smith CM, 2014, NUCLEIC ACIDS RES, V42, pD818, DOI 10.1093/nar/gkt954; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van de Leemput J, 2014, NEURON, V83, P51, DOI 10.1016/j.neuron.2014.05.013; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730	89	60	61	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					888	+		10.1038/ng.3591	http://dx.doi.org/10.1038/ng.3591			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27294618	Green Submitted			2022-12-25	WOS:000380755100012
J	Theurl, I; Hilgendorf, I; Nairz, M; Tymoszuk, P; Haschka, D; Asshoff, M; He, S; Gerhardt, LMS; Holderried, TAW; Seifert, M; Sopper, S; Fenn, AM; Anzai, A; Rattik, S; McAlpine, C; Theurl, M; Wieghofer, P; Iwamoto, Y; Weber, GF; Harder, NK; Chousterman, BG; Arvedson, TL; McKee, M; Wang, FD; Lutz, OMD; Rezoagli, E; Babitt, JL; Berra, L; Prinz, M; Nahrendorf, M; Weiss, G; Weissleder, R; Lin, HY; Swirski, FK				Theurl, Igor; Hilgendorf, Ingo; Nairz, Manfred; Tymoszuk, Piotr; Haschka, David; Asshoff, Malte; He, Shun; Gerhardt, Louisa M. S.; Holderried, Tobias A. W.; Seifert, Markus; Sopper, Sieghart; Fenn, Ashley M.; Anzai, Atsushi; Rattik, Sara; McAlpine, Cameron; Theurl, Milan; Wieghofer, Peter; Iwamoto, Yoshiko; Weber, Georg F.; Harder, Nina K.; Chousterman, Benjamin G.; Arvedson, Tara L.; McKee, Mary; Wang, Fudi; Lutz, Oliver M. D.; Rezoagli, Emanuele; Babitt, Jodie L.; Berra, Lorenzo; Prinz, Marco; Nahrendorf, Matthias; Weiss, Guenter; Weissleder, Ralph; Lin, Herbert Y.; Swirski, Filip K.			On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver	NATURE MEDICINE			English	Article							RED-BLOOD-CELLS; MOUSE MODEL; SPI-C; HOMEOSTASIS; HEPCIDIN; ANEMIA; FERROPORTIN; DEFICIENCY; MONOCYTES; STORAGE	Iron is an essential component of the erythrocyte protein hemoglobin and is crucial to oxygen transport in vertebrates. In the steady state, erythrocyte production is in equilibrium with erythrocyte removal(1). In various pathophysiological conditions, however, erythrocyte life span is compromised severely, which threatens the organism with anemia and iron toxicity(2,3). Here we identify an on-demand mechanism that clears erythrocytes and recycles iron. We show that monocytes that express high levels of lymphocyte antigen 6 complex, locus C1 (LY6C1, also known as Ly-6C) ingest stressed and senescent erythrocytes, accumulate in the liver via coordinated chemotactic cues, and differentiate into ferroportin 1 (FPN1, encoded by SLC40A1)-expressing macrophages that can deliver iron to hepatocytes. Monocyte-derived FPN(1+)Tim-4(neg) macrophages are transient, reside alongside embryonically derived T cell immunoglobulin and mucin domain containing 4 (Timd4, also known as Tim-4)(high) Kupffer cells (KCs), and depend on the growth factor Csf1 and the transcription factor Nrf2 (encoded by Nfe2/2). The spleen, likewise, recruits iron-loaded Ly-6C(high) monocytes, but these do not differentiate into iron-recycling macrophages, owing to the suppressive action of Csf2. The accumulation of a transient macrophage population in the liver also occurs in mouse models of hemolytic anemia, anemia of inflammation, and sickle cell disease. Inhibition of monocyte recruitment to the liver during stressed erythrocyte delivery leads to kidney and liver damage. These observations identify the liver as the primary organ that supports rapid erythrocyte removal and iron recycling, and uncover a mechanism by which the body adapts to fluctuations in erythrocyte integrity.	[Theurl, Igor; Hilgendorf, Ingo; Nairz, Manfred; He, Shun; Gerhardt, Louisa M. S.; Fenn, Ashley M.; Anzai, Atsushi; Rattik, Sara; McAlpine, Cameron; Iwamoto, Yoshiko; Weber, Georg F.; Harder, Nina K.; Chousterman, Benjamin G.; McKee, Mary; Babitt, Jodie L.; Nahrendorf, Matthias; Weissleder, Ralph; Lin, Herbert Y.; Swirski, Filip K.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Theurl, Igor; Hilgendorf, Ingo; Nairz, Manfred; He, Shun; Gerhardt, Louisa M. S.; Fenn, Ashley M.; Anzai, Atsushi; Rattik, Sara; McAlpine, Cameron; Iwamoto, Yoshiko; Weber, Georg F.; Harder, Nina K.; Chousterman, Benjamin G.; McKee, Mary; Rezoagli, Emanuele; Babitt, Jodie L.; Berra, Lorenzo; Nahrendorf, Matthias; Weissleder, Ralph; Lin, Herbert Y.; Swirski, Filip K.] Harvard Med Sch, Boston, MA 02115 USA; [Theurl, Igor; Hilgendorf, Ingo; Nairz, Manfred; He, Shun; Gerhardt, Louisa M. S.; Fenn, Ashley M.; Anzai, Atsushi; Rattik, Sara; McAlpine, Cameron; Iwamoto, Yoshiko; Weber, Georg F.; Harder, Nina K.; Chousterman, Benjamin G.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Theurl, Igor; Tymoszuk, Piotr; Haschka, David; Asshoff, Malte; Seifert, Markus; Weiss, Guenter] Med Univ Innsbruck, Dept Internal Med 6, Infect Dis, Immunol,Rheumatol,Pneumol, Innsbruck, Austria; [Hilgendorf, Ingo] Univ Freiburg, Heart Ctr Freiburg, Freiburg, Germany; [Holderried, Tobias A. W.] Univ Hosp Bonn, Dept Internal Med Oncol Hematol & Rheumatol 3, Bonn, Germany; [Sopper, Sieghart] Med Univ Innsbruck, Dept Internal Med 5, Innsbruck, Austria; [Theurl, Milan] Med Univ Innsbruck, Dept Ophthalmol & Optometry, Innsbruck, Austria; [Wieghofer, Peter; Prinz, Marco] Univ Freiburg, Med Ctr, Inst Neuropathol, Freiburg, Germany; [Wieghofer, Peter] Univ Freiburg, Fac Biol, Freiburg, Germany; [Arvedson, Tara L.] Amgen Inc, Dept Oncol, Thousand Oaks, CA 91320 USA; [McKee, Mary; Babitt, Jodie L.; Lin, Herbert Y.] Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Boston, MA 02114 USA; [Wang, Fudi] Zhejiang Univ, Inst Nutr & Food Safety, Nutr Discovery Innovat Ctr, Dept Nutr,Sch Publ Hlth,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Lutz, Oliver M. D.] Austrian Drug Screening Inst, Innsbruck, Austria; [Rezoagli, Emanuele; Berra, Lorenzo] Massachusetts Gen Hosp, Dept Anaesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Weissleder, Ralph] Harvard Med Sch, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Medical University of Innsbruck; Universitats Herzzentrum Freiburg; University of Freiburg; University of Bonn; Medical University of Innsbruck; Medical University of Innsbruck; University of Freiburg; University of Freiburg; Amgen; Harvard University; Massachusetts General Hospital; Zhejiang University; Harvard University; Massachusetts General Hospital; University of Freiburg; Harvard University; Harvard Medical School	Lin, HY; Swirski, FK (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.; Lin, HY; Swirski, FK (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Swirski, FK (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.; Lin, HY (corresponding author), Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Boston, MA 02114 USA.	Lin.Herbert@mgh.harvard.edu; fswirski@mgh.harvard.edu	Mckee, Martin/E-6673-2018; Wieghofer, Peter/AAV-9572-2020; Swirski, Filip/AAF-1340-2019; Wang, Fudi/L-7888-2018; Hilgendorf, Ingo/AFM-6379-2022; Sopper, Sieghart/I-3155-2018; McKee, Marc D/E-2187-2011; Holderried, Tobias/ABG-1525-2020	Mckee, Martin/0000-0002-0121-9683; Wang, Fudi/0000-0001-8730-0003; Hilgendorf, Ingo/0000-0002-0024-1643; Sopper, Sieghart/0000-0003-2265-1974; McKee, Marc D/0000-0001-8349-965X; Holderried, Tobias/0000-0002-2474-523X; Chousterman, Benjamin Glenn/0000-0002-9592-7014; Rezoagli, Emanuele/0000-0002-4506-7212; Nairz, Manfred/0000-0001-9103-7041; Weiss, Guenter/0000-0003-0709-2158; /0000-0003-0828-4143; Theurl, Igor/0000-0003-3180-4784; Swirski, Filip/0000-0002-3163-9152; McAlpine, Cameron/0000-0002-9832-6345; Tymoszuk, Piotr/0000-0002-0398-6034	US National Institutes of Health (NIH) [1R01HL095612, R01HL128264, R56AI104695]; Massachusetts General Hospital's Howard M. Goodman Fellowship [R01DK071837]; Max Kade Foundation; Austrian Science Fund (FWF) [P28302-B30, P24749-B13, HI 1573/1-1, HI 1573/2-1]; German Research Foundation; FWF Erwin Schroedinger Fellowship [J3486-B13]; Boehringer Ingelheim Fonds; National Natural Science Foundation of China [31530034, 31225013]; Austrian Science Fund (FWF) [J 3486, P 24749] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128264, R01HL095612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI104695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087727, R01DK071837] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital's Howard M. Goodman Fellowship; Max Kade Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); German Research Foundation(German Research Foundation (DFG)); FWF Erwin Schroedinger Fellowship; Boehringer Ingelheim Fonds(Boehringer Ingelheim); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by US National Institutes of Health (NIH) grants 1R01HL095612, R01HL128264, R56AI104695 and the Massachusetts General Hospital's Howard M. Goodman Fellowship (to F.K.S.) and R01DK071837 (to H.Y.L.). I.T. was supported by the Max Kade Foundation and grants by the Austrian Science Fund (FWF) (P28302-B30 and P24749-B13)). I.H. (HI 1573/1-1, HI 1573/2-1) and G.F.W. were supported by the German Research Foundation. M. Nairz was supported by an FWF Erwin Schroedinger Fellowship (J3486-B13). L.M.S.G. and N.K.H. were supported by the Boehringer Ingelheim Fonds. F.W. was supported by the National Natural Science Foundation of China (31530034 and 31225013). We thank D. Capen for help in electron microscopy; N. Bonheur and M. Waring for help with cell sorting; A. Lindau for technical assistance; C. Haerdtner, J. Kornemann, and J. Zou for help with flow cytometry; D. Brown for interpretation of electron microscopy images; C. Robbins for the mouse drawing; and K. Joyes for editing the manuscript.	Boston Massachusetts USA, MASS INT MED, VVI; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Gardenghi S, 2014, BLOOD, V123, P1137, DOI 10.1182/blood-2013-08-521625; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Grundy MA, 2004, J BIOCHEM BIOPH METH, V59, P195, DOI 10.1016/j.jbbm.2004.01.001; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Higgins JM, 2010, P NATL ACAD SCI USA, V107, P20587, DOI 10.1073/pnas.1012747107; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Ludwiczek S, 2007, NAT MED, V13, P448, DOI 10.1038/nm1542; Luten M, 2008, TRANSFUSION, V48, P1478, DOI 10.1111/j.1537-2995.2008.01734.x; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; PRASAD AS, 1968, J CLIN INVEST, V47, P1415, DOI 10.1172/JCI105833; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Ross SL, 2012, CELL METAB, V15, P905, DOI 10.1016/j.cmet.2012.03.017; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Sarrazin S, 2011, SEMIN IMMUNOL, V23, P326, DOI 10.1016/j.smim.2011.08.011; Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Terpstra V, 2000, BLOOD, V95, P2157, DOI 10.1182/blood.V95.6.2157; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Theurl M, 2008, J MOL MED, V86, P825, DOI 10.1007/s00109-008-0346-y; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Weinberg ED, 2010, METALLOMICS, V2, P732, DOI 10.1039/c0mt00023j; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wilairat P, 1992, Southeast Asian J Trop Med Public Health, V23 Suppl 2, P74; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324; ZOCCHI E, 1987, BIOTECHNOL APPL BIOC, V9, P423	40	220	229	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					945	+		10.1038/nm.4146	http://dx.doi.org/10.1038/nm.4146			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27428900	Green Accepted, Green Submitted			2022-12-25	WOS:000381000200021
J	Schrul, B; Kopito, RR				Schrul, Bianca; Kopito, Ron R.			Peroxin-dependent targeting of a lipid-droplet-destined membrane protein to ER subdomains	NATURE CELL BIOLOGY			English	Article							SIGNAL RECOGNITION PARTICLE; TAIL-ANCHORED PROTEINS; ANCIENT UBIQUITOUS PROTEIN-1; ENDOPLASMIC-RETICULUM; MISLOCALIZED PROTEINS; MAMMALIAN-CELLS; QUALITY-CONTROL; INSERTION; BIOGENESIS; PEX3	Lipid droplets (LDs) are endoplasmic reticulum (ER)-derived lipid storage organelles uniquely encapsulated by phospholipid monolayers. LD membrane proteins are embedded into the monolayer in a monotopic hairpin topology and are therefore likely to have requirements for their biogenesis distinct from those inserting as bitopic and polytopic proteins into phospholipid bilayers. UBXD8 belongs to a subfamily of hairpin proteins that localize to both the ER and LDs, and are initially inserted into the cytoplasmic leaflet of the ER bilayer before partitioning to the LD monolayer. The molecular machinery responsible for inserting hairpin proteins into membranes, however, is unknown. Here, we report that newly synthesized UBXD8 is post-translationally inserted into discrete ER subdomains by a mechanism requiring cytosolic PEX19 and membrane-integrated PEX3, proteins hitherto exclusively implicated in peroxisome biogenesis. Farnesylation of PEX19 uncouples ER/LD and peroxisome targeting, expanding the function of this peroxin to an ER-targeting pathway and suggesting a coordinated biogenesis of LDs and peroxisomes.	[Schrul, Bianca; Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Kopito, RR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	kopito@stanford.edu			National Institutes of Health [GM074874]; Shared Instrumentation Grants (SIG) [1S10OD01227601, 1S10RR02678001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shared Instrumentation Grants (SIG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Elias and F. McAllister for protein identification by mass spectrometry, J. Perrino for gold enhancement, embedding and sectioning of the electron microscopy samples, and J. Mulholland for help with structured illumination microscopy. We are grateful to B. Dobberstein (ZMBH, University of Heidelberg, Germany), F. Vilardi (Institute of Molecular Biology, University of Gottingen, Gottingen, Germany), V. Favaloro (Department of Biology, Howard Hughes Medical Institute, Stanford University, Stanford, USA), S. High (Faculty of Life Sciences, University of Manchester, Manchester, UK) and G. Dodt (Interfaculty Institute of Biochemistry, University of Tubingen, Tubingen, Germany) for generously sharing valuable reagents, to S. B. Yamada for technical help, to M. Nachury for access to his fluorescence microscope, and to D. Mick and M. Pearce for critical reading of the manuscript. This work was supported by a National Institutes of Health grant GM074874 to R.R.K. and, in part, by the Shared Instrumentation Grants (SIG) 1S10OD01227601 and 1S10RR02678001.	Agrawal G, 2016, J CELL BIOL, V212, P335, DOI 10.1083/jcb.201506141; Agrawal G, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00286; Aranovich A, 2014, J CELL SCI, V127, P3675, DOI 10.1242/jcs.146282; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; Geuze HJ, 2003, MOL BIOL CELL, V14, P2900, DOI 10.1091/mbc.E02-11-0734; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; Hajra AK, 1996, ANN NY ACAD SCI, V804, P129, DOI 10.1111/j.1749-6632.1996.tb18613.x; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kim PK, 2015, J MOL BIOL, V427, P1176, DOI 10.1016/j.jmb.2015.02.005; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Klemm EJ, 2011, J BIOL CHEM, V286, P37602, DOI 10.1074/jbc.M111.284794; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lee JG, 2013, BIOESSAYS, V35, P377, DOI 10.1002/bies.201200159; Lee JN, 2010, P NATL ACAD SCI USA, V107, P21424, DOI 10.1073/pnas.1011859107; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; LIPP J, 1986, J CELL BIOL, V102, P2169, DOI 10.1083/jcb.102.6.2169; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mayerhofer PU, 2016, TRAFFIC, V17, P117, DOI 10.1111/tra.12350; MEYER DI, 1980, J CELL BIOL, V87, P503, DOI 10.1083/jcb.87.2.503; Olzmann JA, 2013, P NATL ACAD SCI USA, V110, P1345, DOI 10.1073/pnas.1213738110; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rodrigo-Brenni MC, 2014, MOL CELL, V55, P227, DOI 10.1016/j.molcel.2014.05.025; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Schmidt F, 2012, TRAFFIC, V13, P1244, DOI 10.1111/j.1600-0854.2012.01380.x; Schmidt F, 2010, J BIOL CHEM, V285, P25410, DOI 10.1074/jbc.M110.138503; Schrul B, 2010, BIOCHEM J, V427, P523, DOI 10.1042/BJ20091005; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stevanovic A, 2013, J LIPID RES, V54, P503, DOI 10.1194/jlr.M033852; Suzuki M, 2012, MOL BIOL CELL, V23, P800, DOI 10.1091/mbc.E11-11-0950; Tabak HF, 2003, TRAFFIC, V4, P512, DOI 10.1034/j.1600-0854.2003.00110.x; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Toro A, 2007, BIOL RES, V40, P231, DOI 10.4067/S0716-97602007000200014; Vastiau IMK, 2006, CELL MOL LIFE SCI, V63, P1686, DOI 10.1007/s00018-006-6110-y; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700	48	68	68	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2016	18	7					740	+		10.1038/ncb3373	http://dx.doi.org/10.1038/ncb3373			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DP9TS	27295553	Green Accepted			2022-12-25	WOS:000378840900007
J	Hakulinen, JK; Hering, J; Branden, G; Chen, HM; Snijder, A; Ek, M; Johansson, P				Hakulinen, Jonna K.; Hering, Jenny; Branden, Gisela; Chen, Hongming; Snijder, Arjan; Ek, Margareta; Johansson, Patrik			MraY-antibiotic complex reveals details of tunicamycin mode of action	NATURE CHEMICAL BIOLOGY			English	Article							1-PHOSPHATE TRANSFERASE SUPERFAMILY; CELL-WALL SYNTHESIS; PENTAPEPTIDE TRANSLOCASE; ESCHERICHIA-COLI; HIGH-THROUGHPUT; PHOSPHATE; BIOSYNTHESIS; DENSITY; INHIBITION; FAMILY	The rapid increase of antibiotic resistance has created an urgent need to develop novel antimicrobial agents. Here we describe the crystal structure of the promising bacterial target phospho-N-acetylmuramoyl- pentapeptide translocase (MraY) in complex with the nucleoside antibiotic tunicamycin. The structure not only reveals the mode of action of several related natural-product antibiotics but also gives an indication on the binding mode of the MraY UDP-MurNAc-pentapeptide and undecaprenyl-phosphate substrates.	[Hakulinen, Jonna K.; Hering, Jenny; Chen, Hongming; Snijder, Arjan; Ek, Margareta; Johansson, Patrik] AstraZeneca R&D Gothenburg, Discovery Sci Innovat Med & Early Dev Biotech Uni, Gothenburg, Sweden; [Hering, Jenny; Branden, Gisela] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Hakulinen, Jonna K.] MRC, Div Struct Studies, Mol Biol Lab, Cambridge, England	AstraZeneca; University of Gothenburg; MRC Laboratory Molecular Biology	Ek, M; Johansson, P (corresponding author), AstraZeneca R&D Gothenburg, Discovery Sci Innovat Med & Early Dev Biotech Uni, Gothenburg, Sweden.	margareta.e.ek@astrazeneca.com; patrik.johansson@astrazeneca.com		Ek, Margareta/0000-0001-8226-8112; Snijder, Arjan/0000-0003-2829-3098; Branden, Gisela/0000-0001-5615-7187	European Union [317079, 637295]	European Union(European Commission)	We thank A. Shapiro and J. Bernstrom for assistance with activity measurements, beamline scientists at ESRF (Grenoble, France) and Diamond Light Source (Didcot, UK) for assistance during data collection, and members of Global Phasing Ltd. for help with STARANISO. We are also grateful to I. Moraes at the Membrane Protein Laboratory, Diamond for providing beamtime and assistance. This work was supported by the European Union under the programme FP7-PEOPLE-2011-ITN NanoMem, project number 317079 (M.E.) and the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie agreement No 637295, X-probe (M.E.).	Al-Dabbagh B, 2008, BIOCHEMISTRY-US, V47, P8919, DOI 10.1021/bi8006274; Al-Dabbagh B, 2016, BIOCHIMIE, V127, P249, DOI 10.1016/j.biochi.2016.06.005; ANDERSON JS, 1965, P NATL ACAD SCI USA, V53, P881, DOI 10.1073/pnas.53.4.881; Anderson MS, 2000, FEMS MICROBIOL LETT, V191, P169, DOI 10.1111/j.1574-6968.2000.tb09335.x; Backmark AE, 2013, PROTEIN SCI, V22, P1124, DOI 10.1002/pro.2297; Bowler MW, 2010, ACTA CRYSTALLOGR D, V66, P855, DOI 10.1107/S0907444910019591; Boyle DS, 1998, J BACTERIOL, V180, P6429; Brandish PE, 1996, ANTIMICROB AGENTS CH, V40, P1640, DOI 10.1128/AAC.40.7.1640; Chung BC, 2016, NATURE, V533, P557, DOI 10.1038/nature17636; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; COWTAN KD, 2001, INT TABLES CRYSTALLO; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dini C, 2005, CURR TOP MED CHEM, V5, P1221, DOI 10.2174/156802605774463042; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gasteiger J., 1990, TETRAHEDRON COMPUT M, V3, P537, DOI DOI 10.1016/0898-5529(90)90156-3; HEIFETZ A, 1977, J BIOL CHEM, V252, P3057; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KELLER RK, 1979, J BIOL CHEM, V254, P9966; LEHRMAN M A, 1991, Glycobiology, V1, P553, DOI 10.1093/glycob/1.6.553; LEHRMAN MA, 1994, GLYCOBIOLOGY, V4, P768, DOI 10.1093/glycob/4.6.768; Li JK, 2015, ANGEW CHEM INT EDIT, V54, P6618, DOI 10.1002/anie.201501890; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MYERS AG, 1994, J AM CHEM SOC, V116, P4697, DOI 10.1021/ja00090a018; SCHWARZ RT, 1980, TRENDS BIOCHEM SCI, V5, P65, DOI 10.1016/0968-0004(80)90070-5; Shapiro AB, 2012, J BIOMOL SCREEN, V17, P662, DOI 10.1177/1087057112436885; STRUVE WG, 1965, BIOCHEM BIOPH RES CO, V18, P6, DOI 10.1016/0006-291X(65)90873-9; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUAMI T, 1985, CARBOHYD RES, V143, P85, DOI 10.1016/S0008-6215(00)90698-0; TAMURA G, 1976, AGR BIOL CHEM TOKYO, V40, P447, DOI 10.1080/00021369.1976.10862071; TKACZ JS, 1975, BIOCHEM BIOPH RES CO, V65, P248, DOI 10.1016/S0006-291X(75)80086-6; Wyszynski FJ, 2012, NAT CHEM, V4, P539, DOI [10.1038/NCHEM.1351, 10.1038/nchem.1351]	33	65	65	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2017	13	3					265	+		10.1038/NCHEMBIO.2270	http://dx.doi.org/10.1038/NCHEMBIO.2270			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL2DY	28068312	Green Published			2022-12-25	WOS:000394431500007
J	Liley, J; Todd, JA; Wallace, C				Liley, James; Todd, John A.; Wallace, Chris			A method for identifying genetic heterogeneity within phenotypically defined disease subgroups	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ONSET; RISK; AGE; POPULATION; LOCI	Many common diseases show wide phenotypic variation. We present a statistical method for determining whether phenotypically defined subgroups of disease cases represent different genetic architectures, in which disease-associated variants have different effect sizes in two subgroups. Our method models the genome-wide distributions of genetic association statistics with mixture Gaussians. We apply a global test without requiring explicit identification of disease associated variants, thus maximizing power in comparison to standard variant-by-variant subgroup analysis. Where evidence for genetic subgrouping is found, we present methods for post hoc identification of the contributing genetic variants. We demonstrate the method on a range of simulated and test data sets, for which expected results are already known. We investigate subgroups of individuals with type 1 diabetes (T1D) defined by autoantibody positivity, establishing evidence for differential genetic architecture with positivity for thyroidperoxidase-specific antibody, driven generally by variants in known T1 D-associated genomic regions.	[Liley, James; Todd, John A.; Wallace, Chris] Univ Cambridge, JDRF Wellcome Trust Diabet & Inflammat Lab, NIHR Cambridge Biomed Res Ctr, Cambridge Inst Med Res,Dept Med Genet, Cambridge, England; [Liley, James; Wallace, Chris] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge, England; [Todd, John A.] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Wallace, Chris] Univ Forvie Site, Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; MRC Biostatistics Unit; University of Cambridge	Liley, J; Wallace, C (corresponding author), Univ Cambridge, JDRF Wellcome Trust Diabet & Inflammat Lab, NIHR Cambridge Biomed Res Ctr, Cambridge Inst Med Res,Dept Med Genet, Cambridge, England.; Liley, J; Wallace, C (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge, England.; Wallace, C (corresponding author), Univ Forvie Site, Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England.	ajl88@cam.ac.uk; cew54@cam.ac.uk	Liley, James/GSD-4767-2022; Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Wallace, Chris/0000-0001-9755-1703	Wellcome Trust [107212, 089989, 107881, 100140]; JDRF [5-SRA-2015-130-A-N]; NIHR Cambridge Biomedical Research Centre; European Union [241447]; MRC [MC_UP_1302/5]; Medical Research Council [MC_UP_1302/5, MC_UU_00002/4, MR/N01104X/1, G1001799] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10143] Funding Source: researchfish; MRC [MC_UU_00002/4, MR/N01104X/1, G1001799] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); JDRF(Juvenile Diabetes Research Foundation); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge the help of the Diabetes and Inflammation Laboratory Data Service for access and quality control procedures on the data sets used in this study. The JDRF/Wellcome Trust Diabetes and Inflammation Laboratory is in receipt of a Wellcome Trust Strategic Award (107212; J.A.T.) and receives funding from the JDRF (grant 5-SRA-2015-130-A-N; J.A.T.) and the NIHR Cambridge Biomedical Research Centre. The research leading to these results has received funding from the European Union's Seventh Framework Programme (grant FP7/2007-2013; J.A.T.) under grant agreement 241447 (NAIMIT). J.L. is funded by the NIHR Cambridge Biomedical Research Centre and is on the Wellcome Trust PhD program in Mathematical Genomics and Medicine at the University of Cambridge. C.W. is funded by the Wellcome Trust (grants 089989 and 107881) and the MRC (grant MC_UP_1302/5). The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (100140). We thank M. Simmonds, S. Gough, J. Franklyn, and O. Brand for sharing their AITD genetic association data set and all patients with AITD and control subjects for participating in this study. The AITD UK national collection was funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003455; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chatterjee N, 2005, BIOMETRIKA, V92, P399, DOI 10.1093/biomet/92.2.399; Chen HF, 2001, J ROY STAT SOC B, V63, P19, DOI 10.1111/1467-9868.00273; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; Howson JMM, 2009, GENES IMMUN, V10, pS74, DOI 10.1038/gene.2009.96; Howson JMM, 2012, DIABETES, V61, P3012, DOI 10.2337/db11-1694; Howson JMM, 2011, DIABETES, V60, P2645, DOI 10.2337/db11-0364; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Leslie S, 2015, NATURE, V519, P309, DOI 10.1038/nature14230; Li L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9364; Liley J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004926; Morris AP, 2010, GENET EPIDEMIOL, V34, P335, DOI 10.1002/gepi.20486; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Traylor M, 2013, GENET EPIDEMIOL, V37, P495, DOI 10.1002/gepi.21729; Wen YL, 2013, GENET EPIDEMIOL, V37, P715, DOI 10.1002/gepi.21751	20	14	14	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					310	316		10.1038/ng.3751	http://dx.doi.org/10.1038/ng.3751			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	28024155	Green Submitted, Green Accepted			2022-12-25	WOS:000393148600022
J	Liu, MY; Torabifard, H; Crawford, DJ; DeNizio, JE; Cao, XJ; Garcia, BA; Cisneros, GA; Kohli, RM				Liu, Monica Yun; Torabifard, Hedieh; Crawford, Daniel J.; DeNizio, Jamie E.; Cao, Xing-Jun; Garcia, Benjamin A.; Cisneros, G. Andres; Kohli, Rahul M.			Mutations along a TET2 active site scaffold stall oxidation at 5-hydroxymethylcytosine	NATURE CHEMICAL BIOLOGY			English	Article							INITIO QM/MM CALCULATIONS; STABLE DNA MODIFICATION; SUBSTRATE PREFERENCE; MAMMALIAN DNA; DEMETHYLATION; 5-FORMYLCYTOSINE; PROTEINS; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; TDG	Ten-eleven translocation (TET) enzymes catalyze stepwise oxidation of 5-methylcytosine (mC) to yield 5-hydroxymethylcytosine (hmC) and the rarer bases 5-formylcytosine (fC) and 5-carboxylcytosine (caC). Stepwise oxidation obscures how each individual base forms and functions in epigenetic regulation, and prompts the question of whether TET enzymes primarily serve to generate hmC or are adapted to produce fC and caC as well. By mutating a single, conserved active site residue in human TET2, Thr1372, we uncovered enzyme variants that permit oxidation to hmC but largely eliminate fC and caC. Biochemical analyses, combined with molecular dynamics simulations, elucidated an active site scaffold that is required for wild-type (WT) stepwise oxidation and that, when perturbed, explains the mutants' hmC-stalling phenotype. Our results suggest that the TET2 active site is shaped to enable higher-order oxidation and provide the first TET variants that could be used to probe the biological functions of hmC separately from fC and caC.	[Liu, Monica Yun; Crawford, Daniel J.; DeNizio, Jamie E.; Kohli, Rahul M.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Liu, Monica Yun; Crawford, Daniel J.; DeNizio, Jamie E.; Cao, Xing-Jun; Garcia, Benjamin A.; Kohli, Rahul M.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Torabifard, Hedieh; Cisneros, G. Andres] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Cisneros, G. Andres] Univ North Texas, Dept Chem, Denton, TX USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Wayne State University; University of North Texas System; University of North Texas Denton	Kohli, RM (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Kohli, RM (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA.; Cisneros, GA (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.; Cisneros, GA (corresponding author), Univ North Texas, Dept Chem, Denton, TX USA.	andres@unt.edu; rkohli@upenn.edu	Cisneros, G. Andres/H-5197-2017; Torabifard, Hedieh/F-3766-2017	Cisneros, G. Andres/0000-0001-6629-3430; Torabifard, Hedieh/0000-0003-0687-6858; Liu, Monica Yun/0000-0003-3936-9377; Kohli, Rahul/0000-0002-7689-5678	Rita Allen Foundation Scholar Award; NIH [R01 GM110174, R01 GM108583, F30 CA196097]; NATIONAL CANCER INSTITUTE [F30CA196097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229, R01GM108583, R01GM110174, R01GM118501] Funding Source: NIH RePORTER	Rita Allen Foundation Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Niedziolka and the Wistar Institute Protein Expression Facility for help with protein expression in Sf9 cells and all members of our labs for insightful discussions. Computing time from Wayne State C&IT and additional mass spectrometry resources from I. Blair's lab are gratefully acknowledged. This work was supported by the Rita Allen Foundation Scholar Award to R.M.K. and by NIH grants (R01 GM110174 to B.A.G., R01 GM108583 to G.A.C., and F30 CA196097 to M.Y.L.).	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Bachman M, 2015, NAT CHEM BIOL, V11, P555, DOI 10.1038/nchembio.1848; Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Bullard W, 2014, J BIOL CHEM, V289, P20273, DOI 10.1074/jbc.M114.579821; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; Crawford DJ, 2016, J AM CHEM SOC, V138, P730, DOI 10.1021/jacs.5b10554; Fang D, 2014, J CHEM THEORY COMPUT, V10, P5136, DOI 10.1021/ct500572t; Fang D, 2013, J PHYS CHEM B, V117, P6410, DOI 10.1021/jp403116e; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hashimoto H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv870; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu LL, 2015, NATURE, V527, P118, DOI 10.1038/nature15713; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Liu MY, 2016, CURR OPIN CHEM BIOL, V33, P67, DOI 10.1016/j.cbpa.2016.05.029; Lu JY, 2016, PHYS CHEM CHEM PHYS, V18, P4728, DOI 10.1039/c5cp07266b; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Scourzic L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0134-6; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Weber AR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10806; Wu H, 2015, NAT STRUCT MOL BIOL, V22, P1, DOI 10.1038/nsmb.3071; Zheng GQ, 2014, CHEM REV, V114, P4602, DOI 10.1021/cr400432d	32	41	43	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					181	187		10.1038/NCHEMBIO.2250	http://dx.doi.org/10.1038/NCHEMBIO.2250			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27918559	Green Accepted			2022-12-25	WOS:000393533000013
J	DeFrancesco, L				DeFrancesco, Laura			CAR-T's forge ahead, despite Juno deaths	NATURE BIOTECHNOLOGY			English	News Item																		2016, NAT BIOTECHNOL, V34, P793	1	22	23	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					6	7		10.1038/nbt0117-6b	http://dx.doi.org/10.1038/nbt0117-6b			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	28072774				2022-12-25	WOS:000392460800007
J	Hoffmann, TJ; Ehret, GB; Nandakumar, P; Ranatunga, D; Schaefer, C; Kwok, PY; Iribarren, C; Chakravarti, A; Risch, N				Hoffmann, Thomas J.; Ehret, Georg B.; Nandakumar, Priyanka; Ranatunga, Dilrini; Schaefer, Catherine; Kwok, Pui-Yan; Iribarren, Carlos; Chakravarti, Aravinda; Risch, Neil			Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation	NATURE GENETICS			English	Article							PULSE PRESSURE; MEAN ARTERIAL; GENETIC-LOCI; METAANALYSIS; VARIANTS; TRAITS; COMMON; INDIVIDUALS; AFRICAN; HYPERTENSION	Longitudinal electronic health records on 99,785 Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort individuals provided 1,342,814 systolic and diastolic blood pressure measurements for a genome-wide association study on long-term average systolic, diastolic, and pulse pressure. We identified 39 new loci among 75 genome-wide significant loci (P <= 5 x 10(-8)), with most replicating in the combined International Consortium for Blood Pressure (ICBP; n = 69,396) and UK Biobank (UKB; n = 152,081) studies. Combining GERA with ICBP yielded 36 additional new loci, with most replicating in UKB. Combining all three studies (n = 321,262) yielded 241 additional genome-wide significant loci, although no replication sample was available for these. All associated loci explained 2.9%, 2.5%, and 3.1 % of variation in systolic, diastolic, and pulse pressure, respectively, in GERA non-Hispanic whites. Using multiple blood pressure measurements in GERA doubled the variance explained. A normalized risk score was associated with time to onset of hypertension (hazards ratio = 1.18, P = 8.2 x 10(-45)). Expression quantitative trait locus analysis of blood pressure loci showed enrichment in aorta and tibial artery.	[Hoffmann, Thomas J.; Risch, Neil] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hoffmann, Thomas J.; Kwok, Pui-Yan; Risch, Neil] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Ehret, Georg B.; Nandakumar, Priyanka; Chakravarti, Aravinda] McKusick Nathans Inst Genet Med, Ctr Complex Dis Gen, Baltimore, MD USA; [Ehret, Georg B.] Univ Geneva, Dept Specialties Internal Med, Cardiol, Geneva, Switzerland; [Ranatunga, Dilrini; Schaefer, Catherine; Iribarren, Carlos; Risch, Neil] Kaiser Permanente Northern Calif Div Res, Oakland, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Geneva; Kaiser Permanente	Hoffmann, TJ; Risch, N (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Hoffmann, TJ; Risch, N (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.; Risch, N (corresponding author), Kaiser Permanente Northern Calif Div Res, Oakland, CA USA.	thomas.hoffmann@ucsf.edu; neil.risch@ucsf.edu	EHRET, Georg B/A-9532-2009	EHRET, Georg B/0000-0002-5730-0675	National Institute on Aging; National Institute of Mental Health; National Institute of Health Common Fund [RC2 AG036607]; National Heart, Lung, and Blood Institute [R01 HL128782]; Geneva University Hospitals; Foundation of Medical Researchers, Geneva; Medical Research Council [MC_qA137853] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036607] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Health Common Fund; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Geneva University Hospitals; Foundation of Medical Researchers, Geneva; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to the Kaiser Permanente Northern California members who have generously agreed to participate in the Kaiser Permanente Research Program on Genes, Environment, and Health. Support for participant enrollment, survey completion, and biospecimen collection for the RPGEH was provided by the Robert Wood Johnson Foundation, the Wayne and Gladys Valley Foundation, the Ellison Medical Foundation, and Kaiser Permanente Community Benefit Programs. Genotyping of the GERA cohort was funded by a grant from the National Institute on Aging, National Institute of Mental Health, and National Institute of Health Common Fund (RC2 AG036607 to C.S. and N.R.). This research has been conducted using the UK Biobank Resource. This research has also been conducted using access-controlled ICBP data from dbGaP. We thank our colleagues for making these data available. Data analyses were facilitated by National Heart, Lung, and Blood Institute grant R01 HL128782 (to A.C. and N.R.). G.B.E. receives support from Geneva University Hospitals and the Foundation of Medical Researchers, Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Chen GB, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00107; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Ganesh SK, 2014, AM J HUM GENET, V95, P49, DOI 10.1016/j.ajhg.2014.06.002; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Ho JE, 2011, J HYPERTENS, V29, P62, DOI 10.1097/HJH.0b013e3283406927; Hoffmann TJ, 2011, GENOMICS, V98, P422, DOI 10.1016/j.ygeno.2011.08.007; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kelly TN, 2013, HYPERTENSION, V62, P853, DOI 10.1161/HYPERTENSIONAHA.113.01148; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; MIALL WE, 1963, BRIT MED J, P75; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Sewell K, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150348; Simino J, 2014, AM J HUM GENET, V95, P24, DOI 10.1016/j.ajhg.2014.05.010; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Tada H, 2014, CIRC-CARDIOVASC GENE, V7, P583, DOI 10.1161/CIRCGENETICS.113.000420; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; Tragante V, 2014, AM J HUM GENET, V94, P349, DOI 10.1016/j.ajhg.2013.12.016; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Zhang XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-532; Zhu XF, 2015, AM J HUM GENET, V96, P21, DOI 10.1016/j.ajhg.2014.11.011	44	171	172	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					54	64		10.1038/ng.3715	http://dx.doi.org/10.1038/ng.3715			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27841878	Green Accepted, Green Submitted			2022-12-25	WOS:000390976600011
J	Lo Sardo, V; Ferguson, W; Erikson, GA; Topol, EJ; Baldwin, KK; Torkamani, A				Lo Sardo, Valentina; Ferguson, William; Erikson, Galina A.; Topol, Eric J.; Baldwin, Kristin K.; Torkamani, Ali			Influence of donor age on induced pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							SOMATIC-CELLS; EPIGENETIC MEMORY; POINT MUTATIONS; COPY NUMBER; IPS CELLS; METHYLATION; DIFFERENTIATION; EXPRESSION; MOSAICISM; PLASMID	Induced pluripotent stem cells (iPSCs) are being pursued as a source of cells for autologous therapies, many of which will be aimed at aged patients. To explore the impact of age on iPSC quality, we produced iPSCs from blood cells of 16 donors aged 21-100. We find that iPSCs from older donors retain an epigenetic signature of age, which can be reduced through passaging. Clonal expansion via reprogramming also enables the discovery of somatic mutations present in individual donor cells, which are missed by bulk sequencing methods. We show that exomic mutations in iPSCs increase linearly with age, and all iPSC lines analyzed carry at least one gene-disrupting mutation, several of which have been associated with cancer or dysfunction. Unexpectedly, elderly donors (>90 yrs) harbor fewer mutations than predicted, likely due to a contracted blood progenitor pool. These studies establish that donor age is associated with an increased risk of abnormalities in iPSCs and will inform clinical development of reprogramming technology.	[Lo Sardo, Valentina; Ferguson, William; Baldwin, Kristin K.] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Erikson, Galina A.; Topol, Eric J.; Torkamani, Ali] Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Erikson, Galina A.; Topol, Eric J.; Torkamani, Ali] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Baldwin, KK (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	kbaldwin@scripps.edu; atorkama@scripps.edu		Lo Sardo, Valentina/0000-0003-0573-9878; Baldwin, Kristin/0000-0002-6137-030X	Scripps Translational Science Institute pilot award from Scripps Genomic Medicine [5 UL1 TR001114]; NIH-NCATS Clinical and Translational Science Award (CTSA) [5 UL1 RR025774]; NextGen Consortium [NHLBI 5 U01 HL107436, U54GM114833]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114, UL1TR000109] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107436] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM114833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP1AG055944] Funding Source: NIH RePORTER	Scripps Translational Science Institute pilot award from Scripps Genomic Medicine; NIH-NCATS Clinical and Translational Science Award (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NextGen Consortium; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by a Scripps Translational Science Institute pilot award (5 UL1 TR001114) from Scripps Genomic Medicine, a NIH-NCATS Clinical and Translational Science Award (CTSA; 5 UL1 RR025774) to STSI. Further support is provided by the NextGen Consortium NHLBI 5 U01 HL107436 to STSI and TSRI (E.J.T. and K.K.B.), and U54GM114833 to STSI (A.T.).	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Evrony GD, 2016, ELIFE, V5, DOI 10.7554/eLife.12966; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hazen JL, 2016, NEURON, V89, P1223, DOI 10.1016/j.neuron.2016.02.004; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hiler D, 2015, CELL STEM CELL, V17, P101, DOI 10.1016/j.stem.2015.05.015; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Mahmoudi S, 2012, CURR OPIN CELL BIOL, V24, P744, DOI 10.1016/j.ceb.2012.10.004; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Sugiura M, 2014, STEM CELL REP, V2, P52, DOI 10.1016/j.stemcr.2013.11.006; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002	30	112	115	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					69	74		10.1038/nbt.3749	http://dx.doi.org/10.1038/nbt.3749			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	27941802	Green Accepted			2022-12-25	WOS:000392460800024
J	Magnusdottir, S; Heinken, A; Kutt, L; Ravcheev, DA; Bauer, E; Noronha, A; Greenhalgh, K; Jager, C; Baginska, J; Wilmes, P; Fleming, RMT; Thiele, I				Magnusdottir, Stefania; Heinken, Almut; Kutt, Laura; Ravcheev, Dmitry A.; Bauer, Eugen; Noronha, Alberto; Greenhalgh, Kacy; Jager, Christian; Baginska, Joanna; Wilmes, Paul; Fleming, Ronan M. T.; Thiele, Ines			Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota	NATURE BIOTECHNOLOGY			English	Article							BUTYRATE-PRODUCING BACTERIA; CELLULAR-METABOLISM; SYSTEMS BIOLOGY; COMPETITION; ANNOTATION; PREDICTION; NETWORKS; ECOLOGY; MODELS; HEALTH	Genome-scale metabolic models derived from human gut metagenomic data can be used as a framework to elucidate how microbial communities modulate human metabolism and health. We present AGORA (assembly of gut organisms through reconstruction and analysis), a resource of genome-scale metabolic reconstructions semi-automatically generated for 773 human gut bacteria. Using this resource, we identified a defined growth medium for Bacteroides caccae ATCC 34185. We also showed that interactions among modeled species depend on both the metabolic potential of each species and the nutrients available. AGORA reconstructions can integrate either metagenomic or 16S rRNA sequencing data sets to infer the metabolic diversity of microbial communities. AGORA reconstructions could provide a starting point for the generation of high-quality, manually curated metabolic reconstructions. AGORA is fully compatible with Recon 2, a comprehensive metabolic reconstruction of human metabolism, which will facilitate studies of host-microbiome interactions.	[Magnusdottir, Stefania; Heinken, Almut; Kutt, Laura; Ravcheev, Dmitry A.; Bauer, Eugen; Noronha, Alberto; Greenhalgh, Kacy; Jager, Christian; Baginska, Joanna; Wilmes, Paul; Fleming, Ronan M. T.; Thiele, Ines] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg	University of Luxembourg	Thiele, I (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.	ines.thiele@uni.lu	Fleming, Ronan MT/ABC-4093-2021; Bauer, Eugen/L-1837-2019; Wilmes, Paul/B-1707-2017; Magnusdottir, Stefania/ABA-2212-2021; Thiele, Ines/A-7629-2014	Fleming, Ronan MT/0000-0001-5346-9812; Wilmes, Paul/0000-0002-6478-2924; Thiele, Ines/0000-0002-8071-7110; Heinken, Almut/0000-0001-6938-8072; Baginska, Joanna/0000-0001-5182-7575; Noronha, Alberto/0000-0002-0935-4599	Luxembourg National Research Fund (FNR) ATTRACT program grant [FNR/A12/01, FNR/A10/03]; CORE program grant [CORE/11/BM/1186762]; Proof-of-Concept grant [PoC15/11014639]; Aides a la Formation-Recherche [FNR/6951193, FNR/6783162, FNR/9964547]; FNR [6847110]; US Department of Energy, Offices of Advanced Scientific Computing Research and the Biological and Environmental Research as part of the Scientific Discovery Through Advanced Computing program [DE-SC0010429]	Luxembourg National Research Fund (FNR) ATTRACT program grant(Luxembourg National Research Fund); CORE program grant(Luxembourg National Research Fund); Proof-of-Concept grant(Luxembourg National Research Fund); Aides a la Formation-Recherche(Luxembourg National Research Fund); FNR(Luxembourg National Research Fund); US Department of Energy, Offices of Advanced Scientific Computing Research and the Biological and Environmental Research as part of the Scientific Discovery Through Advanced Computing program(United States Department of Energy (DOE))	We thank K. Hiller for valuable discussions and help with the metabolomic data generation and analysis. We thank A. Daujeumont and X. Dong for their technical assistance in the laboratory. This work was supported by the Luxembourg National Research Fund (FNR) ATTRACT program grant (FNR/A12/01 to I.T., A.H., and A.N.; FNR/A10/03 to C.J.), a CORE program grant (CORE/11/BM/1186762 to P.W.), and a Proof-of-Concept grant (PoC15/11014639 to P.W.), by grants by the Aides a la Formation-Recherche (FNR/6951193 to S.M., FNR/6783162 to E.B. and FNR/9964547 to KG.), and FNR 6847110 to DR., which was cofunded under the Marie Curie Actions of the European Commission (FP7-COFUND). R.M.T.F. was supported by the US Department of Energy, Offices of Advanced Scientific Computing Research and the Biological and Environmental Research as part of the Scientific Discovery Through Advanced Computing program, grant #DE-SC0010429.	Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Barghash A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-343; Chiu HC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003695; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Dore J, 2015, CURR OPIN BIOTECH, V32, P195, DOI 10.1016/j.copbio.2015.01.002; Duncan SH, 2003, APPL ENVIRON MICROB, V69, P1136, DOI 10.1128/AEM.69.2.1136-1142.2003; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Fleming RMT, 2016, J THEOR BIOL, V409, P1, DOI 10.1016/j.jtbi.2016.06.033; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Gelfand MS, 2008, PHYS LIFE REV, V5, P22, DOI 10.1016/j.plrev.2007.10.003; GIBBONS RJ, 1967, J BACTERIOL, V93, P510, DOI 10.1128/JB.93.1.510-512.1967; Greenblum S, 2013, CURR OPIN BIOTECH, V24, P810, DOI 10.1016/j.copbio.2013.04.001; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Grosskopf T, 2014, CURR OPIN MICROBIOL, V18, P72, DOI 10.1016/j.mib.2014.02.002; Gudmundsson S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-489; Hamilton JJ, 2014, ENVIRON MICROBIOL, V16, P49, DOI 10.1111/1462-2920.12312; Heinken A, 2015, WIRES SYST BIOL MED, V7, P195, DOI 10.1002/wsbm.1301; Heinken A, 2015, APPL ENVIRON MICROB, V81, P4049, DOI 10.1128/AEM.00101-15; Heinken A, 2014, J BACTERIOL, V196, P3289, DOI 10.1128/JB.01780-14; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Mazumdar V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077617; McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18; McNulty NP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001637; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rigottier-Gois L, 2013, ISME J, V7, P1256, DOI 10.1038/ismej.2013.80; Savijoki K, 2006, LETT APPL MICROBIOL, V42, P202, DOI 10.1111/j.1472-765X.2005.01853.x; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schmidt BJ, 2013, BIOINFORMATICS, V29, P2900, DOI 10.1093/bioinformatics/btt493; Segers ME, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S7; Shafquat A, 2014, TRENDS MICROBIOL, V22, P261, DOI 10.1016/j.tim.2014.01.011; Sridharan GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6492; Taxis TM, 2015, NUCLEIC ACIDS RES, V43, P9600, DOI 10.1093/nar/gkv973; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thorleifsson SG, 2011, BIOINFORMATICS, V27, P2009, DOI 10.1093/bioinformatics/btr308; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14	49	335	340	7	119	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					81	89		10.1038/nbt.3703	http://dx.doi.org/10.1038/nbt.3703			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	27893703	Bronze			2022-12-25	WOS:000392460800026
J	Zetsche, B; Heidenreich, M; Mohanraju, P; Fedorova, I; Kneppers, J; DeGennaro, EM; Winblad, N; Choudhury, SR; Abudayyeh, OO; Gootenberg, JS; Wu, WY; Scott, DA; Severinov, K; van der Oost, J; Zhang, F				Zetsche, Bernd; Heidenreich, Matthias; Mohanraju, Prarthana; Fedorova, Iana; Kneppers, Jeroen; DeGennaro, Ellen M.; Winblad, Nerges; Choudhury, Sourav R.; Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Wu, Wen Y.; Scott, David A.; Severinov, Konstantin; van der Oost, John; Zhang, Feng			Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; RNA; SYSTEM; VECTOR; CPF1	Targeting of multiple genomic loci with Cas9 is limited by the need for multiple or large expression constructs. Here we show that the ability of Cpfl to process its own CRISPR RNA (crRNA) can be used to simplify multiplexed genome editing. Using a single customized CRISPR array, we edit up to four genes in mammalian cells and three in the mouse brain, simultaneously.	[Zetsche, Bernd; Heidenreich, Matthias; Fedorova, Iana; Kneppers, Jeroen; DeGennaro, Ellen M.; Winblad, Nerges; Choudhury, Sourav R.; Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Scott, David A.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zetsche, Bernd; Heidenreich, Matthias; Fedorova, Iana; Winblad, Nerges; Choudhury, Sourav R.; Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Scott, David A.; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zetsche, Bernd; Heidenreich, Matthias; Fedorova, Iana; Winblad, Nerges; Choudhury, Sourav R.; Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zetsche, Bernd; Heidenreich, Matthias; Fedorova, Iana; Winblad, Nerges; Choudhury, Sourav R.; Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zetsche, Bernd] Bonn Med Sch, Inst Pathol, Dept Dev Pathol, Bonn, Germany; [Kneppers, Jeroen; Wu, Wen Y.; van der Oost, John] Wageningen Univ, Dept Agrotechnol & Food Sci, Lab Microbiol, Wageningen, Netherlands; [Fedorova, Iana; Severinov, Konstantin] Skolkovo Inst Sci & Technol, Skolkovo, Russia; [Fedorova, Iana] Peter Great St Petersburg Polytech Univ, St Petersburg, Russia; [DeGennaro, Ellen M.; Abudayyeh, Omar O.] MIT, Harvard MIT Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [van der Oost, John] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ USA; [van der Oost, John] Russian Acad Sci, Inst Mol Genet, Moscow, Russia	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Bonn; Wageningen University & Research; Skolkovo Institute of Science & Technology; Peter the Great St. Petersburg Polytechnic University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Russian Academy of Sciences	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; van der Oost, J (corresponding author), Wageningen Univ, Dept Agrotechnol & Food Sci, Lab Microbiol, Wageningen, Netherlands.	john.vanderoost@wur.nl; zhang@broadinstitute.org	Severinov, Konstantin/C-8545-2016; Abudayyeh, Omar/ABF-1746-2020; Mohanraju, Prarthana/AFK-4376-2022; Macrae, Rhiannon/AAX-1536-2020; Gootenberg, Jonathan/AAY-8174-2021; Fedorova, Iana/A-6804-2014; van+der+Oost, John/Y-2548-2019; Mohanraju, Prarthana/AAG-3127-2022	Abudayyeh, Omar/0000-0002-7979-3220; Mohanraju, Prarthana/0000-0002-4766-8660; Gootenberg, Jonathan/0000-0003-2757-2175; Fedorova, Iana/0000-0001-6144-173X; Mohanraju, Prarthana/0000-0002-4766-8660; Wu, Wen Ying/0000-0001-7147-7293; Kneppers, Jeroen/0000-0002-6548-2480; DeGennaro, Ellen/0000-0001-5506-6451	Human Frontiers Scientific Program; Paul and Daisy Soros Fellowship; Friends of the McGovern Institute Fellowship; D.O.E. Computational Science Graduate Fellowship; National Institute of Biomedical Imaging and Bioengineering (NIBIB), of the National Institutes of Health [5T32EB1680]; NIH [GM10407]; Russian Science Foundation [14-14-00988]; Skoltech; Netherlands Organization for Scientific Research (NWO) through a TOP grant [714.015.001]; NIH through NIMH [5DP1-MH100706, 1R01-MH110049]; New York Stem Cell Foundation; Poitras Foundation; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706, R01MH110049] Funding Source: NIH RePORTER	Human Frontiers Scientific Program; Paul and Daisy Soros Fellowship; Friends of the McGovern Institute Fellowship; D.O.E. Computational Science Graduate Fellowship(United States Department of Energy (DOE)); National Institute of Biomedical Imaging and Bioengineering (NIBIB), of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF)); Skoltech; Netherlands Organization for Scientific Research (NWO) through a TOP grant; NIH through NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); New York Stem Cell Foundation; Poitras Foundation; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank F.A. Ran for helpful discussions and overall support, and B. Cartigny and J. van den Bogaerde for technical assistance, and the entire Zhang laboratory for support and advice. 6-His-MBP-TEV, a pET-based vector, was kindly given to us by Doug Daniels of the Broad Institute. M.H. was supported by the Human Frontiers Scientific Program. O.A.A. is supported by a Paul and Daisy Soros Fellowship and a Friends of the McGovern Institute Fellowship. J.S.G. is supported by a D.O.E. Computational Science Graduate Fellowship. E.M.D.G. is supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), of the National Institutes of Health (5T32EB1680). K.S. is supported by an NIH grant GM10407, Russian Science Foundation grant 14-14-00988, and Skoltech. J.v.d.O. is supported by Netherlands Organization for Scientific Research (NWO) through a TOP grant (714.015.001). F.Z. is supported by the NIH through NIMH (5DP1-MH100706 and 1R01-MH110049); by the New York Stem Cell, Poitras, Simons, Paul G. Allen Family, and Vallee Foundations; and by David R. Cheng, Tom Harriman, and B. Metcalfe. F.Z. is a New York Stem Cell Foundation Robertson Investigator. The authors plan to make the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang lab website (http://www.genome-engineering.org/).	Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	11	475	528	25	320	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					31	34		10.1038/nbt.3737	http://dx.doi.org/10.1038/nbt.3737			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	27918548	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000392460800019
J	Zhernakova, DV; Deelen, P; Vermaat, M; van Iterson, M; van Galen, M; Arindrarto, W; van 't Hof, P; Mei, HL; van Dijk, F; Westra, HJ; Bonder, MJ; van Rooij, J; Verkerk, M; Jhamai, PM; Moed, M; Kielbasa, SM; Bot, J; Nooren, I; Pool, R; van Dongen, J; Hottenga, JJ; Stehouwer, CDA; van der Kallen, CJH; Schalkwijk, CG; Zhernakova, A; Li, Y; Tigchelaar, EF; de Klein, N; Beekman, M; Deelen, J; van Heemst, D; van den Berg, LH; Hofman, A; Uitterlinden, AG; van Greevenbroek, MMJ; Veldink, JH; Boomsma, DI; van Duijn, CM; Wijmenga, C; Slagboom, PE; Swertz, MA; Isaacs, A; van Meurs, JBJ; Jansen, R; Heijmans, BT; 't Hoen, PAC; Franke, L				Zhernakova, Dania V.; Deelen, Patrick; Vermaat, Martijn; van Iterson, Maarten; van Galen, Michiel; Arindrarto, Wibowo; van 't Hof, Peter; Mei, Hailiang; van Dijk, Freerk; Westra, Harm-Jan; Bonder, Marc Jan; van Rooij, Jeroen; Verkerk, Marijn; Jhamai, P. Mila; Moed, Matthijs; Kielbasa, Szymon M.; Bot, Jan; Nooren, Irene; Pool, Rene; van Dongen, Jenny; Hottenga, Jouke J.; Stehouwer, Coen D. A.; van der Kallen, Carla J. H.; Schalkwijk, Casper G.; Zhernakova, Alexandra; Li, Yang; Tigchelaar, Ettje F.; de Klein, Niek; Beekman, Marian; Deelen, Joris; van Heemst, Diana; van den Berg, Leonard H.; Hofman, Albert; Uitterlinden, Andre G.; van Greevenbroek, Marleen M. J.; Veldink, Jan H.; Boomsma, Dorret I.; van Duijn, Cornelia M.; Wijmenga, Cisca; Slagboom, P. Eline; Swertz, Morris A.; Isaacs, Aaron; van Meurs, Joyce B. J.; Jansen, Rick; Heijmans, Bastiaan T.; 't Hoen, Peter A. C.; Franke, Lude			Identification of context-dependent expression quantitative trait loci in whole blood	NATURE GENETICS			English	Article							GENE-EXPRESSION; CELL; OBESITY; ASSOCIATION; ENRICHMENT; VARIANTS; EQTLS	Genetic risk factors often localize to noncoding regions of the genome with unknown effects on disease etiology1,2. Expression quantitative trait loci (eQTLs) help to explain the regulatory mechanisms underlying these genetic associations(3-6). Knowledge of the context that determines the nature and strength of eQTLs may help identify cell types relevant to pathophysiology and the regulatory networks underlying disease(7-17). Here we generated peripheral blood RNA-seq data from 2,116 unrelated individuals and systematically identified context-dependent eQTLs using a hypothesis-free strategy that does not require previous knowledge of the identity of the modifiers. Of the 23,060 significant cis-regulated genes (false discovery rate (FDR) <= 0.05), 2,743 (12%) showed context-dependent eQTL effects. The majority of these effects were influenced by cell type composition. A set of 145 cis-eQTLs depended on type I interferon signaling. Others were modulated by specific transcription factors binding to the eQTL SNPs.	[Zhernakova, Dania V.; Deelen, Patrick; van Dijk, Freerk; Bonder, Marc Jan; Zhernakova, Alexandra; Li, Yang; Tigchelaar, Ettje F.; de Klein, Niek; Wijmenga, Cisca; Swertz, Morris A.; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Deelen, Patrick; van Dijk, Freerk; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Vermaat, Martijn; van Galen, Michiel; 't Hoen, Peter A. C.] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands; [van Iterson, Maarten; Moed, Matthijs; Kielbasa, Szymon M.; Beekman, Marian; Deelen, Joris; Slagboom, P. Eline; Heijmans, Bastiaan T.] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Mol Epidemiol Sect, Leiden, Netherlands; [Arindrarto, Wibowo; van 't Hof, Peter; Mei, Hailiang] Leiden Univ, Med Ctr, Sequence Anal Support Core, Leiden, Netherlands; [Westra, Harm-Jan] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Westra, Harm-Jan] Brigham & Womens Hosp, Dept Med, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA; [Westra, Harm-Jan] Harvard Med Sch, Boston, MA USA; [Westra, Harm-Jan] Partners Ctr Personalized Genet Med, Boston, MA USA; [Westra, Harm-Jan] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [van Rooij, Jeroen; Verkerk, Marijn; Jhamai, P. Mila; Uitterlinden, Andre G.; van Meurs, Joyce B. J.] ErasmusMC, Dept Internal Med, Rotterdam, Netherlands; [Bot, Jan; Nooren, Irene] SURFsara, Amsterdam, Netherlands; [Pool, Rene; van Dongen, Jenny; Hottenga, Jouke J.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Stehouwer, Coen D. A.; van der Kallen, Carla J. H.; Schalkwijk, Casper G.; van Greevenbroek, Marleen M. J.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Stehouwer, Coen D. A.; van der Kallen, Carla J. H.; Schalkwijk, Casper G.; van Greevenbroek, Marleen M. J.; Isaacs, Aaron] Maastricht Univ, Med Ctr, Sch Cardiovasc Dis CARIM, Maastricht, Netherlands; [van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [van den Berg, Leonard H.; Veldink, Jan H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands; [Hofman, Albert] ErasmusMC, Dept Epidemiol, Rotterdam, Netherlands; [van Duijn, Cornelia M.; Isaacs, Aaron] ErasmusMC, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Isaacs, Aaron] Maastricht Univ, Maastricht Ctr Syst Biol MaCSBio, Maastricht, Netherlands; [Jansen, Rick] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Neurosci Campus Amsterdam, Amsterdam, Netherlands	University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Franke, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands.; 't Hoen, PAC (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands.; Heijmans, BT (corresponding author), Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Mol Epidemiol Sect, Leiden, Netherlands.	b.t.heijmans@lumc.nl; p.a.c._t_hoen@lumc.nl; lude@ludesign.nl	Deelen, Patrick/B-3566-2013; Li, Yang/HGT-8446-2022; Boomsma, Dorret I/AAX-4470-2020; Deelen, Joris/H-3201-2019; Pool, René/AFO-8147-2022; Kiełbasa, Szymon M./K-2792-2019; Zhernakova, Alexandra/ABA-9372-2020; Beekman, Marian/L-3004-2019; Kiełbasa, Szymon/G-1636-2018; Stehouwer, Coen/AAB-3435-2021; Hoen, Peter A 't/D-3950-2018; Zhernakova, Daria/M-5619-2016; Wijmenga, Cisca/AAE-7719-2019; Franke, Lude/P-7036-2016	Deelen, Patrick/0000-0002-5654-3966; Li, Yang/0000-0003-4022-7341; Deelen, Joris/0000-0003-4483-3701; Pool, René/0000-0001-5579-0933; Beekman, Marian/0000-0003-0585-6206; Kiełbasa, Szymon/0000-0003-2805-6535; Hoen, Peter A 't/0000-0003-4450-3112; Zhernakova, Daria/0000-0001-6531-3890; Wijmenga, Cisca/0000-0002-5635-1614; van Greevenbroek, Marleen/0000-0002-2989-1631; Jansen, Rick/0000-0002-3333-6737; Bonder, Marc Jan/0000-0002-8431-3180; van der Kallen, Carla/0000-0003-1468-8793; Van Duijn, Cornelia/0000-0002-2374-9204; van Dongen, Jenny/0000-0003-2063-8741; Franke, Lude/0000-0002-5159-8802; Arindrarto, Wibowo/0000-0003-0499-0948; Stehouwer, Coen/0000-0001-8752-3223; Schalkwijk, Casper G/0000-0003-0190-2690; van Meurs, Joyce/0000-0001-6245-2123	BBMRI-NL; Dutch government [NWO 184.021.007]; SURF Cooperative; Groningen Center for Information Technology; Target storage; Samenwerkingsverband Noord Nederland; European Fund for Regional Development; Dutch Ministry of Economic Affairs; Pieken in de Delta; province of Groningen; European Research Council [637640]; Erasmus Medical Center, Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Netherlands Organization for Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015]; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) [050-060-810]; NWO [863.13.011]; Top Institute of Food and Nutrition [TiFN GH0001]; ERC advanced grant (FP/ERC) [2012-322698]; Spinoza prize [NWO SPI 92-266]; province of Drenthe; Erasmus University, Rotterdam; the European Commission (DG XII); municipality of Rotterdam	BBMRI-NL; Dutch government; SURF Cooperative; Groningen Center for Information Technology; Target storage; Samenwerkingsverband Noord Nederland; European Fund for Regional Development(European Commission); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Pieken in de Delta; province of Groningen; European Research Council(European Research Council (ERC)European Commission); Erasmus Medical Center, Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Netherlands Organization for Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO)); Top Institute of Food and Nutrition; ERC advanced grant (FP/ERC); Spinoza prize; province of Drenthe; Erasmus University, Rotterdam; the European Commission (DG XII); municipality of Rotterdam	This work was performed within the framework of the Biobank-Based Integrative Omics Studies (BIOS) consortium funded by BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184.021.007). Samples were contributed by LifeLines (http://lifelines.nl/lifelines-research/general), the Leiden Longevity Study (http://www.healthy-ageing.n1/ and http://www.leidenlangleven.n1/), the Rotterdam Studies (http://www.erasmus-epidemiology.nl/research/ergo.httn) and the CODAM study (http://.wwwcarimmaastricht.nl/). We thank the participants of all aforementioned biobanks and acknowledge the contributions of the investigators to this study (Supplementary Note). This work was carried out on the Dutch national e-infrastructure with the support of SURF Cooperative and the Groningen Center for Information Technology (G.J.C. Strikwerda, W Albers, R. Teeninga, H. Gankema and H. Wind) and Target storage (E. Valentyn and R. Williams). Target is supported by Samenwerkingsverband Noord Nederland, the European Fund for Regional Development, the Dutch Ministry of Economic Affairs, Pieken in de Delta, and the provinces of Groningen and Drenthe. This work is supported by a grant from the European Research Council (ERC Starting Grant agreement 637640 ImmRisk) to L.F. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, the Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII) and the municipality of Rotterdam. The authors are grateful to the study participants, the staff from the Rotterdam Study, and the participating general practitioners and pharmacists. The generation and management of GWAS genotype data for the Rotterdam Study are supported by the Netherlands Organization for Scientific Research NWO Investments (175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2) and Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) project 050-060-810. We thank P. Arp, M. Jhamai, M. Verkerk, L. Herrera and M. Peters for their help in creating the GWAS database. Work on cell count estimation was funded by NWO 863.13.011. The LifeLines Deep cohort is made possible by grants from the Top Institute of Food and Nutrition (TiFN GH0001), an ERC advanced grant (FP/2007-2013/ERC grant 2012-322698) and a Spinoza prize (NWO SPI 92-266) to C.W.	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Andiappan AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8971; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Caliskan M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005111; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cvejic A, 2013, NAT GENET, V45, P542, DOI 10.1038/ng.2603; Deelen P, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0152-4; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Facchetti F, 2002, P NATL ACAD SCI USA, V99, P3776, DOI 10.1073/pnas.022042699; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Francesconi M, 2014, NATURE, V505, P208, DOI 10.1038/nature12772; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Heinrichs S, 2013, ELIFE, V2, DOI 10.7554/eLife.00825; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Naranbhai V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8545; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Powell JE, 2012, GENOME RES, V22, P456, DOI 10.1101/gr.126540.111; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Rosen A, 2012, ONCOIMMUNOLOGY, V1, P18, DOI 10.4161/onci.1.1.18400; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; van Greevenbroek MMJ, 2011, EUR J CLIN INVEST, V41, P372, DOI 10.1111/j.1365-2362.2010.02418.x; Westra HJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005223; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328; Yao C, 2014, HUM MOL GENET, V23, P1947, DOI 10.1093/hmg/ddt582	41	207	207	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					139	145		10.1038/ng.3737	http://dx.doi.org/10.1038/ng.3737			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27918533	Green Published, Green Submitted			2022-12-25	WOS:000390976600020
J	Blaas, L; Pucci, F; Messal, HA; Andersson, AB; Ruiz, EJ; Gerling, M; Douagi, I; Spencer-Dene, B; Musch, A; Mitter, R; Bhaw, L; Stone, R; Bornhorst, D; Sesay, AK; Jonkers, J; Stamp, G; Malanchi, I; Toftgard, R; Behrens, A				Blaas, Leander; Pucci, Fabio; Messal, Hendrik A.; Andersson, Agneta B.; Ruiz, E. Josue; Gerling, Marco; Douagi, Iyadh; Spencer-Dene, Bradley; Musch, Alexandra; Mitter, Richard; Bhaw, Leena; Stone, Richard; Bornhorst, Dorothee; Sesay, Abdul K.; Jonkers, Jos; Stamp, Gordon; Malanchi, Ilaria; Toftgard, Rune; Behrens, Axel			Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours	NATURE CELL BIOLOGY			English	Article							ESTROGEN-RECEPTOR-ALPHA; STEM-CELLS; EPITHELIAL-CELLS; MOLECULAR PORTRAITS; BREAST CANCERS; HAIR FOLLICLE; MOUSE; EXPRESSION; BRCA1; MULTIPOTENCY	The mammary gland is composed of a complex cellular hierarchy with unusual postnatal plasticity. The identities of stem/progenitor cell populations, as well as tumour-initiating cells that give rise to breast cancer, are incompletely understood. Here we show that Lgr6 marks rare populations of cells in both basal and luminal mammary gland compartments in mice. Lineage tracing analysis showed that Lgr6(+) cells are unipotent progenitors, which expand clonally during puberty but diminish in adulthood. In pregnancy or following stimulation with ovarian hormones, adult Lgr6(+) cells regained proliferative potency and their progeny formed alveoli over repeated pregnancies. Oncogenic mutations in Lgr6(+) cells resulted in expansion of luminal cells, culminating in mammary gland tumours. Conversely, depletion of Lgr6(+) cells in the MMTV-PyMT model of mammary tumorigenesis significantly impaired tumour growth. Thus, Lgr6 marks mammary gland progenitor cells that can initiate tumours, and cells of luminal breast tumours required for efficient tumour maintenance.	[Blaas, Leander; Andersson, Agneta B.; Gerling, Marco; Musch, Alexandra; Bornhorst, Dorothee; Toftgard, Rune] Karolinska Inst, Dept Biosci & Nutr, Ctr Innovat Med CIMED, S-14183 Huddinge, Sweden; [Pucci, Fabio; Messal, Hendrik A.; Ruiz, E. Josue; Behrens, Axel] Francis Crick Inst, Adult Stem Cell Lab, 1 Midland Rd, London NW1 1AT, England; [Douagi, Iyadh] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, S-14183 Huddinge, Sweden; [Spencer-Dene, Bradley; Stone, Richard] Francis Crick Inst, Expt Histopathol, 1 Midland Rd, London NW1 1A1, England; [Mitter, Richard] Francis Crick Inst, Bioinformat & Biostat, 1 Midland Rd, London NW1 1AT, England; [Bhaw, Leena; Sesay, Abdul K.] Francis Crick Inst, Mill Hill Lab, Adv Sequencing Facil, London NW7 1AA, England; [Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol & Canc, NL-1066 CX Amsterdam, Netherlands; [Malanchi, Ilaria] Francis Crick Inst, Tumour Stroma Interact Canc Lab, 1 Midland Rd, London NW1 1AT, England; [Behrens, Axel] Kings Coll London, Fac Life Sci & Med, Guys Campus, London SE1 1UL, England	Karolinska Institutet; Francis Crick Institute; Karolinska Institutet; Francis Crick Institute; Francis Crick Institute; Netherlands Cancer Institute; Francis Crick Institute; University of London; King's College London	Toftgard, R (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Ctr Innovat Med CIMED, S-14183 Huddinge, Sweden.; Behrens, A (corresponding author), Francis Crick Inst, Adult Stem Cell Lab, 1 Midland Rd, London NW1 1AT, England.; Behrens, A (corresponding author), Kings Coll London, Fac Life Sci & Med, Guys Campus, London SE1 1UL, England.	Rune.Toftgard@ki.se; Axel.Behrens@crick.ac.uk	Jonkers, Jos/AAG-3246-2019; Blaas, Leander/A-5917-2015	Jonkers, Jos/0000-0002-9264-9792; Gerling, Marco/0000-0002-1810-0662; Malanchi, Ilaria/0000-0003-4867-3311; Mitter, Richard/0000-0002-1279-3760; Behrens, Axel/0000-0002-1557-1143; Bornhorst, Dorothee/0000-0003-4084-0250; Blaas, Leander/0000-0002-7822-697X; Stone, Richard/0000-0001-8059-3800	M. Sklodowska-Curie actions [297639]; Wenner Gren Foundation; Swedish Cancer Society; German Research Foundation DFG [DFG Ge 2386/1-1]; German Academic Exchange Service DAAD; Knut and Alice Wallenberg Foundation; Breast Cancer Theme group at the Karolinska Institutet; Swedish Research Council; Center for Innovative Medicine in the Department of Biosciences and Nutrition, Karolinska Institutet; Francis Crick Institute from Cancer Research UK [FC001039]; UK Medical Research Council [FC001039]; Wellcome Trust [FC001039]; Center for Innovative Medicine; Cancer Research UK [14257] Funding Source: researchfish; The Francis Crick Institute [10002, 10009, 10112, 10039] Funding Source: researchfish	M. Sklodowska-Curie actions; Wenner Gren Foundation; Swedish Cancer Society(Swedish Cancer Society); German Research Foundation DFG(German Research Foundation (DFG)); German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Breast Cancer Theme group at the Karolinska Institutet; Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for Innovative Medicine in the Department of Biosciences and Nutrition, Karolinska Institutet; Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Center for Innovative Medicine; Cancer Research UK(Cancer Research UK); The Francis Crick Institute	We thank A. Bergstrom, M. Saghafian and R. Kuiper for technical help and support, and E. Tuksammel formouse husbandry, genotyping and surgery. We are grateful to H. Clevers for providing the Lgr6-EGFP-IRES-CreERT2 mouse line. We also thank P.-M. Blaas and E. Casanova for critical reading of the manuscript. Finally, we thank C. Cremona for her terrific assistance in writing the manuscript. This work was supported by grants from M. Sklodowska-Curie actions (Project no. 297639) and the Wenner Gren Foundation (to L. Blaas), the Swedish Cancer Society (to M.G., R.T.), the German Research Foundation DFG (to M.G., DFG Ge 2386/1-1), the German Academic Exchange Service DAAD (to D.B.), the Knut and Alice Wallenberg Foundation (to I.D.), the Breast Cancer Theme group at the Karolinska Institutet (to A.B.A., R.T.), the Swedish Research Council (to R.T.), the Center for Innovative Medicine in the Department of Biosciences and Nutrition, Karolinska Institutet (to R.T.), and the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001039), the UK Medical Research Council (FC001039) and the Wellcome Trust (FC001039). This study was performed partly at the Francis Crick Institute in London, partly at the Wallenberg Institute for Regenerative Medicine Flow Cytometry Facility, and Regenerative Medicine, Karolinska Institutet, Huddinge, Sweden, and partly at the Live Cell Imaging Unit/Nikon Center of Excellence in the Department of Biosciences and Nutrition, which receives funding from the Knut and Alice Wallenberg Foundation, the Swedish Research Council, the Center for Innovative Medicine and the Jonasson donation to the School of Technology and Health, Kungliga Tekniska Hogskolan, Huddinge, Sweden.	Akhoondi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2788; Arendt LM, 2015, J MAMMARY GLAND BIOL, V20, P9, DOI 10.1007/s10911-015-9337-0; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bao L, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0615-y; Booth BW, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1538; Boras-Granic K, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0487-6; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Burga LN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2850; Chang THT, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3593; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; dos Santos CO, 2013, P NATL ACAD SCI USA, V110, P7123, DOI 10.1073/pnas.1303919110; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fullgrabe A, 2015, STEM CELL REP, V5, P843, DOI 10.1016/j.stemcr.2015.09.013; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giraddi RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9487; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Inman JL, 2015, DEVELOPMENT, V142, P1028, DOI 10.1242/dev.087643; Jandke A, 2011, DEV BIOL, V358, P201, DOI 10.1016/j.ydbio.2011.07.030; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kaanta AS, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3459; Koren S, 2015, NATURE, V525, P114, DOI 10.1038/nature14669; Lafkas D, 2013, J CELL BIOL, V203, P47, DOI 10.1083/jcb.201307046; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malhotra GK, 2014, BMC DEV BIOL, V14, DOI 10.1186/s12861-014-0047-4; Mastroianni M, 2010, CANCER LETT, V289, P23, DOI 10.1016/j.canlet.2009.07.012; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Oeztuerk-Winder F, 2012, EMBO J, V31, P3431, DOI 10.1038/emboj.2012.192; Oshima R., 2012, PLOS ONE, V7; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Rodilla V, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002069; Scata KA, 2007, ADV EXP MED BIOL, V608, P70; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0411-0; Shyamala G, 2006, CANCER RES, V66, P10391, DOI 10.1158/0008-5472.CAN-06-0321; Skibinski A, 2015, ONCOGENE, V34, P5309, DOI 10.1038/onc.2014.475; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tung ND, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2776; Tung N, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2478; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2016, NAT CELL BIOL, V18, P349, DOI 10.1038/ncb3332; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wallace MD, 2012, GENETICS, V192, P385, DOI 10.1534/genetics.112.142802; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Wei Guangwei, 2012, J Cancer Sci Ther, V4, P299; Wright KL, 2015, CANCER RES, V75, P4960, DOI 10.1158/0008-5472.CAN-14-2992; Wuidart A, 2016, GENE DEV, V30, P1261, DOI 10.1101/gad.280057.116; Yin Y, 2005, MOL CARCINOGEN, V44, P42, DOI 10.1002/mc.20119	67	50	52	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2016	18	12					1346	+		10.1038/ncb3434	http://dx.doi.org/10.1038/ncb3434			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	ED8PY	27798604	Green Submitted, Green Accepted			2022-12-25	WOS:000389134600012
J	Kim, D; Sung, YM; Park, J; Kim, S; Kim, J; Park, J; Ha, H; Bae, JY; Kim, S; Baek, D				Kim, Doyeon; Sung, You Me; Park, Jinman; Kim, Sukjun; Kim, Jongkyu; Park, Junhee; Ha, Haeok; Bae, Jung Yoon; Kim, SoHui; Baek, Daehyun			General rules for functional microRNA targeting	NATURE GENETICS			English	Article							MESSENGER-RNAS; MAMMALIAN MICRORNAS; BINDING-SITES; IDENTIFICATION; DETERMINANTS; STABILITY; ABUNDANCE; RECOGNITION; SPECIFICITY; REPRESSION	The functional rules for microRNA (miRNA) targeting remain controversial despite their biological importance because only a small fraction of distinct interactions, called site types, have been examined among an astronomical number of site types that can occur between miRNAs and their target mRNAs. To systematically discover functional site types and to evaluate the contradicting rules reported previously, we used large-scale transcriptome data and statistically examined whether each of approximately 2 billion site types is enriched in differentially downregulated mRNAs responding to overexpressed miRNAs. Accordingly, we identified seven non-canonical functional site types, most of which are novel, in addition to four canonical site types, while also removing numerous false positives reported by previous studies. Extensive experimental validation and significantly elevated 3' UTR sequence conservation indicate that these non-canonical site types may have biologically relevant roles. Our expanded catalog of functional site types suggests that the gene regulatory network controlled by miRNAs may be far more complex than currently understood.	[Kim, Doyeon; Park, Jinman; Kim, Sukjun; Kim, Jongkyu; Kim, SoHui; Baek, Daehyun] Inst for Basic Sci Korea, Ctr RNA Res, Seoul, South Korea; [Kim, Doyeon; Sung, You Me; Park, Jinman; Kim, Sukjun; Kim, Jongkyu; Park, Junhee; Ha, Haeok; Bae, Jung Yoon; Kim, SoHui; Baek, Daehyun] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Baek, Daehyun] Seoul Natl Univ, Bioinformat Inst, Seoul, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU)	Baek, D (corresponding author), Inst for Basic Sci Korea, Ctr RNA Res, Seoul, South Korea.; Baek, D (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.; Baek, D (corresponding author), Seoul Natl Univ, Bioinformat Inst, Seoul, South Korea.	baek@snu.ac.kr	Kim, Sukjun/AAV-8503-2021	Kim, Sukjun/0000-0002-3190-9829; Kim, Doyeon/0000-0003-1522-4341	Institute for Basic Science [IBS-R008-D1]; Ministry of Science ICT and Future Planning, Republic of Korea [NRF-2011-0014523, NRF-2014M3C9A3063541, F15SN01D1305, 2012M3A9D1054622]; Ministry of Health and Welfare, Republic of Korea [HI15C1578, HI15C3224]; TJ Park Science Fellowship of the POSCO TJ Park Foundation	Institute for Basic Science; Ministry of Science ICT and Future Planning, Republic of Korea; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); TJ Park Science Fellowship of the POSCO TJ Park Foundation	We thank V.N. Kim for generous research funding and insightful discussions, and we thank D.P. Bartel, J.W. Nam, S.W. Chi, and members of the Baek laboratory for helpful discussions. This work was supported by the Institute for Basic Science (IBS-R008-D1), the Ministry of Science ICT and Future Planning, Republic of Korea (NRF-2011-0014523, NRF-2014M3C9A3063541, F15SN01D1305, and 2012M3A9D1054622), the Ministry of Health and Welfare, Republic of Korea (HI15C1578 and HI15C3224), and the TJ Park Science Fellowship of the POSCO TJ Park Foundation.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Anderson EM, 2008, RNA, V14, P853, DOI 10.1261/rna.704708; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Khorshid M, 2013, NAT METHODS, V10, P253, DOI [10.1038/NMETH.2341, 10.1038/nmeth.2341]; Kim D, 2014, MOL CELLS, V37, P412, DOI 10.14348/molcells.2014.0100; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Majoros WH, 2013, NAT METHODS, V10, P630, DOI 10.1038/nmeth.2489; Mayr C, 2016, TRENDS CELL BIOL, V26, P227, DOI 10.1016/j.tcb.2015.10.012; Melo SA, 2013, NAT CELL BIOL, V15, P139, DOI 10.1038/ncb2684; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P7100, DOI 10.1093/nar/gkn902; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	46	86	89	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1517	1526		10.1038/ng.3694	http://dx.doi.org/10.1038/ng.3694			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27776116	Green Submitted			2022-12-25	WOS:000389011100012
J	Lyons, JJ; Yu, XM; Hughes, JD; Le, QT; Jamil, A; Bai, Y; Ho, N; Zhao, M; Liu, YH; O'Connell, MP; Trivedi, NN; Nelson, C; DiMaggio, T; Jones, N; Matthews, H; Lewis, KL; Oler, AJ; Carlson, RJ; Arkwright, PD; Hong, C; Agama, S; Wilson, TM; Tucker, S; Zhang, Y; McElwee, JJ; Pao, M; Glover, SC; Rothenberg, ME; Hohman, RJ; Stone, KD; Caughey, GH; Heller, T; Metcalfe, DD; Biesecker, LG; Schwartz, LB; Milner, JD				Lyons, Jonathan J.; Yu, Xiaomin; Hughes, Jason D.; Le, Quang T.; Jamil, Ali; Bai, Yun; Ho, Nancy; Zhao, Ming; Liu, Yihui; O'Connell, Michael P.; Trivedi, Neil N.; Nelson, Celeste; DiMaggio, Thomas; Jones, Nina; Matthews, Helen; Lewis, Katie L.; Oler, Andrew J.; Carlson, Ryan J.; Arkwright, Peter D.; Hong, Celine; Agama, Sherene; Wilson, Todd M.; Tucker, Sofie; Zhang, Yu; McElwee, Joshua J.; Pao, Maryland; Glover, Sarah C.; Rothenberg, Marc E.; Hohman, Robert J.; Stone, Kelly D.; Caughey, George H.; Heller, Theo; Metcalfe, Dean D.; Biesecker, Leslie G.; Schwartz, Lawrence B.; Milner, Joshua D.			Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number	NATURE GENETICS			English	Article							JOINT HYPERMOBILITY; EPIDEMIOLOGY	Elevated basal serum tryptase levels are present in 4-6% of the general population, but the cause and relevance of such increases are unknown(1,2). Previously, we described subjects with dominantly inherited elevated basal serum tryptase levels associated with multisystem complaints including cutaneous flushing and pruritus, dysautonomia, functional gastrointestinal symptoms, chronic pain, and connective tissue abnormalities, including joint hypermobility. Here we report the identification of germline duplications and triplications in the TPSAB1 gene encoding alpha-tryptase that segregate with inherited increases in basal serum tryptase levels in 35 families presenting with associated multisystem complaints. Individuals harboring alleles encoding three copies of alpha-tryptase had higher basal serum levels of tryptase and were more symptomatic than those with alleles encoding two copies, suggesting a gene-dose effect. Further, we found in two additional cohorts (172 individuals) that elevated basal serum tryptase levels were exclusively associated with duplication of alpha-tryptase-encoding sequence in TPSAB1, and affected individuals reported symptom complexes seen in our initial familial cohort. Thus, our findings link duplications in TPSAB1 with irritable bowel syndrome, cutaneous complaints, connective tissue abnormalities, and dysautonomia.	[Lyons, Jonathan J.; Yu, Xiaomin; Jamil, Ali; Bai, Yun; Liu, Yihui; O'Connell, Michael P.; Nelson, Celeste; DiMaggio, Thomas; Carlson, Ryan J.; Agama, Sherene; Wilson, Todd M.; Tucker, Sofie; Stone, Kelly D.; Metcalfe, Dean D.; Milner, Joshua D.] NIAID, Lab Allerg Dis, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hughes, Jason D.; McElwee, Joshua J.] Merck & Co Inc, Merck Res Labs, Boston, MA USA; [Le, Quang T.; Schwartz, Lawrence B.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA; [Ho, Nancy; Heller, Theo] NIDDK, Liver Dis Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Zhao, Ming; Hohman, Robert J.] NIAID, Res Technol Branch, US Natl Inst Hlth, Rockville, MD USA; [Trivedi, Neil N.; Caughey, George H.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Trivedi, Neil N.; Caughey, George H.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Trivedi, Neil N.; Caughey, George H.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Jones, Nina] SAIC Frederick Inc, Frederick Natl Lab Clin Res, Clin Res Directorate CMRP, Frederick, MD USA; [Matthews, Helen] NIAID, Immunol Lab, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA; [Lewis, Katie L.; Hong, Celine; Biesecker, Leslie G.] NHGRI, Med Genom & Metab Genet Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Oler, Andrew J.] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Arkwright, Peter D.] Univ Manchester, Royal Manchester Childrens Hosp, Inst Infect Immun & Resp Med, Manchester, Lancs, England; [Zhang, Yu] NIAID, Host Def Lab, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Pao, Maryland] NIMH, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Glover, Sarah C.] Univ Florida, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA; [Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH 45229 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Merck & Company; Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Royal Manchester Children's Hospital; University of Manchester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); State University System of Florida; University of Florida; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Milner, JD (corresponding author), NIAID, Lab Allerg Dis, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jdmilner@niaid.nih.gov	O'Connell, Michael/F-9236-2017; Biesecker, Leslie/AAG-2526-2021	Heller, Theo/0000-0002-2643-6289; O'Connell, Michael/0000-0002-8615-7660; Glover, Sarah/0000-0002-9899-0473; Lyons, Jonathan/0000-0002-2346-8189; Carlson, Ryan/0000-0001-8311-481X	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, NIH; NCI [HHSN261200800001E]; ARTrust/The Mastocytosis Society Research Award in Mastocytosis; Mast Cell Activation Syndrome; NIH [HL024136]; Intramural Research Program of the NHGRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001183, ZIAAI001192, ZIAAI000249, ZIAAI001092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002922] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ARTrust/The Mastocytosis Society Research Award in Mastocytosis; Mast Cell Activation Syndrome; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the patients, their families, and the numerous healthy volunteers who contributed to this research, as well as the clinical staff of the LAD, NIMH, NIDDK, and NHGRI for their efforts, in particular the Gastrointestinal and Psychiatry Consultation Liaison Services physicians, especially T. Alqassem, who participated in the care of these patients. We thank all the referring care providers, in particular A. Maitland and M. Carter for each referring several families for evaluation. We also acknowledge the collaborative spirit and efforts of the NIAMS and NIAID clinical genomics programs, specifically the investigators (M.J. Lenardo, H.S. Su, and R.T. Goldbach-Mansky) who shared clinical genomics data and study samples. We also thank M.J. Lenardo, W. Gahl, C. Akin, and J.-L. Casanova for their review of the manuscript. Lastly, we thank D. Abdulazeez of VCU for performing the tryptase immunoassays. This study was supported in part by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, NIH. The involvement of N.J. was funded by NCI contract HHSN261200800001E. Funding was also provided in part by ARTrust/The Mastocytosis Society Research Award in Mastocytosis and/or Mast Cell Activation Syndrome (J.J.L.) and by NIH HL024136 (G.H.C.). L.G.B., C.H., and K.L.L. were supported by the Intramural Research Program of the NHGRI.	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Buskila D, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2005; Cardet JC, 2013, CURR ALLERGY ASTHM R, V13, P10, DOI 10.1007/s11882-012-0326-8; Castori Marco, 2012, ISRN Dermatol, V2012, P751768, DOI 10.5402/2012/751768; Chiang PW, 2009, AM J MED GENET A, V149A, P1463, DOI 10.1002/ajmg.a.32948; El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269; Fellinger C, 2014, ALLERGOL IMMUNOPATH, V42, P544, DOI 10.1016/j.aller.2014.05.002; Gonzalez-Quintela A, 2010, CLIN CHEM LAB MED, V48, P701, DOI 10.1515/CCLM.2010.124; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; Li HL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000755; Lyons JJ, 2014, J ALLERGY CLIN IMMUN, V133, P1471, DOI 10.1016/j.jaci.2013.11.039; Remvig L, 2007, J RHEUMATOL, V34, P804; Ross J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7167; Rueff F, 2009, J ALLERGY CLIN IMMUN, V124, P1047, DOI 10.1016/j.jaci.2009.08.027; Sabato V, 2014, J ALLERGY CLIN IMMUN, V134, P1448, DOI 10.1016/j.jaci.2014.06.007; Saito YA, 2002, AM J GASTROENTEROL, V97, P1910; Savova V, 2016, NAT GENET, V48, P231, DOI 10.1038/ng.3493; Sturm GJ, 2014, J ALLERGY CLIN IMMUN, V133, P1635, DOI 10.1016/j.jaci.2013.10.046; Trivedi NN, 2007, J IMMUNOL, V179, P6072, DOI 10.4049/jimmunol.179.9.6072; Zarate N, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01421.x	20	182	182	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1564	1569		10.1038/ng.3696	http://dx.doi.org/10.1038/ng.3696			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27749843	Green Submitted, Green Accepted			2022-12-25	WOS:000389011100018
J	Bonder, MJ; Kurilshikov, A; Tigchelaar, EF; Mujagic, Z; Imhann, F; Vila, AV; Deelen, P; Vatanen, T; Schirmer, M; Smeekens, SP; Zhernakova, DV; Jankipersadsing, SA; Jaeger, M; Oosting, M; Cenit, MC; Masclee, AAM; Swertz, MA; Li, Y; Kumar, V; Joosten, L; Harmsen, H; Weersma, RK; Franke, L; Hofker, MH; Xavier, RJ; Jonkers, D; Netea, MG; Wijmenga, C; Fu, JY; Zhernakova, A				Bonder, Marc Jan; Kurilshikov, Alexander; Tigchelaar, Ettje F.; Mujagic, Zlatan; Imhann, Floris; Vila, Arnau Vich; Deelen, Patrick; Vatanen, Tommi; Schirmer, Melanie; Smeekens, Sanne P.; Zhernakova, Dania V.; Jankipersadsing, Soesma A.; Jaeger, Martin; Oosting, Marije; Cenit, Maria Carmen; Masclee, Ad A. M.; Swertz, Morris A.; Li, Yang; Kumar, Vinod; Joosten, Leo; Harmsen, Hermie; Weersma, Rinse K.; Franke, Lude; Hofker, Marten H.; Xavier, Ramnik J.; Jonkers, Daisy; Netea, Mihai G.; Wijmenga, Cisca; Fu, Jingyuan; Zhernakova, Alexandra			The effect of host genetics on the gut microbiome	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; LACTASE PERSISTENCE; COLORECTAL-CANCER; RECEPTOR; EXPRESSION; DIVERSITY; VARIANTS; OBESITY	The gut microbiome is affected by multiple factors, including genetics. In this study, we assessed the influence of host genetics on microbial species, pathways and gene ontology categories, on the basis of metagenomic sequencing in 1,514 subjects. In a genome-wide analysis, we identified associations of 9 loci with microbial taxonomies and 33 loci with microbial pathways and gene ontology terms at P < 5 x 10(-8). Additionally, in a targeted analysis of regions involved in complex diseases, innate and adaptive immunity, or food preferences, 32 loci were identified at the suggestive level of P < 5 x 10(-6). Most of our reported associations are new, including genome-wide significance for the C-type lectin molecules CLEC4F-CD207 at 2p13.3 and CLEC4A-FAM90A1 at 12p13. We also identified association of a functional LCT SNP with the Bifidobacterium genus (P = 3.45 x 10(-8)) and provide evidence of a gene-diet interaction in the regulation of Bifidobacterium abundance. Our, results demonstrate the importance of understanding host-microbe interactions to gain better insight into human health.	[Bonder, Marc Jan; Kurilshikov, Alexander; Tigchelaar, Ettje F.; Deelen, Patrick; Zhernakova, Dania V.; Jankipersadsing, Soesma A.; Cenit, Maria Carmen; Swertz, Morris A.; Li, Yang; Kumar, Vinod; Franke, Lude; Wijmenga, Cisca; Fu, Jingyuan; Zhernakova, Alexandra] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Kurilshikov, Alexander] RAS, Inst Chem Biol & Fundamental Med, SB, Novosibirsk, Russia; [Kurilshikov, Alexander] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia; [Tigchelaar, Ettje F.; Mujagic, Zlatan; Zhernakova, Alexandra] Top Inst Food & Nutr, Wageningen, Netherlands; [Mujagic, Zlatan; Masclee, Ad A. M.; Jonkers, Daisy] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Div Gastroenterol Hepatol, Dept Internal Med Med Ctr, Maastricht, Netherlands; [Imhann, Floris; Vila, Arnau Vich; Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Deelen, Patrick; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Vatanen, Tommi; Schirmer, Melanie; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Vatanen, Tommi] Aalto Univ, Dept Comp Sci, Sch Sci, Espoo, Finland; [Schirmer, Melanie] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Smeekens, Sanne P.; Jaeger, Martin; Oosting, Marije; Joosten, Leo; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Smeekens, Sanne P.; Jaeger, Martin; Oosting, Marije; Joosten, Leo; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Jankipersadsing, Soesma A.; Hofker, Marten H.; Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Harmsen, Hermie] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Cenit, Maria Carmen] Dr Peset Univ Hosp, Dept Pediat, Valencia, Spain	University of Groningen; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Top Institute Food & Nutrition; Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; University of Groningen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Aalto University; Harvard University; Harvard T.H. Chan School of Public Health; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; University of Groningen; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Wijmenga, C; Fu, JY; Zhernakova, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.; Zhernakova, A (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.; Fu, JY (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.	c.wijmenga@umcg.nl; j.fu@umcg.nl; a.zhernakova@umcg.nl	Smeekens, Sanne/G-8307-2011; Schirmer, Melanie/HDN-5528-2022; Vatanen, Tommi/J-5458-2018; Cenit, Maria Carmen MC/E-9538-2017; Zhernakova, Daria/M-5619-2016; Kurilshikov, Alexander/GWC-1519-2022; Fu, Jingyuan/ABE-6868-2020; Fu, JY/GRR-6179-2022; Deelen, Patrick/B-3566-2013; Weersma, Rinse/ABE-3807-2021; Jaeger, Martin/H-3359-2015; Smeekens, Sanne/AAZ-2061-2021; Joosten, Leo AB/H-3138-2015; Zhernakova, Alexandra/ABA-9372-2020; Fu, Jingyuan/E-8980-2012; Wijmenga, Cisca/AAE-7719-2019; Netea, Mihai/N-5155-2014; Kumar, Vinod/ABC-4866-2020; Li, Yang/HGT-8446-2022; Oosting, Marije/H-7437-2015; Franke, Lude/P-7036-2016	Smeekens, Sanne/0000-0002-7835-914X; Vatanen, Tommi/0000-0003-0949-1291; Cenit, Maria Carmen MC/0000-0001-8667-5313; Zhernakova, Daria/0000-0001-6531-3890; Kurilshikov, Alexander/0000-0003-2541-5627; Fu, Jingyuan/0000-0001-5578-1236; Deelen, Patrick/0000-0002-5654-3966; Jaeger, Martin/0000-0001-6994-493X; Smeekens, Sanne/0000-0002-7835-914X; Joosten, Leo AB/0000-0001-6166-9830; Wijmenga, Cisca/0000-0002-5635-1614; Kumar, Vinod/0000-0002-2775-6049; Li, Yang/0000-0003-4022-7341; Jankipersadsing, Soesma/0000-0001-9225-9236; Schirmer, Melanie/0000-0001-6456-3679; Vich Vila, Arnau/0000-0003-4691-5583; Franke, Lude/0000-0002-5159-8802; Bonder, Marc Jan/0000-0002-8431-3180	Top Institute Food and Nutrition, Wageningen [TiFN GH001]; Netherlands Organization for Scientific Research [NWO-VIDI 864.13.013]; ZonMW-VIDI [917.14.374, 016.136.308]; CardioVasculair Onderzoek Nederland [CVON 2012-03]; University of Groningen; European Research Council under the European Union; ERC [2012-322698]; Spinoza Prize from the Netherlands Organization for Scientific Research; ERC Consolidator Grant [310372, 259867]; ERC Starting Grant [637640]; Netherlands Organization for Scientific Research VENI grant [863.13.011]	Top Institute Food and Nutrition, Wageningen; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ZonMW-VIDI(Netherlands Organization for Health Research and Development); CardioVasculair Onderzoek Nederland; University of Groningen; European Research Council under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); Spinoza Prize from the Netherlands Organization for Scientific Research; ERC Consolidator Grant(European Research Council (ERC)); ERC Starting Grant(European Research Council (ERC)); Netherlands Organization for Scientific Research VENI grant	This project was funded by grants from Top Institute Food and Nutrition, Wageningen, to C.W. (TiFN GH001), the Netherlands Organization for Scientific Research to J.F. (NWO-VIDI 864.13.013), L.F. (ZonMW-VIDI 917.14.374) and R.K.W. (ZonMW-VIDI 016.136.308), and CardioVasculair Onderzoek Nederland to M.H.H., M.G.N., A.Z. and J.F. (CVON 2012-03). A.Z. holds a Rosalind Franklin Fellowship (University of Groningen). This research received funding from the European Research Council under the European Union's Seventh Framework Programme: C.W. is supported by FP7/2007-2013/ERC Advanced Grant (agreement 2012-322698) and a Spinoza Prize from the Netherlands Organization for Scientific Research. M.G.N. holds an ERC Consolidator Grant (310372). L.P. has an FP7/2007-2013 grant (agreement 259867) and an ERC Starting Grant (637640, ImmRisk). Y.L. holds a Netherlands Organization for Scientific Research VENI grant (863.13.011).	Bae JA, 2014, CLIN CANCER RES, V20, P4115, DOI 10.1158/1078-0432.CCR-13-2863; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Bunge J, 2014, ANNU REV STAT APPL, V1, P427, DOI 10.1146/annurev-statistics-022513-115654; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Casals F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-202; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Davenport ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140301; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Doney ASF, 2004, DIABETOLOGIA, V47, P555, DOI 10.1007/s00125-003-1323-1; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Galeone Massimiliano, 2012, Patholog Res Int, V2012, P595380, DOI 10.1155/2012/595380; Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Nguyen HTT, 2014, GASTROENTEROLOGY, V146, P508, DOI 10.1053/j.gastro.2013.10.021; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hromatka BS, 2015, HUM MOL GENET, V24, P2700, DOI 10.1093/hmg/ddv028; Huuskonen J, 2001, ATHEROSCLEROSIS, V155, P269, DOI 10.1016/S0021-9150(01)00447-6; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Juste C, 2014, GUT, V63, P1566, DOI 10.1136/gutjnl-2012-303786; Kalabis J, 2006, J BIOL CHEM, V281, P6434, DOI 10.1074/jbc.M512905200; Kaplan RC, 2011, HUM MOL GENET, V20, P1241, DOI 10.1093/hmg/ddq560; Khan MT, 2012, ANTIOXID REDOX SIGN, V17, P1433, DOI 10.1089/ars.2012.4701; Klingberg S, 2008, AM J CLIN NUTR, V87, P993, DOI 10.1093/ajcn/87.4.993; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Koren I, 2010, CURR BIOL, V20, P1093, DOI 10.1016/j.cub.2010.04.041; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Landy J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12955; Leamy LJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0552-6; Lee S, 2011, PATHOL INT, V61, P210, DOI 10.1111/j.1440-1827.2011.02646.x; Liu TC, 2016, INFLAMM BOWEL DIS, V22, pS4, DOI 10.1097/01.MIB.0000480097.23732.5e; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mujagic Z, 2014, ALIMENT PHARM THER, V40, P288, DOI 10.1111/apt.12829; Netea MG, 2016, NAT MED, V22, P831, DOI 10.1038/nm.4140; Org E, 2015, GENOME RES, V25, P1558, DOI 10.1101/gr.194118.115; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Sadabad MS, 2015, GUT, V64, P1546, DOI 10.1136/gutjnl-2014-307289; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Singh V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8113; Srinivas G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3462; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Tigchelaar EF, 2016, GUT, V65, P540, DOI 10.1136/gutjnl-2015-310328; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Torres J, 2016, ALIMENT PHARM THER, V43, P790, DOI 10.1111/apt.13552; Troelsen JT, 2005, BBA-GEN SUBJECTS, V1723, P19, DOI 10.1016/j.bbagen.2005.02.003; Tyler AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066934; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Yahiro K, 2014, INFECT IMMUN, V82, P4899, DOI 10.1128/IAI.02213-14; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zhou YH, 2013, J MOL HISTOL, V44, P555, DOI 10.1007/s10735-013-9504-9	66	408	418	13	192	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1407	1412		10.1038/ng.3663	http://dx.doi.org/10.1038/ng.3663			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27694959				2022-12-25	WOS:000386543400017
J	Campbell, E; Kaltenbach, M; Correy, GJ; Carr, PD; Porebski, BT; Livingstone, EK; Afriat-Jurnou, L; Buckle, AM; Weik, M; Hollfelder, F; Tokuriki, N; Jackson, CJ				Campbell, Eleanor; Kaltenbach, Miriam; Correy, Galen J.; Carr, Paul D.; Porebski, Benjamin T.; Livingstone, Emma K.; Afriat-Jurnou, Livnat; Buckle, Ashley M.; Weik, Martin; Hollfelder, Florian; Tokuriki, Nobuhiko; Jackson, Colin J.			The role of protein dynamics in the evolution of new enzyme function	NATURE CHEMICAL BIOLOGY			English	Article							MOLECULAR-DYNAMICS; BACTERIAL PHOSPHOTRIESTERASE; CONFORMATIONAL DIVERSITY; COMPUTER-SIMULATIONS; CATALYSIS; NETWORKS; EVOLVABILITY; EPISTASIS; ALGORITHM; DESIGN	Enzymes must be ordered to allow the stabilization of transition states by their active sites, yet dynamic enough to adopt alternative conformations suited to other steps in their catalytic cycles. The biophysical principles that determine how specific protein dynamics evolve and how remote mutations affect catalytic activity are poorly understood. Here we examine a 'molecular fossil record' that was recently obtained during the laboratory evolution of a phosphotriesterase from Pseudomonas diminuta to an arylesterase. Analysis of the structures and dynamics of nine protein variants along this trajectory, and three rationally designed variants, reveals cycles of structural destabilization and repair, evolutionary pressure to 'freeze out' unproductive motions and sampling of distinct conformations with specific catalytic properties in bi-functional intermediates. This work establishes that changes to the conformational landscapes of proteins are an essential aspect of molecular evolution and that change in function can be achieved through enrichment of preexisting conformational sub-states.	[Campbell, Eleanor; Correy, Galen J.; Carr, Paul D.; Livingstone, Emma K.; Afriat-Jurnou, Livnat; Jackson, Colin J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Kaltenbach, Miriam; Tokuriki, Nobuhiko] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Kaltenbach, Miriam; Hollfelder, Florian] Univ Cambridge, Dept Biochem, Cambridge, England; [Porebski, Benjamin T.; Buckle, Ashley M.] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia; [Porebski, Benjamin T.; Buckle, Ashley M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Weik, Martin] Univ Grenoble Alpes, Inst Biol Struct, Commissariat Energie Atom, Grenoble, France; [Weik, Martin] Ctr Natl Rech Sci, Grenoble, France	Australian National University; University of British Columbia; University of Cambridge; Monash University; Monash University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Jackson, CJ (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia.; Tokuriki, N (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada.	tokuriki@msl.ubc.ca; colin.jackson@anu.edu.au	Livingstone, Emma/M-1607-2019; TOKURIKI, NOBUHIKO/A-2968-2010; Livingstone, Emma/R-8876-2016; Weik, Martin/M-2770-2017; Jackson, Colin J/C-1500-2008	Livingstone, Emma/0000-0003-0478-1871; Livingstone, Emma/0000-0003-0478-1871; Weik, Martin/0000-0001-9297-642X; Jackson, Colin J/0000-0001-6150-3822; Hollfelder, Florian/0000-0002-1367-6312; Campbell, Eleanor/0000-0002-0081-6865; Afriat-Jurnou, Livnat/0000-0002-4821-0328; Buckle, Ashley/0000-0003-2943-9044	Australian Research Council [FT140101059, DP130102144]; Natural Sciences and Engineering Research Council of Canada [RGPIN 418262-12]; Victorian Life Sciences Computation Initiative, an initiative of the Victorian Government, Australia; Biotechnology and Biological Sciences Research Council; European Research Council; EU Innovative Training Network (ProSA)	Australian Research Council(Australian Research Council); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Victorian Life Sciences Computation Initiative, an initiative of the Victorian Government, Australia; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); EU Innovative Training Network (ProSA)	We thank D.S. Tawfik for stimulating discussions. C.J.J. thanks the Australian Research Council for a Future Fellowship (FT140101059) and Discovery Project (DP130102144). This research was undertaken on the MX1 and MX2 beamlines at the Australian Synchrotron, Victoria, Australia. F.H. thanks the Biotechnology and Biological Sciences Research Council and European Research Council (starting investigator grants). M.K. thanks the EU Innovative Training Network (ProSA) for a studentship. N.T. is funded as a Canadian Institutes of Health Research new investigator and a Michael Smith Foundation of Health Research (MSFHR) career investigator. N.T. thanks Natural Sciences and Engineering Research Council of Canada Discovery Grant RGPIN 418262-12. A.M.B. is funded as a National Health and Medical Research Senior Research Fellow (1022688). This work was supported by the Victorian Life Sciences Computation Initiative, an initiative of the Victorian Government, Australia.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bhabha G, 2013, NAT STRUCT MOL BIOL, V20, P1243, DOI 10.1038/nsmb.2676; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Bora RP, 2015, J PHYS CHEM B, V119, P3434, DOI 10.1021/jp5124025; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; CALDWELL SR, 1991, BIOCHEMISTRY-US, V30, P7438, DOI 10.1021/bi00244a010; Chao FA, 2013, NAT CHEM BIOL, V9, P81, DOI [10.1038/NCHEMBIO.1138, 10.1038/nchembio.1138]; Colletier JP, 2012, MOL BIOL EVOL, V29, P1683, DOI 10.1093/molbev/mss015; Dellus-Gur E, 2015, J MOL BIOL, V427, P2396, DOI 10.1016/j.jmb.2015.05.011; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Fraser JS, 2011, CELL MOL LIFE SCI, V68, P1829, DOI 10.1007/s00018-010-0611-4; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Giger L, 2013, NAT CHEM BIOL, V9, P494, DOI 10.1038/nchembio.1276; Glowacki DR, 2012, NAT CHEM, V4, P169, DOI [10.1038/NCHEM.1244, 10.1038/nchem.1244]; Gobeil SMC, 2014, CHEM BIOL, V21, P1330, DOI 10.1016/j.chembiol.2014.07.016; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Heinz TN, 2001, J CHEM PHYS, V115, P1125, DOI 10.1063/1.1379764; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson CJ, 2009, P NATL ACAD SCI USA, V106, P21631, DOI 10.1073/pnas.0907548106; Jackson CJ, 2008, J MOL BIOL, V375, P1189, DOI 10.1016/j.jmb.2007.10.061; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khersonsky O, 2011, J MOL BIOL, V407, P391, DOI 10.1016/j.jmb.2011.01.041; Kirby AJ, 2009, FROM ENZYME MODELS TO MODEL ENZYMES, P1; Klinman JP, 2014, J BIOL CHEM, V289, P30205, DOI 10.1074/jbc.R114.565515; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Love CA, 1996, GENE, V176, P49, DOI 10.1016/0378-1119(96)00208-9; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Brien PJ, 2010, CURR OPIN CHEM BIOL, V14, P634, DOI 10.1016/j.cbpa.2010.09.009; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Preiswerk N, 2014, P NATL ACAD SCI USA, V111, P8013, DOI 10.1073/pnas.1401073111; Ramanathan A, 2014, ACCOUNTS CHEM RES, V47, P149, DOI 10.1021/ar400084s; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Silva RG, 2011, P NATL ACAD SCI USA, V108, P18661, DOI 10.1073/pnas.1114900108; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Sykora J, 2014, NAT CHEM BIOL, V10, P428, DOI 10.1038/nchembio.1502; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Tokuriki N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2246; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van den Bedem H, 2013, NAT METHODS, V10, P896, DOI [10.1038/NMETH.2592, 10.1038/nmeth.2592]; van den Bedem H, 2009, ACTA CRYSTALLOGR D, V65, P1107, DOI 10.1107/S0907444909030613; Van Wart AT, 2014, J CHEM THEORY COMPUT, V10, P511, DOI 10.1021/ct4008603; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807	60	163	162	2	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					944	+		10.1038/NCHEMBIO.2175	http://dx.doi.org/10.1038/NCHEMBIO.2175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27618189				2022-12-25	WOS:000386798800016
J	Morrison, C				Morrison, Chris			Hope for anti-amyloid antibodies surges, yet again	NATURE BIOTECHNOLOGY			English	News Item																		2009, NAT BIOTECHNOL, V27, P679; 2016, NATURE, V537, P50; 2012, NAT BIOTECHNOL, V30, P731; 2015, NAT BIOTECHNOL, V33, P438	4	5	5	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1082	1083		10.1038/nbt1116-1082b	http://dx.doi.org/10.1038/nbt1116-1082b			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27824840				2022-12-25	WOS:000387506500005
J	Novotny, CJ; Pollari, S; Park, JH; Lemmon, MA; Shen, WJ; Shokat, KM				Novotny, Chris J.; Pollari, Sirkku; Park, Jin H.; Lemmon, Mark A.; Shen, Weijun; Shokat, Kevan M.			Overcoming resistance to HER2 inhibitors through state-specific kinase binding	NATURE CHEMICAL BIOLOGY			English	Article							BREAST-CANCER; STRUCTURAL-ANALYSIS; TRASTUZUMAB EMTANSINE; DOMAIN; ACTIVATION; EGFR; MUTATIONS; MECHANISM; RECEPTOR; PHOSPHORYLATION	The heterodimeric receptor tyrosine kinase complex formed by HER2 and HER3 can act as an oncogenic driver and is also responsible for rescuing a large number of cancers from a diverse set of targeted therapies. Inhibitors of these proteins, particularly HER2, have dramatically improved patient outcomes in the clinic, but recent studies have demonstrated that stimulating the heterodimeric complex, either via growth factors or by increasing the concentrations of HER2 and HER3 at the membrane, significantly diminishes the activity of the inhibitors. To identify an inhibitor of the active HER2-HER3 oncogenic complex, we developed a panel of Ba/F3 cell lines suitable for ultra-high-throughput screening. Medicinal chemistry on the hit scaffold resulted in a previously uncharacterized inhibitor that acts through preferential inhibition of the active state of HER2 and, as a result, is able to overcome cellular mechanisms of resistance such as growth factors or mutations that stabilize the active form of HER2.	[Novotny, Chris J.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Novotny, Chris J.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Pollari, Sirkku; Shen, Weijun] Calif Inst Biomed Res Calibr, La Jolla, CA 92037 USA; [Park, Jin H.; Lemmon, Mark A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Park, Jin H.; Lemmon, Mark A.] Univ Penn, Grad Grp Biochem & Mol Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lemmon, Mark A.] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Lemmon, Mark A.] Yale Univ, Canc Biol Inst, New Haven, CT USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Yale University; Yale University	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.; Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Shen, WJ (corresponding author), Calif Inst Biomed Res Calibr, La Jolla, CA 92037 USA.	wshen@calibr.org; kevan.shokat@ucsf.edu		Shen, Weijun/0000-0001-8388-729X; Lemmon, Mark/0000-0002-3379-5319	Samuel Waxman Cancer Research Foundation; U.S. National Institutes of Health [R01 GM109176-01A1]; Great Rivers Affiliate of the American Heart Association [11PRE7670020]; NIGMS [R01-GM099891]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109176, T32GM064337, R01GM099891] Funding Source: NIH RePORTER	Samuel Waxman Cancer Research Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Great Rivers Affiliate of the American Heart Association(American Heart Association); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Hull, H. Nguyen, M. Wogan, J. Janes, P.G. Schultz and J. Roland from Calibr for technical assistance and helpful discussions. SK-BR-3 cells were a gift from S. Bandyopadhyay, and parental Ba/F3 cells were a gift from N. Shah (both at the University of California, San Francisco, San Francisco, California, USA). This work was supported in part by the Samuel Waxman Cancer Research Foundation (C.J.N., M.A.L. and K.M.S.), the U.S. National Institutes of Health (grant R01 GM109176-01A1 to K.M.S.), the Great Rivers Affiliate of the American Heart Association (predoctoral fellowship 11PRE7670020 to J.H.P.), and NIGMS (grant R01-GM099891 to M.A.L.).	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chandarlapaty S, 2010, ONCOGENE, V29, P325, DOI 10.1038/onc.2009.337; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Das PM, 2010, ONCOGENE, V29, P5214, DOI 10.1038/onc.2010.271; Doerner A, 2015, CHEM BIOL, V22, P776, DOI 10.1016/j.chembiol.2015.05.008; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Greulich H, 2012, P NATL ACAD SCI USA, V109, P14476, DOI 10.1073/pnas.1203201109; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Littlefield P, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005786; Park JH, 2012, BIOCHEM J, V448, P417, DOI 10.1042/BJ20121513; Phillips GDL, 2014, CLIN CANCER RES, V20, P456, DOI 10.1158/1078-0432.CCR-13-0358; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Rexer BN, 2013, CLIN CANCER RES, V19, P5390, DOI 10.1158/1078-0432.CCR-13-1038; Saez R, 2006, CLIN CANCER RES, V12, P424, DOI 10.1158/1078-0432.CCR-05-1807; Sartor CI, 2001, MOL CELL BIOL, V21, P4265, DOI 10.1128/MCB.21.13.4265-4275.2001; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Schneider MR, 2016, ONCOGENE, V35, P2949, DOI 10.1038/onc.2015.372; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sperinde J, 2010, CLIN CANCER RES, V16, P4226, DOI 10.1158/1078-0432.CCR-10-0410; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Vaught DB, 2012, CANCER RES, V72, P2672, DOI 10.1158/0008-5472.CAN-11-3594; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wang ZH, 2011, NAT STRUCT MOL BIOL, V18, P1388, DOI 10.1038/nsmb.2168; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoshida T, 2012, ONCOTARGET, V3, P1533; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	45	24	26	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					923	+		10.1038/NCHEMBIO.2171	http://dx.doi.org/10.1038/NCHEMBIO.2171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27595329	Green Submitted, Green Accepted			2022-12-25	WOS:000386798800013
J	Malherbe, ST; Shenai, S; Ronacher, K; Loxton, AG; Dolganov, G; Kriel, M; Van, T; Chen, RY; Warwick, J; Via, LE; Song, T; Lee, M; Schoolnik, G; Tromp, G; Alland, D; Barry, CE; Winter, J; Walzl, G				Malherbe, Stephanus T.; Shenai, Shubhada; Ronacher, Katharina; Loxton, Andre G.; Dolganov, Gregory; Kriel, Magdalena; Tran Van; Chen, Ray Y.; Warwick, James; Via, Laura E.; Song, Taeksun; Lee, Myungsun; Schoolnik, Gary; Tromp, Gerard; Alland, David; Barry, Clifton E., III; Winter, Jill; Walzl, Gerhard		Catalysis TB-Biomarker Consortium	Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure	NATURE MEDICINE			English	Article							RECURRENT TUBERCULOSIS; PULMONARY IMPAIRMENT; SHORTENING TREATMENT; COMPUTED-TOMOGRAPHY; RISK-FACTORS; RELAPSE; REINFECTION; SYMPTOMS; HIV; MOXIFLOXACIN	The absence of a gold standard to determine when antibiotics induce a sterilizing cure has confounded the development of new approaches to treat pulmonary tuberculosis (PTB). We detected positron emission tomography and computerized tomography (PET-CT) imaging response patterns consistent with active disease, along with the presence of Mycobacterium tuberculosis (MTB) mRNA in sputum and bronchoalveolar lavage samples, in a substantial proportion of adult, HIV-negative patients with PTB after a standard 6-month treatment plus 1 year follow-up, including patients with a durable cure and others who later developed recurrent disease. The presence of MTB mRNA in the context of nonresolving and intensifying lesions on PET-CT images might indicate ongoing transcription, suggesting that even apparently curative treatment for PTB may not eradicate all of the MTB bacteria in most patients. This suggests an important complementary role for the immune response in maintaining a disease-free state. Sterilizing drugs or host-directed therapies, and better treatment response markers, are probably needed for the successful development of improved and shortened PTB-treatment strategies.	[Malherbe, Stephanus T.; Ronacher, Katharina; Loxton, Andre G.; Kriel, Magdalena; Tromp, Gerard; Barry, Clifton E., III; Walzl, Gerhard] Univ Stellenbosch, Natl Res Fdn Ctr Excellence Biomed TB Res, Dept Sci & Technol, Cape Town, South Africa; [Malherbe, Stephanus T.; Ronacher, Katharina; Loxton, Andre G.; Kriel, Magdalena; Tromp, Gerard; Barry, Clifton E., III; Walzl, Gerhard] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, South African Med Res Council,Ctr TB Res, Cape Town, South Africa; [Shenai, Shubhada] Rutgers New Jersey Med Sch, Dept Med, Ctr Emerging Pathogens, Newark, NJ USA; [Dolganov, Gregory; Tran Van] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Chen, Ray Y.; Via, Laura E.] NIAID, TB Res Sect, Lab Clin Infect Dis, Div Intramural Res,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Warwick, James] Tygerberg Acad Hosp, Western Cape Acad Positron Emiss Tomog Computed T, Cape Town, South Africa; [Warwick, James] Univ Stellenbosch, Div Nucl Med, Dept Med Imaging & Clin Oncol, Fac Med & Hlth Sci, Cape Town, South Africa; [Via, Laura E.; Barry, Clifton E., III] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Clin Lab Sci, Cape Town, South Africa; [Song, Taeksun; Lee, Myungsun] Int TB Res Ctr, Seoul, South Korea; [Winter, Jill] Catalysis Fdn Hlth, Emeryville, CA USA; Natl Med Ctr, Seoul, South Korea; NIAID, Biostat Res Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; Univ Stellenbosch, Divis Pulmonol, Fac Med & Hlth Sci, Cape Town, South Africa; Univ Stellenbosch, Fac Med & Hlth Sci, Med Imaging & Clin Oncol, Div Radiodiag, Cape Town, South Africa	National Research Foundation - South Africa; Stellenbosch University; South African Medical Research Council; Stellenbosch University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stellenbosch University; University of Cape Town; National Medical Center - Korea; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stellenbosch University; Stellenbosch University	Malherbe, ST (corresponding author), Univ Stellenbosch, Natl Res Fdn Ctr Excellence Biomed TB Res, Dept Sci & Technol, Cape Town, South Africa.; Malherbe, ST (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, South African Med Res Council,Ctr TB Res, Cape Town, South Africa.	malherbe@sun.ac.za	Via, Laura/AAD-3917-2021; Tromp, Gerard/B-2677-2017; Chen, Ray/GRJ-6736-2022; Chen, Ray/T-5102-2019; Ronacher, Katharina/N-9603-2016; Barry, III, Clifton/H-3839-2012; van der Spuy, Gian/AAY-7701-2020; Barry, Clifton E/ABE-7992-2020; Walzl, Gerhard/N-6371-2016	Via, Laura/0000-0001-6074-9521; Tromp, Gerard/0000-0002-7761-0806; Ronacher, Katharina/0000-0002-6371-1462; Barry, III, Clifton/0000-0002-2927-270X; van der Spuy, Gian/0000-0002-9067-5903; Barry, Clifton E/0000-0002-2927-270X; Malherbe, Stephanus/0000-0002-7563-8231; Walzl, Gerhard/0000-0003-2487-125X; Loxton, Andre/0000-0003-0659-9803; Warwick, James/0000-0002-2810-0543; Beltran, Caroline/0000-0001-5208-0506; du Plessis, Nelita/0000-0001-7881-925X	Catalysis Foundation for Health (CFH); Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Institute of Allergy and Infectious Diseases, International Collaborations in Infectious Disease Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001214, ZIAAI001067] Funding Source: NIH RePORTER	Catalysis Foundation for Health (CFH); Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, International Collaborations in Infectious Disease Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by grants from the Catalysis Foundation for Health (CFH) (G.W., C.E.B. and D.A.) the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (C.E.B.) and the National Institute of Allergy and Infectious Diseases, International Collaborations in Infectious Disease Research (G.W.), as well as by a bursary from the South African National Research Fund and the Medical Research Council's Clinician Scholarship Program (S.T.M.). We thank our participants for their willingness to take part in this study. We acknowledge R. Thayer and M. Urdea of CFH, the staff at the Stellenbosch University Immunology Research Group, the International TB Research Center (Seoul), the Western Cape Academic PET-CT Centre, Ithemba LABS, Tygerberg Academic Hospital's Nuclear Medicine Department and Pulmonology Unit, as well as the managers and healthcare providers from the City of Cape Town Health Department for assistance with the recruitment of participants and sample collection.	Baig IM, 2010, JCPSP-J COLL PHYSICI, V20, P542, DOI 08.2010/JCPSP.542544; Breen RAM, 2008, INT J TUBERC LUNG D, V12, P44; Cheebsumon P, 2011, J NUCL MED, V52, P1550, DOI 10.2967/jnumed.111.088914; Chen RY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009501; Coleman MT, 2014, INFECT IMMUN, V82, P2400, DOI 10.1128/IAI.01599-13; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Demura Y, 2009, EUR J NUCL MED MOL I, V36, P632, DOI 10.1007/s00259-008-1009-5; Dibble EH, 2012, J NUCL MED, V53, P709, DOI 10.2967/jnumed.111.099531; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Dureja S, 2014, EUR SPINE J, V23, P2449, DOI 10.1007/s00586-014-3483-8; Nihues SDE, 2015, BRAZ J INFECT DIS, V19, P492, DOI 10.1016/j.bjid.2015.06.005; Friedrich SO, 2013, LANCET RESP MED, V1, P462, DOI 10.1016/S2213-2600(13)70119-X; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Hesseling AC, 2010, INT J TUBERC LUNG D, V14, P560; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Hu YM, 2000, J BACTERIOL, V182, P6358, DOI 10.1128/JB.182.22.6358-6365.2000; Huang W, 2011, EUR J NUCL MED MOL I, V38, P1628, DOI 10.1007/s00259-011-1838-5; Ignatov DV, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2197-6; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Jones L. M. C. S., TUBERCULIST TB GENE; Lahtinen SJ, 2008, LETT APPL MICROBIOL, V46, P693, DOI 10.1111/j.1472-765X.2008.02374.x; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2013, ANTIMICROB AGENTS CH, V57, P4237, DOI 10.1128/AAC.00277-13; Luzze H, 2013, INT J TUBERC LUNG D, V17, P361, DOI 10.5588/ijtld.11.0692; Marais B, 2008, INT J TUBERC LUNG D, V12, P1217; Martinez V, 2012, INT J TUBERC LUNG D, V16, P1180, DOI 10.5588/ijtld.12.0010; Marx FM, 2014, CLIN INFECT DIS, V58, P1676, DOI 10.1093/cid/ciu186; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Middelkoop K, 2012, INT J TUBERC LUNG D, V16, P1510, DOI 10.5588/ijtld.12.0049; MITCHISON DA, 1979, CHEST, V76, P771, DOI 10.1378/chest.76.6_Supplement.771; MITTL RL, 1994, AM J RESP CRIT CARE, V149, P630, DOI 10.1164/ajrccm.149.3.8118630; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Pasipanodya JG, 2007, CHEST, V132, P1591, DOI 10.1378/chest.07-0755; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; Pasipanodya JG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-259; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Ramos Lucia Maria Macedo, 2006, J. bras. pneumol., V32, P43, DOI 10.1590/S1806-37132006000100010; Rustad TR, 2013, NUCLEIC ACIDS RES, V41, P509, DOI 10.1093/nar/gks1019; Sathekge M, 2011, J NUCL MED, V52, P880, DOI 10.2967/jnumed.110.083709; Seon HJ, 2014, INT J TUBERC LUNG D, V18, P341, DOI 10.5588/ijtld.13.0565; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Stelzmueller I, 2016, CLIN NUCL MED, V41, pE187, DOI 10.1097/RLU.0000000000001102; Stop TB Partnership, 2016, GLOB PLAN STOP TB 20; Via LE, 2012, ANTIMICROB AGENTS CH, V56, P4391, DOI 10.1128/AAC.00531-12; Walter ND, 2015, J INFECT DIS, V212, P990, DOI 10.1093/infdis/jiv149; Warner DF, 2014, NEW ENGL J MED, V371, P1642, DOI 10.1056/NEJMe1410977; Wejse C, 2008, SCAND J INFECT DIS, V40, P111, DOI 10.1080/00365540701558698; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2015, GLOB TUB REP 2015; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996	52	167	174	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1094	1100		10.1038/nm.4177	http://dx.doi.org/10.1038/nm.4177			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27595324	Green Accepted			2022-12-25	WOS:000384872500012
J	Stellos, K; Gatsiou, A; Stamatelopoulos, K; Matic, LP; John, D; Lunella, FF; Jae, N; Rossbach, O; Amrhein, C; Sigala, F; Boon, RA; Furtig, B; Manavski, Y; You, XT; Uchida, S; Keller, T; Boeckel, JN; Franco-Cereceda, A; Maegdefessel, L; Chen, W; Schwalbe, H; Bindereif, A; Eriksson, P; Hedin, U; Zeiher, AM; Dimmeler, S				Stellos, Konstantinos; Gatsiou, Aikaterini; Stamatelopoulos, Kimon; Matic, Ljubica Perisic; John, David; Lunella, Federica Francesca; Jae, Nicolas; Rossbach, Oliver; Amrhein, Carolin; Sigala, Frangiska; Boon, Reinier A.; Fuertig, Boris; Manavski, Yosif; You, Xintian; Uchida, Shizuka; Keller, Till; Boeckel, Jes-Niels; Franco-Cereceda, Anders; Maegdefessel, Lars; Chen, Wei; Schwalbe, Harald; Bindereif, Albrecht; Eriksson, Per; Hedin, Ulf; Zeiher, Andreas M.; Dimmeler, Stefanie			Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation	NATURE MEDICINE			English	Article							BINDING PROTEIN HUR; HUMAN TRANSCRIPTOME; GENE-EXPRESSION; MESSENGER-RNA; ALU ELEMENTS; TUMOR-GROWTH; ENZYME ADAR1; LUNG INJURY; ANGIOGENESIS; STABILIZATION	Adenosine-to-inosine (A-to-I) RNA editing, which is catalyzed by a family of adenosine deaminase acting on RNA (ADAR) enzymes, is important in the epitranscriptomic regulation of RNA metabolism. However, the role of A-to-I RNA editing in vascular disease is unknown. Here we show that cathepsin S mRNA (CTSS), which encodes a cysteine protease associated with angiogenesis and atherosclerosis, is highly edited in human endothelial cells. The 3' untranslated region (3' UTR) of the CTSS transcript contains two inverted repeats, the AluJo and AluSx(+) regions, which form a long stem loop structure that is recognized by ADAR1 as a substrate for editing. RNA editing enables the recruitment of the stabilizing RNA-binding protein human antigen R (HuR; encoded by ELAVL1) to the 3' UTR of the CTSS transcript, thereby controlling CTSS mRNA stability and expression. In endothelial cells, ADAR1 overexpression or treatment of cells with hypoxia or with the inflammatory cytokines interferon-gamma and tumor-necrosis-factor-alpha induces CTSS RNA editing and consequently increases cathepsin S expression. ADAR1 levels and the extent of CTSS RNA editing are associated with changes in cathepsin S levels in patients with atherosclerotic vascular diseases, including subclinical atherosclerosis, coronary artery disease, aortic aneurysms and advanced carotid atherosclerotic disease. These results reveal a previously unrecognized role of RNA editing in gene expression in human atherosclerotic vascular diseases.	[Stellos, Konstantinos; Gatsiou, Aikaterini; John, David; Lunella, Federica Francesca; Jae, Nicolas; Amrhein, Carolin; Boon, Reinier A.; Manavski, Yosif; Uchida, Shizuka; Boeckel, Jes-Niels; Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, Frankfurt, Germany; [Stellos, Konstantinos; Keller, Till; Zeiher, Andreas M.] Goethe Univ Frankfurt, Ctr Internal Med, Dept Cardiol, Frankfurt, Germany; [Stellos, Konstantinos; Gatsiou, Aikaterini; John, David; Lunella, Federica Francesca; Jae, Nicolas; Boon, Reinier A.; Manavski, Yosif; Uchida, Shizuka; Keller, Till; Boeckel, Jes-Niels; Zeiher, Andreas M.; Dimmeler, Stefanie] Deutsch Zentrum Herz Kreislaufforsch DZHK, German Ctr Cardiovasc Res, Rhein Main Partner Site, Frankfurt, Germany; [Stamatelopoulos, Kimon] Univ Athens, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece; [Matic, Ljubica Perisic; Hedin, Ulf] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Rossbach, Oliver; Bindereif, Albrecht] Univ Giessen, Inst Biochem, Giessen, Germany; [Sigala, Frangiska] Univ Athens, Hippocratio Gen Hosp, Propaedeut Dept Surg 1, Dept Vasc Surg, Athens, Greece; [Fuertig, Boris; Schwalbe, Harald] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Organ Chem & Chem Biol, Frankfurt, Germany; [You, Xintian; Chen, Wei] Max Delbruck Ctr Mol Med Berlin Buch, Lab Funct Genom & Syst Biol, Berlin, Germany; [Franco-Cereceda, Anders] Karolinska Inst, Dept Mol Med & Surg, Cardiothorac Surg Unit, Stockholm, Sweden; [Maegdefessel, Lars; Eriksson, Per] Karolinska Inst, Dept Med, Cardiovasc Med Unit, Stockholm, Sweden; [Maegdefessel, Lars] Tech Univ Munich, Dept Vasc & Endovasc Surg, Munich, Germany	Goethe University Frankfurt; Goethe University Frankfurt; German Centre for Cardiovascular Research; Alexandra Hospital; National & Kapodistrian University of Athens; Karolinska Institutet; Justus Liebig University Giessen; National & Kapodistrian University of Athens; Goethe University Frankfurt; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Karolinska Institutet; Karolinska Institutet; Technical University of Munich	Stellos, K; Dimmeler, S (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, Frankfurt, Germany.; Stellos, K (corresponding author), Goethe Univ Frankfurt, Ctr Internal Med, Dept Cardiol, Frankfurt, Germany.; Stellos, K; Dimmeler, S (corresponding author), Deutsch Zentrum Herz Kreislaufforsch DZHK, German Ctr Cardiovasc Res, Rhein Main Partner Site, Frankfurt, Germany.	konstantinos.stellos@gmail.com; dimmeler@em.uni-frankfurt.de	Rossbach, Oliver/AAO-2529-2020; Boon, Reinier A/E-8423-2011; Stamatelopoulos, Kimon/AAD-6993-2019; Uchida, Shizuka/AAC-6781-2019; Stellos, Konstantinos/AAF-2711-2020; Stellos, Konstantinos/ABH-1523-2021; Schwalbe, Harald J/F-9023-2010; Maegdefessel, Lars/AAW-8243-2020; Schwalbe, Harald/AAB-3143-2020; Maegdefessel, Lars/C-2955-2015	Boon, Reinier A/0000-0001-7944-9748; Stamatelopoulos, Kimon/0000-0001-6444-8734; Uchida, Shizuka/0000-0003-4787-8067; Schwalbe, Harald J/0000-0001-5693-7909; Schwalbe, Harald/0000-0001-5693-7909; YOU, Xintian/0000-0002-1684-7084; Gatsiou, Aikaterini/0000-0003-4144-4305; Maegdefessel, Lars/0000-0001-5228-2634; Keller, Till/0000-0002-0895-6491; Eriksson, Per/0000-0002-5635-2692; Rossbach, Oliver/0000-0002-1172-0359; Dimmeler, Stefanie/0000-0002-1045-2436; John, David/0000-0003-3217-5449; Stellos, Konstantinos/0000-0002-0194-0825; Hedin, Ulf/0000-0001-9212-3945	'FFF-Innovation' program of the J.W. Goethe University Frankfurt; August-Scheidel Stiftung; Excellence Cluster Cardio-Pulmonary System (ECCPS); Else Kroner-Fresenius-Stiftung; LOEWE Center for Cell and Gene Therapy (State of Hessen); German Center for Cardiovascular Research (DZHK); German Cardiac Society; DFG [SFB902]; Swedish Heart and Lung Foundation; Karolinska Institutet; Stockholm County Council; Foundation for Strategic Research; European Commission; Swedish Society for Medical Research (SSMF); Swedish Research Council; Swedish Heart-Lung Foundation; LOEWE program 'Medical RNomics' (State of Hessen); Uppdrag Besegra Stroke	'FFF-Innovation' program of the J.W. Goethe University Frankfurt; August-Scheidel Stiftung; Excellence Cluster Cardio-Pulmonary System (ECCPS)(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; LOEWE Center for Cell and Gene Therapy (State of Hessen); German Center for Cardiovascular Research (DZHK); German Cardiac Society; DFG(German Research Foundation (DFG)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Foundation for Strategic Research; European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Society for Medical Research (SSMF); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); LOEWE program 'Medical RNomics' (State of Hessen); Uppdrag Besegra Stroke	This work was funded by the 'FFF-Innovation 2012' program of the J.W. Goethe University Frankfurt (K. Stellos), the August-Scheidel Stiftung (K. Stellos), the Excellence Cluster Cardio-Pulmonary System (ECCPS) (K. Stellos), the Else Kroner-Fresenius-Stiftung (K. Stellos), the LOEWE Center for Cell and Gene Therapy (State of Hessen) (K. Stellos), the German Center for Cardiovascular Research (DZHK) (K. Stellos) and the German Cardiac Society (K. Stellos). H.S. and S.D. are members of the cluster of excellence 'macromolecular complexes. B.F., H.S. and S.D. are supported by DFG SFB902. The BiKE study (U.H.) was conducted with support from the Swedish Heart and Lung Foundation, the Swedish Research Council, Uppdrag Besegra Stroke, the Strategic Cardiovascular Programs of Karolinska Institutet and the Stockholm County Council, the Foundation for Strategic Research and the European Commission (CarTarDis, AtheroRemo, VIA and AtheroFlux projects). L.P.M. was supported by the Swedish Society for Medical Research (SSMF). The thoracic aortic aneurysm study (P.E.) was supported by the Swedish Research Council, the Swedish Heart-Lung Foundation and a donation by F. Lundberg. O.R. is supported by the LOEWE program 'Medical RNomics' (State of Hessen). The authors would like to thank I. Dikic (Goethe University Frankfurt) for providing us with the HeLa cells, A. Knau for expert technical support, G. Georgiopoulos for statistical consulting, R. Achangwa and M. Sachse for proofreading, M. Karakitsou for technical assistance in subclinical atherosclerosis assessment, and A. Mareti, C. Kritsioti and A. Kotsogianni for helping with the recruitment of patients of the PBMC cohort.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Barak M, 2009, NUCLEIC ACIDS RES, V37, P6905, DOI 10.1093/nar/gkp729; Bass BL, 1997, RNA, V3, P947; Bazak L, 2014, NUCLEIC ACIDS RES, V42, P6876, DOI 10.1093/nar/gku414; Chang SH, 2013, J BIOL CHEM, V288, P4908, DOI 10.1074/jbc.M112.423871; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Daniel C, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r28; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Folkersen L, 2011, MOL MED, V17, P1365, DOI 10.2119/molmed.2011.00286; Gandy SZ, 2007, J VIROL, V81, P13544, DOI 10.1128/JVI.01521-07; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Holdt LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003588; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Jobs E, 2011, JAMA-J AM MED ASSOC, V306, P1113, DOI 10.1001/jama.2011.1246; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2622, DOI 10.1161/01.ATV.0000246779.78003.cf; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Nemlich Y, 2013, J CLIN INVEST, V123, P2703, DOI 10.1172/JCI62980; Nevo-Caspi Y, 2011, SHOCK, V35, P585, DOI 10.1097/SHK.0b013e31820fe4b7; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Perisic L, 2016, J INTERN MED, V279, P293, DOI 10.1111/joim.12448; Qiu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.125; Rabinovici R, 2001, CIRC RES, V88, P1066, DOI 10.1161/hh1001.090877; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Stamatelopoulos K, 2015, J AM COLL CARDIOL, V65, P904, DOI 10.1016/j.jacc.2014.12.035; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Wu YM, 2009, SHOCK, V31, P410, DOI 10.1097/SHK.0b013e31817c1068; Wulff BE, 2011, NAT REV GENET, V12, P81, DOI 10.1038/nrg2915; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yang JH, 2003, IMMUNOLOGY, V109, P15, DOI 10.1046/j.1365-2567.2003.01598.x	52	159	163	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1140	1150		10.1038/nm.4172	http://dx.doi.org/10.1038/nm.4172			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27595325				2022-12-25	WOS:000384872500017
J	Mitchell, AJ; Zhu, Q; Maggiolo, AO; Ananth, NR; Hillwig, ML; Liu, XY; Boal, AK				Mitchell, Andrew J.; Zhu, Qin; Maggiolo, Ailiena O.; Ananth, Nikhil R.; Hillwig, Matthew L.; Liu, Xinyu; Boal, Amie K.			Structural basis for halogenation by iron- and 2-oxo-glutarate-dependent enzyme WelO5	Nature Chemical Biology			English	Article							ALIPHATIC HALOGENASE; ALPHA-KETOGLUTARATE; CRYSTAL-STRUCTURE; BIOSYNTHESIS; SYRB2; CRYSTALLOGRAPHY; CHLORINATION; INTERMEDIATE; HYDROXYLASES; MECHANISM	A 2.4-angstrom-resolution X-ray crystal structure of the carrier-protein-independent halogenase WelO5 in complex with its welwitindolinone precursor substrate, 12-epi-fischerindole U, reveals that the C13 chlorination target is proximal to the anticipated site of the oxo group in a presumptive cis-halo-oxo-iron(IV) (haloferryl) intermediate. Prior study of related halogenases forecasts substrate hydroxylation in this active-site configuration, but X-ray crystallographic verification of C13 halogenation in single crystals mandates that ligand dynamics must reposition the oxygen ligand to enable the observed outcome. S189A WelO5 produces a mixture of halogenation and hydroxylation products, showing that an outer-sphere hydrogen-bonding group orchestrates ligand movements to achieve a configuration that promotes halogen transfer.	[Mitchell, Andrew J.; Maggiolo, Ailiena O.; Ananth, Nikhil R.; Boal, Amie K.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Zhu, Qin; Hillwig, Matthew L.; Liu, Xinyu] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Boal, Amie K.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Boal, AK (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Liu, XY (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.; Boal, AK (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	xinyuliu@pitt.edu; akb20@psu.edu		Maggiolo, Ailiena/0000-0003-1707-5060; Mitchell, Andrew/0000-0003-3726-6569; Hillwig, Matthew/0000-0002-1168-4191	US National Institutes of Health [GM100011]; Searle Scholars Program; Department of Chemistry at the University of Pittsburgh; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]; US federal funds from the National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119707, R00GM100011] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Department of Chemistry at the University of Pittsburgh; US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor; US federal funds from the National Cancer Institute; National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R.J. Martinie, C. Krebs, and J.M. Bollinger, Jr. for critical discussions and reading of the manuscript. We acknowledge D. Smith, J. Brunzelle, and the staff at the CCP4/APS School for Macromolecular Crystallography for assistance with X-ray data collection and analysis. This work has been supported by US National Institutes of Health grant GM100011 (A.K.B.), the Searle Scholars Program (A.K.B.), and the Department of Chemistry at the University of Pittsburgh (X.L.). Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). GM/CA CAT has been funded in whole or in part with US federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104).	Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Bollinger JM, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P95; Borowski T, 2010, J AM CHEM SOC, V132, P12887, DOI 10.1021/ja101877a; Chang WC, 2014, SCIENCE, V343, P1140, DOI 10.1126/science.1248000; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Galonic DP, 2006, J AM CHEM SOC, V128, P3900, DOI 10.1021/ja060151n; Gu LC, 2009, NATURE, V459, P731, DOI 10.1038/nature07870; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hillwig ML, 2016, ANGEW CHEM INT EDIT, V55, P5780, DOI 10.1002/anie.201601447; Hillwig ML, 2014, NAT CHEM BIOL, V10, P921, DOI [10.1038/NCHEMBIO.1625, 10.1038/nchembio.1625]; Hillwig ML, 2014, CHEMBIOCHEM, V15, P665, DOI 10.1002/cbic.201300794; Hillwig ML, 2014, ACS CHEM BIOL, V9, P372, DOI 10.1021/cb400681n; Jiang W, 2011, BIOCHEMISTRY-US, V50, P6063, DOI 10.1021/bi200656k; Khare D, 2010, P NATL ACAD SCI USA, V107, P14099, DOI 10.1073/pnas.1006738107; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Kulik HJ, 2013, J BIOL CHEM, V288, P11233, DOI 10.1074/jbc.M112.415570; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Martinie RJ, 2015, J AM CHEM SOC, V137, P6912, DOI 10.1021/jacs.5b03370; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neumann CS, 2008, J AM CHEM SOC, V130, P14022, DOI 10.1021/ja8064667; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandian S, 2009, DALTON T, P6201, DOI 10.1039/b906866j; Podgorsek A, 2009, ANGEW CHEM INT EDIT, V48, P8424, DOI 10.1002/anie.200901223; Pratter SM, 2014, CHEMBIOCHEM, V15, P567, DOI 10.1002/cbic.201300345; Que L, 2000, NAT STRUCT BIOL, V7, P182, DOI 10.1038/73270; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; TENEYCK LF, 1985, METHOD ENZYMOL, V115, P324; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong C, 2009, J AM CHEM SOC, V131, P4872, DOI 10.1021/ja8097355; Wong SD, 2013, NATURE, V499, P320, DOI 10.1038/nature12304; Zhang ZH, 2002, FEBS LETT, V517, P7, DOI 10.1016/S0014-5793(02)02520-6; Zhu Q, 2016, CHEMBIOCHEM, V17, P466, DOI 10.1002/cbic.201500674	43	83	83	6	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2016	12	8					636	+		10.1038/NCHEMBIO.2112	http://dx.doi.org/10.1038/NCHEMBIO.2112			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2UW	27348090	Green Accepted			2022-12-25	WOS:000380640100011
J	Ohira, T; Suzuki, T				Ohira, Takayuki; Suzuki, Tsutomu			Precursors of tRNAs are stabilized by methylguanosine cap structures	Nature Chemical Biology			English	Article							RAPID TRANSFER-RNA; YEAST SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; NONCODING RNAS; NUCLEAR EXPORT; DECAY; GENE; PURIFICATION; DEGRADATION; IDENTIFICATION	Efficient maturation of transfer RNAs (tRNAs) is required for rapid cell growth. However, the precise timing of tRNA processing in coordination with the order of tRNA modifications has not been thoroughly elucidated. To analyze the modification status of tRNA precursors (pre-tRNAs) during maturation, we isolated pre-tRNAs at various stages from Saccharomyces cerevisiae and subjected them to MS analysis. We detected methylated guanosine cap structures at the 5' termini of pre-tRNAs bearing 5' leader sequences. These capped pre-tRNAs accumulated substantially after inhibition of RNase P activity. Upon depletion of the capping enzyme Ceg1p, the steady state level of capped pre-tRNA was markedly reduced. In addition, a population of capped pre-tRNAs accumulated in strains in which 5' exonucleases were inhibited, indicating that the 5' cap structures protect pre-tRNAs from 5'-exonucleolytic degradation during maturation.	[Ohira, Takayuki; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan	University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.	ts@chembio.t.u-tokyo.ac.jp	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y. Sakaguchi, K. Miyauchi, T. Suzuki and other members of T. S.'s laboratory for technical support and discussion. We also thank Y. Ohya (University of Tokyo), T. Yoshihisa (University of Hyogo) and M. Werner (Institute of Biology and Technology-Saclay) for providing materials. This work was supported by Grants-in-Aid for Young Scientists (B) (T.O.) and by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, and Culture of Japan (T.S.).	Abdelhamid RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102895; AEBI M, 1990, J BIOL CHEM, V265, P16216; Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Boon KL, 2010, FEBS LETT, V584, P3299, DOI 10.1016/j.febslet.2010.07.001; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Cook AG, 2009, NATURE, V461, P60, DOI 10.1038/nature08394; Copela LA, 2008, RNA, V14, P1214, DOI 10.1261/rna.1050408; DEROBERTIS EM, 1979, NATURE, V278, P137, DOI 10.1038/278137a0; Dewe JM, 2012, RNA, V18, P1886, DOI 10.1261/rna.033654.112; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; GARBER RL, 1979, CELL, V18, P817, DOI 10.1016/0092-8674(79)90134-X; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; Guy MP, 2014, GENE DEV, V28, P1721, DOI 10.1101/gad.245936.114; HARADA F, 1984, NUCLEIC ACIDS RES, V12, P9263, DOI 10.1093/nar/12.24.9263; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hiley SL, 2005, NUCLEIC ACIDS RES, V33, P3048, DOI 10.1093/nar/gki608; Hopper AK, 2013, GENETICS, V194, P43, DOI 10.1534/genetics.112.147470; ITOH N, 1984, J BIOL CHEM, V259, P3923; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; KOSKI RA, 1982, J BIOL CHEM, V257, P4514; Kramer EB, 2013, P NATL ACAD SCI USA, V110, P21042, DOI 10.1073/pnas.1316579110; Kufel J, 2003, RNA, V9, P202, DOI 10.1261/rna.2145103; Lee Y, 1997, RNA, V3, P175; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; Miyauchi K, 2013, NAT CHEM BIOL, V9, P105, DOI [10.1038/NCHEMBIO.1137, 10.1038/nchembio.1137]; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Murguia JR, 1996, J BIOL CHEM, V271, P29029, DOI 10.1074/jbc.271.46.29029; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; OCONNOR JP, 1991, MOL CELL BIOL, V11, P425, DOI 10.1128/MCB.11.1.425; Ohira T, 2013, J BIOL CHEM, V288, P7645, DOI 10.1074/jbc.M112.439554; Ohira T, 2011, P NATL ACAD SCI USA, V108, P10502, DOI 10.1073/pnas.1105645108; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Sakaguchi Y, 2015, METHOD ENZYMOL, V560, P19, DOI 10.1016/bs.mie.2015.03.015; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; Shaheen HH, 2005, P NATL ACAD SCI USA, V102, P11290, DOI 10.1073/pnas.0503836102; Skowronek E, 2014, RNA, V20, P115, DOI 10.1261/rna.041467.113; STEVENS A, 1980, J BIOL CHEM, V255, P3080; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Takano A, 2005, SCIENCE, V309, P140, DOI 10.1126/science.1113346; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Thuillier V, 1996, EMBO J, V15, P618, DOI 10.1002/j.1460-2075.1996.tb00394.x; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Whipple JM, 2011, GENE DEV, V25, P1173, DOI [10.1101/gad.2050711, 10.1101/gad.2050711.]; WILLIS I, 1986, J BIOL CHEM, V261, P5878; Wilusz JE, 2011, SCIENCE, V334, P817, DOI 10.1126/science.1213671; YAMAGISHI M, 1995, MOL GEN GENET, V249, P147, DOI 10.1007/BF00290360; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757; Yukawa Y, 2011, GENOMICS, V97, P166, DOI 10.1016/j.ygeno.2010.12.001	53	35	35	4	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2016	12	8					648	+		10.1038/NCHEMBIO.2117	http://dx.doi.org/10.1038/NCHEMBIO.2117			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2UW	27348091				2022-12-25	WOS:000380640100013
J	Garber, K				Garber, Ken			Bristol-Myers Squibb locks into novel autoimmune strategy	NATURE BIOTECHNOLOGY			English	News Item																			0	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2016	34	6					577	579		10.1038/nbt0616-577	http://dx.doi.org/10.1038/nbt0616-577			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DO5TT	27281396				2022-12-25	WOS:000377846400003
J	Gordon, CT; Xue, SF; Yigit, G; Filali, H; Chen, K; Rosins, N; Yoshiura, K; Oufadem, M; Beck, TJ; McGowan, R; Magee, AC; Altmuller, J; Dion, C; Thiele, H; Gurzau, AD; Nurnberg, P; Meschede, D; Muhlbauer, W; Okamoto, N; Varghese, V; Irving, R; Sigaudy, S; Williams, D; Ahmed, SF; Bonnard, C; Kong, MK; Ratbi, I; Fejjal, N; Fikri, M; Elalaoui, SC; Reigstad, H; Bole-Feysot, C; Nitschke, P; Ragge, N; Levy, N; Tuncbilek, G; Teo, ASM; Cunningham, ML; Sefiani, A; Kayserili, H; Murphy, JM; Chatdokmaiprai, C; Hillmer, AM; Wattanasirichaigoon, D; Lyonnet, S; Magdinier, F; Javed, A; Blewitt, ME; Amiel, J; Wollnik, B; Reversade, B				Gordon, Christopher T.; Xue, Shifeng; Yigit, Goekhan; Filali, Hicham; Chen, Kelan; Rosins, Nadine; Yoshiura, Koh-ichiro; Oufadem, Myriam; Beck, Tamara J.; McGowan, Ruth; Magee, Alex C.; Altmueller, Janine; Dion, Camille; Thiele, Holger; Gurzau, Alexandra D.; Nuernberg, Peter; Meschede, Dieter; Muehlbauer, Wolfgang; Okamoto, Nobuhiko; Varghese, Vinod; Irving, Rachel; Sigaudy, Sabine; Williams, Denise; Ahmed, S. Faisal; Bonnard, Carine; Kong, Mung Kei; Ratbi, Ilham; Fejjal, Nawfal; Fikri, Meriem; Elalaoui, Siham Chafai; Reigstad, Hallvard; Bole-Feysot, Christine; Nitschke, Patrick; Ragge, Nicola; Levy, Nicolas; Tuncbilek, Goekhan; Teo, Audrey S. M.; Cunningham, Michael L.; Sefiani, Abdelaziz; Kayserili, Huelya; Murphy, James M.; Chatdokmaiprai, Chalermpong; Hillmer, Axel M.; Wattanasirichaigoon, Duangrurdee; Lyonnet, Stanislas; Magdinier, Frederique; Javed, Asif; Blewitt, Marnie E.; Amiel, Jeanne; Wollnik, Bernd; Reversade, Bruno			De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal development	NATURE GENETICS			English	Article							INACTIVE X-CHROMOSOME; STRUCTURAL-MAINTENANCE; HINGE DOMAIN; METHYLATION; REPAIR; GHKL	Bosma arhinia microphthalmia syndrome (BAMS) is an extremely rare and striking condition characterized by complete absence of the nose with or without ocular defects. We report here that missense mutations in the epigenetic regulator SMCHD1 mapping to the extended ATPase domain of the encoded protein cause BAMS in all 14 cases studied. All mutations were de novo where parental DNA was available. Biochemical tests and in vivo assays in Xenopus laevis embryos suggest that these mutations may behave as gain-of-function alleles. This finding is in contrast to the loss-of-function mutations in SMCHD1 that have been associated with facioscapulohumeral muscular dystrophy (FSHD) type 2. Our results establish SMCHD1 as a key player in nasal development and provide biochemical insight into its enzymatic function that may be exploited for development of therapeutics for FSHD.	[Gordon, Christopher T.; Filali, Hicham; Oufadem, Myriam; Lyonnet, Stanislas; Amiel, Jeanne] INSERM, Inst Imagine, Lab Embryol & Genet Congenital Malformat, UMR 1163, Paris, France; [Gordon, Christopher T.; Filali, Hicham; Oufadem, Myriam; Bole-Feysot, Christine; Nitschke, Patrick; Lyonnet, Stanislas; Amiel, Jeanne] Sorbonne Paris Cite, Inst Imagine, Paris, France; [Xue, Shifeng; Bonnard, Carine; Kong, Mung Kei; Reversade, Bruno] ASTAR, Inst Med Biol, Human Genet & Embryol Lab, Singapore, Singapore; [Xue, Shifeng; Reversade, Bruno] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Yigit, Goekhan; Rosins, Nadine; Wollnik, Bernd] Univ Med Ctr Gottingen, Inst Human Genet, Gottingen, Germany; [Filali, Hicham; Ratbi, Ilham; Elalaoui, Siham Chafai; Sefiani, Abdelaziz] Mohammed V Univ, Fac Med & Pharm, Ctr Genom Humaine, Rabat, Morocco; [Chen, Kelan; Gurzau, Alexandra D.; Murphy, James M.; Blewitt, Marnie E.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Chen, Kelan; Gurzau, Alexandra D.; Murphy, James M.; Blewitt, Marnie E.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Yoshiura, Koh-ichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki, Japan; [McGowan, Ruth] Queen Elizabeth Univ Hosp, West Scotland Reg Genet Serv, Glasgow, Lanark, Scotland; [Magee, Alex C.] Belfast City Hosp, Northern Ireland Reg Genet Serv, Belfast, Antrim, North Ireland; [Altmueller, Janine; Thiele, Holger; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Altmueller, Janine; Wollnik, Bernd] Univ Cologne, Inst Human Genet, Cologne, Germany; [Altmueller, Janine; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Dion, Camille] Aix Marseille Univ, INSERM, Genet Med & Genom Fonct, UMRS 910, Marseille, France; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Muehlbauer, Wolfgang] ATOS Klin Munchen, Plast & Asthet Chirurg, Munich, Germany; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Izumi, Osaka, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Izumi, Osaka, Japan; [Varghese, Vinod; Irving, Rachel] Univ Wales Hosp, Inst Med Genet, Cardiff, S Glam, Wales; [Sigaudy, Sabine; Levy, Nicolas] Hop Enfants La Timone, AP HP, Dept Med Genet, Marseille, France; [Williams, Denise; Ragge, Nicola] Birmingham Womens NHS Fdn Trust, West Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Ahmed, S. Faisal] Univ Glasgow, RHC, Dev Endocrinol Res Grp, Glasgow, Lanark, Scotland; [Fejjal, Nawfal] Mohammed V Univ, CHU Ibn Sina, Hop Enfants, Serv Chirurg Plast Pediatr, Rabat, Morocco; [Fikri, Meriem] Mohammed V Univ, CHU Ibn Sina, Hop Specialites, Serv Neuroradiol, Rabat, Morocco; [Elalaoui, Siham Chafai; Sefiani, Abdelaziz] Natl Inst Hyg, Dept Med Genet, Rabat, Morocco; [Reigstad, Hallvard] Haukeland Hosp, Childrens Dept, Neonatal Intens Care Unit, Bergen, Norway; [Bole-Feysot, Christine] INSERM, Inst Imagine, Genom Platform, UMR 1163, Paris, France; [Nitschke, Patrick] INSERM, Inst Imagine, Bioinformat Platform, UMR 1163, Paris, France; [Ragge, Nicola] Oxford Brookes Univ, Fac Hlth & Life Sci, Oxford, England; [Tuncbilek, Goekhan] Hacettepe Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Ankara, Turkey; [Teo, Audrey S. M.; Hillmer, Axel M.; Javed, Asif] ASTAR, Genome Inst Singapore, Canc Therapeut & Stratified Oncol, Singapore, Singapore; [Cunningham, Michael L.] Univ Washington, Dept Pediat, Div Craniofacial Med, Seattle, WA 98195 USA; [Cunningham, Michael L.] Seattle Childrens Hosp, Craniofacial Ctr, Seattle, WA 98105 USA; [Kayserili, Huelya; Reversade, Bruno] Koc Univ, Sch Med, Dept Med Genet, Istanbul, Turkey; [Chatdokmaiprai, Chalermpong] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Surg,Plast & Maxillofacial Surg, Bangkok, Thailand; [Wattanasirichaigoon, Duangrurdee] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Med Genet,Dept Pediat, Bangkok, Thailand; [Lyonnet, Stanislas; Amiel, Jeanne] Hop Necker Enfants Malad, AP HP, Dept Genet, Paris, France; [Reversade, Bruno] Natl Univ Singapore, Sch Med, Dept Paediat, Singapore, Singapore; [Reversade, Bruno] Acad Med Ctr, Amsterdam Reprod & Dev, Amsterdam, Netherlands; [Reversade, Bruno] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Gottingen; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Walter & Eliza Hall Institute; University of Melbourne; Nagasaki University; Queen Elizabeth University Hospital (QEUH); Belfast City Hospital; University of Cologne; University of Cologne; University of Cologne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Cologne; Osaka Medical Center for Cancer & Cardiovascular Diseases; Cardiff University; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Glasgow; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; University of Bergen; Haukeland University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Oxford Brookes University; Hacettepe University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Washington; University of Washington Seattle; Seattle Children's Hospital; Koc University; Mahidol University; Mahidol University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; National University of Singapore; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Amiel, J (corresponding author), INSERM, Inst Imagine, Lab Embryol & Genet Congenital Malformat, UMR 1163, Paris, France.; Amiel, J (corresponding author), Sorbonne Paris Cite, Inst Imagine, Paris, France.; Reversade, B (corresponding author), ASTAR, Inst Med Biol, Human Genet & Embryol Lab, Singapore, Singapore.; Reversade, B (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.; Wollnik, B (corresponding author), Univ Med Ctr Gottingen, Inst Human Genet, Gottingen, Germany.; Wollnik, B (corresponding author), Univ Cologne, Inst Human Genet, Cologne, Germany.; Reversade, B (corresponding author), Koc Univ, Sch Med, Dept Med Genet, Istanbul, Turkey.; Amiel, J (corresponding author), Hop Necker Enfants Malad, AP HP, Dept Genet, Paris, France.; Reversade, B (corresponding author), Natl Univ Singapore, Sch Med, Dept Paediat, Singapore, Singapore.; Reversade, B (corresponding author), Acad Med Ctr, Amsterdam Reprod & Dev, Amsterdam, Netherlands.; Reversade, B (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands.	jeanne.amiel@inserm.fr; bernd.wollnik@med.uni-goettingen.de; bruno@reversade.com	Lyonnet, Stanislas/H-5483-2017; Javed, Asif/Q-5904-2019; Filali, Hicham/D-1279-2014; Thiele, Holger/ABE-6792-2020; Wollnik, Bernd/GRY-6062-2022; amiel, jeanne/H-3501-2017; LEVY, Nicolas/J-1632-2014; amiel, jeanne/AGX-1124-2022; Magdinier, Frederique/I-4735-2016; Murphy, James/B-4863-2017; Gordon, Chris/F-1267-2017; Hillmer, Axel/B-7485-2015	Lyonnet, Stanislas/0000-0001-5426-9417; Filali, Hicham/0000-0003-3352-740X; Thiele, Holger/0000-0002-0169-998X; Wollnik, Bernd/0000-0003-2589-0364; amiel, jeanne/0000-0001-5973-4728; LEVY, Nicolas/0000-0001-5171-6365; Magdinier, Frederique/0000-0002-0159-9559; Murphy, James/0000-0003-0195-3949; Gordon, Chris/0000-0002-9300-8399; REVERSADE, Bruno/0000-0002-4070-7997; Hillmer, Axel/0000-0002-3381-7266; Xue, Shifeng/0000-0002-4668-5952; Chen, Kelan/0000-0003-1973-5405; Gurzau, Alexandra/0000-0001-8664-0698; Beck, Tamara/0000-0002-1125-1871; Javed, Asif/0000-0002-6945-9624; Altmuller, Janine/0000-0003-4372-1521; Blewitt, Marnie/0000-0002-2984-1474	Jean Renny Endowed Chair for Craniofacial Research; French Ministry of Education and Research; INSERM; inaugural AAA Fellowship in Amsterdam; Agence Nationale de la Recherche (CranioRespiro) [ANR-10-IAHU-01]; Cancer Council Victoria; National Health and Medical Research Council (NHMRC) of Australia [1098290, 1110206, 1105754]; Scientific and Technological Research Council of Turkey (TUBITAK) [112S398]; Scientific and Technological Research Council of Turkey (TUBITAK) (E-RARE network CRANIRARE-2); Association Francaise contre les Myopathies (AFM); Victorian State Government Operational Infrastructure Support; NHMRC TRUSS grant [9000220]; German Federal Ministry of Education and Research (BMBF) [01GM1211A]; German Federal Ministry of Education and Research (BMBF) (E-RARE network CRANIRARE-2); German Research Foundation [SFB1002]; MACS; VICTA; Baillie Gifford grant; Faculty of Medicine Ramathibodi Hospital; A<SUP>star</SUP>STAR JCO Career Development grant; A<SUP>star</SUP>STAR BMRC Young Investigator Grant; Strategic Positioning Fund on Genetic Orphan Diseases from the Biomedical Research Council, A<SUP>star</SUP>STAR, Singapore; MRC [MR/N003403/1] Funding Source: UKRI	Jean Renny Endowed Chair for Craniofacial Research; French Ministry of Education and Research; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); inaugural AAA Fellowship in Amsterdam; Agence Nationale de la Recherche (CranioRespiro)(French National Research Agency (ANR)); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Scientific and Technological Research Council of Turkey (TUBITAK) (E-RARE network CRANIRARE-2)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Victorian State Government Operational Infrastructure Support; NHMRC TRUSS grant(National Health and Medical Research Council (NHMRC) of Australia); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF) (E-RARE network CRANIRARE-2)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); MACS; VICTA; Baillie Gifford grant; Faculty of Medicine Ramathibodi Hospital; A<SUP>star</SUP>STAR JCO Career Development grant; A<SUP>star</SUP>STAR BMRC Young Investigator Grant; Strategic Positioning Fund on Genetic Orphan Diseases from the Biomedical Research Council, A<SUP>star</SUP>STAR, Singapore; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank all family members and their relatives for their participation and kind contribution to this study. N. Akarsu was instrumental for recruiting patient 11. Support from the Jean Renny Endowed Chair for Craniofacial Research (M.L.C.) is acknowledged. C.D. is the recipient of a fellowship from the French Ministry of Education and Research. H.F. was supported by a postdoctoral grant from INSERM. B.R. is a fellow of the Branco Weiss Foundation, an A<SUP>star</SUP>STAR Investigator, an EMBO Young Investigator and a recipient of the inaugural AAA Fellowship in Amsterdam. This work was supported by funding from the Agence Nationale de la Recherche (ANR-10-IAHU-01, CranioRespiro), the Cancer Council Victoria (fellowship to K.C.), the National Health and Medical Research Council (NHMRC) of Australia to M.E.B. and J.M.M. (1098290 and fellowships 1110206 and 1105754), the Scientific and Technological Research Council of Turkey (TUBITAK) to H.K. (grant 112S398, E-RARE network CRANIRARE-2), the Association Francaise contre les Myopathies (AFM) to F.M., Victorian State Government Operational Infrastructure Support, an NHMRC TRUSS grant (9000220), the German Federal Ministry of Education and Research (BMBF) to B.W. (grant 01GM1211A, E-RARE network CRANIRARE-2), the German Research Foundation (SFB1002, project D02) to B.W., MACS, VICTA and Baillie Gifford grant support to N. Ragge, Mahidol University and Research Career Development Awards from the Faculty of Medicine Ramathibodi Hospital to D. Wattanasirichaigoon, an A<SUP>star</SUP>STAR JCO Career Development grant to A.J., an A<SUP>star</SUP>STAR BMRC Young Investigator Grant to S.X. and a Strategic Positioning Fund on Genetic Orphan Diseases from the Biomedical Research Council, A<SUP>star</SUP>STAR, Singapore, to B.R.	Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Brasseur B, 2016, AM J MED GENET A, V170, P1302, DOI 10.1002/ajmg.a.37572; Brideau NJ, 2015, MOL CELL BIOL, V35, P4053, DOI 10.1128/MCB.00432-15; Chen KL, 2016, BIOCHEM J, V473, P1733, DOI 10.1042/BCJ20160189; Chen KL, 2015, P NATL ACAD SCI USA, V112, pE3535, DOI 10.1073/pnas.1504232112; Coker H, 2014, J CELL SCI, V127, P1869, DOI 10.1242/jcs.140020; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Forni PE, 2015, FRONT NEUROENDOCRIN, V36, P165, DOI 10.1016/j.yfrne.2014.09.004; Gendrel AV, 2013, MOL CELL BIOL, V33, P3150, DOI 10.1128/MCB.00145-13; Gendrel AV, 2012, DEV CELL, V23, P265, DOI 10.1016/j.devcel.2012.06.011; Graham JM, 2006, AM J MED GENET A, V140A, P189, DOI 10.1002/ajmg.a.31039; Hewitt JE, 2015, HUM MOL GENET, V24, pR17, DOI 10.1093/hmg/ddv237; Lemmers RJLF, 2015, HUM MOL GENET, V24, P659, DOI 10.1093/hmg/ddu486; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Mould AW, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-19; Nickell MD, 2012, J COMP NEUROL, V520, P2608, DOI 10.1002/cne.23052; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Sacconi S, 2013, AM J HUM GENET, V93, P744, DOI 10.1016/j.ajhg.2013.08.004; Shaw N. D., 2017, NAT GENET; Szabo-Rogers HL, 2009, DEVELOPMENT, V136, P219, DOI 10.1242/dev.023978; Tang MF, 2014, J BIOL CHEM, V289, P34024, DOI 10.1074/jbc.M114.601179; Tryggestad Jeanie B, 2013, J Med Case Rep, V7, P52, DOI 10.1186/1752-1947-7-52	24	56	59	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					249	255		10.1038/ng.3765	http://dx.doi.org/10.1038/ng.3765			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	28067911	Green Published, Green Accepted			2022-12-25	WOS:000393148600013
J	van Arensbergen, J; FitzPatrick, VD; de Haas, M; Pagie, L; Sluimer, J; Bussemaker, HJ; van Steensel, B				van Arensbergen, Joris; FitzPatrick, Vincent D.; de Haas, Marcel; Pagie, Ludo; Sluimer, Jasper; Bussemaker, Harmen J.; van Steensel, Bas			Genome-wide mapping of autonomous promoter activity in human cells	NATURE BIOTECHNOLOGY			English	Article							PARALLEL REPORTER ASSAY; LONG TERMINAL REPEAT; CORE-PROMOTER; IN-VIVO; SYSTEMATIC DISSECTION; ENDOGENOUS RETROVIRUS; ENHANCER ACTIVITIES; GENE-EXPRESSION; TRANSCRIPTION; INITIATION	Previous methods to systematically characterize sequence-intrinsic activity of promoters have been limited by relatively low throughput and the length of the sequences that could be tested. Here we present 'survey of regulatory elements' (SuRE), a method that assays more than 108 DNA fragments, each 0.2-2 kb in size, for their ability to drive transcription autonomously. In SuRE, a plasmid library of random genomic fragments upstream of a 20-bp barcode is constructed, and decoded by paired end sequencing. This library is used to transfect cells, and barcodes in transcribed RNA are quantified by high-throughput sequencing. When applied to the human genome, we achieve 55-fold genome coverage, allowing us to map autonomous promoter activity genome-wide in K562 cells. By computational modeling we delineate subregions within promoters that are relevant for their activity. We show that antisense promoter transcription is generally dependent on the sense core promoter sequences, and that most enhancers and several families of repetitive elements act as autonomous transcription initiation sites.	[van Arensbergen, Joris; de Haas, Marcel; Pagie, Ludo; Sluimer, Jasper; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [FitzPatrick, Vincent D.; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [FitzPatrick, Vincent D.; Bussemaker, Harmen J.] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10027 USA	Netherlands Cancer Institute; Columbia University; Columbia University	van Arensbergen, J; van Steensel, B (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands.; Bussemaker, HJ (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.; Bussemaker, HJ (corresponding author), Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10027 USA.	j.v.arensbergen@nki.nl; hjb2004@columbia.edu; b.v.steensel@nki.nl		Bussemaker, Harmen/0000-0002-7274-5277	ERC [293662]; NWO-ALW VICI; NIH [R01HG003008, S10OD021764, T32GM008281]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281, T32GM008798] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021764] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); NWO-ALW VICI(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the NKI Genomics Core Facility for technical support, J. Omar lafiez Cuna for scripts and advice, and members of our laboratories for helpful discussions, and T. Rube in particular for suggesting the 2D analysis of CpG content. Supported by ERC Advanced Grant 293662 and NWO-ALW VICI (B.v.S.); NIH grants R01HG003008 and S10OD021764 (H.LB.); and NIH grants R01HG003008 and S10OD021764 and T32GM008281 (V.D.F.). Addgene plasmid #49157 is a gift from James Thomson, University of Wisconsin, Madison.	Amer E, 2015, SCIENCE, V347, P1010, DOI DOI 10.1126/SCIENCE.1259418; Andersson R, 2015, BIOESSAYS, V37, P314, DOI 10.1002/bies.201400162; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; DEAN A, 1983, P NATL ACAD SCI-BIOL, V80, P5515, DOI 10.1073/pnas.80.18.5515; Dickel DE, 2014, NAT METHODS, V11, P566, DOI [10.1038/NMETH.2886, 10.1038/nmeth.2886]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duttke SHC, 2015, MOL CELL, V57, P674, DOI 10.1016/j.molcel.2014.12.029; Farley EK, 2015, SCIENCE, V350, P325, DOI 10.1126/science.aac6948; Faulkner GJ, 2008, GENOMICS, V91, P281, DOI 10.1016/j.ygeno.2007.11.003; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Kwasnieski JC, 2014, GENOME RES, V24, P1595, DOI 10.1101/gr.173518.114; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; Landolin JM, 2010, GENOME RES, V20, P890, DOI 10.1101/gr.100370.109; Ling JH, 2002, J VIROL, V76, P2410, DOI 10.1128/JVI.76.5.2410-2423.2002; Lubliner S, 2015, GENOME RES, V25, P1008, DOI 10.1101/gr.188193.114; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Mogno I, 2013, GENOME RES, V23, P1908, DOI 10.1101/gr.157891.113; Murtha M, 2014, NAT METHODS, V11, P559, DOI [10.1038/nmeth.2885, 10.1038/NMETH.2885]; Nguyen TA, 2016, GENOME RES, V26, P1023, DOI 10.1101/gr.204834.116; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Smith RP, 2013, NAT GENET, V45, P1021, DOI 10.1038/ng.2713; Tahara T, 2004, BIOCHEM BIOPH RES CO, V324, P77, DOI 10.1016/j.bbrc.2004.09.022; TEMIN HM, 1981, CELL, V27, P1, DOI 10.1016/0092-8674(81)90353-6; VANASSENDELFT GB, 1989, CELL, V56, P969, DOI 10.1016/0092-8674(89)90630-2; Yu XP, 2005, J BIOL CHEM, V280, P35184, DOI 10.1074/jbc.M508138200; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	46	47	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2017	35	2					145	153		10.1038/nbt.3754	http://dx.doi.org/10.1038/nbt.3754			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EK7BP	28024146	Green Accepted			2022-12-25	WOS:000394080800020
J	Mohimani, H; Gurevich, A; Mikheenko, A; Garg, N; Nothias, LF; Ninomiya, A; Takada, K; Dorrestein, PC; Pevzner, PA				Mohimani, Hosein; Gurevich, Alexey; Mikheenko, Alla; Garg, Neha; Nothias, Louis-Felix; Ninomiya, Akihiro; Takada, Kentaro; Dorrestein, Pieter C.; Pevzner, Pavel A.			Dereplication of peptidic natural products through database search of mass spectra	NATURE CHEMICAL BIOLOGY			English	Article							MOLECULAR NETWORKING; BACILLUS-SUBTILIS; POSTTRANSLATIONAL MODIFICATIONS; NONRIBOSOMAL PEPTIDES; PSEUDOMONAS-TOLAASII; DRUG DISCOVERY; GENE-CLUSTER; A-E; GENOME; SPECTROMETRY	Peptidic natural products (PNPs) are widely used compounds that include many antibiotics and a variety of other bioactive peptides. Although recent breakthroughs in PNP discovery raised the challenge of developing new algorithms for their analysis, identification of PNPs via database search of tandem mass spectra remains an open problem. To address this problem, natural product researchers use dereplication strategies that identify known PNPs and lead to the discovery of new ones, even in cases when the reference spectra are not present in existing spectral libraries. DEREPLICATOR is a new dereplication algorithm that enables high-throughput PNP identification and that is compatible with large-scale mass-spectrometry-based screening platforms for natural product discovery. After searching nearly one hundred million tandem mass spectra in the Global Natural Products Social (GNPS) molecular networking infrastructure, DEREPLICATOR identified an order of magnitude more PNPs (and their new variants) than any previous dereplication efforts.	[Mohimani, Hosein; Pevzner, Pavel A.] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Gurevich, Alexey; Mikheenko, Alla; Pevzner, Pavel A.] St Petersburg State Univ, Inst Translat Biomed, Ctr Algorithm Biotechnol, St Petersburg, Russia; [Garg, Neha; Nothias, Louis-Felix; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Collaborat Mass Spectrometry Innovat Ctr, La Jolla, CA 92093 USA; [Ninomiya, Akihiro; Takada, Kentaro] Univ Tokyo, Sch Agr & Life Sci, Lab Aquat Nat Prod Chem, Tokyo, Japan; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Saint Petersburg State University; University of California System; University of California San Diego; University of Tokyo; University of California System; University of California San Diego	Pevzner, PA (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.; Pevzner, PA (corresponding author), St Petersburg State Univ, Inst Translat Biomed, Ctr Algorithm Biotechnol, St Petersburg, Russia.	ppevzner@ucsd.edu	Gurevich, Alexey/Q-6888-2016; Mikheenko, Alla/G-6405-2018; Dorrestein, Pieter/ABF-2930-2020; Takada, Kentaro/AAH-7191-2020; Garg, Neha/L-3120-2018	Gurevich, Alexey/0000-0002-5855-3519; Mikheenko, Alla/0000-0003-3400-9719; Takada, Kentaro/0000-0003-3835-1482; Garg, Neha/0000-0002-2760-7123	US National Institutes of Health [2-P41-GM103484]; Russian Science Foundation [14-50-00069];  [GM097509]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097509, P41GM103484] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Wang and N. Bandeira for insightful suggestions on using molecular networking and spectral library search, and M. Medema for guidelines on running antiSMASH. The work of N.M., P.D. and P.A.P. was supported by the US National Institutes of Health (grant 2-P41-GM103484). P.D. is supported by GM097509. A.G., A.M. and P.A.P. were supported by Russian Science Foundation (grant 14-50-00069).	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Balkovec JM, 2014, NAT PROD REP, V31, P15, DOI 10.1039/c3np70070d; Bandeira N, 2007, BIOTECHNIQUES, V42, P687, DOI 10.2144/000112487; Bandeira N, 2007, P NATL ACAD SCI USA, V104, P6140, DOI 10.1073/pnas.0701130104; Bassarello C, 2004, J NAT PROD, V67, P811, DOI 10.1021/np0303557; Blunt J.W., 2007, ANTIMARIN DATABASE; Bouslimani A, 2015, P NATL ACAD SCI USA, V112, pE2120, DOI 10.1073/pnas.1424409112; Bumpus SB, 2009, NAT BIOTECHNOL, V27, P951, DOI 10.1038/nbt.1565; da Silva RR, 2015, P NATL ACAD SCI USA, V112, P12549, DOI 10.1073/pnas.1516878112; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Duncan KR, 2015, CHEM BIOL, V22, P460, DOI 10.1016/j.chembiol.2015.03.010; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gerard J, 1997, J NAT PROD, V60, P223, DOI 10.1021/np9606456; Gonzalez DJ, 2011, MICROBIOL-SGM, V157, P2485, DOI 10.1099/mic.0.048736-0; Govaerts C, 2003, RAPID COMMUN MASS SP, V17, P1366, DOI 10.1002/rcm.1058; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; HASENBOHLER A, 1974, ARCH MICROBIOL, V99, P307, DOI 10.1007/BF00696245; Hathout Y, 2000, J NAT PROD, V63, P1492, DOI 10.1021/np000169q; Ibrahim A, 2012, P NATL ACAD SCI USA, V109, P19196, DOI 10.1073/pnas.1206376109; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Liu WT, 2014, J ANTIBIOT, V67, P99, DOI 10.1038/ja.2013.99; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Medema MH, 2015, NAT CHEM BIOL, V11, P639, DOI [10.1038/nchembio.1884, 10.1038/NCHEMBIO.1884]; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; Mohimani H, 2016, NAT PROD REP, V33, P73, DOI 10.1039/c5np00050e; Mohimani H, 2014, ACS CHEM BIOL, V9, P1545, DOI 10.1021/cb500199h; Mohimani H, 2013, J PROTEOME RES, V12, P1560, DOI 10.1021/pr300453t; Mohimani H, 2011, J COMPUT BIOL, V18, P1371, DOI 10.1089/cmb.2011.0158; Ng J, 2009, NAT METHODS, V6, P596, DOI 10.1038/nmeth.1350; NUTKINS JC, 1991, J AM CHEM SOC, V113, P2621, DOI 10.1021/ja00007a040; Penn K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-86; Pesic A, 2013, MAR DRUGS, V11, P4834, DOI 10.3390/md11124834; PEYPOUX F, 1986, J ANTIBIOT, V39, P636, DOI 10.7164/antibiotics.39.636; Reybroeck W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098266; Sheil M., 2005, J MASS SPECTROM, V28, P574; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Takada K, 2013, J ORG CHEM, V78, P6746, DOI 10.1021/jo400708u; Traxler MF, 2013, MBIO, V4, DOI 10.1128/mBio.00459-13; Tsuge K, 1999, ANTIMICROB AGENTS CH, V43, P2183, DOI 10.1128/AAC.43.9.2183; Tsur D, 2005, NAT BIOTECHNOL, V23, P1562, DOI 10.1038/nbt1168; Vaniya A, 2015, TRAC-TREND ANAL CHEM, V69, P52, DOI 10.1016/j.trac.2015.04.002; Walsh CT, 2015, NAT CHEM BIOL, V11, P620, DOI 10.1038/nchembio.1894; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s; Zaburannyi N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-97	50	124	127	2	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					30	37		10.1038/NCHEMBIO.2219	http://dx.doi.org/10.1038/NCHEMBIO.2219			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27820803	Green Accepted			2022-12-25	WOS:000393267200010
J	Zhu, SY; Li, W; Liu, JZ; Chen, CH; Liao, Q; Xu, P; Xu, H; Xiao, TF; Cao, ZZ; Peng, JY; Yuan, PF; Brown, M; Liu, XLS; Wei, WS				Zhu, Shiyou; Li, Wei; Liu, Jingze; Chen, Chen-Hao; Liao, Qi; Xu, Ping; Xu, Han; Xiao, Tengfei; Cao, Zhongzheng; Peng, Jingyu; Yuan, Pengfei; Brown, Myles; Liu, Xiaole Shirley; Wei, Wensheng			Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; FUNCTIONAL GENOMICS; CRISPR/CAS9 LIBRARY; ESSENTIAL GENES; ACTIVATION; SYSTEM; DNA; IDENTIFICATION; REPRESSION; CANCER	CRISPR-Cas9 screens have been widely adopted to analyze coding-gene functions, but high-throughput screening of non-coding elements using this method is more challenging because indels caused by a single cut in non-coding regions are unlikely to produce a functional knockout. A high-throughput method to produce deletions of non-coding DNA is needed. We report a high throughput genomic deletion strategy to screen for functional long non-coding RNAs (IncRNAs) that is based on a lentiviral paired-guide RNA (pgRNA) library. Applying our screening method, we identified 51 IncRNAs that can positively or negatively regulate human cancer cell growth. We validated 9 of 51 IncRNA hits using CRISPR-Cas9-mediated genomic deletion, functional rescue, CRISPR activation or inhibition and gene-expression profiling. Our high-throughput pgRNA genome deletion method will enable rapid identification of functional mammalian non-coding elements.	[Zhu, Shiyou; Liu, Jingze; Xu, Ping; Cao, Zhongzheng; Peng, Jingyu; Yuan, Pengfei; Wei, Wensheng] Peking Univ, State Key Lab Prot & Plant Gene Res, Sch Life Sci,Biodynam Opt Imaging Ctr BIOPIC, Beijing Adv Innovat Ctr Genom,Peking Tsinghua Ctr, Beijing, Peoples R China; [Zhu, Shiyou; Liu, Jingze] Peking Univ, Peking Univ Tsinghua Univ Natl Inst Biol Sci Join, Beijing, Peoples R China; [Li, Wei; Chen, Chen-Hao; Liu, Xiaole Shirley] Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Li, Wei; Chen, Chen-Hao; Xiao, Tengfei; Brown, Myles; Liu, Xiaole Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Liao, Qi] Ningbo Univ, Sch Med, Dept Prevent Med, Ningbo, Zhejiang, Peoples R China; [Xu, Han] Broad Inst MIT & Harvard, Cambridge Ctr, Cambridge, MA USA; [Xiao, Tengfei; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA USA; [Cao, Zhongzheng] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China; [Brown, Myles] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Brown, Myles] Harvard Med Sch, Boston, MA USA	Peking University; Peking University; Tsinghua University; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Ningbo University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Peking University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wei, WS (corresponding author), Peking Univ, State Key Lab Prot & Plant Gene Res, Sch Life Sci,Biodynam Opt Imaging Ctr BIOPIC, Beijing Adv Innovat Ctr Genom,Peking Tsinghua Ctr, Beijing, Peoples R China.; Liu, XLS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.; Liu, XLS (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA.	xsliu.dfci@gmail.com; wswei@pku.edu.cn	Wei, Wensheng/AAF-1325-2020; Brown, Myles/B-6906-2008; Brown, Myles/AAX-5332-2021	Brown, Myles/0000-0002-8213-1658; Li, Wei/0000-0002-2163-7903; Wei, Wensheng/0000-0002-8053-2423	National Science Foundation of China [NSFC31430025, NSFC31170126, NSFC81471909]; Peking-Tsinghua Center for Life Sciences; NIH grant [U01 CA180980, R01 HG008728]; Claudia Adams Barr Award in Innovative Basic Cancer Research from the Dana-Farber Cancer Institute; Beijing Advanced Innovation Center for Genomics at Peking University; NATIONAL CANCER INSTITUTE [U01CA180980] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008728] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking-Tsinghua Center for Life Sciences; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Adams Barr Award in Innovative Basic Cancer Research from the Dana-Farber Cancer Institute; Beijing Advanced Innovation Center for Genomics at Peking University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the staff of the BIOPIC sequencing facility (Peking University) for their assistance, and National Center for Protein Sciences Beijing (Peking University) for help in Fluorescence Activated Cell Sorting. The project was supported by funds from the National Science Foundation of China (NSFC31430025, NSFC31170126, NSFC81471909), Beijing Advanced Innovation Center for Genomics at Peking University, and the Peking-Tsinghua Center for Life Sciences (to VV.W), the NIH grant U01 CA180980 (to X.S.L.), R01 HG008728 (to M.B. and X.S.L.), and the Claudia Adams Barr Award in Innovative Basic Cancer Research from the Dana-Farber Cancer Institute.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Du Z, 2013, NAT STRUCT MOL BIOL, V20, P908, DOI 10.1038/nsmb.2591; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Han JX, 2014, RNA BIOL, V11, P829, DOI 10.4161/rna.29624; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Peng JY, 2015, FEBS J, V282, P2089, DOI 10.1111/febs.13251; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Ren QP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08865; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yin YF, 2015, CELL STEM CELL, V16, P504, DOI 10.1016/j.stem.2015.03.007; Zheng QP, 2014, BIOTECHNIQUES, V57, P115, DOI 10.2144/000114196; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	35	261	279	7	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1279	1286		10.1038/nbt.3715	http://dx.doi.org/10.1038/nbt.3715			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27798563	Green Accepted			2022-12-25	WOS:000390185300019
J	Stevens, MM; Maire, CL; Chou, N; Murakami, MA; Knoff, DS; Kikuchi, Y; Kimmerling, RJ; Liu, HY; Haidar, S; Calistri, NL; Cermak, N; Olcum, S; Cordero, NA; Idbaih, A; Wen, PY; Weinstock, DM; Ligon, KL; Manalis, SR				Stevens, Mark M.; Maire, Cecile L.; Chou, Nigel; Murakami, Mark A.; Knoff, David S.; Kikuchi, Yuki; Kimmerling, Robert J.; Liu, Huiyun; Haidar, Samer; Calistri, Nicholas L.; Cermak, Nathan; Olcum, Selim; Cordero, Nicolas A.; Idbaih, Ahmed; Wen, Patrick Y.; Weinstock, David M.; Ligon, Keith L.; Manalis, Scott R.			Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate	NATURE BIOTECHNOLOGY			English	Article							RESISTANCE; RECLASSIFICATION; GLIOBLASTOMA; CHEMOTHERAPY; MECHANISMS; MEDICINE; LEUKEMIA; GROWTH; SIZE	Assays that can determine the response of tumor cells to cancer therapeutics could greatly aid the selection of drug regimens for individual patients. However, the utility of current functional assays is limited, and predictive genetic biomarkers are available for only a small fraction of cancer therapies. We found that the single-cell mass accumulation rate (MAR), profiled over many hours with a suspended microchannel resonator, accurately defined the drug sensitivity or resistance of glioblastoma and B-cell acute lymphocytic leukemia cells. MAR revealed heterogeneity in drug sensitivity not only between different tumors, but also within individual tumors and tumor-derived cell lines. MAR measurement predicted drug response using samples as small as 25 ml of peripheral blood while maintaining cell viability and compatibility with downstream characterization. MAR measurement is a promising approach for directly assaying single-cell therapeutic responses and for identifying cellular subpopulations with phenotypic resistance in heterogeneous tumors.	[Stevens, Mark M.; Murakami, Mark A.; Kimmerling, Robert J.; Liu, Huiyun; Cermak, Nathan; Cordero, Nicolas A.; Manalis, Scott R.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Stevens, Mark M.] MIT, Dept Biol, Cambridge, MA USA; [Maire, Cecile L.; Murakami, Mark A.; Knoff, David S.; Liu, Huiyun; Haidar, Samer; Cordero, Nicolas A.; Weinstock, David M.; Ligon, Keith L.] Harvard Med Sch, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA USA; [Chou, Nigel; Kimmerling, Robert J.; Manalis, Scott R.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kikuchi, Yuki] Hitachi High Technol Corp, Ibaraki, Japan; [Cermak, Nathan] MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Idbaih, Ahmed] UFMC Univ Paris 06, Sorbonne Univ, CNRS, UMR 7225,INSERM U 1127,UMR S 1127,ICM,Inst Cervea, Paris, France; [Idbaih, Ahmed] Hop Univ La Pitie Salpetriere Charles Foix, AP HP, Serv Neurol Mazarin 2, Faris, France; [Wen, Patrick Y.] Harvard Med Sch, Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA USA; [Weinstock, David M.; Ligon, Keith L.] Broad Inst, Cambridge, MA USA; [Ligon, Keith L.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Manalis, Scott R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts Institute of Technology (MIT); Hitachi Limited; Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT)	Manalis, SR (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Weinstock, DM; Ligon, KL (corresponding author), Harvard Med Sch, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA USA.; Manalis, SR (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Weinstock, DM; Ligon, KL (corresponding author), Broad Inst, Cambridge, MA USA.; Ligon, KL (corresponding author), Boston Childrens Hosp, Dept Pathol, Boston, MA USA.; Ligon, KL (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Manalis, SR (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	davidm_weinstock@dfci.harvard.edu; keith_lligon@dfci.harvard.edu; srm@mit.edu	Wen, Patrick/AAE-3776-2022; Idbaih, Ahmed/N-8746-2017	Idbaih, Ahmed/0000-0001-5290-1204; Calistri, Nicholas/0000-0002-8541-0919; Knoff, David/0000-0001-6233-2893; Cermak, Nathan/0000-0002-8389-8236; Chou, Shijie, Nigel/0000-0002-6280-7729; Stevens, Mark/0000-0001-9207-4979	US National Institutes of Health [R01 CA170592, P50 CA165962, P01 CA112536, R33 CA191113]; National Cancer Institute [U54 CA143874, P30 CA14051, T32 CA009172]; Koch Institute for Integrative Cancer Research at MIT; Dana-Farber/Harvard Cancer Center (DF/HCC); Dana-Farber Cancer Institute Brain Tumor Therapeutics Accelerator Program; Vondation ARC pour la Recherche sur le Cancer; Institut Universitaire de Cancerologie; Onco Neuro Theque; program Investissements d'aveniC [ANR-10-IAIHU-06]; NIHNIGMS [T32 GM008334]; Interdepartmental Biotechnology Training Program grant; National Science Scholarship, Agency for Science, Technology and Research (STAR), Singapore; NATIONAL CANCER INSTITUTE [P01CA142536, T32CA009172, R33CA191143, R01CA170592, P50CA165962, U54CA143874, R01CA188228, P30CA014051, DP1CA174420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM087237, T32GM008334] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Koch Institute for Integrative Cancer Research at MIT; Dana-Farber/Harvard Cancer Center (DF/HCC); Dana-Farber Cancer Institute Brain Tumor Therapeutics Accelerator Program; Vondation ARC pour la Recherche sur le Cancer; Institut Universitaire de Cancerologie; Onco Neuro Theque; program Investissements d'aveniC(French National Research Agency (ANR)); NIHNIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Interdepartmental Biotechnology Training Program grant; National Science Scholarship, Agency for Science, Technology and Research (STAR), Singapore; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by R01 CA170592 (S.R.M., K.L.L.,P.Y.W.), P50 CA165962 (K.L.L., P.Y.W), P01 CA112536 (K.L.L.) and R33 CA191113 (S.R.M., D.M.W.) from the US National Institutes of Health, U54 CA143874 from the National Cancer Institute (S.R.M), and partially by Cancer Center Support (core) Grant P30 CA14051 from the National Cancer Institute, The Bridge Project, a partnership between the Koch Institute for Integrative Cancer Research at MIT and the Dana-Farber/Harvard Cancer Center (DF/HCC) (S.R.M,D.M.W.), and the Dana-Farber Cancer Institute Brain Tumor Therapeutics Accelerator Program (P.Y.W., K.L.L.). A.I. acknowledges support from Vondation ARC pour la Recherche sur le Cancer, The Institut Universitaire de Cancerologie, Onco Neuro Theque and the program Investissements d'aveniC ANR-10-IAIHU-06. M.M.S. acknowledges support from the NIHNIGMS T32 GM008334, Interdepartmental Biotechnology Training Program grant, N. Chou acknowledges support from the National Science Scholarship, Agency for Science, Technology and Research (STAR), Singapore. D.M.W. is a Leukemia and Lymphoma Scholar. M.A.M. gratefully acknowledges support from the institutional research training grant T32 CA009172, from the National Cancer Institute.	Andreeff M, 2016, CLIN CANCER RES, V22, P868, DOI 10.1158/1078-0432.CCR-15-0481; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Burstein HJ, 2011, J CLIN ONCOL, V29, P3328, DOI 10.1200/JCO.2011.36.0354; Byun S, 2015, BIOPHYS J, V109, P1565, DOI 10.1016/j.bpj.2015.08.038; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cermak N., 2016, NAT BIOTECHNOL; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Deleyrolle LP, 2011, BRAIN, V134, P1331, DOI 10.1093/brain/awr081; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Jeay S, 2015, ELIFE, V4, DOI 10.7554/eLife.06498; Jonas O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010564; Klco JM, 2013, BLOOD, V121, P1633, DOI 10.1182/blood-2012-09-459313; Klempner SJ, 2013, CANCER DISCOV, V3, P1345, DOI 10.1158/2159-8290.CD-13-0063; Lane AA, 2014, NAT GENET, V46, P618, DOI 10.1038/ng.2949; Lathia JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024807; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Son S, 2012, NAT METHODS, V9, P910, DOI 10.1038/nmeth.2133; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Verreault M, 2016, CLIN CANCER RES, V22, P1185, DOI 10.1158/1078-0432.CCR-15-1015; Wu SQ, 2016, BIOSENS BIOELECTRON, V77, P164, DOI 10.1016/j.bios.2015.09.024	31	68	73	4	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1161	+		10.1038/nbt.3697	http://dx.doi.org/10.1038/nbt.3697			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27723727	Green Accepted, Green Submitted			2022-12-25	WOS:000387506500028
J	Hansel-Hertsch, R; Beraldi, D; Lensing, SV; Marsico, G; Zyner, K; Parry, A; Di Antonio, M; Pike, J; Kimura, H; Narita, M; Tannahill, D; Balasubramanian, S				Hansel-Hertsch, Robert; Beraldi, Dario; Lensing, Stefanie V.; Marsico, Giovanni; Zyner, Katherine; Parry, Aled; Di Antonio, Marco; Pike, Jeremy; Kimura, Hiroshi; Narita, Masashi; Tannahill, David; Balasubramanian, Shankar			G-quadruplex structures mark human regulatory chromatin	NATURE GENETICS			English	Article							SMALL-MOLECULE; HUMAN GENOME; DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; FORMING SEQUENCES; BINDING; TARGETS; MOTIFS; CELLS; TRANSCRIPTION	G-quadruplex (G4) structural motifs have been linked to transcription(1,2), replication(3) and genome instability(4,5) and are implicated in cancer and other diseases(6-8). However, it is crucial to demonstrate the bona fide formation of G4 structures within an endogenous chromatin context(9,10). Herein we address this through the development of G4 ChIP-seq, an antibody-based G4 chromatin immunoprecipitation and high-throughput sequencing approach. We find similar to 10,000 G4 structures in human chromatin, predominantly in regulatory, nucleosome-depleted regions. G4 structures are enriched in the promoters and 5' UTRs of highly transcribed genes, particularly in genes related to cancer and in somatic copy number amplifications, such as MYC. Strikingly, de novo and enhanced G4 formation are associated with increased transcriptional activity, as shown by HDAC inhibitor-induced chromatin relaxation and observed in immortalized as compared to normal cellular states. Our findings show that regulatory, nucleosome-depleted chromatin and elevated transcription shape the endogenous human G4 DNA landscape.	[Hansel-Hertsch, Robert; Beraldi, Dario; Lensing, Stefanie V.; Marsico, Giovanni; Zyner, Katherine; Parry, Aled; Pike, Jeremy; Narita, Masashi; Tannahill, David; Balasubramanian, Shankar] Li Ka Shing Ctr, Cambridge Inst, Canc Res UK, Cambridge, England; [Di Antonio, Marco; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge, England; [Kimura, Hiroshi] Tokyo Inst Technol, Inst Innovat Res, Cell Biol Unit, Yokohama, Kanagawa, Japan; [Balasubramanian, Shankar] Univ Cambridge, Sch Clin Med, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Tokyo Institute of Technology; University of Cambridge	Balasubramanian, S (corresponding author), Li Ka Shing Ctr, Cambridge Inst, Canc Res UK, Cambridge, England.; Balasubramanian, S (corresponding author), Univ Cambridge, Dept Chem, Cambridge, England.; Balasubramanian, S (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge, England.	sb10031@cam.ac.uk	Pike, Jeremy/B-3995-2017; Balasubramanian, Shankar/C-1671-2009; Kimura, Hiroshi/B-9524-2015	Pike, Jeremy/0000-0003-4163-0335; Kimura, Hiroshi/0000-0003-0854-083X; Narita, Masashi/0000-0001-7764-577X; Tannahill, David/0000-0002-3811-6864; Di Antonio, Marco/0000-0002-7321-1867; Balasubramanian, Shankar/0000-0002-0281-5815; Zyner, Katherine/0000-0002-4997-0150; Beraldi, Dario/0000-0003-1504-5212; Haensel-Hertsch, Robert/0000-0002-2835-4471; Parry, Aled/0000-0001-5192-3727	European Molecular Biology Organization; EMBO Long-Term Fellowship; University of Cambridge; Cancer Research UK [C14303/A17197]; Wellcome Trust [099232/z/12/z]; Cancer Research UK [19836, 15890, 18618] Funding Source: researchfish	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK)	The authors would like to thank the staff at the Genomic and Light Microscopy and Biorepository core facilities at Cancer Research UK Cambridge Institute. We are grateful to the European Molecular Biology Organization for funding R.H.-H. with the EMBO Long-Term Fellowship. We acknowledge support from University of Cambridge and Cancer Research UK program. The Balasubramanian and Narita laboratories are supported by core funding from Cancer Research UK (C14303/A17197). S.B. is a Senior Investigator of the Wellcome Trust (grant no. 099232/z/12/z).	Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Biffi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102711; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Foulk MS, 2015, GENOME RES, V25, P725, DOI 10.1101/gr.183848.114; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hoffmann RF, 2016, NUCLEIC ACIDS RES, V44, P152, DOI 10.1093/nar/gkv900; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kanoh Y, 2015, NAT STRUCT MOL BIOL, V22, P889, DOI 10.1038/nsmb.3102; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; Mukundan VT, 2013, J AM CHEM SOC, V135, P5017, DOI 10.1021/ja310251r; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Raiber EA, 2012, NUCLEIC ACIDS RES, V40, P1499, DOI 10.1093/nar/gkr882; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rodriguez R, 2014, NAT REV GENET, V15, P783, DOI 10.1038/nrg3796; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sabouri N, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0101-5; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tomazou EM, 2015, CELL REP, V10, P1082, DOI 10.1016/j.celrep.2015.01.042; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Zhao M, 2016, NUCLEIC ACIDS RES, V44, pD1023, DOI 10.1093/nar/gkv1268	43	441	449	17	147	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1267	1272		10.1038/ng.3662	http://dx.doi.org/10.1038/ng.3662			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27618450	Green Submitted			2022-12-25	WOS:000384391600023
J	Jenkinson, EM; Rodero, MP; Kasher, PR; Uggenti, C; Oojageer, A; Goosey, LC; Rose, Y; Kershaw, CJ; Urquhart, JE; Williams, SG; Bhaskar, SS; O'Sullivan, J; Baerlocher, GM; Haubitz, M; Aubert, G; Baranano, KW; Barnicoat, AJ; Battini, R; Berger, A; Blair, EM; Brunstrom-Hernandez, JE; Buckard, JA; Cassiman, DM; Caumes, R; Cordelli, DM; De Waele, LM; Fay, AJ; Ferreira, P; Fletcher, NA; Fryer, AE; Goel, H; Hemingway, CA; Henneke, M; Hughes, I; Jefferson, RJ; Kumar, R; Lagae, L; Landrieu, PG; Lourenco, CM; Malpas, TJ; Mehta, SG; Metz, I; Naidu, S; Ounap, K; Panzer, A; Prabhakar, P; Quaghebeur, G; Schiffmann, R; Sherr, EH; Sinnathuray, KR; Soh, C; Stewart, HS; Stone, J; Van Esch, H; Van Mol, CEG; Vanderver, A; Wakeling, EL; Whitney, A; Pavitt, GD; Griffiths-Jones, S; Rice, GI; Revy, P; van der Knaap, MS; Livingston, JH; O'Keefe, RT; Crow, YJ				Jenkinson, Emma M.; Rodero, Mathieu P.; Kasher, Paul R.; Uggenti, Carolina; Oojageer, Anthony; Goosey, Laurence C.; Rose, Yoann; Kershaw, Christopher J.; Urquhart, Jill E.; Williams, Simon G.; Bhaskar, Sanjeev S.; O'Sullivan, James; Baerlocher, Gabriela M.; Haubitz, Monika; Aubert, Geraldine; Baranano, Kristin W.; Barnicoat, Angela J.; Battini, Roberta; Berger, Andrea; Blair, Edward M.; Brunstrom-Hernandez, Janice E.; Buckard, Johannes A.; Cassiman, David M.; Caumes, Rosaline; Cordelli, Duccio M.; De Waele, Liesbeth M.; Fay, Alexander J.; Ferreira, Patrick; Fletcher, Nicholas A.; Fryer, Alan E.; Goel, Himanshu; Hemingway, Cheryl A.; Henneke, Marco; Hughes, Imelda; Jefferson, Rosalind J.; Kumar, Ram; Lagae, Lieven; Landrieu, Pierre G.; Lourenco, Charles M.; Malpas, Timothy J.; Mehta, Sarju G.; Metz, Imke; Naidu, Sakkubai; Ounap, Katrin; Panzer, Axel; Prabhakar, Prab; Quaghebeur, Gerardine; Schiffmann, Raphael; Sherr, Elliott H.; Sinnathuray, Kanaga R.; Soh, Calvin; Stewart, Helen S.; Stone, John; Van Esch, Hide; Van Mol, Christine E. G.; Vanderver, Adeline; Wakeling, Emma L.; Whitney, Andrea; Pavitt, Graham D.; Griffiths-Jones, Sam; Rice, Gillian I.; Revy, Patrick; van der Knaap, Marjo S.; Livingston, John H.; O'Keefe, Raymond T.; Crow, Yanick J.			Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts	NATURE GENETICS			English	Article							BOX-C/D; CEREBRORETINAL MICROANGIOPATHY; LSM PROTEINS; COMPONENT 1; U8 SNORNA; IDENTIFICATION; INVOLVEMENT; BIOGENESIS; RIBOSOMES; DISORDER	Although ribosomes are ubiquitous and essential for life, recent data indicate that monogenic causes of ribosomal dysfunction can confer a remarkable degree of specificity in terms of human disease phenotype. Box C/D small nucleolar RNAs (snoRNAs) are evolutionarily conserved non-protein-coding RNAs involved in ribosome biogenesis. Here we show that biallelic mutations in the gene SNORD118, encoding the box C/D snoRNA U8, cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts (LCC), presenting at any age from early childhood to late adulthood. These mutations affect U8 expression, processing and protein binding and thus implicate U8 as essential in cerebral vascular homeostasis.	[Jenkinson, Emma M.; Kasher, Paul R.; Oojageer, Anthony; Goosey, Laurence C.; Urquhart, Jill E.; Williams, Simon G.; Bhaskar, Sanjeev S.; O'Sullivan, James; Rice, Gillian I.; Crow, Yanick J.] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Div Evolut & Genom Sci, Manchester, Lancs, England; [Rodero, Mathieu P.; Uggenti, Carolina; Rose, Yoann; Crow, Yanick J.] Hop Necker Enfants Malad, INSERM UMR 1163, Inst Imagine, Lab Neurogenet & Neuroinflammat, Paris, France; [Kershaw, Christopher J.; Pavitt, Graham D.; Griffiths-Jones, Sam; O'Keefe, Raymond T.] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Div Mol & Cellular Funct, Manchester, Lancs, England; [Baerlocher, Gabriela M.; Haubitz, Monika] Univ Bern, Univ Hosp Bern, Inselspital, Dept Hematol, Bern, Switzerland; [Baerlocher, Gabriela M.; Haubitz, Monika] Univ Bern, Univ Hosp Bern, Inselspital, Dept Clin Res,Expt Hematol, Bern, Switzerland; [Aubert, Geraldine] Repeat Diagnost Inc, N Vancouver, BC, Canada; [Aubert, Geraldine] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Baranano, Kristin W.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Kennedy Krieger Inst, Div Neurogenet, Baltimore, MD USA; [Barnicoat, Angela J.] Great Ormond St Hosp NHS Fdn Trust, Dept Clin Genet, London, England; [Battini, Roberta] IRCCS Stella Maris, Dept Dev, Pisa, Italy; [Berger, Andrea] Klinikum Weiden, Dept Neuropediat, Weiden, Germany; [Berger, Andrea] Klinikum Harlaching, Dept Neuropediat, Munich, Germany; [Blair, Edward M.] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Dept Clin Genet, Oxford, England; [Brunstrom-Hernandez, Janice E.] CP Pl PLLC, Plano, TX USA; Washington Univ, St Louis Childrens Hosp, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Sozialpadiatr Zentrum EVK Dusseldorf, Dept Neuropediat, Dusseldorf, Germany; [Cassiman, David M.] Leuven Univ Hosp, Metab Ctr, Leuven, Belgium; [Cassiman, David M.] Katholieke Univ Leuven, Leuven, Belgium; [Caumes, Rosaline] Hop Roger Salengro, Dept Neuropediat, Lille, France; [Cordelli, Duccio M.] St Orsola Marcello Malpighi Hosp, Paediat Neurol Unit, Bologna, Italy; [De Waele, Liesbeth M.] Univ Hosp Leuven, Dept Paediat Neurol, Leuven, Belgium; [De Waele, Liesbeth M.; Lagae, Lieven] Univ Leuven, Dept Dev & Regenerat, Paediat Neurol, Leuven, Belgium; [Ferreira, Patrick] Alberta Childrens Prov Gen Hosp, Div Med Genet, Calgary, AB, Canada; [Fletcher, Nicholas A.] Walton Ctr NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England; [Fryer, Alan E.] Liverpool Womens NHS Fdn Trust, Dept Clin Genet, Liverpool, Merseyside, England; [Goel, Himanshu] Hunter Genet Hunter New England Local Hlth Dist, Waratah, NSW, Australia; [Goel, Himanshu] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Hemingway, Cheryl A.; Prabhakar, Prab] Great Ormond St Hosp NHS Fdn Trust, Dept Paediat Neurol, London, England; [Henneke, Marco] Georg August Univ, Univ Med Ctr, Dept Pediat & Adolescent Med, Gottingen, Germany; [Hughes, Imelda] Cent Manchester Univ Hosp NHS Fdn Trust, Pediat Neurol, Manchester, Lancs, England; [Jefferson, Rosalind J.] Royal Berkshire Hosp, Dingley Specialist Childrens Ctr, Reading, Berks, England; [Kumar, Ram] Alder Hey Childrens NHS Fdn Trust, Dept Paediat Neurol, Liverpool, Merseyside, England; [Landrieu, Pierre G.] CHU Paris Sud Bicetre, Dept Paediat Neurol, Le Kremlin Bicetre, France; [Lourenco, Charles M.] Univ Sao Paulo, Clin Hosp Ribeirao Preto, Neurogenet Div, Sao Paulo, Brazil; [Malpas, Timothy J.] Jersey Gen Hosp, Dept Pediat, St Helier, England; [Mehta, Sarju G.] Addenbrookes Hosp, East Anglian Reg Genet Serv, Cambridge, England; Georg August Univ, Univ Med Ctr, Dept Neuropathol, Gottingen, Germany; [Naidu, Sakkubai] Johns Hopkins Med Inst Neurol & Pediat, Kennedy Krieger Inst, Hugo Moser Res Inst, Baltimore, MD USA; [Ounap, Katrin] Tartu Univ Hosp, Dept Genet, Tartu, Estonia; [Ounap, Katrin] Univ Tartu, Inst Clin Med, Dept Pediat, Tartu, Estonia; [Panzer, Axel] DRK Kliniken BerlinWestend, Paediat Neurol, Epilepsy Ctr, Berlin, Germany; [Quaghebeur, Gerardine] Oxford Univ Hosp NHS Fdn Trust, Dept Neuroradiol, Oxford, England; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Sherr, Elliott H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Sinnathuray, Kanaga R.] Wexham Pk Hosp, Dept Pediat, Slough, Berks, England; [Soh, Calvin] Salford Royal NHS Fdn Trust, Neuroradiol Dept, Salford, Lancs, England; [Stone, John] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; [Van Esch, Hide] Katholieke Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Van Mol, Christine E. G.] St Augustinusziekenhuis, Dept Pediat Neonatol, Antwerp, Belgium; [Vanderver, Adeline] George Washington Univ, Childrens Natl Hlth Syst, Sch Med, Dept Neurol, Washington, DC USA; [Vanderver, Adeline] George Washington Univ, Childrens Natl Hlth Syst, Sch Med, Ctr Genet Med Res, Washington, DC USA; [Wakeling, Emma L.] London North West Healthcare NHS Trust, North West Thames Reg Genet Serv, Harrow, Middx, England; [Whitney, Andrea] Univ Hosp Southampton NHS Trust, Dept Child Neurol, Southampton, Hants, England; [Revy, Patrick] Hop Necker Enfants Malad, Inst Imagine, INSERM UMR 1163, Lab Genome Dynam Immune Syst, Paris, France; [Revy, Patrick; Crow, Yanick J.] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr, Child Neurol & Amsterdam Neurosci, Amsterdam, Netherlands; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Funct Genom, Amsterdam, Netherlands; [Livingston, John H.] Leeds Gen Infirm, Dept Paediat Neurol, Leeds, W Yorkshire, England	University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Manchester; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; British Columbia Cancer Agency; Johns Hopkins University; Kennedy Krieger Institute; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; IRCCS Fondazione Stella Maris; Munchen Klinik; Oxford University Hospitals NHS Foundation Trust; University of Oxford; St. Louis Children's Hospital; Washington University (WUSTL); KU Leuven; University Hospital Leuven; KU Leuven; Universite de Lille - ISITE; CHU Lille; IRCCS Azienda Ospedaliero-Universitaria di Bologna; KU Leuven; University Hospital Leuven; KU Leuven; Alberta Childrens Hospital; University of Calgary; Walton Centre; University of Newcastle; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Gottingen; University of Manchester; Royal Berkshire Hospital; Alder Hey Children's NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Universidade de Sao Paulo; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Gottingen; Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; University of Tartu; Oxford University Hospitals NHS Foundation Trust; Baylor Scott & White Health; Baylor University Medical Center; University of California System; University of California San Francisco; Salford Royal NHS Foundation Trust; University of Edinburgh; KU Leuven; University Hospital Leuven; Children's National Health System; George Washington University; Children's National Health System; George Washington University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leeds General Infirmary; University of Leeds	Crow, YJ (corresponding author), Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Div Evolut & Genom Sci, Manchester, Lancs, England.; Crow, YJ (corresponding author), Hop Necker Enfants Malad, INSERM UMR 1163, Inst Imagine, Lab Neurogenet & Neuroinflammat, Paris, France.; Crow, YJ (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France.	yanickcrow@mac.com	Rice, Gillian I/G-3128-2015; Revy, Patrick/H-8137-2017; Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Pavitt, Graham D/A-1363-2010; Stone, Jon/C-3119-2014; Uggenti, Carolina/G-9145-2017; rodero, mathieu/C-8083-2011; Cordelli, Duccio Maria/N-4725-2019; Ounap, Katrin/Q-1103-2016; Crow, Yanick J/N-6120-2014; Vanderver, Adeline/CAG-5072-2022; battini, roberta/P-9095-2017; Cordelli, Duccio Maria/Q-4983-2016; Van+Esch, Hilde/AAU-5688-2020; Cassiman, David/H-6813-2014; Griffiths-Jones, Sam/H-2998-2014	Rice, Gillian I/0000-0002-4223-0571; Pavitt, Graham D/0000-0002-8593-2418; Stone, Jon/0000-0001-9829-8092; Uggenti, Carolina/0000-0003-2673-5120; rodero, mathieu/0000-0002-1300-0187; Cordelli, Duccio Maria/0000-0002-1367-6419; Ounap, Katrin/0000-0002-4594-6364; Crow, Yanick J/0000-0001-7211-7564; battini, roberta/0000-0002-7889-1355; Cordelli, Duccio Maria/0000-0002-1367-6419; Kasher, Paul/0000-0002-9213-502X; Cassiman, David/0000-0002-6154-0970; Prabhakar, Prab/0000-0002-1641-8714; Williams, Simon/0000-0001-7396-4108; Revy, Patrick/0000-0003-0758-8022; Vanderver, Adeline/0000-0002-6290-6751; van der Knaap, Marjo/0000-0001-8912-0954; Van Esch, Hilde/0000-0002-9604-5726; Wakeling, Emma/0000-0001-5712-0044; Griffiths-Jones, Sam/0000-0001-6043-807X; Haubitz, Monika/0000-0001-7660-401X; Kershaw, Christopher/0000-0001-6625-7894	Newlife Foundation [14-15/15]; Great Ormond Street Hospital Children's Charity [V1212]; Investments for the Future [ANR-10-IAHU-01]; Wellcome Trust [104981, 097820/Z/11/B]; La Ligue (Equipe Lab Elisee); Centre National de la Recherche Scientifique (CNRS); Biotechnology and Biological Sciences Research Council [BB/M006565/1] Funding Source: researchfish; Newlife [14-15/15] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1212] Funding Source: researchfish; BBSRC [BB/M006565/1] Funding Source: UKRI	Newlife Foundation; Great Ormond Street Hospital Children's Charity; Investments for the Future; Wellcome Trust(Wellcome TrustEuropean Commission); La Ligue (Equipe Lab Elisee); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newlife; Great Ormond Street Hospital Childrens Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are very grateful to the affected families for their involvement in our research. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. DNA panels from the NINDS Human Genetics Resource Center DNA and Cell Line Repository were used in this study, as well as clinical data. The submitters who contributed samples are acknowledged in detailed descriptions of each panel: NDPT099 and NAPT095. Y.J.C. acknowledges funding from the Newlife Foundation (14-15/15), the Great Ormond Street Hospital Children's Charity (V1212) and a state subsidy managed by the National Research Agency (France) under 'Investments for the Future' (ANR-10-IAHU-01). R.T.O'K. acknowledges the Wellcome Trust (104981). This work was supported by Wellcome Trust funding (097820/Z/11/B) to Y.J.C. and R.T.O'K. P.R. has received research support from La Ligue (Equipe Lab Elisee) and the Centre National de la Recherche Scientifique (CNRS). This paper is dedicated to the memory of John L. Tolmie.	Anderson BH, 2012, NAT GENET, V44, P338, DOI 10.1038/ng.1084; Briggs TA, 2008, AM J MED GENET A, V146A, P182, DOI 10.1002/ajmg.a.32080; Christopher KJ, 2012, DEV BIOL, V368, P382, DOI 10.1016/j.ydbio.2012.06.008; Corboy JR, 2006, NEUROLOGY, V67, P1890, DOI 10.1212/01.wnl.0000244470.06748.18; Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Kufel J, 2003, J BIOL CHEM, V278, P2147, DOI 10.1074/jbc.M208856200; Labrune P, 1996, NEUROLOGY, V46, P1297, DOI 10.1212/WNL.46.5.1297; Lafontaine DLJ, 2015, NAT STRUCT MOL BIOL, V22, P11, DOI 10.1038/nsmb.2939; Livingston JH, 2014, NEUROPEDIATRICS, V45, P175, DOI 10.1055/s-0033-1364180; Nagae-Poetscher LM, 2004, NEUROLOGY, V62, P1206, DOI 10.1212/01.WNL.0000119341.59445.CF; PECULIS BA, 1994, GENE DEV, V8, P2241, DOI 10.1101/gad.8.18.2241; Peculis BA, 1997, MOL CELL BIOL, V17, P3702, DOI 10.1128/MCB.17.7.3702; Peculis BA, 2001, GENE, V274, P83, DOI 10.1016/S0378-1119(01)00596-0; Polvi A, 2012, AM J HUM GENET, V90, P540, DOI 10.1016/j.ajhg.2012.02.002; RAMAGOPAL S, 1992, BIOCHEM CELL BIOL, V70, P269, DOI 10.1139/o92-042; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Shaheen R, 2015, HUM MOL GENET, V24, P5211, DOI 10.1093/hmg/ddv242; Takai H, 2016, GENE DEV, V30, P812, DOI 10.1101/gad.276873.115; Tomasevic N, 2002, MOL CELL BIOL, V22, P4101, DOI 10.1128/MCB.22.12.4101-4112.2002; TYC K, 1989, EMBO J, V8, P3113, DOI 10.1002/j.1460-2075.1989.tb08463.x; Watkins NJ, 2007, MOL CELL BIOL, V27, P7018, DOI 10.1128/MCB.00516-07; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359	27	78	81	1	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1185	1192		10.1038/ng.3661	http://dx.doi.org/10.1038/ng.3661			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27571260	Green Submitted, Green Accepted			2022-12-25	WOS:000384391600013
J	Mascher, M; Schuenemann, VJ; Davidovich, U; Marom, N; Himmelbach, A; Hubner, S; Korol, A; David, M; Reiter, E; Riehl, S; Schreiber, M; Vohr, SH; Green, RE; Dawson, IK; Russell, J; Kilian, B; Muehlbauer, GJ; Waugh, R; Fahima, T; Krause, J; Weiss, E; Stein, N				Mascher, Martin; Schuenemann, Verena J.; Davidovich, Uri; Marom, Nimrod; Himmelbach, Axel; Hubner, Sariel; Korol, Abraham; David, Michal; Reiter, Ella; Riehl, Simone; Schreiber, Mona; Vohr, Samuel H.; Green, Richard E.; Dawson, Ian K.; Russell, Joanne; Kilian, Benjamin; Muehlbauer, Gary J.; Waugh, Robbie; Fahima, Tzion; Krause, Johannes; Weiss, Ehud; Stein, Nils			Genomic analysis of 6,000-year-old cultivated grain illuminates the domestication history of barley	NATURE GENETICS			English	Article							ANCIENT DNA; GENETIC-EVIDENCE; HORDEUM-VULGARE; EVOLUTION; ADMIXTURE; REVEALS; ORIGIN; LANDRACES; SEQUENCES; FRAMEWORK	The cereal grass barley was domesticated about 10,000 years before the present in the Fertile Crescent and became a founder crop of Neolithic agriculture(1). Here we report the genome sequences of five 6,000-year-old barley grains excavated at a cave in the Judean Desert close to the Dead Sea. Comparison to whole-exome sequence data from a diversity panel of present-day barley accessions showed the close affinity of ancient samples to extant landraces from the Southern Levant and Egypt, consistent with a proposed origin of domesticated barley in the Upper Jordan Valley. Our findings suggest that barley landraces grown in present-day Israel have not experienced major lineage turnover over the past six millennia, although there is evidence for gene flow between cultivated and sympatric wild populations. We demonstrate the usefulness of ancient genomes from desiccated archaeobotanical remains in informing research into the origin, early domestication and subsequent migration of crop species.	[Mascher, Martin; Himmelbach, Axel; Schreiber, Mona; Kilian, Benjamin; Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Seeland, Germany; [Mascher, Martin] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Schuenemann, Verena J.; Reiter, Ella; Riehl, Simone; Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany; [Schuenemann, Verena J.; Riehl, Simone; Krause, Johannes] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany; [Davidovich, Uri] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel; [Marom, Nimrod] Univ Haifa, Zinman Inst Archaeol, Lab Archaeozool, Haifa, Israel; [Hubner, Sariel] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Hubner, Sariel] Tel Hai Coll, Dept Biotechnol, Upper Galilee, Israel; [Korol, Abraham; Fahima, Tzion] Univ Haifa, Inst Evolut, Haifa, Israel; [Korol, Abraham; Fahima, Tzion] Univ Haifa, Dept Evolutionary & Environm Biol, Haifa, Israel; [David, Michal; Weiss, Ehud] Bar Ilan Univ, Martin Szusz Dept Land Israel Studies & Archaeol, Ramat Gan, Israel; [Vohr, Samuel H.; Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Dawson, Ian K.; Russell, Joanne; Waugh, Robbie] James Hutton Inst, Cell & Mol Sci, Dundee, Scotland; [Muehlbauer, Gary J.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Waugh, Robbie] Univ Dundee, Div Plant Sci, Dundee, Scotland; [Krause, Johannes] Max Planck Inst Sci Human Hist, Jena, Germany; [Kilian, Benjamin] Bayer CropSci, BCS Breeding & Trait Dev, Ghent, Belgium	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Hebrew University of Jerusalem; University of Haifa; University of British Columbia; Tel Hai Academy College; University of Haifa; University of Haifa; Bar Ilan University; University of California System; University of California Santa Cruz; James Hutton Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Dundee; Bayer AG; Bayer CropScience	Stein, N (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Seeland, Germany.; Krause, J (corresponding author), Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany.; Krause, J (corresponding author), Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany.; Fahima, T (corresponding author), Univ Haifa, Inst Evolut, Haifa, Israel.; Fahima, T (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, Haifa, Israel.; Weiss, E (corresponding author), Bar Ilan Univ, Martin Szusz Dept Land Israel Studies & Archaeol, Ramat Gan, Israel.; Krause, J (corresponding author), Max Planck Inst Sci Human Hist, Jena, Germany.	fahima@research.haifa.ac.il; krause@shh.mpg.de; ehud.weiss@biu.ac.il; stein@ipk-gatersleben.de	Stein, Nils/F-7507-2017; Riehl, Simone/AAI-5815-2020; Krause, Johannes/AFP-2642-2022; Schreiber, Mona/AAY-7024-2020; Weiss, Ehud/AAJ-3619-2020; Schreiber, Mona/AAV-5372-2021	Stein, Nils/0000-0003-3011-8731; Riehl, Simone/0000-0002-1744-0032; Krause, Johannes/0000-0001-9144-3920; Schreiber, Mona/0000-0002-6771-6914; Weiss, Ehud/0000-0002-9730-4726; Marom, Nimrod/0000-0002-1057-154X; Kilian, Benjamin/0000-0002-9145-6980; Vohr, Samuel/0000-0002-4338-3756; Dawson, Ian/0000-0003-1345-3642; Dawson, Ian/0000-0003-4245-6973; Fahima, Tzion/0000-0001-5555-0040; Mascher, Martin/0000-0001-6373-6013; Davidovich, Uri/0000-0001-5947-1534; Himmelbach, Axel/0000-0001-7338-0946; Green, Richard/0000-0003-0516-5827	Israel Science Foundation [1179/13]; Endowed Chair in Molecular Genetics Applied to Crop Improvement at the University of Minnesota; Triticeae Coordinated Agricultural Project [USDA-NIFA 2011-68002-30029]; IPK Gatersleben; Scottish government; University of Dundee; Irene Levi Sela CARE Foundation	Israel Science Foundation(Israel Science Foundation); Endowed Chair in Molecular Genetics Applied to Crop Improvement at the University of Minnesota; Triticeae Coordinated Agricultural Project; IPK Gatersleben; Scottish government; University of Dundee; Irene Levi Sela CARE Foundation	We gratefully acknowledge B. Schafer for providing photographs of barley spikes and A. Fiebig for sequence data submission. This work was supported by a grant of the Israel Science Foundation (1179/13) to E.W., funding from the Endowed Chair in Molecular Genetics Applied to Crop Improvement at the University of Minnesota and the Triticeae Coordinated Agricultural Project, USDA-NIFA 2011-68002-30029 to G.J.M., and core funding of IPK Gatersleben to N.S. and M.M. R.W., J.R. and I.K.D. were supported by Research Programme funding from the Scottish government and the University of Dundee (R.W.). N.M. and U.D. acknowledge a grant from the Irene Levi Sela CARE Foundation.	Abdel-Ghani AH, 2004, THEOR APPL GENET, V109, P588, DOI 10.1007/s00122-004-1657-1; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Arend D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-214; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Bilgic H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151974; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; da Fonseca RR, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.3, 10.1038/NPLANTS.2014.3]; Dickson A.D., 1978, BARLEY ORIGIN BOT CU; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Frumin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13308; Giuffra E, 2000, GENETICS, V154, P1785; Haber M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003316; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Himmelbach A., 2014, BIO-PROTOCOL, V4, pe1166, DOI DOI 10.21769/BioProtoc.1166; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kircher M, 2012, METHODS MOL BIOL, V840, P197, DOI 10.1007/978-1-61779-516-9_23; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kistler L., 2015, THERMAL AGE CYTOSINE; Kistler L, 2012, METHODS MOL BIOL, V840, P71, DOI 10.1007/978-1-61779-516-9_10; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Li CX, 2011, J ARCHAEOL SCI, V38, P115, DOI 10.1016/j.jas.2010.08.016; Li H., 2013, PREPRINT, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Meiri M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03035; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Palmer SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006301; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Poets AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0712-3; Pourkheirandish M, 2015, CELL, V162, P527, DOI 10.1016/j.cell.2015.07.002; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Renaud G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku699; Russell J., 2016, NAT GENET; Russell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086021; Russell J, 2011, NEW PHYTOL, V191, P564, DOI 10.1111/j.1469-8137.2011.03704.x; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schick, 2002, ATIQOT, V41, P223; Schiffels S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10408; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; Smith O, 2015, SCIENCE, V347, P998, DOI 10.1126/science.1261278; Snir A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131422; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Van Zeist W, 1984, PALAEOHISTORIA, V24, P165; Weiss CL, 2015, ELIFE, V4, DOI 10.7554/eLife.10005.001; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	59	81	84	3	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1089	+		10.1038/ng.3611	http://dx.doi.org/10.1038/ng.3611			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27428749	Green Submitted			2022-12-25	WOS:000382398800023
J	Zhou, AD; Lin, KY; Zhang, SC; Chen, YH; Zhang, N; Xue, JF; Wang, ZY; Aldape, KD; Xie, KP; Woodgett, JR; Huang, SY				Zhou, Aidong; Lin, Kangyu; Zhang, Sicong; Chen, Yaohui; Zhang, Nu; Xue, Jianfei; Wang, Zhongyong; Aldape, Kenneth D.; Xie, Keping; Woodgett, James R.; Huang, Suyun			Nuclear GSK3 beta promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22	NATURE CELL BIOLOGY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; FACTOR-KAPPA-B; THERAPEUTIC TARGET; CELL-SURVIVAL; SELF-RENEWAL; BETA-CATENIN; C-MYC; LSD1; INHIBITION; CANCER	Emerging evidence has shown that GSK3 beta plays oncogenic roles in multiple tumour types; however, the underlying mechanisms remain largely unknown. Here, we show that nuclear GSK3 beta is responsible for the accumulation of the histone demethylase KDM1A and critically regulates histone H3K4 methylation during tumorigenesis. GSK3 beta phosphorylates KDM1A Ser683 upon priming phosphorylation of KDM1A Ser687 by CK1 alpha. Phosphorylation of KDM1A induces its binding with and deubiquitylation by USP22, leading to KDM1A stabilization. GSK3 beta- and USP22-dependent KDM1A stabilization is required for the demethylation of histone H3K4, thereby repressing BMP2, CDKN1A and GATA6 transcription, which results in cancer stem cell self-renewal and glioblastoma tumorigenesis. In human glioblastoma specimens, KDM1A levels are correlated with nuclear GSK3 beta and USP22 levels. Furthermore, a GSK3 inhibitor, tideglusib, sensitizes tumour xenografts to chemotherapy in mice via KDM1A downregulation and improves survival. Our findings demonstrate that nuclear GSK3 beta- and USP22-mediated KDM1A stabilization is essential for glioblastoma tumorigenesis.	[Zhou, Aidong; Lin, Kangyu; Zhang, Sicong; Chen, Yaohui; Xue, Jianfei; Wang, Zhongyong; Huang, Suyun] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Zhang, Sicong; Xie, Keping; Huang, Suyun] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX 77030 USA; [Zhang, Nu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou 510080, Guangdong, Peoples R China; [Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Xie, Keping] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Woodgett, James R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Aldape, Kenneth D.] Univ Toronto, MacFeeters Hamilton Brain Tumour Ctr, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada	University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Huang, SY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA.; Huang, SY (corresponding author), Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX 77030 USA.	suhuang@mdanderson.org	Zhang, Sicong/AAI-1348-2019; Woodgett, Jim/F-1087-2010; Lin, Kangyu/I-8050-2016	Zhang, Sicong/0000-0001-5610-7761; Woodgett, Jim/0000-0003-3731-5797; Zhou, Aidong/0000-0001-8389-9522; Lin, Kangyu/0000-0003-0140-2557	US National Cancer Institute [R01CA157933, R01CA182684, R01CA152309, P50CA127001, R01CA195651, CA16672]; NATIONAL CANCER INSTITUTE [R01CA182684, R01CA198090, R01CA195651, R01CA152309, R01CA157933, P50CA127001, R01CA172233, P30CA016672] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Munch in MD Anderson's Department of Scientific Publications for editing the manuscript. We thank Y. Shi (Boston Children's Hospital) for providing the Flag-KDM1A plasmid; J. Yang (Texas Children's Cancer Center) for providing the USP2, USP4, USP5, USP8, USP13, USP14, USP16, USP18, USP21, USP25, USP26, USP28, USP29, USP30, USP36, USP39, USP46 and USP48 expression plasmids; H.-K. Lin (MD Anderson Cancer Center) for providing the USP1, USP3, USP11, USP15, USP22 and CYLD expression plasmids; and X. He (Boston Children's Hospital) for providing beta-catenin<SUP>+/+</SUP> and beta-catenin<SUP>-/-</SUP> MEFs. This work was supported in part by US National Cancer Institute grants R01CA157933, R01CA182684, R01CA152309, P50CA127001, R01CA195651 and CA16672 (Cancer Center Support Grant).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Bolos M, 2010, J BIOL CHEM, V285, P17693, DOI 10.1074/jbc.M109.096594; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Elliott PR, 2014, MOL CELL, V54, P335, DOI 10.1016/j.molcel.2014.03.018; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Gong AH, 2015, CANCER RES, V75, P2337, DOI 10.1158/0008-5472.CAN-14-2800; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Hill EV, 2015, EUR J IMMUNOL, V45, P1103, DOI 10.1002/eji.201444661; Hirose Y, 2001, CANCER RES, V61, P1957; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Kamnasaran D, 2007, P NATL ACAD SCI USA, V104, P8053, DOI 10.1073/pnas.0611669104; Kauffman EC, 2011, MOL CARCINOGEN, V50, P931, DOI 10.1002/mc.20758; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Kubic JD, 2012, MOL CANCER RES, V10, P1065, DOI 10.1158/1541-7786.MCR-11-0387; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lv SA, 2010, EUR J CELL BIOL, V89, P557, DOI 10.1016/j.ejcb.2010.01.004; Dominguez JM, 2012, J BIOL CHEM, V287, P893, DOI 10.1074/jbc.M111.306472; Miyashita K, 2009, CLIN CANCER RES, V15, P887, DOI 10.1158/1078-0432.CCR-08-0760; Naito S, 2010, CLIN CANCER RES, V16, P5124, DOI 10.1158/1078-0432.CCR-10-0275; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Persano L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.153; Reddiconto G, 2012, BLOOD, V119, P2335, DOI 10.1182/blood-2011-06-361261; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Sareddy GR, 2013, ONCOTARGET, V4, P18, DOI 10.18632/oncotarget.725; Schaeffer V, 2014, MOL CELL, V54, P349, DOI 10.1016/j.molcel.2014.03.016; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sereno L, 2009, NEUROBIOL DIS, V35, P359, DOI 10.1016/j.nbd.2009.05.025; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Tang QL, 2012, JNCI-J NATL CANCER I, V104, P749, DOI 10.1093/jnci/djs210; Tolosa E, 2014, MOVEMENT DISORD, V29, P470, DOI 10.1002/mds.25824; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Wu YD, 2013, CELL REP, V5, P224, DOI 10.1016/j.celrep.2013.08.030; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015	49	103	107	3	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2016	18	9					954	966		10.1038/ncb3396	http://dx.doi.org/10.1038/ncb3396			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DU7TF	27501329	Green Accepted			2022-12-25	WOS:000382416800006
J	Rozo, M; Li, LJ; Fan, CM				Rozo, Michelle; Li, Liangji; Fan, Chen-Ming			Targeting beta 1-integrin signaling enhances regeneration in aged and dystrophic muscle in mice	NATURE MEDICINE			English	Article							RECEPTOR TYROSINE KINASES; SKELETAL-MUSCLE; SATELLITE CELLS; EXTRACELLULAR-MATRIX; SELF-RENEWAL; INTEGRINS; ADULT; PROLIFERATION; ACTIVATION; EXPRESSION	Interactions between stem cells and their microenvironment, or niche, are essential for stem cell maintenance and function. Our knowledge of the niche for the skeletal muscle stem cell, i.e., the satellite cell (SC), is incomplete. Here we show that beta 1-integrin is an essential niche molecule that maintains SC homeostasis, and sustains the expansion and self-renewal of this stem cell pool during regeneration. We further show that beta 1-integrin cooperates with fibroblast growth factor 2 (Fgf2), a potent growth factor for SCs, to synergistically activate their common downstream effectors, the mitogen-activated protein (MAP) kinase Erk and protein kinase B (Akt). Notably, SCs in aged mice show altered beta 1-integrin activity and insensitivity to Fgf2. Augmenting beta 1-integrin activity with a monoclonal antibody restores Fgf2 sensitivity and improves regeneration after experimentally induced muscle injury. The same treatment also enhances regeneration and function of dystrophic muscles in mdx mice, a model for Duchenne muscular dystrophy. Therefore, beta 1-integrin senses the SC niche to maintain responsiveness to Fgf2, and this integrin represents a potential therapeutic target for pathological conditions of the muscle in which the stem cell niche is compromised.	[Rozo, Michelle; Li, Liangji; Fan, Chen-Ming] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Rozo, Michelle; Li, Liangji; Fan, Chen-Ming] Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA	Johns Hopkins University; Carnegie Institution for Science	Fan, CM (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.; Fan, CM (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA.	fan@ciwemb.edu	Li, Liangji/AAM-7800-2021		Carnegie Institution; National Institutes of Health (NIH) [AR060042]; NIH [HD075345]; Carnegie Institution of Washington internal funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD075345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060042] Funding Source: NIH RePORTER	Carnegie Institution; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carnegie Institution of Washington internal funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank E. Dikovskaia and S. Satchell for technical assistance, and C. Lepper, Y. Zheng and members of the Fan laboratory for comments. We especially thank A. Wagers for generously sharing the FACS and SC isolation protocol. Funding for this work was provided by the Carnegie Institution (C.-M.F.) and the National Institutes of Health (NIH) (grant no. AR060042; C.-M.F.). M.R. is supported by a predoctoral fellowship from the NIH (HD075345), and L.L. is supported by Carnegie Institution of Washington internal funds.	Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Barton ER., 2008, MEASURING ISOMETRIC; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Hakim CH, 2013, JOVE-J VIS EXP, DOI 10.3791/50183; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hintermann E, 2001, J CELL BIOL, V153, P465, DOI 10.1083/jcb.153.3.465; Hogan B, 1994, MANIPULATING MOUSE E; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lukjanenko, 2016, NAT MED; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Mori S., 2013, MED SCI, V1, P20; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Polanska UM, 2009, DEV DYNAM, V238, P277, DOI 10.1002/dvdy.21757; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Sahni A, 2004, BLOOD, V104, P3635, DOI 10.1182/blood-2004-04-1358; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; Siegel AL, 2009, STEM CELLS, V27, P2527, DOI 10.1002/stem.178; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Webster MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081757; Wood LK, 2014, J APPL PHYSIOL, V117, P363, DOI 10.1152/japplphysiol.00256.2014	46	105	107	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					889	+		10.1038/nm.4116	http://dx.doi.org/10.1038/nm.4116			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376575	Green Accepted			2022-12-25	WOS:000381000200014
J	Stirman, JN; Smith, IT; Kudenov, MW; Smith, SL				Stirman, Jeffrey N.; Smith, Ikuko T.; Kudenov, Michael W.; Smith, Spencer L.			Wide field-of-view, multi-region, two-photon imaging of neuronal activity in the mammalian brain	NATURE BIOTECHNOLOGY			English	Article							MOUSE VISUAL-CORTEX; CELLULAR RESOLUTION; IN-VIVO; MICROSCOPY; MICE; SPECIFICITY; INFERENCE	Two-photon calcium imaging provides an optical readout of neuronal activity in populations of neurons with subcellular resolution. However, conventional two-photon imaging systems are limited in their field of view to similar to 1 mm(2), precluding the visualization of multiple cortical areas simultaneously. Here, we demonstrate a two-photon microscope with an expanded field of view (>9.5 mm(2)) for rapidly reconfigurable simultaneous scanning of widely separated populations of neurons. We custom designed and assembled an optimized scan engine, objective, and two independently positionable, temporally multiplexed excitation pathways. We used this new microscope to measure activity correlations between two cortical visual areas in mice during visual processing.	[Stirman, Jeffrey N.; Smith, Ikuko T.; Smith, Spencer L.] Univ N Carolina, Sch Med, Neurosci Ctr, Chapel Hill, NC 27599 USA; [Stirman, Jeffrey N.; Smith, Spencer L.] Univ N Carolina, Sch Med, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Smith, Ikuko T.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Kudenov, Michael W.] North Carolina State Univ, Dept Elect & Comp Engn, Raleigh, NC USA; [Smith, Spencer L.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Smith, Spencer L.] Univ N Carolina, Sch Med, Neurobiol Curriculum, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Smith, SL (corresponding author), Univ N Carolina, Sch Med, Neurosci Ctr, Chapel Hill, NC 27599 USA.; Smith, SL (corresponding author), Univ N Carolina, Sch Med, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA.; Smith, SL (corresponding author), Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Smith, SL (corresponding author), Univ N Carolina, Sch Med, Neurobiol Curriculum, Chapel Hill, NC 27599 USA.	slab@unc.edu		Kudenov, Michael/0000-0001-5601-6309	National Institute of Child Health and Human Development [T32-HD40127]; Burroughs Wellcome Fund Career Award at the Scientific Interface; Helen Lyng White Fellowship; Career Development Award from Human Frontier Science Program [00063/2012]; National Science Foundation [1450824]; Whitehall Foundation; McKnight Foundation; Klingenstein Foundation; Simons Foundation [SCGB 325407SS]; NIH [R01NS091335, R01EY024294]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040127, U54HD079124, P30HD003110] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY024294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091335, P30NS045892] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Helen Lyng White Fellowship; Career Development Award from Human Frontier Science Program; National Science Foundation(National Science Foundation (NSF)); Whitehall Foundation; McKnight Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Hongkui Zeng (Allen Institute) for kindly providing transgenic mice, Kei Eto (UNC-CH) for providing mice for imaging in pilot experiments, Janet Berrios (UNC-CH) for providing the YFP labeled brain section, Sally Kim and Ben Philpot (UNC-CH) for providing the Thy1-GFP O-line mouse, and Zemax LLC for providing upgraded software. This work was supported by the following: the National Institute of Child Health and Human Development (T32-HD40127) and Burroughs Wellcome Fund Career Award at the Scientific Interface (J.N.S.); a Helen Lyng White Fellowship (I.T.S.); a Career Development Award from the Human Frontier Science Program (00063/2012), and grants from the National Science Foundation (1450824), the Whitehall Foundation, the McKnight Foundation, the Klingenstein Foundation, the Simons Foundation (SCGB 325407SS), and the NIH (R01NS091335, R01EY024294) (S.L.S.). Custom-made image acquisition software (adapted by J.N.S.) is from code kindly provided by David Ferster, formerly of Northwestern University.	Amir W, 2007, OPT LETT, V32, P1731, DOI 10.1364/OL.32.001731; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cheng A, 2011, NAT METHODS, V8, P139, DOI 10.1038/NMETH.1552; Cotton RJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00151; Denk W., 1990, NATURE, V248, P73, DOI DOI 10.1126/SCIENCE.2321027; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Driscoll JD, 2011, J NEUROPHYSIOL, V105, P3106, DOI 10.1152/jn.00649.2010; Fuster JM, 2006, INT J PSYCHOPHYSIOL, V60, P125, DOI 10.1016/j.ijpsycho.2005.12.015; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Grewe BF, 2011, BIOMED OPT EXPRESS, V2, P2035, DOI 10.1364/BOE.2.002035; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Lecoq J, 2014, NAT NEUROSCI, V17, P1825, DOI 10.1038/nn.3867; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Moon S, 2008, OPT EXPRESS, V16, P13990, DOI 10.1364/OE.16.013990; Nelson J.D., 2009, P SOC PHOTO-OPT INS, V7433; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Tian XZ, 2010, INTERNATIONAL CONFERENCE OF CHINA COMMUNICATION (ICCC2010), P398; Tsai PS, 2015, OPT EXPRESS, V23, P13833, DOI 10.1364/OE.23.013833; VISSER TD, 1994, SCANNING, V16, P198, DOI 10.1002/sca.4950160403; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; Voigt F.F., 2015, P SOC PHOTO-OPT INS, V9329, p2C; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Zinter JP, 2011, OPT EXPRESS, V19, P15348, DOI 10.1364/OE.19.015348; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	34	177	180	8	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2016	34	8					857	+		10.1038/nbt.3594	http://dx.doi.org/10.1038/nbt.3594			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2VJ	27347754	Green Accepted, Green Submitted			2022-12-25	WOS:000381339600023
J	Fang, J; Liu, XN; Bolanos, L; Barker, B; Rigolino, C; Cortelezzi, A; Oliva, EN; Cuzzola, M; Grimes, HL; Fontanillo, C; Komurov, K; MacBeth, K; Starczynowski, DT				Fang, Jing; Liu, Xiaona; Bolanos, Lyndsey; Barker, Brenden; Rigolino, Carmela; Cortelezzi, Agostino; Oliva, Esther N.; Cuzzola, Maria; Grimes, H. Leighton; Fontanillo, Celia; Komurov, Kakajan; MacBeth, Kyle; Starczynowski, Daniel T.			A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes	NATURE MEDICINE			English	Article							CELL-LINE; MULTIPLE-MYELOMA; CHROMOSOME 5Q; DEL(5Q); DEGRADATION; EXPRESSION; PROTEINS; BIOLOGY; IKAROS; MDS	Despite the high response rates of individuals with myelodysplastic syndrome (MDS) with deletion of chromosome 5q (del(5q)) to treatment with lenalidomide (LEN) and the recent identification of cereblon (CRBN) as the molecular target of LEN, the cellular mechanism by which LEN eliminates MDS clones remains elusive. Here we performed an RNA interference screen to delineate gene regulatory networks that mediate LEN responsiveness in an MDS cell line, MDSL. We identified GPR68, which encodes a G-protein-coupled receptor that has been implicated in calcium metabolism, as the top candidate gene for modulating sensitivity to LEN. LEN induced GPR68 expression via IKAROS family zinc finger 1 (IKZF1), resulting in increased cytosolic calcium levels and activation of a calcium-dependent calpain, CAPN1, which were requisite steps for induction of apoptosis in MDS cells and in acute myeloid leukemia (AML) cells. In contrast, deletion of GPR68 or inhibition of calcium and calpain activation suppressed LEN-induced cytotoxicity. Moreover, expression of calpastatin (CAST), an endogenous CAPN1 inhibitor that is encoded by a gene (CAST) deleted in del(5q) MDS, correlated with LEN responsiveness in patients with del(5q) MDS. Depletion of CAST restored responsiveness of LEN-resistant non-del(5q) MDS cells and AML cells, providing an explanation for the superior responses of patients with del(5q) MDS to LEN treatment. Our study describes a cellular mechanism by which LEN, acting through CRBN and IKZF1, has cytotoxic effects in MDS and AML that depend on a calcium- and calpain-dependent pathway.	[Fang, Jing; Liu, Xiaona; Bolanos, Lyndsey; Barker, Brenden; Grimes, H. Leighton; Komurov, Kakajan; Starczynowski, Daniel T.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Rigolino, Carmela; Cuzzola, Maria] Azienda Osped Bianchi Melacrino Morelli, Bone Marrow Transplant Unit, Reggio Di Calabria, Italy; [Cortelezzi, Agostino] Univ Milan, Fdn Ist Ricovero & Cura Carattere Sci Ca Granda O, Dept Hematol, Milan, Italy; [Oliva, Esther N.] Azienda Osped Bianchi Melacrino Morelli, Hematol Unit, Reggio Di Calabria, Italy; [Fontanillo, Celia] Celgene Corp, Seville, Spain; [MacBeth, Kyle] Celgene Corp, San Francisco, CA USA; [Starczynowski, Daniel T.] Univ Cincinnati, Dept Canc Biol, Cincinnati, OH USA; [Fang, Jing] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC USA	Cincinnati Children's Hospital Medical Center; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Bristol-Myers Squibb; Celgene Corporation; University System of Ohio; University of Cincinnati; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Starczynowski, DT (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH USA.; Starczynowski, DT (corresponding author), Univ Cincinnati, Dept Canc Biol, Cincinnati, OH USA.	daniel.starczynowski@cchmc.org	cortelezzi, agostino/L-2633-2016	Fontanillo, Celia/0000-0002-3631-7881; Bolanos, Lyndsey/0000-0002-5447-5277; CORTELEZZI, AGOSTINO/0000-0001-9283-4800; Grimes, H. Leighton/0000-0001-8162-6758	Cincinnati Children's Hospital Research Foundation; NIDDK [P30DK090971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111103, R01HL114582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Research Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Cincinnati Children's Hospital Research Foundation (D.T.S.). We thank J. Bailey and V. Summey for assistance with transplantations. The normal bone marrow samples were received through the Normal Donor Repository in the Translational Core Laboratory at Cincinnati Children's Research Foundation, which is supported through the NIDDK-funded Center of Excellence in Molecular Hematology (grant no. P30DK090971; to Y. Zheng (CCHMC)). We thank B. Ebert (Harvard Medical School; Dana-Farber Cancer Institute) for providing the EGI and EGI-IKZF1 vectors, and for his expertise and discussions. In addition, we thank Y. Xu (Indiana University School of Medicine) for providing the MIG-GPR68 vector and K. Tohyama (Kawasaki Medical School) for the MDSL cells.	Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Frick KK, 2009, J BONE MINER RES, V24, P305, DOI 10.1359/JBMR.081015; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Giagounidis AAN, 2012, SEMIN HEMATOL, V49, P312, DOI 10.1053/j.seminhematol.2012.07.001; Giorgi C, 2015, CELL CYCLE, V14, P933, DOI 10.1080/15384101.2015.1010973; Giorgi C, 2015, P NATL ACAD SCI USA, V112, P1779, DOI 10.1073/pnas.1410723112; Huang WC, 2008, CURR BIOL, V18, P781, DOI 10.1016/j.cub.2008.04.049; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jadersten M, 2011, J CLIN ONCOL, V29, P1971, DOI 10.1200/JCO.2010.31.8576; Jaras M, 2014, J EXP MED, V211, P605, DOI 10.1084/jem.20131033; Jerez A, 2012, J CLIN ONCOL, V30, P1343, DOI 10.1200/JCO.2011.36.1824; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuoka A, 2010, LEUKEMIA, V24, P748, DOI 10.1038/leu.2009.296; McDaniel Jessica M, 2012, Adv Hematol, V2012, P513702, DOI 10.1155/2012/513702; Pan BQ, 2012, PHARMACOL THERAPEUT, V136, P56, DOI 10.1016/j.pharmthera.2012.07.004; Pellagatti A, 2007, P NATL ACAD SCI USA, V104, P11406, DOI 10.1073/pnas.0610477104; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Rhyasen GW, 2014, LEUKEMIA, V28, P1142, DOI 10.1038/leu.2013.372; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Russell JL, 2012, ACS CHEM BIOL, V7, P1077, DOI 10.1021/cb300001m; Saft L, 2014, HAEMATOLOGICA, V99, P1041, DOI 10.3324/haematol.2013.098103; Sorimachi H, 2011, J BIOCHEM, V150, P23, DOI 10.1093/jb/mvr070; TOHYAMA K, 1995, BRIT J HAEMATOL, V91, P795, DOI 10.1111/j.1365-2141.1995.tb05391.x; Wei S, 2013, ONCOGENE, V32, P1110, DOI 10.1038/onc.2012.139; Zhu YX, 2014, BLOOD, V124, P536, DOI 10.1182/blood-2014-02-557819	34	51	52	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					727	734		10.1038/nm.4127	http://dx.doi.org/10.1038/nm.4127			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27294874	Green Accepted			2022-12-25	WOS:000379366900011
J	Jean-Alphonse, FG; Wehbi, VL; Chen, JM; Noda, M; Taboas, JM; Xiao, KH; Vilardaga, JP				Jean-Alphonse, Frederic G.; Wehbi, Vanessa L.; Chen, Jingming; Noda, Masaki; Taboas, Juan M.; Xiao, Kunhong; Vilardaga, Jean-Pierre			beta(2)-adrenergic receptor control of endosomal PTH receptor signaling via G beta gamma	NATURE CHEMICAL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; ADENYLYL-CYCLASE; HORMONAL-STIMULATION; CAMP; PKA; PHOSPHORYLATION; ACTIVATION; DYNAMICS; MODULATORS; RETROMER	Cells express several G-protein-coupled receptors (GPCRs) at their surfaces, transmitting simultaneous extracellular hormonal and chemical signals into cells. A comprehensive understanding of mechanisms underlying the integrated signaling response induced by distinct GPCRs is thus required. Here we found that the b2-adrenergic receptor, which induces a short cAMP response, prolongs nuclear cAMP and protein kinase A (PKA) activation by promoting endosomal cAMP production in parathyroid hormone (PTH) receptor signaling through the stimulatory action of G protein G beta gamma subunits on adenylate cyclase type 2.	[Jean-Alphonse, Frederic G.; Wehbi, Vanessa L.; Xiao, Kunhong; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCRCR Biol, Pittsburgh, PA 15260 USA; [Chen, Jingming; Taboas, Juan M.] Univ Pittsburgh, Dept Biomed Engn, Sch Med, Pittsburgh, PA USA; [Noda, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, Tokyo, Japan; [Taboas, Juan M.] Univ Pittsburgh, McGowan Inst Regenerat Med, Sch Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tokyo Medical & Dental University (TMDU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vilardaga, JP (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCRCR Biol, Pittsburgh, PA 15260 USA.	jpv@pitt.edu	Xiao, Kunhong/AAG-4275-2020	Xiao, Kunhong/0000-0002-1069-1226; JEAN-ALPHONSE, Frederic/0000-0002-7380-5825; Vilardaga, Jean-Pierre/0000-0002-1217-1435	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health (NIH) [R01 DK087688, R01 DK102495, K01AR062598]; Cotswold Foundation Fellowship Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR062598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102495, R01DK087688] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health (NIH); Cotswold Foundation Fellowship Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health (NIH) under Award numbers R01 DK087688 and R01 DK102495 (J.-P.V.), and K01AR062598 (J.M.T.), and the Cotswold Foundation Fellowship Award (F.G.J.-A.). The authors thank P. Friedman (University of Pittsburgh) for critical discussion, T. Gardella (Mass general hospital) for providing PTH<SUP>TMR</SUP>, and M. Bastepe (Mass general hospital) for providing G alpha<INF>S</INF>-knockout MEF cells.	Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Conley JM, 2013, J PHARMACOL EXP THER, V347, P276, DOI 10.1124/jpet.113.207449; Cooper DMF, 2014, BIOCHEM J, V462, P199, DOI 10.1042/BJ20140560; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Fonseca TL, 2011, J BONE MINER RES, V26, P591, DOI 10.1002/jbmr.243; Gidon A, 2016, METHOD CELL BIOL, V132, P109, DOI 10.1016/bs.mcb.2015.10.007; Gidon A, 2014, NAT CHEM BIOL, V10, P707, DOI [10.1038/NCHEMBIO.1589, 10.1038/nchembio.1589]; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Hanyu R, 2012, P NATL ACAD SCI USA, V109, P7433, DOI 10.1073/pnas.1109036109; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Isensee J, 2014, J CELL SCI, V127, P216, DOI 10.1242/jcs.136580; Kahsai AW, 2014, NAT PROTOC, V9, P1301, DOI 10.1038/nprot.2014.075; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Manni S, 2008, J BIOL CHEM, V283, P24145, DOI 10.1074/jbc.M802278200; McGarvey JC, 2016, J BIOL CHEM, V291, P10986, DOI 10.1074/jbc.M115.697045; Mlakar V, 2015, J CELL MOL MED, V19, P1520, DOI 10.1111/jcmm.12505; Nagao M, 2011, P NATL ACAD SCI USA, V108, P17767, DOI 10.1073/pnas.1109402108; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Quitterer U, 1999, P NATL ACAD SCI USA, V96, P10626, DOI 10.1073/pnas.96.19.10626; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vilardaga JP, 2011, CURR TOP MEMBR, V67, P101, DOI 10.1016/B978-0-12-384921-2.00005-7; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979	34	34	34	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2017	13	3					259	+		10.1038/NCHEMBIO.2267	http://dx.doi.org/10.1038/NCHEMBIO.2267			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL2DY	28024151	Green Accepted			2022-12-25	WOS:000394431500005
J	Terhorst, J; Kamm, JA; Song, YS				Terhorst, Jonathan; Kamm, John A.; Song, Yun S.			Robust and scalable inference of population history froth hundreds of unphased whole genomes	NATURE GENETICS			English	Article							CONDITIONAL SAMPLING DISTRIBUTION; HUMAN-EVOLUTION; CLIMATE-CHANGE; RECOMBINATION; NEANDERTHAL; SEQUENCES; INTROGRESSION; DIVERGENCE; COALESCENT; HUMANS	It has recently been demonstrated that inference methods based on genealogical processes with recombination can uncover past population history in unprecedented detail. However, these methods scale poorly with sample size, limiting resolution in the recent past, and they require phased genomes, which contain switch errors that can catastrophically distort the inferred history. Here we present SMC++, a new statistical tool capable of analyzing orders of magnitude more samples than existing methods while requiring only unphased genomes (its results are independent of phasing). SMC++ can jointly infer population size histories and split times in diverged populations, and it employs a novel spline regularization scheme that greatly reduces estimation error. We apply SMC++ to analyze sequence data from over a thousand human genomes in Africa and Eurasia, hundreds of genomes from a Drosophila melanogaster population in Africa, and tens of genomes from zebra finch and long-tailed finch populations in Australia.	[Terhorst, Jonathan; Kamm, John A.; Song, Yun S.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Kamm, John A.; Song, Yun S.] Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA; [Song, Yun S.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Song, Yun S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Song, Yun S.] Univ Penn, Dept Math, Philadelphia, PA 19104 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Pennsylvania; University of Pennsylvania	Song, YS (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.; Song, YS (corresponding author), Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA.; Song, YS (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.; Song, YS (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.; Song, YS (corresponding author), Univ Penn, Dept Math, Philadelphia, PA 19104 USA.	yss@eecs.berkeley.edu		Kamm, Jack/0000-0003-2412-756X	NIH [R01 GM094402, R01 GM108805]; Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108805, R01GM094402] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Pool and C. Langley for helpful comments on our inferred Drosophila demography. We also thank H. Li for providing us with the Ust'-Ishim genome sequence. This research is supported in part by NIH grants R01 GM094402 and R01 GM108805 and by a Packard Fellowship for Science and Engineering (Y.S.S.).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bhaskar A, 2015, GENOME RES, V25, P268, DOI 10.1101/gr.178756.114; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dutheil JY, 2009, GENETICS, V183, P259, DOI 10.1534/genetics.109.103010; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Kamm J. A., J COMPUT GR IN PRESS; Keightley PD, 2014, GENETICS, V196, P313, DOI 10.1534/genetics.113.158758; Lack JB, 2015, GENETICS, V199, P1229, DOI 10.1534/genetics.115.174664; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Marjoram P, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-16; McVean GAT, 2005, PHILOS T R SOC B, V360, P1387, DOI 10.1098/rstb.2005.1673; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Paul JS, 2011, GENETICS, V187, P1115, DOI 10.1534/genetics.110.125534; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; SAWYER SA, 1992, GENETICS, V132, P1161; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Sheehan S, 2013, GENETICS, V194, P647, DOI 10.1534/genetics.112.149096; Singhal S, 2015, SCIENCE, V350, P928, DOI 10.1126/science.aad0843; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Steinrucken M., 2015, BIORXIV; Steinrucken M, 2013, THEOR POPUL BIOL, V87, P51, DOI 10.1016/j.tpb.2012.08.004; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Terhorst J, 2015, P NATL ACAD SCI USA, V112, P7677, DOI 10.1073/pnas.1503717112; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wiuf C, 1999, THEOR POPUL BIOL, V55, P248, DOI 10.1006/tpbi.1998.1403	37	182	183	6	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					303	309		10.1038/ng.3748	http://dx.doi.org/10.1038/ng.3748			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	28024154	Green Accepted			2022-12-25	WOS:000393148600021
J	Carter, L; Rothwell, DG; Mesquita, B; Smowton, C; Leong, HS; Fernandez-Gutierrez, F; Li, YY; Burt, DJ; Antonello, J; Morrow, CJ; Hodgkinson, CL; Morris, K; Priest, L; Carter, M; Miller, C; Hughes, A; Blackhall, F; Dive, C; Brady, G				Carter, Louise; Rothwell, Dominic G.; Mesquita, Barbara; Smowton, Christopher; Leong, Hui Sun; Fernandez-Gutierrez, Fabiola; Li, Yaoyong; Burt, Deborah J.; Antonello, Jenny; Morrow, Christopher J.; Hodgkinson, Cassandra L.; Morris, Karen; Priest, Lynsey; Carter, Mathew; Miller, Crispin; Hughes, Andrew; Blackhall, Fiona; Dive, Caroline; Brady, Ged			Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer	NATURE MEDICINE			English	Article							TOPOTECAN; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; VINCRISTINE	In most patients with small-cell lung cancer (SCLC)-a metastatic, aggressive disease-the condition is initially chemosensitive but then relapses with acquired chemoresistance. In a minority of patients, however, relapse occurs within 3 months of initial treatment; in these cases, disease is defined as chemorefractory. The molecular mechanisms that differentiate chemosensitive from chemorefractory disease are currently unknown. To identify genetic features that distinguish chemosensitive from chemorefractory disease, we examined copy-number aberrations (CNAs) in circulating tumor cells (CTCs) from pretreatment SCLC blood samples. After analysis of 88 CTCs isolated from 13 patients (training set), we generated a CNA-based classifier that we validated in 18 additional patients (testing set, 112 CTC samples) and in six SCLC patient-derived CTC explant tumors(1). The classifier correctly assigned 83.3% of the cases as chemorefractory or chemosensitive. Furthermore, a significant difference was observed in progression-free survival (PFS) (Kaplan-Meier P value = 0.0166) between patients designated as chemorefractory or chemosensitive by using the baseline CNA classifier. Notably, CTC CNA profiles obtained at relapse from five patients with initially chemosensitive disease did not switch to a chemorefractory CNA profile, which suggests that the genetic basis for initial chemoresistance differs from that underlying acquired chemoresistance.	[Carter, Louise; Rothwell, Dominic G.; Mesquita, Barbara; Smowton, Christopher; Fernandez-Gutierrez, Fabiola; Burt, Deborah J.; Antonello, Jenny; Morrow, Christopher J.; Hodgkinson, Cassandra L.; Morris, Karen; Priest, Lynsey; Carter, Mathew; Dive, Caroline; Brady, Ged] Univ Manchester, CRUK Manchester Inst, Clin & Expt Pharmacol Grp, Manchester, Lancs, England; [Leong, Hui Sun; Miller, Crispin] Univ Manchester, CRUK Manchester Inst, Computat Biol Support Grp, Manchester, Lancs, England; [Li, Yaoyong] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Miller, Crispin] Univ Manchester, CRUK Manchester Inst, RNA Biol Grp, Manchester, Lancs, England; [Hughes, Andrew] AstraZeneca, Alderley Pk, Macclesfield, Cheshire, England; [Blackhall, Fiona] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England; [Blackhall, Fiona; Dive, Caroline] Univ Manchester, CRUK Manchester Inst, Cancer Res UK Lung Canc Ctr Excellence, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; AstraZeneca; University of Manchester; University of Manchester	Dive, C; Brady, G (corresponding author), Univ Manchester, CRUK Manchester Inst, Clin & Expt Pharmacol Grp, Manchester, Lancs, England.; Dive, C (corresponding author), Univ Manchester, CRUK Manchester Inst, Cancer Res UK Lung Canc Ctr Excellence, Manchester, Lancs, England.	Caroline.Dive@cruk.manchester.ac.uk; Ged.Brady@cruk.manchester.ac.uk	; Blackhall, Fiona/N-2186-2015	Miller, Crispin/0000-0003-4341-1283; Carter, Louise/0000-0002-9854-2304; Blackhall, Fiona/0000-0001-8716-3395; Priest, Lynsey/0000-0003-3780-8508; Dive, Caroline/0000-0002-1726-8850; Rothwell, Dominic/0000-0002-8757-3893	CRUK; AstraZeneca [C147/A12328]; Menarini Biomarkers Singapore PTE Ltd.;  [C5759/A12328];  [A12197]; Cancer Research UK [20465, 15675, 19278] Funding Source: researchfish	CRUK(Cancer Research UK); AstraZeneca(AstraZeneca); Menarini Biomarkers Singapore PTE Ltd.; ; ; Cancer Research UK(Cancer Research UK)	L.C. was funded via a Clinical Pharmacology Fellowship educational grant from CRUK and AstraZeneca (C147/A12328). We would like to acknowledge the help of the CRUK Molecular Biology Core Facilities and members of the CRUK Manchester Institute Clinical and Experimental Pharmacology Group for their support of this study. We also thank the patients and healthy volunteers who provided their blood samples. This work was supported by core funding to CRUK Manchester Institute (C5759/A12328), and via Manchester CRUK Centre Award (A12197) and a research grant from Menarini Biomarkers Singapore PTE Ltd. (funding for all assigned to C.D.)	Chan BA, 2013, J THORAC DIS, V5, pS565, DOI 10.3978/j.issn.2072-1439.2013.07.43; Dowlati A, 2016, ANN ONCOL, V27, P642, DOI 10.1093/annonc/mdw005; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Hagmann R, 2015, J CANCER, V6, P1148, DOI 10.7150/jca.13080; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Hou JM, 2009, AM J PATHOL, V175, P808, DOI 10.2353/ajpath.2009.090078; Lally BE, 2007, ONCOLOGIST, V12, P1096, DOI 10.1634/theoncologist.12-9-1096; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Polzer B, 2014, EMBO MOL MED, V6, P1371, DOI 10.15252/emmm.201404033; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Semenova EA, 2015, GENE DEV, V29, P1447, DOI 10.1101/gad.263145.115; Smyth G. K., STAT APPL GENET MOL, V3, P1544; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; von Pawel J, 1999, J CLIN ONCOL, V17, P658, DOI 10.1200/JCO.1999.17.2.658	18	206	214	2	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					114	119		10.1038/nm.4239	http://dx.doi.org/10.1038/nm.4239			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27869802				2022-12-25	WOS:000391646800020
J	Leidecker, O; Bonfiglio, JJ; Colby, T; Zhang, Q; Atanassov, I; Zaja, R; Palazzo, L; Stockum, A; Ahel, I; Matic, I				Leidecker, Orsolya; Bonfiglio, Juan Jose; Colby, Thomas; Zhang, Qi; Atanassov, Ilian; Zaja, Roko; Palazzo, Luca; Stockum, Anna; Ahel, Ivan; Matic, Ivan			Serine is a new target residue for endogenous ADP-ribosylation on histones	NATURE CHEMICAL BIOLOGY			English	Article							NUDIX HYDROLASES; IDENTIFICATION; PROTEOMICS; CHROMATIN; RIBOSE; SITES; CELLS	ADP-ribosylation (ADPr) is a biologically and clinically important post-translational modification, but little is known about the amino acids it targets on cellular proteins. Here we present a proteomic approach for direct in vivo identification and quantification of ADPr sites on histones. We have identified 12 unique ADPr sites in human osteosarcoma cells and report serine ADPr as a new type of histone mark that responds to DNA damage.	[Leidecker, Orsolya; Bonfiglio, Juan Jose; Colby, Thomas; Zhang, Qi; Atanassov, Ilian; Stockum, Anna; Matic, Ivan] Max Planck Inst Biol Ageing, Cologne, Germany; [Zaja, Roko; Palazzo, Luca; Ahel, Ivan] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England	Max Planck Society; University of Oxford	Matic, I (corresponding author), Max Planck Inst Biol Ageing, Cologne, Germany.	imatic@age.mpg.de	Bonfiglio, Juan José/B-5853-2013; Atanassov, Ilian/L-2464-2016; Matic, Ivan/HFZ-7772-2022; Palazzo, Luca/Q-1084-2017; Matic, Ivan/F-7284-2010	Bonfiglio, Juan José/0000-0001-7767-0799; Atanassov, Ilian/0000-0001-8259-2545; Matic, Ivan/0000-0003-0170-7991; Palazzo, Luca/0000-0002-5556-5549; Matic, Ivan/0000-0003-0170-7991; Ahel, Ivan/0000-0002-9446-3756; Zaja, Roko/0000-0003-3944-0153	Deutsche Forschungsgemeinschaft (Cellular Stress Responses in Aging-Associated Diseases) [EXC 229]; European Union [657501]; Wellcome Trust [101794]; European Research Council [281739]	Deutsche Forschungsgemeinschaft (Cellular Stress Responses in Aging-Associated Diseases); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	Many thanks to A. Zhiteneva, W. Earnshaw (University of Edinburgh) and M. Tatham (University of Dundee) for comments on the manuscript. Chicken bursal lymphoma DT40 cells were a gift from W. Earnshaw (Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, UK). pGEX-4T1 GST-PARP10cd plasmid was a gift from B. Luscher (Department of Biochemistry and Molecular Biology, RWTH Aachen University, Aachen, Germany). This work was funded by Deutsche Forschungsgemeinschaft (Cellular Stress Responses in Aging-Associated Diseases) (grant EXC 229 to I. M.) and the European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant agreement no. 657501 to J.J.B. and I. M.). The work in the Ahel laboratory is funded by the Wellcome Trust (grant 101794) and the European Research Council (grant 281739).	Affar EB, 1998, ANAL BIOCHEM, V259, P280, DOI 10.1006/abio.1998.2664; Bock FJ, 2015, MOL CELL, V58, P911, DOI 10.1016/j.molcel.2015.06.012; CERVANTESLAUREAN D, 1995, J BIOL CHEM, V270, P7929, DOI 10.1074/jbc.270.14.7929; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Daniels CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep18271; Daniels CM, 2014, J PROTEOME RES, V13, P3510, DOI 10.1021/pr401032q; Feng FY, 2015, MOL CELL, V58, P925, DOI 10.1016/j.molcel.2015.04.016; Hengel SM, 2012, INT J MASS SPECTROM, V312, P114, DOI 10.1016/j.ijms.2011.06.003; Hottiger MO, 2015, ANNU REV BIOCHEM, V84, P227, DOI 10.1146/annurev-biochem-060614-034506; Huang H, 2015, CHEM REV, V115, P2376, DOI 10.1021/cr500491u; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Messner S, 2011, TRENDS CELL BIOL, V21, P534, DOI 10.1016/j.tcb.2011.06.001; Messner S, 2010, NUCLEIC ACIDS RES, V38, P6350, DOI 10.1093/nar/gkq463; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Palazzo L, 2015, BIOCHEM J, V468, P293, DOI 10.1042/BJ20141554; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp273; Rosenthal F, 2015, J PROTEOME RES, V14, P4072, DOI 10.1021/acs.jproteome.5b00432; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Wang FW, 2013, TRENDS CELL BIOL, V23, P175, DOI 10.1016/j.tcb.2012.11.005; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]	28	134	141	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					998	+		10.1038/nchembio.2180	http://dx.doi.org/10.1038/nchembio.2180			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27723750	Green Accepted, Green Submitted			2022-12-25	WOS:000388582900005
J	Sheridan, C				Sheridan, Cormac			Despite slow progress, bispecifics generate buzz	NATURE BIOTECHNOLOGY			English	News Item																		2012, NAT BIOTECHNOL, V30, P300; 2015, NAT BIOTECHNOL, V33, P219	2	16	17	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1215	1217		10.1038/nbt1216-1215	http://dx.doi.org/10.1038/nbt1216-1215			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27926715				2022-12-25	WOS:000390185300004
J	Li, KH; Condurso, HL; Li, GN; Ding, YS; Bruner, SD				Li, Kunhua; Condurso, Heather L.; Li, Gengnan; Ding, Yousong; Bruner, Steven D.			Structural basis for precursor protein-directed ribosomal peptide macrocyclization	NATURE CHEMICAL BIOLOGY			English	Article							LEADER PEPTIDE; NATURAL-PRODUCTS; LANTIBIOTIC SYNTHETASE; BIOSYNTHESIS; LIGASE; DIVERSITY; MODEL; GUIDE	Macrocyclization is a common feature of natural product biosynthetic pathways including the diverse family of ribosomal peptides. Microviridins are architecturally complex cyanobacterial ribosomal peptides that target proteases with potent reversible inhibition. The product structure is constructed via three macrocyclizations catalyzed sequentially by two members of the ATP-grasp family, a unique strategy for ribosomal peptide macrocyclization. Here we describe in detail the structural basis for the enzyme-catalyzed macrocyclizations in the microviridin J pathway of Microcystis aeruginosa. The macrocyclases MdnC and MdnB interact with a conserved alpha-helix of the precursor peptide using a novel precursor-peptide recognition mechanism. The results provide insight into the unique protein-protein interactions that are key to the chemistry, suggest an origin for the natural combinatorial synthesis of microviridin peptides, and provide a framework for future engineering efforts to generate designed compounds.	[Li, Kunhua; Condurso, Heather L.; Li, Gengnan; Bruner, Steven D.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Ding, Yousong] Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bruner, SD (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	bruner@ufl.edu	Li, Gengnan/GVU-0714-2022	Li, Gengnan/0000-0003-4566-6538; Li, Kunhua/0000-0002-9139-4257	US National Institutes of Health [GM086570]; University of Florida; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086570] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida(University of Florida); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the 21-ID-G and 22-ID beamlines at Argonne National Laboratory Advanced Photon Source for help with data acquisition and processing. We thank T. Montavon and S. Lagishetty for providing experimental contributions supporting this work. We also are grateful to N. Polfer and A. Patrick for assistance with peptide synthesis. This work was supported by US National Institutes of Health grant GM086570 and funds from the University of Florida (S.D.B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Burkhart BJ, 2015, NAT CHEM BIOL, V11, P564, DOI 10.1038/nchembio.1856; Cheung WL, 2010, J AM CHEM SOC, V132, P2514, DOI 10.1021/ja910191u; Crone WJK, 2012, CHEM SCI, V3, P3516, DOI 10.1039/c2sc21190d; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dong SH, 2015, ELIFE, V4, DOI 10.7554/eLife.07607; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Iyer LM, 2009, MOL BIOSYST, V5, P1636, DOI 10.1039/b917682a; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Koehnke J, 2015, NAT CHEM BIOL, V11, P558, DOI 10.1038/nchembio.1841; Koehnke J, 2012, NAT STRUCT MOL BIOL, V19, P767, DOI 10.1038/nsmb.2340; Liu SP, 2006, P NATL ACAD SCI USA, V103, P15178, DOI 10.1073/pnas.0604905103; Liu Y, 2011, CHEM BIOL, V18, P1482, DOI 10.1016/j.chembiol.2011.09.018; Mathavan I, 2014, NAT CHEM BIOL, V10, P340, DOI [10.1038/nchembio.1499, 10.1038/NCHEMBIO.1499]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Oman TJ, 2012, J AM CHEM SOC, V134, P6952, DOI 10.1021/ja3017297; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Ortega MA, 2016, CELL CHEM BIOL, V23, P31, DOI 10.1016/j.chembiol.2015.11.012; Ortega MA, 2015, NATURE, V517, P509, DOI 10.1038/nature13888; Ouchi T, 2013, NAT CHEM BIOL, V9, P277, DOI [10.1038/NCHEMBIO.1200, 10.1038/nchembio.1200]; Pan SJ, 2012, CHEMBIOCHEM, V13, P367, DOI 10.1002/cbic.201100596; Pan SJ, 2011, J AM CHEM SOC, V133, P5016, DOI 10.1021/ja1109634; Philmus B, 2009, ACS CHEM BIOL, V4, P429, DOI 10.1021/cb900088r; Philmus B, 2008, CHEMBIOCHEM, V9, P3066, DOI 10.1002/cbic.200800560; Rohrlack T, 2004, APPL ENVIRON MICROB, V70, P5047, DOI 10.1128/AEM.70.8.5047-5050.2004; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tianero MD, 2016, P NATL ACAD SCI USA, V113, P1772, DOI 10.1073/pnas.1525438113; Wang BY, 2015, P NATL ACAD SCI USA, V112, P10679, DOI 10.1073/pnas.1506030112; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Weiz AR, 2014, ANGEW CHEM INT EDIT, V53, P3735, DOI 10.1002/anie.201309721; Weiz AR, 2011, CHEM BIOL, V18, P1413, DOI 10.1016/j.chembiol.2011.09.011; Xie LL, 2004, SCIENCE, V303, P679, DOI 10.1126/science.1092600; Zhao GX, 2013, PROTEINS, V81, P1847, DOI 10.1002/prot.24311; Ziemert N, 2008, ANGEW CHEM INT EDIT, V47, P7756, DOI 10.1002/anie.200802730	46	43	44	3	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					973	+		10.1038/NCHEMBIO.2200	http://dx.doi.org/10.1038/NCHEMBIO.2200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27669417	Green Accepted			2022-12-25	WOS:000386798800020
J	Branca, MA				Branca, Malorye Allison			Rekindling cancer vaccines	NATURE BIOTECHNOLOGY			English	Article							CELLS; COMBINATION; IPILIMUMAB	Interest in cancer vaccines is being reignited by a greater understanding of tumor immunology and the potential of combining immunogens with new breakthrough immunotherapies.										Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bouchie A, 2016, NAT BIOTECHNOL, V34, P484, DOI 10.1038/nbt.3564; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Feuerstein A., 2015, STREET; Fong L, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju268; Garde D., 2015, FIERCE BIOTECH  1124; Gulley JL, 2005, CLIN CANCER RES, V11, P3353, DOI 10.1158/1078-0432.CCR-04-2062; Jochems C, 2014, CANCER IMMUNOL IMMUN, V63, P407, DOI 10.1007/s00262-014-1524-0; Le DT, 2013, J IMMUNOTHER, V36, P382, DOI 10.1097/CJI.0b013e31829fb7a2; Lutz ER, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.962401; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sheikh N, 2016, CANCER RES, V76, P3711, DOI 10.1158/0008-5472.CAN-15-3173; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102	15	34	38	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2016	34	10					1019	1024		10.1038/nbt.3690	http://dx.doi.org/10.1038/nbt.3690			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EA0ZG	27727216				2022-12-25	WOS:000386317500013
J	Shukla, AK; Upadhyay, SK; Mishra, M; Saurabh, S; Singh, R; Singh, H; Thakur, N; Rai, P; Pandey, P; Hans, AL; Srivastava, S; Rajapure, V; Yadav, SK; Singh, MK; Kumar, J; Chandrashekar, K; Verma, PC; Singh, AP; Nair, KN; Bhadauria, S; Wahajuddin, M; Singh, S; Sharma, S; Omkar; Upadhyay, RS; Ranade, SA; Tuli, R; Singh, PK				Shukla, Anoop Kumar; Upadhyay, Santosh Kumar; Mishra, Manisha; Saurabh, Sharad; Singh, Rahul; Singh, Harpal; Thakur, Nidhi; Rai, Preeti; Pandey, Paras; Hans, Aradhana L.; Srivastava, Subhi; Rajapure, Vikram; Yadav, Sunil Kumar; Singh, Mithlesh Kumar; Kumar, Jitendra; Chandrashekar, K.; Verma, Praveen C.; Singh, Ajit Pratap; Nair, K. N.; Bhadauria, Smrati; Wahajuddin, Muhammad; Singh, Sarika; Sharma, Sharad; Omkar; Upadhyay, Ram Sanmukh; Ranade, Shirish A.; Tuli, Rakesh; Singh, Pradhyumna Kumar			Expression of an insecticidal fern protein in cotton protects against whitefly	NATURE BIOTECHNOLOGY			English	Article							RESISTANCE; APHID	Whitefly (Bemisia tabaci) damages field crops by sucking sap and transmitting viral diseases. None of the insecticidal proteins used in genetically modified (GM) crop plants to date are effective against whitefly. We report the identification of a protein (Tma12) from an edible fern, Tectaria macrodonta (Fee) C. Chr., that is insecticidal to whitefly (median lethal concentration = 1.49 mu g/ml in in vitro feeding assays) and interferes with its life cycle at sublethal doses. Transgenic cotton lines that express Tmal2 at similar to 0.01% of total soluble leaf protein were resistant to whitefly infestation in contained field trials, with no detectable yield penalty. The transgenic cotton lines were also protected from whitefly-borne cotton leaf curl viral disease. Rats fed Tma12 showed no detectable histological or biochemical changes, and this, together with the predicted absence of allergenic domains in Tma12, indicates that Tma12 might be well suited for deployment in GM crops to control whitefly and the viruses it carries.	[Shukla, Anoop Kumar; Upadhyay, Santosh Kumar; Mishra, Manisha; Saurabh, Sharad; Singh, Rahul; Singh, Harpal; Thakur, Nidhi; Rai, Preeti; Pandey, Paras; Hans, Aradhana L.; Srivastava, Subhi; Rajapure, Vikram; Yadav, Sunil Kumar; Singh, Mithlesh Kumar; Chandrashekar, K.; Verma, Praveen C.; Ranade, Shirish A.; Tuli, Rakesh; Singh, Pradhyumna Kumar] CSIR Natl Bot Res Inst, Genet & Plant Mol Biol, Lucknow, Uttar Pradesh, India; [Mishra, Manisha; Thakur, Nidhi; Pandey, Paras; Hans, Aradhana L.; Yadav, Sunil Kumar; Singh, Mithlesh Kumar; Verma, Praveen C.; Singh, Ajit Pratap; Nair, K. N.; Ranade, Shirish A.; Singh, Pradhyumna Kumar] Acad Sci & Innovat Res, New Delhi, India; [Kumar, Jitendra] Natl Agri Food Biotechnol Inst, Mohali, Punjab, India; [Singh, Ajit Pratap; Nair, K. N.] CSIR Natl Bot Res Inst, Plant Div Systemat & Herbarium Div, Lucknow, Uttar Pradesh, India; [Bhadauria, Smrati; Singh, Sarika; Sharma, Sharad] CSIR Cent Drug Res Inst, Toxicol Div, Lucknow, Uttar Pradesh, India; [Wahajuddin, Muhammad] CSIR Cent Drug Res Inst, Pharmacokinet & Metab Div, Lucknow, Uttar Pradesh, India; [Omkar] Univ Lucknow, Dept Zool, Ladybird Beetle Res Lab, Lucknow, Uttar Pradesh, India; [Upadhyay, Ram Sanmukh] Banaras Hindu Univ, Dept Bot, Varanasi, Uttar Pradesh, India; [Upadhyay, Santosh Kumar] Panjab Univ, Dept Bot, Chandigarh, India; [Chandrashekar, K.] Indian Agr Res Inst, Reg Stn, Pune, Maharashtra, India; [Tuli, Rakesh] Panjab Univ, Univ Inst Engn & Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Academy of Scientific & Innovative Research (AcSIR); Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Lucknow University; Banaras Hindu University (BHU); Panjab University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Panjab University	Singh, PK (corresponding author), CSIR Natl Bot Res Inst, Genet & Plant Mol Biol, Lucknow, Uttar Pradesh, India.; Singh, PK (corresponding author), Acad Sci & Innovat Res, New Delhi, India.	pksingh@nbri.res.in	Singh, Rahul/AAT-2337-2021; Kumar, Jitendra/AAP-5018-2020; Upadhyay, Santosh/ABD-2302-2020; TULI, RAKESH/AAD-3047-2021; Chadrashekar, K/AAX-4996-2021; --, Wahajuddin/B-4413-2010; Verma, Praveen C/F-9709-2010; SINGH, SARIKA/AAO-7571-2021	Upadhyay, Santosh/0000-0001-6991-0502; --, Wahajuddin/0000-0003-3362-7558; Verma, Praveen C/0000-0002-3732-0564; SRIVASTAVA, SUBHI/0000-0002-1305-9779; UPADHYAY, RAM SANMUKH/0000-0001-9738-0465	Council of Scientific and Industrial Research, India under Supra Institutional Project [SIP05]; Council of Scientific and Industrial Research, India under Network Projects [NWP03, PlaGen BSC0107]; CSIR; Indian Council of Medical Research; University Grant Commission; Department of Science and Technology (DST) JC Bose National Fellowship	Council of Scientific and Industrial Research, India under Supra Institutional Project; Council of Scientific and Industrial Research, India under Network Projects; CSIR(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); University Grant Commission(University Grants Commission, India); Department of Science and Technology (DST) JC Bose National Fellowship(Department of Science & Technology (India))	The authors acknowledge H.K. Yadav, R. Kamal and S. Sharma for help in statistical analysis; M. Lal, Rajesh K. Srivastava, S.H.M. Abidi, A. Bano (deceased) and Rakesh K. Srivastava for technical assistance; and A.C. Little for photography. The authors thank the Council of Scientific and Industrial Research, India, for funding under the Supra Institutional Project (SIP05), the Network Projects (NWP03 and PlaGen BSC0107) and the Council of Scientific and Industrial Research-National Botanical Research Institute for providing research facilities. A.K.S., S.K.U., R.S., KM., S. Saurabh, H.S., N.T., RR, A.L.H. and V.R. are supported by CSIR. P.R. and S.K.Y. are supported by the Indian Council of Medical Research. S. Srivastava is supported by the University Grant Commission. R.T. is supported by a Department of Science and Technology (DST) JC Bose National Fellowship.	Balasubramanian R., 2008, Journal of Biopesticides, V1, P201; Berge Jean Baptiste, 2010, GM Crops, V1, P214, DOI 10.4161/gmcr.1.4.13421; Bonning BC, 2014, NAT BIOTECHNOL, V32, P102, DOI 10.1038/nbt.2753; Chougule NP, 2012, TOXINS, V4, P405, DOI 10.3390/toxins4060405; Das S., 2009, Indian patent, Patent No. 228783; Dubey AK, 2008, ORIENT INSECTS, V42, P49, DOI 10.1080/00305316.2008.10417536; HENDRIX SD, 1980, AM NAT, V115, P171, DOI 10.1086/283554; Horowitz AR, 2011, WHITEFLY, BEMISIA TABACI (HOMOPTERA: ALEYRODIDAE) INTERACTION WITH GEMINIVIRUS-INFECTED HOST PLANTS: BEMISIA TABACI, HOST PLANTS AND GEMINIVIRUSES, P293, DOI 10.1007/978-94-007-1524-0_11; Jin SX, 2012, PLANT BIOTECHNOL J, V10, P313, DOI 10.1111/j.1467-7652.2011.00663.x; Legg J., 2005, WHITEFLY WHITEFLY BO, P15; Markham K, 2006, INT J PLANT SCI, V167, P111, DOI 10.1086/497651; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Nwosu MO, 2002, ECON BOT, V56, P255, DOI 10.1663/0013-0001(2002)056[0255:ESOSPO]2.0.CO;2; Petterino C, 2006, EXP TOXICOL PATHOL, V57, P213, DOI 10.1016/j.etp.2005.10.002; Sahayaraj K, 2013, LEGUME RES, V36, P84; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Shrestha D., 2013, International Journal of Biodiversity and Conservation, V5, P98; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Uprety Yadav, 2011, Environment Development and Sustainability, V13, P463, DOI 10.1007/s10668-010-9271-7; VanDoorn A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00222	20	49	51	6	52	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2016	34	10					1046	1051		10.1038/nbt.3665	http://dx.doi.org/10.1038/nbt.3665			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EA0ZG	27598229				2022-12-25	WOS:000386317500019
J	Chen, Y; Pai, AA; Herudek, J; Lubas, M; Meola, N; Jarvelin, AI; Andersson, R; Pelechano, V; Steinmetz, LM; Jensen, TH; Sandelin, A				Chen, Yun; Pai, Athma A.; Herudek, Jan; Lubas, Michal; Meola, Nicola; Jaervelin, Aino I.; Andersson, Robin; Pelechano, Vicent; Steinmetz, Lars M.; Jensen, Torben Heick; Sandelin, Albin			Principles for RNA metabolism and alternative transcription initiation within closely spaced promoters	NATURE GENETICS			English	Article							DIVERGENT TRANSCRIPTION; FACTOR-BINDING; U1 SNRNP; LANDSCAPE; COMPLEX; DIRECTIONALITY; ORGANIZATION; ARCHITECTURE; DEPLETION; UPSTREAM	Mammalian transcriptomes are complex and formed by extensive promoter activity. In addition, gene promoters are largely divergent and initiate transcription of reverse-oriented promoter upstream transcripts (PROMPTs). Although PROMPTs are commonly terminated early, influenced by polyadenylation sites, promoters often cluster so that the divergent activity of one might impact another. Here we found that the distance between promoters strongly correlates with the expression, stability and length of their associated PROMPTs. Adjacent promoters driving divergent mRNA transcription support PROMPT formation, but owing to polyadenylation site constraints, these transcripts tend to spread into the neighboring mRNA on the same strand. This mechanism to derive new alternative mRNA transcription start sites (TSSs) is also evident at closely spaced promoters supporting convergent mRNA transcription. We suggest that basic building blocks of divergently transcribed core promoter pairs, in combination with the wealth of TSSs in mammalian genomes, provide a framework with which evolution shapes transcriptomes.	[Chen, Yun; Andersson, Robin; Sandelin, Albin] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Chen, Yun; Lubas, Michal; Sandelin, Albin] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Pai, Athma A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Herudek, Jan; Lubas, Michal; Meola, Nicola; Jensen, Torben Heick] Aarhus Univ, Dept Mol Biol & Genet, Ctr MRNP Biogenesis & Metab, Aarhus, Denmark; [Jaervelin, Aino I.; Pelechano, Vicent; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Steinmetz, Lars M.] Stanford Genome Technol Ctr, Palo Alto, CA USA; [Steinmetz, Lars M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Jaervelin, Aino I.; Pelechano, Vicent] Univ Oxford, Dept Biochem, Oxford, England; [Jaervelin, Aino I.; Pelechano, Vicent] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SciLifeLab, Stockholm, Sweden	University of Copenhagen; University of Copenhagen; Massachusetts Institute of Technology (MIT); Aarhus University; European Molecular Biology Laboratory (EMBL); Stanford University; Stanford University; University of Oxford; Karolinska Institutet; SciLifeLab	Sandelin, A (corresponding author), Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark.; Sandelin, A (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark.; Jensen, TH (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Ctr MRNP Biogenesis & Metab, Aarhus, Denmark.	thj@mbg.au.dk; albin@binf.ku.dk	Andersson, Robin/B-5311-2009; Pelechano, Vicent/A-8431-2011; Jensen, Torben H/G-2954-2017; Sandelin, Albin/G-2881-2011; Pelechano, Vicent/ABF-2597-2020	Andersson, Robin/0000-0003-1516-879X; Pelechano, Vicent/0000-0002-9415-788X; Sandelin, Albin/0000-0002-7109-7378; Pelechano, Vicent/0000-0002-9415-788X; Jensen, Torben Heick/0000-0001-5127-1239; Steinmetz, Lars/0000-0002-3962-2865; Pai, Athma/0000-0002-7995-9948	European Research Council (ERC) [339953, 638273]; Danish National Research Foundation [DNRF58]; Lundbeck Foundation; Novo Nordisk Foundation; Innovation Fund Denmark; Boehringer-Ingelheim PhD fellowship; Deutsche Forschungsgemeinschaft [1422/3-1]; Jane Coffin Childs postdoctoral fellowship; Lundbeck Foundation [R198-2015-172] Funding Source: researchfish; Novo Nordisk Fonden [NNF10SA1016550, NNF15OC0017010] Funding Source: researchfish	European Research Council (ERC)(European Research Council (ERC)European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Innovation Fund Denmark; Boehringer-Ingelheim PhD fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jane Coffin Childs postdoctoral fellowship; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	Work in the T.H.J. laboratory was supported by the European Research Council (ERC) (grant 339953) as well as the Danish National Research Foundation (grant DNRF58), the Lundbeck Foundation and the Novo Nordisk Foundation. Work in the A.S. laboratory was supported by grants from the Lundbeck Foundation, the Novo Nordisk-Foundation and the Innovation Fund Denmark. J.H. was supported by a Boehringer-Ingelheim PhD fellowship. R.A. was supported by ERC grant 638273. Work in the L.M.S. laboratory was supported by the Deutsche Forschungsgemeinschaft (grant 1422/3-1). A.A.P. was supported by a Jane Coffin Childs postdoctoral fellowship. We thank the European Molecular Biology Laboratory Genomics Core Facility for technical support.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersen PR, 2013, NAT STRUCT MOL BIOL, V20, P1367, DOI 10.1038/nsmb.2703; Andersson R, 2015, MOL CELL, V60, P346, DOI 10.1016/j.molcel.2015.10.015; Andersson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6336; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duttke SHC, 2015, MOL CELL, V57, P674, DOI 10.1016/j.molcel.2014.12.029; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Jensen TH, 2013, MOL CELL, V52, P473, DOI 10.1016/j.molcel.2013.10.032; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Marstrand TT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001623; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Pelechano V, 2014, NAT PROTOC, V9, P1740, DOI 10.1038/nprot.2014.121; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Pugh BF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149339; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048	52	51	51	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					984	+		10.1038/ng.3616	http://dx.doi.org/10.1038/ng.3616			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27455346	Green Submitted, Green Accepted			2022-12-25	WOS:000382398800008
J	Weiner, A; Lara-Astiaso, D; Krupalnik, V; Gafni, O; David, E; Winter, DR; Hanna, JH; Amit, I				Weiner, Assaf; Lara-Astiaso, David; Krupalnik, Vladislav; Gafni, Ohad; David, Eyal; Winter, Deborah R.; Hanna, Jacob H.; Amit, Ido			Co-ChIP enables genome-wide mapping of histone mark co-occurrence at single-molecule resolution	NATURE BIOTECHNOLOGY			English	Article							CHROMATIN STATE DYNAMICS; TRANSCRIPTION FACTORS; MASS-SPECTROMETRY; STEM-CELLS; ENHANCERS; DISCOVERY; REVEALS; GENES	Histone modifications play an important role in chromatin organization and transcriptional regulation, but despite the large amount of genome-wide histone modification data collected in different cells and tissues, little is known about co-occurrence of modifications on the same nucleosome. Here we present a genome-wide quantitative method for combinatorial indexed chromatin immunoprecipitation (co-ChIP) to characterize co-occurrence of histone modifications on nucleosomes. Using co-ChIP, we study the genome-wide co-occurrence of 14 chromatin marks (70 pairwise combinations), and find previously undescribed co-occurrence patterns, including the co-occurrence of H3K9me1 and H3K27ac in super-enhancers. Finally, we apply co-ChIP to measure the distribution of the bivalent H3K4me3-H3K27me3 domains in two distinct mouse embryonic stem cell (mESC) states and in four adult tissues. We observe dynamic changes in 5,786 regions and discover both loss and de novo gain of bivalency in key tissue-specific regulatory genes, suggesting a functional role for bivalent domains during different stages of development. These results show that co-ChIP can reveal the complex interactions between histone modifications.	[Weiner, Assaf; Lara-Astiaso, David; David, Eyal; Winter, Deborah R.; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Krupalnik, Vladislav; Gafni, Ohad; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	ido.amit@weizmann.ac.il	Hanna, Jacob/K-1339-2012; Winter, Deborah R./AAQ-9253-2020	Hanna, Jacob/0000-0003-2042-9974; Winter, Deborah R./0000-0003-1806-673X	European Research Council [309788]; Israel Science foundation [782/11]; BLUEPRINT FP7 consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; National Human Genome Research Institute Center for Excellence in Genome Science [1P50HG006193]; Israeli Ministry of Science, Technology and Space; David and Fela Shapell Family Foundation; Abramson Family Center for Young Scientists; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Israel Science foundation(Israel Science Foundation); BLUEPRINT FP7 consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; National Human Genome Research Institute Center for Excellence in Genome Science; Israeli Ministry of Science, Technology and Space(Ministry of Science, Technology and Space (MOST), Israel); David and Fela Shapell Family Foundation; Abramson Family Center for Young Scientists; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank G. Brodsky for art work. I. A. is supported by the European Research Council (309788), the Israel Science foundation (782/11) and the BLUEPRINT FP7 consortium, the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine, a Minerva Stiftung research grant, and the National Human Genome Research Institute Center for Excellence in Genome Science (1P50HG006193), the Israeli Ministry of Science, Technology and Space, the David and Fela Shapell Family Foundation, and the Abramson Family Center for Young Scientists. I. A. is the incumbent of the Alan and Laraine Fischer Career Development Chair. ChIP-Seq and co-ChIP data are deposited in Gene Expression Omnibus, accession number GSE83833.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Britton LMP, 2011, EXPERT REV PROTEOMIC, V8, P631, DOI [10.1586/epr.11.47, 10.1586/EPR.11.47]; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Grandy RA, 2016, MOL CELL BIOL, V36, P615, DOI 10.1128/MCB.00877-15; Guan XY, 2013, MOL CELL PROTEOMICS, V12, P2048, DOI 10.1074/mcp.M112.026716; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yan LY, 2016, J BIOL CHEM, V291, P4386, DOI 10.1074/jbc.M115.672931	24	56	57	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2016	34	9					953	+		10.1038/nbt.3652	http://dx.doi.org/10.1038/nbt.3652			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DW0RE	27454738				2022-12-25	WOS:000383348500022
J	Palchaudhuri, R; Saez, B; Hoggatt, J; Schajnovitz, A; Sykes, DB; Tate, TA; Czechowicz, A; Kfoury, Y; Ruchika, FNU; Rossi, DJ; Verdine, GL; Mansour, MK; Scadden, DT				Palchaudhuri, Rahul; Saez, Borja; Hoggatt, Jonathan; Schajnovitz, Amir; Sykes, David B.; Tate, Tiffany A.; Czechowicz, Agnieszka; Kfoury, Youmna; Ruchika, F. N. U.; Rossi, Derrick J.; Verdine, Gregory L.; Mansour, Michael K.; Scadden, David T.			Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin	NATURE BIOTECHNOLOGY			English	Article							BONE-MARROW-TRANSPLANTATION; CHRONIC GRANULOMATOUS-DISEASE; GENE-THERAPY; MONOCLONAL-ANTIBODIES; MIXED CHIMERISM; FANCONI-ANEMIA; CANCER; MOUSE; CYCLOPHOSPHAMIDE; ENGRAFTMENT	Hematopoietic stem cell transplantation (HSCT) offers curative therapy for patients with hemoglobinopathies, congenital immunodeficiencies, and other conditions, possibly including AIDS. Autologous HSCT using genetically corrected cells would avoid the risk of graft-versus-host disease (GVHD), but the genotoxicity of conditioning remains a substantial barrier to the development of this approach. Here we report an internalizing immunotoxin targeting the hematopoietic-cell-restricted CD45 receptor that effectively conditions immunocompetent mice. A single dose of the immunotoxin, CD45-saporin (SAP), enabled efficient (>90%) engraftment of donor cells and full correction of a sickle-cell anemia model. In contrast to irradiation, CD45-SAP completely avoided neutropenia and anemia, spared bone marrow and thymic niches, enabling rapid recovery of T and B cells, preserved anti-fungal immunity, and had minimal overall toxicity. This non-genotoxic conditioning method may provide an attractive alternative to current conditioning regimens for HSCT in the treatment of non-malignant blood diseases.	[Palchaudhuri, Rahul; Saez, Borja; Hoggatt, Jonathan; Schajnovitz, Amir; Sykes, David B.; Tate, Tiffany A.; Czechowicz, Agnieszka; Kfoury, Youmna; Ruchika, F. N. U.; Rossi, Derrick J.; Verdine, Gregory L.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Palchaudhuri, Rahul; Saez, Borja; Hoggatt, Jonathan; Schajnovitz, Amir; Sykes, David B.; Tate, Tiffany A.; Kfoury, Youmna; Ruchika, F. N. U.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Palchaudhuri, Rahul; Saez, Borja; Hoggatt, Jonathan; Schajnovitz, Amir; Sykes, David B.; Tate, Tiffany A.; Czechowicz, Agnieszka; Kfoury, Youmna; Ruchika, F. N. U.; Rossi, Derrick J.; Verdine, Gregory L.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Palchaudhuri, Rahul; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Czechowicz, Agnieszka; Rossi, Derrick J.] Boston Childrens Hosp, Div Hematol Oncol, Program Cellular & Mol Med, Boston, MA USA; [Czechowicz, Agnieszka; Rossi, Derrick J.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Czechowicz, Agnieszka] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Mansour, Michael K.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	Palchaudhuri, R; Scadden, DT (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Palchaudhuri, R; Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.; Palchaudhuri, R; Scadden, DT (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Palchaudhuri, R (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	rpalcha2@gmail.com; david_scadden@harvard.edu	Saez, Borja/L-7411-2015	Saez, Borja/0000-0001-7908-7089	Life Science Research Foundation fellowship - Jake Wetchler Foundation; American Society of Hematology scholar award; NIH NHLBI [K99/R00 HL119559, HL44851, HL129903, HL107630]; NIAID NIH [1K08AI110655]; Gerald and Darlene Jordan Chair of Medicine of Harvard University; Harvard Blavatnik Biomedical Accelerator Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007574, K99HL119559, U19HL129903, R01HL044851, R01HL107630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI110655] Funding Source: NIH RePORTER	Life Science Research Foundation fellowship - Jake Wetchler Foundation; American Society of Hematology scholar award; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Gerald and Darlene Jordan Chair of Medicine of Harvard University; Harvard Blavatnik Biomedical Accelerator Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank R.T. Bronson (Harvard Medical School) for histology services, G. Sempowski (Duke University) for mouse sjTREC plasmid, and the Harvard Stem Cell and Regenerative Biology flow cytometry core. We would like to acknowledge N. Van Gastel and A. Papazian for technical assistance. R.P. was supported by a Life Science Research Foundation fellowship sponsored by the Jake Wetchler Foundation. B.S. was supported by an American Society of Hematology scholar award. J.H. was supported by an NIH NHLBI K99/R00 HL119559. M.K.M. was supported by NIAID NIH 1K08AI110655. D.T.S. was supported by the Gerald and Darlene Jordan Chair of Medicine of Harvard University. Grants from the Harvard Blavatnik Biomedical Accelerator Fund (D.T.S.), NIH NHLBI HL44851 (D.T.S.), HL129903 (D.T.S., D.J.R.), and HL107630 (D.J.R.) funded this work.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Andreani M, 2000, BONE MARROW TRANSPL, V25, P401, DOI 10.1038/sj.bmt.1702151; Andreani M, 1996, BLOOD, V87, P3494, DOI 10.1182/blood.V87.8.3494.bloodjournal8783494; [Anonymous], 2006, HCUP STAT BRIEFS; Bergamaschi G, 1996, BRIT J HAEMATOL, V93, P789, DOI 10.1046/j.1365-2141.1996.d01-1730.x; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Bikoue A, 2002, J IMMUNOL METHODS, V266, P19, DOI 10.1016/S0022-1759(02)00094-7; Booth C, 2016, TRENDS MOL MED, V22, P317, DOI 10.1016/j.molmed.2016.02.002; Bouchard H, 2014, BIOORG MED CHEM LETT, V24, P5357, DOI 10.1016/j.bmcl.2014.10.021; Brenner MK, 2003, ANN NY ACAD SCI, V996, P80, DOI 10.1111/j.1749-6632.2003.tb03236.x; Cartier N, 2008, CURR OPIN MOL THER, V10, P471; Cavazzana M, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.4797.4797; Chandrasekaran D, 2014, HUM GENE THER, V25, P1013, DOI 10.1089/hum.2014.031; Chen J, 2006, BLOOD, V107, P3764, DOI 10.1182/blood-2005-09-3593; Chen Y, 2012, BLOOD, V119, P1130, DOI 10.1182/blood-2011-09-380436; Colvin GA, 2004, LEUKEMIA, V18, P575, DOI 10.1038/sj.leu.2403268; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; D'Addio F, 2014, DIABETES, V63, P3041, DOI 10.2337/db14-0295; Dahlke MH, 2004, LEUKEMIA LYMPHOMA, V45, P229, DOI 10.1080/1042819031000151932; Dai JL, 2014, CLIN CANCER RES, V20, P617, DOI 10.1158/1078-0432.CCR-13-0839; Dalle JH, 2008, BONE MARROW TRANSPL, V42, pS51, DOI 10.1038/bmt.2008.284; Derderian SC, 2015, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00278; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Fedeli M, 2009, J IMMUNOL, V183, P2506, DOI 10.4049/jimmunol.0901361; Fewkes NM, 2010, BLOOD, V115, P4120, DOI 10.1182/blood-2009-10-248898; Hoffman R., 2009, HEMATOLOGY BASIC PRI; Hsieh MM, 2009, NEW ENGL J MED, V361, P2309, DOI 10.1056/NEJMoa0904971; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Iannone R, 2001, BLOOD, V97, P3960, DOI 10.1182/blood.V97.12.3960; Ignatavicus D.D., 2010, MED SURG NURSING PAT; Jia W, 2005, BLOOD, V106, P3854, DOI 10.1182/blood-2005-04-1658; Jiang Q, 2008, BLOOD, V112, P2858, DOI 10.1182/blood-2008-03-145946; Kamala T, 2007, J IMMUNOL METHODS, V328, P204, DOI 10.1016/j.jim.2007.08.004; Kraft D.L., 2004, ASH ANN M, V104, P4963; La Nasa G, 2005, BONE MARROW TRANSPL, V36, P971, DOI 10.1038/sj.bmt.1705173; Leventhal J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003509; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Locatelli Franco, 2006, Hematology Am Soc Hematol Educ Program, P398; Luznik L, 2001, BLOOD, V98, P3456, DOI 10.1182/blood.V98.12.3456; Lynch Heather E, 2013, Methods Mol Biol, V979, P147, DOI 10.1007/978-1-62703-290-2_12; MacMillan ML, 2015, BLOOD, V125, P3798, DOI 10.1182/blood-2015-02-626002; Malech HL, 2004, JPN J INFECT DIS, V57, pS27; Malech HL, 1999, J INFECT DIS, V179, pS318, DOI 10.1086/513852; Marr KA, 2012, HEMATOL-AM SOC HEMAT, P265, DOI 10.1182/asheducation-2012.1.265; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Mikulska M, 2012, INFECTION, V40, P271, DOI 10.1007/s15010-011-0229-y; Nakamura-Ishizu A, 2014, DEVELOPMENT, V141, P4656, DOI 10.1242/dev.106575; Ogawa M, 2000, INT IMMUNOL, V12, P313, DOI 10.1093/intimm/12.3.313; Pagel JM, 2006, BLOOD, V107, P2184, DOI 10.1182/blood-2005-06-2317; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Persons Derek A, 2009, Hematology Am Soc Hematol Educ Program, P690, DOI 10.1182/asheducation-2009.1.690; Pietersz G, 2005, IMMUNOL CELL BIOL, V83, P450; PRESS OW, 1994, BLOOD, V83, P1390; Rodriguez R, 1998, PROSTATE, V34, P259, DOI 10.1002/(SICI)1097-0045(19980301)34:4<259::AID-PROS3>3.0.CO;2-C; Rousso SZ, 2015, J PEDIAT HEMATOL ONC, V37, pe295, DOI 10.1097/MPH.0000000000000352; RYAN TM, 1990, SCIENCE, V247, P566, DOI 10.1126/science.2154033; Saez B, 2014, BLOOD, V124, P2937, DOI 10.1182/blood-2014-08-593426; Schabath R, 1999, J LEUKOCYTE BIOL, V66, P996, DOI 10.1002/jlb.66.6.996; Schmidt MM, 2008, CANCER IMMUNOL IMMUN, V57, P1879, DOI 10.1007/s00262-008-0518-1; Straathof KC, 2009, LANCET, V374, P912, DOI 10.1016/S0140-6736(09)60945-4; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; van Laar JM, 2014, JAMA-J AM MED ASSOC, V311, P2490, DOI 10.1001/jama.2014.6368; Walters MC, 2001, BIOL BLOOD MARROW TR, V7, P665, DOI 10.1053/bbmt.2001.v7.pm11787529; Weidle UH, 2014, CANCER GENOM PROTEOM, V11, P25; Williams KM, 2009, CTS-CLIN TRANSL SCI, V2, P279, DOI 10.1111/j.1752-8062.2009.00128.x; Worth AJJ, 2013, CURR OPIN HEMATOL, V20, P501, DOI 10.1097/MOH.0b013e328365a13b; Wulf GG, 2003, BLOOD, V101, P2434, DOI 10.1182/blood-2002-08-2379; Xue XK, 2010, BLOOD, V116, P5419, DOI 10.1182/blood-2010-07-295949; YAKURA H, 1983, J EXP MED, V157, P1077, DOI 10.1084/jem.157.4.1077	69	127	137	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2016	34	7					738	+		10.1038/nbt.3584	http://dx.doi.org/10.1038/nbt.3584			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2TT	27272386	Green Accepted			2022-12-25	WOS:000381335400028
J	Szajek, AY; Chess, E; Johansen, K; Gratzl, G; Gray, E; Keire, D; Linhardt, RJ; Liu, J; Morris, T; Mulloy, B; Nasr, M; Shriver, Z; Torralba, P; Viskov, C; Williams, R; Woodcock, J; Workman, W; Al-Hakim, A				Szajek, Anita Y.; Chess, Edward; Johansen, Kristian; Gratzl, Gyongyi; Gray, Elaine; Keire, David; Linhardt, Robert J.; Liu, Jian; Morris, Tina; Mulloy, Barbara; Nasr, Moheb; Shriver, Zachary; Torralba, Pearle; Viskov, Christian; Williams, Roger; Woodcock, Janet; Workman, Wesley; Al-Hakim, Ali			The US regulatory and pharmacopeia response to the global heparin contamination crisis	NATURE BIOTECHNOLOGY			English	Article							OVERSULFATED CHONDROITIN SULFATE; ANTITHROMBIN-BINDING OCTASACCHARIDES; PRODUCTS KEY TESTS; MOLECULAR-WEIGHT; SODIUM; EVENTS; NMR; API	The contamination of the widely used lifesaving anticoagulant drug heparin in 2007 has drawn renewed attention to the challenges that are associated with the characterization, quality control and standardization of complex biological medicines from natural sources. Heparin is a linear, highly sulfated polysaccharide consisting of alternating glucosamine and uronic acid monosaccharide residues. Heparin has been used successfully as an injectable antithrombotic medicine since the 1930s, and its isolation from animal sources (primarily porcine intestine) as well as its manufacturing processes have not changed substantially since its introduction. The 2007 heparin contamination crisis resulted in several deaths in the United States and hundreds of adverse reactions worldwide, revealing the vulnerability of a complex global supply chain to sophisticated adulteration. This Perspective discusses how the US Food and Drug Administration (FDA), the United States Pharmacopeia! Convention (USP) and international stakeholders collaborated to redefine quality expectations for heparin, thus making an important natural product better controlled and less susceptible to economically motivated adulteration.	[Szajek, Anita Y.; Morris, Tina] US Pharmacopeia, Biol & Biotechnol Dept, Rockville, MD USA; [Chess, Edward] Baxter Healthcare Corp, Struct Elucidat Technol Resources, Round Lake, IL 60073 USA; [Johansen, Kristian] Sjolundspk, Hellebaek, Denmark; [Gratzl, Gyongyi] Ben Venue Labs Inc, Boehringer Ingelheim, Bedford, OH USA; [Gray, Elaine; Mulloy, Barbara] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Keire, David] US FDA, Div Pharmaceut Anal, St Louis, MO USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA; [Mulloy, Barbara] Kings Coll London, Inst Pharmaceut Sci, Wilkins Bldg,Waterloo Campus, London, England; [Nasr, Moheb] GlaxoSmithKline, R&D, Collegeville, PA USA; [Shriver, Zachary] MIT, Harvard Mit Div Hlth Sci & Technol, Koch Inst Integrat Canc Res, Dept Biol Engn, Cambridge, MA 02139 USA; [Torralba, Pearle] Fresenius Kabi USA, Prod Dev Analyt Innovat & Dev, Skokie, IL USA; [Viskov, Christian] Sanofi, Vitry Sur Seine, France; [Williams, Roger] US Pharmacopeia, Rockville, MD USA; [Woodcock, Janet; Al-Hakim, Ali] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Workman, Wesley] Pfizer Qual Operat Biotech, Chesterfield, MO USA	Baxter International Inc; Boehringer Ingelheim; National Institute for Biological Standards & Control; US Food & Drug Administration (FDA); Rensselaer Polytechnic Institute; University of North Carolina; University of North Carolina Chapel Hill; University of London; King's College London; GlaxoSmithKline; Harvard University; Massachusetts Institute of Technology (MIT); Sanofi-Aventis; Sanofi France; US Food & Drug Administration (FDA); Pfizer	Al-Hakim, A (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.	Ali.Alhakim@fda.hhs.gov	Keire, David/AAN-8378-2020	Keire, David/0000-0002-7767-7904; Morris, Tina/0000-0002-1112-1516	USP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM102137] Funding Source: NIH RePORTER	USP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors appreciate the financial and logistical support provided by USP; the contributions of USP volunteers, the scientific community, and the collaborating laboratories; the public comments; and the collaboration of the FDA, including helpful review and discussion.	[Anonymous], 2009, OFF MON HEP SOD US 3; Barrowcliffe T W, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-23056-1_1; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Brustkern AM, 2010, ANAL CHEM, V82, P9865, DOI 10.1021/ac102301j; Guerrini M, 2008, J BIOL CHEM, V283, P26662, DOI 10.1074/jbc.M801102200; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Guerrini M, 2010, J MED CHEM, V53, P8030, DOI 10.1021/jm100771s; Honchel R, 2011, REGUL TOXICOL PHARM, V60, P318, DOI 10.1016/j.yrtph.2011.04.008; Keire DA, 2013, ANAL METHODS-UK, V5, P2984, DOI 10.1039/c3ay40226f; Keire DA, 2011, ANAL BIOANAL CHEM, V399, P581, DOI 10.1007/s00216-010-4023-y; Keire DA, 2010, J PHARMACEUT BIOMED, V52, P656, DOI 10.1016/j.jpba.2010.02.019; Keire DA, 2010, J PHARMACEUT BIOMED, V51, P921, DOI 10.1016/j.jpba.2009.10.017; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Laremore TN, 2009, CURR OPIN CHEM BIOL, V13, P633, DOI 10.1016/j.cbpa.2009.08.017; Lee SE, 2011, ANAL BIOANAL CHEM, V399, P651, DOI 10.1007/s00216-010-4262-y; Lindahl U, 2000, GLYCOCONJUGATE J, V17, P597, DOI 10.1023/A:1011030711317; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu J, 2014, NAT PROD REP, V31, P1676, DOI 10.1039/c4np00076e; Mazak K, 2014, CARBOHYD RES, V384, P13, DOI 10.1016/j.carres.2013.11.007; McMahon AW, 2010, PHARMACOEPIDEM DR S, V19, P921, DOI 10.1002/pds.1991; Mourier PAJ, 2012, J PHARMACEUT BIOMED, V67-68, P169, DOI 10.1016/j.jpba.2012.04.015; Mulloy B, 2014, ANAL BIOANAL CHEM, V406, P4815, DOI 10.1007/s00216-014-7940-3; Mulloy Barbara, 2012, Handb Exp Pharmacol, P77, DOI 10.1007/978-3-642-23056-1_5; Nemes P, 2013, ANAL CHEM, V85, P7405, DOI 10.1021/ac401318q; NEVILLE GA, 1989, J PHARM SCI, V78, P101, DOI 10.1002/jps.2600780205; OGREN S, 1975, J BIOL CHEM, V250, P2690; Petitou M, 2003, BIOCHIMIE, V85, P83, DOI 10.1016/S0300-9084(03)00078-6; Raman K, 2013, MOL PHARMACEUT, V10, P1442, DOI 10.1021/mp300679a; Sommers CD, 2012, J PHARMACEUT BIOMED, V67-68, P28, DOI 10.1016/j.jpba.2012.04.017; Sommers CD, 2011, ANAL BIOANAL CHEM, V401, P2445, DOI 10.1007/s00216-011-5362-z; Sommers CD, 2011, ANAL CHEM, V83, P7102, DOI 10.1021/ac201412z; Sommers CD, 2011, ANAL CHEM, V83, P3422, DOI 10.1021/ac200011s; Spencer JA, 2009, J PHARM SCI-US, V98, P3540, DOI 10.1002/jps.21660; Tami C, 2008, BIOMATERIALS, V29, P4808, DOI 10.1016/j.biomaterials.2008.08.024; Toby TK, 2012, ANAL METHODS-UK, V4, P1488, DOI 10.1039/c2ay25198a; Trehy ML, 2009, J PHARMACEUT BIOMED, V49, P670, DOI 10.1016/j.jpba.2008.12.013; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; United States Pharmacopeia, 2011, OFF MON HEP SOD US 3; United States Pharmacopeia, OFF MON HEP SOD US 3; United States Pharmacopeia, 1950, OFF MON HEP SOD US 1; Viskov C., 2005, US patent, Patent No. [0,215,519, 0215519]; Ye HP, 2013, J PHARMACEUT BIOMED, V85, P99, DOI 10.1016/j.jpba.2013.06.033; Zang QD, 2011, ANAL BIOANAL CHEM, V401, P939, DOI 10.1007/s00216-011-5155-4; Zang QD, 2011, ANAL CHEM, V83, P1030, DOI 10.1021/ac102832t; Zang QD, 2011, J PHARMACEUT BIOMED, V54, P1020, DOI 10.1016/j.jpba.2010.12.008; Zhang ZQ, 2009, J PHARM SCI-US, V98, P4017, DOI 10.1002/jps.21729	46	76	78	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2016	34	6					625	630		10.1038/nbt.3606	http://dx.doi.org/10.1038/nbt.3606			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DO5TT	27281424	Green Accepted			2022-12-25	WOS:000377846400028
J	Westcott, NP; Fernandez, JP; Molina, H; Hang, HC				Westcott, Nathan P.; Fernandez, Joseph P.; Molina, Henrik; Hang, Howard C.			Chemical proteomics reveals ADP-ribosylation of small GTPases during oxidative stress	NATURE CHEMICAL BIOLOGY			English	Article							WIDE IDENTIFICATION; S-NITROSYLATION; POLY(ADP-RIBOSE); RAS; PALMITOYLATION; PROTEINS; PROMOTES; REPORTERS; PARP-1; INHIBITION	ADP-ribosylation is a post-translational modification that is known to be involved in cellular homeostasis and stress but has been challenging to analyze biochemically. To facilitate the detection of ADP-ribosylated proteins, we show that an alkyne-adenosine analog, N-6-propargyl adenosine (N(6)pA), is metabolically incorporated in mammalian cells and enables fluorescence detection and proteomic analysis of ADP-ribosylated proteins. Notably, our analysis of N(6)pA-labeled proteins that are upregulated by oxidative stress revealed differential ADP-ribosylation of small GTPases. We discovered that oxidative stress induced ADP-ribosylation of Hras on Cys181 and Cys184 in the C-terminal hypervariable region, which are normally S-fatty-acylated. Downstream Hras signaling is impaired by ADP-ribosylation during oxidative stress, but is rescued by ADP-ribosyltransferase inhibitors. Our study demonstrates that ADP-ribosylation of small GTPases not only is mediated by bacterial toxins but is endogenously regulated in mammalian cells. N(6)pA provides a useful tool to characterize ADP-ribosylated proteins and their regulatory mechanisms in cells.	[Westcott, Nathan P.; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, 1230 York Ave, New York, NY 10021 USA; [Fernandez, Joseph P.; Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Hang, HC (corresponding author), Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, 1230 York Ave, New York, NY 10021 USA.	hhang@mail.rockefeller.edu			NIH-NIGMS [R01 GM087544]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087544] Funding Source: NIH RePORTER	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.P.W. is a Leukemia and Lymphoma Society postdoctoral fellow. The authors thank R. Pagano (Mayo Clinic) for GFP-HA-Rab7, G. Wahl (Salk Institute) for the histone H2B-GFP, M. Phillips (New York University) for the HA-Kras4A and Flag-Kras4B constructs and V. Schreiber (University of Strasbourg) for the ARTD1<SUP>-/-</SUP> (PARP1<SUP>-/-</SUP>) MEFs. H.C.H. acknowledges support from NIH-NIGMS R01 GM087544 grant.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Barkauskaite E, 2015, MOL CELL, V58, P935, DOI 10.1016/j.molcel.2015.05.007; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bock FJ, 2015, MOL CELL, V58, P911, DOI 10.1016/j.molcel.2015.06.012; Burgoyne JR, 2012, FASEB J, V26, P832, DOI 10.1096/fj.11-189415; Carter-O'Connell I, 2016, CELL REP, V14, P621, DOI 10.1016/j.celrep.2015.12.045; CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X; Chapman JD, 2013, J PROTEOME RES, V12, P1868, DOI 10.1021/pr301219h; Cho SH, 2009, BLOOD, V113, P2416, DOI 10.1182/blood-2008-03-144121; Choudhary S, 2011, MOL CARCINOGEN, V50, P215, DOI 10.1002/mc.20708; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Daniels CM, 2014, J PROTEOME RES, V13, P3510, DOI 10.1021/pr401032q; Evangelista AM, 2013, ANTIOXID REDOX SIGN, V19, P1209, DOI 10.1089/ars.2012.5056; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Ganesan AK, 1999, J BIOL CHEM, V274, P21823, DOI 10.1074/jbc.274.31.21823; Gibson BA, 2016, SCIENCE, V353, P45, DOI 10.1126/science.aaf7865; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Grammel M, 2013, NAT CHEM BIOL, V9, P475, DOI 10.1038/nchembio.1296; Grammel M, 2012, CHEMBIOCHEM, V13, P1112, DOI 10.1002/cbic.201200091; Grammel M, 2011, J AM CHEM SOC, V133, P17103, DOI 10.1021/ja205137d; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; HONJO T, 1968, J BIOL CHEM, V243, P3553; Jiang H, 2010, J AM CHEM SOC, V132, P9363, DOI 10.1021/ja101588r; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kauppinen TM, 2009, J CEREBR BLOOD F MET, V29, P820, DOI 10.1038/jcbfm.2009.9; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kraus WL, 2015, MOL CELL, V58, P902, DOI 10.1016/j.molcel.2015.06.006; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Leung AKL, 2014, J CELL BIOL, V205, P613, DOI 10.1083/jcb.201402114; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; Morgan RK, 2015, ACS CHEM BIOL, V10, P1778, DOI 10.1021/acschembio.5b00213; Nguyen T, 2003, ORG LETT, V5, P3245, DOI 10.1021/ol035135z; OGATA N, 1980, J BIOL CHEM, V255, P7610; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wallrodt S, 2016, ANGEW CHEM INT EDIT, V55, P7660, DOI 10.1002/anie.201600464; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; WEST RE, 1985, J BIOL CHEM, V260, P4428; Westcott NP, 2014, CURR OPIN CHEM BIOL, V23, P56, DOI 10.1016/j.cbpa.2014.10.002; WILLIAMS GT, 1983, BIOSCIENCE REP, V3, P461, DOI 10.1007/BF01121957; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603	52	22	22	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2017	13	3					302	+		10.1038/NCHEMBIO.2280	http://dx.doi.org/10.1038/NCHEMBIO.2280			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL2DY	28092360	Green Accepted			2022-12-25	WOS:000394431500014
J	Arnold, CD; Zabidi, MA; Pagani, M; Rath, M; Schernhuber, K; Kazmar, T; Stark, A				Arnold, Cosmas D.; Zabidi, Muhammad A.; Pagani, Michaela; Rath, Martina; Schernhuber, Katharina; Kazmar, Tomas; Stark, Alexander			Genome-wide assessment of sequence-intrinsic enhancer responsiveness at single-base-pair resolution	NATURE BIOTECHNOLOGY			English	Article							RNA-POLYMERASE; CORE-PROMOTER; POL II; GENE; TRANSCRIPTION; EXPRESSION; PERSPECTIVES; ELEMENT; BINDING; IMPACT	Gene expression is controlled by enhancers that activate transcription from the core promoters of their target genes. Although a key function of core promoters is to convert enhancer activities into gene transcription, whether and how strongly they activate transcription in response to enhancers has not been systematically assessed on a genome-wide level. Here we describe self transcribing active core promoter sequencing (STAP-seq), a method to determine the responsiveness of genomic sequences to enhancers, and apply it to the Drosophila melanogastergenome. We cloned candidate fragments at the position of the core promoter (also called minimal promoter) in reporter plasmids with or without a strong enhancer, transfected the resulting library into cells, and quantified the transcripts that initiated from each candidate for each setup by deep sequencing. In the presence of a single strong enhancer, the enhancer responsiveness of different sequences differs by several orders of magnitude, and different levels of responsiveness are associated with genes of different functions. We also identify sequence features that predict enhancer responsiveness and discuss how different core promoters are employed for the regulation of gene expression.	[Arnold, Cosmas D.; Zabidi, Muhammad A.; Pagani, Michaela; Rath, Martina; Schernhuber, Katharina; Kazmar, Tomas; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Stark, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria.	stark@starklab.org	Stark, Alexander/D-1473-2012	Stark, Alexander/0000-0003-2611-0841	European Research Council (ERC) under the European Union's Horizon research and innovation programme [647320]; Austrian Science Fund (FWF) [F4303-B09]; Boehringer Ingelheim GmbH; Austrian Research Promotion Agency (FFG)	European Research Council (ERC) under the European Union's Horizon research and innovation programme(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Boehringer Ingelheim GmbH(Boehringer Ingelheim); Austrian Research Promotion Agency (FFG)	We thank L. Cochella and members of the Stark group for comments on the manuscript and Life Science Editors (http://(ifescienceeditors.com) for editorial support. We are grateful to P. Heine and E. lam (MaxCyte) for help setting up efficient plasmid transfection. Deep sequencing was performed at the Vienna Biocenter Core Facilities GmbH (VBCF) Next-Generation Sequencing Unit (http://vbcf.ac.at). The Stark group is supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 647320) and by the Austrian Science Fund (FWF, F4303-B09). Basic research at the IMP is supported by Boehringer Ingelheim GmbH and the Austrian Research Promotion Agency (FFG).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Andersson R, 2015, MOL CELL, V60, P346, DOI 10.1016/j.molcel.2015.10.015; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Duttke SHC, 2015, MOL CELL, V60, P348, DOI 10.1016/j.molcel.2015.10.014; Ede C, 2016, ACS SYNTH BIOL, V5, P395, DOI 10.1021/acssynbio.5b00266; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Gu WF, 2012, CELL, V151, P1488, DOI 10.1016/j.cell.2012.11.023; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Lubliner S, 2015, GENOME RES, V25, P1008, DOI 10.1101/gr.188193.114; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Ohler U, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	39	48	48	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2017	35	2					136	144		10.1038/nbt.3739	http://dx.doi.org/10.1038/nbt.3739			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EK7BP	28024147	Green Accepted			2022-12-25	WOS:000394080800019
J	Rzuczek, SG; Colgan, LA; Nakai, Y; Cameron, MD; Furling, D; Yasuda, R; Disney, MD				Rzuczek, Suzanne G.; Colgan, Lesley A.; Nakai, Yoshio; Cameron, Michael D.; Furling, Denis; Yasuda, Ryohei; Disney, Matthew D.			Precise small-molecule recognition of a toxic CUG RNA repeat expansion	NATURE CHEMICAL BIOLOGY			English	Article							MYOTONIC-DYSTROPHY TYPE-1; SEQUENCE-BASED DESIGN; MUSCLEBLIND PROTEINS; IN-SITU; TRANSCRIPTS; LOCALIZATION; ANTIBIOTICS; INHIBITION; REVERSAL; ELEMENT	Excluding the ribosome and riboswitches, developing small molecules that selectively target RNA is a longstanding problem in chemical biology. A typical cellular RNA is difficult to target because it has little tertiary, but abundant secondary structure. We designed allele-selective compounds that target such an RNA, the toxic noncoding repeat expansion (r(CUG)(exp)) that causes myotonic dystrophy type 1 (DM1). We developed several strategies to generate allele-selective small molecules, including non-covalent binding, covalent binding, cleavage and on-site probe synthesis. Covalent binding and cleavage enabled target profiling in cells derived from individuals with DM1, showing precise recognition of r(CUG)(exp). In the on-site probe synthesis approach, small molecules bound adjacent sites in r(CUG)(exp) and reacted to afford picomolar inhibitors via a proximity based click reaction only in DM1-affected cells. We expanded this approach to image r(CUG)(exp) in its natural context.	[Rzuczek, Suzanne G.; Nakai, Yoshio; Disney, Matthew D.] Scripps Res Inst, Dept Chem, Jupiter, FL USA; [Rzuczek, Suzanne G.; Nakai, Yoshio; Disney, Matthew D.] Scripps Res Inst, Dept Neurosci, Jupiter, FL USA; [Colgan, Lesley A.; Yasuda, Ryohei] Max Planck Florida Inst Neurosci, Jupiter, FL USA; [Cameron, Michael D.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Furling, Denis] UPMC Univ Paris 06, Sorbonne Univ, INSERM, CNRS,Ctr Rech Myol,Inst Myol, Paris, France	Scripps Research Institute; Scripps Research Institute; Max Planck Society; Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Disney, MD (corresponding author), Scripps Res Inst, Dept Chem, Jupiter, FL USA.; Disney, MD (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL USA.	disney@scripps.edu	Furling, Denis/M-2346-2017	Furling, Denis/0000-0001-7912-4409; Cameron, Michael/0000-0003-3154-4775; Yasuda, Ryohei/0000-0001-6263-9297; Colgan, Lesley/0000-0003-2089-6820; Disney, Matthew/0000-0001-8486-1796	US National Institutes of Health [DP1NS096898, DP1NS096787]; Muscular Dystrophy Association [380467]; Myotonic Dystrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS096898] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Myotonic Dystrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Kodadek, G. Joyce, W. Ja, J. Childs-Disney, K. Sobczak and J. Cleveland for advice and critical review of the manuscript, and M.D.D. acknowledges J. and H. (nee McDougall) Disney. We also thank the platform for immortalization of human cells from the Institut de Myologie. This work was funded by the US National Institutes of Health (grants DP1NS096898 to M.D.D. and DP1NS096787 to R.Y.) and the Muscular Dystrophy Association (grant 380467 to M.D.D.). S.G.R. was partially supported by a postdoctoral fellowship from the Myotonic Dystrophy Foundation.	Baker M, 2012, NAT METHODS, V9, P787, DOI 10.1038/nmeth.2108; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Blount KF, 2015, ANTIMICROB AGENTS CH, V59, P5736, DOI 10.1128/AAC.01282-15; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CARTER BJ, 1990, P NATL ACAD SCI USA, V87, P9373, DOI 10.1073/pnas.87.23.9373; Childs-Disney JL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3044; Childs-Disney JL, 2012, ACS CHEM BIOL, V7, P856, DOI 10.1021/cb200408a; Disney MD, 2016, ACS CHEM BIOL, V11, P1720, DOI 10.1021/acschembio.6b00001; Furling D, 2001, NEUROMUSCULAR DISORD, V11, P728, DOI 10.1016/S0960-8966(01)00226-7; Guan LR, 2013, ANGEW CHEM INT EDIT, V52, P10010, DOI 10.1002/anie.201301639; Hamshere MG, 1997, P NATL ACAD SCI USA, V94, P7394, DOI 10.1073/pnas.94.14.7394; Howe JA, 2015, NATURE, V526, P672, DOI 10.1038/nature15542; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; JOHNSON LF, 1977, J CELL PHYSIOL, V90, P465, DOI 10.1002/jcp.1040900310; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lee MM, 2009, ACS CHEM BIOL, V4, P345, DOI 10.1021/cb900025w; Lewis WG, 2002, ANGEW CHEM INT EDIT, V41, P1053, DOI 10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4; LIMA WF, 1992, BIOCHEMISTRY-US, V31, P12055, DOI 10.1021/bi00163a013; Mastroyiannopoulos NP, 2005, EMBO REP, V6, P458, DOI 10.1038/sj.embor.7400390; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Pushechnikov A, 2009, J AM CHEM SOC, V131, P9767, DOI 10.1021/ja9020149; Rzuczek SG, 2014, ANGEW CHEM INT EDIT, V53, P10956, DOI 10.1002/anie.201406465; Rzuczek SG, 2013, ACS CHEM BIOL, V8, P2312, DOI 10.1021/cb400265y; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Strack RL, 2013, NAT METHODS, V10, P1219, DOI [10.1038/NMETH.2701, 10.1038/nmeth.2701]; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Velagapudi SP, 2016, P NATL ACAD SCI USA, V113, P5898, DOI 10.1073/pnas.1523975113; Velagapudi SP, 2014, NAT CHEM BIOL, V10, P291, DOI [10.1038/NCHEMBIO.1452, 10.1038/nchembio.1452]; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Wojtkowiak-Szlachcic A, 2015, NUCLEIC ACIDS RES, V43, P3318, DOI 10.1093/nar/gkv163; Yang WY, 2015, J AM CHEM SOC, V137, P5336, DOI 10.1021/ja507448y	33	119	121	1	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					188	193		10.1038/NCHEMBIO.2251	http://dx.doi.org/10.1038/NCHEMBIO.2251			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27941760	Green Accepted			2022-12-25	WOS:000393533000014
J	Teixeira, PF; Kmiec, B; Branca, RMM; Murcha, MW; Byzia, A; Ivanova, A; Whelan, J; Drag, M; Lehtio, J; Glaser, E				Teixeira, Pedro F.; Kmiec, Beata; Branca, Rui M. M.; Murcha, Monika W.; Byzia, Anna; Ivanova, Aneta; Whelan, James; Drag, Marcin; Lehtio, Janne; Glaser, Elzbieta			A multi-step peptidolytic cascade for amino acid recovery in chloroplasts	NATURE CHEMICAL BIOLOGY			English	Article							TARGETING PEPTIDE DEGRADATION; LEUCINE AMINOPEPTIDASE; PROTEIN MATURATION; MITOCHONDRIA; PATHWAY; OLIGOPEPTIDASE; LOCALIZATION; PROTEOLYSIS; PREP	Plastids (including chloroplasts) are subcellular sites for a plethora of proteolytic reactions, required in functions ranging from protein biogenesis to quality control. Here we show that peptides generated from pre-protein maturation within chloroplasts of Arabidopsis thaliana are degraded to amino acids by a multi-step peptidolytic cascade consisting of oligopeptidases and aminopeptidases, effectively allowing the recovery of single amino acids within these organelles.	[Teixeira, Pedro F.; Kmiec, Beata; Glaser, Elzbieta] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, Stockholm, Sweden; [Branca, Rui M. M.; Lehtio, Janne] Sci Life Lab, Dept Oncol Pathol, Clin Prote Mass Spectrometry, Stockholm, Sweden; [Branca, Rui M. M.; Lehtio, Janne] Karolinska Inst, Stockholm, Sweden; [Murcha, Monika W.; Ivanova, Aneta] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley, WA, Australia; [Byzia, Anna; Drag, Marcin] Wroclaw Univ Technol, Dept Chem, Div Bioorgan Chem, Wroclaw, Poland; [Whelan, James] La Trobe Univ, Sch Life Sci, Dept Anim Plant & Soil Sci, ARC Ctr Excellence Plant Energy Biol, Bundoora, Vic, Australia	Stockholm University; Karolinska Institutet; University of Western Australia; Wroclaw University of Science & Technology; La Trobe University	Teixeira, PF (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, Stockholm, Sweden.	pedro@dbb.su.se	Murcha, Monika W/H-5495-2014; Whelan, James/F-6402-2011	Murcha, Monika W/0000-0002-3689-6158; Whelan, James/0000-0001-5754-025X; Lehtio, Janne/0000-0002-8100-9562; Branca, Rui/0000-0003-3890-6476	Swedish Research Council [DN2015-04833, DN2012-5145]; Sigurd och Elsa Goljes Minne Foundation; ARC Discovery program [DP130102384]; National Science Centre for Scientific Research [NN401042838]; STINT Institutional grant; ARC future fellowship	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sigurd och Elsa Goljes Minne Foundation; ARC Discovery program(Australian Research Council); National Science Centre for Scientific Research; STINT Institutional grant; ARC future fellowship(Australian Research Council)	We would like to thank the Swedish Metabolomics Centre (Umea) for assistance with amino acid quantification, H. Fu (Academia Sinica) for Rpn10 antisera and U. Langel (Stockholm University) for the galanin peptide. This study was supported by grants from the Swedish Research Council to E.G. (DN2015-04833) and J.L. (DN2012-5145), from the Sigurd och Elsa Goljes Minne Foundation to PET. and BK., the ARC future fellowship to M.W.M., ARC Discovery program grant DP130102384 to J.W, Polish National Science Centre for Scientific Research grant NN401042838 to M.D. and the STINT Institutional grant for cooperation between the laboratories of E.G. and J.W.	Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Bhushan S, 2003, EMBO REP, V4, P1073, DOI 10.1038/sj.embor.7400011; Bhushan S, 2006, FEBS LETT, V580, P3966, DOI 10.1016/j.febslet.2006.06.018; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Johnson KA, 2006, EMBO J, V25, P1977, DOI 10.1038/sj.emboj.7601080; KELLY JA, 1983, J NEUROCHEM, V40, P1727, DOI 10.1111/j.1471-4159.1983.tb08148.x; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kmiec B, 2014, TRENDS PLANT SCI, V19, P771, DOI 10.1016/j.tplants.2014.09.004; Kmiec B, 2013, P NATL ACAD SCI USA, V110, pE3761, DOI 10.1073/pnas.1307637110; Law SR, 2012, PLANT PHYSIOL, V158, P1610, DOI 10.1104/pp.111.192351; Lowther WT, 2002, CHEM REV, V102, P4581, DOI 10.1021/cr0101757; Narvaez-Vasquez J, 2008, PLANTA, V227, P341, DOI 10.1007/s00425-007-0621-0; Polge C, 2009, J BIOL CHEM, V284, P35412, DOI 10.1074/jbc.M109.035394; Rowland E, 2015, PLANT PHYSIOL, V169, P1881, DOI 10.1104/pp.15.01214; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; Stahl A, 2002, J BIOL CHEM, V277, P41931, DOI 10.1074/jbc.M205500200; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Teixeira PF, 2013, BBA-MOL CELL RES, V1833, P360, DOI 10.1016/j.bbamcr.2012.03.012; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; van Wijk KJ, 2015, ANNU REV PLANT BIOL, V66, P75, DOI 10.1146/annurev-arplant-043014-115547; Walling LL, 2006, CURR OPIN PLANT BIOL, V9, P227, DOI 10.1016/j.pbi.2006.03.009; Zimorski V, 2014, CURR OPIN MICROBIOL, V22, P38, DOI 10.1016/j.mib.2014.09.008	23	20	20	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					15	17		10.1038/NCHEMBIO.2227	http://dx.doi.org/10.1038/NCHEMBIO.2227			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27820795				2022-12-25	WOS:000393267200007
J	Hansen, RK; Mund, A; Poulsen, SL; Sandoval, M; Klement, K; Tsouroula, K; Tollenaere, MAX; Raschle, M; Soria, R; Offermanns, S; Worzfeld, T; Grosse, R; Brandt, DT; Rozell, B; Mann, M; Cole, F; Soutoglou, E; Goodarzi, AA; Daniel, JA; Mailand, N; Bekker-Jensen, S				Hansen, Rebecca Kring; Mund, Andreas; Poulsen, Sara Lund; Sandoval, Maria; Klement, Karolin; Tsouroula, Katerina; Tollenaere, Maxim A. X.; Raeschle, Markus; Soria, Rebeca; Offermanns, Stefan; Worzfeld, Thomas; Grosse, Robert; Brandt, Dominique T.; Rozell, Bjorn; Mann, Matthias; Cole, Francesca; Soutoglou, Evi; Goodarzi, Aaron A.; Daniel, Jeremy A.; Mailand, Niels; Bekker-Jensen, Simon			SCAI promotes DNA double-strand break repair in distinct chromosomal contexts	NATURE CELL BIOLOGY			English	Article							DAMAGE-RESPONSE; KAP-1 PHOSPHORYLATION; DSB REPAIR; 53BP1; RECOMBINATION; RESECTION; HETEROCHROMATIN; UBIQUITIN; PATHWAYS; PREVENTS	DNA double-strand breaks (DSBs) are highly cytotoxic DNA lesions, whose accurate repair by non-homologous end-joining (NHEJ) or homologous recombination (HR) is crucial for genome integrity and is strongly influenced by the local chromatin environment(1,2). Here, we identify SCAI (suppressor of cancer cell invasion) as a 53BP1-interacting chromatin-associated protein that promotes the functionality of several DSB repair pathways in mammalian cells. SCAI undergoes prominent enrichment at DSB sites through dual mechanisms involving 53BP1-dependent recruitment to DSB-surrounding chromatin and 53BP1-independent accumulation at resected DSBs. Cells lacking SCAI display reduced DSB repair capacity, hypersensitivity to DSB-inflicting agents and genome instability. We demonstrate that SCAI is a mediator of 53BP1-dependent repair of heterochromatin-associated DSBs, facilitating ATM kinase signalling at DSBs in repressive chromatin environments. Moreover, we establish an important role of SCAI in meiotic recombination, as SCAI deficiency in mice leads to germ cell loss and subfertility associated with impaired retention of the DMC1 recombinase on meiotic chromosomes. Collectively, our findings uncover SCAI as a physiologically important component of both NHEJ-and HR-mediated pathways that potentiates DSB repair efficiency in specific chromatin contexts.	[Hansen, Rebecca Kring; Poulsen, Sara Lund; Tollenaere, Maxim A. X.; Mailand, Niels; Bekker-Jensen, Simon] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Ubiquitin Signaling Grp,Prot Signaling Program, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Mund, Andreas; Soria, Rebeca; Daniel, Jeremy A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Chromatin Struct & Funct Grp,Prot Signaling Progr, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Sandoval, Maria; Cole, Francesca] Univ Texas MD Anderson Canc Ctr, Epigenet & Mol Carcinogenesis Dept, Smithville, TX 78957 USA; [Klement, Karolin; Goodarzi, Aaron A.] Univ Calgary, Cumming Sch Med, Robson DNA Sci Ctr, Arnie Charbonneau Canc Inst,Dept Biochem & Mol Bi, Calgary, AB T2N 4N1, Canada; [Klement, Karolin; Goodarzi, Aaron A.] Univ Calgary, Cumming Sch Med, Robson DNA Sci Ctr, Arnie Charbonneau Canc Inst,Dept Oncol, Calgary, AB T2N 4N1, Canada; [Tsouroula, Katerina; Soutoglou, Evi] Univ Strasbourg, IGBMC, F-67404 Illkirch Graffenstaden, France; [Tollenaere, Maxim A. X.; Bekker-Jensen, Simon] Univ Copenhagen, Ctr Hlth Aging, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Raeschle, Markus] TU Kaiserslautern, Dept Mol Genet, Paul Ehrlich Str 24, D-67663 Kaiserslautern, Germany; [Offermanns, Stefan; Worzfeld, Thomas] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Worzfeld, Thomas; Grosse, Robert; Brandt, Dominique T.] Univ Marburg, Inst Pharmacol, D-35032 Marburg, Germany; [Rozell, Bjorn] Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18, D-82152 Martinsried, Germany	University of Copenhagen; University of Copenhagen; University of Texas System; UTMD Anderson Cancer Center; University of Calgary; University of Calgary; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Copenhagen; University of Kaiserslautern; Max Planck Society; Philipps University Marburg; University of Copenhagen; Max Planck Society	Mailand, N; Bekker-Jensen, S (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Ubiquitin Signaling Grp,Prot Signaling Program, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.; Daniel, JA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Chromatin Struct & Funct Grp,Prot Signaling Progr, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.; Bekker-Jensen, S (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark.	jeremy.daniel@cpr.ku.dk; niels.mailand@cpr.ku.dk; simon.bekker-jensen@cpr.ku.dk	Daniel, Jeremy/S-4729-2016; Mund, Andreas/AAU-5941-2020; Offermanns, Stefan/L-3313-2017	Daniel, Jeremy/0000-0002-1981-5571; Mund, Andreas/0000-0002-7843-5341; Cole, Francesca/0000-0001-6391-2363; Soutoglou, Evi/0000-0002-3724-5613; Tollenaere, Maxim/0000-0002-2653-0777; Offermanns, Stefan/0000-0001-8676-6805	Novo Nordisk Foundation [NNF14CC0001, NNF15OC0016926]; European Research Council (ERC); Danish Cancer Society; Danish Medical Research Council; Lundbeck Foundation; Center for Integrated Protein Research Munich (CIPSM); Marie Curie Intra-European Fellowship for Career Development [627187]; Canadian Institutes of Health Research; Canada Research Chairs programme; Cancer Prevention and Research Institute of Texas [R1213]; Jeanne F. Shelby Scholarship Fund; National Institutes of Health [DP2HD087943]; German Research Foundation [GR 2111/2-2]; Novo Nordisk Fonden [NNF15OC0016926] Funding Source: researchfish; The Danish Cancer Society [R124-A7677, R124-A7601] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD087943] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council (ERC)(European Research Council (ERC)European Commission); Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Center for Integrated Protein Research Munich (CIPSM); Marie Curie Intra-European Fellowship for Career Development; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs programme(Canada Research Chairs); Cancer Prevention and Research Institute of Texas; Jeanne F. Shelby Scholarship Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation Center for Protein Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. Obuse (University of Hokkaido, Japan) and H. Kimura (University of Osaka, Japan) for sharing unpublished data, A. Nussenzweig (National Institutes of Health, USA), J. Rouse (University of Dundee, UK), V. Gorbunova (University of Rochester, USA), A. Hyman and I. Poser (both Max Planck Institute of Cell Biology and Genetics, Germany) for providing reagents, G. Karemore for statistical analysis support and J. Bulkescher (both University of Copenhagen, Denmark) for technical assistance with imaging. Work in the laboratory of N.M. was supported by grants from the Novo Nordisk Foundation (Grants no. NNF14CC0001 and NNF15OC0016926), European Research Council (ERC), The Danish Cancer Society, Danish Medical Research Council, and the Lundbeck Foundation. Work in the laboratory of M.M. was supported by the Center for Integrated Protein Research Munich (CIPSM). Work in the laboratory of J.A.D. was supported by grants from the Novo Nordisk Foundation (Grant no. NNF14CC0001) and the Danish Medical Research Council, and A.M. is supported by a Marie Curie Intra-European Fellowship for Career Development (Project no. 627187). The laboratory of A. A. G. is supported by the Canadian Institutes of Health Research. A. A. G is currently the Canada Research Chair for Genome Damage and Instability Disease and this work was undertaken, in part, thanks to funding from the Canada Research Chairs programme. Work in the laboratory of F.C. is supported by the Cancer Prevention and Research Institute of Texas (R1213), the Jeanne F. Shelby Scholarship Fund for the R. Lee Clark Fellowship, and the National Institutes of Health (DP2HD087943). Work in the laboratory of R. G. is supported by the German Research Foundation (Grant GR 2111/2-2). All experiments were performed in full compliance with the ethical guidelines for biological research in Denmark. Work with all animals has been approved by the Department of Experimental Medicine (University of Copenhagen), the Danish Working Environment Authority, the Danish Animal Experiment Inspectorate, the MDACC Institutional Animal Care and Use Committee (IACUC) and the Regierungsprasidia Karlsruhe and Darmstadt.	Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Brandt DT, 2009, CELL CYCLE, V8, P2523, DOI 10.4161/cc.8.16.9398; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Broering TJ, 2014, J CELL BIOL, V205, P663, DOI 10.1083/jcb.201311050; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Daniel JA, 2012, J CELL BIOL, V198, P295, DOI 10.1083/jcb.201204035; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Eberl HC, 2013, MOL CELL, V49, P368, DOI 10.1016/j.molcel.2012.10.026; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jackson SP, 2009, BIOCHEM SOC T, V37, P483, DOI 10.1042/BST0370483; Kakarougkas A, 2013, NUCLEIC ACIDS RES, V41, P9719, DOI 10.1093/nar/gkt729; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Klement K, 2014, J CELL BIOL, V207, P717, DOI 10.1083/jcb.201405077; Lemaitre C, 2014, DNA REPAIR, V19, P163, DOI 10.1016/j.dnarep.2014.03.015; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Munoz IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109752; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Raschle M, 2015, SCIENCE, V348, DOI 10.1126/science.1253671; Schwertman P, 2016, NAT REV MOL CELL BIO, V17, P379, DOI 10.1038/nrm.2016.58; Seluanov A., 2010, J VIS EXP; Svetlanov A, 2004, EXP CELL RES, V296, P71, DOI 10.1016/j.yexcr.2004.03.020; TOLEDO LI, 2013, Patent No. 1551088; Tsouroula K, 2016, MOL CELL, V63, P293, DOI 10.1016/j.molcel.2016.06.002; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	50	26	26	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2016	18	12					1357	+		10.1038/ncb3436	http://dx.doi.org/10.1038/ncb3436			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	ED8PY	27820601	Green Submitted, Green Accepted			2022-12-25	WOS:000389134600013
J	Kalyoncu, S; Heaner, DP; Kurt, Z; Bethel, CM; Ukachukwu, CU; Chakravarthy, S; Spain, JC; Lieberman, RL				Kalyoncu, Sibel; Heaner, David P., Jr.; Kurt, Zohre; Bethel, Casey M.; Ukachukwu, Chiamaka U.; Chakravarthy, Srinivas; Spain, Jim C.; Lieberman, Raquel L.			Enzymatic hydrolysis by transition-metal-dependent nucleophilic aromatic substitution	NATURE CHEMICAL BIOLOGY			English	Article							5-NITROANTHRANILIC ACID; DEGRADATION; MECHANISMS; BIODEGRADATION; BIOSYNTHESIS; EVOLUTIONARY; DEACETYLASE; RESISTANCE; RESOLUTION; DIVERSITY	Nitroaromatic compounds are typically toxic and resistant to degradation. Bradyrhizobium species strain JS329 metabolizes 5-nitroanthranilic acid (5NAA), which is a molecule secreted by Streptomyces scabies, the plant pathogen responsible for potato scab. The first biodegradation enzyme is 5NAA-aminohydrolase (5NAA-A), a metalloprotease family member that converts 5NAA to 5-nitrosalicylic acid. We characterized 5NAA-A biochemically and obtained snapshots of its mechanism. 5NAA-A, an octamer that can use several divalent transition metals for catalysis in vitro, employs a nucleophilic aromatic substitution mechanism. Unexpectedly, the metal in 5NAA-A is labile but is readily loaded in the presence of substrate. 5NAA-A is specific for 5NAA and cannot hydrolyze other tested derivatives, which are likewise poor inhibitors. The 5NAA-A structure and mechanism expand our understanding of the chemical ecology of an agriculturally important plant and pathogen, and will inform bioremediation and biocatalytic approaches to mitigate the environmental and ecological impact of nitroanilines and other challenging substrates.	[Kalyoncu, Sibel; Heaner, David P., Jr.; Bethel, Casey M.; Ukachukwu, Chiamaka U.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Spain, Jim C.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Chakravarthy, Srinivas] Argonne Natl Labs, Adv Photon Source, Biophys Collaborat Access Team, Lemont, IL USA; [Spain, Jim C.] Univ West Florida, Ctr Environm Diagnost & Bioremediat, Pensacola, FL 32514 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; University of West Florida	Lieberman, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	Raquel.lieberman@chemistry.gatech.edu	Kurt, Zohre/ABA-1832-2020; Kalyoncu, Sibel/H-3225-2019	Kalyoncu, Sibel/0000-0003-2264-0757; Kurt, Zohre/0000-0001-8862-5846	Pew Scholar; NSF CAREER award [0845445]; Georgia Tech Molecular Biophysics Training Award; Petit Undergraduate Research Fellowship; President's Undergraduate Research Award; Georgia Internship for Teachers award; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NIH NIGMS [9P41 GM103622]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	Pew Scholar; NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Georgia Tech Molecular Biophysics Training Award; Petit Undergraduate Research Fellowship; President's Undergraduate Research Award; Georgia Internship for Teachers award; US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by a Pew Scholar and NSF CAREER award (0845445) to R.L.L., a Georgia Tech Molecular Biophysics Training Award to S.K., a Petit Undergraduate Research Fellowship and a President's Undergraduate Research Award to D.P.H., and a Georgia Internship for Teachers award to C.M.B. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. Work performed at Bio CAT was supported by NIH NIGMS 9P41 GM103622. Use of the Pilatus 3 1M detector was provided by NIGMS 1S10OD018090-01.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARMSTRONG RN, 1979, BIOCHEMISTRY-US, V18, P1230, DOI 10.1021/bi00574a018; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; BOYEN A, 1992, GENE, V116, P1, DOI 10.1016/0378-1119(92)90621-U; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Conticello SG, 2007, NAT STRUCT MOL BIOL, V14, P7, DOI 10.1038/nsmb0107-7; Culotta VC, 2013, ANTIOXID REDOX SIGN, V19, P933, DOI 10.1089/ars.2012.5093; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Davies J, 2007, J BIOTECHNOL, V129, P3, DOI 10.1016/j.jbiotec.2006.11.023; Diallo S, 2011, FEMS MICROBIOL ECOL, V75, P351, DOI 10.1111/j.1574-6941.2010.01023.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feig A. L., 1999, RNA WORLD, P287; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; JEFFERSON JR, 1990, ANAL BIOCHEM, V187, P328, DOI 10.1016/0003-2697(90)90465-L; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; King RR, 1998, PHYTOCHEMISTRY, V49, P1265, DOI 10.1016/S0031-9422(98)00137-X; King RR, 2009, PHYTOCHEMISTRY, V70, P833, DOI 10.1016/j.phytochem.2009.04.013; Kobayashi A, 2015, MICROBES ENVIRON, V30, P301, DOI 10.1264/jsme2.ME15109; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lambert DH, 2005, AM J POTATO RES, V82, P309, DOI 10.1007/BF02871961; Lerat S, 2009, MOL PLANT PATHOL, V10, P579, DOI [10.1111/J.1364-3703.2009.00561.X, 10.1111/j.1364-3703.2009.00561.x]; Makarova KS, 1999, J MOL BIOL, V292, P11, DOI 10.1006/jmbi.1999.3059; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Martinez-Rodriguez S, 2012, J BACTERIOL, V194, P5759, DOI 10.1128/JB.01056-12; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuinness M, 2009, INT J ENV RES PUB HE, V6, P2226, DOI 10.3390/ijerph6082226; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nocek BP, 2010, J MOL BIOL, V397, P617, DOI 10.1016/j.jmb.2010.01.062; Orwig SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016347; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parry R, 2011, NAT PROD REP, V28, P152, DOI 10.1039/c0np00024h; Pelmenschikov V, 2002, J BIOL INORG CHEM, V7, P284, DOI 10.1007/s007750100295; Prashar P, 2014, REV ENVIRON SCI BIO, V13, P63, DOI 10.1007/s11157-013-9317-z; Qu Y, 2011, J BACTERIOL, V193, P3057, DOI 10.1128/JB.01188-10; Qu Y, 2010, APPL ENVIRON MICROB, V76, P1417, DOI 10.1128/AEM.02816-09; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi DS, 2007, BIOPHYS CHEM, V126, P86, DOI 10.1016/j.bpc.2006.05.013; Silverman R.B., 2002, ORGANIC CHEM ENZYME, P251; Slobodkin A, 1997, INT J SYST BACTERIOL, V47, P969, DOI 10.1099/00207713-47-4-969; SPAIN JC, 1995, ANNU REV MICROBIOL, V49, P523, DOI 10.1146/annurev.mi.49.100195.002515; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Symons ZC, 2006, NAT PROD REP, V23, P845, DOI 10.1039/b502796a; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3613926; Winkler R, 2007, CHEMBIOCHEM, V8, P973, DOI 10.1002/cbic.200700042	60	10	10	3	38	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1031	+		10.1038/nchembio.2191	http://dx.doi.org/10.1038/nchembio.2191			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27694799	Green Accepted			2022-12-25	WOS:000388582900011
J	Khurana, S; Fuentes, S; Coyle, EM; Ravichandran, S; Davey, RT; Beigel, JH				Khurana, Surender; Fuentes, Sandra; Coyle, Elizabeth M.; Ravichandran, Supriya; Davey, Richard T., Jr.; Beigel, John H.			Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies	NATURE MEDICINE			English	Article							PROTECTS NONHUMAN-PRIMATES; RANDOMIZED CLINICAL-TRIAL; INFLUENZA VACCINE; MEDIATED PROTECTION; AFFINITY MATURATION; B-CELLS; INFECTION; RESPONSES; GLYCOPROTEIN; CHALLENGE	Development of an effective vaccine against Ebola virus is of high priority. However, knowledge about potential correlates of protection and the durability of immune response after vaccination is limited. Here, we elucidate the human antibody repertoire after administration of vesicular stomatitis virus (VSV)-Ebola vaccine at 3 million, 20 million and 100 million plaque-forming units (PFU) and homologous VSV-Ebola vaccine boost in healthy adult volunteers. Whole genome-fragment phage display libraries, expressing linear and conformational epitopes of Ebola glycoprotein (GP), showed higher diversity of antibody epitopes in individuals vaccinated with 20 million PFU than in those vaccinated with 3 million or 100 million PFU. Surface plasmon resonance kinetics showed higher levels of GP-binding antibodies after a single vaccination with 20 million or 100 million PFU than with 3 million PFU, and these correlated strongly with neutralization titers. A second vaccination did not boost antibody or virus neutralization titers, which declined rapidly, and induced only minimal antibody affinity maturation. Isotype analysis revealed a predominant IgM response even after the second vaccination, which contributed substantially to virus neutralization in vitro. These findings may help identify new vaccine targets and aid development and evaluation of effective countermeasures against Ebola.	[Khurana, Surender; Fuentes, Sandra; Coyle, Elizabeth M.; Ravichandran, Supriya] US FDA, Div Viral Prod, CBER, Silver Spring, MD 20993 USA; [Davey, Richard T., Jr.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Beigel, John H.] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Frederick, MD USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Khurana, S (corresponding author), US FDA, Div Viral Prod, CBER, Silver Spring, MD 20993 USA.	surender.khurana@fda.hhs.gov	Beigel, John H/GNP-2628-2022; Beigel, John/AAQ-4289-2021	Beigel, John/0000-0002-4879-4941	US National Institute of Allergy and Infectious Diseases; FDA-MCMi-Ebola funds; US National Cancer Institute [HHSN261200800001E]; US Department of Defense (DoD) Medical Countermeasures Systems' Joint Vaccine Acquisition Program at Fort Detrick, Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000984] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FDA-MCMi-Ebola funds; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense (DoD) Medical Countermeasures Systems' Joint Vaccine Acquisition Program at Fort Detrick, Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Rubin and H. Golding for reviewing the manuscript and J. Voell, P. Munoz, R. McConnell, H. Baus, C. Rehm and J. Metcalf for help with clinical studies. We thank J. Crowe (Vanderbilt University) for the gift of MAb 289 and MAb 324. The clinical trial from which the test sera were derived was funded partly by the US National Institute of Allergy and Infectious Diseases. The antibody characterization work described in this manuscript was supported by FDA-MCMi-Ebola funds to S.K. The latter funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This project was funded in whole or in part with federal funds from the US National Cancer Institute under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. We thank the US Army Medical Research Institute of Infectious Diseases team, including S. Kwilas, M. Wisniewski and J. Hooper, for providing the pseudovirion neutralization assay data used in this study. The pseudovirion work was funded by the US Department of Defense (DoD) Medical Countermeasures Systems' Joint Vaccine Acquisition Program at Fort Detrick, Maryland. The opinions, interpretations, conclusions and recommendations contained herein are those of the authors and are not necessarily endorsed by the US DoD.	Blaney JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003389; Centers for Disease Control and Prevention, 2016, 2014 EB OUTBR W AFR; Chung KY, 2015, VACCINE, V33, P3953, DOI 10.1016/j.vaccine.2015.06.047; Cohen J, 2015, SCIENCE, V349, P1272, DOI 10.1126/science.349.6254.1272; Davidson E, 2015, J VIROL, V89, P10982, DOI 10.1128/JVI.01490-15; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022; Fuentes S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005554; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Halliley JL, 2015, J INFECT DIS, V212, P1270, DOI 10.1093/infdis/jiv210; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Holtsberg FW, 2016, J VIROL, V90, P266, DOI 10.1128/JVI.02171-15; Jackson LA, 2015, JAMA-J AM MED ASSOC, V314, P237, DOI 10.1001/jama.2015.7916; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166; Khurana S, 2013, J INFECT DIS, V208, P413, DOI 10.1093/infdis/jit178; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Krause PR, 2015, LANCET, V386, P831, DOI 10.1016/S0140-6736(15)00002-1; Krause PR, 2015, LANCET INFECT DIS, V15, P627, DOI 10.1016/S1473-3099(15)00027-4; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920; Marzi A, 2015, EMERG INFECT DIS, V21, P305, DOI 10.3201/eid2102.141649; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Matassov D, 2015, J INFECT DIS, V212, pS443, DOI 10.1093/infdis/jiv316; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Regules JA, 2015, N ENGL J MED; Ruibal P, 2016, NATURE, V533, P100, DOI 10.1038/nature17949; Talaat KR, 2014, J INFECT DIS, V209, P1860, DOI 10.1093/infdis/jiu123; Tapia MD, 2016, LANCET INFECT DIS, V16, P31, DOI 10.1016/S1473-3099(15)00362-X; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wong G, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004582; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	40	68	70	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1439	+		10.1038/nm.4201	http://dx.doi.org/10.1038/nm.4201			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27798615	Bronze			2022-12-25	WOS:000389549000021
J	Ng, ES; Azzola, L; Bruveris, FF; Calvanese, V; Phipson, B; Vlahos, K; Hirst, C; Jokubaitis, VJ; Yu, QC; Maksimovic, J; Liebscher, S; Januar, V; Zhang, Z; Williams, B; Conscience, A; Durnall, J; Jackson, S; Costa, M; Elliott, D; Haylock, DN; Nilsson, SK; Saffery, R; Schenke-Layland, K; Oshlack, A; Mikkola, HKA; Stanley, EG; Elefanty, AG				Ng, Elizabeth S.; Azzola, Lisa; Bruveris, Freya F.; Calvanese, Vincenzo; Phipson, Belinda; Vlahos, Katerina; Hirst, Claire; Jokubaitis, Vanta J.; Yu, Qing C.; Maksimovic, Jovana; Liebscher, Simone; Januar, Vania; Zhang, Zhen; Williams, Brenda; Conscience, Aude; Durnall, Jennifer; Jackson, Steven; Costa, Magdaline; Elliott, David; Haylock, David N.; Nilsson, Susan K.; Saffery, Richard; Schenke-Layland, Katja; Oshlack, Alicia; Mikkola, Hanna K. A.; Stanley, Edouard G.; Elefanty, Andrew G.			Differentiation of human embryonic stem cells to HOXA(+) hemogenic vasculature that resembles the aorta-gonad-mesonephros	NATURE BIOTECHNOLOGY			English	Article							HEMATOPOIETIC STEM; EXPRESSION ANALYSIS; HAEMOGENIC ENDOTHELIUM; TRANSCRIPTOME ANALYSIS; BIOCONDUCTOR PACKAGE; HSC ACTIVITY; HOX GENES; FETAL; IDENTIFICATION; PROGENITOR	The ability to generate hematopoietic stem cells from human pluripotent cells would enable many biomedical applications. We find that hematopoietic CD34(+) cells in spin embryoid bodies derived from human embryonic stem cells (hESCs) lack HOXA expression compared with repopulation-competent human cord blood CD34(+) cells, indicating incorrect mesoderm patterning. Using reporter hESC lines to track the endothelial (SOX17) to hematopoietic (RUNX1C) transition that occurs in development, we show that simultaneous modulation of WNT and ACTIVIN signaling yields CD34(+) hematopoietic cells with HOXA expression that more closely resembles that of cord blood. The cultures generate a network of aorta-like SOX17(+) vessels from which RUNX1C(+) blood cells emerge, similar to hematopoiesis in the aorta-gonad-mesonephros (AGM). Nascent CD34(+) hematopoietic cells and corresponding cells sorted from human AGM show similar expression of cell surface receptors, signaling molecules and transcription factors. Our findings provide an approach to mimic in vitro a key early stage in human hematopoiesis for the generation of AGM-derived hematopoietic lineages from hESCs.	[Ng, Elizabeth S.; Azzola, Lisa; Bruveris, Freya F.; Phipson, Belinda; Vlahos, Katerina; Maksimovic, Jovana; Januar, Vania; Durnall, Jennifer; Elliott, David; Saffery, Richard; Oshlack, Alicia; Stanley, Edouard G.; Elefanty, Andrew G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Ng, Elizabeth S.; Bruveris, Freya F.; Conscience, Aude; Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Dept Anat & Dev Biol, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Calvanese, Vincenzo; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Calvanese, Vincenzo; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem cell, Los Angeles, CA USA; [Hirst, Claire; Williams, Brenda; Haylock, David N.; Nilsson, Susan K.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Jokubaitis, Vanta J.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Anat & Neurosci, Parkville, Vic, Australia; [Yu, Qing C.] Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Liebscher, Simone; Schenke-Layland, Katja] Eberhard Karls Univ Tubingen, Res Inst Womens Hlth, Dept Womens Hlth, Tubingen, Germany; [Zhang, Zhen; Williams, Brenda; Haylock, David N.; Nilsson, Susan K.] CSIRO, Mfg, Clayton, Vic, Australia; [Jackson, Steven] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI USA; [Costa, Magdaline] Monash Univ Alfred Med Res Precinct, Australian Ctr Blood Dis, Melbourne, Vic, Australia; [Schenke-Layland, Katja] Fraunhoter Inst Interfacial Engn & Biotechnol IGB, Dept Cell & Tissue Engn, Stuttgart, Germany; [Schenke-Layland, Katja] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Cardiovasc Res Labs, Los Angeles, CA USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA USA; [Stanley, Edouard G.; Elefanty, Andrew G.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Parkville, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Monash University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Australian Regenerative Medicine Institute; Monash University; University of Melbourne; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Eberhard Karls University of Tubingen; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Wisconsin System; University of Wisconsin Madison; Fraunhofer Gesellschaft; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Melbourne	Ng, ES; Stanley, EG; Elefanty, AG (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia.; Ng, ES; Stanley, EG; Elefanty, AG (corresponding author), Monash Univ, Dept Anat & Dev Biol, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia.; Stanley, EG; Elefanty, AG (corresponding author), Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Parkville, Vic, Australia.	elizabeth.ng@mcri.edu.au; ed.stanley@mcri.edu.au; andrew.elefanty@mcri.edu.au	Schenke-Layland, Katja/E-5940-2013; Elliott, David/H-3334-2012; Maksimovic, Jovana/H-8654-2019; Phipson, Belinda/AAP-2213-2020; Stanley, Ed G/A-2985-2013; Oshlack, Alicia/P-6139-2014; Calvanese, Vincenzo/E-1145-2016; Nilsson, Susie K/C-5563-2015; Saffery, Richard/GLS-1976-2022; Calvanese, Vincenzo/AAO-4311-2020	Schenke-Layland, Katja/0000-0001-8066-5157; Elliott, David/0000-0003-1052-7407; Maksimovic, Jovana/0000-0002-9458-3061; Phipson, Belinda/0000-0002-1711-7454; Stanley, Ed G/0000-0002-6389-3665; Oshlack, Alicia/0000-0001-9788-5690; Calvanese, Vincenzo/0000-0002-7937-1511; Nilsson, Susie K/0000-0002-7926-7335; Saffery, Richard/0000-0002-9510-4181; Calvanese, Vincenzo/0000-0002-7937-1511; Hirst, Claire/0000-0002-3570-3625; Elefanty, Andrew/0000-0001-6448-8314	Australian Stem Cell Centre, Stem Cells Australia; Juvenile Diabetes Research Foundation; National Health and Medical Research Council (NHMRC) of Australia; California Institute for Regenerative Medicine [RT3-07761]; Stafford Fox Medical Research Foundation; Medical Research Council Independent Research Institute Infrastructure Support Scheme (NHMRC IRIISS); State Government of Victoria; Australian Government; Senior Research Fellows of the NHMRC; Ministry of Science, Research; Arts of Baden-Wuerttemberg [33-729.55-3/214-3, 33-729.55-312149]; National Institutes of Health [IR0113K100959-01A1]	Australian Stem Cell Centre, Stem Cells Australia; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Stafford Fox Medical Research Foundation; Medical Research Council Independent Research Institute Infrastructure Support Scheme (NHMRC IRIISS)(National Health and Medical Research Council (NHMRC) of Australia); State Government of Victoria; Australian Government(Australian GovernmentCGIAR); Senior Research Fellows of the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Science, Research; Arts of Baden-Wuerttemberg; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The assistance and cooperation of the Mercy Hospital for Women in the collection and provision of umbilical cord blood samples, and the expertise of M. Burton and P. Lau in the MCRI Flowcore facility, as well as FlowCore at Monash University, are gratefully acknowledged. The assistance of D. Cardozo with animal work is also gratefully acknowledged. This work was supported by grants from the Australian Stem Cell Centre, Stem Cells Australia, the Juvenile Diabetes Research Foundation, the National Health and Medical Research Council (NHMRC) of Australia, the California Institute for Regenerative Medicine (RT3-07761), the Stafford Fox Medical Research Foundation and the Victorian Government's Operational Infrastructure Support Program and Australian Government National Health and Medical Research Council Independent Research Institute Infrastructure Support Scheme (NHMRC IRIISS). The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. A.G.E. and E.G.S. are supported as Senior Research Fellows of the NHMRC. Work in the laboratory of K.S.-L. was supported by grants from the Ministry of Science, Research and the Arts of Baden-Wuerttemberg (Az: 33-729.55-3/214-3, 33-729.55-312149). Work in the laboratory of H.K.A.M. was also supported by the National Institutes of Health (IR0113K100959-01A1).	Ackermann M, 2015, EMBO MOL MED, V7, P1388, DOI 10.15252/emmm.201505301; Aranguren XL, 2013, BLOOD, V122, P3982, DOI 10.1182/blood-2013-02-483255; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bauer DE, 2015, CURR OPIN GENET DEV, V33, P62, DOI 10.1016/j.gde.2015.08.001; Bee T, 2010, BLOOD, V115, P3042, DOI 10.1182/blood-2009-08-238626; Bijl J, 2006, BLOOD, V108, P116, DOI 10.1182/blood-2005-06-2245; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Chanda B, 2013, CELL, V155, P215, DOI 10.1016/j.cell.2013.08.055; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Delgado-Olguin P, 2014, DEVELOPMENT, V141, P4610, DOI 10.1242/dev.112607; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Di-Poi N, 2010, DEV BIOL, V341, P488, DOI 10.1016/j.ydbio.2010.03.006; Ditadi A, 2015, NAT CELL BIOL, V17, P580, DOI 10.1038/ncb3161; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donate-Correa J, 2013, INT J CARDIOL, V165, P179, DOI 10.1016/j.ijcard.2011.08.850; Dou DR, 2016, NAT CELL BIOL, V18, P595, DOI 10.1038/ncb3354; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fujita Y, 2001, BIOCHEM BIOPH RES CO, V281, P1248, DOI 10.1006/bbrc.2001.4513; Gazit R, 2013, STEM CELL REP, V1, P266, DOI 10.1016/j.stemcr.2013.07.004; Gertow K, 2013, STEM CELL REP, V1, P53, DOI 10.1016/j.stemcr.2013.04.002; Goldie LC, 2008, BLOOD, V112, P3194, DOI 10.1182/blood-2008-02-139055; Gragert L, 2014, NEW ENGL J MED, V371, P339, DOI 10.1056/NEJMsa1311707; Heazlewood SY, 2014, ANN NY ACAD SCI, V1310, P119, DOI 10.1111/nyas.12329; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivanovs A, 2014, STEM CELL REP, V2, P449, DOI 10.1016/j.stemcr.2014.02.004; Ivanovs A, 2011, J EXP MED, V208, P2417, DOI 10.1084/jem.20111688; Kartalaei PS, 2015, J EXP MED, V212, P93, DOI 10.1084/jem.20140767; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leandra S, 2015, CELL STEM CELL, V16, P80, DOI 10.1016/j.stem.2014.10.020; Lebert-Ghali CE, 2010, EXP HEMATOL, V38, P1074, DOI 10.1016/j.exphem.2010.07.006; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1191, DOI 10.1038/nn.3490; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MIYOSHI H, 1995, NUCLEIC ACIDS RES, V23, P2762, DOI 10.1093/nar/23.14.2762; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Montavon T, 2014, SEMIN CELL DEV BIOL, V34, P76, DOI 10.1016/j.semcdb.2014.06.005; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Nobuhisa I, 2014, MOL CELL BIOL, V34, P1976, DOI 10.1128/MCB.01485-13; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Pozner A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-84; Ramos-Mejia V, 2014, BLOOD, V124, P3065, DOI 10.1182/blood-2014-03-558825; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rybtsov S, 2016, DEVELOPMENT, V143, P1284, DOI 10.1242/dev.131193; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sinka L, 2012, BLOOD, V119, P3712, DOI 10.1182/blood-2010-11-314781; Sroczynska P, 2009, BLOOD, V114, P5279, DOI 10.1182/blood-2009-05-222307; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI 10.1038/nbt.2915; Sun GJ, 2015, MOLECULES, V20, P18539, DOI 10.3390/molecules201018539; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Thambyrajah R, 2016, NAT CELL BIOL, V18, P21, DOI 10.1038/ncb3276; Touleimat N, 2012, EPIGENOMICS-UK, V4, P325, DOI [10.2217/epi.12.21, 10.2217/EPI.12.21]; VISWANATHAN M, 1991, BIOCHEM BIOPH RES CO, V179, P1361, DOI 10.1016/0006-291X(91)91723-P; Wang CC, 2000, DEV BIOL, V224, P152, DOI 10.1006/dbio.2000.9749; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Yoshimoto M, 2012, BLOOD, V119, P5706, DOI 10.1182/blood-2011-12-397489; Yu QC, 2012, BLOOD, V119, P6243, DOI 10.1182/blood-2011-12-396093; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997	81	96	97	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1168	+		10.1038/nbt.3702	http://dx.doi.org/10.1038/nbt.3702			16	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27748754				2022-12-25	WOS:000387506500029
J	Rohm, M; Schafer, M; Laurent, V; Ustunel, BE; Niopek, K; Algire, C; Hautzinger, O; Sijmonsma, TP; Zota, A; Medrikova, D; Pellegata, NS; Ryden, M; Kulyte, A; Dahlman, I; Arner, P; Petrovic, N; Cannon, B; Amri, EZ; Kemp, BE; Steinberg, GR; Janovska, P; Kopecky, J; Wolfrum, C; Bluher, M; Diaz, MB; Herzig, S				Rohm, Maria; Schaefer, Michaela; Laurent, Victor; Uestuenel, Bilgen Ekim; Niopek, Katharina; Algire, Carolyn; Hautzinger, Oksana; Sijmonsma, Tjeerd P.; Zota, Annika; Medrikova, Dasa; Pellegata, Natalia S.; Ryden, Mikael; Kulyte, Agne; Dahlman, Ingrid; Arner, Peter; Petrovic, Natasa; Cannon, Barbara; Amri, Ez-Zoubir; Kemp, Bruce E.; Steinberg, Gregory R.; Janovska, Petra; Kopecky, Jan; Wolfrum, Christian; Blueher, Matthias; Diaz, Mauricio Berriel; Herzig, Stephan			An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice	NATURE MEDICINE			English	Article							WHOLE-BODY LIPOLYSIS; ADIPOCYTE LIPOLYSIS; LIPID HOMEOSTASIS; CELL-DEATH; MECHANISM; AICAR; ALPHA; CIDEA; LIPOGENESIS; RESISTANT	Cachexia represents a fatal energy-wasting syndrome in a large number of patients with cancer that mostly results in a pathological loss of skeletal muscle and adipose tissue. Here we show that tumor cell exposure and tumor growth in mice triggered a futile energy-wasting cycle in cultured white adipocytes and white adipose tissue (WAT), respectively. Although uncoupling protein 1 (Ucp1)-dependent thermogenesis was dispensable for tumor-induced body wasting, WAT from cachectic mice and tumor-cell-supernatant-treated adipocytes were consistently characterized by the simultaneous induction of both lipolytic and lipogenic pathways. Paradoxically, this was accompanied by an inactivated AMP-activated protein kinase (Ampk), which is normally activated in peripheral tissues during states of low cellular energy. Ampk inactivation correlated with its degradation and with upregulation of the Ampk-interacting protein Cidea. Therefore, we developed an Ampk-stabilizing peptide, ACIP, which was able to ameliorate WAT wasting in vitro and in vivo by shielding the Cidea-targeted interaction surface on Ampk. Thus, our data establish the Ucp1-independent remodeling of adipocyte lipid homeostasis as a key event in tumor-induced WAT wasting, and we propose the ACIP-dependent preservation of Ampk integrity in the WAT as a concept in future therapies for cachexia.	[Rohm, Maria; Schaefer, Michaela; Laurent, Victor; Uestuenel, Bilgen Ekim; Niopek, Katharina; Algire, Carolyn; Hautzinger, Oksana; Sijmonsma, Tjeerd P.; Zota, Annika; Medrikova, Dasa; Pellegata, Natalia S.; Diaz, Mauricio Berriel; Herzig, Stephan] Helmholtz Ctr Munich, IDC, Neuherberg, Germany; [Rohm, Maria; Schaefer, Michaela; Laurent, Victor; Uestuenel, Bilgen Ekim; Niopek, Katharina; Algire, Carolyn; Hautzinger, Oksana; Sijmonsma, Tjeerd P.; Zota, Annika; Medrikova, Dasa; Pellegata, Natalia S.; Diaz, Mauricio Berriel; Herzig, Stephan] Univ Heidelberg Hosp, Inner Med 1, Joint Heidelberg IDC Translat Diabet Program, Heidelberg, Germany; [Rohm, Maria; Schaefer, Michaela; Laurent, Victor; Uestuenel, Bilgen Ekim; Niopek, Katharina; Zota, Annika; Pellegata, Natalia S.; Diaz, Mauricio Berriel; Herzig, Stephan] Deutsch Zentrum Diabetesforsch, Neuherberg, Germany; [Ryden, Mikael; Kulyte, Agne; Dahlman, Ingrid; Arner, Peter] Karolinska Inst, Dept Med, Lipid Lab, Stockholm, Sweden; [Petrovic, Natasa; Cannon, Barbara] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Amri, Ez-Zoubir] Univ Cote Azur, Nice, France; [Amri, Ez-Zoubir] CNRS, Nice, France; [Kemp, Bruce E.] Univ Melbourne, St Vincents Inst Med Res, Fitzroy, Vic, Australia; [Kemp, Bruce E.] Res Australian Catholic Univ, Mary MacKillop Inst Hlth, Melbourne, Vic, Australia; [Steinberg, Gregory R.] McMaster Univ, Div Endocrinol & Metab, Dept Med, Hamilton, ON, Canada; [Janovska, Petra; Kopecky, Jan] Acad Sci Czech Republ, Inst Physiol, Department Adipose Tissue Biol, Prague, Czech Republic; [Wolfrum, Christian] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland; [Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Karolinska Institutet; Stockholm University; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); St. Vincent's Institute of Medical Research; University of Melbourne; Australian Catholic University; McMaster University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich; Leipzig University	Herzig, S (corresponding author), Helmholtz Ctr Munich, IDC, Neuherberg, Germany.; Herzig, S (corresponding author), Univ Heidelberg Hosp, Inner Med 1, Joint Heidelberg IDC Translat Diabet Program, Heidelberg, Germany.; Herzig, S (corresponding author), Deutsch Zentrum Diabetesforsch, Neuherberg, Germany.	stephan.herzig@helmholtz-muenchen.de	Diaz, Mauricio Berriel/AAF-8285-2021; Pellegata, Natalia S/I-1256-2012; Kopecky, Jan/B-8244-2012; Rohm, Maria/O-4196-2017; Janovska, Petra/E-7160-2013; Kemp, Bruce/G-9602-2019; Cannon, Barbara/B-3089-2016	Pellegata, Natalia S/0000-0002-8000-7784; Kopecky, Jan/0000-0001-8072-2035; Rohm, Maria/0000-0003-3926-1534; Janovska, Petra/0000-0002-6154-2175; Kemp, Bruce/0000-0001-6735-5082; Berriel Diaz, Mauricio/0000-0003-4670-919X; Dahlman, Ingrid/0000-0003-3819-5977; Arner, Peter/0000-0002-6208-6220; Cannon, Barbara/0000-0001-6594-2363; Kulyte, Agne/0000-0001-7745-2767; Steinberg, Gregory/0000-0001-5425-8275; Wolfrum, Christian/0000-0002-3862-6805; amri, Ez-Zoubir/0000-0001-8426-5396	Swedish Cancer Fund; Deutsche Forschungsgemeinschaft [He3260/8-1]; European Foundation for the Study of Diabetes; EU FP7 project DIABAT [HEALTH-F2-2011-278373]; DKFZ-Bayer Cooperation Program; HGF Cross Program Topic 'Metabolic Dysfunction'; HGF 'ICEMED' Program; Novo Nordisk Fonden [NNF14OC0010187] Funding Source: researchfish	Swedish Cancer Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Foundation for the Study of Diabetes; EU FP7 project DIABAT; DKFZ-Bayer Cooperation Program; HGF Cross Program Topic 'Metabolic Dysfunction'; HGF 'ICEMED' Program; Novo Nordisk Fonden(Novo Nordisk Foundation)	We would like to thank K. Muller-Decker, K. Friedrich, D. Sohn, F. Ilmberger, Y. Feuchter, B. Meissburger, M. Kirilov, A. Vegiopoulos, P. Flachs, J. Hansikova, N. Petrovic and M. Christian for helpful discussions and experimental support and D.G. Hardie (University of Dundee) for Ampk-alpha 1-specific and Ampk-alpha 2-specific sheep antibodies. We particularly thank T. Schafmeier for comments on the manuscript. This work was supported by grants from the Swedish Cancer Fund (P.A.), the Deutsche Forschungsgemeinschaft grant He3260/8-1 (S.H.), the European Foundation for the Study of Diabetes (S.H.), the EU FP7 project DIABAT (HEALTH-F2-2011-278373; S.H.), the DKFZ-Bayer Cooperation Program (S.H.), the HGF Cross Program Topic 'Metabolic Dysfunction' (S.H.) and the HGF 'ICEMED' Program (S.H.).	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Anthony NM, 2009, OBESITY, V17, P1312, DOI 10.1038/oby.2008.645; Batista ML, 2013, CYTOKINE, V61, P532, DOI 10.1016/j.cyto.2012.10.023; Blum D, 2011, CRIT REV ONCOL HEMAT, V80, P114, DOI 10.1016/j.critrevonc.2010.10.004; Boon H, 2008, DIABETOLOGIA, V51, P1893, DOI 10.1007/s00125-008-1108-7; Bourron O, 2010, DIABETOLOGIA, V53, P768, DOI 10.1007/s00125-009-1639-6; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; de Vos-Geelen J, 2014, CURR OPIN CLIN NUTR, V17, P509, DOI 10.1097/MCO.0000000000000106; Deminice R., 2016, AMINO ACIDS; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Di Sebastiano KM, 2013, BRIT J NUTR, V109, P302, DOI 10.1017/S0007114512001067; Diao L, 2015, MOL MED, V21, P959, DOI 10.2119/molmed.2015.00123; Diaz MB, 2008, HEPATOLOGY, V48, P782, DOI 10.1002/hep.22383; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gaidhu MP, 2012, AM J PHYSIOL-CELL PH, V303, pC1192, DOI 10.1152/ajpcell.00159.2012; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Jatoi A, 2010, LUNG CANCER, V68, P234, DOI 10.1016/j.lungcan.2009.06.020; Jones A, 2013, EMBO MOL MED, V5, P294, DOI 10.1002/emmm.201201869; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; KLEIN S, 1990, J CLIN INVEST, V86, P1403, DOI 10.1172/JCI114854; Kumar NB, 2010, CURR TREAT OPTION ON, V11, P107, DOI 10.1007/s11864-010-0127-z; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Lainscak M, 2008, AM J CARDIOL, V101, p8E, DOI 10.1016/j.amjcard.2008.02.065; Laurencikiene J, 2008, CANCER RES, V68, P9247, DOI 10.1158/0008-5472.CAN-08-1343; Mondello P, 2015, NUTR CANCER, V67, P12, DOI 10.1080/01635581.2015.976318; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Nowakowska M, 2014, TUMOR BIOL, V35, P9291, DOI 10.1007/s13277-014-2196-2; Pausch T, 2012, SURGERY, V152, pS81, DOI 10.1016/j.surg.2012.05.028; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Ryden M, 2008, CANCER-AM CANCER SOC, V113, P1695, DOI 10.1002/cncr.23802; Schafer M, 2016, MOL METAB, V5, P67, DOI 10.1016/j.molmet.2015.11.004; SHERRY BA, 1989, FASEB J, V3, P1956, DOI 10.1096/fasebj.3.8.2721856; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; TANAKA Y, 1990, CANCER RES, V50, P2290; THEOLOGIDES A, 1979, CANCER-AM CANCER SOC, V43, P2004, DOI 10.1002/1097-0142(197905)43:5+<2004::AID-CNCR2820430708>3.0.CO;2-#; THURESONKLEIN A, 1976, ACTA PHYSIOL SCAND, V98, P8, DOI 10.1111/j.1748-1716.1976.tb10296.x; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Tsoli M, 2016, SEMIN CELL DEV BIOL, V54, P68, DOI 10.1016/j.semcdb.2015.10.039; Tsoli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092966; VAUGHAN M, 1962, J BIOL CHEM, V237, P3354; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wang ZG, 2011, AM J PHYSIOL-ENDOC M, V301, pE703, DOI 10.1152/ajpendo.00050.2011; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	55	73	75	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1120	1130		10.1038/nm.4171	http://dx.doi.org/10.1038/nm.4171			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27571348				2022-12-25	WOS:000384872500015
J	Besseling, J; Bringmann, H				Besseling, Judith; Bringmann, Henrik			Engineered non-Mendelian inheritance of entire parental genomes in C. elegans	NATURE BIOTECHNOLOGY			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CORTICAL FORCE GENERATORS; DYNEIN; EXPRESSION; LINEAGES; EMBRYO	The ability to rewrite the rules of genetic segregation would open new possibilities in diverse areas of biotechnology ranging from breeding to epigenetics. Here we engineer non-Mendelian inheritance of the entire maternal or paternal genome in Caenorhabditis elegans by changing the structure of the mitotic spindle during the first cell division of the zygote. Using germline-specific overexpression of a single protein, the conserved microtubule force regulator GPR-1, we increase forces that pull on spindle poles to convert the single bipolar mitotic spindle to two monopolar spindles. This generates two-cell embryos in which one cell contains only the maternal chromosomes and the other cell contains only the paternal chromosomes. As the embryo develops, each cell of the animal, including the germ cells, contains the genetic material of only one parent, resulting in hybrid F-1 animals. Progeny of these animals (F-2) inherit either only F-0 maternal or only F-0 paternal chromosomes, and thus descend from only either of their grandparents' gametes.	[Besseling, Judith; Bringmann, Henrik] Max Planck Inst Biophys Chem, Gottingen, Germany	Max Planck Society	Bringmann, H (corresponding author), Max Planck Inst Biophys Chem, Gottingen, Germany.	Henrik.Bringmann@mpibpc.mpg.de			Max Planck Society	Max Planck Society(Max Planck Society)	The Max Planck Society funded this work.	BRENNER S, 1974, GENETICS, V77, P71; Bringmann H, 2007, CURR BIOL, V17, P185, DOI 10.1016/j.cub.2006.11.070; Bringmann H, 2012, CYTOSKELETON, V69, P819, DOI 10.1002/cm.21066; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Couwenbergs C, 2007, J CELL BIOL, V179, P15, DOI 10.1083/jcb.200707085; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Frokjaer-Jensen C, 2014, NAT METHODS, V11, P529, DOI [10.1038/NMETH.2889, 10.1038/nmeth.2889]; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; HAACK H, 1991, MOL GEN GENET, V228, P482, DOI 10.1007/BF00260643; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; Kotak S, 2012, J CELL BIOL, V199, P97, DOI 10.1083/jcb.201203166; Krueger LE, 2010, J CELL BIOL, V189, P481, DOI 10.1083/jcb.201001115; MEYER BJ, 2005, WORMBOOK; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; Oegema K., 2006, WORMBOOK, DOI 10.1895/wormbook.1.72.1; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Rose L., 2014, WORMBOOK, DOI [10.1895/wormbook.1.30.2, DOI 10.1895/WORMBOOK.1.30.2]; Sarkies P, 2014, NAT REV MOL CELL BIO, V15, P525, DOI 10.1038/nrm3840; Schaner CE., 2006, WORMBOOK; Sha K, 2005, GENETICS, V170, P1633, DOI 10.1534/genetics.104.040303; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4	26	13	13	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2016	34	9					982	+		10.1038/nbt.3643	http://dx.doi.org/10.1038/nbt.3643			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DW0RE	27479498	Green Published			2022-12-25	WOS:000383348500025
J	Zhang, Y; Zhang, D; Li, Q; Liang, J; Sun, LY; Yi, X; Chen, Z; Yan, RR; Xie, GJ; Li, WJ; Liu, SM; Xu, BS; Li, L; Yang, JG; He, L; Shang, YF				Zhang, Yu; Zhang, Di; Li, Qian; Liang, Jing; Sun, Luyang; Yi, Xia; Chen, Zhe; Yan, Ruorong; Xie, Guojia; Li, Wanjin; Liu, Shumeng; Xu, Bosen; Li, Lei; Yang, Jianguo; He, Lin; Shang, Yongfeng			Nucleation of DNA repair factors by FOXA1 links DNA demethylation to transcriptional pioneering	NATURE GENETICS			English	Article							BASE EXCISION-REPAIR; CHROMATIN-STRUCTURE; RECEPTOR FUNCTION; POLYMERASE BETA; BINDING; GLYCOSYLASE; COMPLEX; FAMILY; ACTIVATION; DISCOVERY	FOXA1 functions in epigenetic reprogramming and is described as a 'pioneer factor'. However, exactly how FOXA1 achieves these remarkable biological functions is not fully understood. Here we report that FOXA1 associates with DNA repair complexes and is required for genomic targeting of DNA polymerase beta (POLB) in human cells. Genome-wide DNA methylomes demonstrate that the FOXA1 DNA repair complex is functionally linked to DNA demethylation in a lineage-specific fashion. Depletion of FOXA1 results in localized reestablishment of methylation in a large portion of FOXA1-bound regions, and the regions with the most consistent hypermethylation exhibit the greatest loss of POLB and are represented by active promoters and enhancers. Consistently, overexpression of FOXA1 commits its binding sites to active DNA demethylation in a POLB-dependent manner. Finally, FOXA1-associated DNA demethylation is tightly coupled with estrogen receptor genomic targeting and estrogen responsiveness. Together, these results link FOXA1-associated DNA demethylation to transcriptional pioneering by FOXA1.	[Zhang, Yu; Zhang, Di; Li, Qian; Liang, Jing; Sun, Luyang; Yi, Xia; Chen, Zhe; Yan, Ruorong; Xie, Guojia; Li, Wanjin; Liu, Shumeng; Xu, Bosen; Li, Lei; Yang, Jianguo; He, Lin; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci,Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Shang, Yongfeng] Tianjin Med Univ, Key Lab Hormones & Dev, Tianjin Key Lab Med Epigenet, Dept Biochem & Mol Biol,Sch Basic Med Sci,Minist, Tianjin, Peoples R China	Peking University; Tianjin Medical University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci,Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China.; Shang, YF (corresponding author), Tianjin Med Univ, Key Lab Hormones & Dev, Tianjin Key Lab Med Epigenet, Dept Biochem & Mol Biol,Sch Basic Med Sci,Minist, Tianjin, Peoples R China.	yshang@hsc.pku.edu.cn	Zhang, Di/AAE-2027-2021; Zhang, Di/AAD-6936-2021; Chen, Zhe/AAA-3235-2020	Chen, Zhe/0000-0002-5303-9879; Xie, Guojia/0000-0002-8250-6157; Li, Wanjin/0000-0003-4177-8006	National Natural Science Foundation of China [91219201, 81530073, 81130048, 81300254]; (973 Program) from Ministry of Science and Technology of China [2014CB542004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); (973 Program) from Ministry of Science and Technology of China(National Basic Research Program of China)	This work was supported by grants (91219201, 81530073, and 81130048 to Y.S. and 81300254 to Y.Z.) from the National Natural Science Foundation of China and a grant (973 Program: 2014CB542004 to J.L.) from the Ministry of Science and Technology of China.	Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Billaud M, 2011, CANCER RES, V71, P6572, DOI 10.1158/0008-5472.CAN-11-2158; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dalton SR, 2012, EPIGENOMICS-UK, V4, P459, DOI [10.2217/EPI.12.36, 10.2217/epi.12.36]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Katoh M, 2004, INT J ONCOL, V25, P1495; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li Q, 2013, EMBO J, V32, P858, DOI 10.1038/emboj.2013.35; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu ZJ, 2014, CELL, V159, P358, DOI 10.1016/j.cell.2014.08.027; Lloyd RS, 1999, PROG NUCLEIC ACID RE, V62, P155; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Menet JS, 2014, GENE DEV, V28, P8, DOI 10.1101/gad.228536.113; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Pihlajamaa P, 2014, EMBO J, V33, P312, DOI 10.1002/embj.201385895; R Development Core Team, 2014, R LANG ENV STAT COMP; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Serandour AA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r147; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	69	44	48	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1003	+		10.1038/ng.3635	http://dx.doi.org/10.1038/ng.3635			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27500525				2022-12-25	WOS:000382398800010
J	Makishima, H; Yoshizato, T; Yoshida, K; Sekeres, MA; Radivoyevitch, T; Suzuki, H; Przychodzen, B; Nagata, Y; Meggendorfer, M; Sanada, M; Okuno, Y; Hirsch, C; Kuzmanovic, T; Sato, Y; Sato-Otsubo, A; LaFramboise, T; Hosono, N; Shiraishi, Y; Chiba, K; Haferlach, C; Kern, W; Tanaka, H; Shiozawa, Y; Gomez-Segui, I; Husseinzadeh, HD; Thota, S; Guinta, KM; Dienes, B; Nakamaki, T; Miyawaki, S; Saunthararajah, Y; Chiba, S; Miyano, S; Shih, LY; Haferlach, T; Ogawa, S; Maciejewski, JP				Makishima, Hideki; Yoshizato, Tetsuichi; Yoshida, Kenichi; Sekeres, Mikkael A.; Radivoyevitch, Tomas; Suzuki, Hiromichi; Przychodzen, Bartlomiej; Nagata, Yasunobu; Meggendorfer, Manja; Sanada, Masashi; Okuno, Yusuke; Hirsch, Cassandra; Kuzmanovic, Teodora; Sato, Yusuke; Sato-Otsubo, Aiko; LaFramboise, Thomas; Hosono, Naoko; Shiraishi, Yuichi; Chiba, Kenichi; Haferlach, Claudia; Kern, Wolfgang; Tanaka, Hiroko; Shiozawa, Yusuke; Gomez-Segui, Ines; Husseinzadeh, Holleh D.; Thota, Swapna; Guinta, Kathryn M.; Dienes, Brittney; Nakamaki, Tsuyoshi; Miyawaki, Shuichi; Saunthararajah, Yogen; Chiba, Shigeru; Miyano, Satoru; Shih, Lee-Yung; Haferlach, Torsten; Ogawa, Seishi; Maciejewski, Jaroslaw P.			Dynamics of clonal evolution in myelodysplastic syndromes	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; SF3B1 MUTATION; HEMATOPOIESIS; FLT3; TET2; MACHINERY; PATHWAY; GENES; ASXL1; RUNX1	To elucidate differential roles of mutations in myelodysplastic syndromes (MDS), we investigated clonal dynamics using wholeexome and/or targeted sequencing of 699 patients, of whom 122 were analyzed longitudinally. Including the results from previous reports, we assessed a total of 2,250 patients for mutational enrichment patterns. During progression, the number of mutations, their diversity and clone sizes increased, with alterations frequently present in dominant clones with or without their sweeping previous clones. Enriched in secondary acute myeloid leukemia (sAML; in comparison to high-risk MDS), FLT3, PTPN11, WT1, IDH1, NPM1, IDH2 and NRAS mutations (type 1) tended to be newly acquired, and were associated with faster sAML progression and a shorter overall survival time. Significantly enriched in high-risk MDS (in comparison to low-risk MDS), TP53, GATA2, KRAS, RUNX1, STAG2, ASXL1, ZRSR2 and TET2 mutations (type 2) had a weaker impact on sAML progression and overall survival than type-1 mutations. The distinct roles of type-1 and type-2 mutations suggest their potential utility in disease monitoring.	[Makishima, Hideki; Sekeres, Mikkael A.; Radivoyevitch, Tomas; Przychodzen, Bartlomiej; Hirsch, Cassandra; Kuzmanovic, Teodora; Hosono, Naoko; Gomez-Segui, Ines; Husseinzadeh, Holleh D.; Thota, Swapna; Guinta, Kathryn M.; Dienes, Brittney; Saunthararajah, Yogen; Maciejewski, Jaroslaw P.] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA; [Makishima, Hideki; Yoshizato, Tetsuichi; Yoshida, Kenichi; Suzuki, Hiromichi; Nagata, Yasunobu; Okuno, Yusuke; Sato, Yusuke; Sato-Otsubo, Aiko; Shiozawa, Yusuke; Ogawa, Seishi] Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan; [Makishima, Hideki; Yoshizato, Tetsuichi; Yoshida, Kenichi; Suzuki, Hiromichi; Nagata, Yasunobu; Okuno, Yusuke; Sato, Yusuke; Sato-Otsubo, Aiko; Shiozawa, Yusuke; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Canc Genom Project, Tokyo, Japan; [Sekeres, Mikkael A.] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Leukemia Program, Cleveland, OH 44106 USA; [Meggendorfer, Manja] MLL Munich Leukemia Lab, Munich, Germany; [Sanada, Masashi; Haferlach, Claudia; Kern, Wolfgang; Haferlach, Torsten] Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [LaFramboise, Thomas] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA; [Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Nakamaki, Tsuyoshi] Showa Univ, Sch Med, Dept Med, Div Hematol, Tokyo, Japan; [Miyawaki, Shuichi] Tokyo Metropolitan Otsuka Hosp, Div Hematol, Tokyo, Japan; [Chiba, Shigeru] Univ Tsukuba, Fac Med, Dept Hematol, Tsukuba, Ibaraki, Japan; [Shih, Lee-Yung] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Div Hematol Oncol, Taoyuan, Taiwan	Cleveland Clinic Foundation; Kyoto University; University of Tokyo; Cleveland Clinic Foundation; MLL Munich Leukemia Laboratory; Nagoya Medical Center; Case Western Reserve University; University of Tokyo; Showa University; University of Tsukuba; Chang Gung Memorial Hospital; Chang Gung University	Maciejewski, JP (corresponding author), Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA.; Ogawa, S (corresponding author), Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan.; Ogawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Canc Genom Project, Tokyo, Japan.	sogawa-tky@umin.ac.jp; maciejj@ccf.org	Yoshizato, Tetsuichi/AAD-7308-2019; Okuno, Yusuke/C-9082-2009; Ogawa, Seishi/AAE-7088-2019; Suzuki, Hiromichi/AAO-4664-2021; Seguí, Inés Gómez/ABH-5290-2020	Yoshizato, Tetsuichi/0000-0003-4283-2983; Okuno, Yusuke/0000-0003-3139-9272; Suzuki, Hiromichi/0000-0002-8858-0294; Yoshida, Kenichi/0000-0003-4612-2778; Sekeres, Mikkael/0000-0003-2009-6524; Miyano, Satoru/0000-0002-1753-6616	US National Institutes of Health (NIH) [RO1HL-082983, U54 RR019391, K24 HL-077522]; AA & MDS International Foundation; Robert Duggan Charitable Fund; Edward P. Evans Foundation; Scott Hamilton CARES grant; Ministry of Health, Labor and Welfare of Japan; Japanese Agency for Medical Research and Development (Health and Labour Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer); KAKENHI [26221308, 23249052, 22134006, 15H05909, hp160219, 21790907, 15km0305018h0101, 16H05338, 26890016]; project for development of innovative research on cancer therapies (FIRST, p-direct); Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for World-Leading Innovative R&D on Science and Technology'; Council for Science and Technology Policy (CSTP); National Aeronautics and Space Administration grant [NNJ13ZSA001N]; American Cancer Society (Research Scholar Grant) [123436-RSG-12-159-01-DMC];  [NHRI-EX100-10003NI]; Grants-in-Aid for Scientific Research [15H05909, 26221308] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118281] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AA & MDS International Foundation; Robert Duggan Charitable Fund; Edward P. Evans Foundation; Scott Hamilton CARES grant; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Agency for Medical Research and Development (Health and Labour Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); project for development of innovative research on cancer therapies (FIRST, p-direct); Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for World-Leading Innovative R&D on Science and Technology'(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); National Aeronautics and Space Administration grant; American Cancer Society (Research Scholar Grant)(American Cancer Society); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by US National Institutes of Health (NIH) grants RO1HL-082983 (J.P.M.), U54 RR019391 (J.P.M.) and K24 HL-077522 (J.P.M.), a grant from the AA & MDS International Foundation (J.P.M., M.A.S. and H.M.), the Robert Duggan Charitable Fund (J.P.M.), a grant from Edward P. Evans Foundation (J.P.M. and M.A.S.), Scott Hamilton CARES grant (H.M.), Grant in-Aids from the Ministry of Health, Labor and Welfare of Japan, the Japanese Agency for Medical Research and Development (Health and Labour Sciences Research Expenses for Commission and Applied Research for Innovative Treatment of Cancer) and KAKENHI (26221308, 23249052, 22134006, 15H05909, hp160219 and 21790907; S.O.), (15km0305018h0101, 16H05338; H.M.), (26890016; K.Y.), project for development of innovative research on cancer therapies (FIRST, p-direct; S.O.), the Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for World-Leading Innovative R&D on Science and Technology', initiated by the Council for Science and Technology Policy (CSTP) (S.O.), NHRI-EX100-10003NI Taiwan (L.-Y.S.), National Aeronautics and Space Administration grant NNJ13ZSA001N (T.R.), and a grant from the American Cancer Society (Research Scholar Grant 123436-RSG-12-159-01-DMC, to T.L.). Supercomputing resources were also provided by the Human Genome Center, the Institute of Medical Science, The University of Tokyo.	Badar T, 2015, LEUKEMIA RES, V39, P1367, DOI 10.1016/j.leukres.2015.10.005; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dicker F, 2010, LEUKEMIA, V24, P1528, DOI 10.1038/leu.2010.124; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; Huang DY, 2015, HAEMATOLOGICA, V100, P1051, DOI 10.3324/haematol.2014.111989; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kihara R, 2014, LEUKEMIA, V28, P1586, DOI 10.1038/leu.2014.55; Kurtovic-Kozaric A, 2015, LEUKEMIA, V29, P126, DOI 10.1038/leu.2014.144; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Malcovati L, 2015, BLOOD, V126, P233, DOI 10.1182/blood-2015-03-633537; Malcovati L, 2011, BLOOD, V118, P6239, DOI 10.1182/blood-2011-09-377275; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; Merlevede J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10767; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Schnittger S, 2011, LEUKEMIA, V25, P615, DOI 10.1038/leu.2010.299; Shih LY, 2004, LEUKEMIA, V18, P466, DOI 10.1038/sj.leu.2403274; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	42	245	261	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					204	212		10.1038/ng.3742	http://dx.doi.org/10.1038/ng.3742			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27992414	Green Accepted			2022-12-25	WOS:000393148600009
J	Doll, S; Proneth, B; Tyurina, YY; Panzilius, E; Kobayashi, S; IngoId, I; Irmler, M; Beckers, J; Aichler, M; Walch, A; Prokisch, H; Trumbach, D; Mao, GW; Qu, F; Bayir, H; Fullekrug, J; Scheel, CH; Wurst, W; Schick, JA; Kagan, VE; Angeli, JPF; Conrad, M				Doll, Sebastian; Proneth, Bettina; Tyurina, Yulia Y.; Panzilius, Elena; Kobayashi, Sho; IngoId, Irina; Irmler, Martin; Beckers, Johannes; Aichler, Michaela; Walch, Axel; Prokisch, Holger; Trumbach, Dietrich; Mao, Gaowei; Qu, Feng; Bayir, Hulya; Fullekrug, Joachim; Scheel, Christina H.; Wurst, Wolfgang; Schick, Joel A.; Kagan, Valerian E.; Angeli, Jose Pedro Friedmann; Conrad, Marcus			ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition	NATURE CHEMICAL BIOLOGY			English	Article							PLACEBO-CONTROLLED TRIAL; GLUTATHIONE-PEROXIDASE 4; COA SYNTHETASE 4; DEATH; PIOGLITAZONE; ROSIGLITAZONE; BREAST; IDENTIFICATION; EXPRESSION; ISCHEMIA	Ferroptosis is a form of regulated necrotic cell death controlled by glutathione peroxidase 4 (GPX4). At present, mechanisms that could predict sensitivity and/or resistance and that may be exploited to modulate ferroptosis are needed. We applied two independent approaches a genome-wide CRISPR-based genetic screen and microarray analysis of ferroptosis-resistant cell lines to uncover acyl-CoA synthetase long-chain family member 4 (ACSL4) as an essential component for ferroptosis execution. Specifically, Gpx4-AcsL4 double-knockout cells showed marked resistance to ferroptosis. Mechanistically, ACSL4 enriched cellular membranes with long polyunsaturated co6 fatty acids. Moreover, ACSL4 was preferentially expressed in a panel of basal-like breast cancer cell lines and predicted their sensitivity to ferroptosis. Pharmacological targeting of ACSL4 with thiazolidinediones, a class of antidiabetic compound, ameliorated tissue demise in a mouse model of ferroptosis, suggesting that ACSL4 inhibition is a viable therapeutic approach to preventing ferroptosis-related diseases.	[Doll, Sebastian; Proneth, Bettina; Kobayashi, Sho; IngoId, Irina; Trumbach, Dietrich; Wurst, Wolfgang; Schick, Joel A.; Angeli, Jose Pedro Friedmann; Conrad, Marcus] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Tyurina, Yulia Y.; Mao, Gaowei; Qu, Feng; Bayir, Hulya; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Panzilius, Elena; Scheel, Christina H.] Helmholtz Zentrum Munchen, Inst Stem Cell Biol, Neuherberg, Germany; [Irmler, Martin; Beckers, Johannes] Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Aichler, Michaela; Walch, Axel] Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Fullekrug, Joachim] Heidelberg Univ, Dept Gastroenterol, Heidelberg, Germany; [Kobayashi, Sho] Yamagata Univ, Grad Sch Med Sci, Dept Biochem & Mol Biol, Yamagata, Japan; [Schick, Joel A.] Helmholtz Zentrum Munchen, Inst Toxicol, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Ruprecht Karls University Heidelberg; Yamagata University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Angeli, JPF; Conrad, M (corresponding author), Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany.	pedro.angeli@helmholtz-muenchen.de; marcus.conrad@helmholtz-muenchen.de	Beckers, Johannes/K-7237-2012; Schick, Joel/ABA-3728-2021; Conrad, Marcus/E-8792-2015; Angeli, J Pedro Friedmann/ABG-6270-2020; Aichler, Michaela/B-5356-2014; Walch, Axel/B-4554-2012; Proneth, Bettina/AGZ-9097-2022; Irmler, Martin/B-3317-2013	Beckers, Johannes/0000-0001-7874-3822; Schick, Joel/0000-0002-8623-4910; Conrad, Marcus/0000-0003-1140-5612; Angeli, J Pedro Friedmann/0000-0001-7706-1379; Walch, Axel/0000-0001-5578-4023; Tyurina, Yulia/0000-0003-0287-2091; Kagan, Valerian E./0000-0002-7245-1885; Wurst, Wolfgang/0000-0003-4422-7410; Prokisch, Holger/0000-0003-2379-6286; Doll, Sebastian/0000-0002-8933-5362; Irmler, Martin/0000-0003-3169-479X	Deutsche Forschungsgemeinschaft (DFG) [CO 291/2-3, CO 291/5-1]; Japan Society for the Promotion of Science (JSPS); Human Frontier Science Program (HFSP) [RGP0013]; German Bundesministerium fur Bildung und Forschung (BMBF) through the European E-Rare Network for mitochondrial disorders GENOMIT [01GM1603]; National Institute of Health (NIH) [P01HL114453, U19AI068021, NS076511, NS061817, ES020693]; Bavarian Ministry of Economic Affairs (m4 Award); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076511, R01NS061817] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program (HFSP)(Human Frontier Science Program); German Bundesministerium fur Bildung und Forschung (BMBF) through the European E-Rare Network for mitochondrial disorders GENOMIT; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bavarian Ministry of Economic Affairs (m4 Award); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank B.R. Stockwell (Columbia University, New York, USA) for providing RSL3 and F. Ursini and M. Maiorino (Universita degli Studi di Padova, Padua, Italy) for phosphatidylcholine hydroperoxide. We would also like to thank A. Berns (the Netherlands Cancer Institute) for providing the ROSA26-CreER<SUP>T2</SUP> mouse line. SK-BR-3 cells were a gift from G. Multhoff (Technical University Munich). This work was in part supported by grants from the Deutsche Forschungsgemeinschaft (DFG) CO 291/2-3 and CO 291/5-1 to M.C., a fellowship from the Japan Society for the Promotion of Science (JSPS) to S.K., the Human Frontier Science Program (HFSP) RGP0013 to M.C. and V.E.K., the German Bundesministerium fur Bildung und Forschung (BMBF) through the European E-Rare Network for mitochondrial disorders GENOMIT (01GM1603) to H.P., the National Institute of Health (NIH) (P01HL114453, U19AI068021, NS076511, NS061817, ES020693) to V.E.K. and the Bavarian Ministry of Economic Affairs (m<SUP>4</SUP> Award) to J.A.S. and M.C.	Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Canli O, 2016, BLOOD, V127, P139, DOI 10.1182/blood-2015-06-654194; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; Culman J, 2012, EXP NEUROL, V238, P243, DOI 10.1016/j.expneurol.2012.09.003; Dixon SJ, 2015, ACS CHEM BIOL, V10, P1604, DOI 10.1021/acschembio.5b00245; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Gale EAM, 2001, LANCET, V357, P1870, DOI 10.1016/S0140-6736(00)04960-6; Han LJ, 2015, STROKE, V46, P2628, DOI 10.1161/STROKEAHA.115.010091; Hayano M, 2016, CELL DEATH DIFFER, V23, P270, DOI 10.1038/cdd.2015.93; Heneka MT, 2015, ANN NEUROL, V78, P284, DOI 10.1002/ana.24439; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; ISHII T, 1987, J CELL PHYSIOL, V133, P330, DOI 10.1002/jcp.1041330217; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Jin J, 2013, J NEUROCHEM, V125, P410, DOI 10.1111/jnc.12190; Kagan V. E., 2016, NAT CHEM BIOL; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kuboki S, 2008, HEPATOLOGY, V47, P215, DOI 10.1002/hep.21963; Kuch EM, 2014, BBA-MOL CELL BIOL L, V1841, P227, DOI 10.1016/j.bbalip.2013.10.018; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Louandre C, 2013, INT J CANCER, V133, P1732, DOI 10.1002/ijc.28159; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; Monaco ME, 2010, TRANSL ONCOL, V3, P91, DOI 10.1593/tlo.09202; Orlando UD, 2015, ONCOTARGET, V6, P42632, DOI 10.18632/oncotarget.5822; Pratt DA, 2003, J AM CHEM SOC, V125, P5801, DOI 10.1021/ja034182j; Rennings AJ, 2010, EUR HEART J, V31, P983, DOI 10.1093/eurheartj/ehp562; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; URSINI F, 1982, BIOCHIM BIOPHYS ACTA, V710, P197, DOI 10.1016/0005-2760(82)90150-3; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Wortmann M, 2013, CIRC RES, V113, P408, DOI 10.1161/CIRCRESAHA.113.279984; Wu JS, 2009, CIRCULATION, V119, P1124, DOI 10.1161/CIRCULATIONAHA.108.812537; Wu XY, 2015, ONCOTARGET, V6, P44849, DOI 10.18632/oncotarget.6438; Wu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077060; Yamanaka K, 2012, RSC ADV, V2, P7894, DOI 10.1039/c2ra20816d; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z	44	1117	1180	65	568	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					91	98		10.1038/NCHEMBIO.2239	http://dx.doi.org/10.1038/NCHEMBIO.2239			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27842070	Green Accepted			2022-12-25	WOS:000393267200018
J	Forment, JV; Herzog, M; Coates, J; Konopka, T; Gapp, BV; Nijman, SM; Adams, DJ; Keane, TM; Jackson, SP				Forment, Josep V.; Herzog, Mareike; Coates, Julia; Konopka, Tomasz; Gapp, Bianca V.; Nijman, Sebastian M.; Adams, David J.; Keane, Thomas M.; Jackson, Stephen P.			Genome-wide genetic screening with chemically mutagenized haploid embryonic stem cells	NATURE CHEMICAL BIOLOGY			English	Article							MISMATCH REPAIR; DESIGN; ART; DEFICIENCY; DERIVATION	In model organisms, classical genetic screening via random mutagenesis provides key insights into the molecular bases of genetic interactions, helping to define synthetic lethality, synthetic viability and drug-resistance mechanisms. The limited genetic tractability of diploid mammalian cells, however, precludes this approach. Here, we demonstrate the feasibility of classical genetic screening in mammalian systems by using haploid cells, chemical mutagenesis and next-generation sequencing, providing a new tool to explore mammalian genetic interactions.	[Forment, Josep V.; Herzog, Mareike; Coates, Julia; Jackson, Stephen P.] Univ Cambridge, Wellcome Trust, Cambridge, England; [Forment, Josep V.; Herzog, Mareike; Coates, Julia; Jackson, Stephen P.] Univ Cambridge, Canc Res UK Gurdon Inst, Cambridge, England; [Forment, Josep V.; Herzog, Mareike; Coates, Julia; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge, England; [Forment, Josep V.; Herzog, Mareike; Adams, David J.; Keane, Thomas M.; Jackson, Stephen P.] Welcome Trust Sanger Inst, Cambridge, England; [Konopka, Tomasz; Gapp, Bianca V.; Nijman, Sebastian M.] Ludwig Inst Canc Res Ltd, Oxford, England; [Konopka, Tomasz; Gapp, Bianca V.; Nijman, Sebastian M.] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford, England; [Nijman, Sebastian M.] Austrian Acad Sci CeMM, Res Ctr Mol Med, Vienna, Austria	University of Cambridge; Wellcome Trust Sanger Institute; Cancer Research UK; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Ludwig Institute for Cancer Research; University of Oxford; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Forment, JV; Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust, Cambridge, England.; Forment, JV; Jackson, SP (corresponding author), Univ Cambridge, Canc Res UK Gurdon Inst, Cambridge, England.; Forment, JV; Jackson, SP (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.; Forment, JV; Jackson, SP (corresponding author), Welcome Trust Sanger Inst, Cambridge, England.	j.forment@gurdon.cam.ac.uk; s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Forment, Josep/J-3678-2015	Jackson, Stephen Philip/0000-0001-9317-7937; Herzog, Mareike/0000-0001-9747-2327; Forment, Josep/0000-0002-7797-2583; Adams, David/0000-0001-9490-0306; Keane, Thomas/0000-0001-7532-6898	Cancer Research UK (CRUK) [C6/A11224]; European Community Seventh Framework Programme [HEALTH -F2-2010-259893]; Cancer Research UK [C6946/A14492]; Wellcome Trust [WT092096]; Cancer Research UK programme [C6/A11224]; Ataxia Telangiectasia Society; CRUK; European Research Council under the European Union's Seventh Framework Programme; Boehringer Ingelheim Fonds PhD fellowship; European Research Council; University of Cambridge; ERC [311166]; Cancer Research UK [18796, 21717, 13031] Funding Source: researchfish	Cancer Research UK (CRUK)(Cancer Research UK); European Community Seventh Framework Programme(European Commission); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Cancer Research UK programme(Cancer Research UK); Ataxia Telangiectasia Society; CRUK(Cancer Research UK); European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Boehringer Ingelheim Fonds PhD fellowship(Boehringer Ingelheim); European Research Council(European Research Council (ERC)European Commission); University of Cambridge(University of Cambridge); ERC(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	We thank all S.P.J. laboratory members for discussions, especially A. Blackford, F.Puddu, C. Schmidt and P. Marco-Casanova for critical reading of the manuscript, and C. Le Sage and T.-W Chiang for advice with CRISPR-Cas9 gene editing. We thank M. Leeb for H129-3 cells and advice on haploid ES cell culture conditions, and J. Hackett (Gurdon Institute, University of Cambridge) for advice in generating stable ES cell lines. We thank C.D. Robles-Espinoza for helping to design the array of baits for the exon-capture experiment, and J. Hewinson for technical support. Research in the S.P.J. laboratory is funded by Cancer Research UK (CRUK; programme grant C6/A11224), the European Research Council and the European Community Seventh Framework Programme (grant agreement no. HEALTH -F2-2010-259893; DDResponse). Core funding is provided by Cancer Research UK (C6946/A14492) and the Wellcome Trust (WT092096). S.P.J. receives salary from the University of Cambridge, supplemented by CRUK. J.V.F. was funded by Cancer Research UK programme grant C6/A11224 and the Ataxia Telangiectasia Society. J.C. was funded by Cancer Research UK programme grant C6/A11224. D.J.A. is supported by CRUK. Research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) and ERC grant agreement no. (311166). B.V.G. is supported by a Boehringer Ingelheim Fonds PhD fellowship.	Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Elting U., 2011, CELL STEM CELL, V9, P563; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Guo G, 2004, NATURE, V429, P891, DOI 10.1038/nature02653; Jinnah HA, 2000, MUTAT RES-REV MUTAT, V463, P309, DOI 10.1016/S1383-5742(00)00052-1; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; Kasap C, 2014, NAT CHEM BIOL, V10, P626, DOI 10.1038/nchembio.1551; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; LEPAGE GA, 1961, CANCER RES, V21, P642; Loughery JEP, 2011, HUM MOL GENET, V20, P3241, DOI 10.1093/hmg/ddr236; Munroe Robert, 2009, V530, P131, DOI 10.1007/978-1-59745-471-1_7; Sagi I, 2016, NATURE, V532, P107, DOI 10.1038/nature17408; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smurnyy Y, 2014, NAT CHEM BIOL, V10, P623, DOI 10.1038/nchembio.1550; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109	20	28	29	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					12	14		10.1038/NCHEMBIO.2226	http://dx.doi.org/10.1038/NCHEMBIO.2226			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27820796	Green Accepted, Green Submitted			2022-12-25	WOS:000393267200006
J	Shankar, V				Shankar, Vijay			Gut microbiome profiling tests propelled by customer demand	NATURE BIOTECHNOLOGY			English	News Item																		2013, NAT BIOTECHNOL, V31, P90; 2016, GENOME BIOL, V17, P189; 2015, CELL, V163, P1079	3	5	5	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					9	9		10.1038/nbt0117-9	http://dx.doi.org/10.1038/nbt0117-9			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	28072776				2022-12-25	WOS:000392460800010
J	Genee, HJ; Bali, AP; Petersen, SD; Siedler, S; Bonde, MT; Gronenberg, LS; Kristensen, M; Harrison, SJ; Sommer, MOA				Genee, Hans J.; Bali, Anne P.; Petersen, Soren D.; Siedler, Solvej; Bonde, Mads T.; Gronenberg, Luisa S.; Kristensen, Mette; Harrison, Scott J.; Sommer, Morten O. A.			Functional mining of transporters using synthetic selections	NATURE CHEMICAL BIOLOGY			English	Article							COMPARATIVE GENOMICS; ESCHERICHIA-COLI; HUMAN GUT; EVOLUTION; BACTERIA; THIAMINE; PROTEINS; BIOTECHNOLOGY; OPTIMIZATION; RIBOSWITCHES	Only 25% of bacterial membrane transporters have functional annotation owing to the difficulty of experimental study and of accurate prediction of their function. Here we report a sequence-independent method for high-throughput mining of novel transporters. The method is based on ligand-responsive biosensor systems that enable selective growth of cells only if they encode a ligand-specific importer. We developed such a synthetic selection system for thiamine pyrophosphate and mined soil and gut metagenomes for thiamine-uptake functions. We identified several members of a novel class of thiamine transporters, PnuT, which is widely distributed across multiple bacterial phyla. We demonstrate that with modular replacement of the biosensor, we could expand our method to xanthine and identify xanthine permeases from gut and soil metagenomes. Our results demonstrate how synthetic-biology approaches can effectively be deployed to functionally mine metagenomes and elucidate sequence-function relationships of small-molecule transport systems in bacteria.	[Genee, Hans J.; Bali, Anne P.; Petersen, Soren D.; Siedler, Solvej; Bonde, Mads T.; Kristensen, Mette; Harrison, Scott J.; Sommer, Morten O. A.] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Lyngby, Denmark; [Genee, Hans J.; Bali, Anne P.; Gronenberg, Luisa S.] Biosyntia ApS, Copenhagen, Denmark	Novo Nordisk Foundation; Technical University of Denmark	Sommer, MOA (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Lyngby, Denmark.	msom@bio.dtu.dk		Sommer, Morten Otto Alexander/0000-0003-4005-5674; Siedler, Solvej/0000-0002-5445-8792; Petersen, Soren Dalsgard/0000-0003-4104-5144	Novo Nordisk Foundation; European Union [613745]; Novozymes A/S; Lundbeck Foundation [R77-2010-6772, R140-2013-13496] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517, NNF13SA0009311, NNF13SA0006019, NNF14OC0011335] Funding Source: researchfish; NNF Center for Biosustainability [Synthetic Biology Tools for Yeast, Bacterial Synthetic Biology, iLoop] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Union(European Commission); Novozymes A/S; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	We thank Y. Yokobayashi (University of California, Davis, California, USA) for providing plasmid pLacthiM19tetA-gfpuv, J. Gallivan (Emory University, Atlanta, Georgia, USA) for providing plasmid pSKD314, D. Paiva (Technical University of Denmark, Kongens Lyngby, Denmark) for metagenomic libraries, R. Lavallee for technical HPLC support, and C. Munck for critical reading of the manuscript. This study was funded by the Novo Nordisk Foundation and the European Union Seventh Framework Programme (FP7-KBBE-2013-7 single stage) under grant agreement no. 613745, Promys. H.J.G. acknowledges additional financial support from Novozymes A/S.	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, V33, pW690, DOI 10.1093/nar/gki445; Arai M, 2004, PROTEIN SCI, V13, P2170, DOI 10.1110/ps.04814404; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Binder S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r40; BONTEMPS J, 1984, J CHROMATOGR, V307, P283, DOI 10.1016/S0378-4347(00)84100-6; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Degnan PH, 2014, CELL HOST MICROBE, V15, P47, DOI 10.1016/j.chom.2013.12.007; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Fiet SV, 2006, P NATL ACAD SCI USA, V103, P1693, DOI 10.1073/pnas.0504733102; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Gelfand MS, 2008, PHYS LIFE REV, V5, P22, DOI 10.1016/j.plrev.2007.10.003; Genee HJ, 2015, ACS SYNTH BIOL, V4, P342, DOI 10.1021/sb500194z; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goler JA, 2014, METHODS MOL BIOL, V1111, P221, DOI 10.1007/978-1-62703-755-6_16; Grose JH, 2005, J BACTERIOL, V187, P4521, DOI 10.1128/JB.187.13.4521-4530.2005; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Hemberger S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-119; Herbert M, 2003, INFECT IMMUN, V71, P5398, DOI 10.1128/IAI.71.9.5398-5401.2003; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Jaehme M, 2015, BIOL CHEM, V396, P955, DOI 10.1515/hsz-2015-0113; Jaehme M, 2015, BBA-GEN SUBJECTS, V1850, P565, DOI 10.1016/j.bbagen.2014.05.006; Jaehme M, 2014, NAT STRUCT MOL BIOL, V21, P1013, DOI 10.1038/nsmb.2909; Jeanguenin L, 2012, FUNCT INTEGR GENOMIC, V12, P25, DOI 10.1007/s10142-011-0255-y; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Kell DB, 2015, TRENDS BIOTECHNOL, V33, P237, DOI 10.1016/j.tibtech.2015.02.001; Libis V., 2016, ACS SYNTH BIOL; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Lynch SA, 2009, NUCLEIC ACIDS RES, V37, P184, DOI 10.1093/nar/gkn924; Mahr R, 2016, APPL MICROBIOL BIOT, V100, P79, DOI 10.1007/s00253-015-7090-3; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Michener JK, 2012, METAB ENG, V14, P306, DOI 10.1016/j.ymben.2012.04.004; Muranaka N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp039; NEDENSKOV P, 1994, APPL ENVIRON MICROB, V60, P3450, DOI 10.1128/AEM.60.9.3450-3453.1994; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Raman S, 2014, P NATL ACAD SCI USA, V111, P17803, DOI 10.1073/pnas.1409523111; Ren QH, 2007, J MOL MICROB BIOTECH, V12, P165, DOI 10.1159/000099639; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Rodionova IA, 2015, ENV MICROBIOL REP, V7, P204, DOI 10.1111/1758-2229.12227; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer E, 2004, ANTIMICROB AGENTS CH, V48, P4532, DOI 10.1128/AAC.48.12.4532-4541.2004; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Schyns G, 2005, J BACTERIOL, V187, P8127, DOI 10.1128/JB.187.23.8127-8136.2005; Siedler S, 2014, ACS SYNTH BIOL, V3, P41, DOI 10.1021/sb400110j; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Taylor ND, 2016, NAT METHODS, V13, P177, DOI [10.1038/NMETH.3696, 10.1038/nmeth.3696]; van der Helm Eric, 2015, BMC Res Notes, V8, P328, DOI 10.1186/s13104-015-1281-y; Vogl C, 2007, J BACTERIOL, V189, P7367, DOI 10.1128/JB.00590-07; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Webb E, 1998, J BIOL CHEM, V273, P8946, DOI 10.1074/jbc.273.15.8946; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Wittmann A, 2012, FEBS LETT, V586, P2076, DOI 10.1016/j.febslet.2012.02.038; Yang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2404	58	47	49	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1015	+		10.1038/nchembio.2189	http://dx.doi.org/10.1038/nchembio.2189			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27694800				2022-12-25	WOS:000388582900009
J	Over, B; Matsson, P; Tyrchan, C; Artursson, P; Doak, BC; Foley, MA; Hilgendorf, C; Johnston, SE; Lee, MD; Lewis, RJ; McCarren, P; Muncipinto, G; Norinder, U; Perry, MWD; Duvall, JR; Kihlberg, J				Over, Bjorn; Matsson, Par; Tyrchan, Christian; Artursson, Per; Doak, Bradley C.; Foley, Michael A.; Hilgendorf, Constanze; Johnston, Stephen E.; Lee, Maurice D.; Lewis, Richard J.; McCarren, Patrick; Muncipinto, Giovanni; Norinder, Ulf; Perry, Matthew W. D.; Duvall, Jeremy R.; Kihlberg, Jan			Structural and conformational determinants of macrocycle cell permeability	NATURE CHEMICAL BIOLOGY			English	Article							DRUG DISCOVERY; BUILD/COUPLE/PAIR STRATEGY; QUANTITATIVE ASSESSMENT; PASSIVE PERMEABILITY; ORAL BIOAVAILABILITY; CYCLIC-PEPTIDES; ABSORPTION; SOLUBILITY; SPACE; RULE	Macrocycles are of increasing interest as chemical probes and drugs for intractable targets like protein-protein interactions, but the determinants of their cell permeability and oral absorption are poorly understood. To enable rational design of cell-permeable macrocycles, we generated an extensive data set under consistent experimental conditions for more than 200 nonpeptidic, de novo-designed macrocycles from the Broad Institute's diversity-oriented screening collection. This revealed how specific functional groups, substituents and molecular properties impact cell permeability. Analysis of energy-minimized structures for stereo- and regioisomeric sets provided fundamental insight into how dynamic, intramolecular interactions in the 3D conformations of macrocycles may be linked to physicochemical properties and permeability. Combined use of quantitative structure-permeability modeling and the procedure for conformational analysis now, for the first time, provides chemists with a rational approach to design cell-permeable non-peptidic macrocycles with potential for oral absorption.	[Over, Bjorn] AstraZeneca R&D Gothenburg, Innovat Med & Early Dev Biotech Unit, Cardiovasc & Metab Dis, Molndal, Sweden; [Matsson, Par; Artursson, Per] Uppsala Univ, Dept Pharm, Uppsala, Sweden; [Matsson, Par; Artursson, Per] Uppsala Univ, Sci Life Lab, Uppsala Univ Drug Optimizat & Pharmaceut Profilin, Chem Biol Consortium Sweden, Uppsala, Sweden; [Tyrchan, Christian; Lewis, Richard J.] AstraZeneca R&D Gothenburg, Innovat Med & Early Dev Biotech Unit, Resp Inflammat & Autoimmun Dis, Molndal, Sweden; [Doak, Bradley C.; Kihlberg, Jan] Uppsala Univ, Dept Chem, Uppsala, Sweden; [Foley, Michael A.; Johnston, Stephen E.; Lee, Maurice D.; McCarren, Patrick; Muncipinto, Giovanni; Duvall, Jeremy R.] Broad Inst, Ctr Sci Therapeut, Cambridge, MA 02142 USA; [Hilgendorf, Constanze] AstraZeneca R&D Gothenburg, Safety & ADME Translat Sci, Drug Safety & Metab, Molndal, Sweden; [Norinder, Ulf] Swedish Toxicol Sci Res Ctr, Sodertalje, Sweden; [Foley, Michael A.] Triinst Therapeut Discovery Inst, New York, NY USA; [Lee, Maurice D.; Muncipinto, Giovanni; Duvall, Jeremy R.] Ensemble Therapeut, Cambridge, MA 02139 USA	AstraZeneca; Uppsala University; Uppsala University; AstraZeneca; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; AstraZeneca	Duvall, JR (corresponding author), Broad Inst, Ctr Sci Therapeut, Cambridge, MA 02142 USA.; Duvall, JR (corresponding author), Ensemble Therapeut, Cambridge, MA 02139 USA.	jduvall@ensembletx.com; jan.kihlberg@kemi.uu.se	Doak, Bradley C/A-4313-2013; Kihlberg, Jan/S-4739-2019	Doak, Bradley C/0000-0001-8422-675X; Lewis, Richard/0000-0001-9404-8520; Hilgendorf, Constanze/0000-0001-9445-4692; Perry, Matthew/0000-0002-9799-0746; Tyrchan, Christian/0000-0002-6470-984X; Over, Bjorn/0000-0002-9185-5420; Matsson, Par/0000-0002-9094-2581; Norinder, Ulf/0000-0003-3107-331X	AstraZeneca RD Gothenburg; Carl Trygger Foundation; Swedish Research Council [2822]; NIGMS-Center of Excellence in Chemical Methodology and Library Development (Broad Institute CMLD) [P50 GM069721]	AstraZeneca RD Gothenburg(AstraZeneca); Carl Trygger Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); NIGMS-Center of Excellence in Chemical Methodology and Library Development (Broad Institute CMLD)	This work was funded by a postdoctoral fellowship at AstraZeneca R&D Gothenburg (B.O.), the Carl Trygger Foundation (P. Matsson), the Swedish Research Council (grant no. 2822; P.A.) and the NIGMS-sponsored Center of Excellence in Chemical Methodology and Library Development (Broad Institute CMLD; P50 GM069721). ChemAxon and Simulations Plus are graciously acknowledged for providing access to the Instant JChem and ADMET Predictor software, respectively. We thank J. Wernevik, O. Hedge and R. Svensson for determining logD and pK<INF>a</INF> data, respectively, and J. Holmgren, L. Fredlund and C. Vedin for assistance with Caco-2 cell measurements. We also thank C. Mulrooney and J. Ulander for helpful discussions pertaining to computational experiments.	Abraham MH, 2014, J ORG CHEM, V79, P11075, DOI 10.1021/jo502080p; Alelyunas YW, 2009, EUR J PHARM SCI, V37, P172, DOI 10.1016/j.ejps.2009.02.007; Alex A, 2011, MEDCHEMCOMM, V2, P669, DOI 10.1039/c1md00093d; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Artursson P, 1996, ADV DRUG DELIVER REV, V22, P67, DOI 10.1016/S0169-409X(96)00415-2; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/NCHEM.1243, 10.1038/nchem.1243]; Bockus AT, 2015, J MED CHEM, V58, P7409, DOI 10.1021/acs.jmedchem.5b00919; Bockus AT, 2015, J MED CHEM, V58, P4581, DOI 10.1021/acs.jmedchem.5b00128; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Comer E, 2011, P NATL ACAD SCI USA, V108, P6751, DOI 10.1073/pnas.1015255108; Desai PV, 2012, BIOORG MED CHEM LETT, V22, P6540, DOI 10.1016/j.bmcl.2012.08.059; Doak BC, 2016, J MED CHEM, V59, P2312, DOI 10.1021/acs.jmedchem.5b01286; Doak BC, 2014, CHEM BIOL, V21, P1115, DOI 10.1016/j.chembiol.2014.08.013; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Ferreira RJ, 2013, J CHEM INF MODEL, V53, P1747, DOI 10.1021/ci400195v; Fitzgerald ME, 2012, ACS COMB SCI, V14, P89, DOI 10.1021/co200161z; Freyhult E, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-50; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Giordanetto F, 2014, J MED CHEM, V57, P278, DOI 10.1021/jm400887j; Guimaraes CRW, 2012, J CHEM INF MODEL, V52, P882, DOI 10.1021/ci300010y; Heinis C, 2014, NAT CHEM BIOL, V10, P696, DOI 10.1038/nchembio.1605; Hewitt WM, 2015, J AM CHEM SOC, V137, P715, DOI 10.1021/ja508766b; Hitchcock SA, 2012, J MED CHEM, V55, P4877, DOI 10.1021/jm201136z; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Kalvass JC, 2007, PHARM RES-DORDR, V24, P265, DOI 10.1007/s11095-006-9135-x; Kuhn B, 2010, J MED CHEM, V53, P2601, DOI 10.1021/jm100087s; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lovering F, 2013, MEDCHEMCOMM, V4, P515, DOI 10.1039/c2md20347b; Mallinson J, 2012, FUTURE MED CHEM, V4, P1409, DOI [10.4155/FMC.12.93, 10.4155/fmc.12.93]; Marcaurelle LA, 2010, J AM CHEM SOC, V132, P16962, DOI 10.1021/ja105119r; MARION D, 1985, FEBS LETT, V192, P99, DOI 10.1016/0014-5793(85)80051-X; Mateus A, 2013, MOL PHARMACEUT, V10, P2467, DOI 10.1021/mp4000822; Mathiowetz AM, 2015, RSC DRUG DISCOV, V40, P367; Matsson P, 2005, J MED CHEM, V48, P604, DOI 10.1021/jm049711o; Matsson P, 2009, PHARM RES-DORDR, V26, P1816, DOI 10.1007/s11095-009-9896-0; Nielsen DS, 2014, ANGEW CHEM INT EDIT, V53, P12059, DOI 10.1002/anie.201405364; Raub TJ, 2006, MOL PHARMACEUT, V3, P3, DOI 10.1021/mp0500871; Rezai T, 2006, J AM CHEM SOC, V128, P14073, DOI 10.1021/ja063076p; Rosenquist A, 2014, J MED CHEM, V57, P1673, DOI 10.1021/jm401507s; Sauer WHB, 2003, J CHEM INF COMP SCI, V43, P987, DOI 10.1021/ci025599w; Schreiber SL, 2009, NATURE, V457, P153, DOI 10.1038/457153a; Surade S, 2012, CHEM BIOL, V19, P42, DOI 10.1016/j.chembiol.2011.12.013; Thansandote P, 2015, BIOORGAN MED CHEM, V23, P322, DOI 10.1016/j.bmc.2014.11.034; Varma MVS, 2010, J MED CHEM, V53, P1098, DOI 10.1021/jm901371v; Villar EA, 2014, NAT CHEM BIOL, V10, P723, DOI [10.1038/nchembio.1584, 10.1038/NCHEMBIO.1584]; VONKIENLIN M, 1991, J MAGN RESON, V93, P423, DOI 10.1016/0022-2364(91)90020-T; Wang CK, 2015, EUR J MED CHEM, V97, P202, DOI 10.1016/j.ejmech.2015.04.049; Wang CK, 2014, P NATL ACAD SCI USA, V111, P17504, DOI 10.1073/pnas.1417611111; Waring MJ, 2010, EXPERT OPIN DRUG DIS, V5, P235, DOI 10.1517/17460441003605098; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; Zamek-Gliszczynski MJ, 2006, MOL PHARMACOL, V70, P2127, DOI 10.1124/mol.106.026955	52	105	106	1	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1065	+		10.1038/NCHEMBIO.2203	http://dx.doi.org/10.1038/NCHEMBIO.2203			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27748751				2022-12-25	WOS:000388582900016
J	Tanaka, M; Roberts, JM; Seo, HS; Souza, A; Paulk, J; Scott, TG; DeAngelo, SL; Dhe-Paganon, S; Bradner, JE				Tanaka, Minoru; Roberts, Justin M.; Seo, Hyuk-Soo; Souza, Amanda; Paulk, Joshiawa; Scott, Thomas G.; DeAngelo, Stephen L.; Dhe-Paganon, Sirano; Bradner, James E.			Design and characterization of bivalent BET inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							ELONGATION-FACTOR B; BROMODOMAIN INHIBITION; P-TEFB; TARGET; TRANSCRIPTION; BINDING; RECRUITMENT; SELECTIVITY; STRATEGY; POTENT	Cellular signaling is often propagated by multivalent interactions. Multivalency creates avidity, allowing stable biophysical recognition. Multivalency is an attractive strategy for achieving potent binding to protein targets, as the affinity of bivalent ligands is often greater than the sum of monovalent affinities. The bromodomain and extraterminal domain (BET) family of transcriptional coactivators features tandem bromodomains through which BET proteins bind acetylated histones and transcription factors. All reported antagonists of the BET protein BRD4 bind in a monovalent fashion. Here we describe, to our knowledge for the first time, a bivalent BET bromodomain inhibitor-MT1-which has unprecedented potency. Biophysical and biochemical studies suggest MT1 is an intramolecular bivalent BRD4 binder that is more than 100-fold more potent, in cellular assays, than the corresponding monovalent antagonist, JQ1. MT1 significantly (P < 0.05) delayed leukemia progression in mice, as compared to JQ1. These data qualify a powerful chemical probe for BET bromodomains and a rationale for further development of multidomain inhibitors of epigenetic reader proteins.	[Tanaka, Minoru; Roberts, Justin M.; Souza, Amanda; Paulk, Joshiawa; Scott, Thomas G.; DeAngelo, Stephen L.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Tanaka, Minoru; Bradner, James E.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Seo, Hyuk-Soo; DeAngelo, Stephen L.; Dhe-Paganon, Sirano] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Bradner, James E.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Novartis	Bradner, JE (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Bradner, JE (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Bradner, JE (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	james_bradner@dfci.harvard.edu		Scott, Thomas/0000-0003-4743-2786; DeAngelo, Stephen/0000-0002-7984-5780; Roberts, Justin/0000-0001-6112-7476	William Lawrence and Blanche Hughes Foundation; Leukemia and Lymphoma Society; US National Institutes of Health [CA066996-01A1]; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER	William Lawrence and Blanche Hughes Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J.A. Perry for critical reading of the manuscript and discussions. NMC797 cells were a gift from C. French (Brigham and Women's Hospital). Crystallographic work was based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines. We thank Mitsubishi Tanabe Pharma Corporation for nonresearch support of M.T. This research was supported by the William Lawrence and Blanche Hughes Foundation (J.E.B.), the Leukemia and Lymphoma Society (J.E.B.) and the US National Institutes of Health (CA066996-01A1, J.E.B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders L, 2014, NAT BIOTECHNOL, V32, P92, DOI 10.1038/nbt.2776; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bach A, 2009, ANGEW CHEM INT EDIT, V48, P9685, DOI 10.1002/anie.200904741; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Baud MGJ, 2014, SCIENCE, V346, P638, DOI 10.1126/science.1249830; Brumatti G, 2008, METHODS, V44, P235, DOI 10.1016/j.ymeth.2007.11.010; Chaidos A, 2014, BLOOD, V123, P697, DOI 10.1182/blood-2013-01-478420; Dahlin JL, 2015, J MED CHEM, V58, P2091, DOI 10.1021/jm5019093; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; Illendula A, 2015, SCIENCE, V347, P779, DOI 10.1126/science.aaa0314; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kiessling LL, 2000, CURR OPIN CHEM BIOL, V4, P696, DOI 10.1016/S1367-5931(00)00153-8; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKeown MR, 2014, J MED CHEM, V57, P9019, DOI 10.1021/jm501120z; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Monsigny M, 2000, Carbohydr Lett, V4, P35; Picaud S, 2013, P NATL ACAD SCI USA, V110, P19754, DOI 10.1073/pnas.1310658110; Profit AA, 1999, J AM CHEM SOC, V121, P280, DOI 10.1021/ja983515n; Roberts Justin M, 2015, Curr Protoc Chem Biol, V7, P263, DOI 10.1002/9780470559277.ch150024; Roy R. Dutta, 2015, PREPRINT; Sanchez R, 2014, BBA-GENE REGUL MECH, V1839, P676, DOI 10.1016/j.bbagrm.2014.03.011; Schroder S, 2012, J BIOL CHEM, V287, P1090, DOI 10.1074/jbc.M111.282855; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Smith SG, 2016, ACS CHEM BIOL, V11, P598, DOI 10.1021/acschembio.5b00831; Sun H., J AM CHEM SOC, V129, P15279; Tanaka M, 2015, PHARM PAT ANAL, V4, P261, DOI [10.4155/ppa.15.16, 10.4155/PPA.15.16]; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216; Zhang GT, 2012, J BIOL CHEM, V287, P28840, DOI 10.1074/jbc.M112.359505; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	45	89	92	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1089	+		10.1038/NCHEMBIO.2209	http://dx.doi.org/10.1038/NCHEMBIO.2209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27775715	Green Accepted, Green Submitted			2022-12-25	WOS:000388582900019
J	Frentzas, S; Simoneau, E; Bridgeman, VL; Vermeulen, PB; Foo, S; Kostaras, E; Nathan, MR; Wotherspoon, A; Gao, ZH; Shi, Y; Van den Eynden, G; Daley, F; Peckitt, C; Tan, X; Salman, A; Lazaris, A; Gazinska, P; Berg, TJ; Eltahir, Z; Ritsma, L; van Rheenen, J; Khashper, A; Brown, G; Nystrom, H; Sund, M; Van Laere, S; Loyer, E; Dirix, L; Cunningham, D; Metrakos, P; Reynolds, AR				Frentzas, Sophia; Simoneau, Eve; Bridgeman, Victoria L.; Vermeulen, Peter B.; Foo, Shane; Kostaras, Eleftherios; Nathan, Mark R.; Wotherspoon, Andrew; Gao, Zu-Hua; Shi, Yu; Van den Eynden, Gert; Daley, Frances; Peckitt, Clare; Tan, Xianming; Salman, Ayat; Lazaris, Anthoula; Gazinska, Patrycja; Berg, Tracy J.; Eltahir, Zak; Ritsma, Laila; van Rheenen, Jacco; Khashper, Alla; Brown, Gina; Nystrom, Hanna; Sund, Malin; Van Laere, Steven; Loyer, Evelyne; Dirix, Luc; Cunningham, David; Metrakos, Peter; Reynolds, Andrew R.			Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases	NATURE MEDICINE			English	Article							BEVACIZUMAB PLUS CAPECITABINE; PHASE-III TRIAL; ANTIANGIOGENIC THERAPY; TUMOR INVASION; EXPERT CONSENSUS; VEGF ANTIBODY; CANCER; GROWTH; PROGRESSION; CHEMOTHERAPY	The efficacy of angiogenesis inhibitors in cancer is limited by resistance mechanisms that are poorly understood. Notably, instead of through the induction of angiogenesis, tumor vascularization can occur through the nonangiogenic mechanism of vessel co-option. Here we show that vessel co-option is associated with a poor response to the anti-angiogenic agent bevacizumab in patients with colorectal cancer liver metastases. Moreover, we find that vessel co-option is also prevalent in human breast cancer liver metastases, a setting in which results with anti-angiogenic therapy have been disappointing. In preclinical mechanistic studies, we found that cancer cell motility mediated by the actin-related protein 2/3 complex (Arp2/3) is required for vessel co-option in liver metastases in vivo and that, in this setting, combined inhibition of angiogenesis and vessel co-option is more effective than the inhibition of angiogenesis alone. Vessel co-option is therefore a clinically relevant mechanism of resistance to anti-angiogenic therapy and combined inhibition of angiogenesis and vessel co-option might be a warranted therapeutic strategy.	[Frentzas, Sophia; Bridgeman, Victoria L.; Vermeulen, Peter B.; Foo, Shane; Kostaras, Eleftherios; Nathan, Mark R.; Berg, Tracy J.; Reynolds, Andrew R.] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, Tumour Biol Team, London, England; [Frentzas, Sophia; Wotherspoon, Andrew; Peckitt, Clare; Eltahir, Zak; Brown, Gina; Cunningham, David] Royal Marsden Hosp, London, England; [Simoneau, Eve; Gao, Zu-Hua; Shi, Yu; Salman, Ayat; Lazaris, Anthoula; Khashper, Alla; Metrakos, Peter] McGill Univ, Ctr Hlth, Royal Victoria Hosp Glen Site, Montreal, PQ, Canada; [Vermeulen, Peter B.; Van den Eynden, Gert; Nystrom, Hanna; Van Laere, Steven; Dirix, Luc] Gasthuiszusters Antwerpen Hosp St Augustinus, Translat Canc Res Unit, Antwerp, Belgium; [Daley, Frances] Royal Marsden Hosp, Breast Canc Now Histopathol Core Facil, London, England; [Tan, Xianming] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Gazinska, Patrycja] Kings Coll London, Sch Med, Guys Hosp, Breast Canc Now Unit, London, England; [Ritsma, Laila; van Rheenen, Jacco] Netherlands Hubrecht Inst Royal Netherlands Acad, Canc Genom Ctr, Utrecht, Netherlands; [Ritsma, Laila; van Rheenen, Jacco] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Nystrom, Hanna; Sund, Malin] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Loyer, Evelyne] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; McGill University; Royal Marsden NHS Foundation Trust; University of North Carolina; University of North Carolina Chapel Hill; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Utrecht University; Utrecht University; Utrecht University Medical Center; Umea University; University of Texas System; UTMD Anderson Cancer Center	Reynolds, AR (corresponding author), Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, Tumour Biol Team, London, England.; Cunningham, D (corresponding author), Royal Marsden Hosp, London, England.; Metrakos, P (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp Glen Site, Montreal, PQ, Canada.	David.Cunningham@rmh.nhs.uk; peter.metrakos@mcgill.ca; andrew.reynolds@icr.ac.uk	Eltahir, Zakaria/AGW-7511-2022; metrakos, peter/D-3726-2013; Ritsma, Laila/AAZ-6620-2020; Nystrom, Hanna/AAK-4743-2021; Dirix, Luc/AAI-8880-2020; Eltahir, Zakaria/AAG-9869-2020; Van Laere, Steven/GQA-8872-2022	Eltahir, Zakaria/0000-0001-6815-4100; Ritsma, Laila/0000-0002-0214-2008; Eltahir, Zakaria/0000-0001-6815-4100; Van Laere, Steven/0000-0002-2640-0040; Brown, Gina/0000-0002-2336-622X; Cunningham, David/0000-0001-5158-1069	Breakthrough Breast Cancer; NHS; Liver Disease Biobank (Montreal); De Stichting tegen Kanker (Antwerp); Breast Cancer Now; National Institute for Health Research [NF-SI-0515-10045] Funding Source: researchfish	Breakthrough Breast Cancer; NHS; Liver Disease Biobank (Montreal); De Stichting tegen Kanker (Antwerp); Breast Cancer Now; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by Breakthrough Breast Cancer (which recently merged with the Breast Cancer Campaign to form Breast Cancer Now), NHS funding to the NIHR Biomedical Research Centre at RM/ICR (London), the Liver Disease Biobank (Montreal) and De Stichting tegen Kanker (Antwerp). We thank I. Hart, K. Hodivala-Dilke, C. Isacke, R. Kerbel, A. Tutt and the members of the Liver Metastasis Research Network for their critical comments on the work. We thank Genentech for providing B20-4.1.1, S. Petrillo for assistance with the Liver Disease Biobank, J. Campbell for advice on statistical analysis and M. Balazsi for assistance with digital pathology. For their technical assistance, we thank the staff of the ICR Biological Services Unit and the staff of the Breast Cancer Now Histopathology Core Facility.	Adams RB, 2013, HPB, V15, P91, DOI 10.1111/j.1477-2574.2012.00557.x; Boonsirikamchai P, 2011, AM J ROENTGENOL, V197, pW1060, DOI 10.2214/AJR.11.6459; Brufsky AM, 2011, J CLIN ONCOL, V29, P4286, DOI 10.1200/JCO.2010.34.1255; Bugyik E, 2011, J NEUROPATH EXP NEUR, V70, P979, DOI 10.1097/NEN.0b013e318233afd7; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Chaudhury P, 2010, HPB, V12, P37, DOI 10.1111/j.1477-2574.2009.00119.x; Chun YS, 2009, JAMA-J AM MED ASSOC, V302, P2338, DOI 10.1001/jama.2009.1755; Colpaert CG, 2003, HISTOPATHOLOGY, V42, P530, DOI 10.1046/j.1365-2559.2003.01629.x; Cunningham D, 2013, LANCET ONCOL, V14, P1077, DOI 10.1016/S1470-2045(13)70154-2; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; Depner C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12329; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gray MJ, 2008, ONCOGENE, V27, P7192, DOI 10.1038/onc.2008.356; Gruenberger B, 2008, J CLIN ONCOL, V26, P1830, DOI 10.1200/JCO.2007.13.7679; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iwaya K, 2007, CANCER SCI, V98, P992, DOI 10.1111/j.1349-7006.2007.00488.x; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Jeong HS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv155; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; Kuczynski EA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw030; Kusters B, 2002, CANCER RES, V62, P341; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Naresh KN, 2001, HISTOPATHOLOGY, V38, P466, DOI 10.1046/j.1365-2559.2001.01061.x; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Nyati MK, 2002, GENE THER, V9, P844, DOI 10.1038/sj.gt.3301706; Otsubo T, 2004, MODERN PATHOL, V17, P461, DOI 10.1038/modpathol.3800062; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pezzella F, 1996, EUR J CANCER, V32A, P2494, DOI 10.1016/S0959-8049(96)00377-2; Pezzella F, 2000, LANCET, V355, P1787; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; Semelka RC, 2000, RADIOLOGY, V215, P89, DOI 10.1148/radiology.215.1.r00mr2989; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Shindoh J, 2012, J CLIN ONCOL, V30, P4566, DOI 10.1200/JCO.2012.45.2854; Stessels F, 2004, BRIT J CANCER, V90, P1429, DOI 10.1038/sj.bjc.6601727; Szabo V, 2015, J PATHOL, V235, P384, DOI 10.1002/path.4464; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Van den Eynden GG, 2013, CANCER RES, V73, P2031, DOI 10.1158/0008-5472.CAN-12-3931; Van den Eynden GG, 2012, CLIN EXP METASTAS, V29, P541, DOI 10.1007/s10585-012-9469-1; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Vermeulen PB, 2001, J PATHOL, V195, P336, DOI 10.1002/path.966; Wong R, 2011, ANN ONCOL, V22, P2042, DOI 10.1093/annonc/mdq714	53	240	245	5	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1294	1302		10.1038/nm.4197	http://dx.doi.org/10.1038/nm.4197			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27748747	Green Accepted, Green Submitted			2022-12-25	WOS:000387302300022
J	Liu, KI; Ramli, MNB; Woo, CWA; Wang, YM; Zhao, TY; Zhang, XJ; Yim, GRD; Chong, BY; Gowher, A; Chua, MZH; Jung, J; Lee, JHJ; Tan, MH				Liu, Kaiwen Ivy; Ramli, Muhammad Nadzim Bin; Woo, Cheok Wei Ariel; Wang, Yuanming; Zhao, Tianyun; Zhang, Xiujun; Yim, Guo Rong Daniel; Chong, Bao Yi; Gowher, Ali; Chua, Mervyn Zi Hao; Jung, Jonathan; Lee, Jia Hui Jane; Tan, Meng How			A chemical-inducible CRISPR-Cas9 system for rapid control of genome editing	NATURE CHEMICAL BIOLOGY			English	Article							OFF-TARGET CLEAVAGE; HUMAN-CELLS; CAS9 PROTEIN; NUCLEASES; TRANSCRIPTION; SPECIFICITY; DELIVERY	Cas9 has emerged as a powerful technology that enables ready modification of the mammalian genome. The ability to modulate Cas9 activity can reduce off-target cleavage and facilitate precise genome engineering. Here we report the development of a Cas9 variant whose activity can be switched on and off in human cells with 4-hydroxytamoxifen (4-HT) by fusing the Cas9 enzyme with the hormone-binding domain of the estrogen receptor (ERT2). The final optimized variant, termed iCas, showed low endonuclease activity without 4-HT but high editing efficiency at multiple loci with the chemical. We also tuned the duration and concentration of 4-HT treatment to reduce off-target genome modification. Additionally, we benchmarked iCas against other chemical-inducible methods and found that it had the fastest on rate and that its activity could be toggled on and off repeatedly. Collectively, these results highlight the utility of iCas for rapid and reversible control of genome-editing function.	[Liu, Kaiwen Ivy; Ramli, Muhammad Nadzim Bin; Woo, Cheok Wei Ariel; Wang, Yuanming; Zhao, Tianyun; Zhang, Xiujun; Yim, Guo Rong Daniel; Chong, Bao Yi; Gowher, Ali; Chua, Mervyn Zi Hao; Jung, Jonathan; Lee, Jia Hui Jane; Tan, Meng How] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Wang, Yuanming; Zhang, Xiujun; Tan, Meng How] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore; [Chong, Bao Yi] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Chua, Mervyn Zi Hao] Ngee Ann Polytech, Sch Life Sci & Chem Technol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, MH (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore.; Tan, MH (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore.	mh.tan@ntu.edu.sg	Tan, Meng How/M-8605-2015; liu, kaiwen/GVS-5259-2022; Zhang, Xiujun/P-5253-2015; Yim, Daniel/J-8834-2013	Tan, Meng How/0000-0003-3627-5586; Woo, Ariel/0000-0002-6765-6632; Yim, Daniel/0000-0001-6153-4725; Zhang, Xiujun/0000-0001-8041-0592	Genome Institute of Singapore; Agency for Science Technology and Research Joint Council Office grant [1431AFG103]; Nanyang Technological University	Genome Institute of Singapore; Agency for Science Technology and Research Joint Council Office grant; Nanyang Technological University(Nanyang Technological University)	We thank R. Dasgupta for helpful discussions, Y. Wan for critical reading of the manuscript, and H.H. Ng (Genome Institute of Singapore), R. Dasgupta (Genome Institute of Singapore), and B. Lim (Genome Institute of Singapore) for reagents. STF3A cells were a gift from D. Virshup (Duke-National University of Singapore Graduate Medical School). This work was supported by core funding from the Genome Institute of Singapore (M.H.T.), an Agency for Science Technology and Research Joint Council Office grant 1431AFG103 (M.H.T.), and a startup grant from Nanyang Technological University (M.H.T.).	Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Inlay MA, 2013, CHEM COMMUN, V49, P4971, DOI 10.1039/c3cc42179a; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McCulloch MWB, 2009, BIOORGAN MED CHEM, V17, P2189, DOI 10.1016/j.bmc.2008.10.077; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Shen ZF, 2014, DEV CELL, V30, P625, DOI 10.1016/j.devcel.2014.07.017; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	35	122	199	4	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					980	+		10.1038/nchembio.2179	http://dx.doi.org/10.1038/nchembio.2179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27618190				2022-12-25	WOS:000386798800021
J	O'Donovan, MC; Owen, MJ				O'Donovan, Michael C.; Owen, Michael J.			The implications of the shared genetics of psychiatric disorders	NATURE MEDICINE			English	Article							COPY NUMBER VARIANTS; GLOBAL BURDEN; SCHIZOPHRENIA; DISEASE; RISK; LOCI; PSYCHOPATHOLOGY; CHALLENGES; PLEIOTROPY; MUTATIONS	Recent genomic studies have revealed the highly polygenic nature of psychiatric disorders, including schizophrenia, bipolar disorder and major depressive disorder. Many of the individual genetic associations are shared across multiple disorders in a way that points to extensive biological pleiotropy and further challenges the biological validity of existing diagnostic approaches. Here we argue that the existence of risk alleles specific to a single diagnostic category is unlikely. We also highlight some of the important clinical repercussions of pleiotropy.	[O'Donovan, Michael C.; Owen, Michael J.] Cardiff Univ, Sch Med, Div Psychiat & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales	Cardiff University	O'Donovan, MC (corresponding author), Cardiff Univ, Sch Med, Div Psychiat & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales.	odonovanmc@cardiff.ac.uk	O'Donovan, Michael C/P-7005-2018	O'Donovan, Michael C/0000-0001-7073-2379	Medical Research Council (MRC) [MR/L010305/1, G0800509]; Medical Research Council [MR/L010305/1, G0800509] Funding Source: researchfish; MRC [G0800509] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Medical Research Council (MRC) Centre grant MR/L010305/1 and program grant G0800509.	Antilla V., 2016, PREPRINT; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Consortium Cross-Disorder Group of the Psychiatric Genomics Consortium, 2012, NAT GENET, V45, P984; Costain G, 2013, HUM MOL GENET, V22, P4485, DOI 10.1093/hmg/ddt297; Cuthbert BN, 2014, WORLD PSYCHIATRY, V13, P28, DOI 10.1002/wps.20087; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Flint J, 2014, TRENDS NEUROSCI, V37, P733, DOI 10.1016/j.tins.2014.08.007; Franke B, 2016, NAT NEUROSCI, V19, P420, DOI 10.1038/nn.4228; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Gershon ES, 2013, AM J PSYCHIAT, V170, P968, DOI 10.1176/appi.ajp.2013.12121558; Green EK, 2016, MOL PSYCHIATR, V21, P89, DOI 10.1038/mp.2014.174; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Hamshere ML, 2013, BRIT J PSYCHIAT, V203, P107, DOI 10.1192/bjp.bp.112.117432; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kirov G, 2014, BIOL PSYCHIAT, V75, P378, DOI 10.1016/j.biopsych.2013.07.022; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Linden DEJ, 2012, NEURON, V73, P8, DOI 10.1016/j.neuron.2011.12.014; Malaspina D, 2013, SCHIZOPHR RES, V150, P21, DOI 10.1016/j.schres.2013.04.026; Niarchou M, 2014, BRIT J PSYCHIAT, V204, P46, DOI 10.1192/bjp.bp.113.132324; Owen MJ, 2014, NEURON, V84, P564, DOI 10.1016/j.neuron.2014.10.028; Paaby AB, 2013, TRENDS GENET, V29, P66, DOI 10.1016/j.tig.2012.10.010; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rees E, 2014, MOL PSYCHIATR, V19, P37, DOI 10.1038/mp.2013.156; Rees E, 2016, JAMA PSYCHIAT, V73, P963, DOI 10.1001/jamapsychiatry.2016.1831; Rees E, 2014, BRIT J PSYCHIAT, V204, P108, DOI 10.1192/bjp.bp.113.131052; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ruderfer DM, 2011, MOL PSYCHIATR, V16, P887, DOI 10.1038/mp.2011.34; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Singh T, 2016, NAT NEUROSCI, V19, P571, DOI 10.1038/nn.4267; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Tansey KE, 2016, MOL PSYCHIATR, V21, P1085, DOI 10.1038/mp.2015.143; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Walters JTR, 2007, MOL PSYCHIATR, V12, P886, DOI 10.1038/sj.mp.4002068; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	44	86	87	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1214	1219		10.1038/nm.4196	http://dx.doi.org/10.1038/nm.4196			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27783064	Green Accepted			2022-12-25	WOS:000387302300012
J	Zhao, XH; Kotilinek, LA; Smith, B; Hlynialuk, C; Zahs, K; Ramsden, M; Cleary, J; Ashe, KH				Zhao, Xiaohui; Kotilinek, Linda A.; Smith, Benjamin; Hlynialuk, Chris; Zahs, Kathleen; Ramsden, Martin; Cleary, James; Ashe, Karen H.			Caspase-2 cleavage of tau reversibly impairs memory	NATURE MEDICINE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; SILENT SYNAPSES; IN-VIVO; NEURODEGENERATION; ACTIVATION; APOPTOSIS; TAUOPATHY; PATHOLOGY; TANGLES	In Alzheimer's disease (AD) and other tauopathies, the tau protein forms fibrils, which are believed to be neurotoxic. However, fibrillar tau has been dissociated from neuron death and network dysfunction, suggesting the involvement of nonfibrillar species. Here we describe a novel pathological process in which caspase-2 cleavage of tau at Asp314 impairs cognitive and synaptic function in animal and cellular models of tauopathies by promoting the missorting of tau to dendritic spines. The truncation product, Delta tau314, resists fibrillation and is present at higher levels in brains from cognitively impaired mice and humans with AD. The expression of tau mutants that resisted caspase-2 cleavage prevented tau from infiltrating spines, dislocating glutamate receptors and impairing synaptic function in cultured neurons, and it prevented memory deficits and neurodegeneration in mice. Decreasing the levels of caspase-2 restored long-term memory in mice that had existing deficits. Our results suggest an overall treatment strategy for re-establishing synaptic function and restoring memory in patients with AD by preventing tau from accumulating in dendritic spines.	[Zhao, Xiaohui; Kotilinek, Linda A.; Smith, Benjamin; Hlynialuk, Chris; Zahs, Kathleen; Ramsden, Martin; Cleary, James; Ashe, Karen H.] Univ Minnesota, N Bud Grossman Ctr Memory Res & Care, Minneapolis, MN 55455 USA; [Zhao, Xiaohui; Kotilinek, Linda A.; Smith, Benjamin; Hlynialuk, Chris; Zahs, Kathleen; Ramsden, Martin; Cleary, James; Ashe, Karen H.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Zhao, Xiaohui; Kotilinek, Linda A.; Smith, Benjamin; Hlynialuk, Chris; Zahs, Kathleen; Ramsden, Martin; Cleary, James; Ashe, Karen H.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Cleary, James; Ashe, Karen H.] Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Minneapolis, MN 55417 USA; [Ramsden, Martin] R&D Syst, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Ashe, KH (corresponding author), Univ Minnesota, N Bud Grossman Ctr Memory Res & Care, Minneapolis, MN 55455 USA.; Ashe, KH (corresponding author), Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA.; Ashe, KH (corresponding author), Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA.; Ashe, KH (corresponding author), Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Minneapolis, MN 55417 USA.	hsiao005@umn.edu	Zhao, Xiaohui/G-7626-2012		US National Institutes of Health (NIH) (EUREKA) [R01-NS63214, R01-NS79374]; T. and P. Grossman Family Foundation; Rush Alzheimer's Disease Center [R01-AG17917]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079374, R01NS063214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017917] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) (EUREKA); T. and P. Grossman Family Foundation; Rush Alzheimer's Disease Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Sources of funding for this study include the US National Institutes of Health (NIH) (EUREKA grant no. R01-NS63214 (K.H.A.) and R01-NS79374 (K.H.A.)), the T. and P. Grossman Family Foundation (K.H.A.), B. Grossman (K.H.A.) and K. Moe (K.H.A.). We thank P. Davies (Albert Einstein College of Medicine) for the antibodies Alz-50, MC-1 and CP-13, as well as B. Roth (University of North Carolina at Chapel Hill) for the pAAV-CaMKIIa-EGFP vector. We are grateful to the participants of the Memory and Aging Project, as well as the staff and director (D. Bennett) of the Rush Alzheimer's Disease Center (grant no. R01-AG17917 (D. Bennett)). We thank L. Kemper, K. Leinonen and E. Steuer for excellent assistance with mouse breeding, genotyping and behavioral tests, M. Kuskowski for help with statistical analyses, and C. Wilmot, D. Liao, M. Koob and M. Walters for valuable advice and encouragement.	Abraha A, 2000, J CELL SCI, V113, P3737; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Carroll JB, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-59; Cotman CW, 2005, J NEUROPATH EXP NEUR, V64, P104, DOI 10.1093/jnen/64.2.104; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Fasulo L, 2000, J NEUROCHEM, V75, P624, DOI 10.1046/j.1471-4159.2000.0750624.x; Fath T, 2002, J NEUROSCI, V22, P9733; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; GomezIsla T, 1996, ANN NEUROL, V39, P62, DOI 10.1002/ana.410390110; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kopeikina KJ, 2013, J COMP NEUROL, V521, P1334, DOI 10.1002/cne.23234; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Lee Sangmook, 2012, Int J Alzheimers Dis, V2012, P731063, DOI 10.1155/2012/731063; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; lttner L. M., 2010, CELL, V142, P387; Menkes-Caspi N, 2015, NEURON, V85, P959, DOI 10.1016/j.neuron.2015.01.025; Miller EC, 2014, EUR J NEUROSCI, V39, P1214, DOI 10.1111/ejn.12507; Pozueta J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2927; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Rocher AB, 2010, EXP NEUROL, V223, P385, DOI 10.1016/j.expneurol.2009.07.029; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shalini S, 2015, ONCOGENE, V34, P4995, DOI 10.1038/onc.2014.413; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Tiwari M, 2014, AUTOPHAGY, V10, P1054, DOI 10.4161/auto.28528; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700	37	106	113	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1268	1276		10.1038/nm.4199	http://dx.doi.org/10.1038/nm.4199			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27723722				2022-12-25	WOS:000387302300019
J	Corces, MR; Buenrostro, JD; Wu, BJ; Greenside, PG; Chan, SM; Koenig, JL; Snyder, MP; Pritchard, JK; Kundaje, A; Gkeenleaf, WJ; Majeti, R; Chang, HY				Corces, M. Ryan; Buenrostro, Jason D.; Wu, Beijing; Greenside, Peyton G.; Chan, Steven M.; Koenig, Julie L.; Snyder, Michael P.; Pritchard, Jonathan K.; Kundaje, Anshul; Gkeenleaf, William J.; Majeti, Ravindra; Chang, Howard Y.			Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; EPIGENETIC REGULATORS; TRANSCRIPTION FACTORS; CLONAL HEMATOPOIESIS; DNA-BINDING; STEM-CELLS; EXPRESSION; MICE; IDENTIFICATION; COMMITMENT	We define the chromatin accessibility and transcriptional landscapes in 13 human primary blood cell types that span the hematopoietic hierarchy. Exploiting the finding that the enhancer landscape better reflects cell identity than mRNA levels, we enable 'enhancer cytometry' for enumeration of pure cell types from complex populations. We identify regulators governing hematopoietic differentiation and further show the lineage ontogeny of genetic elements linked to diverse human diseases. In acute myeloid leukemia (AML), chromatin accessibility uncovers unique regulatory evolution in cancer cells with a progressively increasing mutation burden. Single AML cells exhibit distinctive mixed regulome profiles corresponding to disparate developmental stages. A method to account for this regulatory heterogeneity identified cancer-specific deviations and implicated HOX factors as key regulators of preleukemic hematopoietic stem cell characteristics. Thus, regulome dynamics can provide diverse insights into hematopoietic development and disease.	[Corces, M. Ryan; Koenig, Julie L.; Majeti, Ravindra] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Corces, M. Ryan; Koenig, Julie L.; Majeti, Ravindra] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Corces, M. Ryan; Buenrostro, Jason D.; Snyder, Michael P.; Gkeenleaf, William J.; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Buenrostro, Jason D.; Wu, Beijing; Greenside, Peyton G.; Snyder, Michael P.; Pritchard, Jonathan K.; Kundaje, Anshul; Gkeenleaf, William J.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Buenrostro, Jason D.] Harvard Univ, Broad Inst MIT & Harvard, Cambridge, MA 02138 USA; [Greenside, Peyton G.] Stanford Univ, Sch Med, Program Biomed Informat, Stanford, CA 94305 USA; [Chan, Steven M.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Stanford University; Howard Hughes Medical Institute; Stanford University	Majeti, R (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Majeti, R (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA.; Chang, HY (corresponding author), Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.	rmajeti@stanford.edu; howchang@stanford.edu	Corces, M. Ryan/ABG-6947-2020; Kundaje, Anshul/Y-2739-2019; wang, edwin/G-5372-2010; Kundaje, Anshul/Y-2598-2019	Corces, M. Ryan/0000-0001-7465-7652; Kundaje, Anshul/0000-0003-3084-2287; Kundaje, Anshul/0000-0003-3084-2287; Majeti, Ravindra/0000-0002-5814-0984; Snyder, Michael/0000-0003-0784-7987	NIH [R25CA180993, T32HG000044, P50HG007735, R01CA18805]; NIH F31 Predoctoral fellowship [F31CA180659]; National Science Foundation; NHGRI [5U54HG00455805]; Stanford Cancer Center; Howard Hughes Medical Institute; Stinehart-Reed Foundation; Ludwig Institute;  [UH2AR067676]; NATIONAL CANCER INSTITUTE [R01CA188055, R25CA180993, F31CA180659, P30CA124435] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH F31 Predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Stanford Cancer Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stinehart-Reed Foundation; Ludwig Institute; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank C. Mazumdar and A. Raj for assistance with RNA-seq, A. Newman for expert assistance with CIBERSORT, and our laboratory members for discussion. We thank the Stanford Hematology Division Tissue Bank and the patients for donating their samples. M.R.C. acknowledges NIH training grant R25CA180993 and NIH F31 Predoctoral fellowship F31CA180659. J.D.B. acknowledges National Science Foundation Graduate Research Fellowships and NIH training grant T32HG000044 for support. M.P.S. acknowledges the NIH and NHGRI for funding through 5U54HG00455805. Research was also supported by the NIH (P50HG007735 to H.Y.C., WJ.G., and M.P.S.), UH2AR067676 (H.Y.C.), the Stanford Cancer Center (H.Y.C.), the Howard Hughes Medical Institute (H.Y.C. and J.K.P.), the Stinehart-Reed Foundation (R.M.), the Ludwig Institute (R.M.), and the NIH (R01CA18805 to R.M.). R.M. is a New York Stem Cell Foundation Robertson Investigator.	BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cauchy P, 2015, CELL REP, V12, P821, DOI 10.1016/j.celrep.2015.06.069; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gonzalez AJ, 2015, NAT GENET, V47, P1249, DOI 10.1038/ng.3402; Hartman AD, 2006, EXP HEMATOL, V34, P1360, DOI 10.1016/j.exphem.2006.05.019; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; MACEDO A, 1995, ANN HEMATOL, V70, P189; Magnusson M, 2007, EXP HEMATOL, V35, P1421, DOI 10.1016/j.exphem.2007.05.011; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Manning C.D., 2008, INTRO INFORM RETRIEV; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; QUESENBERRY PJ, 2005, WILLIAMS HEMATOLOGY, P153; Rangatia J, 2003, ONCOGENE, V22, P4760, DOI 10.1038/sj.onc.1206664; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Tiacci E, 2004, CANCER RES, V64, P7399, DOI 10.1158/0008-5472.CAN-04-1865; VANTVEER MB, 1992, ANN HEMATOL, V64, P161, DOI 10.1007/BF01696217; Volk A, 2014, J EXP MED, V211, P1093, DOI 10.1084/jem.20130990; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Whitaker JW, 2015, NAT METHODS, V12, P265, DOI [10.1038/NMETH.3065, 10.1038/nmeth.3065]	45	536	540	9	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1193	1203		10.1038/ng.3646	http://dx.doi.org/10.1038/ng.3646			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27526324	Green Accepted			2022-12-25	WOS:000384391600014
J	Ortuno, MJ; Robinson, ST; Subramanyam, P; Paone, R; Huang, YY; Guo, XE; Colecraft, HM; Mann, JJ; Ducy, P				Ortuno, Maria Jose; Robinson, Samuel T.; Subramanyam, Prakash; Paone, Riccardo; Huang, Yung-yu; Guo, X. Edward; Colecraft, Henry M.; Mann, J. John; Ducy, Patricia			Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect	NATURE MEDICINE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; OSTEOCLAST DIFFERENTIATION; RHEUMATOID-ARTHRITIS; LEPTIN REGULATION; RAT MODEL; FLUOXETINE; TRANSPORTER; 5-HYDROXYTRYPTAMINE; ANTAGONISTS; RECEPTORS	The use of selective serotonin-reuptake inhibitors (SSRIs) has been associated with an increased risk of bone fracture, raising concerns about their increasingly broader usage. This deleterious effect is poorly understood, and thus strategies to avoid this side effect remain elusive. We show here that fluoxetine (Flx), one of the most-prescribed SSRIs, acts on bone remodeling through two distinct mechanisms. Peripherally, Flx has anti-resorptive properties, directly impairing osteoclast differentiation and function through a serotonin-reuptake-independent mechanism that is dependent on intracellular Ca2+ levels and the transcription factor Nfatc1. With time, however, Flx also triggers a brain-serotonin-dependent rise in sympathetic output that increases bone resorption sufficiently to counteract its local anti-resorptive effect, thus leading to a net effect of impaired bone formation and bone loss. Accordingly, neutralizing this second mode of action through co-treatment with the beta-blocker propranolol, while leaving the peripheral effect intact, prevents Flx-induced bone loss in mice. Hence, this study identifies a dual mode of action of SSRIs on bone remodeling and suggests a therapeutic strategy to block the deleterious effect on bone homeostasis from their chronic use.	[Ortuno, Maria Jose; Paone, Riccardo] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY USA; [Robinson, Samuel T.; Guo, X. Edward] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Subramanyam, Prakash; Colecraft, Henry M.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Paone, Riccardo] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy; [Huang, Yung-yu; Mann, J. John] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Ducy, Patricia] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; University of L'Aquila; Columbia University; Columbia University	Ducy, P (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA.	pd2193@cumc.columbia.edu		Robinson, Samuel/0000-0003-2356-9905; Ortuno Romero, Maria Jose/0000-0002-0200-9952; Paone, Riccardo/0000-0002-8688-9191	US National Institutes of Health [AG032959]; NATIONAL INSTITUTE ON AGING [P01AG032959] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Luo for help with histomorphometry, T. Hanna for handling the mouse colony, and G. Karsenty and S. Kousteni for critically reading the manuscript. The US National Institutes of Health grant AG032959 (P.D.) supported this work.	Aydin H, 2011, J PSYCHIATR RES, V45, P1316, DOI 10.1016/j.jpsychires.2011.04.005; Baharav E, 2012, NEUROIMMUNOMODULAT, V19, P309, DOI 10.1159/000339109; Battaglino R, 2004, J BONE MINER RES, V19, P1420, DOI 10.1359/JBMR.040606; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Blardi P, 2005, NEUROPSYCHOBIOLOGY, V51, P72, DOI 10.1159/000084163; Bliziotes M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P291; Bolo NR, 2000, NEUROPSYCHOPHARMACOL, V23, P428, DOI 10.1016/S0893-133X(00)00116-0; Bonnet N, 2007, TOXICOL APPL PHARM, V221, P111, DOI 10.1016/j.taap.2007.02.005; Boyce BF, 2013, J DENT RES, V92, P860, DOI 10.1177/0022034513500306; Branco-de-Almeida LS, 2012, J PERIODONTOL, V83, P664, DOI 10.1902/jop.2011.110370; Bristow LJ, 2000, NEUROPHARMACOLOGY, V39, P1222, DOI 10.1016/S0028-3908(99)00191-4; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Chen W, 2013, P NATL ACAD SCI USA, V110, P7294, DOI 10.1073/pnas.1211383110; Deak F, 2000, NEUROPHARMACOLOGY, V39, P1029, DOI 10.1016/S0028-3908(99)00206-3; Diem SJ, 2014, J CLIN ENDOCR METAB, V99, pE1732, DOI 10.1210/jc.2014-2288; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fox MA, 2007, PSYCHOPHARMACOLOGY, V195, P147, DOI 10.1007/s00213-007-0910-0; Fukunaga T, 2014, J BIOL CHEM, V289, P13554, DOI 10.1074/jbc.M114.550731; FULLER RW, 1990, ANN N Y ACAD SCI, V600, P68; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gebara MA, 2014, J AM GERIATR SOC, V62, P1434, DOI 10.1111/jgs.12945; Gobin V, 2015, CELL CALCIUM, V58, P254, DOI 10.1016/j.ceca.2015.06.003; Hahn SJ, 1999, EUR J PHARMACOL, V367, P113, DOI 10.1016/S0014-2999(98)00955-8; Haney EM, 2010, BONE, V46, P13, DOI 10.1016/j.bone.2009.07.083; HIDAKA H, 1981, MOL PHARMACOL, V20, P571; Hochberg MC, 2012, J RHEUMATOL, V39, P352, DOI 10.3899/jrheum.110307; Hodge JM, 2013, BIOL PSYCHIAT, V74, P32, DOI 10.1016/j.biopsych.2012.11.003; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kecskemeti V, 2005, BRAIN RES BULL, V67, P126, DOI 10.1016/j.brainresbull.2005.06.027; KENNETT GA, 1994, NEUROPHARMACOLOGY, V33, P1581, DOI 10.1016/0028-3908(94)90133-3; Kim HJ, 2013, BRAIN RES, V1490, P23, DOI 10.1016/j.brainres.2012.10.062; Kubera M, 2000, NEUROPSYCHOPHARMACOL, V23, P89, DOI 10.1016/S0893-133X(99)00150-5; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Misra M, 2010, CNS SPECTRUMS, V15, P579, DOI 10.1017/S1092852900000559; Mojtabai R, 2011, HEALTH AFFAIR, V30, P1434, DOI 10.1377/hlthaff.2010.1024; Okamoto K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3323; Orleans RJ, 2014, NEW ENGL J MED, V370, P1777, DOI 10.1056/NEJMp1402080; Oury F, 2010, GENE DEV, V24, P2330, DOI 10.1101/gad.1977210; Pellegrino TC, 1998, PHARMACOL BIOCHEM BE, V59, P151, DOI 10.1016/S0091-3057(97)00382-1; Rizzoli R, 2012, BONE, V51, P606, DOI 10.1016/j.bone.2012.05.018; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sacre S, 2010, ARTHRITIS RHEUM-US, V62, P683, DOI 10.1002/art.27304; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Schett G, 2009, J BONE MINER RES, V24, P1142, DOI 10.1359/jbmr.090533; Seifert CF, 2013, CLIN THER, V35, P1412, DOI 10.1016/j.clinthera.2013.07.423; Shenoy AR, 2013, J NEUROIMMUNOL, V262, P46, DOI 10.1016/j.jneuroim.2013.06.006; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Warden SJ, 2008, MENOPAUSE, V15, P1176, DOI 10.1097/gme.0b013e318173566b; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Wu Q, 2009, OSTEOPOROSIS INT, V20, P1309, DOI 10.1007/s00198-009-0918-x; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yamauchi M, 2004, PHARMACOL BIOCHEM BE, V78, P683, DOI 10.1016/j.pbb.2004.05.003; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12	59	57	59	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1170	1179		10.1038/nm.4166	http://dx.doi.org/10.1038/nm.4166			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27595322	Green Accepted			2022-12-25	WOS:000384872500020
J	Secrier, M; Li, XD; de Silva, N; Eldridge, MD; Contino, G; Bornschein, J; MacRae, S; Grehan, N; O'Donovan, M; Miremadi, A; Yang, TP; Bower, L; Chettouh, H; Crawte, J; Galeano-Dalmau, N; Grabowska, A; Saunders, J; Underwood, T; Waddell, N; Barbour, AP; Nutzinger, B; Achilleos, A; Edwards, PAW; Lynch, AG; Tavare, S; Fitzgerald, RC				Secrier, Maria; Li, Xiaodun; de Silva, Nadeera; Eldridge, Matthew D.; Contino, Gianmarco; Bornschein, Jan; MacRae, Shona; Grehan, Nicola; O'Donovan, Maria; Miremadi, Ahmad; Yang, Tsun-Po; Bower, Lawrence; Chettouh, Hamza; Crawte, Jason; Galeano-Dalmau, Nuria; Grabowska, Anna; Saunders, John; Underwood, Tim; Waddell, Nicola; Barbour, Andrew P.; Nutzinger, Barbara; Achilleos, Achilleas; Edwards, Paul A. W.; Lynch, Andy G.; Tavare, Simon; Fitzgerald, Rebecca C.		OCCAMS Consortium	Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance	NATURE GENETICS			English	Article							ADAPTIVE IMMUNE RESISTANCE; RANDOMIZED PHASE-2 TRIAL; DNA-DAMAGE CHECKPOINT; OVARIAN-CANCER; GASTROESOPHAGEAL CANCER; PANCREATIC-CANCER; PARP INHIBITORS; CTLA-4 BLOCKADE; PD-1 BLOCKADE; MUTANT-CELLS	Esophageal adenocarcinoma (EAC) has a poor outcome, and targeted therapy trials have thus far been disappointing owing to a lack of robust stratification methods. Whole-genome sequencing (WGS) analysis of 129 cases demonstrated that this is a heterogeneous cancer dominated by copy number alterations with frequent large-scale rearrangements. Co-amplification of receptor tyrosine kinases (RTKs) and/or downstream mitogenic activation is almost ubiquitous; thus tailored combination RTK inhibitor (RTKi) therapy might be required, as we demonstrate in vitro. However, mutational signatures showed three distinct molecular subtypes with potential therapeutic relevance, which we verified in an independent cohort (n = 87): (i) enrichment for BRCA signature with prevalent defects in the homologous recombination pathway; (ii) dominant T>G mutational pattern associated with a high mutational load and neoantigen burden; and (iii) C>A/T mutational pattern with evidence of an aging imprint. These subtypes could be ascertained using a clinically applicable sequencing strategy (low coverage) as a basis for therapy selection.	[Secrier, Maria; Eldridge, Matthew D.; Bower, Lawrence; Achilleos, Achilleas; Lynch, Andy G.; Tavare, Simon] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Li, Xiaodun; de Silva, Nadeera; Contino, Gianmarco; Bornschein, Jan; MacRae, Shona; Grehan, Nicola; O'Donovan, Maria; Miremadi, Ahmad; Yang, Tsun-Po; Chettouh, Hamza; Crawte, Jason; Galeano-Dalmau, Nuria; Nutzinger, Barbara; Fitzgerald, Rebecca C.] Univ Cambridge, MRC, Canc Unit, Hutchison Med Res Council,Res Ctr, Cambridge, England; [O'Donovan, Maria; Miremadi, Ahmad] Cambridge Univ Hosp NHS Trust, Dept Histopathol, Cambridge, England; [Grabowska, Anna] Univ Nottingham, Queens Med Ctr, Nottingham, England; [Saunders, John] Nottingham Univ Hosp NHS Trust, Dept Oesophagogastr Surg, Nottingham, England; [Underwood, Tim] Univ Southampton, Canc Sci Div, Southampton, Hants, England; [Underwood, Tim] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Waddell, Nicola] QIMR Berghofer, Dept Genet & Computat Biol, Herston, Qld, Australia; [Barbour, Andrew P.] Univ Queensland, Translat Res Inst, Princess Alexandra Hosp, Surg Oncol Grp,Sch Med, Brisbane, Qld, Australia; [Barbour, Andrew P.] Univ Queensland, Princess Alexandra Hosp, Sch Med, Dept Surg, Brisbane, Qld, Australia; [Edwards, Paul A. W.] Univ Cambridge, Dept Pathol, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Nottingham; Nottingham University Hospital NHS Trust; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; University of Cambridge	Fitzgerald, RC (corresponding author), Univ Cambridge, MRC, Canc Unit, Hutchison Med Res Council,Res Ctr, Cambridge, England.	rcf29@mrc-cu.cam.ac.uk	Edwards, Paul A/M-8291-2014; Grabowska, Anna/D-2931-2012; Bornschein, Jan/U-9402-2018; Waddell, Nicola/H-4929-2015; Grimmond, Sean/K-3246-2019; Lovat, Laurence/C-1986-2009	Edwards, Paul A/0000-0002-4789-3374; Grabowska, Anna/0000-0003-1507-921X; Bornschein, Jan/0000-0001-8673-3122; Waddell, Nicola/0000-0002-3950-2476; Grimmond, Sean/0000-0002-8102-7998; Barbour, Andrew/0000-0002-0991-7662; Fitzgerald, Rebecca/0000-0002-3434-3568; Lynch, Andy/0000-0002-7876-7338; Davies, Jim/0000-0003-4664-6862; Lovat, Laurence/0000-0003-4542-3915; Yang, Tsun-Po/0000-0002-9077-4434; Contino, Gianmarco/0000-0001-5874-0405; Ang, Yeng/0000-0003-0496-6710; Chang, Fuju/0000-0003-0973-6949; Crichton, Charles/0000-0002-9171-1427; Li, Xiaodun/0000-0002-5859-9429; Underwood, Tim/0000-0001-9455-2188; Abdullahi, Zarah/0000-0002-7077-2781; Pearson, John/0000-0003-0904-4598; Secrier, Maria/0000-0003-2758-1741; Hupp, Ted/0000-0003-0391-0352; Old, Oliver/0000-0002-1547-0502; Eldridge, Matthew/0000-0002-5799-8911; Zylstra, Janine/0000-0002-9839-7629; Turkington, Richard/0000-0003-3164-1890; KUMAR, BHASKAR/0000-0001-5705-1384	Cancer Research UK [RG66287, RG81771, RG84119, C14303/A17197]; Addenbrooke's Hospital; UCL; NIHR Professorship [RG67258]; Medical Research Council [RG84369]; Experimental Cancer Medicine Centre [RG62923]; University of Cambridge; Hutchison Whampoa Limited; Department of Health's NIHR Biomedical Research Centres; CRUK UCL Early Cancer Medicine Centre; Cancer Research UK [22310, 19556, 15874] Funding Source: researchfish; Medical Research Council [G1002565] Funding Source: researchfish; Versus Arthritis [20406] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Addenbrooke's Hospital; UCL; NIHR Professorship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Experimental Cancer Medicine Centre; University of Cambridge(University of Cambridge); Hutchison Whampoa Limited; Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); CRUK UCL Early Cancer Medicine Centre; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	Whole-genome sequencing of esophageal adenocarcinoma samples was carried out in concert with the International Cancer Genome Consortium (ICGC) through the OCCAMS Consortium and was funded by program grants from Cancer Research UK (RG66287, RG81771, RG84119). We thank the ICGC members for their input on verification standards as part of the benchmarking exercise. We thank the Human Research Tissue Bank, which is supported by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre, from Addenbrooke's Hospital and UCL. We also thank the University Hospital of Southampton Trust; the Southampton, Birmingham, Edinburgh and UCL Experimental Cancer Medicine Centres; and the QEHB charities. R.C.F. is funded by an NIHR Professorship (RG67258) and receives core funding from the Medical Research Council (RG84369) and infrastructure support from the Biomedical Research Centre (RG64237) and the Experimental Cancer Medicine Centre (RG62923). We acknowledge the support of the University of Cambridge, Cancer Research UK (C14303/A17197) and Hutchison Whampoa Limited. We thank P. Van Loo for providing the NGS version of ASCAT for copy number calling. We are grateful to all the patients who provided written consent for participation in this study and to the staff at all participating centres.; Some of the work was undertaken at UCLH/UCL, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The views expressed in this publication are those of the authors and are not necessarily those of the Department of Health. The work at UCLH/UCL was also supported by the CRUK UCL Early Cancer Medicine Centre.	Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alexandrov LB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9683; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Bang YJ, 2010, LANCET, V376, P1302; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Benafif S, 2015, ONCOTARGETS THER, V8, P519, DOI 10.2147/OTT.S30793; Bridges KA, 2011, CLIN CANCER RES, V17, P5638, DOI 10.1158/1078-0432.CCR-11-0650; Brooks K, 2013, ONCOGENE, V32, P788, DOI 10.1038/onc.2012.72; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Chantrill LA, 2015, CLIN CANCER RES, V21, P2029, DOI 10.1158/1078-0432.CCR-15-0426; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Cunningham D, 2010, NEW ENGL J MED, V362, P858, DOI 10.1056/NEJMc0911925; Demel HR, 2015, AM J CANCER RES, V5, P1649; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Gehring JS, 2015, BIOINFORMATICS, V31, P3673, DOI 10.1093/bioinformatics/btv408; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kelly RJ, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.4031; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMc1509660, 10.1056/NEJMoa1504030]; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Liu DSH, 2015, GUT, V64, P1506, DOI 10.1136/gutjnl-2015-309770; Liu QH, 2000, GENE DEV, V14, P1448; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nakamura H, 2015, NAT GENET, V47, P1003, DOI 10.1038/ng.3375; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Oza AM, 2015, LANCET ONCOL, V16, P87, DOI 10.1016/S1470-2045(14)71135-0; Paterson AL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1685-z; Paterson AL, 2013, J PATHOL, V230, P118, DOI 10.1002/path.4044; Pearl LH, 2015, NAT REV CANCER, V15, P166, DOI 10.1038/nrc3891; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shen JF, 2015, CANCER DISCOV, V5, P752, DOI 10.1158/2159-8290.CD-14-0849; Shiraishi Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005657; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Stewart A, 2015, ANN ONCOL, V26, P1504, DOI 10.1093/annonc/mdv188; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Van Cutsem E, 2015, GASTRIC CANCER, V18, P476, DOI 10.1007/s10120-014-0402-y; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Vera J, 2015, CELL SIGNAL, V27, P951, DOI 10.1016/j.cellsig.2015.01.020; Verhagen CVM, 2015, RADIOTHER ONCOL, V116, P358, DOI 10.1016/j.radonc.2015.03.028; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang YL, 2001, CANCER RES, V61, P8211; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Watkins JA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3670; Weaver JMJ, 2014, NAT GENET, V46, P837, DOI 10.1038/ng.3013; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764	64	227	232	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1131	1141		10.1038/ng.3659	http://dx.doi.org/10.1038/ng.3659			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27595477	Green Accepted, Green Submitted			2022-12-25	WOS:000384391600008
J	Yang, JH; Liu, DY; Wang, XW; Ji, CM; Cheng, F; Liu, BN; Hu, ZY; Chen, S; Pental, D; Ju, YH; Yao, P; Li, XM; Xie, K; Zhang, JH; Wang, JL; Liu, F; Ma, WW; Shopan, J; Zheng, HK; Mackenzie, SA; Zhang, MF				Yang, Jinghua; Liu, Dongyuan; Wang, Xiaowu; Ji, Changmian; Cheng, Feng; Liu, Baoning; Hu, Zhongyuan; Chen, Sheng; Pental, Deepak; Ju, Youhui; Yao, Pu; Li, Xuming; Xie, Kun; Zhang, Jianhui; Wang, Jianlin; Liu, Fan; Ma, Weiwei; Shopan, Jannat; Zheng, Hongkun; Mackenzie, Sally A.; Zhang, Mingfang			The genome sequence of allopolyploid Brassica juncea and analysis of differential homoeolog gene expression influencing selection	NATURE GENETICS			English	Article							EVOLUTION; REVEALS; POLYPLOIDY; DIVERSITY; OLERACEA; DATABASE; ORIGIN	The Brassica genus encompasses three diploid and three allopolyploid genomes, but a clear understanding of the evolution of agriculturally important traits via polyploidy is lacking. We assembled an allopolyploid Brassica juncea genome by shotgun and single-molecule reads integrated to genomic and genetic maps. We discovered that the A subgenomes of B. juncea and Brassica napus each had independent origins. Results suggested that A subgenomes of B. juncea were of monophyletic origin and evolved into vegetable-use and oil-use subvarieties. Homoeolog expression dominance occurs between subgenomes of allopolyploid B. juncea, in which differentially expressed genes display more selection potential than neutral genes. Homoeolog expression dominance in B. juncea has facilitated selection of glucosinolate and lipid metabolism genes in subvarieties used as vegetables and for oil production. These homoeolog expression dominance relationships among Brassicaceae genomes have contributed to selection response, predicting the directional effects of selection in a polyploid crop genome.	[Yang, Jinghua; Hu, Zhongyuan; Ma, Weiwei; Shopan, Jannat; Zhang, Mingfang] Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou, Zhejiang, Peoples R China; [Yang, Jinghua; Hu, Zhongyuan; Zhang, Mingfang] Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Peoples R China; [Yang, Jinghua; Hu, Zhongyuan; Zhang, Mingfang] Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou, Zhejiang, Peoples R China; [Liu, Dongyuan; Ji, Changmian; Liu, Baoning; Ju, Youhui; Yao, Pu; Li, Xuming; Xie, Kun; Zhang, Jianhui; Zheng, Hongkun] Biomarker Technol Corp, Beijing, Peoples R China; [Wang, Xiaowu; Cheng, Feng] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China; [Chen, Sheng] Univ Western Australia, Sch Plant Biol M084, Perth, WA, Australia; [Chen, Sheng] Univ Western Australia, UWA Inst Agr, Perth, WA, Australia; [Pental, Deepak] Univ Delhi South Campus, Ctr Genet Manipulat Crop Plants, New Delhi, India; [Wang, Jianlin] Tibet Univ, Agr & Anim Husb Coll, Coll Plant Sci & Technol, Linzhi, Peoples R China; [Liu, Fan] Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Beijing, Peoples R China; [Yang, Jinghua; Liu, Dongyuan; Wang, Xiaowu; Ji, Changmian; Cheng, Feng; Mackenzie, Sally A.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	Zhejiang University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Western Australia; University of Western Australia; University of Delhi; Tibet University; Beijing Academy of Agriculture & Forestry; University of Nebraska System; University of Nebraska Lincoln	Zhang, MF (corresponding author), Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou, Zhejiang, Peoples R China.; Zhang, MF (corresponding author), Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Peoples R China.; Zhang, MF (corresponding author), Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou, Zhejiang, Peoples R China.; Mackenzie, SA (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA.	sally.mackenzie@unl.edu; mfzhang@zju.edu.cn	wang, jian/GVS-0711-2022; Wang, Xiaowu/L-2579-2019; Zhang, Jianhui/ABD-5476-2020; Zhang, Jianhui/K-8793-2019; Chen, Sheng/B-1340-2011; Yang, Jinghua/G-9164-2016	Zhang, Jianhui/0000-0002-6362-4027; Zhang, Jianhui/0000-0002-6362-4027; Chen, Sheng/0000-0002-5238-3432; Ji, Changmian/0000-0001-8781-4063; Li, Xuming/0000-0002-5049-9706	Science and Technology Program of Zhejiang Province [2015C32046]; Ear-marked Special Fund from Ministry of Agriculture [09162130135252]; National Natural Science Foundation of China [31372063]	Science and Technology Program of Zhejiang Province; Ear-marked Special Fund from Ministry of Agriculture; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank X.H. Qi for the construction of F<INF>2</INF> population for genetic mapping, and L.J. Fan for the flow cytometry analysis. This work was supported by grants from Science and Technology Program of Zhejiang Province (2015C32046), Ear-marked Special Fund from Ministry of Agriculture (09162130135252) and the National Natural Science Foundation of China (31372063).	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Bottley A, 2006, PLANT J, V47, P897, DOI 10.1111/j.1365-313X.2006.02841.x; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chang PL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r125; Chen S, 2013, J HERED, V104, P416, DOI 10.1093/jhered/est015; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Flagel L, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-16; Grover CE, 2012, NEW PHYTOL, V196, P966, DOI 10.1111/j.1469-8137.2012.04365.x; Institute of Archaeology of Chinese Academy of Science, 1963, SPEC ISS ARCH; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Michael TP, 2015, CURR OPIN PLANT BIOL, V24, P71, DOI 10.1016/j.pbi.2015.02.002; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nagaharu U., 1935, JPN J BOT, V7, P389, DOI DOI 10.1038/35036519; Ostergaard L, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-10; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Prakash S., 1980, OPERA BOT, V55, P1, DOI DOI 10.1016/B978-1-891127-79-3.50001-9; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Verkerk R, 2009, MOL NUTR FOOD RES, V53, pS219, DOI 10.1002/mnfr.200800065; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Warwick SI, 2011, PLANT GENET GENOMICS, V9, P33, DOI 10.1007/978-1-4419-7118-0_2; Ye YN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-769; Zhang DW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00957; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zou J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2343-1	35	292	321	15	215	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1225	1232		10.1038/ng.3657	http://dx.doi.org/10.1038/ng.3657			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27595476	hybrid			2022-12-25	WOS:000384391600018
J	Novikova, PY; Hohmann, N; Nizhynska, V; Tsuchimatsu, T; Ali, J; Muir, G; Guggisberg, A; Paape, T; Schmid, K; Fedorenko, OM; Holm, S; Sall, T; Schlotterer, C; Marhold, K; Widmer, A; Sese, J; Shimizu, KK; Weigel, D; Kramer, U; Koch, MA; Nordborg, M				Novikova, Polina Yu; Hohmann, Nora; Nizhynska, Viktoria; Tsuchimatsu, Takashi; Ali, Jamshaid; Muir, Graham; Guggisberg, Alessia; Paape, Tim; Schmid, Karl; Fedorenko, Olga M.; Holm, Svante; Sall, Torbjorn; Schlotterer, Christian; Marhold, Karol; Widmer, Alex; Sese, Jun; Shimizu, Kentaro K.; Weigel, Detlef; Kramer, Ute; Koch, Marcus A.; Nordborg, Magnus			Sequencing of the genus Arabidopsis identifies a complex history of nonbifurcating speciation and abundant trans-specific polymorphism	NATURE GENETICS			English	Article							ALLOPOLYPLOID ARABIDOPSIS; METAL HYPERACCUMULATION; PHYLOGENETIC ANALYSIS; PARTITIONING SCHEMES; GENOME; EVOLUTION; POPULATION; SELECTION; THALIANA; PLANTS	The notion of species as reproductively isolated units related through a bifurcating tree implies that gene trees should generally agree with the species tree and that sister taxa should not share polymorphisms unless they diverged recently and should be equally closely related to outgroups. It is now possible to evaluate this model systematically. We sequenced multiple individuals from 27 described taxa representing the entire Arabidopsis genus. Cluster analysis identified seven groups, corresponding to described species that capture the structure of the genus. However, at the level of gene trees, only the separation of Arabidopsis thaliana from the remaining species was universally supported, and, overall, the amount of shared polymorphism demonstrated that reproductive isolation was considerably more recent than the estimated divergence times. We uncovered multiple cases of past gene flow that contradict a bifurcating species tree. Finally, we showed that the pattern of divergence differs between gene ontologies, suggesting a role for selection.	[Novikova, Polina Yu; Nizhynska, Viktoria; Tsuchimatsu, Takashi; Nordborg, Magnus] Austrian Acad Sci, Vienna Bioctr VBC, Gregor Mendel Inst, Vienna, Austria; [Novikova, Polina Yu; Muir, Graham] Vetmeduni, Inst Populat Genet, Vienna Grad Sch Populat Genet, Vienna, Austria; [Hohmann, Nora; Koch, Marcus A.] Heidelberg Univ, Ctr Organismal Studies Heidelberg, Heidelberg, Germany; [Ali, Jamshaid; Widmer, Alex; Kramer, Ute] Ruhr Univ Bochum, Dept Plant Physiol, Bochum, Germany; [Guggisberg, Alessia] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Paape, Tim; Shimizu, Kentaro K.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmid, Karl] Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, Stuttgart, Germany; [Fedorenko, Olga M.] Russian Acad Sci, Karelian Res Ctr, Inst Biol, Petrozavodsk, Russia; [Holm, Svante] Mid Sweden Univ, Dept Nat Sci, Fac Sci Technol & Media, Sundsvall, Sweden; [Sall, Torbjorn] Lund Univ, Dept Biol, Lund, Sweden; [Schlotterer, Christian] Vetmeduni, Inst Populat Genet, Vienna, Austria; [Marhold, Karol] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Marhold, Karol] Slovak Acad Sci, Inst Bot, Bratislava, Slovakia; [Sese, Jun] Natl Inst Adv Ind Sci & Technol, Artificial Intelligence Res Ctr, Tokyo, Japan; [Weigel, Detlef] Max Planck Inst Dev Biol, Tubingen, Germany; [Tsuchimatsu, Takashi] Chiba Univ, Dept Biol, Chiba, Japan	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Ruprecht Karls University Heidelberg; Ruhr University Bochum; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Hohenheim; Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Biology of Karelian Research Centre RAS; Mid-Sweden University; Lund University; Charles University Prague; Slovak Academy of Sciences; National Institute of Advanced Industrial Science & Technology (AIST); Max Planck Society; Chiba University	Nordborg, M (corresponding author), Austrian Acad Sci, Vienna Bioctr VBC, Gregor Mendel Inst, Vienna, Austria.	magnus.nordborg@gmi.oeaw.ac.at	Widmer, Alex/B-6841-2009; Guggisberg, Alessia/ABD-9839-2021; Weigel, Detlef/C-1418-2008; Sese, Jun/A-5651-2017; Tsuchimatsu, Takashi/A-9218-2017; Koch, Marcus A/A-4924-2011; Weigel, Detlef/AAR-3312-2021; Tsuchimatsu, Takashi/T-7402-2019; Weigel, Detlef/GSJ-0799-2022; Novikova, Polina Yu./AAZ-9233-2020; Schlötterer, Christian/Q-5264-2019; Marhold, Karol/B-4699-2011; Walden, Nora/AAV-4074-2020; Kraemer, Ute/C-5025-2008	Widmer, Alex/0000-0001-8253-5137; Guggisberg, Alessia/0000-0001-8258-0472; Weigel, Detlef/0000-0002-2114-7963; Sese, Jun/0000-0003-3495-4382; Tsuchimatsu, Takashi/0000-0003-1241-9338; Koch, Marcus A/0000-0002-1693-6829; Tsuchimatsu, Takashi/0000-0003-1241-9338; Weigel, Detlef/0000-0002-2114-7963; Novikova, Polina Yu./0000-0002-4552-4575; Schlötterer, Christian/0000-0003-4710-6526; Marhold, Karol/0000-0002-7658-0844; Walden, Nora/0000-0002-3078-6791; Kraemer, Ute/0000-0001-7870-4508; Nordborg, Magnus/0000-0001-7178-9748; Paape, Timothy/0000-0002-3595-2875; Shimizu, Kentaro K./0000-0002-6483-1781; Ali, Jamshaid/0000-0001-5732-1444	German Research Foundation [DFG SPP 1529, KO 2302/13-2, KO 2302/14-1]; Swiss National Science Foundation; URPP Evolution in Action; HFSP; EU; Czech Science Foundation [P506/12/0668]; Austrian Science Funds [FWF DK W1225]; Grants-in-Aid for Scientific Research [15K18583] Funding Source: KAKEN	German Research Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); URPP Evolution in Action; HFSP(Human Frontier Science Program); EU(European Commission); Czech Science Foundation(Grant Agency of the Czech Republic); Austrian Science Funds(Austrian Science Fund (FWF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Belkhadir, K. Bomblies and J. de Meaux for discussions and comments on the manuscript; R. Schmickl, L. Paule, C. Tremblay, J. Cayouette, G. Mitrow, H. Tsukaya and O. Savolainen for help with collections; and P. Forai, M. Hatakeyama and M. Kiefer for IT support. This work was supported by the German Research Foundation (DFG SPP 1529 to M.A.K., U.K., M.N., C.S., D.W. and A.W., and KO 2302/13-2, KO 2302/14-1 to M. A. K.), by the Swiss National Science Foundation and URPP Evolution in Action (to K.K.S.), by HFSP (to J.S. and K.K.S.), by the EU Plant Fellows Program (to T.P.), by the Czech Science Foundation (P506/12/0668 to K.M.), and by the Austrian Science Funds (FWF DK W1225 to C.S.).	Akama S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1376; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Brandvain Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003754; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Carvalho CM, 2008, PLANT J, V55, P869, DOI 10.1111/j.1365-313X.2008.03556.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cui XF, 2007, PLANT CELL, V19, P1388, DOI 10.1105/tpc.107.051375; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524; Garrigan D, 2012, GENOME RES, V22, P1499, DOI 10.1101/gr.130922.111; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guo YL, 2011, PLANT PHYSIOL, V157, P757, DOI 10.1104/pp.111.181990; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hallstrom BM, 2010, MOL BIOL EVOL, V27, P2804, DOI 10.1093/molbev/msq166; Hohmann N, 2015, PLANT CELL, V27, P2770, DOI 10.1105/tpc.15.00482; Hohmann N, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0224-x; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; HYLANDER NILS, 1957, BULL JARD BOT ETAT BRUXELLES, V27, P591, DOI 10.2307/3666887; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; Jonsson H, 2014, P NATL ACAD SCI USA, V111, P18655, DOI 10.1073/pnas.1412627111; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KLEIN J, 1993, J MED PRIMATOL, V22, P57; Kofler R, 2012, BIOINFORMATICS, V28, P2084, DOI 10.1093/bioinformatics/bts315; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leffler EM, 2013, SCIENCE, V339, P1578, DOI 10.1126/science.1234070; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Mailund T., 2014, ELS; Mallet J, 2016, BIOESSAYS, V38, P140, DOI 10.1002/bies.201500149; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nagylaki T, 1998, GENETICS, V148, P1325; Nishihara H, 2009, P NATL ACAD SCI USA, V106, P5235, DOI 10.1073/pnas.0809297106; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2000, GENETICS, V154, P923; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pavlidis P, 2010, MOL ECOL RESOUR, V10, P723, DOI 10.1111/j.1755-0998.2010.02832.x; Pease JB, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002379; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Schmickl R, 2011, P NATL ACAD SCI USA, V108, P14192, DOI 10.1073/pnas.1104212108; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Shen W, 2009, PLANT PHYSIOL, V150, P996, DOI 10.1104/pp.108.132787; Shimizu Kentaro K., 2005, APG Acta Phytotaxonomica et Geobotanica, V56, P163; Shimizu KK, 2015, ANNU REV ECOL EVOL S, V46, P593, DOI 10.1146/annurev-ecolsys-112414-054249; Shimizu KK, 2002, POPUL ECOL, V44, P221, DOI 10.1007/s101440200025; Shimizu-Inatsugi R, 2009, MOL ECOL, V18, P4024, DOI 10.1111/j.1365-294X.2009.04329.x; Slatkin M, 2008, MOL BIOL EVOL, V25, P2241, DOI 10.1093/molbev/msn172; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suh A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002224; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; TAJIMA F, 1989, GENETICS, V123, P585; The 1001 Genomes Consortium, 2016, CELL; Toivainen T, 2014, MOL ECOL, V23, P1040, DOI 10.1111/mec.12682; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Willems G, 2007, GENETICS, V176, P659, DOI 10.1534/genetics.106.064485; Wiuf C, 2004, GENETICS, V168, P2363, DOI 10.1534/genetics.104.029488	73	122	125	2	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1077	+		10.1038/ng.3617	http://dx.doi.org/10.1038/ng.3617			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27428747	hybrid, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000382398800021
J	Ji, SG; Juran, BD; Mucha, S; Folseraas, T; Jostins, L; Melum, E; Kumasaka, N; Atkinson, EJ; Schlicht, EM; Liu, JZ; Shah, T; Gutierrez-Achury, J; Boberg, KM; Bergquist, A; Vermeire, S; Eksteen, B; Durie, PR; Farkkila, M; Muller, T; Schramm, C; Sterneck, M; Weismuller, TJ; Gotthardt, DN; Ellinghaus, D; Braun, F; Teufel, A; Laudes, M; Lieb, W; Jacobs, G; Beuers, U; Weersma, RK; Wijmenga, C; Marschall, HU; Milkiewicz, P; Pares, A; Kontula, K; Chazouilleres, O; Invernizzi, P; Goode, E; Spiess, K; Moore, C; Sambrook, J; Ouwehand, WH; Roberts, DJ; Danesh, J; Floreani, A; Gulamhusein, AF; Eaton, JE; Schreiber, S; Coltescu, C; Bowlus, CL; Luketic, VA; Odin, JA; Chopra, KB; Kowdley, KV; Chalasani, N; Manns, MP; Srivastava, B; Mells, G; Sandford, RN; Alexander, G; Gaffney, DJ; Chapman, RW; Hirschfield, GM; de Andrade, M; Rushbrook, SM; Franke, A; Karlsen, TH; Lazaridis, KN; Anderson, CA				Ji, Sun-Gou; Juran, Brian D.; Mucha, Soeren; Folseraas, Trine; Jostins, Luke; Melum, Espen; Kumasaka, Natsuhiko; Atkinson, Elizabeth J.; Schlicht, Erik M.; Liu, Jimmy Z.; Shah, Tejas; Gutierrez-Achury, Javier; Boberg, Kirsten M.; Bergquist, Annika; Vermeire, Severine; Eksteen, Bertus; Durie, Peter R.; Farkkila, Martti; Mueller, Tobias; Schramm, Christoph; Sterneck, Martina; Weismueller, Tobias J.; Gotthardt, Daniel N.; Ellinghaus, David; Braun, Felix; Teufel, Andreas; Laudes, Mattias; Lieb, Wolfgang; Jacobs, Gunnar; Beuers, Ulrich; Weersma, Rinse K.; Wijmenga, Cisca; Marschall, Hanns-Ulrich; Milkiewicz, Piotr; Pares, Albert; Kontula, Kimmo; Chazouilleres, Olivier; Invernizzi, Pietro; Goode, Elizabeth; Spiess, Kelly; Moore, Carmel; Sambrook, Jennifer; Ouwehand, Willem H.; Roberts, David J.; Danesh, John; Floreani, Annarosa; Gulamhusein, Aliya F.; Eaton, John E.; Schreiber, Stefan; Coltescu, Catalina; Bowlus, Christopher L.; Luketic, Velimir A.; Odin, Joseph A.; Chopra, Kapil B.; Kowdley, Kris V.; Chalasani, Naga; Manns, Michael P.; Srivastava, Brijesh; Mells, George; Sandford, Richard N.; Alexander, Graeme; Gaffney, Daniel J.; Chapman, Roger W.; Hirschfield, Gideon M.; de Andrade, Mariza; Rushbrook, Simon M.; Franke, Andre; Karlsen, Tom H.; Lazaridis, Konstantinos N.; Anderson, Carl A.		UK-PSC Consortium; Int IBD Genetics Consortium; Int PSC Study Grp	Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCI; PSORIATIC-ARTHRITIS; ULCERATIVE-COLITIS; TRANSCRIPTOME; METAANALYSIS; VARIANTS; REVEALS; REGIONS	Primary sclerosing cholangitis (PSC) is a rare progressive disorder leading to bile duct destruction; similar to 75% of patients have comorbid inflammatory bowel disease (IBD). We undertook the largest genome-wide association study of PSC (4,796 cases and 19,955 population controls) and identified four new genome-wide significant loci. The most associated SNP at one locus affects splicing and expression of UBASH3A, with the protective allele (C) predicted to cause nonstop-mediated mRNA decay and lower expression of UBASH3A. Further analyses based on common variants suggested that the genome-wide genetic correlation (r(G)) between PSC and ulcerative colitis (UC) (r(G) = 0.29) was significantly greater than that between PSC and Crohn's disease (CD) (r(G) = 0.04) (P = 2.55 x 10(-15)). UC and CD were genetically more similar to each other (r(G) = 0.56) than either was to PSC (P < 1.0 x 10(-15)). Our study represents a substantial advance in understanding of the genetics of PSC.	[Ji, Sun-Gou; Kumasaka, Natsuhiko; Liu, Jimmy Z.; Shah, Tejas; Gutierrez-Achury, Javier; Ouwehand, Willem H.; Danesh, John; Gaffney, Daniel J.; Anderson, Carl A.] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Hinxton, England; [Juran, Brian D.; Schlicht, Erik M.; Gulamhusein, Aliya F.; Eaton, John E.; Lazaridis, Konstantinos N.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA; [Mucha, Soeren; Ellinghaus, David; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Folseraas, Trine; Melum, Espen; Boberg, Kirsten M.; Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Div Canc Med Surg & Transplantat, Norwegian PSC Res Ctr, N-0450 Oslo, Norway; [Folseraas, Trine; Melum, Espen; Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Folseraas, Trine; Boberg, Kirsten M.; Karlsen, Tom H.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Jostins, Luke] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Jostins, Luke] Univ Oxford Christ Church, Oxford OX1 1DP, England; [Atkinson, Elizabeth J.; de Andrade, Mariza] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Boberg, Kirsten M.; Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Div Canc Surg & Transplantat, Dept Transplantat Med,Sect Gastroenterol, Oslo, Norway; [Bergquist, Annika] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Gastroenterol & Hepatol, Stockholm, Sweden; [Vermeire, Severine] Katholieke Univ Leuven, Dept Clin & Expt Med, Leuven, Belgium; [Vermeire, Severine] Univ Hosp Leuven, Dept Gastroenterol, Leuven, Belgium; [Eksteen, Bertus] Univ Calgary, Dept Med, Snyder Inst Chron Dis, Calgary, AB, Canada; [Durie, Peter R.] Hosp Sick Children, Res Inst, Physiol & Expt Med, Toronto, ON, Canada; [Farkkila, Martti] Univ Helsinki, Helsinki, Finland; [Farkkila, Martti] Helsinki Univ Hosp, Gastroenterol Clin, Helsinki, Finland; [Mueller, Tobias] Charite, Dept Internal Med Hepatol & Gastroenterol, Berlin, Germany; [Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Sterneck, Martina] Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary Surg & Transplantat, Hamburg, Germany; [Weismueller, Tobias J.; Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Weismueller, Tobias J.; Manns, Michael P.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Weismueller, Tobias J.] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany; [Gotthardt, Daniel N.] Univ Heidelberg Hosp, Dept Med, Heidelberg, Germany; [Braun, Felix] Univ Med Ctr Schleswig Holstein, Dept Gen Visceral Thorac Transplantat & Pediat Su, Campus Kiel, Kiel, Germany; [Teufel, Andreas] Univ Med Ctr, Dept Med 1, Regensburg, Germany; [Laudes, Mattias] Univ Hosp Schleswig Holstein, Clin Internal Med 1, Kiel, Germany; [Lieb, Wolfgang; Jacobs, Gunnar] Univ Hosp Schleswig Holstein, Inst Epidemiol, Kiel, Germany; [Lieb, Wolfgang; Jacobs, Gunnar] Univ Hosp Schleswig Holstein, Biobank PopGen, Kiel, Germany; [Beuers, Ulrich] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Marschall, Hanns-Ulrich] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Milkiewicz, Piotr] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Liver & Internal Med Unit, Warsaw, Poland; [Pares, Albert] Univ Barcelona, CIBERehd, IDIBAPS, Liver Unit,Hosp Clin, Barcelona, Spain; [Kontula, Kimmo] Univ Helsinki, Dept Med, Helsinki, Finland; [Chazouilleres, Olivier] Univ Paris 06, Hop St Antoine, AP HP, Dept Hepatol, Paris, France; [Invernizzi, Pietro] Humanitas Clin & Res Ctr, Ctr Autoimmune Liver Dis, Milan, Italy; [Goode, Elizabeth; Spiess, Kelly; Srivastava, Brijesh; Mells, George; Sandford, Richard N.; Rushbrook, Simon M.] Univ Cambridge, Acad Dept Med Genet, Cambridge, England; [Ouwehand, Willem H.; Roberts, David J.; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [Moore, Carmel; Sambrook, Jennifer; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, INTERVAL Coordinating Ctr, Cambridge, England; [Sambrook, Jennifer; Ouwehand, Willem H.] Univ Cambridge, Dept Hematol, Cambridge, England; [Ouwehand, Willem H.] NHS Blood & Transplant, Cambridge, England; [Roberts, David J.] John Radcliffe Hosp, NHS Blood & Transplant Oxford Ctr, Oxford, England; [Roberts, David J.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford, England; [Floreani, Annarosa] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Padua, Italy; [Schreiber, Stefan] Univ Hosp Schleswig, Dept Gen Internal Med, Holstein Campus Kiel, Kiel, Germany; [Coltescu, Catalina] Toronto Western Hosp, Ctr Liver, Toronto, ON, Canada; [Bowlus, Christopher L.] Univ Calif Davis, Div Gastroenterol & Hepatol, Davis, CA 95616 USA; [Luketic, Velimir A.] Virginia Commonwealth Univ, Gastroenterol & Hepatol Sect, Richmond, VA USA; [Odin, Joseph A.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Chopra, Kapil B.] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Kowdley, Kris V.] Swedish Med Ctr, Liver Care Network & Organ Care Res, Seattle, WA USA; [Chalasani, Naga] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Mells, George] Addenbrookes Hosp, Div Gastroenterol & Hepatol, Cambridge, England; [Alexander, Graeme] Univ Cambridge, Div Hepatol, Dept Med, Cambridge, England; [Chapman, Roger W.] Oxford Univ Hosp NHS Trust, Dept Translat Gastroenterol, Oxford, England; [Hirschfield, Gideon M.] Univ Birmingham, NIHR Biomed Res Unit, Liver Res Ctr, Birmingham, W Midlands, England; [Hirschfield, Gideon M.] Univ Toronto, Toronto, ON, Canada; [Hirschfield, Gideon M.] Toronto Western Hosp, Ctr Liver, Toronto, ON, Canada	Wellcome Trust Sanger Institute; Mayo Clinic; University of Kiel; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Mayo Clinic; University of Oslo; National Hospital Norway; Karolinska Institutet; Karolinska University Hospital; KU Leuven; KU Leuven; University Hospital Leuven; University of Calgary; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Hannover Medical School; University of Bonn; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital; University of Regensburg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Groningen; University of Gothenburg; Medical University of Warsaw; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Helsinki; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Oxford; University of Oxford; University of Padua; University of Kiel; Schleswig Holstein University Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California Davis; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Swedish Medical Center; Indiana University System; Indiana University Bloomington; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Oxford University Hospitals NHS Foundation Trust; University of Birmingham; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Anderson, CA (corresponding author), Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Hinxton, England.; Lazaridis, KN (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA.	lazaridis.konstantinos@mayo.edu; carl.anderson@sanger.ac.uk	Pares, Albert/M-6268-2019; D'Amato, Mauro/B-5050-2019; Färkkilä, Martti/AAG-6970-2021; Wijmenga, Cisca/AAE-7719-2019; Weersma, Rinse/ABE-3807-2021; Lieb, Wolfgang/AAC-7650-2022; Ellinghaus, David/G-4467-2012; Franke, Andre/B-2151-2010; Pares, Albert/G-1328-2011; Ellinghaus, David/ABC-3610-2020; Invernizzi, Pietro/AAB-8367-2022; Teufel, Andreas/ABD-8000-2021; D'Amato, Mauro/F-2450-2010; Braun, Felix/AAK-8329-2021; Laudes, Matthias/C-8885-2011; Weismüller, Tobias J./I-1879-2019; Kowdley, Kris/AAF-5202-2019; Marschall, Hanns-Ulrich/K-8842-2017; Bowlus, Christopher/N-9276-2016; Hirschfield, Gideon/M-2143-2015	Pares, Albert/0000-0002-5413-9687; D'Amato, Mauro/0000-0003-2743-5197; Färkkilä, Martti/0000-0002-0250-8559; Wijmenga, Cisca/0000-0002-5635-1614; Franke, Andre/0000-0003-1530-5811; Pares, Albert/0000-0002-5413-9687; Ellinghaus, David/0000-0002-4332-6110; Invernizzi, Pietro/0000-0003-3262-1998; D'Amato, Mauro/0000-0003-2743-5197; Braun, Felix/0000-0002-5296-2020; Weismüller, Tobias J./0000-0001-9736-1483; Marschall, Hanns-Ulrich/0000-0001-7347-3085; Roberts, David/0000-0003-0648-6585; Mucha, Soren/0000-0002-1647-2526; Bowlus, Christopher/0000-0002-3906-6811; Ji, Sun-Gou/0000-0001-8652-6318; Mueller, Tobias/0000-0003-3426-5421; Vermeire, Severine/0000-0001-9942-3019; Bergquist, Annika/0000-0002-3858-6241; Hirschfield, Gideon/0000-0002-6736-2255; Milkiewicz, Piotr/0000-0002-1817-0724; Gutierrez-Achury, Javier/0000-0002-4971-1474; Anderson, Carl/0000-0003-1719-7009	National Institute on Aging [U01AG009740, RC2AG036495, RC4AG039029]; German Ministry for Education and Research [01EY1103]; Mayo Clinic Biobank; Mayo Clinic Center for Individualized Medicine; INTERVAL study; National Health Service Blood and Transplant (NHSBT); FOCUS biobank; NoPSC; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1DK084960]; Wellcome Trust [098759/Z/12/Z, 098051]; Kwanjeong Educational Foundation; German Federal Ministry of Education and Research (B.M.B.F.); SysInflame grant [01ZX1306A]; YAEL-Foundation; DFG [SFB841]; National Institute of Health Research (NIHR); NIHR BioResource; NIHR Cambridge Biomedical Research Centre; NIHR Blood and Transplant Research Unit in Donor Health and Genomics; UK Medical Research Council [G0800270]; British Heart Foundation [SP/09/002]; NIHR Research Cambridge Biomedical Research Centre; the Netherlands Organization for Scientific Research [90.700.281]; Medical Research Council, United Kingdom; Deutsche Forschungsgemeinschaft; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestives (CIBERehd); Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion [PI071318]; Ministerio de Economia y Competitvidad, Spain [PI12/01448]; Canadian Institutes of Health research (CIHR); Genome Canada; Celiac Disease Consortium [BSIK03009]; Netherlands Organization for Scientific Research (NWO, VICI grant) [918.66.620]; MRC [MR/L003120/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036495, RC4AG039029, U01AG009740] Funding Source: NIH RePORTER; British Heart Foundation [RG/09/012/28096, RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, RP-PG-0310-1004, NF-SI-0513-10151, NF-SI-0510-10214, RP-PG-0310-1002] Funding Source: researchfish	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Mayo Clinic Biobank; Mayo Clinic Center for Individualized Medicine; INTERVAL study; National Health Service Blood and Transplant (NHSBT); FOCUS biobank; NoPSC; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); Kwanjeong Educational Foundation; German Federal Ministry of Education and Research (B.M.B.F.)(Federal Ministry of Education & Research (BMBF)); SysInflame grant; YAEL-Foundation; DFG(German Research Foundation (DFG)); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR BioResource; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Blood and Transplant Research Unit in Donor Health and Genomics; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); NIHR Research Cambridge Biomedical Research Centre; the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestives (CIBERehd); Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitvidad, Spain; Canadian Institutes of Health research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Celiac Disease Consortium; Netherlands Organization for Scientific Research (NWO, VICI grant)(Netherlands Organization for Scientific Research (NWO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the patients and healthy controls for their participation, and are grateful to the physicians, scientists and nursing staff who recruited individuals whose data is used in our study. We acknowledge the use of DNA or genotype data from a number of sources, including: the Health and Retirement Study (HSR) conducted by the University of Michigan, funded by the National Institute on Aging (grant numbers U01AG009740, RC2AG036495 and RC4AG039029) and accessed via dbGaP; Popgen 2.0, supported by a grant from the German Ministry for Education and Research (01EY1103); The Mayo Clinic Biobank, supported by the Mayo Clinic Center for Individualized Medicine; the INTERVAL study, undertaken by the University of Cambridge with funding from the National Health Service Blood and Transplant (NHSBT) (the views expressed in this publication are those of the authors and not necessarily those of the NHSBT); the FOCUS biobank. We thank the investigators of the 1000 Genomes and UK10K projects for generating and sharing the population haplotypes and Jie Huang for advice regarding imputation. We thank all members of the International IBD Genetics Consortium for sharing genetic data vital to the success of our study. This study was supported by NoPSC, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK RO1DK084960, KNL), the Wellcome Trust (098759/Z/12/Z: L.J.; 098051: S.-G.J., J.Z.L., T.S., J.G.-A., N.K., D.J.G. and C.A.A.), the Kwanjeong Educational Foundation (S.-G.J.), the German Federal Ministry of Education and Research (B.M.B.F.) within the framework of the e:Med research and funding concept (SysInflame grant 01ZX1306A) and the Chris M. Carlos and Catharine Nicole Jockisch Carlos Endowment in PSC. This project received infrastructure support from the DFG Excellence Cluster 306 "Inflammation at Interfaces" and the PopGen Biobank (Kiel, Germany), an endowment professorship (A.F.) by the Foundation for Experimental Medicine (Zurich, Switzerland). The recruitment of patients in Hamburg was supported by the YAEL-Foundation and the DFG (SFB841). B.A. Lie and the Norwegian Bone Marrow Donor Registry at Oslo University Hospital, Rikshospitalet in Oslo are acknowledged for sharing the healthy Norwegian controls. Participants in the INTERVAL randomized controlled trial were recruited with the active collaboration of NHS Blood and Transplant England (http://www.nhsbt.nhs.uk), which has supported field work and other elements of the trial. DNA extraction and genotyping was funded by the National Institute of Health Research (NIHR), the NIHR BioResource (http://bioresource.nihr.ac.uk/) and the NIHR Cambridge Biomedical Research Centre (http://www.cambridge-brc.org.uk). The academic coordinating centre for INTERVAL was supported by core funding from: NIHR Blood and Transplant Research Unit in Donor Health and Genomics, UK Medical Research Council (G0800270), British Heart Foundation (SP/09/002), and NIHR Research Cambridge Biomedical Research Centre. We thank K. Cloppenborg-Schmidt, I. Urbach, I. Pauselis, T. Wesse, T. Henke, R. Vogler, V. Pelkonen, K. Holm, H. Dahlen Sollid, B. Woldseth, J. Andreas and L. Wenche Torbjornsen for expert help. R.K.W. is supported by a clinical fellowship grant (90.700.281) from the Netherlands Organization for Scientific Research. B.E. receives support from Medical Research Council, United Kingdom. T.M. and D.G. are supported by Deutsche Forschungsgemeinschaft, Grant. A.P.; is supported by Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestives (CIBERehd), grant PI071318 Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, and grant PI12/01448, from Ministerio de Economia y Competitvidad, Spain. P.R.D. is supported by Canadian Institutes of Health research (CIHR) and Genome Canada. C.W. is supported by grants from the Celiac Disease Consortium (BSIK03009) and Netherlands Organization for Scientific Research (NWO, VICI grant918.66.620). We acknowledge members of the International PSC Study Group, the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC), and the UK-PSC Consortium for their participation. We thank J. Rud for secretarial support.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bergquist A, 2008, CLIN GASTROENTEROL H, V6, P939, DOI 10.1016/j.cgh.2008.03.016; Boonstra K, 2012, INFLAMM BOWEL DIS, V18, P2270, DOI 10.1002/ibd.22938; Bowes J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7046; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; de Vries AB, 2015, WORLD J GASTROENTERO, V21, P1956, DOI 10.3748/wjg.v21.i6.1956; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Ellinghaus D, 2013, HEPATOLOGY, V58, P1074, DOI 10.1002/hep.25977; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Karlsen TH, 2011, SEMIN LIVER DIS, V31, P188, DOI 10.1055/s-0031-1276647; Karlsen TH, 2010, DIGEST LIVER DIS, V42, P390, DOI 10.1016/j.dld.2010.01.011; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Srivastava B, 2012, SCAND J GASTROENTERO, V47, P820, DOI 10.3109/00365521.2012.682090; Stuart PE, 2015, AM J HUM GENET, V97, P816, DOI 10.1016/j.ajhg.2015.10.019; Tischendorf JJW, 2007, AM J GASTROENTEROL, V102, P107, DOI 10.1111/j.1572-0241.2006.00872.x; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	34	128	130	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					269	273		10.1038/ng.3745	http://dx.doi.org/10.1038/ng.3745			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27992413	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000393148600016
J	Kim, Y; Lee, HM; Xiong, Y; Sciaky, N; Hulbert, SW; Cao, XY; Everitt, JI; Jin, J; Roth, BL; Jiang, YH				Kim, Yuna; Lee, Hyeong-Min; Xiong, Yan; Sciaky, Noah; Hulbert, Samuel W.; Cao, Xinyu; Everitt, Jeffrey I.; Jin, Jian; Roth, Bryan L.; Jiang, Yong-hui			Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome	NATURE MEDICINE			English	Article							SMALL NUCLEOLAR RNA; NOVO DNA METHYLATION; PATERNAL DELETION; CHEMICAL PROBE; REGION; UBE3A; GLP; MUTATIONS; MAGEL2; TRANSCRIPT	Prader-Willi syndrome (PWS) is an imprinting disorder caused by a deficiency of paternally expressed gene(s) in the 15q11-q13 chromosomal region. The regulation of imprinted gene expression in this region is coordinated by an imprinting center (PWS-IC). In individuals with PWS, genes responsible for PWS on the maternal chromosome are present, but repressed epigenetically, which provides an opportunity for the use of epigenetic therapy to restore expression from the maternal copies of PWS-associated genes. Through a high-content screen (HCS) of >9,000 small molecules, we discovered that UNC0638 and UNC0642 two selective inhibitors of euchromatic histone lysine N-methyltransferase-2 (EHMT2, also known as G9a)-activated the maternal (m) copy of candidate genes underlying PWS, including the SnoRNA cluster SNORD116, in cells from humans with PWS and also from a mouse model of PWS carrying a paternal (p) deletion from small nuclear ribonucleoprotein N (Snrpn (S)) to ubiquitin protein ligase E3A (Ube3a (U)) (mouse model referred to hereafter as m(+)/p(Delta s-U)). Both UNC0642 and UNC0638 caused a selective reduction of the dimethylation of histone H3 lysine 9 (H3K9me2) at PWS-IC, without changing DNA methylation, when analyzed by bisulfite genomic sequencing. This indicates that histone modification is essential for the imprinting of candidate genes underlying PWS. UNC0642 displayed therapeutic effects in the PWS mouse model by improving the survival and the growth of in m(+)/p(Delta s-U) newborn pups. This study provides the first proof of principle for an epigenetics-based therapy for PWS.	[Kim, Yuna; Cao, Xinyu; Jiang, Yong-hui] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27708 USA; [Lee, Hyeong-Min] Univ N Carolina, Dept Cell Biol & Physiol, Sch Med, Chapel Hill, NC USA; [Lee, Hyeong-Min; Sciaky, Noah; Roth, Bryan L.] Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27514 USA; [Xiong, Yan; Jin, Jian] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Xiong, Yan; Jin, Jian] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Hulbert, Samuel W.; Jiang, Yong-hui] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27708 USA; [Everitt, Jeffrey I.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Program Neurosci, Chapel Hill, NC 27514 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, NIMH Psychoact Drug Screening Program, Chapel Hill, NC 27514 USA; [Jiang, Yong-hui] Duke Univ, Sch Med, Program Genet & Genom, Durham, NC 27708 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Jiang, YH (corresponding author), Duke Univ, Sch Med, Dept Pediat, Durham, NC 27708 USA.; Roth, BL (corresponding author), Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27514 USA.; Jiang, YH (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27708 USA.; Roth, BL (corresponding author), Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Program Neurosci, Chapel Hill, NC 27514 USA.; Roth, BL (corresponding author), Univ N Carolina, Sch Med, NIMH Psychoact Drug Screening Program, Chapel Hill, NC 27514 USA.; Jiang, YH (corresponding author), Duke Univ, Sch Med, Program Genet & Genom, Durham, NC 27708 USA.	bryan_roth@med.unc.edu; yong-hui.jiang@duke.edu	Roth, Bryan L/F-3928-2010; Lee, HM/ABC-2680-2020; Lee, HM/D-2777-2011; Kim, Yuna/GXV-6765-2022; xiong, yan/H-7881-2018; Roth, Bryan/ABE-7032-2020	Lee, HM/0000-0002-9381-3611; Lee, HM/0000-0002-9381-3611; Roth, Bryan/0000-0002-0561-6520; Everitt, Jeffrey/0000-0003-0273-6284	US National Institutes of Health [HD077197, R01GM103893]; Foundation for Prader Willi Syndrome Research (FPWR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD077197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122749, R01GM103893] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Prader Willi Syndrome Research (FPWR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Beaudet at Baylor College of Medicine for providing the SnrpnEGFP mice and some of the PWS cell lines; B. Philpot and M. Zlyka (University of North Carolina at Chapel Hill) for discussion. K. Konze for his advice on the ChIP experiment; S.-O. Han for his advice on blood-sample collection; C. Means and R. Rodriguiz for their assistance with neurological screening; and A. Bey for proofreading and discussion. This study is supported by grants from the US National Institutes of Health (HD077197 to Y.-H.J. and R01GM103893 to J.J.). Y.-H. Jiang is also supported by a grant from the Foundation for Prader Willi Syndrome Research (FPWR). We thank the International Rett Syndrome Foundation and GlaxoSmithKline for providing the CNS-penetrating drug library (SMART library) and Published Kinase Inhibitor Set (PKIS), the NIMH Psychoactive Drug Screening Program (B.L. Roth) and the Michael Hooker Chair of Translational Proteomics (B.L. Roth).	Auclair G, 2016, GENOME RES, V26, P192, DOI 10.1101/gr.198291.115; Bieth E, 2015, EUR J HUM GENET, V23, P252, DOI 10.1038/ejhg.2014.103; Bittencourt D, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-27; Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Booth MJ, 2013, NAT PROTOC, V8, P1841, DOI 10.1038/nprot.2013.115; Buiting K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-40; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Collins R, 2010, NUCLEIC ACIDS RES, V38, P3503, DOI 10.1093/nar/gkq081; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Cruvinel E, 2014, HUM MOL GENET, V23, P4674, DOI 10.1093/hmg/ddu187; de los Santos T, 2000, AM J HUM GENET, V67, P1067, DOI 10.1086/303106; de Smith AJ, 2009, HUM MOL GENET, V18, P3257, DOI 10.1093/hmg/ddp263; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Fulmer-Smentek SB, 2001, HUM MOL GENET, V10, P645, DOI 10.1093/hmg/10.6.645; Galiveti CR, 2014, SCI REP-UK, V4, DOI 10.1038/srep06445; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Garcia-Manero G, 2013, J CLIN ONCOL, V31, P2548, DOI 10.1200/JCO.2012.44.6823; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kanber D, 2009, EUR J HUM GENET, V17, P582, DOI 10.1038/ejhg.2008.232; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Le Meur E, 2005, DEV BIOL, V286, P587, DOI 10.1016/j.ydbio.2005.07.030; Leung DC, 2011, P NATL ACAD SCI USA, V108, P5718, DOI 10.1073/pnas.1014660108; Liu F, 2013, J MED CHEM, V56, P8931, DOI 10.1021/jm401480r; Liu F, 2011, J MED CHEM, V54, P6139, DOI 10.1021/jm200903z; Lu XY, 2013, J AM CHEM SOC, V135, P9315, DOI 10.1021/ja4044856; Mackay DJG, 2006, HUM GENET, V120, P262, DOI 10.1007/s00439-006-0205-2; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Martins-Taylor K, 2014, HUM MOL GENET, V23, P2364, DOI 10.1093/hmg/ddt628; Meng LY, 2012, HUM MOL GENET, V21, P3001, DOI 10.1093/hmg/dds130; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Saitoh S, 2000, AM J HUM GENET, V66, P1958, DOI 10.1086/302917; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Schaaf CP, 2013, NAT GENET, V45, P1405, DOI 10.1038/ng.2776; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Treppendahl MB, 2014, J CLIN INVEST, V124, P47, DOI 10.1172/JCI69737; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wu MY, 2006, GENE DEV, V20, P2859, DOI 10.1101/gad.1452206; Xin ZH, 2003, J BIOL CHEM, V278, P14996, DOI 10.1074/jbc.M211753200; Xin ZH, 2001, AM J HUM GENET, V69, P1389, DOI 10.1086/324469; Yarnasaki K, 2003, HUM MOL GENET, V12, P837, DOI 10.1093/hmg/ddg106; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106	54	63	70	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					213	222		10.1038/nm.4257	http://dx.doi.org/10.1038/nm.4257			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28024084	Green Accepted, Green Submitted			2022-12-25	WOS:000393729000013
J	Schwarz, KA; Daringer, NM; Dolberg, TB; Leonard, JN				Schwarz, Kelly A.; Daringer, Nichole M.; Dolberg, Taylor B.; Leonard, Joshua N.			Rewiring human cellular input-output using modular extracellular sensors	NATURE CHEMICAL BIOLOGY			English	Article							T-CELLS; CANCER-IMMUNOTHERAPY; ACTIVATION; ANTIBODY; DESIGN; GROWTH; VEGF; TRANSCRIPTION; BEVACIZUMAB; SPECIFICITY	Engineered cell-based therapies comprise a promising emerging strategy for treating diverse diseases. Realizing this promise requires new tools for engineering cells to sense and respond to soluble extracellular factors, which provide information about both physiological state and the local environment. Here, we report such a biosensor engineering strategy, leveraging a self-contained receptor-signal transduction system termed modular extracellular sensor architecture (MESA). We developed MESA receptors that enable cells to sense vascular endothelial growth factor (VEGF) and, in response, secrete interleukin 2 (IL-2). By implementing these receptors in human T cells, we created a customized function not observed in nature an immune cell that responds to a normally immunosuppressive cue (VEGF) by producing an immunostimulatory factor (IL-2). Because this platform utilizes modular, engineerable domains for ligand binding (antibodies) and output (programmable transcription factors based upon Cas9), this approach may be readily extended to novel inputs and outputs. This generalizable approach for rewiring cellular functions could enable both translational applications and fundamental biological research.	[Schwarz, Kelly A.; Daringer, Nichole M.; Dolberg, Taylor B.; Leonard, Joshua N.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Schwarz, Kelly A.; Dolberg, Taylor B.; Leonard, Joshua N.] Northwestern Univ, Ctr Synthet Biol, Evanston, IL USA; [Leonard, Joshua N.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA; [Leonard, Joshua N.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Leonard, JN (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA.; Leonard, JN (corresponding author), Northwestern Univ, Ctr Synthet Biol, Evanston, IL USA.; Leonard, JN (corresponding author), Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA.; Leonard, JN (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA.	j-leonard@northwestern.edu	Leonard, Joshua/B-7649-2009	Dolberg, Taylor/0000-0001-8172-8762; Leonard, Joshua/0000-0003-4359-6126	National Institutes of Health T32 Training Grant through Northwestern University's Biotechnology Training Program [GM 008449]; Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; Northwestern University Flow Cytometry Facility; Cancer Center Support Grant [NCI CA060553]; Defense Advanced Research Projects Agency [W911NF-11-2-0066]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008449] Funding Source: NIH RePORTER	National Institutes of Health T32 Training Grant through Northwestern University's Biotechnology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; Northwestern University Flow Cytometry Facility; Cancer Center Support Grant; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.A.S. and N.M.D. were supported in part by the National Institutes of Health T32 Training Grant GM 008449 through Northwestern University's Biotechnology Training Program. T.B.D. was supported by the Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program. This work was supported by the Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant (NCI CA060553). This project was supported by the Defense Advanced Research Projects Agency, Award number W911NF-11-2-0066 (to J.N.L.). No funding sources had any involvement in the writing of this manuscript.	[Anonymous], 2014, DNA 2 0 CRISPR GRNA; Anthony K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095790; Antunes MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016292; Arenas-Ramirez N, 2015, TRENDS IMMUNOL, V36, P763, DOI 10.1016/j.it.2015.10.003; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Daringer NM, 2014, ACS SYNTH BIOL, V3, P892, DOI 10.1021/sb400128g; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Duportet X, 2014, NUCLEIC ACIDS RES, V42, P13440, DOI 10.1093/nar/gku1082; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110; Fesnak AD, 2016, NAT REV CANCER, V16, P566, DOI 10.1038/nrc.2016.97; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Heathman TRJ, 2015, REGEN MED, V10, P49, DOI [10.2217/RME.14.73, 10.2217/rme.14.73]; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; KOTB M, 1990, J IMMUNOL, V145, P1332; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Pei Y, 2010, CURR PROTOC NEUROSC, V50; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Schukur L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4964; Schwarz KA, 2016, ADV DRUG DELIVER REV, V105, P55, DOI 10.1016/j.addr.2016.05.019; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	36	86	87	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					202	209		10.1038/NCHEMBIO.2253	http://dx.doi.org/10.1038/NCHEMBIO.2253			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27941759				2022-12-25	WOS:000393533000016
J	Okondo, MC; Johnson, DC; Sridharan, R; Bin Go, E; Chui, AJ; Wang, MS; Poplawski, SE; Wu, WG; Liu, YX; Lai, JH; Sanford, DG; Arciprete, MO; Golub, TR; Bachovchin, WW; Bachovchin, DA				Okondo, Marian C.; Johnson, Darren C.; Sridharan, Ramya; Bin Go, Eun; Chui, Ashley J.; Wang, Mitchell S.; Poplawski, Sarah E.; Wu, Wengen; Liu, Yuxin; Lai, Jack H.; Sanford, David G.; Arciprete, Michael O.; Golub, Todd R.; Bachovchin, William W.; Bachovchin, Daniel A.			DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis	NATURE CHEMICAL BIOLOGY			English	Article							PROLYL DIPEPTIDASE DPP8; INFLAMMASOME ACTIVATION; PEPTIDASES 8; GASDERMIN D; CANCER; EXPRESSION; POTENT; IMMUNOSURVEILLANCE; LOCALIZATION; CASPASE-11	Val-boroPro (Talabostat, PT-100), a nonselective inhibitor of post-proline cleaving serine proteases, stimulates mammalian immune systems through an unknown mechanism of action. Despite this lack of mechanistic understanding, Val-boroPro has attracted substantial interest as a potential anticancer agent, reaching phase 3 trials in humans. Here we show that Val-boroPro stimulates the immune system by triggering a proinflammatory form of cell death in monocytes and macrophages known as pyroptosis. We demonstrate that the inhibition of two serine proteases, DPP8 and DPP9, activates the pro-protein form of caspase-1 independent of the inflammasome adaptor ASC. Activated pro-caspase-1 does not efficiently process itself or IL-113 but does cleave and activate gasdermin D to induce pyroptosis. Mice lacking caspase-1 do not show immune stimulation after treatment with Val-boroPro. Our data identify what is to our knowledge the first small molecule that induces pyroptosis and reveals a new checkpoint that controls the activation of the innate immune system.	[Okondo, Marian C.; Bachovchin, Daniel A.] Mem Sloan Kettering Canc Ctr, Chem Biol Program, 1275 York Ave, New York, NY 10021 USA; [Johnson, Darren C.; Bin Go, Eun; Chui, Ashley J.; Bachovchin, Daniel A.] Mem Sloan Kettering Canc Ctr, Triinst PhD Program Chem Biol, 1275 York Ave, New York, NY 10021 USA; [Sridharan, Ramya; Wang, Mitchell S.; Bachovchin, Daniel A.] Weill Cornell Grad Sch Med Sci, Grad Program Pharmacol, New York, NY 10065 USA; [Poplawski, Sarah E.; Wu, Wengen; Liu, Yuxin; Lai, Jack H.; Sanford, David G.; Arciprete, Michael O.; Bachovchin, William W.] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Dev Chem & Mol Biol, Boston, MA 02111 USA; [Golub, Todd R.] Eli & Edythe L Broad Inst, Cambridge, MA USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Harvard Med Sch, Boston, MA USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bachovchin, William W.] Arisaph Pharmaceut, Boston, MA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Tufts University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Bachovchin, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Chem Biol Program, 1275 York Ave, New York, NY 10021 USA.; Bachovchin, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Triinst PhD Program Chem Biol, 1275 York Ave, New York, NY 10021 USA.; Bachovchin, DA (corresponding author), Weill Cornell Grad Sch Med Sci, Grad Program Pharmacol, New York, NY 10065 USA.	bachovcd@mskcc.org	william.bachovchin@tufts.edu/AAA-3538-2022; liu, yuxin/GRY-3592-2022	Okondo, Marian/0000-0003-0065-8155; Wang, Mitchell/0000-0002-6851-3596; Chui, Ashley/0000-0003-0037-5761; Johnson, Darren/0000-0002-0858-6152; Sridharan, Ramya/0000-0003-0235-6396	Josie Robertson Foundation; MSKCC Core Grant [P30 CA008748]; NCI [U54CA112962]; HHMI; NIH [CA174008-01A1, NIH NIGMS T32 GM115327-Tan]; NATIONAL CANCER INSTITUTE [R41CA174008, U54CA112962, R01CA163930, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM115327] Funding Source: NIH RePORTER	Josie Robertson Foundation; MSKCC Core Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Fujisawa for microscopy assistance, E. De Stanchina and B. Qeriqi for assistance harvesting mEMDMs, C. Taabazuing for helpful comments and A. Kentsis and F. Brown (Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center) for the HL-60 cell line. This work was supported by the Josie Robertson Foundation (D.A.B.), the MSKCC Core Grant (P30 CA008748), the NCI (grant no. U54CA112962 to T.R.G.), HHMI (T.R.G.) and the NIH (CA174008-01A1 to W.W.B. and NIH NIGMS T32 GM115327-Tan to D.C.J.).	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Adams S, 2004, CANCER RES, V64, P5471, DOI 10.1158/0008-5472.CAN-04-0447; Ajami K, 2004, BBA-GENE STRUCT EXPR, V1679, P18, DOI 10.1016/j.bbaexp.2004.03.010; Augeri DJ, 2005, J MED CHEM, V48, P5025, DOI 10.1021/jm050261p; Bachovchin DA, 2014, NAT CHEM BIOL, V10, P656, DOI [10.1038/NCHEMBIO.1578, 10.1038/nchembio.1578]; Broz P, 2015, NATURE, V526, P642, DOI 10.1038/nature15632; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Burkey BF, 2008, DIABETES OBES METAB, V10, P1057, DOI 10.1111/j.1463-1326.2008.00860.x; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Guey B, 2014, P NATL ACAD SCI USA, V111, P17254, DOI 10.1073/pnas.1415756111; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Jesson MI, 2007, P 98 ANN M AM ASS CA; Jiaang WT, 2005, BIOORG MED CHEM LETT, V15, P687, DOI 10.1016/j.bmcl.2004.11.023; Jones B, 2003, BLOOD, V102, P1641, DOI 10.1182/blood-2003-01-0208; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kortmann J, 2015, J IMMUNOL, V195, P815, DOI 10.4049/jimmunol.1403100; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Lee HJ, 2006, J BIOL CHEM, V281, P38653, DOI 10.1074/jbc.M603895200; Matheeussen V, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0350-4; Ohnuma K, 2004, P NATL ACAD SCI USA, V101, P14186, DOI 10.1073/pnas.0405266101; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Rosenblum J. S., 2007, AM DIAB ASS C; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Tang HK, 2009, ARCH BIOCHEM BIOPHYS, V485, P120, DOI 10.1016/j.abb.2009.02.015; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Van Opdenbosch N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4209; Villhauer EB, 2003, J MED CHEM, V46, P2774, DOI 10.1021/jm030091l; Wagner L, 2016, CLIN EXP IMMUNOL, V184, P265, DOI 10.1111/cei.12757; Walsh MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058860; Waumans Y, 2016, INFLAMMATION, V39, P413, DOI 10.1007/s10753-015-0263-5; Waumans Y, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00387; Wilson CH, 2013, J BIOL CHEM, V288, P13936, DOI 10.1074/jbc.M112.445841; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wu JJ, 2009, BIOCHEM PHARMACOL, V78, P203, DOI 10.1016/j.bcp.2009.03.032; Zhang H, 2015, FEBS J, V282, P3737, DOI 10.1111/febs.13371; Zhang H, 2013, MOL CANCER RES, V11, P1487, DOI 10.1158/1541-7786.MCR-13-0272; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	42	132	139	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					46	53		10.1038/NCHEMBIO.2229	http://dx.doi.org/10.1038/NCHEMBIO.2229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27820798	Green Accepted			2022-12-25	WOS:000393267200012
J	Jagadeesh, KA; Wenger, AM; Berger, MJ; Guturu, H; Stenson, PD; Cooper, DN; Bernstein, JA; Bejerano, G				Jagadeesh, Karthik A.; Wenger, Aaron M.; Berger, Mark J.; Guturu, Harendra; Stenson, Peter D.; Cooper, David N.; Bernstein, Jonathan A.; Bejerano, Gill			M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity	NATURE GENETICS			English	Article							MENDELIAN DISORDERS; MUTATIONS; STANDARDS; IDENTIFICATION; PREDICTION; GENOMICS; ELEMENTS	Variant pathogenicity classifiers such as SIFT, PolyPhen-2, CADD, and MetaLR assist in interpretation of the hundreds of rare, missense variants in the typical patient genome by deprioritizing some variants as likely benign. These widely used methods misclassify 26 to 38% of known pathogenic mutations, which could lead to missed diagnoses if the classifiers are trusted as definitive in a clinical setting. We developed M-CAP, a clinical pathogenicity classifier that outperforms existing methods at all thresholds and correctly dismisses 60% of rare, missense variants of uncertain significance in a typical genome at 95% sensitivity.	[Jagadeesh, Karthik A.; Berger, Mark J.; Bejerano, Gill] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Wenger, Aaron M.; Guturu, Harendra; Bernstein, Jonathan A.; Bejerano, Gill] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Stenson, Peter D.; Cooper, David N.] Cardiff Univ, Dept Med Genet, Heath Pk, Cardiff, S Glam, Wales; [Bejerano, Gill] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Cardiff University; Stanford University	Bejerano, G (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.; Bejerano, G (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.; Bejerano, G (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	bejerano@stanford.edu	Cooper, David N/H-4384-2011	Cooper, David N/0000-0002-8943-8484	Qiagen; Cardiff University; Stanford Pediatrics Department; DARPA; Packard Foundation Fellowship; Microsoft Faculty Fellowship	Qiagen; Cardiff University; Stanford Pediatrics Department; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Packard Foundation Fellowship; Microsoft Faculty Fellowship(Microsoft)	We thank the members of the Bejerano laboartory, particularly J. Notwell, S. Chinchali, and J. Birgmeier, for technical advice and helpful discussions. P.D.S. and D.N.C. receive financial support from Qiagen through a license agreement with Cardiff University. We thank the PolyPhen-2, CADD, Eigen, FATHMM, MutationTaster, and MetaLR teams for making their training and testing data readily available. This work was funded in part by the Stanford Pediatrics Department, DARPA, a Packard Foundation Fellowship, and a Microsoft Faculty Fellowship to G.B.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Brownstein CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r53; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Fusi N., 2015, SILICO PREDICTIVE MO; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Hastie T., 2003, ELEMENTS STAT LEARNI; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Iglesias A, 2014, GENET MED, V16, P922, DOI 10.1038/gim.2014.58; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ogutu J.O., 2011, BIOMED CENTRAL, V5, pS11, DOI [DOI 10.1186/1753-6561-5-S3-S11, 10.1186/1753-6561-5-S3-S11]; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	34	436	441	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1581	1586		10.1038/ng.3703	http://dx.doi.org/10.1038/ng.3703			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27776117				2022-12-25	WOS:000389011100021
J	Moynihan, KD; Opel, CF; Szeto, GL; Tzeng, A; Zhu, EF; Engreitz, JM; Williams, RT; Rakhra, K; Zhang, MH; Rothschilds, AM; Kumari, S; Kelly, RL; Kwan, BH; Abraham, W; Hu, K; Mehta, NK; Kauke, MJ; Suh, H; Cochran, JR; Lauffenburger, DA; Wittrup, KD; Irvine, DJ				Moynihan, Kelly D.; Opel, Cary F.; Szeto, Gregory L.; Tzeng, Alice; Zhu, Eric F.; Engreitz, Jesse M.; Williams, Robert T.; Rakhra, Kavya; Zhang, Michael H.; Rothschilds, Adrienne M.; Kumari, Sudha; Kelly, Ryan L.; Kwan, Byron H.; Abraham, Wuhbet; Hu, Kevin; Mehta, Naveen K.; Kauke, Monique J.; Suh, Heikyung; Cochran, Jennifer R.; Lauffenburger, Douglas A.; Wittrup, K. Dane; Irvine, Darrell J.			Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses	NATURE MEDICINE			English	Article							T-CELL IMMUNITY; DENDRITIC CELLS; CANCER-IMMUNOTHERAPY; METASTATIC MELANOMA; MYELOID COMPARTMENT; BREAST-CANCER; ANTIGEN; ANTIBODY; THERAPY; REGRESSION	Checkpoint blockade with antibodies specific for cytotoxic T lymphocyte-associated protein (CTLA)-4 or programmed cell death 1 (PDCD1; also known as PD-1) elicits durable tumor regression in metastatic cancer, but these dramatic responses are confined to a minority of patients. This suboptimal outcome is probably due in part to the complex network of immunosuppressive pathways present in advanced tumors, which are unlikely to be overcome by intervention at a single signaling checkpoint. Here we describe a combination immunotherapy that recruits a variety of innate and adaptive immune cells to eliminate large tumor burdens in syngeneic tumor models and a genetically engineered mouse model of melanoma; to our knowledge tumors of this size have not previously been curable by treatments relying on endogenous immunity. Maximal antitumor efficacy required four components: a tumor-antigen-targeting antibody, a recombinant interleukin-2 with an extended half-life, anti-PD-1 and a powerful T cell vaccine. Depletion experiments revealed that CD8(+) T cells, cross-presenting dendritic cells and several other innate immune cell subsets were required for tumor regression. Effective treatment induced infiltration of immune cells and production of inflammatory cytokines in the tumor, enhanced antibody-mediated tumor antigen uptake and promoted antigen spreading. These results demonstrate the capacity of an elicited endogenous immune response to destroy large, established tumors and elucidate essential characteristics of combination immunotherapies that are capable of curing a majority of tumors in experimental settings typically viewed as intractable.	[Moynihan, Kelly D.; Opel, Cary F.; Szeto, Gregory L.; Tzeng, Alice; Zhu, Eric F.; Rakhra, Kavya; Zhang, Michael H.; Rothschilds, Adrienne M.; Kumari, Sudha; Kelly, Ryan L.; Kwan, Byron H.; Abraham, Wuhbet; Mehta, Naveen K.; Kauke, Monique J.; Suh, Heikyung; Lauffenburger, Douglas A.; Wittrup, K. Dane; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Moynihan, Kelly D.; Szeto, Gregory L.; Tzeng, Alice; Rothschilds, Adrienne M.; Kelly, Ryan L.; Kwan, Byron H.; Hu, Kevin; Mehta, Naveen K.; Lauffenburger, Douglas A.; Wittrup, K. Dane; Irvine, Darrell J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Moynihan, Kelly D.; Szeto, Gregory L.; Lauffenburger, Douglas A.; Irvine, Darrell J.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA USA; [Opel, Cary F.; Zhu, Eric F.; Kauke, Monique J.; Wittrup, K. Dane] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Engreitz, Jesse M.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Engreitz, Jesse M.] Broad Inst MIT & Harvard Univ, Cambridge, MA USA; [Williams, Robert T.] MIT, Dept Biol, Cambridge, MA USA; [Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Cochran, Jennifer R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Cochran, Jennifer R.] Stanford Canc Inst, Stanford, CA USA; [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Szeto, Gregory L.; Zhang, Michael H.] Univ Maryland, Dept Chem Biochem & Environm Engn, Baltimore, MD 21201 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Stanford Cancer Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore	Wittrup, KD; Irvine, DJ (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Wittrup, KD; Irvine, DJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Irvine, DJ (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA USA.; Wittrup, KD (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Irvine, DJ (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.; Irvine, DJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	wittrup@mit.edu; djirvine@mit.edu	Szeto, Gregory/N-9648-2019	Szeto, Gregory/0000-0001-7604-1333; Moynihan, Kelly/0000-0001-6200-7863; Williams, Robert/0000-0002-9509-9327; Engreitz, Jesse/0000-0002-5754-1719; Kelly, Ryan/0000-0001-5003-9104; Tzeng, Alice/0000-0001-7316-6923; Kumari, Sudha/0000-0001-7082-2825	Koch Institute from the National Cancer Institute [P30-CA14051]; US National Institutes of Health (NIH) [CA174795]; Koch Institute for Integrative Cancer Research; Dana Farber-Harvard Cancer Center (DF-HCC); V Foundation; Ragon Institute; Fannie and John Hertz Foundation Fellowship; NSF Graduate Research Fellowships; NIGMS-NIH Interdepartmental Biotechnology Training Program (NIH) [T32GM008334]; Siebel Scholarship; NIH; Ruth L. Kirschstein National Research Service Award [CA180586]; NATIONAL CANCER INSTITUTE [R01CA174795, P30CA014051, F32CA180586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008334] Funding Source: NIH RePORTER	Koch Institute from the National Cancer Institute; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koch Institute for Integrative Cancer Research; Dana Farber-Harvard Cancer Center (DF-HCC); V Foundation; Ragon Institute; Fannie and John Hertz Foundation Fellowship; NSF Graduate Research Fellowships(National Science Foundation (NSF)); NIGMS-NIH Interdepartmental Biotechnology Training Program (NIH); Siebel Scholarship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute, the US National Institutes of Health (NIH) grant CA174795 (K.D.W.), the Bridge Project partnership between the Koch Institute for Integrative Cancer Research and the Dana Farber-Harvard Cancer Center (DF-HCC) (D.J.I.), the V Foundation (D.J.I.) and the Ragon Institute (D.J.I.). K.D.M. and J.M.E. are supported by the Fannie and John Hertz Foundation Fellowship; K.D.M., C.F.O., J.M.E., B.H.K. and E.F.Z. are supported by NSF Graduate Research Fellowships; A.M.R. is supported by the NIGMS-NIH Interdepartmental Biotechnology Training Program (NIH #T32GM008334); A.T. is supported by the Siebel Scholarship; and G.L.S. was supported by the NIH with a Ruth L. Kirschstein National Research Service Award (CA180586). We thank T.C. Wu (Johns Hopkins University) for kindly providing the TC-1 tumor cells, D. Sabatini (Whitehead Institute) for providing the Cas9 constructs and G. Dranoff (Dana-Farber Cancer Institute) for providing the DD-Her2/neu and B16-OVA cells. We thank M. Ghebremichael (Ragon Institute of MGH, MIT and Harvard) for helpful statistical advice. We thank the Koch Institute Swanson Biotechnology Center for technical support, specifically the applied therapeutics and wholeanimal imaging core facility, the histology and the flow cytometry core facilities. D.J.I. is an investigator of the Howard Hughes Medical Institute.	Albanesi M, 2013, BLOOD, V122, P3160, DOI 10.1182/blood-2013-04-497446; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Carmi Y, 2015, NATURE, V521, P99, DOI 10.1038/nature14424; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen G, 2014, CANCER IMMUNOL RES, V2, P949, DOI 10.1158/2326-6066.CIR-14-0058; Clatworthy MR, 2014, NAT MED, V20, P1458, DOI 10.1038/nm.3709; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DiLillo DJ, 2015, CELL, V161, P1035, DOI 10.1016/j.cell.2015.04.016; Drake CG, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds262; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; Gajewski TF, 2015, SEMIN ONCOL, V42, P663, DOI 10.1053/j.seminoncol.2015.05.011; Gasteiger G, 2013, J EXP MED, V210, P1167, DOI 10.1084/jem.20122462; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Guevara-Patino JA, 2006, J CLIN INVEST, V116, P1382, DOI 10.1172/JCI25591; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hooijkaas AI, 2012, AM J PATHOL, V181, P785, DOI 10.1016/j.ajpath.2012.06.002; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMc1509660, 10.1056/NEJMoa1504030]; LIST J, 1992, CANCER RES, V52, P1123; Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978; Lum LG, 2015, CLIN CANCER RES, V21, P2305, DOI 10.1158/1078-0432.CCR-14-2280; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mendiratta SK, 2001, CANCER RES, V61, P859; Moore SJ, 2013, P NATL ACAD SCI USA, V110, P14598, DOI 10.1073/pnas.1311333110; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nelson MH, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0110-8; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Phan GQ, 2001, J CLIN ONCOL, V19, P3477, DOI 10.1200/JCO.2001.19.15.3477; Rafiq K, 2002, J CLIN INVEST, V110, P71, DOI 10.1172/JCI200215640; Rapoport AP, 2014, CLIN CANCER RES, V20, P1355, DOI 10.1158/1078-0432.CCR-13-2817; Ribas A., 2015, ASCO ANN M P, V33; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Smyth MJ, 2016, NAT REV CLIN ONCOL, V13, P143, DOI 10.1038/nrclinonc.2015.209; Stromnes IM, 2015, CANCER CELL, V28, P638, DOI 10.1016/j.ccell.2015.09.022; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tzeng A, 2015, P NATL ACAD SCI USA, V112, P3320, DOI 10.1073/pnas.1416159112; van Egmond M, 2013, SEMIN CANCER BIOL, V23, P190, DOI 10.1016/j.semcancer.2012.12.002; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; van Stipdonk MJB, 2009, CANCER RES, V69, P7784, DOI 10.1158/0008-5472.CAN-09-1724; Vigneron Nathalie, 2013, Cancer Immun, V13, P15; Weiskopf K, 2015, MABS-AUSTIN, V7, P303, DOI 10.1080/19420862.2015.1011450; Woo SR, 2015, ANNU REV IMMUNOL, V33, P445, DOI 10.1146/annurev-immunol-032414-112043; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Zhu EF, 2015, CANCER CELL, V27, P489, DOI 10.1016/j.ccell.2015.03.004; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	64	315	327	9	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1402	+		10.1038/nm.4200	http://dx.doi.org/10.1038/nm.4200			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27775706	Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000389549000017
J	Zhang, JR; Liu, N; Cacho, RA; Gong, Z; Liu, Z; Qin, WM; Tang, C; Tang, Y; Zhou, JH				Zhang, Jinru; Liu, Nicholas; Cacho, Ralph A.; Gong, Zhou; Liu, Zhu; Qin, Wenming; Tang, Chun; Tang, Yi; Zhou, Jiahai			Structural basis of nonribosomal peptide macrocyclization in fungi	NATURE CHEMICAL BIOLOGY			English	Article							MOLECULAR-MECHANISMS; CONDENSATION; CYCLIZATION; SYNTHETASE; DOMAIN; CRYSTALLIZATION; OPTIMIZATION	Nonribosomal peptide synthetases (NRPSs) in fungi biosynthesize important pharmaceutical compounds, including penicillin, cyclosporine and echinocandin. To understand the fungal strategy of forging the macrocyclic peptide linkage, we determined the crystal structures of the terminal condensation-like (C-T) domain and the holo thiolation (T)-C-T complex of Penicillium aethiopicum TqaA. The first, to our knowledge, structural depiction of the terminal module in a fungal NRPS provides a molecular blueprint for generating new macrocyclic peptide natural products.	[Zhang, Jinru; Zhou, Jiahai] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai, Peoples R China; [Liu, Nicholas; Cacho, Ralph A.; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Dept Chem & Biomol Engn, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Gong, Zhou; Tang, Chun] Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom Mol Phys, Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Liu, Zhu; Tang, Chun] Zhejiang Univ, Dept Pharmacol, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Qin, Wenming] Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Ctr Prot Sci Shanghai, Shanghai, Peoples R China; [Zhou, Jiahai] Shanghai Collaborat Innovat Ctr Biomfg Technol, Shanghai, Peoples R China; [Cacho, Ralph A.] Univ Washington, Dept Biochem, Inst Prot Design, Mol Engn & Sci, Seattle, WA 98195 USA	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Washington; University of Washington Seattle	Zhou, JH (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai, Peoples R China.; Tang, Y (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Dept Chem & Biomol Engn, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Zhou, JH (corresponding author), Shanghai Collaborat Innovat Ctr Biomfg Technol, Shanghai, Peoples R China.	yitang@ucla.edu; jiahai@sioc.ac.cn		liu, zhu/0000-0003-4073-7237; Tang, Chun/0000-0001-6477-6500; Qin, Wenming/0000-0002-8157-6647	Science and Technology Commission of Shanghai Municipality [15JC1400403]; Chinese Ministry of Science and Technology [2013CB910200]; National Natural Science Foundation of China [31470187]; US National Institutes of Health [1DP1GM106413, 1R35GM118056]; State Key Laboratory of Bioreactor Engineering; State Key Laboratory of Microbial Metabolism at Shanghai Jiao Tong University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067555, R35GM118056, DP1GM106413] Funding Source: NIH RePORTER	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State Key Laboratory of Bioreactor Engineering; State Key Laboratory of Microbial Metabolism at Shanghai Jiao Tong University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at beamline BL17U1 of the Shanghai Synchrotron Radiation Facility (China), beamline BL5a of the Photon Factory (Japan), and beamlines BL19U1 and 19U2 of National Center for Protein Science Shanghai (China) for access and help with data collection. This work was supported by grants from the Science and Technology Commission of Shanghai Municipality (15JC1400403 to J.Z.), the Chinese Ministry of Science and Technology (2013CB910200 to C.T.), the National Natural Science Foundation of China (31470187 to J.Z.), US National Institutes of Health (1DP1GM106413 and 1R35GM118056 to Y.T.), and the Open Fund from the State Key Laboratory of Bioreactor Engineering and the State Key Laboratory of Microbial Metabolism at Shanghai Jiao Tong University (to J.Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; Bloudoff K, 2013, J MOL BIOL, V425, P3137, DOI 10.1016/j.jmb.2013.06.003; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Cacho RA, 2012, J AM CHEM SOC, V134, P16781, DOI 10.1021/ja307220z; Chen SCA, 2011, DRUGS, V71, P11, DOI 10.2165/11585270-000000000-00000; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Drake EJ, 2016, NATURE, V529, P235, DOI 10.1038/nature16163; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gao X, 2012, NAT CHEM BIOL, V8, P823, DOI 10.1038/NCHEMBIO.1047; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Haynes SW, 2012, J AM CHEM SOC, V134, P17444, DOI 10.1021/ja308371z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Kohli RM, 2002, NATURE, V418, P658, DOI 10.1038/nature00907; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWEN A, 1990, J BIOL CHEM, V265, P11355; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller BR, 2016, METHODS MOL BIOL, V1401, P3, DOI 10.1007/978-1-4939-3375-4_1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng C, 2012, P NATL ACAD SCI USA, V109, P8540, DOI 10.1073/pnas.1204232109; Ren AM, 2010, ACTA CRYSTALLOGR F, V66, P1635, DOI 10.1107/S174430911004114X; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Samel SA, 2014, ACTA CRYSTALLOGR D, V70, P1442, DOI 10.1107/S1399004714004398; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	31	42	45	1	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1001	+		10.1038/nchembio.2202	http://dx.doi.org/10.1038/nchembio.2202			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27748753	Green Accepted			2022-12-25	WOS:000388582900006
J	Bian, YY; Li, L; Dong, MM; Liu, XG; Kaneko, T; Cheng, K; Liu, HD; Voss, C; Cao, X; Wang, Y; Litchfield, D; Ye, ML; Li, SSC; Zou, HF				Bian, Yangyang; Li, Lei; Dong, Mingming; Liu, Xuguang; Kaneko, Tomonori; Cheng, Kai; Liu, Huadong; Voss, Courtney; Cao, Xuan; Wang, Yan; Litchfield, David; Ye, Mingliang; Li, Shawn S-C; Zou, Hanfa			Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder	NATURE CHEMICAL BIOLOGY			English	Article							ION AFFINITY-CHROMATOGRAPHY; BREAST-CANCER CELLS; FACTOR-I RECEPTOR; POSTTRANSLATIONAL MODIFICATIONS; PHOSPHORYLATION DYNAMICS; SIGNALING NETWORKS; MASS-SPECTROMETRY; ACTIVATION LOOP; HUMAN PROTEOME; LUNG-CANCER	We present a new strategy for systematic identification of phosphotyrosine (pTyr) by affinity purification mass spectrometry (AP-MS) using a Src homology 2 (SH2)-domain-derived pTyr superbinder as the affinity reagent. The superbinder allows for markedly deeper coverage of the Tyr phosphoproteome than anti-pTyr antibodies when an optimal amount is used. We identified similar to 20,000 distinct phosphotyrosyl peptides and >10,000 pTyr sites, of which 36% were 'novel', from nine human cell lines using the superbinder approach. Tyrosine kinases, SH2 domains and phosphotyrosine phosphatases were preferably phosphorylated, suggesting that the toolkit of kinase signaling is subject to intensive regulation by phosphorylation. Cell-type-specific global kinase activation patterns inferred from label-free quantitation of Tyr phosphorylation guided the design of experiments to inhibit cancer cell proliferation by blocking the highly activated tyrosine kinases. Therefore, the superbinder is a highly efficient and cost-effective alternative to conventional antibodies for systematic and quantitative characterization of the tyrosine phosphoproteome under normal or pathological conditions.	[Bian, Yangyang; Dong, Mingming; Cheng, Kai; Ye, Mingliang; Zou, Hanfa] Chinese Acad Sci, Dalian Inst Chem Phys, Natl Chromatog R&D Ctr, Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Bian, Yangyang; Dong, Mingming] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Lei; Liu, Xuguang; Kaneko, Tomonori; Liu, Huadong; Voss, Courtney; Cao, Xuan; Litchfield, David; Li, Shawn S-C] Western Univ, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Li, Lei] Qingdao Univ, Sch Basic Med Sci, Qingdao, Peoples R China; [Litchfield, David; Li, Shawn S-C] Western Univ, Schulich Sch Med & Dent, Dept Oncol, London, ON, Canada; [Li, Shawn S-C] Western Univ, Schulich Sch Med & Dent, Childrens Hlth Res Inst, London, ON, Canada	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Western University (University of Western Ontario); Qingdao University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Ye, ML; Zou, HF (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, Natl Chromatog R&D Ctr, Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China.; Li, SSC (corresponding author), Western Univ, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada.; Li, SSC (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Oncol, London, ON, Canada.; Li, SSC (corresponding author), Western Univ, Schulich Sch Med & Dent, Childrens Hlth Res Inst, London, ON, Canada.	mingliang@dicp.ac.cn; sli@uwo.ca; hanfazou@dicp.ac.cn	Cheng, Kai/AAI-8344-2020; bian, yangyang/G-1659-2013	Cheng, Kai/0000-0002-6045-0244; Dong, Mingming/0000-0002-0770-7880; bian, yangyang/0000-0002-9909-1699; Kaneko, Tomonori/0000-0001-5448-9639	China State Key Basic Research Program [2012CB910101, 2016YFA0501402, 2013CB911202]; National Natural Science Foundation of China [21235006, 21321064, 21535008, 81361128015]; Canadian Cancer Society; Canadian Institute of Health Research; Ontario Research Fund; National Science Fund of China [21525524]; Canadian Research Chair in Functional Genomics and Cellular Proteomics	China State Key Basic Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; National Science Fund of China(National Natural Science Foundation of China (NSFC)); Canadian Research Chair in Functional Genomics and Cellular Proteomics	This work was supported, in part, by funds from the China State Key Basic Research Program Grants (2012CB910101 and 2016YFA0501402 to M.Y. and 2013CB911202 to H.Z.), the National Natural Science Foundation of China (21235006, 21321064 and 21535008 to H.Z., and 81361128015 to M.Y. and S.S.-C.L.), the Canadian Cancer Society (to S.S.-C.L.), the Canadian Institute of Health Research (to S.S.-C.L. and M.Y.) and the Ontario Research Fund (to S.S.-C.L.). L.L. is a recipient of "Distinguished Expert of Overseas Tai Shan Scholar". M.Y. is a recipient of the National Science Fund of China for Distinguished Young Scholars (21525524). S.S.-C.L. holds a Canadian Research Chair in Functional Genomics and Cellular Proteomics.	Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Boersema PJ, 2010, MOL CELL PROTEOMICS, V9, P84, DOI 10.1074/mcp.M900291-MCP200; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; de Graaf EL, 2014, MOL CELL PROTEOMICS, V13, P2426, DOI 10.1074/mcp.O113.036608; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dey BR, 1996, MOL ENDOCRINOL, V10, P631, DOI 10.1210/me.10.6.631; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Findlay GM, 2013, CELL, V152, P1008, DOI 10.1016/j.cell.2013.01.056; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jin LL, 2015, MOL CELL PROTEOMICS, V14, P695, DOI 10.1074/mcp.M114.044404; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; Kim HG, 2013, ACS CHEM BIOL, V8, P2145, DOI 10.1021/cb400430t; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levitzki A, 2013, ANNU REV PHARMACOL, V53, P161, DOI 10.1146/annurev-pharmtox-011112-140341; Li L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6469; Lu CT, 2013, NUCLEIC ACIDS RES, V41, pD295, DOI 10.1093/nar/gks1229; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matlock MK, 2015, NUCLEIC ACIDS RES, V43, pD521, DOI 10.1093/nar/gku1154; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Qian XL, 2009, CANCER CELL, V16, P246, DOI 10.1016/j.ccr.2009.07.031; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sabbatini P, 2009, MOL CANCER THER, V8, P2811, DOI 10.1158/1535-7163.MCT-09-0423; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; SeppLorenzino L, 1996, ONCOGENE, V12, P1679; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Stokes MP, 2015, PROTEOMES, V3, DOI [10.3390/proteomes3030160, 10.3390/proteomes3030159]; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Takeuchi K, 2011, BIOL PHARM BULL, V34, P1774, DOI 10.1248/bpb.34.1774; TARTAREDECKERT S, 1995, J BIOL CHEM, V270, P23456, DOI 10.1074/jbc.270.40.23456; Tinti M, 2012, NEW BIOTECHNOL, V29, P571, DOI 10.1016/j.nbt.2011.12.001; Wang FJ, 2010, ANAL CHEM, V82, P3007, DOI 10.1021/ac100075y; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Xie YM, 1995, J BIOL CHEM, V270, P30717, DOI 10.1074/jbc.270.51.30717; Zaman N, 2013, CELL REP, V5, P216, DOI 10.1016/j.celrep.2013.08.028; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zhou HJ, 2008, J PROTEOME RES, V7, P3957, DOI 10.1021/pr800223m; Zhou HJ, 2013, NAT PROTOC, V8, P461, DOI 10.1038/nprot.2013.010	54	93	99	9	179	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					959	+		10.1038/NCHEMBIO.2178	http://dx.doi.org/10.1038/NCHEMBIO.2178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27642862				2022-12-25	WOS:000386798800018
J	Liang, JR; Zhang, YL; Xie, T; Liu, NS; Chen, HY; Geng, Y; Kurkciyan, A; Mena, JM; Stripp, BR; Jiang, DH; Noble, PW				Liang, Jiurong; Zhang, Yanli; Xie, Ting; Liu, Ningshan; Chen, Huaiyong; Geng, Yan; Kurkciyan, Adrianne; Mena, Jessica Monterrosa; Stripp, Barry R.; Jiang, Dianhua; Noble, Paul W.			Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice	NATURE MEDICINE			English	Article							TOLL-LIKE RECEPTORS; CAPILLARY VASCULAR NICHE; STEM-CELLS; LUNG EPITHELIUM; REPAIR; PROLIFERATION; REGENERATION; EXPRESSION; INJURY; INFLAMMATION	Successful recovery from lung injury requires the repair and regeneration of alveolar epithelial cells to restore the integrity of gas-exchanging regions within the lung and preserve organ function. Improper regeneration of the alveolar epithelium is often associated with severe pulmonary fibrosis, the latter of which involves the recruitment and activation of fibroblasts, as well as matrix accumulation. Type 2 alveolar epithelial cells (AEC2s) are stem cells in the adult lung that contribute to the lung repair process. The mechanisms that regulate AEC2 renewal are incompletely understood. We provide evidence that expression of the innate immune receptor Toll-like receptor 4 (TLR4) and the extracellular matrix glycosaminoglycan hyaluronan (HA) on AEC2s are important for AEC2 renewal, repair of lung injury and limiting the extent of fibrosis. Either deletion of TLR4 or HA synthase 2 in surfactant-protein-C-positive AEC2s leads to impaired renewal capacity, severe fibrosis and mortality. Furthermore, AEC2s from patients with severe pulmonary fibrosis have reduced cell surface HA and impaired renewal capacity, suggesting that HA and TLR4 are key contributors to lung stem cell renewal and that severe pulmonary fibrosis is the result of distal epithelial stem cell failure.	[Liang, Jiurong; Zhang, Yanli; Xie, Ting; Liu, Ningshan; Geng, Yan; Kurkciyan, Adrianne; Mena, Jessica Monterrosa; Stripp, Barry R.; Jiang, Dianhua; Noble, Paul W.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Liang, Jiurong; Zhang, Yanli; Xie, Ting; Liu, Ningshan; Geng, Yan; Kurkciyan, Adrianne; Mena, Jessica Monterrosa; Stripp, Barry R.; Jiang, Dianhua; Noble, Paul W.] Cedars Sinai Med Ctr, Womens Guild Lung Inst, Los Angeles, CA 90048 USA; [Chen, Huaiyong] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Zhang, Yanli] Tsinghua Univ, Dept Biochem & Mol Biol, Peking Union Med Coll, Beijing, Peoples R China; [Chen, Huaiyong] Tianjin Haihe Hosp, Tianjin, Peoples R China; [Chen, Huaiyong] Tianjin Inst Resp Dis, Tianjin, Peoples R China	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Duke University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University	Jiang, DH; Noble, PW (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.; Jiang, DH; Noble, PW (corresponding author), Cedars Sinai Med Ctr, Womens Guild Lung Inst, Los Angeles, CA 90048 USA.	dianhua.jiang@cshs.org; paul.noble@cshs.org	Xie, Ting/I-9538-2019; Jiang, Dianhua/B-1421-2009; Liang, Carol Jiurong/AAI-4963-2021; Stripp, Barry/AAI-1467-2021; Chen, Huaiyong/G-3822-2014; Geng, Yan/ABH-7789-2022	Jiang, Dianhua/0000-0002-4508-3829; Liang, Jiurong/0000-0001-5179-5016; Monterrosa, Jessica/0000-0002-3315-4431; Xie, Ting/0000-0002-9958-3888; Stripp, Barry/0000-0003-4348-2137; Geng, Yan/0000-0001-8861-7686	US National Institute of Health (NIH) [P01 HL108793, R01 HL060539, AI052201, R01 HL122068]; California Institute for Regenerative Medicine [RB5-07302]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060539, R01HL122068, P01HL108793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052201] Funding Source: NIH RePORTER	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Leonado, Y. Jung and V. Hu for technical support. This work was supported by US National Institute of Health (NIH) grants P01 HL108793 (P.W.N.), R01 HL060539 (P.W.N.), AI052201 (P.W.N.) and R01 HL122068 (D.J.),. and California Institute for Regenerative Medicine grant RB5-07302 (P.W.N.). We thank B.L.M. Hogan for critical reading of the manuscript and for providing invaluable comments. We are grateful to S. Akira (University of Osaka, Japan), Y. Yamaguchi (Sanford-Burnham Medical Research Institute) and L. Dobbs (University of California, San Francisco) for providing critical reagents for the study.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Amin RS, 2001, J PEDIATR-US, V139, P85, DOI 10.1067/mpd.2001.114545; Armstrong L, 2004, AM J RESP CELL MOL, V31, P241, DOI 10.1165/rcmb.2004-0078OC; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cao ZW, 2016, NAT MED, V22, P154, DOI 10.1038/nm.4035; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen HY, 2012, STEM CELLS, V30, P1948, DOI 10.1002/stem.1150; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Garcia Christine Kim, 2011, Proc Am Thorac Soc, V8, P158, DOI 10.1513/pats.201008-056MS; Gonzalez RF, 2010, J HISTOCHEM CYTOCHEM, V58, P891, DOI 10.1369/jhc.2010.956433; Guzy RD, 2015, AM J RESP CELL MOL, V52, P116, DOI 10.1165/rcmb.2014-0184OC; Hofer CC, 2015, AM J PHYSIOL-LUNG C, V308, pL628, DOI 10.1152/ajplung.00373.2014; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Le TTT, 2014, J IMMUNOL, V193, P3755, DOI 10.4049/jimmunol.1302470; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu YR, 2015, AM J RESP CELL MOL, V53, P113, DOI 10.1165/rcmb.2013-0497OC; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769; Neal MD, 2012, J BIOL CHEM, V287, P37296, DOI 10.1074/jbc.M112.375881; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; O'Donoghue RJJ, 2012, EMBO MOL MED, V4, P939, DOI 10.1002/emmm.201100604; Oh K, 2011, J EXP MED, V208, P1707, DOI 10.1084/jem.20101457; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Rafii S, 2015, NAT CELL BIOL, V17, P123, DOI 10.1038/ncb3096; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Selman MS, 2004, DRUGS, V64, P405, DOI 10.2165/00003495-200464040-00005; Tadokoro T, 2014, P NATL ACAD SCI USA, V111, pE3641, DOI 10.1073/pnas.1409781111; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Zhang SJ, 2014, STEM CELLS, V32, P1616, DOI 10.1002/stem.1632	46	166	171	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1285	1293		10.1038/nm.4192	http://dx.doi.org/10.1038/nm.4192			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27694932	Green Accepted			2022-12-25	WOS:000387302300021
J	Loubiere, V; Delest, A; Thomas, A; Bonev, B; Schuettengruber, B; Sati, S; Martinez, AM; Cavalli, G				Loubiere, Vincent; Delest, Anna; Thomas, Aubin; Bonev, Boyan; Schuettengruber, Bernd; Sati, Satish; Martinez, Anne-Marie; Cavalli, Giacomo			Coordinate redeployment of PRC1 proteins suppresses tumor formation during Drosophila development	NATURE GENETICS			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; POLYCOMB-GROUP; DYNAMIC REGULATION; GENE-EXPRESSION; CELL-CYCLE; COMPLEXES; METHYLATION; REPRESSION; ENHANCER; TARGETS	Polycomb group proteins form two main complexes, PRC2 and PRC1, which generally coregulate their target genes. Here we show that PRC1 components act as neoplastic tumor suppressors independently of PRC2 function. By mapping the distribution of PRC1 components and trimethylation of histone H3 at Lys27 (H3K27me3) across the genome, we identify a large set of genes that acquire PRC1 in the absence of H3K27me3 in Drosophila larval tissues. These genes massively outnumber canonical targets and are mainly involved in the regulation of cell proliferation, signaling and polarity. Alterations in PRC1 components specifically deregulate this set of genes, whereas canonical targets are derepressed in both PRC1 and PRC2 mutants. In human embryonic stem cells, PRC1 components colocalize with H3K27me3 as in Drosophila embryos, whereas in differentiated cell types they are selectively recruited to a large set of proliferation and signaling -associated genes that lack H3K27me3, suggesting that the redeployment of PRC1 components during development is evolutionarily conserved.	[Loubiere, Vincent; Delest, Anna; Thomas, Aubin; Bonev, Boyan; Schuettengruber, Bernd; Sati, Satish; Martinez, Anne-Marie; Cavalli, Giacomo] CNRS, UPR1142, Inst Human Genet, Montpellier, France; [Loubiere, Vincent; Delest, Anna; Thomas, Aubin; Bonev, Boyan; Schuettengruber, Bernd; Sati, Satish; Martinez, Anne-Marie; Cavalli, Giacomo] Univ Montpellier, Dept Biol & Hlth, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier	Martinez, AM; Cavalli, G (corresponding author), CNRS, UPR1142, Inst Human Genet, Montpellier, France.; Martinez, AM; Cavalli, G (corresponding author), Univ Montpellier, Dept Biol & Hlth, Montpellier, France.	anne-marie.martinez@igh.cnrs.fr; giacomo.cavalli@igh.cnrs.fr	martinez, Anne-marie A.M/R-2751-2017; Cavalli, Giacomo/A-7958-2008; Sati, Satish/Q-6951-2019; cavalli, giacomo/Z-2754-2019; Sati, Satish/F-3531-2012	martinez, Anne-marie A.M/0000-0001-8562-7627; Cavalli, Giacomo/0000-0003-3709-3469; Sati, Satish/0000-0001-8236-9466; cavalli, giacomo/0000-0003-3709-3469; Bonev, Boyan/0000-0002-7502-9399; Schuettengruber, Bernd/0000-0001-7338-4648	European Research Council [ERC-2008-AdG No 232947]; CNRS; European Network of Excellence EpiGeneSys; European H2020 E-INFRASTRUCTURES Multiscale Genomics (MuG) grant; agence Nationale de la Recherche; Laboratory of Excellence EpiGenMed; Fondation ARC pour la Recherche sur le Cancer; Canceropole Grand Sud-Ouest [2012-E10]; Sir Henry Wellcome Postdoctoral Fellowship [WT100136MA]; Laboratory of Excellence (Labex) EpiGenMed; L'Institut National de la Saut et de la Recherche Medicale; Labex EpiGenMed	European Research Council(European Research Council (ERC)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Network of Excellence EpiGeneSys; European H2020 E-INFRASTRUCTURES Multiscale Genomics (MuG) grant; agence Nationale de la Recherche(French National Research Agency (ANR)); Laboratory of Excellence EpiGenMed; Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Canceropole Grand Sud-Ouest; Sir Henry Wellcome Postdoctoral Fellowship; Laboratory of Excellence (Labex) EpiGenMed; L'Institut National de la Saut et de la Recherche Medicale; Labex EpiGenMed	We thank F. Bantignies for his contribution on immuno-FISH experiments, S. Roux and C. Jacquier for producing and testing anti-SU(Z)12 rabbit antibodies. We thank the Montpellier RIO imaging facility for assistance with microscopy and the MGX facility for genomic data production and first-level processing. We are grateful to J. Kassis for anti-PHO antibodies, V. Pirrotta and R. Jones for anti-E(Z) antibodies and J. Muller for Sce-mutant fly lines. We thank the Bloomington Stock Center (Indiana University) and the Developmental Studies Hybridoma Bank (University of Iowa) for fly stocks and antibodies. We thank the laboratory of J. Wang for the ph<SUP>del</SUP> stock. We thank S. Perez-Lluch and Montserrat Corominas for providing the RNA-seq data on wild-type eye and wing imaginal discs before publication. We are grateful to the Genotoul bioinformatics platform Toulouse Midi-Pyrenees for providing computing and storage resources. Research in the laboratory of G.C. was supported by grants from the European Research Council (ERC-2008-AdG No 232947), CNRS, the European Network of Excellence EpiGeneSys, the European H2020 E-INFRASTRUCTURES Multiscale Genomics (MuG) grant, agence Nationale de la Recherche, the Laboratory of Excellence EpiGenMed and the Fondation ARC pour la Recherche sur le Cancer. A.-M.M. was supported by a grant from the Canceropole Grand Sud-Ouest (2012-E10). B.B. is supported by the Sir Henry Wellcome Postdoctoral Fellowship (WT100136MA). V.L. is supported by a doctoral fellowship from the Laboratory of Excellence (Labex) EpiGenMed. B.S. is supported by L'Institut National de la Saut et de la Recherche Medicale. S.S. is supported by a postdoctoral fellowship from the Labex EpiGenMed.	Beuchle D, 2001, DEVELOPMENT, V128, P993; Bunker BD, 2015, ELIFE, V4, DOI 10.7554/eLife.03189; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Classen AK, 2009, NAT GENET, V41, P1150, DOI 10.1038/ng.445; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Fisher KH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-506; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gregory SL, 2007, FLY, V1, P13, DOI 10.4161/fly.3806; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Grossniklaus U, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019331; Gutierrez L, 2012, DEVELOPMENT, V139, P117, DOI 10.1242/dev.074450; Herz HM, 2012, MOL CELL BIOL, V32, P1683, DOI 10.1128/MCB.06503-11; Kloet SL, 2016, NAT STRUCT MOL BIOL, V23, P682, DOI 10.1038/nsmb.3248; Koppens M, 2016, ONCOGENE, V35, P1341, DOI 10.1038/onc.2015.195; Kurzhals RL, 2008, DEV BIOL, V313, P293, DOI 10.1016/j.ydbio.2007.10.025; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Martinez AM, 2009, NAT GENET, V41, P1076, DOI 10.1038/ng.414; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Munoz-Descalzo S, 2011, DEVELOPMENT, V138, P1501, DOI 10.1242/dev.061309; Oguro H, 2012, J EXP MED, V209, P445, DOI 10.1084/jem.20111709; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pemberton H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r23; PHILLIPS MD, 1990, GENETICS, V125, P91; Piunti A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4649; Schaaf CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003560; Schuettengruber B, 2014, CELL REP, V9, P219, DOI 10.1016/j.celrep.2014.08.072; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Stowers RS, 1999, GENETICS, V152, P1631; Vidal M, 2009, INT J DEV BIOL, V53, P355, DOI 10.1387/ijdb.082690mv; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604	39	48	48	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1436	1442		10.1038/ng.3671	http://dx.doi.org/10.1038/ng.3671			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27643538	Green Accepted			2022-12-25	WOS:000386543400022
J	Marx, H; Minogue, CE; Jayaraman, D; Richards, AL; Kwiecien, NW; Siahpirani, AF; Rajasekar, S; Maeda, J; Garcia, K; Del Valle-Echevarria, AR; Volkening, JD; Westphall, MS; Roy, S; Sussman, MR; Ane, JM; Coon, JJ				Marx, Harald; Minogue, Catherine E.; Jayaraman, Dhileepkumar; Richards, Alicia L.; Kwiecien, Nicholas W.; Siahpirani, Alireza F.; Rajasekar, Shanmugam; Maeda, Junko; Garcia, Kevin; Del Valle-Echevarria, Angel R.; Volkening, Jeremy D.; Westphall, Michael S.; Roy, Sushmita; Sussman, Michael R.; Ane, Jean-Michel; Coon, Joshua J.			A proteomic atlas of the legume Medicago truncatula and its nitrogen-fixing endosymbiont Sinorhizobium meliloti	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION ATLAS; ARABIDOPSIS-THALIANA; PROVIDES INSIGHT; PLANT PEPTIDES; IN-VIVO; PHOSPHORYLATION; IDENTIFICATION; DATABASE; NODULATION; MODEL	Legumes are essential components of agricultural systems because they enrich the soil in nitrogen and require little environmentally deleterious fertilizers. A complex symbiotic association between legumes and nitrogen-fixing soil bacteria called rhizobia culminates in the development of root nodules, where rhizobia fix atmospheric nitrogen and transfer it to their plant host. Here we describe a quantitative proteomic atlas of the model legume Medicago truncatula and its rhizobial symbiont Sinorhizobium meliloti, which includes more than 23,000 proteins, 20,000 phosphorylation sites, and 700 lysine acetylation sites. Our analysis provides insight into mechanisms regulating symbiosis. We identify a calmodulin-binding protein as a key regulator in the host and assign putative roles and targets to host factors (bioactive peptides) that control gene expression in the symbiont. Further mining of this proteomic resource may enable engineering of crops and their microbial partners to increase agricultural productivity and sustainability.	[Marx, Harald; Minogue, Catherine E.; Richards, Alicia L.; Kwiecien, Nicholas W.; Westphall, Michael S.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Jayaraman, Dhileepkumar; Rajasekar, Shanmugam; Ane, Jean-Michel] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA; [Siahpirani, Alireza F.] Univ Wisconsin, Dept Comp Sci, 1210 W Dayton St, Madison, WI 53706 USA; [Maeda, Junko; Garcia, Kevin; Del Valle-Echevarria, Angel R.; Ane, Jean-Michel] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Volkening, Jeremy D.; Sussman, Michael R.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Roy, Sushmita] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI USA; [Roy, Sushmita] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Coon, JJ (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.; Ane, JM (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.; Ane, JM (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	jeanmichel.ane@wisc.edu; jcoon@chem.wisc.edu	Ané, Jean-Michel/G-5921-2010; Volkening, Jeremy/AAC-2454-2020; Siahpirani, Alireza Fotuhi/AAS-1941-2021; Rajasekar, Shanmugam/U-2222-2019	Ané, Jean-Michel/0000-0002-3128-9439; Volkening, Jeremy/0000-0002-8892-7155; Garcia, Kevin/0000-0003-0821-1024; Del Valle Echevarria, Angel/0000-0001-7702-0147	NSF IOS-PGRP Grants [1237936, 1546742]; NSF CAREER award [DBI 1350677]; NLM training grant [NLM T15LM007359]; National Institutes of Health-Genomic Sciences Training Program [5T32HG002760]; ACS Division of Analytical Chemistry; Society of Analytical Chemists of Pittsburgh (SACP); Division Of Integrative Organismal Systems [1546742] Funding Source: National Science Foundation	NSF IOS-PGRP Grants; NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NLM training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health-Genomic Sciences Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS Division of Analytical Chemistry; Society of Analytical Chemists of Pittsburgh (SACP); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank T. Rhoads, K. Overmyer, and A. Hebert for fruitful discussions. This work was supported mainly by funds from the NSF IOS-PGRP Grants 1237936 and 1546742. S.R. gratefully acknowledges support from an NSF CAREER award (DBI 1350677). C.E.M. was supported by an NLM training grant to the Computation and Informatics in Biology and Medicine Training Program (NLM T15LM007359). A.L.R. gratefully acknowledges support from a National Institutes of Health-funded Genomic Sciences Training Program (5T32HG002760), the ACS Division of Analytical Chemistry, and the Society of Analytical Chemists of Pittsburgh (SACP).	Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Bhar K, 2015, PROTEIN J, V34, P158, DOI 10.1007/s10930-015-9608-z; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Clarke VC, 2015, MOL CELL PROTEOMICS, V14, P1301, DOI 10.1074/mcp.M114.043166; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deruyffelaere C, 2015, PLANT CELL PHYSIOL, V56, P1374, DOI 10.1093/pcp/pcv056; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Durgo H, 2015, PROTEOMICS, V15, P2291, DOI 10.1002/pmic.201400385; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Farkas A, 2014, P NATL ACAD SCI USA, V111, P5183, DOI 10.1073/pnas.1404169111; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gallardo K, 2003, PLANT PHYSIOL, V133, P664, DOI 10.1104/pp.103.025254; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Gong ZY, 2006, CELL RES, V16, P818, DOI 10.1038/sj.cr.7310096; Grimsrud PA, 2010, PLANT PHYSIOL, V152, P19, DOI 10.1104/pp.109.149625; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurihara D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-73; Lang C, 2015, MOL PLANT MICROBE IN, V28, P856, DOI 10.1094/MPMI-12-14-0407-R; Lauressergues D, 2015, NATURE, V520, P90, DOI 10.1038/nature14346; Limpens E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064377; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; Marx H, 2013, J PROTEOME RES, V12, P2386, DOI 10.1021/pr400215r; Maunoury N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009519; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Moreau M, 2012, MOL PLANT MICROBE IN, V25, P421, DOI 10.1094/MPMI-05-11-0111; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Nallu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060355; Niebel FD, 1998, MOL PLANT MICROBE IN, V11, P504; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ott T, 2005, CURR BIOL, V15, P531, DOI 10.1016/j.cub.2005.01.042; Penterman J, 2014, P NATL ACAD SCI USA, V111, P3561, DOI 10.1073/pnas.1400450111; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Poliakov A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007039; Roitinger E, 2015, MOL CELL PROTEOMICS, V14, P556, DOI 10.1074/mcp.M114.040352; Rose CM, 2012, MOL CELL PROTEOMICS, V11, P724, DOI 10.1074/mcp.M112.019208; Rose CM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00122; Roy S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003252; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Senko MW, 2013, ANAL CHEM, V85, P11710, DOI 10.1021/ac403115c; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tang HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-312; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; Thain D, 2005, CONCURR COMP-PRACT E, V17, P323, DOI 10.1002/cpe.938; Timmers ACJ, 1999, DEVELOPMENT, V126, P3617; Tiricz H, 2013, APPL ENVIRON MICROB, V79, P6737, DOI 10.1128/AEM.01791-13; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; Van de Velde W, 2006, PLANT PHYSIOL, V141, P711, DOI 10.1104/pp.106.078691; van Wijk KJ, 2014, PLANT CELL, V26, P2367, DOI 10.1105/tpc.114.125815; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Volkening JD, 2012, MOL CELL PROTEOMICS, V11, P933, DOI 10.1074/mcp.M112.019471; Walley JW, 2013, P NATL ACAD SCI USA, V110, pE4808, DOI 10.1073/pnas.1319113110; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; Xiao TT, 2014, DEVELOPMENT, V141, P3517, DOI 10.1242/dev.110775; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	71	66	71	3	105	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1198	+		10.1038/nbt.3681	http://dx.doi.org/10.1038/nbt.3681			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27748755	Green Published, Green Accepted			2022-12-25	WOS:000387506500032
J	Dror, S; Sander, L; Schwartz, H; Sheinboim, D; Barzilai, A; Dishon, Y; Apcher, S; Golan, T; Greenberger, S; Barshack, I; Malcov, H; Zilberberg, A; Levin, L; Nessling, M; Friedmann, Y; Igras, V; Barzilay, O; Vaknine, H; Brenner, R; Zinger, A; Schroeder, A; Gonen, P; Khaled, M; Erez, N; Hoheisel, JD; Levy, C				Dror, Shani; Sander, Laureen; Schwartz, Hila; Sheinboim, Danna; Barzilai, Aviv; Dishon, Yuval; Apcher, Sebastien; Golan, Tamar; Greenberger, Shoshana; Barshack, Iris; Malcov, Hagar; Zilberberg, Alona; Levin, Lotan; Nessling, Michelle; Friedmann, Yael; Igras, Vivien; Barzilay, Ohad; Vaknine, Hananya; Brenner, Ronen; Zinger, Assaf; Schroeder, Avi; Gonen, Pinchas; Khaled, Mehdi; Erez, Neta; Hoheisel, Joerg D.; Levy, Carmit			Melanoma miRNA trafficking controls tumour primary niche formation	NATURE CELL BIOLOGY			English	Article							CANCER-ASSOCIATED FIBROBLASTS; STROMAL FIBROBLASTS; MALIGNANT-MELANOMA; BREAST CARCINOMAS; SUPPRESSOR GENE; GROWTH; CELLS; MELANOSOMES; METASTASIS; CONTRIBUTE	Melanoma originates in the epidermis and becomes metastatic after invasion into the dermis. Prior interactions between melanoma cells and dermis are poorly studied. Here, we show that melanoma cells directly affect the formation of the dermal tumour niche by microRNA trafficking before invasion. Melanocytes, cells of melanoma origin, are specialized in releasing pigment vesicles, termed melanosomes. In melanoma in situ, we found melanosome markers in distal fibroblasts before melanoma invasion. The melanosomes carry microRNAs into primary fibroblasts triggering changes, including increased proliferation, migration and pro-inflammatory gene expression, all known features of cancer-associated fibroblasts (CAFs). Specifically, melanosomal microRNA-211 directly targets IGF2R and leads to MAPK signalling activation, which reciprocally encourages melanoma growth. Melanosome release inhibitor prevented CAF formation. Since the first interaction of melanoma cells with blood vessels occurs in the dermis, our data suggest an opportunity to block melanoma invasion by preventing the formation of the dermal tumour niche.	[Dror, Shani; Sheinboim, Danna; Dishon, Yuval; Golan, Tamar; Malcov, Hagar; Zilberberg, Alona; Levin, Lotan; Gonen, Pinchas; Levy, Carmit] Tel Aviv Univ, Dept Human Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Sander, Laureen; Hoheisel, Joerg D.] Deutsch Krebsforschungszentrum DKFZ, Funct Genome Anal, D-69120 Heidelberg, Germany; [Schwartz, Hila; Erez, Neta] Tel Aviv Univ, Dept Pathol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Barzilai, Aviv; Greenberger, Shoshana; Barshack, Iris] Sheba Med Ctr, Inst Pathol, IL-52621 Tel Hashomer, Israel; [Apcher, Sebastien] Univ Paris, Inst Gustave Roussy, Dept Immunol, F-94805 Villejuif, France; [Nessling, Michelle] Deutsch Krebsforschungszentrum DKFZ, Unit Electron Microscopy, Imaging & Cytometry Core Facil, D-69120 Heidelberg, Germany; [Friedmann, Yael] Hebrew Univ Jerusalem, Bioimaging Unit, IL-91904 Jerusalem, Israel; [Igras, Vivien] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Dept Dermatol, Boston, MA 02114 USA; [Igras, Vivien] Massachusetts Gen Hosp, MGH Canc Ctr, Boston, MA 02114 USA; [Barzilay, Ohad] Tel Aviv Univ, Coller Sch Management, IL-69978 Tel Aviv, Israel; [Vaknine, Hananya; Brenner, Ronen] E Wolfson Med Ctr, Inst Pathol, IL-58100 Holon, Israel; [Zinger, Assaf; Schroeder, Avi] Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel; [Khaled, Mehdi] Univ Paris Saclay, INSERM 1186, F-94805 Villejuif, France	Tel Aviv University; Sackler Faculty of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Hebrew University of Jerusalem; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Tel Aviv University; Technion Israel Institute of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Levy, C (corresponding author), Tel Aviv Univ, Dept Human Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	carmitlevy@post.tau.ac.il	Apcher, Sebastien/B-6356-2015; Apcher, Sebastien/P-2590-2018; Dror, Shani/ABE-4402-2021; Zinger, Assaf/S-6709-2019; khaled, mehdi/C-4854-2012	khaled, mehdi/0000-0002-9880-858X; Erez, Neta/0000-0001-6506-9074; Schroeder, Avi/0000-0003-2571-5937; Doron, Hila/0000-0001-9704-7240; dror, shani/0000-0002-9909-8110	Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israel's Ministry of Science, Technology and Space (MOST); Israel Science Foundation (ISF)	Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israel's Ministry of Science, Technology and Space (MOST); Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported in part by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and Israel's Ministry of Science, Technology and Space (MOST) and by the Israel Science Foundation (ISF). We thank the microarray unit of the DKFZ Genomics and Proteomics Core Facility for performing microarray analyses on the Illumina Human Sentrix-12 BeadChip array and the Agilent Human miRNA Microarray.	Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Barker HE, 2013, MOL CANCER RES, V11, P1425, DOI 10.1158/1541-7786.MCR-13-0033-T; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Bedrosian I, 2000, ANN SURG ONCOL, V7, P262, DOI 10.1007/s10434-000-0262-z; Bell RE, 2014, J INVEST DERMATOL, V134, P441, DOI 10.1038/jid.2013.340; Bell RE, 2011, PIGM CELL MELANOMA R, V24, P1088, DOI 10.1111/j.1755-148X.2011.00931.x; Bellei B, 2014, CELL SIGNAL, V26, P716, DOI 10.1016/j.cellsig.2013.12.023; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Boissy RE, 2003, EXP DERMATOL, V12, P5, DOI 10.1034/j.1600-0625.12.s2.1.x; Chappell SA, 1997, BRIT J CANCER, V76, P1558, DOI 10.1038/bjc.1997.596; Chen KG, 2006, P NATL ACAD SCI USA, V103, P9903, DOI 10.1073/pnas.0600213103; CORNIL I, 1991, P NATL ACAD SCI USA, V88, P6028, DOI 10.1073/pnas.88.14.6028; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Flach EH, 2011, MOL PHARMACEUT, V8, P2039, DOI 10.1021/mp200421k; Gallagher PG, 2005, CANCER RES, V65, P4134, DOI 10.1158/0008-5472.CAN-04-0415; Gamma A, 2000, LUNG CANCER-J IASLC, V30, P91, DOI 10.1016/S0169-5002(00)00130-6; Golan T., 2015, MOL CELL; Gu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052465; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; Hankins GR, 1996, ONCOGENE, V12, P2003; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; Joshi PG, 2007, PIGM CELL RES, V20, P380, DOI 10.1111/j.1600-0749.2007.00397.x; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lazova R, 2009, EXP DERMATOL, V18, P934, DOI 10.1111/j.1600-0625.2009.00933.x; Leibowitz-Amit R, 2012, PIGM CELL MELANOMA R, V25, P740, DOI 10.1111/pcmr.12018; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Levy C, 2010, CELL, V141, P994, DOI 10.1016/j.cell.2010.05.004; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YJ, 2015, CHEM COMMUN, V51, P15241, DOI 10.1039/c5cc05551b; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mitra AK, 2012, CANCER DISCOV, V2, P1100, DOI 10.1158/2159-8290.CD-12-0206; Oates AJ, 1998, BREAST CANCER RES TR, V47, P269, DOI 10.1023/A:1005959218524; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Ruiter D, 2002, LANCET ONCOL, V3, P35, DOI 10.1016/S1470-2045(01)00620-9; Sato Iwao, 2005, Okajimas Folia Anatomica Japonica, V82, P49, DOI 10.2535/ofaj.82.49; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Sharon Y, 2015, CANCER RES, V75, P963, DOI 10.1158/0008-5472.CAN-14-1990; Soderberg A, 2007, FREE RADICAL BIO MED, V43, P90, DOI 10.1016/j.freeradbiomed.2007.03.026; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Sun V, 2014, BRIT J DERMATOL, V171, P234, DOI 10.1111/bjd.12989; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D; van den Boorn JG, 2011, J INVEST DERMATOL, V131, P1240, DOI 10.1038/jid.2011.16; Watabe Hidenori, 2005, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0314s26; Xiao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046874; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Zhao F, 2009, CLIN CANCER RES, V15, P4382, DOI 10.1158/1078-0432.CCR-09-0399	56	123	127	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2016	18	9					1006	1017		10.1038/ncb3399	http://dx.doi.org/10.1038/ncb3399			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DU7TF	27548915				2022-12-25	WOS:000382416800010
J	Russell, J; Mascher, M; Dawson, IK; Kyriakidis, S; Calixto, C; Freund, F; Bayer, M; Milne, I; Marshall-Griffiths, T; Heinen, S; Hofstad, A; Sharma, R; Himmelbach, A; Knauft, M; van Zonneveld, M; Brown, JWS; Schmid, K; Kilian, B; Muehlbauer, GJ; Stein, N; Waugh, R				Russell, Joanne; Mascher, Martin; Dawson, Ian K.; Kyriakidis, Stylianos; Calixto, Cristiane; Freund, Fabian; Bayer, Micha; Milne, Iain; Marshall-Griffiths, Tony; Heinen, Shane; Hofstad, Anna; Sharma, Rajiv; Himmelbach, Axel; Knauft, Manuela; van Zonneveld, Maarten; Brown, John W. S.; Schmid, Karl; Kilian, Benjamin; Muehlbauer, Gary J.; Stein, Nils; Waugh, Robbie			Exome sequencing of geographically diverse barley landraces and wild relatives gives insights into environmental adaptation	NATURE GENETICS			English	Article							SELECTIVE SWEEPS; HORDEUM-VULGARE; EVOLUTIONARY HISTORY; POPULATION-STRUCTURE; MAIZE DOMESTICATION; ALLELE FREQUENCIES; CULTIVATED BARLEY; GENETIC-ANALYSIS; CIRCADIAN CLOCK; CLIMATE-CHANGE	After domestication, during a process of widespread range extension, barley adapted to a broad spectrum of agricultural environments. To explore how the barley genome responded to the environmental challenges it encountered, we sequenced the exomes of a collection of 267 georeferenced landraces and wild accessions. A combination of genome-wide analyses showed that patterns of variation have been strongly shaped by geography and that variant-by-environment associations for individual genes are prominent in our data set. We observed significant correlations of days to heading (flowering) and height with seasonal temperature and dryness variables in common garden experiments, suggesting that these traits were major drivers of environmental adaptation in the sampled germplasm. A detailed analysis of known flowering-associated genes showed that many contain extensive sequence variation and that patterns of single-and multiple-gene haplotypes exhibit strong geographical structuring. This variation appears to have substantially contributed to range-wide ecogeographical adaptation, but many factors key to regional success remain unidentified.	[Russell, Joanne; Dawson, Ian K.; Kyriakidis, Stylianos; Bayer, Micha; Milne, Iain; Marshall-Griffiths, Tony; Brown, John W. S.; Waugh, Robbie] James Hutton Inst, Cell & Mol Sci, Dundee, Scotland; [Mascher, Martin; Sharma, Rajiv; Himmelbach, Axel; Knauft, Manuela; Kilian, Benjamin; Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Stadt Seeland, Germany; [Mascher, Martin] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Calixto, Cristiane; Sharma, Rajiv; Brown, John W. S.; Waugh, Robbie] Univ Dundee, Sch Life Sci, James Hutton Inst, Div Plant Sci, Dundee, Scotland; [Freund, Fabian; Schmid, Karl] Univ Hohenheim, Dept Crop Biodivers & Breeding Informat, Stuttgart, Germany; [Heinen, Shane; Hofstad, Anna; Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [van Zonneveld, Maarten] Biovers Int, Costa Rica Off, Turrialba, Costa Rica; [Kilian, Benjamin] Bayer CropSci, Innovat Ctr, BCS Breeding & Trait Dev, Zwijnaarde, Gent, Belgium; [Muehlbauer, Gary J.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA	James Hutton Institute; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; James Hutton Institute; University of Dundee; University Hohenheim; University of Minnesota System; University of Minnesota Twin Cities; Alliance; Bioversity International; Bayer AG; Bayer CropScience; University of Minnesota System; University of Minnesota Twin Cities	Waugh, R (corresponding author), James Hutton Inst, Cell & Mol Sci, Dundee, Scotland.; Waugh, R (corresponding author), Univ Dundee, Sch Life Sci, James Hutton Inst, Div Plant Sci, Dundee, Scotland.	robbie.waugh@hutton.ac.uk	Sharma, Rajiv/W-9683-2019; Calixto, Cristiane P./L-7471-2017; Stein, Nils/F-7507-2017	Sharma, Rajiv/0000-0003-3488-8688; Calixto, Cristiane P./0000-0002-9935-9325; Stein, Nils/0000-0003-3011-8731; Mascher, Martin/0000-0001-6373-6013; Himmelbach, Axel/0000-0001-7338-0946; Dawson, Ian/0000-0003-1345-3642; Bayer, Micha/0000-0003-0041-3115; Freund, Fabian/0000-0002-9958-2703; Kilian, Benjamin/0000-0002-9145-6980; Dawson, Ian/0000-0003-4245-6973; Milne, Iain/0000-0002-4126-0859	Scottish Government Research Program; European Union Framework Programme 7 WHEALBI project; CGIAR Climate Change, Agriculture and Food Security (CCAFS) program; BBSRC [BB/I00663X/1]; German Science Foundation (DFG) [KI1465/6-1, SPP1530]; BMBF TRITEX [0315954]; US Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) as part of the Triticeae Coordinated Agricultural Project (TCAP) [2011-68002-30029]; Universities of the State of Baden-Wurttemberg, Germany; Ministry of Science, Research and the Arts Baden-Wurttemberg; BBSRC [BB/M018466/1, BB/I022198/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00663X/1, BB/I022198/1, BB/M018466/1] Funding Source: researchfish	Scottish Government Research Program; European Union Framework Programme 7 WHEALBI project; CGIAR Climate Change, Agriculture and Food Security (CCAFS) program; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Science Foundation (DFG)(German Research Foundation (DFG)); BMBF TRITEX(Federal Ministry of Education & Research (BMBF)); US Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) as part of the Triticeae Coordinated Agricultural Project (TCAP); Universities of the State of Baden-Wurttemberg, Germany; Ministry of Science, Research and the Arts Baden-Wurttemberg; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We specifically thank B. Thomas and A. Booth for helpful discussions around the common garden experiments. We would like to acknowledge funding from the Scottish Government Research Program to R.W., J.R., I.K.D., M.B. and I.M. and from the European Union Framework Programme 7 WHEALBI project to J.R., R.W., N.S., I.K.D., S.K. and B.K. M.v.Z. has been supported by the CGIAR Climate Change, Agriculture and Food Security (CCAFS) program. The work would not have been possible without funding from BBSRC grant BB/I00663X/1 to R.W., German Science Foundation (DFG) SPP1530 grant KI1465/6-1 to B.K. and BMBF TRITEX 0315954 A to N.S. Funding to G.J.M. was provided by the US Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) as part of the Triticeae Coordinated Agricultural Project (TCAP), grant 2011-68002-30029. Analysis carried out by F.F. and K.S. was mainly performed on the computational resource bwUniCluster funded by the Ministry of Science, Research and the Arts Baden-Wurttemberg and the Universities of the State of Baden-Wurttemberg, Germany, within the framework program bwHPC.	Alachiotis N, 2012, BIOINFORMATICS, V28, P2274, DOI 10.1093/bioinformatics/bts419; Arend D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-214; Baker K, 2014, PLANT J, V79, P981, DOI 10.1111/tpj.12600; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beddington JR, 2012, SCIENCE, V335, P289, DOI 10.1126/science.1217941; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; BESAG J, 1991, BIOMETRIKA, V78, P301; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Calixto CPG, 2015, J MOL EVOL, V80, P108, DOI 10.1007/s00239-015-9665-0; Casas AM, 2011, THEOR APPL GENET, V122, P1293, DOI 10.1007/s00122-011-1531-x; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/nclimate2153, 10.1038/NCLIMATE2153]; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Dawson IK, 2015, NEW PHYTOL, V206, P913, DOI 10.1111/nph.13266; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Falush D, 2003, GENETICS, V164, P1567; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Frichot E, 2014, GENETICS, V196, P973, DOI 10.1534/genetics.113.160572; Gunther T, 2013, GENETICS, V195, P205, DOI 10.1534/genetics.113.152462; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harlan J.R., 1975, CROPS MAN; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOLM S, 1979, SCAND J STAT, V6, P65; Hudson RR, 2001, GENETICS, V159, P1805; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hurst LD, 2009, NAT REV GENET, V10, P83, DOI 10.1038/nrg2506; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Jones H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-320; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kunzel G, 2000, GENETICS, V154, P397; Kunzel G, 2002, THEOR APPL GENET, V105, P660, DOI 10.1007/s00122-002-0913-5; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Morrell PL, 2014, J HERED, V105, P253, DOI 10.1093/jhered/est083; Morrell PL, 2003, P NATL ACAD SCI USA, V100, P10812, DOI 10.1073/pnas.1633708100; Nakamichi N, 2015, PLANT CELL PHYSIOL, V56, P594, DOI 10.1093/pcp/pcu181; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nordborg M, 1997, GENETICS, V146, P1185; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pasam RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116164; Pavlidis P, 2013, MOL BIOL EVOL, V30, P2224, DOI 10.1093/molbev/mst112; Poets AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0712-3; Pourkheirandish M, 2015, CELL, V162, P527, DOI 10.1016/j.cell.2015.07.002; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Russell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086021; Russell J, 2011, NEW PHYTOL, V191, P564, DOI 10.1111/j.1469-8137.2011.03704.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Taketa S, 2008, P NATL ACAD SCI USA, V105, P4062, DOI 10.1073/pnas.0711034105; Tange O., 2011, THE USENIX MAGAZINE, P42, DOI [DOI 10.5281/ZENODO.16303, 10.5281/zenodo.16303]; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Zeileis A, 2005, J STAT SOFTW, V14; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	67	152	155	2	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1024	+		10.1038/ng.3612	http://dx.doi.org/10.1038/ng.3612			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27428750	Green Submitted			2022-12-25	WOS:000382398800012
J	Zhang, XT; Su, JZ; Jeong, M; Ko, M; Huang, Y; Park, HJ; Guzman, A; Lei, Y; Huang, YH; Rao, A; Li, W; Goodall, MA				Zhang, Xiaotian; Su, Jianzhong; Jeong, Mira; Ko, Myunggon; Huang, Yun; Park, Hyun Jung; Guzman, Anna; Lei, Yong; Huang, Yung-Hsin; Rao, Anjana; Li, Wei; Goodall, Margaret A.			DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells	NATURE GENETICS			English	Article							EPIGENETIC REGULATORS; CLONAL HEMATOPOIESIS; B-CELL; MUTATIONS; DNA; 5-HYDROXYMETHYLCYTOSINE; LEADS; MOUSE; 5-METHYLCYTOSINE; HYPERMETHYLATION	Mutations in the epigenetic modifiers DNMT3A and TET2 non-randomly co-occur in lymphoma and leukemia despite their epistasis in the methylation-hydroxymethylation pathway. Using Dnmt3a and Tet2 double-knockout mice in which the development of malignancy is accelerated, we show that the double-knockout methylome reflects regions of independent, competitive and cooperative activity. Expression of lineage-specific transcription factors, including the erythroid regulators Klf1 and Epor, is upregulated in double-knockout hematopoietic stem cells (HSCs). DNMT3A and TET2 both repress Klf1, suggesting a model of cooperative inhibition by epigenetic modifiers. These data demonstrate a dual role for TET2 in promoting and inhibiting HSC differentiation, the loss of which, along with DNMT3A, obstructs differentiation, leading to transformation.	[Zhang, Xiaotian; Jeong, Mira; Guzman, Anna; Lei, Yong; Huang, Yung-Hsin; Goodall, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Zhang, Xiaotian; Jeong, Mira; Guzman, Anna; Lei, Yong; Huang, Yung-Hsin; Goodall, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Zhang, Xiaotian; Goodall, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Su, Jianzhong; Park, Hyun Jung; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Ko, Myunggon; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Ko, Myunggon] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea; [Huang, Yun] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; La Jolla Institute for Immunology; Ulsan National Institute of Science & Technology (UNIST); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Goodall, MA (corresponding author), Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.; Goodall, MA (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.; Goodall, MA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Li, W (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA.	wl1@bcm.edu; goodell@bcm.edu	Lei, Yong/Q-9013-2018	Lei, Yong/0000-0003-4864-7017; Ko, Myunggon/0000-0002-6007-2570; Goodell, Margaret A./0000-0003-1111-2932; Su, Jianzhong/0000-0002-1172-7411; Huang, Yung-Hsin/0000-0002-5180-934X; Huang, Yun/0000-0001-5950-9168; Zhang, Xiaotian/0000-0002-9533-4761; Rao, Anjana/0000-0002-1870-1775	Wellcome Trust Gene-Environment training program; US NIH [DK092883, CA183252, HG007538, CA193466, CA125123, P50CA126752, CA151535]; Samuel Waxman Medical Research Foundation; Edward P. Evans Foundation; Adrienne Helis Malvin Medical Research Foundation; Leukemia and Lymphoma Society; CPRIT [RP140001]; CPRIT Scholar award [RP140053]; NATIONAL CANCER INSTITUTE [R01CA193466, P50CA126752, R01CA151535, R35CA210043, P30CA125123, R01CA183252] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK092883, R01DK092883] Funding Source: NIH RePORTER	Wellcome Trust Gene-Environment training program(Wellcome Trust); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Medical Research Foundation; Edward P. Evans Foundation; Adrienne Helis Malvin Medical Research Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); CPRIT; CPRIT Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Kampmann for discussions at AACR, C. Gillespie for editing, and R. Nitsal, S. Hexige and Y. Zheng for assistance with histology, pathology and BMT, respectively. X.Z. is supported by the Wellcome Trust Gene-Environment training program. This work was supported by the US NIH (DK092883, CA183252, HG007538, CA193466, CA125123, P50CA126752 and CA151535), the Samuel Waxman Medical Research Foundation, the Edward P. Evans Foundation, the Adrienne Helis Malvin Medical Research Foundation, the Leukemia and Lymphoma Society (Translational Research Program to A. R. and Special Fellow Award to M.K.), and CPRIT (RP140001) and a CPRIT Scholar award to Y.H. (RP140053).	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; An J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10071; Celik H, 2015, BLOOD, V125, P619, DOI 10.1182/blood-2014-08-594564; Challen GA, 2014, CELL STEM CELL, V15, P350, DOI 10.1016/j.stem.2014.06.018; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Cimmino L, 2015, NAT IMMUNOL, V16, P653, DOI 10.1038/ni.3148; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Grossmann V, 2013, GENE CHROMOSOME CANC, V52, P410, DOI 10.1002/gcc.22039; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Hasemann MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004079; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Huang Y, 2012, NAT PROTOC, V7, P1897, DOI 10.1038/nprot.2012.103; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Madzo J, 2014, CELL REP, V6, P231, DOI 10.1016/j.celrep.2013.11.044; Mayle A, 2015, BLOOD, V125, P629, DOI 10.1182/blood-2014-08-594648; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nimmo RA, 2015, TRENDS CELL BIOL, V25, P459, DOI 10.1016/j.tcb.2015.04.004; Orkin SH, 2003, IMMUNITY, V19, P633, DOI 10.1016/S1074-7613(03)00302-9; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pollier Jacob, 2013, Methods Mol Biol, V1011, P305, DOI 10.1007/978-1-62703-414-2_24; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rasmussen KD, 2015, GENE DEV, V29, P910, DOI 10.1101/gad.260174.115; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Scourzic L, 2016, LEUKEMIA, V30, P1388, DOI 10.1038/leu.2016.29; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tallack MR, 2012, GENOME RES, V22, P2385, DOI 10.1101/gr.135707.111; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tsagaratou A, 2014, P NATL ACAD SCI USA, V111, pE3306, DOI 10.1073/pnas.1412327111; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang LF, 2015, NATURE, V523, P621, DOI 10.1038/nature14482; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Zhang Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr053; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao ZG, 2015, CELL REP, V13, P1692, DOI 10.1016/j.celrep.2015.10.037; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	67	141	143	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1014	+		10.1038/ng.3610	http://dx.doi.org/10.1038/ng.3610			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27428748	Green Accepted			2022-12-25	WOS:000382398800011
J	Nicod, J; Davies, RW; Cai, N; Hassett, C; Goodstadt, L; Cosgrove, C; Yee, BK; Lionikaite, V; McIntyre, RE; Remme, CA; Lodder, EM; Gregory, JS; Hough, T; Joynson, R; Phelps, H; Nell, B; Rowe, C; Wood, J; Walling, A; Bopp, N; Bhomra, A; Hernandez-Pliego, P; Callebert, J; Aspden, RM; Talbot, NP; Robbins, PA; Harrison, M; Fray, M; Launay, JM; Pinto, YM; Blizard, DA; Bezzina, CR; Adams, DJ; Franken, P; Weaver, T; Wells, S; Brown, SDM; Potter, PK; Klenerman, P; Lionikas, A; Mott, R; Flint, J				Nicod, Jerome; Davies, Robert W.; Cai, Na; Hassett, Carl; Goodstadt, Leo; Cosgrove, Cormac; Yee, Benjamin K.; Lionikaite, Vikte; McIntyre, Rebecca E.; Remme, Carol Ann; Lodder, Elisabeth M.; Gregory, Jennifer S.; Hough, Tertius; Joynson, Russell; Phelps, Hayley; Nell, Barbara; Rowe, Clare; Wood, Joe; Walling, Alison; Bopp, Nasrin; Bhomra, Amarjit; Hernandez-Pliego, Polinka; Callebert, Jacques; Aspden, Richard M.; Talbot, Nick P.; Robbins, Peter A.; Harrison, Mark; Fray, Martin; Launay, Jean-Marie; Pinto, Yigal M.; Blizard, David A.; Bezzina, Connie R.; Adams, David J.; Franken, Paul; Weaver, Tom; Wells, Sara; Brown, Steve D. M.; Potter, Paul K.; Klenerman, Paul; Lionikas, Arimantas; Mott, Richard; Flint, Jonathan			Genome-wide association of multiple complex traits in outbred mice by ultra-low-coverage sequencing	NATURE GENETICS			English	Article							B-CELL DEVELOPMENT; C-MET; MOUSE; GENOTYPE; MODEL; PHENOTYPES; FRAMEWORK; RECEPTOR; LACKING	Two bottlenecks impeding the genetic analysis of complex traits in rodents are access to mapping populations able to deliver gene-level mapping resolution and the need for population-specific genotyping arrays and haplotype reference panels. Here we combine low-coverage ( 0.15x) sequencing with a new method to impute the ancestral haplotype space in 1,887 commercially available outbred mice. We mapped 156 unique quantitative trait loci for 92 phenotypes at a 5% false discovery rate. Gene-level mapping resolution was achieved at about one-fifth of the loci, implicating Unc13c and Pgc1a at loci for the quality of sleep, Adarb2 for home cage activity, Rtkn2 for intensity of reaction to startle, Bmp2 for wound healing, Il15 and Id2 for several T cell measures and Prkca for bone mineral content. These findings have implications for diverse areas of mammalian biology and demonstrate how genome-wide association studies can be extended via low-coverage sequencing to species with highly recombinant outbred populations.	[Nicod, Jerome; Davies, Robert W.; Cai, Na; Goodstadt, Leo; Bopp, Nasrin; Bhomra, Amarjit; Hernandez-Pliego, Polinka; Mott, Richard; Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford, England; [Hassett, Carl; Hough, Tertius; Joynson, Russell; Phelps, Hayley; Nell, Barbara; Rowe, Clare; Wood, Joe; Walling, Alison; Harrison, Mark; Fray, Martin; Weaver, Tom; Wells, Sara] MRC Harwell, Mary Lyon Ctr, Harwell Sci & Innovat Campus, Harwell, Berks, England; [Cosgrove, Cormac; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England; [Yee, Benjamin K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Lionikaite, Vikte; Gregory, Jennifer S.; Aspden, Richard M.; Lionikas, Arimantas] Univ Aberdeen, Sch Med Med Sci & Nutr, Coll Life Sci & Med, Aberdeen, Scotland; [McIntyre, Rebecca E.; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton, England; [Remme, Carol Ann; Lodder, Elisabeth M.; Pinto, Yigal M.; Bezzina, Connie R.] Acad Med Ctr, Dept Clin & Expt Cardiol, Ctr Heart, Amsterdam, Netherlands; [Callebert, Jacques; Launay, Jean-Marie] Hop Lariboisiere, AP HP, Dept Biochem, INSERM U942, Paris, France; [Talbot, Nick P.; Robbins, Peter A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Blizard, David A.] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Franken, Paul] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Brown, Steve D. M.; Potter, Paul K.] MRC Harwell, Mammalian Genet Unit, Harwell Sci & Innovat Campus, Harwell, Berks, England; [Mott, Richard] UCL, UCL Genet Inst, London, England; [Flint, Jonathan] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA	University of Oxford; Wellcome Centre for Human Genetics; MRC Harwell; University of Oxford; Hong Kong Polytechnic University; University of Aberdeen; Wellcome Trust Sanger Institute; University of Amsterdam; Academic Medical Center Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Lausanne; MRC Harwell; University of London; University College London; University of California System; University of California Los Angeles	Mott, R; Flint, J (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.; Mott, R (corresponding author), UCL, UCL Genet Inst, London, England.; Flint, J (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA.	r.mott@ucl.ac.uk; jflint@mednet.ucla.edu	Potter, Paul Keith/GWU-6398-2022; Franken, Paul/A-9633-2018; Cai, Na/I-2977-2019; callebert, jacques/L-4569-2017; Lodder, Elisabeth/X-5385-2019; Yee, Benjamin K/AAW-6048-2021	Potter, Paul Keith/0000-0003-2689-2361; Franken, Paul/0000-0002-2500-2921; Cai, Na/0000-0001-7496-2075; Lodder, Elisabeth/0000-0001-6017-3796; Yee, Benjamin K/0000-0002-3220-9162; Aspden, Richard/0000-0002-0693-1194; Talbot, Nick/0000-0002-9186-8950; klenerman, paul/0000-0003-4307-9161; , yigal/0000-0002-2836-571X; BHOMRA, AMARJIT/0000-0002-0439-0128; Adams, David/0000-0001-9490-0306; Gregory, Jennifer/0000-0002-6328-4560; Mott, Richard/0000-0002-1022-9330; Bezzina, Connie/0000-0002-0633-3514	Wellcome Trust [090532/Z/09/Z, 097308/Z/11/Z]; Mary Lyon Centre; Mammalian Genetics Unit (Medical Research Council, UK) [G0900747 91070, MC U142684172]; NIH [R01AR056280]; state of Vaud (Switzerland); Swiss National Science Foundation [SNF 14694, 136201]; Netherlands CardioVascular Research Initiative; Dutch Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organization for Health Research and Development; Royal Netherlands Academy of Sciences; PREDICT project, InterUniversity Cardiology Institute of the Netherlands [061.02]; Agency of Science, Technology and Research (A*STAR) Graduate Academy; MRC [MC_UP_1502/1, MC_U142684172, MR/L007428/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056280] Funding Source: NIH RePORTER; Medical Research Council [MR/L007428/1, MC_UP_1502/1, MC_U142684172] Funding Source: researchfish; National Institute for Health Research [ACF-2009-13-013, NF-SI-0515-10005] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Mary Lyon Centre; Mammalian Genetics Unit (Medical Research Council, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); state of Vaud (Switzerland); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands CardioVascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Federation of University Medical Centres; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences; PREDICT project, InterUniversity Cardiology Institute of the Netherlands; Agency of Science, Technology and Research (A*STAR) Graduate Academy; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors wish to acknowledge excellent technical assistance from A. Kurioka, L. Swadling, C. de Lara, J. Ussher, R. Townsend, S. Lionikaite, A.S. Lionikiene, R. Wolswinkel and I. van der Made. We would like to thank T.M. Keane and A.G. Doran for their help in annotating variants and adding the FVB/NJ strain to the MGP. We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics and the Wellcome Trust Sanger Institute for the generation of the sequencing data. This work was funded by Wellcome Trust grant 090532/Z/09/Z (J.F.). Primary phenotyping of the mice was supported by the Mary Lyon Centre and Mammalian Genetics Unit (Medical Research Council, UK Hub grant G0900747 91070 and Medical Research Council, UK grant MC U142684172). D.A.B. acknowledges support from NIH R01AR056280. The sleep work was supported by the state of Vaud (Switzerland) and the Swiss National Science Foundation (SNF 14694 and 136201 to P.F.). The ECG work was supported by the Netherlands CardioVascular Research Initiative (Dutch Heart Foundation, Dutch Federation of University Medical Centres, Netherlands Organization for Health Research and Development and the Royal Netherlands Academy of Sciences) PREDICT project, InterUniversity Cardiology Institute of the Netherlands (ICIN; 061.02; C.A.R. and C.R.B.). N.C. is supported by the Agency of Science, Technology and Research (A*STAR) Graduate Academy. R.W.D. is supported by a grant from the Wellcome Trust (097308/Z/11/Z).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Chen ZX, 2013, J NEUROSCI, V33, P8336, DOI 10.1523/JNEUROSCI.5128-12.2013; Cheng RY, 2013, G3-GENES GENOM GENET, V3, P1861, DOI 10.1534/g3.113.007948; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Collier FM, 2004, BIOCHEM BIOPH RES CO, V324, P1360, DOI 10.1016/j.bbrc.2004.09.205; Coury F, 2013, P NATL ACAD SCI USA, V110, P2163, DOI 10.1073/pnas.1206392110; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; Davies R.W., 2016, NAT GENET; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Dougherty SE, 2014, NEUROSCIENCE, V271, P137, DOI 10.1016/j.neuroscience.2014.04.023; Duprez DM, 1996, DEV BIOL, V174, P448, DOI 10.1006/dbio.1996.0087; Flint J, 2012, NAT REV GENET, V13, P807, DOI 10.1038/nrg3335; Galea GL, 2014, J BIOL CHEM, V289, P25509, DOI 10.1074/jbc.M114.580365; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Lamble S, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-104; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li N, 2003, GENETICS, V165, P2213; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Munoz-Bravo JL, 2013, DEVELOPMENT, V140, P3669, DOI 10.1242/dev.091256; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Ma PC, 2003, CANCER RES, V63, P6272; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Mittaz L, 1997, HUM GENET, V100, P398, DOI 10.1007/s004390050523; Nakura A, 2011, BONE, V48, P476, DOI 10.1016/j.bone.2010.09.238; Pallares LF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005607; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Ramos-Quiroga JA, 2014, J PSYCHIATR RES, V49, P60, DOI 10.1016/j.jpsychires.2013.10.022; Reddy SY, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0061-1; Sanyal M, 2007, BLOOD, V109, P4191, DOI 10.1182/blood-2006-10-054213; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Team R.D.C., 2015, R LANG ENV STAT COMP; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Webster MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081757; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Wong K, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r72; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Zaffaroni D, 2005, ONCOGENE, V24, P1084, DOI 10.1038/sj.onc.1208324; Zhang XK, 2008, J IMMUNOL, V181, P1644, DOI 10.4049/jimmunol.181.3.1644	57	77	80	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					912	+		10.1038/ng.3595	http://dx.doi.org/10.1038/ng.3595			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27376238	Green Submitted, Green Accepted			2022-12-25	WOS:000380755100015
J	Eichner, R; Heider, M; Fernandez-Saiz, V; van Bebber, F; Garz, AK; Lemeer, S; Rudelius, M; Targosz, BS; Jacobs, L; Knorn, AM; Slawska, J; Platzbecker, U; Germing, U; Langer, C; Knop, S; Einsele, H; Peschel, C; Haass, C; Keller, U; Schmid, B; Gotze, KS; Kuster, B; Bassermann, F				Eichner, Ruth; Heider, Michael; Fernandez-Saiz, Vanesa; van Bebber, Frauke; Garz, Anne-Kathrin; Lemeer, Simone; Rudelius, Martina; Targosz, Bianca-Sabrina; Jacobs, Laura; Knorn, Anna-Maria; Slawska, Jolanta; Platzbecker, Uwe; Germing, Ulrich; Langer, Christian; Knop, Stefan; Einsele, Herrmann; Peschel, Christian; Haass, Christian; Keller, Ulrich; Schmid, Bettina; Goetze, Katharina S.; Kuster, Bernhard; Bassermann, Florian			Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity	NATURE MEDICINE			English	Article							E3 UBIQUITIN LIGASE; T-CELL-ACTIVATION; MULTIPLE-MYELOMA; DEXAMETHASONE COMBINATION; MYELODYSPLASTIC SYNDROMES; LENALIDOMIDE; CEREBLON; THALIDOMIDE; CD147; DEGRADATION	Immunomodulatory drugs (IMiDs), such as thalidomide and its derivatives lenalidomide and pomalidomide, are key treatment modalities for hematologic malignancies, particularly multiple myeloma (MM) and del(5q) myelodysplastic syndrome (MDS). Cereblon (CRBN), a substrate receptor of the CRL4 ubiquitin ligase complex, is the primary target by which IMiDs mediate anticancer and teratogenic effects. Here we identify a ubiquitin-independent physiological chaperone-like function of CRBN that promotes maturation of the basigin (BSG; also known as CD147) and solute carrier family 16 member 1 (SLC16A1; also known as MCT1) proteins. This process allows for the formation and activation of the CD147-MCT1 transmembrane complex, which promotes various biological functions, including angiogenesis, proliferation, invasion and lactate export. We found that IMiDs outcompete CRBN for binding to CD147 and MCT1, leading to destabilization of the CD147-MCT1 complex. Accordingly, IMiD-sensitive MM cells lose CD147 and MCT1 expression after being exposed to IMiDs, whereas IMiD-resistant cells retain their expression. Furthermore, del(5q) MDS cells have elevated CD147 expression, which is attenuated after IMiD treatment. Finally, we show that BSG (CD147) knockdown phenocopies the teratogenic effects of thalidomide exposure in zebrafish. These findings provide a common mechanistic framework to explain both the teratogenic and pleiotropic antitumor effects of IMiDs.	[Eichner, Ruth; Heider, Michael; Fernandez-Saiz, Vanesa; Garz, Anne-Kathrin; Targosz, Bianca-Sabrina; Jacobs, Laura; Knorn, Anna-Maria; Slawska, Jolanta; Peschel, Christian; Keller, Ulrich; Goetze, Katharina S.; Bassermann, Florian] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, Munich, Germany; [Fernandez-Saiz, Vanesa; Garz, Anne-Kathrin; Peschel, Christian; Keller, Ulrich; Goetze, Katharina S.; Kuster, Bernhard; Bassermann, Florian] German Canc Consortium DKTK, Heidelberg, Germany; [Fernandez-Saiz, Vanesa; Garz, Anne-Kathrin; Peschel, Christian; Keller, Ulrich; Goetze, Katharina S.; Kuster, Bernhard; Bassermann, Florian] German Canc Res Ctr, Heidelberg, Germany; [van Bebber, Frauke; Haass, Christian; Schmid, Bettina] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Lemeer, Simone; Kuster, Bernhard] Tech Univ Munich, Dept Prote & Bioanalyt, Freising Weihenstephan, Germany; [Rudelius, Martina] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Rudelius, Martina] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Platzbecker, Uwe] Tech Univ, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany; [Germing, Ulrich] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany; [Langer, Christian] Univ Ulm, Dept Internal Med 3, Ulm, Germany; [Knop, Stefan; Einsele, Herrmann] Univ Wurzburg, Med Ctr, Dept Internal Med 2, Div Hematol & Med Oncol, Wurzburg, Germany; [Haass, Christian; Schmid, Bettina] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Haass, Christian] Univ Munich, Biomed Ctr, Munich, Germany; [Kuster, Bernhard] Ctr Integrated Prot Sci Munich CIPSM, Freising Weihenstephan, Germany	Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Wurzburg; University of Wurzburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Heinrich Heine University Dusseldorf; Ulm University; University of Wurzburg; University of Munich; University of Munich	Bassermann, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, Munich, Germany.; Bassermann, F (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.; Bassermann, F (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	florian.bassermann@tum.de	Germing, Ulrich/AAX-1036-2021; Kuster, Bernhard/Q-6031-2016; Fernandez, Vanesa/ABD-6688-2021; Keller, Ulrich/L-1763-2016	Kuster, Bernhard/0000-0002-9094-1677; Eichner, Ruth/0000-0002-8433-9452; Heider, Michael/0000-0001-6218-8828; Fernandez-Saiz, Vanesa/0000-0002-7139-8680; Keller, Ulrich/0000-0002-8485-1958	Helmholtz cross-program topic 'Metabolic Dysfunction'; TU Munich (KKF) [B10-13]; Jose Carreras Leukemia Foundation [DJCLS R 14/16]; German Research Foundation [FOR2033 GO 713/2-1, SFB 1243, SFB 824, KE 222/7-1, BA 2851/4-1]; German Cancer Aid [111051, 111305, 111430]; Wilhelm Sander Stiftung [2012.096.1]	Helmholtz cross-program topic 'Metabolic Dysfunction'; TU Munich (KKF); Jose Carreras Leukemia Foundation; German Research Foundation(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); Wilhelm Sander Stiftung	We thank M. Buschbeck (Institute of Predictive and Personalized Medicine of Cancer, Barcelona) for the SKK-1 and SKM-1 cell lines, X. Bustelo (Centro de Investigacion del Cancer, Salamanca) for a EGFP-CD147 expression plasmid, Y. Cang (Life Science Institute, Zheijang University) for a CRBN expression construct, B. Ebert (Dana-Farber Cancer Institute) for an IKZF3 expression construct, A. Halestrap (School of Biochemistry, University of Bristol) for MCT1 expression constructs, H. Handa (Tokyo Institute of Technology Japan) for an aliquot of mouse monoclonal CRBN-specific antibody, K. Kadomatsu (Department of Molecular Biology, Nagoya University) for CD147 expression constructs, W. Kaelin (Dana-Farber Cancer Institute) for CRISPR-based HEK293FT CBRN<SUP>-/-</SUP> cells and two clones of MM1.S CBRN<SUP>-/-</SUP> cells (T11, T21), D. Sabatini (Whitehead Institute) for a MCT1 and an shMCT1 construct, K. Stewart (Mayo Clinic) for a shCRBN plasmid, N. Thoma (Friedrich Miescher Institute for Biomedical Research, Basel) for a MEIS2 expression construct and purified CRL4<SUP>CRBN</SUP> protein, K. Tohyama (Kawasaki Medical School, Okayama) for the del(5q) MDS cell line MDSL, N. Thoma and E. Fisher for suggestions, R. Rojas for fish care and B. Nuscher for help with gel filtration chromatography. This work was supported by the Helmholtz cross-program topic 'Metabolic Dysfunction' (B.S.), a fellowship of the TU Munich (KKF # B10-13; to R.E.), grants from the Jose Carreras Leukemia Foundation (DJCLS R 14/16; to K.S.G.), the German Research Foundation (FOR2033 GO 713/2-1 and SFB 1243 (K.S.G.), SFB 824 (U.K.), KE 222/7-1 (U.K.), BA 2851/4-1 (F.B.) and SFB 1243 (F.B.)), the German Cancer Aid (#111051 (M.H.), #111305 (U.K.) and #111430 (F.B.)) and the Wilhelm Sander Stiftung (#2012.096.1; to F.B.). An application for a patent has been filed at the European Patent Office.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Baumann U, 2014, NAT MED, V20, P1401, DOI 10.1038/nm.3740; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chesi M, 2012, BLOOD, V120, P376, DOI 10.1182/blood-2012-02-412783; Fenaux P, 2011, BLOOD, V118, P3765, DOI 10.1182/blood-2011-01-330126; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P233, DOI 10.1111/bjh.12622; Giagounidis A, 2014, ANN HEMATOL, V93, P1, DOI 10.1007/s00277-013-1863-5; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Hu JS, 2010, J CELL MOL MED, V14, P2132, DOI 10.1111/j.1582-4934.2010.01012.x; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Kelaidi C, 2008, LEUKEMIA RES, V32, P1049, DOI 10.1016/j.leukres.2007.11.037; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Kumar SK, 2014, LANCET ONCOL, V15, P1503, DOI 10.1016/S1470-2045(14)71125-8; Landskron J, 2013, CELL IMMUNOL, V282, P17, DOI 10.1016/j.cellimm.2013.04.008; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Mahony C, 2013, P NATL ACAD SCI USA, V110, P12703, DOI 10.1073/pnas.1307684110; MELLIN GW, 1962, NEW ENGL J MED, V267, P1238, DOI 10.1056/NEJM196212132672407; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Roussel M, 2014, J CLIN ONCOL, V32, P2712, DOI 10.1200/JCO.2013.54.8164; Shortt J, 2013, ONCOGENE, V32, P4191, DOI 10.1038/onc.2012.599; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Staffler G, 2003, J IMMUNOL, V171, P1707, DOI 10.4049/jimmunol.171.4.1707; Stewart AK, 2015, NEW ENGL J MED, V372, P142, DOI 10.1056/NEJMoa1411321; Strupp C, 2003, LEUKEMIA, V17, P1200, DOI 10.1038/sj.leu.2402894; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Walters DK, 2013, CELL CYCLE, V12, P3175, DOI 10.4161/cc.26193; Zhu D, 2015, NAT MED, V21, P572, DOI 10.1038/nm.3867; Zhu YX, 2014, BLOOD, V124, P536, DOI 10.1182/blood-2014-02-557819; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	43	115	119	5	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					735	743		10.1038/nm.4128	http://dx.doi.org/10.1038/nm.4128			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27294876				2022-12-25	WOS:000379366900012
J	Dubach, JM; Kim, E; Yang, K; Cuccarese, M; Giedt, RJ; Meirnetis, LG; Vinegoni, C; Weissleder, R				Dubach, J. Matthew; Kim, Eunha; Yang, Katherine; Cuccarese, Michael; Giedt, Randy J.; Meirnetis, Libros G.; Vinegoni, Claudio; Weissleder, Ralph			Quantitating drug-target engagement in single cells in vitro and in vivo	NATURE CHEMICAL BIOLOGY			English	Article							PARP INHIBITOR; IMMUNOFLUORESCENCE; IDENTIFICATION; RESISTANCE; BINDING; AGENTS; BTK	Quantitation of drug target engagement in single cells has proven to be difficult, often leaving unanswered questions in the drug development process. We found that intracellular target engagement of unlabeled new therapeutics can be quantitated using polarized microscopy combined with competitive binding of matched fluorescent companion imaging probes. We quantitated the dynamics of target engagement of covalent BTK inhibitors, as well as reversible PARP inhibitors, in populations of single cells using a single companion imaging probe for each target. We then determined average in vivo tumor concentrations and found marked population heterogeneity following systemic delivery, revealing single cells with low target occupancy at high average target engagement in vivo.	[Dubach, J. Matthew; Kim, Eunha; Yang, Katherine; Cuccarese, Michael; Giedt, Randy J.; Meirnetis, Libros G.; Vinegoni, Claudio; Weissleder, Ralph] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA USA; [Weissleder, Ralph] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Kim, Eunha] Ajou Univ, Dept Mol Sci & Technol, Suwon, South Korea	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Ajou University	Vinegoni, C; Weissleder, R (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA USA.; Weissleder, R (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA USA.	cvinegoni@mgh.harvard.edu; rweissleder@mgh.harvard.edu	vinegoni, claudio/AGU-2461-2022; Vinegoni, Claudio/A-9490-2012; Kim, Eunha/ABC-9281-2020	Vinegoni, Claudio/0000-0002-9818-3639; Kim, Eunha/0000-0002-0766-696X; /0000-0003-0828-4143	US National Institutes of Health [T32CA079443, K99CA198857, R01CA164448, P50CA086355, R01HL122208]; Department of Defense grant BCRP [BC134081]; NATIONAL CANCER INSTITUTE [K99CA198857, T32CA079443, P50CA086355, R01CA164448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010011] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense grant BCRP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank T. Mitchison for his thoughts on experimental approaches and comments on the manuscript. This work was supported by US National Institutes of Health grants T32CA079443 (J.M.D., M.C. and R.W.), K99CA198857 (J.M.D.), R01CA164448, P50CA086355 and R01HL122208 (R.W.), and Department of Defense grant BCRP #BC134081 (R.J.G.).	Aboagye EO, 2001, DRUG DISCOV TODAY, V6, P293, DOI 10.1016/S1359-6446(01)01684-1; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Bachovchin DA, 2009, NAT BIOTECHNOL, V27, P387, DOI 10.1038/nbt.1531; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Bunnage ME, 2013, NAT CHEM BIOL, V9, P195, DOI 10.1038/nchembio.1197; Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Dubach JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4946; Evans EK, 2013, J PHARMACOL EXP THER, V346, P219, DOI 10.1124/jpet.113.203489; Fischman AJ, 2002, CLIN PHARMACOKINET, V41, P581, DOI 10.2165/00003088-200241080-00003; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Hargreaves RJ, 2014, NEUROBIOL DIS, V61, P32, DOI 10.1016/j.nbd.2013.08.017; Henneman L, 2015, P NATL ACAD SCI USA, V112, P8409, DOI 10.1073/pnas.1500223112; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Kim E, 2015, BIOCONJUGATE CHEM, V26, P1513, DOI 10.1021/acs.bioconjchem.5b00152; Lin JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9390; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Mateo J, 2013, NAT REV CLIN ONCOL, V10, P688, DOI 10.1038/nrclinonc.2013.177; Matthews PM, 2012, BRIT J CLIN PHARMACO, V73, P175, DOI 10.1111/j.1365-2125.2011.04085.x; Meimetis LG, 2016, CHEM COMMUN, V52, P9953, DOI 10.1039/c6cc04129a; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Miller MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9692; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Morgan P, 2012, DRUG DISCOV TODAY, V17, P419, DOI 10.1016/j.drudis.2011.12.020; Munteanu B, 2014, ANAL CHEM, V86, P4642, DOI 10.1021/ac500038j; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Roux J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145584; Shen YQ, 2013, CLIN CANCER RES, V19, P5003, DOI 10.1158/1078-0432.CCR-13-1391; Simon GM, 2013, NAT CHEM BIOL, V9, P200, DOI 10.1038/nchembio.1211; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Stadler C, 2013, NAT METHODS, V10, P315, DOI [10.1038/NMETH.2377, 10.1038/nmeth.2377]; Thurber GM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2506; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Turetsky A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04782; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694	41	63	64	0	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					168	173		10.1038/NCHEMBIO.2248	http://dx.doi.org/10.1038/NCHEMBIO.2248			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27918558	Green Accepted			2022-12-25	WOS:000393533000011
J	Lane, JM; Liang, JJ; Vlasac, I; Anderson, SG; Bechtold, DA; Bowden, J; Emsley, R; Gill, S; Little, MA; Luik, AI; Loudon, A; Scheer, FAJL; Purcell, SM; Kyle, SD; Lawlor, DA; Zhu, XF; Redline, S; Ray, DW; Rutter, MK; Saxena, R				Lane, Jacqueline M.; Liang, Jingjing; Vlasac, Irma; Anderson, Simon G.; Bechtold, David A.; Bowden, Jack; Emsley, Richard; Gill, Shubhroz; Little, Max A.; Luik, Annemarie I.; Loudon, Andrew; Scheer, Frank A. J. L.; Purcell, Shaun M.; Kyle, Simon D.; Lawlor, Deborah A.; Zhu, Xiaofeng; Redline, Susan; Ray, David W.; Rutter, Martin K.; Saxena, Richa			Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits	NATURE GENETICS			English	Article							RESTLESS LEGS SYNDROME; CHROMOSOME FUSION SITE; SLOW-WAVE SLEEP; UK BIOBANK; DAYTIME SLEEPINESS; PARALOGOUS REGIONS; 5-HT2C RECEPTORS; SEROTONIN 5-HT2A; COMMON VARIANTS; MEIS1	Chronic sleep disturbances, associated with cardiometabolic diseases, psychiatric disorders and all-cause mortality(1,2), affect 25-30% of adults worldwide(3). Although environmental factors contribute substantially to self-reported habitual sleep duration and disruption, these traits are heritable(4-9) and identification of the genes involved should improve understanding of sleep, mechanisms linking sleep to disease and development of new therapies. We report single- and multiple-trait genome-wide association analyses of self-reported sleep duration, insomnia symptoms and excessive daytime sleepiness in the UK Biobank (n = 112,586). We discover loci associated with insomnia symptoms (near MEIS1, TMEM132E, CYCL1 and TGFBI in females and WDR27 in males), excessive daytime sleepiness (near AR-OPHN1) and a composite sleep trait (near PATJ (INADL) and HCRTR2) and replicate a locus associated with sleep duration (at PAX8). We also observe genetic correlation between longer sleep duration and schizophrenia risk (r(g) = 0.29, P = 1.90 x 10(-13)) and between increased levels of excessive daytime sleepiness and increased measures for adiposity traits (body mass index (BMI): r(g) = 0.20, P = 3.12 x 10(-9); waist circumference: r(g) = 0.20, P = 2.12 x 10(-7)).	[Lane, Jacqueline M.; Vlasac, Irma; Saxena, Richa] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Lane, Jacqueline M.; Saxena, Richa] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Lane, Jacqueline M.; Saxena, Richa] Harvard Med Sch, Boston, MA 02115 USA; [Lane, Jacqueline M.; Vlasac, Irma; Gill, Shubhroz; Purcell, Shaun M.; Saxena, Richa] Broad Inst, Cambridge, MA 02142 USA; [Liang, Jingjing; Zhu, Xiaofeng] Case Western Reserve Univ, Dept Epidemiol & Biostat, Sch Med, Cleveland, OH 44106 USA; [Anderson, Simon G.] Univ Manchester, Sch Med Sci, Fac Biol Med & Hlth, Div Cardiovasc Sci, Manchester, Lancs, England; [Anderson, Simon G.] Univ Oxford, Oxford Martin Sch, George Inst Global Hlth, Oxford, England; [Bechtold, David A.; Ray, David W.; Rutter, Martin K.] Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Div Endocrinol Diabet & Gastroenterol, Manchester, Lancs, England; [Bowden, Jack; Lawlor, Deborah A.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Bowden, Jack; Lawlor, Deborah A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Emsley, Richard] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Hlth Sci,Div Populat Hlth Hlth Serv Res & Pri, Manchester, Lancs, England; [Little, Max A.] Aston Univ, Engn & Appl Sci, Birmingham, W Midlands, England; [Little, Max A.] MIT, Media Lab, Cambridge, MA USA; [Luik, Annemarie I.] Univ Oxford, Nuffield Dept Clin Neurosci, Sleep & Circadian Neurosci Inst, Oxford, England; [Scheer, Frank A. J. L.; Saxena, Richa] Harvard Med Sch, Div Sleep & Circadian Disorders, Brigham & Womens Hosp, Boston, MA USA; [Scheer, Frank A. J. L.; Saxena, Richa] Harvard Med Sch, Div Sleep Med, Boston, MA USA; [Purcell, Shaun M.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA USA; [Purcell, Shaun M.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Redline, Susan] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Redline, Susan] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA; Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Diabet Ctr, Manchester, Lancs, England	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Case Western Reserve University; University of Manchester; University of Oxford; University of Manchester; University of Bristol; University of Bristol; University of Manchester; Aston University; Massachusetts Institute of Technology (MIT); University of Oxford; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Manchester	Saxena, R (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.; Saxena, R (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.; Saxena, R (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Saxena, R (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	rsaxena@partners.org	Scheer, Frank A.J.L./C-2795-2012; Bowden, Jack/AAF-2305-2019; Saxena, Richa/AAG-7279-2020; Zhu, Xiaofeng/O-6874-2019; Anderson, Simon G/AGM-2359-2022; Emsley, Richard/N-1342-2016; Luik, Annemarie I/E-1292-2015	Scheer, Frank A.J.L./0000-0002-2014-7582; Anderson, Simon G/0000-0002-8896-073X; Emsley, Richard/0000-0002-1218-675X; Kyle, Simon/0000-0002-9581-5311; Saxena, Richa/0000-0003-2233-1065; Bechtold, David/0000-0001-8676-8704; Loudon, Andrew/0000-0003-3648-445X; Zhu, Xiaofeng/0000-0003-0037-411X; Ray, David/0000-0002-4739-6773; Rutter, Martin/0000-0001-6380-539X; Luik, Annemarie I/0000-0001-7517-197X; Lawlor, Debbie A/0000-0002-6793-2262	US NIH grants [R01DK107859, R21HL121728, F32DK102323, R01HL113338, R01DK102696, R01DK105072, T32HL007567, HG003054]; University of Manchester (Research Infrastructure Fund); Wellcome Trust; UK Medical Research Council [MC_UU_12013/5]; US NIH grants [R01DK107859, R21HL121728, F32DK102323, R01HL113338, R01DK102696, R01DK105072, T32HL007567, HG003054]; University of Manchester (Research Infrastructure Fund); Wellcome Trust; UK Medical Research Council [MC_UU_12013/5]; BBSRC [BB/L000954/1] Funding Source: UKRI; MRC [MR/P023576/1, MC_UU_12013/1, MC_UU_12013/5, MR/M008908/1, MC_UU_12013/9, MR/L010240/1, MC_EX_MR/L012286/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL121728, T32HL007567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107859, R01DK102696, F32DK102323, R01DK105072] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/L000954/1, 1497765] Funding Source: researchfish; Medical Research Council [MR/P023576/1, MC_UU_12013/9, MR/L010240/1, MR/M008908/1, MC_qA137853, MC_UU_12013/1, MC_UU_12013/5, MR/N501906/1, MC_EX_MR/L012286/1] Funding Source: researchfish; National Institute for Health Research [CL-2012-06-001] Funding Source: researchfish; Parkinson&quot;s UK [J-1403] Funding Source: researchfish	US NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Manchester (Research Infrastructure Fund); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Manchester (Research Infrastructure Fund); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	This research has been conducted using the UK Biobank Resource under application number 6818. We would like to thank the participants and researchers from the UK Biobank who contributed or collected data. This work was supported by US NIH grants R01DK107859 (R.S.), R21HL121728 (R.S.), F32DK102323 (J.M.L.), R01HL113338 (J.M.L., S.R. and R.S.), R01DK102696 (R.S. and F.A.J.L.S.), R01DK105072 (R.S. and F.A.J.L.S.), T32HL007567 (J.L.) and HG003054 (X.Z.), the University of Manchester (Research Infrastructure Fund), the Wellcome Trust (salary support for D.W.R. and A.L.) and UK Medical Research Council MC_UU_12013/5 (D.A.L.). Data on glycemic traits have been contributed by MAGIC investigators and were downloaded from http://www.magicinvestigators.org/. Data on coronary artery disease and myocardial infarction have been contributed by CARDIoGRAMplusC4D investigators and were downloaded from http://www.cardiogramplusc4d.org/. We thank the International Genomics of Alzheimer's Project (IGAP) for providing summary results data for these analyses.	Allebrandt KV, 2013, MOL PSYCHIATR, V18, P122, DOI 10.1038/mp.2011.142; Allen RP, 2013, NEUROLOGY, V80, P2028, DOI 10.1212/WNL.0b013e318294b3f6; Ananthakrishnan AN, 2014, CLIN GASTROENTEROL H, V12, P1879, DOI 10.1016/j.cgh.2014.04.021; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Byrne EM, 2016, SLEEP, V39, P1853, DOI 10.5665/sleep.6168; Byrne EM, 2013, AM J MED GENET B, V162B, P439, DOI 10.1002/ajmg.b.32168; Cade BE, 2016, HUM MOL GENET, V25, P167, DOI 10.1093/hmg/ddv434; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Chouinard S, 2004, SCHIZOPHRENIA BULL, V30, P957, DOI 10.1093/oxfordjournals.schbul.a007145; Dalal J, 2013, GENE DEV, V27, P565, DOI 10.1101/gad.207654.112; Davidson S, 2006, MOL PSYCHIATR, V11, P410, DOI 10.1038/sj.mp.4001787; de Castro JM, 2002, PHYSIOL BEHAV, V76, P479, DOI 10.1016/S0031-9384(02)00699-6; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Erhardt A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.85; Evans DS, 2011, SLEEP, V34, P661, DOI 10.1093/sleep/34.5.661; Fan Y, 2002, GENOME RES, V12, P1651, DOI 10.1101/gr.337602; Fan YX, 2002, GENOME RES, V12, P1663, DOI 10.1101/gr.338402; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fernandez-Mendoza J, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0418-8; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Foral Pamela, 2011, Consult Pharm, V26, P414, DOI 10.4140/TCP.n.2011.414; Gehrman PR, 2015, PSYCHIAT CLIN N AM, V38, P667, DOI 10.1016/j.psc.2015.07.004; Gonnissen HKJ, 2013, PHYSIOL BEHAV, V121, P112, DOI 10.1016/j.physbeh.2013.04.007; Gottlieb DJ, 2015, MOL PSYCHIATR, V20, P1232, DOI 10.1038/mp.2014.133; Gottlieb DJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S9; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Han B, 2014, HUM MOL GENET, V23, P4597, DOI 10.1093/hmg/ddu173; Han KE, 2016, PROG RETIN EYE RES, V50, P67, DOI 10.1016/j.preteyeres.2015.11.002; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Heath A C, 1998, Twin Res, V1, P176, DOI 10.1375/twin.1.4.176; HEATH AC, 1990, SLEEP, V13, P318, DOI 10.1093/sleep/13.4.318; Herring WJ, 2016, BIOL PSYCHIAT, V79, P136, DOI 10.1016/j.biopsych.2014.10.003; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Horikoshi M, 2013, NAT GENET, V45, P76, DOI 10.1038/ng.2477; Hu YN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10448; Jones SE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006125; Kurant E, 1998, DEVELOPMENT, V125, P1037; Lane JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10889; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mignot E, 2004, SLEEP MED, V5, pS2, DOI 10.1016/S1389-9457(04)90001-9; Moore H, 2014, SLEEP, V37, P1535, DOI 10.5665/sleep.4006; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nedeltcheva AV, 2014, CURR OPIN ENDOCRINOL, V21, P293, DOI 10.1097/MED.0000000000000082; Oh-hashi K, 2003, J BIOL CHEM, V278, P10531, DOI 10.1074/jbc.M212083200; PARTINEN M, 1983, SLEEP, V6, P179, DOI 10.1093/sleep/6.3.179; Patry M, 2015, DIABETES, V64, P4212, DOI 10.2337/db15-0638; Peirson SN, 2007, CURR BIOL, V17, P1363, DOI 10.1016/j.cub.2007.07.045; Pemberton R, 2016, J AFFECT DISORDERS, V200, P103, DOI 10.1016/j.jad.2016.04.023; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Poulin J, 2010, PSYCHIAT RES, V179, P274, DOI 10.1016/j.psychres.2009.08.009; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rosenberg R, 2008, SLEEP, V31, P1663, DOI 10.1093/sleep/31.12.1663; Roth T, 2015, J CLIN PSYCHIAT, V76, P1518, DOI [10.4088/JCP.14019tx3c, 10.4088/JCP.14019tx2c, 10.4088/JCP.14019tx1c, 10.4088/JCP.14019co5c]; Schulte EC, 2014, AM J HUM GENET, V95, P85, DOI 10.1016/j.ajhg.2014.06.005; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; SHARPLEY AL, 1994, NEUROPHARMACOLOGY, V33, P467, DOI 10.1016/0028-3908(94)90077-9; SHIEH BH, 1995, NEURON, V14, P201, DOI 10.1016/0896-6273(95)90255-4; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Spieler D, 2014, GENOME RES, V24, P592, DOI 10.1101/gr.166751.113; Stranges S, 2012, SLEEP, V35, P1173, DOI 10.5665/sleep.2012; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Swanson JM, 2012, LANCET, V380, P110, DOI 10.1016/S0140-6736(12)61179-9; Takahama K, 2012, BIOCHEM BIOPH RES CO, V417, P807, DOI 10.1016/j.bbrc.2011.12.040; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Thompson MD, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00057; Vgontzas AN, 1998, ARCH INTERN MED, V158, P1333, DOI 10.1001/archinte.158.12.1333; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Wing YK, 2012, SLEEP MED, V13, P985, DOI 10.1016/j.sleep.2012.04.013; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171; Wulff K, 2012, BRIT J PSYCHIAT, V200, P308, DOI 10.1192/bjp.bp.111.096321; Xiong L, 2009, HUM MOL GENET, V18, P1065, DOI 10.1093/hmg/ddn443; Yelin-Bekerman L, 2015, ELIFE, V4, DOI [10.7554/eLife.08633, 10.7554/eLife.08638]; Zhu XF, 2015, AM J HUM GENET, V96, P21, DOI 10.1016/j.ajhg.2014.11.011	82	186	186	3	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					274	281		10.1038/ng.3749	http://dx.doi.org/10.1038/ng.3749			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27992416	Green Submitted, Green Accepted			2022-12-25	WOS:000393148600017
J	Okimoto, RA; Breitenbuecher, F; Olivas, VR; Wu, W; Gini, B; Hofree, M; Asthana, S; Hrustanovic, G; Flanagan, J; Tulpule, A; Blakely, CM; Haringsma, HJ; Simmons, AD; Gowen, K; Suh, J; Miller, VA; Ali, S; Schuler, M; Bivona, TG				Okimoto, Ross A.; Breitenbuecher, Frank; Olivas, Victor R.; Wu, Wei; Gini, Beatrice; Hofree, Matan; Asthana, Saurabh; Hrustanovic, Gorjan; Flanagan, Jennifer; Tulpule, Asmin; Blakely, Collin M.; Haringsma, Henry J.; Simmons, Andrew D.; Gowen, Kyle; Suh, James; Miller, Vincent A.; Ali, Siraj; Schuler, Martin; Bivona, Trever G.			Inactivation of Capicua drives cancer metastasis	NATURE GENETICS			English	Article							MATRIX METALLOPROTEINASES; DOWN-REGULATION; LUNG; ACTIVATION; MUTATIONS; REPRESSOR; TORSO	Metastasis is the leading cause of death in people with lung cancer, yet the molecular effectors underlying tumor dissemination remain poorly defined. Through the development of an in vivo spontaneous lung cancer metastasis model, we show that the developmentally regulated transcriptional repressor Capicua (CIC) suppresses invasion and metastasis. Inactivation of CIC relieves repression of its effector ETV4, driving ETV4-mediated upregulation of MMP24, which is necessary and sufficient for metastasis. Loss of CIC, or an increase in levels of its effectors ETV4 and MMP24, is a biomarker of tumor progression and worse outcomes in people with lung and/or gastric cancer. Our findings reveal CIC as a conserved metastasis suppressor, highlighting new anti-metastatic strategies that could potentially improve patient outcomes.	[Okimoto, Ross A.; Olivas, Victor R.; Wu, Wei; Gini, Beatrice; Tulpule, Asmin; Blakely, Collin M.; Bivona, Trever G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Okimoto, Ross A.; Wu, Wei; Gini, Beatrice; Asthana, Saurabh; Hrustanovic, Gorjan; Flanagan, Jennifer; Tulpule, Asmin; Blakely, Collin M.; Bivona, Trever G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Breitenbuecher, Frank; Schuler, Martin] Univ Hosp Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany; [Hofree, Matan] Broad Inst MIT & Harvard, Cambridge, MA USA; [Hofree, Matan] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA; [Haringsma, Henry J.; Simmons, Andrew D.] Clovis Oncol Inc, San Francisco, CA USA; [Gowen, Kyle; Suh, James; Miller, Vincent A.; Ali, Siraj] Fdn Med, Cambridge, MA USA; [Schuler, Martin] German Canc Consortium DKTK, Heidelberg, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Duisburg Essen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Foundation Medicine; Helmholtz Association; German Cancer Research Center (DKFZ)	Bivona, TG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Bivona, TG (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	trever.bivona@ucsf.edu	Ali, Siraj/AAE-2958-2019; wu, wei/J-2797-2019	wu, wei/0000-0002-6556-067X; Hofree, Matan/0000-0001-8368-0299	A.P. Giannini Foundation; NIH Director's New Innovator Award [DP2 CA174497]; NIH/NCI [RO1 CA169338]; Pew-Stewart Foundation Trusts;  [NIHT32CA177555-01]; NATIONAL CANCER INSTITUTE [T32CA177555, T32CA128583, R01CA169338, DP2CA174497] Funding Source: NIH RePORTER	A.P. Giannini Foundation; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pew-Stewart Foundation Trusts; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.A.O. was supported by the A.P. Giannini Foundation and NIHT32CA177555-01. T.G.B. acknowledges support from NIH Director's New Innovator Award DP2 CA174497, NIH/NCI RO1 CA169338, and the Pew-Stewart Foundation Trusts. We thank B. Hann (UCSF Preclinical Therapeutics Core) for helpful discussions. The lentiviral GFP-Luc vector was a kind gift from M. Jensen (Seattle Children's Research Institute, Seattle, Washington, USA).	Astigarraga S, 2007, EMBO J, V26, P668, DOI 10.1038/sj.emboj.7601532; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Blakely CM, 2015, CELL REP, V11, P98, DOI 10.1016/j.celrep.2015.03.012; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Choi N, 2015, ONCOTARGET, V6, P23533, DOI 10.18632/oncotarget.4372; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elkin Michael, 2001, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1902s12; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Futran AS, 2015, P NATL ACAD SCI USA, V112, P8590, DOI 10.1073/pnas.1501373112; Gleize V, 2015, ANN NEUROL, V78, P355, DOI 10.1002/ana.24443; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Grimm O, 2012, DEVELOPMENT, V139, P3962, DOI 10.1242/dev.084327; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hayashita-Kinoh H, 2001, CELL GROWTH DIFFER, V12, P573; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jimenez G, 2012, J CELL SCI, V125, P1383, DOI 10.1242/jcs.092965; Jin YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005634; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Lee Y, 2011, DEV CELL, V21, P746, DOI 10.1016/j.devcel.2011.08.017; Madero-Visbal RA, 2012, SURG ONCOL, V21, P23, DOI 10.1016/j.suronc.2010.07.008; Mordant P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026073; Porlan E, 2014, NAT CELL BIOL, V16, P629, DOI 10.1038/ncb2993; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Schoppmann SF, 2014, CANCER INVEST, V32, P363, DOI 10.3109/07357907.2014.919304; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Szasz AM, 2016, ONCOTARGET, DOI 10.18632/oncotarget.10337; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	31	93	95	5	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					87	96		10.1038/ng.3728	http://dx.doi.org/10.1038/ng.3728			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27869830	Green Accepted, Green Submitted			2022-12-25	WOS:000390976600014
J	Schilling, F; Ros, S; Hu, DE; D'Santos, P; McGuire, S; Mair, R; Wright, AJ; Mannion, E; Franklin, RJM; Neves, AA; Brindle, KM				Schilling, Franz; Ros, Susana; Hu, De-En; D'Santos, Paula; McGuire, Sarah; Mair, Richard; Wright, Alan J.; Mannion, Elizabeth; Franklin, Robin J. M.; Neves, Andre A.; Brindle, Kevin M.			MRI measurements of reporter-mediated increases in transmembrane water exchange enable detection of a gene reporter	NATURE BIOTECHNOLOGY			English	Article							MAGNETIZATION-TRANSFER; EXPRESSION; DIFFUSION; UREA; TRANSPORTER; CONTRAST; LYSINE; CELLS	Non-invasive imaging of gene expression can be used to track implanted cells in vivo but often requires the addition of an exogenous contrast agent that may have limited tissue access'. We show that the urea transporter (UT-B) can be used as a gene reporter, where reporter expression is detected using H-1 MRI measurements of UT-B-mediated increases in plasma membrane water exchange. HEK cells transfected with the reporter showed an increased apparent water exchange rate (AXR), which increased in line with UT-B expression. AXR values measured in vivo, in UT-B-expressing HEK cell xenografts, were significantly higher (about twofold, P < 0.0001), compared with non-expressing controls. Fluorescence imaging of a red fluorescent protein (mStrawberry), co-expressed with UT-B showed that UT-B expression correlated in a linear fashion with AXR. Transduction of rat brain cells in situ with a lentiviral vector expressing UT-B resulted in about a twofold increase in AXR at the site of virus injection.	[Schilling, Franz; Ros, Susana; Hu, De-En; D'Santos, Paula; McGuire, Sarah; Mair, Richard; Wright, Alan J.; Mannion, Elizabeth; Neves, Andre A.; Brindle, Kevin M.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England; [Franklin, Robin J. M.] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge Biomed Campus, Cambridge, England; [Franklin, Robin J. M.] Univ Cambridge, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England; [Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Brindle, KM (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England.; Brindle, KM (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.	kmb1001@cam.ac.uk	Neves, Andre/B-8397-2011; Ros, Susana/B-6350-2019; Schilling, Franz/ABF-4848-2021	Neves, Andre/0000-0003-2740-5166; Schilling, Franz/0000-0001-5239-4628; Franklin, Robin/0000-0001-6522-2104; Ros, Susana/0000-0002-5451-1880	Cancer Research UK Programme grant [17242]; CRUK-EPSRC Imaging Centre in Cambridge and Manchester [16465]; Aleiander von Humboldt Foundation; Cancer Research UK [17242, 16465] Funding Source: researchfish; Medical Research Council [MC_PC_12009] Funding Source: researchfish	Cancer Research UK Programme grant(Cancer Research UK); CRUK-EPSRC Imaging Centre in Cambridge and Manchester; Aleiander von Humboldt Foundation; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Cancer Research UK Programme grant to K.M.B. (17242) and by the CRUK-EPSRC Imaging Centre in Cambridge and Manchester (16465). F.S. is in receipt of funding from the Aleiander von Humboldt Foundation in the form of a Feodor Lynen Research Fellowship. We thank S. Patrickfor the PGK-S-UTB cell line and his help with the UT-B functional assay and D. Honess and D. McIntyre for helpful suggestions and support with the MRI experiments. We thank M. Strzelecki for cell sorting (Flow Cytometry Facility, Cancer Research UK CI), and the Histopathology Facility and the BRU unit (Cancer Research UK CI) for their help. Lentiviral vector, pBOBI<SUP>27</SUP> was a gift from the Verma laboratory, Salk Institute, La Jolla, USA.	Ahrens ET, 2013, NAT REV IMMUNOL, V13, P755, DOI 10.1038/nri3531; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; Deans AE, 2006, MAGN RESON MED, V56, P51, DOI 10.1002/mrm.20914; Deliolanis NC, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2967184; Farrar CT, 2015, RADIOLOGY, V275, P746, DOI 10.1148/radiol.14140251; Gilad AA, 2007, NAT BIOTECHNOL, V25, P217, DOI 10.1038/nbt1277; Janjic JM, 2009, WIRES NANOMED NANOBI, V1, P492, DOI 10.1002/wnan.35; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Lasic S, 2011, MAGN RESON MED, V66, P356, DOI 10.1002/mrm.22782; McMahon MT, 2006, MAGN RESON MED, V55, P836, DOI 10.1002/mrm.20818; Ogami A, 2006, BIOCHEM BIOPH RES CO, V351, P619, DOI 10.1016/j.bbrc.2006.10.097; Oh SH, 2012, MAGN RESON MED, V68, P1239, DOI 10.1002/mrm.23317; Patrick PS, 2015, MAGN RESON MED, V73, P1401, DOI 10.1002/mrm.25254; Patrick PS, 2014, P NATL ACAD SCI USA, V111, P415, DOI 10.1073/pnas.1319000111; Rabolli V, 2014, J BIOL CHEM, V289, P13937, DOI 10.1074/jbc.M113.534594; Smouha E, 2001, MAGN RESON MED, V46, P68, DOI 10.1002/mrm.1161; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Vandsburger MH, 2013, NMR BIOMED, V26, P872, DOI 10.1002/nbm.2869; Weissleder R, 1997, RADIOLOGY, V204, P425, DOI 10.1148/radiology.204.2.9240530; Weissleder Ralph, 2000, Nature Medicine, V6, P351, DOI 10.1038/73219; Welvaert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077089; Yang BX, 2002, J BIOL CHEM, V277, P36782, DOI 10.1074/jbc.M206948200; Zaiss M, 2011, J MAGN RESON, V211, P149, DOI 10.1016/j.jmr.2011.05.001; Zurkiya O, 2008, MAGN RESON MED, V59, P1225, DOI 10.1002/mrm.21606	24	44	45	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2017	35	1					75	80		10.1038/nbt.3714	http://dx.doi.org/10.1038/nbt.3714			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EI4JV	27918546	Green Submitted, Green Accepted			2022-12-25	WOS:000392460800025
J	Steinhart, Z; Pavlovic, Z; Chandrashekhar, M; Hart, T; Wang, XW; Zhang, XY; Robitaille, M; Browne, KR; Jaksani, S; Overmeer, R; Boj, SF; Adams, J; Pan, J; Clevers, H; Sidhu, S; Moffat, J; Angers, S				Steinhart, Zachary; Pavlovic, Zvezdan; Chandrashekhar, Megha; Hart, Traver; Wang, Xiaowei; Zhang, Xiaoyu; Robitaille, Melanie; Browne, Kevin R.; Jaksani, Sridevi; Overmeer, Rene; Boj, Sylvia F.; Adams, Jarrett; Pan, James; Clevers, Hans; Sidhu, Sachdev; Moffat, Jason; Angers, Stephane			Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors	NATURE MEDICINE			English	Article							MUTATIONAL LANDSCAPE; ESSENTIAL GENES; HUMAN-CELLS; WNT; CANCER; GROWTH; RNF43; INHIBITION; MECHANISMS; RECEPTORS	Forward genetic screens with CRISPR-Cas9 genome editing enable high-resolution detection of genetic vulnerabilities in cancer cells. We conducted genome-wide CRISPR-Cas9 screens in RNF43-mutant pancreatic ductal adenocarcinoma (PDAC) cells, which rely on Wnt signaling for proliferation. Through these screens, we discovered a unique requirement for a Wnt signaling circuit: engaging FZD5, one of the ten Frizzled receptors encoded in the human genome. Our results uncover an underappreciated level of context-dependent specificity at the Wnt receptor level. We further derived a panel of recombinant antibodies that reports the expression of nine FZD proteins and confirms that FZD5 functional specificity cannot be explained by protein expression patterns. Additionally, antibodies that specifically bind FZD5 and FZD8 robustly inhibited the growth of RNF43-mutant PDAC cells grown in vitro and as xenografts in vivo, providing orthogonal support for the functional specificity observed genetically. Proliferation of a patient-derived PDAC cell line harboring an RNF43 variant was also selectively inhibited by the FZD5 antibodies, further demonstrating their use as a potential targeted therapy. Tumor organoid cultures from colorectal carcinoma patients that carried RNF43 mutations were also sensitive to the FZD5 antibodies, highlighting the potential generalizability of these findings beyond PDAC. Our results show that CRIPSR-based genetic screens can be leveraged to identify and validate cell surface targets for antibody development and therapy.	[Steinhart, Zachary; Robitaille, Melanie; Angers, Stephane] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada; [Pavlovic, Zvezdan; Chandrashekhar, Megha; Hart, Traver; Wang, Xiaowei; Zhang, Xiaoyu; Browne, Kevin R.; Adams, Jarrett; Pan, James; Sidhu, Sachdev; Moffat, Jason] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Chandrashekhar, Megha; Zhang, Xiaoyu; Sidhu, Sachdev; Moffat, Jason] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Wang, Xiaowei; Pan, James] Ctr Commercializat Antibodies & Biol, Toronto, ON, Canada; [Jaksani, Sridevi; Overmeer, Rene; Clevers, Hans] Univ Med Ctr, Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands; [Jaksani, Sridevi; Overmeer, Rene; Clevers, Hans] Fdn Hubrecht Organoid Technol, Utrecht, Netherlands; [Moffat, Jason] Canadian Inst Adv Res, Toronto, ON, Canada; [Angers, Stephane] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Hart, Traver] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX USA	University of Toronto; University of Toronto; University of Toronto; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Canadian Institute for Advanced Research (CIFAR); University of Toronto; University of Texas System; UTMD Anderson Cancer Center	Angers, S (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada.; Sidhu, S; Moffat, J (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.; Sidhu, S; Moffat, J (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Moffat, J (corresponding author), Canadian Inst Adv Res, Toronto, ON, Canada.; Angers, S (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	sachdev.sidhu@utoronto.ca; j.moffat@utoronto.ca; stephane.angers@utoronto.ca	Wang, Xiaowei/R-3888-2019; Robitaille, Melanie/ABA-5861-2020; Angers, Stephane/E-1432-2014; Zhang, xiaoyu/GXA-3206-2022; Moffat, Jason/AAC-1110-2020; Overmeer, René M/E-5698-2011	Wang, Xiaowei/0000-0001-8658-7399; Robitaille, Melanie/0000-0001-9354-5162; Angers, Stephane/0000-0001-7241-9044; Moffat, Jason/0000-0002-5663-8586; Brown, Kevin/0000-0002-5514-2538; Hart, Traver/0000-0002-1880-3341	Canadian Institutes for Health Research [CIHR-273548, CIHR-342551]; Ontario Research Fund; Ontario Research Fund [19442, 30961]; Canadian Foundation for Innovation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Ontario Research Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation)	We wish to thank members of the Angers and Moffat labs for discussions. We are thankful to D. Hedley (Princess Margaret Hospital, Toronto, Canada) and M. Tsao (Ontario Cancer Institute, Toronto, Canada) for providing the patient-derived xenograft cells; P. Mero (Moffat lab) for help with images. This work was supported from grants funded by the Canadian Institutes for Health Research to S.A. (CIHR-273548) and J.M. (CIHR-342551) and by the Ontario Research Fund to S.S. J.M. holds a Canada Research Chair in Functional Genomics of Cancer and S.A. holds a Canada Research Chair in Functional Architecture of Signal Transduction. Some of the equipment used in this study was supported by The 3D (Diet, Digestive Tract and Disease) Centre funded by the Canadian Foundation for Innovation and Ontario Research Fund, project numbers 19442 and 30961.	Afelik S, 2015, DEV BIOL, V399, P204, DOI 10.1016/j.ydbio.2014.12.031; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arensman MD, 2014, ONCOGENE, V33, P899, DOI 10.1038/onc.2013.23; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hart T, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1015-8; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Jo YS, 2015, HUM PATHOL, V46, P1640, DOI 10.1016/j.humpath.2015.07.004; Koo BK, 2015, P NATL ACAD SCI USA, V112, P7548, DOI 10.1073/pnas.1508113112; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; Madan B, 2015, MOL CANCER THER, V14, P1087, DOI 10.1158/1535-7163.MCT-14-1038; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; Polakis P, 2012, COLD SPRING HARB PER, V4; Ryland GL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0210-y; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59	31	176	181	8	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					60	68		10.1038/nm.4219	http://dx.doi.org/10.1038/nm.4219			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27869803				2022-12-25	WOS:000391646800014
J	Royer, LA; Lemon, WC; Chhetri, RK; Wan, YN; Coleman, M; Myers, EW; Keller, PJ				Royer, Loiec A.; Lemon, William C.; Chhetri, Raghav K.; Wan, Yinan; Coleman, Michael; Myers, Eugene W.; Keller, Philipp J.			Adaptive light-sheet microscopy for long-term, high-resolution imaging in living organisms	NATURE BIOTECHNOLOGY			English	Article							PLANE ILLUMINATION MICROSCOPY; FLUORESCENCE MICROSCOPY; DEEP; BIOLOGY; EMBRYOS; CELLS	Optimal image quality in light-sheet microscopy requires a perfect overlap between the illuminating light sheet and the focal plane of the detection objective. However, mismatches between the light-sheet and detection planes are common owing to the spatiotemporally varying optical properties of living specimens. Here we present the AutoPilot framework, an automated method for spatiotemporally adaptive imaging that integrates (i) a multi-view light-sheet microscope capable of digitally translating and rotating light-sheet and detection planes in three dimensions and (ii) a computational method that continuously optimizes spatial resolution across the specimen volume in real time. We demonstrate long-term adaptive imaging of entire developing zebrafish (Danio rerio) and Drosophila melanogaster embryos and perform adaptive whole-brain functional imaging in larval zebrafish. Our method improves spatial resolution and signal strength two to five-fold, recovers cellular and sub-cellular structures in many regions that are not resolved by non-adaptive imaging, adapts to spatiotemporal dynamics of genetically encoded fluorescent markers and robustly optimizes imaging performance during large-scale morphogenetic changes in living organisms.	[Royer, Loiec A.; Lemon, William C.; Chhetri, Raghav K.; Wan, Yinan; Keller, Philipp J.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Royer, Loiec A.; Myers, Eugene W.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Coleman, Michael] Coleman Technol Inc, Newtown Sq, PA USA	Howard Hughes Medical Institute; Max Planck Society	Royer, LA; Keller, PJ (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.; Royer, LA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	royer@mpi-cbg.de; kellerp@janelia.hhmi.org	Royer, Loic/C-7593-2017; Wan, Yinan/ABD-5538-2020	Royer, Loic/0000-0002-9991-9724; Wan, Yinan/0000-0002-7076-1791; Chhetri, Raghav/0000-0001-6039-4505; Lemon, William/0000-0003-4541-738X; Keller, Philipp/0000-0003-2896-4920	Howard Hughes Medical Institute; Max Planck Institute for Cell Biology and Genetics; German Federal Ministry of Research and Education (BMBF) [031A099]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Max Planck Institute for Cell Biology and Genetics; German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank all members of the Keller laboratory for extensive testing of the AutoPilot framework; Tzumin Lee (Janelia Research Campus) for deadpanEE-Ga14 Drosophila stocks; Misha Ahrens for Tg(elav1.3:GCaMP6f) zebrafish stocks; Nicola Maghelli for help with illustrations; Martin Weigert for 3D rendering software; Vanessa de Oliveira Carlos for D. rerio graphics; and Misha Ahrens, Chen Wang, Katie McDole, Kaspar Podgorski, Na Ji, Eric Betzig and fain Patten for helpful discussions and thoughtful comments on the manuscript. This work was supported by the Howard Hughes Medical Institute, the Max Planck Institute for Cell Biology and Genetics and the German Federal Ministry of Research and Education (BMBF) under the funding code 031A099.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/nmeth.2434, 10.1038/NMETH.2434]; Bourgenot C, 2012, OPT EXPRESS, V20, P13252, DOI 10.1364/OE.20.013252; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chhetri RK, 2015, NAT METHODS, V12, P1171, DOI 10.1038/nmeth.3632; Duck F.A., 1990, MED PHYS, V18; Fahrbach FO, 2013, OPT EXPRESS, V21, P21010, DOI 10.1364/OE.21.021010; Fahrbach FO, 2010, NAT PHOTONICS, V4, P780, DOI [10.1038/nphoton.2010.204, 10.1038/NPHOTON.2010.204]; Hockendorf B, 2012, DEV CELL, V23, P1111, DOI 10.1016/j.devcel.2012.10.008; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kaufmann A, 2012, DEVELOPMENT, V139, P3242, DOI 10.1242/dev.082586; Keller P. J., 2005, THESIS; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2015, NEURON, V85, P462, DOI 10.1016/j.neuron.2014.12.039; Keller PJ, 2013, SCIENCE, V340, P1184, DOI 10.1126/science.1234168; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Lemon WC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8924; Masson A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16898; Palero J, 2010, OPT EXPRESS, V18, P8491, DOI 10.1364/OE.18.008491; Pantazis P, 2014, NAT REV MOL CELL BIO, V15, P327, DOI 10.1038/nrm3786; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Quirin S, 2016, OPT LETT, V41, P855, DOI 10.1364/OL.41.000855; Santi PA, 2011, J HISTOCHEM CYTOCHEM, V59, P129, DOI 10.1369/0022155410394857; Scherf N, 2015, NAT BIOTECHNOL, V33, P815, DOI 10.1038/nbt.3310; Stelzer EHK, 2015, NAT METHODS, V12, P23, DOI 10.1038/nmeth.3219; Tomer R, 2015, CELL, V163, P1796, DOI 10.1016/j.cell.2015.11.061; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/nmeth.2062, 10.1038/NMETH.2062]; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Turaga D, 2013, BIOMED OPT EXPRESS, V4, P1654, DOI 10.1364/BOE.4.001654; Turaga D, 2010, APPL OPTICS, V49, P2030, DOI 10.1364/AO.49.002030; Wang C, 2014, NAT METHODS, V11, P1037, DOI [10.1038/nmeth.3068, 10.1038/NMETH.3068]; Wang K, 2014, NAT METHODS, V11, P625, DOI [10.1038/NMETH.2925, 10.1038/nmeth.2925]; Weber M, 2011, CURR OPIN GENET DEV, V21, P566, DOI 10.1016/j.gde.2011.09.009; Winter PW, 2014, CURR OPIN CHEM BIOL, V20, P46, DOI 10.1016/j.cbpa.2014.04.008; Wu YC, 2013, NAT BIOTECHNOL, V31, P1032, DOI 10.1038/nbt.2713; Wu YC, 2011, P NATL ACAD SCI USA, V108, P17708, DOI 10.1073/pnas.1108494108	37	136	141	3	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1267	1278		10.1038/nbt.3708	http://dx.doi.org/10.1038/nbt.3708			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27798562				2022-12-25	WOS:000390185300018
J	Yuan, WY; Luo, X; Li, ZC; Yang, WN; Wang, YZ; Liu, R; Du, JM; He, YH				Yuan, Wenya; Luo, Xiao; Li, Zicong; Yang, Wannian; Wang, Yizhong; Liu, Rui; Du, Jiamu; He, Yuehui			A cis cold memory element and a trans epigenome reader mediate Polycomb silencing of FLC by vernalization in Arabidopsis	NATURE GENETICS			English	Article							B3 DOMAIN PROTEIN; FLOWERING TIME; PHD FINGER; TRIMETHYLATION; REPRESSION; CHROMATIN; THALIANA; TRIGGERS; SWITCH; LHP1	Some plants acquire competence to flower in spring after experiencing a seasonal temperature drop winter cold, in a process termed vernalization. In Arabidopsis thaliana, prolonged exposure to cold induces epigenetic silencing of the potent floral repressor locus FLOWERING LOCUS C (FLC) by Polycomb group (PcG) proteins, and this silencing is stably maintained in subsequent growth and development upon return to warm temperatures. Here we show that a cis-regulatory DNA element in the nucleation region for PcG silencing at FLC and two homologous trans-acting epigenome readers, VAL1 and VAL2, control vernalization-mediated FLC silencing. The sequence-specific readers recognize both the cis element (termed the cold memory element) and a repressive mark, trimethylation of histone H3 at lysine 27 (H3K27me3), and directly associate with LIKE HETEROCHROMATIN PROTEIN 1 (LHP1), leading to establishment of the H3K27me3 peak in the nucleation region at FLC during vernalization. Thus, our work describes a mechanism for PcG-mediated silencing by a DNA sequence-specific epigenome reader.	[Yuan, Wenya; Luo, Xiao; Li, Zicong; Wang, Yizhong; Liu, Rui; Du, Jiamu; He, Yuehui] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Mol Plant Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China; [Yuan, Wenya; Yang, Wannian; He, Yuehui] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Yuan, Wenya] Novolife Biomed Res Co Ltd, Beijing, Peoples R China; [Yang, Wannian; Wang, Yizhong] Huazhong Normal Univ, Sch Life Sci, Wuhan, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National University of Singapore; Central China Normal University	He, YH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Mol Plant Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China.; He, YH (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.	yhhe@sibs.ac.cn	HE, Yuehui/H-9795-2012; HE, Yuehui/Y-8792-2018; Du, Jiamu/I-1334-2013	HE, Yuehui/0000-0003-3304-4555; HE, Yuehui/0000-0003-3304-4555; Du, Jiamu/0000-0002-1337-0786; Yuan, Wenya/0000-0002-7224-9206	Chinese Academy of Sciences; Ministry of Science and Technology of China [2016YFA0503200]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank M. Suzuki (University of Florida) for kindly providing val1 and val2 seeds and the Flanders Interuniversity Institute for Biotechnology (Belgium) for providing pBGW vector. This work was supported in part by funding from the Chinese Academy of Sciences and from the Ministry of Science and Technology of China (grant 2016YFA0503200 to J.D.).	Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Berry S, 2015, ELIFE, V4, DOI 10.7554/eLife.07205; Berry S, 2015, PLANT J, V83, P133, DOI 10.1111/tpj.12869; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Derkacheva M, 2013, EMBO J, V32, P2073, DOI 10.1038/emboj.2013.145; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Helliwell CA, 2015, TRENDS PLANT SCI, V20, P76, DOI 10.1016/j.tplants.2014.12.004; Helliwell CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021513; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hoppmann V, 2011, EMBO J, V30, P1939, DOI 10.1038/emboj.2011.108; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; King GJ, 2013, J BIOL CHEM, V288, P3198, DOI 10.1074/jbc.M112.438572; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Meller VH, 2015, ANNU REV GENET, V49, P673, DOI 10.1146/annurev-genet-112414-055205; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Questa JI, 2016, SCIENCE, V353, P485, DOI 10.1126/science.aaf7354; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tsukagoshi H, 2005, PLANT PHYSIOL, V138, P675, DOI 10.1104/pp.104.057752; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Veerappan V, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0293-4; Veerappan V, 2012, PLANTA, V236, P1, DOI 10.1007/s00425-012-1630-1; Wang YZ, 2014, DEV CELL, V28, P727, DOI 10.1016/j.devcel.2014.01.029; Yamasaki K, 2004, PLANT CELL, V16, P3448, DOI 10.1105/tpc.104.026112; Yang C, 2013, CURR BIOL, V23, P1324, DOI 10.1016/j.cub.2013.05.050; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283	34	112	121	4	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1527	1534		10.1038/ng.3712	http://dx.doi.org/10.1038/ng.3712			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27819666				2022-12-25	WOS:000389011100013
J	Zhang, JZ; Sokol, KP; Paul, N; Romero, E; van Grondelle, R; Reisner, E				Zhang, Jenny Z.; Sokol, Katarzyna P.; Paul, Nicholas; Romero, Elisabet; van Grondelle, Rienk; Reisner, Erwin			Competing charge transfer pathways at the photosystem II-electrode interface	NATURE CHEMICAL BIOLOGY			English	Article							CHLOROPHYLL-A; REDOX POTENTIALS; BETA-CAROTENE; FLOW-THROUGH; WATER; MECHANISM; SITE; CORE; Q(B); PHOTOSYNTHESIS	The integration of the water-oxidation enzyme photosystem II (PSII) into electrodes allows the electrons extracted from water oxidation to be harnessed for enzyme characterization and to drive novel endergonic reactions. However, PSII continues to underperform in integrated photoelectrochemical systems despite extensive optimization efforts. Here we carried out protein-film photoelectrochemistry using spinach and Thermosynechococcus elongatus PSII, and we identified a competing charge transfer pathway at the enzyme-electrode interface that short-circuits the known water-oxidation pathway. This undesirable pathway occurs as a result of photo-induced O-2 reduction occurring at the chlorophyll pigments and is promoted by the embedment of PSII in an electron-conducting fullerene matrix, a common strategy for enzyme immobilization. Anaerobicity helps to recover the PSII photoresponse and unmasks the onset potentials relating to the Q(A)/Q(B) charge transfer process. These findings impart a fuller understanding of the charge transfer pathways within PSII and at photosystem-electrode interfaces, which will lead to more rational design of pigment-containing photoelectrodes in general.	[Zhang, Jenny Z.; Sokol, Katarzyna P.; Paul, Nicholas; Reisner, Erwin] Univ Cambridge, Dept Chem, Cambridge, England; [Romero, Elisabet; van Grondelle, Rienk] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands	University of Cambridge; Vrije Universiteit Amsterdam	Reisner, E (corresponding author), Univ Cambridge, Dept Chem, Cambridge, England.	reisner@ch.cam.ac.uk	Sokol, Katarzyna P./AAN-5619-2020; Zhang, Jenny/GXV-4980-2022	Romero, Elisabet/0000-0003-3630-1617; Zhang, Jenny/0000-0003-4407-5621	UK Engineering and Physical Sciences Research Council [EP/H00338X/2]; UK Biology and Biotechnological Sciences Research Council [BB/K010220/1]; Marie Curie International Incoming Fellowship [PIIF-GA-2012-328085 RPSII]; Winton Programme for the Physics of Sustainability; VU Amsterdam; Laserlab-Europe Consortium; Foundation of Chemical Sciences of NWO [700.58.305]; European Research Council [267333]; EU FP7 project PAPETS [GA 323901]; Royal Netherlands Academy of Arts and Sciences; BBSRC [BB/K010220/1] Funding Source: UKRI; EPSRC [EP/H00338X/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K010220/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H00338X/2, 1504802] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Biology and Biotechnological Sciences Research Council; Marie Curie International Incoming Fellowship(European Commission); Winton Programme for the Physics of Sustainability; VU Amsterdam; Laserlab-Europe Consortium; Foundation of Chemical Sciences of NWO; European Research Council(European Research Council (ERC)European Commission); EU FP7 project PAPETS; Royal Netherlands Academy of Arts and Sciences; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the UK Engineering and Physical Sciences Research Council (EP/H00338X/2 to E. Reisner; DTA PhD studentship to K.P.S.), the UK Biology and Biotechnological Sciences Research Council (BB/K010220/1 to E. Reisner), and a Marie Curie International Incoming Fellowship (PIIF-GA-2012-328085 RPSII to J.Z.Z.). N.P. was supported by the Winton Programme for the Physics of Sustainability. E. Romero. and R.v.G. were supported by the VU Amsterdam, the Laserlab-Europe Consortium, the Foundation of Chemical Sciences of NWO (TOP grant 700.58.305), the European Research Council (Advanced Investigator grant 267333, PHOTPROT), and EU FP7 project PAPETS (GA 323901). R.v.G. gratefully acknowledges an 'Academy Professor' grant from the Royal Netherlands Academy of Arts and Sciences. We also thank K. Brinkert and W.A. Rutherford (Imperial College London, London, UK) for samples of T. elongatus PSII, and H. van Roon for preparation of the spinach PSII samples. Lastly, we thank D.W. Wakerley and T.E. Rosser for valuable discussions.	Adamiak W, 2010, J ELECTROANAL CHEM, V643, P82, DOI 10.1016/j.jelechem.2010.03.005; Alcantara K, 2006, J AM CHEM SOC, V128, P14930, DOI 10.1021/ja0645537; Allakhverdiev SI, 2011, P NATL ACAD SCI USA, V108, P8054, DOI 10.1073/pnas.1100173108; Ananyev G, 2005, PHOTOSYNTH RES, V84, P355, DOI 10.1007/s11120-004-7081-1; Badura A, 2008, ELECTROANAL, V20, P1043, DOI 10.1002/elan.200804191; Badura A, 2011, ENERG ENVIRON SCI, V4, P3263, DOI 10.1039/c1ee01285a; Barazzouk S, 2005, J PHYS CHEM B, V109, P716, DOI 10.1021/jp046474s; Barber J, 2000, BBA-BIOENERGETICS, V1459, P239, DOI 10.1016/S0005-2728(00)00158-4; BIELSKI BHJ, 1985, J PHYS CHEM REF DATA, V14, P1041, DOI 10.1063/1.555739; Cai P, 2015, NANOSCALE, V7, P10908, DOI 10.1039/c5nr02322j; El-Khouly ME, 2001, PHOTOCHEM PHOTOBIOL, V74, P22, DOI 10.1562/0031-8655(2001)074<0022:PETBCA>2.0.CO;2; Groot ML, 1999, BIOPHYS J, V77, P3328, DOI 10.1016/S0006-3495(99)77164-X; Huang ZJ, 2015, ANGEW CHEM INT EDIT, V54, P6857, DOI 10.1002/anie.201500274; Ishikita H, 2005, J AM CHEM SOC, V127, P1963, DOI 10.1021/ja045058i; JOHNSON GN, 1995, BBA-BIOENERGETICS, V1229, P202, DOI 10.1016/0005-2728(95)00003-2; Kashino Y, 1996, PLANT CELL PHYSIOL, V37, P976, DOI 10.1093/oxfordjournals.pcp.a029047; Kato M, 2014, CHEM SOC REV, V43, P6485, DOI 10.1039/c4cs00031e; Kato M, 2013, J AM CHEM SOC, V135, P10610, DOI 10.1021/ja404699h; Kato M, 2012, J AM CHEM SOC, V134, P8332, DOI 10.1021/ja301488d; Kato Y, 2016, P NATL ACAD SCI USA, V113, P620, DOI 10.1073/pnas.1520211113; KAY A, 1994, J PHYS CHEM-US, V98, P952, DOI 10.1021/j100054a035; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Kruse O, 2005, PHOTOCH PHOTOBIO SCI, V4, P957, DOI 10.1039/b506923h; Lai YH, 2014, FARADAY DISCUSS, V176, P199, DOI 10.1039/c4fd00059e; Leger C, 2008, CHEM REV, V108, P2379, DOI 10.1021/cr0680742; Merry SAP, 1998, BIOCHEMISTRY-US, V37, P17439, DOI 10.1021/bi980502d; Mersch D, 2015, J AM CHEM SOC, V137, P8541, DOI 10.1021/jacs.5b03737; MIYASAKA T, 1980, PHOTOCHEM PHOTOBIOL, V32, P217, DOI 10.1111/j.1751-1097.1980.tb04012.x; NAKATO Y, 1974, B CHEM SOC JPN, V47, P3001, DOI 10.1246/bcsj.47.3001; Nath K, 2013, FEBS LETT, V587, P3372, DOI 10.1016/j.febslet.2013.09.015; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pospisil P, 2012, BBA-BIOENERGETICS, V1817, P218, DOI 10.1016/j.bbabio.2011.05.017; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Romero E, 2014, NAT PHYS, V10, P677, DOI [10.1038/nphys3017, 10.1038/NPHYS3017]; Romero E, 2012, BIOPHYS J, V103, P185, DOI 10.1016/j.bpj.2012.06.026; Romero E, 2010, BIOCHEMISTRY-US, V49, P4300, DOI 10.1021/bi1003926; SATOH K, 1995, PLANT CELL PHYSIOL, V36, P597; SEELY GR, 1978, PHOTOCHEM PHOTOBIOL, V27, P639, DOI 10.1111/j.1751-1097.1978.tb07658.x; Shibamoto T, 2010, FEBS LETT, V584, P1526, DOI 10.1016/j.febslet.2010.03.002; Shibamoto T, 2009, BIOCHEMISTRY-US, V48, P10682, DOI 10.1021/bi901691j; Stevenson GP, 2012, LANGMUIR, V28, P9864, DOI 10.1021/la205037e; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; Terasaki N, 2008, THIN SOLID FILMS, V516, P2553, DOI 10.1016/j.tsf.2007.04.127; TRIBUTSCH H, 1972, PHOTOCHEM PHOTOBIOL, V16, P261; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; van Roon H, 2000, PHOTOSYNTH RES, V64, P155, DOI 10.1023/A:1006476213540; VANLEEUWEN PJ, 1991, PHOTOSYNTH RES, V28, P149, DOI 10.1007/BF00054128; Vopel T, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4938090; Wakerley DW, 2015, ENERG ENVIRON SCI, V8, P2283, DOI 10.1039/c5ee01167a; Yamakoshi Y, 2003, J AM CHEM SOC, V125, P12803, DOI 10.1021/ja0355574	53	34	34	4	82	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1046	+		10.1038/NCHEMBIO.2192	http://dx.doi.org/10.1038/NCHEMBIO.2192			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27723748	Green Submitted, Green Accepted			2022-12-25	WOS:000388582900013
J	Ernst, J; Melnikov, A; Zhang, XL; Wang, L; Rogov, P; Mikkelsen, TS; Kellis, M				Ernst, Jason; Melnikov, Alexandre; Zhang, Xiaolan; Wang, Li; Rogov, Peter; Mikkelsen, Tarjei S.; Kellis, Manolis			Genome-scale high-resolution mapping of activating and repressive nucleotides in regulatory regions	NATURE BIOTECHNOLOGY			English	Article							CHROMATIN-STATE; SYSTEMATIC DISSECTION; FUNCTIONAL DISSECTION; TRANSCRIPTION FACTORS; ENHANCERS; DISCOVERY; ELEMENTS; MOTIFS; IDENTIFICATION; VARIANTS	Massively parallel reporter assays (MPRAs) enable nucleotide-resolution dissection of transcriptional regulatory regions, such as enhancers, but only few regions at a time. Here we present a combined experimental and computational approach, Systematic high-resolution activation and repression profiling with reporter tiling using MPRA (Sharpr-MPRA), that allows high-resolution analysis of thousands of regions simultaneously. Sharpr-MPRA combines dense tiling of overlapping MPRA constructs with a probabilistic graphical model to recognize functional regulatory nucleotides, and to distinguish activating and repressive nucleotides, using their inferred contribution to reporter gene expression. We used Sharpr-MPRA to test 4.6 million nucleotides spanning 15,000 putative regulatory regions tiled at 5-nucleotide resolution in two human cell types. Our results recovered known cell-type-specific regulatory motifs and evolutionarily conserved nucleotides, and distinguished known activating and repressive motifs. Our results also showed that endogenous chromatin state and DNA accessibility are both predictive of regulatory function in reporter assays, identified retroviral elements with activating roles, and uncovered ` attenuator' motifs with repressive roles in active chromatin.	[Ernst, Jason] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Ernst, Jason] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Ernst, Jason] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Ernst, Jason] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Ernst, Jason] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Melnikov, Alexandre; Zhang, Xiaolan; Wang, Li; Rogov, Peter; Mikkelsen, Tarjei S.; Kellis, Manolis] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA USA; [Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Ernst, J (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA.; Ernst, J (corresponding author), Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA.; Ernst, J (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA.; Ernst, J (corresponding author), Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Ernst, J (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Kellis, M (corresponding author), Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA USA.; Kellis, M (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jason.ernst@ucla.edu; manoli@mit.edu	Mikkelsen, Tarjei S/A-1306-2007; Kellis, Manolis/ABE-7385-2020	Mikkelsen, Tarjei S/0000-0002-8133-3135; Kellis, Manolis/0000-0001-7113-9630	US National Institutes of Health (NIH) [R01ES024995, U01NG007912, U01MH105578, R01HG006785, R01GM113708, U01H0007610, R01H6004037, U54HG006991, U41HG007000]; US National Science Foundation CAREER Award [1251200]; Alfred P. Sloan Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008155, U01HG007610, U01HG007912, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG054012] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation CAREER Award(National Science Foundation (NSF)); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Kheradpour and J.-P. Vert for useful discussions related to this work. This work was supported by US National Institutes of Health (NIH) grants R01ES024995, U01NG007912 and U01MH105578 (J.E.), R01HG006785 (T.S.M) R01GM113708, U01H0007610, R01H6004037, U54HG006991 and U41HG007000 (M.K.), an US National Science Foundation CAREER Award #1251200, and an Alfred P. Sloan Fellowship (J.E.).	Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Bickel P.J., 2015, MATH STAT BASIC IDEA, VI; Blattler A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-13; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dickel DE, 2014, NAT METHODS, V11, P566, DOI [10.1038/NMETH.2886, 10.1038/nmeth.2886]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gisselbrecht SS, 2013, NAT METHODS, V10, P774, DOI [10.1038/nmeth.2558, 10.1038/NMETH.2558]; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Hu JH, 2007, J MOL BIOL, V366, P1064, DOI 10.1016/j.jmb.2006.12.047; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kwasnieski JC, 2014, GENOME RES, V24, P1595, DOI 10.1101/gr.173518.114; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Melnikov A., 2014, JOVE-J VIS EXP, V90; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Mikula M, 2010, DNA RES, V17, P245, DOI 10.1093/dnares/dsq016; Murtha M, 2014, NAT METHODS, V11, P559, DOI [10.1038/nmeth.2885, 10.1038/NMETH.2885]; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Sammons MA, 2015, GENOME RES, V25, P179, DOI 10.1101/gr.181883.114; Shen SQ, 2016, GENOME RES, V26, P238, DOI 10.1101/gr.193789.115; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Smit A, 1996, REPEATMASKER OPEN 30; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Watts JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002277; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang Ying, 2007, Einstein J Biol Med, V23, P2	59	72	74	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1180	+		10.1038/nbt.3678	http://dx.doi.org/10.1038/nbt.3678			15	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27701403	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000387506500030
J	Leithner, A; Eichner, A; Muller, J; Reversat, A; Brown, M; Schwarz, J; Merrin, J; de Gorter, DJJ; Schur, F; Bayerl, J; de Vries, I; Wieser, S; Hauschild, R; Lai, FPL; Moser, M; Kerjaschki, D; Rottner, K; Small, JV; Stradal, TEB; Sixt, M				Leithner, Alexander; Eichner, Alexander; Mueller, Jan; Reversat, Anne; Brown, Markus; Schwarz, Jan; Merrin, Jack; de Gorter, David J. J.; Schur, Florian; Bayerl, Jonathan; de Vries, Ingrid; Wieser, Stefan; Hauschild, Robert; Lai, Frank P. L.; Moser, Markus; Kerjaschki, Dontscho; Rottner, Klemens; Small, J. Victor; Stradal, Theresia E. B.; Sixt, Michael			Diversified actin protrusions promote environmental exploration but are dispensable for locomotion of leukocytes	NATURE CELL BIOLOGY			English	Article							ARP2/3 COMPLEX; CELL-MIGRATION; LAMELLIPODIA; CHEMOTAXIS; RAC; ORGANIZATION; CONFINEMENT; DYNAMICS; ADHESION; PROTEIN	Most migrating cells extrude their front by the force of actin polymerization. Polymerization requires an initial nucleation step, which is mediated by factors establishing either parallel filaments in the case of filopodia or branched filaments that form the branched lamellipodial network. Branches are considered essential for regular cell motility and are initiated by the Arp2/3 complex, which in turn is activated by nucleation-promoting factors of the WASP and WAVE families(1). Here we employed rapid amoeboid crawling leukocytes and found that deletion of the WAVE complex eliminated actin branching and thus lamellipodia formation. The cells were left with parallel filaments at the leading edge, which translated, depending on the differentiation status of the cell, into a unipolar pointed cell shape or cells with multiple filopodia. Remarkably, unipolar cells migrated with increased speed and enormous directional persistence, while they were unable to turn towards chemotactic gradients. Cells with multiple filopodia retained chemotactic activity but their migration was progressively impaired with increasing geometrical complexity of the extracellular environment. These findings establish that diversified leading edge protrusions serve as explorative structures while they slow down actual locomotion.	[Leithner, Alexander; Eichner, Alexander; Mueller, Jan; Reversat, Anne; Brown, Markus; Schwarz, Jan; Merrin, Jack; de Vries, Ingrid; Wieser, Stefan; Hauschild, Robert; Sixt, Michael] Inst Sci & Technol Austria IST Austria, Campus 1, A-3400 Klosterneuburg, Austria; [Mueller, Jan; Schur, Florian; Bayerl, Jonathan; Small, J. Victor] Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria; [Brown, Markus; Kerjaschki, Dontscho] Med Univ Vienna, Dept Clin Pathol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria; [de Gorter, David J. J.; Stradal, Theresia E. B.] Univ Munster, Inst Mol Cell Biol, Schlosspl 5, D-48149 Munster, Germany; [Lai, Frank P. L.; Rottner, Klemens; Stradal, Theresia E. B.] Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Moser, Markus] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Rottner, Klemens] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Mol Cell Biol Div, Spielmannstr 7, D-38106 Braunschweig, Germany	Institute of Science & Technology - Austria; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna; University of Munster; Helmholtz Association; Helmholtz-Center for Infection Research; Max Planck Society; Braunschweig University of Technology	Sixt, M (corresponding author), Inst Sci & Technol Austria IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	Sixi@ist.ac.at	wieser, stefan/ABH-4102-2020	wieser, stefan/0000-0002-2670-2217; Leithner, Alexander/0000-0002-1073-744X; /0000-0003-4790-8078; Rottner, Klemens/0000-0003-4244-4198; Reversat, Anne/0000-0003-0666-8928; Bayerl, Jonathan/0000-0002-2096-7652; Stradal, Theresia/0000-0002-0352-9474; Sixt, Michael/0000-0002-6620-9179	German Research Foundation (DFG) [SP 1464]; European Research Council [ERC GA 281556]; Human Frontiers Program; Austrian Science Fund (FWF) [I 1674] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Human Frontiers Program; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the German Research Foundation (DFG) Priority Program SP 1464 to T.E.B.S. and M.S., and European Research Council (ERC GA 281556) and Human Frontiers Program grants to M.S. We thank H. Haecker for his generous help with HoxB8 immortalization, J. Renkawitz for critical reading of the manuscript and the Scientific Service Units of IST Austria for excellent technical support.	Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Bergert M, 2015, NAT CELL BIOL, V17, P524, DOI 10.1038/ncb3134; Blagg SL, 2003, CURR BIOL, V13, P1480, DOI 10.1016/S0960-9822(03)00580-3; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Case LB, 2015, NAT CELL BIOL, V17, P955, DOI 10.1038/ncb3191; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Heuze ML, 2013, IMMUNOL REV, V256, P240, DOI 10.1111/imr.12108; Heuze ML, 2011, METHODS MOL BIOL, V769, P415, DOI 10.1007/978-1-61779-207-6_28; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; HROMAS R, 1991, BIOCHIM BIOPHYS ACTA, V1090, P241, DOI 10.1016/0167-4781(91)90109-Y; Insall R. H, 2010, UNDERSTANDING EUKARY, P1; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Le Berre M, 2014, METHOD CELL BIOL, V121, P213, DOI 10.1016/B978-0-12-800281-0.00014-2; Leithner A., 2016, NAT PROTOC EXCHANGE; Maiuri P, 2015, CELL, V161, P374, DOI 10.1016/j.cell.2015.01.056; Narita A, 2012, J MOL BIOL, V419, P359, DOI 10.1016/j.jmb.2012.03.015; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/nmeth.2510, 10.1038/NMETH.2510]; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Skau CT, 2015, ANNU REV BIOPHYS, V44, P285, DOI 10.1146/annurev-biophys-060414-034308; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Thiam HR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10997; Vinzenz M, 2012, J CELL SCI, V125, P2775, DOI 10.1242/jcs.107623; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Winkler C, 2012, J STRUCT BIOL, V178, P19, DOI 10.1016/j.jsb.2012.02.011; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034	43	93	96	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1253	+		10.1038/ncb3426	http://dx.doi.org/10.1038/ncb3426			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27775702	Green Submitted			2022-12-25	WOS:000387165600018
J	Wang, J; Thingholm, LB; Skieceviciene, J; Rausch, P; Kummen, M; Hov, JR; Degenhardt, F; Heinsen, FA; Ruhlemann, MC; Szymczak, S; Holm, K; Esko, T; Sun, J; Pricop-Jeckstadt, M; Al-Dury, S; Bohov, P; Bethune, J; Sommer, F; Ellinghaus, D; Berge, RK; Hubenthal, M; Koch, M; Schwarz, K; Rimbach, G; Hubbe, P; Pan, WH; Sheibani-Tezerji, R; Hasler, R; Rosenstiel, P; D'Amato, M; Cloppenborg-Schmidt, K; Kunzel, S; Laudes, M; Marschall, HU; Lieb, W; Nothlings, U; Karlsen, TH; Baines, JF; Franke, A				Wang, Jun; Thingholm, Louise B.; Skieceviciene, Jurgita; Rausch, Philipp; Kummen, Martin; Hov, Johannes R.; Degenhardt, Frauke; Heinsen, Femke-Anouska; Ruehlemann, Malte C.; Szymczak, Silke; Holm, Kristian; Esko, Tonu; Sun, Jun; Pricop-Jeckstadt, Mihaela; Al-Dury, Samer; Bohov, Pavol; Bethune, Joern; Sommer, Felix; Ellinghaus, David; Berge, Rolf K.; Huebenthal, Matthias; Koch, Manja; Schwarz, Karin; Rimbach, Gerald; Huebbe, Patricia; Pan, Wei-Hung; Sheibani-Tezerji, Raheleh; Haesler, Robert; Rosenstiel, Philipp; D'Amato, Mauro; Cloppenborg-Schmidt, Katja; Kuenzel, Sven; Laudes, Matthias; Marschall, Hanns-Ulrich; Lieb, Wolfgang; Noethlings, Ute; Karlsen, Tom H.; Baines, John F.; Franke, Andre			Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota	NATURE GENETICS			English	Article							GENE; DISEASE; EXPRESSION; ACID; POPULATION; SHAPE; MICE; SUSCEPTIBILITY; INFLAMMATION; METABOLISM	Human gut microbiota is an important determinant for health and disease, and recent studies emphasize the numerous factors shaping its diversity. Here we performed a genome-wide association study (GWAS) of the gut microbiota using two cohorts from northern Germany totaling 1,812 individuals. Comprehensively controlling for diet and non-genetic parameters, we identify genome-wide significant associations for overall microbial variation and individual taxa at multiple genetic loci, including the VDR gene (encoding vitamin D receptor). We observe significant shifts in the microbiota of Vdr(-/-) mice relative to control mice and correlations between the microbiota and serum measurements of selected bile and fatty acids in humans, including known ligands and downstream metabolites of VDR. Genome-wide significant (P < 5 x 10(-8)) associations at multiple additional loci identify other important points of host-microbe intersection, notably several disease susceptibility genes and sterol metabolism pathway components. Non-genetic and genetic factors each account for approximately 10% of the variation in gut microbiota, whereby individual effects are relatively small.	[Wang, Jun; Rausch, Philipp; Kuenzel, Sven; Baines, John F.] Max Planck Inst Evolutionary Biol, Evolutionary Genom, Plon, Germany; [Wang, Jun; Rausch, Philipp; Cloppenborg-Schmidt, Katja; Baines, John F.] Univ Kiel, Inst Expt Med, Kiel, Germany; [Thingholm, Louise B.; Skieceviciene, Jurgita; Degenhardt, Frauke; Heinsen, Femke-Anouska; Ruehlemann, Malte C.; Szymczak, Silke; Bethune, Joern; Sommer, Felix; Ellinghaus, David; Huebenthal, Matthias; Pan, Wei-Hung; Sheibani-Tezerji, Raheleh; Haesler, Robert; Rosenstiel, Philipp; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Kummen, Martin; Hov, Johannes R.; Holm, Kristian; Karlsen, Tom H.] Norwegian PSC Res Ctr, Div Surg Inflammatory Med & Transplantat, Oslo, Norway; [Kummen, Martin; Hov, Johannes R.; Holm, Kristian; Karlsen, Tom H.] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Kummen, Martin; Hov, Johannes R.; Holm, Kristian; Karlsen, Tom H.] Univ Oslo, Inst Clin Med, KG Jebsen Inflammat Res Ctr, Oslo, Norway; [Kummen, Martin; Hov, Johannes R.; Holm, Kristian; Karlsen, Tom H.] Natl Hosp Norway, Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway; [Hov, Johannes R.; Karlsen, Tom H.] Natl Hosp Norway, Oslo Univ Hosp, Dept Transplantat Med, Sect Gastroenterol, Oslo, Norway; [Esko, Tonu] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Sun, Jun] Univ Chicago, Dept Med, Div Gastroenterol & Hepatol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Pricop-Jeckstadt, Mihaela; Noethlings, Ute] Univ Bonn, Dept Nutr & Food Sci, Nutr Epidemiol, Bonn, Germany; [Al-Dury, Samer; Marschall, Hanns-Ulrich] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Bohov, Pavol; Berge, Rolf K.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Berge, Rolf K.] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Koch, Manja; Lieb, Wolfgang] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Schwarz, Karin; Rimbach, Gerald; Huebbe, Patricia] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany; [D'Amato, Mauro] BioDonostia Hlth Res Inst, San Sebastian, Spain; [D'Amato, Mauro] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [D'Amato, Mauro] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Laudes, Matthias] Univ Hosp SH UKSH, Dept Internal Med 1, Campus Kiel, Kiel, Germany; [Karlsen, Tom H.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Wang, Jun] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Wang, Jun] VIB, Ctr Biol Dis, Leuven, Belgium; [Szymczak, Silke] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany	Max Planck Society; University of Kiel; University of Kiel; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Tartu; University of Chicago; University of Bonn; University of Gothenburg; University of Bergen; University of Bergen; Haukeland University Hospital; University of Kiel; University of Kiel; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science; Karolinska Institutet; University of Kiel; Schleswig Holstein University Hospital; University of Bergen; KU Leuven; Flanders Institute for Biotechnology (VIB); University of Kiel	Franke, A (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	a.franke@mucosa.de	Baines, John F/B-3580-2010; Nöthlings, Ute/B-2713-2010; Szymczak, Silke/HGT-8202-2022; Laudes, Matthias/C-8885-2011; Häsler, Robert/A-4908-2009; Hov, Johannes R/J-1480-2019; Rausch, Philipp/J-4258-2017; Ellinghaus, David/ABC-3610-2020; Rühlemann, Malte Christoph/AAA-6528-2019; Pricop-Jeckstadt, Mihaela/AAP-8645-2021; Sun, Jun/S-7440-2019; Hübenthal, Matthias/M-8149-2015; Marschall, Hanns-Ulrich/K-8842-2017; pricop-Jeckstadt, Mihaela/GRO-7319-2022; Schwarz, Karin/K-3102-2014; D'Amato, Mauro/B-5050-2019; Ellinghaus, David/G-4467-2012; Sommer, Felix/I-1706-2017; Rimbach, Gerald/A-7178-2011; Lieb, Wolfgang/AAC-7650-2022; D'Amato, Mauro/F-2450-2010; Sommer, Felix/AAL-1746-2020; Kummen, Martin/I-6663-2019; Franke, Andre/B-2151-2010; Rosenstiel, Philip/A-5137-2009; Szymczak, Silke/C-6625-2013	Baines, John F/0000-0002-8132-4909; Häsler, Robert/0000-0003-4174-8229; Hov, Johannes R/0000-0002-5900-8096; Rausch, Philipp/0000-0003-3133-5674; Ellinghaus, David/0000-0002-4332-6110; Rühlemann, Malte Christoph/0000-0002-0685-0052; Sun, Jun/0000-0001-7465-3133; Hübenthal, Matthias/0000-0002-5956-3006; Marschall, Hanns-Ulrich/0000-0001-7347-3085; Schwarz, Karin/0000-0002-3943-0564; D'Amato, Mauro/0000-0003-2743-5197; Sommer, Felix/0000-0002-6545-3487; Rimbach, Gerald/0000-0001-7888-4684; D'Amato, Mauro/0000-0003-2743-5197; Sommer, Felix/0000-0002-6545-3487; Kummen, Martin/0000-0001-9660-6290; Franke, Andre/0000-0003-1530-5811; Rosenstiel, Philip/0000-0002-9692-8828; Szymczak, Silke/0000-0002-8897-9035; Sheibani Tezerji, Raheleh/0000-0002-1025-646X; Pricop-Jeckstadt, Mihaela/0000-0003-0173-6493; Koch, Manja/0000-0002-4794-4821; Degenhardt, Frauke/0000-0001-7516-3179; Heinsen, Femke-Anouska/0000-0003-3652-6402	Der Norddeutsche Verbund fur Hoch- und Hochstleistungsrechnen (HLRN); German Research Foundation (DFG) Collaborative Research Center [1182, 306]; German Federal Ministry of Education and Research (BMBF); Norwegian PSC Research Center; Western Norway Regional Health Authority [911802]; German Research Foundation (DFG); Norwegian Research Council [240787/F20]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105118, R03DK089010] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/K032208/1] Funding Source: researchfish; EPSRC [EP/K032208/1] Funding Source: UKRI	Der Norddeutsche Verbund fur Hoch- und Hochstleistungsrechnen (HLRN); German Research Foundation (DFG) Collaborative Research Center(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Norwegian PSC Research Center; Western Norway Regional Health Authority; German Research Foundation (DFG)(German Research Foundation (DFG)); Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A.D. Paterson and colleagues for support in selection of models for GWAS. We further thank Der Norddeutsche Verbund fur Hoch- und Hochstleistungsrechnen (HLRN) and S. Knief and H. Marten for computational resources and support. This work was supported by German Research Foundation (DFG) Collaborative Research Center 1182, 'Origin and Function of Metaorganisms' (J.F.B and A.F.) and Excellence Cluster 306, 'Inflammation at Interfaces' (J.F.B. and A.F.) and by German Federal Ministry of Education and Research (BMBF) project 'SysINFLAME' (J.F.B. and A.E). Project support was also provided by the Norwegian PSC Research Center and the Western Norway Regional Health Authority (grant 911802) (T.H.K.). M.K. is the recipient of a Postdoctoral Research Fellowship from the German Research Foundation (DFG). J.R.H. was funded by the Norwegian Research Council (240787/F20).	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arimura Y, 2014, J GASTROENTEROL, V49, P1217, DOI 10.1007/s00535-013-0866-2; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Biedermann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059260; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; D'Aldebert E, 2009, GASTROENTEROLOGY, V136, P1435, DOI 10.1053/j.gastro.2008.12.040; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Duparc T., 2016, GUT; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Jin D., 2015, CLIN THER, V37; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Krude H, 2003, ANN NY ACAD SCI, V994, P233, DOI 10.1111/j.1749-6632.2003.tb03185.x; Leamy LJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0552-6; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Muller N, 2015, J LIPID RES, V56, P1034, DOI 10.1194/jlr.P052209; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Olivares M, 2015, GUT, V64, P406, DOI 10.1136/gutjnl-2014-306931; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Rehman A, 2016, GUT, V65, P238, DOI 10.1136/gutjnl-2014-308341; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Sato H, 2009, BIOCHEM J, V421, P17, DOI 10.1042/BJ20082429; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Srinivas G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3462; Sun J, 2016, AUTOPHAGY, V12, P1057, DOI 10.1080/15548627.2015.1072670; Terao C, 2013, AM J HUM GENET, V93, P289, DOI 10.1016/j.ajhg.2013.05.024; Tuoresmaki P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096105; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7440; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	50	360	370	8	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1396	1406		10.1038/ng.3695	http://dx.doi.org/10.1038/ng.3695			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27723756	Green Accepted			2022-12-25	WOS:000386543400016
J	Guesdon, A; Bazilel, F; Buey, RM; Mohan, R; Monier, S; Garcia, RR; Angevin, M; Heichette, C; Wieneke, R; Tampe, R; Duchesne, L; Akhmanova, A; Steinmetz, MO; Chretien, D				Guesdon, Audrey; Bazilel, Franck; Buey, Ruben M.; Mohan, Renu; Monier, Solange; Garcia, Ruddi Rodriguez; Angevin, Morgane; Heichette, Claire; Wieneke, Ralph; Tampe, Robert; Duchesne, Laurence; Akhmanova, Anna; Steinmetz, Michel O.; Chretien, Denis			EB1 interacts with outwardly curved and straight regions of the microtubule lattice	NATURE CELL BIOLOGY			English	Article							SLOWLY HYDROLYZABLE ANALOG; ASSEMBLED IN-VITRO; ALPHA-BETA-TUBULIN; GTP HYDROLYSIS; DYNAMIC INSTABILITY; CRYOELECTRON TOMOGRAPHY; STRUCTURAL-CHANGES; POLYMERIZATION; INFORMATION; TRANSITIONS	EB1 is a microtubule plus-end tracking protein that recognizes GTP-tubulin dimers in microtubules(1-4) and thus represents a unique probe to investigate the architecture of the GTP cap of growing microtubule ends(5,6). Here, we conjugated EB1 to gold nanoparticles (EB1-gold) and imaged by cryo-electron tomography its interaction with dynamic microtubules assembled in vitro from purified tubulin. EB1-gold forms comets at the ends of microtubules assembled in the presence of GTP, and interacts with the outer surface of curved and straight tubulin sheets as well as closed regions of the microtubule lattice. Microtubules assembled in the presence of GTP, different GTP analogues or cell extracts display similarly curved sheets at their growing ends, which gradually straighten as their protofilament number increases until they close into a tube. Together, our data provide unique structural information on the interaction of EB1 with growing microtubule ends. They further offer insights into the conformational changes that tubulin dimers undergo during microtubule assembly and the architecture of the GTP-cap region.	[Guesdon, Audrey; Bazilel, Franck; Monier, Solange; Angevin, Morgane; Heichette, Claire; Duchesne, Laurence; Chretien, Denis] Univ Rennes 1, CNRS, UMR6290, Inst Genet & Dev Rennes, Campus Univ Beaulieu, F-35042 Rennes, France; [Buey, Ruben M.; Steinmetz, Michel O.] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Buey, Ruben M.] Univ Salamanca, Dept Genet & Microbiol, Metab Engn Grp, Campus Miguel Unamuno S-N, Salamanca 37007, Spain; [Mohan, Renu; Garcia, Ruddi Rodriguez; Akhmanova, Anna] Univ Utrecht, Fac Sci, Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Wieneke, Ralph; Tampe, Robert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Wieneke, Ralph; Tampe, Robert] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Chretien, Denis] Univ Rennes 1, Microscopy Rennes Imaging Ctr, Campus Sante Villejean, F-35043 Rennes, France; [Chretien, Denis] Univ Rennes 1, CNRS, UMS3480, Biosit, Campus Sante Villejean, F-35043 Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Salamanca; Utrecht University; Goethe University Frankfurt; Goethe University Frankfurt; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Chretien, D (corresponding author), Univ Rennes 1, CNRS, UMR6290, Inst Genet & Dev Rennes, Campus Univ Beaulieu, F-35042 Rennes, France.; Steinmetz, MO (corresponding author), Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland.; Chretien, D (corresponding author), Univ Rennes 1, Microscopy Rennes Imaging Ctr, Campus Sante Villejean, F-35043 Rennes, France.; Chretien, D (corresponding author), Univ Rennes 1, CNRS, UMS3480, Biosit, Campus Sante Villejean, F-35043 Rennes, France.	michel.steinmetz@psi.ch; denis.chretien@univ-rennes1.fr	Tschöpe, Solange Monier/L-9120-2018; Steinmetz, Michel O/AAA-3349-2022; Martinez-Buey, Ruben/K-4296-2014; Tampé, Robert/H-2953-2015	Steinmetz, Michel O/0000-0001-6157-3687; Martinez-Buey, Ruben/0000-0003-1263-0221; Tampé, Robert/0000-0002-0403-2160; Duchesne, Laurence/0000-0003-1985-6266; Chretien, Denis/0000-0001-8261-4396; Wieneke, Ralph/0000-0002-0767-4679	French National Agency for Research [ANR PCV06_142769, PCV07_190830]; University of Rennes 1 (Emerging Scientific Challenges); Federative Research Institute Biosit (Innovative Scientific Project); Association for Cancer Research (Blank Program); Netherlands Organization for Scientific Research Aard-en-Levenswetenschapen VICI; Swiss National Science Foundation [310030B_138659, 31003A_166608]; German Research Foundation [SFB807, SPP1623]; French Ministry of Education and Research; French Association for Cancer Research (ARC); 'Ramon y Cajal' programme of the Spanish Ministry of Economy and Competitivity; Marie Curie Career Integration Grant (EB-SxIP) [FP7-PEOPLE-2011-CIG-293831]; European Molecular Biology Organization Long-Term Fellowship; Marie Curie International Incoming Fellowship	French National Agency for Research(French National Research Agency (ANR)); University of Rennes 1 (Emerging Scientific Challenges); Federative Research Institute Biosit (Innovative Scientific Project); Association for Cancer Research (Blank Program); Netherlands Organization for Scientific Research Aard-en-Levenswetenschapen VICI(Netherlands Organization for Scientific Research (NWO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG)); French Ministry of Education and Research; French Association for Cancer Research (ARC); 'Ramon y Cajal' programme of the Spanish Ministry of Economy and Competitivity; Marie Curie Career Integration Grant (EB-SxIP); European Molecular Biology Organization Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie International Incoming Fellowship(European Commission)	We thank F. Percevault and C. Brigand for their help with cell cultures, and M.F. Carlier for her advice on BeF<INF>3</INF><SUP>-</SUP> experiments. D.C. was supported by grants from the French National Agency for Research (ANR PCV06_142769 and PCV07_190830), the University of Rennes 1 (Emerging Scientific Challenges 2011-12), the Federative Research Institute Biosit (Innovative Scientific Project 2012), and the Association for Cancer Research (Blank Program 2011-15). A.A. was supported by a grant from the Netherlands Organization for Scientific Research Aard-en-Levenswetenschapen VICI. M.O.S. was supported by grants from the Swiss National Science Foundation (310030B_138659 and 31003A_166608). R.T. was supported by the German Research Foundation (Cluster of Excellence-Macromolecular Complexes, SFB807 and SPP1623). A.G. was the recipient of a PhD fellowship from the French Ministry of Education and Research. F.B. was the recipient of a post-doctoral fellowship from the French Association for Cancer Research (ARC). R.M.B. was the recipient of a contract from the 'Ramon y Cajal' programme of the Spanish Ministry of Economy and Competitivity, and was supported by a Marie Curie Career Integration Grant (EB-SxIP; FP7-PEOPLE-2011-CIG-293831). R.M. was the recipient of a European Molecular Biology Organization Long-Term Fellowship and Marie Curie International Incoming Fellowship. R.R.G. was the recipient of a European Molecular Biology Organization Long-Term Fellowship.	Akhmanova A, 2011, CURR BIOL, V21, pR283, DOI 10.1016/j.cub.2011.03.023; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bowne-Anderson H, 2013, BIOESSAYS, V35, P452, DOI 10.1002/bies.201200131; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; CARLIER MF, 1984, P NATL ACAD SCI-BIOL, V81, P771, DOI 10.1073/pnas.81.3.771; CHRETIEN D, 1991, BIOL CELL, V71, P161, DOI 10.1016/0248-4900(91)90062-R; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Coquelle FM, 2011, METHODS MOL BIOL, V777, P193, DOI 10.1007/978-1-61779-252-6_14; Doodhi H, 2014, CURR BIOL, V24, P322, DOI 10.1016/j.cub.2014.01.005; Duchesne L, 2008, LANGMUIR, V24, P13572, DOI 10.1021/la802876u; Duellberg C, 2016, ELIFE, V5, DOI 10.7554/eLife.13470; Guesdon A, 2013, J STRUCT BIOL, V181, P169, DOI 10.1016/j.jsb.2012.11.004; Hyams J. S., 1994, MICROTUBULES; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Janosi IM, 1998, EUR BIOPHYS J BIOPHY, V27, P501, DOI 10.1007/s002490050160; Levy R, 2006, CHEMBIOCHEM, V7, P592, DOI 10.1002/cbic.200500457; Maurer SP, 2014, CURR BIOL, V24, P372, DOI 10.1016/j.cub.2013.12.042; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; MELKI R, 1990, BIOCHEMISTRY-US, V29, P8921, DOI 10.1021/bi00490a007; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; PANTALONI D, 1986, ANN NY ACAD SCI, V466, P496, DOI 10.1111/j.1749-6632.1986.tb38427.x; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Seetapun D, 2012, CURR BIOL, V22, P1681, DOI 10.1016/j.cub.2012.06.068; Tinazli A, 2005, CHEM-EUR J, V11, P5249, DOI 10.1002/chem.200500154; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Zanic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007585; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012	33	56	57	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2016	18	10					1102	1108		10.1038/ncb3412	http://dx.doi.org/10.1038/ncb3412			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DY2ZX	27617931				2022-12-25	WOS:000384961700009
J	Pollock, JA; Wardell, SE; Parent, AA; Stagg, DB; Ellison, SJ; Alley, HM; Chao, CA; Lawrence, SA; Stice, JP; Spasojevic, I; Baker, JG; Kim, SH; McDonnell, DP; Katzenellenbogen, JA; Norris, JD				Pollock, Julie A.; Wardell, Suzanne E.; Parent, Alexander A.; Stagg, David B.; Ellison, Stephanie J.; Alley, Holly M.; Chao, Christina A.; Lawrence, Scott A.; Stice, James P.; Spasojevic, Ivan; Baker, Jennifer G.; Kim, Sung Hoon; McDonnell, Donald P.; Katzenellenbogen, John A.; Norris, John D.			Inhibiting androgen receptor nuclear entry in castration-resistant prostate cancer	NATURE CHEMICAL BIOLOGY			English	Article							HSP90 CHAPERONE; LNCAP CELLS; ANTIANDROGEN; DERIVATIVES; MUTATION; ENZALUTAMIDE; DETERMINANTS; PROGRESSION; ANTAGONISTS; EXPRESSION	Clinical resistance to the second-generation antiandrogen enzalutamide in castration-resistant prostate cancer (CRPC), despite persistent androgen receptor (AR) activity in tumors, highlights an unmet medical need for next-generation antagonists. We have identified and characterized tetra-aryl cyclobutanes (CBs) as a new class of competitive AR antagonists that exhibit a unique mechanism of action. These CBs are structurally distinct from current antiandrogens (hydroxyflutamide, bicalutamide, and enzalutamide) and inhibit AR-mediated gene expression, cell proliferation, and tumor growth in several models of CRPC. Conformational profiling revealed that CBs stabilize an AR conformation resembling an unliganded receptor. Using a variety of techniques, it was determined that the AR-CB complex was not recruited to AR-regulated promoters and, like apo AR, remains sequestered in the cytoplasm, bound to heat shock proteins. Thus, we have identified third-generation AR antagonists whose unique mechanism of action suggests that they may have therapeutic potential in CRPC.	[Pollock, Julie A.; Parent, Alexander A.; Kim, Sung Hoon; Katzenellenbogen, John A.] Univ Illinois, Dept Chem, Urbana, IL USA; [Wardell, Suzanne E.; Stagg, David B.; Ellison, Stephanie J.; Alley, Holly M.; Chao, Christina A.; Lawrence, Scott A.; Stice, James P.; Baker, Jennifer G.; McDonnell, Donald P.; Norris, John D.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Spasojevic, Ivan] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Canc Inst, Pharmaceut Res PK PD Core Lab, Durham, NC USA; [Pollock, Julie A.] Univ Richmond, Dept Chem, Richmond, VA 23173 USA	University of Illinois System; University of Illinois Urbana-Champaign; Duke University; Duke University; Duke University; University of Richmond	Norris, JD (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	jdn001@duke.edu		Stagg, David/0000-0002-1044-118X; Pollock, Julie/0000-0003-0153-9991; Norris, John/0000-0001-6553-8053	CDMRP (Synergistic Idea Development Award) [W81XWH-10-1-0179]; NIH [PHS5R01DK015556]; DOD [W81XWH-13-1-0196]; NIH Training grant [T32ES007326]; NIH NRSA [1 F30 DK083899]; Pharmaceutical Research Shared resource-PK/PD Core [5-P30-CA14236-29]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015556, F30DK083899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	CDMRP (Synergistic Idea Development Award); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NIH Training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Research Shared resource-PK/PD Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the CDMRP (Synergistic Idea Development Award W81XWH-10-1-0179 to D.P.M. and J.A.K.), the NIH (PHS5R01DK015556 to J.A.K.), and the DOD (W81XWH-13-1-0196 to J.D.N.). J.A.P. was supported by an NIH Training grant (T32ES007326). A.A.P. was supported by NIH NRSA (1 F30 DK083899). We would like to thank J.R. Gunther, K.E. Carlson, and T.A. Martin for their early contributions to the project. We are thankful to P. Fan for performing the LC/MS/MS assays within the PK/PD Core Laboratory. I.S. is grateful for the support of the Pharmaceutical Research Shared resource-PK/PD Core laboratory by NIH/NCI Core Grant, 5-P30-CA14236-29.	Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; Davis RA, 2007, J NAT PROD, V70, P1118, DOI 10.1021/np070073x; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Dembitsky VM, 2008, J NAT MED-TOKYO, V62, P1, DOI 10.1007/s11418-007-0166-3; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Fernandez D, 2009, BIOORGAN MED CHEM, V17, P3824, DOI 10.1016/j.bmc.2009.04.035; Flaherty K, 2009, J CLIN ONCOL, V27; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gillis JL, 2013, ONCOTARGET, V4, P691, DOI 10.18632/oncotarget.975; Hara T, 2003, CANCER RES, V63, P149; Hockemeyer J, 2004, J ORG CHEM, V69, P3308, DOI 10.1021/jo0358574; Joseph JD, 2013, CANCER DISCOV, V3, DOI 10.1158/2159-8290.CD-13-0226; Joseph JD, 2009, P NATL ACAD SCI USA, V106, P12178, DOI 10.1073/pnas.0900185106; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Kuruma H, 2013, MOL CANCER THER, V12, P567, DOI 10.1158/1535-7163.MCT-12-0798; Li Y, 2012, ONCOGENE, V31, P4759, DOI 10.1038/onc.2011.637; Liu Q, 2012, J MED CHEM, V55, P250, DOI 10.1021/jm201150j; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Lu YR, 1999, PHYTOCHEMISTRY, V51, P91, DOI 10.1016/S0031-9422(98)00730-4; Nakazawa M, 2014, HORM CANCER-US, V5, P265, DOI 10.1007/s12672-014-0190-1; Ni L, 2010, MOL CELL BIOL, V30, P1243, DOI 10.1128/MCB.01891-08; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Norris JD, 2009, CHEM BIOL, V16, P452, DOI 10.1016/j.chembiol.2009.01.016; Oh S, 2010, CHEMMEDCHEM, V5, P529, DOI 10.1002/cmdc.200900509; Parent AA, 2008, J MED CHEM, V51, P6512, DOI 10.1021/jm800698b; Parent AA, 2014, J ORG CHEM, V79, P5448, DOI 10.1021/jo500457n; Pearce AN, 2008, TETRAHEDRON, V64, P5748, DOI 10.1016/j.tet.2008.04.012; Rick FG, 2015, UROL ONCOL-SEMIN ORI, V33, P270, DOI 10.1016/j.urolonc.2014.11.006; Rick FG, 2013, ONCOTARGETS THER, V6, P391, DOI 10.2147/OTT.S32426; Sagawa T, 2005, J NAT PROD, V68, P502, DOI 10.1021/np040187y; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Wakabayashi KI, 2008, BIOORGAN MED CHEM, V16, P6799, DOI 10.1016/j.bmc.2008.05.063; Watanabe K, 2007, TETRAHEDRON LETT, V48, P7502, DOI 10.1016/j.tetlet.2007.08.059; Yamamoto S, 2013, BIOORGAN MED CHEM, V21, P70, DOI 10.1016/j.bmc.2012.11.001; Yin DH, 2003, J PHARMACOL EXP THER, V304, P1334, DOI 10.1124/jpet.102.040840	45	13	13	2	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					795	+		10.1038/nchembio.2131	http://dx.doi.org/10.1038/nchembio.2131			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27501397	Green Accepted			2022-12-25	WOS:000384248600010
J	Tavana, O; Li, DW; Dai, C; Lopez, G; Banerjee, D; Kon, N; Chen, C; Califano, A; Yamashiro, DJ; Sun, HB; Gu, W				Tavana, Omid; Li, Dawei; Dai, Chao; Lopez, Gonzalo; Banerjee, Debarshi; Kon, Ning; Chen, Chao; Califano, Andrea; Yamashiro, Darrell J.; Sun, Hongbin; Gu, Wei			HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma	NATURE MEDICINE			English	Article							SMALL-MOLECULE INHIBITOR; TARGETED DISRUPTION; EMBRYONIC LETHALITY; P53; USP7/HAUSP; PHOSPHORYLATION; COMPLEX; PROTEIN; CANCER; AURORA	The MYCN proto-oncogene is amplified in a number of advanced-stage human tumors, such as neuroblastomas. Similar to other members of the MYC family of oncoproteins, MYCN (also known as N-Myc) is a transcription factor, and its stability and activity are tightly controlled by ubiquitination-dependent proteasome degradation(1-4). Although numerous studies have demonstrated that N-Myc is a driver of neuroblastoma tumorigenesis, therapies that directly suppress N-Myc activity in human tumors are limited. Here we have identified ubiquitin-specific protease 7 (USP7; also known as HAUSP)(5-7) as a regulator of N-Myc function in neuroblastoma. HAUSP interacts with N-Myc, and HAUSP expression induces deubiquitination and subsequent stabilization of N-Myc. Conversely, RNA interference (RNAi)-mediated knockdown of USP7 in neuroblastoma cancer cell lines, or genetic ablation of Usp7 in the mouse brain, destabilizes N-Myc, which leads to inhibition of N-Myc function. Notably, HAUSP is more abundant in patients with neuroblastoma who have poorer prognosis, and HAUSP expression substantially correlates with N-Myc transcriptional activity. Furthermore, small-molecule inhibitors of HAUSP's deubiquitinase activity markedly suppress the growth of MYCN-amplified human neuroblastoma cell lines in xenograft mouse models. Taken together, our findings demonstrate a crucial role of HAUSP in regulating N-Myc function in vivo and suggest that HAUSP inhibition is a potential therapy for MYCN-amplified tumors.	[Tavana, Omid; Li, Dawei; Dai, Chao; Lopez, Gonzalo; Kon, Ning; Califano, Andrea; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY USA; [Tavana, Omid; Li, Dawei; Dai, Chao; Lopez, Gonzalo; Banerjee, Debarshi; Kon, Ning; Califano, Andrea; Yamashiro, Darrell J.; Gu, Wei] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Lopez, Gonzalo; Califano, Andrea] Columbia Univ, Dept Syst Biol, Coll Phys & Surg, New York, NY USA; [Lopez, Gonzalo; Califano, Andrea] Columbia Univ, Coll Phys & Surg, Ctr Computat Biol & Bioinformat, New York, NY USA; [Banerjee, Debarshi; Yamashiro, Darrell J.] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY 10027 USA; [Chen, Chao; Sun, Hongbin] China Pharmaceut Univ, Jiangsu Key Lab Drug Discovery Metab Dis, Nanjing, Jiangsu, Peoples R China; [Chen, Chao; Sun, Hongbin] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Califano, Andrea] Columbia Univ, Dept Biomed Informat Biochem & Mol Biophys, Coll Phys & Surg, New York, NY USA; [Gu, Wei] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; China Pharmaceutical University; China Pharmaceutical University; Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY USA.; Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY USA.; Gu, W (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA.	wg8@cumc.columbia.edu	banerjee, debarshi/AAF-5704-2020	Yamashiro, Darrell/0000-0002-1250-0235; Tavana, Omid/0000-0001-8401-4546; Califano, Andrea/0000-0003-4742-3679; Lopez, Gonzalo/0000-0002-5092-1284; Li, Dawei/0000-0002-1094-9282	National Cancer Institute, US National Institutes of Health (NIH) [5R01CA193890, 5RO1CA190477, 5RO1CA085533, 2P01CA080058]; NIH cancer biology training grant [T32-CA09503]; NATIONAL CANCER INSTITUTE [T32CA009503, U01CA217858, U01CA168426, P01CA080058, R01CA085533, R01CA193890, R01CA190477] Funding Source: NIH RePORTER	National Cancer Institute, US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH cancer biology training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank J. Maris (Children's Hospital of Philadelphia) for providing cell lines. This work was supported by the National Cancer Institute, US National Institutes of Health (NIH) (grant no. 5R01CA193890, 5RO1CA190477, 5RO1CA085533 and 2P01CA080058; all to W.G.) and was partially supported by the NIH cancer biology training grant T32-CA09503 (O.T.). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Cheng CD, 2013, ONCOL REP, V29, P1730, DOI 10.3892/or.2013.2342; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Conacci-Sorrell Maralice, 2014, Cold Spring Harb Perspect Med, V4, pa014357, DOI 10.1101/cshperspect.a014357; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; Gustafson WC, 2014, CANCER CELL, V26, P414, DOI 10.1016/j.ccr.2014.07.015; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Kim ES, 2002, P NATL ACAD SCI USA, V99, P11399, DOI 10.1073/pnas.172398399; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kon N, 2011, CELL DEATH DIFFER, V18, P1366, DOI 10.1038/cdd.2011.12; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Lee HR, 2011, NAT STRUCT MOL BIOL, V18, P1336, DOI 10.1038/nsmb.2142; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Ma HH, 2012, P NATL ACAD SCI USA, V109, P4828, DOI 10.1073/pnas.1116349109; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Pfoh R, 2015, ENDOCR-RELAT CANCER, V22, pT35, DOI 10.1530/ERC-14-0516; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Reverdy C, 2012, CHEM BIOL, V19, P467, DOI 10.1016/j.chembiol.2012.02.007; SAWAI S, 1993, DEVELOPMENT, V117, P1445; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	40	110	115	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1180	1186		10.1038/nm.4180	http://dx.doi.org/10.1038/nm.4180			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27618649	Green Accepted			2022-12-25	WOS:000384872500021
J	Hohmann, AF; Martin, LJ; Minder, JL; Roe, JS; Shi, JW; Steurer, S; Bader, G; McConnell, D; Pearson, M; Gerstberger, T; Gottschamel, T; Thompson, D; Suzuki, Y; Koegl, M; Vakoc, CR				Hohmann, Anja F.; Martin, Laetitia J.; Minder, Jessica L.; Roe, Jae-Seok; Shi, Junwei; Steurer, Steffen; Bader, Gerd; McConnell, Darryl; Pearson, Mark; Gerstberger, Thomas; Gottschamel, Teresa; Thompson, Diane; Suzuki, Yutaka; Koegl, Manfred; Vakoc, Christopher R.			Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition	NATURE CHEMICAL BIOLOGY			English	Article							CHEMICAL BIOLOGY; SMALL MOLECULES; CANCER-THERAPY; DRUG TARGET; BROMODOMAIN; DISCOVERY; STRATEGY; COMPLEX; IDENTIFICATION; VALIDATION	Here we show that acute myeloid leukemia (AML) cells require the BRD9 subunit of the SWI-SNF chromatin-remodeling complex to sustain MYC transcription, rapid cell proliferation and a block in differentiation. Based on these observations, we derived small-molecule inhibitors of the BRD9 bromodomain that selectively suppress the proliferation of mouse and human AML cell lines. To establish these effects as on-target, we engineered a bromodomain-swap allele of BRD9 that retains functionality despite a radically altered bromodomain pocket. Expression of this allele in AML cells confers resistance to the antiproliferative effects of our compound series, thus establishing BRD9 as the relevant cellular target. Furthermore, we used an analogous domain-swap strategy to generate an inhibitor-resistant allele of EZH2. To our knowledge, our study provides the first evidence for a role of BRD9 in cancer and reveals a simple genetic strategy for constructing resistance alleles to demonstrate on-target activity of chemical probes in cells.	[Hohmann, Anja F.; Minder, Jessica L.; Roe, Jae-Seok; Shi, Junwei; Vakoc, Christopher R.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Hohmann, Anja F.; Vakoc, Christopher R.] Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA; [Martin, Laetitia J.; Steurer, Steffen; Bader, Gerd; McConnell, Darryl; Pearson, Mark; Gerstberger, Thomas; Gottschamel, Teresa; Thompson, Diane; Koegl, Manfred] Boehringer Ingelheim Reg Ctr Vienna GmbH & Co KG, Vienna, Austria; [Shi, Junwei] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA; [Suzuki, Yutaka] Univ Tokyo, Dept Med Genome Sci, Kashiwa, Chiba, Japan	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Boehringer Ingelheim; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tokyo	Vakoc, CR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.; Vakoc, CR (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	vakoc@cshl.edu		Roe, Jae-Seok/0000-0002-9994-3062	Cold Spring Harbor Laboratory US National Cancer Institute (NCI) Cancer Center Support grant [CA455087]; Alex's Lemonade Stand Foundation; V Foundation; Pershing Square Sohn Cancer Research Alliance; Boehringer Ingelheim; Boehringer Ingelheim Fonds PhD Fellowship; Martin Sass Foundation; Lauri Strauss Leukemia Foundation; Burroughs-Wellcome Fund; National Institutes of Health [NCI RO1 CA174793]; NATIONAL CANCER INSTITUTE [P30CA045508, R01CA174793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020122] Funding Source: NIH RePORTER	Cold Spring Harbor Laboratory US National Cancer Institute (NCI) Cancer Center Support grant; Alex's Lemonade Stand Foundation; V Foundation; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); Boehringer Ingelheim(Boehringer Ingelheim); Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Martin Sass Foundation; Lauri Strauss Leukemia Foundation; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Bhagwat for critical reading of the manuscript and members of the Vakoc laboratory for discussion of the presented findings. The phylogenetic tree of human bromodomains was provided by S. Knapp. This work was supported by Cold Spring Harbor Laboratory US National Cancer Institute (NCI) Cancer Center Support grant CA455087 for developmental funds and shared resource support. Additional funding was provided by the Alex's Lemonade Stand Foundation, the V Foundation, Pershing Square Sohn Cancer Research Alliance and by Boehringer Ingelheim. A.F.H. is supported by a Boehringer Ingelheim Fonds PhD Fellowship. J.-S.R. is supported by the Martin Sass Foundation and the Lauri Strauss Leukemia Foundation. C.R.V. is supported by a Burroughs-Wellcome Fund Career Award and National Institutes of Health grant NCI RO1 CA174793.	Armour CD, 2009, NAT METHODS, V6, P647, DOI [10.1038/NMETH.1360, 10.1038/nmeth.1360]; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Balzano D, 2011, CHEM BIOL, V18, P966, DOI 10.1016/j.chembiol.2011.04.013; Bennett J, 2016, J MED CHEM, V59, P1642, DOI 10.1021/acs.jmedchem.5b00458; Blagg J, 2014, CURR OPIN PHARMACOL, V17, P87, DOI 10.1016/j.coph.2014.07.007; Brand M, 2015, ACS CHEM BIOL, V10, P22, DOI 10.1021/cb500996u; Buscarlet M, 2014, BLOOD, V123, P1720, DOI 10.1182/blood-2013-02-483495; Chen PL, 2016, J MED CHEM, V59, P1410, DOI 10.1021/acs.jmedchem.5b00209; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark PGK, 2015, ANGEW CHEM INT EDIT, V54, P6217, DOI 10.1002/anie.201501394; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cruickshank VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142806; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; Hay DA, 2014, J AM CHEM SOC, V136, P9308, DOI 10.1021/ja412434f; Hohmann AF, 2014, TRENDS GENET, V30, P356, DOI 10.1016/j.tig.2014.05.001; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Machleidt T, 2015, ACS CHEM BIOL, V10, P1797, DOI 10.1021/acschembio.5b00143; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martin LJ, 2016, J MED CHEM, V59, P4462, DOI 10.1021/acs.jmedchem.5b01865; McCabe MT, 2014, EPIGENOMICS-UK, V6, P341, DOI [10.2217/EPI.14.23, 10.2217/epi.14.23]; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Middeljans E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033834; Mullard A, 2011, NAT REV DRUG DISCOV, V10, P643, DOI 10.1038/nrd3545; Neff T, 2012, P NATL ACAD SCI USA, V109, P5028, DOI 10.1073/pnas.1202258109; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki A, 2014, NUCLEIC ACIDS RES, V42, P13557, DOI 10.1093/nar/gku885; Theodoulou NH, 2016, J MED CHEM, V59, P1425, DOI 10.1021/acs.jmedchem.5b00256; Titov DV, 2012, BIOORGAN MED CHEM, V20, P1902, DOI 10.1016/j.bmc.2011.11.070; Vangamudi B, 2015, CANCER RES, V75, P3865, DOI 10.1158/0008-5472.CAN-14-3798; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Zeng L, 2005, J AM CHEM SOC, V127, P2376, DOI 10.1021/ja044885g; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	53	101	106	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					672	+		10.1038/nchembio.2115	http://dx.doi.org/10.1038/nchembio.2115			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27376689	Green Accepted			2022-12-25	WOS:000382255100007
J	Uluisik, S; Chapman, NH; Smith, R; Poole, M; Adams, G; Gillis, RB; Besong, TMD; Sheldon, J; Stiegelmeyer, S; Perez, L; Samsulrizal, N; Wang, DD; Fisk, ID; Yang, N; Baxter, C; Rickett, D; Fray, R; Blanco-Ulate, B; Powell, ALT; Harding, SE; Craigon, J; Rose, JKC; Fich, EA; Sun, L; Domozych, DS; Fraser, PD; Tucker, GA; Grierson, D; Seymour, GB				Uluisik, Selman; Chapman, Natalie H.; Smith, Rebecca; Poole, Mervin; Adams, Gary; Gillis, Richard B.; Besong, Tabot M. D.; Sheldon, Judith; Stiegelmeyer, Suzy; Perez, Laura; Samsulrizal, Nurul; Wang, Duoduo; Fisk, Ian D.; Yang, Ni; Baxter, Charles; Rickett, Daniel; Fray, Rupert; Blanco-Ulate, Barbara; Powell, Ann L. T.; Harding, Stephen E.; Craigon, Jim; Rose, Jocelyn K. C.; Fich, Eric A.; Sun, Li; Domozych, David S.; Fraser, Paul D.; Tucker, Gregory A.; Grierson, Don; Seymour, Graham B.			Genetic improvement of tomato by targeted control of fruit softening	NATURE BIOTECHNOLOGY			English	Article							LYCOPERSICON-ESCULENTUM; POLYGALACTURONASE GENE; FRESH TOMATO; CELL-WALLS; EXPRESSION; HOMOGALACTURONAN; INHIBITION; REDUCTION	Controlling the rate of softening to extend shelf life was a key target for researchers engineering genetically modified (GM) tomatoes in the 1990s, but only modest improvements were achieved. Hybrids grown nowadays contain 'non-ripening mutations' that slow ripening and improve shelf life, but adversely affect flavor and color. We report substantial, targeted control of tomato softening, without affecting other aspects of ripening, by silencing a gene encoding a pectate lyase.	[Uluisik, Selman; Chapman, Natalie H.; Smith, Rebecca; Adams, Gary; Gillis, Richard B.; Besong, Tabot M. D.; Samsulrizal, Nurul; Wang, Duoduo; Fisk, Ian D.; Yang, Ni; Fray, Rupert; Harding, Stephen E.; Craigon, Jim; Tucker, Gregory A.; Grierson, Don; Seymour, Graham B.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England; [Poole, Mervin] Bugbrooke Mills, Heygates Ltd, Bugbrooke, England; [Adams, Gary; Gillis, Richard B.] Univ Nottingham, Sch Hlth Sci, Queens Med Ctr, Nottingham, England; [Sheldon, Judith; Baxter, Charles; Rickett, Daniel] Jealotts Hill Int Res Stn, Syngenta Seeds, Bracknell, Berks, England; [Stiegelmeyer, Suzy] Syngenta Crop Protect, Res Triangle Pk, NC USA; [Perez, Laura; Fraser, Paul D.] Royal Holloway Univ London, Sch Biol Sci, Egham Hill, Egham, Surrey, England; [Blanco-Ulate, Barbara; Powell, Ann L. T.] Univ Calif Davis, Plant Sci Dept, Davis, CA 95616 USA; [Rose, Jocelyn K. C.; Fich, Eric A.] Cornell Univ, Plant Biol Sect, Sch Integrat Plant Sci, Ithaca, NY 14853 USA; [Sun, Li; Domozych, David S.] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Sun, Li; Domozych, David S.] Skidmore Coll, Skidmore Microscopy Imaging Ctr, Saratoga Springs, NY 12866 USA; [Smith, Rebecca] Springalls Farm, Valley Produce, Reading, Berks, England; [Besong, Tabot M. D.] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Thuwal, Saudi Arabia; [Stiegelmeyer, Suzy] Q2 Solut, EA Genom, Morrisville, NC USA	University of Nottingham; University of Nottingham; Syngenta; Syngenta; University of London; Royal Holloway University London; University of California System; University of California Davis; Cornell University; Skidmore College; Skidmore College; King Abdullah University of Science & Technology	Seymour, GB (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	graham.seymour@nottingham.ac.uk	Blanco-Ulate, Barbara/K-9437-2017; Yang, Ni/A-7253-2017; Yang, Ni/V-4499-2019; Fisk, Ian/AAN-2636-2020; Wang, Duoduo/AAG-8106-2021; Fisk, Ian D/A-8191-2008; Adams, Gary/ABG-2959-2020; Fray, Rupert G/A-9059-2016; Rickett, Daniel/K-8638-2016	Yang, Ni/0000-0002-6920-8569; Yang, Ni/0000-0002-6920-8569; Fisk, Ian D/0000-0001-8448-3123; Adams, Gary/0000-0002-0335-2162; Fray, Rupert G/0000-0002-3935-8945; Rickett, Daniel/0000-0002-2547-4232; Craigon, Jim/0000-0003-4570-5138; Chapman, Natalie/0000-0001-7785-0845; Seymour, Graham/0000-0001-8365-4947; Gillis, Richard B/0000-0002-7607-6808; Harding, Stephen E./0000-0002-7798-9692; Perez-Fons, Laura/0000-0002-8567-7074; Fich, Eric/0000-0002-8948-7112	Ministry of Education of the Turkish Republic; BBSRC; Syngenta Seeds Ltd. through BBSRC [BB/J015598/1, BB/J016071/1]; EU; European Cooperation in Science and Technology (COST) Action [FA1106]; US National Science Foundation [NSF-MRI 1337280, NSF-MRI 0922805, IOS 0957264, IOS 0544504]; Plant Genome Research Program of the US National Science Foundation [IOS-1339287]; Direct For Biological Sciences [1339287] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1337280] Funding Source: National Science Foundation; BBSRC [BB/J015598/1, BB/G02491X/1, BB/J016071/1] Funding Source: UKRI; EPSRC [EP/M02315X/1, EP/G065802/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J016071/1, BB/J015598/1, BB/G02491X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/M02315X/1, EP/G065802/1] Funding Source: researchfish	Ministry of Education of the Turkish Republic; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Syngenta Seeds Ltd. through BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); European Cooperation in Science and Technology (COST) Action(European Cooperation in Science and Technology (COST)); US National Science Foundation(National Science Foundation (NSF)); Plant Genome Research Program of the US National Science Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	S.U. was funded by Ministry of Education of the Turkish Republic. The work was partly funded by BBSRC and Syngenta Seeds Ltd. through BBSRC 'stand-alone LINK' grants to P.D.F. and G.B.S. (BB/J015598/1 and BB/J016071/1). As part of the BBSRC grant, Syngenta staff (J.S., S.S., C.B. and D.R.) provided support with generating the transgenic plants, the bioinformatics analysis, the microscopy and writing the paper. G.B.S. and P.D.F. acknowledge support from EU project FP6 EUSOL and the European Cooperation in Science and Technology (COST) Action FA1106. D.D. was funded by US National Science Foundation grants NSF-MRI 1337280 and NSF-MRI 0922805. B.B.-U. and A.L.T.P. were funded by US National Science Foundation grants IOS 0957264 and IOS 0544504. J.R. was funded by a grant (IOS-1339287) from the Plant Genome Research Program of the US National Science Foundation. We acknowledge Syngenta Crop Protection, Research Triangle Park, North Carolina, USA, M. Franco for cDNA library preparation and J. Ni for RNASeq quality checks, read alignment and gene counting. We acknowledge J. Jones, V. Nekrasov and S. Kamoun, T.S.L. and The Gatsby Charitable Foundation for provision of the CRISPR-Cas 9 vectors. We also thank M. Bennett and J. Labavitch for useful discussions. COS<SUP>488</SUP> was kindly provided by J. Mravec and W.G.T. Willats of the Department of Plant and Environmental Sciences of the University of Copenhagen.	Abe M, 2003, DEVELOPMENT, V130, P635, DOI 10.1242/dev.00292; Andrews S, 2010, FASTQC; BESFORD RT, 1972, PHYTOCHEMISTRY, V11, P2201, DOI 10.1016/S0031-9422(00)88376-4; BIRD CR, 1988, PLANT MOL BIOL, V11, P651, DOI 10.1007/BF00017465; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Bolger A, 2014, NAT GENET, V46, P1034, DOI 10.1038/ng.3046; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; BUTTERY RG, 1987, J AGR FOOD CHEM, V35, P540, DOI 10.1021/jf00076a025; Causse M, 2010, J FOOD SCI, V75, pS531, DOI 10.1111/j.1750-3841.2010.01841.x; Chapman NH, 2012, PLANT PHYSIOL, V159, P1644, DOI 10.1104/pp.112.200634; COLLMER A, 1988, METHOD ENZYMOL, V161, P329; Dam J, 2004, METHOD ENZYMOL, V384, P185; Domozych DS, 2007, PROTOPLASMA, V230, P99, DOI 10.1007/s00709-006-0197-8; ESHED Y, 1994, EUPHYTICA, V79, P175, DOI 10.1007/BF00022516; Fraser PD, 2000, PLANT J, V24, P551, DOI 10.1111/j.1365-313X.2000.00896.x; Halket JM, 2005, J EXP BOT, V56, P219, DOI 10.1093/jxb/eri069; HALL LN, 1993, PLANT J, V3, P121, DOI 10.1111/j.1365-313X.1993.tb00015.x; Jarvis MC, 2003, PLANT CELL ENVIRON, V26, P977, DOI 10.1046/j.1365-3040.2003.01034.x; Jimenez-Bermudez S, 2002, PLANT PHYSIOL, V128, P751, DOI 10.1104/pp.010671; Kitagawa M, 2005, PHYSIOL PLANTARUM, V123, P331, DOI 10.1111/j.1399-3054.2005.00460.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marin-Rodriguez MC, 2003, PLANT MOL BIOL, V51, P851, DOI 10.1023/A:1023057202847; Martin LBB, 2014, J EXP BOT, V65, P4639, DOI 10.1093/jxb/eru301; Mravec J, 2014, DEVELOPMENT, V141, P4841, DOI 10.1242/dev.113365; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Orfila C, 2001, PLANT PHYSIOL, V126, P210, DOI 10.1104/pp.126.1.210; Perez-Fons L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03859; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson R., 1968, GENET COOP, V18, P36; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schuck P, 2014, ANALYST, V139, P79, DOI 10.1039/c3an01507f; Seymour GB, 2013, ANNU REV PLANT BIOL, V64, P219, DOI 10.1146/annurev-arplant-050312-120057; SHEEHY RE, 1988, P NATL ACAD SCI USA, V85, P8805, DOI 10.1073/pnas.85.23.8805; SMITH CJS, 1990, PLANT MOL BIOL, V14, P369, DOI 10.1007/BF00028773; SMITH CJS, 1988, NATURE, V334, P724, DOI 10.1038/334724a0; Smith DL, 2002, PLANT PHYSIOL, V129, P1755, DOI 10.1104/pp.011025; TIEMAN DM, 1992, PLANT CELL, V4, P667, DOI 10.1105/tpc.4.6.667; TIEMAN DM, 1994, PLANT PHYSIOL, V106, P429, DOI 10.1104/pp.106.2.429; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vincent H, 2013, BIOL CONSERV, V167, P265, DOI 10.1016/j.biocon.2013.08.011; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Ward T. M., 1978, ISOLATION PLANT GROW, V4; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	47	160	173	14	226	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2016	34	9					950	+		10.1038/nbt.3602	http://dx.doi.org/10.1038/nbt.3602			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DW0RE	27454737	Green Accepted			2022-12-25	WOS:000383348500020
J	Hay, D; Hughes, JR; Babbs, C; Davies, JOJ; Graham, BJ; Hanssen, LLP; Kassouf, MT; Oudelaar, AM; Sharpe, JA; Suciu, MC; Telenius, J; Williams, R; Rode, C; Li, PS; Pennacchio, LA; Sloane-Stanley, JA; Ayyub, H; Butler, S; Sauka-Spengler, T; Gibbons, RJ; Smith, AJH; Wood, WG; Higgs, DR				Hay, Deborah; Hughes, Jim R.; Babbs, Christian; Davies, James O. J.; Graham, Bryony J.; Hanssen, Lars L. P.; Kassouf, Mira T.; Oudelaar, A. Marieke; Sharpe, Jacqueline A.; Suciu, Maria C.; Telenius, Jelena; Williams, Ruth; Rode, Christina; Li, Pik-Shan; Pennacchio, Len A.; Sloane-Stanley, Jacqueline A.; Ayyub, Helena; Butler, Sue; Sauka-Spengler, Tatjana; Gibbons, Richard J.; Smith, Andrew J. H.; Wood, William G.; Higgs, Douglas R.			Genetic dissection of the alpha-globin super-enhancer in vivo	NATURE GENETICS			English	Article							CIS-REGULATORY ELEMENTS; CELL IDENTITY GENES; HUMAN GENOME; TRANSCRIPTION FACTORS; TRANSGENIC MICE; EXPRESSION; SEQUENCES; CHROMATIN; DISEASE; PROMOTERS	Many genes determining cell identity are regulated by clusters of Mediator-bound enhancer elements collectively referred to as super-enhancers. These super-enhancers have been proposed to manifest higher-order properties important in development and disease. Here we report a comprehensive functional dissection of one of the strongest putative super-enhancers in erythroid cells. By generating a series of mouse models, deleting each of the five regulatory elements of the alpha-globin super-enhancer individually and in informative combinations, we demonstrate that each constituent enhancer seems to act independently and in an additive fashion with respect to hematological phenotype, gene expression, chromatin structure and chromosome conformation, without clear evidence of synergistic or higher-order effects. Our study highlights the importance of functional genetic analyses for the identification of new concepts in transcriptional regulation.	[Hay, Deborah; Hughes, Jim R.; Babbs, Christian; Davies, James O. J.; Graham, Bryony J.; Hanssen, Lars L. P.; Kassouf, Mira T.; Oudelaar, A. Marieke; Sharpe, Jacqueline A.; Suciu, Maria C.; Telenius, Jelena; Rode, Christina; Li, Pik-Shan; Pennacchio, Len A.; Sloane-Stanley, Jacqueline A.; Ayyub, Helena; Butler, Sue; Gibbons, Richard J.; Smith, Andrew J. H.; Wood, William G.; Higgs, Douglas R.] Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford, England; [Williams, Ruth] Weatherall Inst Mol Med, Oxford, England; [Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Genom Div, MS 84-171, Berkeley, CA USA	University of Oxford; University of Oxford; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Higgs, DR (corresponding author), Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford, England.	doug.higgs@imm.ox.ac.uk	Babbs, Christian/AAA-5917-2022; Davies, James/AAP-9555-2020	Babbs, Christian/0000-0002-1898-5878; Davies, James/0000-0002-4108-4357; Telenius, Jelena/0000-0003-4353-3854; Sauka-Spengler, Tatjana/0000-0001-9289-0263; Oudelaar, Aukje Marieke/0000-0002-4016-6158; Rode, Christina/0000-0002-9951-6757; Higgs, Douglas/0000-0003-3579-8705; Graham, Bryony/0000-0002-4464-5770; Hughes, Jim/0000-0002-8955-7256; Pennacchio, Len/0000-0002-8748-3732; Kassouf, Mira/0000-0002-9781-921X; Suciu, Maria/0000-0002-3873-8874; Hanssen, Lars/0000-0002-2551-2278	Wellcome Trust; UK Medical Research Council (MRC); National Institute for Health Research Biomedical Research Centre, Oxford; NIDCR [U01DE020060NIH]; NHGRI [R01HG003988, U54HG006997]; US Department of Energy [DE-AC02-05CH11231]; Medical Research Council [MC_U137961144, MC_UU_12009/10, MC_UU_12009/15, MC_UU_12009/4, MC_U137961145, MR/N00969X/1, MC_U137961147, MC_PC_15069, G1000801b] Funding Source: researchfish; Wellcome Trust [106130/Z/14/Z] Funding Source: researchfish; MRC [MC_UU_12009/10, MC_U137961147, MC_UU_12009/1, MC_UU_12009/3, MC_PC_15069, MC_UU_12009/4, MC_U137961144, MR/N00969X/1, MC_UU_12009/15, MC_U137961145] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988, U54HG006997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE020060] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US Department of Energy(United States Department of Energy (DOE)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This manuscript is dedicated to the memory of Professor Bill Wood who initiated the project and died in 2014 during the course of this work. The work was supported by the Wellcome Trust (D.H.), the UK Medical Research Council (MRC) and the National Institute for Health Research Biomedical Research Centre, Oxford. L.A.P. was supported by NIDCR FaceBase grant U01DE020060NIH and by NHGRI grants R01HG003988 and U54HG006997, and research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under US Department of Energy contract DE-AC02-05CH11231, University of California.	Anguita E, 2002, BLOOD, V100, P3450, DOI 10.1182/blood-2002-05-1409; Bender MA, 2012, BLOOD, V119, P3820, DOI 10.1182/blood-2011-09-380485; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Davies JOJ, 2016, NAT METHODS, V13, P74, DOI [10.1038/NMETH.3664, 10.1038/nmeth.3664]; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Hosseini M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003570; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Ing-Simmons E, 2015, GENOME RES, V25, P504, DOI 10.1101/gr.184986.114; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kvon EZ, 2015, GENOMICS, V106, P185, DOI 10.1016/j.ygeno.2015.06.007; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; McGowan SJ, 2013, BIOINFORMATICS, V29, P2477, DOI 10.1093/bioinformatics/btt406; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Russell E. S., 1966, BIOLOGY LABORATORY M; Sauka-Spengler T, 2008, METHOD CELL BIOL, V87, P237, DOI 10.1016/S0091-679X(08)00212-4; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035	43	200	204	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					895	+		10.1038/ng.3605	http://dx.doi.org/10.1038/ng.3605			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27376235	Green Accepted, Green Submitted			2022-12-25	WOS:000380755100013
J	Davidson, SM; Jonas, O; Keibler, MA; Hou, HW; Luengo, A; Mayers, JR; Wyckoff, J; Del Rosario, AM; Whitman, M; Chin, CR; Condon, KJ; Lammers, A; Kellersberger, KA; Stall, BK; Stephanopoulos, G; Bar-Sagi, D; Han, J; Rabinowitz, JD; Cima, MJ; Langer, R; Vander Heiden, MG				Davidson, Shawn M.; Jonas, Oliver; Keibler, Mark A.; Hou, Han Wei; Luengo, Alba; Mayers, Jared R.; Wyckoff, Jeffrey; Del Rosario, Amanda M.; Whitman, Matthew; Chin, Christopher R.; Condon, Kendall J.; Lammers, Alex; Kellersberger, Katherine A.; Stall, Brian K.; Stephanopoulos, Gregory; Bar-Sagi, Dafna; Han, Jongyoon; Rabinowitz, Joshua D.; Cima, Michael J.; Langer, Robert; Vander Heiden, Matthew G.			Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors	NATURE MEDICINE			English	Article							SERUM-ALBUMIN; PICHIA-PASTORIS; DEGRADATION; MACROPINOCYTOSIS; ADENOCARCINOMA; METABOLISM; EXPRESSION; SURVIVAL	Mammalian tissues rely on a variety of nutrients to support their physiological functions'. It is known that altered metabolism is involved in the pathogenesis of cancer, but which nutrients support the inappropriate growth of intact malignant tumors is incompletely understood(2,3). Amino acids are essential nutrients for many cancer cells(4,5) that can be obtained through the scavenging and catabolism of extracellular protein via macropinocytosis(6,7). In particular, macropinocytosis can be a nutrient source for pancreatic cancer cells, but it is not fully understood how the tumor environment influences metabolic phenotypes(8) and whether macropinocytosis supports the maintenance of amino acid levels within pancreatic tumors. Here we utilize miniaturized plasma exchange to deliver labeled albumin to tissues in live mice, and we demonstrate that breakdown of albumin contributes to the supply of free amino acids in pancreatic tumors. We also deliver albumin directly into tumors using an implantable microdevice, which was adapted and modified from ref. 9. Following implantation, we directly observe protein catabolism and macropinocytosis in situ by pancreatic cancer cells, but not by adjacent, non-cancerous pancreatic tissue. In addition, we find that intratumoral inhibition of macropinocytosis decreases amino acid levels. Taken together, these data suggest that pancreatic cancer cells consume extracellular protein, including albumin, and that this consumption serves as an important source of amino acids for pancreatic cancer cells in vivo.	[Davidson, Shawn M.; Jonas, Oliver; Luengo, Alba; Mayers, Jared R.; Wyckoff, Jeffrey; Del Rosario, Amanda M.; Whitman, Matthew; Chin, Christopher R.; Lammers, Alex; Cima, Michael J.; Langer, Robert; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Davidson, Shawn M.; Luengo, Alba; Mayers, Jared R.; Condon, Kendall J.; Vander Heiden, Matthew G.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Davidson, Shawn M.; Vander Heiden, Matthew G.] Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA; [Jonas, Oliver] Brigham & Womens Hosp, Dept Radiol, Cambridge, MA USA; [Jonas, Oliver] Harvard Med Sch, Cambridge, MA USA; [Keibler, Mark A.; Stephanopoulos, Gregory; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Hou, Han Wei; Han, Jongyoon] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Kellersberger, Katherine A.; Stall, Brian K.] Bruker Daltron Inc, Billerica, MA USA; [Bar-Sagi, Dafna] NYU, Sch Med, New York, NY USA; [Han, Jongyoon] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Rabinowitz, Joshua D.] Princeton Univ, Dept Chem & Integrat Genom, Princeton, NJ 08544 USA; [Cima, Michael J.] MIT, Dept Mat Sci, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Vander Heiden, Matthew G.] Harvard Med Sch, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Bruker Corporation; New York University; Massachusetts Institute of Technology (MIT); Princeton University; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA.; Vander Heiden, MG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Vander Heiden, MG (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mvh@mit.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; /0000-0002-9515-8892; Mayers, Jared/0000-0002-8607-1787; Chin, Christopher/0000-0002-2140-3197; Luengo, Alba/0000-0002-4236-0229; Hou, Han Wei/0000-0001-6631-6321; Lammers, Alex/0000-0002-2401-8331; Bar-Sagi, Dafna/0000-0003-2597-8948; Whitman, Matthew/0000-0002-5399-5318	National Science Foundation [T32 GM007287]; Koch Institute Frontier Grant; Prostate Cancer Foundation; NCI [F30CA183474]; NIGMS [T32 GM007753]; NIH [1R01 DK075850-01, 1R01 CA160458-01A1, P30 CA1405141, R01 CA168653]; Lustgarten Foundation; Ludwig Center at MIT; Broad Institute SPARC program; Burroughs Wellcome Fund; SU2C; DARPA's Dialysis-Like Therapy (DLT) program [N66001-11-1-4182]; MIT's Microsystems Technology Laboratories; NATIONAL CANCER INSTITUTE [R01CA160458, P30CA014051, R01CA168653, R21CA177391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, T32GM007753] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Koch Institute Frontier Grant; Prostate Cancer Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lustgarten Foundation; Ludwig Center at MIT; Broad Institute SPARC program; Burroughs Wellcome Fund(Burroughs Wellcome Fund); SU2C; DARPA's Dialysis-Like Therapy (DLT) program; MIT's Microsystems Technology Laboratories; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to dedicate this paper to the memory of Katherine Kellersberger. We thank the MIT Department of Chemical Engineering and). Francois-Hamel for access to bioreactor equipment, R. Bronson for pathological grading of tumors and A. Lau for providing tumor-bearing mice. S.M.D. and A.L. received support from a National Science Foundation Graduate Research Award Fellowship, and support from T32 GM007287 is also acknowledged. O.J. received support from the Koch Institute Frontier Grant and the Prostate Cancer Foundation. J.R.M. acknowledges support from grant F30CA183474 from the NCI and grant T32 GM007753 from NIGMS. M.A.K. and G.S. acknowledge support from NIH grants 1R01 DK075850-01 and 1R01 CA160458-01A1. M.G.V.H. acknowledges support from the Lustgarten Foundation, the Ludwig Center at MIT, the Broad Institute SPARC program, the Burroughs Wellcome Fund, SU2C and the NIH (P30 CA1405141, R01 CA168653). H.W.H. and J.H. acknowledge support by DARPA's Dialysis-Like Therapy (DLT) program under SSC Pacific grant N66001-11-1-4182. This work is also supported by the use of MIT's Microsystems Technology Laboratories.	ANDERSSON C, 1990, J SURG RES, V49, P23, DOI 10.1016/0022-4804(90)90105-B; ANDERSSON C, 1991, J SURG RES, V50, P156, DOI 10.1016/0022-4804(91)90240-M; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; BRENNER DA, 1990, J CLIN INVEST, V85, P248, DOI 10.1172/JCI114419; Commisso C, 2014, NAT PROTOC, V9, P182, DOI 10.1038/nprot.2014.004; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Fearon KCH, 1998, ANN SURG, V227, P249, DOI 10.1097/00000658-199802000-00015; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Hou HW, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4710992; Hou HW, 2010, LAB CHIP, V10, P2605, DOI 10.1039/c003873c; JEWELL WR, 1975, CANCER RES, V35, P405; Jonas O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010564; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Klionsky D. J., 2009, METHOD ENZYMOL, V452, pxxi; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Manic G, 2014, MOL CELL ONCOL, V1, DOI 10.4161/mco.29911; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; Merlot AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00299; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; ROTHSCHILD MA, 1975, ANNU REV MED, V26, P91, DOI 10.1146/annurev.me.26.020175.000515; SCHILLING U, 1992, NUCL MED BIOL, V19, P685; STEINFELD JL, 1960, CANCER, V13, P974, DOI 10.1002/1097-0142(196009/10)13:5<974::AID-CNCR2820130519>3.0.CO;2-Y; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tolner B, 2006, NAT PROTOC, V1, P1006, DOI 10.1038/nprot.2006.126; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; White E, 2013, GENE DEV, V27, P2065, DOI 10.1101/gad.228122.113; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wosikowski K, 2003, CLIN CANCER RES, V9, P1917	36	202	205	3	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					235	241		10.1038/nm.4256	http://dx.doi.org/10.1038/nm.4256			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28024083	Green Submitted, Green Accepted			2022-12-25	WOS:000393729000015
J	Meyer, E; Carss, KJ; Rankin, J; Nichols, JME; Grozeva, D; Joseph, AP; Mencacci, NE; Papandreou, A; Ng, J; Barra, S; Ngoh, A; Ben-Pazi, H; Willemsen, MA; Arkadir, D; Barnicoat, A; Bergman, H; Bhate, S; Boys, A; Darin, N; Foulds, N; Gutowski, N; Hills, A; Houlden, H; Hurst, JA; Israe, Z; Kaminska, M; Limousin, P; Lumsden, D; Mckee, S; Misra, S; Mohammed, SS; Nakou, V; Nicolai, J; Nilsson, M; Pall, H; Peall, KJ; Peters, GB; Prabhakar, P; Reuter, MS; Rump, P; Sege, R; Sinnema, M; Smith, M; Turnpenny, P; White, SM; Wieczorek, D; Wiethoff, S; Wilson, BT; Winter, G; Wragg, C; Pope, S; Heales, SJH; Morrogh, D; Pittman, A; Carr, LJ; Perez-Duenas, B; Lin, JP; Reis, A; Gahl, WA; Toro, C; Bhatia, KP; Wood, NW; Kamsteeg, EJ; Chong, WK; Gissen, P; Topf, M; Dale, RC; Chubby, JR; Raymond, FL; Kurian, MA				Meyer, Esther; Carss, Keren J.; Rankin, Julia; Nichols, John M. E.; Grozeva, Detelina; Joseph, Agnel P.; Mencacci, Niccolo E.; Papandreou, Apostolos; Ng, Joanne; Barra, Serena; Ngoh, Adeline; Ben-Pazi, Hilla; Willemsen, Michel A.; Arkadir, David; Barnicoat, Angela; Bergman, Hagai; Bhate, Sanjay; Boys, Amber; Darin, Niklas; Foulds, Nicola; Gutowski, Nicholas; Hills, Alison; Houlden, Henry; Hurst, Jane A.; Israe, Zvi; Kaminska, Margaret; Limousin, Patricia; Lumsden, Daniel; Mckee, Shane; Misra, Shibalik; Mohammed, Shekeeb S.; Nakou, Vasiliki; Nicolai, Joost; Nilsson, Magnus; Pall, Hardev; Peall, Kathryn J.; Peters, Gregory B.; Prabhakar, Prab; Reuter, Miriam S.; Rump, Patrick; Sege, Reeval; Sinnema, Margje; Smith, Martin; Turnpenny, Peter; White, Susan M.; Wieczorek, Dagmar; Wiethoff, Sarah; Wilson, Brian T.; Winter, Gidon; Wragg, Christopher; Pope, Simon; Heales, Simon J. H.; Morrogh, Deborah; Pittman, Alan; Carr, Lucinda J.; Perez-Duenas, Belen; Lin, Jean-Pierre; Reis, Andre; Gahl, William A.; Toro, Camilo; Bhatia, Kailash P.; Wood, Nicholas W.; Kamsteeg, Erik-Jan; Chong, Wui K.; Gissen, Paul; Topf, Maya; Dale, Russell C.; Chubby, Jonathan R.; Raymond, F. Lucy; Kurian, Manju A.		UK10K Consortium; Deciphering Dev Disorders Study; NIHR BioResource Rare	Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia	NATURE GENETICS			English	Article							PROTEIN STABILITY; NEURODEGENERATION; METHYLATION; DISORDERS	Histone lysine methylation, mediated by mixed-lineage leukemia (MLL) proteins, is now known to be critical in the regulation of gene expression, genomic stability, cell cycle and nuclear architecture. Despite MLL proteins being postulated as essential for normal development, little is known about the specific functions of the different MLL lysine methyltransferases. Here we report heterozygous variants in the gene KMT2B (also known as MLL4) in 27 unrelated individuals with a complex progressive childhood-onset dystonia, often associated with a typical facial appearance and characteristic brain magnetic resonance imaging findings. Over time, the majority of affected individuals developed prominent cervical, cranial and laryngeal dystonia. Marked clinical benefit, including the restoration of independent ambulation in some cases, was observed following deep brain stimulation (DBS). These findings highlight a clinically recognizable and potentially treatable form of genetic dystonia, demonstrating the crucial role of KMT2B in the physiological control of voluntary movement.	[Meyer, Esther; Ng, Joanne; Barra, Serena; Ngoh, Adeline; Kurian, Manju A.] UCL Inst Child Hlth, London, England; [Carss, Keren J.] Univ Cambridge, NHS Blood & Transplant Ctr, Dept Hematol, Cambridge, England; [Carss, Keren J.; Raymond, F. Lucy] Cambridge Univ Hosp, NIHR BioResource Rare Dis, Cambridge Biomed Campus, Cambridge, England; [Rankin, Julia; Turnpenny, Peter] Royal Devon & Exeter NHS Fdn Trust, Clin Genet, Exeter, Devon, England; [Nichols, John M. E.; Gissen, Paul; Chubby, Jonathan R.] UCL, MRC Lab Mol Cell Biol, London, England; [Nichols, John M. E.; Gissen, Paul; Chubby, Jonathan R.] UCL, Dept Cell & Dev Biol, London, England; [Grozeva, Detelina; Raymond, F. Lucy] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England; [Joseph, Agnel P.; Topf, Maya] Univ London, Birkbeck Coll, Dept Biol Sci, Inst Struct & Mol Biol,Crystallog, London, England; [Mencacci, Niccolo E.; Houlden, Henry; Wiethoff, Sarah; Pittman, Alan; Wood, Nicholas W.] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Papandreou, Apostolos; Ng, Joanne; Ngoh, Adeline; Bhate, Sanjay; Prabhakar, Prab; Carr, Lucinda J.; Kurian, Manju A.] Great Ormond St Hosp Sick Children, Dept Neurol, London, England; [Ben-Pazi, Hilla; Winter, Gidon] Shaare Zedek Mem Hosp, Pediatr Neurol & Dev, Jerusalem, Israel; [Willemsen, Michel A.] Radboud Univ Nijmegen Med Ctr, Donders Ctr Brain Cognit & Behav, Dept Paediat Neurol, Nijmegen, Netherlands; [Arkadir, David] Hadassah Med Ctr, Dept Neurol, Jerusalem, Israel; [Arkadir, David] Hebrew Univ Jerusalem, Jerusalem, Israel; [Barnicoat, Angela; Hurst, Jane A.; Wilson, Brian T.] Great Ormond St Hosp Sick Children, Dept Clin Genet, London, England; [Bergman, Hagai] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Neurobiol & Neurosurg, Jerusalem, Israel; [Boys, Amber; White, Susan M.] Murdoch Childrens Res Inst, Victoria Clin Genet Serv, Parkville, Vic, Australia; [Darin, Niklas] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden; [Foulds, Nicola] Southampton Gen Hosp, Dept Clin Genet, Southampton, Hants, England; [Gutowski, Nicholas] Royal Devon & Exeter NHS Fdn Trust, Dept Neurol, Exeter, Devon, England; [Hills, Alison; Wragg, Christopher] Southmead Hosp, Bristol Genet Lab, Pathol Sci, Bristol, Avon, England; [Israe, Zvi] Hadassah Univ Hosp, Funct & Restorat Neurosurg, Jerusalem, Israel; [Kaminska, Margaret; Lumsden, Daniel; Nakou, Vasiliki; Lin, Jean-Pierre] Guys & St Thomas NHS Fdn Trust, Evelina Childrens Hosp, Complex Motor Disorders Serv, London, England; [Limousin, Patricia; Bhatia, Kailash P.] Natl Hosp Neurol & Neurosurg, Sobell Dept, London, England; [Mckee, Shane] Belfast City Hosp, Northern Ireland Reg Genet Serv, Belfast, Antrim, North Ireland; [Misra, Shibalik; Mohammed, Shekeeb S.; Dale, Russell C.] Univ Sydney, Child & Adolescent Hlth, Sydney, NSW, Australia; [Misra, Shibalik; Mohammed, Shekeeb S.; Dale, Russell C.] Univ Sydney, Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia; [Nicolai, Joost] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [Papandreou, Apostolos; Nilsson, Magnus] Pitea Hosp, Dept Pediat, Umea, Sweden; [Nilsson, Magnus] Umea Univ Hosp, Umea, Sweden; [Pall, Hardev] Univ Birmingham, Coll Med & Dent Studies, Birmingham, W Midlands, England; [Peall, Kathryn J.] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales; [Peters, Gregory B.] Childrens Hosp Westmead, Dept Cytogenet, Westmead, NSW, Australia; [Reuter, Miriam S.; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Rump, Patrick] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Sege, Reeval] Shaare Zedek Med Ctr, Inst Med Genet, Jerusalem, Israel; [Sege, Reeval] Shaare Zedek Med Ctr, Pediat, Jerusalem, Israel; [Sege, Reeval] Hebrew Univ Jerusalem, Sch Med, Jerusalem, Israel; [Sinnema, Margje] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Sinnema, Margje] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands; [Smith, Martin] John Radcliffe Hosp, Dept Pediat Neurol, Oxford, England; [White, Susan M.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Wieczorek, Dagmar] Univ Duisburg Essen, Inst Human Genet, Essen, Germany; [Wieczorek, Dagmar] Heinrich Heine Univ, Fac Med, Inst Human Genet, Dusseldorf, Germany; [Heales, Simon J. H.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London, England; [Heales, Simon J. H.] NHS Fdn Trust, Great Ormond St Hosp, Clin Chem, London, England; [Morrogh, Deborah] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London, England; [Perez-Duenas, Belen] Univ Barcelona, Hosp St Joan de Deu, Dept Child Neurol, Barcelona, Spain; [Perez-Duenas, Belen] Hosp St Joan de Deu, Ctr Biomed Res Rare Dis CIBERER ISCIII, Barcelona, Spain; [Gahl, William A.; Toro, Camilo] US Natl Inst Hlth, Off Director, Common Fund, NIH Undiagnosed Dis Program, Bethesda, MD USA; [Kamsteeg, Erik-Jan] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Chong, Wui K.] Great Ormond St Hosp Sick Children, Dept Radiol, London, England	University of London; University College London; University of Cambridge; University of Cambridge; University of Exeter; MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of Cambridge; University of London; Birkbeck University London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Radboud University Nijmegen; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Hebrew University of Jerusalem; Hadassah University Medical Center; Murdoch Children's Research Institute; Sahlgrenska University Hospital; University of Gothenburg; University of Southampton; University of Exeter; Southmead Hospital; Hebrew University of Jerusalem; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Belfast City Hospital; University of Sydney; University of Sydney; Maastricht University; Umea University; University of Birmingham; Cardiff University; University of Sydney; University of Erlangen Nuremberg; University of Groningen; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Maastricht University; Maastricht University; University of Oxford; University of Melbourne; University of Duisburg Essen; Heinrich Heine University Dusseldorf; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; National Institutes of Health (NIH) - USA; Radboud University Nijmegen; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Kurian, MA (corresponding author), UCL Inst Child Hlth, London, England.; Kurian, MA (corresponding author), Great Ormond St Hosp Sick Children, Dept Neurol, London, England.	manju.kurian@ucl.ac.uk	Wieczorek, Dagmar/AAU-6008-2021; Pittman, Alan M/D-6231-2012; Darin, Niklas/AAL-6345-2020; Willemsen, Michel A.A.P./H-8119-2014; Bergman, Hagai/AAI-4683-2021; Pittman, Alan/AAP-2534-2020; Reis, André/D-2309-2009; Kamsteeg, Erik-Jan/L-4421-2015; Perez-Duenas, Belen/AAG-9054-2019; Mohammad, Shekeeb/AAD-1282-2022; Wood, Nicholas W/C-2505-2009; Lin, Jean-Pierre/R-3779-2019; Houlden, Henry J/C-1532-2008	Wieczorek, Dagmar/0000-0003-2812-6492; Pittman, Alan M/0000-0002-8112-2987; Bergman, Hagai/0000-0002-2402-6673; Pittman, Alan/0000-0002-8112-2987; Reis, André/0000-0002-6301-6363; Mohammad, Shekeeb/0000-0003-1219-4781; Wood, Nicholas W/0000-0002-9500-3348; Lin, Jean-Pierre/0000-0001-9314-2259; Houlden, Henry J/0000-0002-2866-7777; Prabhakar, Prab/0000-0002-1641-8714; Kingston, Nathalie/0000-0002-9190-2231; Mencacci, Niccolo Emanuele/0000-0003-3383-9665; Carss, Keren/0000-0003-4939-156X; Ng, Joanne/0000-0002-7946-9965; Gissen, Paul/0000-0002-9712-6122; McKee, Shane/0000-0002-1772-0106; benpazi, hilla/0000-0002-8039-4761; Lumsden, Daniel/0000-0002-5524-6177; Pope, Simon Alexander Samuel/0000-0002-2991-3722; Papandreou, Apostolos/0000-0001-5093-6075; Chong, Kling/0000-0002-4335-3864; barral, serena/0000-0002-1430-3614; Kelly, Kirsten/0000-0003-4234-543X; Topf, Maya/0000-0002-8185-1215; Grozeva, Detelina/0000-0003-3239-8415; Reis, AlessanRSS/0000-0001-8486-7469; Nichols, John/0000-0003-2061-1485	Rosetrees Trust; Great Ormond Street Hospital Children's Charity; Gracious Heart Foundation; UK Department of Health's NIHR Biomedical Research Centers; Daniel Turnberg Trust Fund; MRC; Wellcome Trust (Synaptopathies award); Prusiner-Abramsky Award; Dystonia Society (UK); La Marato de TV3 [20143130]; Ministerio Espanol de Economia y Competitividad [PI15/00287]; Guy's and St Thomas' Charity New Services and Innovation Grant [G060708]; Dystonia Society (UK) [01/2011, 07/2013]; Action Medical Research [AMR-GN2097]; NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London; University of Cambridge; NIHR for the BioResource for Rare Diseases [RG65966]; Wellcome Trust [UK10K (WT091310)]; DDD study; Health Innovation Challenge Fund [HICF-1009-003]; Intramural Research Program of the National Human Genome Research Institute; Common Fund, NIH Office of the Director; German Ministry of Research and Education as part of National Genome Research Network [0IGS08160, 01GS08167]; German Ministry of Research and Education (German Mental Retardation Network) as part of National Genome Research Network; Deutsche Forschungsgemeinschaft [AB393/2-2]; UK Human Brain Expression Consortium (UKBEC); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215, ZIDHG200352] Funding Source: NIH RePORTER; Academy of Medical Sciences (AMS) [AMS-SGCL11-Peall] Funding Source: researchfish; Medical Research Council [G108/638, G0802760, MR/K02342X/1, MR/P008593/1, G1001253, MR/J004758/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082, NF-SI-0513-10064, NF-SI-0507-10376] Funding Source: researchfish; Parkinson&quot;s UK [G-1107] Funding Source: researchfish; Rosetrees Trust [M576] Funding Source: researchfish; Action Medical Research [2358, 2465] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1284] Funding Source: researchfish; MRC [MR/K02342X/1, MR/P008593/1, MR/J004758/1, G108/638, G1001253, G0802760] Funding Source: UKRI	Rosetrees Trust(Rosetrees Trust); Great Ormond Street Hospital Children's Charity; Gracious Heart Foundation; UK Department of Health's NIHR Biomedical Research Centers; Daniel Turnberg Trust Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (Synaptopathies award)(Wellcome Trust); Prusiner-Abramsky Award; Dystonia Society (UK); La Marato de TV3; Ministerio Espanol de Economia y Competitividad(Spanish Government); Guy's and St Thomas' Charity New Services and Innovation Grant; Dystonia Society (UK); Action Medical Research; NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London(General Electric); University of Cambridge(University of Cambridge); NIHR for the BioResource for Rare Diseases; Wellcome Trust(Wellcome Trust); DDD study; Health Innovation Challenge Fund; Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Common Fund, NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Research and Education as part of National Genome Research Network; German Ministry of Research and Education (German Mental Retardation Network) as part of National Genome Research Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Human Brain Expression Consortium (UKBEC); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); Rosetrees Trust(Rosetrees Trust); Action Medical Research; Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all our patients and their families for taking part in this study and encouraging international collaboration to seek out similar cases. Thanks are given to M. Ishida (GOS-ICH) for kindly providing the fetal cDNA, K. Tuschl (GOS-ICH) for kindly providing the human cDNA panel, L. Bassioni (Great Ormond Street Hospital, GOSH) for kindly selecting DaTSCAN images for the supplementary manuscript, M. Adams (National Hospital for Neurology and Neurosurgery, NHNN) for reviewing the imaging of the patients at NHNN and R. Meijer for helping with the sequencing analysis at the Department of Human Genetics (Nijmegen). We thank G. Moore (GOS-ICH) and P. Stanier (GOS-ICH) for proofreading the manuscript. Many thanks are given to A. Panahian-Jand (GOSH) for excellent administrative support. M.A.K. has a Wellcome Intermediate Clinical Fellowship (WT098524MA). E.M. and M.A.K. received funding from the Rosetrees Trust, the Great Ormond Street Hospital Children's Charity and the Gracious Heart Foundation. N.E.M. receives support from the UK Department of Health's NIHR Biomedical Research Centers funding streams. A. Papandreou has a joint Action Medical Research/British Paediatric Neurology Association Research Training Fellowship. J. Ng has an MRC Research Training Fellowship. A.N. has an Action Medical Research Training Fellowship. H.B.-P. has a DBS training travel grant from the Daniel Turnberg Trust Fund. H.H. is funded by the MRC and Wellcome Trust (Synaptopathies award). D.A. is supported by the Prusiner-Abramsky Award. H.P. has received grant support from the Dystonia Society (UK). K.J.P. has an Academy of Medical Sciences Clinical Starter Grant. B.P.-D. received funding from grants 20143130-La Marato de TV3 and PI15/00287-Ministerio Espanol de Economia y Competitividad. J.-P.L. has been supported by Guy's and St Thomas' Charity New Services and Innovation Grant G060708, the Dystonia Society (UK), grants 01/2011 and 07/2013 and an Action Medical Research, AMR-GN2097. This research was supported by the NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust, University College London and University of Cambridge and by funding from the NIHR for the BioResource for Rare Diseases (grant RG65966). This study makes use of data generated by the DECIPHER community. A full list of centers contributing to the generation of the data is available from http://decipher.sanger.ac.uk/ and via e-mail from decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust for UK10K (WT091310) and the DDD study. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003); see http://www.ddduk.org/access.html for full acknowledgment. This work was supported in part by the Intramural Research Program of the National Human Genome Research Institute and the Common Fund, NIH Office of the Director. This work was supported in part by the German Ministry of Research and Education (grants 0IGS08160 and 01GS08167; German Mental Retardation Network) as part of the National Genome Research Network to A.R. and D.W., and by the Deutsche Forschungsgemeinschaft (AB393/2-2) to A.R. Brain expression data were provided by the UK Human Brain Expression Consortium (UKBEC), which comprises John A. Hardy, Mina Ryten, Michael Weale, Daniah Trabzuni, Adaikalavan Ramasamy, Colin Smith and Robert Walker, affiliated with the UCL Institute of Neurology (J.A.H., M.R. and D.T.), King's College London (M.R., M.W. and A.R.) and the University of Edinburgh (C.S. and R.W.).	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Ang SY, 2016, DEVELOPMENT, V143, P810, DOI 10.1242/dev.132688; Balint B, 2015, EUR J NEUROL, V22, P610, DOI 10.1111/ene.12650; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Charlesworth G, 2013, BRAIN, V136, P2017, DOI 10.1093/brain/awt138; Chubb JR, 2006, DEV BIOL, V292, P519, DOI 10.1016/j.ydbio.2005.12.054; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dale RC, 2012, DEV MED CHILD NEUROL, V54, P618, DOI 10.1111/j.1469-8749.2012.04287.x; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jakovcevski M, 2015, J NEUROSCI, V35, P5097, DOI 10.1523/JNEUROSCI.3004-14.2015; Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruer MC, 2012, AM J NEURORADIOL, V33, P407, DOI 10.3174/ajnr.A2677; Laimer J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0548-6; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin JP, 2014, J NEUROL NEUROSUR PS, V85, P1239, DOI 10.1136/jnnp-2013-307041; Liu ZH, 2014, J BIOL CHEM, V289, P10069, DOI 10.1074/jbc.M113.535351; Malan V, 2009, J MED GENET, V46, P635, DOI 10.1136/jmg.2008.062034; Marras K. C., 2003, GENEREVIEWS; Meyer E, 2015, ANNU REV GENOM HUM G, V16, P257, DOI 10.1146/annurev-genom-090314-025011; Micale L, 2014, HUM MUTAT, V35, P841, DOI 10.1002/humu.22547; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Musselman CA, 2011, NUCLEIC ACIDS RES, V39, P9061, DOI 10.1093/nar/gkr613; Ng J, 2015, NAT REV NEUROL, V11, P567, DOI 10.1038/nrneurol.2015.172; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ozelius L., 1999, GENEREVIEWS; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pless B, 2011, LEUKEMIA, V25, P663, DOI 10.1038/leu.2010.308; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Shanker Vicki, 2016, Continuum (Minneap Minn), V22, P1227, DOI 10.1212/CON.0000000000000352; Shao GB, 2014, IN VITRO CELL DEV-AN, V50, P603, DOI 10.1007/s11626-014-9741-6; Shen E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0514; Singh T, 2016, NAT NEUROSCI, V19, P571, DOI 10.1038/nn.4267; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Wang Y, 2014, GENOMICS, V103, P222, DOI 10.1016/j.ygeno.2014.02.002; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036	40	130	136	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					223	237		10.1038/ng.3740	http://dx.doi.org/10.1038/ng.3740			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27992417	Green Accepted, Green Submitted			2022-12-25	WOS:000393148600011
J	Jones, DS; Jenney, AP; Swantek, JL; Burke, JM; Lauffenburger, DA; Sorger, PK				Jones, Douglas S.; Jenney, Anne P.; Swantek, Jennifer L.; Burke, John M.; Lauffenburger, Douglas A.; Sorger, Peter K.			Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation	NATURE CHEMICAL BIOLOGY			English	Article							MONOCYTE CHEMOATTRACTANT; MULTIPLE-REGRESSION; CELLS; INFLAMMATION; CHEMOKINES; MIGRATION; TAK1; INTERLEUKIN-8; SYNOVIOCYTES; MACROPHAGE	Activation of synovial fibroblasts (SFs) contributes to rheumatoid arthritis (RA) by damaging synovial membranes and generating inflammatory cytokines that recruit immune cells to the joint. In this paper we profile cytokine secretion by primary human SFs from healthy tissues and from donors with RA and show that SF activation by TNF, IL-1 alpha, and polyinosinicpolycytidylic acid (Poly(I:C)) cause secretion of multiple cytokines found at high levels in RA synovial fluids. We used interaction multiple linear regression to quantify therapeutic and countertherapeutic drug effects across activators and donors and found that the ability of drugs to block SF activation was strongly dependent on the identity of the activating cytokine. (5z)-7-oxozeaenol (5Z0), a preclinical drug that targets transforming growth factor-a-activated kinase 1 (TAK1), was more effective at blocking SF activation across all contexts than the approved drug tofacitinib, which supports the development of molecules similar to 5Z0 for use as RA therapeutics.	[Jones, Douglas S.; Jenney, Anne P.; Sorger, Peter K.] Harvard Med Sch, HMS LINCS Ctr, Lab Syst Pharmacol, Boston, MA 02115 USA; [Jones, Douglas S.; Lauffenburger, Douglas A.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Swantek, Jennifer L.; Burke, John M.] Boehringer Ingelheim GmbH & Co KG, Immunol & Inflammat, Ridgefield, CT USA; [Burke, John M.] Boehringer Ingelheim GmbH & Co KG, Syst Biol, Ridgefield, CT USA; [Swantek, Jennifer L.] AbbVie, Worcester, MA USA; [Burke, John M.] Appl BioMath LLC, Lincoln, MA USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Boehringer Ingelheim; Boehringer Ingelheim; AbbVie	Sorger, PK (corresponding author), Harvard Med Sch, HMS LINCS Ctr, Lab Syst Pharmacol, Boston, MA 02115 USA.	peter_sorger@hms.harvard.edu		Burke, John/0000-0002-1706-5973; Sorger, Peter/0000-0002-3364-1838; Jones, Douglas/0000-0002-8456-6073	NIH (LINCS grant) [U54HL127365, P50 GM107618]; Boehringer Ingelheim Inc.; NIH (NRSA Fellowship) [5F32AR062931]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL127365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR062931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107618] Funding Source: NIH RePORTER	NIH (LINCS grant); Boehringer Ingelheim Inc.(Boehringer Ingelheim); NIH (NRSA Fellowship)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Rudnicki and the HMS ICCB for automation assistance; B. Joughin, D. Clarke, M. Morris, J. Copeland, G. Nabozny, D. Klatte, and S. Pullen for helpful discussions; and N. Gray and T. Zhang at DFCI (Boston, Massachusetts, USA) for providing JNK-IN-8. This work was supported by the NIH (LINCS grant U54HL127365 to P.K.S., grant P50 GM107618 to P.K.S., and NRSA Fellowship 5F32AR062931 to D.S.J.) and by a sponsored research agreement dated 1 August 2009 from Boehringer Ingelheim Inc. to P.K.S. and D.A.L.	Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Boiardi L, 1999, CLIN EXP RHEUMATOL, V17, P419; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; COHEN J, 1968, PSYCHOL BULL, V70, P426, DOI 10.1037/h0026714; Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; Ellingsen T, 2001, J RHEUMATOL, V28, P41; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Filer A, 2013, CURR OPIN PHARMACOL, V13, P413, DOI 10.1016/j.coph.2013.02.006; JACCARD J, 1990, MULTIVAR BEHAV RES, V25, P467, DOI 10.1207/s15327906mbr2504_4; Jaccard J., 2003, INTERACTION EFFECTS; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; KAHLE P, 1992, ANN RHEUM DIS, V51, P731, DOI 10.1136/ard.51.6.731; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Li XX, 2005, J MOL MED, V83, P258, DOI 10.1007/s00109-004-0622-4; Lindstrom TM, 2010, RHEUM DIS CLIN N AM, V36, P367, DOI 10.1016/j.rdc.2010.02.005; Maghazachi AA, 1996, EUR J IMMUNOL, V26, P315, DOI 10.1002/eji.1830260207; Malemud CJ, 2007, CLIN CHIM ACTA, V375, P10, DOI 10.1016/j.cca.2006.06.033; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; MullerLadner U, 1996, AM J PATHOL, V149, P1607; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; OPDENAKKER G, 1993, BIOCHEM BIOPH RES CO, V191, P535, DOI 10.1006/bbrc.1993.1251; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shaw SY, 2008, P NATL ACAD SCI USA, V105, P7387, DOI 10.1073/pnas.0802878105; SOUZA LM, 1986, SCIENCE, V232, P61, DOI 10.1126/science.2420009; Stanczyk J, 2008, CURR OPIN RHEUMATOL, V20, P257, DOI 10.1097/BOR.0b013e3282fa13ee; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tan L, 2015, J MED CHEM, V58, P183, DOI 10.1021/jm500480k; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010	46	45	49	3	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					38	45		10.1038/NCHEMBIO.2211	http://dx.doi.org/10.1038/NCHEMBIO.2211			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27820799	Green Accepted, Green Submitted			2022-12-25	WOS:000393267200011
J	Nett, RS; Montanares, M; Marcassa, A; Lul, X; Nagel, R; Charles, TC; Hedden, P; Rojas, MC; Peters, RJ				Nett, Ryan S.; Montanares, Mariana; Marcassa, Ariana; Lul, Xuan; Nagel, Raimund; Charles, Trevor C.; Hedden, Peter; Rojas, Maria Cecilia; Peters, Reuben J.			Elucidation of gibberellin biosynthesis in bacteria reveals convergent evolution	NATURE CHEMICAL BIOLOGY			English	Article							CYTOCHROME-P450 GENE-CLUSTER; ENT-KAURENE; BRADYRHIZOBIUM-JAPONICUM; ARTEMISININ BIOSYNTHESIS; GREEN-REVOLUTION; CLONING; PLANTS; FUNGI; IDENTIFICATION; REARRANGEMENT	Gibberellins (GAs) are crucial phytohormones involved in many aspects of plant growth and development, including plant-microbe interactions, which has led to GA production by plant-associated fungi and bacteria as well. While the GA biosynthetic pathways in plants and fungi have been elucidated and found to have arisen independently through convergent evolution, little has been uncovered about GA biosynthesis in bacteria. Some nitrogen-fixing, symbiotic, legume-associated rhizobia, including Bradyrhizobium japonicum-the symbiont of soybean and Sinorhizobium fredii-a broad-host-nodulating species-contain a putative GA biosynthetic operon, or gene cluster. Through functional characterization of five unknown genes, we demonstrate that this operon encodes the enzymes necessary to produce GA(9), thereby elucidating bacterial GA biosynthesis. The distinct nature of these enzymes indicates that bacteria have independently evolved a third biosynthetic pathway for GA production. Furthermore, our results also reveal a central biochemical logic that is followed in all three convergently evolved GA biosynthetic pathways.	[Nett, Ryan S.; Lul, Xuan; Nagel, Raimund; Peters, Reuben J.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Montanares, Mariana; Rojas, Maria Cecilia] Univ Chile, Fac Ciencias, Dept Quim, Lab Bioorgan, Santiago, Chile; [Marcassa, Ariana; Charles, Trevor C.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada; [Hedden, Peter] Rothamsted Res, Harpenden, Herts, England	Iowa State University; Universidad de Chile; University of Waterloo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Peters, RJ (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	rjpeters@iastate.edu	Charles, Trevor C./A-5014-2010; Peters, Reuben J./D-1196-2010; Nagel, Raimund/P-9116-2018	Charles, Trevor C./0000-0002-0344-5932; Peters, Reuben J./0000-0003-4691-8477; Nagel, Raimund/0000-0002-3878-7123; Nett, Ryan/0000-0002-2537-7010	NIH [GM109773]; Iowa Soybean Association; Natural Sciences and Research Engineering Council of Canada (NSERC); Ontario Graduate Scholarship; 20:20 Wheat Integrated Strategic Programme at Rothamsted Research - Biotechnology and Biological Sciences Research Council of the United Kingdom; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1150797]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109773] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004161, BBS/E/C/000I0220, BBS/E/C/00005202] Funding Source: researchfish; BBSRC [BBS/E/C/000I0220, BBS/E/C/00005202] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa Soybean Association; Natural Sciences and Research Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); 20:20 Wheat Integrated Strategic Programme at Rothamsted Research - Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the NIH (GM109773 to R.J.P.) and the Iowa Soybean Association (grant to R.J.P.); a Discovery Grant and an Engage Grant, both from Natural Sciences and Research Engineering Council of Canada (NSERC; grants to T.C.C.); an Ontario Graduate Scholarship (A.M.); the 20:20 Wheat Integrated Strategic Programme at Rothamsted Research, funded by the Biotechnology and Biological Sciences Research Council of the United Kingdom (support to P.H.); and the Fondo Nacional de Desarrollo Cientifico y Tecnologico (grant 1150797 to M.C.R.). Authentic ent-7 alpha-hydroxykaurenoic acid (5), GA<INF>15</INF>, (8), and GA<INF>24</INF> (9)-methyl ester were provided by P. Hedden. ent-[17-<SUP>14</SUP>C1]GA<INF>12</INF>, Kaurenoic acid, [17-<SUP>14</SUP>C<INF>1</INF>]GA<INF>12</INF>, [17-<SUP>14</SUP>C<INF>1</INF>]GA<INF>15</INF>, [17-<SUP>14</SUP>C<INF>1</INF>]GA<INF>24</INF>, and [17-<SUP>14</SUP>C<INF>1</INF>]GA<INF>9</INF> were obtained from L. Mander (Australian National University, Canberra, Australia).	Anderson JP, 2010, FUNCT PLANT BIOL, V37, P499, DOI 10.1071/FP09304; ATZORN R, 1988, PLANTA, V175, P532, DOI 10.1007/BF00393076; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; Bhattacharya A, 2012, PLANT PHYSIOL, V160, P837, DOI 10.1104/pp.112.201756; Bomke C, 2009, PHYTOCHEMISTRY, V70, P1876, DOI 10.1016/j.phytochem.2009.05.020; Cao R, 2010, PROTEINS, V78, P2417, DOI 10.1002/prot.22751; Citron CA, 2014, CHEM COMMUN, V50, P5224, DOI 10.1039/c3cc45982a; de Montellano PRO, 2011, ARCH BIOCHEM BIOPHYS, V507, P95, DOI 10.1016/j.abb.2010.10.016; Du L, 2016, J BIOL CHEM, V291, P6583, DOI 10.1074/jbc.M115.695320; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hayashi K, 2010, PLANT PHYSIOL, V153, P1085, DOI 10.1104/pp.110.157909; Hayashi S, 2014, J INTEGR PLANT BIOL, V56, P971, DOI 10.1111/jipb.12201; Hedden P, 2015, J PLANT GROWTH REGUL, V34, P740, DOI 10.1007/s00344-015-9546-1; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Hershey DM, 2014, J BACTERIOL, V196, P100, DOI 10.1128/JB.01031-13; Jensen NB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1271; Keister DL, 1999, J GEN APPL MICROBIOL, V45, P301, DOI 10.2323/jgam.45.301; Lange T, 1997, P NATL ACAD SCI USA, V94, P6553, DOI 10.1073/pnas.94.12.6553; Liu WT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06214; Lu X, 2015, NEW PHYTOL, V206, P295, DOI 10.1111/nph.13187; MacMillan J, 2001, J PLANT GROWTH REGUL, V20, P387, DOI 10.1007/s003440010038; Magome H, 2013, P NATL ACAD SCI USA, V110, P1947, DOI 10.1073/pnas.1215788110; MANDER LN, 1992, CHEM REV, V92, P573, DOI 10.1021/cr00012a005; Delamuta JRM, 2013, INT J SYST EVOL MICR, V63, P3342, DOI 10.1099/ijs.0.049130-0; Mendez C, 2014, PHYTOCHEMISTRY, V98, P101, DOI 10.1016/j.phytochem.2013.11.013; Morrone D, 2009, FEBS LETT, V583, P475, DOI 10.1016/j.febslet.2008.12.052; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Peters R.J., 2013, ISOPRENOID SYNTHESIS, P233; Rojas MC, 2001, P NATL ACAD SCI USA, V98, P5838, DOI 10.1073/pnas.091096298; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Silva LF, 2002, TETRAHEDRON, V58, P9137, DOI 10.1016/S0040-4020(02)00990-0; Song ZL, 2011, CHEM REV, V111, P7523, DOI 10.1021/cr200055g; Sukdeo N, 2003, ARCH MICROBIOL, V179, P301, DOI 10.1007/s00203-003-0532-9; Teoh KH, 2009, BOTANY, V87, P635, DOI 10.1139/B09-032; Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1; TULLY RE, 1993, APPL ENVIRON MICROB, V59, P4136, DOI 10.1128/AEM.59.12.4136-4142.1993; Tully RE, 1998, BBA-GENE STRUCT EXPR, V1398, P243, DOI 10.1016/S0167-4781(98)00069-4; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Yang DL, 2008, MOL PLANT, V1, P528, DOI 10.1093/mp/ssn021	45	52	53	1	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2017	13	1					69	74		10.1038/NCHEMBIO.2232	http://dx.doi.org/10.1038/NCHEMBIO.2232			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ5OI	27842068	Green Accepted, Green Submitted			2022-12-25	WOS:000393267200015
J	Faridani, OR; Abdullayev, I; Hagemann-Jensen, M; Schell, JP; Lanner, F; Sandberg, R				Faridani, Omid R.; Abdullayev, Ilgar; Hagemann-Jensen, Michael; Schell, John P.; Lanner, Fredrik; Sandberg, Rickard			Single-cell sequencing of the small-RNA transcriptome	NATURE BIOTECHNOLOGY			English	Article							STEM-CELLS; DIFFERENTIATION; BIOGENESIS; FRAGMENTS	Little is known about the heterogeneity of small-RNA expression as small-RNA profiling has so far required large numbers of cells. Here we present a single-cell method for small-RNA sequencing and apply it to naive and primed human embryonic stem cells and cancer cells. Analysis of microRNAs and fragments of tRNAs and small nucleolar RNAs (snoRNAs) reveals the potential of microRNAs as markers for different cell types and states.	[Faridani, Omid R.; Abdullayev, Ilgar; Hagemann-Jensen, Michael; Sandberg, Rickard] Ludwig Inst Canc Res, Stockholm, Sweden; [Abdullayev, Ilgar; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Hagemann-Jensen, Michael] Dept Med, Resp Med Unit, Solna, Sweden; [Hagemann-Jensen, Michael] Ctr Mol Med, Stockholm, Sweden; [Schell, John P.; Lanner, Fredrik] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Schell, John P.; Lanner, Fredrik] Karolinska Univ Hosp, Div Obstet & Gynecol, Stockholm, Sweden	Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Faridani, OR; Sandberg, R (corresponding author), Ludwig Inst Canc Res, Stockholm, Sweden.; Sandberg, R (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	omid.faridani@licr.ki.se; rickard.sandberg@ki.se	Hagemann-Jensen, Michael/AAO-8176-2020	Hagemann-Jensen, Michael/0000-0002-6423-8216; Faridani, Omid/0000-0001-9330-887X; Sandberg, Rickard/0000-0001-6473-1740; Lanner, Fredrik/0000-0002-2771-7445	Knut and Alice Wallenberg Foundation [2015.0096]; Swedish Research Council; Ragnar Soderberg Foundation; Swedish Foundation for Strategic Research; Bert L. and N. Kuggie Vallee Foundation; European Research Council [648842]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ragnar Soderberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Bert L. and N. Kuggie Vallee Foundation; European Research Council(European Research Council (ERC)European Commission)	We thank J. Muhr and D. Topcic (Ludwig Institute for Cancer Research, Stockholm) for providing glioblastoma cells, and W Kang for constructive comments on the computational pipeline. This work was supported by Knut and Alice Wallenberg Foundation (2015.0096) (F.L.), the Swedish Research Council (F.L. and R.S.), Ragnar Soderberg Foundation (F.L.), the Swedish Foundation for Strategic Research (F.L. and R.S.), the Bert L. and N. Kuggie Vallee Foundation (R.S.) and the European Research Council (648842) (R.S.).	Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Fan XY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0706-1; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Kebschull J. M., 2015, NUCLEIC ACIDS RES, V43, P143; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Rosa A, 2014, DEV BIOL, V391, P81, DOI 10.1016/j.ydbio.2014.03.020; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Sperber H, 2015, NAT CELL BIOL, V17, P1523, DOI 10.1038/ncb3264; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Zhang ZH, 2015, STEM CELL REP, V4, P645, DOI 10.1016/j.stemcr.2015.02.009	20	113	115	4	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2016	34	12					1264	1266		10.1038/nbt.3701	http://dx.doi.org/10.1038/nbt.3701			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EF2WC	27798564				2022-12-25	WOS:000390185300017
J	Lee, J; Boutz, DR; Chromikova, V; Joyce, MG; Vollmers, C; Leung, K; Horton, AP; DeKosky, BJ; Lee, CH; Lavinder, JJ; Murrin, EM; Chrysostomou, C; Hoi, KH; Tsybovsky, Y; Thomas, PV; Druz, A; Zhang, BS; Zhang, Y; Wang, LS; Kong, WP; Park, D; Popova, LI; Dekker, CL; Davis, MM; Carter, CE; Ross, TM; Ellington, AD; Wilson, PC; Marcotte, EM; Mascola, JR; Ippolito, GC; Krammer, F; Quake, SR; Kwong, PD; Georgiou, G				Lee, Jiwon; Boutz, Daniel R.; Chromikova, Veronika; Joyce, M. Gordon; Vollmers, Christopher; Leung, Kwanyee; Horton, Andrew P.; DeKosky, Brandon J.; Lee, Chang-Han; Lavinder, Jason J.; Murrin, Ellen M.; Chrysostomou, Constantine; Hoi, Kam Hon; Tsybovsky, Yaroslav; Thomas, Paul V.; Druz, Aliaksandr; Zhang, Baoshan; Zhang, Yi; Wang, Lingshu; Kong, Wing-Pui; Park, Daechan; Popova, Lyubov I.; Dekker, Cornelia L.; Davis, Mark M.; Carter, Chalise E.; Ross, Ted M.; Ellington, Andrew D.; Wilson, Patrick C.; Marcotte, Edward M.; Mascola, John R.; Ippolito, Gregory C.; Krammer, Florian; Quake, Stephen R.; Kwong, Peter D.; Georgiou, George			Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination	NATURE MEDICINE			English	Article							MONOCLONAL-ANTIBODIES; IN-VIVO; NEUTRALIZING EPITOPE; VIRUS HEMAGGLUTININ; ELECTRON-MICROSCOPY; H5N1 VACCINATION; GLOBULAR HEAD; B VIRUSES; PROTECTION; VACCINES	Molecular understanding of serological immunity to influenza has been confounded by the complexity of the polyclonal antibody response in humans. Here we used high-resolution proteomics analysis of immunoglobulin (referred to as Ig-seq) coupled with high-throughput sequencing of transcripts encoding B cell receptors (BCR-seq) to quantitatively determine the antibody repertoire at the individual clonotype level in the sera of young adults before and after vaccination with trivalent seasonal influenza vaccine. The serum repertoire comprised between 40 and 147 clonotypes that were specific to each of the three monovalent components of the trivalent influenza vaccine, with boosted pre-existing clonotypes accounting for similar to 60% of the response. An unexpectedly high fraction of serum antibodies recognized both the H1 and H3 monovalent vaccines. Recombinant versions of these H1 + H3 cross-reactive antibodies showed broad binding to hemagglutinins (HAs) from previously circulating virus strains; several of these antibodies, which were prevalent in the serum of multiple donors, recognized the same conserved epitope in the HA head domain. Although the HA-head-specific H1 + H3 antibodies did not show neutralization activity in vitro, they protected mice against infection with the H1N1 and H3N2 virus strains when administered before or after challenge. Collectively, our data reveal unanticipated insights regarding the serological response to influenza vaccination and raise questions about the added benefits of using a quadrivalent vaccine instead of a trivalent vaccine.	[Lee, Jiwon; DeKosky, Brandon J.; Lee, Chang-Han; Lavinder, Jason J.; Murrin, Ellen M.; Chrysostomou, Constantine; Park, Daechan; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Boutz, Daniel R.; Horton, Andrew P.; Ellington, Andrew D.; Marcotte, Edward M.; Georgiou, George] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Chromikova, Veronika; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Joyce, M. Gordon; Leung, Kwanyee; Thomas, Paul V.; Druz, Aliaksandr; Zhang, Baoshan; Zhang, Yi; Wang, Lingshu; Kong, Wing-Pui; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Vollmers, Christopher; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Hoi, Kam Hon; Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Tsybovsky, Yaroslav] Frederick Natl Lab Canc Res, Electron Microscopy Lab, Canc Res Technol Program, Leidos Biomed Res Inc, Frederick, MD USA; [Popova, Lyubov I.; Wilson, Patrick C.] Univ Chicago, Dept Med, Rheumatol Sect, Gwen Knapp Ctr Lupus & Immunol Res, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Dekker, Cornelia L.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Davis, Mark M.; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Carter, Chalise E.; Ross, Ted M.] Univ Georgia, Dept Infect Dis, Ctr Vaccines & Immunol, Athens, GA 30602 USA; [Ellington, Andrew D.; Marcotte, Edward M.; Ippolito, Gregory C.; Georgiou, George] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [DeKosky, Brandon J.] NIAID, Vaccine Res Ctr, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hoi, Kam Hon] Genentech Inc, Antibody Engn Dept, San Francisco, CA 94080 USA; [Popova, Lyubov I.] SRI Int, Div Infect Dis, Harrisonburg, VA USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University; University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University System of Georgia; University of Georgia; University of Texas System; University of Texas Austin; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Roche Holding; Genentech; SRI International	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	gg@che.utexas.edu	Krammer, Florian/H-3237-2019; Ippolito, Gregory C./AAR-2930-2021; Mascola, John/AAI-7193-2021; Lee, Chang-Han/AAG-9178-2019; Wilson, Patrick/HGC-3157-2022	Krammer, Florian/0000-0003-4121-776X; Ippolito, Gregory C./0000-0002-7565-7002; Lee, Chang-Han/0000-0002-7156-4423; Ross, Ted/0000-0003-1947-7469; Lee, Jiwon/0000-0001-7835-3621; Davis, Mark/0000-0001-6868-657X; Marcotte, Edward/0000-0001-8808-180X; Hoi, Kam Hon/0000-0003-4158-0446; Park, Daechan/0000-0003-4991-5247; Wang, Lingshu/0000-0002-8404-4910	NIH [5U19AI057234-09, PO1 AI089618, U19 AI109946]; NIH-NCRR CTSA award [UL1 RR025744]; Intramural Research Program of the Vaccine Research Center, NIAID, NIH; Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; Leidos Biomedical Research, Inc.; DTRA contract [HDTRA1-12-C-0105]; CPRIT grant [673 RP100890]; Clayton Foundation; Centers of Influenza Virus Research and Surveillance (CEIRS) [HHSN272201400008C, HHSN272201400005C]; Welch Foundation [F1515, F1654]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234, U19AI109946, ZIAAI005022, U19AI057229, U19AI082724, ZICAI005113, P01AI089618, ZICAI005112] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCRR CTSA award; Intramural Research Program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Frederick National Laboratory for Cancer Research, NIH; Leidos Biomedical Research, Inc.; DTRA contract; CPRIT grant; Clayton Foundation; Centers of Influenza Virus Research and Surveillance (CEIRS); Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to C. Das for help with monoclonal antibody expression, G. Wu, S. Schatzle and Y. Wine for preliminary experiments and advice, and S. Harrison and A. Schmidt (Harvard Medical School) for providing rHAs and critical comments on the manuscript. We are indebted to Sanofi-Pasteur for their kind gift of IIV1s and to BEI Resources for rHAs. We also thank our study volunteers and S. Mackey for clinical project management, and regulatory and data management support, and S. Swope for conducting the study visits. This work was supported by NIH grants 5U19AI057234-09 (G. G.), PO1 AI089618 (G. G.) and U19 AI109946 (F.K. and P.C.W.), NIH-NCRR CTSA award number UL1 RR025744 (C.L.D.), the Intramural Research Program of the Vaccine Research Center, NIAID, NIH (M.G.J., K.L., P.V.T., A.D., B.Z., Y.Z., L.W., W.-P.K., J.R.M. and P.D.K.), federal funds from the Frederick National Laboratory for Cancer Research, NIH, under contract HHSN261200800001E and Leidos Biomedical Research, Inc. (Y.T.), DTRA contract HDTRA1-12-C-0105 (G.G.), CPRIT grant 673 RP100890 for LC-MS/MS instrumentation at University of Texas at Austin (G. G.), the Clayton Foundation (G. G.), the Centers of Influenza Virus Research and Surveillance (CEIRS) contracts HHSN272201400008C (F.K.) and HHSN272201400005C (P.C.W.), and Welch Foundation grants F1515 (E.M.Marcotte) and F1654 (A.D.E.).	Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Andrews SF, 2015, J VIROL, V89, P3308, DOI 10.1128/JVI.02871-14; Baz M, 2012, EMERG INFECT DIS, V18, P1132, DOI 10.3201/eid1807.111680; Boutz DR, 2014, ANAL CHEM, V86, P4758, DOI 10.1021/ac4037679; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cox J, 2011, J AM SOC MASS SPECTR, V22, P1373, DOI 10.1007/s13361-011-0142-8; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Dunand CJH, 2016, CELL HOST MICROBE, V19, P800, DOI 10.1016/j.chom.2016.05.014; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ellebedy AH, 2014, P NATL ACAD SCI USA, V111, P13133, DOI 10.1073/pnas.1414070111; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gillim-Ross L, 2006, CLIN MICROBIOL REV, V19, P614, DOI 10.1128/CMR.00005-06; GODLEY L, 1992, CELL, V68, P635, DOI 10.1016/0092-8674(92)90140-8; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Iba Y, 2014, J VIROL, V88, P7130, DOI 10.1128/JVI.00420-14; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; Jain VK, 2013, NEW ENGL J MED, V369, P2481, DOI 10.1056/NEJMoa1215817; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Lee PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4614; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McDaniel JR, 2016, NAT PROTOC, V11, P429, DOI 10.1038/nprot.2016.024; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; MORRIS JA, 1966, NEW ENGL J MED, V274, P527, DOI 10.1056/NEJM196603102741001; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Radigan KA, 2015, INFECT DRUG RESIST, V8, P311, DOI 10.2147/IDR.S58551; Rimmelzwaan GF, 2008, VACCINE, V26, pD41, DOI 10.1016/j.vaccine.2008.07.043; Ross TM, 2000, NAT IMMUNOL, V1, P127, DOI 10.1038/77802; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tinoco JC, 2014, VACCINE, V32, P1480, DOI 10.1016/j.vaccine.2014.01.022; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wine Y, 2015, CURR OPIN IMMUNOL, V35, P89, DOI 10.1016/j.coi.2015.06.009; Wohlbold TJ, 2016, J VIROL, V90, P851, DOI 10.1128/JVI.02275-15; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yang ZY, 2004, J VIROL, V78, P4029, DOI 10.1128/JVI.78.8.4029-4036.2004; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927	59	160	175	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1456	+		10.1038/nm.4224	http://dx.doi.org/10.1038/nm.4224			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27820605	Green Accepted			2022-12-25	WOS:000389549000023
J	Xiong, XZ; Panchenko, T; Yang, S; Zhao, S; Yan, PQ; Zhang, WH; Xie, W; Li, YY; Zhao, YM; Allis, CD; Li, HT				Xiong, Xiaozhe; Panchenko, Tatyana; Yang, Shuang; Zhao, Shuai; Yan, Peiqiang; Zhang, Wenhao; Xie, Wei; Li, Yuanyuan; Zhao, Yingming; Allis, C. David; Li, Haitao			Selective recognition of Histone crotonylation by double PHD fingers of MOZ and DPF2	NATURE CHEMICAL BIOLOGY			English	Article							GENE-EXPRESSION; YEATS DOMAIN; ACETYLTRANSFERASE; ACETYLATION; BINDING; LYSINE; H3; READOUT; CROTONYLLYSINE; IDENTIFICATION	Recognition of histone covalent modifications by 'reader' modules constitutes a major mechanism for epigenetic regulation. A recent upsurge of newly discovered histone lysine acylations, such as crotonylation (Kcr), butyrylation (Kbu), and propionylation (Kpr), greatly expands the coding potential of histone lysine modifications. Here we demonstrate that the histone-acetylation-binding double PHD finger (DPF) domains of human MOZ (also known as KAT6A) and DPF2 (also known as BAF45d) accommodate a wide range of histone lysine acylations with the strongest preference for Kcr. Crystal structures of the DPF domain of MOZ in complex with H3K14cr, H3K14bu, and H3K14pr peptides reveal that these non-acetyl acylations are anchored in a hydrophobic 'dead-end' pocket with selectivity for crotonylation arising from intimate encapsulation and an amide-sensing hydrogen bonding network. Immunofluorescence and chromatin immunoprecipitation (ChIP)-quantitative PCR (qPCR) showed that MOZ and H3K14cr colocalize in a DPF-dependent manner. Our studies call attention to a new regulatory mechanism centered on histone crotonylation readout by DPF family members.	[Xiong, Xiaozhe; Yang, Shuang; Zhao, Shuai; Yan, Peiqiang; Li, Yuanyuan; Li, Haitao] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing Adv Innovat Ctr Struct Biol,MOE Key Lab P, Beijing, Peoples R China; [Panchenko, Tatyana; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10021 USA; [Yan, Peiqiang; Zhang, Wenhao; Xie, Wei] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Zhang, Wenhao; Xie, Wei; Li, Yuanyuan; Li, Haitao] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing, Peoples R China; [Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Li, Haitao] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Panchenko, Tatyana] NYU, Perlmutter Canc Ctr, New York, NY USA	Tsinghua University; Rockefeller University; Tsinghua University; Tsinghua University; University of Chicago; Sichuan University; New York University	Li, HT (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing Adv Innovat Ctr Struct Biol,MOE Key Lab P, Beijing, Peoples R China.; Li, HT (corresponding author), Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing, Peoples R China.; Li, HT (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China.	lht@tsinghua.edu.cn	Li, Haitao/B-2668-2012; Zhang, Wenhao/AGZ-7068-2022	Li, Haitao/0000-0001-6741-293X; Zhang, Wenhao/0000-0002-3739-0415; Zhao, Shuai/0000-0003-4240-2430	Ministry of Science and Technology of China [2016YFA0500700, 2015CB910503]; National Natural Science Foundation of China [91519304]; Tsinghua University Initiative Scientific Research Program; Rockefeller University; US National Institute of General Medicine [GM040922, GM105933, DK107868, GM115961, GM112365]; NATIONAL CANCER INSTITUTE [R01CA204639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM112365, R01GM105933, R01GM040922, R01GM115961] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program; Rockefeller University; US National Institute of General Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Chen for critical comments. We thank the staff members at beamline BL17U of the Shanghai Synchrotron Radiation Facility and S. Fan at Tsinghua Center for Structural Biology for their assistance in data collection, and the China National Center for Protein Sciences Beijing for providing facility support. This work was supported by grants from the Ministry of Science and Technology of China (2016YFA0500700 and 2015CB910503), the National Natural Science Foundation of China (91519304), and the Tsinghua University Initiative Scientific Research Program to H.L. We acknowledge support from The Rockefeller University to C.D.A., and the US National Institute of General Medicine to C.D.A. (GM040922), to Y.Z. (GM105933, DK107868, and GM115961), and to T.P. (GM112365).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali M, 2012, J MOL BIOL, V424, P328, DOI 10.1016/j.jmb.2012.10.004; Andrews FH, 2016, NAT CHEM BIOL, V12, P396, DOI 10.1038/nchembio.2065; Arib G, 2011, CURR OPIN CELL BIOL, V23, P346, DOI 10.1016/j.ceb.2010.12.005; Bao XC, 2014, ELIFE, V3, DOI 10.7554/eLife.02999; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Carlson S, 2014, J CELL PHYSIOL, V229, P1571, DOI 10.1002/jcp.24617; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Cruickshank VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142806; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dreveny I, 2014, NUCLEIC ACIDS RES, V42, P822, DOI 10.1093/nar/gkt931; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Flynn EM, 2015, STRUCTURE, V23, P1801, DOI 10.1016/j.str.2015.08.004; Gattner MJ, 2013, CHEM COMMUN, V49, P379, DOI 10.1039/c2cc37836a; Huang H, 2015, CHEM REV, V115, P2376, DOI 10.1021/cr500491u; Huang H, 2014, CELL, V159, P458, DOI 10.1016/j.cell.2014.09.037; Kim CH, 2012, ANGEW CHEM INT EDIT, V51, P7246, DOI 10.1002/anie.201203349; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li YY, 2016, MOL CELL, V62, P181, DOI 10.1016/j.molcel.2016.03.028; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Montellier E, 2012, BIOESSAYS, V34, P187, DOI 10.1002/bies.201100141; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Perez-Campo FM, 2013, IMMUNOLOGY, V139, P161, DOI 10.1111/imm.12072; Qiu Y, 2012, GENE DEV, V26, P1376, DOI 10.1101/gad.188359.112; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Vu LP, 2013, CELL REP, V5, P1625, DOI 10.1016/j.celrep.2013.11.025; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Xie ZY, 2016, MOL CELL, V62, P194, DOI 10.1016/j.molcel.2016.03.036; Yang XJ, 2015, BBA-MOL CELL RES, V1853, P1818, DOI 10.1016/j.bbamcr.2015.04.014; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zhao D, 2016, CELL RES, V26, P629, DOI 10.1038/cr.2016.49	45	95	98	4	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1111	+		10.1038/NCHEMBIO.2218	http://dx.doi.org/10.1038/NCHEMBIO.2218			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27775714	Green Accepted			2022-12-25	WOS:000388582900022
J	Aboy, M; Liddell, K; Liddicoat, J; Crespo, C				Aboy, Mateo; Liddell, Kathleen; Liddicoat, Johnathon; Crespo, Cristina			Myriad's impact on gene patents	NATURE BIOTECHNOLOGY			English	Editorial Material								Three years later, the landmark Myriad decision on gene patents has led to some striking and unforeseen implications.	[Aboy, Mateo; Liddell, Kathleen; Liddicoat, Johnathon; Crespo, Cristina] Univ Cambridge, Fac Law, Ctr Law Med & Life Sci LML, Cambridge, England; [Aboy, Mateo] Oregon Inst Technol, Coll Engn Technol & Management, Klamath Falls, OR USA	University of Cambridge	Aboy, M (corresponding author), Univ Cambridge, Fac Law, Ctr Law Med & Life Sci LML, Cambridge, England.	ma608@cam.ac.uk	Aboy, Mateo/K-4060-2019; Liddicoat, Johnathon/J-7156-2014	Aboy, Mateo/0000-0002-5168-4321; Liddicoat, Johnathon/0000-0001-7370-3936				Arora A., 2001, MARKETS TECHNOLOGY; Bubela T, 2013, NAT BIOTECHNOL, V31, P202, DOI 10.1038/nbt.2521; Burk DL, 2015, J LAW BIOSCI, V2, P606, DOI 10.1093/jlb/lsv042; Cook-Deegan Robert, 2014, Curr Genet Med Rep, V2, P223; Cook-Deegan R, 2010, ANNU REV GENOM HUM G, V11, P383, DOI 10.1146/annurev-genom-082509-141811; Gold ER, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006849; Gordon J., 2014, COLD SPRING HARB PER, V5; Graff GD, 2013, NAT BIOTECHNOL, V31, P404, DOI 10.1038/nbt.2568; Guerrini CJ, 2016, NAT BIOTECHNOL, V34, P145, DOI 10.1038/nbt.3470; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Offit K, 2013, J CLIN ONCOL, V31, P2743, DOI 10.1200/JCO.2013.49.7388; Ratner M, 2013, NAT BIOTECHNOL, V31, P663, DOI 10.1038/nbt0813-663; Royzman I, 2015, NAT BIOTECHNOL, V33, P925, DOI 10.1038/nbt.3334; Sherkow JS, 2015, ANNU REV GENET, V49, P161, DOI 10.1146/annurev-genet-112414-054731; Sichelman Ted, 2010, MICH TELECOMM TECH L, V17, P111; Woessner WD, 2013, PHARM PAT ANAL, V2, P165, DOI [10.4155/ppa.13.1, 10.4155/PPA.13.1]	16	16	16	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2016	34	11					1119	1123		10.1038/nbt.3719	http://dx.doi.org/10.1038/nbt.3719			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EB6PG	27824831				2022-12-25	WOS:000387506500021
J	Bass, TE; Luzwick, JW; Kavanaugh, G; Carroll, C; Dungrawala, H; Glick, GG; Feldkamp, MD; Putney, R; Chazin, WJ; Cortez, D				Bass, Thomas E.; Luzwick, Jessica W.; Kavanaugh, Gina; Carroll, Clinton; Dungrawala, Huzefa; Glick, Gloria G.; Feldkamp, Michael D.; Putney, Reid; Chazin, Walter J.; Cortez, David			ETAA1 acts at stalled replication forks to maintain genome integrity	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE RESPONSE; TOPOISOMERASE-III-ALPHA; SYNDROME PROTEIN; ATR; BLM; HELICASE; COMPLEX; RECOMBINATION; RECOGNITION; RECRUITMENT	The ATR checkpoint kinase coordinates cellular responses to DNA replication stress. Budding yeast contain three activators of Mec1 (the ATR orthologue); however, only TOPBP1 is known to activate ATR in vertebrates. We identified ETAA1 as a replication stress response protein in two proteomic screens. ETAA1-deficient cells accumulate double-strand breaks, sister chromatid exchanges, and other hallmarks of genome instability. They are also hypersensitive to replication stress and have increased frequencies of replication fork collapse. ETAA1 contains two RPA-interaction motifs that localize ETAA1 to stalled replication forks. It also interacts with several DNA damage response proteins including the BLM/TOP3 alpha/RMI1/RMI2 and ATR/ATRIP complexes. It binds ATR/ATRIP directly using a motif with sequence similarity to the TOPBP1 ATR-activation domain; and like TOPBP1, ETAA1 acts as a direct ATR activator. ETAA1 functions in parallel to the TOPBP1/RAD9/HUS1/RAD1 pathway to regulate ATR and maintain genome stability. Thus, vertebrate cells contain at least two ATR-activating proteins.	[Bass, Thomas E.; Luzwick, Jessica W.; Kavanaugh, Gina; Carroll, Clinton; Dungrawala, Huzefa; Glick, Gloria G.; Cortez, David] Vanderbilt Univ, Dept Biochem, Sch Med, 613 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA; [Feldkamp, Michael D.; Putney, Reid; Chazin, Walter J.] Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 613 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu	Classen, Scott/AAY-8176-2020; Dungrawala, Huzefa/AAO-1931-2021	Dungrawala, Huzefa/0000-0003-1868-7923	Vanderbilt-Ingram Cancer Center;  [R01GM116616];  [R01CA102729];  [R01GM65484];  [P01CA092584];  [T32CA009582-28]; NATIONAL CANCER INSTITUTE [R01CA102729, T32CA009582, K12CA090625, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R01GM116616, R01GM065484] Funding Source: NIH RePORTER	Vanderbilt-Ingram Cancer Center; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported primarily by R01GM116616 to D.C. with additional support from R01CA102729 and the Vanderbilt-Ingram Cancer Center. NMR experiments were supported by R01GM65484 and P01CA092584 to W.J.C. T.E.B. is supported by training grant T32CA009582-28. We thank R. Guo for performing the initial Flag-RPA1 immunopurifications and W. Hayes McDonald in the Vanderbilt Proteomics Laboratory for performing the mass spectrometry.	Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Blackford AN, 2015, MOL CELL, V57, P1133, DOI 10.1016/j.molcel.2015.02.012; Borowski A, 2006, CANCER IMMUNOL IMMUN, V55, P363, DOI 10.1007/s00262-005-0017-6; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Childs EJ, 2015, NAT GENET, V47, P911, DOI 10.1038/ng.3341; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Feldkamp MD, 2014, BIOCHEMISTRY-US, V53, P3052, DOI 10.1021/bi500252w; GERMAN J, 2001, CURR PROTOC HUM GENE, pCH8; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lindsey-Boltz LA, 2015, CELL CYCLE, V14, P99, DOI 10.4161/15384101.2014.967076; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Peter H, 2016, NAT CELL BIOL; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Putnam CD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000933; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Wang JD, 2013, MOL CELL, V52, P667, DOI 10.1016/j.molcel.2013.10.012; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	45	134	144	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1185	+		10.1038/ncb3415	http://dx.doi.org/10.1038/ncb3415			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27723720	Green Accepted			2022-12-25	WOS:000387165600012
J	Haahr, P; Hoffmann, S; Tollenaere, MAX; Ho, T; Toledo, LI; Mann, M; Bekker-Jensen, S; Raschle, M; Mailand, N				Haahr, Peter; Hoffmann, Saskia; Tollenaere, Maxim A. X.; Ho, Teresa; Toledo, Luis Ignacio; Mann, Matthias; Bekker-Jensen, Simon; Raeschle, Markus; Mailand, Niels			Activation of the ATR kinase by the RPA-binding protein ETAA1	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE RESPONSE; DISTINCT MODES; TOPBP1; CANCER; REPAIR; SUSCEPTIBILITY; RECOGNITION; DISRUPTION; REGULATOR; MEC1/ATR	Activation of the ATR kinase following perturbations to DNA replication relies on a complex mechanism involving ATR recruitment to RPA-coated single-stranded DNA via its binding partner ATRIP and stimulation of ATR kinase activity by TopBP1. Here, we discovered an independent ATR activation pathway in vertebrates, mediated by the uncharacterized protein ETAA1 (Ewing's tumour-associated antigen 1). Human ETAA1 accumulates at DNA damage sites via dual RPA-binding motifs and promotes replication fork progression and integrity, ATR signalling and cell survival after genotoxic insults. Mechanistically, this requires a conserved domain in ETAA1 that potently and directly stimulates ATR kinase activity independently of TopBP1. Simultaneous loss of ETAA1 and TopBP1 gives rise to synthetic lethality characterized by massive genome instability and abrogation of ATR-dependent signalling. Our findings demonstrate that parallel TopBP1-and ETAA1-mediated pathways underlie ATR activation and that their combined action is essential for coping with replication stress.	[Haahr, Peter; Hoffmann, Saskia; Tollenaere, Maxim A. X.; Ho, Teresa; Toledo, Luis Ignacio; Bekker-Jensen, Simon; Mailand, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Prot Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Ho, Teresa; Mailand, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Chromosome Stabil, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Mann, Matthias; Raeschle, Markus] Max Planck Inst Biochem, Dept Prot & Signal Transduct, Klopferspitz 18, D-82152 Martinsried, Germany; [Raeschle, Markus] TU Kaiserslautern, Dept Mol Genet, Paul Ehrlich Str 24, D-67663 Kaiserslautern, Germany	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Max Planck Society; University of Kaiserslautern	Mailand, N (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Prot Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.; Mailand, N (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Chromosome Stabil, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.; Raschle, M (corresponding author), Max Planck Inst Biochem, Dept Prot & Signal Transduct, Klopferspitz 18, D-82152 Martinsried, Germany.; Raschle, M (corresponding author), TU Kaiserslautern, Dept Mol Genet, Paul Ehrlich Str 24, D-67663 Kaiserslautern, Germany.	markus.raeschle@biologie.uni-kl.de; niels.mailand@cpr.ku.dk	Haahr, Peter/K-4617-2017; Toledo, Luis/R-2065-2016; Toledo, Luis/M-6685-2019; Haahr, Peter/AAA-7995-2019	Haahr, Peter/0000-0001-9680-2304; Toledo, Luis/0000-0001-9509-9944; Toledo, Luis/0000-0001-9509-9944; Haahr, Peter/0000-0001-9680-2304; Hoffmann, Saskia/0000-0003-4835-0504; Mailand, Niels/0000-0002-6623-709X; Tollenaere, Maxim/0000-0002-2653-0777	Novo Nordisk Foundation [NNF14CC0001, NNF12OC0002114]; European Research Council (ERC) [616236]; Danish Cancer Society; Danish Council for Independent Research; Danish National Research Foundation [DNRF115]; Center for Integrated Protein Science Munich (CIPSM); Novo Nordisk Fonden [NNF15OC0016926] Funding Source: researchfish; The Danish Cancer Society [R124-A7601] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council (ERC)(European Research Council (ERC)European Commission); Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); Center for Integrated Protein Science Munich (CIPSM); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation Center for Protein Research	We thank D. Cortez and A. Kumagai for providing reagents. We thank K. Mayr, I. Paron and G. Sowa for mass spectrometry support and M. Steger and B. Splettstosser (all from Max Planck Institute of Biochemistry) for experimental advice. This work was supported by grants from The Novo Nordisk Foundation (grants no. NNF14CC0001 and NNF12OC0002114), European Research Council (ERC, grant agreement no. 616236 (DDRegulation)), The Danish Cancer Society, The Danish Council for Independent Research, Danish National Research Foundation (grant no. DNRF115) and Center for Integrated Protein Science Munich (CIPSM).	Bass T. E., 2016, NAT CELL BIOL; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Borowski A, 2006, CANCER IMMUNOL IMMUN, V55, P363, DOI 10.1007/s00262-005-0017-6; Brown EJ, 2000, GENE DEV, V14, P397; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Childs EJ, 2015, NAT GENET, V47, P911, DOI 10.1038/ng.3341; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; de Oliveira FMB, 2015, MOL CELL, V57, P1124, DOI 10.1016/j.molcel.2015.01.043; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Fokas E, 2014, CANCER TREAT REV, V40, P109, DOI 10.1016/j.ctrv.2013.03.002; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Liu QH, 2000, GENE DEV, V14, P1448; Lopez-Contreras AJ, 2010, DNA REPAIR, V9, P1249, DOI 10.1016/j.dnarep.2010.09.012; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Raschle M, 2015, SCIENCE, V348, DOI 10.1126/science.1253671; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wanrooij PH, 2016, J BIOL CHEM, V291, P393, DOI 10.1074/jbc.M115.687145; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhou ZW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003702; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	61	136	139	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2016	18	11					1196	+		10.1038/ncb3422	http://dx.doi.org/10.1038/ncb3422			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EB2CV	27723717	Green Submitted			2022-12-25	WOS:000387165600013
J	Reinius, B; Mold, JE; Ramskold, D; Deng, QL; Johnsson, P; Michaelsson, J; Frisen, J; Sandberg, R				Reinius, Bjorn; Mold, Jeff E.; Ramskold, Daniel; Deng, Qiaolin; Johnsson, Per; Michaelsson, Jakob; Frisen, Jonas; Sandberg, Rickard			Analysis of allelic expression patterns in clonal somatic cells by single-cell RNA-seq	NATURE GENETICS			English	Article							RANDOM MONOALLELIC EXPRESSION; STOCHASTIC GENE-EXPRESSION; EMBRYONIC STEM-CELLS; MAMMALIAN-CELLS; MOUSE; MECHANISMS; NANOG; TRANSCRIPTOME; PLURIPOTENCY; DYNAMICS	Cellular heterogeneity can emerge from the expression of only one parental allele. However, it has remained controversial whether, or to what degree, random monoallelic expression of autosomal genes (aRME) is mitotically inherited (clonal) or stochastic (dynamic) in somatic cells, particularly in vivo. Here we used allele-sensitive single-cell RNA-seq on clonal primary mouse fibroblasts and freshly isolated human CD8(+) T cells to dissect clonal and dynamic monoallelic expression patterns. Dynamic aRME affected a considerable portion of the cells' transcriptomes, with levels dependent on the cells' transcriptional activity. Notably, clonal aRME was detected, but it was surprisingly scarce (<1 % of genes) and mainly affected the most weakly expressed genes. Consequently, the overwhelming majority of aRME occurs transiently within individual cells, and patterns of aRME are thus primarily scattered throughout somatic cell populations rather than, as previously hypothesized, confined to patches of clonally related cells.	[Reinius, Bjorn; Mold, Jeff E.; Ramskold, Daniel; Deng, Qiaolin; Frisen, Jonas; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Reinius, Bjorn; Ramskold, Daniel; Johnsson, Per; Sandberg, Rickard] Ludwig Inst Canc Res, Stockholm, Sweden; [Michaelsson, Jakob] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska University Hospital	Sandberg, R (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.; Sandberg, R (corresponding author), Ludwig Inst Canc Res, Stockholm, Sweden.	rickard.sandberg@ki.se	Deng, Qiaolin/AAD-6905-2020	Ramskold, Daniel/0000-0003-2892-673X; Sandberg, Rickard/0000-0001-6473-1740; Deng, Qiaolin/0000-0001-5934-7816; Reinius, Bjorn/0000-0002-7021-5248; Mold, Jeffrey/0000-0003-2195-2978	Human Frontiers Science Program Long-Term Fellowship [LT-000231/2011-1]; Swedish Research Council, the European Research Council [648842]; Swedish Foundation for Strategic Research; Swedish Cancer Society; Karolinska Institute; Tobias Stiftelsen; Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen); Knut och Alice Wallenbergs Stiftelse; Torsten Soderbergs Stiftelse	Human Frontiers Science Program Long-Term Fellowship; Swedish Research Council, the European Research Council; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Torsten Soderbergs Stiftelse	We thank D. Edsgard for assistance in handling sequence data and members of the Sandberg laboratory for their input. J.M. was supported by a Human Frontiers Science Program Long-Term Fellowship (LT-000231/2011-1), and the work was supported by grants from the Swedish Research Council, the European Research Council (648842), the Swedish Foundation for Strategic Research, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, the Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen), Knut och Alice Wallenbergs Stiftelse, and Torsten Soderbergs Stiftelse.	Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234; Borel C, 2015, AM J HUM GENET, V96, P70, DOI 10.1016/j.ajhg.2014.12.001; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Eckersiey-Maslin MA, 2014, TRENDS GENET, V30, P237, DOI 10.1016/j.tig.2014.03.003; Eckersley-Maslin MA, 2014, DEV CELL, V28, P351, DOI 10.1016/j.devcel.2014.01.017; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Filipczyk A, 2013, CELL STEM CELL, V13, P12, DOI 10.1016/j.stem.2013.04.025; Gendre AV, 2014, DEV CELL, V28, P366, DOI 10.1016/j.devcel.2014.01.016; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Nag A, 2013, ELIFE, V2, DOI 10.7554/eLife.01256; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Ohlsson R, 1999, DEV GENES EVOL, V209, P113, DOI 10.1007/s004270050233; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Paul W., 2012, FUNDAMENTAL IMMUNOLO, V7th; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Pinter SF, 2015, GENETICS, V200, P537, DOI 10.1534/genetics.115.176263; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Reinius B, 2015, NAT REV GENET, V16, P653, DOI 10.1038/nrg3888; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; Savova V, 2016, NAT GENET, V48, P231, DOI 10.1038/ng.3493; Savova V, 2016, NUCLEIC ACIDS RES, V44, pD753, DOI 10.1093/nar/gkv1106; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	34	77	81	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1430	1435		10.1038/ng.3678	http://dx.doi.org/10.1038/ng.3678			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27668657	Green Accepted			2022-12-25	WOS:000386543400021
J	Stone, LK; Baym, M; Lieberman, TD; Chait, R; Clardy, J; Kishony, R				Stone, Laura K.; Baym, Michael; Lieberman, Tami D.; Chait, Remy; Clardy, Jon; Kishony, Roy			Compounds that select against the tetracycline-resistance efflux pump	NATURE CHEMICAL BIOLOGY			English	Article							ANTIBIOTIC-RESISTANCE; STAPHYLOCOCCUS-AUREUS; MULTIDRUG-RESISTANCE; COMBINATIONS; DISCOVERY; FITNESS; ELEMENT; ACID	We developed a competition-based screening strategy to identify compounds that invert the selective advantage of antibiotic resistance. Using our assay, we screened over 19,000 compounds for the ability to select against the TetA tetracycline-resistance efflux pump in Escherichia coli and identified two hits, beta-thujaplicin and disulfiram. Treating a tetracycline-resistant population with beta-thujaplicin selects for loss of the resistance gene, enabling an effective second-phase treatment with doxycycline.	[Stone, Laura K.; Baym, Michael; Lieberman, Tami D.; Chait, Remy; Kishony, Roy] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Chait, Remy] IST Austria, A-3400 Klosterneuburg, Austria; [Clardy, Jon] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Kishony, Roy] Technion Israel Inst Technol, Dept Biol, Haifa, Israel; [Kishony, Roy] Technion Israel Inst Technol, Dept Comp Sci, Haifa, Israel	Harvard University; Harvard Medical School; Institute of Science & Technology - Austria; Harvard University; Harvard Medical School; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Kishony, R (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Kishony, R (corresponding author), Technion Israel Inst Technol, Dept Biol, Haifa, Israel.; Kishony, R (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, Haifa, Israel.	rkishony@technion.ac.il		/0000-0001-5430-3937; Chait, Remy/0000-0003-0876-3187; Baym, Michael/0000-0003-1303-5598	National Institute of Allergy and Infectious Diseases grant [U54 AI057159]; US National Institutes of Health grant [R01 GM081617, GM086258]; European Research Council FP7 ERC grant [281891]; National Science Foundation Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086258, R01GM081617] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases grant; US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council FP7 ERC grant; National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Rudner, R. Mazitschek, and R. Moellering for helpful insights; J. Horn and J. Marchionna for custom screening plate manufacture and technical advice; D. Flood and S. Rudnicki for technical support in the primary screen; and J. Wang and J. Moore for technical support in the flow cytometry assay. All primary screening was performed at Harvard Medical School ICCB-L Screening Facility. This work was supported in part by National Institute of Allergy and Infectious Diseases grant U54 AI057159, US National Institutes of Health grants R01 GM081617 (to R.K.) and GM086258 (to J.C.), European Research Council FP7 ERC grant 281891 (to R.K.) and a National Science Foundation Graduate Fellowship (to L.K.S.).	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; ANDERSON AB, 1948, ACTA CHEM SCAND, V2, P644, DOI 10.3891/acta.chem.scand.02-0644; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292; Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chait R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10333; Chait R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015179; CHAO L, 1978, NATURE, V271, P385, DOI 10.1038/271385a0; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Gonzales PR, 2015, NAT CHEM BIOL, V11, P855, DOI 10.1038/nchembio.1911; Hiramatsu K, 2012, INT J ANTIMICROB AG, V39, P478, DOI 10.1016/j.ijantimicag.2012.02.007; Imamovic L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006609; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Keane TM, 2013, BIOINFORMATICS, V29, P389, DOI 10.1093/bioinformatics/bts697; Kim S, 2014, P NATL ACAD SCI USA, V111, P14494, DOI 10.1073/pnas.1409800111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lazar V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.57; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lukens AK, 2014, P NATL ACAD SCI USA, V111, P799, DOI 10.1073/pnas.1320886110; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; MERLIN TL, 1989, ANTIMICROB AGENTS CH, V33, P1549, DOI 10.1128/AAC.33.9.1549; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; Palmer AC, 2010, NAT CHEM BIOL, V6, P105, DOI [10.1038/NCHEMBIO.289, 10.1038/nchembio.289]; PHILLIPS M, 1991, ANTIMICROB AGENTS CH, V35, P785, DOI 10.1128/AAC.35.4.785; Stone GW, 2004, ANTIMICROB AGENTS CH, V48, P477, DOI 10.1128/AAC.48.2.477-483.2004; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Wang HX, 1999, LIFE SCI, V65, P849, DOI 10.1016/S0024-3205(99)00083-1; World Health Organization, 2014, ANT RES GLOB REP SUR; Wright GD, 2011, CHEM COMMUN, V47, P4055, DOI 10.1039/c0cc05111j	35	30	31	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					902	+		10.1038/NCHEMBIO.2176	http://dx.doi.org/10.1038/NCHEMBIO.2176			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27642863	Green Accepted, Green Submitted			2022-12-25	WOS:000386798800008
J	Hirayama, S; Hori, Y; Benedek, Z; Suzuki, T; Kikuchi, K				Hirayama, Shinya; Hori, Yuichiro; Benedek, Zsolt; Suzuki, Tadashi; Kikuchi, Kazuya			Fluorogenic probes reveal a role of GLUT4 N-glycosylation in intracellular trafficking	NATURE CHEMICAL BIOLOGY			English	Article							LIVE-CELL; ENDOPLASMIC-RETICULUM; SKELETAL-MUSCLE; PROTEIN; WASH; INSULIN; TAG; FLUOROPHORE; SURFACE; TIME	Glucose transporter 4 (GLUT4) is an N-glycosylated protein that maintains glucose homeostasis by regulating the protein translocation. To date, it has been unclear whether the N-glycan of GLUT4 contributes to its intracellular trafficking. Here, to clarify the role of the N-glycan, we developed fluorogenic probes that label cytoplasmic and plasma-membrane proteins for multicolor imaging of GLUT4 translocation. One of the probes, which is cell impermeant, selectively detected exocytosed GLUT4. Using this probe, we verified the 'log' of the trafficking, in which N-glycan-deficient GLUT4 was transiently translocated to the cell membrane upon insulin stimulation and was rapidly internalized without retention on the cell membrane. The results strongly suggest that the N-glycan functions in the retention of GLUT4 on the cell membrane. This study showed the utility of the fluorogenic probes and indicated that this imaging tool will be applicable for research on various membrane proteins that show dynamic changes in localization.	[Hirayama, Shinya; Hori, Yuichiro; Benedek, Zsolt; Kikuchi, Kazuya] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka, Japan; [Hori, Yuichiro; Kikuchi, Kazuya] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Hori, Yuichiro] JST, PRESTOTO, Suita, Osaka, Japan; [Suzuki, Tadashi] RIKEN, Global Res Cluster, Glycometabolome Team, Wako, Saitama, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); RIKEN	Kikuchi, K (corresponding author), Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka, Japan.; Kikuchi, K (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka, Japan.	kkikuchi@mls.eng.osaka-u.ac.jp	Benedek, Zsolt/AAJ-8974-2021; Suzuki, Tadashi/I-4536-2014; Suzuki, Tadashi/AAX-5707-2021; Benedek, Zsolt/G-4634-2019	Benedek, Zsolt/0000-0002-0174-9676; Suzuki, Tadashi/0000-0003-1030-7631; Benedek, Zsolt/0000-0002-0174-9676	JST, PRESTO; MEXT of Japan [25220207, 26102529, 15K12754, 26282215, 14J00755]; CREST of JST; Asahi Glass Foundation; Uehara Memorial Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Program for Creating Future Wisdom, Osaka University; Grants-in-Aid for Scientific Research [26282215, 15K12754, 16K13099] Funding Source: KAKEN	JST, PRESTO(Japan Science & Technology Agency (JST)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST of JST(Core Research for Evolutional Science and Technology (CREST)); Asahi Glass Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Program for Creating Future Wisdom, Osaka University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JST, PRESTO, MEXT of Japan (grants 25220207, 26102529, 15K12754 to K.K.; 26282215 to Y.H.; and 14J00755 to S.H.), CREST of JST (K.K.), the Asahi Glass Foundation (K.K.), the Uehara Memorial Foundation (K.K.), the Naito Foundation (Y.H.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (Y.H.), and the Program for Creating Future Wisdom, Osaka University, selected in 2014 (Y.H.). We thank Y. Haga (Japanese Foundation for Cancer Research, Tokyo, Japan) for valuable suggestions and the gift of GLUT4 plasmids, and M. Nishiura for experimental support.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Chen YC, 2014, ANGEW CHEM INT EDIT, V53, P13785, DOI 10.1002/anie.201408015; Crivat G, 2012, TRENDS BIOTECHNOL, V30, P8, DOI 10.1016/j.tibtech.2011.08.002; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gonzalez DS, 1999, J BIOL CHEM, V274, P21375, DOI 10.1074/jbc.274.30.21375; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Haga Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1906; Haga Y, 2011, J BIOL CHEM, V286, P31320, DOI 10.1074/jbc.M111.253955; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hori Y, 2015, ANGEW CHEM INT EDIT, V54, P14368, DOI 10.1002/anie.201506935; Hori Y, 2013, J AM CHEM SOC, V135, P12360, DOI 10.1021/ja405745v; Hori Y, 2013, CURR OPIN CHEM BIOL, V17, P644, DOI 10.1016/j.cbpa.2013.05.015; Hori Y, 2012, ANGEW CHEM INT EDIT, V51, P5611, DOI 10.1002/anie.201200867; Hori Y, 2009, J AM CHEM SOC, V131, P16610, DOI 10.1021/ja904800k; Ing BL, 1996, BIOCHEM BIOPH RES CO, V218, P76, DOI 10.1006/bbrc.1996.0015; Ishida H, 2010, COORDIN CHEM REV, V254, P2449, DOI 10.1016/j.ccr.2010.04.006; Jing CR, 2013, ACS CHEM BIOL, V8, P1704, DOI 10.1021/cb300657r; Johansson MK, 2003, CHEM-EUR J, V9, P3466, DOI 10.1002/chem.200304941; Komatsu T, 2011, J AM CHEM SOC, V133, P6745, DOI 10.1021/ja200225m; Kukuruzinska MA, 1998, CRIT REV ORAL BIOL M, V9, P415, DOI 10.1177/10454411980090040301; Kumauchi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P956, DOI 10.1111/j.1751-1097.2008.00335.x; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Liu TK, 2014, ACS CHEM BIOL, V9, P2359, DOI 10.1021/cb500502n; Lizunov VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057559; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/nchem.1546, 10.1038/NCHEM.1546]; MEYER TE, 1985, BIOCHIM BIOPHYS ACTA, V806, P175, DOI 10.1016/0005-2728(85)90094-5; Mizukami S, 2012, J AM CHEM SOC, V134, P1623, DOI 10.1021/ja208290f; Nadler A, 2013, ANGEW CHEM INT EDIT, V52, P2408, DOI 10.1002/anie.201209733; ROTMAN B, 1966, P NATL ACAD SCI USA, V55, P134, DOI 10.1073/pnas.55.1.134; Ryder JW, 2000, DIABETES, V49, P647, DOI 10.2337/diabetes.49.4.647; Sadhu KK, 2010, CHEM COMMUN, V46, P7403, DOI 10.1039/c0cc02432e; Sadler JBA, 2013, INT J MOL SCI, V14, P9963, DOI 10.3390/ijms14059963; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Sun XL, 2011, CHEMBIOCHEM, V12, P2217, DOI 10.1002/cbic.201100173; Sunbul M, 2013, ANGEW CHEM INT EDIT, V52, P13401, DOI 10.1002/anie.201306622; Telmer CA, 2015, ACS CHEM BIOL, V10, P1239, DOI 10.1021/cb500957k; Vagin O, 2004, J BIOL CHEM, V279, P39026, DOI 10.1074/jbc.M405453200; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; WEBER G, 1957, T FARADAY SOC, V53, P646, DOI 10.1039/tf9575300646; Zaarour N, 2012, BIOCHEM J, V445, P265, DOI 10.1042/BJ20120232; Zhang CJ, 2011, ORG LETT, V13, P4160, DOI 10.1021/ol201430x	42	35	37	3	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					853	+		10.1038/NCHEMBIO.2156	http://dx.doi.org/10.1038/NCHEMBIO.2156			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27547921				2022-12-25	WOS:000384248600018
J	Xu, M; Lee, EM; Wen, ZX; Cheng, YC; Huang, WK; Qian, XY; Julia, TCW; Kouznetsova, J; Ogden, SC; Hammack, C; Jacob, F; Nguyen, HN; Itkin, M; Hanna, C; Shinn, P; Allen, C; Michael, SG; Simeonov, A; Huang, WW; Christian, KM; Goate, A; Brennand, KJ; Huang, RL; Xia, MH; Ming, GL; Zheng, W; Song, HJ; Tang, HL				Xu, Miao; Lee, Emily M.; Wen, Zhexing; Cheng, Yichen; Huang, Wei-Kai; Qian, Xuyu; Julia, T. C. W.; Kouznetsova, Jennifer; Ogden, Sarah C.; Hammack, Christy; Jacob, Fadi; Ha Nam Nguyen; Itkin, Misha; Hanna, Catherine; Shinn, Paul; Allen, Chase; Michael, Samuel G.; Simeonov, Anton; Huang, Wenwei; Christian, Kimberly M.; Goate, Alison; Brennand, Kristen J.; Huang, Ruili; Xia, Menghang; Ming, Guo-li; Zheng, Wei; Song, Hongjun; Tang, Hengli			Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen	NATURE MEDICINE			English	Article							SEXUAL TRANSMISSION; CDK9 INHIBITORS; REPLICATION; ORGANOIDS; THERAPY; BIOLOGY; MODEL	In response to the current global health emergency posed by the Zika virus (ZIKV) outbreak and its link to microcephaly and other neurological conditions, we performed a drug repurposing screen of similar to 6,000 compounds that included approved drugs, clinical trial drug candidates and pharmacologically active compounds; we identified compounds that either inhibit ZIKV infection or suppress infection-induced caspase-3 activity in different neural cells. A pan-caspase inhibitor, emricasan, inhibited ZIKV-induced increases in caspase-3 activity and protected human cortical neural progenitors in both monolayer and three-dimensional organoid cultures. Ten structurally unrelated inhibitors of cyclin-dependent kinases inhibited ZIKV replication. Niclosamide, a category B anthelmintic drug approved by the US Food and Drug Administration, also inhibited ZIKV replication. Finally, combination treatments using one compound from each category (neuroprotective and antiviral) further increased protection of human neural progenitors and astrocytes from ZIKV-induced cell death. Our results demonstrate the efficacy of this screening strategy and identify lead compounds for anti-ZIKV drug development.	[Xu, Miao; Kouznetsova, Jennifer; Itkin, Misha; Shinn, Paul; Michael, Samuel G.; Simeonov, Anton; Huang, Wenwei; Huang, Ruili; Xia, Menghang; Zheng, Wei] NIH, Natl Ctr Adv Translat, Bldg 10, Bethesda, MD 20892 USA; [Xu, Miao] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China; [Lee, Emily M.; Cheng, Yichen; Ogden, Sarah C.; Hammack, Christy; Hanna, Catherine; Allen, Chase; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Wen, Zhexing] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Wen, Zhexing] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Wen, Zhexing] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Wen, Zhexing; Huang, Wei-Kai; Qian, Xuyu; Jacob, Fadi; Ha Nam Nguyen; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Huang, Wei-Kai] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Qian, Xuyu; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21218 USA; [Julia, T. C. W.; Goate, Alison] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Jacob, Fadi; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Ha Nam Nguyen; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; Zhejiang University; State University System of Florida; Florida State University; Emory University; Emory University; Emory University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins University	Zheng, W (corresponding author), NIH, Natl Ctr Adv Translat, Bldg 10, Bethesda, MD 20892 USA.; Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21218 USA.; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21218 USA.	gming1@jhmi.edu; wzheng@mail.nih.gov; shongju1@jhmi.edu; tang@bio.fsu.edu	Zheng, Wei/GOE-5990-2022; Brennand, Kristen J/U-5470-2019; Zheng, Wei/J-8889-2014; Brennand, Kristen J/J-8704-2012; Wen, Zhexing/L-1228-2018; xu, miao/U-1176-2017; Huang, WW/GXH-0977-2022; Huang, Wenwei/AFO-1997-2022; Huang, Wei-Kai/GRR-9057-2022; Qian, Xuyu/C-1240-2017	Zheng, Wei/0000-0003-1034-0757; Brennand, Kristen J/0000-0003-0993-5956; Wen, Zhexing/0000-0002-1518-3845; Qian, Xuyu/0000-0001-5944-3816; Goate, Alison/0000-0002-0576-2472; Jacob, Fadi/0000-0002-0094-8454; Ming, Guo-li/0000-0002-2517-6075	Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health (NIH); Florida State University; Emory University; Brain and Behavior Research Foundation; New York Stem Cell Foundation; Maryland Stem Cell Research Fund; Simons Foundation Autism Research Initiative [308988]; NIH [NS048271, NS095348, MH105128, NS047344, NS097206, MH106434, MH101454, MH106056, AG005138, AG046170, AI119530]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000018, ZIATR000269, ZICTR000242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309, T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101454, R56MH101454, U19MH106434, T32MH015330, R01MH106056, R01MH105128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R01NS047344, R21NS095348, R01NS048271, P01NS097206, R56NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005138, U01AG046170] Funding Source: NIH RePORTER	Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health (NIH); Florida State University; Emory University; Brain and Behavior Research Foundation; New York Stem Cell Foundation; Maryland Stem Cell Research Fund; Simons Foundation Autism Research Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Tesh and P.-Y. Shi (University of Texas Medical Branch) and the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA) for the FSS-13025 isolate of ZIKV, and D. Meckes (Florida State University) for the glioblastoma SNB-19 cell line. We also thank L. Liu and Y. Cai for technical support. This work was supported by the Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health (NIH) (W.Z.), ZIKV seed funding from Florida State University (H.T.), a start-up fund from Emory University (Z.W.), the Brain and Behavior Research Foundation (K.J.B.), the New York Stem Cell Foundation (K.J.B.), the Maryland Stem Cell Research Fund (G.M. and H.S.), the Simons Foundation Autism Research Initiative (award no. 308988; H.S.), and partially by NIH grants NS048271 (G.M.), NS095348 (G.M.), MH105128 (G.M.), NS047344 (H.S.), NS097206 (H.S.), MH106434 (H.S.), MH101454 (K.J.B.), MH106056 (K.J.B.), AG005138 (K.J.B.), AG046170 (K.J.B.) and AI119530 (H.T.).	Abbink P., 2016, SCIENCE; Al-Hadiya Badraddin M H, 2005, Profiles Drug Subst Excip Relat Methodol, V32, P67, DOI 10.1016/S0099-5428(05)32002-8; ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X; [Anonymous], NATURE; Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035; Badia R, 2016, J ANTIMICROB CHEMOTH, V71, P387, DOI 10.1093/jac/dkv363; Barreyro FJ, 2015, LIVER INT, V35, P953, DOI 10.1111/liv.12570; Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004; BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709; Brasil P., 2016, N ENGL J MED; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Chen CZ, 2011, ANTIMICROB AGENTS CH, V55, P667, DOI 10.1128/AAC.00618-10; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; Debnath A, 2012, NAT MED, V18, P956, DOI 10.1038/nm.2758; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425; Fontes C. A., 2016, NEURORADIOLOGY; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Haddad JJ, 2013, RECENT PATENTS INFLA, V7, P229, DOI 10.2174/1872213X113079990017; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Hoglen NC, 2004, J PHARMACOL EXP THER, V309, P634, DOI 10.1124/jpet.103.062034; Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597; Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976; Khanim FL, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.38; Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9; McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Nemeth G, 2011, CURR MED CHEM, V18, P342, DOI 10.2174/092986711794839188; Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012; Okamoto M, 2015, ANTIVIR RES, V123, P1, DOI 10.1016/j.antiviral.2015.08.012; Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001; Pfizer Inc, 2015, IBR PALB CAPS PRESCR; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Schang Luis M., 2006, Antiviral Chemistry & Chemotherapy, V17, P293; Shiffman ML, 2010, ALIMENT PHARM THER, V31, P969, DOI 10.1111/j.1365-2036.2010.04264.x; Sun W, 2016, DRUG DISCOV TODAY, V21, P1189, DOI 10.1016/j.drudis.2016.05.015; Sun W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03743; Sun W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070506; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Van Duyne R, 2013, J MOL BIOL, V425, P812, DOI 10.1016/j.jmb.2012.12.005; Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004; Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58; Yamamoto M, 2014, J CLIN INVEST, V124, P3479, DOI 10.1172/JCI73805; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JJ, 2010, J VIROL, V84, P12619, DOI 10.1128/JVI.01696-10	59	443	457	6	228	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1101	1107		10.1038/nm.4184	http://dx.doi.org/10.1038/nm.4184			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27571349	Green Accepted, Bronze			2022-12-25	WOS:000384872500013
J	Hofer, K; Li, SS; Abele, F; Frindert, J; Schlotthauer, J; Grawenhoff, J; Du, JM; Patel, DJ; Jaschke, A				Hoefer, Katharina; Li, Sisi; Abele, Florian; Frindert, Jens; Schlotthauer, Jasmin; Grawenhoff, Julia; Du, Jiamu; Patel, Dinshaw J.; Jaeschke, Andres			Structure and function of the bacterial decapping enzyme NudC	NATURE CHEMICAL BIOLOGY			English	Article							RNA; HYDROLASES; PROTEINS; FAMILY; NAD; CAP	RNA capping and decapping are thought to be distinctive features of eukaryotes. The redox cofactor NAD was recently discovered to be attached to small regulatory RNAs in bacteria in a cap-like manner, and Nudix hydrolase NudC was found to act as a NAD-decapping enzyme in vitro and in vivo. Here, crystal structures of Escherichia coli NudC in complex with substrate NAD and with cleavage product NMN reveal the catalytic residues lining the binding pocket and principles underlying molecular recognition of substrate and product. Biochemical mutation analysis identifies the conserved Nudix motif as the catalytic center of the enzyme, which needs to be homodimeric, as the catalytic pocket is composed of amino acids from both monomers. NudC is single-strand specific and has a purine preference for the 5'-terminal nucleotide. The enzyme strongly prefers NAD-linked RNA (NAD-RNA) over NAD and binds to a diverse set of cellular RNAs in an unspecific manner.	[Hoefer, Katharina; Abele, Florian; Frindert, Jens; Schlotthauer, Jasmin; Grawenhoff, Julia; Jaeschke, Andres] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Li, Sisi; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA; [Du, Jiamu] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Ruprecht Karls University Heidelberg; Memorial Sloan Kettering Cancer Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jaschke, A (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.; Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	pateld@mskcc.org; jaeschke@uni-hd.de	Du, Jiamu/I-1334-2013; Jäschke, Andres/F-1575-2010	Du, Jiamu/0000-0002-1337-0786; Jäschke, Andres/0000-0002-4625-2655; Li, Sisi/0000-0002-7290-8128; Grawenhoff, Julia/0000-0002-7639-358X; Hofer, Katharina/0000-0002-7472-9887	German Research Foundation (DFG) [SPP 1784, JA 794/10-1]; Baden-Wurttemberg Stiftung [BWST-NCRNA-045]; US National Institutes of Health (NIH) [GM104962]; Thousand Young Talent Program of China; Chinese Academy of Sciences; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104962] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Baden-Wurttemberg Stiftung; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thousand Young Talent Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to L. Obenauer (Heidelberg University) for assistance with NGS data analysis, L. Kiss for experimental assistance and to W. Shi at beamline X29A at the Brookhaven National Laboratory for support in diffraction data collection. A.J. is supported by the German Research Foundation (DFG SPP 1784, grant JA 794/10-1) and by the Baden-Wurttemberg Stiftung (BWST-NCRNA-045). The structural research was supported by funds from US National Institutes of Health (NIH) grant GM104962 to D.J.P. and the Thousand Young Talent Program of China and the Chinese Academy of Sciences to J.D.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aglietti RA, 2013, STRUCTURE, V21, P1571, DOI 10.1016/j.str.2013.06.021; Arribas-Layton M, 2013, BBA-GENE REGUL MECH, V1829, P580, DOI 10.1016/j.bbagrm.2012.12.006; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Cahova H, 2015, NATURE, V519, P374, DOI 10.1038/nature14020; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YG, 2009, NAT CHEM BIOL, V5, P879, DOI 10.1038/nchembio.235; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Deshmukh MV, 2008, MOL CELL, V29, P324, DOI 10.1016/j.molcel.2007.11.027; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRICK DN, 1995, J BIOL CHEM, V270, P1529, DOI 10.1074/jbc.270.4.1529; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Hofer K, 2016, BIOCONJUGATE CHEM, V27, P874, DOI 10.1021/acs.bioconjchem.6b00072; Jaschke A, 2016, CURR OPIN MICROBIOL, V30, P44, DOI 10.1016/j.mib.2015.12.009; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee CR, 2014, NUCLEIC ACIDS RES, V42, P12746, DOI 10.1093/nar/gku926; Luciano DJ, 2015, TRENDS BIOCHEM SCI, V40, P245, DOI 10.1016/j.tibs.2015.03.004; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Marbaniang CN, 2016, CURR OPIN MICROBIOL, V30, P50, DOI 10.1016/j.mib.2016.01.001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; McLennan AG, 2013, CELL MOL LIFE SCI, V70, P373, DOI 10.1007/s00018-012-1210-3; O'Handley SF, 1998, J BIOL CHEM, V273, P3192, DOI 10.1074/jbc.273.6.3192; Olejnik K, 2009, ACTA BIOCHIM POL, V56, P291; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; She MP, 2006, NAT STRUCT MOL BIOL, V13, P63, DOI 10.1038/nsmb1033; Song MG, 2013, RNA, V19, P390, DOI 10.1261/rna.037309.112; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Vasilyev N, 2015, J BIOL CHEM, V290, P9487, DOI 10.1074/jbc.M114.634824	32	47	47	4	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2016	12	9					730	+		10.1038/nchembio.2132	http://dx.doi.org/10.1038/nchembio.2132			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU5MF	27428510	Green Accepted			2022-12-25	WOS:000382255100015
J	Lin, CH; Chi, CY; Shih, HP; Ding, JY; Lo, CC; Wang, SY; Kuo, CY; Yeh, CF; Tu, KH; Liu, SH; Chen, HK; Ho, CH; Ho, MW; Lee, CH; Lai, HC; Ku, CL				Lin, Chia-Hao; Chi, Chih-Yu; Shih, Han-Po; Ding, Jing-Ya; Lo, Chia-Chi; Wang, Shang-Yu; Kuo, Chen-Yen; Yeh, Chun-Fu; Tu, Kun-Hua; Liu, Shou-Hsuan; Chen, Hung-Kai; Ho, Chen-Hsuan; Ho, Mao-Wang; Lee, Chen-Hsiang; Lai, Hsin-Chin; Ku, Cheng-Lung			Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease	NATURE MEDICINE			English	Article							IFN-GAMMA; MOLECULAR MIMICRY; GM-CSF; MENDELIAN SUSCEPTIBILITY; BIOLOGICAL-ACTIVITY; CLINICAL-FEATURES; CRYSTAL-STRUCTURE; INFECTION; RITUXIMAB; IMMUNODEFICIENCY	The binding of autoantibodies (autoAbs) to interferon (IFN)-gamma in people with mycobacterial diseases has become an emerging medical concern. Many patients display specific human leukocyte antigen (HLA) class II haplotypes, which suggests that a common T cell-dependent and B cell-dependent mechanism might underlie the production of specific anti-IFN-gamma autoAbs. We show here that these autoAbs target a major epitope (amino acids 121-131, designated position (P)(121-131)) in a region crucial for IFN-gamma receptor (IFN-gamma R) activation to impair IFN-gamma-mediated activities. The amino acid sequence of this epitope is highly homologous to a stretch in the Noc2 protein of Aspergillus spp., which was cross-reactive with autoAbs from patients. Rats immunized with Aspergillus Noc2 developed antibodies that reacted with human IFN-gamma. We generated an epitope-erased variant of IFN-gamma (EE-IFN-gamma), in which the major neutralizing epitope region was altered. The binding affinity of anti-IFN-gamma autoAbs for EE-IFN-gamma was reduced by about 40%, as compared to that for IFN-(gamma 1-131). Moreover, EE-IFN-gamma activated the IFN-gamma R downstream signaling pathway ex vivo, irrespectively of anti-IFN-gamma autoAbs. In conclusion, we identified a common, crucial B cell epitope that bound to anti-IFN-gamma autoAbs in patients, and we propose a molecular-mimicry model for autoAb development. In addition, treatment with EE-IFN-gamma might be worth investigating in patients producing anti-IFN-gamma autoAbs.	[Lin, Chia-Hao; Chi, Chih-Yu; Shih, Han-Po; Ding, Jing-Ya; Lo, Chia-Chi; Wang, Shang-Yu; Kuo, Chen-Yen; Yeh, Chun-Fu; Tu, Kun-Hua; Liu, Shou-Hsuan; Ku, Cheng-Lung] Chang Gung Univ, Grad Inst Clin Med Sci, Lab Human Immunol & Infect Dis, Taoyuan, Taiwan; [Lin, Chia-Hao; Lai, Hsin-Chin] Chang Gung Univ, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Chi, Chih-Yu; Ho, Mao-Wang] China Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan; [Chi, Chih-Yu] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Wang, Shang-Yu] Chang Gung Mem Hosp, Dept Gen Surg, Div Trauma & Emergency Surg, Taoyuan, Taiwan; [Kuo, Chen-Yen] Chang Gung Mem Hosp, Dept Pediat, Div Infect Dis, Taoyuan, Taiwan; [Yeh, Chun-Fu; Ku, Cheng-Lung] Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Taoyuan, Taiwan; [Yeh, Chun-Fu; Tu, Kun-Hua; Liu, Shou-Hsuan] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Tu, Kun-Hua; Liu, Shou-Hsuan] Chang Gung Mem Hosp, Kidney Res Ctr, Dept Nephrol, Taipei, Taiwan; [Chen, Hung-Kai; Ho, Chen-Hsuan] Dev Ctr Biotechnol, Lab Translat Med, New Taipei, Taiwan; [Lee, Chen-Hsiang] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lee, Chen-Hsiang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lai, Hsin-Chin; Ku, Cheng-Lung] Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Taoyuan, Taiwan; [Lai, Hsin-Chin; Ku, Cheng-Lung] Chang Gung Univ, Taoyuan, Taiwan; [Ku, Cheng-Lung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	Chang Gung University; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan	Ku, CL (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Lab Human Immunol & Infect Dis, Taoyuan, Taiwan.; Ku, CL (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Taoyuan, Taiwan.; Ku, CL (corresponding author), Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Taoyuan, Taiwan.; Ku, CL (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.; Ku, CL (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.	clku@mail.cgu.edu.tw	Tu, Kun-Hua/ABD-1751-2021; KU, Cheng-Lung/AAT-1033-2020	Tu, Kun-Hua/0000-0002-7146-4481; KU, Cheng-Lung/0000-0002-0643-2256; Wang, Shang Yu/0000-0003-1514-3015; Chen, Hung-Kai/0000-0002-2169-4924; Chi, Chih-Yu/0000-0002-1425-8585	Taiwan National Health Research Institutes [NHRI-EX100-10028SC]; Taiwan Ministry of Science and Technology [100-2314-B-182-050, 102-2320-B-182-024, 103-2320-B-182-012]; Chang Gung Memorial Hospital [CMRPD1F0201, CORPD1F0041, BMRPB98]	Taiwan National Health Research Institutes; Taiwan Ministry of Science and Technology; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	We thank all the clinicians and patients who participated in this study. This work was supported by the Taiwan National Health Research Institutes grant NHRI-EX100-10028SC (C.-L.K.), Taiwan Ministry of Science and Technology grant 100-2314-B-182-050 (C.-L.K.), 102-2320-B-182-024 (C.-L.K.) and 103-2320-B-182-012 (C.-L.K.), and Chang Gung Memorial Hospital grant CMRPD1F0201 (C.-L.K.), CORPD1F0041 (C.-L.K.) and BMRPB98 (C.-L.K.).	Barnes PD, 2006, INFECT DIS CLIN N AM, V20, P545, DOI 10.1016/j.idc.2006.06.001; BASHAM TY, 1983, J IMMUNOL, V130, P1492; Baxter CG, 2013, CLIN MICROBIOL INFEC, V19, pE197, DOI 10.1111/1469-0691.12133; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Browne SK, 2014, ANNU REV IMMUNOL, V32, P635, DOI 10.1146/annurev-immunol-032713-120222; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Browne SK, 2012, BLOOD, V119, P3933, DOI 10.1182/blood-2011-12-395707; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Casanova JL, 1996, PEDIATRICS, V98, P774; Chaudhary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009036; Chi CY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003927; Chi CY, 2013, BLOOD, V121, P1357, DOI 10.1182/blood-2012-08-452482; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; Doffinger R, 2004, CLIN INFECT DIS, V38, pE10, DOI 10.1086/380453; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Hoflich C, 2004, BLOOD, V103, P673, DOI 10.1182/blood-2003-04-1065; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Keating GM, 2010, DRUGS, V70, P1445, DOI 10.2165/11201110-000000000-00000; Ku CL, 2016, J ALLERGY CLIN IMMUN, V137, P945, DOI 10.1016/j.jaci.2015.09.018; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lee WI, 2013, IMMUNOBIOLOGY, V218, P762, DOI 10.1016/j.imbio.2012.08.281; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; LUNDELL D, 1991, PROTEIN ENG, V4, P335, DOI 10.1093/protein/4.3.335; Neal COS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-203; Nguyen LDN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00089; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Patel SY, 2005, J IMMUNOL, V175, P4769, DOI 10.4049/jimmunol.175.7.4769; Piccoli L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8375; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Puel A, 2013, BLOOD, V121, P1246, DOI 10.1182/blood-2013-01-474213; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Rao VK, 2009, PEDIATR BLOOD CANCER, V52, P847, DOI 10.1002/pbc.21965; Rosen LB, 2015, CLIN INFECT DIS, V60, P1017, DOI 10.1093/cid/ciu968; Rosen LB, 2013, J IMMUNOL, V190, P3959, DOI 10.4049/jimmunol.1202526; ROWLEY D, 1962, NATURE, V193, P151, DOI 10.1038/193151a0; Savan R, 2009, CYTOKINE GROWTH F R, V20, P115, DOI 10.1016/j.cytogfr.2009.02.006; SEELIG GF, 1988, BIOCHEMISTRY-US, V27, P1981, DOI 10.1021/bi00406a026; Sfriso P, 2010, J LEUKOCYTE BIOL, V87, P385, DOI 10.1189/jlb.0709517; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Sologuren I, 2011, HUM MOL GENET, V20, P1509, DOI 10.1093/hmg/ddr029; Thiel DJ, 2000, STRUCTURE, V8, P927, DOI 10.1016/S0969-2126(00)00184-2; van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; Wang YN, 2013, P NATL ACAD SCI USA, V110, P7832, DOI 10.1073/pnas.1216011110	46	52	52	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					994	+		10.1038/nm.4158	http://dx.doi.org/10.1038/nm.4158			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27525523				2022-12-25	WOS:000382542800010
J	Mann, KM; Newberg, JY; Black, MA; Jones, DJ; Amaya-Manzanares, F; Guzman-Rojas, L; Kodama, T; Ward, JM; Rust, AG; van der Weyden, L; Yew, CCK; Waters, JL; Leung, ML; Rogers, K; Rogers, SM; McNoe, LA; Selvanesan, L; Navin, N; Jenkins, NA; Copeland, NG; Mann, MB				Mann, Karen M.; Newberg, Justin Y.; Black, Michael A.; Jones, Devin J.; Amaya-Manzanares, Felipe; Guzman-Rojas, Liliana; Kodama, Takahiro; Ward, Jerrold M.; Rust, Alistair G.; van der Weyden, Louise; Yew, Christopher Chin Kuan; Waters, Jill L.; Leung, Marco L.; Rogers, Keith; Rogers, Susan M.; McNoe, Leslie A.; Selvanesan, Luxmanan; Navin, Nicholas; Jenkins, Nancy A.; Copeland, Neal G.; Mann, Michael B.			Analyzing tumor heterogeneity and driver genes in single myeloid leukemia cells with SBCapSeq	NATURE BIOTECHNOLOGY			English	Article							SLEEPING-BEAUTY MUTAGENESIS; MOUSE MODEL; IDENTIFIES GENES; CANCER; P53; PATHWAYS; MUTATION; GAIN; EXPRESSION; ALIGNMENT	A central challenge in oncology is how to kill tumors containing heterogeneous cell populations defined by different combinations of mutated genes. Identifying these mutated genes and understanding how they cooperate requires single-cell analysis, but current single-cell analytic methods, such as PCR-based strategies or whole-exome sequencing, are biased, lack sequencing depth or are cost prohibitive. Transposon-based mutagenesis allows the identification of early cancer drivers, but current sequencing methods have limitations that prevent single-cell analysis. We report a liquid-phase, capture-based sequencing and bioinformatics pipeline, Sleeping Beauty (SB) capture hybridization sequencing (SBCapSeq), that facilitates sequencing of transposon insertion sites from single tumor cells in a SB mouse model of myeloid leukemia (ML). SBCapSeq analysis of just 26 cells from one tumor revealed the tumor's major clonal subpopulations, enabled detection of clonal insertion events not detected by other sequencing methods and led to the identification of dominant subclones, each containing a unique pair of interacting gene drivers along with three to six cooperating cancer genes with SB-driven expression changes.	[Mann, Karen M.; Newberg, Justin Y.; Jones, Devin J.; Amaya-Manzanares, Felipe; Guzman-Rojas, Liliana; Kodama, Takahiro; Jenkins, Nancy A.; Copeland, Neal G.; Mann, Michael B.] Houston Methodist Res Inst, Canc Res Program, Houston, TX 77030 USA; [Mann, Karen M.; Ward, Jerrold M.; Yew, Christopher Chin Kuan; Rogers, Keith; Rogers, Susan M.; Jenkins, Nancy A.; Copeland, Neal G.; Mann, Michael B.] Inst Mol & Cell Biol, Singapore, Singapore; [Black, Michael A.; McNoe, Leslie A.; Selvanesan, Luxmanan] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Rust, Alistair G.; van der Weyden, Louise] Wellcome Trust Sanger Inst, Expt Canc Genet, Cambridge, England; [Waters, Jill L.; Leung, Marco L.; Navin, Nicholas] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Ward, Jerrold M.] Global VetPathol, Montgomery Village, MD USA; [Rust, Alistair G.] Inst Canc Res, Chester Beatty Labs, Tumour Profiling Unit, London, England; [Yew, Christopher Chin Kuan] Natl Heart Res Inst Singapore, Singapore, Singapore; [Waters, Jill L.] Illumina Inc, San Diego, CA USA; [Selvanesan, Luxmanan] Pacific Edge Ltd, Dunedin, Otago, New Zealand	The Methodist Hospital System; The Methodist Hospital - Houston; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Otago; Wellcome Trust Sanger Institute; University of Texas System; UTMD Anderson Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Illumina	Copeland, NG; Mann, MB (corresponding author), Houston Methodist Res Inst, Canc Res Program, Houston, TX 77030 USA.; Copeland, NG; Mann, MB (corresponding author), Inst Mol & Cell Biol, Singapore, Singapore.	ncopeland@houstonmethodist.org; mbmann@houstonmethodist.org	Leung, Marco/AAH-3178-2021; Mann, Michael Bruce/M-4674-2019; Kodama, Takahiro/AAW-9605-2021; van der Weyden, Louise/AAV-5711-2021; Mann, Karen/AAW-8323-2020	Mann, Michael Bruce/0000-0002-7515-6515; Kodama, Takahiro/0000-0002-6250-1324; van der Weyden, Louise/0000-0002-0645-1879; Rust, Alistair/0000-0001-7287-192X; Black, Michael/0000-0003-1174-6054	Cancer Prevention Research Institute of Texas; Biomedical Research Council, Agency for Science, Technology, and Research, Singapore; Cancer Research UK; Medical Research Council, UK; Wellcome Trust; NATIONAL CANCER INSTITUTE [R01CA169244, P30CA016672, R21CA174397] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; Biomedical Research Council, Agency for Science, Technology, and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Cancer Research UK(Cancer Research UK); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank D. Adams, T. Whipp, R. Rance and the Wellcome Trust Sanger Institute sequencing and informatics teams for 454 sequencing; the Institute for Molecular and Cell Biology Histopathology Core; P. Cheok, N. Lim, D. Chen and C. Wee for assistance with tumor monitoring and animal husbandry at IMCB (Singapore), H. Lee and E. Freiter for assistance with animal husbandry at HMRI (Houston), R. Zahr (Integrated DNA Technologies, Inc.) for assistance with SBCapture probe design and D. Adams and C. Print for valuable discussions and critical reading of the manuscript. Histology work was performed by the Advanced Molecular Pathology Laboratory, IMCB, A*STAR. This work was supported by the Cancer Prevention Research Institute of Texas (N.G.C. and N.A.J.), the Biomedical Research Council, Agency for Science, Technology, and Research, Singapore (N.G.C. and N.A.J.), Cancer Research UK (A.G.R.), the Medical Research Council, UK (A.G.R.) and the Wellcome Trust (A.G.R.).	Anderson K, 2007, BLOOD, V109, P3697, DOI 10.1182/blood-2006-05-026021; Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Doyle B, 2010, J PATHOL, V222, P129, DOI 10.1002/path.2748; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Friedel RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072338; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Genovesi LA, 2013, P NATL ACAD SCI USA, V110, pE4325, DOI 10.1073/pnas.1318639110; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; Hayashi AA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1647, DOI 10.1152/ajpendo.00674.2006; Henare K, 2012, BRIT J CANCER, V106, P1134, DOI 10.1038/bjc.2012.63; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koudijs MJ, 2011, GENOME RES, V21, P2181, DOI 10.1101/gr.112763.110; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leung ML, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0616-2; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu GY, 2005, J MOL BIOL, V346, P161, DOI 10.1016/j.jmb.2004.09.086; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Mann Karen M, 2014, Cold Spring Harb Protoc, V2014, P235, DOI 10.1101/pdb.top069849; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Mann MB, 2015, NAT GENET, V47, P486, DOI 10.1038/ng.3275; Mann MB, 2014, CURR OPIN GENET DEV, V24, P16, DOI 10.1016/j.gde.2013.11.004; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Marcucci G, 2007, J CLIN ONCOL, V25, P3337, DOI 10.1200/JCO.2007.10.8720; Marziali G, 2002, BLOOD CELL MOL DIS, V29, P553, DOI 10.1006/bcmd.2002.0595; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; R Core Team, 2021, R LANG ENV STAT COMP; Rehg JE, 2012, TOXICOL PATHOL, V40, P345, DOI 10.1177/0192623311430695; Ricciardi MR, 2005, LEUKEMIA, V19, P1543, DOI 10.1038/sj.leu.2403859; Sliwa T, 2014, INT J CLIN EXP PATHO, V7, P882; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Takeda H, 2015, NAT GENET, V47, P142, DOI 10.1038/ng.3175; Tanaka Y, 2012, DEV BIOL, V366, P404, DOI 10.1016/j.ydbio.2012.03.024; Tang JZ, 2013, P NATL ACAD SCI USA, V110, P6091, DOI 10.1073/pnas.1304234110; Taoudi S, 2011, GENE DEV, V25, P251, DOI 10.1101/gad.2009211; Thoms JAI, 2011, BLOOD, V117, P7079, DOI 10.1182/blood-2010-12-317990; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878	62	28	28	0	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2016	34	9					962	+		10.1038/nbt.3637	http://dx.doi.org/10.1038/nbt.3637			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DW0RE	27479497	Green Accepted			2022-12-25	WOS:000383348500023
J	Massoud, AH; Charbonnier, LM; Lopez, D; Pellegrini, M; Phipatanakul, W; Chatila, TA				Massoud, Amir Hossein; Charbonnier, Louis-Marie; Lopez, David; Pellegrini, Matteo; Phipatanakul, Wanda; Chatila, Talal A.			An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to T(H)17-like cells	NATURE MEDICINE			English	Article							IL-4; CYTOKINE; HYPERRESPONSIVENESS; GENERATION; MUTATION; STAT6; DIFFERENTIATION; ACTIVATION; PATHWAYS; DISTINCT	Mechanisms by which regulatory T (T-reg) cells fail to control inflammation in asthma remain poorly understood. We show that a severe asthma-associated polymorphism in the gene encoding the interleukin (IL)-4 receptor alpha chain (Il4ra(R576)) promotes conversion of induced T-reg (iT(reg)) cells toward a T helper 17 (T(H)17) cell fate. This skewing is mediated by the recruitment by IL-4R alpha(R576) of the growth-factor-receptor-bound protein 2 (GRB2) adaptor protein, which drives IL-17 expression by activating a pathway that involves extracellular-signal-regulated kinase, IL-6 and the transcription factor STAT3. T-reg cell-specific deletion of genes that regulate T(H)17 cell differentiation, including Il6ra and RAR-related orphan receptor gamma (Rorc), but not of Il4 or Il13, prevented exacerbated airway inflammation in mice expressing Il4ra(R576) (hereafter referred to as Il4ra(R576) mice). Furthermore, treatment of Il4ra(R576) mice with a neutralizing IL-6-specific antibody prevented iT(reg) cell reprogramming into TH17-like cells and protected against severe airway inflammation. These findings identify a previously unknown mechanism for the development of mixed TH2-TH17 cell inflammation in genetically prone individuals and point to interventions that stabilize iT(reg) cells as potentially effective therapeutic strategies.	[Massoud, Amir Hossein; Charbonnier, Louis-Marie; Phipatanakul, Wanda; Chatila, Talal A.] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Massoud, Amir Hossein; Charbonnier, Louis-Marie; Phipatanakul, Wanda; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Lopez, David; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles	Chatila, TA (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA USA.; Chatila, TA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA USA.	talal.chatila@childrens.harvard.edu	Massoud, Amir Hossein/AAO-2940-2021	Charbonnier, Louis-Marie/0000-0002-4594-7893; Chatila, Talal/0000-0001-7439-2762; Pellegrini, Matteo/0000-0001-9355-9564	National Institutes of Health [R01 AI065617, U10HL098102, U10HL109172]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL109172, U10HL098102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065617, K24AI106822, U01AI126614, U01AI110397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health grants R01 AI065617 (T.A.C.), U10HL098102 (W.P.) and U10HL109172 (W.P.). We thank E. Crestani, D. Schierembergg and A. Cunningham for help with patient recruitment, and H.C. Oettgen and L.-M. Charbonnier for their critical review of the manuscript.	Al-Muhsen S, 2014, ANN THORAC MED, V9, P81, DOI 10.4103/1817-1737.128849; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bhakta NR, 2014, J ALLERGY CLIN IMMUN, V134, P1187, DOI 10.1016/j.jaci.2014.07.034; Blaeser F, 2003, J EXP MED, V198, P1189, DOI 10.1084/jem.20030471; Carrera P, 2001, Methods Mol Biol, V163, P95; Charbonnier LM, 2015, NAT IMMUNOL, V16, P1162, DOI 10.1038/ni.3288; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; Ford AQ, 2009, J IMMUNOL, V183, P1607, DOI 10.4049/jimmunol.0803266; Gour N, 2015, CYTOKINE, V75, P68, DOI 10.1016/j.cyto.2015.05.014; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hoshino A, 2004, INT IMMUNOL, V16, P1497, DOI 10.1093/intimm/dxh151; Hou LF, 2015, J AUTOIMMUN, V65, P56, DOI 10.1016/j.jaut.2015.08.006; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kessels HWHG, 2002, P NATL ACAD SCI USA, V99, P8524, DOI 10.1073/pnas.142224499; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Little S., 2001, CURR PROTOC HUM GENE, V7, P98; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mamessier E, 2008, ALLERGY, V63, P1202, DOI 10.1111/j.1398-9995.2008.01687.x; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Muraro A, 2016, J ALLERGY CLIN IMMUN, V137, P1347, DOI 10.1016/j.jaci.2016.03.010; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Rojas Jose M, 2011, Genes Cancer, V2, P298, DOI 10.1177/1947601911408078; Rosa-Rosa L, 1999, J ALLERGY CLIN IMMUN, V104, P1008, DOI 10.1016/S0091-6749(99)70082-5; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Ryan JJ, 1998, J IMMUNOL, V161, P1811; Saleh A, 2009, J IMMUNOL, V182, P3357, DOI 10.4049/jimmunol.0801882; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Stephenson L, 2004, J IMMUNOL, V173, P4523, DOI 10.4049/jimmunol.173.7.4523; Tachdjian R, 2010, J ALLERGY CLIN IMMUN, V125, P1128, DOI 10.1016/j.jaci.2010.01.054; Tachdjian R, 2009, J EXP MED, V206, P2191, DOI 10.1084/jem.20091480; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Voehringer D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-69; Wang HY, 1999, J IMMUNOL, V162, P4385; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wenzel SE, 2007, AM J RESP CRIT CARE, V175, P570, DOI 10.1164/rccm.200607-909OC; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Xia MC, 2015, J ALLERGY CLIN IMMUN, V136, P441, DOI 10.1016/j.jaci.2015.02.014; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	66	106	111	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1013	+		10.1038/nm.4147	http://dx.doi.org/10.1038/nm.4147			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27479084	Green Submitted, Green Accepted			2022-12-25	WOS:000382542800012
J	Andersson, M; Jia, QP; Abella, A; Lee, XY; Landreh, M; Purhonen, P; Hebert, H; Tenje, M; Robinson, CV; Meng, Q; Plaza, GR; Johansson, J; Rising, A				Andersson, Marlene; Jia, Qiupin; Abella, Ana; Lee, Xiau-Yeen; Landreh, Michael; Purhonen, Pasi; Hebert, Hans; Tenje, Maria; Robinson, Carol V.; Meng, Qing; Plaza, Gustavo R.; Johansson, Jan; Rising, Anna			Biomimetic spinning of artificial spider silk from a chimeric minispidroin	NATURE CHEMICAL BIOLOGY			English	Article							MECHANICAL-PROPERTIES; SECONDARY STRUCTURE; TERMINAL DOMAIN; PROTEIN; FIBERS; PH; DRAGLINE; FLAGELLIFORM; GLAND	Herein we present a chimeric recombinant spider silk protein (spidroin) whose aqueous solubility equals that of native spider silk dope and a spinning device that is based solely on aqueous buffers, shear forces and lowered pH. The process recapitulates the complex molecular mechanisms that dictate native spider silk spinning and is highly efficient; spidroin from one liter of bacterial shake-flask culture is enough to spin a kilometer of the hitherto toughest as-spun artificial spider silk fiber.	[Andersson, Marlene; Johansson, Jan; Rising, Anna] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Jia, Qiupin; Meng, Qing] Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai, Peoples R China; [Abella, Ana; Lee, Xiau-Yeen; Plaza, Gustavo R.] Univ Politecn Madrid, ETSI Caminos, Madrid, Spain; [Abella, Ana; Lee, Xiau-Yeen; Plaza, Gustavo R.] Univ Politecn Madrid, Ctr Biomed Technol, Madrid, Spain; [Landreh, Michael; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford, England; [Purhonen, Pasi; Hebert, Hans] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Purhonen, Pasi; Hebert, Hans] KTH Royal Inst Technol, Sch Technol & Hlth, Stockholm, Sweden; [Tenje, Maria] Uppsala Univ, Dept Engn Sci, SciLifeLab, Uppsala, Sweden; [Tenje, Maria] Lund Univ, Dept Biomed Engn, Lund, Sweden; [Johansson, Jan; Rising, Anna] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden	Swedish University of Agricultural Sciences; Donghua University; Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); University of Oxford; Karolinska Institutet; Royal Institute of Technology; SciLifeLab; Uppsala University; Lund University; Karolinska Institutet	Johansson, J; Rising, A (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.; Johansson, J; Rising, A (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden.	janne.johansson@ki.se; anna.rising@slu.se	Plaza, Gustavo R./E-4455-2012; Tenje, Maria/AAW-5703-2021; Rising, Anna/ABE-8822-2020; Lee, Xiau Yeen/AGH-1491-2022; Tenje, Maria/G-9978-2011	Plaza, Gustavo R./0000-0002-5555-5498; Tenje, Maria/0000-0002-1264-1337; Rising, Anna/0000-0002-1872-1207; Tenje, Maria/0000-0002-1264-1337; Andersson, Marlene/0000-0002-4528-0582; robinson, carol/0000-0001-7829-5505; Johansson, Jan/0000-0002-8719-4703	Chinese Scholarship Council; Swedish Research Council [2014-2408, 2014-10371]; CIMED; FORMAS [2015-629]	Chinese Scholarship Council(China Scholarship Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); CIMED; FORMAS(Swedish Research Council Formas)	We thank L. Holm, the Swedish University of Agricultural Sciences for help with photography, as well as S. Takeuchi and A. Hsiao at the University of Tokyo for introduction into the use of pulled glass capillaries for fiber formation. We also thank F. Palm, Uppsala University, for lending us a microelectrode puller. Q.J. was supported by a stipend from the Chinese Scholarship Council. The Swedish Research Council (grants no. 2014-2408 and 2014-10371 to A.R. and J.J.), CIMED (to J.J.) and FORMAS (2015-629 to A.R.) supported this work.	Adrianos SL, 2013, BIOMACROMOLECULES, V14, P1751, DOI 10.1021/bm400125w; Albertson AE, 2014, J MECH BEHAV BIOMED, V29, P225, DOI 10.1016/j.jmbbm.2013.09.002; Andersson M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001921; Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; Copeland CG, 2015, ACS BIOMATER SCI ENG, V1, P577, DOI 10.1021/acsbiomaterials.5b00092; Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121; Gauthier M, 2014, BIOMACROMOLECULES, V15, P4447, DOI 10.1021/bm501241n; Giesa T, 2016, BIOMACROMOLECULES, V17, P427, DOI 10.1021/acs.biomac.5b01246; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Heidebrecht A, 2015, ADV MATER, V27, P2189, DOI 10.1002/adma.201404234; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; Huang WW, 2014, MACROMOLECULES, V47, P8107, DOI 10.1021/ma5016227; Jiang P, 2014, SCI REP-UK, V4, DOI 10.1038/srep07326; Kronqvist N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4254; Larson JL, 2000, PROTEIN SCI, V9, P427; Lefevre T, 2008, BIOMACROMOLECULES, V9, P2399, DOI 10.1021/bm800390j; Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339; Lin Z, 2013, ADV MATER, V25, P1216, DOI 10.1002/adma.201204357; Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106; Ling SJ, 2011, BIOMACROMOLECULES, V12, P3344, DOI 10.1021/bm2006032; Porter D, 2013, ADV MATER, V25, P1275, DOI 10.1002/adma.201204158; Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Rising A, 2015, NAT CHEM BIOL, V11, P309, DOI [10.1038/NCHEMBIO.1789, 10.1038/nchembio.1789]; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Teule F, 2007, J MATER SCI, V42, P8974, DOI 10.1007/s10853-007-1642-6; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6; Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107; Xu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050227; Zhang HB, 2016, PREP BIOCHEM BIOTECH, V46, P552, DOI 10.1080/10826068.2015.1084637	32	148	154	19	303	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2017	13	3					262	+		10.1038/NCHEMBIO.2269	http://dx.doi.org/10.1038/NCHEMBIO.2269			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL2DY	28068309	Green Submitted			2022-12-25	WOS:000394431500006
J	Park, RJ; Wang, T; Koundakjian, D; Hultquist, JF; Lamothe-Molina, P; Monel, B; Schumann, K; Yu, HY; Krupzcak, KM; Garcia-Beltran, W; Piechocka-Trocha, A; Krogan, NJ; Marson, A; Sabatini, DM; Lander, ES; Hacohen, N; Walker, BD				Park, Ryan J.; Wang, Tim; Koundakjian, Dylan; Hultquist, Judd F.; Lamothe-Molina, Pedro; Monel, Blandine; Schumann, Kathrin; Yu, Haiyan; Krupzcak, Kevin M.; Garcia-Beltran, Wilfredo; Piechocka-Trocha, Alicja; Krogan, Nevan J.; Marson, Alexander; Sabatini, David M.; Lander, Eric S.; Hacohen, Nir; Walker, Bruce D.			A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors	NATURE GENETICS			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ADHESION MOLECULE; CELL-ADHESION; T-CELLS; ANTIRETROVIRAL THERAPY; TYROSINE SULFATION; TYROSYLPROTEIN SULFOTRANSFERASES; GP120 BINDING; EARLY-STAGE; REPLICATION	Host proteins are essential for HIV entry and replication and can be important nonviral therapeutic targets. Large-scale RNA interference (RNAi)-based screens have identified nearly a thousand candidate host factors, but there is little agreement among studies and few factors have been validated. Here we demonstrate that a genome-wide CRISPR-based screen identifies host factors in a physiologically relevant cell system. We identify five factors, including the HIV co-receptors CD4 and CCR5, that are required for HIV infection yet are dispensable for cellular proliferation and viability. Tyrosylprotein sulfotransferase 2 (TPST2) and solute carrier family 35 member B2 (SLC3562) function in a common pathway to sulfate CCR5 on extracellular tyrosine residues, facilitating CCR5 recognition by the HIV envelope. Activated leukocyte cell adhesion molecule (ALCAM) mediates cell aggregation, which is required for cell-to-cell HIV transmission. We validated these pathways in primary human CD4(+) T cells through Cas9-mediated knockout and antibody blockade. Our findings indicate that HIV infection and replication rely on a limited set of host-dispensable genes and suggest that these pathways can be studied for therapeutic intervention.	[Park, Ryan J.; Koundakjian, Dylan; Lamothe-Molina, Pedro; Monel, Blandine; Garcia-Beltran, Wilfredo; Piechocka-Trocha, Alicja; Walker, Bruce D.] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Park, Ryan J.; Koundakjian, Dylan; Lamothe-Molina, Pedro; Monel, Blandine; Garcia-Beltran, Wilfredo; Piechocka-Trocha, Alicja; Walker, Bruce D.] Harvard Univ, Cambridge, MA 02138 USA; [Park, Ryan J.; Garcia-Beltran, Wilfredo] Harvard Med Sch, Harvard MIT Hlth Sci & Technol, Boston, MA 02115 USA; [Park, Ryan J.; Wang, Tim; Yu, Haiyan; Sabatini, David M.; Lander, Eric S.; Hacohen, Nir; Walker, Bruce D.] Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA; [Wang, Tim; Sabatini, David M.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wang, Tim; Krupzcak, Kevin M.; Sabatini, David M.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Wang, Tim; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hultquist, Judd F.; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; [Hultquist, Judd F.; Marson, Alexander] J David Gladstone Inst, Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Lamothe-Molina, Pedro] Harvard TH Chan Sch Publ Hlth, Biol Sci Publ Hlth, Boston, MA 02115 USA; [Monel, Blandine; Walker, Bruce D.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Monel, Blandine; Walker, Bruce D.] Harvard Med Sch, Boston, MA 02115 USA; [Schumann, Kathrin; Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Marson, Alexander] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Walker, Bruce D.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Walker, BD (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Walker, BD (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.; Sabatini, DM; Lander, ES; Hacohen, N; Walker, BD (corresponding author), Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA.; Sabatini, DM; Lander, ES (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Walker, BD (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.; Walker, BD (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Sabatini, DM (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA.; Lander, ES (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Hacohen, N (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.; Walker, BD (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sabatini@wi.mit.edu; lander@broadinstitute.org; nhacohen@mgh.harvard.edu; bwalker@mgh.harvard.edu	Schumann, Kathrin/HHZ-8041-2022	Park, Ryan/0000-0003-4725-2937; Schumann, Kathrin/0000-0002-0993-3910; Wang, Timothy/0000-0001-5730-3019; Koundakjian, Dylan/0000-0002-5921-2337; /0000-0002-1446-7256; Hultquist, Judd/0000-0001-6424-4280; Lamothe, Pedro/0000-0001-9262-2920; Monel, Blandine/0000-0002-6096-873X	Howard Hughes Medical Institute; National Institutes of Health [CA103866, F31 CA189437, P50 GM082250, U19 AI106754, P01 AI090935]; National Human Genome Research Institute [2U54HG003067-10]; National Science Foundation; MIT Whitaker Health Sciences Fund; UCSF Sandler Fellowship; UCSF MPHD T32 Training Grant; Deutsche Forschungsgemeinschaft [SCHU3020/2-1]; NIH [P30 AI027763, P30 AI060354]; Harvard University Center for AIDS Research [P30 AI060354]; NIH; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; OAR; NATIONAL CANCER INSTITUTE [F31CA189437, R01CA103866] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537, P30AI027763, P01AI090935, F31AI116366, U19AI106754, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250, T32GM007753] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); MIT Whitaker Health Sciences Fund; UCSF Sandler Fellowship; UCSF MPHD T32 Training Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC; OAR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the Ragon Institute Virology, Imaging, and Flow Cytometry cores, as well as the Center for Computational and Integrative Biology (CCIB) DNA Core Facility at Massachusetts General Hospital. We would like to thank A. McKeon, P. Jani, N.W. Hughes, and B.X. Liu for superb technical assistance, and A. Brass, G. Gaiha, and J.S. Park for helpful discussions. pMM310 was obtained through the AIDS Reagent Program, Division of AIDS, NIAID, NIH from M. Miller (Merck Research Laboratories). All plasmid reagents generated in this study have been deposited in Addgene. This work was supported by the Howard Hughes Medical Institute (D.M.S. and B.D.W.), the National Institutes of Health (grants CA103866 (D.M.S.), F31 CA189437 (T.W.), P50 GM082250 (A.M. and N.J.K.), U19 AI106754 (J.F.H. and N.J.K.), and P01 AI090935 (N.J.K.)), the National Human Genome Research Institute (grant 2U54HG003067-10; E.S.L.), the National Science Foundation (T.W.), the MIT Whitaker Health Sciences Fund(T.W.), the UCSF Sandler Fellowship(A.M.), a gift from J. Aronov (A.M.), the UCSF MPHD T32 Training Grant (J.F.H.), and the Deutsche Forschungsgemeinschaft (grant SCHU3020/2-1; KS.). Support was also provided by NIH-funded Centers for AIDS Research (grant P30 AI027763, UCSF Center for AIDS Research (N.J.K.) and grant P30 AI060354, Harvard University Center for AIDS Research (B.D.W.)), which are supported by the following NIH co-funding and participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, and OAR. D.M.S. and B.D.W. are investigators of the Howard Hughes Medical Institute. R.J.P. is a Howard Hughes Medical Institute Research Fellow.	Agosto LM, 2015, TRENDS MICROBIOL, V23, P289, DOI 10.1016/j.tim.2015.02.003; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/nmeth.1330, 10.1038/NMETH.1330]; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Connell BJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00385; Desfosses Y, 2005, J VIROL, V79, P9180, DOI 10.1128/JVI.79.14.9180-9191.2005; Ding ZM, 1999, J IMMUNOL, V163, P5029; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Egan ES, 2015, SCIENCE, V348, P711, DOI 10.1126/science.aaa3526; Eri R, 2004, GENES IMMUN, V5, P444, DOI 10.1038/sj.gene.6364113; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Friedrich BM, 2011, VIRUS RES, V161, P101, DOI 10.1016/j.virusres.2011.08.001; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Gartner ZJ, 2009, P NATL ACAD SCI USA, V106, P4606, DOI 10.1073/pnas.0900717106; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hommel M, 2003, J EXP MED, V197, P269, DOI 10.1084/jem.20021512; Hourmant M, 1996, TRANSPLANTATION, V62, P1565, DOI 10.1097/00007890-199612150-00006; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; INABA K, 1984, J EXP MED, V160, P858, DOI 10.1084/jem.160.3.858; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Iolyeva M, 2013, FASEB J, V27, P978, DOI 10.1096/fj.12-217844; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Kajumo F, 2000, VIROLOGY, V271, P240, DOI 10.1006/viro.2000.0308; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lai MMC, 1998, VIROLOGY, V244, P1, DOI 10.1006/viro.1998.9098; Lin G, 2003, J VIROL, V77, P931, DOI 10.1128/JVI.77.2.931-942.2003; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Rolando M, 2014, TRENDS CELL BIOL, V24, P771, DOI 10.1016/j.tcb.2014.06.002; Rosmarin DM, 2012, P NATL ACAD SCI USA, V109, P10059, DOI 10.1073/pnas.1120244109; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Santangelo PJ, 2015, NAT METHODS, V12, P427, DOI [10.1038/NMETH.3320, 10.1038/nmeth.3320]; Sasaki N, 2007, MOL ENDOCRINOL, V21, P1713, DOI 10.1210/me.2007-0040; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Seibert C, 2002, P NATL ACAD SCI USA, V99, P11031, DOI 10.1073/pnas.172380899; Seibert C, 2008, BIOCHEMISTRY-US, V47, P11251, DOI 10.1021/bi800965m; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Singh H, 2008, ONCOL RES, V17, P87, DOI 10.3727/096504008784523667; Singh PK, 2015, GENE DEV, V29, P2287, DOI 10.1101/gad.267609.115; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Sowd GA, 2016, P NATL ACAD SCI USA, V113, pE1054, DOI 10.1073/pnas.1524213113; Srivastava A, 2008, SCAND J IMMUNOL, V67, P516, DOI 10.1111/j.1365-3083.2008.02097.x; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; te Riet J, 2014, J CELL SCI, V127, P1595, DOI 10.1242/jcs.141077; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Williams DW, 2015, J LEUKOCYTE BIOL, V97, P401, DOI 10.1189/jlb.5A0714-347R; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhu J, 2014, CELL REP, V9, P752, DOI 10.1016/j.celrep.2014.09.031; Zumwalde NA, 2013, J IMMUNOL, V191, P3681, DOI 10.4049/jimmunol.1201954	69	189	195	6	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					193	203		10.1038/ng.3741	http://dx.doi.org/10.1038/ng.3741			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27992415	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000393148600008
J	Zheng, HQ; Colvin, CJ; Johnson, BK; Kirchhoff, PD; Wilson, M; Jorgensen-Muga, K; Larsen, SD; Abramovitch, RB				Zheng, Huiqing; Colvin, Christopher J.; Johnson, Benjamin K.; Kirchhoff, Paul D.; Wilson, Michael; Jorgensen-Muga, Katriana; Larsen, Scott D.; Abramovitch, Robert B.			Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence	NATURE CHEMICAL BIOLOGY			English	Article							ANTIMALARIAL-DRUG ARTEMISININ; HYPOXIC RESPONSE; ATP HOMEOSTASIS; DORMANCY; HEME; DOSS; VIRULENCE; SENSOR; REGULON; HEMOGLOBIN	The Mycobacterium tuberculosis (Mtb) DosRST two-component regulatory system promotes the survival of Mtb during non-replicating persistence (NRP). NRP bacteria help drive the long course of tuberculosis therapy; therefore, chemical inhibition of DosRST may inhibit the ability of Mtb to establish persistence and thus shorten treatment. Using a DosRST-dependent fluorescent Mtb reporter strain, a whole-cell phenotypic high-throughput screen of a -540,000 compound small-molecule library was conducted. The screen discovered novel inhibitors of the DosRST regulon, including three compounds that were subject to follow-up studies: artemisinin, HC102A and HC103A. Under hypoxia, all three compounds inhibit Mtb-persistence-associated physiological processes, including triacylglycerol synthesis, survival and antibiotic tolerance. Artemisinin functions by disabling the heme-based DosS and DosT sensor kinases by oxidizing ferrous heme and generating heme-artemisinin adducts. In contrast, HC103A inhibits DosS and DosT autophosphorylation activity without targeting the sensor kinase heme.	[Zheng, Huiqing; Colvin, Christopher J.; Johnson, Benjamin K.; Abramovitch, Robert B.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Kirchhoff, Paul D.; Wilson, Michael; Larsen, Scott D.] Univ Michigan, Coll Pharm, Vahlteich Med Chem Core, 428 Church St, Ann Arbor, MI 48109 USA; [Jorgensen-Muga, Katriana] Sweet Briar Coll, Sweet Briar, VA 24595 USA	Michigan State University; University of Michigan System; University of Michigan	Abramovitch, RB (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	abramov5@msu.edu	Abramovitch, Robert/O-6798-2019	Abramovitch, Robert/0000-0002-4119-4169	New England Regional Center of Excellence [U54 AI057159]; Institute of Chemistry and Cell Biology (ICCB) at Harvard Medical School; Ella and Hans Vahlteich Fund; Beverly Vahlteich Delaney; Michigan State University and AgBioResearch; NIH-NIAID [R21A1105867]; Grand Challenges Explorations awards from the Bill & Melinda Gates Foundation [OPP1059227, OPP1119065]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R21AI105867] Funding Source: NIH RePORTER	New England Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institute of Chemistry and Cell Biology (ICCB) at Harvard Medical School; Ella and Hans Vahlteich Fund; Beverly Vahlteich Delaney; Michigan State University and AgBioResearch; NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grand Challenges Explorations awards from the Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	High-throughput screening libraries and their preparation was supported by the New England Regional Center of Excellence (U54 AI057159) and the Institute of Chemistry and Cell Biology (ICCB) at Harvard Medical School. M. Farrugia and B. Hausinger provided support with the UV-visible spectroscopy experiments. The MSU RTSF provided technical support for the RNA-seq library preparation and sequencing. The Vahlteich Medicinal Chemistry Core is grateful for ongoing support from the Ella and Hans Vahlteich Fund and Beverly Vahlteich Delaney. We thank members of the Abramovitch lab for critical reading of the manuscript. This project was supported by start-up funding from Michigan State University and AgBioResearch, a grant from the NIH-NIAID (R21A1105867), and Grand Challenges Explorations awards (OPP1059227 and OPP1119065) from the Bill & Melinda Gates Foundation.	Anthouard R, 2013, MBIO, V4, DOI 10.1128/mBio.00403-13; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Baker JJ, 2014, MOL MICROBIOL, V94, P56, DOI 10.1111/mmi.12688; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Cho HY, 2011, FEBS LETT, V585, P1873, DOI 10.1016/j.febslet.2011.04.050; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gautam US, 2015, AM J RESP CELL MOL, V52, P708, DOI 10.1165/rcmb.2014-0230OC; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gupta RK, 2009, J MED CHEM, V52, P6324, DOI 10.1021/jm900358q; Honaker RW, 2009, INFECT IMMUN, V77, P3258, DOI 10.1128/IAI.01449-08; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Ioanoviciu A, 2009, BIOCHEMISTRY-US, V48, P5839, DOI 10.1021/bi802309y; Johnson BK, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0923-y; Johnson BK, 2015, ANTIMICROB AGENTS CH, V59, P4436, DOI 10.1128/AAC.00719-15; Kim MJ, 2010, J BACTERIOL, V192, P4868, DOI 10.1128/JB.00550-10; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Krishna S, 2008, TRENDS PHARMACOL SCI, V29, P520, DOI 10.1016/j.tips.2008.07.004; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Li W, 2014, ANTIMICROB AGENTS CH, V58, P6413, DOI 10.1128/AAC.03229-14; Mak PA, 2012, ACS CHEM BIOL, V7, P1190, DOI 10.1021/cb2004884; Mehra S, 2015, AM J RESP CRIT CARE, V191, P1185, DOI 10.1164/rccm.201408-1502OC; Messori L, 2006, BIOORGAN MED CHEM, V14, P2972, DOI 10.1016/j.bmc.2005.12.038; Miller MJ, 2011, J AM CHEM SOC, V133, P2076, DOI 10.1021/ja109665t; Ng WL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002767; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Robert A, 2002, CHEM COMMUN, P414, DOI 10.1039/b110817b; Robert A, 2002, ACCOUNTS CHEM RES, V35, P167, DOI 10.1021/ar990164o; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rybniker J, 2014, CELL HOST MICROBE, V16, P538, DOI 10.1016/j.chom.2014.09.008; Selmeczi K, 2004, FEBS LETT, V556, P245, DOI 10.1016/S0014-5793(03)01448-0; Sivaramakrishnan S, 2013, BIOSENSORS-BASEL, V3, P259, DOI 10.3390/bios3030259; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; Tan SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003282; Taneja NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010860; VanderVen BC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004679; Vos MH, 2012, BIOCHEMISTRY-US, V51, P159, DOI 10.1021/bi201467c; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Zhang SM, 2008, BIOORGAN MED CHEM, V16, P7853, DOI 10.1016/j.bmc.2008.02.034	49	89	92	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2017	13	2					218	225		10.1038/NCHEMBIO.2259	http://dx.doi.org/10.1038/NCHEMBIO.2259			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ9FW	27992879				2022-12-25	WOS:000393533000018
J	Chun, SK; Du, F; Westmoreland, JJ; Han, SB; Wang, YD; Eddins, D; Bayazitov, IT; Devaraju, P; Yu, J; Lagarde, MMM; Anderson, K; Zakharenko, SS				Chun, Sungkun; Du, Fei; Westmoreland, Joby J.; Han, Seung Baek; Wang, Yong-Dong; Eddins, Donnie; Bayazitov, Ildar T.; Devaraju, Prakash; Yu, Jing; Lagarde, Marcia M. Mellado; Anderson, Kara; Zakharenko, Stanislav S.			Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion	NATURE MEDICINE			English	Article							CARDIO-FACIAL SYNDROME; PREPULSE INHIBITION; DELETION SYNDROME; PSYCHIATRIC-DISORDERS; SCHIZOPHRENIA; DOPAMINE; HALLUCINATIONS; DYSFUNCTION; ADULTS; BRAIN	Although 22q11.2 deletion syndrome (22q11DS) is associated with early-life behavioral abnormalities, affected individuals are also at high risk for the development of schizophrenia symptoms, including psychosis, later in life. Auditory thalamocortical (TC) projections recently emerged as a neural circuit that is specifically disrupted in mouse models of 22q11DS (hereafter referred to as 22q11DS mice), in which haploinsufficiency of the microRNA (miRNA)-processing-factor-encoding gene Dgcr8 results in the elevation of the dopamine receptor Drd2 in the auditory thalamus, an abnormal sensitivity of thalamocortical projections to antipsychotics, and an abnormal acoustic-startle response. Here we show that these auditory TC phenotypes have a delayed onset in 22q11DS mice and are associated with an age-dependent reduction of miR-338-3p, a miRNA that targets Drd2 and is enriched in the thalamus of both humans and mice. Replenishing depleted miR-338-3p in mature 22q11DS mice rescued the TC abnormalities, and deletion of Mir338 (which encodes miR-338-3p) or reduction of miR-338-3p expression mimicked the TC and behavioral deficits and eliminated the age dependence of these deficits. Therefore, miR-338-3p depletion is necessary and sufficient to disrupt auditory TC signaling in 22q11DS mice, and it may mediate the pathogenic mechanism of 22q11DS-related psychosis and control its late onset.	[Chun, Sungkun; Du, Fei; Westmoreland, Joby J.; Han, Seung Baek; Eddins, Donnie; Bayazitov, Ildar T.; Devaraju, Prakash; Yu, Jing; Lagarde, Marcia M. Mellado; Anderson, Kara; Zakharenko, Stanislav S.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Wang, Yong-Dong] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Chun, Sungkun; Du, Fei; Westmoreland, Joby J.] Chonbuk Natl Univ, Sch Med, Dept Physiol, Jeonju, South Korea; [Chun, Sungkun; Du, Fei; Westmoreland, Joby J.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Chun, Sungkun; Du, Fei; Westmoreland, Joby J.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Jeonbuk National University; Harvard University; Brigham & Women's Hospital; Tulane University	Zakharenko, SS (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA.	stanislav.zakharenko@stjude.org	Zakharenko, Stanislav/D-3287-2013; Chun, Sungkun/R-1614-2016	Zakharenko, Stanislav/0000-0001-8115-202X; Chun, Sungkun/0000-0001-9837-2299; Han, Seung Baek/0000-0002-9798-0679; Devaraju, Prakash/0000-0002-9744-0488	National Institutes of Health [MH097742, DC012833, MH095810]; NARSAD Independent Investigator Award; ALSAC; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097742, R01MH095810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Independent Investigator Award(NARSAD); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health grants MH097742 (S.S.Z.), DC012833 (S.S.Z.), and MH095810 (S.S.Z.), the NARSAD Independent Investigator Award (S.S.Z.), and ALSAC (S.S.Z.). The funding sources had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript. We thank the St. Jude Vector Core for producing the AAVs, the St. Jude Hartwell Center for Biotechnology and Bioinformatics for performing the microarrays, the Maryland Brain Collection for providing post-mortem human brain samples, and A. McArthur for editing the manuscript. Knockout mice, viruses and other materials described in this manuscript can be obtained through a material transfer agreement.	Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; ALMEIDA OP, 1995, BRIT J PSYCHIAT, V166, P205, DOI 10.1192/bjp.166.2.205; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039; Bassett AS, 2000, AM J MED GENET, V97, P45, DOI 10.1002/(SICI)1096-8628(200021)97:1<45::AID-AJMG6>3.0.CO;2-9; Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; Bassett AS, 2003, AM J PSYCHIAT, V160, P1580, DOI 10.1176/appi.ajp.160.9.1580; Bauer SM, 2011, COMPR PSYCHIAT, V52, P319, DOI 10.1016/j.comppsych.2010.06.008; Behrendt RP, 2003, CONSCIOUS COGN, V12, P413, DOI 10.1016/S1053-8100(03)00017-5; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179, DOI 10.1016/0893-133X(88)90012-7; Chow EWC, 2006, SCHIZOPHR RES, V87, P270, DOI 10.1016/j.schres.2006.04.007; Chun S, 2014, SCIENCE, V344, P1178, DOI 10.1126/science.1253895; Chun SK, 2013, J NEUROSCI, V33, P7345, DOI 10.1523/JNEUROSCI.4500-12.2013; Clinton SM, 2004, SCHIZOPHR RES, V69, P237, DOI 10.1016/j.schres.2003.09.017; Conn PJ, 2008, MOL INTERV, V8, P99, DOI 10.1124/mi.8.2.7; Cronenwett WJ, 2010, CURR TOP BEHAV NEURO, V4, P509, DOI 10.1007/7854_2010_55; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Earls LR, 2014, NEUROSCIENTIST, V20, P257, DOI 10.1177/1073858413498307; Earls LR, 2012, J NEUROSCI, V32, P14132, DOI 10.1523/JNEUROSCI.1312-12.2012; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; Feinstein C, 2002, BIOL PSYCHIAT, V51, P312, DOI 10.1016/S0006-3223(01)01231-8; Flurkey K, 2007, FACULTY RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Fung WLA, 2010, AM J PSYCHIAT, V167, P998, DOI 10.1176/appi.ajp.2010.09101463; Gothelf D, 1999, SCHIZOPHR RES, V35, P105, DOI 10.1016/S0920-9964(98)00114-5; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Horga G, 2014, J NEUROSCI, V34, P8072, DOI 10.1523/JNEUROSCI.0200-14.2014; Javitt DC, 2015, NAT REV NEUROSCI, V16, P535, DOI 10.1038/nrn4002; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; OKE AF, 1988, BIOL PSYCHIAT, V24, P79, DOI 10.1016/0006-3223(88)90123-0; Pulver AE, 2000, BIOL PSYCHIAT, V47, P221; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; SHPRINTZEN RJ, 1992, AM J MED GENET, V42, P141, DOI 10.1002/ajmg.1320420131; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; Sobin C, 2005, MOL PSYCHIATR, V10, P553, DOI 10.1038/sj.mp.4001609; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; Thaker GK, 2001, NAT MED, V7, P667, DOI 10.1038/89040; Vorstman JAS, 2013, SCHIZOPHR RES, V143, P55, DOI 10.1016/j.schres.2012.10.010; Welsh R.C., 2010, SCHIZOPHR B, V36, P713; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; Woo Peter Ym, 2014, J Med Case Rep, V8, P400, DOI 10.1186/1752-1947-8-400; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Zhang JH, 1999, PSYCHOPHARMACOLOGY, V141, P189, DOI 10.1007/s002130050824	60	36	37	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					39	48		10.1038/nm.4240	http://dx.doi.org/10.1038/nm.4240			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27892953	Green Accepted			2022-12-25	WOS:000391646800012
J	Costa, G; Harrington, KI; Lovegrove, HE; Page, DJ; Chakravartula, S; Bentley, K; Herbert, SP				Costa, Guilherme; Harrington, Kyle I.; Lovegrove, Holly E.; Page, Donna J.; Chakravartula, Shilpa; Bentley, Katie; Herbert, Shane P.			Asymmetric division coordinates collective cell migration in angiogenesis	NATURE CELL BIOLOGY			English	Article							ENDOTHELIAL-CELLS; EXPRESSION; VEGFR3; ERK; MORPHOGENESIS; MECHANISMS; FILOPODIA; VESSELS	The asymmetric division of stem or progenitor cells generates daughters with distinct fates and regulates cell diversity during tissue morphogenesis. However, roles for asymmetric division in other more dynamic morphogenetic processes, such as cell migration, have not previously been described. Here we combine zebrafish in vivo experimental and computational approaches to reveal that heterogeneity introduced by asymmetric division generates multicellular polarity that drives coordinated collective cell migration in angiogenesis. We find that asymmetric positioning of the mitotic spindle during endothelial tip cell division generates daughters of distinct size with discrete 'tip' or 'stalk' thresholds of pro-migratory Vegfr signalling. Consequently, post-mitotic Vegfr asymmetry drives Dll4/Notch-independent self-organization of daughters into leading tip or trailing stalk cells, and disruption of asymmetry randomizes daughter tip/stalk selection. Thus, asymmetric division seamlessly integrates cell proliferation with collective migration, and, as such, may facilitate growth of other collectively migrating tissues during development, regeneration and cancer invasion.	[Costa, Guilherme; Lovegrove, Holly E.; Page, Donna J.; Herbert, Shane P.] Univ Manchester, Fac Biol Med & Hlth, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Harrington, Kyle I.; Chakravartula, Shilpa; Bentley, Katie] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Computat Biol Lab, Boston, MA 02215 USA; [Bentley, Katie] Uppsala Univ, Immunol Genet & Pathol Dept, S-75185 Uppsala, Sweden	University of Manchester; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Uppsala University	Herbert, SP (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	shane.herbert@manchester.ac.uk		Herbert, Shane/0000-0003-2517-1845; Bentley, Katie/0000-0002-9391-659X; Costa, Guilherme/0000-0003-2313-3319	BBSRC [BB/N013174/1]; BHF [PG/16/2/31863]; BIDMC; NSF [1517390]; NHLBI of the NIH [T32 HL07893]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007893] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/N013174/1, 1200431] Funding Source: researchfish; British Heart Foundation [PG/16/2/31863] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BHF(British Heart Foundation); BIDMC; NSF(National Science Foundation (NSF)); NHLBI of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	We thank B. M. Hogan and N. D. Lawson for advice regarding the pErk staining protocol, and B. Plusa, M. Baron, K. Dorey, T. Millard and C. Thompson for critical reading of the manuscript. S.P.H. is a Wellcome Trust Research Career Development Fellow (Ref: 095718/Z/11/Z) and is funded by the BBSRC (Ref. BB/N013174/1) and BHF (PG/16/2/31863). K.B. is funded by BIDMC and NSF (Ref. 1517390). K.I.H. is supported by institutional training grant T32 HL07893 from the NHLBI of the NIH. S.C. is funded by NSF (Ref. 1517390).	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Arima S, 2011, DEVELOPMENT, V138, P4763, DOI 10.1242/dev.068023; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Aydogan V, 2015, BIOL OPEN, V4, P1259, DOI 10.1242/bio.012740; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Bentley K., 2014, ALIFE; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Bussmann J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000064; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Fielding AB, 2012, P NATL ACAD SCI USA, V109, P6572, DOI 10.1073/pnas.1117401109; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fukuhara S, 2014, DEV BIOL, V393, P10, DOI 10.1016/j.ydbio.2014.06.015; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Herbert SP, 2012, CURR BIOL, V22, P1789, DOI 10.1016/j.cub.2012.07.037; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Horowitz A, 2012, CELL SIGNAL, V24, P1810, DOI 10.1016/j.cellsig.2012.05.007; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Koltowska K, 2015, CELL REP, V13, P1828, DOI 10.1016/j.celrep.2015.10.055; Le Guen L, 2014, DEVELOPMENT, V141, P1239, DOI 10.1242/dev.100495; Li R, 2013, DEV CELL, V25, P439, DOI 10.1016/j.devcel.2013.05.003; Matsuda M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7195; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Meissner M, 2008, J INVEST DERMATOL, V128, P2084, DOI 10.1038/jid.2008.37; Meissner M, 2009, CANCER RES, V69, P1976, DOI 10.1158/0008-5472.CAN-08-3150; Murakami M, 2011, J CLIN INVEST, V121, P2668, DOI 10.1172/JCI44762; Nagasawa-Masuda A., 2016, GENES CELLS; Nicenboim J, 2015, NATURE, V522, P56, DOI 10.1038/nature14425; Phng LK, 2013, DEVELOPMENT, V140, P4031, DOI 10.1242/dev.097352; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sauteur L, 2014, CELL REP, V9, P504, DOI 10.1016/j.celrep.2014.09.024; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Shin M, 2016, DEVELOPMENT, V143, P3785, DOI 10.1242/dev.137901; Shin M, 2016, DEVELOPMENT, V143, P3796, DOI 10.1242/dev.137919; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Steketee MB, 2002, J NEUROSCI, V22, P8071; Villefranc JA, 2013, DEVELOPMENT, V140, P1497, DOI 10.1242/dev.084152; Zarkada G, 2015, P NATL ACAD SCI USA, V112, P761, DOI 10.1073/pnas.1423278112; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	48	59	59	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2016	18	12					1292	+		10.1038/ncb3443	http://dx.doi.org/10.1038/ncb3443			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	ED8PY	27870831	Green Accepted, Green Submitted			2022-12-25	WOS:000389134600007
J	Hao, JJ; Lin, DC; Dinh, HQ; Mayakonda, A; Jiang, YY; Chang, C; Jiang, Y; Lu, CC; Shi, ZZ; Xu, X; Zhang, Y; Cai, Y; Wang, JW; Zhan, QM; Wei, WQ; Berrnan, BP; Wang, MR; Koeffler, HP				Hao, Jia-Jie; Lin, De-Chen; Dinh, Huy Q.; Mayakonda, Anand; Jiang, Yan-Yi; Chang, Chen; Jiang, Ye; Lu, Chen-Chen; Shi, Zhi-Zhou; Xu, Xin; Zhang, Yu; Cai, Yan; Wang, Jin-Wu; Zhan, Qi-Min; Wei, Wen-Qiang; Berrnan, Benjamin P.; Wang, Ming-Rong; Koeffler, H. Phillip			Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma	NATURE GENETICS			English	Article							CPG ISLAND SHORES; DNA METHYLATION; TUMOR-SUPPRESSOR; CANCER EVOLUTION; MUTATIONAL PROCESSES; COLORECTAL-CANCER; HYPERMETHYLATION; EPIGENOME; GENES; ADENOCARCINOMA	Esophageal squamous cell carcinoma (ESCC) is among the most common malignancies, but little is known about its spatial intratumoral heterogeneity (ITH) and temporal clonal evolutionary processes. To address this, we performed multiregion whole-exome sequencing on 51 tumor regions from 13 ESCC cases and multiregion global methylation profiling for 3 of these 13 cases. We found an average of 35.8% heterogeneous somatic mutations with strong evidence of ITH. Half of the driver mutations located on the branches of tumor phylogenetic trees targeted oncogenes, including PIK3CA, NFE2L2 and MTOR, among others. By contrast, the majority of truncal and clonal driver mutations occurred in tumor-suppressor genes, including TP53, KMT2D and ZNF750, among others. Interestingly, phyloepigenetic trees robustly recapitulated the topological structures of the phylogenetic trees, indicating a possible relationship between genetic and epigenetic alterations. Our integrated investigations of spatial ITH and clonal evolution provide an important molecular foundation for enhanced understanding of tumorigenesis and progression in ESCC.	[Hao, Jia-Jie; Chang, Chen; Jiang, Ye; Lu, Chen-Chen; Xu, Xin; Zhang, Yu; Cai, Yan; Zhan, Qi-Min; Wang, Ming-Rong] Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, State Key Lab Mol Oncol, Beijing, Peoples R China; [Hao, Jia-Jie; Chang, Chen; Jiang, Ye; Lu, Chen-Chen; Xu, Xin; Zhang, Yu; Cai, Yan; Zhan, Qi-Min; Wei, Wen-Qiang; Wang, Ming-Rong] Peking Union Med Coll, Beijing, Peoples R China; [Lin, De-Chen; Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA; [Lin, De-Chen] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China; [Dinh, Huy Q.; Berrnan, Benjamin P.] Cedars Sinai Med Ctr, Biomed Sci, Ctr Bioinformat & Funct Genom, Los Angeles, CA 90048 USA; [Mayakonda, Anand; Jiang, Yan-Yi; Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Shi, Zhi-Zhou] Kunming Univ Sci & Technol, Fac Med, Kunming, Peoples R China; [Wang, Jin-Wu] Linzhou Canc Hosp, Dept Pathol, Linzhou, Henan, Peoples R China; [Wei, Wen-Qiang] Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Dept Canc Epidemiol, Beijing, Peoples R China; [Koeffler, H. Phillip] Natl Univ Singapore, Inst Canc, Natl Univ Singapore Hosp, Singapore, Singapore	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Sun Yat Sen University; Cedars Sinai Medical Center; National University of Singapore; Kunming University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; National University of Singapore	Wang, MR (corresponding author), Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, State Key Lab Mol Oncol, Beijing, Peoples R China.; Wei, WQ; Wang, MR (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Lin, DC (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA.; Lin, DC (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China.; Berrnan, BP (corresponding author), Cedars Sinai Med Ctr, Biomed Sci, Ctr Bioinformat & Funct Genom, Los Angeles, CA 90048 USA.; Wei, WQ (corresponding author), Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Dept Canc Epidemiol, Beijing, Peoples R China.	dchlinll@gmail.com; weiwq2006@126.com; benjamin.berman@csmc.edu; wangmr2015@126.com	BERMAN, BENJAMIN/AAT-3720-2021; Berman, Benjamin P/D-5942-2014; Dinh, Huy/M-8646-2016	BERMAN, BENJAMIN/0000-0002-2099-9005; Berman, Benjamin P/0000-0002-2099-9005; Dinh, Huy/0000-0002-3307-1126; WANG, Ming-Rong/0000-0002-8767-9356; Mayakonda, Anand/0000-0003-1162-687X	Singapore Ministry of Health's National Medical Research Council (NMRC) through its Singapore Translational Research (STaR) Investigator Award; NMRC Individual Research Grant [NMRC/1311/2011]; NMRC Centre Grant; National Research Foundation Singapore; Singapore Ministry of Education under its Research Centres of Excellence initiatives; American Society of Hematology Fellow Scholar Award; National Natural Science Foundation of China [81672786, 81330052, 81520108023, 81321091]; National Center for Advancing Translational Sciences UCLA CTSI Grant [UL1TR000124]; Beijing Natural Science Foundation [7151008]; NIH/NCI grant [1U01CA184826]; NATIONAL CANCER INSTITUTE [U01CA184826] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	Singapore Ministry of Health's National Medical Research Council (NMRC) through its Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NMRC Individual Research Grant; NMRC Centre Grant(National Medical Research Council, Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under its Research Centres of Excellence initiatives(Ministry of Education, Singapore); American Society of Hematology Fellow Scholar Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Advancing Translational Sciences UCLA CTSI Grant; Beijing Natural Science Foundation(Beijing Natural Science Foundation); NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank H. Shen and D. Weisenberger as well as A.D. Jeyasekharan for their kind help on analysis and discussion. This work was funded by the Singapore Ministry of Health's National Medical Research Council (NMRC) through its Singapore Translational Research (STaR) Investigator Award to H.P.K., an NMRC Individual Research Grant (NMRC/1311/2011) and the NMRC Centre Grant awarded to the National University Cancer Institute of Singapore, the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centres of Excellence initiatives to H.P.K. D.-C.L. was supported by the American Society of Hematology Fellow Scholar Award, the National Natural Science Foundation of China (81672786) and National Center for Advancing Translational Sciences UCLA CTSI Grant UL1TR000124. M.-R.W. was supported by the National Natural Science Foundation of China (81330052, 81520108023 and 81321091). Y.Z. was supported by the Beijing Natural Science Foundation (7151008). This study was partially supported by a generous donation from the Melamed family and NIH/NCI grant 1U01CA184826 as well as institutional support from the Samuel Oschin Comprehensive Cancer Institute to B.P.B. and H.Q.D.	Agarwal R, 2012, ENDOCR-RELAT CANCER, V19, pL5, DOI 10.1530/ERC-11-0364; Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Brocks D, 2014, CELL REP, V8, P798, DOI 10.1016/j.celrep.2014.06.053; Cao W, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.34; Cheng CX, 2016, AM J HUM GENET, V98, P256, DOI 10.1016/j.ajhg.2015.12.013; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Gerlinger M, 2014, ANNU REV GENET, V48, P215, DOI 10.1146/annurev-genet-120213-092314; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gharwan H, 2016, NAT REV CLIN ONCOL, V13, P209, DOI 10.1038/nrclinonc.2015.213; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jao TM, 2014, INT J CANCER, V135, P2593, DOI 10.1002/ijc.28899; Kiehl S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06899; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lay FD, 2015, GENOME RES, V25, P467, DOI 10.1101/gr.183368.114; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Lopez-Nieva P, 2012, CARCINOGENESIS, V33, P452, DOI 10.1093/carcin/bgr271; Lu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088918; Luo ML, 2006, CANCER RES, V66, P11690, DOI 10.1158/0008-5472.CAN-06-1484; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Mercier PL, 2011, MOL ONCOL, V5, P438, DOI 10.1016/j.molonc.2011.07.003; Murugaesu N, 2015, CANCER DISCOV, V5, P821, DOI 10.1158/2159-8290.CD-15-0412; Narayan G, 2013, GENE CHROMOSOME CANC, V52, P1030, DOI 10.1002/gcc.22098; Oricchio E, 2011, CELL, V147, P554, DOI 10.1016/j.cell.2011.09.035; Quante T, 2016, NAT REV MOL CELL BIO, V17, P257, DOI 10.1038/nrm.2015.31; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Saulnier A, 2012, INT J CANCER, V130, P2484, DOI 10.1002/ijc.26299; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shang L, 2016, ONCOTARGET, V7, P24374, DOI 10.18632/oncotarget.8223; Shi ZZ, 2013, CLIN CANCER RES, V19, P5867, DOI 10.1158/1078-0432.CCR-12-3753; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Toh Y, 2013, GEN THORAC CARDIOVAS, V61, P262, DOI 10.1007/s11748-013-0235-3; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang JD, 2005, ONCOGENE, V24, P5637, DOI 10.1038/sj.onc.1208720; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zhang L, 2015, AM J HUM GENET, V96, P597, DOI 10.1016/j.ajhg.2015.02.017; Zhao Y, 2014, CANCER RES, V74, P5103, DOI 10.1158/0008-5472.CAN-14-0427	53	149	156	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1500	1507		10.1038/ng.3683	http://dx.doi.org/10.1038/ng.3683			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27749841	Green Submitted, Green Accepted			2022-12-25	WOS:000389011100010
J	Leonard, PG; Satani, N; Maxwell, D; Lin, YH; Hammoudi, N; Peng, ZH; Pisaneschi, F; Link, TM; Lee, GR; Sun, DL; Prasad, BAB; Di Francesco, ME; Czako, B; Asara, JM; Wang, YA; Bornmann, W; DePinho, RA; Muller, FL				Leonard, Paul G.; Satani, Nikunj; Maxwell, David; Lin, Yu-Hsi; Hammoudi, Naima; Peng, Zhenghong; Pisaneschi, Federica; Link, Todd M.; Lee, Gilbert R.; Sun, Duoli; Prasad, Basvoju A. Bhanu; Di Francesco, Maria Emilia; Czako, Barbara; Asara, John M.; Wang, Y. Alan; Bornmann, William; DePinho, Ronald A.; Muller, Florian L.			SF2312 is a natural phosphonate inhibitor of enolase	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; YEAST ENOLASE; ACTIVE-SITE; MECHANISM; COMPLEX; PHOSPHONOACETOHYDROXAMATE; EVOLUTION; SUBSTRATE; ANALOGS; CELLS	Despite being crucial for energy generation in most forms of life, few if any microbial antibiotics specifically inhibit glycolysis. To develop a specific inhibitor of the glycolytic enzyme enolase 2 (ENO2) for the treatment of cancers with deletion of ENO1 (encoding enolase 1), we modeled the synthetic tool compound inhibitor phosphonoacetohydroxamate (PhAH) into the active site of human ENO2. A ring-stabilized analog of PhAH, in which the hydroxamic nitrogen is linked to C alpha by an ethylene bridge, was predicted to increase binding affinity by stabilizing the inhibitor in a bound conformation. Unexpectedly, a structure-based search revealed that our hypothesized backbone-stabilized PhAH bears strong similarity to SF2312, a phosphonate antibiotic of unknown mode of action produced by the actinomycete Micromonospora, which is active under anaerobic conditions. Here, we present multiple lines of evidence, including a novel X-ray structure, that SF2312 is a highly potent, low-nanomolar inhibitor of enolase.	[Leonard, Paul G.; Lee, Gilbert R.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Leonard, Paul G.; Lee, Gilbert R.] Univ Texas MD Anderson Canc Ctr, Core Biomol Struct & Funct, Houston, TX 77030 USA; [Satani, Nikunj; Lin, Yu-Hsi; Hammoudi, Naima; Pisaneschi, Federica; Muller, Florian L.] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Maxwell, David] Univ Texas MD Anderson Canc Ctr, Dept Inst Analyt & Informat, Houston, TX 77030 USA; [Peng, Zhenghong] Cardtronics Inc, Houston, TX USA; [Sun, Duoli; Prasad, Basvoju A. Bhanu] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Di Francesco, Maria Emilia; Czako, Barbara] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Asara, John M.] Harvard Med Sch, Boston, MA USA; [Wang, Y. Alan; DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Bornmann, William] Bayou Therapeut Inc, Missouri, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center	Muller, FL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA.	fmuller@mdanderson.org	Pisaneschi, Federica/GYU-7470-2022; Satani, Nikunj/U-1119-2017; Pisaneschi, Federica/GYU-7584-2022	Pisaneschi, Federica/0000-0002-1989-4417; Satani, Nikunj/0000-0003-3908-3731; Pisaneschi, Federica/0000-0002-1989-4417; DePinho, Ronald/0000-0002-5625-577X; Lin, Yu-Hsi/0000-0001-5763-1530; Muller, Florian/0000-0001-7568-2948; Link, Todd/0000-0003-1939-9755	US National Institutes of Health (NIH) National Cancer Institute [P30CA016672]; NIH-NCI [7P01CA095616-10]; Cancer Prevention Research Institute of Texas (CPRIT) [RP140612]; NCI [5P01CA120964, 5P30CA006516]; NIH Career Development Project through the Specialized Programs of Research Excellence (SPORE) [P50CA127001-07]; American Cancer Society [RSG-15-145-01-CDD]; NATIONAL CANCER INSTITUTE [P01CA120964, P01CA095616, P30CA006516, P50CA127001, P30CA016672] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention Research Institute of Texas (CPRIT); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Career Development Project through the Specialized Programs of Research Excellence (SPORE); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Holton and G. Meigs for their assistance with X-ray diffraction data collection at the Advanced Light Source, beamline 8.3.1. We thank K. Kalhurachi and J. McMurray for assistance with <SUP>13</SUP>C-NMR measurements. We thank S. Millward, J. Marszalek and Y. Sun for critical comments and suggestions. We thank M. Yuan and S. Breitkopf for help with MS experiments. We thank M. Protopopova for assistance with Operetta cell imaging. We thank L. Lebioda, G. Reed and R. Poyner for useful discussions about the catalytic mechanism of enolase. We thank R. Zielinski for assistance with hypoxia experiments. The cell line D423-MG (D423) was kindly shared by D. Bigner (Duke University Medical Center) while the Gli56 cell line was shared by D. Louis (Massachusetts General Hospital) and TS neurospheres were shared by C. Brennan (Memorial Sloan Kettering Cancer Center). Inhibitors were provided by the Pharmaceutical Chemistry Facility at MD Anderson, supported by the US National Institutes of Health (NIH) National Cancer Institute under award number P30CA016672. Financial support was provided by NIH-NCI grant 7P01CA095616-10 (R.A.D.); Cancer Prevention Research Institute of Texas (CPRIT) grant RP140612 (R.A.D.); NCI grants 5P01CA120964 (J.M.A.) and 5P30CA006516 (J.M.A.) and NIH Career Development Project through the Specialized Programs of Research Excellence (SPORE) P50CA127001-07 (F.L.M.). F.L.M. was supported by Research Scholar Grant RSG-15-145-01-CDD from the American Cancer Society.	ANDERSON VE, 1984, BIOCHEMISTRY-US, V23, P2779, DOI 10.1021/bi00307a038; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bady P, 2012, NEURO-ONCOLOGY, V14, P701, DOI 10.1093/neuonc/nos072; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BREWER JM, 1981, CRC CR REV BIOCH MOL, V11, P209, DOI 10.3109/10409238109108702; Brewer JM, 2001, INT J BIOL MACROMOL, V28, P213, DOI 10.1016/S0141-8130(00)00168-9; Chai GQ, 2004, J MOL BIOL, V341, P1015, DOI 10.1016/j.jmb.2004.05.068; DETTE GA, 1983, J ANTIMICROB CHEMOTH, V11, P517, DOI 10.1093/jac/11.6.517; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Hanaya T, 2011, HETEROCYCLES, V82, P1675, DOI 10.3987/COM-10-S(E)80; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HIGASHIDE E, 1985, J ANTIBIOT, V38, P296, DOI 10.7164/antibiotics.38.296; HORII S, 1985, J ANTIBIOT, V38, P302, DOI 10.7164/antibiotics.38.302; Lee J, 2009, PROTEIN EXPRES PURIF, V63, P58, DOI 10.1016/j.pep.2008.09.005; Liu YA, 2011, TETRAHEDRON, V67, P2206, DOI 10.1016/j.tet.2011.01.073; MARANGOS PJ, 1978, J NEUROCHEM, V31, P727, DOI 10.1111/j.1471-4159.1978.tb07847.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Muller F.L., 2013, US patent, Patent No. [WO2013090732A2, 2013090732]; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Navarro MVDS, 2007, FEBS J, V274, P5077, DOI 10.1111/j.1742-4658.2007.06027.x; POYNER RR, 1992, BIOCHEMISTRY-US, V31, P7166, DOI 10.1021/bi00146a020; Qin J, 2012, J INORG BIOCHEM, V111, P187, DOI 10.1016/j.jinorgbio.2012.02.011; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Torsvik A, 2014, CANCER MED-US, V3, P812, DOI 10.1002/cam4.219; Watanabe H., 1986, SCI REPORTS MEIJI SE, V25, P12; WEDEKIND JE, 1994, BIOCHEMISTRY-US, V33, P9333, DOI 10.1021/bi00197a038; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhang E, 1997, BIOCHEMISTRY-US, V36, P12526, DOI 10.1021/bi9712450; ZHANG EL, 1994, BIOCHEMISTRY-US, V33, P6295, DOI 10.1021/bi00186a032	37	60	60	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2016	12	12					1053	+		10.1038/NCHEMBIO.2195	http://dx.doi.org/10.1038/NCHEMBIO.2195			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED1CZ	27723749	Green Accepted, Green Submitted			2022-12-25	WOS:000388582900014
J	Marin, O				Marin, Oscar			Developmental timing and critical windows for the treatment of psychiatric disorders	NATURE MEDICINE			English	Article							FRAGILE-X-SYNDROME; CRITICAL PERIOD PLASTICITY; ULTRA-HIGH RISK; PRIMARY SOMATOSENSORY CORTEX; AUTISM SPECTRUM DISORDERS; 22Q11.2 DELETION SYNDROME; FAST-SPIKING INTERNEURONS; PREVENTS ADULT DEFICITS; KNOCK-OUT MICE; AGE-OF-ONSET	There is a growing understanding that pathological genetic variation and environmental insults during sensitive periods in brain development have long-term consequences on brain function, which range from learning disabilities to complex psychiatric disorders such as schizophrenia. Furthermore, recent experiments in animal models suggest that therapeutic interventions during sensitive periods, typically before the onset of clear neurological and behavioral symptoms, might prevent or ameliorate the development of specific pathologies. These studies suggest that understanding the dynamic nature of the pathophysiological mechanisms underlying psychiatric disorders is crucial for the development of effective therapies. In this Perspective, I explore the emerging concept of developmental windows in psychiatric disorders, their relevance for understanding disease progression and their potential for the design of new therapies. The limitations and caveats of early interventions in psychiatric disorders are also discussed in this context.	[Marin, Oscar] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Dev Neurobiol, London WC2R 2LS, England; [Marin, Oscar] Kings Coll London, MRC Ctr Neurodev Disorders, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Marin, O (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Dev Neurobiol, London WC2R 2LS, England.; Marin, O (corresponding author), Kings Coll London, MRC Ctr Neurodev Disorders, London WC2R 2LS, England.	oscar.marin@kcl.ac.uk	Marin, Oscar/F-3856-2012	Marin, Oscar/0000-0001-6264-7027	European Research Council [ERC-2011-AdG 293683]; Wellcome Trust [103714MA]; Simons Foundation Autism Research Initiative [SFARI 239766OM]; De Spoelberch Foundation; MRC [MR/N026063/1] Funding Source: UKRI; Medical Research Council [MR/N026063/1] Funding Source: researchfish; Wellcome Trust [103714/Z/14/Z] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Simons Foundation Autism Research Initiative; De Spoelberch Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	I apologize for not citing all relevant references, owing to space limitations. I thank B. Rico and members of the Marin lab for valuable discussions and their critical reading of this manuscript. The European Research Council (ERC-2011-AdG 293683), Wellcome Trust (103714MA), Simons Foundation Autism Research Initiative (SFARI 239766OM) and De Spoelberch Foundation support work on this topic in my laboratory. O.M. is a Wellcome Trust Investigator.	Anderson PJ, 2012, NEUROPSYCHOL REV, V22, P345, DOI 10.1007/s11065-012-9220-3; Andreou C, 2015, SCHIZOPHRENIA BULL, V41, P930, DOI 10.1093/schbul/sbu121; Ausio J, 2014, TRENDS MOL MED, V20, P487, DOI 10.1016/j.molmed.2014.03.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Ari Y, 2015, NAT REV NEUROSCI, V16, P498, DOI 10.1038/nrn3956; Berry-Kravis E, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aab4109; Berry-Kravis E, 2010, AJIDD-AM J INTELLECT, V115, P461, DOI 10.1352/1944-7558-115.6.461; Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Bodatsch M, 2015, BIOL PSYCHIAT, V77, P951, DOI 10.1016/j.biopsych.2014.09.025; Bousman CA, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.23; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brugger S, 2011, BIOL PSYCHIAT, V69, P495, DOI 10.1016/j.biopsych.2010.10.004; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Cabungcal JH, 2014, NEURON, V83, P1073, DOI 10.1016/j.neuron.2014.07.028; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Corcoran CM, 2012, SCHIZOPHR RES, V135, P170, DOI 10.1016/j.schres.2011.11.035; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Davidson M, 1999, AM J PSYCHIAT, V156, P1328; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; del Pino I, 2013, NEURON, V79, P1152, DOI 10.1016/j.neuron.2013.07.010; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; Dobbs D, 2010, NATURE, V468, P154, DOI 10.1038/468154a; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Du YJ, 2013, NEUROPSYCHOPHARMACOL, V38, P1881, DOI 10.1038/npp.2013.101; Durand S, 2012, NEURON, V76, P1078, DOI 10.1016/j.neuron.2012.12.004; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Egerton A, 2012, CURR PHARM DESIGN, V18, P466, DOI 10.2174/138161212799316244; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Farokhnia M, 2013, CLIN NEUROPHARMACOL, V36, P185, DOI 10.1097/WNF.0000000000000001; Friedmann N, 2015, CURR OPIN NEUROBIOL, V35, P27, DOI 10.1016/j.conb.2015.06.003; Fusar-Poli P, 2013, NEUROSCI BIOBEHAV R, V37, P1680, DOI 10.1016/j.neubiorev.2013.06.001; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P220, DOI 10.1001/archgenpsychiatry.2011.1472; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Goncalves JT, 2013, NAT NEUROSCI, V16, P903, DOI 10.1038/nn.3415; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Green J, 2013, J AUTISM DEV DISORD, V43, P2502, DOI 10.1007/s10803-013-1797-8; Green MF, 1996, AM J PSYCHIAT, V153, P321; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Greenhill SD, 2015, SCIENCE, V349, P424, DOI 10.1126/science.aaa8481; Hadjikhani N, 2015, AUTISM, V19, P149, DOI 10.1177/1362361313514141; Hagberg B, 2002, MENT RETARD DEV D R, V8, P61, DOI 10.1002/mrdd.10020; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hall J, 2015, BIOL PSYCHIAT, V77, P52, DOI 10.1016/j.biopsych.2014.07.011; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; He Q, 2014, J NEUROSCI, V34, P446, DOI 10.1523/JNEUROSCI.4447-13.2014; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Howes O, 2011, MOL PSYCHIATR, V16, P885, DOI 10.1038/mp.2011.20; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Hubener M, 2014, CELL, V159, P727, DOI 10.1016/j.cell.2014.10.035; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Jeste SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9874; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Kaiser T, 2015, NAT MED, V21, P979, DOI 10.1038/nm.3935; Kalia A, 2014, P NATL ACAD SCI USA, V111, P2035, DOI 10.1073/pnas.1311041111; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Katz DM, 2016, TRENDS NEUROSCI, V39, P100, DOI 10.1016/j.tins.2015.12.008; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kim H, 2013, J NEUROSCI, V33, P15686, DOI 10.1523/JNEUROSCI.3246-12.2013; Kim IH, 2015, NAT NEUROSCI, V18, P883, DOI 10.1038/nn.4015; Kirkby LA, 2013, NEURON, V80, P1129, DOI 10.1016/j.neuron.2013.10.030; Koseki T, 2012, INT J NEUROPSYCHOPH, V15, P1489, DOI 10.1017/S1461145711001672; Kraguljac NV, 2013, JAMA PSYCHIAT, V70, P1294, DOI 10.1001/jamapsychiatry.2013.2437; Krishnan K, 2015, P NATL ACAD SCI USA, V112, pE4782, DOI 10.1073/pnas.1506499112; Kron M, 2012, J NEUROSCI, V32, P13860, DOI 10.1523/JNEUROSCI.2159-12.2012; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; Lee FS, 2014, SCIENCE, V346, P547, DOI 10.1126/science.1260497; Lee H, 2012, NEURON, V75, P714, DOI 10.1016/j.neuron.2012.06.016; Lemonnier E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.124; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Lin A, 2015, AM J PSYCHIAT, V172, P249, DOI 10.1176/appi.ajp.2014.13030418; LIPSKA BK, 1993, NEUROPSYCHOPHARMACOL, V9, P67, DOI 10.1038/npp.1993.44; Lombardi LM, 2015, J CLIN INVEST, V125, P2914, DOI 10.1172/JCI78167; Maayan L, 2011, J CHILD ADOL PSYCHOP, V21, P517, DOI 10.1089/cap.2011.0015; Marguet SL, 2015, NAT MED, V21, P1436, DOI 10.1038/nm.3987; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; McGlashan TH, 2006, AM J PSYCHIAT, V163, P790, DOI 10.1176/appi.ajp.163.5.790; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Mierau SB, 2016, BIOL PSYCHIAT, V79, P746, DOI 10.1016/j.biopsych.2015.05.018; Miklowitz DJ, 2014, J AM ACAD CHILD PSY, V53, P848, DOI 10.1016/j.jaac.2014.04.020; Millan MJ, 2016, NAT REV DRUG DISCOV, V15, P485, DOI 10.1038/nrd.2016.28; Modinos G, 2015, TRENDS NEUROSCI, V38, P129, DOI 10.1016/j.tins.2014.12.005; Moghaddam B, 2012, SCHIZOPHRENIA BULL, V38, P942, DOI 10.1093/schbul/sbs075; Morishita H, 2015, BIOL PSYCHIAT, V78, P396, DOI 10.1016/j.biopsych.2014.12.026; Mukai J, 2015, NEURON, V86, P680, DOI 10.1016/j.neuron.2015.04.003; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Nabel Elisa M, 2013, Front Psychiatry, V4, P146, DOI 10.3389/fpsyt.2013.00146; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Patrizi A, 2016, BIOL PSYCHIAT, V79, P755, DOI 10.1016/j.biopsych.2015.08.018; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Perkins DO, 2015, SCHIZOPHRENIA BULL, V41, P419, DOI 10.1093/schbul/sbu099; Pratt J, 2012, NAT REV DRUG DISCOV, V11, P560, DOI 10.1038/nrd3649; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Richtand NM, 2006, NEUROPSYCHOPHARMACOL, V31, P77, DOI 10.1038/sj.npp.1300791; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson D, 1999, ARCH GEN PSYCHIAT, V56, P241, DOI 10.1001/archpsyc.56.3.241; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Scharf SH, 2015, CURR OPIN PHARMACOL, V20, P124, DOI 10.1016/j.coph.2014.11.004; Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; Schobel SA, 2013, NEURON, V78, P81, DOI 10.1016/j.neuron.2013.02.011; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Sigurdsson T, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00190; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008; Sourdet V, 2003, J NEUROSCI, V23, P10238; Steullet P, 2010, J NEUROSCI, V30, P2547, DOI 10.1523/JNEUROSCI.3857-09.2010; Su T, 2011, PSYCHOPHARMACOLOGY, V215, P291, DOI 10.1007/s00213-010-2130-2; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun LM, 2013, SCHIZOPHR RES, V150, P519, DOI 10.1016/j.schres.2013.08.023; Tamura M, 2016, NEURON, V89, P1100, DOI 10.1016/j.neuron.2016.01.025; Till SM, 2012, HUM MOL GENET, V21, P2143, DOI 10.1093/hmg/dds030; Tognin S, 2014, FRONT PSYCHIATRY, V4, DOI 10.3389/fpsyt.2013.00187; Toyoizumi T, 2013, NEURON, V80, P51, DOI 10.1016/j.neuron.2013.07.022; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Veenstra-VanderWeele J, 2015, NEUROPSYCHOPHARMACOL, V40, P225, DOI 10.1038/npp.2014.232; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060, DOI 10.1152/jn.1965.28.6.1060; Willsey AJ, 2015, CURR OPIN NEUROBIOL, V30, P92, DOI 10.1016/j.conb.2014.10.015; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; WYATT RJ, 1991, SCHIZOPHRENIA BULL, V17, P325, DOI 10.1093/schbul/17.2.325; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003	156	173	179	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1229	1238		10.1038/nm.4225	http://dx.doi.org/10.1038/nm.4225			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27783067	Green Submitted			2022-12-25	WOS:000387302300014
J	Serdiuk, T; Balasubramaniam, D; Sugihara, J; Mari, SA; Kaback, HR; Muller, DJ				Serdiuk, Tetiana; Balasubramaniam, Dhandayuthapani; Sugihara, Junichi; Mari, Stefania A.; Kaback, H. Ronald; Muller, Daniel J.			YidC assists the stepwise and stochastic folding of membrane proteins	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI YIDC; LACTOSE PERMEASE; OUTER-MEMBRANE; CHAPERONE; BINDING; BACTERIORHODOPSIN; TRANSLOCATION; PATHWAYS; EXPRESSION; RHODOPSIN	How chaperones, insertases and translocases facilitate insertion and folding of complex cytoplasmic proteins into cellular membranes is not fully understood. Here we utilize single-molecule force spectroscopy to observe YidC, a transmembrane chaperone and insertase, sculpting the folding trajectory of the polytopic alpha-helical membrane protein lactose permease (LacY). In the absence of YidC, unfolded LacY inserts individual structural segments into the membrane; however, misfolding dominates the process so that folding cannot be completed. YidC prevents LacY from misfolding by stabilizing the unfolded state from which LacY inserts structural segments stepwise into the membrane until folding is completed. During stepwise insertion, YidC and the membrane together stabilize the transient folds. Remarkably, the order of insertion of structural segments is stochastic, indicating that LacY can fold along variable pathways toward the native structure. Since YidC is essential in membrane protein biogenesis and LacY is a model for the major facilitator superfamily, our observations have general relevance.	[Serdiuk, Tetiana; Mari, Stefania A.; Muller, Daniel J.] ETH, Dept Biosyst Sci & Engn, Basel, Switzerland; [Balasubramaniam, Dhandayuthapani; Sugihara, Junichi; Kaback, H. Ronald] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA; [Kaback, H. Ronald] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Kaback, H. Ronald] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Muller, DJ (corresponding author), ETH, Dept Biosyst Sci & Engn, Basel, Switzerland.; Kaback, HR (corresponding author), Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA.; Kaback, HR (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA.; Kaback, HR (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.	rkaback@mednet.ucla.edu; daniel.mueller@bsse.ethz.ch	Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665; Serdiuk, Tetiana/0000-0002-3706-5911	Eidgenossische Technische Hochschule Zurich; Swiss National Science Foundation [205320_160199]; Swiss National Center of Competence in Research "NCCR Molecular Systems Engineering"; European Union Marie Curie Actions program through the ACRITAS Initial Training Network (FP7-PEOPLE-ITN) [317348]; U.S. National Institutes of Health [DK51131, DK069463, GM073210]; U.S. National Science Foundation [MCB-1129551]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK051131, R56DK069463] Funding Source: NIH RePORTER	Eidgenossische Technische Hochschule Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Center of Competence in Research "NCCR Molecular Systems Engineering"; European Union Marie Curie Actions program through the ACRITAS Initial Training Network (FP7-PEOPLE-ITN); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R.E. Dalbey (The Ohio State University) for providing plasmid pT7-7 encoding YidC with a His<INF>10</INF> tag at the C terminus; R. Newton, J. Thoma, S. Hiller and R.E. Dalbey for encouraging and constructive comments; and S. Weiser for assistance. This work was supported by the Eidgenossische Technische Hochschule Zurich (to D.J.M.), the Swiss National Science Foundation (grant 205320_160199 to D.J.M.), the Swiss National Center of Competence in Research "NCCR Molecular Systems Engineering" (to D.J.M.), the European Union Marie Curie Actions program through the ACRITAS Initial Training Network (FP7-PEOPLE-2012-ITN, project 317348 to D.J.M.), U.S. National Institutes of Health grants DK51131, DK069463 and GM073210 (to H.R.K.), and U.S. National Science Foundation grant MCB-1129551 (to H.R.K.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; BIBI E, 1990, P NATL ACAD SCI USA, V87, P4325, DOI 10.1073/pnas.87.11.4325; Bippes CA, 2013, P NATL ACAD SCI USA, V110, pE3978, DOI 10.1073/pnas.1312959110; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bosshart PD, 2012, STRUCTURE, V20, P121, DOI 10.1016/j.str.2011.11.002; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Damaghi M, 2011, ANGEW CHEM INT EDIT, V50, P7422, DOI 10.1002/anie.201101450; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; Fanelli F, 2010, FASEB J, V24, P3196, DOI 10.1096/fj.09-151084; Ge L, 2011, P NATL ACAD SCI USA, V108, pE890, DOI 10.1073/pnas.1109597108; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guan L, 2009, BIOCHEMISTRY-US, V48, P9250, DOI 10.1021/bi9014067; Harris NJ, 2012, BBA-BIOMEMBRANES, V1818, P1055, DOI 10.1016/j.bbamem.2011.11.006; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HERZLINGER D, 1984, BIOCHEMISTRY-US, V23, P3688, DOI 10.1021/bi00311a018; Kaiser CM, 2012, BIOPHYS J, V102, P2212, DOI 10.1016/j.bpj.2012.03.013; Kappel C, 2011, BIOPHYS J, V100, P1109, DOI 10.1016/j.bpj.2011.01.004; Kawamura S, 2013, STRUCTURE, V21, P426, DOI 10.1016/j.str.2013.01.011; Kedrov A, 2006, J MOL BIOL, V355, P2, DOI 10.1016/j.jmb.2005.10.028; Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455; Kessler M, 2006, J MOL BIOL, V357, P644, DOI 10.1016/j.jmb.2005.12.065; Kumazaki K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07299; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Luirink J, 2012, BBA-BIOENERGETICS, V1817, P965, DOI 10.1016/j.bbabio.2011.12.006; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309; Muller DJ, 2003, J MOL BIOL, V327, P925, DOI 10.1016/S0022-2836(03)00206-7; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nunes JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7307; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Saller MJ, 2012, BIOL CHEM, V393, P1279, DOI 10.1515/hsz-2012-0199; Sapra KT, 2006, J MOL BIOL, V355, P640, DOI 10.1016/j.jmb.2005.10.080; Serdiuk T, 2015, STRUCTURE, V23, P754, DOI 10.1016/j.str.2015.02.009; Serdiuk T, 2014, P NATL ACAD SCI USA, V111, pE1571, DOI 10.1073/pnas.1404446111; Shimokawa-Chiba N, 2015, P NATL ACAD SCI USA, V112, P5063, DOI 10.1073/pnas.1423817112; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Stephenson K, 2005, MOL MEMBR BIOL, V22, P17, DOI 10.1080/09687860500063308; Thoma J, 2015, NAT STRUCT MOL BIOL, V22, P795, DOI 10.1038/nsmb.3087; van Bloois E, 2005, J BIOL CHEM, V280, P12996, DOI 10.1074/jbc.M414094200; Van Lehn RC, 2015, ELIFE, V4, DOI 10.7554/eLife.08697; VIITANEN P, 1986, METHOD ENZYMOL, V125, P429; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; White SH, 2015, ELIFE, V4, DOI 10.7554/eLife.12100; ZEN KH, 1994, BIOCHEMISTRY-US, V33, P8198, DOI 10.1021/bi00193a005; Zhu L, 2013, J BIOL CHEM, V288, P28180, DOI 10.1074/jbc.M113.491613	53	47	48	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2016	12	11					911	+		10.1038/NCHEMBIO.2169	http://dx.doi.org/10.1038/NCHEMBIO.2169			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA7GP	27595331	Green Accepted, Green Published			2022-12-25	WOS:000386798800011
J	Zeller, P; Padeken, J; van Schendel, R; Kalck, V; Tijsterman, M; Gasser, SM				Zeller, Peter; Padeken, Jan; van Schendel, Robin; Kalck, Veronique; Tijsterman, Marcel; Gasser, Susan M.			Histone H3K9 methylation is dispensable for Caenorhabditis elegans development but suppresses RNA:DNA hybrid-associated repeat instability	NATURE GENETICS			English	Article							REPLICATION FORK PROGRESSION; POSITION-EFFECT VARIEGATION; DAMAGE-INDUCED APOPTOSIS; C-ELEGANS; GENOME INSTABILITY; METHYLTRANSFERASE G9A; LYSINE-9 METHYLATION; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; EPIGENETIC CONTROL	Histone H3 lysine 9 (H3K9) methylation is a conserved modification that generally represses transcription. In Caenorhabditis elegans it is enriched on silent tissue-specific genes and repetitiye elements. In met-2 set-25 double mutants, which lack all H3K9 methylation (H3K9me), embryos differentiate normally, although mutant adults are sterile owing to extensive DNA-damage driven apoptosis in the germ line. Transposons and simple repeats are derepressed in both germline and somatic tissues. This unprogrammed transcription correlates with increased rates of repeat-specific insertions and deletions, copy number variation, R loops and enhanced sensitivity to replication stress. We propose that H3K9me2 or H3K9me3 stabilizes and protects repeat-rich genomes by suppressing transcription-induced replication stress.	[Zeller, Peter; Padeken, Jan; Kalck, Veronique; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Zeller, Peter; Gasser, Susan M.] Univ Basel, Fac Nat Sci, Basel, Switzerland; [van Schendel, Robin; Tijsterman, Marcel] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands	Friedrich Miescher Institute for Biomedical Research; University of Basel; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.; Gasser, SM (corresponding author), Univ Basel, Fac Nat Sci, Basel, Switzerland.	susan.gasser@fmi.ch	Tijsterman, Marcel/H-5663-2018; Padeken, Jan/AFU-6352-2022	Tijsterman, Marcel/0000-0001-8465-9002; Padeken, Jan/0000-0001-6538-0946; Gasser, Susan/0000-0003-3610-9123; Zeller, Peter/0000-0003-2537-0254	NIH Office of Research Infrastructure Programs [P40 OD010440]; long-term EMBO fellowship; Swiss National Science Foundation; Novartis Research Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); long-term EMBO fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Research Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A number of strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We thank R. Ciosk and P. Pasero for reagents and materials, I. Katic and members of the Friedrich Miescher Institute Genomics and Microscopy facilities for advice and discussion, and P. Ginno and L. Constantino for advice on R-loop detection. J.P. is supported by a long-term EMBO fellowship. S.M.G. thanks the Swiss National Science Foundation as well as the Novartis Research Foundation for support.	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; CANGIANO G, 1993, NUCLEIC ACIDS RES, V21, P1133, DOI 10.1093/nar/21.5.1133; Castellano-Pozo M, 2013, MOL CELL, V52, P583, DOI 10.1016/j.molcel.2013.10.006; Castellano-Pozo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052447; Chan YA, 2014, TRENDS GENET, V30, P245, DOI 10.1016/j.tig.2014.03.005; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; COLLINS J, 1987, NATURE, V328, P726, DOI 10.1038/328726a0; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; El Hage A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004716; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Greiss S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-334; Harris J, 2006, GENETICS, V174, P601, DOI 10.1534/genetics.106.058701; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Hoffman EA, 2015, GENOME RES, V25, P402, DOI 10.1101/gr.180497.114; Hua KT, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-189; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kilchert C, 2016, NAT REV MOL CELL BIO, V17, P227, DOI 10.1038/nrm.2015.15; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kouzine F, 2014, NUCLEUS-PHILA, V5, P195, DOI 10.4161/nucl.28909; Kumari D, 2010, HUM MOL GENET, V19, P4634, DOI 10.1093/hmg/ddq394; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee J, 2013, ACTA NEUROPATHOL, V125, P727, DOI 10.1007/s00401-013-1103-z; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Liu S, 2014, GENE DEV, V28, P2041, DOI 10.1101/gad.244848.114; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Nakamori M, 2011, HUM MOL GENET, V20, P580, DOI 10.1093/hmg/ddq501; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Padeken J, 2015, CURR OPIN GENET DEV, V31, P12, DOI 10.1016/j.gde.2015.03.009; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Prak ETL, 2000, NAT REV GENET, V1, P134; ROSENKRANZ HS, 1965, BIOCHIM BIOPHYS ACTA, V95, P181, DOI 10.1016/0005-2787(65)90225-X; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tijsterman M, 2002, GENETICS, V161, P651; Towbin BD, 2010, COLD SH Q B, V75, P555, DOI 10.1101/sqb.2010.75.041; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Vermezovic J, 2012, CELL DEATH DIFFER, V19, P1847, DOI 10.1038/cdd.2012.69; Wagner T, 2012, NAT BIOTECHNOL, V30, P622, DOI 10.1038/nbt.2300; Wahba L, 2016, GENE DEV, V30, P1327, DOI 10.1101/gad.280834.116; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yuan Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.191; Zhang H, 2007, MOL CELL, V27, P367, DOI 10.1016/j.molcel.2007.06.012; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	71	118	119	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1385	1395		10.1038/ng.3672	http://dx.doi.org/10.1038/ng.3672			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27668659				2022-12-25	WOS:000386543400015
J	Olofsson, PS; Steinberg, BE; Sobbi, R; Cox, MA; Ahmed, MN; Oswald, M; Szekeres, F; Hanes, WM; Introini, A; Liu, SF; Holodick, NE; Rothstein, TL; Lovdahl, C; Chavan, SS; Yang, H; Pavlov, VA; Broliden, K; Andersson, U; Diamond, B; Miller, EJ; Arner, A; Gregersen, PK; Backx, PH; Mak, TW; Tracey, KJ				Olofsson, Peder S.; Steinberg, Benjamin E.; Sobbi, Roozbeh; Cox, Maureen A.; Ahmed, Mohamed N.; Oswald, Michaela; Szekeres, Ferenc; Hanes, William M.; Introini, Andrea; Liu, Shu Fang; Holodick, Nichol E.; Rothstein, Thomas L.; Lovdahl, Cecilia; Chavan, Sangeeta S.; Yang, Huan; Pavlov, Valentin A.; Broliden, Kristina; Andersson, Ulf; Diamond, Betty; Miller, Edmund J.; Arner, Anders; Gregersen, Peter K.; Backx, Peter H.; Mak, Tak W.; Tracey, Kevin J.			Blood pressure regulation by CD4(+) lymphocytes expressing choline acetyltransferase	NATURE BIOTECHNOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; T-CELLS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; SMOOTH-MUSCLE; ACETYLCHOLINE; MICE; HYPERTENSION; DYSFUNCTION; REFLEX	Blood pressure regulation is known to be maintained by a neuro-endocrine circuit, but whether immune cells contribute to blood pressure homeostasis has not been determined. We previously showed that CD4(+) T lymphocytes that express choline acetyltransferase (ChAT), which catalyzes the synthesis of the vasorelaxant acetylcholine, relay neural signals(1). Here we show that these CD4(+)CD44(hi)CD62L(Io) T helper cells by gene expression are a distinct T-cell population defined by ChAT (CD4 T-ChAT). Mice lacking ChAT expression in CD4(+) cells have elevated arterial blood pressure, compared to littermate controls. Jurkat T cells overexpressing ChAT (JT(ChAT)) decreased blood pressure when infused into mice. Co-incubation of JT(ChAT) and endothelial cells increased endothelial cell levels of phosphorylated endothelial nitric oxide synthase, and of nitrates and nitrites in conditioned media, indicating increased release of the potent vasorelaxant nitric oxide. The isolation and characterization of CD4 T-ChAT cells will enable analysis of the role of these cells in hypotension and hypertension, and may suggest novel therapeutic strategies by targeting cell-mediated vasorelaxation.	[Olofsson, Peder S.] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Ctr Bioelect Med,Dept Med, Stockholm, Sweden; [Olofsson, Peder S.; Steinberg, Benjamin E.; Hanes, William M.; Chavan, Sangeeta S.; Yang, Huan; Pavlov, Valentin A.; Tracey, Kevin J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA; [Steinberg, Benjamin E.; Cox, Maureen A.; Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Sobbi, Roozbeh; Backx, Peter H.] Univ Hlth Network, Peter Munk Cardiac Ctr, Div Cardiol, Toronto, ON, Canada; [Ahmed, Mohamed N.; Liu, Shu Fang; Miller, Edmund J.] Feinstein Inst Med Res, Ctr Heart & Lung Res, Manhasset, NY USA; [Oswald, Michaela; Gregersen, Peter K.] Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; [Szekeres, Ferenc; Lovdahl, Cecilia; Arner, Anders] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Szekeres, Ferenc] Univ Skovde, Sch Hlth & Educ, Skovde, Sweden; [Introini, Andrea; Broliden, Kristina] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Dept Med,Unit Infect Dis, Stockholm, Sweden; [Holodick, Nichol E.; Rothstein, Thomas L.] Feinstein Inst Med Res, Ctr Oncol & Cell Biol, Manhasset, NY USA; [Andersson, Ulf] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Diamond, Betty] Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA; [Backx, Peter H.] York Univ, Dept Biol, Toronto, ON, Canada	Karolinska Institutet; Karolinska University Hospital; Northwell Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Northwell Health; Northwell Health; Karolinska Institutet; University of Skovde; Karolinska Institutet; Karolinska University Hospital; Northwell Health; Karolinska Institutet; Northwell Health; York University - Canada	Olofsson, PS (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Ctr Bioelect Med,Dept Med, Stockholm, Sweden.; Olofsson, PS (corresponding author), Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA.	peder.olofsson@ki.se	Hanes, William/B-8749-2016; Cox, Maureen/AAY-7685-2020; Andersson, Ulf/ABD-5162-2021; Szekeres, Ferenc L M/E-4586-2018; Introini, Andrea/ABC-9951-2020	Hanes, William/0000-0001-9005-1941; Andersson, Ulf/0000-0003-0316-3860; Introini, Andrea/0000-0002-9929-8964; Tracey, Kevin J/0000-0003-1884-6314; Chavan, Sangeeta S./0000-0002-4822-3356; Pavlov, Valentin/0000-0002-1994-2853; Cox, Maureen/0000-0001-8030-3340	NIH; NIGMS [RO1 GM57226, RO1 GM098446, RO1GM089807]; NIAID [R01029690]; Canadian Institutes for Health Research [FRN 119339]; Knut and Alice Wallenberg's Foundation [2014.0212]; Swedish Heart-Lung Foundation [20150767]; Svenska Lakaresallskapet;  [VR 2013-3003]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI102852, R01AI029690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057226, R01GM098446, R01GM089807, R35GM118182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Knut and Alice Wallenberg's Foundation(Knut & Alice Wallenberg Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Svenska Lakaresallskapet; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the flow cytometry facility at the Feinstein Institute, the laboratory of C. Benoist at Harvard Medical School for assistance, and G.K. Hansson for comments. We thank C. James Kirkpatrick (Institute of Pathology, Johannes-Gutenberg University, Mainz, Germany), who kindly provided PMEC-ST1.6R cells. This work benefitted from the data assembled by the ImmGen consortium. This work was supported by the following grants: NIH, NIGMS RO1 GM57226 to K.J.T., NIGMS RO1 GM098446 to H.Y. and NIGMS RO1GM089807 to K.J.T. and V.A.P., VR 2013-3003 to A.A., NIAID R01029690 to T.L.R., Canadian Institutes for Health Research FRN 119339 to P.H.B., and Knut and Alice Wallenberg's Foundation 2014.0212, The Swedish Heart-Lung Foundation 20150767 and Svenska Lakaresallskapet to P.S.O. Jurkat cells (originally obtained from ATCC) were a gift from C. Chu, The Feinstein Institute for Medical Research. eNOS-deficient mice were provided by J. Lundberg and E. Weitzberg, Karolinska Institutet, Stockholm, Sweden.	Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Bearden SE, 2004, J PHYSIOL-LONDON, V561, P535, DOI 10.1113/jphysiol.2004.068262; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fleming I, 1999, J MOL CELL CARDIOL, V31, P5, DOI 10.1006/jmcc.1998.0839; Fujimoto K, 2001, LIFE SCI, V69, P1629, DOI 10.1016/S0024-3205(01)01237-1; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; FURCHGOTT RF, 1955, PHARMACOL REV, V7, P183; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawashima K, 2012, ANN NY ACAD SCI, V1261, P7, DOI 10.1111/j.1749-6632.2012.06516.x; Laurat E, 2001, CIRCULATION, V104, P197, DOI 10.1161/01.CIR.104.2.197; Marvar PJ, 2012, EXP PHYSIOL, V97, P1161, DOI 10.1113/expphysiol.2011.061507; Matrougui K, 2011, AM J PATHOL, V178, P434, DOI 10.1016/j.ajpath.2010.11.034; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; MULVANY MJ, 1990, PHYSIOL REV, V70, P921, DOI 10.1152/physrev.1990.70.4.921; Olofsson P. S., 2015, BIOELECTRON MED, V1, P30; Olofsson PS, 2012, IMMUNOL REV, V248, P188, DOI 10.1111/j.1600-065X.2012.01138.x; Olofsson PS, 2012, MOL MED, V18, P539, DOI 10.2119/molmed.2011.00405; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tracey KJ, 2015, SCI AM, V312, P28, DOI 10.1038/scientificamerican0315-28	29	43	43	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2016	34	10					1066	1071		10.1038/nbt.3663	http://dx.doi.org/10.1038/nbt.3663			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	EA0ZG	27617738	Green Accepted, Green Submitted			2022-12-25	WOS:000386317500022
J	Shou, QY; Feng, LK; Long, YL; Han, J; Nunnery, JK; Powell, DH; Butcher, RA				Shou, Qingyao; Feng, Likui; Long, Yaoling; Han, Jungsoo; Nunnery, Joshawna K.; Powell, David H.; Butcher, Rebecca A.			A hybrid polyketide-nonribosomal peptide in nematodes that promotes larval survival	NATURE CHEMICAL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; IDENTIFICATION; DOMAIN	Polyketides and nonribosomal peptides are two important types of natural products that are produced by many species of bacteria and fungi but are exceedingly rare in metazoans. Here, we elucidate the structure of a hybrid polyketide-nonribosomal peptide from Caenorhabditis elegans that is produced in the canal-associated neurons (CANs) and promotes survival during starvation-induced larval arrest. Our results uncover a novel mechanism by which animals respond to nutrient fluctuations to extend survival.	[Shou, Qingyao; Feng, Likui; Long, Yaoling; Han, Jungsoo; Nunnery, Joshawna K.; Powell, David H.; Butcher, Rebecca A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Butcher, RA (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	butcher@chem.ufl.edu	Feng, Likui/AAC-4957-2020	Feng, Likui/0000-0003-4601-4224; Han, Jungsoo/0000-0002-5066-0555	NIH Office of Research Infrastructure Programs [P40 OD010440]; NemaGENETAG consortium; NIH [GM118775]; NSF [1555050]; Ellison Medical Foundation [AG-NS-0963-12]; Alfred P. Sloan Foundation [BR2014-071]; National High Magnetic Field Laboratory; NSF Cooperative [DMR-1157490]; State of Florida; Division Of Chemistry [1555050] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118775] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NemaGENETAG consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Ellison Medical Foundation(Lawrence Ellison Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National High Magnetic Field Laboratory; NSF Cooperative(National Science Foundation (NSF)); State of Florida; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Fire, A. Frand, N. Moghal and P. Sengupta for plasmids, J. Rocca for help with NMR acquisition, J. Johnson for MS-MS analysis, Y. Ding and Y. Zhang for help with Sybyl software, S. Hagan, G. Fanucci, and Z. Liu for help with CD spectroscopy, and Y. Zhu for help with calculating CD spectra. We acknowledge the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440), and the NemaGENETAG consortium for providing strains. This work was supported by funds to R.A.B. from the NIH (GM118775), the NSF (1555050), the Ellison Medical Foundation (AG-NS-0963-12), the Alfred P. Sloan Foundation (BR2014-071), and the National High Magnetic Field Laboratory, which is supported by NSF Cooperative Agreement No. DMR-1157490 and the State of Florida.	Aron ZD, 2005, J AM CHEM SOC, V127, P14986, DOI 10.1021/ja055247g; Artyukhin AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02777; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Bhushan R, 2004, AMINO ACIDS, V27, P231, DOI 10.1007/s00726-004-0118-0; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Castoe TA, 2007, GENE, V392, P47, DOI 10.1016/j.gene.2006.11.005; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chen YT, 2014, DEV BIOL, V394, P314, DOI 10.1016/j.ydbio.2014.08.002; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Forrester WC, 1998, GENETICS, V148, P151; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Fukuyama M, 2015, CURR BIOL, V25, P1241, DOI 10.1016/j.cub.2015.03.016; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; Hojo M, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-014-0001-0; Kwan DH, 2011, MOLECULES, V16, P6092, DOI 10.3390/molecules16076092; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Modzelewska K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001465; Nass R., 2007, CURR PROTOC TOXICOL, V31; O'Brien RV, 2014, J ANTIBIOT, V67, P89, DOI 10.1038/ja.2013.125; Omura S, 2014, TRENDS PARASITOL, V30, P445, DOI 10.1016/j.pt.2014.07.005; Ramaswamy V, 2013, J MAGN RESON, V235, P58, DOI 10.1016/j.jmr.2013.07.012; Ritter AD, 2013, GENOME RES, V23, P954, DOI 10.1101/gr.150466.112; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang H, 2014, P NATL ACAD SCI USA, V111, P9259, DOI 10.1073/pnas.1401734111; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Zhang XC, 2011, P NATL ACAD SCI USA, V108, P17997, DOI 10.1073/pnas.1105982108; Zhang XX, 2015, P NATL ACAD SCI USA, V112, P3955, DOI 10.1073/pnas.1423951112	31	28	28	1	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2016	12	10					770	+		10.1038/nchembio.2144	http://dx.doi.org/10.1038/nchembio.2144			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX3BU	27501395	Green Accepted			2022-12-25	WOS:000384248600005
J	Hoare, M; Ito, Y; Kang, TW; Weekes, MP; Matheson, NJ; Patten, DA; Shetty, S; Parry, AJ; Menon, S; Salama, R; Antrobus, R; Tomimatsu, K; Howat, W; Lehner, PJ; Zender, L; Narita, M				Hoare, Matthew; Ito, Yoko; Kang, Tae-Won; Weekes, Michael P.; Matheson, Nicholas J.; Patten, Daniel A.; Shetty, Shishir; Parry, Aled J.; Menon, Suraj; Salama, Rafik; Antrobus, Robin; Tomimatsu, Kosuke; Howat, William; Lehner, Paul J.; Zender, Lars; Narita, Masashi			NOTCH1 mediates a switch between two distinct secretomes during senescence	NATURE CELL BIOLOGY			English	Article							CELLULAR SENESCENCE; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; LIVER; ONCOGENE; GROWTH; DIFFERENTIATION; CLEARANCE; FATE; BETA	Senescence, a persistent form of cell-cycle arrest, is often associated with a diverse secretome, which provides complex functionality for senescent cells within the tissue microenvironment. We show that oncogene-induced senescence is accompanied by a dynamic fluctuation of NOTCH1 activity, which drives a TGF-beta-rich secretome, while suppressing the senescence-associated pro-inflammatory secretome through inhibition of C/EBP beta. NOTCH1 and NOTCH1-driven TGF-beta contribute to 'lateral induction of senescence' through a juxtacrine NOTCH-JAG1 pathway. In addition, NOTCH1 inhibition during senescence facilitates upregulation of pro-inflammatory cytokines, promoting lymphocyte recruitment and senescence surveillance in vivo. As enforced activation of NOTCH1 signalling confers a near mutually exclusive secretory profile compared with typical senescence, our data collectively indicate that the dynamic alteration of NOTCH1 activity during senescence dictates a functional balance between these two distinct secretomes: one representing TGF-beta and the other pro-inflammatory cytokines, highlighting that NOTCH1 is a temporospatial controller of secretome composition.	[Hoare, Matthew; Ito, Yoko; Parry, Aled J.; Menon, Suraj; Salama, Rafik; Tomimatsu, Kosuke; Howat, William; Narita, Masashi] Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England; [Hoare, Matthew; Weekes, Michael P.; Matheson, Nicholas J.; Lehner, Paul J.] Univ Cambridge, Dept Med, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Kang, Tae-Won; Zender, Lars] Univ Hosp Tuebingen, Div Translat Gastrointestinal Oncol, Dept Internal Med 1, Otfried Mueller Str 12, D-72076 Tubingen, Germany; [Kang, Tae-Won; Zender, Lars] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, D-69120 Heidelberg, Germany; [Weekes, Michael P.; Matheson, Nicholas J.; Antrobus, Robin; Lehner, Paul J.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Patten, Daniel A.; Shetty, Shishir] Univ Birmingham, Birmingham Liver Biomed Res Unit, Natl Inst Hlth Res, Birmingham B15 2TT, W Midlands, England; [Patten, Daniel A.; Shetty, Shishir] Univ Birmingham, Liver Res Ctr, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Birmingham; University of Birmingham	Narita, M (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	masashi.narita@cruk.cam.ac.uk	Shetty, Shishir/AAU-4047-2021; Kang, Tae Won/S-4864-2019	Shetty, Shishir/0000-0002-4729-2173; Kang, Tae Won/0000-0003-1497-8926; Hoare, Matthew/0000-0001-5990-9604; Parry, Aled/0000-0001-5192-3727; Narita, Masashi/0000-0001-7764-577X; Matheson, Nicholas/0000-0002-3318-1851; Salama, Rafik/0000-0001-5549-7796; Patten, Daniel/0000-0002-8745-0578; Lehner, Paul Joseph/0000-0001-9383-1054; Weekes, Michael/0000-0003-3196-5545	University of Cambridge; Hutchison Whampoa; Cancer Research UK Cambridge Institute Core Grant [C14303/A17197]; CRUK Translational Medicine Research Fellowship; CRUK Clinician Scientist Fellowship [C52489/A19924]; Wellcome Trust [WT101835, 108070/Z/15/Z, 093964/Z/10/Z, 097162/Z/11/Z]; German Research Foundation (DFG) [FOR2314, SFB685]; Gottfried Wilhelm Leibniz Program; European Research Council (projects 'CholangioConcepf'); German Ministry for Education and Research (BMBF) (eMed-Multiscale HCC); German Universities Excellence Initiative (third funding line: 'future concept'); German Center for Translational Cancer Research (DKTK); German-Israeli Cooperation in Cancer Research (DKFZ-MOST); Cancer Research UK [19159, 22310, 15890, 19924] Funding Source: researchfish	University of Cambridge(University of Cambridge); Hutchison Whampoa; Cancer Research UK Cambridge Institute Core Grant; CRUK Translational Medicine Research Fellowship; CRUK Clinician Scientist Fellowship; Wellcome Trust(Wellcome Trust); German Research Foundation (DFG)(German Research Foundation (DFG)); Gottfried Wilhelm Leibniz Program; European Research Council (projects 'CholangioConcepf'); German Ministry for Education and Research (BMBF) (eMed-Multiscale HCC)(Federal Ministry of Education & Research (BMBF)); German Universities Excellence Initiative (third funding line: 'future concept'); German Center for Translational Cancer Research (DKTK); German-Israeli Cooperation in Cancer Research (DKFZ-MOST); Cancer Research UK(Cancer Research UK)	We are very grateful to J. Gil (Imperial College London, UK), A. Harris (CRUK, Oxford, UK) and D. Peeper (NKI, Amsterdam) for reagents; J. Miller and L.-A. McDuffus for assistance with the immunohistochemistry; E. Serrao and K. Brindle (CRUK Cambridge Institute, UK) for the murine pancreatic tissue; G. Slater for analysis of the ILIA locus; M. Clayton for the tail-vein injections; and A. Young and M. Narita for technical support. This work was supported by the University of Cambridge, Cancer Research UK and Hutchison Whampoa. The M.N. laboratory is supported by Cancer Research UK Cambridge Institute Core Grant (C14303/A17197). M.H. was supported by CRUK Translational Medicine Research Fellowship and CRUK Clinician Scientist Fellowship (C52489/A19924). This work was also supported by a Wellcome Trust PRF (WT101835) to P.J.L., a Wellcome Trust Senior Fellowship to M.P.W. (108070/Z/15/Z), a Wellcome Trust Training Fellowship to N.J.M. (093964/Z/10/Z), and a Wellcome Trust Intermediate Fellowship (097162/Z/11/Z) to S.S. L.Z. was funded by the German Research Foundation (DFG; grants FOR2314 and SFB685), the Gottfried Wilhelm Leibniz Program, the European Research Council (projects 'CholangioConcepf), the German Ministry for Education and Research (BMBF) (eMed-Multiscale HCC), the German Universities Excellence Initiative (third funding line: 'future concept'), the German Center for Translational Cancer Research (DKTK) and the German-Israeli Cooperation in Cancer Research (DKFZ-MOST).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Avila JL, 2013, TRENDS MOL MED, V19, P320, DOI 10.1016/j.molmed.2013.03.003; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Caldwell ME, 2012, ONCOGENE, V31, P1599, DOI 10.1038/onc.2011.350; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cui H, 2013, CANCER RES, V73, P3451, DOI 10.1158/0008-5472.CAN-12-3902; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520; Huggins CJ, 2013, MOL CELL BIOL, V33, P3242, DOI 10.1128/MCB.01674-12; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kagawa S, 2015, ONCOGENE, V34, P2347, DOI 10.1038/onc.2014.169; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kirschner K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005053; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee WY, 2008, J HEPATOL, V48, P504, DOI 10.1016/j.jhep.2007.12.005; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Nakazato Y, 1998, KIDNEY INT, V54, P71, DOI 10.1046/j.1523-1755.1998.00967.x; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Pitt LA, 2015, CANCER CELL, V27, P755, DOI 10.1016/j.ccell.2015.05.002; Procopio MG, 2015, NAT CELL BIOL, V17, P1193, DOI 10.1038/ncb3228; Shetty S, 2014, JOVE-J VIS EXP, DOI 10.3791/51330; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Weekes MP, 2013, SCIENCE, V340, P199, DOI 10.1126/science.1235047; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	48	241	248	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2016	18	9					979	992		10.1038/ncb3397	http://dx.doi.org/10.1038/ncb3397			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DU7TF	27525720	Green Accepted, Green Submitted			2022-12-25	WOS:000382416800008
J	Scott, EM; Halees, A; Itan, Y; Spencer, EG; He, Y; Azab, MA; Gabriel, SB; Belkadi, A; Boisson, B; Abel, L; Clark, AG; Alkurayal, FS; Casanova, JL; Gleeson, JG				Scott, Eric M.; Halees, Anason; Itan, Yuval; Spencer, Emily G.; He, Yupeng; Azab, Mostafa Abdellateef; Gabriel, Stacey B.; Belkadi, Aziz; Boisson, Bertrand; Abel, Laurent; Clark, Andrew G.; Alkurayal, Fowzan S.; Casanova, Jean-Laurent; Gleeson, Joseph G.		Greater Middle East Variome	Characterization of Greater Middle Eastern genetic variation for enhanced disease gene iscovery	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EXOME SEQUENCING DATA; HUMAN-POPULATIONS; SPASTIC PARAPLEGIA; NORTH-AFRICA; CONSANGUINITY; HOMOZYGOSITY; MUTATIONS; NEANDERTHAL; DISORDERS	The Greater Middle East (GME) has been a central hub of human migration and population admixture. The tradition of consanguinity, variably practiced in the Persian Gulf region, North Africa, and Central Asia(1-3), has resulted in an elevated burden of recessive disease(4). Here we generated a whole-exome GME variome from 1,111 unrelated subjects. We detected substantial diversity and admixture in continental and subregional populations, corresponding to several ancient founder populations with little evidence of bottlenecks. Measured consanguinity rates were an order of magnitude above those in other sampled populations, and the GME population exhibited an increased burden of runs of homozygosity (ROHs) but showed no evidence for reduced burden of deleterious variation due to classically theorized 'genetic purging'. Applying this database to unsolved recessive conditions in the GME population reduced the number of potential disease-causing variants by four-to sevenfold. These results show variegated genetic architecture in GME populations and support future human genetic discoveries in Mendelian and population genetics.	[Scott, Eric M.; Spencer, Emily G.; He, Yupeng; Azab, Mostafa Abdellateef; Casanova, Jean-Laurent; Gleeson, Joseph G.] Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA; [Scott, Eric M.; Spencer, Emily G.; He, Yupeng; Azab, Mostafa Abdellateef; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, Rady Childrens Inst Genom Med, Dept Neurosci, San Diego, CA 92103 USA; [Scott, Eric M.; Spencer, Emily G.; He, Yupeng; Azab, Mostafa Abdellateef; Gleeson, Joseph G.] Rockefeller Univ, Lab Pediat Brain Dis, 1230 York Ave, New York, NY 10021 USA; [Halees, Anason] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh, Saudi Arabia; [Halees, Anason; Alkurayal, Fowzan S.] Res Ctr, Riyadh, Saudi Arabia; [Itan, Yuval; Boisson, Bertrand; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Gabriel, Stacey B.] MIT, Broad Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gabriel, Stacey B.] Harvard, Cambridge, MA USA; [Belkadi, Aziz; Boisson, Bertrand; Abel, Laurent; Casanova, Jean-Laurent] Necker Hosp Sick Children, INSERM, INSERM U1163, Lab Human Genet Infect Dis, Paris, France; [Belkadi, Aziz; Boisson, Bertrand; Abel, Laurent; Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, Paris, France; [Clark, Andrew G.] Cornell Univ, Dept Biol Stat & Computat Biol, Dept Mol Biol & Genet, Ithaca, NY USA; [Alkurayal, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia; [Alkurayal, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh, Saudi Arabia	Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California San Diego; Rockefeller University; King Faisal Specialist Hospital & Research Center; Rockefeller University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Cornell University; King Faisal Specialist Hospital & Research Center; Alfaisal University	Gleeson, JG (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.; Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Rady Childrens Inst Genom Med, Dept Neurosci, San Diego, CA 92103 USA.; Gleeson, JG (corresponding author), Rockefeller Univ, Lab Pediat Brain Dis, 1230 York Ave, New York, NY 10021 USA.	jogleeson@rockefeller.edn	Condino-Neto, Antonio/D-4762-2012; Abel, Laurent/H-8888-2017; YESIL, GOZDE/ABE-1615-2020; Egritas Gurkan, Odul/O-1363-2016; Cobat, Aurélie/H-4722-2017; Nampoothiri, Sheela/AAQ-4854-2021; KM, Girisha/AAK-6867-2020; Emiroğlu, Melike/AAH-3566-2019; Wang, Guilin/G-8794-2018; Boisson-Dupuis, Stéphanie/I-2040-2017; Boisson, Bertrand/AAC-6058-2019; mahdaviani, alireza/G-3256-2017; Mahlaoui, Nizar/J-7928-2017; Zhang, Shen-Ying/I-2685-2017; Jouanguy, Emmanuelle/H-7901-2017; Casanova, Jean-Laurent/I-3418-2017; mansouri, davood/G-6471-2017; adimi-naghan, parisa/G-5849-2017; Bustamante, Jacinta/H-7877-2017; Boisson, Bertrand/I-2485-2017; MAHLAOUI, Nizar/AAH-6103-2020; RAOULT, Didier/A-8434-2008; Puel, Anne/H-7305-2017; Cakmak Celik, Fatma/AAH-4077-2021; Gezdirici, Alper/W-8459-2018; Rezaei, Nima/B-4245-2008	Condino-Neto, Antonio/0000-0002-1069-3117; Abel, Laurent/0000-0001-7016-6493; YESIL, GOZDE/0000-0003-1964-6306; Egritas Gurkan, Odul/0000-0003-0230-7551; Cobat, Aurélie/0000-0001-7209-6257; Nampoothiri, Sheela/0000-0002-9575-0722; KM, Girisha/0000-0002-0139-8239; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Boisson, Bertrand/0000-0001-5240-3555; mahdaviani, alireza/0000-0001-6224-4797; Mahlaoui, Nizar/0000-0002-0030-8094; Zhang, Shen-Ying/0000-0002-9449-3672; Jouanguy, Emmanuelle/0000-0002-7358-9157; mansouri, davood/0000-0002-0564-8282; adimi-naghan, parisa/0000-0002-4201-2822; Bustamante, Jacinta/0000-0002-3439-2482; Boisson, Bertrand/0000-0001-5240-3555; MAHLAOUI, Nizar/0000-0002-0030-8094; RAOULT, Didier/0000-0002-0633-5974; Puel, Anne/0000-0003-2603-0323; Cakmak Celik, Fatma/0000-0002-6833-9786; Selim, laila/0000-0002-6548-6545; Tuysuz, Beyhan/0000-0002-9620-5021; Casanova, Jean-Laurent/0000-0002-7782-4169; Zaki, Maha/0000-0001-7840-0002; Gezdirici, Alper/0000-0002-2432-9279; Halees, Anason/0000-0001-5880-7067; Houshmand, Massoud/0000-0002-2198-223X; Clark, Andrew/0000-0001-7159-8511; Dogu, Figen/0000-0002-7869-4941; Yuksel, Adnan/0000-0002-7275-8254; , Masoud/0000-0001-7687-7464; Spencer, Emily/0000-0003-2650-4357; Rezaei, Nima/0000-0002-3836-1827; kilic, sara sebnem/0000-0001-8571-2581; Alhashem, Amal/0000-0002-9668-7809; Kariminejad, Ariana/0000-0002-8467-4728; Valente, Enza Maria/0000-0002-0600-6820; , NeerjaG/0000-0001-9640-4728; Aksu, Guzide/0000-0003-2714-0903; kissani, najib/0000-0002-8105-5622; El Ruby, Mona/0000-0001-7171-341X; MEKKI, NAJLA/0000-0002-5842-9147; Emiroglu, Melike/0000-0003-1307-0246; Mikati, Mohamad/0000-0003-0363-8715	US National Institutes of Health [P01HD070494, R01NS048453]; Qatari National Research Foundation [NPRP6-1463]; Simons Foundation Autism Research Initiative [175303, 275275]; Yale Center for Mendelian Disorders [U54HG006504]; Broad Institute [U54HG003067]; Rockefeller University CTSA [5UL1RR024143-04]; Howard Hughes Medical Institute; INSERM; St. Giles Foundation; Candidoser Association [R01AI088364, R37AI095983, P01AI061093, U01AI109697, U01AI088685, R21AI107508]; DHFMR Collaborative Research Grant; KACST [13-BIO1113-20]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001866, UL1TR000043] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107508, U01AI088685, R01AI088364, R37AI095983, U01AI109697, P01AI061093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, P30NS047101] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatari National Research Foundation; Simons Foundation Autism Research Initiative; Yale Center for Mendelian Disorders; Broad Institute; Rockefeller University CTSA; Howard Hughes Medical Institute(Howard Hughes Medical Institute); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); St. Giles Foundation; Candidoser Association; DHFMR Collaborative Research Grant; KACST; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank S. Sunyaev and D. Reich for help with PolyPhen-2 and DAF corrections, M. Turchin for help with purging analysis, J. Pickrell for help with TreeMix, and V. Bafna, N. Schork, and S. Bonissone for suggestions. Work was supported by grants from the US National Institutes of Health (P01HD070494 and R01NS048453), the Qatari National Research Foundation (NPRP6-1463), the Simons Foundation Autism Research Initiative (175303 and 275275) to J.G.G., the Yale Center for Mendelian Disorders (U54HG006504), the Broad Institute (U54HG003067), the Rockefeller University CTSA (5UL1RR024143-04), the Howard Hughes Medical Institute (to J.G.G. and J.-L.C.), INSERM, the St. Giles Foundation, and the Candidoser Association and by grants R01AI088364, R37AI095983, P01AI061093, U01AI109697 (to J.-L.C.), U01AI088685 (to J.-L.C. and L.A.), R21AI107508 (to E. Jouanguy), the DHFMR Collaborative Research Grant, and KACST 13-BIO1113-20 (to F.S.A.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Gazali L, 2006, BMJ-BRIT MED J, V333, P831, DOI 10.1136/bmj.38982.704931.AE; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alsalem AB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004030; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anwar WA, 2014, EUR J PUBLIC HEALTH, V24, P57, DOI 10.1093/eurpub/cku104; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Cann HM, 2002, SCIENCE, V296, P261; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Do R, 2015, NAT GENET, V47, P126, DOI 10.1038/ng.3186; Erichsen AK, 2009, BRAIN, V132, P1577, DOI 10.1093/brain/awp056; Estrada K, 2014, JAMA-J AM MED ASSOC, V311, P2305, DOI 10.1001/jama.2014.6511; Gerard N, 2006, HUM BIOL, V78, P307, DOI 10.1353/hub.2006.0045; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; Hussain R, 1998, J BIOSOC SCI, V30, P261, DOI 10.1017/S0021932098002612; Itan Y, 2015, P NATL ACAD SCI USA, V112, P11426, DOI 10.1073/pnas.1515057112; Jones S., 2011, DARWIN ARCHIPELAGO; Leutenegger AL, 2011, EUR J HUM GENET, V19, P583, DOI 10.1038/ejhg.2010.205; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lowery RK, 2013, GENE, V530, P83, DOI 10.1016/j.gene.2013.06.005; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Magi A, 2014, BIOINFORMATICS, V30, P2852, DOI 10.1093/bioinformatics/btu401; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Overall ADJ, 2002, HEREDITY, V88, P474, DOI 10.1038/sj/hdy/6800090; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pippucci T, 2014, HUM HERED, V77, P63, DOI 10.1159/000362412; Polasek O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-139; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ravindranath V, 2015, NATURE, V527, pS198, DOI 10.1038/nature16036; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; SHAMI SA, 1991, LANCET, V338, P954, DOI 10.1016/0140-6736(91)91828-I; Sharp J., 2005, CRS REP C; Sheffield VC, 1998, TRENDS GENET, V14, P391, DOI 10.1016/S0168-9525(98)01556-X; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Stevanin G, 2008, BRAIN, V131, P772, DOI 10.1093/brain/awm293; Stoltenberg C, 1997, AM J EPIDEMIOL, V145, P439; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Szpiech ZA, 2013, AM J HUM GENET, V93, P90, DOI 10.1016/j.ajhg.2013.05.003; Tadmouri Ghazi O, 2009, Reprod Health, V6, P17, DOI 10.1186/1742-4755-6-17; Vardi-Saliternik R, 2002, ANN HUM BIOL, V29, P422, DOI 10.1080/03014460110100928; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang SG, 2013, GENOME BIOL EVOL, V5, P2075, DOI 10.1093/gbe/evt160; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828	68	205	206	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1071	+		10.1038/ng.3592	http://dx.doi.org/10.1038/ng.3592			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27428751	Green Submitted, Green Accepted			2022-12-25	WOS:000382398800020
J	Sun, ZQ; Tseng, HY; Tan, S; Senger, F; Kurzawa, L; Dedden, D; Mizuno, N; Wasik, AA; Thery, M; Dunn, AR; Fassler, R				Sun, Zhiqi; Tseng, Hui-Yuan; Tan, Steven; Senger, Fabrice; Kurzawa, Laetitia; Dedden, Dirk; Mizuno, Naoko; Wasik, Anita A.; Thery, Manuel; Dunn, Alexander R.; Faessler, Reinhard			Kank2 activates talin, reduces force transduction across integrins and induces central adhesion formation	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESIONS; CELL-ADHESION; MYOSIN-II; DYNAMICS; ACTIN; RIAM; VINCULIN; BETA(1); FIBROBLASTS; RECRUITMENT	Integrin-based adhesions play critical roles in cell migration. Talin activates integrins and flexibly connects integrins to the actomyosin cytoskeleton, thereby serving as a 'molecular clutch' that transmits forces to the extracellular matrix to drive cell migration. Here we identify the evolutionarily conserved Kank protein family as novel components of focal adhesions (FAs). Kank proteins accumulate at the lateral border of FAs, which we term the FA belt, and in central sliding adhesions, where they directly bind the talin rod domain through the Kank amino-terminal (KN) motif and induce talin and integrin activation. In addition, Kank proteins diminish the talin-actomyosin linkage, which curbs force transmission across integrins, leading to reduced integrin-ligand bond strength, slippage between integrin and ligand, central adhesion formation and sliding, and reduced cell migration speed. Our data identify Kank proteins as talin activators that decrease the grip between the integrin-talin complex and actomyosin to regulate cell migration velocity.	[Sun, Zhiqi; Tseng, Hui-Yuan; Dedden, Dirk; Mizuno, Naoko; Wasik, Anita A.; Faessler, Reinhard] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Tan, Steven; Dunn, Alexander R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Senger, Fabrice; Kurzawa, Laetitia; Thery, Manuel] CEA INRA CNRS Univ, CytoMorpho Lab, Biosci & Biotechnol Inst Grenoble, UMR5168, F-38054 Grenoble, France	Max Planck Society; Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Fassler, R (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de	Sun, Zhiqi/E-9303-2012; Mizuno, Naoko/AAY-1926-2021	Sun, Zhiqi/0000-0002-2792-2158; Mizuno, Naoko/0000-0002-1594-2821; Senger, Fabrice/0000-0002-3391-2044	National Institutes of Health [R01GM112998]; Stanford Graduate Fellowship; EEC; DFG; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); EEC; DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Nagaraj for technical support, and C. Grashoff, O. Rosslier, G. Giannone and R. Bottcher for discussions and reading of the manuscript. The work was supported by the National Institutes of Health R01GM112998 (to A.R.D.), Stanford Graduate Fellowship (to S.T.) and EEC, DFG and Max Planck Society (to R.F.).	Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Austen K, 2015, NAT CELL BIOL, V17, P1597, DOI 10.1038/ncb3268; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Case LB, 2015, NAT CELL BIOL, V17, P955, DOI 10.1038/ncb3191; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chang YC, 2014, STRUCTURE, V22, P1810, DOI 10.1016/j.str.2014.09.020; Comrie WA, 2015, J CELL BIOL, V208, P475, DOI 10.1083/jcb.201406121; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Ding M, 2003, DEVELOPMENT, V130, P5791, DOI 10.1242/dev.00791; Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI 10.1172/JCI79504; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2013, J STRUCT BIOL, V184, P21, DOI 10.1016/j.jsb.2013.05.014; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Himmel M, 2009, J BIOL CHEM, V284, P13832, DOI 10.1074/jbc.M900266200; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Ihara S, 2011, NAT CELL BIOL, V13, P641, DOI 10.1038/ncb2233; Iskratsch T, 2013, DEV CELL, V27, P545, DOI 10.1016/j.devcel.2013.11.003; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Klapproth S, 2015, BLOOD, V126, P2704, DOI 10.1182/blood-2015-05-647453; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Legate KR, 2012, J CELL SCI, V125, P5636, DOI 10.1242/jcs.102145; Legate KR, 2011, EMBO J, V30, P4539, DOI 10.1038/emboj.2011.332; Lerer I, 2005, HUM MOL GENET, V14, P3911, DOI 10.1093/hmg/ddi415; Medves S, 2011, HAEMATOL-HEMATOL J, V96, P1406, DOI 10.3324/haematol.2011.040147; Morimatsu M, 2015, NANO LETT, V15, P2220, DOI 10.1021/nl5047335; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Song XQ, 2012, CELL RES, V22, P1533, DOI 10.1038/cr.2012.97; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Stritt S, 2015, BLOOD, V125, P219, DOI 10.1182/blood-2014-08-597542; Theodosiou M, 2016, ELIFE, V5, DOI 10.7554/eLife.10130; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; van der Vaart B, 2013, DEV CELL, V27, P145, DOI 10.1016/j.devcel.2013.09.010; Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653; Wang XF, 2015, BIOPHYS J, V109, P2259, DOI 10.1016/j.bpj.2015.10.029; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097258; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607	48	87	90	3	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2016	18	9					941	953		10.1038/ncb3402	http://dx.doi.org/10.1038/ncb3402			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DU7TF	27548916	Green Accepted			2022-12-25	WOS:000382416800005
